PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Menon, P; Rao, SL				Menon, P; Rao, SL			Memory storage and encoding in patients with memory deficits after closed dead injury	NIMHANS JOURNAL			English	Article						closed head injuries; cognition disorders; head injuries; memory disorders; neuropsychological tests	HEAD-INJURY; DAMAGE; SCALE	We studied the storage and processing of memory in 16 patients with closed head injury who complained of memory deficits. We compared the performance of patients on several measures with that of 16 age, education and sex matched normal controls, Patients had deficient short term storage and were slower to learn. The Long term storage and retrieval were adequate. Depth of encoding and automaticity of encoding were poorer in quality though present in patients. Patients remembered better when the encoding was semantic and the retrieval cue was congruent. Storage and encoding deficits were not related. We postulate that the adequate retrieval in patients appears to involve a compensatory coping mechanism of greater mental effort.	NATL INST MENTAL HLTH & NEUROSCI,DEPT CLIN PSYCHOL,BANGALORE 560029,KARNATAKA,INDIA								BOND MR, 1975, CIBA FDN S, V34, P11; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS DN, 1975, NERV MENT DIS, V155, P350; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CERMAK LS, 1979, LEVELS PROCESSING HU, P119; CERMAK LS, 1978, BRAIN LANG, V5, P212; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; FISHER RP, 1977, J EXP PSYCHOL HUMAN, V76, P241; FOLSTEIN MF, 1973, PSYCHOL MED, V3, P479, DOI 10.1017/S0033291700054283; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Hayden M E, 1986, Adv Psychosom Med, V16, P194; HIRST W, 1985, J CLIN EXP NEUROPSYC, V7, P175; HIRST W, 1980, HDB COGNITIVE NEUROS, P369; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P292; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEVIN HS, 1977, J CONSULT CLIN PSYCH, V45, P648; MARIADAS AC, 1989, NIHMANS J, P37; MAYES AR, 1986, NEUROPSYCHOLOGIA, V24, P26; MORRIS RG, 1984, COGNITIVE NEUROPSYCH, V1, P143, DOI 10.1080/02643298408252019; NAYAK N, 1984, THESIS BANGALORE U; PAIVIO A, 1969, PSYCHOL REV, V76, P241, DOI 10.1037/h0027272; RAO SL, 1985, NIMHANS J, V3, P141; ROY BP, 1986, ARCH GEN PSYCHIAT, V43, P265; SARASWATHY NE, 1987, THESIS BANGALORE U; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74	31	2	2	0	1	NATL INST MENTAL HEALTH NEURO SCIENCES	BANGALORE	DEEMED UNIV, PO BOX 2900, BANGALORE 560 029, INDIA	0254-0886			NIMHANS J	Nimhans J.	JAN	1997	15	1					83	92					10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XM904	WOS:A1997XM90400011					2022-02-06	
J	Wright, MT; Cummings, JL; Mendez, MF; Foti, DJ				Wright, MT; Cummings, JL; Mendez, MF; Foti, DJ			Bipolar syndromes following brain trauma	NEUROCASE			English	Article						bipolar syndromes; traumatic brain injury; pathogenesis; differential diagnosis; treatment	HEAD-INJURY; SECONDARY MANIA; AFFECTIVE-DISORDER; LITHIUM; LESIONS; DEPRESSION; ILLNESS; STATE	A number of illnesses can produce mood abnormalities. Case reports suggest that syndromes resembling idiopathic bipolar disorders can follow traumatic brain injuries (TBI). We describe a TBI patient who developed episodes of depression and mania after his injuries and review the recent literature on posttraumatic bipolar syndromes. While unipolar depression is common after TBI, bipolar syndromes occur in only a small segment of the TBI population. A bipolar syndrome can appear immediately after a TBI or after a delay of months or years. Patients with post-traumatic mania are often irritable and aggressive. Factors that may predispose a TBI patient to bipolar illness include an inherited vulnerability to mood disorders, preexistent frontal subcortical and diencephalic atrophy, and post-traumatic seizures. Studies of patients who developed a bipolar syndrome after a brain insult show a preponderance of right hemisphere lesions, particularly right orbitofrontal and basotemporal cortical, caudate and thalamic lesions. Right cortical lesions can produce unipolar mania, and right subcortical lesions can produce mania and depression. Right basotemporal cortical dysfunction may play an important role in both primary and post-traumatic bipolar syndromes. Patients with post-traumatic bipolar syndromes can be treated effectively with medication or electroconvulsive therapy.	UNIV CALIF LOS ANGELES, SCH MED, DEPT NEUROL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT PSYCHIAT & BIOBEHAV SCI, LOS ANGELES, CA 90024 USA; W LOS ANGELES VET AFFAIRS MED CTR, PSYCHIAT SERV, BEHAV NEUROSCI SECT, LOS ANGELES, CA 90073 USA								ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 1994, Am J Psychiatry, V151, P1; BAKCHINE S, 1989, NEUROLOGY, V39, P777, DOI 10.1212/WNL.39.6.777; BAMRAH JS, 1991, BRIT J PSYCHIAT, V158, P117, DOI 10.1192/bjp.158.1.117; BRACKEN P, 1987, BRIT J PSYCHIAT, V150, P690, DOI 10.1192/bjp.150.5.690; Calabrese JR, 1996, AM J PSYCHIAT, V153, P1236; CLARK AF, 1987, BRIT J PSYCHIAT, V150, P841, DOI 10.1192/bjp.150.6.841; COHN CK, 1977, DIS NERV SYST, V38, P630; CUMMINGS JL, 1984, AM J PSYCHIAT, V141, P1084; CUMMINGS JL, 1986, PSYCHIAT CLIN N AM, V9, P293; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JOSHI P, 1985, J DEV BEHAV PEDIATR, V6, P352; KHANNA S, 1985, CAN J PSYCHIAT, V30, P236, DOI 10.1177/070674378503000325; KRAUTHAMMER C, 1978, ARCH GEN PSYCHIAT, V35, P1333; Lezak MD, 1995, NEUROPSYCHOLOGICAL A, P544; MAYBERG HS, 1988, AM J PSYCHIAT, V145, P937; MIGLIORELLI R, 1993, J NEUROPSYCH CLIN N, V5, P379; MILLER LS, 1992, J CLIN PSYCHIAT, V53, P171; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; NIZAMIE SH, 1988, ACTA PSYCHIAT SCAND, V77, P637, DOI 10.1111/j.1600-0447.1988.tb05181.x; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; RANEN NG, 1993, PHYSICIANS GUIDE MAN; RIESS H, 1987, J CLIN PSYCHIAT, V48, P29; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; Robinson Robert G., 1994, P219; SANTOS AB, 1992, J CLIN PSYCHIAT, V53, P377; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; SILVER JM, 1992, TXB NEUROPSYCHIATRY, P363; SINANAN K, 1984, BRIT J PSYCHIAT, V144, P330, DOI 10.1192/bjp.144.3.330; STARKSTEIN SE, 1991, BIOL PSYCHIAT, V29, P149, DOI 10.1016/0006-3223(91)90043-L; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; STARKSTEIN SE, 1987, ARCH NEUROL-CHICAGO, V44, P1069, DOI 10.1001/archneur.1987.00520220065019; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; STARKSTEIN SE, 1988, BRAIN RES, V473, P74, DOI 10.1016/0006-8993(88)90317-4; STARKSTEIN SE, 1989, BRIT J PSYCHIAT, V154, P170, DOI 10.1192/bjp.154.2.170; STEWART JT, 1988, J CLIN PSYCHIAT, V49, P74; YATHAM LN, 1988, ACTA PSYCHIAT SCAND, V77, P359, DOI 10.1111/j.1600-0447.1988.tb05135.x; ZWIL AS, 1992, INT J PSYCHIAT MED, V22, P377, DOI 10.2190/J71J-FTML-JY1E-RKKG; ZWIL AS, 1993, BRAIN INJURY, V7, P147, DOI 10.3109/02699059309008168	43	2	2	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		1997	3	2					111	118		10.1080/13554799708404044			8	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	XL491	WOS:A1997XL49100004					2022-02-06	
J	Schweighofer, F; Schippinger, G; Peicha, G				Schweighofer, F; Schippinger, G; Peicha, G			Posterior dislocation fracture of the shoulder	CHIRURG			German	Article						shoulder; posterior dislocation; seizure	STRENGTH	Posterior dislocation fracture of the shoulder is a rare injury that often occurs in association with a grand mal seizure. Our aim with this paper is to emphasize diagnosis and therapy. In the past 5 years seven patients with nine posterior dislocation fractures were treated operatively. In six patients a grand mal seizure was the cause of the injury and in one a direct trauma. Three four-part fractures were found in two patients and six locked posterior dislocation fractures in five patients. Clinical examination in locked posterior dislocation fractures showed a lack of external rotation, and flexion was performed by movement of the scapula. Radiological examination demonstrated an overlapping of the contours of the humeral head and the glenoid and the ''trough line''. The operations were performed in the time between 4 h and 10 days later. Two of the three four-part fractures (in one patient) were treated with hemiarthroplaties, and one was fixed with screws. Closed reduction was attemted in six shoulders but was possible only in one patient. In this patient a redislocation occurred 3 days later and a combined anterior and posterior approach was done. A fracture of the anatomical neck was produced in another shoulder. Six open reductions and stabilizations with screws were performed, and three times we fixed the subscapular tendon in the reversed Hill-Sachs lesion with anchor sutures. Patients after grand mal seizures may have a posterior shoulder dislocation, and clinical and radiological examination should be emphasized. In locked posterior dislocation we favour early open reduction, fixation of the subscapular tendon with anchor sutures in the reversed Hill-Sachs lesion and stabilization of the lesser tuberosity with screws.			Schweighofer, F (corresponding author), GRAZ UNIV,UNFALLCHIRURG KLIN,AUENBRUGGERPL 7A,A-8036 GRAZ,AUSTRIA.						BARBER FA, 1993, ARTHROSCOPY, V9, P647, DOI 10.1016/S0749-8063(05)80500-6; BECKER R, 1990, UNFALLCHIRURG, V93, P66; BLATTER G, 1990, SCHWEIZ MED WSCHR, V120, P1400; CARPENTER JE, 1993, ARTHROSCOPY, V9, P109, DOI 10.1016/S0749-8063(05)80354-8; HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; Kadletz R, 1990, Unfallchirurgie, V16, P270, DOI 10.1007/BF02589881; KARPINSKI MRK, 1983, INFJRUY, V15, P274; MCLAUGHLIN HL, 1952, J BONE JOINT SURG AM, V34-A, P584, DOI 10.2106/00004623-195234030-00011; MOWERY CA, 1985, J BONE JOINT SURG AM, V67, P77; PARRISH GA, 1985, ANN EMERG MED, V14, P264, DOI 10.1016/S0196-0644(85)80453-4; Poigenfurst J, 1986, Unfallchirurgie, V12, P171, DOI 10.1007/BF02588453; ROWE CR, 1982, J BONE JOINT SURG AM, V64, P494, DOI 10.2106/00004623-198264040-00004; SCHPPINGER G, 1992, INTER J ORTHOP TRAUM, V2, P176; SHAW JL, 1971, J BONE JOINT SURG AM, VA 53, P1437, DOI 10.2106/00004623-197153070-00023; WADLINGTON VR, 1992, J TRAUMA, V32, P113, DOI 10.1097/00005373-199201000-00024	15	2	2	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0009-4722			CHIRURG	Chirurg	DEC	1996	67	12					1251	1254		10.1007/s001040050134			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WB106	WOS:A1996WB10600009	9081788				2022-02-06	
J	Zafonte, RD; Hammond, FD; Rahimi, R				Zafonte, RD; Hammond, FD; Rahimi, R			Air embolism in the agitated traumatic brain injury patient: An unusual complication	BRAIN INJURY			English	Article								Central venous catheters are often utilized in the acute care management of the traumatic brain injury (TBI) patient. While in the agitated phase of recovery, TBI patients often focus on removing indwelling tubes or venous access lines. Air embolism is among the most serious complications reported in the use of central venous catheters. We present a case of air embolism in an agitated patient, and discuss prevention methodologies. A 38-year-old male was involved in a fall, with an initial Glasgow Coma Scale of 12. CAT scan imaging revealed a left frontal intracerebral haematoma. He required central venous catheter placement for management of associated chest and abdominal injuries. Agitated from early in his stay, the patient was able to twist off several hubs from the central venous catheter with his teeth, resulting in an air embolus. The patient experienced sudden clinical deterioration with oxygen saturation decling to 70%. The patient's course improved after several days of ventilatory support. He eventually successfully completed inpatient rehabilitation, achieving independence in activities of daily living and ambulation. This case illustrates a serious potential complication in the agitated patient. Physicians and rehabilitation specialists should advocate for secured taping of central venous catheter hubs and adequate padding of catheter dressings in agitated patients.	WAYNE STATE UNIV,SCH MED,DETROIT,MI								CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DURANT THOMAS M., 1963, HEART BULL, V12, P66; FLANAGAN JP, 1969, NEW ENGL J MED, V281, P488, DOI 10.1056/NEJM196908282810907; HLAATALA M, 1979, RESP PHYSL, V36, P1; OQUIN RJ, 1982, ARCH INTERN MED, V142, P2173; ORDWAY CB, 1976, ANN SURG, V179, P479; PETERS J, 1979, ANN SURG, V179, P266	8	2	2	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1996	10	10					759	761		10.1080/026990596124025			3	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	VH730	WOS:A1996VH73000006	8879666				2022-02-06	
J	Hildebrandt, H; Zieger, A; Engel, A; Fritz, KW; vonderFecht, A				Hildebrandt, H; Zieger, A; Engel, A; Fritz, KW; vonderFecht, A			The endogenous ''Zeitgeber'' as an indicator for depth, and remission of comata	EEG-EMG-ZEITSCHRIFT FUR ELEKTROENZEPHALOGRAPHIE ELEKTROMYOGRAPHIE UND VERWANDTE GEBIETE			German	Article						come; endogenous 'Zeitgeber'; autonomous nervous system; neuromonitoring; heart rate; electromyography; electrodermal activity; spectral analysis; time-series cross-correlation	POWER SPECTRUM ANALYSIS; HEART-RATE-VARIABILITY; CARDIOVASCULAR CONTROL	Present scales for the evaluation of coma depth do not consider psychophysiological data. This is scientifically unjustified: results of chronomedical and psychophysiological studies reveal that essential autonomous functions such as heart frequency and muscle tonus are subject to periodical fluctuations which enable indications with regard to the state of the subcortical integration. And this is why endogenous 'Zeitgeber' might enable a differentiated analysis about the coma patients condition. Moreover, clinical observation of the coma depth does not allow an evaluation of the efficacy of performed rehabilitation procedures which are, on the other hand, presuppositions for their evaluation. Heart frequency, muscle tonus, and electrodermal activity were recorded under controlled conditions for 23 patients with covered traumatic brain injuries or - in a few cases - intracerebral mass bleedings. The recordings were carried out several times until the awakening from coma (91 measurements in total). The correlation between heart frequency, muscle tonus, electrodermal activity, and coma depth was analyzed. In addition, the frequency spectrum of the heart frequency was examined try a Fast Fourier Transformation and the time-series crosscorrelation between heart frequency on the one hand and muscle tonus and/or electrodermal activity on the other were analyzed. The results reveal that during the process of coma remission the integration of endogenous 'Zeitgeber' is continuously increasing. In a middle coma depth, we found a sympathetic modulation of heart frequency and an electrodermal activity, With increasing consciousness, indications for an additional parasympathetic modulation of the heart frequency and for a resumption of the cardio-somatic coupling showed up.	KLIN PARK,WILHELMSHAVEN,GERMANY		Hildebrandt, H (corresponding author), UNIV OLDENBURG,ARBEITSEINHEIT PSYCHOL GESUNDHEITSWESEN,D-26111 OLDENBURG,GERMANY.						AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; BAHARAV A, 1995, NEUROLOGY, V45, P1183, DOI 10.1212/WNL.45.6.1183; BASAR E, 1985, INT J NEUROSCI, V26, P161; BESSER R, 1983, NEUROLOGIE PRAXIS KL, V1; Birbaumer N, 1991, BIOL PSYCHOL; DELETIS V, 1990, COMA EMERGING PATIEN, V4, P421; Freeman Edward, 1993, NEUROPSYCHOL REHABIL, V3, P139; Garcia A.L., 1994, NUMERICAL METHODS PH; GELSEMA AJ, 1985, PSYCHOPHYSIOLOGY CAR, P99; HILDEBRANDT G, 1993, CHRONOBIOLOGY CHRONO, P194; JANIG W, 1987, PHYSL MENSCHEN, P349; JENNINGS JR, 1993, BIOL PSYCHOL, V35, P237, DOI 10.1016/0301-0511(93)90004-R; KEIDEL M, 1987, CHRONOBIOLOGY CHRONO, P202; LITSCHER G, 1994, EEG-EMG-Z ELEK ELEKT, V25, P200; LITSCHER G, 1994, MULTIVARIATE NICHT I; MULDER G, 1981, PSYCHOPHYSIOLOGY, V18, P392, DOI 10.1111/j.1469-8986.1981.tb02470.x; Obrist PA, 1981, CARDIOVASCULAR PSYCH; PLUM F, 1993, ABNORMAL STATES BRAI, P29; PLUM F, 1974, DIAGNOSIS STUPOR COM; POECK K, 1992, NEUROLOGIE; Pruyn A. T. H., 1985, PSYCHOPHYSIOLOGY CAR, P365; RASCHKE F, 1987, CHRONOBIOLOGY CHRONO, P164; SCHURI U, 1979, ARCH PSYCHIAT NERVEN, V227, P143; SCHURI U, 1981, PSYCHOPHYSIOLOGY, V18, P248, DOI 10.1111/j.1469-8986.1981.tb03027.x; SCHURI U, 1982, BEHAV BRAIN RES, V4, P95, DOI 10.1016/0166-4328(82)90167-X; STOBER T, 1990, NEUROKARDIOLOGIE; STROEEL CF, 1986, PSYCHIAT PRAXIS KLIN, P60; ZHONG S, 1993, AM J PHYSIOL, V265, pR1026, DOI 10.1152/ajpregu.1993.265.5.R1026; ZIEGER A, 1996, IN PRESS FALLBUCH NE; ZWIENER U, 1994, NEUROMONITORING ANAS, P17; [No title captured]	31	2	2	0	1	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0941-3790			EEG-EMG-Z ELEK ELEKT	EEG-EMG-Z. Elektroenz. Elektron. Geb.	SEP	1996	27	3					126	135					10	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	VN116	WOS:A1996VN11600004					2022-02-06	
J	Shephard, RJ				Shephard, RJ			Asphyxial death of a young skier - Case report	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						skiing; cervical injuries; emergencies; hypothermia; rewarming		Objective. Review of the cause of death in fatal downhill skiing accidents is important to prevention; this report concerns a boy found dead with his head buried in powder snow. Experimental design. Case history of an 11-year-old boy who was found dead 4 hours following descent of a steep ski slope. Setting. Treatment by mountain rescue team and hospital emergency room. Patient. A bog who was discovered immersed head first in one meter of powder snow, with no sign of an avalanche or struggling, and no vital signs. The differential diagnosis included concussion + asphyxia, cervical injury, loss of consciousness from other causes, and hypothermia. Interventions. Standard cardio-pulmonary resuscitation, rewarming by bladder irrigation and extracorporeal circulation. Results. The rectal temperature, initially 29.4 degrees C, fell further to 23.3 degrees C during evacuation in a heated ambulance. On hospital admission, a blood sample showed creatine kinase 5306 units, K+ 16 mM, pH 6.38, PaCO2 223 Torr, and PaO2 67 Torr. There was no ECG rhythm, and radiography revealed pulmonary edema but no cervical malignment. Emergency measures normalized blood gases, but did not restore cardiac action. Conclusions. Death was caused by asphyxia, secondary to mild concussion. The public needs education on the dangers of deep powder snow Adventurous skiers should wear helmets, and should not ski alone on steep mountainsides.	UNIV TORONTO,FAC MED,DEPT PREVENT MED & BIOSTAT,TORONTO,ON,CANADA; BROCK UNIV,HLTH STUDIES PROGRAMME,ST CATHARINES,ON L2S 3A1,CANADA		Shephard, RJ (corresponding author), UNIV TORONTO,SCH PHYS & HLTH EDUC,320 HURON ST,TORONTO,ON M5S 1A1,CANADA.						FRIM J, 1985, CURRENT THERAPY SPOR, P40; Hurst JW, 1974, HEART; KERR DJA, 1946, FORENSIC MED; Kizer KM, 1994, PHYSICIAN SPORTSMED, V22, P49; Lexow K, 1991, Arctic Med Res, V50 Suppl 6, P112; PANDOLF KB, 1988, HUMAN PERFORMANCE PH, P450; SCHALLER MD, 1990, JAMA-J AM MED ASSOC, V264, P1842, DOI 10.1001/jama.264.14.1842; SHEPHARD RJ, 1985, CURRENT THERAPY SPOR, P39; STALSBERG H, 1989, VIRCHOWS ARCH A, V414, P415, DOI 10.1007/BF00718625; TOUGH SC, 1993, AM J FOREN MED PATH, V14, P12, DOI 10.1097/00000433-199303000-00003; VALLERAND A, 1995, CURRENT THERAPY SPOR, P582; WEDIN B, 1976, CIRCUMPOLAR HLTH, P61	12	2	2	0	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707			J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	SEP	1996	36	3					223	227					5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	VW193	WOS:A1996VW19300011	8979653				2022-02-06	
J	Voogt, RD				Voogt, RD			Quality of life: An aspect of life care planning and long-term care	NEUROREHABILITATION			English	Article						life care planning; long-term care; psycho-social issues; executive functions	BRAIN INJURY	Traumatic brain injury (TBI) has a devastating effect on all aspects of a person's life, which negatively impacts the individual's quality of life. Indeed, the individual is not the same person following TBI. However, through systematic life care planning and appropriate long-term care, this negative impact can be mitigated.			Voogt, RD (corresponding author), ROBERT VOOGT & ASSOCIATES INC,REHABIL CONSULTANTS,3524 CANAL ST,NEW ORLEANS,LA 70119, USA.						BAUER C, 1992, J COGNIT REHABIL, V10, P8; BRAY G, 1987, REHABIL PSYCHOL, P171; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROOKS N, 1986, J NEUR NEUROSURG PSY, V49, P756; DEJONGSTE AB, 1990, PHLEBOLOGY S, V5, P21; EASTON K, 1985, PED REHABILITATION, P99; Goldman-Rakic P. S., 1993, J HEAD TRAUMA REHAB, V8, P13; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; LEHR E, 1990, REHABILITATION I CHI, P137; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; MCMORDIE WR, 1988, BRAIN INJURY, V12, P357; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; RIMEL RW, 1981, NEUROSURGERY, V9, P222; Rosenthal M, 1987, REHABIL PSYCHOL, P37; SCHMIDT MF, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199508000-00003; SMITH S, 1994, ANAL UNDERSTANDING P, P429; STTUSS D, 1986, FRONTAL LOBES; THOMAS R, 1995, INSIDE LIFE CARE PLA, V1, P1; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VARNEY N, 1991, NEUROPSYCHOLOGY, V5, P223; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; VOOGT R, 1994, ANAL UNDERSTANDING P, P25; VOOGT R, 1994, NAT HEAD INJURY FOUN, P229; VOOGT R, 1990, AM J PROOF FACTS, P37; WHYTE J, 1988, REHABILITATION MED P, P585; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; [No title captured]	29	2	2	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	SEP	1996	7	2					95	117		10.1016/1053-8135(96)00183-7			23	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VK756	WOS:A1996VK75600003	24525849				2022-02-06	
J	MacDonald, S; Johnson, CJ				MacDonald, S; Johnson, CJ			Utility of a verbal reasoning test in indicating vocational readiness following traumatic brain injury	BRAIN INJURY			English	Article								Present tests are often inadequate to assess subtle aspects of cognitive-communicative functioning following traumatic brain injury (TBI), making it difficult to predict vocational readiness, particularly for those in professional occupations. This study examined the viability of the Ross Test of Higher Cognitive Processes (RTHCP) as a measure of verbal reasoning deficits following TBI. The verbal reasoning performance of a 43-year-old lawyer with TBI was compared, at two stages in his rehabilitation, to that of a peer group of lawyers (n = 43). The RTHCP detected noticeable differences in speed and accuracy of performance at different stages of recovery. The RTHCP also revealed individual differences among the peer group, who presumably were competent in verbal reasoning. Thus, the RTHCP may be an effective tool to measure subtle deficits in verbal reasoning post-TBI. Some cautions in using this test for the TBI population are presented, as well as suggestions for further test development and validation.	UNIV TORONTO, TORONTO, ON, CANADA		MacDonald, S (corresponding author), ST MICHAELS HOSP, DEPT SPEECH PATHOL, 30 BOND ST, TORONTO, ON M5B 1W8, CANADA.						BAXTER R, 1985, HEAD INJURY REHABILI, P247; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; DEPOMPEI R, 1988, J HEAD TRAUMA REHAB, V3, P13; Freund J, 1994, COGNITIVE COMMUNICAT; GROHER ME, 1990, REHABILITATION ADULT, P294; HAGEN C, 1979, AM SPEECH LANG HEAR; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HARTLEY L, 1989, J SPEECH LANGUAGE PA, V13, P51; Helm-Estabrooks N., 1990, BRIEF TEST HEAD INJU; Jennett B, 1981, MANAGEMENT HEAD INJU; KAY T, 1987, MINOR HEAD INJURY IN; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; MARQUARDT TP, 1988, J LEARN DISABIL, V21, P340, DOI 10.1177/002221948802100605; MILTON SB, 1991, J HEAD TRAUMA REHAB, V6, P35; POSTHUMA A, 1988, COGNITIVE REHABILITA, V2, P2; ROSS J, 1982, ROSS TEST HIGHER COG; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; STUSS DT, 1987, BNI Q, V3, P28; Szekeres S. F., 1987, COMMUNITY REENTRY HE COMMUNITY REENTRY HE, P87; Ylvisaker M., 1994, LANGUAGE INTERVENTIO, P546	20	2	2	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1996	10	7					531	542		10.1080/026990596124241			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UU819	WOS:A1996UU81900006	8806013				2022-02-06	
J	Garner, RL				Garner, RL			The NAT model: Factors in neuropsychological art therapy	AMERICAN JOURNAL OF ART THERAPY			English	Article							BRAIN	Although the use of art therapy with individuals with traumatic brain injury (TBI) has generally been neglected, the application of art therapy in neuropsychological settings supports the development of a neuropsychological art therapy (NAT) model. The NAT model proposed here is based in cognitive-interaction theory, placing emphasis on environmental factors and the need to develop approaches that incorporate an understanding of cognitive, psychological, and neurological processes. A knowledge of developmental and behavioral approaches is also important in the use of art therapy with individuals with TBI; and social support and environment are seen as influential in the success or failure of therapy. The NAT model is intended to provide a foundation upon which art therapists can construct approaches relevant to the deficits of a given individual.	FLORIDA STATE UNIV,TALLAHASSEE,FL 32306; HEALTHSOUTH REHABIL HOSP,TALLAHASSEE,FL								Achterberg J., 1984, IMAGERY DIS; CHEYNEKING SE, 1990, ART PSYCHOTHER, V17, P69, DOI 10.1016/0197-4556(90)90042-O; DILLER L, 1987, NEUROPSYCHOLOGICAL R, P423; ECCLES JC, 1977, BRAIN RES, V127, P327, DOI 10.1016/0006-8993(77)90550-9; HENDRIXSON BN, 1986, AM J ART THER, V25, P15; Kaplan E., 1988, CLIN NEUROPSYCHOLOGY, P125; KINSBOURNE M, 1982, AM PSYCHOL, V37, P411, DOI 10.1037/0003-066X.37.4.411; Kolb B., 1990, FUNDAMENTALS HUMAN N; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCGRAW M, 1989, AM J ART THER, V28, P37; MISHKIN M, 1982, PHILOS T R SOC B, V298, P85, DOI 10.1098/rstb.1982.0074; Papalia D.E., 1992, HUMAN DEV; PARENTE R, 1991, RETRAINING MEMORY TE; POLDINGER W, 1987, COMPR PSYCHIAT, V28, P384, DOI 10.1016/0010-440X(87)90054-X; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; Robbins A., 1976, CREATIVE ART THERAPY; Rubin J. A., 1987, APPROACHES ART THERA; Shermis, 1992, LEARNING THEORIES TE; Springer S. P., 1989, LEFT BRAIN RIGHT BRA, V3rd; STEIN DG, 1988, CLIN NEUROPSYCHOLOGY, P9; THOMPSON RF, 1988, CLIN NEUROPSYCHOLOGY; WALD J, 1986, Clinical Gerontologist, V4, P29, DOI 10.1300/J018v04n03_05	22	2	2	0	3	AMER J ART THERAPY	MONTPELIER	VERMONT COLL OF NORWICH UNIV, MONTPELIER, VT 05602	0007-4764			AM J ART THER	Am. J. Art. Ther.	MAY	1996	34	4					107	111					5	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	UJ067	WOS:A1996UJ06700004					2022-02-06	
J	Prigatano, GP				Prigatano, GP			Neuropsychological rehabilitation after brain injury: Scientific and professional issues	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						neuropsychological rehabilitation; scientific issues; professional issues	CLOSED-HEAD-INJURY; FOLLOW-UP	Neuropsychological rehabilitation after acquired brain injury is an important contribution to our health-care system. Despite a growing database which supports its clinical utility, the insurance coverage for this form of care is now being threatened This paper addresses some of the professional and scientific issues that psychologists need to face in order to continue to provide these services.			Prigatano, GP (corresponding author), BARROW NEUROL INST,350 W THOMAS RD,PHOENIX,AZ 85013, USA.						BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Bergquist TF, 1994, J HEAD TRAUMA REHAB, V9, P50, DOI 10.1097/00001199-199412000-00007; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CHRISTENSEN AL, 1992, ACTA NEUROL SCAND, V85, P32; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; PRIGATANO GP, 1989, REHABIL PSYCHOL, V34, P135, DOI 10.1037//0090-5550.34.2.135; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1987, BNI Q, V3, P10; PRIGATANO GP, 1995, M LINKS COGN SCI ED; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RATTOK J, 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RIVARA JMB, 1994, 4 C INT ASS STUD TRA; RUTTER M, 1983, DEV NEUROPSYCHIATRY; TEASDALE TW, 1995, CTR REHABILITATION B; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260	23	2	2	0	4	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	1068-9583			J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	MAR	1996	3	1					1	10		10.1007/BF01989285			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UJ367	WOS:A1996UJ36700001	24226528				2022-02-06	
J	Harmon, RL; Hodgson, MJ; Cobb, JD				Harmon, RL; Hodgson, MJ; Cobb, JD			Trends in incidence of hospitalization for traumatic brain injury in Wisconsin from 1989 through 1992	BRAIN INJURY			English	Article							HEAD-INJURY	To aid in determining health care service needs, Wisconsin Department of Health and Social Services (DHSS) data on Wisconsin hospital discharges for traumatic brain injury (TBI), using ICD-9-CM codes for intracranial injury with and without skull fracture, and Wisconsin Department of Transportation data on incapacitating non-fatal head injuries (INHI) from traffic accidents from 1989 through 1992 were reviewed. Yearly TBI hospital discharges in Wisconsin declined 15.0%, and by 23.9% for Milwaukee County residents, over 1989 through 1992, correlating closely with changes in yearly INHI in Wisconsin (r = 0.999; p < 0.01) and in Milwaukee County (r = 0.989; p < 0.05). Using 1990 census data the yearly TBI risk ratio for Milwaukee County residents compared to the rest of Wisconsin increased from 1989 (1.76) to 1990 (1.92) and then decreased in 1991 (1.83) and 1992 (1.51). The results of this pilot study suggest there was a decrease in the incidence of hospitalization of patients with TBI in Wisconsin from 1989 through 1992, paralleling a decline in INHI from motor vehicle accidents. There appeared to be a relatively seater decline in these patients in Milwaukee County from 1991 to 1992 as compared to the rest of the state. The techniques employed in this study may be used to help assess rehabilitation service needs in other areas.	UNIV WISCONSIN,SCH MED,DEPT REHABIL MED,MADISON,WI 53792; WISCONSIN DEPT HLTH & SOCIAL SERV,DIV HLTH,MADISON,WI 53707		Harmon, RL (corresponding author), MED COLL OHIO,DEPT PHYS MED & REHABIL,POB 10008,TOLEDO,OH 43699, USA.						BARRY P, 1993, J HEAD TRAUMA REHAB, V8, P48; DIGRE PG, 1994, J HEAD TRAUMA REHAB, V9, P12; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; *FLOR HEAD SPIN CO, 1992, ANN REP; *FLOR HEAD SPIN CO, 1994, END YEAR REP; *FLOR HEAD SPIN CO, 1991, END YEAR REP; GREENBERG RS, 1993, MED EPIDEMIOLOGY; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Kraus JF, 1993, HEAD INJURY, P1; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; *US DEP COMM, 1990, CENSUS 90; WHYTE J, 1988, REHABILITATION MED P, P585; 1993, ICD9CM PRACT MAN INF, V1	13	2	2	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1996	10	2					139	144		10.1080/026990596124638			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UB726	WOS:A1996UB72600008	8696314				2022-02-06	
J	Dubois, SL; Persinger, MA				Dubois, SL; Persinger, MA			Personality profiles of women who report and who do not report physical assault or sexual harassment: Comparisons with traumatic brain injury	SOCIAL BEHAVIOR AND PERSONALITY			English	Article							UNIVERSITY-STUDENTS; TEMPORAL-LOBE; EXPERIENCE; ATTITUDES; IDENTITY; SELF	Standardized personality profiles of young, university women who reported they had been either: 1) never assaulted or harassed, 2) sexually harassed or assaulted, or 3) physically assaulted, were compared with each other and with a group of age- and educationally-matched women, who had sustained verified traumatic brain injuries; 49% of the university volunteers reported the experience of either physical or sexual assault. The groups who had reported a history of physical assault or who had sustained brain trauma, displayed significantly higher scores for scales that infer egocentricity and deviations from rule systems, relative to the group who reported no history of assault. The possibility that even mild brain trauma (from physical assault or from injury during a motor vehicle incident) can adversely affect the sense of self is discussed.	LAURENTIAN UNIV,DEPT PSYCHOL,SUDBURY,ON P3E 2C6,CANADA								BARAK A, 1992, J APPL SOC PSYCHOL, V22, P17, DOI 10.1111/j.1559-1816.1992.tb01519.x; Duckworth J. C., 1986, MMPI INTERPRETATION; LACHAR D, 1985, MMPI CLIN ASSESSMENT; MAZER DB, 1989, SEX ROLES, V20, P135, DOI 10.1007/BF00287987; MILLER L, 1993, PSYCHOTHERAPY BRAIN; MURRELL AJ, 1993, PSYCHOL WOMEN QUART, V17, P169, DOI 10.1111/j.1471-6402.1993.tb00442.x; PERSINGER MA, 1992, BRAIN COGNITION, V20, P217, DOI 10.1016/0278-2626(92)90016-F; PERSINGER MA, 1991, PERCEPT MOTOR SKILL, V73, P1244, DOI 10.2466/pms.1991.73.3f.1244; PERSINGER MA, 1994, PSYCHOL REP, V75, P1059, DOI 10.2466/pr0.1994.75.3.1059; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; POWELL GN, 1986, SEX ROLES, V14, P9, DOI 10.1007/BF00287844; RICHARDS PM, 1992, PERCEPT MOTOR SKILL, V75, P667, DOI 10.2466/PMS.75.5.667-670; TERPSTRA DE, 1986, BASIC APPLIED SOCIAL, V7, P7; VINCENT KR, 1984, MMPI168 CODEBOOK	14	2	2	0	0	SOC PERSONALITY RES INC	PALMERSTON NORTH	P O BOX 1539, PALMERSTON NORTH, NEW ZEALAND	0301-2212			SOC BEHAV PERSONAL	Soc. Behav. Pers.		1996	24	1					87	93		10.2224/sbp.1996.24.1.87			7	Psychology, Social	Social Science Citation Index (SSCI)	Psychology	TY757	WOS:A1996TY75700008					2022-02-06	
J	Ridenour, TA; McCoy, KD; Dean, RS				Ridenour, TA; McCoy, KD; Dean, RS			An exploratory stepwise discriminant function analysis of malingered and nondistorted responses to the neuropsychological symptom inventory	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						discriminating malingering; neuropsychological assessment; closed head injury	BELIEVABLE DEFICITS; INJURY	Clinicians are often asked to evaluate a patient's potential for malingering during a neuropsychological examination. This problem is particularly crucial when financial gain may hinge on the results of the assessment. Response distortion may occur even when a head injury has been verified by radiological means (e.g., MRI). Research in the identification of malingering has yet to produce results that are effective in the clinical setting. The present study addressed several shortcomings of past research with the use of a self-report symptom inventory. The responses of 242 subjects told to distort symptomology were compared to 128 nonmalingerers. A discriminant function analysis of these data produced a 90% hit rate overall with 2.3% false positives. The results were discussed in terms of clinical utility.	BALL STATE UNIV,MUNCIE,IN 47306					Ridenour, Ty/0000-0002-9709-6808			Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; BERRY DTR, 1991, CLIN PSYCHOL REV, V11, P585, DOI 10.1016/0272-7358(91)90005-F; CULLUM CM, 1991, FORENSIC NEUROPSYCHO; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HUBERTY CJ, 1984, PSYCHOL BULL, V95, P156, DOI 10.1037/0033-2909.95.1.156; KEISER L, 1968, TRAUMATIC NEUROSIS; MCCOY KD, 1993, THESIS BALL STATE U; MENSCH AJ, 1986, INT J CLIN NEUROPSYC, V8, P59; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V7; POPE HS, 1993, MMPI MMPI2 MMIPA COU; RATTAN G, 1989, NEUROPSYCHOLOGICAL S; ROGERS R, 1988, CLIN ASSESSMENT MALI; RUBINSKY EW, 1986, BEHAVIORAL SCI LAW, V4, P27; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; Schretlen D., 1992, PSYCHOL ASSESSMENT, V4, P77, DOI [10.1037/1040-3590.4.1.77, DOI 10.1037/1040-3590.4.1.77]; *SPSS, 1993, SPSS WIND; ZIELINSKI JJ, 1994, CLIN PSYCHOL-SCI PR, V1, P169, DOI 10.1111/j.1468-2850.1994.tb00018.x; 1992, AM PSYCHOL, V47, P1597	21	2	2	0	2	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1996	87	1-2					91	95		10.3109/00207459608990756			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	VQ435	WOS:A1996VQ43500008	8913822				2022-02-06	
J	Yablon, SA				Yablon, SA			Botulinum toxin A: Experience in the management of spasticity among patients with traumatic brain injury	EUROPEAN JOURNAL OF NEUROLOGY			English	Article; Proceedings Paper	2nd Botulinum Toxin Symposium - Dystonia and Beyond	MAR 18-19, 1995	CANNES, FRANCE	Allergan		spasticity; contracture; Botulinum toxin; traumatic brain injury; head injury; nerve block; phenol		A number of interventions are available to the clinician in the management of spasticity among patients with traumatic brain injury (TBI). Many of these treatment options can be used concurrently with great effectiveness. Neurolytic and chemodenervation procedures are important elements in spasticity management, and the physician will hopefully understand when these procedures can benefit appropriate patients with spasticity. Evaluation is the most important element in the management of spasticity. Regardless of the treatment modality one selects, successful outcome is contingent upon appropriate patient selection. For appropriately selected TBI patients treated with indicated doses, Botulinum toxin A (BTX-A) intramuscular chemodenervation appears safe and effective in the management of spastic hypertonia.	INST REHABIL & RES, BRAIN INJURY PROGRAM, HOUSTON, TX USA; BAYLOR COLL MED, DEPT PHYS MED & REHABIL, HOUSTON, TX USA; UNIV TEXAS, HLTH SCI CTR, DEPT PHYS MED & REHABIL, HOUSTON, TX USA								AGANA BT, 1994, ARCH PHYS MED REHAB, V75, P1063; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BARBIERI S, 1994, MOVEMENT DISORDER S1, V9, P128; BELL KR, 1990, CRITICAL REV PHYSICA, V1, P231; BIEDERMANN RE, 1993, ARCH PHYSICAL MED RE, V74, P1282; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BURGAR CG, 1994, ARCH PHYSICAL MED RE, V75, P1031; CHAN CH, 1990, NEUROLOGY, V40, P1427, DOI 10.1212/WNL.40.9.1427; Collin C, 1988, Int Disabil Stud, V10, P61; DAS TK, 1989, BRIT J CLIN PRACT, V43, P401; DAS TK, 1989, POSTGRAD MED J, V65, P208, DOI 10.1136/pgmj.65.762.208; Delagi EF., 1980, ANATOMIC GUIDE ELECT, V2nd ed; DENGLER R, 1992, J NEUROL, V239, P375; DUNNE JW, 1995, J NEUROL NEUROSUR PS, V58, P232, DOI 10.1136/jnnp.58.2.232; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; GARLAND DE, 1982, CLIN ORTHOP RELAT R, V165, P217; GRANGER CV, 1986, GUIDE USE UNIFORM DA; GRAZKO M, 1994, MOVEMENT DISORDER S1, V9, P128; HESSE S, 1994, J NEUROL NEUROSUR PS, V57, P1321, DOI 10.1136/jnnp.57.11.1321; Hesse S, 1992, J REHABIL SCI, V5, P98; HOGAN W, 1995, IN PRESS ARCH PHYSIC, V75; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; KATZ RT, 1988, AM J PHYS MED REHAB, V67, P108, DOI 10.1097/00002060-198806000-00004; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; KEENAN MAE, 1988, CLIN ORTHOP RELAT R, V233, P116; KOMAN LA, 1993, J PEDIATR ORTHOPED, V13, P489, DOI 10.1097/01241398-199307000-00013; KOMAN LA, 1992, DEV MED CHILD NE S66, V34, P23; KOSTANZER A, 1992, MOVEMENT DISORDER S1, V7, P137; Lance J.W., 1980, SPASTICITY DISORDERE, P485; LEHMKUHL LD, 1990, J HEAD TRAUMA REHAB, V5, P23, DOI DOI 10.1097/00001199-199012000-00005; Lux Warren E., 1992, Archives of Physical Medicine and Rehabilitation, V73, P1008; MEMIN B, 1992, REV NEUROL, V148, P212; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; OBRIEN CF, 1995, NEUROLOGY, V45, pA329; PIERSON SH, 1994, NEUROLOGY, V44, pA184; REEVES KD, 1992, AJPM, V2, P205; Robinson K. M., 1990, PRACTICAL MANAGEMENT, P201; ROGGENBUCK D, 1995, IN RPESS ARCH PHYSIC, V76; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; YABLON SA, 1995, IN PRESS NEUROLOGY, V45; ZUBER M, 1993, NEUROLOGY, V43, P1715, DOI 10.1212/WNL.43.9.1715; [No title captured]	45	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	NOV	1995	2			3			47	55					9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	TU596	WOS:A1995TU59600009					2022-02-06	
J	CALLAHAN, CD; HAGGLUND, KJ				CALLAHAN, CD; HAGGLUND, KJ			COMPARING NEUROPSYCHOLOGICAL AND PSYCHIATRIC EVALUATION OF COMPETENCE IN REHABILITATION - A CASE EXAMPLE	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SPINAL-CORD INJURY; CONSENT; ASSESSMENTS; DEFICITS; MODEL	This report describes the case of a 20-year-old man who sustained a gunshot wound to the forehead, resulting in traumatic brain injury and C2 ventilator-dependent quadriplegia. Issues of personal control and autonomy typified his psychological adjustment. The question of competency to refuse medical treatment arose when he disallowed intervention for a suspected ear infection not confirmed by culture. Subsequently, the patient was alternately described as incompetent by a psychiatrist and competent by a medical ethics review panel. These decisions are interpreted within the context of existing medical-legal literature and historical precedent of competency in civil law. Central to competency evaluation is the patient's ability to recognize that a decision-making process is required, to review the pros and cons of various options, and to communicate a decision. Importantly, this decision need not be in accordance with the opinion of family or the health care team. Neuropsychological screening indicated the patient's cognitive abilities were within functional limits, and he subsequently agreed to treatment after experiencing pain and fever, and learning of a positive culture. It is concluded that a two-pronged neuropsychological evaluation of competency based on the patient's information processing capabilities is most appropriate in medical rehabilitation settings. (C) 1995 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation	UNIV MISSOURI,SCH MED,DEPT PHYS MED & REHABIL,DIV CLIN HLTH PSYCHOL & NEUROPSYCHOL,COLUMBIA,MO 65211		CALLAHAN, CD (corresponding author), MEM MED CTR,DEPT PSYCHOL,800 N RUTLEDGE ST,SPRINGFIELD,IL 62781, USA.		Hagglund, Kristofer/AAD-9871-2020	Hagglund, Kristofer/0000-0001-7748-7492			AFFLECK G, 1987, J PERS SOC PSYCHOL, V53, P273, DOI 10.1037/0022-3514.53.2.273; ALEXANDER MP, 1988, ARCH NEUROL-CHICAGO, V45, P23, DOI 10.1001/archneur.1988.00520250029013; BUCKELEW SP, 1991, PARAPLEGIA, V29, P125, DOI 10.1038/sc.1991.17; CALLAHAN CD, 1994, J CLIN PSYCHOL MED S, V1, P261, DOI 10.1007/BF01989627; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DRANE JF, 1984, JAMA-J AM MED ASSOC, V252, P925, DOI 10.1001/jama.252.7.925; FARNSWORTH MG, 1990, PSYCHOSOMATICS, V31, P60, DOI 10.1016/S0033-3182(90)72218-9; FARNSWORTH MG, 1989, AM FAM PHYSICIAN, V39, P182; FRANK RG, 1987, J REHABIL, V513, P43; FREEDMAN M, 1991, ANN INTERN MED, V115, P203, DOI 10.7326/0003-4819-115-3-203; HAFFEY WJ, 1989, J HEAD TRAUMA REHAB, V4, P43, DOI DOI 10.1097/00001199-198903000-00007; HUNDERT EM, 1987, AM J PSYCHIAT, V144, P839; KAPLAN KH, 1988, GEN HOSP PSYCHIAT, V10, P385, DOI 10.1016/0163-8343(88)90060-6; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; LIPPERT GP, 1988, CAN J PSYCHIAT, V33, P250, DOI 10.1177/070674378803300403; MAHLER J, 1988, HOSP COMMUNITY PSYCH, V39, P856; MCKINNON K, 1989, HOSP COMMUNITY PSYCH, V40, P1159; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Melton G. B., 1987, PSYCHOL EVALUATIONS; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; RICHARDS PM, 1989, J CONSULT CLIN PSYCH, V57, P396, DOI 10.1037/0022-006X.57.3.396; SWEET JJ, 1992, CLIN PSYCHOL REV, V12, P21, DOI 10.1016/0272-7358(92)90090-U; TEPPER AM, 1984, LAW HUMAN BEHAV, V8, P205, DOI 10.1007/BF01044693; WALLSTON KA, 1987, CURR PSYCHOL RES REV, V6, P5, DOI 10.1007/BF02686633	24	2	2	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	1995	76	10					909	912		10.1016/S0003-9993(95)80065-4			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	RY975	WOS:A1995RY97500004	7487429				2022-02-06	
J	GERVASIO, AH; MATTHIES, BK				GERVASIO, AH; MATTHIES, BK			BEHAVIORAL-MANAGEMENT OF AGITATION IN THE TRAUMATICALLY BRAIN-INJURED PERSON	NEUROREHABILITATION			English	Article						TRAUMATIC BRAIN INJURY; AGITATION; AGGRESSION; BEHAVIOR THERAPY; MANAGEMENT		This paper outlines general management strategies used to prevent and control agitation throughout the continuum of recovery from traumatic brain injury. These include environmental management, alterations in the behavior of staff and family, use of physical and chemical restraints, redirection and substitution, time out, operant procedures, self monitoring and relaxation training. The need for both flexibility in choice of strategies and consistency in application is emphasized, along with the importance of staff training and patient and family participation.			GERVASIO, AH (corresponding author), VIRGINIA COMMONWEALTH UNIV MED COLL VIRGINIA,CTR REHABIL & RES,MCV STN,BOX 980661,RICHMOND,VA 23298, USA.						Bernstein D., 1973, PROGR RELAXATION TRA; BERROL S, 1988, ARCH PHYS MED REHAB, V69, P537; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BRIGMAN C, 1983, AM J NURS, V83, P1408; BROOKS N, 1984, CLOSED HEAD INJURY P; COHENMANSFIELD J, 1989, J GERONTOL, V44, P77; COPE DN, 1986, J HEAD TRAUMA REHAB, V1, P34; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; Diehl L. N., 1983, REHABILITATION HEAD; HAFFEY WJ, 1990, NEUROPSYCHOLOGICAL T, pCH13; HAGEN C, 1979, PROFESSIONAL STAFF A, P87; Herbel K, 1990, Rehabil Nurs, V15, P66; HOWARD M, 1983, ED TRAINING CTR; LONG DF, 1989, NEUROPSYCHOLOGICAL T, P39; MALKMUS D, 1980, PROFESSIONAL STAFF A; MARTIN G, 1992, BEHAVIOR MODIFICATIO; Patterson T S, 1990, Rehabil Nurs, V15, P248; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; PYLAR PA, 1989, J NEUROSCI NURS, V21, P353; RIMM D, 1979, BEHAVIOR THERAPY TEC; Stevenson S, 1991, J Psychosoc Nurs Ment Health Serv, V29, P6; Williams L M, 1990, Rehabil Nurs, V15, P30; WOOD R, 1988, J HEAD TRAUMA REHAB, V3, P53	24	2	2	0	2	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	OCT	1995	5	4					309	316		10.1016/1053-8135(95)00130-1			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ211	WOS:A1995TJ21100004	24525575				2022-02-06	
J	LAMARCHE, JA; REED, LK; RICH, MA; CASH, AW; LUCAS, LH; BOLL, TJ				LAMARCHE, JA; REED, LK; RICH, MA; CASH, AW; LUCAS, LH; BOLL, TJ			THE INTERACTIVE COMMUNITY-BASED MODEL OF VOCATIONAL-REHABILITATION	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article								The major service delivery component of the Southeastern Comprehensive Head Injury Center (SCHIC) is the Interactive Community Based Model (ICBM), a criterion-based, five-phase vocational rehabilitation program designed to maximize employment, independence, and quality of Life through community reintegration for adults with traumatic brain injury and their families. A stepwise approach to establishing attainable goals is accomplished through the five-phase model of intervention and treatment. The model focuses on providing information and services that involve and empower survivors and families to ensure their active participation in service recommendations and decision making.	UNIV ALABAMA,DEPT SURG,BIRMINGHAM,AL 35294; ALABAMA DEPT REHABIL SERV,BIRMINGHAM,AL		LAMARCHE, JA (corresponding author), UNIV ALABAMA,SE COMPREHENS HEAD INJURY CTR,BIRMINGHAM,AL 35294, USA.						Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CERVELLI L, 1990, REHABILITATION ADULT; GOODALL P, 1993, BRAIN INJURY, V7, P455, DOI 10.3109/02699059309029689; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; *WHO, 1981, DIS PREV REH REP WHO	6	2	2	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1995	10	4					81	89		10.1097/00001199-199508000-00008			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RN010	WOS:A1995RN01000008					2022-02-06	
J	TRITTMACHER, S; HUGENSPENZEL, M; TRAUPE, H				TRITTMACHER, S; HUGENSPENZEL, M; TRAUPE, H			HEAD AND BRAIN INJURIES IN CHILDREN	RADIOLOGE			German	Article						HEAD AND BRAIN INJURY; CHILD; COMPUTED TOMOGRAPHY; MAGNETIC RESONANCE TOMOGRAPHY	COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; TRAUMA	Depending on the clinical symptomatology, computed tomography (CT) is the predominant examination technique. CT reliably shows live-threatening intra- or extracerebral hemorrhage. Typical localization and distribution of blood allow differentiation between extradural and/or subarachnoidal effusion. Dislocation of the midline structures or of cortical relief shows the mass effect of intracranial hemorrhage. In many cases localized edema can be identified, but because of the normally very narrow cortical sulci in children and younger people, the general post-traumatic brain swelling is often diagnosed only retrospectively. Magnetic resonance tomography is more sensitive than CT concerning subtle changes in the depth of the white matter and should be used for follow-up studies as a supplementary examination.			TRITTMACHER, S (corresponding author), UNIV GIESSEN,ZENTRUM RADIOL,NEURORADIOL ABT,STEG 22,D-35392 GIESSEN,GERMANY.						HAN JS, 1984, RADIOLOGY, V150, P71, DOI 10.1148/radiology.150.1.6689790; HARTMANN M, 1994, KLIN NEURORADIOL, V4, P226; HARWOODNASH DC, 1971, RADIOLOGY, V102, P151; HENN R, 1989, KLINISCHE NEUROPATHO, P302; JENKINS A, 1986, LANCET, V2, P445; MASTERS SJ, 1980, AM J ROENTGENOL, V135, P539, DOI 10.2214/ajr.135.3.539; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; SELLIER K, 1963, HEFT UNFALLHEILKD, V1, P76; TRAUPE H, 1989, COMPUTERTOMOGRAPHIE, P16; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403	11	2	2	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0033-832X			RADIOLOGE	Radiologe	JUN	1995	35	6					378	384					7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	RF871	WOS:A1995RF87100002	7638343				2022-02-06	
J	ALBANESE, J; MARTIN, C				ALBANESE, J; MARTIN, C			EMERGENCY DRUG-THERAPY OF CLOSED-HEAD INJURY	CNS DRUGS			English	Article							CEREBRAL PERFUSION-PRESSURE; VENOUS OXYGEN-SATURATION; INTRACRANIAL-PRESSURE; BLOOD-FLOW; BRAIN INJURY; HYPERTENSION; METABOLISM; FAILURE; TRIAL	Preventing and treating cerebral ischaemia and secondary brain damage are the most important goals of trauma care in patients with head injury, At present, there are no therapies available for treating cerebral ischaemia and, therefore, the intensive therapy of severe head trauma is based on preventing or protecting against ischaemia and providing optimal conditions for tissue repair processes. This is achieved by the maintenance of an adequate cerebral perfusion pressure. A large number of drugs can be considered and should be used in a stepwise fashion. Relevant monitoring parameters can help in the selection of adequate and effective treatments. An adequate cerebral perfusion pressure is greater than or equal to 70mm Hg. This is achieved in patients with head injury by restoring to the normal range both intracranial pressure (less than or equal to 20 to 25mm Hg) and mean arterial blood pressure (greater than or equal to 90mm Hg). All patients with a Glasgow Coma score less than or equal to 8 are considered at risk of increased intracranial pressure. Sedation and mechanical ventilation are mandatory for these patients. Normoxia [oxyhaemoglobin saturation recorded using a pulse oximeter (SpO(2)) greater than or equal to 95%] and moderate hypocapnia (35 to 38mm Hg) are desirable goals, and hypo-osmolarity and hyperglycaemia must be avoided. A strict control of volaemia is required and in some patients hypervolaemia may be needed to maintain blood pressure. When intracranial pressure starts to increase, treatment includes (in a stepwise fashion): deepening of sedation, hyperventilation in patients with a suspected increase in cerebral blood flow, mannitol or hypertonic saline (7.5%) and, in some patients, continuous infusion of barbiturates. Cerebrospinal fluid removal can be considered in some patients, as well as skull vault removal to decompress widespread and uncontrollable cerebral oedema. Current research for future treatments of cerebral ischaemia has focused on inhibition of lipid peroxidative reactions and the use of glutamate antagonists. Inhibition of free radicals is also under investigation.	HOP NORD MARSEILLE,DEPT ANAESTHESIA & INTENS CARE,MARSEILLE,FRANCE; HOP NORD MARSEILLE,CTR TRAUMA,MARSEILLE,FRANCE				Albanese, Jacques/AAS-7466-2021				ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Chesnut Randall M., 1993, P203; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; Dearden N.M., 1992, YB INTENSIVE CARE EM, P537, DOI [10.1007/978-3-642-84734-9_52, DOI 10.1007/978-3-642-84734-9_52]; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; DONATO T, 1994, ANESTH ANALG, V78, P58; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FAHY BG, 1994, J NEUROSURG ANESTH, V6, P136; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; GREENBERG RS, 1994, CRIT CARE MED, V22, P384, DOI 10.1097/00003246-199403000-00006; HEMMER M, 1993, YB INTENSIVE CARE EM, P579; HSIANG J, 1993, CRIT CARE MED, V21, pS236; LEDINGHAM IM, 1983, LANCET, V2, P1270; LINNIK MD, 1995, CNS DRUGS, V4, P1; MAAS AIR, 1993, YB INTENSIVE CARE EM, P564; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARTIN C, 1994, NEURO ANESTHESIE NEU, P174; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; PARKE TJ, 1992, BRIT MED J, V305, P613, DOI 10.1136/bmj.305.6854.613; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SCHRADER H, 1985, ACTA NEUROL SCAND, V71, P114; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; SHOIZAKI T, 1993, J NEUROSURG, V79, P363; SMITH DH, 1995, CNS DRUGS, V3, P159, DOI 10.2165/00023210-199503030-00001; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; WILSON JA, 1994, J NEUROSURG ANESTH, V6, P139; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830; YOUNG WL, 1993, PROBLEMS ANESTHESIA, V7, P140	37	2	2	0	0	ADIS INTERNATIONAL LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND	1172-7047			CNS DRUGS	CNS Drugs	MAY	1995	3	5					337	350		10.2165/00023210-199503050-00003			14	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	QY137	WOS:A1995QY13700003					2022-02-06	
S	BOIVIE, J		Bromm, B; Desmedt, JE		BOIVIE, J			PAIN SYNDROMES IN PATIENTS WITH CNS LESIONS AND A COMPARISON WITH NOCICEPTIVE PAIN	PAIN AND THE BRAIN: FROM NOCICEPTION TO COGNITION	ADVANCES IN PAIN RESEARCH AND THERAPY		English	Article; Proceedings Paper	From Nociception to Pain Symposium	AUG 27-29, 1993	BEAUNE, FRANCE	Bayer, Boehringer Ingelheim, Byk Gulden, Cascan, Glaxo, Godecke, Hoechst, Knoll AG, Krewel, Lichtwer, Merck Darmstadt, Merck Sharp & Dohme, Mundipharma, Nordmark, Philips, Sandoz, Schwarz Pharma			POST-STROKE PAIN; SOMATOSENSORY EVOKED-POTENTIALS	There are no nociceptors in the nervous tissue of the brain and spinal cord, but some of the tissues around and in the parenchyma are innervated by nociceptors, such as the meninges and arteries. Thus, there is no true nociception in the parenchyma of the central nervous system (CNS). Instead, lesions and other dysfunctions in the CNS may lead to central pain. Many kinds of CNS lesions can cause central pain. These lesions may be located at any level of the neuraxis from the spinal dorsal horn to the cerebral cortex. The most common causes of central pain are cerebrovascular lesions, multiple sclerosis, and traumatic spinal-cord injuries. On the basis of results from studies of these and other patient groups, it is hypothesized that only lesions that affect the spinothalamocortical pathways that are crucial for the sensibility to temperature and pain can cause central pain. These studies have also shown that central pain is usually constant, and that it can have many different qualities, the most common being burning, aching, and pricking. Most patients experience more than one quality of pain. From a comparison between nociceptive and central pain it is concluded that there are fundamental differences between the two pain categories. Nociception is the crucial mechanism for nociceptive pain, whereas this step is bypassed in central pain (i.e., central pain occurs without activation of the primary nociceptive pathways, although activation of these pathways may affect central pain).			BOIVIE, J (corresponding author), LINKOPING UNIV HOSP,DEPT NEUROL,S-58185 LINKOPING,SWEDEN.						ANDERSEN G, 1995, IN PRESS PAIN; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; Boivie J., 1994, TXB PAIN, P871; BONICA JJ, 1991, PAIN CENTRAL NERVOUS, P13; BOUGOUSSLAVSKY J, 1988, NEUROLOGY, V38, P837; CASEY KL, 1990, PAIN S, V5, P204; Dejerine J, 1906, REV NEUROL-FRANCE, V14, P521; HOLMGREN H, 1990, PAIN, V40, P43, DOI 10.1016/0304-3959(90)91049-O; LEIJON G, 1989, PAIN, V36, P13, DOI 10.1016/0304-3959(89)90107-3; LEWISJONES H, 1990, PAIN S, V5, P278; MAUGUIERE F, 1988, ARCH NEUROL-CHICAGO, V45, P1312, DOI 10.1001/archneur.1988.00520360030007; MERSKEY H, 1986, PAIN S, V3, P217; OSTERBERG A, 1994, PROG PAIN RES MANAG, V2, P789; OSTERBERG A, 1993, 7TH P WORLD C PAIN, P407	14	2	2	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	E WASHINGTON SQ, PHILADELPHIA, PA 19105	0146-0722		0-7817-0322-0	ADV PAIN RES THER			1995	22						367	375					9	Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	BE25E	WOS:A1995BE25E00024					2022-02-06	
J	FANTIE, BD; KOSMIDIS, MH				FANTIE, BD; KOSMIDIS, MH			AVOIDANCE RESPONDING AND CLOSED-HEAD INJURY - REPLICATION AND REEVALUATION OF THE ANTICIPATORY BEHAVIOR DEFICIT	CLINICAL NEUROPSYCHOLOGIST			English	Article								Previous research suggests that survivors of closed-head injury (CHI), tested while inpatients, took more trials to learn to avoid a noxious noise in a conditioning task than did controls. In contrast, patients with CHI learned to escape at latencies equal to those of controls. The authors attributed these results to defective anticipation of the consequences of either the warning stimulus and/or the subject's own behaviour. They called this pattern of intact escape with putatively impaired avoidance an Anticipatory Behaviour Deficit (ABD). We tried to detect an ABD in nonhospitalized CHI survivors who had sustained an injury significant enough to produce a dectable deficit on a standard neuropsychological battery. The CHI group (n=24) and controls (n=13) had comparable avoidance latencies, escape latencies, and trials to criterion. Both groups escaped more quickly than they avoided. We conclude that ABD may not be unbiquitous in CHI survivors or that it may be a temporary condition, limited to a few months posttrauma. Since uninjured controls also escaped faster than they avoided, we suggest a reevaluation of the operational definition of an ABD.	AMERICAN UNIV,DEPT PSYCHOL,HUMAN NEUROPSYCHOL LAB,WASHINGTON,DC 20016; NIMH,PSYCHOL & PSYCHOPATHOL LAB,BETHESDA,MD 20892				Kosmidis, Mary H/AAN-2104-2021	Fantie, Bryan D./0000-0002-1901-378X; Kosmidis, Mary/0000-0001-8790-1220			Benson D.F., 1986, FRONTAL LOBES; BLEIBERG J, 1985, INT J CLIN NEUROPSYC, V7, P153; BLOUIN A, 1985, C DIS OPERATIONS MAN; DIKMEN S, 1987, NEUROBEHAVIORAL RECO, P73; FANTIE B D, 1989, Society for Neuroscience Abstracts, V15, P132; FANTIE BD, 1988, CANADIAN PSYCHOL, V29, P235; FANTIE BD, 1991, NEUROPSYCHOLOGY LAW, P186; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; FRITH CD, 1988, BRIT J PSYCHIAT, V15, P437; GOLDBERG G, 1987, FRONTAL LOBES REVISI, P273; GRUBB RL, 1974, NEUROLOGICAL PATHOPH, P292; Kolb B., 1990, FUNDAMENTALS HUMAN N; LAMPERT PW, 1984, JAMA-J AM MED ASSOC, V251, P2676, DOI 10.1001/jama.251.20.2676; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Luria AR, 1969, HDB CLINICAL NEUROLO, P725; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MIRSKY AF, IN PRESS NEUROPSYCHO; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Reitan R. M., 1986, TRAUMATIC BRAIN INJU, VI; ROTHKE S, 1987, INT J CLIN NEUROPSYC, V9, P81; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; [No title captured]; [No title captured]	23	2	2	0	1	SWETS ZEITLINGER BV	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	1994	8	4					379	387		10.1080/13854049408402040			9	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	PX792	WOS:A1994PX79200001					2022-02-06	
J	HAYASHI, Y; SHIMADA, O; YASUDA, H; IKEGAMI, K				HAYASHI, Y; SHIMADA, O; YASUDA, H; IKEGAMI, K			EFFECT OF NIZOFENONE ON EXPERIMENTAL HEAD TRAUMA IN MICE	ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE			English	Article							NEURONAL CELL-LINE; CEREBRAL-ISCHEMIA; PROTECTION; INJURY; INHIBITION; TOXICITY; ACIDS; CATS	The therapeutic effect of nizofenone, a cerebroprotective drug, on experimental traumatic head injury was investigated in mice. The animals under halothane anaesthesia were subjected to a severe concussive head trauma and their neurological status was assessed by a string grip-test for 6 consecutive days. The neurological function of the control groups fell markedly 1 hr after trauma and slowly recovered day by day, but some animals failed to restore to the normal level, even on the 6th day. The post-treatment of the head-injured mice with nizofenone (3 mg/kg/day, i.p.) significantly improved the neurological function. The neurological improvement by nizofenone was dose-dependent and a significant amelioration was observed at 0.3 mg/kg/day. Methylprednisolone (30 mg/kg/day, i.v.) did not exert any significant neurological improvement in this therapeutic, experimental condition. In this study, nizofenone treatment was found to beneficially influence the recovery of the neurological function, maybe by reducing the progress of brain injury following head trauma.	YOSHITOMI PHARMACEUT IND LTD,RES LABS,IRUMA,SAITAMA 358,JAPAN								BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRAUGHLER JM, 1985, J NEUROSURG, V62, P806, DOI 10.3171/jns.1985.62.6.0806; BRAUGHLER JM, 1985, J NEUROCHEM, V44, P1282, DOI 10.1111/j.1471-4159.1985.tb08755.x; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; MATSUMOTO Y, 1993, J CEREB BLOOD FLO S1, V13, pS742; MIYAMOTO M, 1989, J PHARMACOL EXP THER, V250, P1132; MORIMOTO Y, 1984, FOLIA PHARMACOL JPN, V83, P507, DOI 10.1254/fpj.83.507; MORIMOTO Y, 1984, Brain and Nerve (Tokyo), V36, P983; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; OCHIAI C, 1982, STROKE, V13, P788, DOI 10.1161/01.STR.13.6.788; OHTA T, 1986, J NEUROSURG, V64, P420, DOI 10.3171/jns.1986.64.3.0420; Saito I, 1983, Neurol Res, V5, P29; SHUTO S, 1984, FOLIA PHARMACOL JPN, V84, P519, DOI 10.1254/fpj.84.519; TAMURA A, 1979, STROKE, V10, P126, DOI 10.1161/01.STR.10.2.126; YASUDA H, 1979, ARCH INT PHARMACOD T, V242, P77; YASUDA H, 1978, ARCH INT PHARMACOD T, V233, P136; YASUDA H, 1985, J NEUROCHEM, V45, P168, DOI 10.1111/j.1471-4159.1985.tb05489.x; YASUDA H, 1981, J NEUROCHEM, V37, P934, DOI 10.1111/j.1471-4159.1981.tb04480.x; YASUDA H, 1993, CEREBROVAS BRAIN MET, V5, P264; Yasuda H, 1988, Adv Exp Med Biol, V222, P403; YOSHIDA S, 1980, BRAIN NERVE, V32, P931	23	2	2	0	0	ARCH INT PHARMACODYNAMIE	GHENT	DE PINTELAAN 185, B-9000 GHENT, BELGIUM	0003-9780			ARCH INT PHARMACOD T	Arch. Int. Pharmacodyn. Ther.	NOV-DEC	1994	328	3					251	260					10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	QQ412	WOS:A1994QQ41200001	7625881				2022-02-06	
J	IVERSON, GL; IVERSON, AM; BARTON, EA				IVERSON, GL; IVERSON, AM; BARTON, EA			THE CHILDRENS-ORIENTATION-AND-AMNESIA-TEST - EDUCATIONAL STATUS IS A MODERATOR VARIABLE IN TRACKING RECOVERY FROM TBI	BRAIN INJURY			English	Article								The Children's Orientation and Amnesia Test (COAT) is an objective, standardized means of assessing cognitive functioning in children and adolescents who are in the early stages of recovery from traumatic brain injury. The COAT is composed of 16 items that assess general orientation, temporal orientation, and memory. This study was designed to determine if children who are receiving special education services perform more poorly on the COAT than children who are in the regular classroom. It was found that children receiving special services performed significantly more poorly, and 13% of them were classified in the impaired range, as compared to 3% of the students in the regular classroom. The results provide important reference data for interpreting COAT scores of children with traumatic brain injuries who have either premorbid learning disabilities or other special service needs.	UNIV MISSOURI,DEPT PHYS MED & REHABIL,COLUMBIA,MO; UNIV NO IOWA,DEPT EDUC PSYCHOL & FDNE,CEDAR FALLS,IA; UNIV MISSOURI,DEPT EDUC & COUNSELING PSYCHOL,COLUMBIA,MO 65211					Iverson, Grant/0000-0001-7348-9570			EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; IVERSON GL, UNPUB NORMATIVE DATA	2	2	3	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV-DEC	1994	8	8					685	688		10.3109/02699059409151022			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	PT049	WOS:A1994PT04900004	7849687				2022-02-06	
J	KATSIYANNIS, A; CONDERMAN, G				KATSIYANNIS, A; CONDERMAN, G			SERVING INDIVIDUALS WITH TRAUMATIC BRAIN INJURY - A NATIONAL SURVEY	REMEDIAL AND SPECIAL EDUCATION			English	Article							STATE PRACTICES; CHILDREN; STUDENTS	This paper reports findings from a survey of 48 state directors of special education. The survey collected information on current state practices in providing services to individuals with Traumatic Brain Injury, with an emphasis on technical assistance, training, and eligibility criteria. Variations among states in the availability and nature of eligibility criteria, definitions, technical assistance, and training were found.			KATSIYANNIS, A (corresponding author), UNIV NEBRASKA,DEPT SPECIAL EDUC COMMUN DISORDERS,W CTR,KEARNEY,NE 68849, USA.						ABBOT N, 1992, INTERV SCH CLIN, V27, P242; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Colson S. E, 1992, INTERV SCH CLIN, V27, P198; DANIELSON LC, 1989, EXCEPT CHILDREN, V55, P448, DOI 10.1177/001440298905500508; KATSIYANNIS A, 1990, J SPEC EDUC, V24, P246, DOI 10.1177/002246699002400211; KATSIYANNIS A, 1991, REM SPEC EDUC, V12, P24, DOI 10.1177/074193259101200107; KATSIYANNIS A, 1992, J SPEC EDUC, V26, P219, DOI 10.1177/002246699202600206; KATSIYANNIS A, 1991, REM SPEC EDUC, V12, P54, DOI 10.1177/074193259101200210; KRAUS JF, 1987, PEDIATRICS, V79, P501; LARKIN M, 1992, HEADLINES        OCT, P12; *MA DEP ED, 1992, EL GUID SPEC ED; MARTIN R, 1988, J LEARN DISABIL, V21, P471, DOI 10.1177/002221948802100804; MARTIN R, 1988, J LEARN DISABIL, V21, P485; *NAT HEAD INJ F TA, 1988, ED MAN ED KNOW STUD; ROTHOLZ DA, 1989, J SPEC EDUC, V23, P59, DOI 10.1177/002246698902300106; STEENSMA M, 1992, INTERVENTION SCH CLI, V27, P207; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; *US DEP ED, 1989, ASS FREE APPR PUBL E; WERDIN C, 1988, ED299728; 1992, FED REGISTER, V47, P189	20	2	2	0	0	PRO-ED INC	AUSTIN	8700 SHOAL CREEK BLVD, AUSTIN, TX 78757-6897	0741-9325			REM SPEC EDUC	Remedial Spec. Educ.	SEP	1994	15	5					319	325		10.1177/074193259401500507			7	Education, Special	Social Science Citation Index (SSCI)	Education & Educational Research	PE972	WOS:A1994PE97200007					2022-02-06	
J	KOBAYASHIIWATA, N; YAO, GL; SATO, M; KIYAMA, H				KOBAYASHIIWATA, N; YAO, GL; SATO, M; KIYAMA, H			NEUROTENSIN TRANSCRIPTION IS OPPOSITELY REGULATED DURING DEVELOPMENT AND REGENERATION	NEUROREPORT			English	Article						IN SITU HYBRIDIZATION; MOTOR NEURON; REGENERATION; NONRADIOACTIVE; INJURY; HYPOGLOSSAL NUCLEUS; DEVELOPMENT; NEUROTRAUMA; NEUROMEDIN N	INSITU HYBRIDIZATION HISTOCHEMISTRY; MESSENGER-RNA; NEUROMEDIN-N; GENE-EXPRESSION; RAT; PRONEUROTENSIN; INCREASES; ONTOGENY; PROBES; CELLS	OUR previous work demonstrated that neurotensin mRNA expression was transiently up-regulated during development in the hypoglossal motoneurone. The present study was carried out to examine how neurotensin mRNA expression changes during nerve regeneration. Following either unilateral resection or crushing of the hypoglossal nerve, mRNA expression was detected by non-radioactive in situ hybridization histochemistry using an alkaline phosphatase-labelled oligonucleotide probe. A reduction in neurotensin mRNA was observed on the operated side after the nerve injury. It took around 2 months for NT mRNA levels to return to normal. Similar down-regulation was observed following crushing, but recovery was more rapid than that observed with sectioning, probably due to the extent of nerve damage. This finding indicates that neurotensin transcription is up-regulated during development but, on the contrary, down-regulated during regeneration.	OSAKA UNIV,SCH MED,BIOMED RES CTR,DEPT NEUROANAT,SUITA,OSAKA 565,JAPAN				Kiyama, Hiroshi/M-8867-2014	Kiyama, Hiroshi/0000-0001-5963-046X			AUGOOD SJ, 1992, NEUROSCIENCE, V47, P317, DOI 10.1016/0306-4522(92)90247-Y; BURGEVIN MC, 1992, NEUROSCIENCE, V49, P627, DOI 10.1016/0306-4522(92)90232-Q; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; JABLONSKI E, 1986, NUCLEIC ACIDS RES, V14, P6115, DOI 10.1093/nar/14.15.6115; KISLAUSKIS E, 1990, NEURON, V4, P783, DOI 10.1016/0896-6273(90)90205-T; KISLAUSKIS E, 1988, J BIOL CHEM, V263, P4963; KIYAMA H, 1987, DEV BRAIN RES, V31, P303, DOI 10.1016/0165-3806(87)90128-3; KIYAMA H, 1990, MOL BRAIN RES, V7, P213, DOI 10.1016/0169-328X(90)90030-H; KIYAMA H, 1991, DIFFERENTIATION, V46, P69, DOI 10.1111/j.1432-0436.1991.tb00867.x; KIYAMA H, 1990, NEUROSCI RES, V9, P1, DOI 10.1016/0168-0102(90)90041-C; KIYAMA H, 1991, DEV BRAIN RES, V58, P293, DOI 10.1016/0165-3806(91)90018-E; KIYAMA H, 1991, HDB CHEM NEUROANATOM, V10, P399; KOBAYASHI N, 1994, MOL BRAIN RES, V21, P9, DOI 10.1016/0169-328X(94)90373-5; MERCHANT KM, 1992, J NEUROSCI, V12, P652; OHNO K, 1993, NEUROSCI RES, V18, pS138; RUTH JL, 1985, DNA-J MOLEC CELL BIO, V4, P93; SAIKA T, 1991, MOL BRAIN RES, V11, P187, DOI 10.1016/0169-328X(91)90027-U; SATO M, 1991, J COMP NEUROL, V310, P300, DOI 10.1002/cne.903100303	18	2	2	0	0	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	0959-4965			NEUROREPORT	Neuroreport	AUG 15	1994	5	13					1589	1592		10.1097/00001756-199408150-00012			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PE032	WOS:A1994PE03200012	7819525				2022-02-06	
J	VANDEKELFT, E; SEGNARBIEUX, F; CANDON, E; COUCHET, P; FREREBEAU, P; DAURES, JP				VANDEKELFT, E; SEGNARBIEUX, F; CANDON, E; COUCHET, P; FREREBEAU, P; DAURES, JP			CLINICAL RECOVERY OF CONSCIOUSNESS AFTER TRAUMATIC COMA	CRITICAL CARE MEDICINE			English	Article						COMA; CONSCIOUSNESS; GLASGOW COMA SCALE; PATIENT OUTCOME ASSESSMENT; HEAD INJURY; BRAIN-STEM; REFLEX, BLINK; TRAUMA; CRITICAL ILLNESS; NEUROLOGIC EMERGENCIES	SEVERE HEAD-INJURY; REFLEX	Objective: To describe early clinical stages in the recovery of consciousness, using selected items from the Glasgow Coma Scale and the Liege Coma Scale. Design: Validation cohort study, conducted in a tertiary care center. Setting: Neurosurgical intensive therapy unit in a university teaching hospital. Patients: Patients (n = 137) with traumatic coma who were selected according to the following criteria: a) coma due to blunt head trauma with an initial Glasgow Coma Score of less than or equal to 7; b) admission to the neurosurgical intensive therapy unit within the first 24 hrs after trauma; c) patients >14 yrs of age; requiring endotracheal intubation, mechanical ventilation, and the administration of drugs; and d) survival period allowing analysis of the recovery of consciousness. Measurements and Main Results: Arousal, as expressed by stimulated opening of the eyes and recorded as a delay in days, was correlated with the appearance of the localized pain response, capacity to obey commands, blink reflex, and the cessation of drugs in three groups of patients. These groups were defined according to the time in which there was an appearance of the stimulated opening of the eyes: <8 days (group 1); between 8 and 15 days (group 2); and after 15 days (group 3). When the three groups of patients were compared, significant differences existed between the mean delays of appearance of stimulated eye opening and the appearance of the blink reflex. Extubation coincided with the appearance of spontaneous eye opening, with a mean delay of 13.5 days. Conclusions: This study confirms the classical clinical sequence of arousal and recovery of consciousness, with the appearance of stimulated eye opening and the blink reflex first, followed by spontaneous eye opening, and the capacity to obey commands in intubated, traumatized, coma patients. A direct correlation existed between the delay of arousal and the complete recovery of consciousness. When groups of patients with various mean delays for the appearance of stimulated eye opening are considered, reappearance of the blink reflex did not always coincide with stimulated eye opening, suggesting differing structural and functional brain recovery processes.	CHU GUY DE CHAULIAC, MONTPELLIER, FRANCE; HOP LAPEYRONIE, MONTPELLIER, FRANCE								BORN JD, 1982, NEUROCHIRURGIE, V28, P1; BOWERS SA, 1980, NEUROSURGERY, V6, P237; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; COHADON F, 1983, NEUROCHIRURGIE, V29, P303; ECCLES JC, 1991, EVOLUTION BRAIN CREA, P26; FREREBEAU P, 1992, NEUROCHIRURGIE, V38, P35; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1981, MANAGEMENT HEAD INJU, P46; KEANE JR, 1979, ARCH NEUROL-CHICAGO, V36, P52, DOI 10.1001/archneur.1979.00500370082023; LYON LW, 1972, J NEUROL NEUROSUR PS, V35, P582, DOI 10.1136/jnnp.35.5.582; PEREZDOMINGUEZ E, 1976, J NEUROSURG SCI, V20, P293; Plum F, 1982, DIAGNOSIS STUPOR COM, P11; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075	16	2	2	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	1994	22	7					1108	1113					6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA696	WOS:A1994PA69600010	8026199				2022-02-06	
J	PETERS, AV				PETERS, AV			TRAUMATIC BRAIN INJURY INFORMATION DATABASE - A USER SURVEY	BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION			English	Article							STRATEGIES; SEEKING	A major challenge facing individuals with brain injury and the rehabilitation professionals who assist them is the acquisition of current, understandable information. Health professionals in hospitals usually provide initial information, which patients with brain injury and their families often find inadequate. They then find it necessary to seek information from independent sources. One such source, TBI-INFO, an information dissemination service, conducted a survey to determine how effectively it was satisfying consumer and professional demands. Responses generally indicated that the acquisition of information improved patients' integration into the community and enhanced their understanding of brain injury and its effects. Most of the information respondents received was new to them, most shared the information with others, and many requested information more than once. Half of the respondents changed their approach to a specific situation as a result of information they received. These results show that independent sources are capable of providing information that improves the perceived quality of life for individuals with traumatic brain injury.			PETERS, AV (corresponding author), SUNY BUFFALO,232 PARKER HALL,S CAMPUS,3435 MAIN ST,BUFFALO,NY 14214, USA.						AARONSON LS, 1988, HEALTH EDUC QUART, V15, P335, DOI 10.1177/109019818801500307; [Anonymous], 1992, MMWR; ASH CR, 1990, CANCER NURS, V13, P133, DOI 10.1097/00002820-199006000-00001; BARSEVICK AM, 1990, RES NURS HEALTH, V13, P1, DOI 10.1002/nur.4770130103; BEISECKER AE, 1990, MED CARE, V28, P19, DOI 10.1097/00005650-199001000-00004; Beukelman D., 1991, COMMUNICATION DISORD, P1; DAHMER ER, IN PRESS HEAD TRAUMA; DAMROSCH S, 1991, NURS CLIN N AM, V26, P833; DITTMAR SS, 1991, J HEALTHCARE TRAININ, V6, P16; EDWARDS LA, 1989, USING KNOWLEDGE TECH; FELTON BJ, 1984, SOC SCI MED, V18, P889, DOI 10.1016/0277-9536(84)90158-8; FRANK R G, 1990, Brain Injury, V4, P289, DOI 10.3109/02699059009026179; JOHNSON WE, MISCONCEPTIONS BRAIN; MARSHALL JG, 1991, IMPACT INFORMATION P; MCMORDIE W R, 1991, Brain Injury, V5, P43, DOI 10.3109/02699059108998510; Sweetland J, 1990, Nurs Times, V86, P36; *US PHS, 1992, HLTH PEOPL 2000 NAT; WIGGINS NC, 1989, J ADV NURS, V14, P63, DOI 10.1111/j.1365-2648.1989.tb03406.x; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; 1992, COMMUUNITY INTEGRATI, V2, P8	20	2	2	0	1	MED LIBRARY ASSN	CHICAGO	SUITE 300 6 N MICHIGAN AVE, CHICAGO, IL 60602	0025-7338			B MED LIBR ASSOC	Bull. Med. Libr. Assoc.	APR	1994	82	2					153	159					7	Information Science & Library Science	Social Science Citation Index (SSCI)	Information Science & Library Science	NF278	WOS:A1994NF27800004	8004016				2022-02-06	
J	BARYZA, MJ; HALEY, SM				BARYZA, MJ; HALEY, SM			USE OF THE CHILDRENS ORIENTATION AND AMNESIA TEST AT HOSPITAL DISCHARGE FOR CHILDREN WITH NEUROLOGICAL AND NON-NEUROLOGICAL TRAUMATIC INJURIES	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; MEMORY; SEVERITY; SCALE; RECOVERY; COMA	The measurement of post-traumatic amnesia in children is a common clinical index of the extent of brain injury. The only published paediatric test, the Children's Orientation and Amnesia Test (COAT), has been standardized on a sample of children in a school setting who had not been injured or hospitalized. Two questions arise in the use of this test: are the published norms valid for hospitalized children with non-neurological trauma? and does the COAT offer better discriminative power or clinical utility over the adult test, the Galveston Orientation and Amnesia Test (GOAT)? This paper describes scores on the COAT for 28 children hospitalized with non-neurological injuries and compares them with the published scores. The hospitalized children scored within normal limits when compared with the school sample. In addition, 23 children with neurological traumatic injuries were given both the COAT and the GOAT. Failure rate was higher for the COAT. Some implications for the use of the COAT in paediatric trauma arc discussed.	TUFTS UNIV,SCH MED,BOSTON,MA 02111; TUFTS UNIV NEW ENGLAND MED CTR,DEPT REHABIL MED RES & TRAINING CTR REHABIL & CHILDHOOD TRAUMA,BOSTON,MA								BENNETTLEVY JM, 1984, ACTA NEUROL SCAND, V70, P285; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; HELMESTABROOKS N, 1989, BEDSIDE TEST HEAD IN; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; RICHARDSON F, 1963, DEV MED CHILD NEUROL, V5, P471; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603	17	2	3	0	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB-MAR	1994	8	2					167	173		10.3109/02699059409150968			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	NA029	WOS:A1994NA02900006	8193636				2022-02-06	
J	MOORE, AD; STAMBROOK, M; GILL, DD; HAWRYLUK, GA; PETERS, LC; HARRISON, MM				MOORE, AD; STAMBROOK, M; GILL, DD; HAWRYLUK, GA; PETERS, LC; HARRISON, MM			FACTOR STRUCTURE OF THE WECHSLER ADULT INTELLIGENCE SCALE - REVISED IN A TRAUMATIC BRAIN INJURY SAMPLE	CANADIAN JOURNAL OF BEHAVIOURAL SCIENCE-REVUE CANADIENNE DES SCIENCES DU COMPORTEMENT			English	Article; Proceedings Paper	National-Academy-of-Neuropsychology Meeting	NOV, 1990	RENO, NV	NATL ACAD NEUROPSYCHOL			R FACTOR STRUCTURE; WAIS-R	Wechsler Adult Intelligence Scale-Revised (WAIS-R) protocols administered to 102 traumatically brain injured (TBI) patients an average of 9.74 months post-injury were factor analyzed using principal axes factoring with varimax rotation. Although high levels of congruence with psychiatric and standardization samples were achieved, Wechsler's Verbal/Performance dichotomy, strictly defined, did not hold in this sample. In addition, the third factor, consisting of Digit Span, Arithmetic, Digit Symbol and Picture Arrangement, replicated a factor analytic study using psychiatric patients. Clinicians should utilize caution when applying standard interpretation practices in this population. Future research should investigate factors contributing to WAISR factor structure similarities between psychiatric and TBI populations.	UNIV MANITOBA,DEPT PSYCHIAT,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT MED,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,FAC NURSING,WINNIPEG R3T 2N2,MANITOBA,CANADA		MOORE, AD (corresponding author), UNIV MANITOBA,HLTH SCI CLIN RES CTR,NEUROPSYCHOL RES UNIT,MS-779A,THORLAKSON BLDG,WINNIPEG R3A 1M3,MB,CANADA.						ATKINSON L, 1989, J CLIN PSYCHOL, V45, P124, DOI 10.1002/1097-4679(198901)45:1<124::AID-JCLP2270450119>3.0.CO;2-1; ATKINSON L, 1984, J CONSULT CLIN PSYCH, V52, P714, DOI 10.1037/0022-006X.52.4.714; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; BECK NC, 1985, J CONSULT CLIN PSYCH, V53, P402, DOI 10.1037/0022-006X.53.3.402; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Gorsuch R.L., 1983, FACTOR ANAL; GREGORY R, 1987, ADULT INTELLECTUAL A; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; LECKLITER IN, 1986, J CLIN PSYCHOL, V42, P332, DOI 10.1002/1097-4679(198603)42:2<332::AID-JCLP2270420220>3.0.CO;2-2; McDonald R. P., 1985, FACTOR ANAL RELATED; PARKER K, 1983, J CONSULT CLIN PSYCH, V51, P302, DOI 10.1037/0022-006X.51.2.302; RYAN JJ, 1986, J CLIN PSYCHOL, V42, P962, DOI 10.1002/1097-4679(198611)42:6<962::AID-JCLP2270420620>3.0.CO;2-U; SIEGERT RJ, 1988, MULTIVAR BEHAV RES, V23, P481, DOI 10.1207/s15327906mbr2304_5; Wechsler, 1997, WECHSLER ADULT INTEL	14	2	2	0	2	CANADIAN PSYCHOL ASSOC	OTTAWA	151 SLATER ST, STE 205, OTTAWA ON K1P 5H3, CANADA	0008-400X			CAN J BEHAV SCI	Can. J. Behav. Sci.-Rev. Can. Sci. Comport.	OCT	1993	25	4					605	614		10.1037/h0078849			10	Psychology, Multidisciplinary	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychology	MK146	WOS:A1993MK14600008					2022-02-06	
J	HOOPER, SR; ROOF, KD				HOOPER, SR; ROOF, KD			UTILITY OF THE HOBBY WISC-R SPLIT-HALF SHORT FORM FOR CHILDREN AND ADOLESCENTS WITH SEVERE HEAD-INJURY	PSYCHOLOGICAL REPORTS			English	Article								This study investigated the utility of the Hobby WISC-R Split-half Short Form in a sample of children and adolescents with severe head injury. Subjects included 30 patients with severe closed-head injuries who were referred for neuropsychological testing as part of their hospitalization in a pediatric rehabilitation center. Subjects ranged in age from 7.5 to 16.2 years and were of the low to middle socioeconomic range. Analyses yielded significant correlations between scores on the standard WISC-R and the Split-half Short Form. Except for the WISC-R Split-half Short Form slightly overestimating scores on Object Assembly, no other score differences were obtained between the two forms, Patterns of strengths and weaknesses were variable for the two forms, with over-all agreements ranging from 46% on the Performance subtests to 53.7% on the Verbal subtests. The rate of classification agreement between the standard and short-form formats in assigning a child to one of five traditional IQ categories was 76.7%, with nearly all scores on the short form falling within one standard error of measurement of the standard WISC-R scores. There was a tendency for younger children to show more stability in their classification categories across the two WISC-R forms than older children. Issues related to the use of the WISC-R Split-half Short Form for a severely head-injured pediatric population are discussed.	VANDERBILT UNIV,MED CTR,SCH MED,DEPT PSYCHIAT,NASHVILLE,TN 37232		HOOPER, SR (corresponding author), UNIV N CAROLINA,SCH MED,DEPT PSYCHIAT,CLIN CTR DEV & LEARNING,CB 7255,BSRC,CHAPEL HILL,NC 27599, USA.		Hooper, Stephen/X-8171-2019		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ-379154-02-0] Funding Source: Medline		Bawden H. N., 1991, PSYCHOL ASSESSMENT J, V3, P660; BECK NC, 1983, J CONSULT CLIN PSYCH, V51, P864, DOI 10.1037/0022-006X.51.6.864; BOYD TA, 1986, J PSYCHOEDUCATIONAL, V4, P113; FINCH AJ, 1973, AM J MENT DEF, V78, P144; Hobby K., 1982, WISC R SPLIT HALF SH; KARNES FA, 1981, PSYCHOL SCHOOLS, V18, P169, DOI 10.1002/1520-6807(198104)18:2<169::AID-PITS2310180210>3.0.CO;2-N; Kaufman, 1979, INTELLIGENT TESTING; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; RESNICK RJ, 1971, J CONSULT CLIN PSYCH, V36, P97, DOI 10.1037/h0030475; SATTLER JM, 1988, ASSESSMENT CHILDRENS; Wechsler D., 1974, WECHSLER INTELLIGENC; YUDIN LW, 1966, J CONSULT PSYCHOL, V30, P272, DOI 10.1037/h0023312	12	2	2	0	1	PSYCHOLOGICAL REPORTS	MISSOULA	P O BOX 9229, MISSOULA, MT 59807	0033-2941			PSYCHOL REP	Psychol. Rep.	APR	1993	72	2					371	376		10.2466/pr0.1993.72.2.371			6	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	KW159	WOS:A1993KW15900003	8488219				2022-02-06	
J	SPEIGHT, I; LAUFER, ME; MATTES, K				SPEIGHT, I; LAUFER, ME; MATTES, K			CIV (COMPUTER-AIDED INTERACTIVE VIDEO) - A NOVEL APPLICATION IN NEUROPSYCHOLOGICAL REHABILITATION	COMPUTERS IN HUMAN BEHAVIOR			English	Article							CLOSED HEAD-INJURY; TRAUMATIC BRAIN INJURY; COGNITIVE REHABILITATION; RECOVERY; DOMINANCE; ATTENTION; ORIGINS; PROGRAM	After giving a short review of the existing outcome research and highlighting the limitations of computerized training procedures in cognitive remediation, the computer-aided interactive video (CIV) technique is introduced in detail. A system description and examples of its recent applications in educational, industrial, or corporate training schemes, known as computer based training (CBT), are presented. The emphasis of this article is placed on the ability of CIV to employ theoretical concepts and remediation strategies especially for the treatment of attention or memory deficits in a more adequate way, allowing higher ecological validity and faster generalization. Our preliminary experience with the novel application of this interactive technique in neuropsychological rehabilitation is discussed, followed by an outlook on further research and treatment developments.	NEUROL REHABIL CTR BURG LANDSHUT,BERNKASTEL KUES,GERMANY								Ben-Yishay Y., 1987, NEUROPSYCHOLOGICAL R, P165; BENEDICT RHB, 1989, CLIN PSYCHOL REV, V9, P605; BENYISHAY J, 1987, J HEAD TRAUMA REHAB, V2, P45; BENYISHAY Y, 1989, 1ST NEUR WORKSH NEUR; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; COHEN G, 1973, Q J EXP PSYCHOL, V25, P557, DOI 10.1080/14640747308400378; COLAVITA FB, 1974, PERCEPT PSYCHOPHYS, V16, P409, DOI 10.3758/BF03203962; DREW DG, 1987, COMMUN RES, V14, P452, DOI 10.1177/009365087014004005; GLISKY EL, 1987, NEUROPSYCHOLOGIA, V25, P893, DOI 10.1016/0028-3932(87)90094-7; GLISKY EL, 1988, NEUROPSYCHOLOGIA, V26, P173, DOI 10.1016/0028-3932(88)90041-3; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; GOLDSTEIN G, 1983, REHABILITATION BRAIN; Gordon WA, 1987, NEUROPSYCHOL REHABIL, P111; GRIMES T, 1991, ED TECHNOLOGY RES DE, V38, P15; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HANNAFIN MJ, 1985, ED COMMUNICATION TEC, V4, P235; HART T, 1986, CLIN NEUROPSYCHOLOGY, P21; KREUTZER JS, 1989, REHABIL PSYCHOL, V34, P117; LAUFER ME, 1989, OCT INT S BRAIN DAM; LEVIN HS, 1990, ARCH NEUROL-CHICAGO, V47, P223, DOI 10.1001/archneur.1990.00530020131027; Levin HS., 1982, NEUROBEHAVIORAL CONS; LOCATIS C, 1991, ED TECHNOLOGY RES DE, V38, P41; OCONNOR M, 1987, NEUROPSYCHOLOGICAL R, P261; ORGASS B, 1989, 3 S COMP HELF HEIL B; Posner M.I., 1987, NEUROPSYCHOLOGICAL R, P182; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; REITAN RM, 1969, TRAIL MAKING TEST MA; Ruff R. M., 1989, J HEAD TRAUMA REHAB, V4, P20, DOI [10.1097/00001199-198909000-00006, DOI 10.1097/00001199-198909000-00006]; SHALLICE T, 1989, BRAIN, V112, P1587, DOI 10.1093/brain/112.6.1587; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; STURM W, 1983, ARCH PSYCHIAT NERVEN, V233, P9, DOI 10.1007/BF00540034; STURM W, 1987, 22 JAHR TAG DTSCH GE; STURM W, 1989, KLINISCHE NEUROPSYCH, P371; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VOLPE BT, 1990, ARCH NEUROL-CHICAGO, V47, P220, DOI 10.1001/archneur.1990.00530020128026; WILSON B, 1987, REHABILITATION MEMOR; Wilson BA, 1984, CLIN MANAGEMENT MEMO	41	2	2	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0747-5632			COMPUT HUM BEHAV	Comput. Hum. Behav.	SPR	1993	9	1					95	104		10.1016/0747-5632(93)90024-M			10	Psychology, Multidisciplinary; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	KA733	WOS:A1993KA73300008					2022-02-06	
J	SHUTOV, AA; CHUDINOV, AA				SHUTOV, AA; CHUDINOV, AA			THYROID-FUNCTION IN BRAIN CONCUSSION	ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article								RIA was used to study the quantitative content in the blood serum of thyrotropic (TTH), thyroid (total thyroxine (T4), free thyroxine, triiodothyronine (T3) hormones and thyroxine-binding capacity of blood plasma proteins in 30 patients with brain concussion from the first to the 12th day of disease. The patients' hormonal profile was characterized by normal characteristics of TTH, depression of the transport organic phase of thyroid metabolism with a decrease of the T4 concentration, a reduction of the thyroxine-binding capacity of plasma protein, and simultaneous activation of the peripheral stage of iodine metabolism with excess accumulation in the blood of active hormones - free thyroxine and T3. The data obtained deepen our understanding of the pathogenesis of craniocerebral injury (CCI). The neuroendocrine syndrome identified is specific for mild CCI. It can be used as a differential diagnostic criterion for expert medical evaluation purposes.			SHUTOV, AA (corresponding author), PERM MED INST,CHAIR NEUROL,PERM,RUSSIA.						DEVISHEV MI, 1976, MED RADIOL, P50; DZHALATONIYA EK, 1972, SBORNIK T NII TRAVMA, V11, P178; GRASHCHENKOV NI, 1962, MNOGOTOMNE RUKOVODST, V8, P11; INGBAR SH, 1975, ANNU REV MED, V26, P443, DOI 10.1146/annurev.me.26.020175.002303; MAZALOVA MF, 1974, VOPR NEIROKHIR, P15; NEGOESCO I, 1969, Revue Roumaine d'Endocrinologie, V6, P215; OPPENHEI.JH, 1970, J CLIN INVEST, V49, P1016, DOI 10.1172/JCI106301; OPPENHEIMER IH, 1978, CLIN ENDOCRINOL, V7, P145; PFANNESTIEL P, 1978, DIAGNOSIS THYROID DI; RATSEV RR, 1975, TIREOIDNYE GORMONY S; RIECANSKY I, 1965, BRATISL LEK LISTY, V42, P243; SCHIMMEL M, 1977, ANN INTERN MED, V87, P760, DOI 10.7326/0003-4819-87-6-760; SHUTOV AA, 1980, VOPR NEIROKHIR, P23; SHUTOV AA, 1988, ZH NEVROPATOL, P11; SLAVNOV VN, 1978, RADIOIZOTOPNYE RADIO	15	2	2	0	1	IZD VO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	0044-4588			ZH NEVROPATOL PSIKH	Zhurnal Nevropatol. Psikhiatrii Im. S S Korsakova		1993	93	2					39	42					4	Clinical Neurology; Pathology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology; Psychiatry	NH939	WOS:A1993NH93900012	8048305				2022-02-06	
J	IMHOF, HG; DOLDER, E; KACH, K; KUNZI, W; PLATZ, A; RUTTNER, B; VOLLENWEIDER, A				IMHOF, HG; DOLDER, E; KACH, K; KUNZI, W; PLATZ, A; RUTTNER, B; VOLLENWEIDER, A			WHO SHOULD BE ADMITTED FOR A MINOR HEAD-INJURY	HELVETICA CHIRURGICA ACTA			German	Article								The frequency of minor closed head injuries is high. These injuries may be complicated by the development of life-threatening intracranial hematomas. A well-defined selection criteria for admission must be proposed to guarantee an efficacious observation. In our series of 489 hospitalized patients with a GCS of 15 when seen in the emergency room: 4 patients required evacuation of an intracranial hematoma. 11 revision of a depressed skull fracture or a compound fracture of base of the anterior fossa. Using the existence of a skull fracture as a selection for admission, a strategy proposed by JENNETT and colleagues, it would have been possible to reduce the number of patients hospitalized by 70% without missing a patient who developed an intracranial hematoma. Following these criteria no intracranial hematoma would be missed in our patients with a GCS of 15. We suggest that the use of plain x-rays to identify skull fractures and subsequent hospitalization prevents missing an intracranial hematoma. Those patients with diminished levels of consciousness or focal neurologic deficits require admission irrespective of skull fractures.			IMHOF, HG (corresponding author), UNIV HOSP ZURICH,NEUROCHIRURG KLIN,CH-8091 ZURICH,SWITZERLAND.							0	2	2	0	0	SCHWABE & CO AG VERLAG	MUTTENZ 1	FARNSBURGERSTRASSE 8, CH-4132 MUTTENZ 1, SWITZERLAND	0018-0181			HELV CHIR ACTA		MAR	1992	58	5					667	672					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HQ362	WOS:A1992HQ36200012	1592634				2022-02-06	
J	ASSAL, G; BINDSCHAEDLER, C				ASSAL, G; BINDSCHAEDLER, C			RELIGIOUS DELUSION 13 YEARS AFTER HEAD-INJURY	NEUROCHIRURGIE			French	Article						DELUSION; HEAD INJURY	PSYCHOSIS; EPILEPSY	We report herewith a case of religious delusion in a 39 years old woman. She had suffered a head injury with right temporal concussion 13 years before but had no earlier history of psychiatric disorder. In view of the fact that this acute psychiatric state lasted for a short duration of time and that personality and affects were preserved, this incident is compared to the schizophreniform disorder of the type DSM-III-R. The hypothesis of an acquired predisposition due to head injury has been put forward as an explanation.			ASSAL, G (corresponding author), CHU VAUDOIS,DIV AUTONOME NEUROPSYCHOL,CH-1011 LAUSANNE,SWITZERLAND.						ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; ASSAL G, 1973, ARCH SUISS NEUROL, V112, P115; Assal G., 1985, ARCH SUISS NEUROL, V136, P33; BLEULER E, 1951, BRIT MED J, V2, P1233; CUMMINGS JL, 1985, BRIT J PSYCHIAT, V146, P184, DOI 10.1192/bjp.146.2.184; EY H, 1951, ETUDES CLIN, V3, P201; FLORHENRY P, 1969, EPILEPSIA, V10, P363, DOI 10.1111/j.1528-1157.1969.tb03853.x; GUALTIERI T, 1991, BRAIN INJURY, V32, P219; Guard O, 1979, REV MED, V40, P2115; LEVINE DN, 1982, NEUROLOGY, V32, P267, DOI 10.1212/WNL.32.3.267; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MACE CJ, 1991, J NEUROL NEUROSUR PS, V54, P639, DOI 10.1136/jnnp.54.7.639; MAGNAN V, 1893, LECONS CLIN; PEROUTKA SJ, 1982, JOHNS HOPKINS MED J, V151, P181; PRICE BH, 1985, J NERV MENT DIS, V173, P610, DOI 10.1097/00005053-198510000-00006; SHERWIN I, 1982, ARCH NEUROL-CHICAGO, V39, P621, DOI 10.1001/archneur.1982.00510220019004; SLATER E, 1963, BRIT J PSYCHIAT, V109, P95, DOI 10.1192/bjp.109.458.95; STECK H, 1927, SCHWEIZ ARCH NEUR, V21, P214; WAXMAN SG, 1974, NEUROLOGY, V24, P269	19	2	2	0	1	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0028-3770			NEUROCHIRURGIE	Neurochirurgie		1992	38	6					381	384					4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KL098	WOS:A1992KL09800010	1306896				2022-02-06	
J	STARIKOV, AS; KASUMOVA, TT				STARIKOV, AS; KASUMOVA, TT			NONSPECIFIC RESISTANCE AND SOME IMMUNOLOGICAL CHARACTERISTICS IN BRAIN CONCUSSION	ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article								As many as 55 healthy persons and 69 victims with brain contusion of medium and severe degree were examined. Inhibition of cellular immunologic reactions and attenuation of nonspecific resistance as well as increase of immunoglobulins, immune complexes and cerebral antibodies were revealed. These changes were found to be more pronounced in a severe brain contusion.	RYAZAN MED INST,CHAIR MICROBIOL,RYAZAN,USSR		STARIKOV, AS (corresponding author), RYAZAN MED INST,CHAIR NERVOUS DIS & NEUROSURG,RYAZAN,USSR.						AKIMOV GA, 1978, ZH NEVROPATOL PSIKH, P370; ANER L, 1976, J NEUROL PSYCHIAT, V39, P1076; DERYABIN II, 1982, VOPR NEIROKHIR, P9; DETLAV IE, 1976, ZH NEVROPATOL PSIKH, P344; GANNUSHKINA IV, 1974, IMMUNOLOGICHESKIE AS; GRIGOROVA IA, 1986, THESIS KHARKOV; KASUMOVA TT, 1990, THESIS RYAZAN; KHARITONOVA NI, 1983, IMMUNOLOGICHESKIE RE; Livshits L Ia, 1975, Vopr Neirokhir, P33; MOROZOV VV, 1984, VOPR NEIROKHIR, P41; PAVLOVICHEV SA, 1977, VOPR NEIROKHIR, P18; PISHEL YV, 1984, ZH NEVROPATOL PSIKH, P672; Prochazka M, 1971, Int Surg, V55, P322; RUDENKO VA, 1989, ZH NEVROPATOL PSIKH, P28; RUDENKO VA, 1985, THESIS KIEV; SOKOLOVA TF, 1984, VOPR NEIROKHIR, P27; STEFAN I, 1971, INT SURG, V55, P316	17	2	2	0	0	IZD VO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	0044-4588			ZH NEVROPATOL PSIKH	Zhurnal Nevropatol. Psikhiatrii Im. S S Korsakova		1992	92	3					38	40					3	Clinical Neurology; Pathology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology; Psychiatry	HX044	WOS:A1992HX04400013	1332327				2022-02-06	
J	TANAKA, Y; BACHMAN, DL; MIYAZAKI, M				TANAKA, Y; BACHMAN, DL; MIYAZAKI, M			PHARMACOTHERAPY FOR AKINESIA FOLLOWING ANTERIOR COMMUNICATING ARTERY ANEURYSM HEMORRHAGE	JAPANESE JOURNAL OF MEDICINE			English	Article						DOPAMINE AGONIST; BROMOCRIPTINE; HEAD INJURY		The dopamine system may be involved in three situations: the nigral projection to the basal ganglia, the mesocortical projection to the anterior cingulate gyrus, or the medial forebrain bundle projection to cortical and limbic sites. Because of the close association of dopamine systems with the known neurological syndromes of akinesia, we elected to treat a patient with akinesia due to rupture of anterior communicating artery (ACA) aneurysm with the dopamine agonist, bromocriptine. This case has important implications for the understanding of brain/behavior relationships as well as for the development of new therapies for patients who have sustained neurological injury.			TANAKA, Y (corresponding author), YODOGAWA CHRISTIANS HOSP,DEPT CEREBROVASC MED,2-9-26 AWAJI,HIGASHIYODOGAWA KU,OSAKA 553,JAPAN.							0	2	2	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO 113, JAPAN	0021-5120			JPN J MED		NOV-DEC	1991	30	6					542	544					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA499	WOS:A1991HA49900009	1798213				2022-02-06	
J	BOISSON, D				BOISSON, D			SEQUELAE AND REHABILITATION OF HEAD-INJURY	CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY			English	Article							MEMORY; RECOVERY; PERFORMANCE; SURVIVORS; AMNESIA	The increasing prevalence of traumatic brain injury is becoming an enormous problem for health care. Reports about social and vocational outcome are becoming more abundant. At the same time, a better evaluation of the neuropsychological outcome of brain-injured patients, essential for realistic functional treatment in rehabilitation, is developing.			BOISSON, D (corresponding author), HOP NEUROL & NEUROCHIRURG P WERTHEIMER,SERV REEDUCAT,LYON MONTCHAT,F-69394 LYONS,FRANCE.						ADAMS KM, 1991, J CLIN EXP NEUROPSYC, V13, P388, DOI 10.1080/01688639108401053; BENSON DF, 1990, SCHIZOPHRENIA BULL, V16, P403, DOI 10.1093/schbul/16.3.403; BENYISHAY Y, 1987, J HEAD TRAUMA REHABI, V2, P1; BERROL S, 1990, ARCH NEUROL-CHICAGO, V47, P219, DOI 10.1001/archneur.1990.00530020127025; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BRUYER R, 1991, NEUROPSYCHOLOGIE MEM; CORRIGAN J D, 1990, Brain Injury, V4, P215, DOI 10.3109/02699059009026170; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; GROWASSER Z, 1990, J NEUROSURG, V72, P81; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; HUTCHINSON DO, 1991, ELECTROEN CLIN NEURO, V78, P228, DOI 10.1016/0013-4694(91)90037-5; JOHNSTON MV, 1991, AM J PHYS MED REHAB, V70, P40, DOI 10.1097/00002060-199102000-00008; KARNATH HO, 1991, NEUROPSYCHOLOGIA, V29, P271, DOI 10.1016/0028-3932(91)90042-7; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; LEVIN H S, 1990, Annales de Readaptation et de Medecine Physique, V33, P35; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1987, J CLIN EXPT NEUROPSY, V10, P119; LYNCH W, 1990, J HEAD TRAUMA REHAB, V5, P78; LYNCH WJ, 1990, J HEAD TRAUMA REHABI, V5, P101; MALEC J, 1990, J HEAD TRAUMA REHAB, V5, P60; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MILNER B, 1985, HUM NEUROBIOL, V4, P137; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; ONOFRJ M, 1991, ACTA NEUROL SCAND, V83, P273, DOI 10.1111/j.1600-0404.1991.tb04700.x; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; SAZBON L, 1991, J NEUROL NEUROSUR PS, V54, P149, DOI 10.1136/jnnp.54.2.149; SHACTER DL, 1990, J CLIN EXP NEUROPSYC, V12, P155; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; STARKSTEIN SE, 1991, BIOL PSYCHIAT, V29, P149, DOI 10.1016/0006-3223(91)90043-L; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Weber A. M., 1990, J HEAD TRAUMA REHABI, V5, P73, DOI [10.1097/00001199-199003000-00012, DOI 10.1097/00001199-199003000-00012]; Wehman P, 1989, Brain Inj, V3, P397, DOI 10.3109/02699058909004563; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V70, P1047	54	2	3	0	0	CURRENT SCIENCE LTD	LONDON	34-42 CLEVELAND STREET, LONDON, ENGLAND W1P 6LB	0951-7383			CURR OPIN NEUROL NEU		OCT	1991	4	5					720	724					5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH009	WOS:A1991GH00900012	10148438				2022-02-06	
J	STOKES, BT; ALTSCHULD, RA; HOHL, CM; LI, Q; ANDERSON, DK				STOKES, BT; ALTSCHULD, RA; HOHL, CM; LI, Q; ANDERSON, DK			ENERGY DEPLETION IN CULTURE - ADENINE-NUCLEOTIDES ARE ALTERED AS INVIVO	MOLECULAR AND CHEMICAL NEUROPATHOLOGY			English	Article						DEENERGIZATION; TISSUE CULTURE; ENERGY METABOLISM; ATP DEPLETION	TRAUMATIC BRAIN INJURY; CORTICAL CELL-CULTURE; FELINE SPINAL-CORD; GLUTAMATE NEUROTOXICITY; METABOLISM; ISCHEMIA; CALCIUM; NUCLEOSIDES; DAMAGE	Modeling of ischemic phenomena in vitro has been hindered by the inability to create specific alterations in the variables of interest over a defined time-frame. In particular, changes in the adenine nucleotide pool have been quite difficult to mimic because of the putative low metabolic rate in culture and the long times necessary to achieve even partial chemical energy depletion. Here we present evidence for a rapid method of producing a profound chemical energy depletion with the combination of a NADH dehydrogenase inhibitor (amytal) and a mitochondrial proton ionophore (CCCP). Treatment with our protocol in enriched spinal cultures results in a 40% decrease in ATP within 2 min and a fall to one-third of control values by 15 min. The overall pool size of the total adenine nucleotides is decreased 46% by 15 min and does not completely recover after 5 min of reenergization. The ATP/ADP ratio declines to one-third of control values during deenergization and returns to control values after 5 min in control buffer. Such a loss of the total adenylate pool closely mimics that seen in vivo during ischemia and provides an in vitro model system in which the effects of the combination of this means of cellular injury with others (e.g., excitotoxins) may be examined.	OHIO STATE UNIV, DEPT PHYSIOL CHEM, COLUMBUS, OH 43210 USA; VET ADM MED CTR, CINCINNATI, OH 45220 USA; UNIV CINCINNATI, DEPT NEUROL, CINCINNATI, OH 45221 USA		STOKES, BT (corresponding author), OHIO STATE UNIV, DEPT PHYSIOL, COLUMBUS, OH 43210 USA.						ALTSCHULD RA, 1987, J BIOL CHEM, V262, P13527; ANDERSON DK, 1980, J NEUROSURG, V53, P375, DOI 10.3171/jns.1980.53.3.0375; ANDERSON DK, 1983, NEUROLOGY, V33, P722, DOI 10.1212/WNL.33.6.722; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1987, J NEUROSCI, V7, P357; DANIELISOVA V, 1987, NEUROCHEM RES, V12, P241, DOI 10.1007/BF00972133; DEMEDIUK P, 1985, IN VITRO CELL DEV B, V21, P569; GEISBUHLER T, 1984, CIRC RES, V54, P536, DOI 10.1161/01.RES.54.5.536; HAMMER DF, 1988, ANAL BIOCHEM, V169, P300, DOI 10.1016/0003-2697(88)90288-6; HAYASHI N, 1984, Neurological Surgery, V12, P923; LI Q, 1989, AM J PHYSIOL, V257, pC427, DOI 10.1152/ajpcell.1989.257.3.C427; LI Q, 1988, AM J PHYSIOL, V255, pC162, DOI 10.1152/ajpcell.1988.255.2.C162; SCHULTZ V, 1978, J BIOL CHEM, V253, P1938; SIESJO BK, 1988, DIABETES METAB REV, V4, P113, DOI 10.1002/dmr.5610040203; SIESJO BK, 1988, ANN NY ACAD SCI, V522, P638; STOKES BT, 1990, TROPHIC FACTORS NERV, P279; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; WALKER JG, 1979, J NEUROCHEM, V33, P397, DOI 10.1111/j.1471-4159.1979.tb11752.x	19	2	2	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1044-7393			MOL CHEM NEUROPATHOL	Mol. Chem. Neuropathol.	AUG	1991	15	1					29	35		10.1007/BF03161054			7	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	GL469	WOS:A1991GL46900003	1772532	Bronze			2022-02-06	
J	SEGAL, RL; YOUSSEF, EL				SEGAL, RL; YOUSSEF, EL			WRIST MOVEMENTS IN ABLE-BODIED AND BRAIN INJURED INDIVIDUALS	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						SPASTICITY; WRIST	VOLUNTARY MOVEMENT; CO-ACTIVATION; SPASTICITY; MUSCLE; SYSTEM	The purpose of this study was to compare movement velocity characteristics during targeted wrist movements between able-bodied individuals and a sample of individuals with spasticity secondary to closed head injury. Two amplitudes (30-degrees and 60-degrees) of movement were performed at slow and fast velocities, with the forearm either passively supported or actively supported by elbow extension and shoulder flexion. Variables measured were the following: (1) average velocity of entire movement, (2) velocity for 10-degrees increments of a movement, and (3) ratio of average peak 10-degrees increment velocity to average velocity. In addition, qualitative examination of velocity profiles was performed. Slow movements were performed in a discontinuous manner by both groups; however, observable differences in peak/average velocity were noted between groups in the unsupported position during slow and fast movements. Able-bodied individuals performed seven of eight fast movements with greater velocity (p < .05) than brain injured individuals, and the fast movements of the able-bodied subjects were continuous.			SEGAL, RL (corresponding author), EMORY UNIV,SCH MED,DEPT REHABIL MED,DIV PHYS THERAPY,1441 CLIFTON RD NE,ATLANTA,GA 30322, USA.						ANGEL RW, 1981, PROGR CLIN NEUROPHYS, V9, P347; ASHWORTH B, 1964, PRACTITIONER, V192, P540; BENECKE R, 1985, EXP BRAIN RES, V59, P470; BOUISSET S, 1974, BRAIN RES, V71, P451, DOI 10.1016/0006-8993(74)90988-3; BROOKS VB, 1986, NEURAL BASIS MOTOR C, P5; GIELEN CCAM, 1984, J NEUROPHYSIOL, V52, P553, DOI 10.1152/jn.1984.52.3.553; HASAN Z, 1985, EXP BRAIN RES, V59, P441; HASAN Z, 1986, BIOL CYBERN, V53, P373, DOI 10.1007/BF00318203; HOFFMAN DS, 1986, J NEUROSCI, V6, P3309; HOGAN N, 1984, J NEUROSCI, V4, P2745; HUFSCHMIDT A, 1985, J NEUROL NEUROSUR PS, V48, P676, DOI 10.1136/jnnp.48.7.676; HUMPHREY DR, 1986, FED PROC, V45, P2687; KNUTSSON E, 1980, SCAND J REHABIL MED, V12, P93; LEE WA, 1987, EXP NEUROL, V98, P317, DOI 10.1016/0014-4886(87)90245-7; Pachella R., 1974, HUMAN INFORMATION PR, P41; PEW RW, 1969, ACTA PSYCHOL, V30, P16, DOI 10.1016/0001-6918(69)90035-3; ROSENFALCK A, 1980, J NEUROL NEUROSUR PS, V43, P907, DOI 10.1136/jnnp.43.10.907; SAHRMANN SA, 1977, ANN NEUROL, V2, P460, DOI 10.1002/ana.410020604; SEGAL R, 1989, PHYS THER, V69, P383; SMITH AM, 1981, CAN J PHYSIOL PHARM, V59, P733, DOI 10.1139/y81-110; STEIN RB, 1982, BEHAV BRAIN SCI, V5, P535, DOI 10.1017/S0140525X00013327; WOLF SL, 1983, PHYS THER, V63, P1393, DOI 10.1093/ptj/63.9.1393	22	2	2	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	1991	72	7					454	459					6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FP702	WOS:A1991FP70200002	2059115				2022-02-06	
J	BROOKE, MM; ANDARY, MT; MITSUDA, PM; THERRIAULT, TM				BROOKE, MM; ANDARY, MT; MITSUDA, PM; THERRIAULT, TM			TELEPHONE USE TO ELICIT VOICE OR SPEECH IN BRAIN INJURED SUBJECTS	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						BRAIN INJURIES; DYSPHAGIA; SPEECH PATHOLOGY; TELEPHONE	CLOSED HEAD TRAUMA; DISORDERS	The initiation of speech is often delayed in the early stages of recovery from a serious brain injury. We have found a high percentage of patients with both speech and swallowing problems. This makes bedside assessment of swallowing safety difficult because one cannot listen for the sound of aspirated material on the vocal cords when a patient is at high risk for silent aspiration and is often unable to cooperate with a videofluoroscopic study. The use of the telephone has been described several times for aphasia treatment, but not to elicit speech or assess swallowing safety early after brain injury. This study, therefore, recruited subjects who had brain injuries and (1) were referred early for swallowing and other evaluations, (2) were out of coma and able to follow some commands, and (3) did not initiate voice or speak when asked to. Subjects were asked three questions under two different conditions: face to face and after ringing the telephone from another room. The results were recorded on videotape and analyzed by another investigator for quantifiable differences. Six of the seven subjects responded better with the telephone stimulus than without. This technique may elicit voice or speech early after brain injury in some patients and may be useful in bedside assessment of swallowing safety. It may also serve as an example of appropriate stimulation of brain injured subjects coming out of coma.	MICHIGAN STATE UNIV,COLL OSTEOPATH MED,DEPT REHABIL MED,E LANSING,MI 48824		BROOKE, MM (corresponding author), UNIV WASHINGTON,SCH MED,DEPT REHABIL MED,RJ-30,1959 NE PACIFIC ST,SEATTLE,WA 98195, USA.		Andary, Michael/O-9975-2019	Andary, Michael/0000-0003-3897-6327			Brooke MM, 1989, J NEUROL REHABIL, V3, P27; Darley FL, 1982, APHASIA; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; Hagen C, 1979, REHABILITATION HEAD, P87; HELMESTABROOKS N, 1986, ARCH PHYS MED REHAB, V67, P51; JENNETT B, 1975, LANCET, V1, P480; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Vaughn G R, 1976, ASHA, V18, P13; Yorkston KM, 1989, J HEAD TRAUMA REHAB, V4, P1	9	2	2	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	1991	72	2					106	108					3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	EX239	WOS:A1991EX23900003	1703759				2022-02-06	
J	TOMINAGA, I; MATSUO, Y; KATO, Y; ONAYA, M; KASAHARA, M; YUZURIHA, T; ODA, T; KASHIMA, H; WASADA, K				TOMINAGA, I; MATSUO, Y; KATO, Y; ONAYA, M; KASAHARA, M; YUZURIHA, T; ODA, T; KASHIMA, H; WASADA, K			PROLONGED TRAUMATIC COMA DUE TO DIFFUSE AXONAL INJURY	REVUE NEUROLOGIQUE			French	Article							COMPUTED-TOMOGRAPHY; HEAD-INJURIES; BRAIN-DAMAGE	A 22-year old male patient was admitted for deep coma probably of traumatic origin. There was neither fracture of the skull nor expansive intracranial lesion. The patient survived for 6 years and 8 months without any change in consciousness. Post-mortem neuropathological examination showed lesions which predominated in the white matter and had features that were compatible with diffuse axonal injury. The mechanism responsible for these lesions seems to be stretching and shearing of axones at the moment of impact. The exceptionally long duration of survival probably accounts for the severity of the lesions observed.	BUR EXAMINATEURS MED TOKYO, TOKYO, JAPAN; UNIV MEIJI GAKUIN, FAC SOCIOL, TOKYO, JAPAN; UNIV KEIO, FAC MED, SERV NEUROPSYCHIAT, TOKYO, JAPAN; HOP CENT FORCES DEF, SERV NEUROCHIRURG, TOKYO, JAPAN		TOMINAGA, I (corresponding author), HOP NATL CHIBA, SERV NEUROPSYCHIAT, 4-1-2 TSUBAKIMORI, CHIBA 260, JAPAN.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ANDERSON JR, 1973, J NEUROL NEUROSUR PS, V36, P826, DOI 10.1136/jnnp.36.5.826; BETHLEM J, 1968, PSYCHIAT NEUROL NEUR, V71, P281; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; DENST J, 1958, J NEUROPATH EXP NEUR, V17, P450, DOI 10.1097/00005072-195807000-00005; FRENCH JD, 1952, AMA ARCH NEUROL PSY, V68, P727, DOI 10.1001/archneurpsyc.1952.02320240002001; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GIRARD P. F., 1963, ACTA NEUROPATHOL, V2, P313; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Holbourn AHS, 1943, LANCET, V2, P438; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; OSETOWSKA E, 1964, J NEUROL SCI, V1, P458, DOI 10.1016/0022-510X(64)90114-5; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; YOKOTA H, 1989, Neurological Surgery, V17, P1133; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; [No title captured]	22	2	3	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787	2213-0004		REV NEUROL-FRANCE	Rev. Neurol.		1991	147	10					658	662					5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GN137	WOS:A1991GN13700004	1763255				2022-02-06	
J	RUSONIS, ES				RUSONIS, ES			ADOLESCENTS WITH CLOSED HEAD-INJURY - NEUROPSYCHOLOGICAL CONSEQUENCES	MEDICAL CLINICS OF NORTH AMERICA			English	Article									UNIV MARYLAND,SCH MED,DEPT PEDIAT,DIV ADOLESCENT MED,ADOLESCENT TRAUMA RECOVERY PROGRAM,BALTIMORE,MD 21201								ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BAKER SP, 1984, INJURY FACT BOOK; BAUMRIND D, 1987, ADOLESCENT SOCIAL BE; BRINK JD, 1970, DEV MED CHILD NEUROL, V24, P1019; BROOKS DN, 1976, NEUROL NEUROPSYCHIAT, V339, P593; FRANKOWSKI RF, EPIDEMIOLOGICAL DE 1; GAIDOLFI E, 1980, ITAL J NEUROL SCI, V1, P65; IRWIN CE, 1986, J ADOLESCENT HEALTH, V7, pS82; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RICHARDSON F, 1963, DEV MED CHILD NEUROL, V5, P471; RUNYAN CW, 1989, JAMA-J AM MED ASSOC, V262, P2273, DOI 10.1001/jama.262.16.2273; SLATER EJ, 1988, AM J DIS CHILD, V142, P1048, DOI 10.1001/archpedi.1988.02150100042022; SLATER EJ, 1989, J ADOLESCENT HEALTH, V10, P237, DOI 10.1016/0197-0070(89)90240-4; SLATER EJ, 1988, MAY SOC PED RES WASH; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WILLIAMS AF, 1985, PEDIATRICIAN, V12, P37; 1985, INJURY AM CONTINUING; 1984, MORBID MORTAL WEEKLY, V33, P699; 1989, JAMA-J AM MED ASSOC, V261, P2025	26	2	2	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0025-7125			MED CLIN N AM	Med. Clin. N. Am.	SEP	1990	74	5					1311	1319		10.1016/S0025-7125(16)30518-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DX295	WOS:A1990DX29500017	2201859				2022-02-06	
J	LEISMAN, G				LEISMAN, G			LATERALIZED EFFECTS OF MIGRAINE AND ANS SEIZURES AFTER CLOSED HEAD-INJURY	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article; Proceedings Paper	SYMP AT THE 12TH ANNUAL MEETING OF THE EUROPEAN CONF OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOC : NEUROPSYCHOLOGICAL SYSTEMS DEFICITS AFTER CLOSED HEAD INJURY	JUL 05-08, 1989	ANTWERP, BELGIUM	INT NEUROPSYCHOL SOC							LEISMAN, G (corresponding author), NATL INST COMPLEMENTARY MED,50 MAPLE PL,MANHASSET,NY 11030, USA.		Leisman, Gerry/U-3267-2019	Leisman, Gerry/0000-0002-9975-7331			ASHWORTH B, 1985, SCOT MED J, V30, P240, DOI 10.1177/003693308503000413; BAROLIN G. S., 1966, EPILEPSIA, V7, P53, DOI 10.1111/j.1528-1157.1966.tb03370.x; BASSER LS, 1969, BRAIN, V82, P285; BEHRMAN S, 1977, INJURY, V9, P74, DOI 10.1016/0020-1383(77)90059-6; BLISS TVP, 1983, J PHYSIOL-LONDON, V334, P475, DOI 10.1113/jphysiol.1983.sp014507; CANTOR FK, 1971, NEUROLOGY, V21, P430; CAPLAN L, 1981, NEUROLOGY, V31, P1167, DOI 10.1212/WNL.31.9.1167; Caveness W F, 1977, Trans Am Neurol Assoc, V102, P136; COLLINS RC, 1979, ANN NEUROL, V6, P117, DOI 10.1002/ana.410060207; COTMAN CW, 1980, BEHAVIORAL NEUROSCIE; COWAN DP, 1979, SCIENCE, V205, P1401; CROWELL GF, 1984, ARCH NEUROL-CHICAGO, V41, P75, DOI 10.1001/archneur.1984.04050130081029; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; DENOORDHOUT AM, 1985, CEPHALALGIA S3, V5, P34; FEDIO P, 1974, BRAIN LANG, V1, P29, DOI 10.1016/0093-934X(74)90024-8; FEROMILONE F, 1985, CEPHALALGIA, V5, P470; FISHER CM, 1982, ARCH NEUROL-CHICAGO, V39, P605, DOI 10.1001/archneur.1982.00510220003001; Fisher CM, 1964, ACTA NEUROL SCAND S9, V40, P1; FRIED I, 1982, BRAIN, V105, P349, DOI 10.1093/brain/105.2.349; GLOOR P, 1982, ANN NEUROL, V12, P129, DOI 10.1002/ana.410120203; GRANT SJ, 1981, PSYCHOPHARMACOLOGY C, P5; JACOME DE, 1986, HEADACHE, V26, P515, DOI 10.1111/j.1526-4610.1986.hed2610515.x; Lashley KS, 1941, ARCH NEURO PSYCHIATR, V46, P331, DOI 10.1001/archneurpsyc.1941.02280200137007; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LIEB JP, 1976, EPILEPSIA, V17, P137, DOI 10.1111/j.1528-1157.1976.tb03392.x; LIEB JP, 1982, EPILEPSIA, V23, P1, DOI 10.1111/j.1528-1157.1982.tb05046.x; LOE PR, 1969, ELECTROEN CLIN NEURO, V26, P395, DOI 10.1016/0013-4694(69)90089-3; LUX HD, 1974, EPILEPSIA, V15, P375, DOI 10.1111/j.1528-1157.1974.tb04015.x; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MATTHEW NT, 1974, STROKE, V5, P303; MAYEUX R, 1980, NEUROLOGY, V30, P120, DOI 10.1212/WNL.30.2.120; Maynert E W, 1975, Adv Neurol, V13, P79; MILNER B, 1958, Res Publ Assoc Res Nerv Ment Dis, V36, P244; MISHKIN M, 1982, PHILOS T R SOC B, V298, P85, DOI 10.1098/rstb.1982.0074; NOVELLY RA, 1984, ANN NEUROL, V15, P64, DOI 10.1002/ana.410150112; OJEMANN G, 1980, EPILEPSY WINDOW BRAI, P243; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; OLIVIER A, 1982, ANN NEUROL, V10, P428; OMMAYA AK, 1956, HEAD INJURIES, P49; RAO NS, 1971, BRAIN, V94, P289, DOI 10.1093/brain/94.2.289; RAUCH R, 1982, EPILEPSIA, V23, P292; SAKAI F, 1979, HEADACHE, V19, P257, DOI 10.1111/j.1526-4610.1979.hed1905257.x; Schoenen J, 1985, CEPHALALGIA S3, V5, P480; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHUPING JR, 1980, ANN NEUROL, V7, P281, DOI 10.1002/ana.410070313; VIJAYAN N, 1975, ARCH NEUROL-CHICAGO, V32, P649, DOI 10.1001/archneur.1975.00490520019001; WEISER HG, 1980, ELECTROENCEPHALOGR C, V48, P558; WELCH KMA, 1982, DEV NEUROSCI-AMSTER, V14, P551; WELCH KMA, 1984, NEUROLOGY, V24, P705	49	2	2	0	0	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1990	54	1-2					63	82		10.3109/00207459008986622			20	Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ078	WOS:A1990DZ07800007	2265966				2022-02-06	
J	DILLER, L				DILLER, L			COGNITIVE REMEDIATION FOLLOWING TRAUMATIC BRAIN INJURY - RESPONSE	REHABILITATION PSYCHOLOGY			English	Article											DILLER, L (corresponding author), NYU MED CTR,RES & TRAINING CTR HEAD TRAUMA & STROKE,400 E 34TH ST,NEW YORK,NY 10016, USA.						GLISKY EL, 1988, J LEARN DISABIL-US, V21, P333, DOI 10.1177/002221948802100604; GROSS T, 1986, CLIN NEUROPSYCHOLOGY, P179; LUBORSKY L, 1988, INT J PSYCHOANAL, V69, P75; MAYER NH, 1986, CLIN NEUROPSYCHOLOGY, P205; Milton S. B., 1986, CLIN NEUROPSYCHOLOGY, P223, DOI [10.1007/978-1-4613-2291-7_11, DOI 10.1007/978-1-4613-2291-7_11]; Scheerer M., 1941, PSYCHOL MONOGRAPHS, P53; SIVAK M, 1984, ARCH PHYS MED REHAB, V65, P163; WEHMAN P, 1988, REHABIL COUNS BULL, V31, P298	8	2	2	0	0	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	SUM	1989	34	2					131	133		10.1037//0090-5550.34.2.131			3	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AE974	WOS:A1989AE97400012					2022-02-06	
J	Braun, CMJ; Baribeau, JMC; Ethier, M				Braun, Claude M. J.; Baribeau, Jacinthe M. C.; Ethier, Marie			Interhemispheric Transfer after Spontaneous Recovery in 43 Cases of Severe Closed Head Injury	NEUROPSYCHOLOGY			English	Article						Interhemispheric transfer; closed head injury; corpus callosum; unilateral anomia; unilateral apraxia; bilateral writing	CORPUS-CALLOSUM; MAGNETIC-RESONANCE; CHRONIC-SCHIZOPHRENIA; LEFT HAND; LESIONS; TRAUMA; INFORMATION; PERCEPTION; APRAXIA	Postmortem histology, brain imaging, and four previously published case reports based on untimed behavioral tests suggest the possibility of frequent callosal disconnection following closed head injury (CHI). No group study has evaluated the frequency of occurrence of this syndrome in CHI using untimed behavioral measures of interhemispheric transfer. The present study consisted of an evaluation of interhemispheric transfer in 43 severe closed-head-injured patients using a wide-ranging battery of untimed behavioral tasks, after the period of spontaneous recovery. Only one patient showed signs of callosal disconnection. It was concluded that much effective interhemispheric transfer occurred in closed-head-injured patients after the period Of spontaneous recovery. More frequent occurrence of the disconnection syndrome in its acute phase is a possibility that cannot be excluded at the present time, however.	[Braun, Claude M. J.] Univ Quebec, Dept Psychol, POB 8888,Stn A, Montreal, PQ H3C 3P8, Canada; [Braun, Claude M. J.] Hotel Dieu Hosp, Dept Neurol, Montreal, PQ, Canada; [Braun, Claude M. J.; Baribeau, Jacinthe M. C.; Ethier, Marie] Concordia Univ, Dept Psychol, Montreal, PQ H3G 1M8, Canada		Braun, CMJ (corresponding author), Univ Quebec, Dept Psychol, POB 8888,Stn A, Montreal, PQ H3C 3P8, Canada.				National Research Council in Science and Engineering of Canada; FCAR council of the government of Quebec; CQRS council of the government of Quebec	This research was supported in part by grants from the National Research Council in Science and Engineering of Canada and the FCAR and CQRS councils of the government of Quebec. Thanks is given to Francine Lussier, who contributed some of the data collection and analysis.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ALEXANDER MP, 1982, PSYCHIATRIC ASPECTS, V2, P219; BENTIN S, 1984, NEUROPSYCHOLOGIA, V22, P601, DOI 10.1016/0028-3932(84)90024-1; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; Bogen J. E., 1985, THE DUAL BRAIN HEMIS; Bogen J. E., 1985, CLINICAL NEUROPSYCHO, P295; Braun C M, 1989, Brain Inj, V3, P345, DOI 10.3109/02699058909004559; Braun C M, 1989, Brain Inj, V3, P5, DOI 10.3109/02699058909008068; Braun C. M. J., 1987, P CLIN APH C; Braun C. M. J., 1989, J NEUROLOGIC REHABIL, V2, P21; CARR SA, 1980, BRIT J PSYCHIAT, V136, P53, DOI 10.1192/bjp.136.1.53; De Renzi E., 1982, DISORDERS SPACE EXPL; DIMOND SJ, 1980, J ABNORM PSYCHOL, V89, P505, DOI 10.1037/0021-843X.89.3.505; GANDY SE, 1984, ANN NEUROL, V16, P254, DOI 10.1002/ana.410160217; GEFFEN G, 1985, NEUROPSYCHOLOGIA, V23, P497, DOI 10.1016/0028-3932(85)90004-1; GERSH F, 1981, ARCH NEUROL-CHICAGO, V38, P634, DOI 10.1001/archneur.1981.00510100062009; GREEN P, 1980, J ABNORM PSYCHOL, V89, P399, DOI 10.1037/0021-843X.89.3.399; HAN JS, 1984, RADIOLOGY, V150, P71, DOI 10.1148/radiology.150.1.6689790; HANNAY H J, 1982, Journal of Clinical Neuropsychology, V4, P117; Harris A. J., HARRIS TESTS LATERAL; HATTA T, 1984, BIOL PSYCHIAT, V19, P1027; Holbourn A. H., 1943, LANCET, V438, P121; JONES GH, 1981, BRIT J PSYCHIAT, V139, P553, DOI 10.1192/bjp.139.6.553; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KIMURA D, 1964, Q J EXP PSYCHOL, V16, P355, DOI 10.1080/17470216408416391; KIMURA D, 1961, CAN J PSYCHOLOGY, V15, P166, DOI 10.1037/h0083219; Kimura D., 1967, CORTEX, V3, P163, DOI [10.1016/S0010-9452(67)80010-8, DOI 10.1016/S0010-9452(67)80010-8]; LASSONDE M, 1986, BRAIN, V109, P953, DOI 10.1093/brain/109.5.953; Lepore F., 1986, 2 HEMISPHERES ONE BR; Levin H. S., 1981, ARCH NEUROL-CHICAGO, V42, P963; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1985, ARCH NEUROL-CHICAGO, V42, P963, DOI 10.1001/archneur.1985.04060090045012; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; Levin HS., 1982, NEUROBEHAVIORAL CONS; LINDENBERG R, 1955, AM J PATHOL, V31, P297; Morrison D., 1985, SEMINARS NEUROLOGY, V5, P221; NASRALLAH HA, 1983, PSYCHIAT RES, V8, P251, DOI 10.1016/0165-1781(83)90013-6; Nilsson J., 1983, THESIS; Poffenberger A.T., 1912, ARCH PSYCHOL, V12, P1; Poncet M., 1983, NEUROLOGIE, V31, P539; POTTER SM, 1988, NEUROPSYCHOLOGIA, V26, P319, DOI 10.1016/0028-3932(88)90084-X; Rowbotyham G. F., 1949, ACUTE INJURIES HEAD; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; SCHOTT B, 1969, REV NEUROL-FRANCE, V120, P359; Sperry R.W., 1974, NEUROSCIENCES 3 STUD; SPERRY RW, 1968, AM PSYCHOL, V23, P723, DOI 10.1037/h0026839; Stritch S., 1979, LATE EFFECTS HEAD IN, P501; WALE J, 1986, NEUROPSYCHOLOGIA, V24, P483, DOI 10.1016/0028-3932(86)90093-X; WATSON RT, 1983, BRAIN, V106, P391, DOI 10.1093/brain/106.2.391; WEINSTEIN S, 1958, J COMP PHYSIOL PSYCH, V51, P269, DOI 10.1037/h0047187; Yamadori A, 1988, Behav Neurol, V1, P11, DOI 10.3233/BEN-1988-1103	51	2	2	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology		1989	3	2					91	102					12	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	V44JU	WOS:000209746100004					2022-02-06	
J	NYLANDER, I; RYDELIUS, PA				NYLANDER, I; RYDELIUS, PA			POST-CONCUSSION SYNDROME - BRAIN-DAMAGE, CONSTITUTIONAL CHARACTERISTICS AND ENVIRONMENTAL REACTIONS	ACTA PAEDIATRICA SCANDINAVICA			English	Article									KAROLINSKA INST,ST GORANS CHILDRENS HOSP,DEPT CHILD & ADOLESCENT PSYCHIAT,S-11281 STOCKHOLM,SWEDEN								HJERN B, 1962, ARCH DIS CHILD, V37, P113, DOI 10.1136/adc.37.192.113; HJERN B, 1964, ACTA PAEDIATR SCAN S, V152; MULLER R, 1958, ACTA PSYCHIATR NEU S, V126; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; RUTTER M, 1982, AM J PSYCHIAT, V139, P21; SANDBERG B, 1977, SVENSKA FORENINGEN P, V8; [No title captured]	7	2	2	0	2	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0001-656X			ACTA PAEDIATR SCAND		MAY	1988	77	3					475	477		10.1111/j.1651-2227.1988.tb10685.x			3	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	N9163	WOS:A1988N916300033	3389145				2022-02-06	
J	ZEFF, K; CHUNG, R				ZEFF, K; CHUNG, R			TRAUMATIC BRAIN INJURY AS AN ETIOLOGY OF ORGANIC AFFECTIVE SYNDROME	MILITARY MEDICINE			English	Article											ZEFF, K (corresponding author), TRIPLER ARMY MED CTR,DEPT PSYCHIAT,HONOLULU,HI 96859, USA.							0	2	2	0	0	ASSN MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814	0026-4075			MIL MED	Milit. Med.	OCT	1987	152	10					529	530					2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	K4607	WOS:A1987K460700014	3120050				2022-02-06	
J	KATAYAMA, Y; YOSHIDA, K; OGAWA, H; TSUBOKAWA, T				KATAYAMA, Y; YOSHIDA, K; OGAWA, H; TSUBOKAWA, T			TRAUMATIC HOMONYMOUS HEMIANOPIA ASSOCIATED WITH A JUXTASELLAR HEMATOMA AFTER ACUTE CLOSED HEAD-INJURY	SURGICAL NEUROLOGY			English	Article											KATAYAMA, Y (corresponding author), NIHON UNIV,SCH MED,DEPT NEUROL SURG,30-1 OYAGUCHIKAMIMACHI,ITABASHI KU,TOKYO 173,JAPAN.						BRANDLE K, 1955, Confin Neurol, V15, P169; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; HUGHES B, 1962, B JOHNS HOPKINS HOSP, V111, P98; ROWBOTHAM GF, 1964, ACUTE INJURIES HEAD, P410; SAVINO PJ, 1980, NEUROLOGY, V30, P963, DOI 10.1212/WNL.30.9.963; SCHESCHY H, 1972, KLIN MONATSBL AUGENH, V161, P309; STREIFF E B, 1951, Rev Otoneuroophtalmol, V23, P321; TIBBS PA, 1979, J TRAUMA, V19, P129, DOI 10.1097/00005373-197902000-00013; Traquair HM, 1935, BRAIN, V58, P398, DOI 10.1093/brain/58.3.398; WALSH FB, 1969, CLIN NEUROOPHTHALMOL, V3	10	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.		1985	24	3					289	292		10.1016/0090-3019(85)90041-2			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	APH12	WOS:A1985APH1200013	4023911				2022-02-06	
J	THIENPRASIT, P; FISHER, SV; ALCORN, MH				THIENPRASIT, P; FISHER, SV; ALCORN, MH			LONGTERM OUTCOME OF CLOSED HEAD-INJURY	MINNESOTA MEDICINE			English	Article											THIENPRASIT, P (corresponding author), UNIV MINNESOTA,DEPT NEUROSURG,MINNEAPOLIS,MN 55455, USA.						BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; JENNETT B, 1976, LANCET, V1, P1031; PAZZAGLIA P, 1975, J NEUROL NEUROSUR PS, V38, P149, DOI 10.1136/jnnp.38.2.149; [No title captured]	4	2	2	0	0	MINN MED ASSN	MINNEAPOLIS	SUITE 400 2221 UNIV AVE S E, MINNEAPOLIS, MN 55414	0026-556X			MINN MED			1985	68	7					559	561					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ALG63	WOS:A1985ALG6300017	4021975				2022-02-06	
J	SUMERKINA, MM				SUMERKINA, MM			CLINICAL-FEATURES OF CEREBRAL CONCUSSIONS IN CHILDHOOD	ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article											SUMERKINA, MM (corresponding author), YAROSLAVL MED INST,DEPT NERVOUS DIS,YAROSLAVL,USSR.						BADALYAN LO, 1980, RUKOVODSTVO NEVROLOG, P326; BADALYAN LO, 1975, DETSKAYA NEVROLOGIYA, P334; BEZUKH MS, 1960, VOPR NEIROKHIR, P40; BOEVA EM, 1961, THESIS MOSCOW; BONDARENKO ES, 1976, SOV MEDITISINA, P42; DAME NG, 1950, TRAVMATIZM DETEI BOR; KISELEV VP, 1971, CHEREPNO MOZGOVAYA T; KLYUCHIKOV VN, 1978, SOV MEDITISINA, P60; MAKAROVA EK, 1966, THESIS LENINGRAD; MOLODETSKIKH TD, 1979, THESIS MOSCOW; STOYANOV S, 1982, NEVROL PSIKHIATR NEV, V21, P129; SUMERKINA MM, 1978, 4YA VSER K NEVR PSIK, P89; SUSHKOV ND, 1971, VESTN KHIR, P118; WOLTER M, 1959, Zentralbl Neurochir, V19, P193; ZOGRABYAN SG, 1965, CHEREPNO MOZGOVAYA T	15	2	3	0	0	IZD VO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	0044-4588			ZH NEVROPATOL PSIKH	Zhurnal Nevropatol. Psikhiatrii Im. S S Korsakova		1984	84	2					218	221					4	Clinical Neurology; Pathology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology; Psychiatry	SF129	WOS:A1984SF12900014	6711209				2022-02-06	
J	VERIER, A; LESOIN, F; LOZES, G; JOMIN, M				VERIER, A; LESOIN, F; LOZES, G; JOMIN, M			CLINICAL AND PROGNOSTIC EVALUATION OF POST-TRAUMATIC COMA ACCORDING TO THE LEVEL OF BRAIN-STEM INJURY	SEMAINE DES HOPITAUX			French	Article											VERIER, A (corresponding author), CHU LILLE,SERV NEUROCHIRURG,F-59037 LILLE,FRANCE.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; BARGE M, 1979, REV EEG NEUROPHYSIOL, V9, P83, DOI 10.1016/S0370-4475(79)80062-3; BARGE M, 1977, NEUROCHIRURGIE, V23, P227; BLOND S, 1979, LILLE MED, V24, P388; BORN JD, 1982, NEUROCHIRURGIE, V28, P1; CHODKIEWICZ JP, 1972, NEUROCHIRURGIE, V18, P77; de Rougemont J, 1979, Neurochirurgie, V25, P199; ESPAGNO C, 1979, NEUROCHIRURGIE, V25, P206; ESPAGNO J, 1980, J TRAUMATOLOGIE, V1, P125; FISCHER CM, 1969, ACTA NEUROL SCAN S36, V45, P5; FREREBEAU P, 1979, NEUROCHIRURGIE, V25, P209; GARREL S, 1979, REV EEG NEUROPHYSIOL, V9, P139, DOI 10.1016/S0370-4475(79)80068-4; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; JENNETT B, 1977, LANCET, V1, P878; JOUVET M, 1964, Acta Neurochir (Wien), V12, P258, DOI 10.1007/BF01402097; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PEREZDOMINGUEZ E, 1978, NEUROCHIRURGIE, V24, P261; Plum F, 1966, DIAGNOSIS STUPOR COM; PRIVAT JM, 1979, NEUROCHIRURGIE, V25, P215; SICHEZ JP, 1980, J TRAUMATOLOGIE, V1, P115; TEASDALE G, 1974, LANCET, V2, P81; UZIEL A, 1979, REV EEG NEUROPHYSIOL, V9, P202, DOI 10.1016/S0370-4475(79)80076-3; [No title captured]; [No title captured]	24	2	2	0	0	EXPANSION SCI FRANCAISE	PARIS	31 BLVD LATOUR MAUBOURG, 75007 PARIS, FRANCE	0037-1777			SEM HOP PARIS	Sem. Hop.		1984	60	14					1014	1019					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ983	WOS:A1984SJ98300010	6326282				2022-02-06	
J	GIBSON, PH				GIBSON, PH			A QUANTITATIVE METHOD FOR COMPARING THE DISTRIBUTION OF CEREBRAL TRAUMA IN CLOSED-HEAD INJURIES WITH AND WITHOUT TENTORIAL HERNIATION	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article									NEWCASTLE GEN HOSP, DEPT PATHOL NEUROPATHOL, NEWCASTLE UPON TYNE NE4 6BE, TYNE & WEAR, ENGLAND								ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; BROWN DD, 1941, BRAIN, V64, P93; CROMPTON MR, 1971, LANCET, V1, P669; GIBSON PH, 1982, NEUROPATH APPL NEURO, V8, P489, DOI 10.1111/j.1365-2990.1982.tb00316.x; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Mayer E T, 1967, Arch Psychiatr Nervenkr (1970), V210, P238, DOI 10.1007/BF00367551; MITCHELL DE, 1973, LANCET, V2, P215; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; STRICH SJ, 1961, LANCET, V2, P443; STRICH SJ, 1976, GREENFIELDS NEUROPAT, P326; STRICH SJ, 1970, J CLIN PATHOL S4, V23, P166; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154	14	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.		1983	9	2					135	148		10.1111/j.1365-2990.1983.tb00331.x			14	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	QP463	WOS:A1983QP46300004	6866209				2022-02-06	
J	MOLODETSKIKH, TD; KIRDAN, KP				MOLODETSKIKH, TD; KIRDAN, KP			PSYCHOLOGICAL STRUCTURE OF POST-TRAUMATIC SYNDROMES IN CHILDREN WHO SUFFERED BRAIN CONCUSSIONS	ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article											MOLODETSKIKH, TD (corresponding author), MINIST PUBL HLTH USSR,PEDIAT & CHILD SURG RES INST,MOSCOW,USSR.						Besse M D, 1980, Anesth Analg (Paris), V37, P181; EKELOVABAGALEI EM, 1973, ZH NEVR PS, P1517; FISIRROVA F, 1974, CSL PEDIAT, V29, P276; GORDOVA TN, 1969, 5I VSES SEZD NEVR PS, V3, P355; IGNATENKO AM, 1972, THESIS LENINGRAD; KLEINPETER U, 1976, ACTA PAEDOPSYCHIATR, V42, P68; KOGAN VM, 1967, PSIKHOLOGICHESKIE ME, P72; KOLOSAR AV, 1973, 5I SEZD NEVR PSIKH U, P202; MANDRUSOVA ES, 1974, 1YA VSES K NEVR PSIK, P188; PETRENKO LV, 1976, NARUSHENIE VYSSHIKH	10	2	2	0	1	IZD VO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	0044-4588			ZH NEVROPATOL PSIKH	Zhurnal Nevropatol. Psikhiatrii Im. S S Korsakova		1983	83	10					1450	1454					5	Clinical Neurology; Pathology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pathology; Psychiatry	RQ417	WOS:A1983RQ41700003	6659776				2022-02-06	
J	GIBSON, PH				GIBSON, PH			A METHOD FOR DETERMINING TENTORIAL HERNIATION IN CLOSED-HEAD INJURY FROM A QUANTITATIVE ESTIMATION OF CEREBRAL TRAUMA	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article									NEWCASTLE GEN HOSP,DEPT PATHOL NEUROPATHOL,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND								ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; CROMPTON MR, 1971, LANCET, V1, P669; STRICH SJ, 1976, GREENFIELDS NEUROPAT, P327; STRICH SJ, 1961, LANCET, V2, P442; Tomlinson B, 1970, J CLIN PATHOL S4, V23, P154	5	2	2	0	0	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0305-1846			NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.		1982	8	6					489	493		10.1111/j.1365-2990.1982.tb00316.x			5	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	PX937	WOS:A1982PX93700006	7162561				2022-02-06	
J	WRIGHTSON, P; GRONWALL, D				WRIGHTSON, P; GRONWALL, D			ATTITUDES TO CONCUSSION IN YOUNG NEW-ZEALAND MEN	NEW ZEALAND MEDICAL JOURNAL			English	Article											WRIGHTSON, P (corresponding author), AUCKLAND HOSP,DEPT NEUROSURG,AUCKLAND,NEW ZEALAND.						EWING R, J CLIN NEUROPSYCHOL; GRONWALL, 1974, LANCET, V2, P605; GRONWALL D, 1975, LANCET, V2, P995; 1976, LANCET, V1, P401	4	2	2	0	1	NEW ZEALAND MED ASSN	WELLINGTON	PO BOX 156, WELLINGTON, NEW ZEALAND	0028-8446			NEW ZEAL MED J	N. Z. Med. J.		1980	92	671					359	361					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KQ267	WOS:A1980KQ26700009	6935553				2022-02-06	
J	NORMAN, RW; BISHOP, PJ; PIERRYNOWSKI, MR; PEZZACK, JC				NORMAN, RW; BISHOP, PJ; PIERRYNOWSKI, MR; PEZZACK, JC			AIRCREW HELMET PROTECTION AGAINST POTENTIAL CEREBRAL CONCUSSION IN LOW-MAGNITUDE IMPACTS	AVIATION SPACE AND ENVIRONMENTAL MEDICINE			English	Article											NORMAN, RW (corresponding author), UNIV WATERLOO,DEPT KINESIOL,WATERLOO N2L 3G1,ONTARIO,CANADA.						ADVANI SH, 1974, AUTOMOTIVE ENGINEERI; BENEDICT JV, 1971, ASME71WABHF6 PAP; CHOU CC, 1973, AUTOMOTIVE ENGINEERI; GADD CW, 1972, REPORT SAE PERFORMAN; GADD CW, 1966, 10 STAPP CAR CRASH C, P164; GLAISTER DH, 1975, AGARD629 REP; GURDJIAN ES, 1966, J TRAUMA, V5, P600; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; HODGSON VR, 1972, 16TH STAPP CAR CRASH, P292; HODGSON VR, 1973, BIOMECHANICAL STUDY; NEWMAN JA, 1975, 19TH STAPP CAR CRASH, P615; NOBLE RE, 1974, DCIEM74OR1057 OP REP; PEZZACK JC, 1977, J BIOMECH, V10, P377, DOI 10.1016/0021-9290(77)90010-0; RAYNE JM, 1969, AEROSPACE MED, V40, P631; RAYNE JM, 1969, RAE69160 TECHN REP; RAYNE JM, 1973, RAE73053 TECHN REP; SACZALSKI KJ, 1978, AVIAT SPACE ENVIR MD, V49, P114; SOPER DJG, 1965, 8TH COMM DEF C CLOTH; VERSACE J, 1971, 15TH P STAPP CAR CRA, P771; VIANO DC, 1975, 19TH P STAPP CAR CRA, P807; WINER BJ, 1972, STATISTICAL PRINCIPL, P309; WINTER DA, 1974, J BIOMECH, V7, P157, DOI 10.1016/0021-9290(74)90056-6; 1962, HELMET DESIGN CRITER	23	2	2	0	0	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579	0095-6562			AVIAT SPACE ENVIR MD	Aviat. Space Environ. Med.		1979	50	6					553	561					9	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	GY560	WOS:A1979GY56000001	475701				2022-02-06	
J	MATSUYAMA, M; NAMBA, S; HIGAKI, T; YAMADA, I; OSAWA, E				MATSUYAMA, M; NAMBA, S; HIGAKI, T; YAMADA, I; OSAWA, E			FLUORESCEIN ANGIOGRAPHIC STUDIES ON FUNDUS CHANGES IN OCULAR CONCUSSION	FOLIA OPHTHALMOLOGICA JAPONICA			Japanese	Article									OSAKA UNIV,SCH MED,DEPT OPHTHALMOL,OSAKA,JAPAN									0	2	2	0	0	ASSOC OF FOLIA OPHTHALMOL JAP	FUKUSHIMA-KU OSAKA	OSAKA UNIVERSITY MED SCHOOL DEPT OF OPHTHALMOLOGY, FUKUSHIMA-KU OSAKA JAPAN	0015-5667			FOLIA OPHTHALMOL JPN			1977	28	2					298	307					10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	DD383	WOS:A1977DD38300011					2022-02-06	
J	COE, JE; ANGYAN, AJ				COE, JE; ANGYAN, AJ			EFFECT OF HYPERBARIC OXYGENATION UPON RECOVERY OF MAZE PERFORMANCE AFTER EXPERIMENTAL CONCUSSION	JOURNAL OF TRAUMA			English	Article																	COE J, 1964, J NEUROSURG, V21, P433, DOI 10.3171/jns.1964.21.6.0433; Coe J E, 1966, Am Surg, V32, P493; EDWARDS AL, STATISTICAL METHODS, P542; OLSON LJ, 1961, EXP PAR, V19, P77; WEBB DO, 1946, J SURG PSYCH, V34, P59	5	2	2	0	0							J TRAUM			1971	11	5					436	&		10.1097/00005373-197105000-00009			0	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	J3817	WOS:A1971J381700009	5091699				2022-02-06	
J	GOVONS, SR; MERKEL, RA				GOVONS, SR; MERKEL, RA			INSTANTANEOUS POSTURAL REACTION OF CATTLE TO BRAIN CONCUSSION	AEROSPACE MEDICINE			English	Article																	ACCLES, PERSONAL COMMUNICATI; ALTMAN PL, 1962, GROWTH, P416; Denny-Brown D, 1941, BRAIN, V64, P7; Eden K., 1941, PROC ROY SOC MED, V34, P685; FINNEY L A, 1965, J Trauma, V5, P223, DOI 10.1097/00005373-196503000-00009; Govons S R, 1969, Bull Hist Med, V43, P473; GOVONS SR, 1968, CONFIN NEUROL, V30, P77; Magnus R, 1926, LANCET, V2, P531; Magnus R, 1926, LANCET, V2, P585; ROBERTS TD, 1967, NEUROPHYSIOLOGY POST, P201; ROBERTS TD, 1967, NEUROPHYSIOLOGY POST, P69; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SHERRINGTON CS, 1947, INTEGRATIVE ACTION N, P324	14	2	2	0	0	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579	0001-9402			AEROSPACE MED			1971	42	4					421	&					0		Science Citation Index Expanded (SCI-EXPANDED)		J0791	WOS:A1971J079100011	5155126				2022-02-06	
J	LIDBERG, L				LIDBERG, L			FREQUENCY OF CONCUSSION AND TYPE OF CRIMINALITY - PRELIMINARY REPORT	ACTA PSYCHIATRICA SCANDINAVICA			English	Article																	ANTONI N, 1945, NORD MED, V26, P955; EKBLAD M, 1948, EJNAR MUNKSGAARD COP; FREY T, 1951, NORDISK TIDSKRIFT KR, V39, P1; Healy W, 1925, ARCH NEURO PSYCHIATR, V14, P25, DOI 10.1001/archneurpsyc.1925.02200130028004; JOHANSSON E, 1968, ACT PSYC SC, V44, P203; JONSSON G, 1964, 222 STOCKHOLMSPOJKAR; JONSSON G, 1967, ACTA PSYCHIAT S S195, V43; KAILA M, 1947, ACTA PSYCHIAT NEUR S, V47, P80; MADSEN J, 1942, NORD MED, V16, P3657; OTTO U, 1960, Acta Paedopsychiatr, V27, P6; PENNINGTON LA, 1943, WAR MED, V4, P465; SNEDECHOR CW, 1967, STATISTICAL METHODS	12	2	2	0	7	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-690X			ACTA PSYCHIAT SCAND	Acta Psychiatr. Scand.		1971	47	4					452	&		10.1111/j.1600-0447.1971.tb03702.x			0	Psychiatry	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	L7244	WOS:A1971L724400009	5146716				2022-02-06	
J	PONTEN, U				PONTEN, U			TRAUMATIC BRAIN INJURIES	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article																	ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; BERMAN IR, 1969, J NEUROSURG, V30, P532, DOI 10.3171/jns.1969.30.5.0532; CUSHING H, 1902, MITTEILUNGEN GRENZGE, V9, P773; EICHBAUM FW, 1964, VIRCHOWS ARCH A, V338, P78, DOI 10.1007/BF00957632; Fay T, 1935, ANN SURG, V101, P76, DOI 10.1097/00000658-193501000-00011; GORDON E, 1971, ACTA ANAESTH SCA S39; Gurdjian E. S., 1944, SURG GYNECOL AND OBSTET, V78, P618; PONTEN U, 1971, SCAND NEUROSURG SOC; [No title captured]	9	2	2	0	1	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.		1971				45			123	&					0	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	L0954	WOS:A1971L095400020	5290066				2022-02-06	
J	BRYAN, N; WALKER, BE				BRYAN, N; WALKER, BE			CELLULAR RESPONSE IN BRAIN TO CONCUSSION	TEXAS REPORTS ON BIOLOGY AND MEDICINE			English	Article																	ADRAIN EK, 1962, J NEUROPATH EXP NEUR, V21, P597; GROAT R, 1950, J NEUROPATH EXP NEUR, V9, P150, DOI 10.1097/00005072-195004000-00003; HOMMES OR, 1967, J COMP NEUROL, V129, P269, DOI 10.1002/cne.901290304; KONIGSMARK BW, 1963, J NEUROPATH EXP NEUR, V22, P643; SMART I, 1961, J COMP NEUROL, V116, P349, DOI 10.1002/cne.901160307; SMITH CW, 1967, TEX REP BIOL MED, V25, P585; WALKER BR, 1963, TEX REP BIOL MED, V21, P615; WINDLE W. F., 1944, TRANS AMER NEUROL ASSOC, V70, P117	8	2	2	0	0	UNIV TEXAS	GALVESTON	MEDICAL BRANCH, GALVESTON, TX 77550	0040-4675			TEX REP BIOL MED			1969	27	1					27	&					0	Medicine, Research & Experimental; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Science & Technology - Other Topics	C8876	WOS:A1969C887600003	5782200				2022-02-06	
J	SHEV, EE; FINKLE, AL				SHEV, EE; FINKLE, AL			REVERSIBLE NEUROGENIC BLADDER FOLLOWING CEREBRAL AND-OR SPINAL CORD CONCUSSION	JOURNAL OF UROLOGY			English	Article																	BORS E, 1957, Urol Surv, V7, P177; BOSHES B, 1954, NEUROLOGY, V4, P690, DOI 10.1212/WNL.4.9.690; CARPENTER M B, 1952, U S Armed Forces Med J, V3, P1441; DEWEERD JH, 1957, JAMA-J AM MED ASSOC, V165, P1916, DOI 10.1001/jama.1957.02980330018005; EMMETT JL, 1954, UROLOGY, V2, P1285; MCCARROLL HR, 1957, JAMA-J AM MED ASSOC, V165, P1913, DOI 10.1001/jama.1957.02980330015004; MCLELLAN FC, 1939, NEUROGENIC BLADDER; MULLENIX RB, 1946, J UROLOGY, V55, P470, DOI 10.1016/S0022-5347(17)69940-3; Munger AD, 1937, J UROLOGY, V37, P54, DOI 10.1016/S0022-5347(17)72004-6; Munro D, 1943, NEW ENGL J MED, V229, P919, DOI 10.1056/NEJM194312162292501; NAFFZIGER HC, 1955, CLIN NEUROLOGY, V3, P1422; PRATHER GC, 1953, INJURIES SPINAL CORD; SCHWARTZ J W, 1954, Mil Med, V115, P411; WHITE JC, 1957, JAMA-J AM MED ASSOC, V165, P1924, DOI 10.1001/jama.1957.02980330026007	14	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0022-5347			J UROLOGY	J. Urol.		1959	81	5					653	658		10.1016/S0022-5347(17)66086-5			6	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	WF690	WOS:A1959WF69000012	13655379				2022-02-06	
J	SRIRAMACHARI, S; PIRANI, CL; HAYMAKER, W				SRIRAMACHARI, S; PIRANI, CL; HAYMAKER, W			THE EFFECT OF TRAUMATIC INJURY ON THE BRAIN OF VITAMIN-C-DEFICIENT GUINEA-PIGS	AMERICAN JOURNAL OF PATHOLOGY			English	Article																	BOURNE GH, 1942, LANCET, P661; GALLOWAY NM, 1948, BRIT J NUTR, V2, P228, DOI 10.1079/BJN19480039; GERSH I, 1949, AM J ANAT, V85, P457, DOI 10.1002/aja.1000850304; Glasunow M, 1937, VIRCHOWS ARCH A, V299, P120, DOI 10.1007/BF02084467; GORDON AS, 1952, ANAT REC, V112, P153, DOI 10.1002/ar.1091120203; MEYER ARTHUR W., 1928, STANFORD UNIV PUBL UNIV SER MED SCI, V2, P7; PENNEY JR, 1949, J PATHOL BACTERIOL, V61, P171, DOI 10.1002/path.1700610204; PIRANI CL, 1950, ARCH PATHOL, V49, P710; PIRANI CL, 1951, 81 US ARM MED NUTR L; PIRANI CL, 1951, 80 US ARM MED NUTR L; Wolbach S, 1936, NEW ENGL J MED, V215, P1158, DOI 10.1056/NEJM193612172152506; Wolbach SB, 1926, ARCH PATHOL LAB MED, V1, P1; Wolbach SB, 1933, AM J PATHOL, V9, P689	13	2	2	0	1	AMER SOC INVESTIGATIVE PATHOLOGY, INC	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202-3993	0002-9440			AM J PATHOL	Am. J. Pathol.		1956	32	1					131	139					9	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	WD466	WOS:A1956WD46600010	13275570				2022-02-06	
J	Dalsgaard-Nielsen, T; Hertz, H				Dalsgaard-Nielsen, T.; Hertz, H.			ELECTROENCEPHALOGRAPHY IN SIMPLE CONCUSSIONS	ACTA PSYCHIATRICA ET NEUROLOGICA SCANDINAVICA SUPPLEMENTUM			English	Article																		0	2	2	0	0	BLACKWELL MUNKSGAARD	FREDERIKSBERG C	1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK				ACTA PSYCH NEUROL SC	Acta Psychiatr. Neurol. Scand. Suppl.		1951	74						233	234					2	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	V00SZ	WOS:000206809000042	14902574				2022-02-06	
J	Silfverskiold, B				Silfverskiold, B. P.			THE TREATMENT OF THE POST-CONCUSSION SYNDROME	ACTA PSYCHIATRICA ET NEUROLOGICA SCANDINAVICA SUPPLEMENTUM			English	Article									Skeppargatan 56, Stockholm, Sweden									0	2	2	0	0	BLACKWELL MUNKSGAARD	FREDERIKSBERG C	1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK				ACTA PSYCH NEUROL SC	Acta Psychiatr. Neurol. Scand. Suppl.		1951	74						264	268					5	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	V00SZ	WOS:000206809000052	14902584				2022-02-06	
J	ECHLIN, FA				ECHLIN, FA			SPREADING DEPRESSION OF ELECTRICAL ACTIVITY IN THE CEREBRAL CORTEX FOLLOWING LOCAL TRAUMA AND ITS POSSIBLE ROLE IN CONCUSSION	ARCHIVES OF NEUROLOGY AND PSYCHIATRY			English	Article																	DENNYBROWN, 1941, BRAIN, V64, P223; 1944, J NEUROPHYSIOL, V7, P391; 1945, J NEUROPHYSIOL, V8, P33; 1947, J NEUROPHYSIOL, V10, P409; 1944, J NEUROPHYSIOL, V7, P369	5	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0096-6754			ARCH NEURO PSYCHIATR			1950	63	5					830	832					3	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	UF301	WOS:A1950UF30100015	15414072				2022-02-06	
J	ENGEL, D				ENGEL, D			HIGH BLOOD PRESSURE AFTER CONCUSSION	ACTA PSYCHIATRICA ET NEUROLOGICA			English	Article																	BEIGLBOCK W, 1934, Z KLIN MED, V127, P144; Berner O, 1930, VIRCHOWS ARCH A, V277, P386, DOI 10.1007/BF02275335; BORDLEY, J HOPKINS HOSP, V38, P320; Brock S, 1940, INJURIES SKULL BRAIN; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DIXONHELLER, 1932, ARCH EXPT PATHOL, V166; DURET H, 1920, TRAUMATISMES CEREBRA; FRIEDMANN M, 1892, ARCH PSYCHIATRIE NER, V23, P231; GOLDRING W, 1944, HYPERTENSION HYPERTE; KAHLER, 1924, ERG INN MED, V25; LASZLO, 1930, KLIN WOCHENSCHR, V34, P1576; MARBURG, 1936, BUMKEFORSTERS HDB NE, V11; NORDMANN M, 1932, VERH DTSCH GES KREIS, V5, P142; PAL, 1905, GEFASSKRISEN; POLIS A, 1894, REV CHIR, V14, P645; Polis A, 1894, REV CHIR, V14, P273; RAAB W., 1931, ZEITSCHR KLIN MED, V118, P181; RAAB W, 1931, MED KLIN; RAAB W, 1939, Z KLIN MED, V136, P362; ROBINSON SAMUEL C., 1939, ARCH INTERNAL MED, V64, P409; STAHLI W, 1947, SCHWEIZ MED WOCH, V51, P1342; WEISSMANN A, 1935, WIEN KLIN WOCH I, V48, P494; ZETTERHOLM S, 1947, ACTA PSYCHIATR NEU S, V45	23	2	2	2	2	BLACKWELL MUNKSGAARD	FREDERIKSBERG C	1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK	0365-558X			ACTA PSYCH NEUROL	Acta Psychiatr. Neurol.		1950	25	2-3					153	166		10.1111/j.1600-0447.1950.tb01629.x			14	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	XW906	WOS:A1950XW90600003	14770899				2022-02-06	
J	HOOPER, RS				HOOPER, RS			COMPLICATIONS OF CLOSED HEAD INJURIES	MEDICAL JOURNAL OF AUSTRALIA			English	Article																	CAIRNS H, 1946, BRIT MED J, V2, P322, DOI 10.1136/bmj.2.4470.322; CAIRNS H, 1943, BRIT MED J, V1, P591; COURVILLE CB, 1946, ARCH NEUROLOGY PSYCH, V55, P79; COURVILLE CB, 1945, ASS RES NERVOUS MENT, P132; COURVILLE CB, 1945, PATHOLOGY CENTRAL NE, P265; Dandy WE, 1933, J AMER MED ASSOC, V101, P772, DOI 10.1001/jama.1933.27430350002009; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; EVANS JP, 1943, ASS RES NERVOUS MENT, V6, P98; GREENFIELD J G, 1947, Proc R Soc Med, V40, P695; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; GURDJIAN FS, 1943, ASS RES NERVOUS MENT, P50; Holbourn AHS, 1943, LANCET, V2, P438; HOOPER RS, 1949, MED J AUSTRALIA, V2, P840, DOI 10.5694/j.1326-5377.1949.tb37400.x; JEFFERSON G, 1944, BRIT MED J, V1, P1; KREMER M, 1947, J NEUROL NEUROSUR PS, V10, P49, DOI 10.1136/jnnp.10.2.49; McConnell AA, 1944, LANCET, V1, P273; Penfield W, 1943, CAN MED ASSOC J, V48, P99; PUDENZ H, 1946, J NEUROSURGERY, V3, P487; Reynell WR, 1944, J MENT SCI, V90, P710; SYMONDS CP, 1940, INJURIES SKULL BRAIN, P73; TOOTH G, 1947, J NEUROL NEUROSUR PS, V10, P1, DOI 10.1136/jnnp.10.1.1; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WRIGHT RD, 1946, SURGERY, V19, P661; 1941, 4 MED RES COUNC PRIV	24	2	2	0	0	AUSTRALASIAN MED PUBL CO LTD	SYDNEY	LEVEL 1, 76 BERRY ST, SYDNEY NSW 2060, AUSTRALIA	0025-729X			MED J AUSTRALIA	Med. J. Aust.		1949	2	24					845	850		10.5694/j.1326-5377.1949.tb37401.x			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH140	WOS:A1949YH14000006	15400697				2022-02-06	
J	ROWBOTHAM, GF				ROWBOTHAM, GF			THE PROBLEM OF CLOSED HEAD INJURY - LECTURE DELIVERED AT THE ROYAL-COLLEGE-OF-SURGEONS-OF-ENGLAND ON 8TH OCTOBER, 1947	ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND			English	Article																		0	2	2	0	1	ROYAL COLL SURGEONS ENGLAND	LONDON	35-43 LINCOLN'S INN FIELDS, LONDON WC2A 3PN, ENGLAND	0035-8843			ANN ROY COLL SURG	Ann. R. Coll. Surg. Engl.		1949	4	5					308	316					9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	YG683	WOS:A1949YG68300004	18126469				2022-02-06	
J	ABBOTT, KH				ABBOTT, KH			ABDOMINAL RIGIDITY - A SYMPTOM OF CONCUSSION OF THE SPINAL CORD	ARCHIVES OF NEUROLOGY AND PSYCHIATRY			English	Article																	Bazett HC, 1922, BRAIN, V45, P185, DOI 10.1093/brain/45.2.185; CLAUDE H, 1915, ANN MED, V2, P479; DAVISON C, 1940, INJURIES SKULL BRAIN, P453; ERICHSEN JE, 1882, CONCUSSION SPINE NER, P93; Fulton JF, 1930, BRAIN, V53, P327, DOI 10.1093/brain/53.3.327; Fulton JF, 1930, BRAIN, V53, P311, DOI 10.1093/brain/53.3.311; FULTON JF, 1943, PHYSL NERVOUS SYSTEM, P140; FULTON JF, 1943, PHYSL NERVOUS SYSTEM, P118; GROAT RA, 1945, SURG GYNECOL OBSTET, V81, P63; Hassin GB, 1923, ARCH NEURO PSYCHIATR, V10, P194, DOI 10.1001/archneurpsyc.1923.02190260055004; Holmes G, 1915, Br Med J, V2, P769; Holmes G, 1915, BRIT MED J, V1915, P855; Homes G, 1915, BRIT MED J, V1915, P815, DOI 10.1136/bmj.2.2866.815; KISLOW VA, 1944, B WAR MED, V4, P705; Lhermitte J, 1932, REV NEUROL-FRANCE, V57, P210; MAGNUS R, CITED INDIRECTLY; MARBURG O, 1936, HDB NEUROLOGIE, V11, P100; OBERSTEINER H, 1879, MED JB, P531; OBERSTEINER H, 1880, SCHMIDTS JB, V186, P236; Ranson SW, 1932, J COMP NEUROL, V54, P13, DOI 10.1002/cne.900540103; SPILLER WG, 1899, AM J M SC, V118, P190; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103	22	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0096-6754			ARCH NEURO PSYCHIATR			1947	57	2					220	227		10.1001/archneurpsyc.1947.02300250098008			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	UK100	WOS:A1947UK10000008	20287633				2022-02-06	
J	WRIGHT, RD				WRIGHT, RD			CONCUSSION AND CONTUSION	SURGERY			English	Article																	Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Holbourn AHS, 1943, LANCET, V2, P438; REICHARDT M, 1927, HDB NORMALEN PATHOLO, V10, P116; ROMANES GJ, 1885, INT SC SERIES; SCHMIDT CF, 1941, SCIENCE, V93, P465	5	2	2	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0039-6060			SURGERY	Surgery		1946	19	5					661	668					8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UM523	WOS:A1946UM52300007	21028541				2022-02-06	
J	Kaila, M				Kaila, Martti			CAN TRAUMATIC EPILEPSY DEVELOP AS A SEQUELA OF AN UNCOMPLICATED, SIMPLE CEREBRAL CONCUSSION?	ACTA PSYCHIATRICA ET NEUROLOGICA			German	Article																		0	2	2	0	0	BLACKWELL MUNKSGAARD	FREDERIKSBERG C	1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK	0365-558X			ACTA PSYCH NEUROL	Acta Psychiatr. Neurol.		1933	8	3					549	554		10.1111/j.1600-0447.1933.tb03653.x			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	V01ES	WOS:000206839500015					2022-02-06	
J	Brown, TG				Brown, TG			A case of concussion of the spinal cord, resultant on a graze by a live shell with especial reference to the phenomenon of 'heter ae sthesia'	JOURNAL OF NEUROLOGY AND PSYCHOPATHOLOGY			English	Article																		0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0266-8637			J NEUROL PSYCHOPATHO	J. Neurol. Psychopathol.	MAY	1920	1	1					54	59		10.1136/jnnp.s1-1.1.54			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V21BL	WOS:000201423300007	21611438	Green Published, Bronze			2022-02-06	
J	Jakob, A				Jakob, A			On the pathology of spinal concussion	ZEITSCHRIFT FUR DIE GESAMTE NEUROLOGIE UND PSYCHIATRIE			German	Article																	RICKER, 1919, VIRCHOWS ARCH, V226; 1917, MONATSSCHR PSYCHIAT, V42; 1917, VOLKMANNS SAMMLUNG K; 1917, KRIEGSBESCHADIGUNGEN; LEHRBUCH NEUROLOGIE; 1879, STRICKERS MED JB; 1912, DTSCH MED WOCHENSCHR; 1903, THESIS WIESBADEN; 1905, DTSCH Z NERVENHEILK, V29; 1899, ARCH CHIRURG, V59; 1917, JB PSYCHOL NEUROLOGI, V38; 1890, VIRCHOWS ARCH PATHOL; 1917, BRUNNS BEITRAGE; 1918, MUNCH MED WOCHENSCHR; 1916, MONATSSCHR PSYCHIAT, V39; 1918, JAHRESKURSE ARZTL FO; LEWANDOWSKYS HDB NEU, V2; 1912, HISTOL HISTOPATH ARB, V5; 1891, ARCH KLIN CHIRURG, V42; 1915, BERLINER KLIN WOCHEN; 1918, ARCH PSYCHIAT, V59; 1900, JB PSYCHIAT, V19	22	2	2	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-4194			Z GESAMTE NEUROL PSY	Z. Gesamte Neurol. Psychiatr.		1919	51						247	U8		10.1007/BF02899799			17	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	V37XL	WOS:000202562100009					2022-02-06	
J	Gilles, A				Gilles, Andre			History of the war. Functional troubles from concussion	ANNALES MEDICO-PSYCHOLOGIQUES			French	Article																		0	2	2	0	1	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0003-4487			ANN MED-PSYCHOL	Ann. Med.-Psychol.	APR	1917	8	2					207	227					21	Pharmacology & Pharmacy; Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pharmacology & Pharmacy; Psychiatry; Psychology	V03HS	WOS:000206982500004					2022-02-06	
J	Harwood, TE				Harwood, TE			A preliminary note on the nature and treatment of concussion.	BRITISH MEDICAL JOURNAL			English	Article																		0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN-JUN	1916	1916						551	551		10.1136/bmj.1.2885.551			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V07LW	WOS:000200504000256	20768090	Green Published			2022-02-06	
J	Hertz, AF; Ormond, AW				Hertz, AF; Ormond, AW			The treatment of "concussion blindness"	LANCET			English	Article																		0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet		1916	1						15	17					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V9561	WOS:000188723900003					2022-02-06	
J	Evans, JJ				Evans, JJ			Organic lesions from shell concussion	BRITISH MEDICAL JOURNAL			English	Article																		0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL-DEC	1915	1915						848	848		10.1136/bmj.2.2867.848			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V07LU	WOS:000200503800605	20767927	Green Published			2022-02-06	
J	Tubby, AH				Tubby, AH			Remarks on cases of nerve concussion due to bullet and shell wounds	BMJ-BRITISH MEDICAL JOURNAL			English	Article																		0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN-JUN	1915	1915		1				57	59		10.1136/bmj.1.2819.57			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V40ON	WOS:000202741700017	20767433	Green Published			2022-02-06	
J	Frohlich, J; Crone, JS; Johnson, MA; Lutkenhoff, ES; Spivak, NM; Dell'Italia, J; Hipp, JF; Shrestha, V; Tejeda, JER; Real, C; Vespa, PM; Monti, MM				Frohlich, Joel; Crone, Julia S.; Johnson, Micah A.; Lutkenhoff, Evan S.; Spivak, Norman M.; Dell'Italia, John; Hipp, Joerg F.; Shrestha, Vikesh; Tejeda, Jesus E. Ruiz; Real, Courtney; Vespa, Paul M.; Monti, Martin M.			Neural oscillations track recovery of consciousness in acute traumatic brain injury patients	HUMAN BRAIN MAPPING			English	Article; Early Access						biomarker; coma; consciousness; EEG; mesocircuit; neural oscillations; traumatic brain injury	LATERAL THALAMIC NUCLEUS; IMPAIRED CONSCIOUSNESS; GENERAL-ANESTHESIA; MECHANISMS; EEG; DISORDERS; CORTEX; SLEEP; PROJECTIONS; MODULATION	Electroencephalography (EEG), easily deployed at the bedside, is an attractive modality for deriving quantitative biomarkers of prognosis and differential diagnosis in severe brain injury and disorders of consciousness (DOC). Prior work by Schiff has identified four dynamic regimes of progressive recovery of consciousness defined by the presence or absence of thalamically-driven EEG oscillations. These four predefined categories (ABCD model) relate, on a theoretical level, to thalamocortical integrity and, on an empirical level, to behavioral outcome in patients with cardiac arrest coma etiologies. However, whether this theory-based stratification of patients might be useful as a diagnostic biomarker in DOC and measurably linked to thalamocortical dysfunction remains unknown. In this work, we relate the reemergence of thalamically-driven EEG oscillations to behavioral recovery from traumatic brain injury (TBI) in a cohort of N = 38 acute patients with moderate-to-severe TBI and an average of 1 week of EEG recorded per patient. We analyzed an average of 3.4 hr of EEG per patient, sampled to coincide with 30-min periods of maximal behavioral arousal. Our work tests and supports the ABCD model, showing that it outperforms a data-driven clustering approach and may perform equally well compared to a more parsimonious categorization. Additionally, in a subset of patients (N = 11), we correlated EEG findings with functional magnetic resonance imaging (fMRI) connectivity between nodes in the mesocircuit-which has been theoretically implicated by Schiff in DOC-and report a trend-level relationship that warrants further investigation in larger studies.	[Frohlich, Joel; Crone, Julia S.; Johnson, Micah A.; Lutkenhoff, Evan S.; Dell'Italia, John; Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, 6513 Pritzker Hall, Los Angeles, CA 90095 USA; [Crone, Julia S.] Univ Vienna, Vienna Cognit Sci Hub, Vienna, Austria; [Spivak, Norman M.; Shrestha, Vikesh; Tejeda, Jesus E. Ruiz; Real, Courtney; Vespa, Paul M.; Monti, Martin M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Hipp, Joerg F.] Roche Pharma Res & Early Dev, Roche Innovat Ctr Basel, Basel, Switzerland		Frohlich, J (corresponding author), Univ Calif Los Angeles, Dept Psychol, 6513 Pritzker Hall, Los Angeles, CA 90095 USA.	joelfrohlich@gmail.com		Frohlich, Joel/0000-0001-8382-4344	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS049471, NS058489, NS100064]; State of California Neurotrauma Initiative; Tiny Blue Dot Foundation	National Institute of Neurological Disorders and Stroke, Grant/Award Numbers: NS049471, NS058489, NS100064; State of California Neurotrauma Initiative; Tiny Blue Dot Foundation	Alkhachroum A, 2020, J NEUROL NEUROSUR PS, V91, P675, DOI 10.1136/jnnp-2019-322645; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Buzsaki Gyorgy, 2006, RHYTHMS BRAIN; Chiang AKI, 2011, CLIN NEUROPHYSIOL, V122, P1505, DOI 10.1016/j.clinph.2011.01.040; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Comanducci A, 2020, CLIN NEUROPHYSIOL, V131, P2736, DOI 10.1016/j.clinph.2020.07.015; Crone JS, 2020, NEUROSCI CONSCIOUS, V6, DOI 10.1093/nc/niaa008; Crone JS, 2015, NEUROIMAGE, V110, P101, DOI 10.1016/j.neuroimage.2015.01.037; Deschenes M, 1996, NEUROSCIENCE, V72, P679, DOI 10.1016/0306-4522(96)00001-2; Donoghue T, 2020, NAT NEUROSCI, V23, P1655, DOI 10.1038/s41593-020-00744-x; Forgacs PB, 2017, ANN CLIN TRANSL NEUR, V4, P119, DOI 10.1002/acn3.385; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Frohlich J, 2021, BRAIN, V144, P2257, DOI 10.1093/brain/awab095; Frohlich J, 2020, NEUROSCI CONSCIOUS, V6, DOI 10.1093/nc/niaa005; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Hussain SJ, 2019, CEREB CORTEX, V29, P3766, DOI 10.1093/cercor/bhy255; Hyvarinen A, 1999, ISCAS '99: PROCEEDINGS OF THE 1999 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL 5, P57, DOI 10.1109/ISCAS.1999.777510; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kaplan PW, 2004, J CLIN NEUROPHYSIOL, V21, P307; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Landgraf A.J., 2016, LOGISTICPCA; Landgraf AJ, 2020, J MULTIVARIATE ANAL, V180, DOI 10.1016/j.jmva.2020.104668; Lindgren KA, 1999, BIOL PSYCHIAT, V45, P943, DOI 10.1016/S0006-3223(98)00350-3; Liu ZM, 2012, NEUROIMAGE, V63, P1060, DOI 10.1016/j.neuroimage.2012.08.025; Massimini M, 2012, ARCH ITAL BIOL, V150, P44, DOI 10.4449/aib.v150i2.1361; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Morel A, 2005, EUR J NEUROSCI, V21, P1007, DOI 10.1111/j.1460-9568.2005.03921.x; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Provencio JJ, 2020, NEUROCRIT CARE, V33, P1, DOI 10.1007/s12028-020-01028-9; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; Sarnthein J., 2003, Thalamus & Related Systems, V2, P231, DOI 10.1016/S1472-9288(03)00021-9; Sarnthein J, 2007, J NEUROSCI, V27, P124, DOI 10.1523/JNEUROSCI.2411-06.2007; Schiff N.D., 2016, BRAIN FUNCTION RESPO, P195, DOI [10.1007/978-3-319-21425-2_15, DOI 10.1007/978-3-319-21425-2_15]; Schiff ND, 2020, NEURON, V106, P1, DOI 10.1016/j.neuron.2020.02.016; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schreckenberger M, 2004, NEUROIMAGE, V22, P637, DOI 10.1016/j.neuroimage.2004.01.047; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Supp GG, 2011, CURR BIOL, V21, P1988, DOI 10.1016/j.cub.2011.10.017; Sutter R., 2012, EPILEPTOLOGIE, V29, P201; Swadlow HA., 2012, SCHOLARPEDIA, V2, P1451, DOI [10.4249/scholarpedia.1451, DOI 10.4249/SCHOLARPEDIA.1451]; TEASDALE G, 1974, LANCET, V2, P81; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786	53	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.												10.1002/hbm.25725		JAN 2022	17	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	YM5PX	WOS:000746627700001	35076993	gold			2022-02-06	
J	Liu, DJ; Zusman, BE; Shaffer, JR; Li, YQ; Arockiaraj, AI; Liu, SW; Weeks, DE; Desai, SM; Kochanek, PM; Puccio, AM; Okonkwo, DO; Conley, YP; Jha, RM				Liu, Dongjing; Zusman, Benjamin E.; Shaffer, John R.; Li, Yunqi; Arockiaraj, Annie, I; Liu, Shuwei; Weeks, Daniel E.; Desai, Shashvat M.; Kochanek, Patrick M.; Puccio, Ava M.; Okonkwo, David O.; Conley, Yvette P.; Jha, Ruchira M.			Decreased DNA Methylation of RGMA is Associated with Intracranial Hypertension After Severe Traumatic Brain Injury: An Exploratory Epigenome-Wide Association Study	NEUROCRITICAL CARE			English	Article; Early Access						Traumatic brain injury; Intracranial hypertension; Epigenome-wide association study (EWAS); DNA methylation; Repulsive guidance molecule A (RGMA)	SINGLE NUCLEOTIDE POLYMORPHISMS; REPULSIVE GUIDANCE MOLECULE; CEREBRAL EDEMA; EXPRESSION; PACKAGE; CELL; INFLAMMATION; RECOVERY	Background Cerebral edema and intracranial hypertension are major contributors to unfavorable prognosis in traumatic brain injury (TBI). Local epigenetic changes, particularly in DNA methylation, may influence gene expression and thus host response/secondary injury after TBI. It remains unknown whether DNA methylation in the central nervous system is associated with cerebral edema severity or intracranial hypertension post TBI. We sought to identify epigenome-wide DNA methylation patterns associated with these forms of secondary injury after TBI. Methods We obtained genome-wide DNA methylation profiles of DNA extracted from ventricular cerebrospinal fluid samples at three different postinjury time points from a prospective cohort of patients with severe TBI (n = 89 patients, 254 samples). Cerebral edema and intracranial pressure (ICP) measures were clustered to generate composite end points of cerebral edema and ICP severity. We performed an unbiased epigenome-wide association study (EWAS) to test associations between DNA methylation at 419,895 cytosine-phosphate-guanine (CpG) sites and cerebral edema/ICP severity categories. Given inflated p values, we conducted permutation tests for top CpG sites to filter out potential false discoveries. Results Our data-driven hierarchical clustering across six cerebral edema and ICP measures identified two groups differing significantly in ICP based on the EWAS-identified CpG site cg22111818 in RGMA (Repulsive guidance molecule A, permutation p = 4.20 x 10(-8)). At 3-4 days post TBI, patients with severe intracranial hypertension had significantly lower levels of methylation at cg22111818. Conclusions We report a novel potential relationship between intracranial hypertension after TBI and an acute, nonsustained reduction in DNA methylation at cg22111818 in the RGMA gene. To our knowledge, this is the largest EWAS in severe TBI. Our findings are further strengthened by previous findings that RGMA modulates axonal repair in other central nervous system disorders, but a role in intracranial hypertension or TBI has not been previously identified. Additional work is warranted to validate and extend these findings, including assessment of its possible role in risk stratification, identification of novel druggable targets, and ultimately our ability to personalize therapy in TBI.	[Liu, Dongjing] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 1425 Madison Ave, New York, NY 10029 USA; [Zusman, Benjamin E.] Univ Pittsburgh, Sch Med, 3550 Terrace St, Pittsburgh, PA 15213 USA; [Shaffer, John R.; Arockiaraj, Annie, I; Liu, Shuwei; Weeks, Daniel E.; Conley, Yvette P.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, 130 De Soto St, Pittsburgh, PA 15261 USA; [Shaffer, John R.] Univ Pittsburgh, Sch Dent Med, Dept Oral & Craniofacial Sci, 3501 Terrace St, Pittsburgh, PA 15213 USA; [Li, Yunqi] Univ Washington, Sch Publ Hlth, Inst Publ Hlth Genet, 1959 NE Pacific St, Seattle, WA 98195 USA; [Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, 130 De Soto St, Pittsburgh, PA 15261 USA; [Desai, Shashvat M.; Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurol Neurobiol & Neurosurg, 240 West Thomas Rd, Phoenix, AZ 85013 USA; [Desai, Shashvat M.; Jha, Ruchira M.] St Josephs Hosp, 240 West Thomas Rd, Phoenix, AZ 85013 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, John G Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Puccio, Ava M.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA; [Okonkwo, David O.; Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15261 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurobiol, 240 West Thomas Rd, Phoenix, AZ 85013 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurosurg, 240 West Thomas Rd, Phoenix, AZ 85013 USA; [Jha, Ruchira M.] St Josephs Hosp, 240 W Thomas Rd, Phoenix, AZ 85013 USA		Conley, YP (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, 130 De Soto St, Pittsburgh, PA 15261 USA.; Jha, RM (corresponding author), Barrow Neurol Inst, Dept Neurol Neurobiol & Neurosurg, 240 West Thomas Rd, Phoenix, AZ 85013 USA.; Jha, RM (corresponding author), St Josephs Hosp, 240 West Thomas Rd, Phoenix, AZ 85013 USA.; Conley, YP (corresponding author), Univ Pittsburgh, Sch Nursing, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15261 USA.; Jha, RM (corresponding author), Barrow Neurol Inst, Dept Neurobiol, 240 West Thomas Rd, Phoenix, AZ 85013 USA.; Jha, RM (corresponding author), St Josephs Hosp, 240 W Thomas Rd, Phoenix, AZ 85013 USA.	yconley@pitt.edu; Ruchira.jha@barrowneuro.org			National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101036]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS115815, 1R01NS087978-01]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NR015142, P50 NS30318]; NIH/National Institute of Nursing Research (NINR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R00 NR013176]; NIH/NINR Grant [R01NR013342]; Chuck Noll Foundation; Barrow Neurological Foundation	The authors are grateful to funding from the following grants: National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) Grant K23NS101036 (RMJ), NIH/NINDS Grant R01NS115815 (RMJ), NIH Grant R21NR015142 (YPC), NIH/National Institute of Nursing Research (NINR) Grant R00 NR013176 (AMP), NIH Grant P50 NS30318 (DOO), NIH/NINDS Grant 1R01NS087978-01 (PMK), NIH/NINR Grant R01NR013342 (YPC), the Chuck Noll Foundation (PMK and RMJ), and the Barrow Neurological Foundation (RMJ).	Abu Hamdeh S, 2021, J NEUROTRAUM, V38, P1679, DOI 10.1089/neu.2020.7283; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Carr, 2019, BRAIN DERIVED CIRCUL, DOI [10.1101/538827, DOI 10.1101/538827, 10.1101/538827v1]; Chen L, 2017, MOL NEUROBIOL, V54, P1379, DOI 10.1007/s12035-016-9744-2; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Fujita Y, 2017, INFLAMM REGEN, V37, DOI 10.1186/s41232-017-0037-6; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Georges A, 2020, TRAUMATIC BRAIN INJU; Good P, 2000, PERMUTATION TESTS; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Houseman EA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1140-4; Jha RM, 2019, J NEUROTRAUM, V36, P1804, DOI 10.1089/neu.2018.6124; Jha RM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0912-9; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Klein KO, 2016, BIOINFORMATICS, V32, P593, DOI 10.1093/bioinformatics/btv615; Kong YH, 2013, NEUROCHEM RES, V38, P815, DOI 10.1007/s11064-013-0984-5; Law PP, 2019, ESSAYS BIOCHEM, V63, P717, DOI 10.1042/EBC20190031; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lehmann-Werman R, 2016, P NATL ACAD SCI USA, V113, pE1826, DOI 10.1073/pnas.1519286113; Mateen BA, 2017, J NEUROTRAUM, V34, P2379, DOI 10.1089/neu.2017.5007; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Mothe AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10987-7; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Nagalakshmi B, 2018, PROG MOL BIOL TRANSL, V157, P263, DOI 10.1016/bs.pmbts.2017.12.013; Nohra R, 2010, GENES IMMUN, V11, P279, DOI 10.1038/gene.2009.111; O'Leary C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081711; Oldekamp J, 2004, GENE EXPR PATTERNS, V4, P283, DOI 10.1016/j.modgep.2003.11.008; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saffari A, 2018, GENET EPIDEMIOL, V42, P20, DOI 10.1002/gepi.22086; Satoh J, 2013, NEUROPATH APPL NEURO, V39, P109, DOI 10.1111/j.1365-2990.2012.01281.x; Schwab JM, 2005, ARCH NEUROL-CHICAGO, V62, P1561, DOI 10.1001/archneur.62.10.1561; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Team RC, 2018, R LANG ENV STAT COMP; Wilson MM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020588; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Xu ZL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv907; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	43	1	1	2	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01424-9		JAN 2022	12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YG1RL	WOS:000742272800001	35028889				2022-02-06	
J	Daisy, CC; Varinos, S; Howell, DR; Kaplan, K; Mannix, R; Meehan, WP; Wang, F; Berkstresser, B; Lee, RS; Froehlich, JW; Zurakowski, D; Moses, MA				Daisy, Cassandra C.; Varinos, Speros; Howell, David R.; Kaplan, Katherine; Mannix, Rebekah; Meehan, William P.; Wang, Francis; Berkstresser, Brant; Lee, Richard S.; Froehlich, John W.; Zurakowski, David; Moses, Marsha A.			Proteomic Discovery of Noninvasive Biomarkers Associated With Sport-Related Concussions	NEUROLOGY			English	Article							BRAIN; CANCER; ADOLESCENTS; EXPRESSION; PREDICT; INJURY; URINE; MMP-2	Background and Objectives Sport-related concussions affect millions of individuals across the United States each year, and current techniques to diagnose and monitor them rely largely on subjective measures. Our goal was to discover and validate objective, quantifiable noninvasive biomarkers with the potential to be used in sport-related concussion diagnosis. Methods Urine samples from a convenience series of healthy control collegiate athletes who had not sustained a concussion and athletes who sustained a concussion as diagnosed by a sports medicine physician within 7 days were collected prospectively and studied. Participants also completed an instrumented single-task gait analysis as a functional measure. Participants were recruited from a single collegiate athletic program and were >= 18 years of age and were excluded if they had a concomitant injury, active psychiatric conditions, or preexisting neurologic disorders. Using Tandem Mass Tags (TMT) mass spectroscopy and ELISA, we identified and validated urinary biomarkers of concussion. Results Forty-eight control and 47 age- and sex-matched athletes with concussion were included in the study (51.6% female, 48.4% male, average age 19.6 years). Participants represented both contact and noncontact sports. All but I of the postconcussion participants reported experiencing symptoms at the time of data collection. Insulin-like growth factor 1 (IGF-1) and IGF binding protein 5 (IGFBP5) were downregulated in the urine of athletes with concussions compared to healthy controls. Multivariable risk algorithms developed to predict the probability of sport-related concussion showed that IGF-1 multiplexed with single-task gait velocity predicts concussion risk across a range of postinjury time points (area under the curve [AUC] 0.786, 95% confidence interval [CI] 0.690-0.884). When IGF-1 and IGFBP5 are multiplexed with single-task gait velocity, they accurately distinguish between healthy controls and individuals with concussion at acute time points (AUC 0.835, 95% CI 0.701-0.968, p < 0.001). Discussion These noninvasive biomarkers, discovered in an objective and validated manner, may be useful in diagnosing and monitoring sport-related concussions in both acute phases of injury and several days after injury.	[Daisy, Cassandra C.; Varinos, Speros; Kaplan, Katherine; Moses, Marsha A.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Howell, David R.; Meehan, William P.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Howell, David R.; Mannix, Rebekah; Meehan, William P.] Boston Childrens Hosp, Dept Orthopaed, Brain Injury Ctr, Boston, MA USA; [Mannix, Rebekah] Boston Childrens Hosp, Sports Concuss Clin, Boston, MA USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Sports Med, Div Emergency Med, Boston, MA USA; [Lee, Richard S.; Froehlich, John W.] Boston Childrens Hosp, Dept Urol, Boston, MA USA; [Zurakowski, David] Boston Childrens Hosp, Dept Anesthesia, Boston, MA USA; [Moses, Marsha A.] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Howell, David R.; Mannix, Rebekah; Meehan, William P.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Meehan, William P.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P.] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA; [Lee, Richard S.; Froehlich, John W.; Zurakowski, David; Moses, Marsha A.] Harvard Med Sch, Dept Surg, Boston, MA 02115 USA; [Wang, Francis; Berkstresser, Brant] Harvard Sports Med, Boston, MA USA		Moses, MA (corresponding author), Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA.; Moses, MA (corresponding author), Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA.; Moses, MA (corresponding author), Harvard Med Sch, Dept Surg, Boston, MA 02115 USA.	marsha.moses@childrens.harvard.edu		Howell, David/0000-0002-2955-0191; Daisy, Cassandra/0000-0001-5244-8067	Eastern Athletic Trainers Association Foundation; Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurologic Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03HD094560, R01NS100952, R43NS108823]	This study was supported by the Eastern Athletic Trainers Association Foundation, the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560), the National Institute of Neurologic Disorders and Stroke (R01NS100952, R03HD094560, and R43NS108823), and the MINDSOURCE Brain Injury Network. This study was registered at ClinicalTrials.gov (NCT02354469).	Afkarian M, 2010, MOL CELL PROTEOMICS, V9, P2195, DOI 10.1074/mcp.M110.000992; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; BEILHARZ EJ, 1993, MOL BRAIN RES, V18, P209, DOI 10.1016/0169-328X(93)90191-Q; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Coticchia CM, 2011, GYNECOL ONCOL, V123, P295, DOI 10.1016/j.ygyno.2011.07.034; Dagher A, 2017, BJU INT, V120, P130, DOI 10.1111/bju.13832; Dillon ST, 2017, BIOL PSYCHIAT, V81, P145, DOI 10.1016/j.biopsych.2016.03.2098; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Houston MN, 2021, J INT NEUROPSYCH SOC, V27, P23, DOI 10.1017/S1355617720000594; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab3552; Howell DR, 2019, J APPL BIOMECH, V35, P290, DOI 10.1123/jab.2018-0454; Howell DR, 2021, CLIN J SPORT MED, V31, P133, DOI 10.1097/JSM.0000000000000722; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Jedinak Andrej, 2018, Oncotarget, V9, P32534, DOI 10.18632/oncotarget.25946; Jedinak A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1284-z; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Madathil S.K., 2015, BRAIN NEUROTRAUMA MO; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Makdissi Michael, 2015, Neurol Clin Pract, V5, P2, DOI 10.1212/CPJ.0000000000000061; Mancini Martina, 2011, J Bioeng Biomed Sci, VSuppl 1, P007; Mangiola A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/736104; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moses MA, 1998, CANCER RES, V58, P1395; Nordqvist ACS, 1996, MOL BRAIN RES, V38, P285; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; Oliver J, 2015, J EXP NEUROSCI, V9, P67, DOI 10.4137/JEN.S27921; Paxman EJ., 2017, BRIT J SPORT MED, V51, pA4; Quatman-Yates CC, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI 10.2519/jospt.2020.0301; Roy R, 2014, BRIT J CANCER, V111, P1772, DOI 10.1038/bjc.2014.462; Scheepens A, 2001, NEUROSCIENCE, V104, P677, DOI 10.1016/S0306-4522(01)00109-9; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Staffa SJ, 2020, J PEDIATR SURG, V55, P1699, DOI 10.1016/j.jpedsurg.2020.01.003; Vaezzadeh AR, 2010, J PROTEOME RES, V9, P6082, DOI 10.1021/pr100924s; Wilkinson Charles W, 2012, Front Neurol, V3, P11, DOI 10.3389/fneur.2012.00011; Wrigley S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00014; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Ye P, 1998, ENDOCRINOLOGY, V139, P65, DOI 10.1210/en.139.1.65; Yu HR, 2014, J REHABIL RES DEV, V51, P1427, DOI 10.1682/JRRD.2014.04.0095	49	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 11	2022	98	2					E186	E198		10.1212/WNL.0000000000013001			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YE3UA	WOS:000741052300018	34675105				2022-02-06	
J	Baez, AA; Qasim, Z; Wilcox, S; Weir, WB; Loeffler, P; Golden, BM; Schwartz, D; Levy, M				Baez, Amado Alejandro; Qasim, Zaffer; Wilcox, Susan; Weir, William B.; Loeffler, Patrick; Golden, Bradley Michael; Schwartz, Daniel; Levy, Michael			Prehospital Mechanical Ventilation: An NAEMSP Position Statement and Resource Document	PREHOSPITAL EMERGENCY CARE			English	Article						mechanical ventilation; prehospital; critical care transport	LUNG-PROTECTIVE VENTILATION; TRAUMATIC BRAIN-INJURY; BAG-VALVE; TIDAL VOLUMES; CLINICAL-OUTCOMES; DEVICE; TRIAL; ADULT	Airway emergencies and respiratory failure frequently occur in the prehospital setting. Patients undergoing advanced airway management customarily receive manual ventilations. However, manual ventilation is associated with hypo- and hyperventilation, variable tidal volumes, and barotrauma, among other potential complications. Portable mechanical ventilators offer an important strategy for optimizing ventilation and mitigating ventilatory complications. EMS clinicians, including those performing emergency response as well as interfacility transports, should consider using mechanical ventilation after advanced airway insertion. Prehospital mechanical ventilation techniques, strategies, and parameters should be disease-specific and should mirror in-hospital best practices. EMS clinicians must receive training in the general principles of mechanical ventilation as well as detailed training in the operation of the specific system(s) used by the EMS agency. Patients undergoing mechanical ventilation must receive appropriate sedation and analgesia.	[Baez, Amado Alejandro] Augusta Univ, Dept Emergency Med, Med Coll Georgia, Augusta, GA 30912 USA; [Baez, Amado Alejandro] Univ Nacl Pedro Henriquez Urena, Santo Domingo, Dominican Rep; [Qasim, Zaffer] Univ Penn, Perelman Sch Med, Philadelphia, PA USA; [Wilcox, Susan] Harvard Med Sch, Dept Emergency Med, Boston, MA USA; [Weir, William B.] Carle Illinois Coll Med, Champaign, IL USA; [Loeffler, Patrick; Golden, Bradley Michael; Schwartz, Daniel] Augusta Univ, Med Coll Georgia, Augusta, GA USA; [Levy, Michael] Anchorage Fire Dept, Anchorage, AK USA		Baez, AA (corresponding author), Augusta Univ, Dept Emergency Med, Med Coll Georgia, Augusta, GA 30912 USA.; Baez, AA (corresponding author), Univ Nacl Pedro Henriquez Urena, Santo Domingo, Dominican Rep.	aabaezmd@gmail.com					Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Aufderheide TP, 2011, NEW ENGL J MED, V365, P798, DOI 10.1056/NEJMoa1010821; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Benger JR, 2018, JAMA-J AM MED ASSOC, V320, P779, DOI 10.1001/jama.2018.11597; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Dafilou B, 2020, WEST J EMERG MED, V21, P722, DOI 10.5811/westjem.2020.3.45788; Davidson AC, 2016, THORAX, V71, P1, DOI 10.1136/thoraxjnl-2015-208209; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Fuller BM, 2017, CRIT CARE MED, V45, P645, DOI 10.1097/CCM.0000000000002268; George BP, 2020, PREHOSP EMERG CARE, V24, P783, DOI 10.1080/10903127.2019.1705948; GERVAIS HW, 1987, CRIT CARE MED, V15, P761, DOI 10.1097/00003246-198708000-00010; Guszack C., 2021, STATPEARLS; Hanisch JR, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015599; Kolar M, 2008, CRIT CARE, V12, DOI 10.1186/cc7009; Kroll M, 2019, PREHOSP EMERG CARE, V23, P210, DOI 10.1080/10903127.2018.1489020; Laan DV, 2016, INJURY, V47, P797, DOI 10.1016/j.injury.2015.11.045; Maung AA, 2014, J INTENSIVE CARE MED, V29, P128, DOI 10.1177/0885066612457339; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Ni YN, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0810-1; Osadnik CR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004104.pub4; Page D, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1926-4; Panchal AR, 2019, CIRCULATION, V140, pE881, DOI 10.1161/CIR.0000000000000732; Papadakos PJ, 2010, CURR OPIN ANESTHESIO, V23, P228, DOI 10.1097/ACO.0b013e328336ea6e; Robba C, 2020, INTENS CARE MED, V46, P2397, DOI 10.1007/s00134-020-06283-0; Siegler J, 2017, PREHOSP EMERG CARE, V21, P74, DOI 10.1080/10903127.2016.1227003; Stephens RJ, 2019, RESP CARE, V64, P595, DOI 10.4187/respcare.06888; Stoltze AJ, 2015, J CRIT CARE, V30, P495, DOI 10.1016/j.jcrc.2015.02.013; Stroud MH, 2013, PEDIATRICS, V132, P359, DOI 10.1542/peds.2013-0529; Taran Zahra, 2019, J Caring Sci, V8, P199, DOI 10.15171/jcs.2019.028; Turki Mohamed, 2005, Respir Care, V50, P340; Wang HE, 2011, RESUSCITATION, V82, P378, DOI 10.1016/j.resuscitation.2010.12.014; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; Weiss SJ, 2005, SOUTH MED J, V98, P970, DOI 10.1097/01.smj.0000182177.01436.70; Wilcox Susan R, 2016, Air Med J, V35, P161, DOI 10.1016/j.amj.2016.01.004	36	1	1	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JAN 4	2022	26			1	SI		88	95		10.1080/10903127.2021.1994676			8	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	YE0WI	WOS:000740852400011	35001824	hybrid			2022-02-06	
J	Babicz, MA; Woods, SP; Cirino, P; Presley, C; Colton, Z; Podell, K				Babicz, Michelle A.; Woods, Steven Paul; Cirino, Paul; Presley, Chase; Colton, Zachary; Podell, Kenneth			Vestibular/Ocular Motor Screening is Independently Associated With Concussion Symptom Severity in Youths	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; vestibular; ocular motor; symptoms	SPORT-RELATED CONCUSSION; NEUROPSYCHOLOGICAL ASSESSMENT; SMOOTH-PURSUIT; RELIABILITY; PERFORMANCE; RECOVERY; COMMON	Objective: To examine the independent contributions of the Vestibular/Ocular Motor Screening (VOMS) to concussion symptom severity in youths while controlling for computerized neurocognitive screening performance, demographics, and medical history. Study Design: Cross-sectional. Setting: Concussion specialty clinic. Participants: A retrospective review of 278 concussed youths clinical charts resulted in a total of 158 participants (16.5 +/- 2.8 years, 46.8% women, 4.3 +/- 3.3 days post-injury) when exclusionary criteria (ie, neurological or substance use disorders, age >21, >14 days since injury, and missing/incomplete data) were applied. Independent Variables: Vestibular/Ocular Motor Screening items and computerized neurocognitive test scores. Main Outcome Measures: Standardized postconcussion symptom scale scores. Results: At the univariate level, all VOMS items were positively associated with concussion symptom severity at small to medium effect sizes (r range 0.26-0.42). Women and individuals with a concussion history and/or Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder diagnosis reported higher VOMS item scores (Ps < 0.10). In a multiple hierarchical regression, the contribution of VOMS item scores was significant and explained 9.6% of the variance in concussion symptom severity after adjustment for sex, baseline VOMS symptom ratings, and ImPACT scores [F(6, 141) = 3.90, P = 0.001]. Vertical saccades (b = 2.22, P = 0.003) and vertical vestibulo-ocular reflex (VOR; b = -1.46, P = 0.004) VOMS items significantly contributed to concussion symptom severity in the multivariable model. Conclusions: Findings from this study provide support for the independent contributions of the VOMS items, particularly vertical saccades and vertical VOR, to acute concussion symptom severity in youths. Further work is warranted for a comparison of the VOMS to the full gold standard of concussion testing (ie, clinical interview, physical examination, balance testing, and neurocognitive assessment).	[Babicz, Michelle A.; Woods, Steven Paul; Cirino, Paul] Univ Houston, Dept Psychol, Houston, TX USA; [Presley, Chase; Colton, Zachary; Podell, Kenneth] Methodist Hosp, Dept Neurol, 6535 Fannin, Houston, TX 77030 USA		Podell, K (corresponding author), Houston Methodist, Dept Neurol, 6560 Fannin St,Suite 1840, Houston, TX 77030 USA.	kpodell@houstonmethodist.org					[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Cohen J., 2003, APPL MULTIPLE REGRES, V3; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Erkelens CJ, 2006, VISION RES, V46, P163, DOI 10.1016/j.visres.2005.06.027; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Keller EL, 2003, ANN NY ACAD SCI, V1004, P29, DOI 10.1196/annals.1303.004; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR., 2000, NEUROLOGIC ATHLETIC, P32; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Riemann BL, 1999, J SPORT REHABIL, V8, P171, DOI 10.1123/jsr.8.3.171; Russell-Giller S, 2018, SPORTS HEALTH, V10, P334, DOI 10.1177/1941738118765450; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Sherry NS., 2019, CLIN J SPORT MED, V319, P840; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wallace J., 2018, ATHL TRAIN ED J, V3, P112; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	37	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2022	32	1					40	45		10.1097/JSM.0000000000000867			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	XQ7WF	WOS:000731754000013	32941378				2022-02-06	
J	Bergin, A; Blumenfeld, E; Anderson, JC; Campbell, JC; Patch, M				Bergin, Audrey; Blumenfeld, Elizabeth; Anderson, Jocelyn C.; Campbell, Jacquelyn C.; Patch, Michelle			Describing Nonfatal Intimate Partner Strangulation Presentation and Evaluation in a Community-Based Hospital: Partnerships Between the Emergency Department and In-House Advocates	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						advocacy; diagnostic imaging; domestic violence; emergency department; intimate partner violence; strangulation	TRAUMATIC BRAIN-INJURY; CAROTID-ARTERY DISSECTION; VIOLENCE; ASPHYXIA; WOMEN	Objective: To describe characteristics of strangulation, and associated medical care, documentation, and injuries of women after nonfatal intimate partner strangulation (NF-IPS) who present for care to a community-based emergency department (ED) with an associated intimate partner violence (IPV) advocacy program between 2008 and 2016. Setting, Design, and Participants: A retrospective review of 345 female ED patients' medical records who sought care at a community hospital ED following a physical assault including strangulation by an intimate partner was conducted. Demographics, characteristics related to reported signs and symptoms, injuries, and subsequent imaging, diagnoses, and discharge information were abstracted. Results: Commonly reported symptoms were neck pain (67.2%) and headache (45.8%), with fewer patients reporting more severe symptoms such as loss of consciousness (22.6%), dysphagia (25.0%), or dysphonia (26.7%). Rates of patients disclosing strangulation to the entire multidisciplinary team and dedicated neck imaging appeared to improve between 2008 and 2014. Among the 45 patients with noted head and neck findings, 2 patients were found to have an internal carotid artery dissection, 2 patients were found to have strokes, and 1 patient was found to have an intracranial hemorrhage. Conclusions: Survivors of NF-IPS may present to community-based hospitals, and existing imaging guidelines can support clinicians in identifying serious internal injury such as carotid artery dissection and stroke. Further research is needed to better discern symptoms previously attributed to psychological trauma from poststrangulation brain injury. This study contributes to the growing literature on NF-IPS with data specific to community-based ED visits.	[Bergin, Audrey; Blumenfeld, Elizabeth] Northwest Hosp, 5401 Old Ct Rd, Randallstown, MD 21133 USA; [Anderson, Jocelyn C.] Penn State Univ, Coll Nursing, University Pk, PA 16802 USA; [Campbell, Jacquelyn C.; Patch, Michelle] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA		Bergin, A (corresponding author), Northwest Hosp, 5401 Old Ct Rd, Randallstown, MD 21133 USA.	abergin@lifebridgehealth.org; eblumenf@lifebridgehealth.org; jocelyna@psu.edu; jcampbe1@jhu.edu; mpatch1@jh.edu			National Institutes of Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K23AA027288]	The authors thank Rosalyn Berkowitz, BSN, RN, FNE-A/P, Kristen Kalinowski, MS, BSN, RN, Ann M. Myers, RN, and Northwest Hospital for their generous support of the DOVE program; Kelley Jones, PhD, MPH, for advisement on statistical analysis; and Jill Messing, PhD, MSW, for helpful comments on earlier drafts of the manuscript. The authors gratefully acknowledge the following funding source: National Institutes of Alcohol Abuse and Alcoholism (K23AA027288, PI: Anderson).	Agresti A., 2002, CATEGORICAL DATA ANA; Bichard H, 2021, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1868537; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Clarot F, 2005, FORENSIC SCI INT, V149, P143, DOI 10.1016/j.forsciint.2004.06.009; Glass N, 2008, J EMERG MED, V35, P329, DOI 10.1016/j.jemermed.2007.02.065; Harper SB, 2021, J INTERPERS VIOLENCE, DOI 10.1177/08862605211005150; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; IBM Corp, 2020, IBM SPSS STAT WINDOW IBM SPSS STAT WINDOW; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; Le Blanc-Louvry I, 2013, J FORENSIC SCI, V58, P1640, DOI 10.1111/1556-4029.12197; Malek AM, 2000, J NEUROSURG, V92, P481, DOI 10.3171/jns.2000.92.3.0481; Matusz EC, 2020, ANN EMERG MED, V75, P329, DOI 10.1016/j.annemergmed.2019.07.018; McKee GB, 2020, J INTERPERS VIOLENCE, DOI 10.1177/0886260520966673; Messing JT, 2018, WOMEN HEALTH ISS, V28, P104, DOI 10.1016/j.whi.2017.10.002; Monahan K, 2022, J FAM VIOLENCE, V37, P75, DOI 10.1007/s10896-020-00208-7; Patch M, 2021, J EMERG NURS, V47, P437, DOI 10.1016/j.jen.2021.01.008; Patch M, 2018, J EMERG NURS, V44, P384, DOI 10.1016/j.jen.2017.12.001; Patel RR, 2012, CARDIOL REV, V20, P145, DOI 10.1097/CRD.0b013e318247cd15; Rapport F, 2018, J EVAL CLIN PRACT, V24, P117, DOI 10.1111/jep.12741; Sauvageau A, 2010, J FORENSIC SCI, V55, P1259, DOI 10.1111/j.1556-4029.2010.01459.x; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Smith S. G., 2018, NATL INTIMATE PARTNE; Smock B., 2019, RECOMMENDATIONS MEDI; Spencer CM, 2020, TRAUMA VIOLENCE ABUS, V21, P527, DOI 10.1177/1524838018781101; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Strack GB, 2001, J EMERG MED, V21, P303, DOI 10.1016/S0736-4679(01)00399-7; Valera EM, 2019, J AGGRESS MALTREAT T, V28, P695, DOI 10.1080/10926771.2019.1581864; Vilke GM, 2011, J EMERG MED, V40, P355, DOI 10.1016/j.jemermed.2010.02.018; Weaver M., 2018, RECOMMENDATIONS MEDI; Wu XM, 2017, AM J FOREN MED PATH, V38, P35, DOI 10.1097/PAF.0000000000000290	31	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2022	37	1			SI		5	14		10.1097/HTR.0000000000000742			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YB2LC	WOS:000738849500003	34985029				2022-02-06	
J	Brett, BL; Nader, AM; Kerr, ZY; Chandran, A; Walton, SR; DeFreese, JD; Guskiewicz, KM; McCrea, M				Brett, Benjamin L.; Nader, Amy M.; Kerr, Zachary Y.; Chandran, Avinash; Walton, Samuel R.; DeFreese, J. D.; Guskiewicz, Kevin M.; McCrea, Michael			Disparate Associations of Years of Football Participation and a Metric of Head Impact Exposure with Neurobehavioral Outcomes in Former Collegiate Football Players	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Contact sport participation; Repetitive head impacts; Head injury; TBI; Concussion	SUBJECTIVE MEMORY COMPLAINTS; PSYCHOLOGICAL DISTRESS; DEPRESSIVE SYMPTOMS; CONCUSSION; HISTORY; RISK; AGE	Objectives: Years of sport participation (YoP) is conventionally used to estimate cumulative repetitive head impacts (RHI) experienced by contact sport athletes. The relationship of this measure to other estimates of head impact exposure and the potential associations of these measures with neurobehavioral functioning are unknown. We investigated the association between YoP and the Head Impact Exposure Estimate (HIEE), and whether associations between the two estimates of exposure and neurobehavioral functioning varied. Methods: Former American football players (N = 58; age = 37.9 +/- 1.5 years) completed in-person evaluations approximately 15 years following sport discontinuation. Assessments consisted of neuropsychological assessment and structured interviews of head impact history (i.e., HIEE). General linear models were fit to test the association between YoP and the HIEE, and their associations with neurobehavioral outcomes. Results: YoP was weakly correlated with the HIEE, p = .005, R ( 2 ) = .13. Higher YoP was associated with worse performance on the Symbol Digit Modalities Test, p = .004, R ( 2 ) = .14, and Trail Making Test-B, p = .001, R ( 2 ) = .18. The HIEE was associated with worse performance on the Delayed Recall trial of the Hopkins Verbal Learning Test-Revised, p = .020, R ( 2 ) = .09, self-reported cognitive difficulties (Neuro-QoL Cognitive Function), p = .011, R ( 2 ) = .10, psychological distress (Brief Symptom Inventory-18), p = .018, R ( 2 ) = .10, and behavioral regulation (Behavior Rating Inventory of Executive Function for Adults), p = .017, R ( 2 ) = .10. Conclusions: YoP was marginally associated with the HIEE, a comprehensive estimate of head impacts sustained over a career. Associations between each exposure estimate and neurobehavioral functioning outcomes differed. Findings have meaningful implications for efforts to accurately quantify the risk of adverse long-term neurobehavioral outcomes potentially associated with RHI.	[Brett, Benjamin L.; Nader, Amy M.; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael] Med Coll Wisconsin, Dept Neurol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Kerr, Zachary Y.; Chandran, Avinash; Walton, Samuel R.; DeFreese, J. D.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Fetzer Hall,210 South Rd, Chapel Hill, NC 27514 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, 401 W Michigan St 500, Indianapolis, IN 46202 USA		Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	bbrett@mcw.edu		Brett, Benjamin/0000-0003-2849-4658; Walton, Samuel/0000-0003-2647-5701	National Collegiate Athletic Association; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]; National Institute of Neurological Disorders and Stroke under the National Institutes of Health [L30NS113158]	This research was supported through funding from the National Collegiate Athletic Association, and institutional support from the University of North Carolina at Chapel Hill and Medical College of Wisconsin. The REDCap electronic database used for this project were supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR001436. BLB acknowledges support from the National Institute of Neurological Disorders and Stroke under the National Institutes of Health under the Award Number L30NS113158.	Allison P.D., 1999, MULTIPLE REGRESSION; Alosco ML, 2020, NEUROLOGY, V95, pE793, DOI 10.1212/WNL.0000000000010040; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bohr AD, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119868658; Brandt J., 2001, HOPKINS VERBAL LEARN; Brett BL, 2021, J NEUROL NEUROSUR PS, V92, P282, DOI 10.1136/jnnp-2020-324244; Brett BL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00673; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Brett BL, 2019, J NEUROPSYCH CLIN N, V31, P17, DOI 10.1176/appi.neuropsych.18040080; BREUSCH TS, 1979, ECONOMETRICA, V47, P1287, DOI 10.2307/1911963; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Crumley JJ, 2014, PSYCHOL AGING, V29, P250, DOI 10.1037/a0035908; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Darlington R.B., 2016, REGRESSION ANAL LINE; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Deshpande SK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229978; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Edwards Jessie K, 2017, Curr Environ Health Rep, V4, P79, DOI 10.1007/s40572-017-0125-4; Eitle TM, 2002, SOCIOL EDUC, V75, P123, DOI 10.2307/3090288; Gerstorf D, 2008, AGING NEUROPSYCHOL C, V15, P424, DOI 10.1080/13825580701640374; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Jones D, 2001, J Ambul Care Manage, V24, P68; Karton C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54874-9; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; KOENKER R, 1981, J ECONOMETRICS, V17, P107, DOI 10.1016/0304-4076(81)90062-2; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mitchell AJ, 2014, ACTA PSYCHIAT SCAND, V130, P439, DOI 10.1111/acps.12336; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; National Institute of Neurological Disorders and Stroke (NINDS), 2015, US MAN QUAL LIF NEUR; Palerino MT, 2006, INT J OFFENDER THER, V50, P654, DOI 10.1177/0306624X06293522; Reitan R., 1985, HALSTEAD REITAN NEUR; Roberts AL, 2021, J NEUROTRAUM, V38, P189, DOI 10.1089/neu.2020.7070; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Sandmo SB, 2020, SCAND J MED SCI SPOR, V30, P193, DOI 10.1111/sms.13562; Scheier LM, 2019, J NEUROTRAUM, V36, P408, DOI 10.1089/neu.2017.5465; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Smith A., 2007, SYMBOL DIGITS MODALI; Smith GE, 1996, PSYCHOL AGING, V11, P272, DOI 10.1037/0882-7974.11.2.272; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Terpstra AR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00712; WechslerD, 2001, WECHSLER TEST ADULT; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000423; Wilson RS, 2003, NEUROLOGY, V61, P1479, DOI 10.1212/01.WNL.0000096167.56734.59; Yao SQ, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0690-4	68	1	1	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2022	28	1					22	34	PII S1355617721000047	10.1017/S1355617721000047			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	YF3XI	WOS:000741743300004	33563361	Green Accepted			2022-02-06	
J	Brooks, GA; Osmond, AD; Leija, RG; Curl, CC; Arevalo, JA; Duong, JJ; Horning, MA				Brooks, George A.; Osmond, Adam D.; Leija, Robert G.; Curl, Casey C.; Arevalo, Jose A.; Duong, Justin J.; Horning, Michael A.			p The blood lactate/pyruvate equilibrium affair	AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM			English	Article						energy-substrate partitioning; exercise; glycolysis; isotope tracers; oxidative metabolism	TRAUMATIC BRAIN-INJURY; HUMAN SKELETAL-MUSCLE; LACTATE KINETICS; MITOCHONDRIAL RETICULUM; ANAEROBIC METABOLISM; GLUCOSE DISPOSAL; GRADED-EXERCISE; TURNOVER RATE; IN-VIVO; OXIDATION	The Lactate Shuttle hypothesis is supported by a variety of techniques including mass spectrometry analytics following infusion of carbon-labeled isotopic tracers. However, there has been controversy over whether lactate tracers measure lactate (L) or pyruvate (P) turnover. Here, we review the analytical errors, use of inappropriate tissue and animal models, failure to consider L and P pool sizes in modeling results, inappropriate tracer and blood sampling sites, and failure to anticipate roles of heart and lung parenchyma on L () P interactions. With support from magnetic resonance spectroscopy (MRS) and immunocytochemistry, we conclude that carbon-labeled lactate tracers can be used to quantitate lactate fluxes.	[Brooks, George A.; Osmond, Adam D.; Leija, Robert G.; Curl, Casey C.; Arevalo, Jose A.; Duong, Justin J.; Horning, Michael A.] Univ Calif Berkeley, Dept Integrat Biol, Exercise Physiol Lab, Berkeley, CA 94720 USA		Brooks, GA (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Exercise Physiol Lab, Berkeley, CA 94720 USA.	gbrooks@berkeley.edu		Brooks, George A./0000-0002-1389-1629	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 R01 AG059715-01]; UCB Center for Research and Education on Aging (CREA); Pac-12 Conference Grant [3-02-Brooks-17]	This study was supported by NIH 1 R01 AG059715-01, Pac-12 Conference Grant No. 3-02-Brooks-17, and the UCB Center for Research and Education on Aging (CREA) (to G. A. Brooks).	Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; ALPERT NR, 1965, ANN NY ACAD SCI, V119, P995, DOI 10.1111/j.1749-6632.1965.tb47457.x; Atlante A, 2007, BBA-BIOENERGETICS, V1767, P1285, DOI 10.1016/j.bbabio.2007.08.003; BABA N, 1971, J CELL BIOL, V51, P621, DOI 10.1083/jcb.51.3.621; BAKEEVA LE, 1978, BIOCHIM BIOPHYS ACTA, V501, P349, DOI 10.1016/0005-2728(78)90104-4; BALDWIN KM, 1972, AM J PHYSIOL, V222, P373, DOI 10.1152/ajplegacy.1972.222.2.373; BALDWIN KM, 1977, J APPL PHYSIOL, V43, P288, DOI 10.1152/jappl.1977.43.2.288; Bartman CR, 2021, NAT METAB, V3, P896, DOI 10.1038/s42255-021-00419-2; Bergersen LH, 2015, J CEREBR BLOOD F MET, V35, P176, DOI 10.1038/jcbfm.2014.206; Bergman BC, 2000, AM J PHYSIOL-ENDOC M, V278, pE244, DOI 10.1152/ajpendo.2000.278.2.E244; Bergman BC, 1999, J APPL PHYSIOL, V87, P1684, DOI 10.1152/jappl.1999.87.5.1684; Bergman BC, 1999, J APPL PHYSIOL, V86, P479, DOI 10.1152/jappl.1999.86.2.479; Bergman BC, 2009, J PHYSIOL-LONDON, V587, P2087, DOI 10.1113/jphysiol.2008.168286; BERTOCCI LA, 1993, J APPL PHYSIOL, V74, P1342, DOI 10.1152/jappl.1993.74.3.1342; Bertocci LA, 1999, J APPL PHYSIOL, V86, P2077, DOI 10.1152/jappl.1999.86.6.2077; BING RJ, 1954, AM J MED, V16, P504, DOI 10.1016/0002-9343(54)90365-4; Boussouar F, 2004, TRENDS ENDOCRIN MET, V15, P345, DOI 10.1016/j.tem.2004.07.003; Brandt R B, 1989, Prog Clin Biol Res, V292, P497; BRANDT RB, 1987, ARCH BIOCHEM BIOPHYS, V259, P412, DOI 10.1016/0003-9861(87)90507-8; Brooks G.A., 1985, CIRCULATION RESP MET, P208; Brooks GA, 1998, AM J PHYSIOL-REG I, V275, pR1192, DOI 10.1152/ajpregu.1998.275.4.R1192; BROOKS GA, 1992, J APPL PHYSIOL, V72, P2435, DOI 10.1152/jappl.1992.72.6.2435; BROOKS GA, 1986, FASEB J, V45, P2924; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/BST0300258; BROOKS GA, 1985, MED SCI SPORT EXER, V17, P22; Brooks GA, 1999, P NATL ACAD SCI USA, V96, P1129, DOI 10.1073/pnas.96.3.1129; BROOKS GA, 1991, J APPL PHYSIOL, V71, P333, DOI 10.1152/jappl.1991.71.1.333; Brooks GA, 1999, J APPL PHYSIOL, V87, P1713, DOI 10.1152/jappl.1999.87.5.1713; BROOKS GA, 1991, J APPL PHYSIOL, V70, P919, DOI 10.1152/jappl.1991.70.2.919; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; BROOKS GA, 1983, AM J PHYSIOL, V244, pE505, DOI 10.1152/ajpendo.1983.244.5.E505; Brooks GA, 1984, EXERCISE PHYSL HUMAN; Brooks GA, 2019, EXERCISE PHYSL HUMAN; Brooks GA, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.663560; Brooks GA, 2021, J PHYSIOL-LONDON, DOI 10.1113/JP280955; Brooks GA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165733; Brooks GA, 2020, REDOX BIOL, V35, DOI 10.1016/j.redox.2020.101454; Brooks GA, 2018, CELL METAB, V27, P757, DOI 10.1016/j.cmet.2018.03.008; Brooks GA, 2012, OXIDAT STRESS DIS, P131; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Chen YJ, 2016, NAT CHEM BIOL, V12, P937, DOI [10.1038/NCHEMBIO.2172, 10.1038/nchembio.2172]; de Bari L, 2004, BIOCHEM J, V380, P231, DOI 10.1042/BJ20031981; DEPOCAS F, 1969, CAN J PHYSIOL PHARM, V47, P603, DOI 10.1139/y69-106; DIANZANI M. U., 1951, ARCH FISIOL, V50, P181; DONOVAN CM, 1983, AM J PHYSIOL, V244, pE83, DOI 10.1152/ajpendo.1983.244.1.E83; Edwards JD, 1998, CRIT CARE MED, V26, P1356, DOI 10.1097/00003246-199808000-00020; ELDRIDGE FL, 1975, J APPL PHYSIOL, V39, P231, DOI 10.1152/jappl.1975.39.2.231; Ferguson BS, 2018, EUR J APPL PHYSIOL, V118, P691, DOI 10.1007/s00421-017-3795-6; FOSTER DW, 1984, DIABETES, V33, P1188, DOI 10.2337/diab.33.12.1188; FREMINET A, 1974, PFLUG ARCH EUR J PHY, V346, P75, DOI 10.1007/BF00592652; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; GERTZ EW, 1988, J CLIN INVEST, V82, P2017, DOI 10.1172/JCI113822; Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; HALESTRAP AP, 1976, BIOCHEM J, V156, P193, DOI 10.1042/bj1560193; Hamann JJ, 2001, J APPL PHYSIOL, V91, P2635, DOI 10.1152/jappl.2001.91.6.2635; Hashimoto T, 2005, J PHYSIOL-LONDON, V567, P121, DOI 10.1113/jphysiol.2005.087411; Hashimoto T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002915; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; Henderson GC, 2007, AM J PHYSIOL-ENDOC M, V292, pE366, DOI 10.1152/ajpendo.00363.2006; HOOKER AM, 1979, AM J PHYSIOL, V236, pC66, DOI 10.1152/ajpcell.1979.236.1.C66; HUCKABEE WE, 1958, J CLIN INVEST, V37, P264, DOI 10.1172/JCI103605; HUCKABEE WE, 1958, J CLIN INVEST, V37, P255, DOI 10.1172/JCI103604; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Jacobs RA, 2013, AM J PHYSIOL-ENDOC M, V304, pE686, DOI 10.1152/ajpendo.00476.2012; Johnson ML, 2012, AM J PHYSIOL-REG I, V302, pR143, DOI 10.1152/ajpregu.00402.2011; Johnson ML, 2011, AM J PHYSIOL-REG I, V301, pR769, DOI 10.1152/ajpregu.00206.2011; KATZ J, 1982, FED PROC, V41, P123; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; KJAER M, 1986, J APPL PHYSIOL, V61, P1693, DOI 10.1152/jappl.1986.61.5.1693; KLINE ES, 1986, ARCH BIOCHEM BIOPHYS, V246, P673, DOI 10.1016/0003-9861(86)90323-1; Krebs H A, 1969, Adv Enzyme Regul, V7, P397, DOI 10.1016/0065-2571(69)90030-2; Lehninger AL, 1970, BIOCH MOL BASIS CELL; Lusk G, 1924, J BIOL CHEM, V59, P41; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; MAZZEO RS, 1982, BIOMED MASS SPECTROM, V9, P310, DOI 10.1002/bms.1200090708; MAZZEO RS, 1986, J APPL PHYSIOL, V60, P232, DOI 10.1152/jappl.1986.60.1.232; Messonnier LA, 2013, J APPL PHYSIOL, V114, P1593, DOI 10.1152/japplphysiol.00043.2013; Miller BF, 2002, J PHYSIOL-LONDON, V544, P963, DOI 10.1113/jphysiol.2002.027128; Miller BF, 2002, AM J PHYSIOL-ENDOC M, V283, pE889, DOI 10.1152/ajpendo.00266.2002; MOLE PA, 1973, AM J PHYSIOL, V224, P50, DOI 10.1152/ajplegacy.1973.224.1.50; PANDE S V, 1970, Biochimica et Biophysica Acta, V202, P43, DOI 10.1016/0005-2760(70)90216-X; Park JM, 2015, J EXP BIOL, V218, P3308, DOI 10.1242/jeb.123141; Passarella S, 2008, FEBS LETT, V582, P3569, DOI 10.1016/j.febslet.2008.09.042; Passarella S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00407; Ponsot E, 2005, J CELL PHYSIOL, V203, P479, DOI 10.1002/jcp.20245; Rabinowitz JD, 2020, NAT METAB, V2, P566, DOI 10.1038/s42255-020-0243-4; Rasmussen HN, 2002, J PHYSIOL-LONDON, V541, P575, DOI 10.1113/jphysiol.2002.019216; Richardson RS, 1998, J APPL PHYSIOL, V85, P627, DOI 10.1152/jappl.1998.85.2.627; ROMIJN JA, 1994, AM J PHYSIOL, V266, pE334, DOI 10.1152/ajpendo.1994.266.3.E334; Sahlin K, 2002, J PHYSIOL-LONDON, V541, P569, DOI 10.1113/jphysiol.2002.016683; Schurr A, 2007, NEUROSCIENCE, V147, P613, DOI 10.1016/j.neuroscience.2007.05.002; Schurr A, 2008, J PHYSIOL-LONDON, V586, P2665, DOI 10.1113/jphysiol.2008.155416; SEARLE GL, 1989, METABOLISM, V38, P1120, DOI 10.1016/0026-0495(89)90050-4; Skelton Michele S., 1995, American Journal of Physiology, V268, pR1121; STANLEY WC, 1986, J APPL PHYSIOL, V60, P1116, DOI 10.1152/jappl.1986.60.4.1116; STANLEY WC, 1988, METABOLISM, V37, P850, DOI 10.1016/0026-0495(88)90119-9; STANLEY WC, 1985, AM J PHYSIOL, V249, pE595, DOI 10.1152/ajpendo.1985.249.6.E595; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stellingwerff T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1180, DOI 10.1152/ajpendo.00499.2005; SUMEGI B, 1995, BIOCHEM J, V312, P75, DOI 10.1042/bj3120075; Takahashi H, 2019, NAT METAB, V1, P291, DOI 10.1038/s42255-018-0030-7; Urry LA, 2020, CAMPBELL BIOL, V12, P164; VEECH RL, 1979, J BIOL CHEM, V254, P6538; WEBER JM, 1987, AM J PHYSIOL, V253, pR896, DOI 10.1152/ajpregu.1987.253.6.R896; Woerle HJ, 2003, AM J PHYSIOL-ENDOC M, V284, pE716, DOI 10.1152/ajpendo.00365.2002; WOLFE RR, 1988, AM J PHYSIOL, V254, pE532, DOI 10.1152/ajpendo.1988.254.4.E532; Yoshida Y, 2007, J PHYSIOL-LONDON, V582, P1317, DOI 10.1113/jphysiol.2007.135095; Young A, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101339; Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1; Zuntz N, 1901, STUDIEN PHYSIOL MARS	113	1	1	0	0	AMER PHYSIOLOGICAL SOC	Rockville	6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES	0193-1849	1522-1555		AM J PHYSIOL-ENDOC M	Am. J. Physiol.-Endocrinol. Metab.	JAN	2022	322	1					E34	E43		10.1152/ajpendo.00270.2021			10	Endocrinology & Metabolism; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Physiology	YI5VL	WOS:000743915400004	34719944	Bronze			2022-02-06	
J	Gabbe, BJ; Braaf, S; Cameron, PA; Berecki-Gisolf, J				Gabbe, Belinda J.; Braaf, Sandra; Cameron, Peter A.; Berecki-Gisolf, Janneke			Epidemiology and 6-and 12-Month Outcomes of Intimate Partner Violence and Other Violence-Related Traumatic Brain Injury in Major Trauma: A Population-Based Trauma Registry Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						interpersonal violence; intimate partner violence; outcomes; return to work; traumatic brain injury	EMERGENCY-DEPARTMENT	Objective: To compare the epidemiology, in-hospital outcomes, and 6-month and 12-month patient-reported, outcomes of major trauma patients with intimate partner violence (IPV)-related traumatic brain injury (TBI) with other interpersonal violence (OV)-related TBI. Setting: Victoria, Australia. Participants: Adult (>= 18 years) major trauma cases with TBI (concussion, skull fracture, or intracranial injury), injured through IPV or OV, between July 2010 and June 2020, and included on the population-based Victorian State Trauma Registry. There were 133 adult major trauma cases due to IPV and 1796 due to OV. The prevalence of TBI was 39% (n = 52) in the IPV group and 56% (n = 1010) in the OV group. Design: Registry-based cohort study. Main Measures: Trauma care indicators and 6- and 12-month patient-reported outcomes (self-reported disability, Glasgow Outcome Scale-Extended, EQ-5D-3L, and return to work). Results: The annual incidence (95% CI) of major trauma involving TBI was 0.11 (0.08-0.14) per 100 000 population for IPV and 2.11 (1.98-2.24) per 100 000 for OV. A higher proportion of IPV-related cases were women (73% vs 5%), had sustained a severe TBI (Glasgow Coma Scale score 3-8; 27% vs 15%), were admitted to intensive care (56% vs 37%), and died in hospital (14% vs 5%). The median (interquartile range) time to definitive care (4.7 hours vs 3.3 hours) and head computed tomographic scan (5.0 hours vs 3.1 hours) was longer in the IPV group. Follow-up rates at 6 and 12 months were 71% and 69%, respectively. The 6- and 12-month outcomes were generally poorer in the IPV-related group. Conclusion: The incidence of IPV-related major trauma with TBI was low. However, the prevalence of severe TBI, the time to key aspects of clinical care, in-hospital mortality, and longer-term work-related disability were higher. However, power to detect differences was low due to the small number of IPV-related cases compared with the OV group.	[Gabbe, Belinda J.; Braaf, Sandra; Cameron, Peter A.] Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia; [Gabbe, Belinda J.] Swansea Univ, Med Sch, Hlth Data Res UK, Swansea, W Glam, Wales; [Cameron, Peter A.] Alfred, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Berecki-Gisolf, Janneke] Monash Univ, Victorian Injury Surveillance Unit, Accid Res Ctr, Clayton, Vic, Australia		Gabbe, BJ (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia.	belinda.gabbe@monash.edu			Department of Health, State Government of Victoria; Transport Accident Commission; Australian Research Council Future FellowshipAustralian Research Council [FT170100048]; Medical Research Future Fund Practitioner FellowshipMedical Research Future Fund (MRFF)	The Victorian State Trauma Registry (VSTR) is funded by the Department of Health, State Government of Victoria, and the Transport Accident Commission. The researchers were supported by anAustralian Research Council Future Fellowship (FT170100048) to B.J.G. and a Medical Research Future Fund Practitioner Fellowship to P.A.C.	Quezada JA, 2020, AM SURGEON, V86, P1230, DOI 10.1177/0003134820964191; Australian Institute of Health and Welfare (AIHW), 2018, FAMILY DOMESTIC SEXU; Ayton D, 2021, TRAUMA VIOLENCE ABUS, V22, P3, DOI 10.1177/1524838018821951; Boyle A, 2010, EMERG MED J, V27, P203, DOI 10.1136/emj.2009.072033; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Gabbe BJ, 2006, J TRAUMA, V61, P1393, DOI 10.1097/01.ta.0000225926.34180.47; Gabbe BJ, 2016, ANN SURG, V263, P623, DOI 10.1097/SLA.0000000000001564; Gabbe BJ, 2005, ACAD EMERG MED, V12, P318, DOI 10.1197/j.aem.2004.12.002; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hackenberg EAM, 2017, EUR J TRAUMA EMERG S, V43, P319, DOI 10.1007/s00068-016-0646-9; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; McCaffrey N, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0537-0; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mitchell, 2009, INTIMATE PARTNER VIO, P19; Nguyen TQ, 2019, HEALTH INF MANAG J, V48, P127, DOI 10.1177/1833358318769482; Rusticus SA., 2014, PRACTICAL ASSESSMENT, V19, P11; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; Smirl JD, 2019, BRAIN INJURY, V33, P1529, DOI 10.1080/02699052.2019.1658129; Stockl H, 2013, LANCET, V382, P859, DOI 10.1016/S0140-6736(13)61030-2; Victorian State Trauma Outcome Registry and Monitoring Group, 2020, VICTORIAN STATE TRAU; Viney R, 2014, HEALTH ECON, V23, P729, DOI 10.1002/hec.2953; Williamson OD, 2013, INJURY PREV, V19, P238, DOI 10.1136/injuryprev-2012-040457; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2021, J NEUROTRAUM, V38, P2435, DOI 10.1089/neu.2020.7527; Wittenberg E, 2006, MED CARE, V44, P738, DOI 10.1097/01.mlr.0000215860.58954.86; Wittenberg E, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-67; Wong JYH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3879-y; Wong JYH, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-6; World Health Organization, 2018, GLOBAL REGIONAL ESTI; World Health Organization, 2021, VIOLENCE WOMEN PREVA; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503	34	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2022	37	1			SI		E1	E9		10.1097/HTR.0000000000000741			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YB2LC	WOS:000738849500001	34985035				2022-02-06	
J	Kemble, H; Sucaldito, A; Kulow, E; Ramirez, R; Hinton, A; Glasser, A; Wermert, A; Nemeth, JM				Kemble, Hannah; Sucaldito, Ana; Kulow, Emily; Ramirez, Rachel; Hinton, Alice; Glasser, Allison; Wermert, Amy; Nemeth, Julianna M.			How CARE Tools Are Being Used to Address Brain Injury and Mental Health Struggles With Survivors of Domestic Violence	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						advocacy; CARE; domestic violence; education tools; hypoxic-anoxic brain injury; intimate partner violence; mental health; process evaluation; strangulation; traumatic brain injury	INTIMATE-PARTNER-VIOLENCE; WOMEN	Introduction: CARE (connect, Acknowledge, Respond, and Evaluate) is an advocacy framework developed for domestic violence service organization (DVSO) providers to address and accommodate domestic violence (DV) survivors with brain injury and mental health struggles. The CARE tools were designed for use by advocates and include the Just Breathe booklet, the Head Injury education card, and the Invisible Injuries booklet. Objective: The purpose of this study was to report findings on how CARE tools are being used by DVSO providers as well as their impact on DVSO advocacy practice. Methods: Post-CARE retrospective process evaluation online surveys (n = 60) and focus groups (n = 10 groups; 57 advocates) were conducted with consenting staff at 5 DVSOs in Ohio who partnered with the state coalition to develop and evaluate CARE, overseen by a university research partner. Rigorous, iterative coding qualitative analysis methods, endorsed by the Centers for Disease Control and Prevention, were used (Cohen's kappa = 0.903 [stage 1] and 0.810 [stage 2]). Results: The use of CARE tools has been integral to DVSO providers' implementation of the CARE advocacy framework. DVSO advocates are using CARE tools to Connect with self, survivors, and other systems; to Acknowledge that head trauma and mental health struggles are common among survivors and that ongoing education and self-care are necessary for advocates. Advocates have been able to provide a more holistic Response through accommodation within DVS Os and referral to other providers, often by using the CARE tools, including the Head Injury education card. Conclusion: CARE tools were designed for lay use to address head trauma, strangulation, and mental health struggles with DV survivors and are free for download at the Center on Partner Inflicted Brain Injury website: https://www.odvn.org/brain-injury. More widespread use of these tools by advocates has the potential to improve services for DV survivors and address what have historically been invisible injuries and mental health struggles in the population.	[Kemble, Hannah; Sucaldito, Ana; Hinton, Alice; Glasser, Allison; Wermert, Amy; Nemeth, Julianna M.] Ohio State Univ, Coll Publ Hlth, 1841 Neil Ave, Columbus, OH 43210 USA; [Kulow, Emily; Ramirez, Rachel] Ohio Domest Violence Network, Columbus, OH USA		Nemeth, JM (corresponding author), Ohio State Univ, Coll Publ Hlth, 1841 Neil Ave, Columbus, OH 43210 USA.	kemble.10@buckeyemail.osu.edu; sucaldito.3@buckeyemail.osu.edu; emilyk@odvn.org; rachelr@odvn.org; hinton.120@osu.edu; glasser.24@osu.edu; wermert.7@osu.edu; nemeth.37@osu.edu			OVC [2016-XV-GX-K012]	This study was funded by OVC grant 2016-XV-GX-K012.	Ayton D, 2021, TRAUMA VIOLENCE ABUS, V22, P3, DOI 10.1177/1524838018821951; Baxter K, 2019, J AGGRESS MALTREAT T, V28, P660, DOI 10.1080/10926771.2019.1602089; Bichard H, 2021, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1868537; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Colantonio A, 2020, CAN PSYCHOL, V61, P163, DOI 10.1037/cap0000208; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Crowe A, 2019, VIOLENCE GEND, V6, P64, DOI 10.1089/vio.2018.0003; Gagnon KL, 2017, J TRAUMA DISSOCIATIO, V18, P635, DOI 10.1080/15299732.2016.1252001; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Hunnicutt G, 2019, J AGGRESS MALTREAT T, V28, P677, DOI 10.1080/10926771.2019.1587656; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; Kulow E., 2020, WORKING BRAIN INJURI; Lifshitz J, 2019, J AGGRESS MALTREAT T, V28, P655, DOI 10.1080/10926771.2019.1644693; Liu LY, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-01104-4; MacQueen K., 1998, CULTURAL ANTHR METHO, V10, P31; Maldonado-Rodriguez N, 2021, J NEUROTRAUM, DOI 10.1089/neu.2021.0042; Mengo C, 2020, J FAM VIOLENCE, V35, P181, DOI 10.1007/s10896-019-00053-3; Messing JT, 2020, J INTERPERS VIOLENCE, DOI 10.1177/0886260520975854; Monahan K, 2022, J FAM VIOLENCE, V37, P75, DOI 10.1007/s10896-020-00208-7; Monahan K, 2019, J AGGRESS MALTREAT T, V28, P807, DOI 10.1080/10926771.2019.1628154; Monahan K, 2018, SOC WORK, V63, P179, DOI 10.1093/sw/swy005; Nemeth JM, 2019, J AGGRESS MALTREAT T, V28, P744, DOI 10.1080/10926771.2019.1591562; Patch M, 2018, J EMERG NURS, V44, P384, DOI 10.1016/j.jen.2017.12.001; Pritchard AJ, 2017, TRAUMA VIOLENCE ABUS, V18, P407, DOI 10.1177/1524838015622439; Pritchard E, 2019, HEALTH SOC CARE COMM, V27, P1283, DOI 10.1111/hsc.12770; Rajaram SS, 2021, VIOLENCE AGAINST WOM, V27, P1548, DOI 10.1177/1077801220947164; Ralston B, 2019, J AGGRESS MALTREAT T, V28, P732, DOI 10.1080/10926771.2019.1637988; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; Smirl JD, 2019, BRAIN INJURY, V33, P1529, DOI 10.1080/02699052.2019.1658129; St Ivany A, 2021, GLOB QUALIT NURS RES, V8, DOI 10.1177/23333936211008163; St Ivany A, 2019, J AGGRESS MALTREAT T, V28, P785, DOI 10.1080/10926771.2019.1632400; Taylor-Powell E., 2008, DEV LOGIC MODEL TEAC; US Government Accountability Office, 2020, DOMESTIC VIOLENCE IM; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Valera EM, 2018, J WOMENS HEALTH, V27, P735, DOI 10.1089/jwh.2017.6838; Valera EM, 2019, J AGGRESS MALTREAT T, V28, P695, DOI 10.1080/10926771.2019.1581864; Wilbur L, 2001, J EMERG MED, V21, P297, DOI 10.1016/S0736-4679(01)00398-5	38	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2022	37	1			SI		E39	E47		10.1097/HTR.0000000000000745			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YB2LC	WOS:000738849500010	34985039				2022-02-06	
J	Lele, AV; Nair, BG; Fong, C; Walters, AM; Souter, MJ				Lele, Abhijit, V; Nair, Bala G.; Fong, Christine; Walters, Andrew M.; Souter, Michael J.			Anesthetic Management of Brain-dead Adult and Pediatric Organ Donors: The Harborview Medical Center Experience	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						anesthesia; brain-dead; donors; organ recovery	DELAYED GRAFT FUNCTION; DONATION; SEVOFLURANE; ISOFLURANE; CONSENSUS; IMPACT	Introduction: The exposure of anesthesiologists to organ recovery procedures and the anesthetic technique used during organ recovery has not been systematically studied in the United States. Methods: A retrospective cohort study was conducted on all adult and pediatric patients who were declared brain dead between January 1, 2008, and June 30, 2019, and who progressed to organ donation at Harborview Medical Center. We describe the frequency of directing anesthetic care by attending anesthesiologists, anesthetic technique, and donor management targets during organ recovery. Results: In a cohort of 327 patients (286 adults and 41 children), the most common cause of brain death was traumatic brain injury (51.1%). Kidneys (94.4%) and liver (87.4%) were the most common organs recovered. On average, each year, an attending anesthesiologist cared for 1 (range: 1 to 7) brain-dead donor during organ retrieval. The average anesthetic time was 127 +/- 53.5 (mean +/- SD) minutes. Overall, 90% of patients received a neuromuscular blocker, 63.3% an inhaled anesthetic, and 33.9% an opioid. Donor management targets were achieved as follows: mean arterial pressure >= 70mmHg (93%), normothermia (96%), normoglycemia (84%), urine output > 1 to 3mL/kg/h (61%), and lung-protective ventilation (58%). Conclusions: During organ recovery from brain-dead organ donors, anesthesiologists commonly administer neuromuscular blockers, inhaled anesthetics, and opioids, and strive to achieve donor management targets. While infrequently being exposed to these cases, it is expected that all anesthesiologists be cognizant of the physiological perturbations in brain-dead donors and achieve physiological targets to preserve end-organ function. These findings warrant further examination in a larger multi-institutional cohort.	[Lele, Abhijit, V; Nair, Bala G.; Fong, Christine; Walters, Andrew M.; Souter, Michael J.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA		Lele, AV (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	abhijit2@uw.edu					Anderson TA, 2015, CAN J ANESTH, V62, P529, DOI 10.1007/s12630-015-0345-8; Beck-Schimmer B, 2008, ANN SURG, V248, P909, DOI 10.1097/SLA.0b013e31818f3dda; Boutin C, 2012, ANN FR ANESTH, V31, P427, DOI 10.1016/j.annfar.2011.11.027; Champigneulle B, 2019, BMC ANESTHESIOL, V19, DOI 10.1186/s12871-019-0766-y; Cittanova ML, 1996, LANCET, V348, P1620, DOI 10.1016/S0140-6736(96)07588-5; Dal Molin SZF, 2014, EUR J ANAESTH, V31, P695, DOI 10.1097/EJA.0000000000000127; Elkins Laurie J, 2010, AANA J, V78, P293; Fitzgerald RD, 2003, EUR J ANAESTH, V20, P952, DOI 10.1097/00003643-200312000-00003; GELB AW, 1990, CAN J ANAESTH, V37, P806, DOI 10.1007/BF03006543; Health Resources and Services Administration US Department of Health & Human Services Organ Procurement & Transplantation Network, 2019, NAT DAT; Jeong JS, 2017, TRANSPL P, V49, P2188, DOI 10.1016/j.transproceed.2017.07.002; Minou AF, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/930487; Patel MS, 2015, AM J TRANSPLANT, V15, P2152, DOI 10.1111/ajt.13263; Perez-Protto S, 2018, ANAESTH INTENS CARE, V46, P178, DOI 10.1177/0310057X1804600206; Reinhart K, 2012, INTENS CARE MED, V38, P368, DOI 10.1007/s00134-012-2472-9; Rosendale JD, 2003, TRANSPLANTATION, V75, P482, DOI 10.1097/01.TP.0000045683.85282.93; Saposnik G, 2009, CAN J NEUROL SCI, V36, P154, DOI 10.1017/S031716710000651X; Souter MJ, 2018, SEMIN CARDIOTHORAC V, V22, P211, DOI 10.1177/1089253217749053; WETZEL RC, 1985, ANESTH ANALG, V64, P125; Young PJ, 2000, ANAESTHESIA, V55, P105, DOI 10.1046/j.1365-2044.2000.055002105.x	20	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2022	34	1					E34	E39		10.1097/ANA.0000000000000683			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	XJ4ZX	WOS:000726799100010	32149890				2022-02-06	
J	Likitlersuang, J; Brown, EM; Salat, DH; Iverson, KM; Werner, K; McGlinchey, RE; Galovski, TE; Fortier, CB				Likitlersuang, Jirapat; Brown, Emma M.; Salat, David H.; Iverson, Katherine M.; Werner, Kimberly; McGlinchey, Regina E.; Galovski, Tara E.; Fortier, Catherine B.			Neural Correlates of Traumatic Brain Injury in Women Survivors of Intimate Partner Violence: A Structural and Functional Connectivity Neuroimaging Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						amygdala; cortical thickness; default mode; functional connectivity; human brain; intimate partner violence; neuroimaging; posttraumatic stress disorder (PTSD); traumatic brain injury (TBI)	SURFACE-BASED ANALYSIS; GEOMETRICALLY ACCURATE; MRI; SEGMENTATION; RELIABILITY; THICKNESS	Objective: More than one-third of women in the United States experience intimate partner violence (IPV) in their lifetime, increasing their risk for traumatic brain injury (TBI). Despite the prevalence of TBI among IPV survivors, research is sparse in comparison with parallel populations (eg, military, accidents, sports). This pilot study aimed to provide a preliminary investigation of the effect of TBI on brain morphometry and resting-state functional connectivity in women who experience IPV. Participants: A total of 45 community-dwelling women survivors of IPV who screened positive for posttraumatic stress disorder (PTSD). Design: Participants completed comprehensive assessments of trauma exposure, PTSD, TBI history, and brain neurological health. Twenty-three participants (51.1%) met diagnostic criteria for lifetime TBI. Of these, 15 participants experienced 1 or more TBIs resulting from IPV. The remaining participants experienced TBI from non-IPV exposures (eg, sports/motor vehicle accident). Surface-based neuroimaging analyses were performed to examine group differences in cortical thickness and in functional connectivity of amygdala and isthmus cingulate seeds to examine emotion regulation and the default mode network, respectively. Main Measures: Boston Assessment of Traumatic Brain Injury-Lifetime for Intimate Partner Violence (BAT-L/IPV); Clinician Administered PTSD Scale (CAPS); structural and functional neuroimaging. Results: History of lifetime TBI in women IPV survivors was associated with differences in cortical thickness as well as functional connectivity between the isthmus cingulate seed and a variety of regions, including superior parietal and frontal cortices. Individuals with IPV-related TBI showed greater cortical thickness in the right paracentral gyrus than individuals with TBI from other non-IPV etiologies. Conclusion: Significant differences in brain structure and connectivity were observed in individuals with IPV and TBI. A greater mean cortical thickness of the paracentral gyrus was associated with TBI due to IPV than TBI from other etiologies. Although preliminary, findings from this pilot study present a step toward identifying potential mechanisms by which IPV and TBI secondary to IPV impact brain health in women.	[Likitlersuang, Jirapat; Brown, Emma M.; Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, Boston, MA USA; [Likitlersuang, Jirapat; Brown, Emma M.; Salat, David H.; McGlinchey, Regina E.; Fortier, Catherine B.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Iverson, Katherine M.; Galovski, Tara E.] VA Boston Healthcare Syst, Womens Hlth Sci Div, Natl Ctr PTSD, Boston, MA USA; [McGlinchey, Regina E.; Fortier, Catherine B.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA USA; [Salat, David H.] Massachusetts Gen Hosp, Dept Radiol, Athinoula Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Iverson, Katherine M.; McGlinchey, Regina E.; Galovski, Tara E.] Boston Univ, Dept Psychiat, Sch Med, Boston, MA USA; [Werner, Kimberly] Univ Missouri, Coll Nursing, St Louis, MO USA		Fortier, CB (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA.	likitlersuang@hms.harvard.edu; emmargbr@bu.edu; dsalat@mgh.harvard.edu; kateiver@bu.edu; wernerk@umsl.edu; regina_mcglinchey@hms.harvard.edu; galovt@bu.edu; catherine_fortier@hms.harvard.edu	Fortier, Catherine/AAS-2163-2021	Fortier, Catherine/0000-0002-8953-9904	National Center for PTSD, a VA Center for Excellence; Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research and Development National Research Center for Traumatic Brain Injury [B3001-C]	This research was supported by the National Center for PTSD, a VA Center for Excellence, and in part by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VARehabilitation Research and Development National Research Center for Traumatic Brain Injury (B3001-C).	Breiding MJ., 2015, INTIMATE PARTNER VIO; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Corrigan JD., 2018, ENCY CLIN NEUROPSYCH, P2502; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fortier Catherine B, 2021, J Head Trauma Rehabil, DOI 10.1097/HTR.0000000000000700; Galovski TE, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.569335; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Landre L, 2010, PSYCHIAT RES-NEUROIM, V183, P181, DOI 10.1016/j.pscychresns.2010.01.015; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; PTSD: National Center for PTSD, PTSD CHECKLIST DSM 5; R Core Team, 2020, R LANG ENV STAT COMP; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Roos A, 2017, BRAIN IMAGING BEHAV, V11, P1629, DOI 10.1007/s11682-016-9644-0; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith  T., 2018, PROF COUNSEL, V8, P1, DOI DOI 10.15241/TJS.8.1.1; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Wong JYH, 2014, TRAUMA VIOLENCE ABUS, V15, P22, DOI 10.1177/1524838013496333; World Health Organization [WHO], 2012, UNDERSTANDING ADDRES	42	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2022	37	1			SI		E30	E38		10.1097/HTR.0000000000000758			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YB2LC	WOS:000738849500008	34985038				2022-02-06	
J	Manoranjan, B; Scott, T; Szasz, OP; Bzovsky, S; O'Malley, L; Sprague, S; Perera, G; Bhandari, M; Turkstra, LS				Manoranjan, Branavan; Scott, Taryn; Szasz, Olivia Paige; Bzovsky, Sofia; O'Malley, Lauren; Sprague, Sheila; Perera, Gihan; Bhandari, Mohit; Turkstra, Lyn S.			Prevalence and Perception of Intimate Partner Violence-Related Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; concussion; diagnosis; intimate partner violence; neurology; physiatry; rehabilitation	DOMESTIC VIOLENCE; WOMEN; HEAD; VETERANS; VICTIMS; ABUSE; NECK	Background: Traumatic brain injury (TBI) is a serious and often undiagnosed consequence of intimate partner violence (IPV). Data on prevalence of TBI among IPV survivors are emerging, but prevalence of IPV among patients presenting to TBI clinics is unknown. Identification of IPV is important to ensure patients with TBI receive appropriate intervention and referrals. Objective: To determine the proportion of women 18 years and older presenting to an acquired brain injury (ABI) clinic with confirmed or suspected concussion who reported experiencing IPV in the last 12 months or their lifetime. Methods: Single-center cross-sectional cohort study. Proportion of IPV-related TBI or head, neck, or facial) injuries were determined using a modified HELPS Brain Injury Screening Tool and the Neurobehavioral Symptom Inventory. Results: Of the 97 women approached, 50 were enrolled in the study. The average age was 46.1 years and 32 women (64.0%) reported a relationship history with a violent partner; 12-month prevalence of IPV was 26.5% and lifetime prevalence was 44.0%. Within their lifetime, all (44.0%) who reported an IPV history reported emotional abuse, 24.0% reported physical abuse, and 18.0% sexual abuse. HELPS responses indicated a high potential of lifetime IPV-related TBI for 29.2%, most commonly from being hit in the face or head (20.8%). Conclusion: Implementation of IPV screening in community-based ABI clinics is a pivotal step toward understanding the potential scope of TBI and addressing the wide range of somatic, cognitive, and affective symptoms experienced by IPV survivors. IPV screening also will lead to timely referral and follow-up and increase patient safety after discharge from rehabilitation.	[Manoranjan, Branavan] Univ Calgary, Sect Neurosurg, Dept Clin Neurosci, Calgary, AB, Canada; [Scott, Taryn; Szasz, Olivia Paige; Bzovsky, Sofia; Sprague, Sheila; Bhandari, Mohit] McMaster Univ, Div Orthoped Surg, Dept Surg, Hamilton, ON, Canada; [Sprague, Sheila; Bhandari, Mohit] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [O'Malley, Lauren; Perera, Gihan] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Turkstra, Lyn S.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON L8S 4K1, Canada		Turkstra, LS (corresponding author), McMaster Univ, Sch Rehabil Sci, Hamilton, ON L8S 4K1, Canada.	branavan.manoranjan@medportal.ca; scotta@mcmaster.ca; szaszo@mcmaster.ca; bzovskys@mcmaster.ca; omallelg@mcmaster.ca; sprags@mcmaster.ca; pereragc@mcmaster.ca; bhandam@mcmaster.ca; turkstrl@mcmaster.ca					Barber Christopher F, 2008, Nurs Stand, V22, P35; Bhandari M, 2011, J BONE JOINT SURG AM, V93A, P132, DOI 10.2106/JBJS.I.01713; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chemlak D, 2005, J OBSTET GYNAECOL CA, V27, P365; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Davis A, 2014, J TRAUMA NURS, V21, P300, DOI 10.1097/JTN.0000000000000086; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gardner RC, 2020, J ALZHEIMERS DIS, V74, P699, DOI 10.3233/JAD-191138; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Linton KF, 2015, BRAIN INJURY, V29, P639, DOI 10.3109/02699052.2014.989406; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Perciaccante VJ, 1999, J ORAL MAXIL SURG, V57, P760, DOI 10.1016/S0278-2391(99)90808-X; Petrisor BA, 2013, LANCET, V382, P866, DOI 10.1016/S0140-6736(13)61205-2; Picard M., 1991, HELPS TBI SCREENING; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Rodriguez MA, 1999, JAMA-J AM MED ASSOC, V282, P468, DOI 10.1001/jama.282.5.468; Saddki N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-268; Silverberg ND, 2017, J TRAUMA STRESS, V30, P318, DOI 10.1002/jts.22184; Smirl JD, 2019, BRAIN INJURY, V33, P1529, DOI 10.1080/02699052.2019.1658129; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Sprague S, 2012, J INTERPERS VIOLENCE, V27, P881, DOI 10.1177/0886260511423246; Tam S, 2010, J OTOLARYNGOL-HEAD N, V39, P737, DOI 10.2310/7070.2010.090292; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Wadman MC, 1999, AM J EMERG MED, V17, P689, DOI 10.1016/S0735-6757(99)90161-4; Wilbur L, 2001, J EMERG MED, V21, P297, DOI 10.1016/S0736-4679(01)00398-5; Wong JYH, 2014, TRAUMA VIOLENCE ABUS, V15, P22, DOI 10.1177/1524838013496333; World Health Organization, WHO MULTICOUNTRY STU; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503	37	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2022	37	1			SI		53	61		10.1097/HTR.0000000000000749			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YB2LC	WOS:000738849500013	34985034				2022-02-06	
J	Mendonca, LD; Ley, C; Schuermans, J; Wezenbeek, E; Witvrouw, E				Mendonca, Luciana D.; Ley, Christophe; Schuermans, Joke; Wezenbeek, Evi; Witvrouw, Erik		IFSPT	How injury prevention programs are being structured and implemented worldwide: An international survey of sports physical therapists	PHYSICAL THERAPY IN SPORT			English	Article						Athlete; Prevention; Injury; Exercise; Implementation	ATHLETIC PERFORMANCE; RISK-FACTORS; SOCCER PLAYERS; TEAM SPORTS; SLEEP; EXERCISE; EPIDEMIOLOGY; METAANALYSIS; BASKETBALL; CONCUSSION	Objective: To identify the role of sports physical therapists (PT) in the injury prevention process and to compare the structure of preventive programs and associated (organization) policies applied in athletic organizations and sports teams of varying gender and level world-wide. Design: cross-sectional study. Setting: LimeSurvey platform. Participants: Sports PT working with athletes invited through the International Federation of Sports Physical Therapy. Main outcome measures: Sports injury prevention program (IPP) structure and implementation. Results: 414 participants fully participate in this survey study. Athlete's injury history (68.84%), the most common injuries within the sport modality (67.87%) and athlete's preseason screening results (64.01%) were most frequently used to customize IPPs. Warm-up (70.04%) and individually PT-guided exercisetherapy (70.04%) were the preferred methods to organize the prevention routine. The main barrier for IPP implementation was lack of time within the athlete's weekly training schedule (66.66%). The majority of the participants (72.84%) reported to evaluate the perception of IPP's effect by comparing current and preceding seasons' injury occurrences. Conclusion: These survey results are the first identifying contemporary sports injury prevention organization and implementation policies on an international level. This information might support the sports PT community in improving and standardizing IPP (implementation) strategies worldwide. (c) 2021 Elsevier Ltd. All rights reserved.	[Mendonca, Luciana D.] Univ Fed Vales Jequitinhonha & Mucuri UFVJM, Grad Program Rehabil & Funct Performance, Diamantina, MG, Brazil; [Mendonca, Luciana D.; Schuermans, Joke; Wezenbeek, Evi] Univ Ghent, Fac Med & Hlth Sci, Dept Phys Therapy & Motor, Ghent, Belgium; [Mendonca, Luciana D.] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Ley, Christophe] Univ Ghent, Dept Appl Math Comp Sci & Stat, Ghent, Belgium; [Witvrouw, Erik] Univ Ghent, Fac Med & Hlth Sci, Dept Phys Therapy & Motor Rehabil, Ghent, Belgium		Mendonca, LD (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Dept Phys Therapy, Diamantina, MG, Brazil.	lucianademichelis@yahoo.com.br		Ley, Christophe/0000-0002-2290-8437	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Brazil)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [0001]	This work has been partially supported by grants from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Brazil; finance code 0001). The authors certify that they have no affiliations with or financial involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the article.	Ageberg E, 2019, SCAND J MED SCI SPOR, V29, P275, DOI 10.1111/sms.13323; Al Attar WSA, 2017, SPORTS MED, V47, P907, DOI 10.1007/s40279-016-0638-2; Al Attar WSA, 2016, SPORTS MED, V46, P205, DOI 10.1007/s40279-015-0404-x; Andrade R, 2020, SPORTS MED, V50, P1613, DOI 10.1007/s40279-020-01308-6; Asker M, 2018, BRIT J SPORT MED, V52, P1312, DOI 10.1136/bjsports-2017-098254; Bahr R, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094826; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bittencourt NFN, 2016, BRIT J SPORT MED, V50, P1309, DOI 10.1136/bjsports-2015-095850; Bleakley C, 2011, J ATHL TRAINING, V46, P555; Bonazza NA, 2017, AM J SPORT MED, V45, P725, DOI 10.1177/0363546516641937; Bonnar D, 2018, SPORTS MED, V48, P683, DOI 10.1007/s40279-017-0832-x; Breslin G, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0568-6; CHALMERS DJ, 2002, INJ PREV S4, V8, P22; Collings TJ, 2021, SPORTS MED, V51, P759, DOI 10.1007/s40279-020-01410-9; Dallinga JM, 2012, SPORTS MED, V42, P791, DOI 10.2165/11632730-000000000-00000; Dejonghe LAL, 2017, PATIENT EDUC COUNS, V100, P1643, DOI 10.1016/j.pec.2017.04.012; DiFiori JP, 2014, CLIN J SPORT MED, V24, P3, DOI 10.1097/JSM.0000000000000060; DiStefano LJ, 2017, SPORTS HEALTH, V9, P524, DOI 10.1177/1941738117731732; Donaldson A, 2019, INJURY PREV, V25, P244, DOI 10.1136/injuryprev-2017-042639; Donaldson A, 2017, INJURY PREV, V23, P273, DOI 10.1136/injuryprev-2015-041737; Donaldson A, 2016, J SPORT HEALTH SCI, V5, P334, DOI 10.1016/j.jshs.2016.08.003; Donaldson A, 2013, BRIT J SPORT MED, V47, P473, DOI 10.1136/bjsports-2013-092323; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2015, BRIT J SPORT MED, V49, P865, DOI 10.1136/bjsports-2015-094639; Finch C, 2006, J SCI MED SPORT, V9, P490, DOI 10.1016/j.jsams.2006.03.002; Foss KDB, 2018, J ATHL TRAINING, V53, P20, DOI 10.4085/1062-6050-173-16; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; Grant ME, 2014, BRIT J SPORT MED, V48, P63, DOI 10.1136/bjsports-2013-093169; Green B, 2020, BRIT J SPORT MED, V54, P1081, DOI 10.1136/bjsports-2019-100983; Gupta L, 2017, SPORTS MED, V47, P1317, DOI 10.1007/s40279-016-0650-6; Hanson D, 2014, BRIT J SPORT MED, V48, P682, DOI 10.1136/bjsports-2012-091434; Hill L, 2015, PHYSICIAN SPORTSMED, V43, P412, DOI 10.1080/00913847.2015.1077097; Hoffman M., 2014, BRIT J SPORT MED, V48; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Huang YL, 2020, AM J SPORT MED, V48, P1505, DOI 10.1177/0363546519870175; Jones CM, 2017, SPORTS MED, V47, P943, DOI 10.1007/s40279-016-0619-5; Jones S, 2019, SPORTS MED, V49, P1879, DOI 10.1007/s40279-019-01169-8; Kilic O, 2018, PHYS THER SPORT, V32, P308, DOI 10.1016/j.ptsp.2018.01.007; Lopez-Valenciano A, 2020, BRIT J SPORT MED, V54, P711, DOI 10.1136/bjsports-2018-099577; Lund J, 2004, SAFETY SCI, V42, P271, DOI 10.1016/S0925-7535(03)00045-6; Mah CD, 2018, SLEEP HEALTH, V4, P251, DOI 10.1016/j.sleh.2018.02.005; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; O'Brien J, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041087; Petushek EJ, 2019, AM J SPORT MED, V47, P1744, DOI 10.1177/0363546518782460; Pickett W, 2005, INJURY PREV, V11, P213, DOI 10.1136/ip.2004.007021; Plummer A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221346; Reilly T, 2007, PHYSIOL BEHAV, V90, P274, DOI 10.1016/j.physbeh.2006.09.017; Richmond SA, 2020, CLIN J SPORT MED, V30, P231, DOI 10.1097/JSM.0000000000000579; Robey E, 2013, MED SCI SPORT EXER, V45, P1394, DOI 10.1249/MSS.0b013e318287f321; Sadigursky D, 2017, BMC SPORTS SCI MED R, V9, DOI 10.1186/s13102-017-0083-z; Saragiotto BT, 2014, BRAZ J PHYS THER, V18, P137, DOI 10.1590/S1413-35552012005000147; Slimani M, 2018, PHYS THER SPORT, V32, P293, DOI 10.1016/j.ptsp.2018.05.006; Smyth EA, 2019, J SCI MED SPORT, V22, P887, DOI 10.1016/j.jsams.2019.03.002; Soomro N, 2016, AM J SPORT MED, V44, P2415, DOI 10.1177/0363546515618372; Sprague AL, 2018, BRIT J SPORT MED, V52, P1575, DOI 10.1136/bjsports-2017-099000; Taylor JB, 2015, SPORTS HEALTH, V7, P392, DOI 10.1177/1941738115593441; Thorborg K, 2017, BRIT J SPORT MED, V51, P562, DOI 10.1136/bjsports-2016-097066; Toohey LA, 2017, BRIT J SPORT MED, V51, P1670, DOI 10.1136/bjsports-2017-097500; Twomey D, 2009, J SCI MED SPORT, V12, P452, DOI 10.1016/j.jsams.2008.04.002; van Dyk N, 2019, BRIT J SPORT MED, V53, P1362, DOI 10.1136/bjsports-2018-100045; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Webster KE, 2018, J ORTHOP RES, V36, P2696, DOI 10.1002/jor.24043; Whittaker JL, 2017, BRIT J SPORT MED, V51, P580, DOI 10.1136/bjsports-2016-096760; Whittaker JL, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094287; Wiggins AJ, 2016, AM J SPORT MED, V44, P1861, DOI 10.1177/0363546515621554	67	1	1	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	JAN	2022	53						143	150		10.1016/j.ptsp.2021.06.002			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XV1SR	WOS:000734731000017	34238639				2022-02-06	
J	Myers, JR; Solomon, NP; Lange, RT; French, LM; Lippa, SM; Brickell, TA; Staines, S; Nelson, J; Brungart, DS; Coelho, CA				Myers, Jennifer Rae; Solomon, Nancy Pearl; Lange, Rael T.; French, Louis M.; Lippa, Sara M.; Brickell, Tracey A.; Staines, Shelby; Nelson, Jenna; Brungart, Doug S.; Coelho, Carl A.			Analysis of Discourse Production to Assess Cognitive Communication Deficits Following Mild Traumatic Brain Injury With and Without Posttraumatic Stress	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							AUTOBIOGRAPHICAL MEMORY; NARRATIVE DISCOURSE; EXPOSURE THERAPY; HEAD-INJURY; VETERANS; ADULTS; PATTERNS; DISORDER; COMPETENCE; RETRIEVAL	Purpose: Cognitive communication deficits can be difficult to assess in individuals with mild traumatic brain injury (mTBI). However, the use of discourse analysis as a direct and sensitive metric of cognitive communication skills has shown promising clinical utility for other TBI severity levels. This exploratory study investigated discourse production in service members and veterans (SMVs) with uncomplicated mTBI with and without posttraumatic stress disorder (PTSD) and SMVs with neither mTBI or PTSD. Method: Fifteen SMVs with mTBI and PTSD, 26 with mTBI, and 25 controls with no brain injury (NBI) and without PTSD were given a wordless picture story to elicit spontaneous discourse. Discourse samples were analyzed for global coherence, word count, the use of negative emotion words, cognitive process words, nonfluencies, and story completeness. Results: Results revealed a significant difference between the mTBI (Mdn = 3.33) and NBI (Mdn = 3.50) groups, chi(2)(3) = 6.044, p = .017, epsilon(2) = .03, for global coherence. Word count differed significantly between the mTBI + PTSD (Mdn = 135) and NBI (Mdn = 195) groups, chi(2)(3) = 7.968, p = .006, epsilon(2) = .06. No other group differences were observed. Discussion: Structural features of discourse production may serve as potential markers of cognitive communication deficits in mTBI. Furthermore, PTSD may contribute to verbal fluency deficits in individuals with mTBI. Additional research is needed to develop discourse-related measures that are more sensitive to the effects of mTBI and PTSD.	[Myers, Jennifer Rae; Solomon, Nancy Pearl; Brungart, Doug S.] Walter Reed Natl Mil Med Ctr, Natl Mil Audiol & Speech Pathol Ctr, Bethesda, MD 20814 USA; [Solomon, Nancy Pearl; French, Louis M.; Brickell, Tracey A.; Brungart, Doug S.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.; French, Louis M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Traumat Brain Injury Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.; French, Louis M.; Lippa, Sara M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Lange, Rael T.; Brickell, Tracey A.] Gen Dynam Informat Technol, Falls Church, VA USA; [Lange, Rael T.; Brickell, Tracey A.] Ctr Excellence Posttraumat Stress Disorder, Ottawa, ON, Canada; [Staines, Shelby; Coelho, Carl A.] Univ Connecticut, Storrs, CT USA; [Nelson, Jenna] Univ Maryland, College Pk, MD 20742 USA		Myers, JR (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Mil Audiol & Speech Pathol Ctr, Bethesda, MD 20814 USA.	jennifer.r.myers@outlook.com		Solomon, Nancy/0000-0002-5018-7569; french, louis/0000-0002-9451-0604	DHA Contracting Office (CO-NCR) [HT0014];  [HT0014-19-C-0004]	This project is part of the Defense and Veterans Brain Injury Center/Traumatic Brain Injury Center of Excellence (TBICoE) 15-year Longitudinal TBI Study designed to address a congressional mandate (Sec721 NDAAFY2007). The authors would like to express their sincere gratitude to the staff at the TBICoE and the National Military Audiology and Speech Pathology Center at Walter Reed National Military Medical Center, Camp Pendleton, and the Navy Medical Center, San Diego. The identification of specific products or scientific instrumentation does not constitute endorsement or implied endorsement on the part of the author, Department of Defense, or any component agency. The views expressed in this article are those of the authors and do not necessarily represent the official policy or position of the Defense Health Agency, Department of Defense, or any other U.S. government agency. This work was prepared under Contract HT0014-19-C-0004 with DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as U.S. Government work under Title 17 U.S.C. 101. Per Title 17 U.S.C. 105, copyright protection is not available for any work of the U.S. Government. For more information, please contactdha.TBICoEinfo@mail.mil.UNCLASSIFIED	Adamovich B. B., 1992, SCATBI SCALES COGNIT; American Psychiatric Association, 2000, DIAGNOSTIC CRITERIA; Barrett J., 1998, OLD MCDONALD HAD APA, V2nd; Beaudreau SA, 2007, J TRAUMA STRESS, V20, P353, DOI 10.1002/jts.20206; Blackburn K., 2015, DEV PSYCHOMETRIC PRO; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Bremner J Douglas, 2006, Dialogues Clin Neurosci, V8, P445; Breslau Naomi, 2002, J Gend Specif Med, V5, P34; Brewin CR, 2011, ANNU REV CLIN PSYCHO, V7, P203, DOI 10.1146/annurev-clinpsy-032210-104544; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Buckner JP, 1998, APPL COGNITIVE PSYCH, V12, P407, DOI 10.1002/(SICI)1099-0720(199808)12:4<407::AID-ACP575>3.0.CO;2-7; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Cherney L. R., 1998, ANAL DISCOURSE COMMU; Coelho C. A., CULTURAL COMPETENCE; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Cogan AM, 2020, PM&R, V12, P301, DOI 10.1002/pmrj.12237; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Department of Defense, 2021, DOD TBI WORLDW NUMB; Djikic M, 2006, CREATIVITY RES J, V18, P191, DOI 10.1207/s15326934crj1802_5; Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; FOA EB, 1995, J TRAUMA STRESS, V8, P675, DOI 10.1007/BF02102894; Frueh BC, 2001, AGGRESS VIOLENT BEH, V6, P79, DOI 10.1016/S1359-1789(99)00012-9; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Gordon RG, 2015, BRAIN INJURY, V29, P1300, DOI 10.3109/02699052.2015.1042408; Green P, 2004, GREENS MED SYMPTOM V; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Holdnack J. A., 2009, ADV CLIN SOLUTIONS W; Jaeger J, 2014, PSYCHOL TRAUMA-US, V6, P473, DOI 10.1037/a0035239; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kemmerer D., 2015, COGNITIVE NEUROSCIEN; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Kurczek J, 2011, APHASIOLOGY, V25, P700, DOI 10.1080/02687038.2010.537345; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Le K., 2011, ASHA LEADER, V16, P18, DOI [10.1044/leader.FTR4.16022011.18, DOI 10.1044/LEADER.FTR4.16022011.18, DOI 10.1044/leader.FTR4.16022011.18]; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); Leo P, 2016, TRANSLATIONAL RES TR; Lindsey A, 2018, NEUROPSYCHOLOGIA, V119, P308, DOI 10.1016/j.neuropsychologia.2018.08.030; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; Martindale SL, 2020, NEUROPSYCHOLOGY, V34, P735, DOI 10.1037/neu0000672; Meehan S, 2006, J GEN INTERN MED, V21, pS1, DOI 10.1111/j.1525-1497.2006.00382.x; Monson CM, 2009, CLIN PSYCHOL REV, V29, P707, DOI 10.1016/j.cpr.2009.09.002; Moradi AR, 2008, ACTA PSYCHOL, V127, P645, DOI 10.1016/j.actpsy.2007.11.001; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Murray H. A, 1943, THEMATIC APPERCEPTIO; Neumann D. M., 2019, TXB TRAUMATIC BRAIN, V3rd, P281; Norman RS, 2019, BRAIN INJURY, V33, P1173, DOI 10.1080/02699052.2019.1632487; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; O'Kearney R, 2006, J TRAUMA STRESS, V19, P81, DOI 10.1002/jts.20099; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Palombo DJ, 2015, NEUROPSYCHOLOGY, V29, P543, DOI 10.1037/neu0000198; Papini S, 2015, PSYCHOL TRAUMA-US, V7, P295, DOI 10.1037/tra0000019; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheldon S, 2012, HIPPOCAMPUS, V22, P1451, DOI 10.1002/hipo.20985; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; Stark BC, 2019, AM J SPEECH-LANG PAT, V28, P1067, DOI 10.1044/2019_AJSLP-18-0265; Stern R. A., 2003, PSYCHOL ASSESSMENT R; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; TEASDALE G, 1974, LANCET, V2, P81; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; van Minnen A, 2002, J TRAUMA STRESS, V15, P255, DOI 10.1023/A:1015263513654; Vonk JMJ, 2019, CEREB CORTEX, V29, P2694, DOI 10.1093/cercor/bhy138; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Whiteside Douglas M, 2016, Appl Neuropsychol Adult, V23, P29, DOI 10.1080/23279095.2015.1004574; Wright HH, 2014, AGING NEUROPSYCHOL C, V21, P174, DOI 10.1080/13825585.2013.794894; Wright HH, 2010, PROCD SOC BEHV, V6, P111, DOI 10.1016/j.sbspro.2010.08.056	84	1	1	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	JAN	2022	31	1					84	98		10.1044/2021_AJSLP-20-00281			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	YK2KE	WOS:000745047800007	34932411	hybrid			2022-02-06	
J	Norman, RS; Mueller, KD; Huerta, P; Shah, MN; Turkstra, LS; Power, E				Norman, Rocio S.; Mueller, Kimberly D.; Huerta, Paola; Shah, Manish N.; Turkstra, Lyn S.; Power, Emma			Discourse Performance in Adults With Mild Traumatic Brain Injury, Orthopedic Injuries, and Moderate to Severe Traumatic Brain Injury, and Healthy Controls	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							COMMUNICATION DISORDERS; NARRATIVE DISCOURSE; COGNITIVE DEFICITS; WORD RETRIEVAL; HEAD-INJURY; LANGUAGE; IMPAIRMENT; CONCUSSION; PATTERNS; SPEED	Introduction: Adults with mild traumatic brain injury (mTBI) are at risk for communication disorders, yet studies exploring cognitive-communication performance are currently lacking. Aims: This aim of this study was to characterize discourse-level performance by adults with mTBI on a standardized elicitation task and compare it to (a) healthy adults, (b) adults with orthopedic injuries (OIs), and (c) adults with moderate to severe TBI. Method: This study used a cross-sectional design. The participants included mTBI and OI groups recruited prospectively from an emergency medicine department. Moderate to severe TBI and healthy data were acquired from TalkBank. One-way analyses of variance were used to compare mean linguistic scores. Results: Seventy participants across all groups were recruited. Groups did not differ on demographic variables. The study found significant differences in both content and productivity measures among the groups. Variables did not appear sensitive to differentiate between mTBI and OI groups. Discussion: Cognitive and language performance of adults with mTBI is a pressing clinical issue. Studies exploring language with carefully selected control groups can influence the development of sensitive measures to identify individuals with cognitive-communication deficits.	[Norman, Rocio S.; Huerta, Paola] Univ Texas Hlth Sci Ctr San Antonio, Dept Commun Sci & Disorders, San Antonio, TX 78229 USA; [Mueller, Kimberly D.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA; [Shah, Manish N.] Univ Wisconsin, Sch Med & Publ Hlth, BerbeeWalsh Dept Emergency Med, Madison, WI USA; [Turkstra, Lyn S.] McMaster Univ, Sch Rehabil Sci, Speech Language Pathol Program, Hamilton, ON, Canada; [Power, Emma] Univ Technol Sydney, Grad Sch Hlth, Speech Pathol, Sydney, NSW, Australia		Norman, RS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Commun Sci & Disorders, San Antonio, TX 78229 USA.	normanr@uthscsa.edu	Power, Emma/A-9263-2015	Power, Emma/0000-0002-2638-0406; Norman, Rocio/0000-0002-1295-7294; Turkstra, Lyn/0000-0002-6948-6921	National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR002646]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GMO83252]	This project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2 TR002646 to Rocio Norman and was also supported by National Institute of General Medical Sciences (R25GMO83252). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors wish to thank Aimee Balistreri and Kaytlin Hanson for their assistance with data collection. Many thanks to Mackenzie Cross, Sharon Chang, and Gabriel Fragozo for reliability and scoring.	American Speech-Language-Hearing Association, 2004, KNOWL SKILLS NEED SP; American Speech-Language-Hearing Association, 1993, DEF COMM DIS VAR; Barrow IM, 2003, J TRAUMA, V54, P888, DOI 10.1097/01.TA.0000057150.60668.7C; Barrow IM, 2006, BRAIN INJURY, V20, P845, DOI 10.1080/02699050600832445; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Brown C., 2007, COMPUTERIZED PROPOSI; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Crawford MA, 2007, J INT NEUROPSYCH SOC, V13, P178, DOI 10.1017/S135561770707021X; Damico J, 1990, BEST PRACTICES SCH S; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dodge HH, 2015, CURR ALZHEIMER RES, V12, P513, DOI 10.2174/1567205012666150530201917; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Ghayoumi Z, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.21473; Giza C, 2018, HAND CLINIC, V158, P51, DOI 10.1016/B978-0-444-63954-7.00006-9; Hardin KY, 2019, SEMIN SPEECH LANG, V40, P65, DOI 10.1055/s-0038-1676452; Ivanova I, 2014, J INT NEUROPSYCH SOC, V20, P534, DOI 10.1017/S1355617714000228; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kemper S, 2001, PSYCHOL AGING, V16, P600, DOI 10.1037//0882-7974.16.4.600; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Kintsch W., 1974, REPRESENTATION MEANI; Kong APH, 2020, INT J SPEECH-LANG PA, V22, P37, DOI 10.1080/17549507.2019.1581256; Krug H., 2015, SIG 2 PERSPECTIVES N, V25, P17, DOI [10.1044/nnsld25.1.17., DOI 10.1044/NNSLD25.1.17, 10.1044/nnsld25.1.17]; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; LeBlanc J, 2020, BRAIN INJURY, V34, P1472, DOI 10.1080/02699052.2020.1802669; LeBlanc J, 2014, INT J SPEECH-LANG PA, V16, P582, DOI 10.3109/17549507.2013.871335; MacWhinney B., 2000, CHILDES PROJECT; MacWhinney B., 2017, TOOLS ANAL TALK 2; MacWhinney B, 2011, APHASIOLOGY, V25, P1286, DOI 10.1080/02687038.2011.589893; Makdissi Michael, 2015, Neurol Clin Pract, V5, P2, DOI 10.1212/CPJ.0000000000000061; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Mattingly EO, 2015, MIL MED, V180, pE157, DOI 10.7205/MILMED-D-14-00238; McDonald S., 2014, SOCIAL COMMUNICATION, P89; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Mueller KD, 2018, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00437; Norman R. S., 2020, UPDATING REFINING PR, DOI [10.1044/2020_PERSP-20-00011, DOI 10.1044/2020_PERSP-20-00011]; Norman RS, 2019, AM J SPEECH-LANG PAT, V28, P1479, DOI 10.1044/2019_AJSLP-18-0203; Norman RS, 2019, BRAIN INJURY, V33, P1173, DOI 10.1080/02699052.2019.1632487; Norman RS, 2018, MIL MED, V183, pE526, DOI 10.1093/milmed/usy067; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Parrish C., 2009, SIG 2 PERSPECTIVES N, V19, P47, DOI [DOI 10.1044/NNS1D19.2.47, 10.1044/nnsld19.2.47, DOI 10.1044/NNSLD19.2.47]; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Power E, 2020, BRAIN INJURY, V34, P98, DOI 10.1080/02699052.2019.1682192; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Richardson JD, 2016, APHASIOLOGY, V30, P45, DOI 10.1080/02687038.2015.1057891; Riedeman S, 2018, AM J SPEECH-LANG PAT, V27, P181, DOI 10.1044/2017_AJSLP-17-0011; Ruben RJ, 2000, LARYNGOSCOPE, V110, P241, DOI 10.1097/00005537-200002010-00010; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Soares Fernanda Cabral, 2015, Clin Interv Aging, V10, P37, DOI 10.2147/CIA.S68186; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stubbs E, 2018, BRAIN INJURY, V32, P167, DOI 10.1080/02699052.2017.1291989; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Troyanskaya M, 2016, J CLIN EXP NEUROPSYC, V38, P811, DOI 10.1080/13803395.2016.1167172; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Turner A., 1977, 63 U COL I STUD INT, P77; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI [10.2471/BLT.07.045120, 10.1371/journal.pmed.0040296]; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Walhovd KB, 2014, NEUROSCIENCE, V276, P2, DOI 10.1016/j.neuroscience.2014.06.058; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; World Health Organization, 2007, INT CLASS DIS REL HL; World Health Organization, 1977, INT CLASS DIS REL HL	88	1	1	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	JAN	2022	31	1					67	83		10.1044/2021_AJSLP-20-00299			17	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	YK2KE	WOS:000745047800006	34694868				2022-02-06	
J	Popov, N; Mercier, LJ; King, R; Fung, T; Debert, CT				Popov, Nadejda; Mercier, Leah J.; King, Regan; Fung, Tak; Debert, Chantel T.			Factors Associated with Quality of Life in Adults with Persistent Post-Concussion Symptoms	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Concussion; Traumatic brain injury; Post-concussional syndrome; Depression; Quality of life	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; HEAD-INJURY; 1ST YEAR; MILD; DEPRESSION; PREVALENCE; POPULATION; PREDICTORS; PATTERNS	Objective: To assess demographic, clinical, and injury characteristics associated with health-related quality of life (HRQOL) in adults with persistent post-concussion symptoms (PPCS). Methods: Adults with PPCS presenting to a specialized brain injury clinic completed demographic, injury, and clinical outcome questionnaires at the initial clinic assessment. Clinical outcome measures were collected including the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder Scale-7 (GAD-7), and the Fatigue Severity Scale (FSS). HRQOL was measured using the Quality of Life after Brain Injury (QOLIBRI) questionnaire. Stepwise hierarchical multiple regression analysis adjusting for age, sex, and months since injury was used to determine associations between quality of life and clinical outcome measures. Results: Overall, 125 participants were included. The PHQ-9, FSS, and GAD-7 were significant predictors of QOLIBRI scores (R-2 = 0.481, p < .001), indicating that participants with higher levels of depressive symptoms, fatigue, and anxiety reported poorer HRQOL. The PHQ-9 score was the strongest predictor, accounting for 42.0% of the variance in QOLIBRI scores. No demographic or injury characteristics significantly predicted QOLIBRI scores. There was a high prevalence of depressive symptoms with 72.8% of participants having PHQ-9 scores >= 10. Conclusion: Among patients with PPCS, mental health and fatigue are important contributors to HRQOL. As there is a high burden of mood disorders and fatigue in this population, targeted treatments for these concerns may impact the quality of life.	[Popov, Nadejda; Debert, Chantel T.] Univ Calgary, Cumming Sch Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Mercier, Leah J.; King, Regan; Debert, Chantel T.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Mercier, Leah J.; King, Regan; Debert, Chantel T.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Fung, Tak] Univ Calgary, Fac Nursing, Calgary, AB, Canada		Popov, N (corresponding author), Univ Calgary, Cumming Sch Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	nadejda.popov@ucalgary.ca		Popov, Nadejda/0000-0002-9745-3553			Asselstine J, 2020, BRAIN INJURY, V34, P195, DOI 10.1080/02699052.2019.1682670; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carod-Artal FJ, 2009, CEREBROVASC DIS, V27, P204, DOI 10.1159/000200461; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; Doroszkiewicz C, 2021, J NEUROTRAUM, V38, P493, DOI 10.1089/neu.2020.7313; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; IBM Corporation, 2019, SPSS STAT; Iverson GL, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120950682; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jaber AF, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.028993; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Knoll AD, 2017, CAN PSYCHOL, V58, P116, DOI 10.1037/cap0000103; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Malhi GS, 2018, LANCET, V392, P2299, DOI 10.1016/S0140-6736(18)31948-2; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2019, AM J SPORT MED, V47, P3514, DOI 10.1177/0363546519880175; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Plourde V, 2018, J INT NEUROPSYCH SOC, V24, P540, DOI 10.1017/S1355617718000061; Prisnie JC, 2018, GEN HOSP PSYCHIAT, V52, P58, DOI 10.1016/j.genhosppsych.2018.03.009; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Rao DP, 2018, HEALTH PROMOT CHRON, V38, P147, DOI 10.24095/hpcdp.38.3.05; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Rytter HM, 2019, BRAIN INJURY, V33, P266, DOI 10.1080/02699052.2018.1552022; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; World Health Organization, 1993, ICD 10 CLASS MENT BE; Yousefzadeh-Chabok S, 2021, EUR J TRAUMA EMERG S, V47, P839, DOI 10.1007/s00068-019-01252-9	49	1	1	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JAN	2022	49	1					109	117	PII S0317167121000536	10.1017/cjn.2021.53			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU8ES	WOS:000734491800018	33766169				2022-02-06	
J	Portnoy, GA; Relyea, MR; Presseau, C; Orazietti, S; Martino, S; Brandt, CA; Haskell, SG				Portnoy, Galina A.; Relyea, Mark R.; Presseau, Candice; Orazietti, Skye; Martino, Steve; Brandt, Cynthia A.; Haskell, Sally G.			Longitudinal Analysis of Persistent Postconcussion Symptoms, Probable TBI, and Intimate Partner Violence Perpetration Among Veterans	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; intimate partner violence; military; persistent postconcussion symptoms; traumatic; veterans; violence perpetration	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE REHABILITATION; MILITARY VETERANS; CHRONIC PAIN; ACTIVE-DUTY; PTSD; AFGHANISTAN; CONCUSSION; OUTCOMES	Objective: To determine veterans' intimate partner violence (IPV) perpetration following report of traumatic brain injury (TBI) and persistent postconcussion symptoms (PPCSs). Setting: Five Department of Veterans Affairs (VA) medical centers. Participants: Veterans with nonmissing data on main measures, resulting in N = 1150 at baseline and N = 827 at follow-up. Design: Prospective cohort study with secondary data analysis of self-reported TBI, PPCSs, and IPV perpetration, controlling for common predictors of IPV, including binge drinking, marijuana use, pain intensity, and probable posttraumatic stress disorder. Main Measures: VA TBI Screening Tool to assess for probable TBI and PPCSs; Conflict Tactics Scale-Revised (CTS-2S) to assess for IPV perpetration. Results: Almost half (48%) of participants reported IPV perpetration at follow-up. Both probable TBI and higher PPCSs at baseline were associated with overall IPV perpetration and more frequent IPV perpetration at follow-up. Only PPCSs significantly predicted IPV perpetration after controlling for common predictors of IPV perpetration. Neither probably TBI nor PPCSs predicted frequency of IPV perpetration. Conclusion: When considered alongside common risk factors for IPV perpetration, PPCS was uniquely associated with the likelihood of IPV perpetration in this veteran sample. Given post-9/11 veterans' elevated risk for head injury, findings emphasize the distinctive value of PPCSs in understanding risk for IPV perpetration. We recommend increased assessment for PPCSs in clinical practice among veterans enrolled in VA care and highlight several important areas for future research and intervention development.	[Portnoy, Galina A.; Relyea, Mark R.; Presseau, Candice; Orazietti, Skye; Martino, Steve; Brandt, Cynthia A.; Haskell, Sally G.] VA Connecticut Healthcare Syst, 950 Campbell Ave, West Haven, CT 06516 USA; [Portnoy, Galina A.; Relyea, Mark R.; Presseau, Candice; Martino, Steve; Brandt, Cynthia A.; Haskell, Sally G.] Yale Univ, Sch Med, New Haven, CT USA		Portnoy, GA (corresponding author), VA Connecticut Healthcare Syst, 950 Campbell Ave, West Haven, CT 06516 USA.	galina.portnoy@va.gov; Mark.Relyea@va.gov; Candice.Presseau@va.gov; Skye.Orazietti@va.gov; Steve.Martino@va.gov; Cynthia.Brandt@va.gov; Sally.Haskell@va.gov			Department of Veterans Affairs (VA), Veterans Health Administration, Health Services Research and Development (HSR&D) Services AwardsUS Department of Veterans Affairs [CIN13-407, 12-118]; IPV Center for Innovation and Research, an IPVAP Innovation Hub from The National SocialWork Program Office; VAHSR&D Career Development Award [CDA 19-234]	This research was supported by the Department of Veterans Affairs (VA), Veterans Health Administration, Health Services Research and Development (HSR&D) Services Awards (CIN13-407 and IIR #12-118), and by the IPV Center for Innovation and Research, an IPVAP Innovation Hub that receives funding from The National SocialWork Program Office. Dr Portnoy's time was also supported by VAHSR&D Career Development Award (CDA 19-234).	Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Beran R, 2018, J MIL VETERANS HEALT, V26, P20; Blakey SM, 2018, J PAIN, V19, P797, DOI 10.1016/j.jpain.2018.02.012; Breiding MJ., 2015, INTIMATE PARTNER VIO; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Center for Behavioral Health Statistics and Quality, 2015, HHS PUBLICATION SMA, VH50; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cocco KM, 1998, PSYCHOL ASSESSMENT, V10, P408, DOI 10.1037/1040-3590.10.4.408; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P1678, DOI 10.1001/jama.2018.14741; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Gaffey AE, 2021, J WOMENS HEALTH, V30, P944, DOI 10.1089/jwh.2020.8732; Gerlock AA, 2011, AM J NURS, V111, P26, DOI 10.1097/01.NAJ.0000407296.10524.d7; Gromatsky M, 2020, PSYCHIAT RES, V292, DOI 10.1016/j.psychres.2020.113359; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Humenik AM, 2020, AGGRESS VIOLENT BEH, V54, DOI 10.1016/j.avb.2020.101407; Humphreys J, 2011, VIOLENCE AGAINST WOM, V17, P1327, DOI 10.1177/1077801211425216; Institute of Medicine (US) Committee on the Initial Assessment of Readjustment Needs of Military Personnel Veterans and Their Families, 2014, RET HOM IR AFGH PREL; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Iverson KM, 2013, PSYCHOL VIOLENCE, V3, P273, DOI 10.1037/a0030956; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; King EG, 2013, REHABIL PSYCHOL, V58, P272, DOI 10.1037/a0033116; King PR, 2014, J NERV MENT DIS, V202, P231, DOI 10.1097/NMD.0000000000000103; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Maguen S, 2012, J TRAUMA STRESS, V25, P3, DOI 10.1002/jts.21669; Marshall AD, 2005, CLIN PSYCHOL REV, V25, P862, DOI 10.1016/j.cpr.2005.05.009; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Morris DH, 2019, PSYCHOL VIOLENCE, V9, P167, DOI 10.1037/vio0000175; Price RK, 2014, VIOLENCE VICTIMS, V29, P907, DOI 10.1891/0886-6708.VV-D-12-00123; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab K, 2006, NEUROLOGY, V66; Straus Murray A, 2004, Violence Vict, V19, P507; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taft CT, 2015, J TRAUMA STRESS, V28, P314, DOI 10.1002/jts.22017; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Teten AL, 2009, J INTERPERS VIOLENCE, V24, P111, DOI 10.1177/0886260508315782; Tharp AT, 2016, MIL MED, V181, P735, DOI 10.7205/MILMED-D-15-00301; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Watkins LE, 2016, J AGGRESS MALTREAT T, V25, P305, DOI 10.1080/10926771.2015.1129657; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Weathers FW, 1991, PCL C DSM 4; World Health Organization, 2013, RESPONDING INTIMATE; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8	54	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2022	37	1			SI		34	42		10.1097/HTR.0000000000000759			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YB2LC	WOS:000738849500009	34985032	hybrid			2022-02-06	
J	Saadi, A; Chibnik, L; Valera, E				Saadi, Altaf; Chibnik, Lori; Valera, Eve			Examining the Association Between Childhood Trauma, Brain Injury, and Neurobehavioral Symptoms Among Survivors of Intimate Partner Violence: A Cross-Sectional Analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; childhood trauma; domestic violence; intimate partner violence; neurobehavioral symptoms; postconcussion syndrome; postconcussive symptoms; traumatic brain injury	POST-CONCUSSION SYMPTOMS; POSTTRAUMATIC-STRESS-DISORDER; CHRONIC PAIN; EXPERIENCES; DEPRESSION; ABUSE; RISK; QUESTIONNAIRE; ALEXITHYMIA; PREVALENCE	Objective: Understanding factors contributing to neurobehavioral symptom burden among intimate partner violence (IPV) survivors has important implications for prevention, screening, and intervention in this vulnerable population. This study aimed to (1) identify the relationship between childhood trauma and neurobehavioral symptoms among a shelter- and community-based sample of IPV survivors, including investigating the mediating role of posttraumatic stress symptoms and alexithymia in this relationship; (2) assess the association between IPV-related brain injury (BI) severity and neurobehavioral symptoms; and (3) assesses whether physical, emotional, or cognitive domains of neurobehavioral symptom burden show differential associations with childhood trauma or IPV-related BI. Setting: Community sites serving women who had experienced IPV such as domestic violence shelters and transitional housing sites. Participants: Women survivors of IPV with and without BI (n = 99), aged 18 to 54 years. Design: Retrospective, cross-sectional study design. Measures: The following self-reported questionnaires were used: Rivermead Post Concussion Questionnaire (RPQ); Childhood Trauma Questionnaire (CTQ); a modified version of the Conflict Tactics Scale; Brain Injury Severity Assessment (BISA); Clinician-Administered PTSD Scale for DSM IV; and Toronto Alexithymia Scale. The final multivariate regression model assessed the association between childhood abuse, BI severity, and neurobehavioral symptoms (as measured by the RPQ) adjusting for age, educational attainment, and abuse in the past year. We created separate models with total neurobehavioral symptom score as an outcome, as well as somatic, emotional, and cognitive symptom scores. We used structural equation modeling to assess whether posttraumatic stress and alexithymia mediated the effect of childhood trauma and neurobehavioral symptoms. Results: Childhood trauma was associated with higher levels (P < .01) of overall neurobehavioral symptom burden in women independent of BI and specifically associated with RPQ Emotional and Somatic subscale symptoms (P <= .05). BI was positively associated with somatic symptoms in the full sample and cognitive neurobehavioral symptoms in the sample of women with IPV-related BI (P < .05) independent of childhood trauma. Posttraumatic stress symptoms, but not alexithymia, partially mediated the effect of childhood trauma effect on neurobehavioral symptoms. Conclusion: Childhood trauma and BI should not be overlooked as part of efforts to meet the needs of IPV survivors who may experience a range of emotional, somatic, and cognitive symptoms.	[Saadi, Altaf; Chibnik, Lori] Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Valera, Eve] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA; [Saadi, Altaf; Chibnik, Lori; Valera, Eve] Harvard Med Sch, Boston, MA USA; [Chibnik, Lori] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA		Saadi, A (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, 100 Cambridge St,2000, Boston, MA 02114 USA.	asaadi@mgh.harvard.edu; lchibnik@hsph.harvard.edu; eve_valera@hms.harvard.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 F31MH1176301A2]; University of Illinois; Graduate College On-CampusDissertation Research Grant; Women's Studies Funding for Feminist Scholarship; Graduate College Thesis Project Grant;  [R01NS112694-01]	Dr Saadi thanks Bhumi Patel for her research assistance with earlier versions of the draft. Dr Valera acknowledges current funding (R01NS112694-01). This research was funded by National Research Service Award 1 F31MH1176301A2, from the National Institutes of Health, and by 3 grants from the University of Illinois, the Graduate College On-CampusDissertation Research Grant, Women's Studies Funding for Feminist Scholarship, and the Graduate College Thesis Project Grant.	ACRM, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI 10.1097/00001199-199309000-00010; Ahmadabadi Z, 2020, SOC PSYCH PSYCH EPID, V55, P611, DOI 10.1007/s00127-019-01828-1; Anda R, 2010, HEADACHE, V50, P1473, DOI 10.1111/j.1526-4610.2010.01756.x; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bown D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211684; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Campbell R, 2008, J CONSULT CLIN PSYCH, V76, P194, DOI 10.1037/0022-006X.76.2.194; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Chu SY, 2017, BRAIN INJURY, V31, P1674, DOI 10.1080/02699052.2017.1332783; Classen CC, 2005, TRAUMA VIOLENCE ABUS, V6, P103, DOI 10.1177/1524838005275087; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Edwards Emily R, 2019, Psychol Trauma, DOI 10.1037/tra0000539; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Guinn AS, 2019, INJURY PREV, V25, P514, DOI 10.1136/injuryprev-2018-042927; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lee H, 2020, PREV MED, V134, DOI 10.1016/j.ypmed.2020.106039; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Ma ZC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018425; MARSHALL LL, 1992, J FAM VIOLENCE, V7, P103, DOI 10.1007/BF00978700; McLaughlin KA, 2017, BRIT J PSYCHIAT, V211, P280, DOI 10.1192/bjp.bp.116.197640; National Center for Injury Prevention and Control Division of Violence Prevention, 2010, NATL INTIMATE PARTNE, P8; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sachs-Ericsson N, 2007, CHILD ABUSE NEGLECT, V31, P531, DOI 10.1016/j.chiabu.2006.12.007; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, ARCH CLIN NEUROPSYCH, V28, P485, DOI 10.1093/arclin/act023; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Snell DL, 2018, BRAIN INJURY, V32, P583, DOI 10.1080/02699052.2018.1432894; Song MJ, 2018, J HEAD TRAUMA REHAB, V33, P185, DOI 10.1097/HTR.0000000000000310; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba	55	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2022	37	1			SI		24	33		10.1097/HTR.0000000000000752			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YB2LC	WOS:000738849500007	34985031				2022-02-06	
J	Saleem, GT; Champagne, M; Haider, MN; Leddy, JJ; Willer, B; Asante, I; Kent, A; Joseph, T; Fitzpatrick, JM				Saleem, Ghazala T.; Champagne, Madeleine; Haider, Mohammad Nadir; Leddy, John J.; Willer, Barry; Asante, Isaac; Kent, Ariel; Joseph, Tamara; Fitzpatrick, Jessica M.			Prevalence and Risk Factors for Intimate Partner Physical Violence-Related Acquired Brain Injury Among Visitors to Justice Center in New York	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; intimate partner; justice system; minority health; prevalence; risk factors; violence	WOMEN; SYMPTOMS; OUTCOMES; CONSEQUENCE; VICTIMS; DANGER; PTSD	Objective: The recent United States Government Accountability Office report highlights the need for improved data on the prevalence of intimate partner violence (IPV)-related acquired brain injury (ABI) to help direct Health & Human Services public efforts. This article identifies the prevalence and risk factors for IPV-related ABI among survivors of IPV at a Justice Center in New York. Setting: Community Justice Center. Participants: Forty survivors of IPV, aged 17 to 73 years (median 32, interquartile range: 25.25, 42) were assessed within 60 days of sustaining physical violence. Design: Retrospective chart review. Main Measures: The HELPS and the Danger Assessment-Revised were used at the initial Center visit. Results: Of the 40 physical IPV survivors screened, all (100%) reported a prior history of partner-induced ABI within the past 60 days. Thirty-seven (92.5%) survivors also reported sustaining at least 1 potential hypoxic brain injury from strangulation. However, only 16 (40%) survivors screened positive on the HELPS for a history of IPV-related mild traumatic brain injury. Females (95%) and individuals with low income (67.5%) largely comprised our sample. Compared with the County's average, the proportion of African Americans/Blacks and refugees was 227% higher (42.5% vs 13%) and 650% higher (7.5% vs 1.09%), respectively. Refugee status (P = .017) also correlated with number of previous ABIs. On an exploratory binary logistic regression with stepwise selection, only balance difficulties (P = .023) and difficulty concentrating/remembering (P = .009) predicted a positive screen for mild traumatic brain injury. Conclusions: Consistent with previous findings, our data indicate a high prevalence of IPV-related ABI among visitors to a New York Justice Center. An overrepresentation of African Americans/Blacks and refugees in our sample relative to the region signified a higher prevalence of IPV in these populations and warrants a provision of more trauma-informed ABI resources to these groups/communities. Intimate partner violence survivors visiting Justice Centers should be screened for motor/neurocognitive symptoms suggestive of mild traumatic brain injury. Further research to identify the prevalence and risk factors of IPV-related ABI statewide and nationwide is urgently needed to improve resource allocation and clinical management.	[Saleem, Ghazala T.] State Univ New York, Univ Buffalo, Dept Rehabil Sci, 3435 Main St,Kimball Tower 504, New York, NY 14214 USA; [Champagne, Madeleine; Kent, Ariel; Joseph, Tamara] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Haider, Mohammad Nadir; Leddy, John J.] SUNY Buffalo, UBMD, Dept Orthopaed & Sports Med, Buffalo, NY USA; [Willer, Barry] SUNY Buffalo, Dept Psychiat, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Asante, Isaac] SUNY Buffalo, Dept Publ Hlth, Sch Publ Hlth & Hlth, Buffalo, NY USA; [Fitzpatrick, Jessica M.] Buffalo State Coll, Dept Social Work, Buffalo, NY USA		Saleem, GT (corresponding author), State Univ New York, Univ Buffalo, Dept Rehabil Sci, 3435 Main St,Kimball Tower 504, New York, NY 14214 USA.	ghazalas@buffalo.edu; mchampag@buffalo.edu; haider@buffalo.edu; leddy@buffalo.edu; bswiller@buffalo.edu; isaacasa@buffalo.edu; arielken@buffalo.edu; tjoseph5@buffalo.edu; fitzpajm@buffalostate.edu					ACRM, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, 2019, TREAT IMM REF PAT WH; Banks ME, 2002, WOMEN THER, V25, P133, DOI 10.1300/J015v25n03_10; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Baxter K, 2019, J AGGRESS MALTREAT T, V28, P660, DOI 10.1080/10926771.2019.1602089; Bhalotra S., 2020, INTIMATE PARTNER VIO, DOI [10.1596/1813-9450-9118, DOI 10.1596/1813-9450-9118]; Black M C., 2011, NATL INTIMATE PARTNE; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Campbell J., 1995, ASSESSING DANGEROUSN; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; CAMPBELL JC, 1986, ADV NURS SCI, V8, P36, DOI 10.1097/00012272-198607000-00006; Campbell JC., 2003, NATL I JUSTICE J, P14; Cimino AN, 2019, J AGGRESS MALTREAT T, V28, P714, DOI 10.1080/10926771.2019.1587657; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dismuke CE, 2015, AM J PUBLIC HEALTH, V105, P1696, DOI 10.2105/AJPH.2014.302545; Doherty SM, 2016, GLOB MENT HEALTH, V3, DOI 10.1017/gmh.2016.23; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Frye V, 2008, AM J PUBLIC HEALTH, V98, P1473, DOI 10.2105/AJPH.2007.112813; Gagnon KL, 2017, J TRAUMA DISSOCIATIO, V18, P635, DOI 10.1080/15299732.2016.1252001; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Gosangi B, 2021, RADIOLOGY, V298, pE38, DOI 10.1148/radiol.2020202866; Gray M, 2020, PHYS THER SPORT, V42, P68, DOI 10.1016/j.ptsp.2020.01.001; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Hawkins MM, 2021, INT J EQUITY HEALTH, V20, DOI 10.1186/s12939-021-01387-5; Hunnicutt G, 2019, J AGGRESS MALTREAT T, V28, P677, DOI 10.1080/10926771.2019.1587656; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Jenkins EJ, 2002, WOMEN THER, V25, P29, DOI 10.1300/J015v25n03_03; Keselman HJ, 2002, BRIT J MATH STAT PSY, V55, P27, DOI 10.1348/000711002159680; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lutgendorf MA, 2019, OBSTET GYNECOL, V134, P470, DOI 10.1097/AOG.0000000000003326; Maldonado-Rodriguez N, 2021, J NEUROTRAUM, DOI 10.1089/neu.2021.0042; McPherson JI, 2019, DISABIL REHABIL, V41, P1238, DOI 10.1080/09638288.2017.1422038; Mechanic MB, 2008, VIOLENCE AGAINST WOM, V14, P1148, DOI 10.1177/1077801208323792; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Messing JT, 2013, SOC WORK RES, V37, P263, DOI 10.1093/swr/svt019; Meyer JE, 2021, J INTERPERS VIOLENCE, DOI 10.1177/08862605211016362; Monahan K, 2019, FUTUR NEUROL, V14, DOI 10.2217/fnl-2018-0031; Monahan K, 2019, J AGGRESS MALTREAT T, V28, P807, DOI 10.1080/10926771.2019.1628154; Murray NG, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aafcd8; National Center for Injury Prevention and Control, RISK PROTECTIVE FACT; Oden T, 2000, DISSERT ABSTR, V61, P1; Olson-Madden JH, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/174579; Peterson K, 2013, ISSUES MENT HEALTH N, V34, P386, DOI 10.3109/01612840.2013.771233; Picard N., 1999, H128A0002 HELPS US D; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; Smirl JD, 2019, BRAIN INJURY, V33, P1529, DOI 10.1080/02699052.2019.1658129; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Smith S. G., 2018, NATL INTIMATE PARTNE; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; St Ivany A, 2019, J AGGRESS MALTREAT T, V28, P785, DOI 10.1080/10926771.2019.1632400; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; St Vil NM, 2021, J INTERPERS VIOLENCE, DOI 10.1177/0886260521997939; Stockman JK, 2015, J WOMENS HEALTH, V24, P62, DOI 10.1089/jwh.2014.4879; Treves-Kagan S, 2022, J FAM VIOLENCE, V37, P1, DOI 10.1007/s10896-020-00218-5; United Nations Entity for Gender Equality and the Empowerment of Women (UN Women), 2020, IMP COVID 19 VIOL WO; United States Government Accountability Office, 2020, DOM VIOL IMPR DAT NE; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734	68	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2022	37	1			SI		E10	E19		10.1097/HTR.0000000000000750			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YB2LC	WOS:000738849500004	34985036				2022-02-06	
J	Toccalino, D; Haag, H; Estrella, MJ; Cowle, S; Fuselli, P; Ellis, MJ; Gargaro, J; Colantonio, A				Toccalino, Danielle; Haag, Halina (Lin); Estrella, Maria Jennifer; Cowle, Stephanie; Fuselli, Pamela; Ellis, Michael J.; Gargaro, Judith; Colantonio, Angela		COVID TBI-IPV Consortium	The Intersection of Intimate Partner Violence and Traumatic Brain Injury: Findings From an Emergency Summit Addressing System-Level Changes to Better Support Women Survivors	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						care systems; intimate partner violence; traumatic brain injury	HEALTH OUTCOMES; FOLLOW-UP; WOMAN	Background: Traumatic brain injury (TBI) occurring during intimate partner violence (IPV) is a largely unrecognized but significant public health crisis. One in 3 women will experience IPV in their lifetime, up to 75% of whom will sustain a TBI as a result. This article reports on the systems-level findings from a national summit to address barriers, needs, and priorities related to healthcare and support services for women survivors of IPV-TBI. Objectives: (1) To identify key needs, facilitators, and barriers to care for women survivors of IPV presenting with TBI; and (2) to cocreate ideas for resources and principles for identification, clinical care, and support for healthcare practitioners who treat women exposed to IPV and TBI. Methods: Using a community-based participatory research approach, we engaged 30 stakeholders-drawn from a national IPV-TBI Knowledge-to-Practice (K2P) Network including diverse women survivors, service providers, researchers, and decision makers-in 2 half-day virtual meetings. Data were gathered through small group breakout sessions using semistructured discussion guides. Sessions were recorded, transcribed verbatim, and analyzed using thematic analysis techniques. Stakeholders contributed to the analysis and knowledge translation through member-checking activities. Ethics approval was obtained through the University of Toronto. Findings: Three main systems-level themes arose during these discussions: (1) the need for trauma-informed, anti-racist, and equitable health and social care systems; (2) the need for cross-pollination of knowledge between disciplines; and (3) the need for systems-level support for integrated and coordinated care. This article explores these needs and provides recommendations and suggestions for paths forward. Conclusions: The findings of this project enhance understanding of system-level needs among women survivors and provide a template for a national agenda for IPV-TBI research and practice.	[Toccalino, Danielle; Colantonio, Angela] Univ Toronto, Inst Hlth Policy Management & Evaluat, 500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Dept Occupat Sci Occupat Therapy, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Haag, Halina (Lin); Colantonio, Angela] Wilfrid Laurier Univ, Lyle S Hallman Fac Social Work, Waterloo, ON, Canada; [Haag, Halina (Lin); Gargaro, Judith; Colantonio, Angela] Univ Hlth Network, KITE Toronto Rehabil Inst, Toronto, ON, Canada; [Cowle, Stephanie; Fuselli, Pamela] Parachute, Toronto, ON, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Dept Surg, Pan Concuss Program, Winnipeg, MB, Canada; [Gargaro, Judith] Ontario Neurotrauma Fdn, Toronto, ON, Canada		Toccalino, D (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, 500 Univ Ave, Toronto, ON M5G 1V7, Canada.	danielle.toccalino@mail.utoronto.ca; hhaag@wlu.ca; majennifer.estrella@utoronto.ca; scowle@parachute.ca; pfuselli@parachute.ca; mellis3@panamclinic.com; jgargaro@quickemail.com; angela.colantonio@utoronto.ca			Community Foundations of Canada's Emergency Community Support Fund; Canada Research Chair in Underserved Populations	This research was funded by the Community Foundations of Canada's Emergency Community Support Fund with support from a Canada Research Chair in Underserved Populations held by Dr Colantonio.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Andelic N, 2013, J REHABIL MED, V45, P708, DOI [10.2340/16501977-1224, 10.2340/16501977-1216]; Barrett KA, 2009, WOMEN HEALTH ISS, V19, P94, DOI 10.1016/j.whi.2008.10.005; Beydoun HA, 2017, J WOMENS HEALTH, V26, P141, DOI 10.1089/jwh.2016.5840; Birt L, 2016, QUAL HEALTH RES, V26, P1802, DOI 10.1177/1049732316654870; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bukowski LA, 2019, J URBAN HEALTH, V96, P760, DOI 10.1007/s11524-019-00355-3; Burczycka M., 2017, FAMILY VIOLENCE CANA, P1209; Chirwa E, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002156; Cimino AN, 2019, J AGGRESS MALTREAT T, V28, P714, DOI 10.1080/10926771.2019.1587657; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Cullen P, 2021, TRAUMA VIOLENCE ABUS, DOI 10.1177/1524838020985571; Denzin NK., 1998, COLLECTING INTERPRET; Garthe RC, 2018, LGBT HEALTH, V5, P333, DOI 10.1089/lgbt.2018.0034; Gutman S. A., 2004, OCCUP THER MENT HEAL, V20, P49, DOI [10.1300/J004v20n01_03, DOI 10.1300/J004V20N01_03]; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Kumar RG, 2018, BRAIN INJURY, V32, P383, DOI 10.1080/02699052.2018.1427888; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lincoln Y.S., 2000, HDB QUALITATIVE RES; National Inquiry into Missing and Murdered Indigenous Women and Girls (NIMMIWG), 2019, RECLAIMING POWER PLA; Nemeth JM, 2019, J AGGRESS MALTREAT T, V28, P744, DOI 10.1080/10926771.2019.1591562; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ravi KE, 2021, TRAUMA VIOLENCE ABUS, DOI 10.1177/1524838021995954; Roberts AR, 2005, J SOC SERV RES, V32, P33, DOI 10.1300/J079v32n01_03; Robinson SR, 2021, TRAUMA VIOLENCE ABUS, V22, P1279, DOI 10.1177/1524838020916254; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; Sinha M., 2013, MEASURING VIOLENCE W; St Ivany A, 2018, J FORENSIC NURS, V14, P198, DOI 10.1097/JFN.0000000000000220; St Ivany A, 2018, QUAL HEALTH RES, V28, P1708, DOI 10.1177/1049732318786705; Statistics Canada, 2015, FAMILY VIOLENCE CANA; Statistics Canada, 2011, FAMILY VIOLENCE CANA; Stockman JK, 2015, J WOMENS HEALTH, V24, P62, DOI 10.1089/jwh.2014.4879; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Wallerstein N., 2011, COMMUNITY BASED PART; Wallerstein NB, 2006, HEALTH PROMOT PRACT, V7, P312, DOI 10.1177/1524839906289376; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; World Health Organization, 2017, VIOLENCE AGAINST WOM	46	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2022	37	1			SI		E20	E29		10.1097/HTR.0000000000000743			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YB2LC	WOS:000738849500006	34985037	hybrid			2022-02-06	
J	Valera, EM; Daugherty, JC; Scott, OC; Berenbaum, H				Valera, Eve M.; Daugherty, Julia C.; Scott, Olivia C.; Berenbaum, Howard			Strangulation as an Acquired Brain Injury in Intimate-Partner Violence and Its Relationship to Cognitive and Psychological Functioning: A Preliminary Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; cognitive functioning; domestic violence; intimate-partner violence; psychological functioning; strangulation	NONFATAL STRANGULATION; WOMEN; VICTIMS; RELIABILITY; IMPAIRMENT; VALIDATION; DEPRESSION; VALIDITY	Objective: The aim of this work was to examine the relationship between strangulation-related alterations in consciousness (AIC) and cognitive and psychological outcomes in women who have experienced intimate partner violence (IPV). Setting: Participants were recruited from a variety of settings, including women's shelters and support programs. Participants: A total of 99 women were enrolled in the study. After applying exclusion criteria for factors that could mask or confound the effects of strangulation, 52 women remained for analyses. Design: Cross-sectional, retrospective. Main Measures: We used several cognitive measures to assess learning, long-term and working memory, visuomotor speed, cognitive flexibility, and nonverbal cognitive fluency as well as several psychological measures to assess posttraumatic stress symptomatology, general distress, worry, anhedonic depression, and anxious arousal. We also used the Brain Injury Severity Assessment interview to examine the association between strangulation-related AICs and these measures of cognitive and psychological functioning. Results: Women who had experienced strangulation-related AICs performed more poorly on a test of long-term memory (P < .03) and had higher levels of depression (P < .03) and posttraumatic stress symptomatology (P < .02) than women who had not experienced strangulation-related AIC. When controlling for potential confounding variables, including number of IPV-related traumatic brain injuries, women who had experienced strangulation also performed more poorly on a measure of working memory. Conclusion: This is the first report to assess strangulation in this manner and demonstrate links to cognitive and psychological functioning. These preliminary data contribute to our knowledge of strangulation and its effects on women who have experienced IPV.	[Valera, Eve M.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Valera, Eve M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Daugherty, Julia C.] Univ Granada, Mind Brain Behav Res Ctr CIMCYC, Granada, Spain; [Scott, Olivia C.] Harvard Univ, Cambridge, MA USA; [Berenbaum, Howard] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA		Valera, EM (corresponding author), Massachusetts Gen Hosp, Psychiat, Rm 2660,149 Thirteenth St, Charlestown, MA 02129 USA.	Eve_valera@hms.harvard.edu; juliadaugherty1@gmail.com; oliviascott@college.harvard.edu; hberenba@illinois.edu			National Institute of Health's National Research Service Award [1 F31 MH1176301A2]; University of Illinois Urbana-Champaign's Graduate College On-CampusDissertation Research Grant; Women's Studies Funding for Feminist Scholarship; Graduate College Thesis Project Grant;  [R01 NS112694-01]	This research was supported by the R01 NS112694-01 grant as well as 4 grants supporting the principal investigator's doctoral dissertation: National Institute of Health's National Research Service Award 1 F31 MH1176301A2, and the University of Illinois Urbana-Champaign's Graduate College On-CampusDissertation Research Grant, Women's Studies Funding for Feminist Scholarship, and the Graduate College Thesis Project Grant.	ACRM, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI 10.1097/00001199-199309000-00010; Anderson CA, 2010, NEUROREHABILITATION, V26, P47, DOI 10.3233/NRE-2010-0535; Armstrong M, 2016, JAMA OTOLARYNGOL, V142, P891, DOI 10.1001/jamaoto.2016.0293; Army Individual Test Battery, 1944, MAN DIR SCOR; Baker RB, 2008, JOGNN-J OBST GYN NEO, V37, P228, DOI 10.1111/j.1552-6909.2007.00226.x; Fernandez EB, 2011, J INTERPERS VIOLENCE, V26, P1215, DOI 10.1177/0886260510368155; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bichard H, 2021, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1868537; Campbell JC, 2009, J INTERPERS VIOLENCE, V24, P653, DOI 10.1177/0886260508317180; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Chung SY., J PSYCHIAT, DOI [10.4172/Psychiatry.1000148, DOI 10.4172/PSYCHIATRY.1000148]; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Delis DC, 1987, CALIFORNIA VERBAL LE; FALSSTEWART W, 1992, PERCEPT MOTOR SKILL, V74, P39, DOI 10.2466/PMS.74.1.39-42; Glass N, 2008, J EMERG MED, V35, P329, DOI 10.1016/j.jemermed.2007.02.065; Goltermann J, 2021, NEUROPSYCHOPHARMACOL, V46, P891, DOI 10.1038/s41386-020-00794-6; Hebenstreit CL, 2014, J AGGRESS MALTREAT T, V23, P168, DOI 10.1080/10926771.2014.872749; Joshi M, 2012, SOC WORK HEALTH CARE, V51, P798, DOI 10.1080/00981389.2012.692352; Kennedy C M, 2001, CNS Spectr, V6, P787; Maldonado-Rodriguez N, 2021, J NEUROTRAUM, DOI 10.1089/neu.2021.0042; Malek AM, 2000, J NEUROSURG, V92, P481, DOI 10.3171/jns.2000.92.3.0481; Messing JT, 2018, WOMEN HEALTH ISS, V28, P104, DOI 10.1016/j.whi.2017.10.002; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Monahan K, 2022, J FAM VIOLENCE, V37, P75, DOI 10.1007/s10896-020-00208-7; Pritchard AJ, 2018, FEM CRIMINOL, V13, P160, DOI 10.1177/1557085116653181; Rajaram SS, 2021, VIOLENCE AGAINST WOM, V27, P1548, DOI 10.1177/1077801220947164; Roberts AL, 2022, CHILD MALTREATMENT, V27, P100, DOI 10.1177/1077559520970647; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Shields LBE, 2010, AM J FOREN MED PATH, V31, P320, DOI 10.1097/PAF.0b013e3181d3dc02; Smirl JD, 2019, BRAIN INJURY, V33, P1529, DOI 10.1080/02699052.2019.1658129; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Strack GB, 2001, J EMERG MED, V21, P303, DOI 10.1016/S0736-4679(01)00399-7; Thomas KA, 2014, PSYCHOL WOMEN QUART, V38, P124, DOI 10.1177/0361684313488354; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; US Department of Justice Office on Violence Against Women ., 2013, NAT PROT SEX ASS MED; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera EM, 1999, BRAIN INJURY BATTERE; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler D, 1981, WECHSLER ADULT INTEL; Wilbur L, 2001, J EMERG MED, V21, P297, DOI 10.1016/S0736-4679(01)00398-5	45	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2022	37	1			SI		15	23		10.1097/HTR.0000000000000755			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YB2LC	WOS:000738849500005	34985030				2022-02-06	
J	Wang, R; Yang, DX; Liu, YL; Ding, J; Guo, Y; Ding, WH; Tian, HL; Yuan, F				Wang, Ren; Yang, Dian-Xu; Liu, Ying-Liang; Ding, Jun; Guo, Yan; Ding, Wan-Hai; Tian, Heng-Li; Yuan, Fang			Cell cycle exit and neuronal differentiation 1-engineered embryonic neural stem cells enhance neuronal differentiation and neurobehavioral recovery after experimental traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article							PROLIFERATION; EXPRESSION; RATS; BM88	Our previous study showed that cell cycle exit and neuronal differentiation 1 (CEND1) may participate in neural stem cell cycle exit and oriented differentiation. However, whether CEND1-transfected neural stem cells can improve the prognosis of traumatic brain injury remained unclear. In this study, we performed quantitative proteomic analysis and found that after traumatic brain injury, CEND1 expression was downregulated in mouse brain tissue. Three days after traumatic brain injury, we transplanted CEND1-transfected neural stem cells into the area surrounding the injury site. We found that at 5 weeks after traumatic brain injury, transplantation of CEND1-transfected neural stem cells markedly alleviated brain atrophy and greatly improved neurological function. In vivo and in vitro results indicate that CEND1 overexpression inhibited the proliferation of neural stem cells, but significantly promoted their neuronal differentiation. Additionally, CEND1 overexpression reduced protein levels of Notch1 and cyclin D1, but increased levels of p21 in CEND1-transfected neural stem cells. Treatment with CEND1-transfected neural stem cells was superior to similar treatment without CEND1 transfection. These findings suggest that transplantation of CEND1-transfected neural stem cells is a promising cell therapy for traumatic brain injury. This study was approved by the Animal Ethics Committee of the School of Biomedical Engineering of Shanghai Jiao Tong University, China (approval No. 2016034) on November 25, 2016.	[Wang, Ren; Yang, Dian-Xu; Ding, Jun; Guo, Yan; Ding, Wan-Hai; Tian, Heng-Li; Yuan, Fang] Shanghai Jiao Tong Univ, Dept Neurosurg, Affiliated Peoples Hosp 6, Sch Med, Shanghai, Peoples R China; [Liu, Ying-Liang] Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurosurg, Shanghai, Peoples R China		Ding, WH; Tian, HL; Yuan, F (corresponding author), Shanghai Jiao Tong Univ, Dept Neurosurg, Affiliated Peoples Hosp 6, Sch Med, Shanghai, Peoples R China.	dingwanhai@126.com; tianhlsh@126.com; yf021025@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701895]; Shanghai Jiao Tong University Medicine-Engineering Research Fund, China [YG2016QN20]	This work was supported by the National Natural Science Foundation of China, No. 81701895; and Shanghai Jiao Tong University Medicine-Engineering Research Fund, China, No. YG2016QN20 (both to FY).	Adepoju A, 2014, STEM CELLS, V32, P770, DOI 10.1002/stem.1575; Bagnato S, 2020, NEURAL REGEN RES, V15, P1247, DOI 10.4103/1673-5374.272574; Chen JL, 2020, ZHONGGUO ZUZHI GONGC, V24, P3947; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Ding J, 2015, ARQ NEURO-PSIQUIAT, V73, P342, DOI 10.1590/0004-282X20150006; Gaitanou M, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/2054783; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Jiang JP, 2020, NEURAL REGEN RES, V15, P959, DOI 10.4103/1673-5374.268974; Katsimpardi L, 2008, STEM CELLS, V26, P1796, DOI 10.1634/stemcells.2007-0921; Koutmani Y, 2004, EUR J NEUROSCI, V20, P2509, DOI 10.1111/j.1460-9568.2004.03724.x; Li YN, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0865-6; Li YQ, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0081-2; Liu LJ, 2019, NAT CELL BIOL, V21, P1060, DOI 10.1038/s41556-019-0384-4; Liu YL, 2018, J NEUROTRAUM, V35, P2850, DOI 10.1089/neu.2017.5397; Lukaszewicz AS, 2002, J NEUROSCI, V22, P6610; Makri G, 2010, STEM CELLS, V28, P127, DOI 10.1002/stem.258; Masgrau R, 2009, NEUROPHARMACOLOGY, V56, P598, DOI 10.1016/j.neuropharm.2008.10.015; Politis PK, 2007, P NATL ACAD SCI USA, V104, P17861, DOI 10.1073/pnas.0610973104; Sergaki MC, 2010, MOL CELL NEUROSCI, V44, P15, DOI 10.1016/j.mcn.2010.01.011; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Tang HL, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/5173494; Weng L, 2013, J NEUROSCI, V33, P8172, DOI 10.1523/JNEUROSCI.0119-13.2013; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Willing AE, 2020, CNS NEUROSCI THER, V26, P616, DOI 10.1111/cns.13300; Xiong LL, 2018, MOL NEUROBIOL, V55, P2696, DOI 10.1007/s12035-017-0551-1; Yasuhara T, 2020, CNS NEUROSCI THER, V26, P595, DOI 10.1111/cns.13247; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423	28	1	1	9	11	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN	2022	17	1					130	136		10.4103/1673-5374.314316			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	SS2OU	WOS:000661581500030	34100448	Green Published, gold			2022-02-06	
J	Yorkgitis, BK; Tatum, DM; Taghavi, S; Schroeppel, TJ; Noorbakhsh, MR; Philps, FH; Bugaev, N; Mukherjee, K; Bellora, M; Ong, AW; Ratnasekera, A; Nordham, KD; Carrick, MM; Haan, JM; Lightwine, KL; Lottenberg, L; Borrego, R; Cullinane, DC; Berne, JD; Mederos, DR; Hayward, TZ; Kerwin, AJ; Crandall, M				Yorkgitis, Brian K.; Tatum, Danielle M.; Taghavi, Sharven; Schroeppel, Thomas J.; Noorbakhsh, Matthew R.; Philps, Frances Hite; Bugaev, Nikolay; Mukherjee, Kaushik; Bellora, Mellody; Ong, Adrian W.; Ratnasekera, Asanthi; Nordham, Kristen D.; Carrick, Matthew M.; Haan, James M.; Lightwine, Kelly L.; Lottenberg, Lawrence; Borrego, Robert; Cullinane, Daniel C.; Berne, John D.; Mederos, Dalier Rodriguez; Hayward, Thomas Z.; Kerwin, Andy J.; Crandall, Marie			Eastern Association for the Surgery of Trauma Multicenter Trial: Comparison of pre-injury antithrombotic use and reversal strategies among severe traumatic brain injury patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Antithrombotic; antiplatelet; anticoagulation; traumatic brain injury; Xa inhibitor	INTRACRANIAL HEMORRHAGE; ANTIPLATELET; ANTICOAGULATION; THERAPY; TRENDS; IMPACT	BACKGROUND: Trauma teams are often faced with patients on antithrombotic (AT) drugs, which is challenging when bleeding occurs. We sought to compare the effects of different AT medications on head injury severity and hypothesized that AT reversal would not improve mortality in severe traumatic brain injury (TBI) patients. METHODS: An Eastern Association for the Surgery of Trauma-sponsored prospective, multicentered, observational study of 15 trauma centers was performed. Patient demoglaphics, injury burden, comorbidities, AT agents, and reversal attempts were collected. Outcomes of interest were head injury severity and in-hospital mortality. RESULTS: Analysis was performed on 2,793 patients. The majority of patients were on aspirin (acetylsalicylic acid [ASA], 46.1%). Patients on a platelet chemoreceptor blocker (P2Y12) had the highest mean Injury Severity Score (9.1 +/- 8.1). Patients taking P2Y12 inhibitors +/- ASA, and ASA-warfarin had the highest head Abbreviated Injury Scale (AIS) mean (1.2 +/- 1.6). On risk-adjusted analysis, warfarin-ASA was associated with a higher head AIS (odds ratio [OR], 2.43; 95% confidence interval [Cl], 1.34 4.42) after controlling for Injury Severity Score, Charism Comorbidity Index, initial Glasgow Coma Scale score, and initial systolic blood pressure. Among patients with severe TBI (head AIS score, >= 3) on antiplatelet therapy, reversal with desmopressin (DDAVP) and/or platelet transfusion did not improve survival (82.9% reversal vs. 90.4% none,p = 0.30). In severe TBI patients taking Xa inhibitors who received prothrombin complex concentrate, survival was not improved (84.6% reversal vs. 84.6% none,p = 0.68). With risk adjustment as described previously, mortality was not improved with reversal attempts (antiplatelet agents: OR 0.83; 85% CI, 0.12-5.9 [p = 0.85]; Xa inhibitors: OR, 0.76; 95% CI, 0.12-4.64; p = 0.77). CONCLUSION: Reversal attempts appear to confer no mortality benefit in severe TBI patients on antiplatelet agents or Xa inhibitors. Combination therapy was associated with severity of head injury among patients taking preinjury AT therapy, with ASA-warfarin possessing the greatest risk. Copyright (C) 2021 Wolters Kluwer Health, Inc. All rights reserved.	[Yorkgitis, Brian K.; Kerwin, Andy J.; Crandall, Marie] Univ Florida, Coll Med, Dept Surg, 653 W 8th St, Jacksonville, FL 32209 USA; [Tatum, Danielle M.] Our Lady Lake RMC, Trauma Div, Baton Rouge, LA USA; [Taghavi, Sharven] Tulane Sch Med, Dept Surg, New Orleans, LA USA; [Schroeppel, Thomas J.] UC Hlth Mem Hosp, Dept Surg, Colorado Springs, CO USA; [Noorbakhsh, Matthew R.; Philps, Frances Hite] Allegheny Hlth Network, Dept Surg, Pittsburgh, PA USA; [Bugaev, Nikolay] Tufts Med Ctr, Div Trauma Acute Care Surg, Boston, MA 02111 USA; [Mukherjee, Kaushik; Bellora, Mellody] Loma Linda Univ, Med Ctr, Dept Surg, Loma Linda, CA USA; [Ong, Adrian W.] Reading Hosp Tower Hlth, Dept Surg, Reading, PA USA; [Ratnasekera, Asanthi] Crozer Keystone Hlth Syst, Dept Surg, Upland, PA USA; [Nordham, Kristen D.] Tulane Univ, Med Sch, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Carrick, Matthew M.] Med City Plano, Dept Surg, Plano, TX USA; [Haan, James M.; Lightwine, Kelly L.] Via Christi Hosp Wichita, Dept Surg, Wichita, KS USA; [Lottenberg, Lawrence; Borrego, Robert] St Marys Hosp, Dept Surg, W Palm Beach, FL USA; [Cullinane, Daniel C.] Maine Med Ctr, Dept Surg, Portland, ME 04102 USA; [Berne, John D.; Mederos, Dalier Rodriguez] Broward Hlth Med Ctr, Dept Surg, Ft Lauderdale, FL USA; [Hayward, Thomas Z.] Indiana Univ Sch Med, Eskenazi Hlth, Dept Surg, Indianapolis, IN 46202 USA		Yorkgitis, BK (corresponding author), Univ Florida, Coll Med, Dept Surg, 653 W 8th St, Jacksonville, FL 32209 USA.	Brian.yorkgitis2@jax.ufl.edu	Bugaev, Nikolay/AAC-6963-2022	Taghavi, Sharven/0000-0001-6289-2129; Nordham, Kristen/0000-0002-2038-1598	Eastern Association for the Surgery of Trauma Junior Investigator Award	We thank Kokila Jeymurugan, MD, Tufts Medical Center, Boston, MA; Liz Penaloza, MD, Loma Linda University Medical Center, Loma Linda, CA; Sandra Durgin, Crozer Keystone Health System, Upland, PA; Laura Cullinane, Marshfield Clinic, Marshfield, WI; and Ian Tfrin, MPH, Center forData Solutions, University of Florida College of Medicine, Jacksonville, FL. Funding for this project was provided by the Eastern Association for the Surgery of Trauma Junior Investigator Award.	Alvikas J, 2020, J TRAUMA ACUTE CARE, V88, P847, DOI 10.1097/TA.0000000000002640; Asencio LA, 2014, AM J MED, V127, P579, DOI 10.1016/j.amjmed.2014.02.030; Barletta JF, 2020, NEUROCRIT CARE, V33, P405, DOI 10.1007/s12028-019-00899-x; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Connolly SJ, 2019, NEW ENGL J MED, V380, P1326, DOI 10.1056/NEJMoa1814051; Costa OS, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040499; Dregan A, 2018, ANN EPIDEMIOL, V28, P440, DOI 10.1016/j.annepidem.2018.03.006; Dybdahl D, 2019, AM J EMERG MED, V37, P1907, DOI 10.1016/j.ajem.2019.01.008; Ferraris VA, 2012, J TRAUMA ACUTE CARE, V73, P492, DOI 10.1097/TA.0b013e31825b85f1; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Goldstein JN., 2019, NEUROCRIT CARE, V31, P341; Holzmacher JL, 2017, SURG CLIN N AM, V97, P1291, DOI 10.1016/j.suc.2017.07.002; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Krueger EM, 2020, CUREUS, V12, DOI 10.7759/cureus.10508; Kuramatsu JB, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2492-8; Lim XT, 2021, J TRAUMA ACUTE CARE, V90, P191, DOI 10.1097/TA.0000000000002976; Lokhandwala AM, 2021, J SURG RES, V257, P239, DOI 10.1016/j.jss.2020.07.076; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Panos NG, 2020, CIRCULATION, V141, P1681, DOI 10.1161/CIRCULATIONAHA.120.045769; Rawal A, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.07.101; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Tao J, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0303-y; Thorn S, 2019, TRANSFUSION, V59, P3536, DOI 10.1111/trf.15526; US Food and Drug Administration, 2013, XAR HIGHL PRESCR INF; US Food and Drug Administration, 2012, EL HIGHL PRESCR INF	25	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2022	92	1					88	92		10.1097/TA.0000000000003421			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	XR1JJ	WOS:000731994300020	34570064				2022-02-06	
J	Wu, JR; Vodovotz, Y; Abdelhamid, S; Guyette, FX; Yaffe, MB; Gruen, DS; Cyr, A; Okonkwo, DO; Kar, UK; Krishnamoorthi, N; Voinchet, RG; Billiar, IM; Yazer, MH; Namas, RA; Daley, BJ; Miller, RS; Harbrecht, BG; Claridge, JA; Phelan, HA; Zuckerbraun, BS; Johansson, PI; Stensballe, J; Morrissey, JH; Tracy, RP; Wisniewski, SR; Neal, MD; Sperry, JL; Billiar, TR				Wu, Junru; Vodovotz, Yoram; Abdelhamid, Sultan; Guyette, Francis X.; Yaffe, Michael B.; Gruen, Danielle S.; Cyr, Anthony; Okonkwo, David O.; Kar, Upendra K.; Krishnamoorthi, Neha; Voinchet, Robert G.; Billiar, Isabel M.; Yazer, Mark H.; Namas, Rami A.; Daley, Brian J.; Miller, Richard S.; Harbrecht, Brian G.; Claridge, Jeffrey A.; Phelan, Herbert A.; Zuckerbraun, Brian S.; Johansson, Par, I; Stensballe, Jakob; Morrissey, James H.; Tracy, Russell P.; Wisniewski, Stephen R.; Neal, Matthew D.; Sperry, Jason L.; Billiar, Timothy R.		PAMPer Study Grp	Article Multi-omic analysis in injured humans: Patterns align with outcomes and treatment responses	CELL REPORTS MEDICINE			English	Article							TRAUMA-INDUCED COAGULOPATHY; MOLECULAR-PATTERNS; R-PACKAGE; COMPLEMENT; MORTALITY; PLASMA; RISK; INFLAMMATION; COAGULATION; MEDIATORS	Trauma is a leading cause of death and morbidity worldwide. Here, we present the analysis of a longitudinal multi-omic dataset comprising clinical, cytokine, endotheliopathy biomarker, lipidome, metabolome, and proteome data from severely injured humans. A "systemic storm"pattern with release of 1,061 markers, together with a pattern suggestive of the "massive consumption"of 892 constitutive circulating markers, is identified in the acute phase post-trauma. Data integration reveals two human injury response endotypes, which align with clinical trajectory. Prehospital thawed plasma rescues only endotype 2 patients with traumatic brain injury (30-day mortality: 30.3 versus 75.0%; p = 0.0015). Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) was identified as the most predictive circulating biomarker to identify endotype 2-traumatic brain injury (TBI) patients. These response patterns refine the paradigm for human injury, while the datasets provide a resource for the study of critical illness, trauma, and human stress responses.	[Wu, Junru; Vodovotz, Yoram; Abdelhamid, Sultan; Gruen, Danielle S.; Cyr, Anthony; Kar, Upendra K.; Krishnamoorthi, Neha; Voinchet, Robert G.; Billiar, Isabel M.; Namas, Rami A.; Zuckerbraun, Brian S.; Neal, Matthew D.; Sperry, Jason L.; Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Wu, Junru; Vodovotz, Yoram; Abdelhamid, Sultan; Gruen, Danielle S.; Cyr, Anthony; Kar, Upendra K.; Namas, Rami A.; Zuckerbraun, Brian S.; Neal, Matthew D.; Sperry, Jason L.; Billiar, Timothy R.] Univ Pittsburgh, Pittsburgh Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Wu, Junru] Cent South Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Peoples R China; [Wu, Junru] Cent South Univ, Xiangya Hosp 3, Ctr Pharmacol, Changsha, Peoples R China; [Wu, Junru] Cent South Univ, Xiangya Sch Med, Eight Year Program Med, Changsha, Peoples R China; [Guyette, Francis X.] Univ Pittsburgh, Dept Emergency Med, Med, Pittsburgh, PA USA; [Yaffe, Michael B.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Yaffe, Michael B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Yazer, Mark H.] Inst Transfus Med, Pittsburgh, PA USA; [Daley, Brian J.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Knoxville, TN USA; [Miller, Richard S.] JPS Hlth Network, Dept Surg, Ft Worth, TX USA; [Harbrecht, Brian G.] Univ Louisville, Dept Surg, Louisville, KY 40292 USA; [Claridge, Jeffrey A.] Case Western Reserve Univ, Metro Hlth Med Ctr, Cleveland, OH 44106 USA; [Phelan, Herbert A.] Univ Texas Southwestern, Dept Surg, Dallas, TX USA; [Johansson, Par, I; Stensballe, Jakob] Copenhagen Univ Hosp, Rigshosp, Sect Transfus Med, Capital Reg Blood Bank, Copenhagen, Denmark; [Stensballe, Jakob] Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Dept Anesthesia, Copenhagen, Denmark; [Stensballe, Jakob] Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthopaed, Trauma Ctr, Copenhagen, Denmark; [Stensballe, Jakob] Capital Reg Denmark, Emergency Med Serv, Hillerod, Denmark; [Morrissey, James H.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Tracy, Russell P.] Univ Vermont, Lamer Coll Med, Dept Pathol, Colchester, VT USA; [Tracy, Russell P.] Univ Vermont, Lamer Coll Med, Lab Med & Biochem, Colchester, VT USA; [Wisniewski, Stephen R.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA		Neal, MD; Sperry, JL; Billiar, TR (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.; Neal, MD; Sperry, JL; Billiar, TR (corresponding author), Univ Pittsburgh, Pittsburgh Trauma Res Ctr, Pittsburgh, PA 15260 USA.	nealm2@upmc.edu; sperryjl@upmc.edu; billiartr@upmc.edu	Wu, Junru/AAF-7234-2021	Wu, Junru/0000-0002-8593-0703	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-2-0023]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R35GM-127027, R35GM119526, R01HL141080, UM1HL120877]; Xiangya Medical School, Changsha, China	This work was supported by US Army Medical Research and Materiel Command (W81XWH-12-2-0023 to J.L.S.) and National Institutes of Health (R35GM-127027 to T.R.B.; R35GM119526 and R01HL141080 to M.D.N.; UM1HL120877 to J.H.M. and S.R.W. with sub-award to M.D.N.). We acknowledge the contribution of collaborators involved in PAMPer study for the clinical data collection. We acknowledge the contribution of the TACTIC team for proteomic data collection. J.W. was supported by Xiangya Medical School, Changsha, China.	Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Ackerman ME, 2018, NAT MED, V24, P1590, DOI 10.1038/s41591-018-0161-0; Almahmoud K, 2015, CRIT CARE MED, V43, P1395, DOI 10.1097/CCM.0000000000000964; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bohmer AB, 2014, DTSCH ARZTEBL INT, V111, P437, DOI 10.3238/arztebl.2014.0437; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Candia J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14755-5; Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chen R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.337; Chen T., 2020, JCI INSIGHT, V6; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Cuenca AG, 2013, CRIT CARE MED, V41, P1175, DOI 10.1097/CCM.0b013e318277131c; Cyr A, 2021, J AM COLL SURGEONS, V232, P276, DOI 10.1016/j.jamcollsurg.2020.12.022; Davies DR, 2012, P NATL ACAD SCI USA, V109, P19971, DOI 10.1073/pnas.1213933109; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Foley JH, 2016, THROMB RES, V141, pS50, DOI 10.1016/S0049-3848(16)30365-6; Gruen DS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16869; Gruen DS, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135350; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Huber-Lang M, 2013, SEMIN IMMUNOL, V25, P73, DOI 10.1016/j.smim.2013.05.006; Jackson SP, 2019, BLOOD, V133, P906, DOI 10.1182/blood-2018-11-882993; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Johansson P, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1605-5; Keragala CB, 2018, BRIT J HAEMATOL, V180, P782, DOI 10.1111/bjh.15062; Maier RV, 2014, J AM COLL SURGEONS, V219, P335, DOI 10.1016/j.jamcollsurg.2014.04.011; McInnes L, 2018, ARXIV; Moore HB, 2020, J THROMB HAEMOST, V18, P740, DOI 10.1111/jth.14690; Namas RA, 2015, ANTIOXID REDOX SIGN, V23, P1370, DOI 10.1089/ars.2015.6398; Namas RA, 2016, ANN SURG, V263, P191, DOI 10.1097/SLA.0000000000001001; Neal MD, 2015, J TRAUMA ACUTE CARE, V79, P490, DOI 10.1097/TA.0000000000000793; Porter C, 2016, LANCET, V388, P1417, DOI 10.1016/S0140-6736(16)31469-6; Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d; Reyes M, 2020, NAT MED, V26, P333, DOI 10.1038/s41591-020-0752-4; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen B, 2020, CELL, V182, P59, DOI 10.1016/j.cell.2020.05.032; Shilo S, 2020, NAT MED, V26, P29, DOI 10.1038/s41591-019-0727-5; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Thorgersen EB, 2019, HEPATOLOGY, V70, P725, DOI 10.1002/hep.30508; Timmermans K, 2016, INTENS CARE MED, V42, P551, DOI 10.1007/s00134-015-4205-3; Tompkins RG, 2015, J TRAUMA ACUTE CARE, V78, P671, DOI 10.1097/TA.0000000000000568; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wozniak JM, 2020, CELL, V182, P1311, DOI 10.1016/j.cell.2020.07.040; Wu Junru, 2021, Res Sq, DOI 10.21203/rs.3.rs-106579/v1; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	54	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2666-3791			CELL REP MED	Cell Rep. Med.	DEC 21	2021	2	12							100478	10.1016/j.xcrm.2021.100478			23	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	XV8IX	WOS:000735179800005		gold, Green Published			2022-02-06	
J	Yang, HW; Bin Bae, J; Oh, DJ; Moon, DG; Lim, E; Shin, J; Kim, BJ; Lee, DW; Kim, JL; Jhoo, JH; Park, JH; Lee, JJ; Kwak, KP; Lee, SB; Moon, SW; Ryu, SH; Kim, SG; Han, JW; Kim, KW				Yang, Hee Won; Bin Bae, Jong; Oh, Dae Jong; Moon, Dong Gyu; Lim, Eunji; Shin, Jin; Kim, Bong Jo; Lee, Dong Woo; Kim, Jeong Lan; Jhoo, Jin Hyeong; Park, Joon Hyuk; Lee, Jung Jae; Kwak, Kyung Phil; Lee, Seok Bum; Moon, Seok Woo; Ryu, Seung-Ho; Kim, Shin Gyeom; Han, Ji Won; Kim, Ki Woong			Exploration of Cognitive Outcomes and Risk Factors for Cognitive Decline Shared by Couples	JAMA NETWORK OPEN			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; DEMENTIA PATIENTS; KOREAN VERSION; OLDER-PEOPLE; SPOUSE CAREGIVERS; DEPRESSION; HEALTH; IMPAIRMENT; STRESS	IMPORTANCE Although couples could share many risk factors of cognitive disorders in their lifetime, whether shared risk factors mediate the shared risk of cognitive disorders has rarely been investigated. OBJECTIVE To identify the risk factors of cognitive decline shared within couples and investigate their mediating roles in the shared risk of cognitive disorders and cognitive functions within couples. DESIGN, SETTING, AND PARTICIPANTS A prospective cohort study was launched in November 1, 2010, and 784 participants were followed up every 2 years until December 31, 2020. This nationwide, multicenter, community-based study included older couples from the Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD) and a cohort of their spouses (KLOSCAD-S). EXPOSURES The cognitive disorder of a spouse was defined as mild cognitive impairment or dementia. MAIN OUTCOMES AND MEASURES The mediating roles of factors shared within couples on the association between one spouse's cognitive disorder and the other's risk of cognitive disorders was examined with structural equation modeling. RESULTS Included were 784 KLOSCAD participants (307 women [39.2%] and 477 men [60.8%]; mean [SD] age, 74.8 [4.8] years) and their spouses (477 women [60.8%] and 307 men [39.2%]; mean [SD] age, 73.6 [6.2] years). The cognitive disorder of the KLOSCAD participants was associated with almost double the risk of cognitive disorder of their spouses in the KLOSCAD-S cohort (odds ratio, 1.74; 95% CI, 1.12-2.69; P = .01). History of head injury (beta = 0.50; 95% CI, 0.09-0.90; P = .02) and age (beta = 2.57; 95% CI, 1.37-3.76; P < .001) mediated the association between cognitive disorder in the KLOSCAD participants and their spouses' risk of cognitive disorder. Physical inactivity mediated the association through major depressive disorder (beta = 0.33, 95% CI, 0.09-0.57, P = .006 for physical inactivity; beta = 0.28, 95% CI, 0.13-0.44, P < .001 for major depressive disorder). These factors similarly mediated the association between spousal cognitive disorder and cognitive functions such as memory and executive function. CONCLUSIONS AND RELEVANCE These findings suggest that the risk factors shared within couples may mediate approximately three-quarters of the spousal risk of cognitive disorders. Identification of and intervention in the shared risk factors of dementia within couples may reduce the risk of cognitive disorders in the spouses of people with dementia.	[Yang, Hee Won; Bin Bae, Jong; Moon, Dong Gyu; Shin, Jin; Han, Ji Won; Kim, Ki Woong] Seoul Natl Univ, Dept Neuropsychiat, Bundang Hosp, 82 Gumiro,173 Beongil, Seongnam Si 13620, Gyeonggi Do, South Korea; [Bin Bae, Jong; Oh, Dae Jong; Han, Ji Won; Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Oh, Dae Jong] SMG SNU Boramae Med Ctr, Dept Psychiat, Seoul, South Korea; [Lim, Eunji] Gyeongsang Natl Univ, Dept Psychiat, Changwon Hosp, Chang Won, South Korea; [Kim, Bong Jo] Gyeongsang Natl Univ, Sch Med, Dept Psychiat, Jinju, South Korea; [Lee, Dong Woo] Inje Univ, Dept Neuropsychiat, Sanggye Paik Hosp, Seoul, South Korea; [Kim, Jeong Lan] Chungnam Natl Univ, Sch Med, Dept Psychiat, Daejeon, South Korea; [Jhoo, Jin Hyeong] Kangwon Natl Univ Hosp, Dept Neuropsychiat, Chunchon, South Korea; [Park, Joon Hyuk] Jeju Natl Univ Hosp, Dept Neuropsychiat, Jeju, South Korea; [Lee, Jung Jae; Lee, Seok Bum] Dankook Univ Hosp, Dept Psychiat, Cheonan, South Korea; [Kwak, Kyung Phil] Dongguk Univ, Dept Psychiat, Gyeongju Hosp, Gyeongju, South Korea; [Moon, Seok Woo] Konkuk Univ, Chungju Hosp, Sch Med, Dept Psychiat, Chungju, South Korea; [Ryu, Seung-Ho] Konkuk Univ, Med Ctr, Sch Med, Dept Psychiat, Seoul, South Korea; [Kim, Shin Gyeom] Soonchunhyang Univ, Dept Neuropsychiat, Bucheon Hosp, Bucheon, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Dept Brain & Cognit Sci, Coll Nat Sci, Seoul, South Korea		Kim, KW (corresponding author), Seoul Natl Univ, Dept Neuropsychiat, Bundang Hosp, 82 Gumiro,173 Beongil, Seongnam Si 13620, Gyeonggi Do, South Korea.	kwkimmd@snu.ac.kr			 [2020-ER6201-01]	This research was supported by a grant from the RKCDC (grant 2020-ER6201-01).	American Psychiatric Association, 1994, DSM 4 DIAGN STAT MAN, V4th; Ask H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-413; Bath PA, 1999, EUR J EPIDEMIOL, V15, P65, DOI 10.1023/A:1007531101765; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Caswell LW, 2003, EXP AGING RES, V29, P303, DOI 10.1080/03610730303721; Chen Cynthia, 2020, Alzheimers Dement (N Y), V6, pe12082, DOI 10.1002/trc2.12082; Cobb LK, 2016, AM J EPIDEMIOL, V183, P435, DOI 10.1093/aje/kwv112; Cobb LK, 2016, AM J EPIDEMIOL, V183, P444, DOI 10.1093/aje/kwv104; Dassel KB, 2017, GERONTOLOGIST, V57, P319, DOI 10.1093/geront/gnv148; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; de Vugt ME, 2006, AGE AGEING, V35, P160, DOI 10.1093/ageing/afj044; Di Castelnuovo A, 2009, AM J EPIDEMIOL, V169, P1, DOI 10.1093/aje/kwn234; Dufouil C, 2000, J CLIN EPIDEMIOL, V53, P589, DOI 10.1016/S0895-4356(99)00189-4; Feldman AL, 2014, EUR J EPIDEMIOL, V29, P49, DOI 10.1007/s10654-013-9864-1; Han JW, 2018, PSYCHIAT INVEST, V15, P767, DOI 10.30773/pi.2018.06.02; Harada K, 2018, RES Q EXERCISE SPORT, V89, P440, DOI 10.1080/02701367.2018.1510171; Kamphuis MH, 2007, MED SCI SPORT EXER, V39, P1693, DOI 10.1249/mss.0b013e3180f6109f; Kim JY, 2008, PSYCHIAT INVEST, V5, P232, DOI 10.4306/pi.2008.5.4.232; Kim TH, 2010, DEMENT GERIATR COGN, V29, P363, DOI 10.1159/000297523; Kim W, 2017, GERIATR GERONTOL INT, V17, P973, DOI 10.1111/ggi.12820; Kivimaki M, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1495; Kvelde T, 2013, J AM GERIATR SOC, V61, P694, DOI 10.1111/jgs.12209; Leadley K, 2000, J SUBST ABUSE, V11, P253, DOI 10.1016/S0899-3289(00)00025-0; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; Leong A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-12; Liu S, 2017, J CLIN NURS, V26, P1291, DOI 10.1111/jocn.13601; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lu PY, 2019, ASIAN SOC WORK POLIC, V13, P307, DOI 10.1111/aswp.12183; Lyness JM, 2007, AM J GERIAT PSYCHIAT, V15, P214, DOI 10.1097/01.JGP.0000235763.50230.83; Mackenzie CS, 2009, J GERONTOL B-PSYCHOL, V64, P742, DOI 10.1093/geronb/gbp076; Margetts B, 2004, PUBLIC HEALTH NUTR, V7, P361, DOI 10.1079/PHN2004622; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meeks TW, 2011, J AFFECT DISORDERS, V129, P126, DOI 10.1016/j.jad.2010.09.015; Meyler D, 2007, SOC SCI MED, V64, P2297, DOI 10.1016/j.socscimed.2007.02.007; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Norton MC, 2010, J AM GERIATR SOC, V58, P895, DOI 10.1111/j.1532-5415.2010.02806.x; Oh DJ, 2021, AUST NZ J PSYCHIAT, V55, P809, DOI 10.1177/0004867420972763; Pertl MM, 2017, INT PSYCHOGERIATR, V29, P615, DOI 10.1017/S1041610216002337; Pertl MM, 2015, J GERIATR PSYCH NEUR, V28, P260, DOI 10.1177/0891988715588834; Peterson AB, 2019, SURVEILLANCE REPORT; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PRICE RA, 1980, BEHAV GENET, V10, P59, DOI 10.1007/BF01067319; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Schuch FB, 2018, AM J PSYCHIAT, V175, P631, DOI 10.1176/appi.ajp.2018.17111194; Schwartz CR, 2005, DEMOGRAPHY, V42, P621, DOI 10.1353/dem.2005.0036; Seo EH, 2010, AM J GERIAT PSYCHIAT, V18, P801, DOI 10.1097/JGP.0b013e3181cab764; Smits J, 2009, SOC FORCES, V88, P227; Strawbridge WJ, 2011, GERONTOLOGY, V57, P148, DOI 10.1159/000318637; Tschanz JT, 2013, INT REV PSYCHIATR, V25, P673, DOI 10.3109/09540261.2013.849663; Vitaliano PP, 2017, GERONTOLOGIST, V57, P637, DOI 10.1093/geront/gnv690; Vitaliano PP, 2011, J AM GERIATR SOC, V59, P900, DOI 10.1111/j.1532-5415.2011.03368.x; Vitaliano PP, 2009, GERONTOLOGIST, V49, P12, DOI 10.1093/geront/gnp004; Vitaliano PP, 2005, PSYCHOL AGING, V20, P402, DOI 10.1037/0882-7974.20.3.402; von Kanel R, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1033-2; WATKINS MP, 1981, BEHAV GENET, V11, P1, DOI 10.1007/BF01065824; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; World Health Organization, 2000, ASIA PACIFIC PERSPEC; Yoo S.W., 2006, ANXIETY MOOD, V2, P50	58	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	DEC 20	2021	4	12							e2139765	10.1001/jamanetworkopen.2021.39765			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XV4KA	WOS:000734911500008	34928355	Green Published, gold			2022-02-06	
J	Byrne, JP; Witiw, CD; Schuster, JM; Pascual, JL; Cannon, JW; Martin, ND; Reilly, PM; Nathens, AB; Seamon, MJ				Byrne, James P.; Witiw, Christopher D.; Schuster, James M.; Pascual, Jose L.; Cannon, Jeremy W.; Martin, Niels D.; Reilly, Patrick M.; Nathens, Avery B.; Seamon, Mark J.			Association of Venous Thromboembolism Prophylaxis After Neurosurgical Intervention for Traumatic Brain Injury With Thromboembolic Complications, Repeated Neurosurgery, and Mortality	JAMA SURGERY			English	Article; Early Access							BRIEF CONCEPTUAL TUTORIAL; SOCIAL EPIDEMIOLOGY; MULTILEVEL ANALYSIS; RISK; ANTICOAGULATION; CRITERIA	IMPORTANCE There is a lack of evidence regarding the effectiveness and safety of pharmacologic venous thromboembolism (VTE) prophylaxis among patients who undergo neurosurgical interventions for traumatic brain injury (TBI). OBJECTIVE To measure the association between timing of VTE prophylaxis after urgent neurosurgical intervention for TBI and thromboembolic and intracranial complications. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study included adult patients (aged >= 16 years) who underwent urgent neurosurgical interventions (craniotomy/ craniectomy or intracranial monitor/drain insertion within 24 hours after admission) for TBI at level 1 and 2 trauma centers participating in the American College of Surgeons Trauma Quality Improvement Program between January 1, 2012, and December 31, 2016. Data were analyzed from January to August 2020. EXPOSURES Timing of pharmacologic VTE prophylaxis initiation after urgent neurosurgical intervention (prophylaxis delay) measured in days (24-hour periods). MAIN OUTCOMES AND MEASURES The primary outcome was VTE (deep vein thrombosis or pulmonary embolism). Secondary outcomes were repeated neurosurgery (neurosurgical reintervention after initiation of VTE prophylaxis) and mortality. Hierarchical logistic regression models were used to evaluate the association between prophylaxis delay and each outcome at the patient level and were adjusted for patient baseline and injury characteristics. RESULTS The study included 4951 patients (3676 [74%] male; median age, 50 years [IQR, 31-64 years]) who underwent urgent neurosurgical intervention for TBI at 304 trauma centers. The median prophylaxis delay was 3 days (IQR, 1-5 days). After adjustment for patient baseline and injury characteristics, prophylaxis delay was associated with increased odds of VTE (adjusted odds ratio [aOR], 1.08 per day; 95% CI, 1.04-1.12). Earlier initiation of prophylaxis was associated with increased risk of repeated neurosurgery. During the first 3 days, each additional day of prophylaxis delay was associated with a 28% decrease in odds of repeated neurosurgery (aOR, 0.72 per day; 95% CI, 0.59-0.88). After 3 days, each additional day of prophylaxis delay was associated with an additional 15% decrease in odds of repeated neurosurgery (aOR, 0.85 per day; 95% CI, 0.80-0.90). Earlier prophylaxis was associated with greater mortality among patients who initially underwent intracranial monitor/drain procedures, such that each additional day of prophylaxis delay was associated with decreased odds of death (aOR, 0.94 per day; 95% CI, 0.89-0.99). CONCLUSIONS AND RELEVANCE In this cohort study of patients who underwent urgent neurosurgical interventions for TBI, early pharmacologic VTE prophylaxis was associated with reduced risk of thromboembolism. However, earlier initiation of prophylaxis was associated with increased risk of repeated neurosurgery. These findings suggest that although timely initiation of prophylaxis should be prioritized, caution should be used particularly during the first 3 days after the index procedure, when this risk appears to be highest.	[Byrne, James P.] Johns Hopkins Univ Hosp, Dept Surg, 1800 Orleans St,Sheikh Zayed Tower,Ste 6107B, Baltimore, MD 21287 USA; [Witiw, Christopher D.] Univ Toronto, Dept Surg, Div Neurosurg & Spinal Program, Toronto, ON, Canada; [Schuster, James M.] Penn Presbyterian Med Ctr, Dept Neurosurg, Philadelphia, PA USA; [Pascual, Jose L.; Cannon, Jeremy W.; Martin, Niels D.; Reilly, Patrick M.; Seamon, Mark J.] Univ Penn, Perelman Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Nathens, Avery B.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada		Byrne, JP (corresponding author), Johns Hopkins Univ Hosp, Dept Surg, 1800 Orleans St,Sheikh Zayed Tower,Ste 6107B, Baltimore, MD 21287 USA.	jpbyrne@gmail.com					American College of Surgeons, ACS TQP BEST PRACT G; American College of Surgeons, TRAUM QUAL IMPR PROG; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Cohen RA., INTRO PROC LOESS LOC; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Ho KM, 2010, BRIT J ANAESTH, V105, P596, DOI 10.1093/bja/aeq254; Knudson MM, 2011, ANN SURG, V254, P625, DOI 10.1097/SLA.0b013e3182300209; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Lu VM, 2020, NEUROSURG REV, V43, P861, DOI 10.1007/s10143-018-1045-y; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Pastorek RA, 2014, J NEUROTRAUM, V31, P1737, DOI 10.1089/neu.2014.3366; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, pS122, DOI 10.1097/TA.0b013e3182606327; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Shafi S, 2008, J TRAUMA, V64, P599, DOI 10.1097/TA.0b013e31816533f9; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Spano PJ, 2020, J TRAUMA ACUTE CARE, V88, P454, DOI 10.1097/TA.0000000000002580; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Yuan Y, 2011, J STAT SOFTW, V45, P1	25	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.												10.1001/jamasurg.2021.5794		DEC 2021	9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	YC1QU	WOS:000739473500007	34910096				2022-02-06	
J	Kurop, MK; Huyen, CM; Kelly, JH; Blagg, BSJ				Kurop, Margaret K.; Huyen, Cormac M.; Kelly, John H.; Blagg, Brian S. J.			The heat shock response and small molecule regulators	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY			English	Article						HSF1; Hsp90; Heat shock response; Neurodegeneration; Cancer	PROTEIN 90 INHIBITOR; TRAUMATIC BRAIN-INJURY; IMPROVES MITOCHONDRIAL BIOENERGETICS; MULTICENTER PHASE-II; HSP90 INHIBITOR; TRANSCRIPTION FACTOR-1; HSP-90 INHIBITOR; DOSE-ESCALATION; STRESS-RESPONSE; NEURAL DIFFERENTIATION	The heat shock response (HSR) is a highly conserved cellular pathway that is responsible for stress relief and the refolding of denatured proteins [1]. When a host cell is exposed to conditions such as heat shock, ischemia, or toxic substances, heat shock factor-1 (HSF-1), a transcription factor, activates the genes that encode for the heat shock proteins (Hsps), which are a family of proteins that work alongside other chaperones to relieve stress and refold proteins that have been denatured (Burdon, 1986) [2]. Along with the refolding of denatured proteins, Hsps facilitate the removal of misfolded proteins by escorting them to degradation pathways, thereby preventing the accumulation of misfolded proteins [3]. Research has indicated that many pathological conditions, such as diabetes, cancer, neuropathy, cardiovascular disease, and aging have a negative impact on HSR function and are commonly associated with misfolded protein aggregation [4,5]. Studies indicate an interplay between mitochondrial homeostasis and HSF-1 levels can impact stress resistance, proteostasis, and malignant cell growth, which further support the role of Hsps in pathological and metabolic functions [6]. On the other hand, Hsp activation by specific small molecules can induce the heat shock response, which can afford neuroprotection and other benefits [7]. This review will focus on the modulation of Hsps and the HSR as therapeutic options to treat these conditions. (C) 2021 Elsevier Masson SAS. All rights reserved.	[Kurop, Margaret K.; Huyen, Cormac M.; Kelly, John H.; Blagg, Brian S. J.] Univ Notre Dame, Warren Ctr Drug Discovery, Dept Chem & Biochem, Notre Dame, IN 46556 USA		Blagg, BSJ (corresponding author), Univ Notre Dame, Warren Ctr Drug Discovery, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	bblagg@nd.edu		Huyen, Cormac/0000-0001-8991-3735; Kurop, Margaret/0000-0002-9324-1430	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS075311]	Financial support of this work was provided by the National Institutes of Health (NS075311).	Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alvarez LB, 2020, DRUGS, V80, P859, DOI 10.1007/s40265-020-01322-y; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Anderson I, 2014, P NATL ACAD SCI USA, V111, pE1528, DOI 10.1073/pnas.1320178111; Azimi A, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177858; Bedin M, 2004, INT J CANCER, V109, P643, DOI 10.1002/ijc.20010; Bendell JC, 2016, CANCER INVEST, V34, P265, DOI 10.1080/07357907.2016.1193746; Birar VC, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127303; Bjork JK, 2016, ONCOGENE, V35, P1770, DOI 10.1038/onc.2015.241; Bouchecareilh Marion, 2011, Proc Am Thorac Soc, V8, P189, DOI 10.1513/pats.201008-055MS; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Budina-Kolomets A, 2016, CANCER RES, V76, P2720, DOI 10.1158/0008-5472.CAN-15-2137; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Bussenius J, 2012, BIOORG MED CHEM LETT, V22, P5396, DOI 10.1016/j.bmcl.2012.07.052; Calabrese V, 2004, ANTIOXID REDOX SIGN, V6, P895, DOI 10.1089/ars.2004.6.895; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Cavanaugh A, 2015, ONCOTARGET, V6, P39821, DOI 10.18632/oncotarget.5496; Chan JKL, 2011, CURR OPIN HIV AIDS, V6, P12, DOI 10.1097/COH.0b013e32834124fd; Chatterjee BK, 2019, J BIOL CHEM, V294, P6450, DOI 10.1074/jbc.RA118.002502; Chiosis G, 2002, BIOORGAN MED CHEM, V10, P3555, DOI 10.1016/S0968-0896(02)00253-5; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; Dai CK, 2012, J CLIN INVEST, V122, P3742, DOI 10.1172/JCI62727; Dai JJ, 2020, BIOCHEM PHARMACOL, V182, DOI 10.1016/j.bcp.2020.114218; Dai SY, 2015, EMBO J, V34, P275, DOI 10.15252/embj.201489062; de Tommaso M, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7576292; DeFranco Donald B, 2004, Curr Atheroscler Rep, V6, P295, DOI 10.1007/s11883-004-0061-2; Dickson MA, 2013, ANN ONCOL, V24, P252, DOI 10.1093/annonc/mds275; Docrat TF, 2020, EUR J PHARMACOL, V875, DOI 10.1016/j.ejphar.2020.173059; Doeppner TR, 2013, J CEREBR BLOOD F MET, V33, P1778, DOI 10.1038/jcbfm.2013.126; Doeppner TR, 2009, J CEREBR BLOOD F MET, V29, P1187, DOI 10.1038/jcbfm.2009.44; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Dudeja V, 2009, GASTROENTEROLOGY, V136, P1772, DOI 10.1053/j.gastro.2009.01.070; Eroglu Z, 2018, CLIN CANCER RES, V24, P5516, DOI 10.1158/1078-0432.CCR-18-0565; Eskew JD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-468; Fan FF, 2020, CELL DEATH DIFFER, V27, P587, DOI 10.1038/s41418-019-0374-x; Fang MC, 2014, NEUROLOGY, V82, P1033, DOI 10.1212/WNL.0000000000000248; Felip E, 2018, J THORAC ONCOL, V13, P576, DOI 10.1016/j.jtho.2017.11.131; Floris G, 2011, CLIN CANCER RES, V17, P5604, DOI 10.1158/1078-0432.CCR-11-0562; Franklin TB, 2005, INT J HYPERTHER, V21, P379, DOI 10.1080/02656730500069955; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Gabbasov R, 2019, CANCER BIOL THER, V20, P1035, DOI 10.1080/15384047.2019.1595279; Gandhi N, 2013, CANCER BIOL THER, V14, P347, DOI 10.4161/cbt.23626; Garbuz DG, 2019, MOL BIOL+, V53, P176, DOI [10.1134/S0026898419020058, 10.1134/S0026893319020055]; Gaspar N, 2010, MOL CANCER THER, V9, P1219, DOI 10.1158/1535-7163.MCT-09-0683; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Goldman JW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-152; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Gomez-Pastor R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14405; Gorska M, 2012, FRONT BIOSCI-LANDMRK, V17, P2269, DOI 10.2741/4050; Goyal L, 2020, INVEST NEW DRUG, V38, P1533, DOI 10.1007/s10637-019-00889-y; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hargitai J, 2003, BIOCHEM BIOPH RES CO, V307, P689, DOI 10.1016/S0006-291X(03)01254-3; Harper SJ, 2003, EXPERT OPIN THER TAR, V7, P187, DOI 10.1517/eott.7.2.187.23775; He W, 2016, INT J ONCOL, V48, P1710, DOI 10.3892/ijo.2016.3382; Hentze N, 2016, ELIFE, V5, DOI 10.7554/eLife.11576; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hong D, 2013, CLIN CANCER RES, V19, P4824, DOI 10.1158/1078-0432.CCR-13-0477; Houry WA, 2001, CURR PROTEIN PEPT SC, V2, P227, DOI 10.2174/1389203013381134; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jensen MR, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1996; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Johnson ML, 2015, J CLIN ONCOL, V33, P1666, DOI 10.1200/JCO.2014.59.7328; Jones RJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01816; JURIVICH DA, 1995, J BIOL CHEM, V270, P24489, DOI 10.1074/jbc.270.41.24489; Kale S, 2020, N-S ARCH PHARMACOL, V393, P253, DOI 10.1007/s00210-019-01725-z; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kanungo S, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.12.13; Kelly S, 2001, J CEREBR BLOOD F MET, V21, P972, DOI 10.1097/00004647-200108000-00010; Khandelwal A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02013-1; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; Kim H, 2016, SCI REP-UK, V6, DOI 10.1038/srep28896; Kim SH, 2015, J CLIN ENDOCR METAB, V100, pE253, DOI 10.1210/jc.2014-3101; Koike N, 2018, CURR GENET, V64, P907, DOI 10.1007/s00294-018-0809-9; Koren J, 2020, ADV EXP MED BIOL, V1243, P135, DOI 10.1007/978-3-030-40204-4_9; Kourtis N, 2015, NAT CELL BIOL, V17, P322, DOI 10.1038/ncb3121; Labbadia J, 2017, CELL REP, V21, P1481, DOI 10.1016/j.celrep.2017.10.038; Lai CH, 2014, ONCOGENE, V33, P4867, DOI 10.1038/onc.2013.439; Leak RK, 2014, J CELL COMMUN SIGNAL, V8, P293, DOI 10.1007/s12079-014-0243-9; Lee DH, 2015, CELL SIGNAL, V27, P293, DOI 10.1016/j.cellsig.2014.11.013; Lee J, 2008, EJC SUPPL, V6, P49, DOI 10.1016/S1359-6349(08)72085-8; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Lei W, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00294; Lei W, 2017, J BIOL CHEM, V292, P10414, DOI 10.1074/jbc.M116.769489; Li CY, 2012, ASN NEURO, V4, P425, DOI 10.1042/20120047; Li HN, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116747; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li Q, 2002, J GERONTOL A-BIOL, V57, pB93, DOI 10.1093/gerona/57.3.B93; Li X, 2016, AM J TRANSL RES, V8, P3558; Li XK, 2015, MOL CANCER THER, V14, P642, DOI 10.1158/1535-7163.MCT-14-0650; Lian B, 2021, BIOMOL THER, V29, P73, DOI 10.4062/biomolther.2020.012; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Lin S.-F., 2014, ONCOTARGET, V5, P41294, DOI [10.18632/oncotarget.17180,0, DOI 10.18632/ONCOTARGET.17180,0]; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Liu DJ, 2014, J CELL PHYSIOL, V229, P1224, DOI 10.1002/jcp.24556; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Ma JC, 2015, ACS CHEM NEUROSCI, V6, P1637, DOI 10.1021/acschemneuro.5b00165; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Mak OW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215333; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; Mbofung RM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00449-z; McCollum AK, 2008, CANCER RES, V68, P7419, DOI 10.1158/0008-5472.CAN-07-5175; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Medeiros R, 2011, CNS NEUROSCI THER, V17, P514, DOI 10.1111/j.1755-5949.2010.00177.x; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mercier PA, 1999, J CELL SCI, V112, P2765; Min SW, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00053; Molteni M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6978936; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Musuka TD, 2015, CAN MED ASSOC J, V187, P887, DOI 10.1503/cmaj.140355; Nagaraju GP, 2016, EUR J CANCER, V52, P109, DOI 10.1016/j.ejca.2015.10.057; Neckers L, 2018, CELL STRESS CHAPERON, V23, P467, DOI 10.1007/s12192-018-0877-2; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Nimmanapalli R, 2008, BRIT J HAEMATOL, V142, P551, DOI 10.1111/j.1365-2141.2008.07217.x; Oh WK, 2011, UROLOGY, V78, P626, DOI 10.1016/j.urology.2011.04.041; Okui T, 2011, ANTICANCER RES, V31, P1197; Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Pan XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26294; Park KS, 2016, CANCER LETT, V372, P75, DOI 10.1016/j.canlet.2015.12.015; Park SJ, 2014, J BIOL CHEM, V289, P2195, DOI 10.1074/jbc.M113.492587; Patterson J, 2008, CANCER CHEMOTH PHARM, V61, P923, DOI 10.1007/s00280-007-0546-0; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pincus D, 2020, ADV EXP MED BIOL, V1243, P41, DOI 10.1007/978-3-030-40204-4_3; Prince Thomas, 2018, Oncotarget, V9, P32702, DOI 10.18632/oncotarget.26021; Raychaudhuri S, 2014, CELL, V156, P975, DOI 10.1016/j.cell.2014.01.055; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Richter-Landsberg C., 2009, HEAT SHOCK PROTEINS, P81, DOI [10.1007/978-0-387-39954-6_ 7, DOI 10.1007/978-0-387-39954-6_7]; Roesch F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002792; Roman D, 2016, TOXICOL APPL PHARM, V309, P55, DOI 10.1016/j.taap.2016.08.025; Saif MW, 2013, CANCER CHEMOTH PHARM, V71, P1345, DOI 10.1007/s00280-013-2134-9; Sakai K, 2021, THORAC CANCER, V12, P491, DOI 10.1111/1759-7714.13784; Schaefer S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177706; Sessa C, 2013, CLIN CANCER RES, V19, P3671, DOI 10.1158/1078-0432.CCR-12-3404; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Shapiro GI, 2015, CLIN CANCER RES, V21, P87, DOI 10.1158/1078-0432.CCR-14-0979; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Shinkawa T, 2011, MOL BIOL CELL, V22, P3571, DOI 10.1091/mbc.E11-04-0330; Silverthorn D.U., 2019, HUMAN PHYSL INTEGRAT, V8; Smith V, 2005, CANCER CHEMOTH PHARM, V56, P126, DOI 10.1007/s00280-004-0947-2; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Somu P, 2019, HEAT SHOCK PROTEINS, V19, P159, DOI 10.1007/978-3-030-23158-3_8; Song D, 2008, MOL CANCER THER, V7, P3275, DOI 10.1158/1535-7163.MCT-08-0508; Speranza G, 2018, INVEST NEW DRUG, V36, P230, DOI 10.1007/s10637-017-0495-3; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stothert AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18344-4; Subramaniam DS, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00064; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/s002800050328; Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585; Tolnay M, 1999, NEUROPATH APPL NEURO, V25, P171; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Vulpis E, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1279372; Walsby EJ, 2013, BRIT J HAEMATOL, V161, P57, DOI 10.1111/bjh.12215; Wang YS, 2010, CURR OPIN INVEST DR, V11, P1466; West JD, 2012, CHEM RES TOXICOL, V25, P2036, DOI 10.1021/tx300264x; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Workman P, 2004, TRENDS MOL MED, V10, P47, DOI 10.1016/j.molmed.2003.12.005; Yaglom JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-14900-0; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082; You ZY, 2019, EXP NEUROL, V313, P88, DOI 10.1016/j.expneurol.2018.12.006; Yu BY, 2018, TECHNOL CANCER RES T, V17, DOI 10.1177/1533033818785274; Yu MK, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e13112; Zelin E, 2015, J MOL BIOL, V427, P1644, DOI 10.1016/j.jmb.2015.02.010; Zelin E, 2012, MOL CELL, V48, P459, DOI 10.1016/j.molcel.2012.08.026; Zhang HT, 2016, BBA-MOL CELL RES, V1863, P335, DOI 10.1016/j.bbamcr.2015.12.001; Zhang L, 2012, J PROTEOME RES, V11, P2581, DOI 10.1021/pr300056m; Zhang MH, 2018, MOL MED REP, V17, P8079, DOI 10.3892/mmr.2018.8898; Zhang MH, 2006, MOL CELL BIOCHEM, V281, P111, DOI 10.1007/s11010-006-0638-x; Zhang PF, 2020, CELL DEATH DIFFER, V27, P3177, DOI 10.1038/s41418-020-0571-7; Zhao HP, 2014, BIOORG MED CHEM LETT, V24, P3633, DOI 10.1016/j.bmcl.2014.05.020; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Zhou W, 2014, SEMIN CELL DEV BIOL, V35, P14, DOI 10.1016/j.semcdb.2014.07.013; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	186	1	1	14	14	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0223-5234	1768-3254		EUR J MED CHEM	Eur. J. Med. Chem.	DEC 15	2021	226								113846	10.1016/j.ejmech.2021.113846			15	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	WA8FK	WOS:000703119000029	34563965				2022-02-06	
J	Johnston-Brooks, CH; Grassmeyer, RP; Filley, CM; Kelly, JP				Johnston-Brooks, Catharine H.; Grassmeyer, Riley P.; Filley, Christopher M.; Kelly, James P.			The Marcus Institute for Brain Health: an integrated practice unit for the care of traumatic brain injury in military veterans	BRAIN INJURY			English	Article						Traumatic brain injury; integrated practice unit; rehabilitation; post-traumatic stress disorder; depression; anxiety	DEPLOYMENTS; HISTORY; RISK	Primary objective Traumatic brain injury (TBI) is a signature wound of recent Unites States military conflicts. The National Intrepid Center of Excellence (NICoE) has demonstrated that interdisciplinary care is effective for active-duty military personnel with TBI and related psychological health conditions. This paper details how the Marcus Institute for Brain Health (MIBH), established in 2017 as an Integrated Practice Unit (IPU), is founded on the NICoE model and is dedicated to interdisciplinary care for Veterans with persistent symptoms due to TBI and psychological comorbidities. Research design A highly integrated group of clinicians from diverse disciplines combine their expertise to offer comprehensive evaluation, intensive outpatient treatment, and program outcomes evaluation. Methods and procedures The role of each discipline in the provision of care, and the regular interaction of all clinicians, are delineated. A strong connection to academic medicine is maintained so that clinical research and education complement patient care. Main outcomes and results Over three hundred veterans and family members have received treatment at the MIBH. Program evaluation is underway. Conclusions As the understanding of TBI and related psychological conditions continues its rapid evolution, the expert interdisciplinary care at the MIBH has great promise as a Veteran counterpart of the NICoE	[Johnston-Brooks, Catharine H.; Filley, Christopher M.; Kelly, James P.] Univ Colorado, Marcus Inst Brain Hlth, Anschutz Med Campus, Aurora, CO 80217 USA; [Johnston-Brooks, Catharine H.; Grassmeyer, Riley P.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Johnston-Brooks, Catharine H.; Filley, Christopher M.; Kelly, James P.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Grassmeyer, Riley P.] Rocky Mt Mental Illness Res Educ & Clin Ctr, Res Core, Aurora, CO USA; [Filley, Christopher M.; Kelly, James P.] Univ Colorado, Sch Med, Behav Neurol Sect, Aurora, CO USA; [Filley, Christopher M.] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO USA		Johnston-Brooks, CH (corresponding author), Univ Colorado, Marcus Inst Brain Hlth, Anschutz Med Campus, Aurora, CO 80217 USA.	catharine.johnston-brooks@cuanschutz.edu		Johnston-Brooks, Catharine/0000-0002-3686-9045			Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Armed Forces Health Surveillance Center, 2011, MED SURVEILLANCE MON; Armed Forces Health Surveillance Center (AFHSC), 2011, MSMR, V18, P2; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Brundage John F, 2015, MSMR, V22, P2; Carr, 2008, ART THERAPY CLIN NEU; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; Defense and Veterans Brain Injury Center, 2020, DOD TBI WORLDW NUMB; DeGraba TJ, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.580182; DeGraba TJ, 2016, ANN NEUROL, V80, pS235; Fisher, 2021, GUIDE US MILITARY CA; Hebert JR, 2018, J HEAD TRAUMA REHAB, V33, P403, DOI 10.1097/HTR.0000000000000385; Howie, 2017, THERAPY MILITARY POP; Interian A, 2014, J TRAUMA STRESS, V27, P90, DOI 10.1002/jts.21885; Jaycox, 2008, INVISIBLE WOUNDS WAR, P3; Kaimal, 2018, INT J ART THERAPY, V23, P70, DOI [10.1080/17454832.2017.1388263, DOI 10.1080/17454832.2017.1388263]; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; King J.L., 2016, ART THERAPY TRAUMA N; Lequerica AH, 2018, ARCH PHYS MED REHAB, V99, P1811, DOI 10.1016/j.apmr.2018.03.023; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Porter ME, 2013, HARVARD BUS REV, V91, P50; Przekwas A, 2019, MIL MED, V184, P195, DOI 10.1093/milmed/usy344; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Scharf, 2015, CARE TRANSITIONS NAT; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Varga CM, 2018, MIL MED, V183, pE77, DOI 10.1093/milmed/usx012; Waszak DL, 2017, WORKPLACE HEALTH SAF, V65, P430, DOI 10.1177/2165079916682524; Williams DV, 2019, HEALTHCARE-J DEL SCI, V7, P16, DOI 10.1016/j.hjdsi.2018.10.001; Yount R, 2013, PSYCHIAT ANN, V43, P292, DOI 10.3928/00485713-20130605-11	31	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2021	35	14					1702	1710		10.1080/02699052.2021.2013535		DEC 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YP1JQ	WOS:000729335200001	34894933	hybrid			2022-02-06	
J	LaRovere, KL; De Souza, BJ; Szuch, E; Urion, DK; Vitali, SH; Zhang, B; Graham, RJ; Geva, A; Tasker, RC				LaRovere, Kerri L.; De Souza, Bradley J.; Szuch, Eliza; Urion, David K.; Vitali, Sally H.; Zhang, Bo; Graham, Robert J.; Geva, Alon; Tasker, Robert C.			Clinical Characteristics and Outcomes of Children with Acute Catastrophic Brain Injury: A 13-Year Retrospective Cohort Study	NEUROCRITICAL CARE			English	Article; Early Access						Brain injuries; Intensive care units (pediatric); Consciousness disorders; Mortality (child); Organ dysfunction score	CONSCIOUSNESS; DISORDERS; CARE; RECOVERY; MODEL	Background: The purpose of this study was to describe and analyze clinical characteristics and outcomes in children with acute catastrophic brain injury (CBI). Methods: This was a single-center, 13-year (2008-2020) retrospective cohort study of children in the pediatric and cardiac intensive care units with CBI, defined as (1) acute neurologic injury based on clinical and/or imaging findings, (2) the need for life-sustaining intensive care unit therapies, and (3) death or survival with a Glasgow Coma Scale score < 13 at discharge. Patients were excluded if they were discharged directly to home < 14 days from admission or had a chronic neurologic condition with a baseline Glasgow Coma Scale score < 13. The association between the primary outcome of death and clinical variables was analyzed by using Kaplan-Meier estimates and multivariable Cox proportional hazard models. Outcomes assessed after discharge were technology dependence, neurologic deficits, and Functional Status Score. Improved functional status was defined as a change in total Functional Status Score >= 2. Results: Of 106 patients (58% boys, median age 3.9 years) with CBI, 86 (81%) died. Withdrawal of life-sustaining therapies was the most common cause of death (60 of 86, 70%). In our multivariable analysis, each unit increase in admission pediatric sequential organ failure assessment score was associated with 10% greater hazard of death (hazard ratio 1.10, 95% confidence interval 1.04-1.17, p < .01). After controlling for admission pediatric sequential organ failure assessment scores, compared with those of patients with traumatic brain injury, all other etiologies of CBI were associated with a greater hazard of death (p = .02; hazard ratio 3.76-10). The median survival time for the cohort was 22 days (95% confidence interval 14-37 days). Of 23 survivors to hospital discharge, 20 were still alive after a median of 2 years (interquartile range 1-3 years), 6 of 20 (30%) did not have any technology dependence, 12 of 20 (60%) regained normal levels of alertness and responsiveness, and 15 of 20 (75%) had improved functional status. Conclusions: Most children with acute CBI died within 1 month of hospitalization. Having traumatic brain injury as the etiology of CBI was associated with greater survival, whereas increased organ dysfunction score on admission was associated with a higher hazard of mortality. Of the survivors, some recovered consciousness and functional status and did not require permanent technology dependence. Larger prospective studies are needed to improve prediction of CBI among critically ill children, understand factors guiding clinician and family decisions on the continuation or withdrawal of life-sustaining treatments, and characterize the natural history and long-term outcomes among CBI survivors.	[LaRovere, Kerri L.; Urion, David K.; Zhang, Bo] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA; [De Souza, Bradley J.; Vitali, Sally H.; Graham, Robert J.; Geva, Alon; Tasker, Robert C.] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA; [Szuch, Eliza] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Geva, Alon] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA		LaRovere, KL (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.	kerri.larovere@childrens.harvard.edu		LaRovere, Kerri/0000-0002-0901-4279			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bennett TD, 2017, PEDIATR CRIT CARE ME, V18, P442, DOI 10.1097/PCC.0000000000001120; Brogan ME, 2014, J CRIT CARE, V29, P679, DOI 10.1016/j.jcrc.2014.04.014; Centers for Disease Control and Prevention, GLASG COM SCAL; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Greer DM, 2020, JAMA-J AM MED ASSOC, V324, P1078, DOI 10.1001/jama.2020.11586; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Keele L, 2016, PEDIATR CRIT CARE ME, V17, P110, DOI 10.1097/PCC.0000000000000614; LaRovere KL, 2013, PEDIATR NEUROL, V48, P206, DOI 10.1016/j.pediatrneurol.2012.12.006; Matics TJ, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.2352; Molteni E, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10030162; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Pollack MM, 2021, PEDIATR CRIT CARE ME, V22, P27, DOI 10.1097/PCC.0000000000002590; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Williams Cydni N, 2019, Hosp Pediatr, V9, P958, DOI 10.1542/hpeds.2019-0173	19	1	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01408-9		DEC 2021	12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XM7MA	WOS:000729005100001	34893971				2022-02-06	
J	Achar, A; Myers, R; Ghosh, C				Achar, Aneesha; Myers, Rosemary; Ghosh, Chaitali			Drug Delivery Challenges in Brain Disorders across the Blood-Brain Barrier: Novel Methods and Future Considerations for Improved Therapy	BIOMEDICINES			English	Article						blood-brain barrier; drug bioavailability; current routes; drug regulatory mechanism; CNS disorders	TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; P-GLYCOPROTEIN EXPRESSION; ANTIEPILEPTIC DRUGS; MOLECULAR-MECHANISMS; IN-VITRO; CLINICAL PHARMACOKINETICS; GLUCOCORTICOID-RECEPTORS; INTRANASAL DELIVERY; REFRACTORY EPILEPSY	Due to the physiological and structural properties of the blood-brain barrier (BBB), the delivery of drugs to the brain poses a unique challenge in patients with central nervous system (CNS) disorders. Several strategies have been investigated to circumvent the barrier for CNS therapeutics such as in epilepsy, stroke, brain cancer and traumatic brain injury. In this review, we summarize current and novel routes of drug interventions, discuss pharmacokinetics and pharmacodynamics at the neurovascular interface, and propose additional factors that may influence drug delivery. At present, both technological and mechanistic tools are devised to assist in overcoming the BBB for more efficient and improved drug bioavailability in the treatment of clinically devastating brain disorders.	[Achar, Aneesha; Myers, Rosemary; Ghosh, Chaitali] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cerebrovasc Res, Cleveland, OH 44195 USA; [Ghosh, Chaitali] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Biomed Engn & Mol Med, Cleveland, OH 44195 USA		Ghosh, C (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cerebrovasc Res, Cleveland, OH 44195 USA.; Ghosh, C (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Biomed Engn & Mol Med, Cleveland, OH 44195 USA.	ava28@case.edu; myersr4@ccf.org; ghoshc@ccf.org		Ghosh, Chaitali/0000-0003-4078-0278	National Institute of Neurological Disorders and Stroke/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095825]	FundingThe APC was funded by the National Institute of Neurological Disorders and Stroke/National Institutes of Health grants R01NS095825 (to Chaitali Ghosh).	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Achar A, 2021, NEURAL REGEN RES, V16, P2427, DOI 10.4103/1673-5374.313046; Agarwal S, 2011, CURR PHARM DESIGN, V17, P2793, DOI 10.2174/138161211797440186; Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102; Al-Ahmady ZS, 2019, ACS NANO, V13, P12470, DOI 10.1021/acsnano.9b01808; Alimardani S, 2017, J RES PHARM PRACT, V6, P217, DOI 10.4103/jrpp.JRPP_17_58; Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; Altun I, 2018, IRAN J PUBLIC HEALTH, V47, P1218; Amjad M.T., 2021, CANCER CHEMOTH REP; Anderson GD, 2012, ADV DRUG DELIVER REV, V64, P911, DOI 10.1016/j.addr.2012.01.017; Andreasen AH, 2007, EPILEPSIA, V48, P490, DOI 10.1111/j.1528-1167.2007.00924.x; Angeli E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010022; [Anonymous], DRUGS APPROVED BRAIN, P2021; Anoop U.R., 2019, BIORXIV, DOI [10.1101/746966, DOI 10.1101/746966]; Anthony DP, 2021, LIFE SCI, V274, DOI 10.1016/j.lfs.2021.119326; Arif H., 2021, SALICYLIC ACID ASPIR; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; Arora P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248579; Arvanitis CD, 2020, NAT REV CANCER, V20, P26, DOI 10.1038/s41568-019-0205-x; Baglietto-Vargas D, 2013, BIOL PSYCHIAT, V74, P357, DOI 10.1016/j.biopsych.2012.12.003; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Banks W.A., 2021, BURGERS MED CHEM DRU, P1; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Beavers C.J., 2021, CLOPIDOGREL; Bebawy M, 2009, CURR DRUG METAB, V10, P322, DOI 10.2174/138920009788498996; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Benard-Laribiere A, 2016, EUR J CLIN PHARMACOL, V72, P869, DOI 10.1007/s00228-016-2044-y; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Boehme AK, 2017, CIRC RES, V120, P472, DOI 10.1161/CIRCRESAHA.116.308398; Bonsack B, 2020, CNS NEUROSCI THER, V26, P603, DOI 10.1111/cns.13378; Bors LA, 2020, BRAIN RES BULL, V160, P65, DOI 10.1016/j.brainresbull.2020.04.012; Bourassa P, 2019, MOL PHARMACEUT, V16, P583, DOI 10.1021/acs.molpharmaceut.8b00870; Buga AM, 2008, J CELL MOL MED, V12, P2731, DOI 10.1111/j.1582-4934.2008.00252.x; Burks SR, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021915118; Butowski Nicholas A, 2015, Continuum (Minneap Minn), V21, P301, DOI 10.1212/01.CON.0000464171.50638.fa; Byon W, 2019, CLIN PHARMACOKINET, V58, P1265, DOI 10.1007/s40262-019-00775-z; Calias P, 2014, PHARMACOL THERAPEUT, V144, P114, DOI 10.1016/j.pharmthera.2014.05.009; Canet G, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00739; Caughey GE, 2010, AGE AGEING, V39, P488, DOI 10.1093/ageing/afq055; Charalambous M, 2021, BMC VET RES, V17, DOI 10.1186/s12917-021-02805-0; Chen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108880; Chen Y, 2015, J MATER CHEM B, V3, P7255, DOI 10.1039/c5tb00675a; Cheng NT, 2015, NEUROHOSPITALIST, V5, P101, DOI 10.1177/1941874415583116; Chindo B.A., 2016, EPILEPTOLOGY THE MOD, DOI [10.5772/64456, DOI 10.5772/64456]; Choi CH, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-30; Cole JH, 2019, MOL PSYCHIATR, V24, P266, DOI 10.1038/s41380-018-0098-1; Collins VP, 2004, J NEUROL NEUROSUR PS, V75, P2, DOI 10.1136/jnnp.2004.040337; Cook M, 2020, ECLINICALMEDICINE, V22, DOI 10.1016/j.eclinm.2020.100326; Cree IA, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-2999-1; Cummings A., 2021, INTRATHECAL MORPHINE; Dabrowski W, 2021, J CLIN MED, V10, DOI 10.3390/jcm10184141; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Dauchy S, 2008, J NEUROCHEM, V107, P1518, DOI 10.1111/j.1471-4159.2008.05720.x; Davis ME, 2016, CLIN J ONCOL NURS, V20, P2, DOI 10.1188/16.CJON.S1.2-8; De Vries E., 2013, BLOOD BRAIN BARRIER, V1st, DOI [10.1201/b14290, DOI 10.1201/B14290]; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Deli MA, 2001, EUR J PHARMACOL, V411, pR3, DOI 10.1016/S0014-2999(00)00895-5; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Dombrowski SM, 2001, EPILEPSIA, V42, P1501, DOI 10.1046/j.1528-1157.2001.12301.x; Dong XW, 2018, THERANOSTICS, V8, P1481, DOI 10.7150/thno.21254; Dunois C, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9050445; Eikelboom JW, 2012, CHEST, V141, pE89S, DOI 10.1378/chest.11-2293; El-Awady Raafat, 2016, Front Pharmacol, V7, P535, DOI 10.3389/fphar.2016.00535; Erdo F, 2018, BRAIN RES BULL, V143, P155, DOI 10.1016/j.brainresbull.2018.10.009; Erdo F, 2017, J CEREBR BLOOD F MET, V37, P4, DOI 10.1177/0271678X16679420; Falcone JA, 2014, J PHARMACOL EXP THER, V351, P54, DOI 10.1124/jpet.114.216705; Fang M, 2011, MED HYPOTHESES, V76, P871, DOI 10.1016/j.mehy.2011.02.039; Feldmann M, 2013, LANCET NEUROL, V12, P777, DOI 10.1016/S1474-4422(13)70109-1; Fellner S, 2002, J CLIN INVEST, V110, P1309, DOI 10.1172/JCI200215451; Ferguson SS, 2005, MOL PHARMACOL, V68, P747, DOI 10.1124/mol.105.013169; Fredriksson L, 2017, SEMIN THROMB HEMOST, V43, P154, DOI 10.1055/s-0036-1586229; Freskgard PO, 2017, NEUROPHARMACOLOGY, V120, P38, DOI 10.1016/j.neuropharm.2016.03.014; Gaitatzis A, 2013, CNS DRUGS, V27, P435, DOI 10.1007/s40263-013-0063-0; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gellatly RM, 2007, PHARMACOTHERAPY, V27, P933, DOI 10.1592/phco.27.6.933; Ghosh C, 2018, EPILEPSIA, V59, P2049, DOI 10.1111/epi.14567; Ghosh C, 2017, EPILEPSIA, V58, P576, DOI 10.1111/epi.13703; Ghosh C, 2010, EPILEPSIA, V51, P1408, DOI 10.1111/j.1528-1167.2009.02428.x; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Giugliani R, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0849-8; Gorter JA, 2019, EPILEPSY CURR, V19, P177, DOI 10.1177/1535759719844750; GRANT SM, 1992, DRUGS, V43, P873, DOI 10.2165/00003495-199243060-00007; Greenfield LJ, 2013, SEIZURE-EUR J EPILEP, V22, P589, DOI 10.1016/j.seizure.2013.04.015; Grogan S., 2021, PHARMACOKINETICS; Harris L, 2020, J NEUROL, V267, P1774, DOI 10.1007/s00415-020-09769-5; Hartz AMS, 2017, MOL PHARMACEUT, V14, P999, DOI 10.1021/acs.molpharmaceut.6b00770; Haumann R, 2020, CNS DRUGS, V34, P1121, DOI 10.1007/s40263-020-00766-w; Herman L.L., 2021, HYDROCHLOROTHIAZIDE; Hersh DS, 2016, CURR PHARM DESIGN, V22, P1177, DOI 10.2174/1381612822666151221150733; Hersom M, 2016, MOL CELL NEUROSCI, V76, P59, DOI 10.1016/j.mcn.2016.08.009; Honarmand A, 2011, J RES MED SCI, V16, P1062; Hossain M, 2020, MOL NEUROBIOL, V57, P4511, DOI 10.1007/s12035-020-02043-9; Houghton PJ, 2010, CLIN CANCER RES, V16, P1368, DOI 10.1158/1078-0432.CCR-09-1314; Huang YY, 2020, CURR NEUROPHARMACOL, V18, P1227, DOI 10.2174/1570159X18666200620230321; Hubensack M, 2008, J CANCER RES CLIN, V134, P597, DOI 10.1007/s00432-007-0323-9; Hui C., 2021, ISCHEMIC STROKE; Jelveghari M, 2008, AAPS PHARMSCITECH, V9, P939, DOI 10.1208/s12249-008-9112-2; Johnson-Arbor K, 2021, DOXORUBICIN; Juthani R, 2020, CLIN CANCER RES, V26, P147, DOI 10.1158/1078-0432.CCR-19-1834; Kadian R., 2021, ZONISAMIDE; Kammerer M, 2011, N-S ARCH PHARMACOL, V384, P47, DOI 10.1007/s00210-011-0636-8; Kastrissios H, 1996, CANCER CHEMOTH PHARM, V38, P425, DOI 10.1007/s002800050506; Kelly Kathleen, 2005, Proceedings of the American Association for Cancer Research Annual Meeting, V46, P330; Keragala CB, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.577272; Khalili H, 2020, WORLD J SURG, V44, P1844, DOI 10.1007/s00268-020-05391-8; Khan S.A., 2017, JAMC, V28, P455; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Kirchner GI, 2004, CLIN PHARMACOKINET, V43, P83, DOI 10.2165/00003088-200443020-00002; Kiss T, 2020, GEROSCIENCE, V42, P429, DOI 10.1007/s11357-020-00177-1; Kumar A., 2021, LEVETIRACETAM; Kuriakose D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207609; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Kwok KK, 2017, PHARM THERAPEUTICS D, V7th, P530, DOI 10.1016/B978-0-323-39307-2.00036-9; Lansberg MG, 2009, STROKE, V40, P2438, DOI 10.1161/STROKEAHA.109.552547; LaPenna P, 2017, J MED TOXICOL, V13, P329, DOI 10.1007/s13181-017-0626-4; Laurens C, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00033; Laxer KD, 2014, EPILEPSY BEHAV, V37, P59, DOI 10.1016/j.yebeh.2014.05.031; Lee J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13198-y; Lee SY, 2016, GENES DIS, V3, P198, DOI 10.1016/j.gendis.2016.04.007; Lennernas H, 2003, CLIN PHARMACOKINET, V42, P1141, DOI 10.2165/00003088-200342130-00005; Li W, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd6889; Li YS, 2017, INT J NEUROSCI, V127, P539, DOI 10.1080/00207454.2016.1211648; Lin J, 2004, NEOPLASIA, V6, P74, DOI 10.1016/S1476-5586(04)80054-X; Liu C., 2021, RES SQ, DOI [10.21203/rs.3.rs-26742/v2, DOI 10.21203/RS.3.RS-26742/V2]; Liu C, 2012, CURR OPIN NEUROBIOL, V22, P844, DOI 10.1016/j.conb.2012.04.012; Liu MC, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01453; Liu XF, 2011, EXPERT OPIN DRUG DEL, V8, P1681, DOI 10.1517/17425247.2011.633508; Liu YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-16927-9; Lockman PR, 2002, DRUG DEV IND PHARM, V28, P1, DOI 10.1081/DDC-120001481; Loscher W, 2006, EPILEPSIA, V47, P1253, DOI 10.1111/j.1528-1167.2006.00607.x; Long Q, 2017, P NATL ACAD SCI USA, V114, pE3536, DOI 10.1073/pnas.1703920114; LOOSE DS, 1983, J CLIN INVEST, V72, P404, DOI 10.1172/JCI110982; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Luna-Tortos C, 2008, NEUROPHARMACOLOGY, V55, P1364, DOI 10.1016/j.neuropharm.2008.08.032; Mainprize T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36340-0; Marchi N, 2009, EPILEPSIA, V50, P664, DOI 10.1111/j.1528-1167.2008.01989.x; Marino M., 2021, PHARMACODYNAMICS; Mason A., 2021, HYPERTONIC FLUIDS; Masserini Massimo, 2013, ISRN Biochem, V2013, P238428, DOI 10.1155/2013/238428; Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; Meldrum BS, 2007, NEUROTHERAPEUTICS, V4, P18, DOI 10.1016/j.nurt.2006.11.010; Miller DJ, 2011, NEUROHOSPITALIST, V1, P138, DOI 10.1177/1941875211408731; Miyajima M, 2015, NEUROL MED-CHIR, V55, P647, DOI 10.2176/nmc.ra.2015-0003; Morris ME, 2017, AAPS J, V19, P1317, DOI 10.1208/s12248-017-0110-8; Mueck W, 2014, CLIN PHARMACOKINET, V53, P1, DOI 10.1007/s40262-013-0100-7; Nadareishvili Z, 2019, CEREBROVASC DIS, V47, P135, DOI 10.1159/000499666; Noch E, 2009, CANCER BIOL THER, V8, P1791, DOI 10.4161/cbt.8.19.9762; Novotny K., 2021, OMEGA 3 FATTY ACIDS; Nuriya M, 2016, PROG BRAIN RES, V225, P41, DOI 10.1016/bs.pbr.2016.02.001; Ohtsuki S, 2007, PHARM RES-DORDR, V24, P1745, DOI 10.1007/s11095-007-9374-5; Ojaghihaghighi S, 2017, WORLD J EMERG MED, V8, P34, DOI 10.5847/wjem.j.1920-8642.2017.01.006; Okuyama T, 2021, MOL THER, V29, P671, DOI 10.1016/j.ymthe.2020.09.039; Pardridge WM, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14060535; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Pardridge WM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-7; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; Patel S., 2021, WARFARIN; Patsalos PN, 2017, EPILEPSIA, V58, P1234, DOI 10.1111/epi.13802; Patsalos PN, 2000, PHARMACOL THERAPEUT, V85, P77, DOI 10.1016/S0163-7258(99)00052-2; Pearce A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184360; Pereillo JM, 2002, DRUG METAB DISPOS, V30, P1288, DOI 10.1124/dmd.30.11.1288; Perucca E, 2020, LANCET NEUROL, V19, P544, DOI 10.1016/S1474-4422(20)30035-1; Phoenix TN, 2016, CANCER CELL, V29, P508, DOI 10.1016/j.ccell.2016.03.002; Price L., 2016, TRANSLATIONAL RES TR; Proctor CM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau1291; Quintero Gabriel C, 2017, J Exp Pharmacol, V9, P13, DOI 10.2147/JEP.S124391; Rezai AR, 2020, P NATL ACAD SCI USA, V117, P9180, DOI 10.1073/pnas.2002571117; Rogawski Michael A, 2008, Epilepsy Curr, V8, P127, DOI 10.1111/j.1535-7511.2008.00272.x; Ruppert KA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233263; Sarin H, 2010, THER DELIV, V1, P289, DOI 10.4155/TDE.10.22; Sarkaria JN, 2018, NEURO-ONCOLOGY, V20, P184, DOI 10.1093/neuonc/nox175; Scharfman HE, 2007, CURR NEUROL NEUROSCI, V7, P348, DOI 10.1007/s11910-007-0053-z; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shahrokhi M., 2021, PROPRANOLOL; Shi JM, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021655; Sivandzade F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082721; Slezia A, 2019, JOVE-J VIS EXP, DOI 10.3791/59268; Souza DG, 2015, NEUROCHEM INT, V90, P93, DOI 10.1016/j.neuint.2015.07.016; Stafstrom CE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022426; Staley K, 2015, NAT NEUROSCI, V18, P367, DOI 10.1038/nn.3947; Stamatovic SM, 2019, NEUROBIOL DIS, V126, P105, DOI 10.1016/j.nbd.2018.09.006; Stamatovic SM, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1154641; Tang F, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00301; Tashima T, 2020, CHEM PHARM BULL, V68, P316, DOI 10.1248/cpb.c19-00854; Thompson Brandon J, 2014, Adv Pharmacol, V71, P165, DOI 10.1016/bs.apha.2014.06.013; TSURUO T, 1981, CANCER RES, V41, P1967; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van Assema DME, 2012, MOL IMAGING BIOL, V14, P771, DOI 10.1007/s11307-012-0556-0; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Wanat K, 2020, MOL BIOL REP, V47, P3221, DOI 10.1007/s11033-020-05361-2; Wang JT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229156; Wang JTW, 2021, ADV SCI, V8, DOI 10.1002/advs.202101058; Wang YF, 1996, PHARMACEUT RES, V13, P398, DOI 10.1023/A:1016092525901; Wang ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12651; Webb RL, 2018, TRANSL STROKE RES, V9, P530, DOI 10.1007/s12975-017-0599-2; Wessler JD, 2013, J AM COLL CARDIOL, V61, P2495, DOI 10.1016/j.jacc.2013.02.058; Wevers NR, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0108-3; Williams S, 2019, MOL NEUROBIOL, V56, P8392, DOI 10.1007/s12035-019-01673-y; Wouters Y, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00226-z; Wright DFB, 2011, BRIT J CLIN PHARMACO, V71, P815, DOI 10.1111/j.1365-2125.2011.03925.x; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Yadav Pankajkumar S, 2014, ScientificWorldJournal, V2014, P274823, DOI 10.1155/2014/274823; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yasaei R., 2021, GABAPENTIN; Yilmaz CU, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118081; Yousfan A, 2020, RSC ADV, V10, P28992, DOI 10.1039/d0ra04890a; Zhang DL, 2013, DRUG METAB DISPOS, V41, P827, DOI 10.1124/dmd.112.050260; Zhou WL, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3594-2; Zinger A, 2021, ADV FUNCT MATER, V31, DOI 10.1002/adfm.202100722	216	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	DEC	2021	9	12							1834	10.3390/biomedicines9121834			26	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	XX4UR	WOS:000736293200001	34944650	Green Published, gold			2022-02-06	
J	Alkhachroum, A; Bustillo, AJ; Asdaghi, N; Marulanda-Londono, E; Gutierrez, CM; Samano, D; Sobczak, E; Foster, D; Kottapally, M; Merenda, A; Koch, S; Romano, JG; O'Phelan, K; Claassen, J; Sacco, RL; Rundek, T				Alkhachroum, Ayham; Bustillo, Antonio J.; Asdaghi, Negar; Marulanda-Londono, Erika; Gutierrez, Carolina M.; Samano, Daniel; Sobczak, Evie; Foster, Dianne; Kottapally, Mohan; Merenda, Amedeo; Koch, Sebastian; Romano, Jose G.; O'Phelan, Kristine; Claassen, Jan; Sacco, Ralph L.; Rundek, Tatjana			Withdrawal of Life-Sustaining Treatment Mediates Mortality in Patients With Intracerebral Hemorrhage With Impaired Consciousness	STROKE			English	Article						aphasia; cerebral hemorrhage; consciousness; length of stay; logistic models	TRAUMATIC BRAIN-INJURY; NOT-RESUSCITATE ORDERS; THERAPY; ASSOCIATION; PREDICTION; GUIDELINES; SUPPORT	Background and Purpose: Impaired level of consciousness (LOC) on presentation at hospital admission in patients with intracerebral hemorrhage (ICH) may affect outcomes and the decision to withhold or withdraw life-sustaining treatment (WOLST). Methods: Patients with ICH were included across 121 Florida hospitals participating in the Florida Stroke Registry from 2010 to 2019. We studied the effect of LOC on presentation on in-hospital mortality (primary outcome), WOLST, ambulation status on discharge, hospital length of stay, and discharge disposition. Results: Among 37 613 cases with ICH (mean age 71, 46% women, 61% White, 20% Black, 15% Hispanic), 12 272 (33%) had impaired LOC at onset. Compared with cases with preserved LOC, patients with impaired LOC were older (72 versus 70 years), more women (49% versus 45%), more likely to have aphasia (38% versus 16%), had greater ICH score (3 versus 1), greater risk of WOLST (41% versus 18%), and had an increased in-hospital mortality (32% versus 12%). In the multivariable-logistic regression with generalized estimating equations accounting for basic demographics, comorbidities, ICH severity, hospital size and teaching status, impaired LOC was associated with greater mortality (odds ratio, 3.7 [95% CI, 3.1-4.3], P<0.0001) and less likely discharged home or to rehab (odds ratio, 0.3 [95% CI, 0.3-0.4], P<0.0001). WOLST significantly mediated the effect of impaired LOC on mortality (mediation effect, 190 [95% CI, 152-229], P<0.0001). Early WOLST (<2 days) occurred among 51% of patients. A reduction in early WOLST was observed in patients with impaired LOC after the 2015 American Heart Association/American Stroke Association ICH guidelines recommending aggressive treatment and against early do-not-resuscitate. Conclusions: In this large multicenter stroke registry, a third of ICH cases presented with impaired LOC. Impaired LOC was associated with greater in-hospital mortality and worse disposition at discharge, largely influenced by early decision to withhold or WOLST.	[Alkhachroum, Ayham; Bustillo, Antonio J.; Asdaghi, Negar; Marulanda-Londono, Erika; Gutierrez, Carolina M.; Samano, Daniel; Sobczak, Evie; Kottapally, Mohan; Merenda, Amedeo; Koch, Sebastian; Romano, Jose G.; O'Phelan, Kristine; Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Dept Neurol, Miami, FL 33136 USA; [Alkhachroum, Ayham; Bustillo, Antonio J.; Asdaghi, Negar; Marulanda-Londono, Erika; Gutierrez, Carolina M.; Samano, Daniel; Sobczak, Evie; Kottapally, Mohan; Merenda, Amedeo; Koch, Sebastian; Romano, Jose G.; O'Phelan, Kristine; Sacco, Ralph L.; Rundek, Tatjana] Jackson Mem Hosp, Dept Neurol, Miami, FL 33136 USA; [Foster, Dianne] Columbia Univ, Amer Heat Assoc, Qual Improvement, New York, NY 10027 USA; [Claassen, Jan] Columbia Univ, Dept Neurol, New York, NY 10027 USA		Alkhachroum, A (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Div Neurocrit Care, 1120 NW 14th St,Suite 1353, Miami, FL 33136 USA.	axa2610@med.miami.edu			Florida Department of Health	The Florida Stroke Registry is funded by the Florida Department of Health Funding No. COHAN A1.	Alkhachroum A, 2020, J NEUROL NEUROSUR PS, V91, P675, DOI 10.1136/jnnp-2019-322645; Asdaghi N, 2016, STROKE, V47, P2618, DOI 10.1161/STROKEAHA.116.013059; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Claassen J, 2019, NEW ENGL J MED, V380, P2497, DOI 10.1056/NEJMoa1812757; Clarke JL, 2004, NEUROCRIT CARE, V1, P53, DOI 10.1385/NCC:1:1:53; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Elmer J, 2016, RESUSCITATION, V102, P127, DOI 10.1016/j.resuscitation.2016.01.016; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Iacobucci D, 2012, J CONSUM PSYCHOL, V22, P582, DOI 10.1016/j.jcps.2012.03.006; Lazaridis C, 2019, NEUROCRIT CARE, V30, P33, DOI 10.1007/s12028-018-0595-8; Li LL, 2013, STAT METHODS MED RES, V22, P14, DOI 10.1177/0962280211403597; Morgenstern LB, 2015, NEUROLOGY, V84, P1739, DOI 10.1212/WNL.0000000000001525; Naidech AM, 2009, NEUROCRIT CARE, V11, P45, DOI 10.1007/s12028-009-9186-z; Navarrete-Navarro P, 2003, INTENS CARE MED, V29, P1237, DOI 10.1007/s00134-003-1755-6; Pinho J, 2019, J NEUROL SCI, V398, P54, DOI 10.1016/j.jns.2019.01.013; Sacco RL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004073; Smaha LA, 2004, AM HEART J, V148, pS46, DOI 10.1016/j.ahj.2004.09.015; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Varelas PN, 2008, SEMIN NEUROL, V28, P726, DOI 10.1055/s-0028-1105969; Verkade MA, 2012, NEUROCRIT CARE, V16, P130, DOI 10.1007/s12028-011-9567-y; Wabl R, 2019, J NEUROSURG, V131, P114, DOI 10.3171/2018.2.JNS173247; Wahlster S, 2021, NEUROCRIT CARE, V34, P956, DOI 10.1007/s12028-020-01109-9; Weimer JM, 2016, CRIT CARE MED, V44, P1161, DOI 10.1097/CCM.0000000000001570; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72; Zahuranec DB, 2010, NEUROLOGY, V75, P626, DOI 10.1212/WNL.0b013e3181ed9cc9	27	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	DEC	2021	52	12					3891	3898		10.1161/STROKEAHA.121.035233			8	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	XA2AG	WOS:000720456100035	34583530				2022-02-06	
J	Decavele, M; Gault, N; Moyer, JD; Gennequin, M; Allain, PA; Foucrier, A				Decavele, Maxens; Gault, Nathalie; Moyer, Jean Denis; Gennequin, Mael; Allain, Pierre-Antoine; Foucrier, Arnaud			Prediction models of methicillin sensitive Staphylococcus aureus ventilator associated pneumonia relapse in trauma and brain injury patients: A retrospective analysis	JOURNAL OF CRITICAL CARE			English	Article						Ventilator associated pneumonia; Methicillin Sensitive Staphylococcus aureus&nbsp; (MSSA); Ventilator associated pneumonia relapse; Trauma; Brain injury patient	PSEUDOMONAS-AERUGINOSA PNEUMONIA; RISK-FACTORS; EARLY-ONSET; INFLAMMATORY RESPONSE; CONSEQUENCES; RECURRENCE	Purpose: To describe the incidence and risk factors of methicillin sensitive Staphylococcus aureus ventilator associated pneumonia (MSSA-VAP) relapse in trauma and non-traumatic brain injury patients. Materials and methods: Retrospective observational monocentric cohort study of consecutive ICU patients who developed a first episode of MSSA-VAP after trauma and non-traumatic brain injury. MSSA-VAP relapse encompass MSSA-VAP treatment failure (persistence or recurrence of MSSA) or other pathogen VAP. Results: A total of 165 patients (71% of trauma and 29% of non-traumatic brain injury) with MSSA-VAP were included. MSSA-VAP relapse occurred in 54 (33%) patients, including 28 (17%) MSSA-VAP treatment failure and 46 (28%) other pathogen-VAP. Empirical first-line antibiotic therapy was appropriate in 96% of cases. In multivariate analysis, the presence of Streptococcus species (Odds ratio [OR] 7.37) and oropharyngeal flora (OR 3.64) as initial MSSA co-pathogen, suggested aspiration at the time of admission and independently predicted MSSA-VAP treatment failure. Initial Glasgow coma scale (OR 0.89), need for emergent surgery (OR 5.71) and the presence of an acute respiratory distress syndrome at the time of the first MSSA-VAP (3.99), independently predicted the onset of other pathogen - VAP. Conclusion: Early and simple factors may help to identify patients with high-risk of MSSA-VAP relapse. (c) 2021 Published by Elsevier Inc.	[Decavele, Maxens; Moyer, Jean Denis; Gennequin, Mael; Allain, Pierre-Antoine; Foucrier, Arnaud] Univ Paris, Beaujon Hosp, Dept Anaesthesiol & Crit Care, DMU Parabol, F-92110 Clichy, France; [Decavele, Maxens] Sorbonne Univ, Serv Med Intens & Reanimat Dept R3S, Grp Hosp Univ APHP, F-75013 Paris, France; [Decavele, Maxens] Sorbonne Univ, INSERM, UMRS1158, Neurophysiol Respiratoire Experimentale & Clin, F-75005 Paris, France; [Gault, Nathalie] Hop Beaujon, APHP, Dept Epidemiol Biostatist & Rech Clin, F-92110 Clichy, France; [Gault, Nathalie] INSERM, Hop Bichat, CICEC 1425, F-75018 Paris, France		Decavele, M (corresponding author), Grp Hosp Pitie Salpetriere, Serv Med Intens & Reanimat Dept R3S, 47-83 Blvd Hop, F-75013 Paris, France.	maxens.decavele@aphp.fr	Decavele, maxens/ABD-7633-2020				Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Braquet P, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.07.034; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Cavalcanti M, 2006, CRIT CARE MED, V34, P1067, DOI 10.1097/01.CCM.0000206471.44161.A0; Combes A, 2003, CRIT CARE MED, V31, P1102, DOI 10.1097/01.CCM.0000059313.31477.2C; Combes A, 2007, CRIT CARE MED, V35, P146, DOI 10.1097/01.CCM.0000249826.81273.E4; Ferrer M, 2018, CURR OPIN CRIT CARE, V24, P325, DOI 10.1097/MCC.0000000000000536; Giannoudis PV, 2003, INJURY, V34, P397, DOI 10.1016/S0020-1383(02)00416-3; Karaman E, 2012, B-ENT, V8, P13; Kollef MH, 2019, LANCET INFECT DIS, V19, P1299, DOI 10.1016/S1473-3099(19)30403-7; Launey Y, 2021, ANAESTH CRIT CARE PA, V40, DOI 10.1016/j.accpm.2020.01.012; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Nseir S, 2008, J INFECTION, V56, P319, DOI 10.1016/j.jinf.2008.02.012; Paul M, 2011, CLIN MICROBIOL INFEC, V17, P1581, DOI 10.1111/j.1469-0691.2010.03425.x; Planquette B, 2013, AM J RESP CRIT CARE, V188, P69, DOI 10.1164/rccm.201210-1897OC; Rangel EL, 2009, J TRAUMA, V67, P91, DOI 10.1097/TA.0b013e3181a8b2b2; Rello J, 1998, AM J RESP CRIT CARE, V157, P912, DOI 10.1164/ajrccm.157.3.9703014; Restrepo MI, 2013, RESP CARE, V58, P1220, DOI 10.4187/respcare.02173; Roquilly A, 2016, EUR RESPIR J, V47, P1219, DOI 10.1183/13993003.01314-2015; SABATH LD, 1975, ANTIMICROB AGENTS CH, V8, P344, DOI 10.1128/AAC.8.3.344; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Seguin P, 2014, CRIT CARE MED, V42, P1, DOI 10.1097/CCM.0b013e3182a2770f; Siempos II, 2008, SHOCK, V30, P487, DOI 10.1097/SHK.0b013e31816f1f7c; SILVER DR, 1992, CHEST, V101, P194, DOI 10.1378/chest.101.1.194; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017; van der Poll T, 2010, J INNATE IMMUN, V2, P379, DOI 10.1159/000318190; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Zahar JR, 2005, CLIN INFECT DIS, V41, P1224, DOI 10.1086/496923	30	1	1	4	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2021	66						20	25		10.1016/j.jcrc.2021.07.021			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WA6NZ	WOS:000703001800004	34399115				2022-02-06	
J	Delaplain, PT; Grigorian, A; Won, E; Dosch, AR; Schubl, S; Covarrubias, J; Nahmias, J				Delaplain, Patrick T.; Grigorian, Areg; Won, Eugene; Dosch, Austin R.; Schubl, Sebastian; Covarrubias, Jose; Nahmias, Jeffry			Nonaccidental Trauma Is an Independent Risk Factor for Mortality Among Injured Infants	PEDIATRIC EMERGENCY CARE			English	Article						infant; nonaccidental trauma (NAT); traumatic brain injury (TBI)	ABUSE; DISPARITIES; OUTCOMES	Objectives The Centers for Disease Control disclosed over 600,000 cases of child abuse or neglect in 2016. Single-institution studies have shown that nonaccidental trauma (NAT) has higher complication rates than accidental trauma (AT). Nonaccidental trauma is disproportionately represented in infants. We hypothesized that NAT would increase the risk of mortality in infants. This study aims to provide a contemporary descriptive analysis for infant trauma patients and determine the association between NAT and mortality. Methods Infants (<1 year of age) within the Pediatric Trauma Quality Improvement Program database (2014-2016) were identified. Descriptive statistics (chi(2) and t test) were used to compare NAT infants to AT infants. A multivariable logistic regression was used to determine the risk of mortality associated with select variables including NAT. Results From 14,965 infant traumas, most presented to a level I pediatric trauma center (53.5%) with a median injury severity score of 9. The most common mechanism was falls (48.6%), followed by NAT (14.5%). Overall mortality was 2.1%. Although most NAT infants were white (60.2%), black infants were overrepresented (23.6% vs 18.3%; P < 0.0001) compared with AT infants. The incidence of mortality was higher in NAT infants (41.6% vs 13.9%; P < 0.0001), and they were more likely to have traumatic brain injury (TBI) (63.1% vs 50.6%; P < 0.001). Nonaccidental trauma [odds ratio (OR), 2.48; P < 0.001], hypotension within 24 hours (OR, 8.93; P < 0.001), injury severity score (OR, 1.12; P < 0.001), and severe abbreviated injury scale-head (OR 1.62, P = 0.014) had the highest association with mortality. Conclusions This study confirms the incidence of TBI and NAT in infants. Although providers should be vigilant for NAT, suspicion of NAT should prompt close surveillance, as there is a 2-fold increased risk of mortality independent of injury or TBI.	[Delaplain, Patrick T.] Childrens Hosp Los Angeles, Dept Pediat Surg, Los Angeles, CA 90027 USA; [Delaplain, Patrick T.; Grigorian, Areg; Won, Eugene; Dosch, Austin R.; Schubl, Sebastian; Covarrubias, Jose; Nahmias, Jeffry] Univ Calif Irvine, Irvine Med Ctr, Dept Surg, Orange, CA 92868 USA		Delaplain, PT (corresponding author), Univ Calif Irvine, Irvine Med Ctr, 333 City Blvd West,Suite 1600, Orange, CA 92868 USA.	pdelapla@uci.edu		Covarrubias, Jose/0000-0003-0952-8701			Avdimiretz N, 2012, J TRAUMA ACUTE CARE, V72, P1031, DOI 10.1097/TA.0b013e3182452270; Brown JB, 2017, J TRAUMA ACUTE CARE, V82, P995, DOI 10.1097/TA.0000000000001440; Carty H, 2002, EUR RADIOL, V12, P2919, DOI 10.1007/s00330-002-1436-9; Center for Disease Control and Prevention, 2018, CHILD ABUSE NEGLECT; Deans KJ, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-217; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P161, DOI 10.1097/TA.0b013e3182984831; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Estroff JM, 2015, J EMERG MED, V48, P274, DOI 10.1016/j.jemermed.2014.07.030; Falcone RA, 2007, J PEDIATR SURG, V42, P172, DOI 10.1016/j.jpedsurg.2006.09.015; Farrell CA, 2018, CLIN PEDIATR EMERG M, V19, P216, DOI 10.1016/j.cpem.2018.08.001; Fortson B.L., 2016, PREVENTING CHILD ABU; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; Lane WG, 2011, PEDIATRICS, V127, pE1400, DOI 10.1542/peds.2010-2096; Lee Michael Jr, 2017, Hosp Pediatr, V7, P572, DOI 10.1542/hpeds.2017-0027; Leventhal JM, 2012, JAMA-J AM MED ASSOC, V308, P35, DOI 10.1001/jama.2012.6416; Leventhal JM, 2012, PEDIATRICS, V129, P458, DOI 10.1542/peds.2011-1277; Lopez ON, 2018, AM J SURG, V215, P1037, DOI 10.1016/j.amjsurg.2018.05.009; Murphy SL, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3239; Nordin A, 2018, J PEDIATR SURG, V53, P130, DOI 10.1016/j.jpedsurg.2017.10.023; Rangel EL, 2010, J TRAUMA, V69, P20, DOI 10.1097/TA.0b013e3181bbd7c3; Roaten JB, 2006, J PEDIATR SURG, V41, P2013, DOI 10.1016/j.jpedsurg.2006.08.028; Ward A, 2015, AM SURGEON, V81, P835; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031	23	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2021	37	12					E1065	E1069		10.1097/PEC.0000000000001901			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	XK6NI	WOS:000727579500065	31436675				2022-02-06	
J	Eastman, CL; Fender, JS; Klein, P; D'Ambrosio, R				Eastman, Clifford L.; Fender, Jason S.; Klein, Pavel; D'Ambrosio, Raimondo			Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							SYNAPTIC VESICLE PROTEIN; HEAD-INJURY; ADJUNCTIVE BRIVARACETAM; INFLAMMATORY RESPONSES; ANTIEPILEPTIC DRUGS; CLINICAL-TRIALS; LOBE EPILEPSY; ANIMAL-MODELS; LEVETIRACETAM; SEIZURES	Mounting evidence suggests the synaptic vesicle glycoprotein 2A (SV2A) targeted by levetiracetam may contribute to epilepto-genesis. Levetiracetam has shown anti-inflammatory, antioxi-dant, neuroprotective, and possible antiepileptogenic effects in brain injury and seizure/epilepsy models, and a phase 2 study has signaled a possible clinical antiepileptogenic effect. Brivar-acetam shows greater affinity and specificity for SV2A than lev-etiracetam and broader preclinical antiseizure effects. Thus, we assessed the antiepileptogenic/disease-modifying potential of brivaracetam in an etiologically realistic rat posttraumatic epi-lepsy model optimized for efficient drug testing. Brivaracetam delivery protocols were designed to maintain clinical moderate -to-high plasma levels in young (5-week-old) male Sprague-Dawley rats for 4 weeks. Treatment protocols were rapidly screened in 4-week experiments using small groups of ani-mals to ensure against rigorous testing of futile treatment protocols. The antiepileptogenic effects of brivaracetam treat-ment initiated 30 minutes, 4 hours, and 8 hours after rostral parasagittal fluid percussion injury (rpFPI) were then com-pared with vehicle-treated controls in a fully powered blind and randomized 16-week validation. Seizures were evaluated by video-electrocorticography using a 5-electrode epidural montage. Endpoint measures included incidence, frequency, duration, and spread of seizures. Group sizes and recording durations were supported by published power analyses. Three months after treatment ended, rats treated with brivaracetam starting at 4 hours post-FPI (the best-performing protocol) experienced a 38% decrease in overall incidence of seizures, 59% decrease in seizure frequency, 67% decrease in time spent seizing, and a 45% decrease in the proportion of spreading seiz-ures that was independent of duration-based seizure definition. Thus, brivaracetam shows both antiepileptogenic and disease-modifying properties after rpFPI. SIGNIFICANCE STATEMENT The rpFPI model, which likely incorporates epileptogenic mecha-nisms operating after human head injury, can be used to effi-ciently screen investigational treatment protocols and assess antiepileptogenic/disease-modifying effects. Our studies 1) sup-port a role for SV2A in epileptogenesis, 2) suggest that brivarace-tam and other drugs targeting SV2A should be considered for human clinical trials of prevention of post-traumatic epilepsy after head injury, and 3) provide data to inform the design of treatment protocols for clinical trials.	[Eastman, Clifford L.; Fender, Jason S.; D'Ambrosio, Raimondo] Univ Washington, Dept Neurol Surg, 1959 Pacific St, Seattle, WA 98195 USA; [Klein, Pavel] Midatlant Epilepsy & Sleep Ctr, Bethesda, MD USA		Eastman, CL (corresponding author), Univ Washington, Dept Neurol Surg, 1959 Pacific St, Seattle, WA 98195 USA.	cliff@uw.edu			UCB PharmaUCB Pharma SA	Funding for this study was provided by UCB Pharma, which consulted in the design of the study and reporting of the findings but did not contribute to the study execution, data analysis, or interpretation. P.K. has received con-sulting and speaker honoraria from UCB Pharma, who makes brivaracetam.	Butler T, 2013, J NEUROIMAGING, V23, P129, DOI 10.1111/j.1552-6569.2010.00572.x; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2013, ANN NEUROL, V73, P199, DOI 10.1002/ana.23764; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dupuis N, 2015, EPILEPSIA, V56, P800, DOI 10.1111/epi.12973; Eastman CL, 2015, EXP NEUROL, V264, P150, DOI 10.1016/j.expneurol.2014.12.010; Eastman CL, 2011, J PHARMACOL EXP THER, V336, P779, DOI 10.1124/jpet.110.175133; Eastman CL, 2010, EXP NEUROL, V224, P369, DOI 10.1016/j.expneurol.2010.04.013; Feng GB, 2009, J MOL NEUROSCI, V39, P354, DOI 10.1007/s12031-009-9288-2; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; French JA, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.00992.x; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gilliam F, 2004, NEUROLOGY, V63, pS9, DOI 10.1212/WNL.63.10_suppl_4.S9; Grant, 2016, TRANSLATIONAL RES TR; Halford JJ, 2011, EPILEPSIA, V52, P816, DOI 10.1111/j.1528-1167.2010.02960.x; Hanaya R, 2012, NEUROSCIENCE, V221, P12, DOI 10.1016/j.neuroscience.2012.06.058; Hanon E, 2001, SEIZURE-EUR J EPILEP, V10, P287, DOI 10.1053/seiz.2000.0511; Herman ST, 2006, EPILEPSY RES, V68, P35, DOI 10.1016/j.eplepsyres.2005.09.015; Ikeda A, 2009, EPILEPSIA, V50, P2072, DOI 10.1111/j.1528-1167.2009.02097.x; Iqbal M, 2017, J CHROMATOGR B, V1060, P63, DOI 10.1016/j.jchromb.2017.05.039; Itoh K, 2016, BRAIN RES, V1652, P1, DOI 10.1016/j.brainres.2016.09.038; Itoh K, 2015, BRAIN RES, V1608, P225, DOI 10.1016/j.brainres.2015.03.005; Kaminski RM, 2012, JASPERS BASIC MECH E; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Kim JE, 2010, NEUROSCI LETT, V471, P94, DOI 10.1016/j.neulet.2010.01.018; Klein P, 2020, NEUROPHARMACOLOGY, V168, DOI 10.1016/j.neuropharm.2019.107762; Klein P, 2017, EPILEPSY BEHAV, V72, P188, DOI 10.1016/j.yebeh.2017.05.024; Klein P, 2017, EPILEPSIA, V58, pE21, DOI 10.1111/epi.13631; Klein P, 2016, EPILEPSIA, V57, P1130, DOI 10.1111/epi.13409; Klitgaard H, 2016, EPILEPSIA, V57, P538, DOI 10.1111/epi.13340; Liu X, 2017, EPILEPSIA, V58, P1902, DOI 10.1111/epi.13914; Loscher W, 2007, EPILEPSIA, V48, P1245, DOI 10.1111/j.1528-1167.2007.01093.x; Loscher W, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.04.011; Loscher W, 2016, EPILEPSY RES, V126, P157, DOI 10.1016/j.eplepsyres.2016.05.016; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Loscher W, 2017, NEUROCHEM RES, V42, P1873, DOI 10.1007/s11064-017-2222-z; Lugli L, 2018, MINERVA PEDIAT, V2018, P2; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; Mani R, 2011, NEUROSCI LETT, V497, P251, DOI 10.1016/j.neulet.2011.03.010; Matagne A, 2008, BRIT J PHARMACOL, V154, P1662, DOI 10.1038/bjp.2008.198; Nygaard HB, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0110-9; Oliveira AA, 2007, CELL MOL NEUROBIOL, V27, P395, DOI 10.1007/s10571-006-9132-y; Ping XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158231; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; READ NG, 1991, HISTOCHEM J, V23, P436, DOI 10.1007/BF01041373; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Reimers A, 2018, DRUG DES DEV THER, V12, P271, DOI 10.2147/DDDT.S154388; Rogawski MA, 2008, BRIT J PHARMACOL, V154, P1555, DOI 10.1038/bjp.2008.221; Russo E, 2017, EXPERT OPIN DRUG DIS, V12, P1169, DOI 10.1080/17460441.2017.1366985; Sargentini-Maier ML, 2007, BRIT J CLIN PHARMACO, V63, P680, DOI 10.1111/j.1365-2125.2006.02829.x; Schmidt D, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0695-9; Schmidt D, 2014, NEUROTHERAPEUTICS, V11, P401, DOI 10.1007/s13311-013-0252-z; Schmidt D, 2012, EPILEPTIC DISORD, V14, P105, DOI 10.1684/epd.2012.0512; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Sloviter RS, 2011, NEUROPHARMACOLOGY, V61, P1048, DOI 10.1016/j.neuropharm.2011.07.038; Steinhoff BJ, 2019, THER ADV NEUROL DISO, V12, DOI 10.1177/1756286419873518; Stewart KAA, 2010, EPILEPSIA, V51, P1418, DOI 10.1111/j.1528-1167.2009.02405.x; Sugata S, 2011, BRAIN RES BULL, V86, P36, DOI 10.1016/j.brainresbull.2011.05.017; Sugaya Y, 2010, BRAIN RES, V1352, P187, DOI 10.1016/j.brainres.2010.06.061; SWENBERG JA, 1989, TOXICOL APPL PHARM, V97, P35, DOI 10.1016/0041-008X(89)90053-7; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toering ST, 2009, EPILEPSIA, V50, P1409, DOI 10.1111/j.1528-1167.2008.01955.x; van Tuijl JH, 2011, SEIZURE-EUR J EPILEP, V20, P285, DOI 10.1016/j.seizure.2010.12.012; van Vliet EA, 2009, EPILEPSIA, V50, P422, DOI 10.1111/j.1528-1167.2008.01727.x; Vinogradova LV, 2008, EPILEPSIA, V49, P1160, DOI 10.1111/j.1528-1167.2008.01594.x; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wood MD, 2018, EPILEPSIA, V59, pE147, DOI 10.1111/epi.14532; Wood MD, 2017, EPILEPSIA, V58, P255, DOI 10.1111/epi.13638; Yan HD, 2005, EPILEPSIA, V46, P1170, DOI 10.1111/j.1528-1167.2005.35204.x; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	78	1	1	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	DEC 1	2021	379	3					310	323		10.1124/jpet.121.000585			14	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	XK3OA	WOS:000727378000013	34593559				2022-02-06	
J	Friedman, LK; Peng, H; Zeman, RJ				Friedman, L. K.; Peng, H.; Zeman, R. J.			Cannabidiol reduces lesion volume and restores vestibulomotor and cognitive function following moderately severe traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Head trauma; Cannabidiol; Implant; Delivery system; Neuroprotection	OBJECT RECOGNITION; RESISTANT EPILEPSY; PLANT CANNABINOIDS; ANIMAL-MODELS; IN-VITRO; RATS; DELTA(9)-TETRAHYDROCANNABINOL; ENDOCANNABINOIDS; PATHOPHYSIOLOGY; EPIDEMIOLOGY	Despite the high incidence of traumatic brain injury (TBI), there is no universal treatment to safely treat patients. Blunt brain injuries destroy primary neural tissue that results in impaired perfusion, excessive release of glutamate, inflammation, excitotoxicity, and progressive secondary neuronal cell death. We hypothesized that administration of cannabidiol (CBD) directly to a brain contusion site, will optimize delivery to the injured tissue which will reduce local neural excitation and inflammation to spare neural tissue and improve neurological outcome following TBI. CBD was infused into a gelfoam matrix forming an implant (CBDi), then applied over the dura at the contusion site as well as delivered systemically by injection (CBD.IP). Post-injury administration of CBDi+IP greatly reduced defecation scores, lesion volume, the loss of neurons in the ipsilateral hippocampus, the number of injured neurons of the contralateral hippocampus, and reversed TBI-induced glial fibrillary acidic protein (GFAP) upregulation which was superior to either CBD.IP or CBDi treatment alone. Vestibulomotor performance on the beam-balance test was restored by 12 days post-TBI and sustained through 28 days. CBDi+IP treated rats exhibited preinjury levels of spontaneous alternation on the spontaneous alternation T-maze. In the object recognition test, they had greater mobility and exploration of novel objects compared to contusion or implant alone consistent with reduced anxiety and restored cognitive function. These results suggest that dual therapy by targeting the site of injury internally with a CBD-infused medical carrier followed by systemic supplementation may offer a more effective countermeasure than systemic or implant treatment alone for the deleterious effects of penetrating head wounds.	[Friedman, L. K.; Peng, H.; Zeman, R. J.] New York Med Coll, Dept Cell Biol & Anat, 15 Dana Rd, Valhalla, NY 10595 USA		Friedman, LK (corresponding author), New York Med Coll, Dept Cell Biol & Anat, 15 Dana Rd, Valhalla, NY 10595 USA.	Linda_Friedman@nymc.edu					Abu-Sawwa Renad, 2020, J Pediatr Pharmacol Ther, V25, P485, DOI 10.5863/1551-6776-25.6.485; Al-Ghezi ZZ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01921; Alalawi A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033298; Amar MB, 2006, J ETHNOPHARMACOL, V105, P1, DOI 10.1016/j.jep.2006.02.001; Arain M, 2015, ANN CLIN TRANSL NEUR, V2, P289, DOI 10.1002/acn3.163; Arruza L, 2017, PEDIATR RES, V82, P79, DOI 10.1038/pr.2017.104; Auzmendi J, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00032; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Baban B, 2018, AM J PHYSIOL-RENAL, V315, pF1149, DOI 10.1152/ajprenal.00112.2018; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belardo C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00352; Ben-Zeev B, 2020, RAMBAM MAIMONIDES ME, V11, DOI 10.5041/RMMJ.10387; Blizard DA, 2015, BEHAV GENET, V45, P368, DOI 10.1007/s10519-015-9722-x; Boccella S, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00091; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Cheng D, 2014, PSYCHOPHARMACOLOGY, V231, P3009, DOI 10.1007/s00213-014-3478-5; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Consroe P, 1998, NEUROBIOL DIS, V5, P534, DOI 10.1006/nbdi.1998.0220; De Filippis D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028159; De Petrocellis L, 2011, BRIT J PHARMACOL, V163, P1479, DOI 10.1111/j.1476-5381.2010.01166.x; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Dudchenko PA, 2002, ANIM COGN, V5, P115, DOI 10.1007/s10071-002-0134-y; Elmes MW, 2015, J BIOL CHEM, V290, P8711, DOI 10.1074/jbc.M114.618447; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Fride E, 2005, CNS NEUROL DISORD-DR, V4, P633, DOI 10.2174/156800705774933069; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; Guida F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00095; Gururajan A, 2012, J PSYCHOPHARMACOL, V26, P1317, DOI 10.1177/0269881112441865; Haj-Dahmane S, 2009, J PHARMACOL EXP THER, V331, P186, DOI 10.1124/jpet.109.153858; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hess EJ, 2016, EPILEPSIA, V57, P1617, DOI 10.1111/epi.13499; Hill AJ, 2014, NEUROSCI LETT, V566, P269, DOI 10.1016/j.neulet.2014.03.013; Hill AJ, 2012, PHARMACOL THERAPEUT, V133, P79, DOI 10.1016/j.pharmthera.2011.09.002; Hind WH, 2016, BRIT J PHARMACOL, V173, P815, DOI 10.1111/bph.13368; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Huestis MA, 2019, CURR NEUROPHARMACOL, V17, P974, DOI 10.2174/1570159X17666190603171901; Jones NA, 2012, SEIZURE-EUR J EPILEP, V21, P344, DOI 10.1016/j.seizure.2012.03.001; Jones NA, 2010, J PHARMACOL EXP THER, V332, P569, DOI 10.1124/jpet.109.159145; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kobeissy F., 2015, BRAIN NEUROTRAUMA MO; Kozela E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081669; Kozela E, 2011, BRIT J PHARMACOL, V163, P1507, DOI 10.1111/j.1476-5381.2011.01379.x; Kwiatkoski M, 2012, NEUROTOX RES, V21, P271, DOI 10.1007/s12640-011-9273-8; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lecarpentier Y, 2017, PPAR RES, V2017, DOI 10.1155/2017/5879090; Li DH, 2017, EUR J PHARMACOL, V809, P13, DOI 10.1016/j.ejphar.2017.05.011; Mann Aniv, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P209, DOI 10.1515/jbcpp-2015-0092; McGuire JL, 2019, MOL NEUROBIOL, V56, P2908, DOI 10.1007/s12035-018-1276-5; McPartland JM, 2008, J BODYW MOV THER, V12, P169, DOI 10.1016/j.jbmt.2008.01.004; MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7; Mumby DG, 2002, BEHAV BRAIN RES, V132, P215, DOI 10.1016/S0166-4328(01)00444-2; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nichols JM, 2020, CANNABIS CANNABINOID, V5, P12, DOI 10.1089/can.2018.0073; Novick AM, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-39; O'Connell BK, 2017, EPILEPSY BEHAV, V70, P341, DOI 10.1016/j.yebeh.2016.11.012; Ohno-Shosaku T, 2012, NEUROSCIENTIST, V18, P119, DOI 10.1177/1073858410397377; Pacher P, 2012, J MOL MED, V90, P347, DOI 10.1007/s00109-012-0884-1; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Porter BE, 2013, EPILEPSY BEHAV, V29, P574, DOI 10.1016/j.yebeh.2013.08.037; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Quintana P, 2006, EUR J NEUROSCI, V23, P975, DOI 10.1111/j.1460-9568.2006.04617.x; Rajan TS, 2016, FITOTERAPIA, V112, P104, DOI 10.1016/j.fitote.2016.05.008; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rudenko V, 2012, PHARMACOL BIOCHEM BE, V100, P474, DOI 10.1016/j.pbb.2011.10.005; Russo EB, 2005, NEUROCHEM RES, V30, P1037, DOI 10.1007/s11064-005-6978-1; SAMARA E, 1990, BIOPHARM DRUG DISPOS, V11, P785, DOI 10.1002/bdd.2510110906; Sarris J, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-019-2409-8; Schicho R, 2012, PHARMACOLOGY, V89, P149, DOI 10.1159/000336871; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Sun SS, 2017, REDOX BIOL, V11, P577, DOI 10.1016/j.redox.2016.12.029; Tasker JG, 2015, INT REV NEUROBIOL, V125, P163, DOI 10.1016/bs.irn.2015.09.003; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Ueberall MA, 2019, J PAIN RES, V12, P1577, DOI 10.2147/JPR.S192174; Vallee A, 2017, ACTA BIOCH BIOPH SIN, V49, P853, DOI 10.1093/abbs/gmx073; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zuardi AW, 2009, J PSYCHOPHARMACOL, V23, P979, DOI 10.1177/0269881108096519; Zuardi AW, 2008, REV BRAS PSIQUIATR, V30, P271, DOI 10.1590/S1516-44462008000300015; Zuardi AW, 2012, CURR PHARM DESIGN, V18, P5131, DOI 10.2174/138161212802884681	93	1	1	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2021	346								113844	10.1016/j.expneurol.2021.113844			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WP7DW	WOS:000713288500002	34428457				2022-02-06	
J	Keute, M; Gharabaghi, A				Keute, Marius; Gharabaghi, Alireza			Brain plasticity and vagus nerve stimulation	AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL			English	Article						Vagus nerve stimulation; Motor plasticity; Stroke; Neurorehabilitation; Motor restoration; Traumatic injury	ISCHEMIC-STROKE; MOTOR CORTEX; NEURAL ACTIVITY; RECOVERY; REHABILITATION; REORGANIZATION; EXCITABILITY; EXTINCTION; MEMORY; MODEL	After damage to the central nervous system, caused by traumatic injury or ischemia, plasticity becomes critically important for functional recovery. When this inherent capacity to adapt is limited despite training, external stimulation may support this process. Vagus nerve stimulation (VNS) is an effective method to enhance the effect of motor rehabilitation training on functional recovery. However, the mechanisms by which VNS exerts beneficial effects on cortical plasticity are not completely understood. Experimental work suggests that VNS fosters a neurochemical milieu that facilitates synaptic plasticity and supports reinforcement mechanisms. Animal studies, furthermore, suggest that VNS delivery is time-critical and that optima in the parameter space need to be titrated for effect maximization. Human studies suggest that VNS modifies corticospinal excitability. First studies in stroke patients show positive results for invasive, and also promising findings for non-invasive VNS.	[Keute, Marius; Gharabaghi, Alireza] Univ Tubingen, Inst Neuromodulat & Neurotechnol, Dept Neurosurg & Neurotechnol, Tubingen, Germany		Keute, M (corresponding author), Univ Tubingen, Inst Neuromodulat & Neurotechnol, Otfried Mueller Str 45, D-72076 Tubingen, Germany.	marius.keute@uni-tuebingen.de					Baig SS, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104348; Bajbouj M, 2007, J CLIN PSYCHOPHARM, V27, P156, DOI 10.1097/JCP.0b013e31803308f3; Biggio F, 2009, INT J NEUROPSYCHOPH, V12, P1209, DOI 10.1017/S1461145709000200; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; Borland MS, 2016, BRAIN STIMUL, V9, P117, DOI 10.1016/j.brs.2015.08.018; Borland MS, 2019, J NEUROPHYSIOL, V122, P659, DOI 10.1152/jn.00832.2018; Breceda EY, 2013, CURR OPIN NEUROL, V26, P595, DOI 10.1097/WCO.0000000000000024; Buell EP, 2018, BRAIN STIMUL, V11, P1218, DOI 10.1016/j.brs.2018.07.045; Buell EP, 2019, NEUROSCIENCE, V406, P290, DOI 10.1016/j.neuroscience.2019.03.019; Burger AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29561-w; Burger AM, 2016, NEUROBIOL LEARN MEM, V132, P49, DOI 10.1016/j.nlm.2016.05.007; Butefisch CM, 2004, NEUROSCIENTIST, V10, P163, DOI 10.1177/1073858403262152; Capone F, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7876507; Clancy JA, 2014, BRAIN STIMUL, V7, P871, DOI 10.1016/j.brs.2014.07.031; Clark KB, 1999, NAT NEUROSCI, V2, P94, DOI 10.1038/4600; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Daly JJ, 2006, STROKE, V37, P172, DOI 10.1161/01.STR.0000195129.95220.77; Darrow MJ, 2021, BEHAV BRAIN RES, V396, DOI 10.1016/j.bbr.2020.112910; Dawson J, 2021, LANCET, V397, P1545, DOI 10.1016/S0140-6736(21)00475-X; Dawson J, 2016, STROKE, V47, P143, DOI 10.1161/STROKEAHA.115.010477; Di Lazzaro V, 2004, NEUROLOGY, V62, P2310, DOI 10.1212/01.WNL.0000131743.45131.AE; Engineer CT, 2015, BRAIN STIMUL, V8, P637, DOI 10.1016/j.brs.2015.01.408; Engineer ND, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00280; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Fang JL, 2016, BIOL PSYCHIAT, V79, P266, DOI 10.1016/j.biopsych.2015.03.025; Ganzer PD, 2018, ELIFE, V7, DOI 10.7554/eLife.32058; Gebhardt N, 2013, BRAIN STIMUL, V6, P78, DOI 10.1016/j.brs.2012.01.009; Ghacibeh GA, 2006, COGN BEHAV NEUROL, V19, P119, DOI 10.1097/01.wnn.0000213908.34278.7d; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Hays SA, 2016, NEUROBIOL AGING, V43, P111, DOI 10.1016/j.neurobiolaging.2016.03.030; Hays SA, 2014, STROKE, V45, P3097, DOI 10.1161/STROKEAHA.114.006654; Hays SA, 2014, NEUROREPORT, V25, P676, DOI 10.1097/WNR.0000000000000154; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Huffman WJ, 2019, BRAIN STIMUL, V12, P19, DOI 10.1016/j.brs.2018.10.005; Hulsey DR, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112975; Hulsey DR, 2017, EXP NEUROL, V289, P21, DOI 10.1016/j.expneurol.2016.12.005; Hulsey DR, 2016, BRAIN STIMUL, V9, P174, DOI 10.1016/j.brs.2015.12.007; Jacobs HIL, 2015, NEUROBIOL AGING, V36, P1860, DOI 10.1016/j.neurobiolaging.2015.02.023; Kaczmarczyk R, 2018, J NEUROCHEM, V146, P76, DOI 10.1111/jnc.14284; Keute M, 2021, BRAIN STIMUL, V14, P209, DOI 10.1016/j.brs.2021.01.001; Khodaparast N, 2013, NEUROBIOL DIS, V60, P80, DOI 10.1016/j.nbd.2013.08.002; Khodaparast N, 2016, NEUROREHAB NEURAL RE, V30, P676, DOI 10.1177/1545968315616494; Khodaparast N, 2014, NEUROREHAB NEURAL RE, V28, P698, DOI 10.1177/1545968314521006; Kilgard MP, 2018, NEUROREHABILITATION, V42, P159, DOI 10.3233/NRE-172273; Kimberley TJ, 2018, STROKE, V49, P2789, DOI 10.1161/STROKEAHA.118.022279; Kreuzer PM, 2014, BRAIN STIMUL, V7, P740, DOI 10.1016/j.brs.2014.05.003; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lehtimaki J, 2013, ACTA OTO-LARYNGOL, V133, P378, DOI 10.3109/00016489.2012.750736; LEYS D, 1992, STROKE, V23, P317, DOI 10.1161/01.STR.23.3.317; Loerwald KW, 2018, NEUROSCIENCE, V388, P239, DOI 10.1016/j.neuroscience.2018.07.038; Loerwald KW, 2018, BRAIN STIMUL, V11, P271, DOI 10.1016/j.brs.2017.11.007; Manta Stella, 2009, J Psychiatry Neurosci, V34, P272; Meyers EC, 2018, STROKE, V49, P710, DOI 10.1161/STROKEAHA.117.019202; Morrison RA, 2021, BRAIN RES, V1756, DOI 10.1016/j.brainres.2021.147332; Morrison RA, 2020, BEHAV BRAIN RES, V391, DOI 10.1016/j.bbr.2020.112705; Morrison RA, 2019, BRAIN STIMUL, V12, P256, DOI 10.1016/j.brs.2018.10.017; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Ndode-Ekane XE, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126329; Noble LJ, 2019, BRAIN STIMUL, V12, P9, DOI 10.1016/j.brs.2018.09.013; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Pena DF, 2013, BIOL PSYCHIAT, V73, P1071, DOI 10.1016/j.biopsych.2012.10.021; Porter BA, 2012, CEREB CORTEX, V22, P2365, DOI 10.1093/cercor/bhr316; Pruitt DT, 2021, TRANSL STROKE RES, V12, P65, DOI 10.1007/s12975-020-00829-6; Pruitt DT, 2016, J NEUROTRAUM, V33, P871, DOI 10.1089/neu.2015.3972; Redgrave JN, 2018, J STROKE CEREBROVASC, V27, P1998, DOI 10.1016/j.jstrokecerebrovasdis.2018.02.056; Revesz D, 2008, EXP NEUROL, V214, P259, DOI 10.1016/j.expneurol.2008.08.012; Shetake JA, 2012, EXP NEUROL, V233, P342, DOI 10.1016/j.expneurol.2011.10.026; Singh RJ, 2018, INT J STROKE, V13, P787, DOI 10.1177/1747493018798526; Souza RR, 2021, EXP NEUROL, V341, DOI 10.1016/j.expneurol.2021.113718; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Stegeman I, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247221; Szeska C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58412-w; Tyler R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12178-w; Ura H, 2013, BRAIN RES, V1492, P63, DOI 10.1016/j.brainres.2012.11.024; Volpe BT, 2000, NEUROLOGY, V54, P1938, DOI 10.1212/WNL.54.10.1938; Werner JK, 2015, CURR OPIN NEUROL, V28, P565, DOI 10.1097/WCO.0000000000000265; Yuan H, 2016, HEADACHE, V56, P259, DOI 10.1111/head.12650; Zuo YT, 2007, PHYSIOL BEHAV, V90, P583, DOI 10.1016/j.physbeh.2006.11.009	78	1	1	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1566-0702	1872-7484		AUTON NEUROSCI-BASIC	Auton. Neurosci-Basic Clin.	DEC	2021	236								102876	10.1016/j.autneu.2021.102876			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WB4ND	WOS:000703549500001	34537681				2022-02-06	
J	Kolberg, K; Larson, J; Almeida, A; Ichesco, I; Johnson, A; Van Tubbergen, M; Nagappan, BS; Saleem, N; Cranford, JA; Hashikawa, A				Kolberg, Kristen; Larson, Jennifer; Almeida, Andrea; Ichesco, Ingrid; Johnson, Abigail; Van Tubbergen, Marie; Nagappan, Bella S.; Saleem, Noor; Cranford, James A.; Hashikawa, Andrew			The Feasibility of Using Comic-Based Concussion Discharge Instructions Gauging Likeability and Knowledge Improvement Among Adolescents and Parents	PEDIATRIC EMERGENCY CARE			English	Article						discharge instructions; comics; concussion	EMERGENCY; VIDEO; INJURY; IMPACT	Objective The objective of this study was to evaluate feasibility of supplementing emergency department (ED) concussion discharge instructions for adolescents and parents with a newly created educational comic and a publicly available comic-based video at an outpatient sports neurology clinic. Methods We created a gender-neutral, 2-page comic to augment text-only ED concussion discharge instructions. A sample of patients evaluated at a sports neurology clinic and their parents/guardians participated. Patients and their parents were randomized to view either the comic only or both the comic and publicly available comic-based video. Patients and parents completed preintervention and postintervention surveys to assess likeability and concussion knowledge including concussion definition, symptoms, return-to-ED criteria, and resuming normal activity. Data were analyzed using descriptive and comparative statistics. Results A total of 57 patients (47.4% female; mean age, 15 years) and 37 guardians were enrolled. Most (73%) concussions were sports related, with the majority having sought care within 24 hours in an ED (80%). Over half (51%) had experienced 2 or more prior concussions. Overall, 31 adolescents and 20 guardians viewed both comic and video, whereas 26 adolescents and 17 guardians viewed the comic only. Both comic and video were favorably reviewed, but a higher proportion of respondents rated the video more positively than the comic for likability (P < 0.01), comprehensibility (P < 0.05), and increasing understanding (P < 0.05). Patients' knowledge of some concussion symptoms emphasized in the comic increased after reading (emotional changes, P = 0.02; vomiting, P = 0.04). Conclusions Patients showed increased concussion knowledge using the favorably endorsed comic-based discharge instructions. Using comic-based supplemental discharge tools may optimize concussion education for adolescents.	[Kolberg, Kristen] Dept Emergency Med, Ann Arbor, MI USA; [Kolberg, Kristen] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA; [Larson, Jennifer; Johnson, Abigail; Van Tubbergen, Marie] Univ Michigan, Dept Phys Med & Rehabil, Michigan Med, Ann Arbor, MI USA; [Almeida, Andrea] Univ Michigan, Dept Neurol, Michigan Med, Ann Arbor, MI 48109 USA; [Ichesco, Ingrid; Hashikawa, Andrew] Univ Michigan, Dept Pediat, Michigan Med, Ann Arbor, MI 48109 USA; [Nagappan, Bella S.; Cranford, James A.; Hashikawa, Andrew] Univ Michigan, Michigan Med, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Saleem, Noor] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA		Hashikawa, A (corresponding author), Michigan Med, Dept Emergency Med, 2800 Plymouth Rd,Suite G080,NCRC Bldg 10, Ann Arbor, MI 48105 USA.; Hashikawa, A (corresponding author), Michigan Med, Dept Pediat, 2800 Plymouth Rd,Suite G080,NCRC Bldg 10, Ann Arbor, MI 48105 USA.	drewhash@med.umich.edu					Adams KT., 2017, HCI INT 2017 VANC BC; AUSTIN PE, 1995, ANN EMERG MED, V25, P317, DOI 10.1016/S0196-0644(95)70286-5; Bloch SA, 2013, PEDIATR EMERG CARE, V29, P699, DOI 10.1097/PEC.0b013e3182955480; Brooks TM, 2017, PEDIATR EMERG CARE, V33, P553, DOI 10.1097/PEC.0000000000000797; Burgess J., 2018, PEDIATRICS, V142, P361; Centers for Disease Control and Prevention. National Center for Injury Prevention and Control, HEADS HLTH CAR PROV; Chassiakos YR, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2593; Engel KG, 2009, ANN EMERG MED, V53, P454, DOI 10.1016/j.annemergmed.2008.05.016; Genota L, 2018, ED WEEK, V38, P6; Green MJ, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c863; Hanson A, 2017, HEALTH COMMUN, V32, P529, DOI 10.1080/10410236.2016.1211076; Houts PS, 1998, PATIENT EDUC COUNS, V35, P83, DOI 10.1016/S0738-3991(98)00065-2; Hwang V, 2014, J TRAUMA ACUTE CARE, V77, P117, DOI 10.1097/TA.0000000000000275; Ismail S, 2016, J EMERG MED, V50, pE177, DOI 10.1016/j.jemermed.2015.10.006; Jacobs D., 2007, INT J COMIC ART, V9, P502; Kikuyar TakemuraM., 2011, MANGA GUIDE BIOCH; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mednick Z, 2016, CAN J OPHTHALMOL, V51, P471, DOI 10.1016/j.jcjo.2016.04.023; Nagata R, 1999, BIOCHEM EDUC, V27, P200, DOI 10.1016/S0307-4412(99)00052-7; POWERS RD, 1988, ANN EMERG MED, V17, P124, DOI 10.1016/S0196-0644(88)80295-6; Rogow M., 2017, ARE WHITEBOARD ANIMA; Schutzman S., 2016, FLEISHER LUDWIGS TXB, V7th ed, P247; Tatalovic M, 2009, JCOM-J SCI COMMUN, V8, DOI 10.22323/2.08040202; Teare MD, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-264; Tri S, 2018, CAN PHARM J, V151, P368, DOI 10.1177/1715163518802866; Vashi A, 2011, ANN EMERG MED, V57, P315, DOI 10.1016/j.annemergmed.2010.08.024; Wallin D., 2018, PEDIATR EMERG CARE; Zavala S, 2011, J EMERG NURS, V37, P138, DOI 10.1016/j.jen.2009.11.008	31	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2021	37	12					E1603	E1610		10.1097/PEC.0000000000002133			8	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Pediatrics	XK6NI	WOS:000727579500166	32530836				2022-02-06	
J	Maietta, JE; Kuwabara, HC; Cross, CL; Flood, SM; Kinsora, TF; Ross, SR; Allen, DN				Maietta, Julia E.; Kuwabara, Hana C.; Cross, Chad L.; Flood, Sarah M.; Kinsora, Thomas F.; Ross, Staci R.; Allen, Daniel N.			Influence of Autism and Other Neurodevelopmental Disorders on Cognitive and Symptom Profiles: Considerations for Baseline Sport Concussion Assessment	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						ADHD; Assessment; Autism/pervasive developmental disorders; Developmental and learning disabilities; Head injury/traumatic brain injury	HIGH-FUNCTIONING AUTISM; SPECTRUM DISORDERS; HIGH-SCHOOL; INHIBITORY CONTROL; EXECUTIVE FUNCTION; TEST-PERFORMANCE; NEUROCOGNITIVE PERFORMANCE; PHYSICAL-EXERCISE; ASPERGER-SYNDROME; ADHD	Objective: The presence of neurodevelopmental disorders (ND) such as attention-deficit/hyperactivity disorder (ADHD) and learning disorders (LD) have demonstrated effects on Immediate Post-concussion Assessment and Cognitive Testing (ImPACT) performance. No current research has directly examined whether autism spectrum disorder (ASD) has similar effects. The current study compared ImPACT cognitive and symptom profiles in athletes with self-reported ASD to other NDs and healthy controls using case-control matching. Method: The current study compared ImPACT baselines of high school athletes with ASD to athletes with other NDs (ADHD, LD, and co-occurring ADHD/LD) and healthy controls on cognitive composites and symptom reporting. Participants included 435 athletes (87 controls, 87 with ASD, 87 with ADHD, 87 with LD, and 87 with ADHD/LD) selected from a larger naturalistic sample. Athletes were matched to the ASD group based on age, sex, and sport using randomized case-matched selection from the larger database. Results: Results revealed that athletes with ASD performed more poorly than healthy controls on the Visual Motor Speed composite. No differences were found for Post-concussion Symptom Scale (PCSS) domain scores. Differences in cognitive and symptom profiles among the athletes with other NDs were also found. Conclusions: Results elucidate patterns of baseline performance for athletes with ASD, demonstrating that there may not be significant differences between ASD and healthy controls on four of the five ImPACT composites, and no symptom reporting differences. Cognitive and symptom differences found for other NDs should be considered when interpreting baseline performance and for making return-to-play decisions in the absence of baseline assessment.	[Maietta, Julia E.; Kuwabara, Hana C.; Flood, Sarah M.; Allen, Daniel N.] Univ Nevada, Dept Psychol, 4505 Maryland Pkwy,Box 455030, Las Vegas, NV 89154 USA; [Cross, Chad L.] Univ Nevada, UNLV Sch Med, Las Vegas, NV 89154 USA; [Kinsora, Thomas F.; Ross, Staci R.] Ctr Appl Neurosci, Las Vegas, NV USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, 4505 Maryland Pkwy,Box 455030, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Adams NC, 2012, J AUTISM DEV DISORD, V42, P1052, DOI 10.1007/s10803-011-1345-3; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Brett BL, 2017, DEV NEUROPSYCHOL, V42, P70, DOI 10.1080/87565641.2016.1243114; Brighenti S, 2018, NEUROPSYCHOL TRENDS, P63, DOI 10.7358/neur-2018-024-brig; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Carmassi C, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00366; Chien YL, 2014, RES AUTISM SPECT DIS, V8, P881, DOI 10.1016/j.rasd.2014.04.006; Christ SE, 2007, J AUTISM DEV DISORD, V37, P1155, DOI 10.1007/s10803-006-0259-y; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd ed.; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Duquette MM, 2016, PHYS ACT REV, V4, P40, DOI 10.16926/par.2016.04.05; Eagle SR, 2020, AM J SPORT MED, V48, P2544, DOI 10.1177/0363546520937291; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Fang Q, 2019, GAMES HEALTH J, V8, P74, DOI 10.1089/g4h.2018.0032; Fein D., 2011, NEUROPSYCHOLOGY AUTI; Fisher M, 2019, INT J ATHL THER TRAI, V24, P181, DOI 10.1123/ijatt.2018-0089; Flood S., 2020, AM AC PED NEUR ANN C; Foti F, 2015, PSYCHOL MED, V45, P897, DOI 10.1017/S0033291714001950; Gardner RM, 2017, PHYSICIAN SPORTSMED, V45, P1, DOI 10.1080/00913847.2017.1248221; Gotham K, 2015, J AM ACAD CHILD PSY, V54, P369, DOI 10.1016/j.jaac.2015.02.005; Gotham K, 2015, AUTISM, V19, P491, DOI 10.1177/1362361314536625; Guest L, 2017, THER RECREAT J, V51, P109, DOI 10.18666/TRJ-2017-V51-I2-7383; Gunn B., 2019, NEUROLOGY, V93, P1, DOI [10.1212/WNL.0000000000008354, DOI 10.1212/WNL.0000000000008354]; Gunter HL, 2002, J AUTISM DEV DISORD, V32, P263, DOI 10.1023/A:1016326701439; Hilton C, 2020, AM J OCCUP THER, V74, DOI 10.5014/ajot.2020.74S1-PO2111; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Karr JE, 2019, ARCH CLIN NEUROPSYCH, V34, P751, DOI 10.1093/arclin/acz026.21; Kercood S, 2014, RES AUTISM SPECT DIS, V8, P1316, DOI 10.1016/j.rasd.2014.06.011; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Langen M, 2012, CORTEX, V48, P183, DOI 10.1016/j.cortex.2011.05.018; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lazar M, 2014, NEUROIMAGE-CLIN, V4, P417, DOI 10.1016/j.nicl.2014.01.014; Lever AG, 2016, J AUTISM DEV DISORD, V46, P1916, DOI 10.1007/s10803-016-2722-8; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Macoun SJ, 2021, J AUTISM DEV DISORD, V51, P2600, DOI 10.1007/s10803-020-04723-w; Maietta JE, 2021, J INT NEUROPSYCH SOC, V27, P461, DOI 10.1017/S1355617720001149; Manderino L, 2018, CLIN J SPORT MED, V28, P111, DOI 10.1097/JSM.0000000000000433; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martel M, 2007, J AM ACAD CHILD PSY, V46, P1437, DOI 10.1097/chi.0b013e31814cf953; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Minshew NJ, 2001, J CHILD PSYCHOL PSYC, V42, P1095, DOI 10.1111/1469-7610.00808; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; O'Hearn K, 2008, DEV PSYCHOPATHOL, V20, P1103, DOI 10.1017/S0954579408000527; Oliveras-Rentas RE, 2012, J AUTISM DEV DISORD, V42, P655, DOI 10.1007/s10803-011-1289-7; Peltonen K, 2019, CHILD NEUROPSYCHOL, V25, P336, DOI 10.1080/09297049.2018.1474865; Phelan HL, 2011, J AUTISM DEV DISORD, V41, P518, DOI 10.1007/s10803-010-1069-9; Poirier M, 2011, J ABNORM PSYCHOL, V120, P247, DOI 10.1037/a0022298; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rosso EGF, 2016, J AUTISM DEV DISORD, V46, P2526, DOI 10.1007/s10803-016-2759-8; Ryan S, 2018, J APPL RES INTELLECT, V31, P369, DOI 10.1111/jar.12414; Seidman LJ, 2006, CLIN PSYCHOL REV, V26, P466, DOI 10.1016/j.cpr.2006.01.004; Silver CH, 2008, ARCH CLIN NEUROPSYCH, V23, P217, DOI 10.1016/j.acn.2007.09.006; Solomon GS, 2014, AM J SPORT MED, V42, P934, DOI 10.1177/0363546513518742; Sowa M, 2012, RES AUTISM SPECT DIS, V6, P46, DOI 10.1016/j.rasd.2011.09.001; Stefanatos G. A., 2018, TXB CLIN NEUROPSYCHO, V2nd, P185; Tan BWZ, 2016, J AUTISM DEV DISORD, V46, P3126, DOI 10.1007/s10803-016-2854-x; van Heijst BFC, 2020, AUTISM, V24, P680, DOI 10.1177/1362361319872373; Velikonja T, 2019, JAMA PSYCHIAT, V76, P135, DOI 10.1001/jamapsychiatry.2018.3645; Weber ML, 2018, AM J SPORT MED, V46, P1742, DOI 10.1177/0363546518765145; Williams DL, 2017, AUTISM RES, V10, P1523, DOI 10.1002/aur.1801; Zhang MQ, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.564886; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	71	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2021	36	8					1438	1449		10.1093/arclin/acab006			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	YH7IH	WOS:000743336400004	33611342				2022-02-06	
J	Pattinson, CL; Brickell, TA; Bailie, J; Hungerford, L; Lippa, SM; French, LM; Lange, RT				Pattinson, Cassandra L.; Brickell, Tracey A.; Bailie, Jason; Hungerford, Lars; Lippa, Sara M.; French, Louis M.; Lange, Rael T.			Sleep disturbances following traumatic brain injury are associated with poor neurobehavioral outcomes in US military service members and veterans	JOURNAL OF CLINICAL SLEEP MEDICINE			English	Article						TBI; military; veterans; sleep disturbances; posttraumatic stress disorder; PTSD	CLINICAL UTILITY; SYMPTOM EXAGGERATION; MILD TBI; PTSD; VALIDITY-10; DISORDERS; IMPAIRMENT; PREVALENCE; PERSISTENT; RECOVERY	Study objectives: This study examined whether sleep disturbances were associated with neurobehavioral outcome following a traumatic brain injury (TBI) in a well characterized group of service members and veterans. Methods: Six hundred and six participants were enrolled into the Defense and Veterans Brain Injury Center, 15-Year Longitudinal TBI study. All participants completed a battery of tests measuring self-reported sleep disturbances, neurobehavioral symptoms, and posttraumatic stress disorder symptoms. Data were analyzed using analysis of variance with post hoc comparisons. Four groups were analyzed separately: uncomplicated mild TBI; complicated mild, moderate, severe, or penetrating combined TBI; injured controls (ie, orthopedic or soft-tissue injury without TBI); and noninjured controls. Results: A higher proportion of the mild TBI group reported moderate-severe sleep disturbances (66.5%) compared to the injured control group (54.9%), combined TBI (47.5%), and noninjured control groups (34.3%). Participants classified as having Poor Sleep had significantly worse scores on the majority of TBI-Quality of Life scales compared to those classified as having Good Sleep, regardless of TBI severity or the presence of TBI. There was a significant interaction between sleep disturbances and posttraumatic stress disorder. While sleep disturbances and posttraumatic stress disorder by themselves were significant factors associated with worse outcome, both factors combined resulted in worse outcome than either singularly. Conclusions: Regardless of group (injured or noninjured control), sleep disturbances were common and were associated with significantly worse neurobehavioral functioning. When experienced concurrently with posttraumatic stress disorder, sleep disturbances pose significant burden to service members and veterans.	[Pattinson, Cassandra L.] Univ Queensland, Inst Social Sci Res, 80 Meiers Rd,Bldg 1018,Room 305, Brisbane, Qld, Australia; [Brickell, Tracey A.; Bailie, Jason; Hungerford, Lars; French, Louis M.; Lange, Rael T.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Brickell, Tracey A.; Lippa, Sara M.; French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Brickell, Tracey A.; Lippa, Sara M.; French, Louis M.; Lange, Rael T.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Brickell, Tracey A.; Bailie, Jason; Hungerford, Lars; Lange, Rael T.] Gen Dynam Informat Technol, Falls Church, VA USA; [Brickell, Tracey A.; Lange, Rael T.] Ctr Excellence Posttraumat Stress Disorder, Ottawa, ON, Canada; [Bailie, Jason] Naval Hosp Camp Pendleton, Oceanside, CA USA; [Hungerford, Lars] Naval Med Ctr, San Diego, CA USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Pattinson, CL (corresponding author), Univ Queensland, Inst Social Sci Res, 80 Meiers Rd,Bldg 1018,Room 305, Brisbane, Qld, Australia.	c.pattinson@uq.edu.au		french, louis/0000-0002-9451-0604	DHA Contracting Office (CO-NCR) HT0014 [HT0014-19-C-0004]	This work was prepared under Contract HT0014-19-C-0004 with DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as US Government work under Title 17 U.S.C. 101. Per Title 17 U.S.C. 105, copyright protection is not available for any work of the US Government.	Allan AC, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000222; Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryant RA, 2010, SLEEP, V33, P69, DOI 10.1093/sleep/33.1.69; Capaldi VF, 2019, CHEST, V155, P215, DOI 10.1016/j.chest.2018.08.1061; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Kelley A, 2010, 201016 USAARL; Krystal JH, 2016, J CLIN PSYCHIAT, V77, P483, DOI 10.4088/JCP.14m09585; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Lange RT, 2020, NEUROPSYCHOL REHABIL, V30, P1762, DOI 10.1080/09602011.2019.1604385; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lind MJ, 2017, J CLIN SLEEP MED, V13, P291, DOI 10.5664/jcsm.6466; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; Livingston WS, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00059; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McKeon AB, 2019, NEUROREHABILITATION, V45, P163, DOI 10.3233/NRE-192804; Milders M, 2019, BRAIN INJURY, V33, P62, DOI 10.1080/02699052.2018.1531301; Mortera MH, 2018, ARCH PHYS MED REHAB, V99, pS50, DOI 10.1016/j.apmr.2016.11.026; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; O'Donnell D, 2009, J SLEEP RES, V18, P254, DOI 10.1111/j.1365-2869.2008.00719.x; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Pattinson CL, 2020, SLEEP, V43, DOI 10.1093/sleep/zsaa036; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Poritz JMP, 2020, ARCH PHYS MED REHAB, V101, P54, DOI 10.1016/j.apmr.2017.11.018; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Stiers W, 2012, J REHABIL RES DEV, V49, P139, DOI 10.1682/JRRD.2010.07.0131; Stocker RPJ, 2016, J CLIN SLEEP MED, V12, P49, DOI 10.5664/jcsm.5392; Straus LD, 2015, J TRAUMA STRESS, V28, P8, DOI 10.1002/jts.21982; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Taylor MK, 2014, MIL MED, V179, P744, DOI 10.7205/MILMED-D-13-00551; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; VanSolkema M, 2020, NEUROPSYCHOL REV, V30, P345, DOI 10.1007/s11065-020-09445-5; Verfaellie M, 2016, J HEAD TRAUMA REHAB, V31, P309, DOI 10.1097/HTR.0000000000000197; Westermeyer Joseph, 2010, Prim Care Companion J Clin Psychiatry, V12, DOI 10.4088/PCC.07m00563gry; Widiger T, 1994, DSM 4 DIAGN STAT MAN; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266	54	1	1	0	0	AMER ACAD SLEEP MEDICINE	DARIEN	2510 N FRONTAGE RD, DARIEN, IL 60561 USA	1550-9389	1550-9397		J CLIN SLEEP MED	J. Clin. Sleep Med.	DEC 1	2021	17	12					2425	2438		10.5664/jcsm.9454			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XW6LS	WOS:000735728800012	34216198				2022-02-06	
J	Podolak, OE; Chaudhary, S; Haarbauer-Krupa, J; Metzger, KB; Curry, AE; Kessler, RS; Pfeiffer, MR; Breiding, MJ; Master, CL; Arbogast, KB				Podolak, Olivia E.; Chaudhary, Sofia; Haarbauer-Krupa, Juliet; Metzger, Kristina B.; Curry, Allison E.; Kessler, Ronni S.; Pfeiffer, Melissa R.; Breiding, Matthew J.; Master, Christina L.; Arbogast, Kristy B.			Characteristics of Diagnosed Concussions in Children Aged 0 to 4 Years Presenting to a Large Pediatric Healthcare Network	PEDIATRIC EMERGENCY CARE			English	Article						infant; toddler; concussion; traumatic brain injury	TRAUMATIC BRAIN-INJURY; UNITED-STATES; SYMPTOMS; CHILDHOOD; PRESCHOOL; HISTORY	Objective The aim of the study was to comprehensively describe the natural history of concussion in early childhood between 0 and 4 years. Methods Retrospective cohort study of 329 patients aged 0 to 4 years, with an International Classification of Diseases, Ninth Revision, concussion diagnosis in the Children's Hospital of Philadelphia healthcare network from October 1, 2013, to September 30, 2015. Clinical data were abstracted from the Children's Hospital of Philadelphia electronic health record, which captured all clinical care visits and injury characteristics. Results Nearly 9 (86.6%) of 10 patients sought care in the emergency department or urgent care setting, most commonly on the day of injury (56.2%) and as a result of a fall (64.4%). More than two-thirds (64.4%) of patients or their parent/caregiver reported somatic symptoms (ie, vomiting or headache), whereas close to half (49.2%) reported sleep issues. One of 5 patients identified emotional symptoms (21.9%) or visio-vestibular dysfunction (20.4%). Many patients also experienced symptoms not included in standard assessment tools including personality changes (34.0%) and change in appetite (12.8%). Conclusions These results provide insight into the clinical characteristics of concussion in early childhood up to 4 years of age. Because assessment in this group relies heavily on parent/caregiver symptom reporting, rather than patient self-report, these results will aid clinicians with the challenge of diagnosing concussions in this population. These findings highlight the need to develop additional tools to adequately and systematically assess common signs and symptoms of concussion in early childhood that may not be included in standard assessment scales routinely used in older adolescents and adults.	[Podolak, Olivia E.; Chaudhary, Sofia; Metzger, Kristina B.; Curry, Allison E.; Kessler, Ronni S.; Pfeiffer, Melissa R.; Master, Christina L.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19146 USA; [Chaudhary, Sofia; Curry, Allison E.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19146 USA; [Haarbauer-Krupa, Juliet; Breiding, Matthew J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Master, Christina L.; Arbogast, Kristy B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19146 USA		Arbogast, KB (corresponding author), Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Roberts Ctr Pediat Res, 2716 South St,13th Flr, Philadelphia, PA 19146 USA.	arbogast@email.chop.edu			US Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [14IPA1405502, 15IPA1505513, 14IPA1405503, 14IPA1405504]; Children's Hospital of Philadelphia [14IPA1405502, 15IPA1505513, 14IPA1405503, 14IPA1405504]	This research was supported by an intergovernmental personnel act agreement (14IPA1405502, 15IPA1505513, 14IPA1405503, 14IPA1405504) between the US Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) and Children's Hospital of Philadelphia.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Chaudhary Sofia, 2018, Inj Epidemiol, V5, P7, DOI 10.1186/s40621-018-0147-x; Corwin DJ, 2019, AM J EMERG MED, V37, P1219, DOI 10.1016/j.ajem.2018.09.008; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ., 2019, PEDIATR EMERG CARE, P1; Crowe Louise M, 2015, Handb Clin Neurol, V128, P661, DOI 10.1016/B978-0-444-63521-1.00041-8; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Department of Health HS, 2019, CTR DIS CONTROL PREV; Donnell Z, 2018, J SAFETY RES, V67, P203, DOI 10.1016/j.jsr.2018.09.006; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Haarbauer-Krupa J, 2019, J HEAD TRAUMA REHAB, V34, P111, DOI 10.1097/HTR.0000000000000414; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Li Linda, 2018, Glob Pediatr Health, V5, p2333794X18756465, DOI 10.1177/2333794X18756465; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McKinlay Audrey, 2018, Concussion, V3, pCNC52, DOI 10.2217/cnc-2017-0017; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Suskauer SJ, 2018, J PEDIATR REHAB MED, V11, P7, DOI 10.3233/PRM-160424; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	33	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2021	37	12					E1652	E1657		10.1097/PEC.0000000000002148			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Pediatrics	XK6NI	WOS:000727579500174	32555016				2022-02-06	
J	Soltana, K; Moore, L; Bouderba, S; Lauzier, F; Clement, J; Mercier, E; Krouchev, R; Tardif, PA; Belcaid, A; Stelfox, T; Lamontagne, F; Archambault, P; Turgeon, A				Soltana, Kahina; Moore, Lynne; Bouderba, Samy; Lauzier, Francois; Clement, Julien; Mercier, Eric; Krouchev, Radoslav; Tardif, Pier-Alexandre; Belcaid, Amina; Stelfox, Thomas; Lamontagne, Francois; Archambault, Patrick; Turgeon, Alexis		Canadian Traumatic Brain Injury	Adherence to Clinical Practice Guideline Recommendations on Low-Value Injury Care: A Multicenter Retrospective Cohort Study	VALUE IN HEALTH			English	Article						guidelines; injury; low-value clinical practices; quality of care; trauma	PENETRATING NECK INJURIES; CT HEAD RULE; DECOMPRESSIVE CRANIECTOMY; MULTIPLE IMPUTATION; COST-EFFECTIVENESS; TRAUMA; MANAGEMENT; IMPLEMENTATION; STRATEGIES; ADULTS	Objectives: Low-value clinical practices have been identified as one of the most important areas of excess healthcare spending. Nevertheless, there is a knowledge gap on the scale of this problem in injury care. We aimed to identify clinical practice guideline (CPG) recommendations pertaining to low-value injury care, estimate how frequently they are used in practice, and evaluate interhospital variations in their use. Methods: We identified low-value clinical practices from internationally recognized CPGs. We conducted a retrospective cohort study using data from a Canadian trauma system (2014-2019) to calculate frequencies and assess interhospital variations. Results: We identified 29 low-value practices. Fourteen could be measured using trauma registry data. The 3 low-value clinical practices with the highest absolute and relative frequencies were computed tomography (CT) in adults with minor head injury (n = 5591, 24%), cervical spine CT (n = 2742, 31%), and whole-body CT in minor or single-system trauma (n = 530, 32%). We observed high interhospital variation for decompressive craniectomy in diffuse traumatic brain injury. Frequencies and interhospital variations were low for magnetic resonance imaging, intracranial pressure monitoring, inferior vena cava filter use, and surgical management of blunt abdominal injuries. Conclusions: We observed evidence of poor adherence to CPG recommendations on low-value CT imaging and high practice variation for decompressive craniectomy. Results suggest that adherence to recommendations for the 10 other low-value practices is high. These data can be used to advance the research agenda on low-value injury care and inform the development of interventions targeting reductions in healthcare overuse in this population.	[Soltana, Kahina; Lauzier, Francois; Turgeon, Alexis] Laval Univ, CHU Quebec, Canada Res Chair Crit Care Neurol & Trauma, Quebec City, PQ, Canada; [Soltana, Kahina; Turgeon, Alexis] Laval Univ, CHU Quebec, Cochrane Canada Francophone, Quebec City, PQ, Canada; [Soltana, Kahina; Moore, Lynne; Bouderba, Samy; Lauzier, Francois; Mercier, Eric; Tardif, Pier-Alexandre; Belcaid, Amina; Turgeon, Alexis] Laval Univ, CHU Quebec, CHU Quebec Res Ctr, Hop Enfant Jesus, Quebec City, PQ, Canada; [Soltana, Kahina; Moore, Lynne; Bouderba, Samy; Mercier, Eric; Tardif, Pier-Alexandre; Belcaid, Amina; Turgeon, Alexis] Laval Univ, Populat Hlth & Optimal Hlth Practice Res Unit, CHU Quebec Res Ctr, Trauma Emergency Crit Care Med, Quebec City, PQ, Canada; [Moore, Lynne] Univ Laval, Dept Social & Prevent Med, Fac Med, Quebec City, PQ, Canada; [Lauzier, Francois] Laval Univ, Div Crit Care, Dept Med & Anesthesiol & Res Ctr, CHU Quebec, Quebec City, PQ, Canada; [Clement, Julien; Belcaid, Amina] INESSS, Quebec City, PQ, Canada; [Clement, Julien; Krouchev, Radoslav] Univ Laval, Dept Surg, Quebec City, PQ, Canada; [Mercier, Eric] Univ Laval, Dept Family Med & Emergency Med, Fac Med, Quebec City, PQ, Canada; [Stelfox, Thomas] Univ Calgary, Univ Calgary & Alberta Hlth Serv, Dept Crit Care Med Calgary Zone, Calgary, AB, Canada; [Lamontagne, Francois] Univ Sherbrooke, Dept Internal Med, Dept Med, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada; [Archambault, Patrick] CISSS Chaudiere Appalaches Secteur Alphonse Desja, Div Crit Care, Dept Family Med & Emergency Med, Dept Anesthesia, St Marie, PQ, Canada; [Turgeon, Alexis] Univ Laval, Div Crit Care Med, Dept Anesthesiol & Crit Care Med, Fac Med, Quebec City, PQ, Canada		Moore, L (corresponding author), Univ Laval, Dept Social & Prevent Med, 1401,18e Rue,Local H-012a, Quebec City, PQ G1J 1Z4, Canada.	lynne.moore@fmed.ulaval.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [353374]; Fonds de Recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec; Clinical-Embedded Scientist Award from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This research was funded by the Canadian Institutes of Health Research (Foundation grant no. 353374) and the Fonds de Recherche du Quebec-Sante (career award, LM, FLau, FLam, MC). Dr Archambault was supported by the Clinical-Embedded Scientist Award from the Canadian Institutes of Health Research. Dr Turgeon is the Canada Research Chair in Critical Care Neurology and Trauma.	[Anonymous], Unnecessary care in Canada; [Anonymous], The cost of injury in Canada; [Anonymous], Health Spending; Arab AF, 2015, NEURORADIOL J, V28, P591, DOI 10.1177/1971400915610699; Badgery-Parker T, 2019, BMJ QUAL SAF, V28, P205, DOI 10.1136/bmjqs-2018-008338; Chilvers G, 2018, CLIN RADIOL, V73, DOI 10.1016/j.crad.2017.11.006; Colla CH, 2015, J GEN INTERN MED, V30, P221, DOI 10.1007/s11606-014-3070-z; Cooper DJ, 2020, J NEUROTRAUM, V37, P810, DOI 10.1089/neu.2019.6869; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Dane B, 2017, RADIOL CLIN N AM, V55, P321, DOI 10.1016/j.rcl.2016.10.007; de Vries EF, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1656-3; Demetriades D, 1997, WORLD J SURG, V21, P41, DOI 10.1007/s002689900191; Eggenberger Eileen, 2019, Iowa Orthop J, V39, P179; Ellen M, EVIDENCE BRIEF ADDRE; Ene M, MULTILEVEL MODELS CA; Fleming C, HEALTHAFFAIRS, DOI [10.1377/hblog20120612.020274/full/, DOI 10.1377/HBLOG20120612.020274/FULL]; Fodor M, 2018, EUR SURG, V50, P285, DOI 10.1007/s10353-018-0545-x; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Halpern CH, 2010, SPINE, V35, P1721, DOI 10.1097/BRS.0b013e3181e9acb2; Harris R, 2012, ANN ROY COLL SURG, V94, P240, DOI 10.1308/003588412X13171221590052; Hoff WS, 2002, J TRAUMA, V53, P602, DOI 10.1097/00005373-200209000-00038; Holmes MW, 2012, INJURY, V43, P1423, DOI 10.1016/j.injury.2011.07.017; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Jamous M, 2010, EUR J TRAUMA EMERG S, V36, P465, DOI 10.1007/s00068-010-0002-4; Kerwin AJ, 2012, J TRAUMA ACUTE CARE, V73, pS283, DOI 10.1097/TA.0b013e31827013e9; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Krogstad U, 2005, QUAL SAF HEALTH CARE, V14, P438, DOI 10.1136/qshc.2005.014233; Lee WS, 2014, J TRAUMA ACUTE CARE, V77, P527, DOI 10.1097/TA.0000000000000416; Lucas CE, 2000, AM SURGEON, V66, P337; Luke D.A., 2004, MULTILEVEL MODELING, VVol. 143; Manolakaki D, 2009, J TRAUMA, V66, P1008, DOI 10.1097/TA.0b013e31819adba2; McAlister FA, 2018, BMJ QUAL SAF, V27, P1, DOI [10.1136/bmjqs-2017-006778, 10.1136/bmjqs-2017-007524]; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; Moore L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016024; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Morgan DJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4534; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Nason RW, 2001, CAN J SURG, V44, P122; Pendrith Ciara, 2017, CMAJ Open, V5, pE45, DOI 10.9778/cmajo.20160095; Ransom H, 2017, PEDIATR REV, V38, P320, DOI 10.1542/pir.2016-0012; RENZ BM, 1995, J TRAUMA, V38, P350, DOI 10.1097/00005373-199503000-00007; Richardson JD, 2000, ANN SURG, V232, P324, DOI 10.1097/00000658-200009000-00004; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Saini V, 2017, LANCET, V390, P105, DOI 10.1016/S0140-6736(16)32573-9; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; SIRTQ, MIN SANT SERV SOC; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Sultan HY, 2004, EMERG MED J, V21, P420, DOI 10.1136/emj.2003.011353; Verkerk EW, 2018, INT J QUAL HEALTH C, V30, P736, DOI 10.1093/intqhc/mzy100	55	1	1	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	DEC	2021	24	12					1728	1736		10.1016/j.jval.2021.06.008			9	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	XC7VG	WOS:000722217200003	34838270				2022-02-06	
J	Taran, S; Angriman, F; Pinto, R; Ferreyro, BL; Amaral, ACKB				Taran, Shaurya; Angriman, Federico; Pinto, Ruxandra; Ferreyro, Bruno L.; Amaral, Andre Carlos Kajdacsy-Balla		Toronto Intensive Care Observation	Discordances Between Factors Associated With Withholding Extubation and Extubation Failure After a Successful Spontaneous Breathing Trial*	CRITICAL CARE MEDICINE			English	Article						extubation; malignancy; mechanical ventilation; risk factors; sedation; traumatic brain injury	MECHANICAL VENTILATION; INTENSIVE-CARE; RISK-FACTORS; RESPIRATORY-FAILURE; PRESSURE SUPPORT; TIME; PREDICTORS; OUTCOMES; REINTUBATION; STRATEGIES	OBJECTIVES: To identify whether factors associated with withholding extubation in the ICU also predict the risk of extubation failure. DESIGN: Retrospective cohort study. SETTING: Eight medical-surgical ICUs in Toronto. Patients: Adult patients receiving invasive mechanical ventilation, with a first successful spontaneous breathing trial within 28 days of initial ICU admission. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The primary end point had three mutually exclusive levels, including: 1) withholding extubation after a successful spontaneous breathing trial, 2) extubation failure within 48 hours, and 3) successful extubation. Among 9,910 patients, 38% of patients were not extubated within 24 hours of their first successful spontaneous breathing trial. A total of 12.9% of patients who were promptly extubated failed within the next 48 hours. Several discrepancies were evident in the association of factors with risk of withholding extubation and extubation failure. Specifically, both age and female sex were associated with withholding extubation (odds ratio, 1.07; 95% CI, 1.03-1.11; and odds ratio, 1.13; 95% CI, 1.02-1.26, respectively) but not a higher risk of failed extubation (odds ratio, 0.99; 95% CI, 0.93-1.05; and odds ratio, 0.93; 95% CI, 0.77-1.11, respectively). Conversely, both acute cardiovascular conditions and intubation for hypoxemic respiratory failure were associated with a higher risk of failed extubation (odds ratio, 1.32; 95% CI, 1.06-1.66; and odds ratio, 1.46; 95% CI, 1.16-1.82, respectively) but not a higher odds of a withheld extubation attempt (odds ratio, 0.79; 95% CI, 0.68-0.91; and odds ratio, 1.07; 95% CI, 0.93-1.23, respectively). CONCLUSIONS: Several factors showed discordance between the decision to withhold extubation and the risk of extubation failure. This discordance may lead to longer duration of mechanical ventilation or higher reintubation rates. Improving the decision-making behind extubation may help to reduce both exposure to invasive mechanical ventilation and extubation failure.	[Taran, Shaurya; Angriman, Federico; Ferreyro, Bruno L.; Amaral, Andre Carlos Kajdacsy-Balla] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Angriman, Federico; Ferreyro, Bruno L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Angriman, Federico; Pinto, Ruxandra; Amaral, Andre Carlos Kajdacsy-Balla] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Ferreyro, Bruno L.] Sinai Hlth Syst, Dept Med, Toronto, ON, Canada; [Ferreyro, Bruno L.] Univ Hlth Network, Toronto, ON, Canada		Taran, S (corresponding author), Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada.	shaurya.taran@mail.utoronto.ca		Angriman, Federico/0000-0003-0971-386X	Vanier Canada Graduate Scholarship from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	Dr. Ferreyro is supported by a Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research. Dr. Angriman is supported by a Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Afessa B, 1999, CHEST, V116, P456, DOI 10.1378/chest.116.2.456; Angriman F, 2020, CRIT CARE MED, V48, pE227, DOI 10.1097/CCM.0000000000004201; Azoulay E, 2001, CRIT CARE MED, V29, P519, DOI 10.1097/00003246-200103000-00009; Azoulay E, 2013, J CLIN ONCOL, V31, P2810, DOI 10.1200/JCO.2012.47.2365; Blackwood B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7237; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; Cinotti R, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.08.16; Cooke CR, 2010, CHEST, V138, P289, DOI 10.1378/chest.10-0289; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Epstein SK, 2002, INTENS CARE MED, V28, P535, DOI 10.1007/s00134-002-1268-8; Epstein SK, 1998, AM J RESP CRIT CARE, V158, P489, DOI 10.1164/ajrccm.158.2.9711045; Esteban A, 1999, AM J RESP CRIT CARE, V159, P512, DOI 10.1164/ajrccm.159.2.9803106; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Esteban A, 1997, AM J RESP CRIT CARE, V156, P459, DOI 10.1164/ajrccm.156.2.9610109; Farias JA, 1998, INTENS CARE MED, V24, P1070, DOI 10.1007/s001340050718; Ferrer M, 2009, LANCET, V374, P1082, DOI 10.1016/S0140-6736(09)61038-2; Frutos-Vivar F, 2006, CHEST, V130, P1664, DOI 10.1378/chest.130.6.1664; Frutos-Vivar F, 2011, J CRIT CARE, V26, P502, DOI 10.1016/j.jcrc.2010.12.015; Godet T, 2017, ANESTHESIOLOGY, V126, P104, DOI 10.1097/ALN.0000000000001379; Hernandez G, 2016, JAMA-J AM MED ASSOC, V316, P1565, DOI 10.1001/jama.2016.14194; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Khamiees M, 2001, CHEST, V120, P1262, DOI 10.1378/chest.120.4.1262; McCredie VA, 2017, ANN AM THORAC SOC, V14, P85, DOI 10.1513/AnnalsATS.201608-620OC; Mokhlesi B, 2007, RESP CARE, V52, P1710; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Ouellette DR, 2017, CHEST, V151, P166, DOI 10.1016/j.chest.2016.10.036; Rochwerg B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02426-2016; Salam A, 2004, INTENS CARE MED, V30, P1334, DOI 10.1007/s00134-004-2231-7; SCHAPIRA DV, 1993, JAMA-J AM MED ASSOC, V269, P783, DOI 10.1001/jama.269.6.783; Subira C, 2019, JAMA-J AM MED ASSOC, V321, P2175, DOI 10.1001/jama.2019.7234; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Thille AW, 2019, JAMA-J AM MED ASSOC, V322, P1465, DOI 10.1001/jama.2019.14901; Thille AW, 2016, AM J RESP CRIT CARE, V193, P1438, DOI 10.1164/rccm.201601-0187LE; Thille AW, 2015, CRIT CARE MED, V43, P613, DOI 10.1097/CCM.0000000000000748; Thille AW, 2013, AM J RESP CRIT CARE, V187, P1294, DOI 10.1164/rccm.201208-1523CI; Thille AW, 2013, CURR OPIN CRIT CARE, V19, P57, DOI 10.1097/MCC.0b013e32835c5095; Thille AW, 2011, CRIT CARE MED, V39, P2612, DOI 10.1097/CCM.0b013e3182282a5a; Urner M, 2020, LANCET RESP MED, V8, P905, DOI 10.1016/S2213-2600(20)30325-8; Vallverdu I, 1998, AM J RESP CRIT CARE, V158, P1855, DOI 10.1164/ajrccm.158.6.9712135; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	41	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	DEC	2021	49	12					2080	2089		10.1097/CCM.0000000000005107			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WZ6AA	WOS:000720046300035	34259451				2022-02-06	
J	Wang, E; Simmons, B; Holm, KE; Alam, R; Wamboldt, FS				Wang, Eileen; Simmons, Bryan; Holm, Kristen E.; Alam, Rafeul; Wamboldt, Frederick S.			Intimate Partner Violence and Adult Asthma Morbidity: A Population-Based Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE			English	Article						Asthma; Intimate partner violence; Outcomes; Exacerbations; Control; Morbidity	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; 18 US STATES/TERRITORIES; COMMUNITY VIOLENCE; MENTAL-HEALTH; ODDS RATIO; UNCONTROLLED ASTHMA; DOMESTIC VIOLENCE; CHILDHOOD ASTHMA; PANIC DISORDER	BACKGROUND: The etiologies for difficult-to-control asthma are complex and incompletely understood. Intimate partner violence (IPV) is a pervasive problem and may play a role in difficult-to-control asthma. IPV is associated with increased prevalence of asthma. There are no prior studies evaluating IPV's association with adult asthma exacerbations. OBJECTIVE: This study hypothesized that IPV exposure would be associated with increased asthma exacerbations, higher symptom burden, and poorer asthma control among adults. METHODS: Analyses are based on 2634 adults who participated in the 2005 Behavioral Risk Factor Surveillance System survey, reported active asthma, and completed the asthma and IPV questions. We used multivariate logistic regression to examine the association of IPV with asthma morbidity outcomes while controlling for the following potential confounders: sex, race, education, health care coverage, smoking status, age, and body mass index. RESULTS: The prevalence of IPV was 32.4%. IPV was associated with increased odds of an asthma exacerbation (adjusted odds ratio [AOR] = 1.75, 95% confidence interval [CI] = 1.26-2.43), higher symptom burden (AOR = 2.33, 95% CI = 1.53-3.55), and lack of asthma control (AOR = 2.23, 95% CI = 1.22-4.09) when using composite measures for these outcomes. When using single-item measures for outcomes, IPV was also associated with increased asthma-related emergency department or urgent care visits (AOR = 2.35, 95% CI = 1.56-3.54), other urgent provider visits (AOR = 1.84, 95% CI = 1.28-2.64), perceived asthma attacks (AOR = 1.53, 95% CI = 1.12-2.09), limitations (AOR = 2.07, 95% CI = 1.49-2.89), daytime symptoms (AOR = 1.92, 95% CI = 1.35-2.72), and nocturnal awakenings (AOR = 1.88, 95% CI = 1.32-2.69). CONCLUSIONS: IPV is prevalent in adult asthmatics and consistently and significantly associated with worsened adult asthma morbidity, even after adjusting for key confounders. Further research is needed to more fully understand the mechanisms underlying these relationships. (C) 2021 American Academy of Allergy, Asthma & Immunology	[Wang, Eileen; Holm, Kristen E.; Alam, Rafeul] Natl Jewish Hlth, Dept Med, Div Allergy & Immunol, Denver, CO 80206 USA; [Wang, Eileen; Alam, Rafeul] Univ Colorado, Dept Med, Div Allergy & Immunol, Sch Med, Aurora, CO USA; [Simmons, Bryan] Natl Jewish Hlth, Dept Med, Div Sleep Med, Ctr Hlth Promot, Denver, CO 80206 USA; [Holm, Kristen E.] Natl Jewish Hlth, Div Neurol, Dept Med, Denver, CO 80206 USA; [Holm, Kristen E.] Univ Colorado, Dept Community & Behav Hlth, Sch Publ Hlth, Aurora, CO USA; [Wamboldt, Frederick S.] Natl Jewish Hlth, Div Med Behav & Community Hlth, Dept Med, Denver, CO 80206 USA		Wang, E (corresponding author), Natl Jewish Hlth, 1400 Jackson St,K624A, Denver, CO 80206 USA.	wange@njhealth.org		Wang, Eileen/0000-0002-3149-3229	AstraZenecaAstraZeneca; GlaxoSmithKlineGlaxoSmithKline; GenentechRoche HoldingGenentech; NovartisNovartis; TevaTeva Pharmaceutical Industries; National Institute of Allergy and Infectious Diseases (NIAID)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA); National Heart, Lung, and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); Cystic Fibrosis FoundationItalian Cystic Fibrosis Research Foundation; 2 NIAID RO1 grants; 1 NHLBI U19 (PRECISE) grant; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)	E. Wang has received honoraria from AstraZeneca, GlaxoSmithKline, and Clinical Care Options. She has been an investigator on studies sponsored by AstraZeneca, GlaxoSmithKline, Genentech, Novartis, Teva, and National Institute of Allergy and Infectious Diseases (NIAID) for which her institution has received funding. She has no conflicts of interest to report that affect this study. B. Simmons declares no conflicts of interest affecting this study. K. E. Holm has been an investigator on studies sponsored by the National Institute on Drug Abuse (NIDA); National Heart, Lung, and Blood Institute (NHLBI); and the Cystic Fibrosis Foundation for which her institution has received funding. She is also a consultant for AlphaNet, Inc. She has no conflicts of interest to report that affect this study. R. Alam is funded by 2 NIAID RO1 grants and 1 NHLBI U19 (PRECISE) grant. He has no conflict of interest for this study. F. S. Wamboldt has been an investigator on studies sponsored by the NIDA for which his institution has received funding. He has no conflicts of interest to report that affect this study.	Afifi TO, 2009, J INTERPERS VIOLENCE, V24, P1398, DOI 10.1177/0886260508322192; Alhalal E, 2018, J ADV NURS, V74, P2785, DOI 10.1111/jan.13797; Andrade C, 2015, J CLIN PSYCHIAT, V76, pE857, DOI 10.4088/JCP.15f10150; Apter AJ, 2010, J ALLERGY CLIN IMMUN, V126, P552, DOI 10.1016/j.jaci.2010.07.014; Bateman ED, 2015, J ALLERGY CLIN IMMUN, V135, P1457, DOI 10.1016/j.jaci.2014.08.015; Black M C., 2011, NATL INTIMATE PARTNE; Black MC., 2014, INTIMATE PARTNER VIO; Blumberg SJ, 2006, AM J PUBLIC HEALTH, V96, P926, DOI 10.2105/AJPH.2004.057885; Breiding MJ, 2008, ANN EPIDEMIOL, V18, P538, DOI 10.1016/j.annepidem.2008.02.005; Breiding MJ, 2008, AM J PREV MED, V34, P112, DOI 10.1016/j.amepre.2007.10.001; Breiding MJ, 2014, MMWR SURVEILL SUMM, V63, P1; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Center for Disease Control and Prevention, BEH RISK FACT SURV S; Centers for Disease Control and Prevention, UNC ASTHM AD 2016 20; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P113; Chaudhuri R, 2003, AM J RESP CRIT CARE, V168, P1308, DOI 10.1164/rccm.200304-503OC; Cho H, 2012, J INTERPERS VIOLENCE, V27, P344, DOI 10.1177/0886260511416469; Cohen RT, 2016, J PEDIATR-US, V173, P13, DOI 10.1016/j.jpeds.2016.03.043; Colice GL, 2012, ANN ALLERG ASTHMA IM, V108, P157, DOI 10.1016/j.anai.2011.12.017; Coogan PF, 2013, J ALLERGY CLIN IMMUN, V131, P1058, DOI 10.1016/j.jaci.2012.10.023; Cooper A., 2011, HOMICIDE TRENDS US 1; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Diemer MA, 2013, ANAL SOC ISS PUB POL, V13, P77, DOI 10.1111/asap.12001; Engert V, 2020, JAMA PSYCHIAT, V77, P996, DOI 10.1001/jamapsychiatry.2020.0364; Erickson SE, 2007, ARCH INTERN MED, V167, P1846, DOI 10.1001/archinte.167.17.1846; Exley D, 2015, EUR RESPIR REV, V24, P299, DOI 10.1183/16000617.00004114; Ferreira P, 2017, MATURITAS, V102, P34, DOI 10.1016/j.maturitas.2017.05.001; Forno E, 2012, AM J RESP CRIT CARE, V185, P1033, DOI 10.1164/rccm.201202-0350ED; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Hathaway JE, 2000, AM J PREV MED, V19, P302, DOI 10.1016/S0749-3797(00)00236-1; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Hines DA, 2015, AM J PREV MED, V48, P136, DOI 10.1016/j.amepre.2014.08.022; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lay AR, 2018, REV MED CHILE, V146, P323, DOI 10.4067/s0034-98872018000300323; Liu LY, 2002, AM J RESP CRIT CARE, V165, P1062, DOI 10.1164/ajrccm.165.8.2109065; Liu WM, 2017, J ALLERGY CLIN IMMUN, V139, P1548, DOI 10.1016/j.jaci.2016.08.032; Loxton D, 2006, VIOLENCE AGAINST WOM, V12, P715, DOI 10.1177/1077801206291483; Miller E, 2019, NEW ENGL J MED, V380, P850, DOI 10.1056/NEJMra1807166; Miller MK, 2007, RESP MED, V101, P481, DOI 10.1016/j.rmed.2006.07.005; Mosen DM, 2008, J ALLERGY CLIN IMMUN, V122, P507, DOI 10.1016/j.jaci.2008.06.024; National Asthma Education and Prevention Program, 2020, 2020 FOC UPD ASTHM M; National Center for Injury Prevention and Control, 2003, COSTS INTIMATE PARTN; Patel PO, 2017, J ALLER CL IMM-PRACT, V5, P1691, DOI 10.1016/j.jaip.2017.03.034; Petrosky E, 2017, MMWR-MORBID MORTAL W, V66, P741, DOI 10.15585/mmwr.mm6628a1; Petrowski K, 2013, INT J PSYCHOPHYSIOL, V88, P35, DOI 10.1016/j.ijpsycho.2013.01.002; Pinto RJ, 2016, PSYCHONEUROENDOCRINO, V74, P57, DOI 10.1016/j.psyneuen.2016.08.024; Ranganathan Priya, 2015, Perspect Clin Res, V6, P222, DOI 10.4103/2229-3485.167092; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Rennison RM, 2001, INTIMATE PARTNER VIO; Rosenberg SL, 2014, J ALLERGY CLIN IMMUN, V134, P1009, DOI 10.1016/j.jaci.2014.07.005; Sandberg S, 2000, LANCET, V356, P982, DOI 10.1016/S0140-6736(00)02715-X; Sastre J, 2018, J ALLER CL IMM-PRACT, V6, P1953, DOI 10.1016/j.jaip.2018.02.002; Schatz M, 2012, CHEST, V141, P66, DOI 10.1378/chest.11-0574; Simon SD, 2001, J ANDROL, V22, P533; Smith SG, NATL INTIMATE PARTNE; Spitzer C, 2011, EUR RESPIR J, V37, P1068, DOI 10.1183/09031936.00028010; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Stanford RH, 2010, J ASTHMA, V47, P257, DOI 10.3109/02770900903584019; Staufenbiel SM, 2013, PSYCHONEUROENDOCRINO, V38, P1220, DOI 10.1016/j.psyneuen.2012.11.015; Sternthal MJ, 2010, EUR RESPIR J, V36, P1400, DOI 10.1183/09031936.00003010; Steudte S, 2013, BIOL PSYCHIAT, V74, P639, DOI 10.1016/j.biopsych.2013.03.011; Subramanian SV, 2007, INT J EPIDEMIOL, V36, P569, DOI 10.1093/ije/dym007; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Taylor B, 2008, THORAX, V63, P14, DOI 10.1136/thx.2007.082784; Wechsler ME, 2011, AM J RESP CRIT CARE, V184, P1247, DOI 10.1164/rccm.201103-0514OC; Wenzel S, 2005, AM J RESP CRIT CARE, V172, P149, DOI 10.1164/rccm.200409-1181PP; Wichmann S, 2017, PSYCHONEUROENDOCRINO, V83, P135, DOI 10.1016/j.psyneuen.2017.06.005; Wisnivesky JP, 2010, J ASTHMA, V47, P100, DOI 10.3109/02770900903426989; Wright RJ, 2004, ANN ALLERG ASTHMA IM, V93, pS18, DOI 10.1016/S1081-1206(10)61483-4; Wright RJ, 2004, AM J PUBLIC HEALTH, V94, P625, DOI 10.2105/AJPH.94.4.625; Yakubovich AR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025621; Yim IS, 2019, PSYCHONEUROENDOCRINO, V105, P9, DOI 10.1016/j.psyneuen.2018.08.017; Yonas MA, 2012, CURR OPIN ALLERGY CL, V12, P202, DOI 10.1097/ACI.0b013e32835090c9; Zein JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133490; Zein JG, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0528-y; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	82	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2213-2198	2213-2201		J ALLER CL IMM-PRACT	J. Allergy Clin. Immunol.-Pract.	DEC	2021	9	12					4300	+		10.1016/j.jaip.2021.06.023			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	XN4TQ	WOS:000729499700018	34364825				2022-02-06	
J	Washer, L; Abramo, T; Hardgrave, H; Harris, ZL; Meredith, M; Moore, K; Dalabih, A; Williams, D; Jorgenson-Stough, A; Crawley, L				Washer, Leanne; Abramo, Thomas; Hardgrave, Hailey; Harris, Zena Leah; Meredith, Mark; Moore, Katherine; Dalabih, Abudulah; Williams, David; Jorgenson-Stough, Amy; Crawley, Lee			Assessing the Impact of 3% Hypertonic Saline Hyperosmolar Therapy on Intubated Children With Isolated Traumatic Brain Injury by Cerebral Oximetry in a Pediatric Emergency Setting	PEDIATRIC EMERGENCY CARE			English	Article						cerebral oximetry; r(c)SO(2); CBVI; 3% HTS; intubated; PED TBI	NEAR-INFRARED SPECTROSCOPY; BLOOD-VOLUME INDEX; INTRACRANIAL-PRESSURE; HYPOTENSION; HYPOXIA; OXYGENATION	Background Intubated pediatric patients with isolated traumatic brain injury (TBI) are a diagnostic challenge for early detection of altered cerebral physiology instigated by trauma-induced increased intracranial pressure (ICP) while preventing secondary neuronal damage (secondary insult detection) and assessing the effects of increased ICP therapeutic interventions (3% hypertonic saline [HTS]). Invasive brain tissue oxygen monitoring is guiding new intensive care unit TBI management but is not pediatric emergency department (PED) readily accessible. Objective measurements on pediatric isolated TBI-altered bihemispheric cerebral physiology and treatment effects of 3% HTS are currently lacking. Cerebral oximetry can assess increased ICP-induced abnormal bihemispheric cerebral physiology by measuring regional tissue oxygenation (r(c)SO(2)) and cerebral blood volume index (CBVI) and the mechanical cerebrospinal fluid removal effects on the increased ICP-induced abnormal bihemispheric cerebral physiology. In the PED intubated patients with isolated TBI, assessing the 3% HTS therapeutic response is solely by vital signs and limited clinical assessment skills. Objective measurements of the 3% HTS hyperosmolar effects on the PED isolated TBI patients' altered bihemispheric cerebral physiology are lacking. We believe that bihemispheric r(c)SO(2) and CBVI could elucidate similar data on 3% HTS impact and influence in the intubated isolated TBI patients. Objective This study aimed to analyze the effects of 3% HTS on bihemispheric r(c)SO(2) and CBVI in intubated patients with isolated TBI. Methods An observational, retrospective analysis of bihemispheric r(c)SO(2) and CBVI readings in intubated pediatric patients with isolated TBI receiving 3% HTS infusions, was performed. Results From 2010 to 2017, 207 intubated patients with isolated TBI received 3% HTS infusions (median age, 2.9 [1.1-6.9 years]; preintubation Glasgow Coma Scale score, 7 [6-8]). The results were as follows: initial pre-3% HTS, 43% (39.5% to 47.5%; left) and 38% (35% to 42%; right) for r(c)SO(2) < 60%, and 8 (-28 to 21; left) and -15 (-34 to 22; right) for CBVI; post-3% HTS, 68.5% (59.3% to 76%, P < 0.0001; left) and 62.5% (56.0% to 74.8%, P < 0.0001; right) for r(c)SO(2) < 60%, and 12 (-7 to 24, P = 0.04; left) and 14 (-21 to 22, P < 0.0001; right) for CBVI; initial pre-3% HTS, 90% (83% to 91%; left) and 87% (82% to 92%; right) for r(c)SO(2) > 80%, and 16.5 (6 to 33, P < 0.0001; left) and 16.8 (-2.5 to 27.5, P = 0.005; right) for CBVI; and post-3% HTS, 69% (62% to 72.5%, P < 0.0001; left) and 63% (59% to 72%, P < 0.0001; right) for r(c)SO(2) > 80%, and 16.5 (6 to 33, P < 0.0001; left) and 16.8 (-2.5 to 27.5, P = 0.005; right) for CBVI. The following results for cerebral pathology pre-3% HTS were as follows: epidural: 85% (58% to 88.5%) for left r(c)SO(2) and -9.25 (-34 to 19) for left CBVI, and 85.5% (57.5% to 89%) for right r(c)SO(2) and -12.5 (-21 to 27) for CBVI; subdural: 45% (38% to 54%) for left r(c)SO(2) and -9.5 (-25 to 19) for left CBVI, and 40% (33% to 49%) for right r(c)SO(2) and -15 (-30.5 to 5) for CBVI. The following results for cerebral pathology post-3% HTS were as follows: epidural: 66% (58% to 69%, P = 0. 03) for left r(c)SO(2) and 15 (-1 to 21, P = 0.0004) for left CBVI, and 63% (52% to 72%, P = 0.009) for right r(c)SO(2), and 15.5 (-22 to 24, P = 0.02) for CBVI; subdural: 63% (56% to 72%, P < 0.0001) for left r(c)SO(2) and 9 (-20 to 22, P < 0.0001) for left CBVI, and 62.5% (48% to 73%, P < 0.0001) for right r(c)SO(2), and 3 (-26 to 22, P < 0.0001) for CBVI. Overall, heart rate showed no significant change. Three percent HTS effect on interhemispheric r(c)SO(2) difference >10 showed r(c)SO(2) < 60%, and subdural hematomas had the greatest reduction (P < 0.001). The greatest positive changes occurred in bihemispheric or one-hemispheric r(c)SO(2) < 60% with an interhemispheric discordance r(c)SO(2) > 10 and required the greatest number of 3% HTS infusions. For 3% HTS 15% r(c)SO(2) change time effect, all patients achieved positive change with subdural hematomas and hemispheric r(c)SO(2) readings <60% with the shortest achievement time of 1.2 minutes (0.59-1.75; P < 0.001). Conclusions In intubated pediatric patients with isolated TBI who received 3% HTS infusions, bihemispheric r(c)SO(2) and CBVI readings immediately detected and trended the 3% HTS effects on the trauma-induced cerebral pathophysiology. The 3% HTS infusion produced a significant improvement in r(c)SO(2) and CBVI readings and a reduction in interhemispheric r(c)SO(2) discordance differences. In patients with bihemispheric or one-hemispheric r(c)SO(2) readings <60% with or without an interhemispheric discordance, r(c)SO(2) > 10 demonstrated the greatest significant positive delta change and required the greatest numbers of 3% HTS infusions. Overall, 3% HTS produced a significant positive 15% change within 2.1 minutes of infusion, whereas heart rate showed no significant change. During trauma neuroresuscitation, especially in intubated isolated TBI patients requiring 3% HTS, cerebral oximetry has shown its functionality as a rapid adjunct neurological, therapeutic assessment tool and should be considered in the initial emergency department pediatric trauma neurological assessment and neuroresuscitation regimen.	[Washer, Leanne; Abramo, Thomas; Dalabih, Abudulah] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 77205 USA; [Hardgrave, Hailey; Moore, Katherine] Univ Arkansas Med Sci, Little Rock, AR 77205 USA; [Harris, Zena Leah] Lurie Childrens Hosp, Feinberg Sch Med, Dept Pediat, Northwestern Med, Chicago, IL USA; [Meredith, Mark] Univ Tennessee, LeBonheur Childrens Hosp, Dept Pediat, Memphis, TN USA; [Williams, David; Jorgenson-Stough, Amy; Crawley, Lee] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA		Abramo, T (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 77205 USA.	tom.abramo@pemaweb.com		Hardgrave, Hailey/0000-0003-0388-8386; Dalabih, Abdallah/0000-0002-1198-1129			Abramo TJ, 2015, AM J EMERG MED, V33, P1622, DOI 10.1016/j.ajem.2015.07.037; Abramo TJ, 2015, PEDIATR EMERG CARE, V31, P479, DOI 10.1097/PEC.0000000000000141; Al-Rawi PG, 2006, STROKE, V37, P2720, DOI 10.1161/01.STR.0000244807.99073.ae; Bagwell TA, 2016, AM J EMERG MED, V34, P1102, DOI 10.1016/j.ajem.2016.03.005; Bell MJ, 2016, INTENS CARE MED, V42, P1618, DOI 10.1007/s00134-016-4401-9; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; De Georgia MA, 2015, J INTENSIVE CARE MED, V30, P473, DOI 10.1177/0885066614529254; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Hansen G., 2016, PEDIAT EMERG; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Kane I, 2014, AM J EMERG MED, V32, P356, DOI 10.1016/j.ajem.2013.10.047; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Myers D, 2009, CRIT CARE, V13, DOI 10.1186/cc8000; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Padayachy LC, 2012, CHILD NERV SYST, V28, P1911, DOI 10.1007/s00381-012-1837-2; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Rhodes JK, 2016, ACTA NEUROCHIR SUPPL, V122, P9, DOI 10.1007/978-3-319-22533-3_2; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Rohlwink UK, 2012, NEUROSURGERY, V70, P1220, DOI 10.1227/NEU.0b013e318243fc59; Rosenthal G, 2014, J NEUROSURG, V120, P901, DOI 10.3171/2013.12.JNS131089; Salonia R, 2012, J NEUROTRAUM, V29, P1047, DOI 10.1089/neu.2011.1890; Schneider B., 2015, ANN UPDATE INTENSIVE, P273; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Stippler M, 2012, J NEUROSURG-PEDIATR, V10, P383, DOI 10.3171/2012.8.PEDS12165; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678	30	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2021	37	12					E791	E804		10.1097/PEC.0000000000001959			14	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	XK6NI	WOS:000727579500013	32106155				2022-02-06	
J	Davey, DK; Jurick, SM; Crocker, LD; Hoffman, SN; Sanderson-Cimino, M; Tate, DF; Velez, CS; Delano-Wood, L; Jak, AJ				Davey, Delaney K.; Jurick, Sarah M.; Crocker, Laura D.; Hoffman, Samantha N.; Sanderson-Cimino, Mark; Tate, David F.; Velez, Carmen S.; Delano-Wood, Lisa; Jak, Amy J.			White matter integrity, suicidal ideation, and cognitive dysfunction in combat-exposed Iraq and Afghanistan Veterans	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Suicidality; Neuropsychology; Diffusion tensor imaging; Fractional anisotropy; Corona radiata; Superior longitudinal fasciculus	TRAUMATIC BRAIN-INJURY; SUPERIOR LONGITUDINAL FASCICULUS; RISK; BEHAVIOR; CONNECTIVITY; DISORDERS; MORPHOMETRY; PREVALENCE; ATTEMPTERS; NETWORKS	White matter alterations in frontolimbic circuits and poorer cognitive functioning have been observed in individuals endorsing suicidality across numerous psychiatric conditions. However, relationships between white matter integrity, cognition, and suicidality in Veterans are poorly understood, particularly for those at increased risk for suicide due to mental health conditions (e.g., posttraumatic stress disorder, depression) and traumatic brain injury history. We (1) examined white matter alterations in combat-exposed Iraq/Afghanistan Veterans with and without suicidal ideation (SI) and (2) investigated relationships between white matter integrity and neuropsychological functioning in regions that differed between SI groups. No group differences were found regarding psychiatric diagnoses. Participants with SI had lower fractional anisotropy (FA) in the posterior corona radiata, superior corona radiata, and superior longitudinal fasciculus relative to those without SI. Worse processing speed/attention performance was associated with lower FA in the superior longitudinal fasciculus, while worse executive functioning performance was associated with lower FA in the superior corona radiata and superior longitudinal fasciculus. Memory performance was not associated with FA. These findings suggest that white matter integrity may be involved in cognitive dysfunction and increased risk for SI. Interventions that target cognitive dysfunction may ameliorate SI, and in turn, reduce risk for suicide among Veterans.	[Davey, Delaney K.; Crocker, Laura D.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Jurick, Sarah M.; Crocker, Laura D.; Delano-Wood, Lisa; Jak, Amy J.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Jurick, Sarah M.; Delano-Wood, Lisa; Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA 92161 USA; [Hoffman, Samantha N.; Sanderson-Cimino, Mark] San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA USA; [Tate, David F.; Velez, Carmen S.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Tate, David F.] George E Wahlen VA Med Ctr, Salt Lake City, UT USA; [Delano-Wood, Lisa; Jak, Amy J.] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA		Jak, AJ (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr MC 151B, San Diego, CA 92161 USA.	ajak@ucsd.edu			Department of DefenseUnited States Department of Defense; Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]; VA Rehabilitation Research & Development Service [IK2 RX002459]	This work was supported by grant funding from the Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095] and the Department of Veterans Affairs CENC Award [I01 CX001135] . Laura Crocker received salary support during this work from a Career Development Award [IK2 RX002459] from the VA Rehabilitation Research & Development Service. The funding agencies had no role in data collection, analysis, or manuscript devel-opment. No potential conflicts of interest were reported by coauthors. The views, opinions and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy, or decision unless so designated by other official documentation.	Agoub M, 2006, J AFFECT DISORDERS, V90, P223, DOI 10.1016/j.jad.2005.09.014; Allen KJD, 2019, CURR BEHAV NEUROSCI, V6, P151, DOI 10.1007/s40473-019-00189-y; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baca-Garcia E, 2011, J AFFECT DISORDERS, V134, P327, DOI 10.1016/j.jad.2011.06.026; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Balcioglu YH, 2018, PSYCHIAT CLIN PSYCH, V28, P314, DOI 10.1080/24750573.2017.1420378; Bani-Fatemi A, 2018, PSYCHIAT RES-NEUROIM, V278, P77, DOI 10.1016/j.pscychresns.2018.05.008; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bloemen AJP, 2018, PSYCHOL MED, V48, P1787, DOI 10.1017/S0033291717003269; Bostwick JM, 2016, AM J PSYCHIAT, V173, P1094, DOI 10.1176/appi.ajp.2016.15070854; Bredemeier K, 2015, CLIN PSYCHOL REV, V40, P170, DOI 10.1016/j.cpr.2015.06.005; Brenner LA, 2015, ARCH PHYS MED REHAB, V96, P1411, DOI 10.1016/j.apmr.2015.04.010; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullman T, 2018, ARCH SUICIDE RES, V22, P1, DOI 10.1080/13811118.2017.1304308; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Centers for Disease Control and Prevention, 2019, WEB BAS INJ STAT QUE; Chamberlain SR, 2013, J PSYCHIATR RES, V47, P586, DOI 10.1016/j.jpsychires.2012.12.016; Cifu DX, 2018, BRAIN INJURY, V32, P1149, DOI 10.1080/02699052.2018.1496274; Crocker LD, 2021, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2021.1974566; Crocker LD, 2019, J INT NEUROPSYCH SOC, V25, P79, DOI 10.1017/S1355617718000851; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Ellis TE, 2008, INT J COGN THER, V1, P47, DOI 10.1680/ijct.2008.1.1.47; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Gosnell SN, 2018, NEUROMETHODS, V136, P403, DOI 10.1007/978-1-4939-7647-8_22; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hoffmire CA, 2021, MED CARE, V59, pS84, DOI 10.1097/MLR.0000000000001431; Homaifar BY, 2012, REHABIL PSYCHOL, V57, P337, DOI 10.1037/a0030480; Hwang J, 2018, NEUROIMAGE-CLIN, V20, P318, DOI 10.1016/j.nicl.2018.04.021; IBM Corp, 2016, IBM SPSS STAT WINDOW; Institute of Medicine, 2013, RET HOM IR AFGH ASS, DOI [10.17226/13499, DOI 10.17226/13499]; Jia ZY, 2014, J PSYCHIATR NEUROSCI, V39, P170, DOI 10.1503/jpn.130023; Jiang CX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00575; Jollant F, 2011, WORLD J BIOL PSYCHIA, V12, P319, DOI 10.3109/15622975.2011.556200; Jurick SM, 2018, J HEAD TRAUMA REHAB, V33, pE41, DOI 10.1097/HTR.0000000000000313; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Keilp JG, 2014, PSYCHOL MED, V44, P2965, DOI 10.1017/S0033291714000786; Keilp JG, 2013, PSYCHOL MED, V43, P539, DOI 10.1017/S0033291712001419; Kim B, 2015, J AFFECT DISORDERS, V175, P139, DOI 10.1016/j.jad.2015.01.001; Kongs K. S., 2000, WISCONSIN CARD SORTI; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee SJ, 2016, PSYCHIAT RES-NEUROIM, V248, P23, DOI 10.1016/j.pscychresns.2016.01.011; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; Luo L, 2012, BRAIN CONNECT, V2, P33, DOI 10.1089/brain.2011.0026; Malhi GS, 2020, PSYCHOL MED, V50, P1214, DOI 10.1017/S0033291719001132; Mann JJ, 2008, J CLIN PSYCHIAT, V69, P23, DOI 10.4088/JCP.v69n0104; Miller DR, 2017, BRAIN IMAGING BEHAV, V11, P1129, DOI 10.1007/s11682-016-9593-7; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nigg JT, 2017, J CHILD PSYCHOL PSYC, V58, P361, DOI 10.1111/jcpp.12675; O'Connor RC, 2014, LANCET PSYCHIAT, V1, P73, DOI 10.1016/S2215-0366(14)70222-6; Olvet DM, 2014, J PSYCHIATR RES, V51, P60, DOI 10.1016/j.jpsychires.2014.01.002; Owens JA, 2018, BRAIN INJURY, V32, P776, DOI 10.1080/02699052.2018.1451656; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Pisner DA, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101935; Pompili M, 2013, J NERV MENT DIS, V201, P802, DOI 10.1097/NMD.0b013e3182a21458; Richard-Devantoy S, 2014, PSYCHOL MED, V44, P1663, DOI 10.1017/S0033291713002304; Richard-Devantoy S, 2015, WORLD J BIOL PSYCHIA, V16, P544, DOI 10.3109/15622975.2014.925584; Richard-Devantoy S, 2012, CAN J PSYCHIAT, V57, P254, DOI 10.1177/070674371205700409; Rogers ML, 2017, REV GEN PSYCHOL, V21, P132, DOI 10.1037/gpr0000101; Rossom RC, 2017, J AFFECT DISORDERS, V215, P77, DOI 10.1016/j.jad.2017.03.037; Schmaal L, 2020, MOL PSYCHIATR, V25, P408, DOI 10.1038/s41380-019-0587-x; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Sheehan DV., 2014, MINI INT NEUROPSYCHI; Smolker HR, 2015, BRAIN STRUCT FUNCT, V220, P1291, DOI 10.1007/s00429-014-0723-y; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Sudol K, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0781-y; Suicide Prevention Resource Center, 2020, TOP TERMS; Taylor WD, 2015, PROG NEURO-PSYCHOPH, V62, P22, DOI 10.1016/j.pnpbp.2015.05.001; Tombaugh T.N., 2016, TEST MEMORY MALINGER; Urger SE, 2015, J CHILD NEUROL, V30, P9, DOI 10.1177/0883073813520503; van Heeringen K., 2016, INT HDB SUICIDE PREV, P170; Vaughan CA, 2014, PSYCHIAT SERV, V65, P833, DOI 10.1176/appi.ps.201300111; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Vera M, 2011, INT J GEN MED, V4, P197, DOI 10.2147/IJGM.S17156; Veterans Affairs Office of Mental Health and Suicide Prevention, 2019, 2019 NAT VET SUIC PR; Veterans Affairs Office of Mental Health and Suicide Prevention, 2018, NAT STRAT PREV VET S; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Wagner G, 2011, NEUROIMAGE, V54, P1607, DOI 10.1016/j.neuroimage.2010.08.082; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wang XH, 2016, BRAIN STRUCT FUNCT, V221, P2075, DOI 10.1007/s00429-015-1028-5; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; World Health Organization, 2021, SUIC WORLDW 2019 GLO; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	92	1	1	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	NOV 30	2021	317								111389	10.1016/j.pscychresns.2021.111389			9	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	WD5PA	WOS:000704991100002	34563989				2022-02-06	
J	Papalia, WL; Nascimento, AS; Krishnan, G; Broetto, N; Furian, AF; Oliveira, MS; Royes, LFF; Fighera, MR				Papalia, Willian Link; Nascimento, Alexandre Seixas; Krishnan, Gokul; Broetto, Nubia; Furian, Ana Flavia; Oliveira, Mauro Schneider; Freire Royes, Luiz Fernando; Fighera, Michele Rechia			Physical Exercise as a Modulator of Vascular Pathology and Thrombin Generation to Improve Outcomes After Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article; Early Access						Blood-brain barrier; Thrombin; Traumatic brain injury; Physical exercise; Protease-activated receptor-1	OXIDATIVE STRESS; BLOOD-COAGULATION; SYNAPTIC PLASTICITY; RECEPTOR ACTIVATION; BARRIER BREAKDOWN; AEROBIC CAPACITY; INDUCED SEIZURES; HEAT-SHOCK; EXPRESSION; MARKERS	Disruption of the blood-brain barrier and occurrence of coagulopathy after traumatic brain injury (TBI) have important implications for multiple secondary injury processes. Given the extent of post-traumatic changes in neuronal function, significant alterations in some targets, such thrombin (a protease that plays a physiological role in maintaining blood coagulation), play an important role in TBI-induced pathophysiology. Despite the magnitude of thrombin in synaptic plasticity being concentration-dependent, the mechanisms underlying TBI have not been fully elucidated. The understanding of this post-injury neurovascular dysregulation is essential to establish scientific-based rehabilitative strategies. One of these strategies may be supporting physical exercise, considering its relevance in reducing damage after a TBI. However, there are caveats to consider when interpreting the effect of physical exercise on neurovascular dysregulation after TBI. To complete this picture, this review will describe how the interactions established between blood-borne factors (such as thrombin) and physical exercise alter the TBI pathophysiology.	[Papalia, Willian Link; Broetto, Nubia; Freire Royes, Luiz Fernando; Fighera, Michele Rechia] Univ Fed Santa Maria, Ctr Nat & Exact Sci, Grad Program Biol Sci Toxicol Biochem, Santa Maria, RS, Brazil; [Papalia, Willian Link; Nascimento, Alexandre Seixas; Broetto, Nubia; Freire Royes, Luiz Fernando; Fighera, Michele Rechia] Univ Fed Santa Maria, Phys Educ & Sports Ctr, Dept Sports Methods & Tech, Exercise Biochem Lab BIOEX, Santa Maria, RS, Brazil; [Krishnan, Gokul] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Broetto, Nubia; Fighera, Michele Rechia] Univ Fed Santa Maria, Hlth Sci Ctr, Dept Neuropsychiat, Lab Expt & Clin Neuropsychiat, BR-97105900 Santa Maria, RS, Brazil; [Furian, Ana Flavia; Oliveira, Mauro Schneider] Univ Fed Santa Maria, Hlth Sci Ctr, Grad Program Pharmacol, Santa Maria, RS, Brazil		Fighera, MR (corresponding author), Univ Fed Santa Maria, Ctr Nat & Exact Sci, Grad Program Biol Sci Toxicol Biochem, Santa Maria, RS, Brazil.; Fighera, MR (corresponding author), Univ Fed Santa Maria, Phys Educ & Sports Ctr, Dept Sports Methods & Tech, Exercise Biochem Lab BIOEX, Santa Maria, RS, Brazil.; Fighera, MR (corresponding author), Univ Fed Santa Maria, Hlth Sci Ctr, Dept Neuropsychiat, Lab Expt & Clin Neuropsychiat, BR-97105900 Santa Maria, RS, Brazil.	mrfighera@yahoo.com.br		Seixas Nascimento, Alexandre/0000-0002-5588-4558; Fighera, Michele/0000-0002-3111-7530; Broetto Cunha, Nubia/0000-0003-1794-5089	National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordination for the Improvement of Higher Education Personnel (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	This work was supported by the National Council for Scientific and Technological Development (CNPq) and Coordination for the Improvement of Higher Education Personnel (CAPES).	Albert-Weissenberger C, 2019, J NEUROIMMUNOL, V326, P9, DOI 10.1016/j.jneuroim.2018.10.011; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Ang ET, 2007, CURR MED CHEM, V14, P2564, DOI 10.2174/092986707782023280; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; BARTSCH P, 1990, THROMB HAEMOSTASIS, V63, P430; Ben Shimon M, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01532; Buttler L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01048; Chen YC, 2015, CLIN SCI, V128, P425, DOI 10.1042/CS20140498; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Crawley JTB, 2007, J THROMB HAEMOST, V5, P95, DOI 10.1111/j.1538-7836.2007.02500.x; Cwikiel J, 2017, THROMB J, V15, DOI 10.1186/s12959-016-0127-8; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DIHANICH M, 1991, NEURON, V6, P575, DOI 10.1016/0896-6273(91)90060-D; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; El-Sayed MS, 1999, THROMB RES, V96, P467, DOI 10.1016/S0049-3848(99)00140-1; ElSayed MS, 1996, SPORTS MED, V22, P282, DOI 10.2165/00007256-199622050-00002; Eriksson-Berg M, 2002, THROMB RES, V105, P481, DOI 10.1016/S0049-3848(02)00063-4; Esnault P, 2019, NEUROCRIT CARE, V30, P405, DOI 10.1007/s12028-018-0639-0; Fiorin FD, 2016, J NEUROTRAUM, V33, P1317, DOI 10.1089/neu.2015.4068; Fletcher-Sandersjoo A, 2021, NEUROCRIT CARE, V34, P635, DOI 10.1007/s12028-020-01037-8; Fletcher-Sandersjoo A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051596; Franchini M, 2018, SEMIN THROMB HEMOST, V44, P796, DOI 10.1055/s-0038-1673628; Royes LFF, 2019, NEUROSCI BIOBEHAV R, V102, P345, DOI 10.1016/j.neubiorev.2019.05.012; Royes LFF, 2016, MINI-REV MED CHEM, V16, P29, DOI 10.2174/1389557515666150722101926; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gomez-Pinilla F, 2013, COMPR PHYSIOL, V3, P403, DOI 10.1002/cphy.c110063; Gram AS, 2015, EUR J APPL PHYSIOL, V115, P1331, DOI 10.1007/s00421-015-3106-z; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; He YD, 2013, NEUROBIOL DIS, V49, P22, DOI 10.1016/j.nbd.2012.08.014; Hilberg T, 2013, EUR J APPL PHYSIOL, V113, P1423, DOI 10.1007/s00421-012-2564-9; Hua Y, 2002, J CEREBR BLOOD F MET, V22, P55, DOI 10.1097/00004647-200201000-00007; Iannucci J, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00762; Itsekson-Hayosh Z, 2015, J MOL NEUROSCI, V56, P644, DOI 10.1007/s12031-015-0512-y; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Jeffers A, 2015, AM J RESP CELL MOL, V52, P674, DOI 10.1165/rcmb.2014-0084OC; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jiang YJ, 2002, J CEREBR BLOOD F MET, V22, P404, DOI 10.1097/00004647-200204000-00004; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Khaper N, 2010, ANTIOXID REDOX SIGN, V13, P1033, DOI 10.1089/ars.2009.2930; Kicken Cecile H, 2019, TH Open, V3, pe216, DOI 10.1055/s-0039-1692991; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Kisler K, 2017, NAT NEUROSCI, V20, P406, DOI 10.1038/nn.4489; Kottke MA, 2016, SHOCK, V46, P20, DOI 10.1097/SHK.0000000000000666; Kotwal J, 2007, THROMB RES, V120, P391, DOI 10.1016/j.thromres.2006.09.013; Kramer TJ, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0481-5; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; Krishna G, 2017, BBA-MOL BASIS DIS, V1863, P1204, DOI 10.1016/j.bbadis.2017.03.007; Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896; Lindblad C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00015; Liu DZ, 2017, J CEREBR BLOOD F MET, V37, P2359, DOI 10.1177/0271678X16666291; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Ma L, 2012, SEMIN IMMUNOPATHOL, V34, P63, DOI 10.1007/s00281-011-0281-9; Maggio N, 2014, NEUROSCIENCE, V281, P135, DOI 10.1016/j.neuroscience.2014.09.041; Maggio N, 2013, EXP NEUROL, V247, P595, DOI 10.1016/j.expneurol.2013.02.011; Malkiewicz MA, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1403-x; Marques-Aleixo I, 2012, PROG NEUROBIOL, V99, P149, DOI 10.1016/j.pneurobio.2012.08.002; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Masada T, 2000, BRAIN RES, V867, P173, DOI 10.1016/S0006-8993(00)02302-7; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Menzel K, 2011, EUR J APPL PHYSIOL, V111, P253, DOI 10.1007/s00421-010-1640-2; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Moccia Francesco, 2012, World J Biol Chem, V3, P127, DOI 10.4331/wjbc.v3.i7.127; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Motta L, 2013, J SMALL ANIM PRACT, V54, P213, DOI 10.1111/jsap.12028; Nag S, 2009, NEUROPATH APPL NEURO, V35, P417, DOI 10.1111/j.1365-2990.2008.01009.x; Navarro A, 2009, J BIOENERG BIOMEMBR, V41, P517, DOI 10.1007/s10863-009-9250-6; Ni W, 2016, ACTA NEUROCHIR SUPPL, V121, P379, DOI 10.1007/978-3-319-18497-5_65; Pan YX, 2007, HYPERTENSION, V49, P519, DOI 10.1161/01.HYP.0000256955.74461.93; Panagiotakos DB, 2005, PREV MED, V40, P432, DOI 10.1016/j.ypmed.2004.07.010; Perez-Dominguez M, 2014, NEUROCHEM RES, V39, P1219, DOI 10.1007/s11064-014-1300-8; Piao CS, 2019, J CEREBR BLOOD F MET, V39, P58, DOI 10.1177/0271678X17742792; Piao C, 2015, EXP NEUROL, V273, P288, DOI 10.1016/j.expneurol.2015.09.009; Pitsavos C, 2005, EUR J CARDIOV PREV R, V12, P151, DOI 10.1097/00149831-200504000-00010; Posthuma JJ, 2015, BLOOD REV, V29, P171, DOI 10.1016/j.blre.2014.10.005; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Prima V, 2013, J NEUROTRAUM, V30, P1881, DOI 10.1089/neu.2012.2758; Radak D, 2017, CURR VASC PHARMACOL, V15, P115, DOI 10.2174/1570161115666161104095522; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Rajput PS, 2019, BRAIN RES, V1715, P13, DOI 10.1016/j.brainres.2019.03.010; Ramos-Mandujano G, 2007, GLIA, V55, P917, DOI 10.1002/glia.20513; Ryu J, 2000, J BIOL CHEM, V275, P29955, DOI 10.1074/jbc.M001220200; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; Schobersberger W, 1996, FIBRINOLYSIS, V10, P37, DOI 10.1016/S0268-9499(05)80074-8; Sedgwick MJ, 2016, EUR J APPL PHYSIOL, V116, P1139, DOI 10.1007/s00421-016-3370-6; Shannon O, 2021, RES PRACT THROMB HAE, V5, P27, DOI 10.1002/rth2.12465; Sharma R, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9110318; Shlobin NA, 2021, ROLE THROMBIN CENTRA, V11; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SMITHSWINTOSKY VL, 1995, J NEUROSCI, V15, P5840; Stigger FS, 2019, J GERONTOL A-BIOL, V74, P616, DOI 10.1093/gerona/gly173; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Surai PF, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8070235; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Thrall G, 2007, THROMB RES, V120, P819, DOI 10.1016/j.thromres.2007.01.004; Tofas T, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9010013; Toldy A, 2005, BRAIN RES BULL, V65, P487, DOI 10.1016/j.brainresbull.2005.02.028; de Castro MRT, 2017, J PHYSIOL-LONDON, V595, P6023, DOI 10.1113/JP273933; Tozzi-Ciancarelli MG, 2002, EUR J APPL PHYSIOL, V86, P266, DOI 10.1007/s00421-001-0542-8; Tripodi A, 2016, CLIN CHEM, V62, P699, DOI 10.1373/clinchem.2015.248625; Van Gelder CM, 1999, J TRAUMA, V47, P885, DOI 10.1097/00005373-199911000-00012; VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389; Vazquez-Juarez E, 2009, J NEUROCHEM, V111, P1398, DOI 10.1111/j.1471-4159.2009.06418.x; VIGUIE CA, 1993, J APPL PHYSIOL, V75, P566, DOI 10.1152/jappl.1993.75.2.566; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Wang JS, 2009, MED SCI SPORT EXER, V41, P115, DOI 10.1249/MSS.0b013e3181831f27; Wang KY, 2015, BIOSENS BIOELECTRON, V63, P172, DOI 10.1016/j.bios.2014.07.022; Wang LG, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170942; WANG YX, 1994, J EXP BIOL, V195, P227; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Wu LH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04035-7; Xi G, 2000, ACT NEUR S, V76, P511; Xi GH, 1999, STROKE, V30, P1247, DOI 10.1161/01.STR.30.6.1247; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Xiang HK, 2020, J INT MED RES, V48, DOI 10.1177/0300060520957541; Yang Y, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0075-7; Ye XC, 2017, BIOCHEM BIOPH RES CO, V485, P499, DOI 10.1016/j.bbrc.2017.02.019; Zadow EK, 2020, SEMIN THROMB HEMOST, V46, P807, DOI 10.1055/s-0040-1715094; Zadow EK, 2018, SEMIN THROMB HEMOST, V44, P723, DOI 10.1055/s-0038-1673625; Zetterberg E, 2018, SEMIN THROMB HEMOST, V44, P787, DOI 10.1055/s-0038-1675381	127	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.												10.1007/s12035-021-02639-9		NOV 2021	15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XF3MI	WOS:000723978000001	34846694				2022-02-06	
J	Komisarow, JM; Toro, C; Curley, J; Mills, B; Cho, C; Simo, GM; Vavilala, MS; Laskowitz, DT; James, ML; Mathew, JP; Hernandez, A; Sampson, J; Ohnuma, T; Krishnamoorthy, V				Komisarow, Jordan M.; Toro, Camilo; Curley, Jonathan; Mills, Brianna; Cho, Christopher; Simo, Georges Motchoffo; Vavilala, Monica S.; Laskowitz, Daniel T.; James, Michael L.; Mathew, Joseph P.; Hernandez, Adrian; Sampson, John; Ohnuma, Tetsu; Krishnamoorthy, Vijay			Utilization of Brain Tissue Oxygenation Monitoring and Association with Mortality Following Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article; Early Access						TBI; Trauma; ICP monitoring	UNITED-STATES; HEAD-INJURY; MRC CRASH; HYPOXIA; TRIAL; PROGESTERONE; DEATHS; ADULTS	Background The aim of this study was to describe the utilization patterns of brain tissue oxygen (PbtO(2)) monitoring following severe traumatic brain injury (TBI) and determine associations with mortality, health care use, and pulmonary toxicity. Methods We conducted a retrospective cohort study of patients from United States trauma centers participating in the American College of Surgeons National Trauma Databank between 2008 and 2016. We examined patients with severe TBI (defined by admission Glasgow Coma Scale score <= 8) over the age of 18 years who survived more than 24 h from admission and required intracranial pressure (ICP) monitoring. The primary exposure was PbtO(2) monitor placement. The primary outcome was hospital mortality, defined as death during the hospitalization or discharge to hospice. Secondary outcomes were examined to determine the association of PbtO(2) monitoring with health care use and pulmonary toxicity and included the following: (1) intensive care unit length of stay, (2) hospital length of stay, and (3) development of acute respiratory distress syndrome (ARDS). Regression analysis was used to assess differences in outcomes between patients exposed to PbtO(2) monitor placement and those without exposure by using propensity weighting to address selection bias due to the nonrandom allocation of treatment groups and patient dropout. Results A total of 35,501 patients underwent placement of an ICP monitor. There were 1,346 (3.8%) patients who also underwent PbtO(2) monitor placement, with significant variation regarding calendar year and hospital. Patients who underwent placement of a PbtO(2) monitor had a crude in-hospital mortality of 31.1%, compared with 33.5% in patients who only underwent placement of an ICP monitor (adjusted risk ratio 0.84, 95% confidence interval 0.76-0.93). The development of the ARDS was comparable between patients who underwent placement of a PbtO(2) monitor and patients who only underwent placement of an ICP monitor (9.2% vs. 9.8%, adjusted risk ratio 0.89, 95% confidence interval 0.73-1.09). Conclusions PbtO(2) monitor utilization varied widely throughout the study period by calendar year and hospital. PbtO(2) monitoring in addition to ICP monitoring, compared with ICP monitoring alone, was associated with a decreased in-hospital mortality, a longer length of stay, and a similar risk of ARDS. These findings provide further guidance for clinicians caring for patients with severe TBI while awaiting completion of further randomized controlled trials.	[Komisarow, Jordan M.; Sampson, John] Duke Univ, Dept Neurosurg, Box 3807 Med Ctr, Durham, NC 27710 USA; [Komisarow, Jordan M.; Toro, Camilo; Laskowitz, Daniel T.; James, Michael L.; Ohnuma, Tetsu; Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, Crit Care & Perioperat Populat Hlth Res Unit, Durham, NC 27708 USA; [Toro, Camilo] Duke Univ, Sch Med, Durham, NC USA; [Curley, Jonathan; Laskowitz, Daniel T.; James, Michael L.; Mathew, Joseph P.; Ohnuma, Tetsu; Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Mills, Brianna; Cho, Christopher; Simo, Georges Motchoffo; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Dept Neurol, Durham, NC USA; [Hernandez, Adrian] Duke Univ, Dept Med, Durham, NC USA; [Krishnamoorthy, Vijay] Duke Univ, Dept Populat Hlth Sci, Durham, NC USA		Komisarow, JM (corresponding author), Duke Univ, Dept Neurosurg, Box 3807 Med Ctr, Durham, NC 27710 USA.; Komisarow, JM (corresponding author), Duke Univ, Dept Anesthesiol, Crit Care & Perioperat Populat Hlth Res Unit, Durham, NC 27708 USA.	jordan.komisarow@duke.edu		Komisarow, Jordan/0000-0003-3919-7931; Ohnuma, Tetsu/0000-0002-2303-6802	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS109274]	National Institute of Neurological Disorders and Stroke, K23 NS109274, Vijay Krishnamoorthy.	Bardt TF, 1998, ACT NEUR S, V71, P153; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Desai RJ, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5657; Edwards P, 2005, LANCET, V365, P1957; Eworuke E, 2018, J CRIT CARE, V47, P192, DOI 10.1016/j.jcrc.2018.07.002; Garvin R, 2017, NEUROCRIT CARE, V27, pS159, DOI 10.1007/s12028-017-0461-0; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Hirschi R, 2019, J NEUROSURG, V131, P1216, DOI 10.3171/2018.4.JNS172604; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Komisarow JM, 2022, J INTENSIVE CARE MED, V37, P68, DOI 10.1177/0885066620972001; Krishnamoorthy V, 2021, CHEST; Leach MR, 2021, CURR OPIN CRIT CARE, V27, P95, DOI 10.1097/MCC.0000000000000810; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Patchana T, 2020, CUREUS, V12, DOI 10.7759/cureus.7115; Payen JF, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040550; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Truong EI, 2021, J TRAUMA ACUTE CARE; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	26	1	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01394-y		NOV 2021	7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XE7PD	WOS:000723574400001	34845596				2022-02-06	
J	Luo, D; Li, X; Hou, YH; Hou, Y; Luan, JY; Weng, JX; Zhan, JH; Lin, DK				Luo, Dan; Li, Xing; Hou, Yonghui; Hou, Yu; Luan, Jiyao; Weng, Jiaxian; Zhan, Jiheng; Lin, Dingkun			Sodium tanshinone IIA sulfonate promotes spinal cord injury repair by inhibiting blood spinal cord barrier disruption in vitro and in vivo	DRUG DEVELOPMENT RESEARCH			English	Article; Early Access						blood spinal cord barrier; sodium tanshinone IIA sulfonate; spinal cord injury	MICROVASCULAR ENDOTHELIAL-CELLS; ISCHEMIA-REPERFUSION INJURY; INDUCED EXPRESSION; BRAIN-BARRIER; INFLAMMATION; ACTIVATION; RECEPTOR; DELIVERY; PATHWAY; SYSTEM	Spinal cord injury (SCI) leads to microvascular damage and the destruction of the blood spinal cord barrier (BSCB), which can progress into secondary injuries, such as apoptosis and necrosis of neurons and glia, culminating in permanent neurological deficits. BSCB restoration is the primary goal of SCI therapy, although very few drugs can repair damaged barrier structure and permeability. Sodium tanshinone IIA sulfonate (STS) is commonly used to treat cardiovascular disease. However, the therapeutic effects of STS on damaged BSCB during the early stage of SCI remain uncertain. Therefore, we exposed spinal cord microvascular endothelial cells to H2O2 and treated them with different doses of STS. In addition to protecting the cells from H2O2-induced apoptosis, STS also reduced cellular permeability. In the in vivo model of SCI, STS reduced BSCB permeability, relieved tissue edema and hemorrhage, suppressed MMP activation and prevented the loss of tight junction and adherens junction proteins. Our findings indicate that STS treatment promotes SCI recovery, and should be investigated further as a drug candidate against traumatic SCI.	[Luo, Dan; Li, Xing; Hou, Yonghui; Hou, Yu; Zhan, Jiheng; Lin, Dingkun] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Res Lab Spine Degenerat Dis, Guangzhou, Peoples R China; [Luo, Dan; Li, Xing; Hou, Yonghui; Hou, Yu; Luan, Jiyao; Weng, Jiaxian; Zhan, Jiheng; Lin, Dingkun] Guangzhou Univ Chinese Med, Lingnan Med Res Ctr, Lab Osteol & Traumatol Tradit Chinese Med, Guangzhou, Peoples R China; [Luan, Jiyao] Guangzhou Univ Chinese Med, Coll Clin Med 2, Guangzhou, Peoples R China		Zhan, JH; Lin, DK (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Orthoped Surg, 111 Dade Rd, Guangzhou 510120, Guangdong, Peoples R China.	jamywy@163.com; lindingkuntcm@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673992]; Research Project of Traditional Chinese Medicine Bureau of Guangdong Province [20211174]	National Natural Science Foundation of China, Grant/Award Number: 81673992; The Research Project of Traditional Chinese Medicine Bureau of Guangdong Province, Grant/Award Number: 20211174	Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Badner A, 2016, STEM CELL TRANSL MED, V5, P991, DOI 10.5966/sctm.2015-0295; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Chen WK, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01884-4; Cheng J, 2018, CAN J PHYSIOL PHARM, V96, P26, DOI 10.1139/cjpp-2017-0023; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Gao M, 2016, ACS CHEM NEUROSCI, V7, P1482, DOI 10.1021/acschemneuro.6b00217; Gao W, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0272-7; Ge SJ, 2006, J NEUROIMMUNOL, V177, P209, DOI 10.1016/j.jneuroim.2006.05.012; Gordh T, 2006, PAIN, V124, P211, DOI 10.1016/j.pain.2006.05.020; Han JY, 2017, PHARMACOL THERAPEUT, V177, P146, DOI 10.1016/j.pharmthera.2017.03.005; Ishikawa A, 2009, ANESTHESIOLOGY, V111, P818, DOI 10.1097/ALN.0b013e3181b764f6; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Ji BY, 2017, TRANSL STROKE RES, V8, P334, DOI 10.1007/s12975-017-0526-6; Jiao XX, 2019, ACTA PHARM SIN B, V9, P381, DOI 10.1016/j.apsb.2018.12.001; Kanda H, 2013, GLIA, V61, P943, DOI 10.1002/glia.22487; Lee JY, 2016, NEUROBIOL DIS, V95, P66, DOI 10.1016/j.nbd.2016.07.015; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Lee JY, 2017, J ETHNOPHARMACOL, V203, P90, DOI 10.1016/j.jep.2017.03.047; Li FQ, 2015, INT J CLIN EXP MED, V8, P5279; Liu JQ, 2009, AM J PHYSIOL-HEART C, V297, pH1217, DOI 10.1152/ajpheart.00477.2009; Liu XC, 2014, EXP CELL RES, V328, P118, DOI 10.1016/j.yexcr.2014.08.019; Lopez-Serrano C, 2019, BRAIN BEHAV IMMUN, V76, P258, DOI 10.1016/j.bbi.2018.12.007; Pan PY, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1699-6; Pei JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0870-1; Reinhold AK, 2017, PFLUG ARCH EUR J PHY, V469, P123, DOI 10.1007/s00424-016-1920-8; Remacle AG, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1123-7; Ren J, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00753; Rocha LA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00164; Rong YL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1571-8; Sakurai M, 2003, J THORAC CARDIOV SUR, V125, P370, DOI 10.1067/mtc.2003.112; Saunders LL, 2015, ARCH PHYS MED REHAB, V96, P673, DOI 10.1016/j.apmr.2014.11.019; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Wang CC, 2020, REGION ANESTH PAIN M, V45, P783, DOI 10.1136/rapm-2019-101262; Wang HL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00858; Wang L, 2020, NEUROSCIENCE, V441, P46, DOI 10.1016/j.neuroscience.2020.05.054; Watanabe S, 2015, STEM CELLS, V33, P1902, DOI 10.1002/stem.2006; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Wu Q, 2018, J MED CHEM, V61, P10488, DOI 10.1021/acs.jmedchem.8b01018; Xu QQ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9852536; Yang JX, 2016, CELL PHYSIOL BIOCHEM, V40, P195, DOI 10.1159/000452537; Yao YT, 2018, THERANOSTICS, V8, P4181, DOI 10.7150/thno.25707; Yu QJ, 2016, LIFE SCI, V154, P34, DOI 10.1016/j.lfs.2016.03.046; Zhai XF, 2017, ASIAN J PHARM SCI, V12, P85, DOI 10.1016/j.ajps.2016.08.004; Zhang ZY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3583921; Zheng BB, 2016, J CELL MOL MED, V20, P1062, DOI 10.1111/jcmm.12761; Zheng G, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00761; Zhu J, 2017, EUR J PHARMACOL, V815, P427, DOI 10.1016/j.ejphar.2017.09.047	49	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0272-4391	1098-2299		DRUG DEVELOP RES	Drug Dev. Res.												10.1002/ddr.21898		NOV 2021	11	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	XE2CZ	WOS:000723203100001	34842291				2022-02-06	
J	Thomas, BP; Tarumi, T; Wang, CW; Zhu, DC; Tomoto, T; Cullum, CM; Dieppa, M; Diaz-Arrastia, R; Bell, K; Madden, C; Zhang, R; Ding, K				Thomas, Binu P.; Tarumi, Takashi; Wang, Ciwen; Zhu, David C.; Tomoto, Tsubasa; Cullum, C. Munro; Dieppa, Marisara; Diaz-Arrastia, Ramon; Bell, Kathleen; Madden, Christopher; Zhang, Rong; Ding, Kan			Hippocampal and rostral anterior cingulate blood flow is associated with affective symptoms in chronic traumatic brain injury	BRAIN RESEARCH			English	Article						Chronic traumatic brain injury; Cerebral blood flow; Hippocampus; Rostral anterior cingulate; Affective symptoms; Anxiety; Depression; Fatigue; Sleep disturbance; Sleep impairment	HEAD-INJURY; PERFUSION; MRI; RECOVERY; DAMAGE; CONSEQUENCES; CONCUSSION; DISEASE; TISSUE; RATS	Objective: The purpose of this study was to assess cerebral blood flow (CBF) and its association with self-reported symptoms in chronic traumatic brain injury (TBI). Participants: Sixteen participants with mild to severe TBI and persistent self-reported neurological symptoms, 6 to 72 months post-injury were included. For comparison, 16 age- and gender-matched healthy normal control participants were also included. Main Measures: Regional CBF and brain volume were assessed using pseudo-continuous Arterial Spin Labeling (PCASL) and T1-weighted data respectively. Cognitive function and self-reported symptoms were assessed in TBI participants using the national institutes of health (NIH) Toolbox Cognition Battery and Patient-Reported Outcome Measurement Information System respectively. Associations between CBF and cognitive function, symptoms were assessed. Results: Global CBF and regional brain volumes were similar between groups, but region of interest (ROI) analysis revealed lower CBF bilaterally in the thalamus, hippocampus, left caudate, and left amygdala in the TBI group. Voxel-wise analysis revealed that CBF in the hippocampus, parahippocampus, rostral anterior cingulate, inferior frontal gyrus, and other temporal regions were negatively associated with self-reported anger, anxiety, and depression symptoms. Furthermore, region of interest (ROI) analysis revealed that hippocampal and rostral anterior cingulate CBF were negatively associated with symptoms of fatigue, anxiety, depression, and sleep issues. Conclusion: Regional CBF deficit was observed in the group with chronic TBI compared to the normal control (NC) group despite similar volume of cerebral structures. The observed negative correlation between regional CBF and affective symptoms suggests that CBF-targeted intervention may potentially improve affective symptoms and quality of life after TBI, which needs to be assessed in future studies.	[Thomas, Binu P.] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Thomas, Binu P.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Thomas, Binu P.] Univ Texas Arlington, Dept Bioengn, 500 UTA Blvd, Arlington, TX 76010 USA; [Tarumi, Takashi; Wang, Ciwen; Tomoto, Tsubasa; Cullum, C. Munro; Dieppa, Marisara; Zhang, Rong; Ding, Kan] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Tarumi, Takashi; Tomoto, Tsubasa; Zhang, Rong] Texas Hlth Presbyterian Hosp Dallas, Inst Exercise & Environm Med, 8200 Walnut Hill Ln, Dallas, TX 75231 USA; [Zhu, David C.] Michigan State Univ, Dept Radiol, 86 Serv Rd, E Lansing, MI 48824 USA; [Zhu, David C.] Michigan State Univ, Cognit Imaging Res Ctr, 86 Serv Rd, E Lansing, MI 48824 USA; [Cullum, C. Munro; Madden, Christopher] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Univ Penn, Perelman Sch Med, Dept Neurol, 51 North 39th St, Philadelphia, PA 19104 USA; [Bell, Kathleen] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA		Thomas, BP (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	binu.thomas@utsouthwestern.edu; takashi.tarumi@aist.go.jp			Darrell K. Royal Research Fund; Texas Institute for Brain Injury and Repair (TIBIR) at UT Southwestern Medical Center; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HL102457]	The authors thank our study participants, Justin Repshas and Marcel Turner for technical support, and Evie Kwei for editing assistance. We also thank the grant support from the Darrell K. Royal Research Fund, the Texas Institute for Brain Injury and Repair (TIBIR) at UT Southwestern Medical Center, and National Institutes of Health: R01HL102457.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; Andre Jalal B, 2015, Top Magn Reson Imaging, V24, P275, DOI 10.1097/RMR.0000000000000065; Balalla S, 2020, NEUROTRAUMA REP, V1, P63, DOI 10.1089/neur.2020.0017; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS94, DOI 10.1016/j.apmr.2018.05.021; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS102, DOI 10.1016/j.apmr.2018.05.020; Chao LL, 2010, ALZ DIS ASSOC DIS, V24, P19, DOI 10.1097/WAD.0b013e3181b4f736; Clark AL, 2017, NEUROIMAGE-CLIN, V14, P308, DOI 10.1016/j.nicl.2016.12.017; De Vis JB, 2018, J MAGN RESON IMAGING, V48, P449, DOI 10.1002/jmri.25938; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Friston K.J., 1994, FUNCTIONAL NEUROIMAG, P79; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gerberding J, 2003, CTR DIS CONTR PREV, V1, P45; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Haber M, 2018, J NEUROTRAUM, V35, P2250, DOI 10.1089/neu.2018.5684; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Lu HZ, 2005, MAGN RESON MED, V54, P1403, DOI 10.1002/mrm.20705; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Steinman J, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116101; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Tamminga CA, 2012, SCHIZOPHR RES, V138, P157, DOI 10.1016/j.schres.2012.03.019; Thomas BP, 2020, J ALZHEIMERS DIS, V75, P617, DOI 10.3233/JAD-190977; Thomas BP, 2013, J MAGN RESON IMAGING, V38, P1177, DOI 10.1002/jmri.24090; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Z, 2013, NEUROIMAGE-CLIN, V2, P630, DOI 10.1016/j.nicl.2013.04.014; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Xing CY, 2017, HYPERTENSION, V69, P712, DOI 10.1161/HYPERTENSIONAHA.116.08986; Zhu DC, 2005, MAGNET RESON MED, V54, P725, DOI 10.1002/mrm.20602	50	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 15	2021	1771								147631	10.1016/j.brainres.2021.147631			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WD8ON	WOS:000705194200001	34464600				2022-02-06	
J	Zhu, YJ; Sun, LY; Fu, X; Liu, JY; Liang, ZJ; Tan, H; Li, WP; Zhao, YJ				Zhu, Yujuan; Sun, Lingyu; Fu, Xiao; Liu, Junying; Liang, Zhenjiang; Tan, Hui; Li, Weiping; Zhao, Yuanjin			Engineering microcapsules to construct vascularized human brain organoids	CHEMICAL ENGINEERING JOURNAL			English	Article						Microfluidics; Microcapsule; Brain organoid; Vascularization; Neural repair	HYDROGEL CAPSULES; MICROFLUIDICS; GENERATION; DISEASE; ENCAPSULATION	Brain organoid is a promising technique with potential applications in developmental study, drug discovery and regenerative medicine, however, its practical values are restricted by poor flexibility, and lack of nearphysiological structures or functions. Here, we present a multidisciplinary strategy to engineer novel vascularized human induced pluripotent stem cells (hiPSCs)-derived brain organoids system with biomimetic features using microfluidic hydrogel microcapsules. Due to the precise fluids control of microfluidic electrospray technology, its generated microcapsules enable the efficient encapsulation of hiPSCs-derived neural cells and formation of uniform human brain organoids. Through embedding microcapsules in hydrogel, vascularized brain organoids with structured organization and reasonable tissue size are established. We have found hiPSC-derived brain organoids with in vivo-like neural identity, brain region and layered cortex, as well as complex vascular networks, proving the capability to generate more relevant model of vascularized human brain. Thus, this biomimetic neural system could be injected for traumatic brain injury, and in vivo animal study has shown graftto-host functional neural connectivity and neural regeneration, suggesting the organ-level functions for tissue repair. Our studies indicated that this simple, scalable and flexible system could be applied to develop biomimetic human tissues, which potentially advanced the organoid models for biomedical applications.	[Zhu, Yujuan; Tan, Hui; Li, Weiping] Shenzhen Univ, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Dept Neurosurg,Hlth Sci Ctr, Shenzhen 518035, Peoples R China; [Zhu, Yujuan; Sun, Lingyu; Fu, Xiao; Zhao, Yuanjin] Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Clin Lab, Nanjing 210008, Peoples R China; [Zhu, Yujuan; Sun, Lingyu; Zhao, Yuanjin] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China; [Liu, Junying] Shenzhen Univ, Affiliated Hosp 1, Dept Endocrinol, Shenzhen 518035, Peoples R China; [Liang, Zhenjiang] Shenzhen Childrens Hosp, ENT Dept, Shenzhen 518026, Peoples R China		Tan, H; Li, WP (corresponding author), Shenzhen Univ, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Dept Neurosurg,Hlth Sci Ctr, Shenzhen 518035, Peoples R China.; Zhao, YJ (corresponding author), Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Clin Lab, Nanjing 210008, Peoples R China.; Zhao, YJ (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.	huitan@email.szu.edu.cn; wpli@szu.edu.cn; yjzhao@seu.edu.cn			National Key Research and Development Program of China [2020YFA0908200]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [52073060, 61927805, 51773119]; Natural Science Foundation of JiangsuNatural Science Foundation of Jiangsu Province [BE2018707]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2021A1515010720]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2020M682905]; Shenzhen ScienceandTechnology Innovation Commission [JCYJ20170817171930009, JCYJ20180507183036060, JCYJ20190806161409092, ZDSYS2014050 9173142601, ZDSYS20200811142600003]; Guangdong Innovation Platform of Translational Research for Cerebrovascular Diseases	This work was supported by the National Key Research and Development Program of China (2020YFA0908200), the National Natural Science Foundation of China (52073060, 61927805 and 51773119), the Natural Science Foundation of Jiangsu (BE2018707), Natural Science Foundation of Guangdong Province (2021A1515010720), China Postdoctoral Science Foundation (2020M682905), Shenzhen ScienceandTechnology Innovation Commission (JCYJ20170817171930009, JCYJ20180507183036060, JCYJ20190806161409092, ZDSYS2014050 9173142601, ZDSYS20200811142600003), and Guangdong Innovation Platform of Translational Research for Cerebrovascular Diseases.	Barros AS, 2021, ADV DRUG DELIVER REV, V170, P386, DOI 10.1016/j.addr.2020.09.008; Brassard JA, 2021, NAT MATER, V20, P22, DOI 10.1038/s41563-020-00803-5; Chen GP, 2019, RESEARCH-CHINA, V2019, DOI 10.34133/2019/6175398; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Gundabala VR, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.154503; Huang XB, 2012, J BIOSCI BIOENG, V114, P1, DOI 10.1016/j.jbiosc.2012.02.024; Kim J, 2020, NAT REV MOL CELL BIO, V21, P571, DOI 10.1038/s41580-020-0259-3; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Li XY, 2018, ADV DRUG DELIVER REV, V128, P101, DOI 10.1016/j.addr.2017.12.015; Liu HT, 2020, ADV SCI, V7, DOI 10.1002/advs.201903739; Liu HT, 2019, ADV MATER, V31, DOI 10.1002/adma.201902042; Liu ZH, 2020, SMALL, V16, DOI 10.1002/smll.201904673; Luo J, 2020, SMALL, V16, DOI 10.1002/smll.201904076; Ma QM, 2020, ADV SCI, V7, DOI 10.1002/advs.201903359; Mayfield AE, 2014, BIOMATERIALS, V35, P133, DOI 10.1016/j.biomaterials.2013.09.085; Omami M, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0877-0; Park SE, 2019, SCIENCE, V364, P960, DOI 10.1126/science.aaw7894; Parra-Cantu Carolina, 2020, J 3D Print Med, V4, P113, DOI 10.2217/3dp-2019-0027; Poli D, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00162; Qian XY, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.166074; Qian XY, 2018, NAT PROTOC, V13, P565, DOI 10.1038/nprot.2017.152; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rothbauer M, 2018, LAB CHIP, V18, P249, DOI 10.1039/c7lc00815e; Salaris F, 2019, BRAIN RES, V1723, DOI 10.1016/j.brainres.2019.146393; Skardal A, 2016, DRUG DISCOV TODAY, V21, P1399, DOI 10.1016/j.drudis.2016.07.003; Velasco S, 2020, ANNU REV NEUROSCI, V43, P375, DOI 10.1146/annurev-neuro-070918-050154; Wang YQ, 2020, BIOMATER SCI-UK, V8, P5476, DOI 10.1039/d0bm01085e; Xu TL, 2017, ADV MATER, V29, DOI 10.1002/adma.201603250; Yu YR, 2019, RESEARCH-CHINA, V2019, DOI 10.34133/2019/6906275; Yuan H, 2020, SMALL, V16, DOI 10.1002/smll.201904469; Zhang H, 2020, ADV SCI, V7, DOI 10.1002/advs.202000789; Zhang H, 2019, SCI CHINA CHEM, V62, P87, DOI 10.1007/s11426-018-9340-y; Zhang HB, 2014, ADV MATER, V26, P4497, DOI 10.1002/adma.201400953; Zhang YH, 2016, QUAL QUANT ANAL SCI, P1, DOI [10.1007/s10439-016-1612-8, 10.1007/978-3-319-24160-9]; Zhao C, 2019, SCI BULL, V64, P1418, DOI 10.1016/j.scib.2019.07.020; Zhao X, 2016, ADV FUNCT MATER, V26, P2809, DOI 10.1002/adfm.201504943; Zhou LN, 2020, ADV MATER, V32, DOI 10.1002/adma.202002183; Zhu YJ, 2017, LAB CHIP, V17, P2941, DOI 10.1039/c7lc00682a	38	1	1	18	18	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1385-8947	1873-3212		CHEM ENG J	Chem. Eng. J.	NOV 15	2021	424								130427	10.1016/j.cej.2021.130427			7	Engineering, Environmental; Engineering, Chemical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WG5LX	WOS:000707037200079					2022-02-06	
J	Homayounpour, M; Gomez, NG; Vasavada, AN; Merryweather, AS				Homayounpour, Mohammad; Gomez, Nicholas G.; Vasavada, Anita N.; Merryweather, Andrew S.			The role of neck muscle co-contraction and postural changes in head kinematics after safe head impacts: Investigation of head/neck injury reduction	JOURNAL OF BIOMECHANICS			English	Article						Concussion; Postural changes; Muscle co-contraction; Head kinematics; Warning	SEGMENT DYNAMIC STABILIZATION; PRE-ACTIVATION; STRENGTH; CONCUSSION; SINGLE; PERTURBATION; MODULATION; STABILITY; STIFFNESS; FOOTBALL	Concerns surrounding concussions from impacts to the head necessitate research to generate new knowledge about ways to prevent them and reduce risk. In this paper, we report the relative temporal characteristics of the head resulting from neck muscle co-contraction and postural changes following a sudden force applied to the head in four different directions. In the two "prepared" conditions (i.e., co-contraction and postural), participants experienced impulsive forces to the head after hearing a warning. The warning given for the postural condition informed both the direction and timing of the impulsive force. Participants responded to the postural warning by altering their head posture, whereas in the co-contraction warning, the force direction was unknown to them, and they were asked to isometrically co-contract their neck muscles after the warning. Peak angular velocity reduced by 29% in sagittal extension, 18% in sagittal flexion, and 23% in coronal lateral flexion in prepared vs. unwarned conditions. Peak linear acceleration was attenuated by 15% in sagittal extension, 8% in sagittal flexion, and 18% in coronal lateral flexion in prepared vs. unwarned conditions. Changes in peak angular acceleration were not uniform. We also measured a significant delay in the peak angular velocity (22 vs. 44.8 ms) and peak angular acceleration (7 vs. 20 ms) after peak linear acceleration in prepared compared to unwarned conditions. An increase in muscle activation significantly reduced the peak angular velocity and linear acceleration. Gross head movement was significantly decreased with preparation. These findings suggest that a warning prior to impact can reduce head kinematics associated with injury.	[Homayounpour, Mohammad; Gomez, Nicholas G.; Merryweather, Andrew S.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA; [Vasavada, Anita N.] Washington State Univ, Gene & Linda Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Washington Ctr Muscle Biol, Pullman, WA 99164 USA		Merryweather, AS (corresponding author), Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA.	a.merryweather@utah.edu		Merryweather, Andrew/0000-0002-9048-9473; Homayunpour, Mohammad/0000-0002-0155-6348; Gomez, Nicholas/0000-0002-7206-7752	National Science FoundationNational Science Foundation (NSF) [1622741]; National Institute of Occupational Safety and Health (NIOSH Education and Research Center Training Grant)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [5T42OH008414-14]	This research was funded in part by grants from the National Science Foundation (#1622741) and the National Institute of Occupational Safety and Health (NIOSH Education and Research Center Training Grant 5T42OH008414-14) . The authors would like to acknowledge Karina Velarde for the help in data collection and Dr. Jonathon Mortensen for his help in study design and the OpenSim model preparation.	Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P779, DOI 10.2519/jospt.2019.8760; Alsalaheen B, 2018, J ELECTROMYOGR KINES, V39, P70, DOI 10.1016/j.jelekin.2018.01.011; Aston JP, 2020, 2020 3RD IEEE INTERNATIONAL CONFERENCE ON SOFT ROBOTICS (ROBOSOFT), P607, DOI 10.1109/RoboSoft48309.2020.9116034; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Bella F, 2017, TRANSPORT RES F-TRAF, V51, P88, DOI 10.1016/j.trf.2017.09.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beusenberg M., 2001, HEAD NECK BODY COUPL, P295; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Caswell SV., 2014, INT J ATHL THER TRAI, V19, P22; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Eckner JT, 2018, AM J PHYS MED REHAB, V97, P292, DOI 10.1097/PHM.0000000000000843; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Fanta O, 2013, NEUROENDOCRINOL LETT, V34, P708; Fanton M, 2019, IEEE T BIO-MED ENG, V66, P988, DOI 10.1109/TBME.2018.2866147; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Happee R, 2017, J BIOMECH, V58, P203, DOI 10.1016/j.jbiomech.2017.05.005; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Homayounpour M., 2019, P HUM FACT ERG SOC A; Homayounpour M, 2021, ANN BIOMED ENG, V49, P2260, DOI 10.1007/s10439-021-02757-4; Keshner EA, 2000, GAIT POSTURE, V11, P1, DOI 10.1016/S0966-6362(99)00046-6; Kuo C, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0086; Kuo C, 2018, J BIOMECH, V76, P220, DOI 10.1016/j.jbiomech.2018.05.024; Kuramochi R, 2004, NEUROSCI LETT, V366, P206, DOI 10.1016/j.neulet.2004.05.040; Le Flao E, 2018, SPORTS MED, V48, P2641, DOI 10.1007/s40279-018-0984-3; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; Lovering RM, 2005, J BIOMECH, V38, P1501, DOI 10.1016/j.jbiomech.2004.07.008; Luttmer NG, 2020, IEEE INT CONF ROBOT, P9135, DOI 10.1109/ICRA40945.2020.9196600; Mansell J, 2005, J ATHL TRAINING, V40, P310; Bernety HM, 2020, AIP ADV, V10, DOI 10.1063/1.5138650; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mortensen J.D., 2019, ASME INT MECH ENG C; Mortensen JD, 2020, J BIOMECH, V100, DOI 10.1016/j.jbiomech.2019.109411; Mortensen JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199912; Reynier KA, 2020, ANN BIOMED ENG, V48, P2751, DOI 10.1007/s10439-020-02609-7; Siegmund GP, 2003, J BIOMECH, V36, P473, DOI 10.1016/S0021-9290(02)00458-X; Siegmund GP, 2003, SPINE, V28, P671, DOI 10.1097/00007632-200304010-00010; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Zhang YT, 2015, DISCRETE DYN NAT SOC, V2015, DOI 10.1155/2015/980281	43	1	1	8	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	NOV 9	2021	128								110732	10.1016/j.jbiomech.2021.110732			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	WC6JJ	WOS:000704362200007	34509052				2022-02-06	
J	Godor, BP; van der Hallen, R				Godor, Brian P.; van der Hallen, Ruth			Investigating the susceptibility to change of coping and resiliency during COVID-19	SCANDINAVIAN JOURNAL OF PSYCHOLOGY			English	Article; Early Access						Coping; resilience; COPE; SPF; COVID-19	TRAUMATIC BRAIN-INJURY; LONGITUDINAL EVIDENCE; YOUNG ADULTHOOD; EGO-RESILIENCY; STABILITY; PERSONALITY; STRATEGIES; CHILDREN; SCALE; ADOLESCENCE	On 11 March 2020 the World Health Organization (WHO) declared the outbreak of the novel coronavirus SARS-CoV-2 (COVID-19) a global pandemic. As a result, most of public life, including cultural, sporting, religious and political events, came to a standstill. The current study investigates potential changes in individual's coping and resiliency during this phase of the pandemic. The present study investigated potential changes in individuals' coping and resilience during the COVID-19 pandemic. Participants (N = 68), aged between 18 and 34 years old, completed an online survey including the Brief-COPE (Coping Orientation to Problems Experienced) and the SPF-24 (Scale of Protective Factors) at two distinct time points: May 2019 (T-0) and May 2020 (T-1). To investigate changes between T-0 and T-1, one-way within-subjects analysis of variances (ANOVAs)'s were conducted. For 11 of 14 the subscales for the Brief-COPE, no significant within-subject sum scores changes were revealed. However, for three subscales, that is, Active Coping (p = 0.005), Venting (p = 0.024) and Acceptance (p = 0.028), significant sum scores changes were revealed. For all four subscales for the SPF-24, no significant within-subjects sum score changes were revealed. For the Brief-COPE, the susceptibility to change for only three of the 14 coping strategies to be significantly influenced by COVID-19, reveals a strong trait-like character of one's coping strategies. For the SPF-24, all four protective factors were not susceptible to significant changes due to individuals' experiences of COVID-19.	[Godor, Brian P.; van der Hallen, Ruth] Erasmus Univ, Dept Psychol Educ & Child Studies, NL-3062 PA Rotterdam, Netherlands		Godor, BP (corresponding author), Erasmus Univ, Dept Psychol Educ & Child Studies, NL-3062 PA Rotterdam, Netherlands.	godor@essb.eur.nl		Godor, Brian P./0000-0003-3070-3404			Ahern NR, 2006, Compr Child Adoles N, V29, P103, DOI 10.1080/01460860600677643; Baumstarck K, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-016-0581-9; Beckwith S, 2008, INT J NURS STUD, V45, P1831, DOI 10.1016/j.ijnurstu.2008.06.011; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Block JH, 1980, DEV COGNITION AFFECT, P39; Busko V, 2004, REV PSYCHOL, V10, P75; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; CASPI A, 1995, CHILD DEV, V66, P486, DOI 10.2307/1131592; Compas BE, 2001, PSYCHOL BULL, V127, P87, DOI 10.1037//0033-2909.127.1.87; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080; Cooper C, 2008, J NERV MENT DIS, V196, P838, DOI 10.1097/NMD.0b013e31818b504c; Fergus S, 2005, ANNU REV PUBL HEALTH, V26, P399, DOI 10.1146/annurev.publhealth.26.021304.144357; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; Folkman S, 2013, ENCY BEHAV MED, P1913, DOI [10.1007/978-1-4419-1005-9_215, DOI 10.1007/978-1-4419-1005-9_215]; Garcia FE, 2018, PSICOL-REFLEX CRIT, V31, DOI 10.1186/s41155-018-0102-3; Gil KM, 1997, CLIN J PAIN, V13, P110, DOI 10.1097/00002508-199706000-00005; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Hooberman J, 2010, AM J ORTHOPSYCHIAT, V80, P557, DOI 10.1111/j.1939-0025.2010.01060.x; Ingram RE, 2001, VULNERABILITY TO PSYCHOPATHOLOGY, P3; Ipsos MORI, 2020, IPSOS MORI; Lee-Baggley D, 2004, ASIAN J SOC PSYCHOL, V7, P9, DOI 10.1111/j.1467-839X.2004.00131.x; Luminet O, 2001, PSYCHOTHER PSYCHOSOM, V70, P254, DOI 10.1159/000056263; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Masten A.S., 2002, OXFORD HDB POSITIVE, P74; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Nakamura YM, 2005, SWISS J PSYCHOL, V64, P281, DOI 10.1024/1421-0185.64.4.281; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Nielsen MB, 2014, SCAND J PSYCHOL, V55, P142, DOI 10.1111/sjop.12103; Ponce-Garcia E, 2015, VIOLENCE VICTIMS, V30, P735, DOI 10.1891/0886-6708.VV-D-14-00163; Powers DV, 2002, J GERONTOL B-PSYCHOL, V57, pP205, DOI 10.1093/geronb/57.3.P205; Prince-Embury S., 2007, RESILIENCE CHILDREN, P19, DOI [10.1007/978-1-4614-4939-3_3, DOI 10.1007/978-1-4614-4939-3_3]; Prince-Embury S, 2008, CAN J SCH PSYCHOL, V23, P41, DOI 10.1177/0829573508316592; Santor DA, 1997, J PERS SOC PSYCHOL, V73, P1354, DOI 10.1037/0022-3514.73.6.1354; Scheenen ME, 2017, SOC SCI MED, V181, P184, DOI 10.1016/j.socscimed.2017.03.025; Shi L, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14053; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Skinner EA, 2003, PSYCHOL BULL, V129, P216, DOI 10.1037/0033-2909.129.2.216; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stewart SM, 1996, PERS INDIV DIFFER, V20, P245, DOI 10.1016/0191-8869(95)00162-X; Stratta P, 2015, PERS INDIV DIFFER, V77, P55, DOI 10.1016/j.paid.2014.12.035; Van der Hallen R, 2020, ANXIETY STRESS COPIN, V33, P479, DOI 10.1080/10615806.2020.1772969; Vecchione M, 2010, J PERS ASSESS, V92, P212, DOI 10.1080/00223891003670166; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Wang CY, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.569981; Wang SS, 2018, EVOL PSYCHOL SCI, V4, P166, DOI 10.1007/s40806-017-0125-5; Weed K, 2006, J APPL DEV PSYCHOL, V27, P60, DOI 10.1016/j.appdev.2005.12.007; WHO, 2020, COR; Wilson CA, 2019, J PSYCHOEDUC ASSESS, V37, P14, DOI 10.1177/0734282917740017; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Wu G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00010; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Zhao N, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.635546	56	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0036-5564	1467-9450		SCAND J PSYCHOL	Scand. J. Psychol.												10.1111/sjop.12787		NOV 2021	8	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	WR5QJ	WOS:000714553500001	34738232	hybrid, Green Published			2022-02-06	
J	Bartlett, HH; Huie, K; Ginalis, E; Jumah, F; Raju, B; Nanda, A				Bartlett, Hugh H.; Huie, Kevin; Ginalis, Elizabeth; Jumah, Fareed; Raju, Bharath; Nanda, Anil			Legacies of Neurosurgery and its Implications on Global Neurosurgery Today	WORLD NEUROSURGERY			English	Article						Ancient neurosurgery; Global health; Global neurosurgery; History; Neurotrauma; Trephination	TRAUMATIC BRAIN-INJURY; SURGICAL CARE; TREPANATION	Trephination, the practice of boring a hole in the skull, is one of the oldest surgical procedures performed by and on humans. Fossil records show evidence of trephined skulls on separate continents throughout ancient history. Even more remarkably, fossils show that ancient humans actually survived the procedure, some more than once. Ancient mythologies and texts provide context to the fossil record, indicating that trephination was performed some of the time for medical indications, including traumatic head injury and intractable neurologic conditions. In the modern day, traumatic brain injury accounts for a significant percentage of the overall global burden of disease and its incidence is disproportionately increasing in low- and middle-income countries. In critical situations, neurosurgical intervention may be indicated. The burr hole procedure, or trephination, was identified as an essential surgical procedure that all first-level hospitals should be able to perform; however, there exists a dramatic lack of access to neurosurgical specialists and care globally, especially among low- and middle-income countries. Task-shifting/sharing is one paradigm that may be used effectively to broaden access to this life-saving procedure but it is at the moment a contested practice.	[Bartlett, Hugh H.; Huie, Kevin] Rutgers State Univ, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Ginalis, Elizabeth; Jumah, Fareed; Raju, Bharath; Nanda, Anil] Robert Wood Johnson Univ Hosp, Dept Neurosurg, New Brunswick, NJ 08901 USA		Nanda, A (corresponding author), Robert Wood Johnson Univ Hosp, Dept Neurosurg, New Brunswick, NJ 08901 USA.	an651@rwjms.rutgers.edu	Raju, Bharath/AAR-8784-2021	Raju, Bharath/0000-0002-4897-2939; Bartlett, Hugh/0000-0002-1673-2199; Ginalis, Elizabeth/0000-0002-6097-9017			Assina R, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13549; Brasiliense LBC, 2010, NEUROSURGERY, V67, P881, DOI 10.1227/NEU.0b013e3181ee022b; Chao TE, 2015, WORLD J SURG, V39, P2140, DOI 10.1007/s00268-014-2905-4; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Faria Miguel A, 2015, Surg Neurol Int, V6, P72, DOI 10.4103/2152-7806.156634; Filler AG, 2017, NEUROSURG FOCUS, V2, P1; Han KX, 2007, BULL INDO PAC PRE HI, V27, P22; Hobert L, 2017, WORLD NEUROSURG, V101, P451, DOI 10.1016/j.wneu.2016.10.051; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kim AI, 2018, THESIS HARVARD MED S; Kruk M., 2015, DIS CONTROL PRIORITI; Luck T, 2015, ANZ J SURG, V85, P610, DOI 10.1111/ans.13138; Luo G, 2018, ROMANCE 3 KINGDOMS; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Mock CN, 2015, LANCET, V385, P2209, DOI 10.1016/S0140-6736(15)60091-5; Mukhopadhyay S, 2019, J NEUROSURG, V130, P1142, DOI 10.3171/2018.10.JNS171723; Robertson FC, 2020, WORLD NEUROSURG, V6; Robertson FC, 2020, WORLD NEUROSURGERY X, V6; Robertson FC, 2020, WORLD NEUROSURG, V10; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sherer A, 2004, SURG NEUROL, V61, P497, DOI 10.1016/j.surneu.2003.11.037; Tubbs RS, 2011, CHILD NERV SYST, V27, P1357, DOI 10.1007/s00381-011-1423-z; Tyson AF, 2014, INT J SURG, V12, P509, DOI 10.1016/j.ijsu.2014.02.009; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2	25	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2021	155						115	121		10.1016/j.wneu.2021.05.127			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UY6CC	WOS:000701608500014	34098138				2022-02-06	
J	Belding, JN; Khokhar, B; Englert, RM; Fitzmaurice, S; Thomsen, CJ				Belding, Jennifer N.; Khokhar, Bilal; Englert, Robyn Martin; Fitzmaurice, Shannon; Thomsen, Cynthia J.			The Persistence of Blast- Versus Impact-Induced Concussion Symptomology Following Deployment	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blast; concussion; deployment; injury; mTBI; postconcussive syndrome	TRAUMATIC BRAIN-INJURY; LOW-LEVEL BLAST; OCCUPATIONAL OVERPRESSURE EXPOSURE; OPERATION IRAQI FREEDOM; POSTCONCUSSION SYNDROME; HEAD	Objective: To examine the persistence of concussion-related symptoms following injury as a function of mechanism of injury (high-level blast [HLB] vs impact) and low-level blast (LLB) exposure among Marines. Setting: Upon return from deployment and approximately 6 months later, respectively, Marines completed the Post-Deployment Health Assessment and Post-Deployment Health Re-Assessment in an operational or clinic setting. Participants: Data from active duty enlisted Marines who completed both assessments (n = 102 075) and who reported a potentially mild traumatic brain injury (mTBI)-inducing event and completed an mTBI screen (n = 8106) were analyzed. Design: This was a retrospective cohort study of Marines deployed between 2008 and 2012. Marines were categorized into groups with relatively high versus low risk for occupational risk of LLB exposure. A mixed model analysis of variance was used to examine the number of symptoms Marines reported experiencing during deployment as a function of probable concussion, HLB exposure, occupational risk, type of symptom, and time of measurement. Main Measures: Self-reported deployment exposures including HLB, probable mTBIs, and occupational risk of LLB exposure were identified. Outcomes included the proportion of neurological, musculoskeletal, and immunological symptoms for which Marines reported seeking care during and following deployment were analyzed. Results: Probable HLB-induced mTBIs (vs impact-induced) were associated with significantly more neurological symptoms at return from deployment and approximately 6 months later. Although symptom reporting decreased at statistically equivalent rates regardless of mechanism of injury, those with a probable HLB-induced concussion continued to report elevated symptomology post-deployment. Additionally, Marines with probable concussion working in occupations with LLB exposure reported elevated levels of persistent neurological symptoms. Both HLB and LLB exposure were associated with neurological symptoms that persisted following deployment. Conclusion: These findings suggest that blast-induced brain injuries may be fundamentally different from impact-induced injuries, and that additional screening and symptomatic treatment for blast-exposed patients may be warranted.	[Belding, Jennifer N.; Englert, Robyn Martin; Fitzmaurice, Shannon] Leidos, San Diego, CA USA; [Belding, Jennifer N.; Englert, Robyn Martin; Fitzmaurice, Shannon; Thomsen, Cynthia J.] Naval Hlth Res Ctr, Hlth & Behav Sci Dept, San Diego, CA USA; [Khokhar, Bilal] Traumat Brain Injury Ctr Excellence, Silver Spring, MD USA; [Khokhar, Bilal] Gen Dynam Informat Technol, Silver Spring, MD USA		Belding, JN (corresponding author), 140 Sylvester Rd, San Diego, CA 92106 USA.	jennifer.n.belding.ctr@mail.mil			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [N1629]	I am a military service member or employee of the US Government. This work was prepared as part of my official duties. Title 17, U.S.C. 105 provides that copyright protection under this title is not available for any work of the US Government. Title 17, U.S.C. 101 defines a US Government work as work prepared by a military service member or employee of the US Government as part of that person's official duties. Report No. 20-82 was supported by the US Army Medical Research and Materiel Command under work unit no. N1629. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the US Government. The study protocol was approved by the Naval Health Research Center Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects. Research data were derived from an approved Naval Health Research Center Institutional Review Board protocol, number NHRC.2016.0024.; This work was supported by the US Army Medical Research and Materiel Command under work unit no. N1629.	Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Belding JN, 2020, MIL MED, V185, pE538, DOI 10.1093/milmed/usz289; Belding JN., 2020, SELF REPORTED CONCUS; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cernak I, 2017, BRAIN INJURY, V31, P1168, DOI 10.1080/02699052.2016.1274779; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Defense and Veterans Brain Injury Center, 2020, DOD NUMBERS TRAUMATI; Department of Defense, DEP DEF INSTR 6490 1; Farmer CF., 2016, UNDERSTANDING TREATM; Fear NT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-797; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Hauret KG, 2010, AM J PREV MED, V38, pS61, DOI 10.1016/j.amepre.2009.10.021; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kirsch NL, 2010, ARCH PHYS MED REHAB, V91, P35, DOI 10.1016/j.apmr.2009.09.019; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lew HL, 2007, J REHABIL RES DEV, V44, P963, DOI 10.1682/JRRD.2006.12.0169; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Silverberg ND, 2016, J HEAD TRAUMA REHAB, V31, P388, DOI 10.1097/HTR.0000000000000198; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; The Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VADOD CLIN PRACT GUI; Thiel KJ., 2015, EFFECTS LOW LEVEL RE; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9	40	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		E397	E405		10.1097/HTR.0000000000000715			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100006	34320556				2022-02-06	
J	Benavides, AM; Finn, JA; Tang, XY; Ropacki, S; Brown, RM; Smith, AN; Stevens, LF; Rabinowitz, AR; Juengst, SB; Johnson-Greene, D; Hart, T				Benavides, Angela M.; Finn, Jacob A.; Tang, Xinyu; Ropacki, Susan; Brown, Racine M.; Smith, Austin N.; Stevens, Lillian Flores; Rabinowitz, Amanda R.; Juengst, Shannon B.; Johnson-Greene, Doug; Hart, Tessa			Psychosocial and Functional Predictors of Depression and Anxiety Symptoms in Veterans and Service Members With TBI: A VA TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; depression; rehabilitation; traumatic brain injury; VA TBI Model Systems; veterans	TRAUMATIC BRAIN-INJURY; DISABILITY RATING-SCALE; MINOR DEPRESSION; RISK-FACTORS; AFGHANISTAN VETERANS; PREVALENCE; DISORDER; IRAQ; DIAGNOSES; DISTRESS	Objective: To identify psychosocial and functional predictors of self-reported depression and anxiety symptoms at year 2 following traumatic brain injury (TBI). Setting: Five Department of Veterans Affairs (VA) Polytrauma Rehabilitation Centers (PRCs) within the TBI Model Systems (TBIMS). Participants: A total of 319 service members/veterans enrolled in VA TBIMS who were eligible for and completed both 1- and 2-year follow-up evaluations. Design: Secondary analysis from multicenter prospective longitudinal study. Main Measures: Demographic, injury-related, military, mental health, and substance use variables. Questionnaires included the Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), and Neurobehavioral Symptom Inventory. Rating scales included the Participation Assessment with Recombined Tools-Objective and Disability Rating Scale. Results: The final sample was largely male (96%) and predominantly White (65%), with a median age of 27 years. In unadjusted analyses, pre-TBI mental health treatment history and year 1 employment status, community activity, sleep difficulties, and self-reported depression and anxiety symptoms were associated with year 2 PHQ-9 scores; pre-TBI mental health treatment history and year 1 community activity, social contact, problematic substance use, sleep difficulties, and self-reported depression and anxiety symptoms were associated with year 2 GAD-7 scores. In multivariable analyses, only year 1 community activity and depression symptoms uniquely predicted year 2 PHQ-9 scores, and only year 1 employment status, community activity, problematic substance use, and anxiety symptoms uniquely predicted year 2 GAD-7 scores. Conclusion: Anxiety and depression commonly occur after TBI and are important treatment targets. Some predictors (eg, participation and substance use) are modifiable and amenable to treatment as well. Early identification of anxiety and depression symptoms is key.	[Benavides, Angela M.; Finn, Jacob A.] Minneapolis Vet Affairs Hlth Care Syst, Extended Care & Rehabil, Minneapolis, MN USA; [Finn, Jacob A.] Univ Minnesota Twin Cities, Dept Psychiat, Minneapolis, MN USA; [Tang, Xinyu] Univ Arkansas Med Sci, Dept Pediat, Biostat Program, Little Rock, AR USA; [Ropacki, Susan] Vet Affairs Palo Alto Hlth Care Syst, Polytrauma Syst Care, Palo Alto, CA USA; [Brown, Racine M.] James Haley Vet Affairs Med Ctr, Ctr Innovat Disabil & Rehabil Res, Tampa, FL USA; [Brown, Racine M.] Univ S Florida, Dept Anthropol, Tampa, FL USA; [Smith, Austin N.; Stevens, Lillian Flores] Hunter Holmes McGuire Vet Affairs Med Ctr, Def & Vet Brain Injury Ctr, Richmond, VA USA; [Stevens, Lillian Flores] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Stevens, Lillian Flores] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Rabinowitz, Amanda R.; Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Rabinowitz, Amanda R.] Thomas Jefferson Univ, Dept Rehabil, Sidney Kimmel Med Coll, Philadelphia, PA USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX USA; [Johnson-Greene, Doug] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL USA		Finn, JA (corresponding author), Minneapolis VA Hlth Care Syst, One Vet Dr,4K-TBI, Minneapolis, MN 55417 USA.	Jacob.Finn@va.gov			Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research); VHA Central Office VATBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]; National Institute on Disability, Independent Living, and Rehabilitation Research (NI-DILRR)United States Department of Health & Human Services [90DPTB0004, 90DP0046, 90DPTB0013]	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System is a funded collaboration between the Department of Veterans Affairs and the Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is sponsored byVHACentral OfficeVATBI Model System Program of Research and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center within the Defense Health Agency. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Veterans Affairs or Department of Defense position or any other federal agency, policy, or decision unless so designated by other official documentation.; The content of this article was developed under grant support from the National Institute on Disability, Independent Living, and Rehabilitation Research (NI-DILRR) (90DPTB0004: Hart, Rabinowitz; 90DP0046: Johnson-Greene; 90DPTB0013: Juengst). The NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of theNIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Al-Asmi A, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0370-9; Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU DIAGNOSTIC STAT MANU; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Defense and Veterans Brain Injury Center, DOD WORLD WID NUMB T; Dew MA, 2016, TRANSPLANTATION, V100, P988, DOI 10.1097/TP.0000000000000901; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Farrell-Carnahan L, 2015, BRAIN INJURY, V29, P1400, DOI 10.3109/02699052.2015.1063161; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Giardino ND, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-29; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Harkness KL, 2002, EUR J PERSONALITY, V16, P271, DOI 10.1002/per.441; Hart T, 2020, NEUROPSYCHOL REHABIL, V30, P1523, DOI 10.1080/09602011.2019.1592761; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; McDonough E, 2014, J RHEUMATOL, V41, P887, DOI 10.3899/jrheum.130797; McGrady A, 2009, J CARDIOPULM REHABIL, V29, P358, DOI 10.1097/HCR.0b013e3181be7a8f; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Perrin PB, 2017, AM J PHYS MED REHAB, V96, P374, DOI 10.1097/PHM.0000000000000644; Poole H, 2009, PAIN PRACT, V9, P173, DOI 10.1111/j.1533-2500.2009.00274.x; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rubin D.B., 1987, MULTIPLE IMPUTATION; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Sigurdardottir S, 2014, BRAIN INJURY, V28, P1542, DOI 10.3109/02699052.2014.934285; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Taylor-Clift A, 2016, ANXIETY STRESS COPIN, V29, P139, DOI 10.1080/10615806.2015.1006206; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Williams MW, 2017, REHABIL PSYCHOL, V62, P407, DOI 10.1037/rep0000168	46	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		397	407		10.1097/HTR.0000000000000647			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100005	33656470				2022-02-06	
J	Borgen, IMH; Roe, C; Brunborg, C; Tenovuo, O; Azouvi, P; Dawes, H; Majdan, M; Ranta, J; Rusnak, M; Wiegers, EJA; Tverdal, C; Jacob, L; Cogne, M; von Steinbuechel, N; Andelic, N				Borgen, Ida M. H.; Roe, Cecilie; Brunborg, Cathrine; Tenovuo, Olli; Azouvi, Philippe; Dawes, Helen; Majdan, Marek; Ranta, Jukka; Rusnak, Martin; Wiegers, Eveline J. A.; Tverdal, Cathrine; Jacob, Louis; Cogne, Melanie; von Steinbuechel, Nicole; Andelic, Nada		CENTER-TBI Participants Investigat	Care transitions in the first 6 months following traumatic brain injury: Lessons from the CENTER-TBI study	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article							REHABILITATION; PATHWAYS; EPIDEMIOLOGY; MULTICENTER; GUIDELINES	Background: No large international studies have investigated care transitions during or after acute hospitalisations for traumatic brain injury (TBI). Objectives: To characterise various TBI-care pathways and the number of associated transitions during the first 6 months after TBI and to assess the impact of these on functional TBI outcome controlled for demographic and injury-related factors. Methods: This was a cohort study of patients with TBI admitted to various trauma centres enrolled in the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study. Number of transitions and specific care pathways were identified. Multiple logistic regression analyses were used to assess the impact of number of transitions and care pathways on functional outcome at 6 months post injury as assessed by the Glasgow Outcome Scale-Extended (GOSE). Results: In total, 3133 patients survived the acute TBI-care pathway and had at least one documented in hospital transition at 6-month follow-up. The median number of transitions was 3 (interquartile range 2-3). The number of transitions did not predict functional outcome at 6 months (odds ratio 1.08, 95% confidence interval 1.09-1.18; P = 0.063). A total of 378 different care pathways were identified; 8 were identical for at least 100 patients and characterized as "common pathways". Five of these common care pathways predicted better functional outcomes at 6 months, and the remaining 3 pathways were unrelated to outcome. In both models, increased age, violence as the cause of injury, pre-injury presence of systemic disease, both intracranial and overall injury severity, and regions of Southern/Eastern Europe were associated with unfavourable functional outcomes at 6 months. Conclusions: A high number of different and complex care pathways was found for patients with TBI, particularly those with severe injuries. This high number and variety of care pathway possibilities indicates a need for standardisation and development of "common data elements for TBI care pathways" for future studies. (C) 2020 The Authors. Published by Elsevier Masson SAS.	[Borgen, Ida M. H.; Roe, Cecilie; Tverdal, Cathrine; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Borgen, Ida M. H.] Univ Oslo, Fac Social Sci, Dept Psychol, Oslo, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Brunborg, Cathrine] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Brunborg, Cathrine] Univ Turku, Turku Brain Injury Ctr, Turku, Finland; [Tenovuo, Olli] Turku Univ Hosp, Turku, Finland; [Azouvi, Philippe] Hop Raymond Poincare, AP HP, GH Paris Saclay, Garches, France; [Azouvi, Philippe] Univ Paris Saclay, Team DevPsy, CESP, UVSQ,Inserm, F-94807 Villejuif, France; [Dawes, Helen] Oxford Brookes Univ, Hlth & Life Sci, Oxford, England; [Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Inst Global Hlth & Epidemiol, Dept Publ Hlth, Trnava, Slovakia; [Ranta, Jukka] VTT Tech Res Ctr Finland Ltd, Otaniemi, Finland; [Rusnak, Martin] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Wiegers, Eveline J. A.; Jacob, Louis] Univ Versailles St Quentin En Yvelines, Fac Med, F-78180 Montigny Le Bretonneux, France; [Cogne, Melanie] Univ Hosp Rennes, 2 Rue Henri Guilloux, Rennes, France; [von Steinbuechel, Nicole] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Andelic, Nada] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway		Borgen, IMH (corresponding author), Kirkeveien 166, N-0450 Oslo, Norway.	idmbor@ous-hf.no		Ranta, Jukka/0000-0002-1376-542X; Borgen, Ida/0000-0001-9163-6941	European UnionEuropean Commission [247 602150]; Integra LifeSciences Corp. (USA); OneMind (USA); Hannelore Kohl Stiftung (Germany)	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant no. 247 602150) . Additional funding was obtained from the Hannelore Kohl Stiftung (Germany) , OneMind (USA) and Integra LifeSciences Corp. (USA) .	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Cnossen MC, 2017, J REHABIL MED, V49, P395, DOI 10.2340/16501977-2216; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Cox JC, 2016, J ECON BEHAV ORGAN, V131, P1, DOI 10.1016/j.jebo.2015.03.017; Ekdahl AW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002027; Eum RS, 2015, J NEUROTRAUM, V32, P280, DOI 10.1089/neu.2014.3351; Eurovoc, THES EUR; Figures EI, 2011, EUR YB; Groven S, 2011, J TRAUMA, V70, P569, DOI 10.1097/TA.0b013e31820d1a9b; Gupta S, 2019, CLIN GERIATR MED, V35, P45, DOI 10.1016/j.cger.2018.08.005; Heidegger CP, 2005, INTENS CARE MED, V31, P1676, DOI 10.1007/s00134-005-2831-x; Jourdan C, 2019, BRAIN INJURY, V33, P205, DOI 10.1080/02699052.2018.1539869; Leland NE, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.005157; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Mayhew D, 2019, ANAESTHESIA, V74, P373, DOI 10.1111/anae.14569; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Pradat-Diehl P., 2012, Annals of Physical and Rehabilitation Medicine, V55, P546, DOI 10.1016/j.rehab.2012.07.002; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Snow V, 2009, J GEN INTERN MED, V24, P971, DOI 10.1007/s11606-009-0969-x; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Sveen U, 2016, EUR J PHYS REHAB MED, V52, P650; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Tverdal CB, 2018, J REHABIL MED, V50, P505, DOI 10.2340/16501977-2332; van Essen TA, 2019, ACTA NEUROCHIR, V161, P435, DOI 10.1007/s00701-018-3761-z; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	32	1	1	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	NOV	2021	64	6							101458	10.1016/j.rehab.2020.10.009			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	YE3UU	WOS:000741054400029	33246186	Green Published, hybrid			2022-02-06	
J	Buttner, F; Terry, DP; Iverson, GL				Buettner, Fionn; Terry, Douglas P.; Iverson, Grant L.			Using a Likelihood Heuristic to Summarize Conflicting Literature on Predictors of Clinical Outcome Following Sport-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; sex differences; outcome; moderators; age; sports	HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; PROTRACTED RECOVERY; MODIFYING FACTOR; SEX-DIFFERENCES; POSTCONCUSSION SYMPTOMS; PROFESSIONAL FOOTBALL; POSTURAL STABILITY; PROLONGED RECOVERY; SOCCER PLAYERS	Objective: To introduce a new methodology for summarizing the results from systematic reviews-a likelihood heuristic-to the field of sport-related concussion. Data Sources: We applied the likelihood heuristic to the results of a systematic review published by Iverson et al (2017), containing 101 studies, on the predictors of worse clinical outcome following sport-related concussion. Study Selection: We re-examined 5 individual prognostic factors that are of clinical interest and for which there is conflicting literature (female sex = 44 studies, prior concussion history = 41 studies, loss of consciousness = 31 studies, post-traumatic amnesia = 25 studies, and retrograde amnesia = 10 studies). Data Extraction: For each prognostic factor, likelihood ratios were generated using the (1) number of significant and nonsignificant studies, (2) study power, (3) alpha level, and (4) prior probability that the alternative hypothesis was true. Data Synthesis: Assuming each study had 80% power and an alpha level of 5%, observing the reported number of conflicting studies for female sex, prior concussion history, and retrograde amnesia is substantially more likely if each prognostic factor is associated with worse clinical outcome following sport-related concussion. For loss of consciousness, the observed number of conflicting studies is more likely if loss of consciousness is not associated with worse clinical outcome following sport-related concussion. A secondary analysis incorporating potentially more realistic study parameters of statistical power (45%) and alpha level (25%) generates weaker likelihood evidence that the observed numbers of studies for each prognostic factor are associated with worse clinical outcome following sport-related concussion than they are not. Conclusions: Using a likelihood heuristic with 80% power and 5% alpha level, there is very strong likelihood evidence that female sex, prior concussion history, and retrograde amnesia are associated with worse clinical outcome following sport-related concussion. The strength of likelihood evidence that prognostic factors are associated with worse clinical outcome reduces when statistical power is lower and alpha level is inflated.	[Buettner, Fionn] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Terry, Douglas P.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Terry, Douglas P.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Terry, Douglas P.] Spaulding Rehabil Hosp, Spaulding Res Inst, Charlestown, MA USA; [Terry, Douglas P.; Iverson, Grant L.] MassGen Hosp Children Sports Concuss Program & Ho, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA		Iverson, GL (corresponding author), Ctr Hlth & Rehabil Res, Dept Phys Med & Rehabil, 79-96 13th St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu		Buttner, Fionn/0000-0002-5987-3063	National Football League	Supported in part by the National Football League for a program of research entitled "The Spectrum of Concussion: Predictors of Clinical Recovery, Treatment and Rehabilitation, and Possible Long-Term Effects."	Aczel B, 2018, ADV METH PRACT PSYCH, V1, P357, DOI 10.1177/2515245918773742; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Borenstein M., 2011, INTRO META ANAL, DOI DOI 10.1002/9780470743386; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Brook EM, 2016, PHYSICIAN SPORTSMED, V44, P20, DOI 10.1080/00913847.2016.1142834; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bruce JM, 2004, NEUROLOGY, V63, P1516; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; Chermann Jean Francois, 2014, Asian J Sports Med, V5, pe24042, DOI 10.5812/asjsm.24042; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Cohen J, 1998, STAT POWER ANAL BEHA; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Colquhoun D, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140216; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dienes Z, 2008, UNDERSTANDING PSYCHO, P121; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Dise-Lewis JE, 2019, J HEAD TRAUMA REHAB, V34, pE36, DOI 10.1097/HTR.0000000000000469; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P81, DOI 10.1017/S1355617713001288; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Dumas-Mallet E, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160254; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Foley C, 2014, CURR SPORT MED REP, V13, P390, DOI 10.1249/JSR.0000000000000104; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Goodman SN, 1999, ANN INTERN MED, V130, P1005, DOI 10.7326/0003-4819-130-12-199906150-00019; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hales AH, 2016, J EXP SOC PSYCHOL, V66, P39, DOI 10.1016/j.jesp.2015.09.011; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; HEDGES LV, 1980, PSYCHOL BULL, V88, P359, DOI 10.1037/0033-2909.88.2.359; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Ioannidis JPA, 2014, TRENDS COGN SCI, V18, P235, DOI 10.1016/j.tics.2014.02.010; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kerr ZY, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114544107; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P875, DOI 10.1177/1948550617693058; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lax ID, 2015, BRAIN INJURY, V29, P1409, DOI 10.3109/02699052.2015.1043344; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; Mayers LB, 2013, J NEUROPSYCH CLIN N, V25, P115, DOI 10.1176/appi.neuropsych.11120374; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McDevitt J, 2015, BRAIN INJURY, V29, P1674, DOI 10.3109/02699052.2015.1075252; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Patel CJ, 2015, J CLIN EPIDEMIOL, V68, P1046, DOI 10.1016/j.jclinepi.2015.05.029; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Rottman BM, 2017, MEM COGNITION, V45, P270, DOI 10.3758/s13421-016-0658-z; Royall RM, 1997, STAT EVIDENCE LIKELI; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; SEDLMEIER P, 1989, PSYCHOL BULL, V105, P309, DOI 10.1037/0033-2909.105.2.309; Shim J, 2015, J SPORT REHABIL, V24, P72, DOI 10.1123/jsr.2013-0058; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wicherts JM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01832; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	121	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					E476	E483		10.1097/JSM.0000000000000825			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700031	32941376				2022-02-06	
J	Chever, O; Zerimech, S; Scalmani, P; Lemaire, L; Pizzamiglio, L; Loucif, A; Ayrault, M; Krupa, M; Desroches, M; Duprat, F; Lena, I; Cestele, S; Mantegazza, M				Chever, Oana; Zerimech, Sarah; Scalmani, Paolo; Lemaire, Louisiane; Pizzamiglio, Lara; Loucif, Alexandre; Ayrault, Marion; Krupa, Martin; Desroches, Mathieu; Duprat, Fabrice; Lena, Isabelle; Cestele, Sandrine; Mantegazza, Massimo			Initiation of migraine-related cortical spreading depolarization by hyperactivity of GABAergic neurons and Na(V)1.1 channels	JOURNAL OF CLINICAL INVESTIGATION			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; ENHANCED EXCITATORY TRANSMISSION; MOUSE MODEL; INHIBITORY INTERNEURONS; DEPRESSION; SCN1A; ACTIVATION; MUTATION; PARVALBUMIN; MECHANISMS	Spreading depolarizations (SDs) are involved in migraine, epilepsy, stroke, traumatic brain injury, and subarachnoid hemorrhage. However, the cellular origin and specific differential mechanisms are not clear. Increased glutamatergic activity is thought to be the key factor for generating cortical spreading depression (CSD), a pathological mechanism of migraine. Here, we show that acute pharmacological activation of Na(V)1.1 (the main Na+ channel of interneurons) or optogeneticinduced hyperactivity of GABAergic interneurons is sufficient to ignite CSD in the neocortex by spiking-generated extracellular K+ build-up. Neither GABAergic nor glutamatergic synaptic transmission were required for CSD initiation. CSD was not generated in other brain areas, suggesting that this is a neocortex-specific mechanism of CSD initiation. Gain-of-function mutations of Na(V)1.1 (SCN1A) cause familial hemiplegic migraine type-3 (FHM3), a subtype of migraine with aura, of which CSD is the neurophysiological correlate. Our results provide the mechanism linking Na(V)1.1 gain of function to CSD generation in FHM3. Thus, we reveal the key role of hyperactivity of GABAergic interneurons in a mechanism of CSD initiation, which is relevant as a pathological mechanism of Na(v)1.1 FHM3 mutations, and possibly also for other types of migraine and diseases in which SDs are involved.	[Chever, Oana; Zerimech, Sarah; Pizzamiglio, Lara; Loucif, Alexandre; Ayrault, Marion; Duprat, Fabrice; Lena, Isabelle; Cestele, Sandrine; Mantegazza, Massimo] Univ Cote Azur, 660 Route Lucioles, F-06560 Valbonne, France; [Chever, Oana; Zerimech, Sarah; Pizzamiglio, Lara; Loucif, Alexandre; Ayrault, Marion; Duprat, Fabrice; Lena, Isabelle; Cestele, Sandrine; Mantegazza, Massimo] Inst Mol & Cellular Pharmacol IPMC, CNRS UMR7275, 660 Route Lucioles, F-06560 Valbonne, France; [Scalmani, Paolo] Fdn IRCCS Neurol Inst Carlo Besta, Unita Operat VII Clin & Expt Epileptol, Milan, Italy; [Lemaire, Louisiane; Desroches, Mathieu] Inria Sophia Antipolis Mediterranee, MathNeuro Project Team, Valbonne, France; [Krupa, Martin] Univ Cote Azur, Lab Jean Alexandre Dieudonne, Nice, France; [Duprat, Fabrice; Mantegazza, Massimo] INSERM, Valbonne, France; [Chever, Oana] Normandie Univ, INSERM U1239, UNIROUEN, Rouen, France		Mantegazza, M (corresponding author), Univ Cote Azur, 660 Route Lucioles, F-06560 Valbonne, France.; Mantegazza, M (corresponding author), Inst Mol & Cellular Pharmacol IPMC, CNRS UMR7275, 660 Route Lucioles, F-06560 Valbonne, France.	mantegazza@ipmc.cnrs.fr	Mantegazza, Massimo/J-8802-2016; DUPRAT, Fabrice/D-1221-2013	Mantegazza, Massimo/0000-0002-1070-7929; PIZZAMIGLIO, LARA/0000-0003-4723-8510; Chever, Oana/0000-0003-3081-1798; DUPRAT, Fabrice/0000-0001-8774-1220	Investissements d'Avenir-Laboratory of Excellence "Ion Channels Science and Therapeutics"French National Research Agency (ANR) [LabEx ICST ANR-11-LABX-0015-01]; University Cote d'Azur [IDEX Jedi ANR-15-IDEX-01]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [EFP7-602531]; French Research Ministry (MENRT)Ministry of Research, France	We thank Frederic Brau for his skillful expertise on imaging and image processing, Michelle Studer and Pascal Ezan for advice on immunohistochemistry experiments, Etienne Audinat for insightful discussions and advice, and Yuchio Yanagawa for donating GAD67-GFP knock-in mice. Our laboratory is a member of the "Federation Hospitalo-Universitaire" FHU-INOVPAIN and of the Neuromod Institute (Universite Cote d'Azur, France). This research was supported by the Investissements d'Avenir-Laboratory of Excellence "Ion Channels Science and Therapeutics" (grant LabEx ICST ANR-11-LABX-0015-01 to MM), University Cote d'Azur (grant IDEX Jedi ANR-15-IDEX-01 to MM) and the European Commission project DESIRE (grant EFP7-602531 to MM). SZ was a PhD student of the "Ecole doctorale 85" and received a PhD fellowship from the French Research Ministry (MENRT).	Aiba I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4050; Auffenberg E, 2021, J CLIN INVEST, V131; Baalman K, 2015, J NEUROSCI, V35, P2283, DOI 10.1523/JNEUROSCI.3751-14.2015; Barbieri R, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1056-2; Bechi G, 2012, EPILEPSIA, V53, P87, DOI 10.1111/j.1528-1167.2011.03346.x; Beny JL, 2000, BRIT J PHARMACOL, V131, P965, DOI 10.1038/sj.bjp.0703658; Bertelli S, 2019, CEPHALALGIA, V39, P477, DOI 10.1177/0333102418788336; Capuani C, 2016, EMBO MOL MED, V8, P967, DOI 10.15252/emmm.201505944; Cestele S, 2008, J NEUROSCI, V28, P7273, DOI 10.1523/JNEUROSCI.4453-07.2008; Cestele S, 2013, P NATL ACAD SCI USA, V110, P17546, DOI 10.1073/pnas.1309827110; Cestele S, 2013, EPILEPSIA, V54, P927, DOI 10.1111/epi.12123; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Charles AC, 2013, NAT REV NEUROL, V9, P637, DOI 10.1038/nrneurol.2013.192; Chever O, 2010, J NEUROSCI, V30, P15769, DOI 10.1523/JNEUROSCI.2078-10.2010; Chung DY, 2019, CEREB CORTEX, V29, P1150, DOI 10.1093/cercor/bhy021; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Desroches M, 2019, J COMPUT NEUROSCI, V47, P125, DOI 10.1007/s10827-019-00730-8; Dhifallah S, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00232; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Dravet Charlotte, 2005, Adv Neurol, V95, P71; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Fan CX, 2016, CEPHALALGIA, V36, P1238, DOI 10.1177/0333102415608360; Favero M, 2018, J NEUROSCI, V38, P7912, DOI 10.1523/JNEUROSCI.0193-18.2018; Ferrari MD, 2015, LANCET NEUROL, V14, P65, DOI 10.1016/S1474-4422(14)70220-0; Golomb D, 2007, PLOS COMPUT BIOL, V3, P1498, DOI 10.1371/journal.pcbi.0030156; Guedes RCA, 1997, EPILEPSY RES, V27, P33, DOI 10.1016/S0920-1211(96)01017-0; Hedrich UBS, 2014, J NEUROSCI, V34, P14874, DOI 10.1523/JNEUROSCI.0721-14.2014; Jansen NA, 2020, ANN CLIN TRANSL NEUR, V7, P132, DOI 10.1002/acn3.50971; Kaila K, 1997, J NEUROSCI, V17, P7662; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; KOROLEVA VI, 1993, BRAIN RES, V608, P107, DOI 10.1016/0006-8993(93)90780-Q; Kramer DR, 2017, STEREOT FUNCT NEUROS, V95, P1, DOI 10.1159/000452841; Ledri M, 2014, J NEUROSCI, V34, P3364, DOI 10.1523/JNEUROSCI.2734-13.2014; Lemaire L, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009239; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Li Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10503; Liautard C, 2013, EPILEPSIA, V54, P1251, DOI 10.1111/epi.12213; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Major S, 2020, GEROSCIENCE, V42, P57, DOI 10.1007/s11357-019-00142-7; Mantegazza M, 2021, PHYSIOL REV, V101, P1633, DOI 10.1152/physrev.00025.2020; Mantegazza M, 2019, EPILEPSIA, V60, pS25, DOI 10.1111/epi.14700; Mantegazza M, 2018, NEUROSCI LETT, V667, P92, DOI 10.1016/j.neulet.2017.11.025; Mantegazza M, 2011, EPILEPSIA, V52, P62, DOI 10.1111/j.1528-1167.2011.03005.x; Maslarova A, 2011, STROKE, V42, P2917, DOI 10.1161/STROKEAHA.111.621581; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; Perea G, 2016, ELIFE, V5, DOI 10.7554/eLife.20362; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Ptacek LJ, 2015, ANNU REV PHYSIOL, V77, P475, DOI 10.1146/annurev-physiol-021014-071922; Richards KL, 2018, P NATL ACAD SCI USA, V115, pE8077, DOI 10.1073/pnas.1804764115; Shiri Z, 2016, ANN NEUROL, V79, P354, DOI 10.1002/ana.24570; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; Vecchia D, 2014, NEUROBIOL DIS, V69, P225, DOI 10.1016/j.nbd.2014.05.035; Vecchia D, 2012, TRENDS NEUROSCI, V35, P507, DOI 10.1016/j.tins.2012.04.007; Wagnon JL, 2011, GENES BRAIN BEHAV, V10, P765, DOI 10.1111/j.1601-183X.2011.00717.x; Wang BP, 2014, J NEUROSCI, V34, P13314, DOI 10.1523/JNEUROSCI.2848-14.2014; Yekhlef L, 2015, J NEUROPHYSIOL, V113, P1616, DOI 10.1152/jn.00841.2014; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zerimech S, 2020, NEUROPHARMACOLOGY, V166, DOI 10.1016/j.neuropharm.2020.107951; Zhang YH, 2017, NEUROLOGY, V89, P1210, DOI 10.1212/WNL.0000000000004384; Zuberi SM, 2011, NEUROLOGY, V76, P594, DOI 10.1212/WNL.0b013e31820c309b	66	1	1	4	4	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	NOV 1	2021	131	21							e142203	10.1172/JCI142203			16	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	WS2JU	WOS:000715014400003	34491914	hybrid, Green Published			2022-02-06	
J	Daneshvar, DH; Yutsis, M; Baugh, CM; Pea, RD; Goldman, S; Grant, GA; Ghajar, J; Sanders, LM; Chen, CEL; Tenekedjieva, LT; Gurrapu, S; Zafonte, R; Sorcar, P				Daneshvar, Daniel H.; Yutsis, Maya; Baugh, Christine M.; Pea, Roy D.; Goldman, Shelley; Grant, Gerald A.; Ghajar, Jamshid; Sanders, Lee M.; Chen, Christine L.; Tenekedjieva, Lea-Tereza; Gurrapu, Shravya; Zafonte, Ross; Sorcar, Piya			Evaluating the Effect of Concussion-Education Programs on Intent to Report Concussion in High School Football	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; CrashCourse; reporting	SPORT; PLAYERS	Context: Concussion underreporting leads to delays in diagnosis and treatment, prolonging recovery time. Athletes' self-reporting of concussion symptoms, therefore, reduces risk. Objective: To evaluate the effectiveness of 3 concussion education programs in improving concussion-reporting intention. Design: Randomized controlled clinical trial. Setting: Three high schools in California. Patients or Other Participants: A total of 118 male football players (age = 14.88 6 1.19 years). Intervention(s): Participants were randomly assigned to receive concussion education via CrashCourse (CC), Centers for Disease Control and Prevention (CDC) video education materials (CDC-Vi), or CDC written education materials (CDC-Wr). Main Outcome Measure(s): The primary outcome was concussion-reporting intention, which was assessed at baseline, immediately after education, and at 1-month follow-up. Secondary outcomes were concussion knowledge, concussion -reporting attitudes, perceived concussion-reporting norms, and perceived behavioral control. Results: Across all education formats, a total sample of athletes improved in concussion-reporting intention at immediate and 1-month follow-ups (mean improvements = 6.8% and 11.4%, respectively; F-4,F-224 = 11.1, P , .001). Similar findings were observed across all education formats in secondary analyses examining knowledge, attitudes, and perceived behavioral control. However, we noted differences in concussion-reporting intention by education format and time (F-4,F-224 = 2.8, P = .03). Post hoc analysis showed that athletes who received CC had increased concussion-reporting intentions at immediate and 1 month follow-ups (baseline = 4.7, immediate follow-up = 6.1, 1 month follow-up = 6.0; F-16,F-61.1 = 6.1, P = .007) compared with increases only at 1-month follow-up for CDC-Vi (baseline = 4.3, immediate follow-up = 5.2, 1-month follow-up = 5.8; F-1.6,F-61.6 = 8.4, P = .001) and no improvement for CDC-Wr (P = .10). Secondary analyses indicated differences between CC and both CDC interventions in concussion knowledge and attitudes at immediate and 1-month follow-ups. We identified no differences in perceived behavioral control among interventions (F-4,F-216 = 0.2, P = .93) or perceived concussion-reporting norms across (F-4,F-224 = 0.3, P = .73) or among (F-4,F-224 = 1.7, P = .15) interventions. Conclusions: All athletes exhibited an improved intent to report concussions, increased concussion knowledge, better concussion attitudes, and more perceived behavioral control at both immediate and 1-month follow-ups. However, athletes randomized to receive CC reported a greater intent to report concussion, more knowledge, and improved concussion -reporting attitudes when compared with those who received CDC-Vi and CDC-Wr.	[Daneshvar, Daniel H.; Zafonte, Ross] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Charlestown, MA 02129 USA; [Yutsis, Maya] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Baugh, Christine M.] Univ Colorado, Ctr Bioeth & Humanities, Anschutz Med Campus, Aurora, CO USA; [Pea, Roy D.; Goldman, Shelley] Stanford Univ, Grad Sch Educ, Stanford, CA 94305 USA; [Grant, Gerald A.; Ghajar, Jamshid] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Sanders, Lee M.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Chen, Christine L.] Univ Texas Southwestern Med Ctr, Lewisville, TX USA; [Tenekedjieva, Lea-Tereza; Gurrapu, Shravya] Stanford Univ, Sch Humanities & Sci, Stanford, CA 94305 USA; [Gurrapu, Shravya] Stanford Univ, Sch Engn, Stanford, CA USA; [Sorcar, Piya] Stanford Univ, Sch Educ, Stanford, CA 94305 USA		Daneshvar, DH (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Charlestown, MA 02129 USA.	ddaneshvar@mgh.harvard.edu		Chen, Christine/0000-0003-4377-8245	Taube Stanford Concussion Collaborative with Lucile Packard Children's Hospital Stanford	This study was funded by the Taube Stanford Concussion Collaborative with Lucile Packard Children's Hospital Stanford. The funding agency was not involved in study oversight, data acquisition, data analysis, or reporting. We thank Coach Dick Gould for his fearless leadership and determination to bring concussion education to the global sports community. We also thank the research team who made this study possible: Noura Bou Zeid, Ryan Burns, Hannah D'Apice, Krishna Teja Gorrepati, Cara Hanelin, Anafia Thomas, and Jennifer Wiener.	[Anonymous], HEADS UP to school sports; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bookbinder HA, 2020, J ATHL TRAINING, V55, P843, DOI 10.4085/1062-6050-362-19; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; CrashCourse free products, TEACHAIDS WEB SIT; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Esterov D, 2020, NEUROREHABILITATION, V47, P65, DOI 10.3233/NRE-203082; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Hickling A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8244-5; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Howell DR, 2019, CLIN J SPORT MED, V29, P391, DOI 10.1097/JSM.0000000000000629; Kolberg K, 2021, PEDIATR EMERG CARE, V37, pE1603, DOI 10.1097/PEC.0000000000002133; Kroshus E, 2019, HEALTH EDUC BEHAV, V46, P916, DOI 10.1177/1090198119859414; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Piana LE, 2020, PHYSICIAN SPORTSMED, V48, P46, DOI 10.1080/00913847.2019.1624657; Register-Mihalik JK, 2021, RES SPORTS MED, V29, P1, DOI 10.1080/15438627.2020.1719493; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sullivan L, 2018, HEALTH EDUC RES, V33, P492, DOI 10.1093/her/cyy034; Taylor ME, 2017, J SCH NURS, V33, P73, DOI 10.1177/1059840515619683; Warmath D, 2019, SPORTS HEALTH, V11, P416, DOI 10.1177/1941738119856609	30	1	1	1	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2021	56	11					1197	1208		10.4085/509-20			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	WZ4WD	WOS:000719968500005	33428746	gold			2022-02-06	
J	DiBona, VL; Shah, MK; Krause, KJ; Zhu, WX; Voglewede, MM; Smith, DM; Crockett, DP; Zhang, HY				DiBona, Victoria L.; Shah, Mihir K.; Krause, Kayla J.; Zhu, Wenxin; Voglewede, Mikayla M.; Smith, Dana M.; Crockett, David P.; Zhang, Huaye			Metformin reduces neuroinflammation and improves cognitive functions after traumatic brain injury	NEUROSCIENCE RESEARCH			English	Article						Metformin; TBI; Neuroinflammation; Microglia; Par1; MARK	ACTIVATED PROTEIN-KINASE; SYNAPTIC PLASTICITY; KAPPA-B; PHOSPHORYLATION; MEMORY; LKB1; NEUROGENESIS; EPIDEMIOLOGY; ASTROCYTES; BEHAVIOR	Within the brain, traumatic brain injury (TBI) alters synaptic plasticity and increases neuroinflammation and neuronal death. Yet, there lacks effective TBI treatments providing pleiotropic beneficial effects on these diverse cellular processes necessary for functional recovery. Here, we show the diabetes drug, metformin, significantly improves cognitive functions after controlled cortical impact (CCI) injury in mice, showing improved spatial learning and nest building. Furthermore, injured animals treated with metformin exhibit increased ramification of microglia processes, indicating reduced neuroinflammation. Finally, metformin treatment in vitro increased neuronal activation of partitioning defective 1 (Par1), a family of Ser/Thr kinases playing a key role in synaptic plasticity and neuroinflammation. These results suggest metformin is a promising therapeutic agent for targeting multiple cellular processes necessary for functional TBI recovery. (c) 2021 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.	[DiBona, Victoria L.; Shah, Mihir K.; Krause, Kayla J.; Zhu, Wenxin; Voglewede, Mikayla M.; Smith, Dana M.; Crockett, David P.; Zhang, Huaye] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ USA		DiBona, VL (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane W,Res Tower 3rd Floor, Piscataway, NJ 08854 USA.	dibonavl@rutgers.edu		Zhang, Huaye/0000-0002-4844-6111; DiBona, Victoria/0000-0002-1914-2506; Smith, Dana/0000-0001-5410-0400	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS065183, NS089578]; New Jersey Commission for Brain Injury Research predoctoral fellowship; NIH Institutional Research and Career Development Award (IRACDA) [1K12GM093854]; Department of Defense, through the Epilepsy Research ProgramUnited States Department of Defense [W81XQH-18-1-0338]; U.S. Army Medical Research Acquisition Activity, Fort Detrick MD; Aresty Center for Undergraduate Research at Rutgers University; Summer Undergraduate Research Program in Molecular and Developmental Neurobiology (NIH grant)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25MH095722]	We would like to thank Dr. Long-Jun Wu for expert advice and helpful discussions, Drs. George Wagner and Alexander Kusnecov for support with animal behavior studies, and Dr. Qian Wu, Dr. Miao Sun and Laura P. Bernard for technical assistance. This work was supported by NIH grants NS065183 and NS089578 to HZ., and New Jersey Commission for Brain Injury Research predoctoral fellowship and NIH Institutional Research and Career Development Award (IRACDA) 1K12GM093854 to VLD. This work was also supported by the Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, through the Epilepsy Research Program under Award No. W81XQH-18-1-0338 to HZ. Opinions, interpreta-tions, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and adminis-tering acquisition office. MKS, KJK, and WZ received support from the Aresty Center for Undergraduate Research at Rutgers Univer-sity. DMS was supported by the Summer Undergraduate Research Program in Molecular and Developmental Neurobiology (NIH grant R25MH095722) .	Afshari K, 2018, SPINAL CORD, V56, P1032, DOI 10.1038/s41393-018-0168-x; An CR, 2016, TRANSL STROKE RES, V7, P512, DOI 10.1007/s12975-016-0483-5; Aubert A, 1999, NEUROSCI BIOBEHAV R, V23, P1029, DOI 10.1016/S0149-7634(99)00034-2; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bernard LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124816; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Cameron AR, 2016, CIRC RES, V119, P652, DOI 10.1161/CIRCRESAHA.116.308445; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Ciurea A V, 2011, J Med Life, V4, P234; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; DiBona VL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1390-3; Duca FA, 2016, NAT MED, V22, P217, DOI 10.1038/nm0216-217b; Faul M, 2010, TRAUMATIC BRAIN INJU; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gaskill BN, 2013, JOVE-J VIS EXP, DOI 10.3791/51012; Guttenplan KA, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107776; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jirkof P, 2014, J NEUROSCI METH, V234, P139, DOI 10.1016/j.jneumeth.2014.02.001; Kothari V, 2016, J INFLAMM RES, V9, P27, DOI 10.2147/JIR.S86917; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Matejuk A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01416; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Muri L, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1549-6; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruddy RM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1912; Sandry J, 2015, J NEUROL, V262, P59, DOI 10.1007/s00415-014-7523-4; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sofroniew MV, 2020, TRENDS IMMUNOL, V41, P758, DOI 10.1016/j.it.2020.07.004; Sun M, 2013, JOVE-J VIS EXP, DOI 10.3791/50808; Tanokashira D, 2018, FEBS OPEN BIO, V8, P1104, DOI 10.1002/2211-5463.12436; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang HL, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9741369; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; Whiting M.D., 2006, ANIMAL MODELCOGNIT; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Wu Q, 2017, J BIOL CHEM, V292, P16150, DOI 10.1074/jbc.M117.782490; Wu Q, 2012, J BIOL CHEM, V287, P30781, DOI 10.1074/jbc.M112.351452; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2	56	1	1	4	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	NOV	2021	172						99	109		10.1016/j.neures.2021.05.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UR8OF	WOS:000697000800012	34023358				2022-02-06	
J	Hanna, B; Adams, R; Townsend, S; Robinson, M; Soe, S; Stewart, M; Burek, R; Theobald, P				Hanna, Benjamin; Adams, Rhosslyn; Townsend, Scott; Robinson, Michael; Soe, Shwe; Stewart, Matthew; Burek, R.; Theobald, Peter			Auxetic metamaterial optimisation for head impact mitigation in American football	INTERNATIONAL JOURNAL OF IMPACT ENGINEERING			English	Article						Auxetic; Metamaterial; Impact absorption; Head injury; Structural optimization	EPIDEMIOLOGY; PERFORMANCE	American football has a comparatively high rate of sports-related concussions, despite mitigating strategies including the use of protective helmets. The traditional energy absorbing component, elastomeric foam pads, have limited scope for leveraging any further protection. Alternative structures and materials that exhibit novel deformation mechanics have been proposed as a route to increased energy absorption capacity. This study investigated a metamaterial based on the Miura Ori folding pattern. Eighty-one potential structural variations were conceptualised and evaluated via the Taguchi method. Twenty-seven geometries were then additively manufactured using commercially available thermoplastic polyurethane, before being impacted at multiple velocities. Experimental data were then extrapolated to predict the impact behaviour across all 81 variants. An optimised geometry was then proposed, which reduced linear accelerations across the test conditions and performed favourably when compared to current, elastomeric foam solutions. This work provides a promising foundation for future investigation.	[Hanna, Benjamin; Adams, Rhosslyn; Townsend, Scott; Robinson, Michael; Burek, R.; Theobald, Peter] Cardiff Univ, Cardiff Sch Engn, Cardiff, Wales; [Soe, Shwe] Univ West England, Engn Design & Math, Bristol, Avon, England; [Stewart, Matthew; Burek, R.] Charles Owen, Wrexham, Wales		Theobald, P (corresponding author), Cardiff Sch Engn, Cardiff, Wales.	TheobaldPS@Cardiff.ac.uk		Hanna, Benjamin/0000-0002-6339-5607	Head Health Challenge III	This research was funded in part by the Head Health Challenge III. Prof Roy Burek (Charles Owen) was an important part of the wider team that conceptualised this work. His untimely passing has increased our commitment to progressing this technically demanding research area.	Adams R, 2019, MATER DESIGN, V180, DOI 10.1016/j.matdes.2019.107917; Bertoldi K, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.66; Bikas H, 2019, INT J ADV MANUF TECH, V103, P3769, DOI 10.1007/s00170-019-03627-z; Biocore, 2019, HELM TEST PROT; Breedlove KM, 2017, J ATHL TRAINING, V52, P802, DOI 10.4085/1062-6050-52.6.01; Duncan O, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8060941; Fathers RK, 2015, INT J MECH SCI, V101, P421, DOI 10.1016/j.ijmecsci.2015.08.013; Forsberg J, 2006, INT J IMPACT ENG, V32, P759, DOI 10.1016/j.ijimpeng.2005.01.007; Foster L, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8030354; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Hanna B., 2020, DEV METAMATERIAL USE; Harris J., 2017, ADDITIVELY MANUFACTU; Johnston JM, 2015, SPORTS ENG, V18, P11, DOI 10.1007/s12283-014-0160-4; KrzeminskI DE., 2011, SPORTS TECHNOL, V4, P65; Lisiecki J, 2013, PHYS STATUS SOLIDI B, V250, P1988, DOI 10.1002/pssb.201384232; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Robinson M, 2017, IRCOBI; Robinson M., 2019, DEV NOVEL MAT ENHANC; Robinson M, 2019, ADDIT MANUF, V27, P398, DOI 10.1016/j.addma.2019.03.022; Schenk M, 2014, INT J SOLIDS STRUCT, V51, P4196, DOI 10.1016/j.ijsolstr.2014.07.027; Schenk M, 2013, P NATL ACAD SCI USA, V110, P3276, DOI 10.1073/pnas.1217998110; Soe SP, 2015, INT J ADV MANUF TECH, V79, P1975, DOI 10.1007/s00170-015-6972-y; Sood AK, 2010, MATER DESIGN, V31, P287, DOI 10.1016/j.matdes.2009.06.016; Srivastava M, 2018, VIRTUAL PHYS PROTOTY, V13, P203, DOI 10.1080/17452759.2018.1440722; Townsend S, 2020, MATER DESIGN, V195, DOI 10.1016/j.matdes.2020.108930; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Willigenburg NW, 2016, AM J SPORT MED, V44, P753, DOI 10.1177/0363546515622389; Zhang JJ, 2019, INT J MECH SCI, V153, P194, DOI 10.1016/j.ijmecsci.2019.01.044; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	30	1	1	19	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0734-743X	1879-3509		INT J IMPACT ENG	Int. J. Impact Eng.	NOV	2021	157								103991	10.1016/j.ijimpeng.2021.103991			8	Engineering, Mechanical; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics	UK2LN	WOS:000691806500005					2022-02-06	
J	Herring, S; Ben Kibler, W; Putukian, M; Solomon, GS; Boyajian-O'Neill, L; Dec, KL; Franks, RR; Indelicato, PA; LaBella, CR; Leddy, JJ; Matuszak, J; McDonough, EB; O'Connor, F; Sutton, KM				Herring, Stanley; Ben Kibler, W.; Putukian, Margot; Solomon, Gary S.; Boyajian-O'Neill, Lori; Dec, Katherine L.; Franks, R. Robert; Indelicato, Peter A.; LaBella, Cynthia R.; Leddy, John J.; Matuszak, Jason; McDonough, E. Barry; O'Connor, Francis; Sutton, Karen Michelle			Selected issues in sport-related concussion (SRC|mild traumatic brain injury) for the team physician: a consensus statement	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						concussion; brain; physician; sport; exercise	ENCEPHALOPATHY; DIAGNOSIS; RECOVERY; RISK; CONVULSIONS; RELIABILITY; PERFORMANCE; SYMPTOMS; REST	Selected Issues in Sport-Related Concussion (SRC|Mild Traumatic Brain Injury) for the Team Physician: A Consensus Statement is title 22 in a series of annual consensus documents written for the practicing team physician. This document provides an overview of selected medical issues important to team physicians who are responsible for athletes with sports-related concussion (SRC). This statement was developed by the Team Physician Consensus Conference (TPCC), an annual project-based alliance of six major professional associations. The goal of this TPCC statement is to assist the team physician in providing optimal medical care for the athlete with SRC.	[Herring, Stanley] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Herring, Stanley] Univ Washington, Dept Orthopaed, Seattle, WA 98195 USA; [Herring, Stanley] Univ Washington, Dept Sports Med, Seattle, WA 98195 USA; [Herring, Stanley] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Ben Kibler, W.] Lexington Clin, Shoulder Ctr KY, Lexington, KY USA; [Boyajian-O'Neill, Lori] Overland Pk Surg Specialists & Sports Med, Overland Pk, KS USA; [Dec, Katherine L.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil & Orthopaed Surg, Richmond, VA USA; [Franks, R. Robert] Rothman Orthopaed Inst, Philadelphia, PA USA; [Indelicato, Peter A.] Univ Florida, Gainesville, FL USA; [LaBella, Cynthia R.] Northwestern Univ, Pediat, Evanston, IL USA; [LaBella, Cynthia R.] Ann & Robert H Lurie Childrens Hosp Chicago, Pediat Orthoped & Sports Med, Chicago, IL 60611 USA; [Leddy, John J.] SUNY Buffalo, UBMD Orthopaed & Sports Med, New York, NY USA; [McDonough, E. Barry] West Virginia Univ, Morgantown, WV 26506 USA; [O'Connor, Francis] Uniformed Serv Univ Hlth Sci, Mil & Emergency Med, Bethesda, MD 20814 USA; [Sutton, Karen Michelle] HSS, Orthopaed Surg, New York, NY USA		Putukian, M (corresponding author), Princeton Univ, Athlet Med, Princeton, NJ 08544 USA.	mputukian@gmail.com		Putukian, Margot/0000-0002-1478-8068			[Anonymous], 2017, CURR SPORT MED REP, V16, P189, DOI 10.1249/JSR.0000000000000359; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2005, MED SCI SPORT EXER, V37, P2012, DOI 10.1249/01.mss.0000186726.18341.70; [Anonymous], 2013, MED SCI SPORT EXER, V45, P1618, DOI 10.1249/MSS.0b013e31829ba437; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Asken BM, 2018, NEUROLOGY, V91, pE2123, DOI 10.1212/WNL.0000000000006616; Battista J., 2019, NFL PLAYERS UNION RE; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Di Battista AP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1402-y; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Elbin RJ, 2015, RES SPORTS MED, V23, P203, DOI 10.1080/15438627.2015.1005293; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Herring Stanley A, 2012, Med Sci Sports Exerc, V44, P2446, DOI 10.1249/MSS.0b013e3182750534; Hoffman NL, 2020, CLIN J SPORT MED, V30, pS29, DOI 10.1097/JSM.0000000000000538; Hsu AC, 2012, MED SCI SPORT EXER, V44, P178, DOI 10.1249/MSS.0b013e318275044f; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Maddocks DL, 2020, NEUROSURGERY, V87, pE123, DOI 10.1093/neuros/nyaa086; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1108, DOI 10.1136/bjsports-2015-095094; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Najafi Mohammad Reza, 2015, Adv Biomed Res, V4, P82, DOI 10.4103/2277-9175.156640; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Rivara FP, 2020, JAMA PEDIATR, V174, P79, DOI 10.1001/jamapediatrics.2019.4006; Rowson S, 2019, ANN BIOMED ENG, V47, P2048, DOI 10.1007/s10439-019-02329-7; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Smith AM., 2016, BMJ OPEN SPORT EXERC, V2, DOI [10.1136/bmjsem-2015-000074, DOI 10.1136/BMJSEM-2015-000074]; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Taubman B, 2016, J CHILD NEUROL, V31, P1555, DOI 10.1177/0883073816664835; Theadom A, 2020, NEUROEPIDEMIOLOGY, V54, P192, DOI 10.1159/000505424; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; Vandenbussche N, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0875-x; Wennberg R, 2018, CAN J NEUROL SCI, V45, P275, DOI 10.1017/cjn.2017.300; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056	70	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	NOV	2021	55	22					1251	1261		10.1136/bjsports-2021-104235			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	WP5JJ	WOS:000713167500007	34134974	Green Published, hybrid			2022-02-06	
J	Howell, DR; Seehusen, CN; Walker, GA; Reinking, S; Wilson, JC				Howell, David R.; Seehusen, Corrine N.; Walker, Gregory A.; Reinking, Sarah; Wilson, Julie C.			Neuromuscular training after concussion to improve motor and psychosocial outcomes: A feasibility trial	PHYSICAL THERAPY IN SPORT			English	Article						Mild traumatic brain injury; Injury prevention; Dual-task; Gait; Symptoms; Quality of life	SPORT-RELATED CONCUSSION; PREVENTION; STABILITY; INJURIES; TRUNK; TIME	Objective: To determine the feasibility of an 8-week neuromuscular training program initiated upon return-to-play clearance following concussion. Design: Feasibility trial. Setting: A single sports medicine center. Participants: We approached n = 54 patients; n = 32 agreed to participate (59%). N = 27 participants returned for their second visit at return-to-play clearance (84%) and were randomized to neuromuscular training (n = 13) or standard-of-care (n = 14). Main outcome measures: Participants completed three assessments: within 14 days post-concussion, immediately after return-to-play clearance, and 8-weeks following return-to-play clearance. The intervention aimed to achieve positive neuromuscular adaptations and occurred 2x/week for 8 weeks under supervision. Results: N = 2 participants randomized to the intervention elected not to participate, both due to schedule conflicts (e.g., time required to meet with the study team). Participants began the intervention an average of 11 days after return-to-play clearance, the majority (91%) completed >75% of training sessions, and training sessions lasted an average of 18.2 +/- 4.8 min. One participant stopped the intervention after 7 training sessions due to time availability. Conclusion: It is feasible to initiate a neuromuscular training program for most athletes shortly after returning to play following concussion. Clinicians and researchers may consider this approach to mitigate the increased musculoskeletal injury risk for concussion patients returning to sports. (c) 2021 Elsevier Ltd. All rights reserved.	[Howell, David R.; Seehusen, Corrine N.; Walker, Gregory A.; Reinking, Sarah; Wilson, Julie C.] Childrens Hosp Colorado, Ctr Sports Med, Aurora, CO USA; [Howell, David R.; Walker, Gregory A.; Wilson, Julie C.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Wilson, Julie C.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA		Howell, DR (corresponding author), Univ Colorado, Sch Med, Dept Orthoped, ATC Sports Med Ctr Childrens Hosp Colorado, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@CUAnschutz.edu		Walker, Gregory/0000-0003-4919-4638; Wilson, Julie/0000-0002-6834-6257; Howell, David/0000-0002-2955-0191	Children's Hospital Colorado Research Institute Pilot Award Program; Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03HD094560, R01NS100952, R43NS108823]; MINDSOURCE Brain Injury Network	This study was funded by the Children's Hospital Colorado Research Institute Pilot Award Program. Separate from this study, Dr. Howell has received research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560) , the National Institute of Neurological Disorders And Stroke (R01NS100952, R03HD094560, and R43NS108823) , and MINDSOURCE Brain Injury Network. The remaining authors have no conflicts to disclose. We would like to thank Jillian Descoteaux, PhD, ATC, and Scott Long, MS, ATC for their assistance in performing the intervention training.	Abbott JH, 2014, J ORTHOP SPORT PHYS, V44, P555, DOI 10.2519/jospt.2014.0110; Anderson MN, 2019, DEV NEUROPSYCHOL, V44, P443, DOI 10.1080/87565641.2019.1667995; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Brunner R, 2019, BRIT J SPORT MED, V53, P282, DOI 10.1136/bjsports-2017-098944; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Foss KDB, 2018, J ATHL TRAINING, V53, P20, DOI 10.4085/1062-6050-173-16; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2021, AM J SPORT MED, V49, P1912, DOI 10.1177/03635465211005761; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab3552; Howell DR, 2020, PHYSICIAN SPORTSMED, V48, P75, DOI 10.1080/00913847.2019.1632155; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; MacDonald J, 2015, CLIN J SPORT MED, V25, P43, DOI 10.1097/JSM.0000000000000096; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Myer GD, 2008, CLIN SPORT MED, V27, P425, DOI 10.1016/j.csm.2008.02.006; Nielsen RO, 2020, BRIT J SPORT MED, V54, P51, DOI 10.1136/bjsports-2019-100858; Oldham JR, 2020, MED SCI SPORT EXER, V52, P2279, DOI 10.1249/MSS.0000000000002385; Owoeye OBA, 2018, CLIN J SPORT MED, V28, P325, DOI 10.1097/JSM.0000000000000462; Paterno MV, 2018, SPORTS HEALTH, V10, P228, DOI 10.1177/1941738117745806; Pomares-Noguera C, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00040; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Root JM, 2019, CLIN PEDIATR, V58, P731, DOI 10.1177/0009922819839230; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sugimoto D, 2014, J STRENGTH COND RES, V28, P1187, DOI 10.1097/JSC.0000000000000228; Sugimoto D, 2014, SPORTS MED, V44, P551, DOI 10.1007/s40279-013-0135-9; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Varni JW, 2014, QUAL LIFE RES, V23, P1233, DOI 10.1007/s11136-013-0544-0; Webster KE, 2018, J ORTHOP RES, V36, P2696, DOI 10.1002/jor.24043; Westwood C, 2020, J SPORT REHABIL, V29, P131, DOI 10.1123/jsr.2018-0358; Wilkerson GB, 2020, J ATHL TRAINING, V55, P594, DOI 10.4085/1062-6050-0401.19; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Wilson JC, 2021, J STRENGTH COND RES, V35, P1149, DOI 10.1519/JSC.0000000000002907	43	1	1	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	NOV	2021	52						132	139		10.1016/j.ptsp.2021.05.014			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WZ7AW	WOS:000720117900015	34482050				2022-02-06	
J	Iverson, GL; Merz, ZC; Terry, DP				Iverson, Grant L.; Merz, Zachary C.; Terry, Douglas P.			Playing High School Football Is Not Associated With an Increased Risk for Suicidality in Early Adulthood	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						football; concussion; depression; suicide; mental health	CHRONIC TRAUMATIC ENCEPHALOPATHY; MENTAL-HEALTH; LEAGUE PLAYERS; DEPRESSION; ADOLESCENTS; BEHAVIOR; HOPELESSNESS; PAIN; PARTICIPATION; INDIVIDUALS	Objective: To determine if playing high school football is associated with suicide ideation between the ages of 24 and 32 years. Design: Data were analyzed from the National Longitudinal Study of Adolescent to Adult Health. This prospective cohort study sampled nationally representative US participants at 4 time points from 1994 to 2008. Setting: In-home assessment. Participants: There were 3147 boys (age: median = 14.9, SD = 1.8) who participated during adolescence in 1994 to 1995 (wave I), of whom 2353 were reinterviewed in 2008 (wave IV, age: median = 29.1, SD = 1.8). Assessment of Risk Factors: Football participation, history of psychological counseling, suicide ideation, and a suicide attempt in the past year during high school. Main Outcome Measures: Lifetime history of depression, suicide ideation within the past year, and feeling depressed in the past 7 days at wave IV. Results: Men who played high school football, compared with those who did not, reported similar rates of lifetime diagnosis of depression, suicide ideation in the past year, and feeling depressed in the past 7 days. Those who played football reported similar rates of suicide ideation in the past year when they were in their early 20s. Individuals who underwent psychological counseling during adolescence were more likely to report a lifetime history of depression and suicide ideation in the past year. Conclusions: Young men who played high school football are not at an increased risk for suicide ideation during both their early 20s and late 20s. By contrast, those who experienced mental health problems in high school were much more likely to experience suicide ideation during their 20s.	[Iverson, Grant L.; Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Boston, MA USA; [Iverson, Grant L.; Terry, Douglas P.] MassGen Hosp Children Spats Concuss Program, Charlestown, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Home Base, Charlestown, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Ctr Hlth & Rehabil Res, Charlestown, MA USA; [Merz, Zachary C.] Univ N Carolina, Dept Phys Med & Rehabil, UNC Mem Hosp, Chapel Hill, NC USA		Iverson, GL (corresponding author), Harvard Med Sch, Ctr Hlth & Rehabil Res, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu			Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01-HD31921]	This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Information on how to obtain the Add Health data files is available on the Add Health Web site (http://www.cpc.unc.edu/addhealth).No direct support was received from grant P01-HD31921 for this analysis.	Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; BECK AT, 1990, AM J PSYCHIAT, V147, P190; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Bohr AD, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119868658; Bottino SMB, 2015, CAD SAUDE PUBLICA, V31, P463, DOI [10.1590/0102-311x00036114, 10.1590/0102-311X00036114]; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Deshpande SK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229978; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Evans E, 2005, CHILD ABUSE NEGLECT, V29, P45, DOI 10.1016/j.chiabu.2004.06.014; Fergusson DM, 2007, BRIT J PSYCHIAT, V191, P335, DOI 10.1192/bjp.bp.107.036079; Fergusson DM, 2002, ARCH GEN PSYCHIAT, V59, P225, DOI 10.1001/archpsyc.59.3.225; Foster T, 2011, ARCH SUICIDE RES, V15, P1, DOI 10.1080/13811118.2011.540213; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017; Guddal MH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028555; Harold GT, 2018, J CHILD PSYCHOL PSYC, V59, P374, DOI 10.1111/jcpp.12893; Harris K. M., 2009, NATL LONGITUDINAL ST; Harris KM, 2019, INT J EPIDEMIOL, V48, P1415, DOI 10.1093/ije/dyz115; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Ilgen MA, 2008, GEN HOSP PSYCHIAT, V30, P521, DOI 10.1016/j.genhosppsych.2008.09.003; Iverson GL, 2020, ARCH CLIN NEUROPSYCH, V35, P332, DOI 10.1093/arclin/acz023; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jewett R, 2014, J ADOLESCENT HEALTH, V55, P640, DOI 10.1016/j.jadohealth.2014.04.018; Karch Debra L., 2011, Morbidity and Mortality Weekly Report, V60, P1; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Lamela D, 2016, J PEDIAT-BRAZIL, V92, P331, DOI 10.1016/j.jped.2015.09.011; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Li WJ, 2020, DEATH STUD, V44, P450, DOI 10.1080/07481187.2019.1578305; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McAuliffe C, 2002, BEHAV COGN PSYCHOTH, V30, P385, DOI 10.1017/S1352465802004010; McGee R, 2001, J ABNORM CHILD PSYCH, V29, P281, DOI 10.1023/A:1010353711369; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon EM, 2017, EUR CHILD ADOLES PSY, V26, P111, DOI 10.1007/s00787-016-0875-9; Miller A, 2013, CLIN CHILD FAM PSYCH, V16, P146, DOI 10.1007/s10567-013-0131-5; Myklestad I, 2012, SOC PSYCH PSYCH EPID, V47, P771, DOI 10.1007/s00127-011-0380-x; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Perez-Gonzalez A, 2015, ACTAS ESP PSIQUIATRI, V43, P149; Rangul V, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-144; RAO U, 1993, J AM ACAD CHILD PSY, V32, P21, DOI 10.1097/00004583-199301000-00004; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Roustit C, 2010, EUR CHILD ADOLES PSY, V19, P597, DOI 10.1007/s00787-010-0094-8; Sampasa-Kanyinga H, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796018000653; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Serafini G, 2015, EUR CHILD ADOLES PSY, V24, P1423, DOI 10.1007/s00787-015-0760-y; Sorensen EH, 2020, J AFFECT DISORDERS, V262, P55, DOI 10.1016/j.jad.2019.10.054; Steptoe A, 1996, LANCET, V347, P1789, DOI 10.1016/S0140-6736(96)91616-5; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Van Orden KA, 2005, CURR PSYCHIATRY REV, V1, P187, DOI 10.2174/1573400054065541; Verrocchio MC, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00108; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Webner D, 2016, BRAIN INJURY, V30, P1718, DOI 10.1080/02699052.2016.1202451; Weir DR., 2009, NATL FOOTBALL LEAGUE; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS11, DOI 10.1016/j.drugalcdep.2004.08.003; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280	63	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					469	474		10.1097/JSM.0000000000000890			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700027	34704972	Bronze			2022-02-06	
J	Jeong, HS; O'Sullivan, DM; Jeong, DH; Lee, SY				Jeong, Hee Seong; O'Sullivan, David M.; Jeong, Dae Hyoun; Lee, Sae Yong			Sports Injuries and Illnesses After Implementation of the Web-Based Surveillance System in World Taekwondo	JOURNAL OF ATHLETIC TRAINING			English	Article						epidemiologic studies; incidence; injury pre-vention	COMPETITION INJURIES; GAMES; EPIDEMIOLOGY; PREVENTION; SEX	Context: Taekwondo epidemiology studies have been in short supply since the rule changes introduced by World Taekwondo in 2017. Objective: To describe injury and illness patterns at the 2017 World Taekwondo Championships (WTC) in Muju, South Korea, after the implementation of the web-based surveillance system by World Taekwondo. Design: Prospective cohort study. Setting: All injuries and illnesses were recorded during the 2017 WTC using a web-based system developed by the International Olympic Committee. Patients or Other Participants: A total of 971 athletes who participated in the 2017 WTC. Main Outcome Measure(s): Profiles and mechanisms of injury and illness in the 2017 WTC. Results: We analyzed a total of 131 injuries and 26 illnesses, corresponding to an overall clinical incidence of 13.5 (95% CI = 11.2, 15.8) injuries and 2.7 (95% CI = 1.6 3.7) illnesses per 100 athletes and an overall incidence rate of 19.3 (95% CI = 16.0, 22.6) injuries and 3.8 (95% CI = 2.4, 5.3) illnesses per 1000 athlete-days. Most injuries occurred in the lower extremities (n = 61, 46.6%), and knee injuries were most frequent (n = 26, 19.8%). Among head and trunk injuries (n = 39, 29.8%), face injuries (n = 32, 24.4%) were most common, whereas among upper extremity injuries (n = 31, 23.7%), finger injuries (n = 8, 6.1%) were seen most often. Contusions (n = 44, 33.6%) were the most frequent injury type, followed by fractures and ligamentous ruptures or sprains. The most common injury mechanism was contact with another athlete (n = 97, 74.0%), whereas the least common was concussion (n = 5). The major affected system was the respiratory system (n =11, 42.3%), with major symptoms being pain (n = 11, 42.3%) and fever (n = 7, 26.9%). Environmental factors were the most typical cause of illness (n = 15, 57.7%). Conclusions: The web-based surveillance system used at the 2017 WTC revealed that 13.5 per 100 athletes (77.8/1000 athlete-exposures, 13.9/1000 minute-exposures) had new or recurrent injuries, whereas 2.7 per 100 athletes became ill.	[Jeong, Hee Seong] Mokwon Univ, Dept Sports & Hlth Management, Daejeon, South Korea; [O'Sullivan, David M.] Pusan Natl Univ, Dept Sports Sci, Busan, South Korea; [Jeong, Dae Hyoun] Southern Illinois Univ, Sch Med, Dept Family & Community Med, Springfield, IL USA; [Lee, Sae Yong] Yonsei Univ, Dept Phys Educ, Seoul, South Korea		Lee, SY (corresponding author), 310 Sports Sci Complex,50 Yonsei Ro, Seoul 03722, South Korea.	sylee1@yonsei.ac.kr			World Taekwondo Medical & Anti-Doping Committee; Yonsei University	This study was conducted in cooperation with the World Taekwondo Medical & Anti-Doping Committee, which is part of the World Taekwondo Sports and Event Management Department and IOC Research Centre Korea (Yonsei Institute of Sports Science and Exercise Medicine) ; the latter is dedicated to preventing injury to and protecting athletes. We acknowledge all athletes at the 2017 WTC who participated in this study. We deeply appreciate the cooperation of all team physicians and the Yonsei Institution of Sports Science and Exercise Medicine and Muju Taekwondo Committee medical staff who volunteered their time to collect the data for this project. We would like to thank World Taekwondo for all practical support. This work was supported by the Yonsei University Research Grant of 2020.	Alonso JM, 2010, BRIT J SPORT MED, V44, P1100, DOI 10.1136/bjsm.2010.078030; [Anonymous], 2016, WORLD TAEKWONDO 1115; Beis K, 2001, EUR J SPORT TRAUMA R, V23, P130; Bromley SJ, 2018, BRIT J SPORT MED, V52, P8, DOI 10.1136/bjsports-2016-097313; Burger M, 2018, J BACK MUSCULOSKELET, V31, P221, DOI 10.3233/BMR-170804; Cierna D, 2018, BRIT J SPORT MED, V52, P730, DOI 10.1136/bjsports-2017-097756; Competition rules & interpretation, WORLD TAEKWONDO; Dargo L, 2017, J ATHL TRAINING, V52, P1171, DOI 10.4085/1062-6050-52.12.21; Derman W, 2013, BRIT J SPORT MED, V47, P420, DOI 10.1136/bjsports-2013-092375; Dick R, 2007, J ATHL TRAINING, V42, P173; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Fife GP, 2013, BRIT J SPORT MED, V47, P1161, DOI 10.1136/bjsports-2012-090979; Guermazi A, 2018, RADIOLOGY, V287, P922, DOI 10.1148/radiol.2018171510; Hayashi D, 2018, BRIT J SPORT MED, V52, P470, DOI 10.1136/bjsports-2017-098189; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Kazemi M, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-22; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Koh JO, 2001, INT J APPL SPORTS SC, V13, P33; Miarka B, 2018, INT J PERF ANAL SPOR, V18, P229, DOI 10.1080/24748668.2018.1463777; Nikolaidis PT, 2016, OPEN ACCESS J SPORTS, V7, P177, DOI 10.2147/OAJSM.S120344; O'Sullivan DM, 2013, BRIT J SPORT MED, V47, P447, DOI 10.1136/bjsports-2012-091416; Park KJ, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2017-097530; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011; Ramazanoglu N, 2012, ARCH BUDO, V8, P207, DOI 10.12659/AOB.883524; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; Soligard T, 2015, BRIT J SPORT MED, V49, P441, DOI 10.1136/bjsports-2014-094538; Thomas RE, 2017, PHYSICIAN SPORTSMED, V45, P372, DOI 10.1080/00913847.2017.1369193; Yiemsiri P, 2008, J THAI REHABIL MED, V18, P37	29	1	1	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2021	56	11					1232	1238		10.4085/330-19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WZ4WD	WOS:000719968500009	33657209	gold			2022-02-06	
J	Jorna, LS; Westerhof-Evers, HJ; Khosdelazad, S; Rakers, SE; van der Naalt, J; Groen, RJM; Buunk, AM; Spikman, JM				Jorna, Lieke S.; Westerhof-Evers, Herma J.; Khosdelazad, Sara; Rakers, Sandra E.; van der Naalt, Joukje; Groen, Rob J. M.; Buunk, Anne M.; Spikman, Jacoba M.			Behaviors of Concern after Acquired Brain Injury: The Role of Negative Emotion Recognition and Anger Misattribution	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Problem behavior; Social cognition; Emotion recognition; Brain injuries; Subarachnoid hemorrhage; Traumatic brain injury	SUBARACHNOID HEMORRHAGE; SOCIAL COGNITION; FACIAL EXPRESSION; SEX-DIFFERENCES; SELF-AWARENESS; HEAD-INJURY; DEFICITS; IMPAIRMENTS; INDIVIDUALS; AGGRESSION	Objective: Behavioral changes are common after acquired brain injury (ABI) and may be caused by social cognition impairments. We investigated whether impaired emotion recognition, specifically Negative Emotion Recognition (NER) and Anger Misattribution (AM), after ABI was related to behavioral problems, so-called Behaviors of Concern (BoC). Method: The study included 139 participants with ABI and 129 healthy controls. BoC was measured using four scales of the Brock Adaptive Functioning Questionnaire (BAFQ): Impulsivity, Aggression, Social Monitoring, and Empathy. Both self-ratings and informant ratings of BoC were obtained. Emotion recognition was measured with the Ekman 60 Faces Test (FEEST). A NER score was composed of the summed scores on Anger, Disgust, Fear, and Sadness. An AM score was composed of the number of facial expressions wrongly recognized as Anger. Results: Total FEEST scores in ABI participants were significantly worse than in healthy controls. The effect size is moderate. Informants rated significantly more problems in Social Monitoring and Empathy than participants. Effect sizes were small. Scores on FEEST total, NER, and AM were significantly correlated to informant ratings of Social Monitoring. Correlations were weak to moderate. Conclusions: Worse NER and more profound AM were related to more informant-rated problems in social monitoring. In addition, informants rated more problems in social monitoring and empathy than participants. This strongly suggests problems in self-awareness in ABI participants. Consequently, social cognition tests and informant ratings should be used in clinical practice to improve the detection and treatment of BoC after ABI.	[Jorna, Lieke S.; Khosdelazad, Sara; Rakers, Sandra E.; Buunk, Anne M.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol Subdepartment Neuropsychol, Groningen, Netherlands; [Jorna, Lieke S.; Khosdelazad, Sara; Rakers, Sandra E.; van der Naalt, Joukje; Buunk, Anne M.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Westerhof-Evers, Herma J.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil, Groningen, Netherlands; [Groen, Rob J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands		Jorna, LS (corresponding author), Univ Med Ctr Groningen, Dept Neurol AB51, POB 30-001, NL-9700 RB Groningen, Netherlands.	l.s.jorna@umcg.nl		Jorna, Lieke/0000-0001-6276-539X; van der Naalt, Joukje/0000-0001-9873-2418; Khosdelazad, Sara/0000-0001-7674-352X			Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Besharat MA, 2013, ASIAN J PSYCHIATR, V6, P35, DOI 10.1016/j.ajp.2012.07.013; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brooks N., 1990, TRAUMATIC BRAIN INJU, P77; Buchanan KM, 2000, NEUROSURGERY, V46, P831, DOI 10.1097/00006123-200004000-00012; Buunk AM, 2017, NEUROPSYCHOLOGIA, V103, P131, DOI 10.1016/j.neuropsychologia.2017.07.015; Buunk AM, 2016, NEUROPSYCHOLOGY, V30, P961, DOI 10.1037/neu0000296; Buunk AM, 2015, BRAIN INJURY, V29, P1589, DOI 10.3109/02699052.2015.1073789; Carton JS, 1999, J NONVERBAL BEHAV, V23, P91, DOI 10.1023/A:1021339410262; Cohen AS, 2009, PSYCHOPATHOLOGY, V42, P40, DOI 10.1159/000173702; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd Edn; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008; Feeney Timothy J., 2010, Seminars in Speech and Language, V31, P145, DOI 10.1055/s-0030-1257531; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hedlund M, 2011, BRIT J NEUROSURG, V25, P693, DOI 10.3109/02688697.2011.578769; Hicks AJ, 2017, BRAIN INJURY, V31, P1312, DOI 10.1080/02699052.2017.1317361; HOLM S, 1979, SCAND J STAT, V6, P65; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hutter BO, 2014, J NEUROSURG, V120, P923, DOI 10.3171/2013.11.JNS121552; Hunnikin LM, 2020, EUR CHILD ADOLES PSY, V29, P363, DOI 10.1007/s00787-019-01358-w; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P197, DOI 10.1097/HTR.0000000000000259; Neumann D, 2015, REHABIL PSYCHOL, V60, P155, DOI 10.1037/rep0000036; Nijsse B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213725; Olderbak S, 2019, COGNITION EMOTION, V33, P579, DOI 10.1080/02699931.2018.1454403; Perroud N, 2011, J AFFECT DISORDERS, V134, P112, DOI 10.1016/j.jad.2011.05.048; Pickett CL, 2004, PERS SOC PSYCHOL B, V30, P1095, DOI 10.1177/0146167203262085; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rapcsak SZ, 2000, NEUROLOGY, V54, P575, DOI 10.1212/WNL.54.3.575; Spikman JM, 2016, J NEUROTRAUM, V33, P22, DOI 10.1089/neu.2014.3788; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Taft CT, 2017, CURR OPIN PSYCHOL, V14, P67, DOI 10.1016/j.copsyc.2016.11.008; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; Timmer ML, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00246; Verhage F, 1964, INTELLIGENTIE LEEFTI; Voncken L, 2018, TIJDSCHRIFT NEUROPSY, V13, P143; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Young A., 2002, FACIAL EXPRESSIONS E	61	1	1	3	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2021	27	10					1015	1023	PII S135561772000140X	10.1017/S135561772000140X			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	XB4SP	WOS:000721321000008	33441210	Green Published, hybrid			2022-02-06	
J	Kelly, PD; Patel, PD; Yengo-Kahn, AM; Wolfson, DI; Dawoud, F; Ahluwalia, R; Guillamondegui, OD; Bonfield, CM				Kelly, Patrick D.; Patel, Pious D.; Yengo-Kahn, Aaron M.; Wolfson, Daniel, I; Dawoud, Fakhry; Ahluwalia, Ranbir; Guillamondegui, Oscar D.; Bonfield, Christopher M.			Incorporating conditional survival into prognostication for gunshot wounds to the head	JOURNAL OF NEUROSURGERY			English	Article						GSW; gunshot wound; penetrating brain injury; prognostic scores; conditional survival; functional outcome; trauma; traumatic brain injury	BRAIN-INJURY; MANAGEMENT; PREDICTORS; MORTALITY	OBJECTIVE Several scores estimate the prognosis for gunshot wounds to the head (GSWH) at the point of hospital admission. However, prognosis may change over the course of the hospital stay. This study measures the accuracy of the Baylor score among patients who have already survived the acute phase of hospitalization and generates conditional outcome curves for the duration of hospital stay for patients with GSWH. METHODS Patients in whom GSWH with dural penetration occurred between January 2009 and June 2019 were identi-fied from a trauma registry at a level I trauma center in the southeastern US. The Baylor score was calculated using component variables. Conditional overall survival and good functional outcome (Glasgow Outcome Scale score of 4 or 5) curves were generated. The accuracy of the Baylor score in predicting mortality and functional outcome among acute-phase survivors (survival > 48 hours) was assessed using receiver operating characteristic curves and the area under the curve (AUC). RESULTS A total of 297 patients were included (mean age 38.0 [SD 15.7] years, 73.4% White, 85.2% male), and 129 patients survived the initial 48 hours of admission. These acute-phase survivors had a decreased mortality rate of 32.6% (n = 42) compared to 68.4% (n = 203) for all patients, and an increased rate of good functional outcome (48.1%; n = 62) compared to the rate for all patients (23.2%; n = 69). Among acute-phase survivors, the Baylor score accurately predict-ed mortality (AUC = 0.807) and functional outcome (AUC = 0.837). However, the Baylor score generally overestimated true mortality rates and underestimated good functional outcome. Additionally, hospital day 18 represented an inflection point of decreasing probability of good functional outcome. CONCLUSIONS During admission for GSWH, surviving beyond the acute phase of 48 hours doubles the rates of sur-vival and good functional outcome. The Baylor score maintains reasonable accuracy in predicting these outcomes for acute-phase survivors, but generally overestimates mortality and underestimates good functional outcome. Future prog-nostic models should incorporate conditional survival to improve the accuracy of prognostication after the acute phase.	[Kelly, Patrick D.; Yengo-Kahn, Aaron M.; Dawoud, Fakhry; Ahluwalia, Ranbir; Bonfield, Christopher M.] Vanderbilt Univ, Dept Neurol Surg, Med Ctr, Nashville, TN USA; [Patel, Pious D.; Wolfson, Daniel, I] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Dawoud, Fakhry] East Tennessee State Univ, Quillen Coll Med, Mountain Home, TN USA; [Ahluwalia, Ranbir] Florida State Univ, Coll Med, Tallahassee, FL USA; [Guillamondegui, Oscar D.] Vanderbilt Univ, Med Ctr, Div Trauma Emergency Surg & Crit Care, Nashville, TN USA		Patel, PD (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	pious.d.patel@vanderbilt.edu		Kelly, Patrick/0000-0003-4911-4239	NCATS/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445]; National Cancer Institute of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA106183]	Sources of support include the following: REDCap, used for study data management, is supported by NCATS/NIH grant no. UL1 TR000445. Dr. Kelly is supported by a training grant from the National Cancer Institute of the NIH under award no. T32CA106183.	Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; Alao T, 2020, STATPEARLS; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Alvis-Miranda Hernando Raphael, 2015, Korean J Neurotrauma, V11, P35, DOI 10.13004/kjnt.2015.11.2.35; Andrade AF, 2011, INT J GEN MED, V4, P175, DOI 10.2147/IJGM.S13464; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Bandt SK, 2012, J NEUROSURG-PEDIATR, V10, P511, DOI 10.3171/2012.8.PEDS123; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; del Junco DJ, 2013, J TRAUMA ACUTE CARE, V75, pS97, DOI 10.1097/TA.0b013e318298b0a4; Efird JT, 2014, J CARDIOVASC MED, V15, P498, DOI 10.2459/JCM.0b013e328365b615; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Henry, 2018, B AM COLL SURG; Hieke S, 2015, CLIN CANCER RES, V21, P1530, DOI 10.1158/1078-0432.CCR-14-2154; Kim KA, 2005, NEUROSURGERY, V57, P737, DOI [10.1227/01.NEU.0000175727.76530.94, 10.1227/01.NEU.0000164174.07281.F9]; Kim LH, 2020, J CLIN NEUROSCI, V75, P71, DOI 10.1016/j.jocn.2020.03.027; Marshall DC, 2020, CRIT CARE MED, V48, P91, DOI 10.1097/CCM.0000000000004082; Martin GT, 2016, ANN ROY COLL SURG, V98, P6, DOI 10.1308/rcsann.2016.0003; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Mikati AG, 2019, NEUROSURGERY, V85, pE872, DOI 10.1093/neuros/nyz127; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; Seow H, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.1768; Skuladottir H, 2003, J CLIN ONCOL, V21, P3035, DOI 10.1200/JCO.2003.04.521; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Syed A T, 2007, Int J Health Sci (Qassim), V1, P131; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tunthanathip Thara, 2019, Bull Emerg Trauma, V7, P347, DOI 10.29252/beat-070402; Zabor EC, 2013, CANCER-AM CANCER SOC, V119, P3589, DOI 10.1002/cncr.28273; Zamboni BA, 2010, J CLIN ONCOL, V28, P2544, DOI 10.1200/JCO.2009.23.0573; Zheng MH, 2015, ONCOTARGET, V6, P23261, DOI 10.18632/oncotarget.4666	30	1	1	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2021	135	5					1550	1559		10.3171/2020.9.JNS202723			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WS1YJ	WOS:000714984700002	33690152				2022-02-06	
J	Lynall, RC; Johnson, RS; Lempke, LB; Schmidt, JD				Lynall, Robert C.; Johnson, Rachel S.; Lempke, Landon B.; Schmidt, Julianne D.			Test-Retest Reliability of a Functional Reaction Time Assessment Battery	JOURNAL OF SPORT REHABILITATION			English	Article						movement time; concussion; musculoskeletal injury		Context: Reaction time is commonly assessed postconcussion through a computerized neurocognitive battery. Although this measure is sensitive to postconcussion deficits, it is not clear if computerized reaction time reflects the dynamic reaction time necessary to compete effectively and safely during sporting activities. Functional reaction time assessments may be useful postconcussion, but reliability must be determined before clinical implementation. Objective: To determine the test-retest reliability of a functional reaction time assessment battery and to determine if reaction time improved between sessions. Design: Cohort. Setting: Laboratory. Participants: Forty-one participants (21 men and 20 women) completed 2 time points. Participants, on average, were 22.5 (2.1) years old, 72.5 (11.9) cm tall, had a mass of 71.0 (13.7) kg, and were mostly right leg and hand dominant (92.7%). Interventions: Participants completed 2 clinical reaction time tests (computerized Stroop and drop stick) and 5 functional reaction time tests (gait, jump landing, single-leg hop, anticipated cut, and unanticipated cut) across 2 sessions. Drop stick and functional reaction time assessments were performed in single (motor task only) and dual task (motor task with cognitive task). Main Outcome Measures: Reaction time (in seconds) was calculated during all assessments. Test-retest reliability was determined using 2-way mixed-effects intraclass correlation coefficients (3, k). Paired samples t tests compared mean reaction time between sessions. Results: Test-retest reliability was moderate to excellent for all reaction time outcomes (intraclass correlation coefficients [3, k] range = .766-.925). Several statistically significant between-session mean differences were observed, but effect sizes were negligible to small (d range = 0.05-0.44). Conclusions: The functional reaction time assessment battery displayed similar reliability to the standard computerized reaction time assessment battery and may provide important postinjury information, but more research is needed to determine clinical utility.	[Lynall, Robert C.; Johnson, Rachel S.; Lempke, Landon B.; Schmidt, Julianne D.] Univ Georgia, Mary Frances Early Coll Educ, Dept Kinesiol, UGA Biomech Lab, Athens, GA 30602 USA		Lynall, RC (corresponding author), Univ Georgia, Mary Frances Early Coll Educ, Dept Kinesiol, UGA Biomech Lab, Athens, GA 30602 USA.	rlynall@uga.edu			Mary Frances Early College of Education at the University of Georgia	This study was supported by a grant from the Mary Frances Early College of Education at the University of Georgia. The authors have no conflict of interest to disclose.	Armitano-Lago CN, 2020, SCAND J MED SCI SPOR, V30, P1518, DOI 10.1111/sms.13698; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Laby DM, 2018, OPTOMETRY VISION SCI, V95, P557, DOI 10.1097/OPX.0000000000001239; Lempke LB, 2020, SPORTS MED, V50, P1341, DOI 10.1007/s40279-020-01281-0; Lempke LB, 2020, MED SCI SPORT EXER, V52, P1650, DOI 10.1249/MSS.0000000000002300; Lynall RC, 2018, ARCH PHYS MED REHAB, V99, P880, DOI 10.1016/j.apmr.2017.12.011; Lynall RC, 2017, GAIT POSTURE, V52, P308, DOI 10.1016/j.gaitpost.2016.12.023; McDonald AA, 2019, J ATHL TRAINING, V54, P489, DOI 10.4085/1062-6050-152-17; Riemann BL, 2018, J ATHL TRAINING, V53, P98, DOI 10.4085/1062-6050-503-16; Song YH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16244909; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532	11	1	1	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	NOV	2021	30	8					1237	1241		10.1123/jsr.2021-0021			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WM6MX	WOS:000711198600021	33952713				2022-02-06	
J	Mejia-Alvarez, R; Kerwin, J; Vidhate, S; Sandherr, P; Patton, E; Davila-Montero, B; Yucesoy, A; Willis, A				Mejia-Alvarez, Ricardo; Kerwin, Joseph; Vidhate, Suhas; Sandherr, Paul; Patton, Evan; Davila-Montero, Bianca; Yucesoy, Atacan; Willis, Adam			Large cross-section blast chamber: design and experimental characterization	MEASUREMENT SCIENCE AND TECHNOLOGY			English	Article						blast tunnel; traumatic brain injury; explosively driven; shock tube	SHOCK-WAVE ATTENUATION; OBSTACLES	This study shows the basic design and experimental characterization of the advanced blast chamber at Michigan State University. This facility is a large cross-section explosively-driven blast chamber. The cross-section of the facility is 2.03 m x 2.03 m, and the length of its tunnel is 5.5 m. This relatively short length was made possible by introducing a new driver design shaped like a pair of logarithmic spirals with a coincident focus. The experimental characterization of the facility demonstrates that this driver design produces blast fronts with very low curvature, and overpressure durations as short as similar to 1.2 ms. Since this was the initial characterization of the facility, the maximum overpressure considered was similar to 144 kPa. This facility was conceived to perform studies of blast-induced traumatic brain injury based on full-size models of the human body or large animal models. Its large cross section ensures that area blockage is within permissible values, and its driver design ensures short overpressure durations typical of battle field blast events.	[Mejia-Alvarez, Ricardo; Kerwin, Joseph; Vidhate, Suhas; Sandherr, Paul; Patton, Evan; Davila-Montero, Bianca; Yucesoy, Atacan; Willis, Adam] Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA; [Willis, Adam] Brooke Army Med Ctr, Dept Neurol, Ft Sam Houston, TX 78234 USA		Mejia-Alvarez, R (corresponding author), Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA.	rimejal@egr.msu.edu			Michigan State University; Air Force Research Laboratory [FA8650-18-2-6880]	The authors express their gratitude to Mr Jeffrey Grant Osborne from the Transportation Security Administration of the U S Department of Homeland Security. Mr Osborne was instrumental in training our technical personnel, and in developing protocols for the safe operation of the facility with high explosives. This work would have not been possible without his expert guidance. This work was sponsored in part by Michigan State University and in part by the Air Force Research Laboratory (Award No. FA8650-18-2-6880). The view(s) expressed herein are those of the author(s) and do not reflect the official policy or position of Brooke Army Medical Center, the U S Army Medical Department, the U S Army Office of the Surgeon General, the Department of the Army, the Department of the Air Force, the Department of Defense, the U S Government, or the Transportation Security Administration of the U S Department of Homeland Security.	[Anonymous], 2020, DOD TBI WORLDWIDE NU; Courtney MW, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3518970; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; FRIEDLANDER FG, 1946, PROC R SOC LON SER-A, V186, P322, DOI 10.1098/rspa.1946.0046; Igra O., 2016, EXPT METHODS SHOCK W, V9, P478, DOI [10.1007/978-3-319-23745-9, DOI 10.1007/978-3-319-23745-9]; INOUE O, 1993, AIAA J, V31, P1150, DOI 10.2514/3.11740; INOUE O, 1995, SHOCK WAVES, V5, P183, DOI 10.1007/BF01435526; Jeon H, 2015, AEROSPACE, V2, P353, DOI 10.3390/aerospace2020353; Kochavi E, 2020, EXP MECH, V60, P1149, DOI 10.1007/s11340-020-00650-0; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Lee E., 1968, UCRL50422; Mahmadi K., 2003, ASME 2003 PRESS VESS, P243, DOI [10.1115/PVP2003-1969, DOI 10.1115/PVP2003-1969]; McConville JT., 1980, ADA097238 ANTHR RES; McCullough E.A, 1998, ASHRAE T, V104, P1327; MILTON BE, 1969, AIAA J, V7, P779, DOI 10.2514/3.5221; Milton BE., 1989, P INT WORKSH SHOCK W, V384, P155; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Skriudalen S., 2014, FFIRAPPORT201303017; Stewart JB, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4914898; Sundaramurthy A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00253; Tanielian T., 2008, ADA480992 RAND CORP; VandeVord PJ, 2016, METHODS MOL BIOL, V1462, P101, DOI 10.1007/978-1-4939-3816-2_7; Walter PL, 2004, SOUND VIB, V38, P10; Wan Q, 2015, AEROSPACE, V2, P203, DOI 10.3390/aerospace2020203; WHITHAM GB, 1957, J FLUID MECH, V2, P145, DOI 10.1017/S002211205700004X; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	26	1	1	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-0233	1361-6501		MEAS SCI TECHNOL	Meas. Sci. Technol.	NOV	2021	32	11							115902	10.1088/1361-6501/ac12fc			14	Engineering, Multidisciplinary; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Instruments & Instrumentation	TT9LZ	WOS:000680665400001					2022-02-06	
J	Merritt, VC; Lippa, RT; Lippa, SM; Brickell, TA; Soltis, AR; Dalgard, CL; Gill, JM; French, LM				Merritt, Victoria C.; Lippa, Rael T.; Lippa, Sara M.; Brickell, Tracey A.; Soltis, Anthony R.; Dalgard, Clifton L.; Gill, Jessica M.; French, Louis M.			Apolipoprotein e (APOE) epsilon 4 genotype influences memory performance following remote traumatic brain injury in US military service members and veterans	BRAIN AND COGNITION			English	Article						Genetics; Neurocognition; Verbal memory; Military; Neuropsychological assessment; TBI; Head injury	E POLYMORPHISM; NEUROCOGNITIVE PERFORMANCE; ALZHEIMERS-DISEASE; OEF/OIF VETERANS; MODERATE; ALLELE; GENE; MECHANISMS; RECOVERY; SEX	The purpose of this study was to examine the association between the apolipoprotein E (APOE) epsilon 4 allele and neurocognitive functioning following traumatic brain injury (TBI) in military service members and veterans (SMVs). Participants included 176 SMVs with a history of remote TBI (>= 1 year post-injury), categorized into mild (n = 100), moderate (n = 40), and severe (n = 36) TBI groups. Participants completed a neuropsychological assessment and APOE genotyping (n = 46 epsilon 4+, n = 130 epsilon 4-). Neurocognitive composite scores representing memory, executive functioning, and visual processing speed were computed. ANCOVAs adjusting for race, education, combat exposure, and PTSD symptom severity showed a significant main effect of epsilon 4 on the memory composite, such that epsilon 4+ SMVs exhibited poorer memory performance than epsilon 4- SMVs. When epsilon 2 allele carriers were removed from the analyses, associations with memory were strengthened, demonstrating a possible protective effect of the epsilon 2 allele. No main effect of TBI group was identified on any cognitive composite, nor were there any significant TBI group x epsilon 4 status interactions for any cognitive composite. Future studies with larger samples are needed to verify these findings, but our results suggest an important relationship between epsilon 4 status and memory functioning following remote TBI of all severities.	[Merritt, Victoria C.] VA San Diego Healthcare Syst, 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA; [Merritt, Victoria C.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Lippa, Rael T.; Brickell, Tracey A.; French, Louis M.] Tramat Brain Injury Ctr Excellence, Silver Spring, MD USA; [Lippa, Rael T.; Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lippa, Rael T.; Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lippa, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Lippa, Rael T.; Brickell, Tracey A.] Gen Dynam Informat Technol, Falls Church, VA USA; [Lippa, Rael T.; Brickell, Tracey A.] Ctr Excellence Post Traumat Stress Disorder, Ottawa, ON, Canada; [Brickell, Tracey A.; Dalgard, Clifton L.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Soltis, Anthony R.] Henry M Jackson Fdn, Bethesda, MD USA; [Soltis, Anthony R.] PRIMER, Bethesda, MD USA; [Dalgard, Clifton L.] Amer Genome Ctr, Bethesda, MD USA; [Gill, Jessica M.] NINR, NIH, Bethesda, MD 20892 USA		Merritt, VC (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA.	victoria.merritt@va.gov		Dalgard, Clifton/0000-0003-2025-8239	VA Clinical Science Research & Development Service [IK2 CX001952]	Victoria Merritt received salary support during this work from a Career Development Award [IK2 CX001952] from the VA Clinical Science Research & Development Service.	Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; [Anonymous], Neurotrauma, Advance online publication, V38, P1124; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Baxendale S, 2019, PRACT NEUROL, V19, P476, DOI 10.1136/practneurol-2018-002113; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Ben-Moshe H, 2020, J MOL NEUROSCI, V70, P32, DOI 10.1007/s12031-019-01397-7; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bowman GL, 2018, ALZHEIMERS DEMENT, V14, P1640, DOI 10.1016/j.jalz.2018.06.2857; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Dvbic, 2020, DOD WORLDW NUMB TBI; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Evans SL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59272-0; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Green P, 2004, GREENS MED SYMPTOM V; Hodgkinson A, 2009, BRAIN IMPAIR, V10, P162, DOI 10.1375/brim.10.2.162; Horsburgh K, 1997, BRAIN RES, V763, P103, DOI 10.1016/S0006-8993(97)00411-3; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Hunter LE, 2020, JAMA NEUROL, V77, P419, DOI 10.1001/jamaneurol.2019.4828; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Li LZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002028; Lippa SM, 2020, J NEUROTRAUM, V37, P608, DOI 10.1089/neu.2019.6696; Lippa SM, 2018, ARCH CLIN NEUROPSYCH, V33, P606, DOI 10.1093/arclin/acx098; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McCrea M, 2014, MIL MED, V179, P990, DOI 10.7205/MILMED-D-13-00349; McFadyen C. A., 2021, J NEUROTRAUMA ADV ON; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P1050, DOI 10.1080/13803395.2018.1508555; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Padgett CR, 2016, J CLIN EXP NEUROPSYC, V38, P551, DOI 10.1080/13803395.2015.1137557; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Reinvang I, 2013, NEUROSCI BIOBEHAV R, V37, P1322, DOI 10.1016/j.neubiorev.2013.05.006; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Suri S, 2013, NEUROSCI BIOBEHAV R, V37, P2878, DOI 10.1016/j.neubiorev.2013.10.010; Szarka N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133223; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Giau V, 2015, NEUROPSYCH DIS TREAT, V11, P1723, DOI 10.2147/NDT.S84266; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2009, ADV CLIN SOLUTIONS U; Wechsler D., 2009, WECHSLER MEMORY SCAL; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	63	1	1	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	NOV	2021	154								105790	10.1016/j.bandc.2021.105790			10	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	UR6PF	WOS:000696868200003	34487993				2022-02-06	
J	Miguel, CA; Noya-Riobo, MV; Mazzone, GL; Villar, MJ; Coronel, MF				Miguel, C. A.; Noya-Riobo, M. V.; Mazzone, G. L.; Villar, M. J.; Coronel, M. F.			Antioxidant, anti-inflammatory and neuroprotective actions of resveratrol after experimental nervous system insults. Special focus on the molecular mechanisms involved	NEUROCHEMISTRY INTERNATIONAL			English	Article						Resveratrol; Oxidative damage; Neuroinflammation; Autophagy; Motor impairment; Neuropathic pain	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; NF-KAPPA-B; OXIDATIVE STRESS; NEUROPATHIC PAIN; AUTOPHAGY; RATS; RECOVERY; NEUROINFLAMMATION; ACTIVATION	After different types of acute central nervous system insults, including stroke, subarachnoid haemorrhage and traumatic brain and spinal cord injuries, secondary damage plays a central role in the induction of cell death, neurodegeneration and functional deficits. Interestingly, secondary cell death presents an attractive target for clinical intervention because the temporal lag between injury and cell loss provides a potential window for effective treatment. While primary injuries are the direct result of the precipitating insult, secondary damage involves the activation of pathological cascades through which endogenous factors can exacerbate initial tissue damage. Secondary processes, usually interactive and overlapping, include oxidative stress, neuroinflammation and dysregulation of autophagy, ultimately leading to cell death. Resveratrol, a natural stilbene present at relatively high concentrations in grape skin and red wine, exerts a wide range of beneficial health effects. Within the central nervous system, in addition to its inherent free radical scavenging role, resveratrol increases endogenous cellular antioxidant defences thus modulating multiple synergistic pathways responsible for its antioxidant, anti-inflammatory and anti-apoptotic properties. During the last years, a growing body of in vitro and in vivo evidence has been built, indicating that resveratrol can induce a neuroprotective state and attenuate functional deficits when administered acutely after an experimental injury to the central nervous system. In this review, we summarize the most recent findings on the molecular pathways involved in the neuroprotective effects of this multi target polyphenol, and discuss its neuroprotective potential after brain or spinal cord injuries.	[Miguel, C. A.; Noya-Riobo, M. V.; Mazzone, G. L.; Villar, M. J.; Coronel, M. F.] Univ Austral, Lab Dolor Canc, Inst Invest Med Traslac CONICET, Av Pte Preon 1500,B1629AHJ, Buenos Aires, DF, Argentina; [Mazzone, G. L.; Villar, M. J.; Coronel, M. F.] Univ Austral, Fac Ciencias Biomed, Av Pte Preon 1500,B1629AHJ, Buenos Aires, DF, Argentina		Coronel, MF (corresponding author), Univ Austral, Lab Dolor Canc, Inst Invest Med Traslac CONICET, Av Pte Preon 1500,B1629AHJ, Buenos Aires, DF, Argentina.	fcoronel@austral.edu.ar					Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; Ates O, 2006, ACTA PHARMACOL SIN, V27, P1317, DOI 10.1111/j.1745-7254.2006.00416.x; Badhiwala JH, 2019, LANCET NEUROL, V18, P24, DOI 10.1016/S1474-4422(18)30444-7; Bar-Yosef T, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00196; Berman AY, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0038-6; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Brea D, 2009, CEREBROVASC DIS, V27, P48, DOI 10.1159/000200441; Burns J, 2002, J AGR FOOD CHEM, V50, P3337, DOI 10.1021/jf0112973; Cao ZJ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00236; Castaldo L, 2019, MOLECULES, V24, DOI 10.3390/molecules24193626; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Ciftci U, 2016, ULUS TRAVMA ACIL CER, V22, P423, DOI 10.5505/tjtes.2016.44575; Cobley JN, 2018, REDOX BIOL, V15, P490, DOI 10.1016/j.redox.2018.01.008; Coyoy-Salgado A, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3642491; David S, 2015, NEURAL REGENERATION, P245, DOI 10.1016/B978-0-12-801732-6.00016-1; Di Pietro V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030260; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; DiSabato DJ, 2016, J NEUROCHEM, V139, P136, DOI 10.1111/jnc.13607; Etminan N, 2019, JAMA NEUROL, V76, P588, DOI 10.1001/jamaneurol.2019.0006; Fan ZG, 2017, EUR J PHARMACOL, V804, P7, DOI 10.1016/j.ejphar.2017.04.003; Feng Y, 2016, MOL MED REP, V13, P5248, DOI 10.3892/mmr.2016.5201; Finnerup NB, 2017, SPINAL CORD, V55, P1046, DOI 10.1038/sc.2017.70; Fu S, 2018, SAUDI J BIOL SCI, V25, P259, DOI 10.1016/j.sjbs.2016.10.019; Gao Y, 2018, PHARM BIOL, V56, P440, DOI 10.1080/13880209.2018.1502326; Garcia-Altes A, 2012, NEUROEPIDEMIOLOGY, V39, P103, DOI 10.1159/000338297; Hasan MM, 2013, REV ENVIRON SCI BIO, V12, P209, DOI 10.1007/s11157-012-9294-7; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Jiang HS, 2018, CELL MOL NEUROBIOL, V38, P1009, DOI 10.1007/s10571-017-0570-5; Kang Y, 2018, J NEURORESTORATOLOGY, V6, P1, DOI 10.2147/JN.S143236; Kannan, 2000, Pathophysiology, V7, P153, DOI 10.1016/S0928-4680(00)00053-5; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Khoury N, 2019, MOL NEUROBIOL, V56, P4549, DOI 10.1007/s12035-018-1380-6; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kitada M., 2016, ROLE SIRT1 REGULATOR, P89, DOI [10.1016/B978-0-12-802937-4.00003-X, DOI 10.1016/B978-0-12-802937-4.00003-X]; Koronowski KB, 2017, STROKE, V48, P3117, DOI 10.1161/STROKEAHA.117.018562; Kumar A, 2013, CURR MED CHEM, V20, P4640, DOI 10.2174/09298673113209990151; Kumar A, 2010, BIOCHEM BIOPH RES CO, V394, P360, DOI 10.1016/j.bbrc.2010.03.014; Kuzhandaivel Anujaianthi, 2011, Front Cell Neurosci, V5, P9, DOI 10.3389/fncel.2011.00009; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Lamade AM, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113307; Lee SH, 2019, BMB REP, V52, P24, DOI 10.5483/BMBRep.2019.52.1.290; Li XN, 2019, J PAIN RES, V12, P879, DOI 10.2147/JPR.S185873; Liddell JR., 2017, J CLIN CELL IMMUNOL, V8, P1, DOI [10.4172/2155-9899.1000489, DOI 10.4172/2155-9899.1000489]; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu CJ, 2011, BRAIN RES, V1374, P100, DOI 10.1016/j.brainres.2010.11.061; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Liu XH, 2019, MICROSC RES TECHNIQ, V82, P296, DOI 10.1002/jemt.23171; Lopez MS, 2016, J CEREBR BLOOD F MET, V36, P1644, DOI 10.1177/0271678X16656202; Lopez MS, 2015, NEUROCHEM INT, V89, P75, DOI 10.1016/j.neuint.2015.08.009; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; McDaid D, 2019, SPINAL CORD, V57, P778, DOI 10.1038/s41393-019-0285-1; Meng HY, 2018, MOL MED REP, V18, P2237, DOI 10.3892/mmr.2018.9194; Meng J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22390; Merritt Christopher H, 2019, Neuroimmunol Neuroinflamm, V6, DOI 10.20517/2347-8659.2019.15; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Murnion BP, 2018, AUST PRESCR, V41, P60, DOI 10.18773/austprescr.2018.022; Najem D, 2018, BIOCHEM CELL BIOL, V96, P391, DOI 10.1139/bcb-2016-0160; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ovbiagele B, 2011, NEUROTHERAPEUTICS, V8, P319, DOI 10.1007/s13311-011-0053-1; Rabchevsky AG, 2020, EXP NEUROL, V330, DOI 10.1016/j.expneurol.2020.113332; Radad K, 2015, EXPERT REV NEUROTHER, V15, P195, DOI 10.1586/14737175.2015.1002087; Recalde MD, 2020, BRAIN RES, V1748, DOI 10.1016/j.brainres.2020.147079; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Sadria M, 2021, CELL COMMUN SIGNAL, V19, DOI 10.1186/s12964-021-00706-1; Sanchez Carlos, 2005, Acta Farmaceutica Bonaerense, V24, P619; Shi ZH, 2018, MED SCI MONITOR, V24, P1097, DOI 10.12659/MSM.909042; Singh AP, 2019, MED RES REV, V39, P1851, DOI 10.1002/med.21565; Stancu Andreea L, 2015, Discoveries (Craiova), V3, pe53, DOI 10.15190/d.2015.45; Suomi Fumi, 2019, Neuronal Signal, V3, pNS20180134, DOI 10.1042/NS20180134; Tao L, 2016, INT IMMUNOPHARMACOL, V34, P165, DOI 10.1016/j.intimp.2016.02.033; Thapa K, 2021, J MOL NEUROSCI, V71, P1725, DOI 10.1007/s12031-021-01841-7; Tian BR, 2020, J SCI FOOD AGR, V100, P1392, DOI 10.1002/jsfa.10152; Tisdale Michael J, 2005, J Support Oncol, V3, P209; Toklu H.Z., 2015, BRAIN NEUROTRAUMA MO, P43, DOI [10.1201/b18126, DOI 10.1201/B18126]; Vemuganti R, 2015, METAB BRAIN DIS, V30, P353, DOI 10.1007/s11011-014-9585-5; Wang P, 2018, ONCOTARGET, V9, P8427, DOI [10.18632/oncotarget.23877, DOI 10.18632/oncotarget.23877]; Wilson JR, 2012, J NEUROSURG-SPINE, V17, P11, DOI 10.3171/2012.4.AOSPINE1245; Wu JM, 2011, ANN NY ACAD SCI, V1215, P16, DOI 10.1111/j.1749-6632.2010.05854.x; Wu JF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070693; Xie YK, 2019, NEURAL REGEN RES, V14, P1734, DOI 10.4103/1673-5374.257529; Xu BP, 2020, NEURAL REGEN RES, V15, P482, DOI 10.4103/1673-5374.266064; Xu M, 2018, MOL PAIN, V14, DOI 10.1177/1744806918767549; Yan P, 2017, IRAN J BASIC MED SCI, V20, P1029, DOI 10.22038/IJBMS.2017.9272; Yang H, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00484; Yang YJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0550-6; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhang XS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081331; Zhang YD, 2021, ALL LIFE, V14, P66, DOI 10.1080/26895293.2020.1861111; Zhao HS, 2017, NEUROSCIENCE, V348, P241, DOI 10.1016/j.neuroscience.2017.02.027; Zhao X, 2014, NEUROPHARMACOLOGY, V85, P131, DOI 10.1016/j.neuropharm.2014.04.021; Zordoky BNM, 2015, BBA-MOL BASIS DIS, V1852, P1155, DOI 10.1016/j.bbadis.2014.10.016	96	1	1	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2021	150								105188	10.1016/j.neuint.2021.105188			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	WK1EE	WOS:000709475500003	34536545				2022-02-06	
J	O'Neil, ME; Klyce, DW; Pogoda, TK; Cifu, DX; Eggleston, BE; Cameron, DC; Wilde, EA; Walker, WC; Carlson, KF				O'Neil, Maya E.; Klyce, Daniel W.; Pogoda, Terri K.; Cifu, David X.; Eggleston, Barry E.; Cameron, David C.; Wilde, Elisabeth A.; Walker, William C.; Carlson, Kathleen F.			Associations Among PTSD and Postconcussive Symptoms in the Long-Term Impact of Military-Relevant Brain Injury Consortium-Chronic Effects of Neurotrauma Consortium Prospective, Longitudinal Study Cohort	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						combat exposure; confirmatory factor analysis; mild traumatic brain injury; military service members; Neurobehavioral Symptom Inventory; postconcussive symptoms; posttraumatic stress; veterans	POSTTRAUMATIC-STRESS-DISORDER; CENC MULTICENTER; SERVICE MEMBERS; PAIN; PREVALENCE; TBI	Objective: To describe rates of mild traumatic brain injury (mTBI) with and without concurrent posttraumatic stress disorder a sample of former and current military personnel, and to compare the factor structure of the Neurobehavioral Symptom Inventory (NSI) based on whether participants sustained mTBI with and without a positive posttraumatic stress disorder (PTSD) screen. Setting: Participants recruited and tested at 7 Veterans Affairs (VA) sites and 1 military training facility as part of a national, longitudinal study of mental health, physical, and cognitive outcomes among veterans and service members. Participants: Total of 1540 former and current military personnel with a history of combat exposure. Design: Cross-sectional analysis of observational data, including confirmatory factor analysis. Main Measures: NSI and PTSD Checklist for DSM-5 (PCL-5). Results: Most participants (81.5%) had a history of mTBI and almost half of these screened positive for PTSD (40.5%); only 23.9% of participants without a history of mTBI screened positive for PTSD. Participants with a history of mTBI reported higher elevations of NSI and PCL-5 symptoms compared with those without a history of mTBI. Confirmatory factor analyses of the NSI demonstrated good model fit using a 4-factor structure (somatosensory, affective, cognitive, and vestibular symptoms) among groups of participants both with and without a history of mTBI. Conclusion: Symptoms of mTBI and PTSD are strongly associated with each other among veterans and service members with a history of combat exposure. The 4-factor NSI structure is supported among participants with and without a history of mTBI. These findings suggest the potential benefit of a holistic approach to evaluation and treatment of veterans and service members with concurrent and elevated postconcussive and posttraumatic stress symptoms.	[O'Neil, Maya E.; Cameron, David C.; Carlson, Kathleen F.] VA Portland Hlth Care Syst, Portland, OR 97239 USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Med Informat, Portland, OR USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Clin Epidemiol, Portland, OR USA; [Klyce, Daniel W.; Cifu, David X.; Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Richmond, VA USA; [Klyce, Daniel W.; Cifu, David X.] Cent VA Healthcare Syst, Richmond, VA USA; [Klyce, Daniel W.; Cifu, David X.] Sheltering Arms Inst, Richmond, VA USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Wilde, Elisabeth A.] George E Wahlen VA Salt Lake City Healthcare Syst, Salt Lake City, UT USA; [Wilde, Elisabeth A.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Carlson, Kathleen F.] Oregon Heath & Sci Univ, Sch Publ Hlth, Portland, OR USA		O'Neil, ME (corresponding author), VA Portland Hlth Care Syst R&D 66, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	Maya.Oneil@va.gov			US Department of Veterans AffairsUS Department of Veterans Affairs [I01 CX002097, I01 CX002096, I01 HX003155, I01 RX003444, I01 RX003443, I01 RX003442, I01 CX001135, I01 CX001246, I01 RX001774, I01 RX 001135, I01 RX 002076, I01 RX 001880, I01 RX 002172, I01 RX 002173, I01 RX 002171, I01 RX 002174, I01 RX 002170]; Assistant Secretary of Defense for Health Affairs [W81XWH-18-PH/TBIRP-LIMBIC, W81XWH1920067, W81XWH-13-2-0095]	This work was supported by the Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, through the Psychological Health/Traumatic Brain Injury Research Program Long-Term Impact of Military-Relevant Brain Injury Consortium (LIMBIC) Award/W81XWH-18-PH/TBIRP-LIMBIC under Awards No. W81XWH1920067 and W81XWH-13-2-0095, and by the US Department of Veterans Affairs Awards No. I01 CX002097, I01 CX002096, I01 HX003155, I01 RX003444, I01 RX003443, I01 RX003442, I01 CX001135, I01 CX001246, I01 RX001774, I01 RX 001135, I01 RX 002076, I01 RX 001880, I01 RX 002172, I01 RX 002173, I01 RX 002171, I01 RX 002174, and I01 RX 002170. The US Army Medical Research Acquisition Activity, 839 Chandler Street, Fort Detrick, MD 21702, is the awarding and administering acquisition office.	Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2018, BRAIN INJURY, V32, P1149, DOI 10.1080/02699052.2018.1496274; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cifu DX, 2010, AM J PHYS MED REHAB, V89, P688, DOI 10.1097/PHM.0b013e3181e722ad; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hooper D, 2008, 7TH EUROPEAN CONFERENCE ON RESEARCH METHODOLOGY FOR BUSINESS AND MANAGEMENT STUDIES, P195; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2018, BRAIN INJURY, V32, P1079, DOI 10.1080/02699052.2018.1479041; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Weathers FW, PTSD CHECKLIST DSM 5	20	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2021	36	6			SI		E363	E372		10.1097/HTR.0000000000000665			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WV3QT	WOS:000717155100001	33656490				2022-02-06	
J	Parker, HA; Ranson, J; McCrea, MA; Hoelzle, J; deRoon-Cassini, T; Nelson, LD				Parker, Hillary A.; Ranson, Jana; McCrea, Michael A.; Hoelzle, James; deRoon-Cassini, Terri; Nelson, Lindsay D.			Personality Characteristics and Acute Symptom Response Predict Chronic Symptoms After Mild Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain concussion; Post-concussion syndrome; Human characteristics; Psychology; Affect; Recovery of function	POST-CONCUSSION SYMPTOMS; TRAIT MODEL; POSTCONCUSSION SYMPTOMS; 5-FACTOR MODELS; RISK-FACTORS; RESILIENCE; DISORDER; VALIDATION; INVENTORY; SPORT	Objective: Despite consensus that personality influences mild traumatic brain injury (mTBI) recovery, it has been underexamined. We evaluated the extent to which diverse personality and psychiatric symptom dimensions predict mTBI recovery. Methods: This prospective cohort study involved psychological assessments of hospital patients with mTBI (n = 75; median = 2 days post-injury, range = 0-12 days) and orthopedic trauma controls (OTC; n = 79) who were used for comparison in mediation modeling. Chronic symptoms were evaluated at 3 months after mTBI (n = 50) using the Sport Concussion Assessment Tool (SCAT) symptom checklist. Linear regression analyses were used to identify the predominant predictors of chronic symptoms in mTBI. Modern mediation analyses tested the hypothesis that personality traits predict chronic symptoms through acute psychological response to injury. Results: In mTBI, trait psychoticism directly predicted chronic mTBI symptoms and was the strongest personality predictor overall. Furthermore, an internalizing personality dimension emphasizing negative affect/emotionality and detachment predicted chronic mTBI symptoms indirectly through enhancement of acute somatic complaints. In OTC, internalizing personality acted through the same mediator as in mTBI, whereas the effect of psychoticism was also mediated through acute somatic complaints. There was varying support for a moderated direct effect of personality traits at low levels of positive emotionality across models. Conclusion: These causal models provide novel insights about the role of personality in mTBI symptom recovery, highlighting the complexity of how psychological processes may interact to affect recovery and revealing that some of these processes may be non-specific to brain injury.	[Parker, Hillary A.] Dept Neurol, Mt Carmel Hlth Syst, Columbus, OH USA; [Parker, Hillary A.; McCrea, Michael A.] Clement J Zablocki VA Med Ctr, Milwaukee, WI USA; [Ranson, Jana; McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI USA; [Hoelzle, James] Marquette Univ, Dept Psychol, Milwaukee, WI USA; [deRoon-Cassini, Terri] Div Trauma & Acute Care Surg, Dept Surg, Med Coll Wisconsin, Milwaukee, WI USA		Nelson, LD (corresponding author), Med Coll Wisconsin, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu		Parker, Hillary/0000-0002-8610-5975; Nelson, Lindsay/0000-0001-5258-953X	National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000055]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS110856]; Research and Educational Program Fund, a component of the Advancing a Healthier Wisconsin endowment of the Medical College of Wisconsin	This work was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, under Grant UL1TR000055, and the National Institute of Neurological Disorders and Stroke grant #R01 NS110856. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. In addition, this project was funded by the Research and Educational Program Fund, a component of the Advancing a Healthier Wisconsin endowment of the Medical College of Wisconsin. We thank Amy Nader, Tim Geier, and Josh Hunt for their work on the study.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bastiaens T, 2019, ASSESSMENT, V26, P315, DOI 10.1177/1073191117693922; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Chmielewski M, 2014, J PERS DISORD, V28, P483, DOI 10.1521/pedi_2014_28_128; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; DeYong C.G., 2009, CAMBRIDGE HDB PERSON; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gore WL, 2013, J ABNORM PSYCHOL, V122, P816, DOI 10.1037/a0032822; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; HARKNESS AR, 1995, PSYCHOL ASSESSMENT, V7, P104, DOI 10.1037/1040-3590.7.1.104; Hayes, 2018, INTRO MEDIATION MODE; Israel S, 2014, J PERS SOC PSYCHOL, V106, P484, DOI 10.1037/a0035687; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Julien J, 2017, BRAIN INJURY, V31, P1846, DOI 10.1080/02699052.2017.1346289; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kendall MG., 1999, KENDALLS ADV THEORY, V2A; Kennedy JE, 2015, ARCH CLIN NEUROPSYCH, V30, P236, DOI 10.1093/arclin/acv014; Keyes KM, 2013, PSYCHOL MED, V43, P1673, DOI 10.1017/S0033291712002292; Kotov R, 2017, J ABNORM PSYCHOL, V126, P454, DOI 10.1037/abn0000258; Krueger RF, 2012, PSYCHOL MED, V42, P1879, DOI 10.1017/S0033291711002674; Krueger RF, 2007, J ABNORM PSYCHOL, V116, P645, DOI 10.1037/0021-843X.116.4.645; Krueger RF, 2014, ANNU REV CLIN PSYCHO, V10, P477, DOI 10.1146/annurev-clinpsy-032813-153732; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Mccrae RR, 1998, J CROSS CULT PSYCHOL, V29, P171, DOI 10.1177/0022022198291009; McCrea M.A., 2007, MILD TRAUMATIC BRAIN; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; MIDUS, 2018, MIDL US NAT LONG STU; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; Perez-Rodriguez M.M., 2013, FOCUS, V11, P146; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith TW, 2006, CURR DIR PSYCHOL SCI, V15, P227, DOI 10.1111/j.1467-8721.2006.00441.x; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Suvisaari Jaana, 2013, Infectious Disorders - Drug Targets, V13, P59; Suzuki T, 2017, J PERS, V85, P220, DOI 10.1111/jopy.12235; Tellegen, 2008, MINNESOTA MULTIPHASI; Toichi M, 1999, INT J PSYCHOPHYSIOL, V31, P147, DOI 10.1016/S0167-8760(98)00047-6; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wechsler, 1997, WECHSLER ADULT INTEL; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wright AGC, 2012, J ABNORM PSYCHOL, V121, P951, DOI 10.1037/a0027669; Yamagata S, 2006, J PERS SOC PSYCHOL, V90, P987, DOI 10.1037/0022-3514.90.6.987	65	1	1	2	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2021	27	10					992	1003	PII S1355617720001423	10.1017/S1355617720001423			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	XB4SP	WOS:000721321000006	33509312				2022-02-06	
J	Peterson, AL; Young-McCaughan, S; Roache, JD; Mintz, J; Litz, BT; Williamson, DE; Resick, PA; Foa, EB; McGeary, DD; Dondanville, KA; Taylor, DJ; Wachen, JS; Fox, PT; Bryan, CJ; McLean, CP; Pruiksma, KE; Yarvis, JS; Niles, BL; Abdallah, CG; Averill, LA; Back, SE; Baker, MT; Blount, TH; Borah, AM; Borah, EV; Brock, MS; Brown, LA; Burg, MM; Cigrang, JA; DeBeer, BB; DeVoe, ER; Fina, BA; Flanagan, JC; Fredman, SJ; Gardner, CL; Gatchel, RR; Goodie, JL; Gueorguieva, R; Higgs, JB; Jacoby, VM; Kelly, KM; Krystal, JH; Lapiz-Bluhm, MD; Lopez-Roca, AL; Marx, BP; Maurer, DM; McDevitt-Murphy, ME; McGeary, CA; Meyer, EC; Miles, SR; Monson, CM; Morilak, DA; Moring, JC; Mysliwiec, V; Nicholson, KL; Rauch, SAM; Riggs, DS; Rosen, CS; Rudd, MD; Schobitz, RP; Schrader, CC; Shinn, AM; Shiroma, PR; Sloan, DM; Stern, SL; Strong, R; Vannoy, SD; Young, KA; Keane, TM				Peterson, Alan L.; Young-McCaughan, Stacey; Roache, John D.; Mintz, Jim; Litz, Brett T.; Williamson, Douglas E.; Resick, Patricia A.; Foa, Edna B.; McGeary, Donald D.; Dondanville, Katherine A.; Taylor, Daniel J.; Wachen, Jennifer Schuster; Fox, Peter T.; Bryan, Craig J.; McLean, Carmen P.; Pruiksma, Kristi E.; Yarvis, Jeffrey S.; Niles, Barbara L.; Abdallah, Chadi G.; Averill, Lynnette A.; Back, Sudie E.; Baker, Monty T.; Blount, Tabatha H.; Borah, Adam M.; Borah, Elisa V.; Brock, Matthew S.; Brown, Lily A.; Burg, Matthew M.; Cigrang, Jeffrey A.; DeBeer, Bryann B.; DeVoe, Ellen R.; Fina, Brooke A.; Flanagan, Julianne C.; Fredman, Steffany J.; Gardner, Cubby L.; Gatchel, Robert R.; Goodie, Jeffrey L.; Gueorguieva, Ralitza; Higgs, Jay B.; Jacoby, Vanessa M.; Kelly, Kevin M.; Krystal, John H.; Lapiz-Bluhm, M. Danet; Lopez-Roca, Argelio L.; Marx, Brian P.; Maurer, Douglas M.; McDevitt-Murphy, Meghan E.; McGeary, Cindy A.; Meyer, Eric C.; Miles, Shannon R.; Monson, Candice M.; Morilak, David A.; Moring, John C.; Mysliwiec, Vincent; Nicholson, Karin L.; Rauch, Sheila A. M.; Riggs, David S.; Rosen, Craig S.; Rudd, M. David; Schobitz, Richard P.; Schrader, Christian C.; Shinn, Antoinette M.; Shiroma, Paulo R.; Sloan, Denise M.; Stern, Stephen L.; Strong, Randy; Vannoy, Steven D.; Young, Keith A.; Keane, Terence M.			STRONG STAR and the Consortium to Alleviate PTSD: Shaping the future of combat PTSD and related conditions in military and veteran populations	CONTEMPORARY CLINICAL TRIALS			English	Article						STRONG STAR; Consortium to Alleviate PTSD; Posttraumatic stress disorder; Research consortium; Randomized clinical trials	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-PROCESSING THERAPY; MENTAL-HEALTH PROBLEMS; PROLONGED EXPOSURE; IRAQ; TRAJECTORIES; PERSONNEL; IMPACT; TRIAL	The STRONG STAR Consortium (South Texas Research Organizational Network Guiding Studies on Trauma and Resilience) and the Consortium to Alleviate PTSD are interdisciplinary and multi-institutional research consortia focused on the detection, diagnosis, prevention, and treatment of combat-related posttraumatic stress disorder (PTSD) and comorbid conditions in military personnel and veterans. This manuscript outlines the consortia's state-of-the-science collaborative research model and how this can be used as a roadmap for future trauma related research. STRONG STAR was initially funded for 5 years in 2008 by the U.S. Department of Defense's (DoD) Psychological Health and Traumatic Brain Injury Research Program. Since the initial funding of STRONG STAR, almost 50 additional peer-reviewed STRONG STAR-affiliated projects have been funded through the DoD, the U.S. Department of Veterans Affairs (VA), the National Institutes of Health, and private organizations. In 2013, STRONG STAR investigators partnered with the VA's National Center for PTSD and were selected for joint DoD/VA funding to establish the Consortium to Alleviate PTSD. STRONG STAR and the Consortium to Alleviate PTSD have assembled a critical mass of investigators and institutions with the synergy required to make major scientific and public health advances in the prevention and treatment of combat PTSD and related conditions. This manuscript provides an overview of the establishment of these two research consortia, including their history, vision, mission, goals, and accomplishments. Comprehensive tables provide descriptions of over 70 projects supported by the consortia. Examples are provided of collaborations among over 50 worldwide aca-demic research institutions and over 150 investigators.	[Peterson, Alan L.; Young-McCaughan, Stacey; Roache, John D.; Mintz, Jim; McGeary, Donald D.; Dondanville, Katherine A.; Fox, Peter T.; Pruiksma, Kristi E.; Baker, Monty T.; Blount, Tabatha H.; Borah, Elisa V.; Fina, Brooke A.; Jacoby, Vanessa M.; Lapiz-Bluhm, M. Danet; McGeary, Cindy A.; Morilak, David A.; Moring, John C.; Mysliwiec, Vincent; Schobitz, Richard P.; Stern, Stephen L.; Strong, Randy] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Peterson, Alan L.; Young-McCaughan, Stacey; Roache, John D.; Mintz, Jim; McGeary, Donald D.; Fox, Peter T.; Pruiksma, Kristi E.; McGeary, Cindy A.; Morilak, David A.; Stern, Stephen L.; Strong, Randy] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Peterson, Alan L.; McGeary, Donald D.] Univ Texas San Antonio, San Antonio, TX USA; [Litz, Brett T.; Wachen, Jennifer Schuster; Niles, Barbara L.; Marx, Brian P.; Sloan, Denise M.; Keane, Terence M.] VA Boston Healthcare Syst, Boston, MA USA; [Litz, Brett T.; Wachen, Jennifer Schuster; Niles, Barbara L.; Marx, Brian P.; Sloan, Denise M.; Keane, Terence M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Litz, Brett T.; DeVoe, Ellen R.] Boston Univ, Boston, MA 02215 USA; [Williamson, Douglas E.; Resick, Patricia A.] Duke Univ, Durham, NC USA; [Williamson, Douglas E.] Durham VA Hlth Care Syst, Durham, NC USA; [Foa, Edna B.; Brown, Lily A.] Univ Penn, Philadelphia, PA 19104 USA; [Taylor, Daniel J.] Univ Arizona, Tucson, AZ USA; [Wachen, Jennifer Schuster] Natl Ctr PTSD, Womens Hlth Sci Div, Boston, MA USA; [Bryan, Craig J.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [McLean, Carmen P.; Rosen, Craig S.] VA Palo Alto Hlth Care Syst, Natl Ctr PTSD, Disseminat & Training Div, Menlo Pk, CA USA; [McLean, Carmen P.; Rosen, Craig S.] Stanford Univ, Stanford, CA 94305 USA; [Yarvis, Jeffrey S.; Borah, Adam M.; Kelly, Kevin M.; Maurer, Douglas M.; Nicholson, Karin L.; Schrader, Christian C.] Carl R Darnall Army Med Ctr, Ft Hood, TX USA; [Niles, Barbara L.; Marx, Brian P.; Sloan, Denise M.; Keane, Terence M.] Natl Ctr PTSD, Behav Sci Div, Boston, MA USA; [Abdallah, Chadi G.; Averill, Lynnette A.; Krystal, John H.] VA Connecticut Healthcare Syst, Natl Ctr PTSD, Clin Neurosci Div, West Haven, CT USA; [Abdallah, Chadi G.; Averill, Lynnette A.; Burg, Matthew M.; Krystal, John H.] Yale Univ, Sch Med, New Haven, CT USA; [Back, Sudie E.; Flanagan, Julianne C.] Med Univ South Carolina, Charleston, SC 29425 USA; [Back, Sudie E.; Flanagan, Julianne C.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Baker, Monty T.; Brock, Matthew S.; Gardner, Cubby L.; Shinn, Antoinette M.] Joint Base San Antonio Lackland, 59th Med Wing, San Antonio, TX USA; [Cigrang, Jeffrey A.] Wright State Univ, Daytona Beach, FL USA; [DeBeer, Bryann B.; Meyer, Eric C.; Young, Keith A.] VA VISN 17 Ctr Excellence Res Returning War Vet, Waco, TX USA; [DeBeer, Bryann B.; Meyer, Eric C.; Young, Keith A.] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Fredman, Steffany J.] Penn State Univ, University Pk, PA 16802 USA; [Gatchel, Robert R.] Univ Texas Arlington, Arlington, TX 76019 USA; [Goodie, Jeffrey L.; Riggs, David S.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Gueorguieva, Ralitza] Yale Sch Publ Hlth, New Haven, CT USA; [Higgs, Jay B.; Lopez-Roca, Argelio L.; Schobitz, Richard P.] Joint Base San Antonio Ft Sam Houston, Brooke Army Med Ctr, San Antonio, TX USA; [McDevitt-Murphy, Meghan E.; Rudd, M. David] Univ Memphis, Memphis, TN 38152 USA; [Miles, Shannon R.] James A Haley Vet Affairs Hosp, Tampa, FL USA; [Miles, Shannon R.] Univ S Florida, Tampa, FL 33620 USA; [Monson, Candice M.] Ryerson Univ, Toronto, ON, Canada; [Rauch, Sheila A. M.] Emory Univ, Sch Med, Atlanta, GA USA; [Rauch, Sheila A. M.] Atlanta VA Healthcare Syst, Atlanta, GA USA; [Shiroma, Paulo R.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Shiroma, Paulo R.] Univ Minnesota, Minneapolis, MN USA; [Vannoy, Steven D.] Univ Massachusetts, Boston, MA 02125 USA; [Young, Keith A.] Texas A&M Univ, Coll Med, Bryan, TX USA; [Yarvis, Jeffrey S.] Texas A&M Univ Cent Texas, Killeen, TX USA; [Abdallah, Chadi G.; Averill, Lynnette A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Abdallah, Chadi G.; Averill, Lynnette A.] Baylor Coll Med, Houston, TX 77030 USA; [Borah, Adam M.] Cent Texas VA Hlth Care Syst, Temple, TX USA; [Borah, Elisa V.] Univ Texas Austin, Sch Social Work, Austin, TX 78712 USA; [Maurer, Douglas M.] Madigan Army Med Ctr, Joint Base Lewis Mcchord, WA USA; [Meyer, Eric C.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA		Peterson, AL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat & Behav Sci, Div Behav Med, 7550 IH-10 West,Suite 1325, San Antonio, TX 78229 USA.	petersona3@uthscsa.edu; youngs1@uthscsa.edu; roache@uthscsa.edu; mintz@uthscsa.edu; brett.litz@va.gov; douglas.williamson@duke.edu; patricia.resick@duke.edu; foa@pennmedicine.upenn.edu; mcgeary@uthscsa.edu; dondanville@uthscsa.edu; danieljtaylor@arizona.edu; Jennifer.Wachen@va.gov; fox@uthscsa.edu; craig.bryan@osumc.edu; carmen.mclean4@va.gov; pruiksma@uthscsa.edu; jyarvis@tamuct.edu; barbara.niles@va.gov; chadi.abdallah@bcm.edu; lynnette.averill@bcm.edu; backs@musc.edu; blountt@uthscsa.edu; adam.borah@va.gov; elisa.borah@austin.utexas.edu; matthew.s.brock.mil@mail.mil; lilybr@pennmedicine.upenn.edu; matthew.burg@yale.edu; jeffrey.cigrang@wright.edu; bryann.debeer@va.gov; edevoe@bu.edu; fina@uthscsa.edu; hellmuth@musc.edu; sjf23@psu.edu; cubby.l.gardner.mil@mail.mil; gatchel@uta.edu; jeffrey.goodie@usuhs.edu; ralitza.gueorguieva@yale.edu; jacobyv@uthscsa.edu; kevin.m.kelly2.mil@mail.mil; john.krystal@yale.edu; lapiz@uthscsa.edu; argelio.l.lopez-roca.civ@mail.mil; brian.marx@va.gov; douglas.maurer4.mil@mail.mil; mmcdvttm@memphis.edu; mcgearyc@uthscsa.edu; ECM77@pitt.edu; shannon.miles@va.gov; candice.monson@ryerson.ca; morilak@uthscsa.edu; moringj@uthscsa.edu; mysliwiec@uthscsa.edu; karinmd@nicholsonhome.com; sheila.a.m.rauch@emory.edu; david.riggs@usuhs.edu; craig.rosen@va.gov; mdrudd@memphis.edu; richard.p.schobitz.mil@mail.mil; christian.c.schrader.mil@mail.mil; antoinette.m.shinn.mil@mail.mil; paulo.shiroma@va.gov; dsloan@bu.edu; sterns@uthscsa.edu; strong@uthscsa.edu; steven.vannoy@umb.edu; kayoung@tamu.edu; terence.keane@va.gov					Armed Forces Health Surveillance Center (AFHSC), 2011, MSMR, V18, P2; Ben Barnes J, 2019, MIL MED, V184, pE218, DOI 10.1093/milmed/usy226; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402; Bog M, 2018, CAMPBELL SYST REV, V14, DOI 10.4073/csr.2018.6; Buckman JEJ, 2011, OCCUP ENVIRON MED, V68, P69, DOI 10.1136/oem.2009.054692; Cigrang J.A., 2005, PRAGMATIC CASE STUD, V1, P1, DOI [10.14713/pcsp.v1i2.857, DOI 10.14713/PCSP.V1I2.857]; Department of Defense Department of Veterans Affairs Department of Health and Human Services & Department of Education, 2013, NAT RES ACT PLAN; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Department of Veterans Affairs & Department of Defense, 2004, VA DOD CLIN PRACT GU; Dickstein BD, 2010, J TRAUMA STRESS, V23, P331, DOI 10.1002/jts.20523; Foa E.B., 2000, EFFECTIVE TREATMENTS; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Institute of Medicine, 2008, TREATMENT POSTTRAUMA, DOI [10.17226/11955, DOI 10.17226/11955]; Institute of Medicine, 2014, TREATMENT POSTTRAUMA, DOI [10.17226/18724, DOI 10.17226/18724]; Judkins JL, 2020, J TRAUMA STRESS, V33, P994, DOI 10.1002/jts.22558; Krystal JH, 2017, BIOL PSYCHIAT, V82, pE51, DOI 10.1016/j.biopsych.2017.03.007; Litz B. T., 2009, PTSD RES Q, V20, P1; Litz BT, 2007, MIL PSYCHOL, V19, P217, DOI 10.1080/08995600701386358; Meadows S.O., 2016, DEPLOYMENT LIFE STUD, DOI [10.7249/RR1388, DOI 10.7249/RR1388]; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Nash WP, 2015, J ABNORM PSYCHOL, V124, P155, DOI 10.1037/abn0000020; Peterson A.L., 2021, MIL MED; Peterson A.L., 2005, PRAGMAT CASE STUD PS, V1, P4, DOI [10.14713/pcsp.v1i2.859, DOI 10.14713/PCSP.V1I2.859]; Peterson A.L., 2018, MILITARY HLTH SYSTEM; Peterson AL, 2020, MIL MED, V185, P17, DOI 10.1093/milmed/usz345; Resick P.A, 1993, COGN PROCESS, V4; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Resick PA, 2008, J CONSULT CLIN PSYCH, V76, P243, DOI 10.1037/0022-006X.76.2.243; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schreiber M, 2015, J MENT HEALTH, V24, P54, DOI 10.3109/09638237.2014.971147; Steenkamp M., 2010, HDB ASSESSMENT TREAT, V2nd, P301; Stein NR, 2012, BEHAV MODIF, V36, P787, DOI 10.1177/0145445512446945; Tanielian T., 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/mg720, DOI 10.7249/MG720]; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270	39	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	NOV	2021	110								106583	10.1016/j.cct.2021.106583			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	WK4RX	WOS:000709715600009	34600107	hybrid			2022-02-06	
J	Proctor, JL; Medina, J; Rangghran, P; Tamrakar, P; Miller, C; Puche, A; Quan, W; Coksaygan, T; Drachenberg, CB; Rosenthal, RE; Stein, DM; Kozar, R; Wu, F; Fiskum, G				Proctor, Julie L.; Medina, Juliana; Rangghran, Parisa; Tamrakar, Pratistha; Miller, Catriona; Puche, Adam; Quan, Wei; Coksaygan, Turhan; Drachenberg, Cinthia B.; Rosenthal, Robert E.; Stein, Deborah M.; Kozar, Rosemary; Wu, Feng; Fiskum, Gary			Air-Evacuation-Relevant Hypobaria Following Traumatic Brain Injury Plus Hemorrhagic Shock in Rats Increases Mortality and Injury to the Gut, Lungs, and Kidneys	SHOCK			English	Article						Air evacuation; hyperoxia; hypoxia; inflammation; myeloperoxidase	SIMULATED AEROMEDICAL EVACUATION; ORIGIN SEPSIS; INFLAMMATION; MODEL; PROTECTS; SURVIVAL; IMPACT	Rats exposed to hypobaria equivalent to what occurs during aeromedical evacuation within a few days after isolated traumatic brain injury exhibit greater neurologic injury than those remaining at sea level. Moreover, administration of excessive supplemental O-2 during hypobaria further exacerbates brain injury. This study tested the hypothesis that exposure of rats to hypobaria following controlled cortical impact (CCI)-induced brain injury plus mild hemorrhagic shock worsens multiple organ inflammation and associated mortality. In this study, at 24 h after CCI plus hemorrhagic shock, rats were exposed to either normobaria (sea level) or hypobaria (=8,000 ft altitude) for 6 h under normoxic or hyperoxic conditions. Injured rats exhibited mortality ranging from 30% for those maintained under normobaria and normoxia to 60% for those exposed to 6 h under hypobaric and hyperoxia. Lung histopathology and neutrophil infiltration at 2 days postinjury were exacerbated by hypobaria and hyperoxia. Gut and kidney inflammation at 30 days postinjury were also worsened by hypobaric hyperoxia. In conclusion, exposure of rats after brain injury and hemorrhagic shock to hypobaria or hyperoxia results in increased mortality. Based on gut, lung, and kidney histopathology at 2 to 30 days postinjury, increased mortality is consistent with multi-organ inflammation. These findings support epidemiological studies indicating that increasing aircraft cabin pressures to 4,000 ft altitude (compared with standard 8,000 ft) and limiting excessive oxygen administration will decrease critical complications during and following aeromedical transport.	[Proctor, Julie L.; Medina, Juliana; Rangghran, Parisa; Tamrakar, Pratistha; Quan, Wei; Rosenthal, Robert E.; Kozar, Rosemary; Wu, Feng; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, 685 West Baltimore St,MSTF 5-34, Baltimore, MD 21201 USA; [Proctor, Julie L.; Medina, Juliana; Rangghran, Parisa; Tamrakar, Pratistha; Rosenthal, Robert E.; Stein, Deborah M.; Kozar, Rosemary; Wu, Feng; Fiskum, Gary] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Miller, Catriona] US Air Force Sch Aerosp Med, Dept Aeromed Res, Dayton, OH USA; [Puche, Adam] Dept Anat & Neurobiol, San Francisco, CA USA; [Coksaygan, Turhan; Drachenberg, Cinthia B.] Dept Pathol, San Francisco, CA USA; [Rosenthal, Robert E.] Dept Emergency Med Program Trauma, Sect Hyperbar Med, San Francisco, CA USA; [Stein, Deborah M.] Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA USA		Fiskum, G (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, 685 West Baltimore St,MSTF 5-34, Baltimore, MD 21201 USA.	gfiskum@som.umaryland.edu			US Air ForceUnited States Department of Defense [FA8650-15-2-6D21, FA865016-2-6H03]	Support from US Air Force FA8650-15-2-6D21 and FA865016-2-6H03.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Bai W, 2019, SHOCK, V51, P502, DOI 10.1097/SHK.0000000000001170; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Butler WP, 2018, MIL MED, V183, P193, DOI 10.1093/milmed/usx171; Butler WP, 2016, AEROSP MED HUM PERF, V87, P352, DOI 10.3357/AMHP.4378.2016; Cardozo Júnior Luis Carlos Maia, 2014, Rev. bras. ter. intensiva, V26, P148, DOI 10.5935/0103-507X.20140022; Choi M, 2018, J TRAUMA ACUTE CARE, V85, pS68, DOI 10.1097/TA.0000000000001909; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; DEITCH EA, 1992, J TRAUMA, V32, P141; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Demarest TG, 2015, J BIOENERG BIOMEMBR, V47, P173, DOI 10.1007/s10863-014-9583-7; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Goyal K, 2018, INDIAN J CRIT CARE M, V22, P632, DOI 10.4103/ijccm.IJCCM_156_18; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Hu S, 2015, WORLD J GASTROENTERO, V21, P1468, DOI 10.3748/wjg.v21.i5.1468; Humphries DC, 2018, CRIT CARE MED, V46, pE937, DOI 10.1097/CCM.0000000000003270; Hutchinson EB, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00573; Johannigman Jay, 2015, J Trauma Acute Care Surg, V79, pS216, DOI 10.1097/TA.0000000000000736; Kerr NA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010069; Lafrenaye AD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70266-w; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Maddry JK, 2019, MIL MED, V185; Makley AT, 2012, MIL MED, V177, P911, DOI 10.7205/MILMED-D-11-00385; Mayer AR, 2021, SHOCK, V55, P554, DOI 10.1097/SHK.0000000000001653; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Proctor JL, 2017, J TRAUMA ACUTE CARE, V83, pS35, DOI 10.1097/TA.0000000000001478; Proctor Julie L, 2015, J Trauma Acute Care Surg, V79, pS101, DOI 10.1097/TA.0000000000000742; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Schwerin SC, 2018, J NEUROSCI RES, V96, P556, DOI 10.1002/jnr.24218; Scultetus AH, 2020, MIL MED, V185, P57, DOI 10.1093/milmed/usz248; Skovira JW, 2016, J NEUROTRAUM, V33, P1292, DOI 10.1089/neu.2015.4189; Sliman SM, 2013, CELL BIOCHEM BIOPHYS, V67, P399, DOI 10.1007/s12013-011-9330-1; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Torrens-Mas M, 2020, REDOX BIOL, V31, DOI 10.1016/j.redox.2020.101505	34	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	NOV	2021	56	5					793	802		10.1097/SHK.0000000000001761			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	WH1AU	WOS:000707420800021	33625116				2022-02-06	
J	Reppucci, ML; Phillips, R; Meier, M; Acker, SN; Stevens, J; Moulton, SL; Bensard, D				Reppucci, Marina L.; Phillips, Ryan; Meier, Maxene; Acker, Shannon N.; Stevens, Jenny; Moulton, Steven L.; Bensard, Denis			Pediatric age-adjusted shock index as a tool for predicting outcomes in children with or without traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Pediatric trauma; pediatric age-adjusted shock index; Glasgow Coma Scale; traumatic brain injury	GLASGOW COMA SCALE; RISK	BACKGROUND The pediatric age-adjusted shock index (SIPA) accurately identifies severely injured children following trauma without accounting for neurological status. Understanding how the presence of traumatic brain injury (TBI) affects the generalizability of SIPA as a bedside triage tool is important given high rates of TBI in the pediatric trauma population. We hypothesized that SIPA combined with TBI (SIPAB+) would more accurately identify severely injured children. METHODS Patients (1-18 years old) in the American College of Surgeons Pediatric Trauma Quality Improvement Program database (2014-2017) with an elevated SIPA upon arrival to a pediatric trauma center were included. Pediatric age-adjusted shock index combined with TBI was defined as elevated SIPA with Glasgow Coma Scale score of <= 8. Pediatric age-adjusted shock index without TBI (SIPAB-) was defined as elevated SIPA with Glasgow Coma Scale score of >9. Patients were stratified into SIPAB+ and SIPAB-. A subanalysis of patients with isolated brain injury and those with brain injury and multisystem injuries was also performed. Data were compared through univariate models and three separate logistic regression models. RESULTS Overall, 25,068 had an elevated SIPA, with 12.3% classified as SIPAB+ and the remainder SIPAB-. Patients classified as SIPAB+ received more blood transfusions within 4 hours of injury and had higher mortality rates. On logistic regression, SIPAB+ patients had significantly higher odds of early blood transfusion and a combination of both. Mortality and early blood transfusion were also higher in SIPAB+ patients on subanalysis for patients with isolated TBI and those with multisystem injuries. CONCLUSION The use of SIPAB+ as a bedside triage tool accurately identifies traumatically injured children at high risk for early blood transfusion and/or death while incorporating the presence of neurological injury. This is true for patients with isolated TBI and those with multisystem injury, indicating its utility in predicting outcomes for TBI patients with elevated SIPA regardless of presence of concomitant injuries. Incorporation of this as a triage tool should be considered to better predict resources in this population.	[Reppucci, Marina L.; Phillips, Ryan; Acker, Shannon N.; Stevens, Jenny; Moulton, Steven L.; Bensard, Denis] Childrens Hosp Colorado, Pediat Surg, B-323,13123 E 16th Ave, Aurora, CO 80045 USA; [Reppucci, Marina L.; Phillips, Ryan; Acker, Shannon N.; Stevens, Jenny; Moulton, Steven L.; Bensard, Denis] Univ Colorado Sch Med, Dept Surg, Div Pediat Surg, Aurora, CO USA; [Meier, Maxene] Univ Colorado Sch Med, Ctr Childrens Surg, Ctr Res Outcomes Childrens Surg, Aurora, CO USA; [Bensard, Denis] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA		Reppucci, ML (corresponding author), Childrens Hosp Colorado, Pediat Surg, B-323,13123 E 16th Ave, Aurora, CO 80045 USA.	marina.reppucci@childrenscolorado.org; ryan.phillips@childrenscolorado.org; maxene.meier@cuanschutz.edu; shannon.acker@childrenscolorado.org; jenny.stevens@childrenscolorado.org; steven.moulton@childrenscolorado.org; denis.bensard@dhha.org		Stevens, Jenny/0000-0002-9470-3959			Acker SN, 2015, PEDIATR SURG INT, V31, P1041, DOI 10.1007/s00383-015-3789-6; Acker SN, 2015, J PEDIATR SURG, V50, P331, DOI 10.1016/j.jpedsurg.2014.08.009; Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Acker SN, 2014, J TRAUMA ACUTE CARE, V76, P1082, DOI 10.1097/TA.0000000000000095; Arbuthnot M, 2017, J PEDIATR SURG, V52, P989, DOI 10.1016/j.jpedsurg.2017.03.025; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Gandhi G, 2020, J PEDIATR SURG, V55, P1761, DOI 10.1016/j.jpedsurg.2019.09.032; Gelineau-Morel RN, 2019, PEDIATR REV, V40, P468, DOI 10.1542/pir.2018-0257; Keller M S, 2001, Semin Pediatr Surg, V10, P12, DOI 10.1053/spsu.2001.19381; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; Leetch AN, 2018, EMERG MED CLIN N AM, V36, P459, DOI 10.1016/j.emc.2017.12.012; Peiniger S, 2012, PEDIATR CRIT CARE ME, V13, P455, DOI 10.1097/PCC.0b013e31823893c5; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Phillips R, 2020, SURGERY, V168, P690, DOI 10.1016/j.surg.2020.04.061; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003	15	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2021	91	5					856	860		10.1097/TA.0000000000003208			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	WL8JL	WOS:000710645200020	34695062				2022-02-06	
J	Schmitt, RR; Kaliyappan, K; Muthaiah, VPK; Ignatowski, TA; Prasad, PN; Mahajan, SD				Schmitt, Rebecca R.; Kaliyappan, Kathiravan; Muthaiah, Vijaya Prakash Krishnan; Ignatowski, Tracey A.; Prasad, Paras N.; Mahajan, Supriya D.			Blast-induced injury responsive relative gene expression of traumatic brain injury biomarkers in human brain microvascular endothelial cells	BRAIN RESEARCH			English	Article						Traumatic brain injury; Blast injury; Blood-brain barrier; Human brain microvascular cells; Gene expression; Biomarkers	IN-VITRO MODEL; BARRIER DISRUPTION; TIGHT JUNCTION; TNF-ALPHA; PROTEIN; PERMEABILITY; CORTEX; DAMAGE; S100B	Disruption of the blood-brain barrier (BBB) is a critical component of traumatic brain injury (TBI) progression. However, further research into the mechanism of BBB disruption and its specific role in TBI pathophysiology is necessary. To help make progress in elucidating TBI affected BBB pathophysiology, we report herein relative gene expression of eleven TBI biomarkers and other factors of neuronal function in human brain microvascular cells (HBMVEC), one of the main cell types in the BBB. Our in-vitro blast TBI model employs a custom acoustic shock tube to deliver injuries of varying intensities to HBMVECs in culture. Each of the investigated genes exhibit a significant change in expression as a response to TBI, which is dependent on both the injury intensity and time following the injury. This data suggests that cell signaling of HBMVECs could be essential to understanding the interaction of the BBB and TBI pathophysiology, warranting future investigation.	[Schmitt, Rebecca R.; Prasad, Paras N.] Univ Buffalo State Univ New York, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA; [Schmitt, Rebecca R.; Prasad, Paras N.] Univ Buffalo State Univ New York, Dept Chem, Buffalo, NY 14260 USA; [Kaliyappan, Kathiravan; Muthaiah, Vijaya Prakash Krishnan] Univ Buffalo State Univ New York, Sch Publ Hlth & Hlth Profess, Dept Rehabil Sci, Buffalo, NY 14214 USA; [Ignatowski, Tracey A.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pathol & Anat Sci, 955 Main St, Buffalo, NY 14203 USA; [Mahajan, Supriya D.] SUNY Buffalo, Clin Translat Res Ctr, Dept Med, Div Allergy Immunol & Rheurnatol, Buffalo, NY 14203 USA		Prasad, PN (corresponding author), Univ Buffalo State Univ New York, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA.; Prasad, PN (corresponding author), Univ Buffalo State Univ New York, Dept Chem, Buffalo, NY 14260 USA.; Mahajan, SD (corresponding author), SUNY Buffalo, Clin Translat Res Ctr, Dept Med, Div Allergy Immunol & Rheurnatol, Buffalo, NY 14203 USA.	pnprasad@buffalo.edu; smahajan@buffalo.edu		Mahajan, Supriya/0000-0002-5298-6962; Schmitt, Rebecca/0000-0002-7845-0808; Ignatowski, Tracey/0000-0002-8033-4566; Kaliyappan, Kathiravan/0000-0002-0028-1274	office of Vice President for Research and Economic Development; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [1R01DA047410]	The work at the Institute for Lasers, Photonics and Bio-photonics at The University at Buffalo was supported by funds provided by the office of Vice President for Research and Economic Development. Biological experiments conducted and reported in this publication were supported by 1R01DA047410 (NIDA) (SM) .	Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Andrews AM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00043; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Baker TL, 2021, NEUROSCIENTIST, DOI 10.1177/10738584211012264; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bauernfeind AL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3674-x; Berndt P, 2019, CELL MOL LIFE SCI, V76, P1987, DOI 10.1007/s00018-019-03030-7; Bonsack F, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00157; Campos-Pires R, 2018, JOVE-J VIS EXP, DOI 10.3791/58400; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Garcia CM, 2004, DEV BRAIN RES, V152, P25, DOI 10.1016/j.devbrainres.2004.05.008; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Haarbauer-Krupa J, 2021, J NEUROTRAUM, V38, P3235, DOI 10.1089/neu.2021.0062; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hickman TT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28924-7; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Ho KM, 2014, J NEUROSURG, V121, P674, DOI 10.3171/2014.6.JNS132838; Kawoos U, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84730-8; Kempuraj D, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/4243953; Khan A, 2012, 35012A EPHB; Kleindienst Andrea, 2010, Cardiovasc Psychiatry Neurol, V2010, P801295, DOI 10.1155/2010/801295; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Kumaria A, 2017, ATLA-ALTERN LAB ANIM, V45, P201, DOI 10.1177/026119291704500405; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Mankertz J, 2000, J CELL SCI, V113, P2085; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Nito C, 2008, J CEREBR BLOOD F MET, V28, P1686, DOI 10.1038/jcbfm.2008.60; Peacock WF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00641; Qi J, 2015, AM J TRANSL RES, V7, P1826; Rosas-Hernandez H, 2018, MOL NEUROBIOL, V55, P258, DOI 10.1007/s12035-017-0738-5; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shen WY, 2011, EUR J CELL BIOL, V90, P323, DOI 10.1016/j.ejcb.2010.10.013; Uddin Mohammad A, 2021, Brain Disord, V1, DOI 10.1016/j.dscb.2020.100001; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Wu A.H.B., 2020, BIOMARKERS TRAUMATIC, V1; Wu H, 2016, BRAIN RES, V1637, P154, DOI 10.1016/j.brainres.2016.02.026; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Yip PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41689; Yu HC, 2013, INT J BIOL SCI, V9, P966, DOI 10.7150/ijbs.6996; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	45	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 1	2021	1770								147642	10.1016/j.brainres.2021.147642			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UO5MZ	WOS:000694741100005	34474000				2022-02-06	
J	Song, J; Garcia, HA; Finley, EP; Stirman, SW				Song, Jiyoung; Garcia, Hector A.; Finley, Erin P.; Stirman, Shannon Wiltsey			Graduate Training and Provider Concerns About Distress and Comprehension in PTSD Treatment Choice: A Mediation Analysis	PSYCHOLOGICAL SERVICES			English	Article						evidence-based psychotherapies; PTSD; treatment utilization; implementation; treatment decision-making	POSTTRAUMATIC-STRESS-DISORDER; EVIDENCE-BASED PSYCHOTHERAPIES; PROLONGED EXPOSURE THERAPY; TRAUMATIC BRAIN-INJURY; COGNITIVE PROCESSING THERAPY; BEHAVIORAL THERAPY; EXECUTIVE FUNCTION; TREATMENT RESPONSE; RANDOMIZED-TRIAL; VETERANS	The Veterans Health Administration (VHA) recommends that patients with posttraumatic stress disorder (PTSD) receive either of the 2 frontline evidence-based psychotherapies, cognitive processing therapy (CPT) and prolonged exposure (PE). However, VHA providers have reported low use of these treatments, and voiced their concerns over exposing patients to distress in PE and their patients not understanding CPT. In the current study, we surveyed VHA providers (N = 225) in PTSD clinical teams across the United States on their graduate school training experience in structured cognitive- behavioral therapy protocols, agreement with the 2 provider concerns, and use of the 2 treatments. Results from our mediation analyses indicated that graduate school training in structured protocols led to lower discomfort of exposing patients to distress during PE, and in turn, greater PE utilization. However, there was no significant relationship between graduate school training and CPT utilization. Findings suggest an important role for graduate training in the uptake of guideline recommended treatment for PTSD at VHA.	[Song, Jiyoung; Stirman, Shannon Wiltsey] VA Palo Alto Hlth Care Syst, Natl Ctr PSTD, 795 Willow Rd NC PTSD 334, Menlo Pk, CA 94025 USA; [Garcia, Hector A.; Finley, Erin P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Garcia, Hector A.] Texas Valley Coastal Bend Vet Hlth Care Syst, Harlingen, TX USA; [Finley, Erin P.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Stirman, Shannon Wiltsey] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA		Song, J (corresponding author), VA Palo Alto Hlth Care Syst, Natl Ctr PSTD, 795 Willow Rd NC PTSD 334, Menlo Pk, CA 94025 USA.	jiyoung.song@va.gov		Song, Jiyoung/0000-0002-7157-8198			Barnett ER, 2014, BEHAV SCI-BASEL, V4, P410, DOI 10.3390/bs4040410; Becker CB, 2004, BEHAV RES THER, V42, P277, DOI 10.1016/S0005-7967(03)00138-4; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Berg A., 2008, TREATMENT POSTTRAUMA; Bickman L, 2011, PSYCHIAT SERV, V62, P1423, DOI 10.1176/appi.ps.002052011; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Castonguay LG, 2000, J PSYCHOTHER INTEGR, V10, P263, DOI 10.1023/A:1009496929012; Chard KM, 2012, J REHABIL RES DEV, V49, P667, DOI 10.1682/JRRD.2011.10.0198; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Cohen M, 2015, J PSYCHOTHER INTEGR, V25, P90, DOI 10.1037/a0038878; Cook JM, 2015, ADM POLICY MENT HLTH, V42, P147, DOI 10.1007/s10488-014-0555-3; Cook JM, 2014, PROF PSYCHOL-RES PR, V45, P136, DOI 10.1037/a0036183; Cook JM, 2009, PSYCHIAT SERV, V60, P671, DOI 10.1176/appi.ps.60.5.671; Crocker LD, 2018, BEHAV RES THER, V108, P68, DOI 10.1016/j.brat.2018.07.004; Deacon B.J, 2013, HDB TREATING VARIANT, P363, DOI 10.1007/978-1-4614-6458-7_23; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Eftekhari A, 2013, JAMA PSYCHIAT, V70, P949, DOI 10.1001/jamapsychiatry.2013.36; Elliott R, 2011, PSYCHOTHERAPY, V48, P43, DOI 10.1037/a0022187; Finley E. P., 2012, FIELDS COMBAT UNDERS; Finley EP, 2019, J BEHAV HEALTH SER R, V46, P217, DOI 10.1007/s11414-018-9613-z; Finley EP, 2015, PSYCHOL SERV, V12, P73, DOI 10.1037/ser0000014; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; Foa EB, 2002, J CONSULT CLIN PSYCH, V70, P1022, DOI 10.1037//0022-006X.70.4.1022; Greenberg RP, 2006, CLIN PSYCHOL REV, V26, P657, DOI 10.1016/j.cpr.2005.03.002; Hamblen JL, 2015, PROF PSYCHOL-RES PR, V46, P90, DOI 10.1037/a0038535; Hawley KM, 2009, ADM POLICY MENT HLTH, V36, P343, DOI 10.1007/s10488-009-0225-z; Hayes AM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00107; Hundt NE, 2016, PSYCHOL TRAUMA-US, V8, P728, DOI 10.1037/tra0000102; Jak A. J., 2016, BEHAV NEUROBIOLOGY P, P93; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Jensen-Doss A, 2008, J CONSULT CLIN PSYCH, V76, P711, DOI 10.1037/0022-006X.76.5.711; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Lambert MJ, 2001, J CONSULT CLIN PSYCH, V69, P159, DOI 10.1037//0022-006X.69.2.159; Larsen SE, 2016, BEHAV RES THER, V77, P68, DOI 10.1016/j.brat.2015.12.009; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Maguen S, 2018, ADM POLICY MENT HLTH, V45, P519, DOI 10.1007/s10488-018-0850-5; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meyer JM, 2014, BEHAV RES THER, V54, P49, DOI 10.1016/j.brat.2014.01.004; Mohlman J, 2005, BEHAV RES THER, V43, P447, DOI 10.1016/j.brat.2004.03.007; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Mott JM, 2014, J TRAUMA STRESS, V27, P265, DOI 10.1002/jts.21927; Osei-Bonsu PE, 2017, J BEHAV HEALTH SER R, V44, P213, DOI 10.1007/s11414-015-9489-0; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Price M, 2012, PSYCHOTHERAPY, V49, P173, DOI 10.1037/a0024734; R Development Core Team, 2008, R LANG ENV STAT COMP; Raza Gina T, 2015, Psychol Trauma, V7, P547, DOI 10.1037/tra0000059; Resick P.A., 2016, COGN PROCESS; Resick P. A., 2008, COGNITIVE PROCESSING; Rosen CS, 2016, ADM POLICY MENT HLTH, V43, P957, DOI 10.1007/s10488-016-0755-0; Ruzek JI, 2016, PSYCHOL TRAUMA-US, V8, P348, DOI 10.1037/tra0000004; Ruzek JI, 2014, J TRAUMA STRESS, V27, P423, DOI 10.1002/jts.21945; Sayer NA, 2017, ADM POLICY MENT HLTH, V44, P904, DOI 10.1007/s10488-017-0809-y; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Sripada RK, 2018, ADM POLICY MENT HLTH, V45, P353, DOI 10.1007/s10488-017-0828-8; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tingley D, 2014, J STAT SOFTW, V59; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; Verfaellie M, 2012, PTSD MILD TRAUMATIC, P83; Veterans Affairs, 2017, VA DOD CLIN PRACT GU; Waller G, 2016, BEHAV RES THER, V77, P129, DOI 10.1016/j.brat.2015.12.005; Walter KH, 2014, J TRAUMA STRESS, V27, P438, DOI 10.1002/jts.21934; Walter KH, 2010, J TRAUMA STRESS, V23, P292, DOI 10.1002/jts.20506; Watts BV, 2014, PSYCHIAT SERV, V65, P648, DOI 10.1176/appi.ps.201300176; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Zubkoff L, 2016, ADM POLICY MENT HLTH, V43, P250, DOI 10.1007/s10488-015-0635-z	67	1	1	1	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	NOV	2021	18	4					533	542		10.1037/ser0000429			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	WU1WP	WOS:000716342900010	32378933				2022-02-06	
J	Suntai, Z; Laha-Walsh, K; Albright, DL				Suntai, Zainab; Laha-Walsh, Kirsten; Albright, David L.			Effectiveness of Remote Interventions in Improving Caregiver Stress Outcomes for Caregivers of People With Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						remote; caregiver; stress; intervention; TBI	PROBLEM-SOLVING INTERVENTION; FAMILY CAREGIVERS; RANDOMIZED-TRIAL; SUPPORT GROUPS; ONLINE; DEMENTIA; CHILDREN; BURDEN; DISTRESS; PROGRAM	Impact and Implications Remote interventions are effective in improving life satisfaction, quality of life, and overall caregiver functioning among caregivers of people with traumatic brain injury (TBI). Remote interventions are also effective in reducing depression, anxiety, psychological distress, and other psychiatric symptoms among caregivers of people with TBI. Support services for caregivers should consider remote interventions such as online support groups, online psychotherapy, and telephone interventions to reduce access barriers for caregivers of people with TBI. Objective: Caregiver stress is the term used to define the adverse effects of caregiving, and its prevalence among caregivers of people with traumatic brain injury (TBI) is amplified by the suddenness of brain injury. This systematic review aimed to identify whether remote interventions can be helpful in minimizing those financial, emotional, and physical stressors associated with caring for a person with TBI. Method: Studies were located by searching the following databases: PsycINFO, PubMed, Science Direct, Web of Science, Academic Search Premier, CINAHL, Medline, and Cochrane Central Register of Controlled Trials. Studies were included if they met the following criteria: (a) The study must be published in English, (b) The study must be published in a peer-reviewed journal, (c) The study must implement a remote intervention specific to caregivers of people with TBI, and (d) One or more symptoms of caregiver stress must be measured as an outcome. Results: After the review process, 12 articles met the inclusion criteria for the study. Most of the studies were randomized controlled trials, used an online problem-solving module, and targeted parents of children/adolescents with a TBI. Ten out of the 12 studies (83.3%) found that remote/online interventions improved caregiver stress outcomes and only two studies did not find improvement in caregiver stress outcomes. Conclusion: Results from this systematic review indicate that online interventions can be as effective as in-person interventions in reducing the symptoms of caregiver stress for caregivers of people with TBI. Implications for practice, research, and policy are discussed.	[Suntai, Zainab; Laha-Walsh, Kirsten; Albright, David L.] Univ Alabama, Sch Social Work, Little Hall,670 Judy Bonner Dr, Tuscaloosa, AL 35401 USA		Suntai, Z (corresponding author), Univ Alabama, Sch Social Work, Little Hall,670 Judy Bonner Dr, Tuscaloosa, AL 35401 USA.	zsuntai@crimson.ua.edu		Suntai, Zainab/0000-0001-7150-8328; Laha-Walsh, Kirsten/0000-0001-9871-7728			Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007; Anderson LN, 2013, J COMMUNITY PSYCHOL, V41, P709, DOI 10.1002/jcop.21566; Baillargeon RH, 2011, CAN J PSYCHIAT, V56, P614, DOI 10.1177/070674371105601007; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Brickell TA, 2019, REHABIL PSYCHOL, V64, P307, DOI 10.1037/rep0000272; Brown JB, 2019, J NEUROSCI RURAL PRA, V10, P10, DOI 10.4103/jnrp.jnrp_310_18; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Carey JC, 2008, CYBERPSYCHOL BEHAV, V11, P188, DOI 10.1089/cpb.2007.0025; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Chi NC, 2015, J TELEMED TELECARE, V21, P37, DOI 10.1177/1357633X14562734; Cutler S., 2018, MEDSURG NURSING, V27, P359, DOI [10.1007/s11606-017-4265-x, DOI 10.1007/S11606-017-4265-X]; Dam AEH, 2016, MATURITAS, V85, P117, DOI 10.1016/j.maturitas.2015.12.008; Damianakis T, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000178; Effective Public Health Practice Project, 1998, QUAL ASS TOOL QUANT; Harding R, 2015, J PAIN SYMPTOM MANAG, V50, P445, DOI 10.1016/j.jpainsymman.2015.04.005; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Hong QN, 2018, EDUC INFORM, V34, P285, DOI 10.3233/EFI-180221; Kirst-Ashman K.K., 2014, BROOKS COLE EMPOWERM; Kreitzer N, 2018, ARCH PHYS MED REHAB, V99, P2342, DOI 10.1016/j.apmr.2018.04.016; Kreutzer JS, 2018, J HEAD TRAUMA REHAB, V33, P228, DOI 10.1097/HTR.0000000000000390; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Mantell A, 2018, HEALTH SOC CARE COMM, V26, P433, DOI 10.1111/hsc.12476; McDonald S, 2021, NEUROPSYCHOL REHABIL, V31, P392, DOI 10.1080/09602011.2019.1696846; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; Monin JK, 2019, J HEALTH PSYCHOL, V24, P1744, DOI 10.1177/1359105317699682; Petranovich CL, 2015, J PEDIATR PSYCHOL, V40, P680, DOI 10.1093/jpepsy/jsv001; Raj SP, 2015, J HEAD TRAUMA REHAB, V30, P347, DOI 10.1097/HTR.0000000000000052; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Shepherd-Banigan ME, 2018, J GEN INTERN MED, V33, P1177, DOI 10.1007/s11606-018-4417-7; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Suntai Z, 2021, AM J HOSP PALLIAT ME, V38, P494, DOI 10.1177/1049909120959634; The Mayo Clinic, 2019, TRAUMATIC BRAIN INJU; Tremont G, 2015, ALZHEIMERS DEMENT, V11, P541, DOI 10.1016/j.jalz.2014.05.1752; Turner, 2020, SUBJ GUID SYST REV H; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2005, REHABIL PSYCHOL, V50, P337, DOI 10.1037/0090-5550.50.4.337; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; White T.S., 2016, AM NURSE TODAY; Worrall H, 2018, MENT HEALTH SOC INCL, V22, P85, DOI 10.1108/MHSI-12-2017-0055; Yue JK, 2020, J NEUROSCI RURAL PRA, V11, P23, DOI 10.1055/s-0039-3402581	45	1	1	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					415	422		10.1037/rep0000402			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	WOS:000725826700012	34472921				2022-02-06	
J	Terpstra, AR; Cairncross, M; Yeates, KO; Vranceanu, AM; Greenberg, J; Hunt, C; Silverberg, ND				Terpstra, Alex R.; Cairncross, Molly; Yeates, Keith O.; Vranceanu, Ana-Maria; Greenberg, Jonathan; Hunt, Cindy; Silverberg, Noah D.			Psychological Mediators of Avoidance and Endurance Behavior After Concussion	REHABILITATION PSYCHOLOGY			English	Article						concussion; traumatic brain injury; coping	PAIN CATASTROPHIZING SCALE; FACET MINDFULNESS QUESTIONNAIRE; CHRONIC MUSCULOSKELETAL PAIN; TRAUMATIC BRAIN-INJURY; FEAR-AVOIDANCE; PSYCHOMETRIC PROPERTIES; COGNITIVE STRATEGIES; HEAD-INJURY; SYMPTOMS; CONSEQUENCES	Objective: The avoidance-endurance model (AEM) proposes multiple pathways from acute to chronic pain, with distinct cognitive and behavioral components in each pathway. The AEM may also be applicable to persistent symptoms after concussion. In this study, we tested the AEM as an explanatory framework for concussion outcomes, by using mediation analyses through the proposed psychological mechanisms. Based on the AEM, we hypothesized that postconcussion symptoms would significantly predict avoidance behavior through catastrophizing, and endurance behavior through thought suppression and self-distraction. Participants and Methods: We recruited 84 adults seeking treatment at 2 outpatient concussion clinics (M = 41.8 years old, 63% female) who completed measures of postconcussion symptoms, catastrophizing, thought suppression, "self-distraction" (Five Factor Mindfulness Questionnaire "Act with Awareness" Scale reverse-scored), avoidance behavior, and endurance behavior at an average of 17.8 weeks postconcussion. We conducted 3 mediation analyses to assess each of the AEM pathways. Results: We found a significant indirect effect of postconcussion symptoms on avoidance behavior through catastrophizing (ab = .113 (.036), 95% CI [.053, .195]). The indirect effects of postconcussion symptoms on endurance behavior through thought suppression (ab = .011 (.012), 90% CI [.002, .035]) and "self-distraction" (ab = .003 (.009), 90% CI [.008, .022]) were not statistically significant. Conclusions: Results supported the catastrophizing-avoidance pathway in concussion, but not the thought-suppression-endurance or self-distraction-endurance pathways. Therefore, catastrophic thinking about concussion symptoms may be an appropriate treatment target for individuals who exhibit fear-avoidance behavior. Further research is needed to establish whether thought suppression and self-distraction are relevant for interventions aimed at reducing excessive endurance behavior. Impact and Implications This study evaluated a novel theoretical model of persistent symptoms after concussion. For individuals who exhibit avoidance behavior after concussion, catastrophic thinking about symptoms may be a worthwhile intervention target. Psychological interventions for chronic pain might also be suitable for persistent symptoms after concussion.	[Terpstra, Alex R.; Cairncross, Molly; Silverberg, Noah D.] Univ British Columbia, Dept Psychol, 2136 West Mall Room 3505, Vancouver, BC V6T 1Z4, Canada; [Cairncross, Molly; Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Yeates, Keith O.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith O.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith O.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Vranceanu, Ana-Maria; Greenberg, Jonathan] Massachusetts Gen Hosp, Dept Psychiat, Integrated Brain Hlth Clin & Res Program, Boston, MA 02114 USA; [Vranceanu, Ana-Maria; Greenberg, Jonathan] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Hunt, Cindy] St Michaels Hosp, Trauma & Neurosurg Program, Head Injury Clin, Toronto, ON, Canada; [Hunt, Cindy] Concuss Ontario Network Neuroinformat Enhance Cli, Toronto, ON, Canada; [Hunt, Cindy] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada		Silverberg, ND (corresponding author), Univ British Columbia, Dept Psychol, 2136 West Mall Room 3505, Vancouver, BC V6T 1Z4, Canada.	noah.silverberg@ubc.ca			Canadian Institutes of Health Research Vanier Canada Graduate ScholarshipCanadian Institutes of Health Research (CIHR); Ronald and Irene Ward Chair in Pediatric Brain Injury from the Alberta Children's Hospital Foundation; National Center for Complementary and Integrative Health [1 K23 AT010653 01A1]	Alex R. Terpstra is supported by a Canadian Institutes of Health Research Vanier Canada Graduate Scholarship. Keith O. Yeates is supported by the Ronald and Irene Ward Chair in Pediatric Brain Injury from the Alberta Children's Hospital Foundation. Jonathan Greenberg is supported by a grant from the National Center for Complementary and Integrative Health (1 K23 AT010653 01A1).	Andrews NE, 2012, ARCH PHYS MED REHAB, V93, P2109, DOI 10.1016/j.apmr.2012.05.029; Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; Bohlmeijer E, 2011, ASSESSMENT, V18, P308, DOI 10.1177/1073191111408231; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cassetta BD, 2021, REHABIL PSYCHOL, V66, P160, DOI 10.1037/rep0000372; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; CHAVES JF, 1987, J BEHAV MED, V10, P263, DOI 10.1007/BF00846540; Christopher MS, 2012, MINDFULNESS, V3, P124, DOI 10.1007/s12671-011-0086-x; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dunn DS, 2005, REHABIL PSYCHOL, V50, P183, DOI 10.1037/0090-5550.50.2.183; Greenberg J, 2020, PSYCHOSOMATICS, V61, P49, DOI 10.1016/j.psym.2019.09.004; Hanley AW, 2017, J PSYCHOSOM RES, V99, P13, DOI 10.1016/j.jpsychores.2017.05.014; Hasenbring MI, 2020, CLIN J PAIN, V36, P162, DOI 10.1097/AJP.0000000000000785; Hasenbring MI, 2010, CLIN J PAIN, V26, P747, DOI 10.1097/AJP.0b013e3181e104f2; Hayes, 2018, INTRO MEDIATION MODE; Hedman-Lagerlof M, 2019, BEHAV RES THER, V122, DOI 10.1016/j.brat.2019.103478; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kindermans HPJ, 2011, J PAIN, V12, P1049, DOI 10.1016/j.jpain.2011.04.009; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Krzeczkowski JE, 2017, MINDFULNESS, V8, P1594, DOI 10.1007/s12671-017-0731-0; Lame IE, 2008, J HEALTH PSYCHOL, V13, P820, DOI 10.1177/1359105308093866; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Luque-Suarez A, 2019, BRIT J SPORT MED, V53, P554, DOI 10.1136/bjsports-2017-098673; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Miocevic M, 2018, BEHAV RES METHODS, V50, P285, DOI 10.3758/s13428-017-0870-1; Newman SD, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6550; Nijs J, 2013, CLIN RHEUMATOL, V32, P1121, DOI 10.1007/s10067-013-2277-4; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Rassin E, 2003, EUR J PERSONALITY, V17, P285, DOI 10.1002/per.478; Rimes KA, 2013, CLIN PSYCHOL PSYCHOT, V20, P107, DOI 10.1002/cpp.793; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Silverberg ND, 2019, J NEUROTRAUM, V36, P1544, DOI 10.1089/neu.2018.6025; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smeets RJEM, 2006, J PAIN, V7, P261, DOI 10.1016/j.jpain.2005.10.011; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Snell DL, 2020, J NEUROTRAUM, V37, P1566, DOI 10.1089/neu.2019.6729; Snell DL, 2018, BRAIN INJURY, V32, P583, DOI 10.1080/02699052.2018.1432894; SPANOS NP, 1979, J ABNORM PSYCHOL, V88, P282, DOI 10.1037/0021-843X.88.3.282; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Thorn BE, 2007, J PAIN, V8, P938, DOI 10.1016/j.jpain.2007.06.010; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Koulil S, 2010, ARTHRIT CARE RES, V62, P1377, DOI 10.1002/acr.20268; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Wen ZL, 2015, PSYCHOL METHODS, V20, P193, DOI 10.1037/met0000029; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Wismeijer AAJ, 2012, J PSYCHOPATHOL BEHAV, V34, P116, DOI 10.1007/s10862-011-9246-5; Wright B.A., 1960, PHYS DISABILITY A PS	61	1	1	2	2	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2021	66	4					470	478		10.1037/rep0000390			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	XI0QC	WOS:000725826700019	34410757				2022-02-06	
J	Tunthanathip, T; Oearsakul, T				Tunthanathip, Thara; Oearsakul, Thakul			Application of machine learning to predict the outcome of pediatric traumatic brain injury	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Pediatrics; Traumatic brain injury; Machine learning; Support vector machine; Random forest; Logistic regression	HEAD-INJURY; CHILDREN	Purpose: Traumatic brain injury (TBI) generally causes mortality and disability, particularly in children. Machine learning (ML) is a computer algorithm, applied as a clinical prediction tool. The present study aims to assess the predictability of ML for the functional outcomes of pediatric TBI. Methods: A retrospective cohort study was performed targeting children with TBI who were admitted to the trauma center of southern Thailand between January 2009 and July 2020. The patient was excluded if he/she (1) did not undergo a CT scan of the brain, (2) died within the first 24 h, (3) had unavailable complete medical records during admission, or (4) was unable to provide updated outcomes. Clinical and radiologic characteristics were collected such as vital signs, Glasgow coma scale score, and characteristics of intracranial injuries. The functional outcome was assessed using the King's Outcome Scale for Childhood Head Injury, which was thus dichotomized into favourable outcomes and unfavourable outcomes: good recovery and moderate disability were categorized as the former, whereas death, vegetative state, and severe disability were categorized as the latter. The prognostic factors were estimated using traditional binary logistic regression. By data splitting, 70% of data were used for training the ML models and the remaining 30% were used for testing the ML models. The supervised algorithms including support vector machines, neural networks, random forest, logistic regression, naive Bayes and k-nearest neighbor were performed for training of the ML models. Therefore, the ML models were tested for the predictive performances by the testing datasets. Results: There were 828 patients in the cohort. The median age was 72 months (interquartile range 104.7 months, range 2-179 months). Road traffic accident was the most common mechanism of injury, accounting for 68.7%. At hospital discharge, favourable outcomes were achieved in 97.0% of patients, while the mortality rate was 2.2%. Glasgow coma scale score, hypotension, pupillary light reflex, and subarachnoid haemorrhage were associated with TBI outcomes following traditional binary logistic regression; hence, the 4 prognostic factors were used for building ML models and testing performance. The support vector machine model had the best performance for predicting pediatric TBI outcomes: sensitivity 0.95, specificity 0.60, positive predicted value 0.99, negative predictive value 1.0; accuracy 0.94, and area under the receiver operating characteristic curve 0.78. Conclusion: The ML algorithms of the present study have a high sensitivity; therefore they have the potential to be screening tools for predicting functional outcomes and counselling prognosis in general practice of pediatric TBIs. (C) 2021 Chinese Medical Association. Production and hosting by Elsevier B.V.	[Tunthanathip, Thara; Oearsakul, Thakul] Prince Songkla Univ, Fac Med, Dept Surg, Div Neurosurg, Hat Yai 90110, Songkhla, Thailand		Tunthanathip, T (corresponding author), Prince Songkla Univ, Fac Med, Dept Surg, Div Neurosurg, Hat Yai 90110, Songkhla, Thailand.	tsus4@hotmail.com					Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Amorim RL, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01366; Beam AL, 2018, JAMA-J AM MED ASSOC, V319, P1317, DOI 10.1001/jama.2017.18391; Bedry T, 2020, EMERG MED INT, V2020, DOI 10.1155/2020/1965231; Bzdok D, 2018, NAT METHODS, V15, P232, DOI 10.1038/nmeth.4642; Chaitanya K, 2018, CHILD NERV SYST, V34, P1119, DOI 10.1007/s00381-018-3784-z; Delahanty RJ, 2018, CRIT CARE MED, V46, pE481, DOI 10.1097/CCM.0000000000003011; Desautels T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017199; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Gravesteijn BY, 2020, J CLIN EPIDEMIOL, V122, P95, DOI 10.1016/j.jclinepi.2020.03.005; Haveman ME, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2656-6; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Heo J, 2019, STROKE, V50, P1263, DOI 10.1161/STROKEAHA.118.024293; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Kavosi Z, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.22594; ORourke PP, 1989, PEDIATR ANESTH, Vsecond; Papp L, 2018, J NUCL MED, V59, P892, DOI 10.2967/jnumed.117.202267; Parmontree P, 2019, J NEUROSCI RURAL PRA, V10, P582, DOI 10.1055/s-0039-1700791; Phuenpathom N, 2000, J CLIN NEUROSCI, V7, P223, DOI 10.1054/jocn.1999.0203; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Roelen CAM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-105; Stromberg KA, 2019, J HEAD TRAUMA REHAB, V34, pE64, DOI 10.1097/HTR.0000000000000438; Suttipongkaset P, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0594; Taweesomboonyat C, 2020, JHSMR, V38, P267, DOI [10.31584/jhsmr.2020746, DOI 10.31584/JHSMR.2020746]; Tunthanathip T, INT J NUTR PHARM NEU, V2021, P57, DOI [10.4103/ijnpnd.ijnpnd_93_20, DOI 10.4103/IJNPND.IJNPND_93_20]; Tunthanathip T, 2020, J PEDIATR NEUROSCI, V15, P409, DOI [10.4103/jpn.JPN_11_20, 10.4103/JPN.JPN_11_20]; Tunthanathip T, 2020, J NEUROSCI RURAL PRA, V11, P135, DOI 10.1055/s-0039-3403446; Tunthanathip Thara, 2019, Bull Emerg Trauma, V7, P347, DOI 10.29252/beat-070402; Tunthanathip T, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.5.FOCUS19241; Tunthanathip T, 2017, J NEUROSCI RURAL PRA, V8, P601, DOI 10.4103/jnrp.jnrp_381_17; Valdebenito J, 2019, CANCER REP-US, V2, DOI 10.1002/cnr2.1226; Vathanalaoha K, 2017, EMERGENCY, V5; Wetzel RC, 1991, TRAUMA ANESTHESIA, P312	34	1	1	1	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	NOV	2021	24	6					350	355		10.1016/j.cjtee.2021.06.003			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	XC8VW	WOS:000722290800006	34284922	gold, Green Published			2022-02-06	
J	Wang, S; Gan, SQ; Yang, XF; Li, TH; Xiong, F; Jia, XY; Sun, YX; Liu, J; Zhang, M; Bai, LJ				Wang, Shan; Gan, Shuoqiu; Yang, Xuefei; Li, Tianhui; Xiong, Feng; Jia, Xiaoyan; Sun, Yingxiang; Liu, Jun; Zhang, Ming; Bai, Lijun			Decoupling of Structural and Functional Connectivity in Hubs and Cognitive Impairment After Mild Traumatic Brain Injury	BRAIN CONNECTIVITY			English	Article						decoupling; functional connectivity; hub regions; mild traumatic brain injury; structural connectivity	DEFAULT MODE; ANATOMICAL NETWORKS; ARCHITECTURE	Introduction: Mild traumatic brain injury (mild TBI) exhibited abnormal brain network topologies associated with cognitive dysfunction. However, it was still unclear which aspects of network organization were critical underlying the key pathology of mild TBI. Here, a multi-imaging strategy was applied to capture dynamic topological features of both structural and functional connectivity networks (SCNs and FCNs), to provide more sensitive detection of altered FCN from its anatomical backbone and identify novel biomarkers of mild TBI outcomes.Methods: A total of 62 mild TBI patients (30 subjects as an original sample with 3-12 months of follow-up, 32 subjects as independent replicated sample) and 37 healthy controls were recruited. Both diffusion tensor imaging and resting-state functional magnetic resonance imaging were used to create global connectivity matrices in the same individuals. Global and regional network analyses were applied to identify group differences and correlations with clinical assessments.Results: Most global network properties were conserved in both SCNs and FCNs in subacute mild TBI, whereas SCNs presented decreased global efficiency and characteristic path length at follow-up. Specifically, some hubs in healthy brain networks typically became nonhubs in patients and vice versa, such as the medial prefrontal cortex, superior temporal gyrus, and middle frontal gyrus. The relationship between structural and functional connectivity (SC and FC) in patients also showed salient decoupling as a function of time, primarily located in the hubs.Conclusions: These results suggested mild TBI influences the relationship between SCN and FCN, and the SC-FC coupling strength may be used as a potential biomarker to predict long-term outcomes after injury. Impact statementThe current study was the first study to explore the coupling of structural-functional connectivity (SC-FC) from large-scale whole-brain networks in patients with mild traumatic brain injury. The results showed that the global properties homeostatically conserved in functional connectivity networks while altered in structural connectivity networks. The SC-FC coupling strength showed salient decoupling as a function of time and primarily occurred in hub regions.	[Wang, Shan; Gan, Shuoqiu; Yang, Xuefei; Li, Tianhui; Xiong, Feng; Jia, Xiaoyan; Bai, Lijun] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian 710049, Peoples R China; [Gan, Shuoqiu; Sun, Yingxiang; Zhang, Ming] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian 710049, Peoples R China; [Liu, Jun] Cent South Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Peoples R China		Bai, LJ (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian 710049, Peoples R China.; Zhang, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian 710049, Peoples R China.	zhangming01@mail.xjtu.edu.cn; bailijun@xjtu.edu.cn		Jia, Xiaoyan/0000-0002-3730-6877	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771914, 81871993, 82071331, 81671671]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [xjj2018229, xzy022019045]; Clinical Research Center For Medical Imaging In Hunan Province [2020SK4001]; Changsha Science and Technology project [kq1801115]	This research was supported by the National Natural Science Foundation of China (Grant Nos. 81771914, 81871993, 82071331, and 81671671), the Fundamental Research Funds for the Central Universities (Grant Nos. xjj2018229 and xzy022019045) the Clinical Research Center For Medical Imaging In Hunan Province (2020SK4001), and the Changsha Science and Technology project (Grant No. kq1801115).	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Antonakakis M, 2020, FRONT COMPUT NEUROSC, V13, DOI 10.3389/fncom.2019.00090; Antonakakis M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00416; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Christman SD, 2015, BRAIN COGNITION, V98, P82, DOI 10.1016/j.bandc.2015.06.005; Chu SH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23051-9; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Dimitriadis SI, 2017, BRAIN CONNECT, V7, P661, DOI 10.1089/brain.2017.0512; Ding JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063850; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Martensson G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29927-0; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Niu RN, 2018, NEUROIMAGE-CLIN, V18, P943, DOI 10.1016/j.nicl.2018.03.030; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Wang YF, 2019, THERANOSTICS, V9, P8171, DOI 10.7150/thno.35387; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zouridakis G, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400064	65	1	1	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	NOV 1	2021	11	9					745	758		10.1089/brain.2020.0852			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XK8FH	WOS:000727693800007	33605188				2022-02-06	
J	Webb, EK; Weis, CN; Huggins, AA; Fitzgerald, JM; Bennett, K; Bird, CM; Parisi, EA; Kallenbach, M; Miskovich, T; Krukowski, J; deRoon-Cassini, TA; Larson, CL				Webb, E. Kate; Weis, Carissa N.; Huggins, Ashley A.; Fitzgerald, Jacklynn M.; Bennett, Kenneth; Bird, Claire M.; Parisi, Elizabeth A.; Kallenbach, Maddy; Miskovich, Tara; Krukowski, Jessica; deRoon-Cassini, Terri A.; Larson, Christine L.			Neural impact of neighborhood socioeconomic disadvantage in traumatically injured adults	NEUROBIOLOGY OF STRESS			English	Article						Socioeconomic position; Neighborhood disadvantage; Structural fMRI; Functional fMRI; Emotion regulation	POSTTRAUMATIC-STRESS-DISORDER; MEDIAL PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; HEALTH DISPARITIES; AREA DEPRIVATION; TELOMERE LENGTH; BRAIN STRUCTURE; FAMILY INCOME; CHILDHOOD	Nearly 14 percent of Americans live in a socioeconomically disadvantaged neighborhood. Lower individual socioeconomic position (iSEP) has been linked to increased exposure to trauma and stress, as well as to alterations in brain structure and function; however, the neural effects of neighborhood SEP (nSEP) factors, such as neighborhood disadvantage, are unclear. Using a multi-modal approach with participants who recently experienced a traumatic injury (N = 185), we investigated the impact of neighborhood disadvantage, acute post-traumatic stress symptoms, and iSEP on brain structure and functional connectivity at rest. After controlling for iSEP, demographic variables, and acute PTSD symptoms, nSEP was associated with decreased volume and alterations of resting-state functional connectivity in structures implicated in affective processing, including the insula, ventromedial prefrontal cortex, amygdala, and hippocampus. Even in individuals who have recently experienced a traumatic injury, and after accounting for iSEP, the impact of living in a disadvantaged neighborhood is apparent, particularly in brain regions critical for experiencing and regulating emotion. These results should inform future research investigating how various levels of socioeconomic circumstances may impact recovery after a traumatic injury as well as policies and community-developed interventions aimed at reducing the impact of socioeconomic stressors.	[Webb, E. Kate; Weis, Carissa N.; Huggins, Ashley A.; Parisi, Elizabeth A.; Kallenbach, Maddy; Larson, Christine L.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Fitzgerald, Jacklynn M.; Bird, Claire M.; Krukowski, Jessica] Marquette Univ, Dept Psychol, Milwaukee, WI 53233 USA; [Bennett, Kenneth] VA Montana Healthcare Syst, Helena, MT USA; [Miskovich, Tara] VA Northern Calif Healthcare Syst, Martinez, CA USA; [deRoon-Cassini, Terri A.] Med Coll Wisconsin, Dept Surg, Div Trauma & Acute Care Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA		Webb, EK (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	ekwebb@uwm.edu		Krukowski, Jessica/0000-0003-1921-7480; Webb, Elisabeth/0000-0002-4993-7836	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH106574]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [2UL1TR001436, 2TL1TR001437]	The authors extend a special thanks to the iSTAR research team. We also are indebted to all the participants that took part in the study -their dedication and enthusiasm made this project possible and fulfilling. Finally, we would like to thank the reviewers who provided constructive recommendations that greatly improved the manuscript. This research was supported by a National Institute of Mental Health grant (R01 MH106574; PI: Larson).; E.K.W. and C.M.B. were supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Numbers 2UL1TR001436 and 2TL1TR001437. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Ansseau M, 2008, DEPRESS ANXIETY, V25, P506, DOI 10.1002/da.20306; Association A.P., 2013, DIAGNOSTIC STAT MANU; Astur R.S., 2006, CYBERPSYCHOL BEHAV, V240; Baglivio MT, 2017, CRIME DELINQUENCY, V63, P166, DOI 10.1177/0011128715570628; Baker DG, 2012, NEUROPHARMACOLOGY, V62, P663, DOI 10.1016/j.neuropharm.2011.02.027; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; Benelli E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00239; Bird CM, 2021, J TRAUMA STRESS, V34, P995, DOI 10.1002/jts.22670; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bonnici HM, 2012, J NEUROSCI, V32, P16982, DOI 10.1523/JNEUROSCI.2475-12.2012; Brito NH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00276; Calderon-Garciduenas L, 2011, BRAIN COGNITION, V77, P345, DOI 10.1016/j.bandc.2011.09.006; Carlson ED, 2005, RES NURS HEALTH, V28, P306, DOI 10.1002/nur.20084; Carlson JM, 2010, BIOL PSYCHOL, V85, P383, DOI 10.1016/j.biopsycho.2010.08.010; Carretie L, 2009, INT J PSYCHOPHYSIOL, V71, P57, DOI 10.1016/j.ijpsycho.2008.07.006; Chai XQJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2009, DOI 10.1038/npp.2011.88; Chen X, 2020, DEV PSYCHOL, V56, P503, DOI 10.1037/dev0000852; Collins K, 2010, UNDERSTANDING IMPACT; Cross D., 2016, COHESION PTSD SYMPTO; Daskalakis NP, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0898-7; Bert PD, 2018, CURR ENV HLTH REP, V5, P351, DOI 10.1007/s40572-018-0209-9; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Engelen T, 2015, CORTEX, V73, P195, DOI 10.1016/j.cortex.2015.08.013; Farah MJ, 2018, NAT REV NEUROSCI, V19, P428, DOI 10.1038/s41583-018-0023-2; Farah MJ, 2017, NEURON, V96, P56, DOI 10.1016/j.neuron.2017.08.034; Finegood ED, 2020, PSYCHONEUROENDOCRINO, V115, DOI 10.1016/j.psyneuen.2020.104628; Finegood ED, 2017, DEV PSYCHOPATHOL, V29, P1649, DOI 10.1017/S0954579417001304; Ghaziri J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26995-0; Gianaros PJ, 2008, SOC COGN AFFECT NEUR, V3, P91, DOI 10.1093/scan/nsn003; Gianaros PJ, 2008, J NEUROSCI, V28, P990, DOI 10.1523/JNEUROSCI.3606-07.2008; Gianaros PJ, 2013, PSYCHOSOM MED, V75, P610, DOI 10.1097/PSY.0b013e3182a5f9c1; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hagg S, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.73; Hanson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018712; Harnett NG, 2020, NEUROPSYCHOPHARMACOL, V45, P1247, DOI 10.1038/s41386-020-0681-4; Harnett NG, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116086; Hartley CA, 2011, CEREB CORTEX, V21, P1954, DOI 10.1093/cercor/bhq253; Hendler T., 2015, COMPREHENSIVE GUIDE, P1, DOI [10.1007/978-3-319-08613-2_64-1, DOI 10.1007/978-3-319-08613-2_64-1]; Hietbrink F, 2006, World J Emerg Surg, V1, P15, DOI 10.1186/1749-7922-1-15; Hong S.J, 2021, DECOMPOSING COMPLEX, P44; Hu JH, 2018, AM J MED QUAL, V33, P493, DOI 10.1177/1062860617753063; Hunt JFV, 2020, JAMA NEUROL, V77, P451, DOI 10.1001/jamaneurol.2019.4501; Jaggi AS, 2011, NEUROL SCI, V32, P993, DOI 10.1007/s10072-011-0770-6; Janusek LW, 2017, BRAIN BEHAV IMMUN, V60, P126, DOI 10.1016/j.bbi.2016.10.006; Javanbakht A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00154; Jeong H, 2019, BRIT J PSYCHIAT, V214, P347, DOI 10.1192/bjp.2018.260; Johnson SB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3075; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kandilarova S, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00083; Karb RA, 2012, SOC SCI MED, V75, P1038, DOI 10.1016/j.socscimed.2012.03.031; Keding TJ, 2015, NEUROPSYCHOPHARMACOL, V40, P537, DOI 10.1038/npp.2014.239; Kim P, 2013, P NATL ACAD SCI USA, V110, P18442, DOI 10.1073/pnas.1308240110; Kind AJH, 2018, NEW ENGL J MED, V378, P2456, DOI 10.1056/NEJMp1802313; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; Kneebone, 2013, GROWTH SPREAD CONCEN; Koch SBJ, 2016, DEPRESS ANXIETY, V33, P592, DOI 10.1002/da.22478; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Lenroot RK, 2008, DEV PSYCHOPATHOL, V20, P1161, DOI 10.1017/S0954579408000552; LeWinn KZ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00908-7; Li XM, 2017, J AFFECT DISORDERS, V218, P322, DOI 10.1016/j.jad.2017.03.048; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Llera A, 2019, ELIFE, V8, DOI 10.7554/eLife.44443; Luethi M, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.005.2008; Maguire-Jack K, 2017, CHILD YOUTH SERV REV, V72, P44, DOI 10.1016/j.childyouth.2016.10.015; Marshall AT, 2020, NAT MED, V26, P91, DOI 10.1038/s41591-019-0713-y; Marusak HA, 2015, NEUROPSYCHOPHARMACOL, V40, P1250, DOI 10.1038/npp.2014.311; Massey DS, 2018, RSF-RUS SAGE J SOC S, V4, P28, DOI 10.7758/RSF.2018.4.4.02; McCoy DC, 2016, DEVELOPMENTAL SCI, V19, P164, DOI 10.1111/desc.12287; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; McEwen BS, 2012, DEV NEUROBIOL, V72, P878, DOI 10.1002/dneu.20968; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McLaughlin KA, 2016, CURR DIR PSYCHOL SCI, V25, P239, DOI 10.1177/0963721416655883; Merz EC, 2018, J CLIN CHILD ADOLESC, V47, P312, DOI 10.1080/15374416.2017.1326122; Morey RA, 2016, NEUROPSYCHOPHARMACOL, V41, P791, DOI 10.1038/npp.2015.205; Motzkin JC, 2015, BIOL PSYCHIAT, V77, P276, DOI 10.1016/j.biopsych.2014.02.014; Nayback AM, 2008, J PSYCHOSOC NURS MEN, V46, P43; Needham BL, 2014, HEALTH PLACE, V28, P167, DOI 10.1016/j.healthplace.2014.04.009; Neigh GN, 2016, CURR OPIN PHARMACOL, V29, P104, DOI 10.1016/j.coph.2016.07.011; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Noble KG, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00307; Palacios-Barrios EE, 2019, COMPR PSYCHIAT, V90, P52, DOI 10.1016/j.comppsych.2018.12.012; Panaite V, 2019, HEALTH SERV RES, V54, P586, DOI 10.1111/1475-6773.13127; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Piras F, 2011, HUM BRAIN MAPP, V32, P282, DOI 10.1002/hbm.21018; Poldrack RA, 2011, NEURON, V72, P692, DOI 10.1016/j.neuron.2011.11.001; Prater KE, 2013, DEPRESS ANXIETY, V30, P234, DOI 10.1002/da.22014; Pujol J, 2016, NEUROIMAGE, V129, P175, DOI 10.1016/j.neuroimage.2016.01.036; Richardson R, 2015, SOC PSYCH PSYCH EPID, V50, P1641, DOI 10.1007/s00127-015-1092-4; Rive MM, 2013, NEUROSCI BIOBEHAV R, V37, P2529, DOI 10.1016/j.neubiorev.2013.07.018; Ross CE, 2008, CITY COMMUNITY, V7, P163, DOI 10.1111/j.1540-6040.2008.00251.x; Rothbaum BO, 2014, J CLIN PSYCHIAT, V75, P1380, DOI 10.4088/JCP.13m08715; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Sarkheil P, 2013, SOC COGN AFFECT NEUR, V8, P950, DOI 10.1093/scan/nss092; Saxbe D, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12686; Shalev AY, 2019, WORLD PSYCHIATRY, V18, P77, DOI 10.1002/wps.20608; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Simmons AN, 2011, HUM BRAIN MAPP, V32, P1836, DOI 10.1002/hbm.21154; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Staff RT, 2012, ANN NEUROL, V71, P653, DOI 10.1002/ana.22631; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Sun SF, 2020, PSYCHOL TRAUMA-US, V12, P593, DOI 10.1037/tra0000562; Taylor SE, 2006, BIOL PSYCHIAT, V60, P296, DOI 10.1016/j.biopsych.2005.09.027; Tomlinson RC, 2020, NEUROIMAGE, V209, DOI 10.1016/j.neuroimage.2020.116536; Tooley UA, 2020, CEREB CORTEX, V30, P1, DOI 10.1093/cercor/bhz066; Troiani V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00241; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Uys Joachim D K, 2003, Curr Psychiatry Rep, V5, P274; Veenema AH, 2009, FRONT NEUROENDOCRIN, V30, P497, DOI 10.1016/j.yfrne.2009.03.003; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Webb EK, 2021, HEALTH PLACE, V67, DOI 10.1016/j.healthplace.2020.102493; Weis CN, 2021, NEUROIMAGE, V236, DOI 10.1016/j.neuroimage.2021.118076; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Zhao J, 2021, J NEUROSCI, V41, P1331, DOI 10.1523/JNEUROSCI.1906-20.2020	118	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	2352-2895			NEUROBIOL STRESS	Neurobiol. Stress	NOV	2021	15								100385	10.1016/j.ynstr.2021.100385			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UZ9SJ	WOS:000702538100005	34471656	gold, Green Published			2022-02-06	
J	Weiler, R; Blauwet, C; Clarke, D; Dalton, K; Derman, W; Fagher, K; Gouttebarge, V; Kissick, J; Lee, K; Lexell, J; Van de Vliet, P; Verhagen, E; Webborn, N; Ahmed, OH				Weiler, Richard; Blauwet, Cheri; Clarke, David; Dalton, Kristine; Derman, Wayne; Fagher, Kristina; Gouttebarge, Vincent; Kissick, James; Lee, Kenneth; Lexell, Jan; Van de Vliet, Peter; Verhagen, Evert; Webborn, Nick; Ahmed, Osman Hassan			Concussion in para sport: the first position statement of the Concussion in Para Sport (CIPS) Group	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							INJURY; IMPAIRMENT; DISABILITY; GAMES; RISK	Concussion is a frequent injury in many sports and is also common in para athletes. However, there is a paucity of concussion research related to para sport, and prior International Concussion in Sport (CIS) consensus papers have not substantively addressed this population. To remedy this and to improve concussion care provided to para athletes, the concussion in para sport (CIPS) multidisciplinary expert group was created. This group analysed and discussed in-depth para athlete-specific issues within the established key clinical domains of the current (2017) consensus statement on CIS. Due to the onset of the COVID-19 pandemic, the group held all meetings by video conferencing. The existing Sport Concussion Assessment Tool 5 (SCAT5) for the immediate on-field and office-based off-field assessment of concussion was evaluated as part of this process, to identify any para athlete-specific concerns. Regular preparticipation and periodic health examinations are essential to determine a baseline reference point for concussion symptoms but pose additional challenges for the interpreting clinician. Further considerations for concussion management for the para athlete are required within the remove, rest, reconsider and refer consensus statement framework. Considering return to sport (RTS), the 2017 CIS consensus statement has limitations when considering the RTS of the para athlete. Case-by-case decision making related to RTS following concussion is imperative for para athletes. Additional challenges exist for the evaluation and management of concussion in para athletes. There is a need for greater understanding of existing knowledge gaps and attitudes towards concussion among athlete medical staff, coaches and para athletes. Future research should investigate the use and performance of common assessment tools in the para athlete population to better guide their clinical application and inform potential modifications. Concussion prevention strategies and sport-specific rule changes, such as in Para Alpine Skiing and Cerebral Palsy Football also should be carefully considered to reduce the occurrence of concussion in para athletes.	[Weiler, Richard; Gouttebarge, Vincent; Verhagen, Evert] VU Univ Med Ctr Amsterdam, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam Collaborat Hlth & Safety Sports, Amsterdam, Netherlands; [Weiler, Richard] Fortius Clin, Sport & Exercise Med, London, England; [Weiler, Richard; Ahmed, Osman Hassan] Football Fdn, Arnhem, Netherlands; [Blauwet, Cheri] Harvard Med Sch, Brigham & Womens Hosp, Spaulding Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil, Boston, MA 02115 USA; [Blauwet, Cheri] Kelley Adapt Sports Res Inst, Boston, MA USA; [Clarke, David] Univ Hertfordshire, Hatfield, Herts, England; [Dalton, Kristine] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada; [Derman, Wayne] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Surg Sci, Inst Sport & Exercise Med,Div Orthopaed Surg, Cape Town, South Africa; [Derman, Wayne] IOC Res Ctr, Stellenbosch, South Africa; [Fagher, Kristina; Lexell, Jan] Lund Univ, Dept Hlth Sci, Rehabil Med Res Grp, Lund, Sweden; [Gouttebarge, Vincent] Univ Amsterdam, Amsterdam Movement Sci, Amsterdam UMC, Dept Orthopaed Surg, Amsterdam, Netherlands; [Kissick, James] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Kissick, James] Int Paralymp Comm Med Comm, Ottawa, ON, Canada; [Lee, Kenneth] Med Coll Wisconsin, Spinal Cord Injury Disorder Phys Med & Rehabil, Milwaukee, WI 53226 USA; [Van de Vliet, Peter] Int Paralymp Comm, Bonn, Germany; [Webborn, Nick] Univ Brighton, Ctr Sport & Exercise Sci & Med, Eastbourne, England; [Ahmed, Osman Hassan] Univ Hosp Dorset NHS Fdn Trust, Poole, Dorset, England; [Ahmed, Osman Hassan] Univ Portsmouth, Sch Sport Hlth & Exercise Sci, Portsmouth, Hants, England		Verhagen, E (corresponding author), Amsterdam UMC, Dept Publ & Occupat Hlth, Amsterdam, Noord Holland, Netherlands.	e.verhagen@amsterdamumc.nl		Lexell, Jan/0000-0001-5294-3332; Kissick, James/0000-0002-7748-9225; Weiler, Richard/0000-0002-6216-839X; Webborn, Nick/0000-0003-3636-5557; Derman, Wayne/0000-0002-8879-177X			Ahmed OH., 2020, FOOTBALL MED PERFORM, V32, P13; Ahmed OH, 2019, PSYCHOL ASPECTS SPOR; Ahmed OH, 2020, BJSM BLOG; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Blauwet C, 2019, BRIT J SPORT MED, V53, P1391, DOI 10.1136/bjsports-2018-099997; Sanchez-Gonzalez MC, 2019, ANN NY ACAD SCI, V1457, P26, DOI 10.1111/nyas.14224; da Silva ES, 2018, GAIT POSTURE, V62, P355, DOI 10.1016/j.gaitpost.2018.03.049; Derman W, 2021, BRIT J SPORT MED, V55, P1068, DOI 10.1136/bjsports-2020-103464; Derman W, 2020, BRIT J SPORT MED, V54, P38, DOI 10.1136/bjsports-2018-100170; Derman W, 2018, BRIT J SPORT MED, V52, P419, DOI 10.1136/bjsports-2017-098864; Derman W, 2018, BRIT J SPORT MED, V52, P24, DOI 10.1136/bjsports-2017-098039; Derman W, 2014, PM&R, V6, pS23, DOI 10.1016/j.pmrj.2014.05.016; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Fagher K, 2019, THESIS LUND U; Fagher K, 2020, PM&R, V12, P271, DOI 10.1002/pmrj.12211; Fagher K, 2019, J SCI MED SPORT, V22, P902, DOI 10.1016/j.jsams.2019.03.005; Fagher K, 2016, EUR J SPORT SCI, V16, P1240, DOI 10.1080/17461391.2016.1192689; Griffin S, 2017, BR J SPORTS MED, V51, P325, DOI [10.1136/bjsports-2016-097372.106, DOI 10.1136/BJSPORTS-2016-097372.106]; Hronis A, 2017, BRIT J CLIN PSYCHOL, V56, P189, DOI 10.1111/bjc.12133; IFCPF, 2020, IFCPF UNV NEW TEMP C; Kissick J, 2018, PHYS MED REH CLIN N, V29, P299, DOI 10.1016/j.pmr.2018.01.002; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Roberts L, 2018, CLIN PSYCHOL PSYCHOT, V25, P662, DOI 10.1002/cpp.2196; Van de Vliet P., 2016, ASPETAR SPORTS MED J, V5, P74; Webborn N, 2016, PM&R, V8, P545, DOI 10.1016/j.pmrj.2015.09.025; Weiler R, 2018, CLIN J SPORT MED, V28, P43, DOI 10.1097/JSM.0000000000000407; Wessels K., 2013, CONCUSSION ASSESSMEN; Wessels KK, 2012, ARCH PHYS MED REHAB, V93, P275, DOI 10.1016/j.apmr.2011.09.009; West CR, 2014, MED SCI SPORT EXER, V46, P60, DOI 10.1249/MSS.0b013e31829e46f3; West LR, 2017, BRIT J SPORT MED, V51, P1050, DOI 10.1136/bjsports-2016-096767; World Health Organization, 2002, COMM LANG FUNCT DIS; World Health Organization, 2007, INT CLASS FUNCT DIS	33	1	1	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	NOV	2021	55	21					1187	1195		10.1136/bjsports-2020-103696			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WP5JC	WOS:000713166800006	33837003	Green Published, hybrid			2022-02-06	
J	Wicklund, A; Roy, A; Coatsworth, JD				Wicklund, Alissa; Roy, Ashley; Coatsworth, J. Douglas			Providing a Medical Definition of Concussion: Can a Simple Intervention Improve Self-Reported Concussion History in Youth Athletes?	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sports-related concussion; youth sports; concussion reporting	KNOWLEDGE	Objective: Providing a medical definition of concussion improves reliability of self-reported history of concussion in adult former athletes. We examine whether providing a medical definition of concussion to youth athletes increases the number of concussions reported, and whether reporting differs by age, sex, or sport type. Design: Cross-sectional survey. Setting: Concussion specialty clinic. Participants: Convenience sample of youth athletes (n = 301; mean age = 15.1 +/- 1.6 years) presenting for evaluation of sports-related concussion. Independent Variables: Number of concussions reported before and after presentation of the medical definition of concussion ("vignette"). Outcome Measures: Number of concussions reported after vignette. Paired-sample t test examined for main effect of the vignette on reporting behavior. One-way between-subjects analysis of variance with pairwise comparisons assessed for group differences. Results: Thirty percent of youth athletes reported an increase in number of concussions after vignette overall (P < 0.000). There was no significant difference in reporting behavior by age, sex, or sport type. Conclusions: Providing the medical definition of concussion, a simple and brief intervention, gives youth athletes context to understand when a concussion has occurred. This results in an increase in the number of concussions reported when gathering a self-reported history. Reporting behavior after a vignette does not differ across sex, sport type, or age of the athlete.	[Wicklund, Alissa] OCR Reg Concuss Ctr, Ft Collins, CO 80525 USA; [Roy, Ashley] Nationwide Childrens Hosp, Columbus, OH USA; [Coatsworth, J. Douglas] Colorado State Univ, Ft Collins, CO 80523 USA		Wicklund, A (corresponding author), OCR Reg Concuss Ctr, Orthopaed & Spine Ctr Rockies, 2500 E Prospect Rd, Ft Collins, CO 80525 USA.	awicklund@orthohealth.com		Coatsworth, J Douglas/0000-0003-0306-2760			Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; IBM Corp, 2017, SPSS STAT WIND; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690	11	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					E467	E469		10.1097/JSM.0000000000000813			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700026	32032159				2022-02-06	
J	Yengo-Kahn, AM; Patel, PD; Kelly, PD; Wolfson, DI; Dawoud, F; Ahluwalia, R; Bonfield, CM; Guillamondegui, OD				Yengo-Kahn, Aaron M.; Patel, Pious D.; Kelly, Patrick D.; Wolfson, Daniel, I; Dawoud, Fakhry; Ahluwalia, Ranbir; Bonfield, Christopher M.; Guillamondegui, Oscar D.			The value of simplicity: externally validating the Baylor cranial gunshot wound prognosis score	JOURNAL OF NEUROSURGERY			English	Article						gunshot wound; penetrating brain injury; prognostic scores; trauma; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; PREDICTORS; MANAGEMENT; MORTALITY; SURVIVAL; CARE	OBJECTIVE Gunshot wounds to the head (GSWH) are devastating injuries with a grim prognosis. Several prognostic scores have been created to estimate mortality and functional outcome, including the so-called Baylor score, an uncomplicated scoring method based on bullet trajectory, patient age, and neurological status on admission. This study aimed to validate the Baylor score within a temporally, institutionally, and geographically distinct patient population. METHODS Data were obtained from the trauma registry at a level I trauma center in the southeastern US. Patients with a GSWH in which dural penetration occurred were identified from data collected between January 1, 2009, and June 30, 2019. Patient demographics, medical history, bullet trajectory, intent of GSWH (e.g., suicide), admission vital signs, Glasgow Coma Scale score, pupillary response, laboratory studies, and imaging reports were collected. The Baylor score was calculated directly by using its clinical components. The ability of the Baylor score to predict mortality and good functional outcome (Glasgow Outcome Scale score 4 or 5) was assessed using the receiver operating characteristic curve and the area under the curve (AUC) as a measure of performance. RESULTS A total of 297 patients met inclusion criteria (mean age 38.0 [SD 15.7] years, 73.4% White, 85.2% male). A total of 205 (69.0%) patients died, whereas 69 (23.2%) patients had good functional outcome. Overall, the Baylor score showed excellent discrimination of mortality (AUC = 0.88) and good functional outcome (AUC = 0.90). Baylor scores of 3-5 underestimated mortality. Baylor scores of 0, 1, and 2 underestimated good functional outcome. CONCLUSIONS The Baylor score is an accurate and easy-to-use prognostic scoring tool that demonstrated relatively stable performance in a distinct cohort between 2009 and 2019. In the current era of trauma management, providers may continue to use the score at the point of admission to guide family counseling and to direct investment of healthcare resources.	[Yengo-Kahn, Aaron M.; Kelly, Patrick D.; Dawoud, Fakhry; Ahluwalia, Ranbir; Bonfield, Christopher M.] Vanderbilt Univ, Dept Neurol Surg, Med Ctr, Nashville, TN USA; [Patel, Pious D.; Wolfson, Daniel, I] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Dawoud, Fakhry] East Tennessee State Univ, Quillen Coll Med, Mountain Home, TN USA; [Ahluwalia, Ranbir] Florida State Univ, Coll Med, Tallahassee, FL USA; [Guillamondegui, Oscar D.] Vanderbilt Univ, Med Ctr, Div Trauma Emergency Surg & Crit Care, Nashville, TN USA; [Wolfson, Daniel, I] Rush Univ, Dept Neurol Surg, Med Ctr, Chicago, IL USA		Yengo-Kahn, AM (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	a.yengo@vumc.org		Kelly, Patrick/0000-0003-4911-4239	NCATS/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445]; National Cancer Institute of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA106183]	Sources of support include the following: REDCap, used for study data management, is supported by NCATS/NIH grant no. UL1 TR000445. Dr. Kelly is supported by a training grant from the National Cancer Institute of the NIH under award no. T32CA106183.	Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; Alao T, 2020, STATPEARLS; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Alvis-Miranda Hernando Raphael, 2015, Korean J Neurotrauma, V11, P35, DOI 10.13004/kjnt.2015.11.2.35; Bandt SK, 2012, J NEUROSURG-PEDIATR, V10, P511, DOI 10.3171/2012.8.PEDS123; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Brinck T, 2016, SCAND J SURG, V105, P109, DOI 10.1177/1457496915586650; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Garwe T, 2010, ACAD EMERG MED, V17, P1223, DOI 10.1111/j.1553-2712.2010.00918.x; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Henry, 2018, B AM COLL SURG; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Holcomb JB, TRANSFUSION PLASMA P; Holcomb JB, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002339; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kim KA, 2005, NEUROSURGERY, V57, P737, DOI [10.1227/01.NEU.0000175727.76530.94, 10.1227/01.NEU.0000164174.07281.F9]; Kim LH, 2020, J CLIN NEUROSCI, V75, P71, DOI 10.1016/j.jocn.2020.03.027; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Mikati AG, 2019, NEUROSURGERY, V85, pE872, DOI 10.1093/neuros/nyz127; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; Riskin DJ, 2009, J AM COLL SURGEONS, V209, P198, DOI 10.1016/j.jamcollsurg.2009.04.016; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tunthanathip Thara, 2019, Bull Emerg Trauma, V7, P347, DOI 10.29252/beat-070402	28	1	1	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2021	135	5					1560	1568		10.3171/2020.9.JNS201891			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WS1YJ	WOS:000714984700003	33690151				2022-02-06	
J	Kiker, WA; Voumard, RR; Andrews, LIB; Holloway, RG; Brumback, LC; Engelberg, RA; Curtis, JR; Creutzfeldt, CJ				Kiker, Whitney A.; Voumard, Rachel Rutz; Andrews, Leah I. B.; Holloway, Robert G.; Brumback, Lyndia C.; Engelberg, Ruth A.; Curtis, J. Randall; Creutzfeldt, Claire J.			Assessment of Discordance Between Physicians and Family Members Regarding Prognosis in Patients With Severe Acute Brain Injury	JAMA NETWORK OPEN			English	Article							HEALTH-CARE; PALLIATIVE CARE; ILL PATIENTS; COMMUNICATION; ILLNESS; HOPE; STROKE; GOALS; END; US	IMPORTANCE Shared decision-making requires key stakeholders to align in perceptions of prognosis and likely treatment outcomes. OBJECTIVE For patients with severe acute brain injury, the objective of this study was to better understand prognosis discordance between physicians and families by determining prevalence and associated factors. DESIGN, SETTING, AND PARTICIPANTS This mixed-methods cross-sectional study analyzed a cohort collected from January 4, 2018, to July 22, 2020. This study was conducted in the medical and cardiac intensive care units of a single neuroscience center. Participants included families, physicians, and nurses of patients admitted with severe acute brain injury. EXPOSURES Severe acute brain injury was defined as stroke, traumatic brain injury, or hypoxic ischemic encephalopathy with a Glasgow Coma Scale score less than or equal to 12 points after hospital day 2. MAIN OUTCOMES AND MEASURES Prognosis discordance was defined as a 20% or greater difference between family and physician prognosis predictions; misunderstanding was defined as a 20% or greater difference between physician prediction and the family's estimate of physician prediction; and optimistic belief difference was defined as any difference (>0%) between family prediction and their estimate of physician prediction. Logistic regression was used to identify associations with discordance. Optimistic belief differences were analyzed as a subgroup of prognosis discordance. RESULTS Among 222 enrolled patients, prognostic predictions were available for 193 patients (mean [SD] age, 57 [19] years; 106 men [55%]). Prognosis discordance occurred for 118 patients (61%) and was significantly more common among families who identified with minoritized racial groups compared with White families (odds ratio [OR], 3.14; CI, 1.40-7.07, P = .006); among siblings (OR, 4.93; 95% CI, 1.35-17.93, P = .02) and adult children (OR, 2.43; 95% CI, 1.10-5.37; P = .03) compared with spouses; and when nurses perceived family understanding as poor compared with good (OR, 3.73; 95% CI, 1.88-7.40; P < .001). Misunderstanding was present for 80 of 173 patients (46%) evaluated for this type of prognosis discordance, and optimistic belief difference was present for 94 of 173 patients (54%). In qualitative analysis, faith and uncertainty emerged as themes underlying belief differences. Nurse perception of poor family understanding was significantly associated with misunderstanding (OR, 2.06; 95% CI, 1.07-3.94; P = .03), and physician perception with optimistic belief differences (OR, 2.32; 95% CI, 1.10-4.88; P = .03). CONCLUSIONS AND RELEVANCE Results of this cross-sectional study suggest that for patients with severe acute brain injury, prognosis discordance between physicians and families was common. Efforts to improve communication and decision-making should aim to reduce this discordance and find ways to target both misunderstanding and optimistic belief differences.	[Kiker, Whitney A.; Engelberg, Ruth A.; Curtis, J. Randall] Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA; [Kiker, Whitney A.; Brumback, Lyndia C.; Engelberg, Ruth A.; Curtis, J. Randall; Creutzfeldt, Claire J.] Univ Washington, Cambia Palliat Care Ctr Excellence, Seattle, WA 98195 USA; [Voumard, Rachel Rutz; Creutzfeldt, Claire J.] Univ Washington, Harborview Med Ctr, Dept Neurol, Seattle, WA 98195 USA; [Voumard, Rachel Rutz] Univ Lausanne, Lausanne Univ Hosp, Palliat & Support Care Serv, Lausanne, Switzerland; [Andrews, Leah I. B.; Brumback, Lyndia C.] Univ Washington, Dept Biostat, Sch Publ Hlth, Seattle, WA 98195 USA; [Holloway, Robert G.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA		Kiker, WA (corresponding author), Univ Washington, POB 356522,BB1226 Hlth Sci Bldg, Seattle, WA 98195 USA.	wkiker@uw.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS099421]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5 T32 HL125195-02]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [P400PB186732]; National Heart Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)	This study was supported in part by grant K23 NS099421 from the National Institute of Neurological Disorders and Stroke (Dr Creutzfeldt); grant 5 T32 HL125195-02 from the National Institutes of Health and National Heart Lung, and Blood Institute (Dr Kiker); and grant P400PB186732 from the Swiss National Science Foundation (Dr Voumard).	Armstrong K, 2008, J GEN INTERN MED, V23, P827, DOI 10.1007/s11606-008-0561-9; Balaban RB, 2000, J GEN INTERN MED, V15, P195, DOI 10.1046/j.1525-1497.2000.07228.x; Bernacki RE, 2014, JAMA INTERN MED, V174, P1994, DOI 10.1001/jamainternmed.2014.5271; Bhang TN, 2019, J PALLIAT MED, V22, P880, DOI 10.1089/jpm.2019.0193; Boyd EA, 2010, CRIT CARE MED, V38, P1270, DOI 10.1097/CCM.0b013e3181d8a217; Butler R, 2018, AM J MED, V131, DOI 10.1016/j.amjmed.2018.03.015; Chou WYS, 2010, J HEALTH COMMUN, V15, P147, DOI 10.1080/10810730.2010.522692; Clayton JM, 2008, PSYCHO-ONCOL, V17, P641, DOI 10.1002/pon.1288; Creutzfeldt CJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3904; Epstein RM, 2013, PATIENT EDUC COUNS, V90, P200, DOI 10.1016/j.pec.2012.06.035; Faigle R, 2017, CRIT CARE MED, V45, P2046, DOI 10.1097/CCM.0000000000002762; Ford D, 2010, CHEST, V138, P59, DOI 10.1378/chest.09-2124; Frontera JA, 2015, CRIT CARE MED, V43, P1964, DOI 10.1097/CCM.0000000000001131; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P478, DOI 10.1001/jama.284.4.478; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hausmann LRM, 2011, MED CARE, V49, P626, DOI 10.1097/MLR.0b013e318215d93c; Haviland MG, 2005, AM J MED QUAL, V20, P195, DOI 10.1177/1062860605275754; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Lang F, 2004, AM FAM PHYSICIAN, V70, P719; Mirr M P, 1991, AACN Clin Issues Crit Care Nurs, V2, P242; Newman AR, 2016, CANCER NURS, V39, pE48, DOI 10.1097/NCC.0000000000000365; Oppenheim IM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.1945; Paladino J, 2019, JAMA-J AM MED ASSOC, V322, P1345, DOI 10.1001/jama.2019.11533; Pratt AK, 2019, CRIT CARE MED, V47, P591, DOI 10.1097/CCM.0000000000003647; Reinke LF, 2010, J PAIN SYMPTOM MANAG, V39, P982, DOI 10.1016/j.jpainsymman.2009.11.315; Schaufel MA, 2011, INT J QUAL STUD HEAL, V6, DOI 10.3402/qhw.v6i1.5917; Schutz REC, 2017, J PALLIAT MED, V20, P170, DOI 10.1089/jpm.2016.0286; Shen MJ, 2018, J RACIAL ETHN HEALTH, V5, P117, DOI 10.1007/s40615-017-0350-4; Singh T, 2017, STROKE, V48, P2534, DOI 10.1161/STROKEAHA.117.016893; Voumard RR, 2021, CRIT CARE MED, V49, P1322, DOI 10.1097/CCM.0000000000004947; White DB, 2016, JAMA-J AM MED ASSOC, V315, P2086, DOI 10.1001/jama.2016.5351; White DB, 2010, MED DECIS MAKING, V30, P76, DOI 10.1177/0272989X08317012; Zier LS, 2008, CRIT CARE MED, V36, P2341, DOI 10.1097/CCM.0b013e318180ddf9	33	1	1	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	OCT 21	2021	4	10							e2128991	10.1001/jamanetworkopen.2021.28991			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WK7PU	WOS:000709916200002	34673964	Green Published, gold			2022-02-06	
J	Jiang, Q; Wei, D; He, XJ; Gan, C; Long, XB; Zhang, HQ				Jiang, Qian; Wei, Ding; He, Xuejun; Gan, Chao; Long, Xiaobing; Zhang, Huaqiu			Phillyrin Prevents Neuroinflammation-Induced Blood-Brain Barrier Damage Following Traumatic Brain Injury via Altering Microglial Polarization	FRONTIERS IN PHARMACOLOGY			English	Article						traumatic brain injury; phillyrin; microglia; PPAR gamma; neuroinflammation; blood-brain barrier	ACTIVATED RECEPTOR-GAMMA; NEUROLOGICAL DEFICITS; COGNITIVE DEFICITS; OXIDATIVE STRESS; NEURONAL LOSS; M2 MICROGLIA; INFLAMMATION; APOPTOSIS; FORSYTHIASIDE; PHARMACOLOGY	Background: Phillyrin (Phi) is the main polyphenolic compound found in Forsythia suspensa. Recent studies have revealed that Phi has potent antioxidative and anti-inflammatory effects. However, whether Phi could relieve blood-brain barrier (BBB) damage following traumatic brain injury (TBI) remains unknown. Materials and Methods: Lipopolysaccharide (LPS) was used to activate primary microglia, which were then treated with different doses of Phi or the peroxisome proliferator-activated receptor-gamma (PPAR gamma) antagonist (GW9662). CCK-8 assay was used for evaluating cell viability, and the cytokines (including IL-1 beta, IL-6, TNF alpha, IL-4, IL-10, and TGF beta), microglial phenotypic markers (iNOS, COX2, and CD86 for "M1" polarization; Arg1, Ym1, and CD206 for "M2" polarization), PPAR gamma, and NF-kappa B were determined by RT-PCR, Western blot, or cellular immunofluorescence. Primary cultured mouse brain microvascular endothelial cells (BMECs) were stimulated by the condition medium (CM) from microglia. The cell viability, angiogenesis, and tight junction of BMECs were determined via CCK-8 assay, tube formation assay, and Western blot (for detecting MMP3, MMP9, ZO1, claudin-5, and occludin). Furthermore, the mouse TBI model was constructed and treated with Phi and/or GW9662. The BBB integrity was evaluated by H&E staining, Evans blue staining, and tissue immunofluorescence. Results: Phi markedly restrained the pro-inflammatory ("M1" state) cytokines and promoted anti-inflammatory ("M2" polarization) cytokines in LPS-mediated microglia. Phi mitigated "M1" polarization and promoted "M2" polarization of microglia via enhancing PPAR gamma and inhibiting the NF-kappa B pathway. The PPAR gamma antagonist GW9662 significantly repressed Phi-mediated anti-inflammatory effects. Meanwhile, Phi enhanced the viability, tube formation ability, and cell junction of BMECs. In the TBI mouse model, Phi promoted "M2" polarization, whereas it repressed the "M1" polarization of microglia. In addition, Phi reduced TBI-mediated BBB damage. However, the protective effects of Phi were reversed mainly by GW9662 treatment. Conclusion: Phi prevents BBB damage via inhibiting the neuroinflammation of microglia through the PPAR gamma/NF-kappa B pathway, which provides a potential therapeutic drug against TBI.	[Jiang, Qian; He, Xuejun; Gan, Chao; Zhang, Huaqiu] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan, Peoples R China; [Wei, Ding] Wuhan Univ Sci & Technol, Dept Neurosurg, Tianyou Hosp, Wuhan, Peoples R China; [Long, Xiaobing] Wuhan Univ, Dept Emergency, Renmin Hosp, Wuhan, Peoples R China		Zhang, HQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan, Peoples R China.	zhanghq_04@yahoo.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371381]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2018KFYYXJJ105]	Funding This study was supported by the National Natural Science Foundation of China (No. 81371381) and the Fundamental Research Funds for the Central Universities (2018KFYYXJJ105).	Chen LQ, 2019, NEUROCHEM INT, V125, P57, DOI 10.1016/j.neuint.2019.02.008; Chen MR, 2020, NEUROPSYCH DIS TREAT, V16, P3239, DOI 10.2147/NDT.S265478; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Donovan C, 2015, AM J PHYSIOL-LUNG C, V309, pL1219, DOI 10.1152/ajplung.00156.2015; Du YY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/2684672; Fernandes V, 2018, INT J NEUROSCI, V128, P935, DOI 10.1080/00207454.2018.1443926; Gao TL, 2018, BIOCHEM BIOPH RES CO, V497, P430, DOI 10.1016/j.bbrc.2018.02.102; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Gong LH, 2021, PHARMACOL RES, V169, DOI 10.1016/j.phrs.2021.105690; Gonzalez-Burgos E, 2012, CURR MED CHEM, V19, P5319, DOI 10.2174/092986712803833335; Guo X, 2021, EUR J PHARMACOL, V909, DOI 10.1016/j.ejphar.2021.174439; Han LJ, 2015, STROKE, V46, P2628, DOI 10.1161/STROKEAHA.115.010091; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jiang Q, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106083; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kotha RR, 2019, MOLECULES, V24, DOI 10.3390/molecules24162930; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lenglet S, 2015, CURR VASC PHARMACOL, V13, P161, DOI 10.2174/15701611113116660161; Liu H, 2016, BIOCHEM BIOPH RES CO, V472, P648, DOI 10.1016/j.bbrc.2016.03.003; Liu H, 2018, BIOCHEM CELL BIOL, V96, P672, DOI 10.1139/bcb-2017-0209; Liu N, 2021, BRAIN RES BULL, V171, P91, DOI 10.1016/j.brainresbull.2021.03.004; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Long XB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01761-0; Lu ZB, 2020, TOXICOL APPL PHARM, V407, DOI 10.1016/j.taap.2020.115252; Luo H, 2020, CHIN J INTEGR MED, V26, P243, DOI 10.1007/s11655-020-3192-6; Ma QH, 2020, PHYTOMEDICINE, V78, DOI 10.1016/j.phymed.2020.153296; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Peng JH, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2019.101121; Petrosino S, 2017, BRIT J PHARMACOL, V174, P1349, DOI 10.1111/bph.13580; Pu HJ, 2021, J CEREBR BLOOD F MET, V41, P2870, DOI 10.1177/0271678X211028680; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sharma K, 2018, NEUROSCI LETT, V674, P162, DOI 10.1016/j.neulet.2018.03.030; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Thomsen LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134765; Tian XD, 2017, CURR DRUG DELIV, V14, P785, DOI 10.2174/1567201813666160808111933; Tiwari V, 2013, NEUROSCIENCE, V244, P147, DOI 10.1016/j.neuroscience.2013.03.042; Tiwari V, 2014, NEUROSCI BIOBEHAV R, V45, P19, DOI 10.1016/j.neubiorev.2014.05.002; Tiwari V, 2012, PSYCHOPHARMACOLOGY, V224, P519, DOI 10.1007/s00213-012-2779-9; van Vliet EA, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105080; Villapol S, 2018, CELL MOL NEUROBIOL, V38, P121, DOI 10.1007/s10571-017-0554-5; Wang Y, 2016, NEUROCHEM RES, V41, P659, DOI 10.1007/s11064-015-1731-x; Wang Z, 2020, CURR MED CHEM, V27, P5790, DOI 10.2174/0929867326666190527120614; Wei T, 2014, CELL MOL NEUROBIOL, V34, P1165, DOI 10.1007/s10571-014-0091-4; Wen L, 2018, J NEUROTRAUM, V35, P2330, DOI 10.1089/neu.2017.5540; Xia EQ, 2011, ULTRASON SONOCHEM, V18, P549, DOI 10.1016/j.ultsonch.2010.09.015; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Xu XQ, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3176483; Yang LL, 2017, CELL PHYSIOL BIOCHEM, V43, P2074, DOI 10.1159/000484192; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Zhang D, 2020, INFLAMMATION, V43, P540, DOI 10.1007/s10753-019-01136-5; Zhang Y, 2018, J ETHNOPHARMACOL, V218, P27, DOI 10.1016/j.jep.2018.02.033; Zhong WT, 2013, FITOTERAPIA, V90, P132, DOI 10.1016/j.fitote.2013.06.003; Zhou W, 2017, MOLECULES, V22, DOI 10.3390/molecules22040654; Zhuang ZJ, 2020, EUR J INTEGR MED, V37, DOI 10.1016/j.eujim.2020.101139	58	1	1	5	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1663-9812		FRONT PHARMACOL	Front. Pharmacol.	OCT 20	2021	12								719823	10.3389/fphar.2021.719823			17	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	WU7KP	WOS:000716720600001	34744713				2022-02-06	
J	Thygesen, MM; Lund, TE; Mikkelsen, IK; Kasch, H; Dalby, RB; Dyrskog, SE; Pedersen, M; Rasmussen, MM				Thygesen, Mathias Moller; Lund, Torben Ellegaard; Mikkelsen, Irene Klaerke; Kasch, Helge; Dalby, Rikke Beese; Dyrskog, Stig Eric; Pedersen, Michael; Rasmussen, Mikkel Mylius			Diffusional kurtosis imaging as a possible prognostic marker of cervical incomplete spinal cord injury outcome: a prospective pilot study	ACTA NEUROCHIRURGICA			English	Article						Spinal cord injury; Diffusional kurtosis imaging; Magnetic resonance imaging; Prognostic; Predictive; SCIM-III	TRAUMATIC BRAIN-INJURY; MICROSTRUCTURAL CHANGES; SEVERITY; DTI	Background Spinal cord injury (SCI) is associated with substantial chronic morbidity and mortality. Routine imaging techniques such as T1- and T2-weighted magnetic resonance imaging (MRI) are not effective in predicting neurological deficiency grade or outcome. Diffusional kurtosis imaging (DKI) is an MR imaging technique that provides microstructural information about biological tissue. There are no longitudinal prospective studies assessing DKI metrics in acute traumatic SCI. Therefore, the purpose of this study was to establish a DKI protocol for acute SCI and correlate the DKI metrics to the functional neurological outcome of the patients. Methods Eight consecutive SCI patients referred to our institution with cervical SCI were included in the study. An acute diagnostic MRI scan was supplemented with a novel fast, mean kurtosis DKI protocol, which describes the average deviation from Gaussian diffusional along nine different directions. Mean kurtosis values were measured at the injury site and normalized to the mean kurtosis values of a non-injured site. At discharge form specialized rehabilitation, patients were evaluated using the Spinal Cord Independence Measure-III (SCIM-III). The DKI metrics and SCIM-III were analysed using Spearman's rank correlation. Results This pilot study found a significant correlation between decreasing mean kurtosis values at the injury site of the spinal cord and higher grade of disability measured by the SCIM-III (p = 0.002). Conclusion This pilot study found that DKI may be a valuable tool as a prognostic marker in the acute phase of SCI	[Thygesen, Mathias Moller; Pedersen, Michael] Aarhus Univ Hosp, Dept Neurosurg, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark; [Thygesen, Mathias Moller; Rasmussen, Mikkel Mylius] Aarhus Univ, Dept Clin Med, Comparat Med Lab, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark; [Mikkelsen, Irene Klaerke; Kasch, Helge] Aarhus Univ, Ctr Functionally Integrat Neurosci, Noerrebrogade 1A, DK-8000 Aarhus C, Denmark; [Kasch, Helge] Reg Hosp Viborg, Dept Neurol, DK-8800 Viborg, Denmark; [Dalby, Rikke Beese] Aarhus Univ Hosp, Dept Radiol, Sect Neuroradiol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark; [Dyrskog, Stig Eric] Aarhus Univ Hosp, Dept Intens Care, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark		Thygesen, MM (corresponding author), Aarhus Univ Hosp, Dept Neurosurg, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark.; Thygesen, MM (corresponding author), Aarhus Univ, Dept Clin Med, Comparat Med Lab, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark.	matthy@rm.dk; torbenelund@cfin.au.dk; irene@cfin.dk; helgkasc@rm.dk; rikkdalb@rm.dk; stig.dyrskog@rm.dk; michael@clin.au.dk; mikkrasm@rm.dk	Lund, Torben E/B-1919-2008	Lund, Torben E/0000-0002-9002-4676; Rasmussen, Mikkel Mylius/0000-0002-4768-7255; Dyrskog, Stig/0000-0002-1903-1742			Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Badhiwala JH, 2018, J NEUROTRAUM, V35, P1906, DOI 10.1089/neu.2018.5935; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Dalkilic T, 2018, J NEUROTRAUM, V35, P435, DOI 10.1089/neu.2017.5357; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hagen EM, 2015, WORLD J ORTHOP, V6, P17, DOI 10.5312/wjo.v6.i1.17; Hansen B, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3741; Hansen B, 2016, MAGN RESON MED, V76, P1455, DOI 10.1002/mrm.26055; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24389, 10.1002/mrm.24743]; Helpern J., 2003, P 11 ANN M ISMRM; Hicken BL, 2001, AM J PHYS MED REHAB, V80, P916, DOI 10.1097/00002060-200112000-00008; Hori M, 2014, MAGN RESON IMAGING, V32, P428, DOI 10.1016/j.mri.2014.01.018; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kamble Ravindra B, 2011, Indian J Radiol Imaging, V21, P221, DOI 10.4103/0971-3026.85372; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; LEVI R, 1995, PARAPLEGIA, V33, P308, DOI 10.1038/sc.1995.70; Li DW, 2017, CLIN NEUROL NEUROSUR, V156, P71, DOI 10.1016/j.clineuro.2017.03.015; Liu ZH, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01752-x; Martin AR, 2016, NEUROIMAGE-CLIN, V10, P192, DOI 10.1016/j.nicl.2015.11.019; Naess-Schmidt ET, 2021, J NEUROSCI RES, V99, P872, DOI 10.1002/jnr.24773; Naess-Schmidt ET, 2017, BRAIN INJURY, V31, P230, DOI 10.1080/02699052.2016.1229034; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Porter DA, 2009, MAGN RESON MED, V62, P468, DOI 10.1002/mrm.22024; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Raz E, 2013, AM J NEURORADIOL, V34, P1846, DOI 10.3174/ajnr.A3512; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shanmuganathan K, 2008, AM J NEURORADIOL, V29, P655, DOI 10.3174/ajnr.A0916; Shavelle RM, 2015, ARCH PHYS MED REHAB, V96, P645, DOI 10.1016/j.apmr.2014.11.003; Stenberg J, 2021, J NEUROTRAUM, V38, P2560, DOI 10.1089/neu.2021.0074; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Talbott JF, 2019, RADIOL CLIN N AM, V57, P319, DOI 10.1016/j.rcl.2018.09.004; Tietze A, 2015, AM J NEURORADIOL, V36, P1472, DOI 10.3174/ajnr.A4311; Vedantam A, 2015, WORLD NEUROSURG, V83, P824, DOI 10.1016/j.wneu.2013.09.017; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; WADA E, 1995, SPINE, V20, P2226, DOI 10.1097/00007632-199510001-00009; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Zhu TJ, 2021, MAGN RESON MED, V85, P1895, DOI 10.1002/mrm.28548; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	45	1	1	3	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2022	164	1					25	32		10.1007/s00701-021-05018-4		OCT 2021	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YH5HB	WOS:000709320200001	34671848				2022-02-06	
J	Tan, SW; Zhao, Y; Li, P; Ning, YL; Huang, ZZ; Yang, N; Liu, D; Zhou, YG				Tan, Si-Wei; Zhao, Yan; Li, Ping; Ning, Ya-Lei; Huang, Zhi-Zhong; Yang, Nan; Liu, Dong; Zhou, Yuan-Guo			HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						NLRP3 inflammasome; HMGB1; Cognitive dysfunction; Traumatic brain injury	NMDA RECEPTORS; NEUROINFLAMMATION; INHIBITOR; ACTIVATION; DISEASE; MEMORY; PHASE	Background Cognitive impairment in the late stage of traumatic brain injury (TBI) is associated with the NOD-, LRR and pyrin domain-containing protein 3 (NLRP3) inflammasome, which plays an important role in neuroinflammation. Although classical inflammatory pathways have been well-documented in the late stage of TBI (4-8 weeks post-injury), the mechanism by which the NLRP3 inflammasome impairs cognition is still unclear. Methods Mice lacking the gene encoding for NLRP3 (NLRP3-knockout mice) and their wild-type littermates were used in a controlled cortical impact model of TBI. Levels of NLRP3 inflammasome and inflammatory factors such as IL-1 beta and HMGB1 were detected in post-injury hippocampal tissue, as well as long-term potentiation. Behaviors were assessed by T-maze test, novel object recognition, and nesting tests. Glycyrrhizin was used to antagonize HMGB1. Calcium imaging were performed on primary neuronal cultures. Results By using the NLRP3-knockout TBI model, we found that the continuous activation of the NLRP3 inflammasome and high mobility group box 1 (HMGB1) release were closely related to cognitive impairment. We also found that inhibition of HMGB1 improved LTP reduction and cognitive function by increasing the phosphorylation level of the NMDAR1 subunit at serine 896 while reducing NLRP3 inflammasome activation. Conclusion NLRP3 inflammasome damages memory in the late stage of TBI primarily through HMGB1 upregulation and provides an explanation for the long-term progression of cognitive dysfunction.	[Tan, Si-Wei; Zhao, Yan; Li, Ping; Ning, Ya-Lei; Huang, Zhi-Zhong; Yang, Nan; Zhou, Yuan-Guo] Army Med Univ, Daping Hosp, Dept Occupat Dis, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Liu, Dong] Army Med Univ, Daping Hosp, Med Ctr Trauma & War Injury, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China		Zhou, YG (corresponding author), Army Med Univ, Daping Hosp, Dept Occupat Dis, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	yuanguo.zhou@gmail.com		Li, Ping/0000-0002-4926-3835	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31771118]; Military Pre-Research Project of the Third Military Medical University [2016XYY11]	The study was funded by the National Natural Science Foundation of China (No. 31771118) and the Military Pre-Research Project of the Third Military Medical University (2016XYY11).	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao ZY, 2020, J AFFECT DISORDERS, V265, P247, DOI 10.1016/j.jad.2020.01.048; Costello DA, 2011, J NEUROSCI, V31, P3871, DOI 10.1523/JNEUROSCI.6676-10.2011; Costenla AR, 2011, EUR J NEUROSCI, V34, P12, DOI 10.1111/j.1460-9568.2011.07719.x; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Ferreira SG, 2015, BRIT J PHARMACOL, V172, P1074, DOI 10.1111/bph.12970; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Gao HM, 2011, J NEUROSCI, V31, P1081, DOI 10.1523/JNEUROSCI.3732-10.2011; Guo DH, 2020, J CLIN INVEST, V130, P1961, DOI 10.1172/JCI126078; Heneka MT, 2018, NAT REV NEUROSCI, V19, P610, DOI 10.1038/s41583-018-0055-7; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Hida H, 2015, NEUROPSYCHOPHARMACOL, V40, P601, DOI 10.1038/npp.2014.207; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Ising C, 2019, NATURE, V575, P669, DOI 10.1038/s41586-019-1769-z; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kobeissy F. H, 2015, BRAIN NEUROTRAUMA MO; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Mazarati A, 2011, EXP NEUROL, V232, P143, DOI 10.1016/j.expneurol.2011.08.012; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Paudel YN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00628; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Sun Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01518; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Wallisch JS, 2017, NEUROCRIT CARE, V27, P44, DOI 10.1007/s12028-017-0378-7; Webster KM, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112979; Xu HX, 2011, J NEUROSCI, V31, P17074, DOI 10.1523/JNEUROSCI.4072-11.2011; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yi HJ, 2020, J NEUROSURG, V133, P1083, DOI 10.3171/2019.6.JNS1954; Yu M, 2019, BRAIN BEHAV IMMUN, V82, P167, DOI 10.1016/j.bbi.2019.08.007; Zhang X, 2020, AGING-US, V12, P9405, DOI 10.18632/aging.103215; Zhao ZA, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.98	40	1	1	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	OCT 19	2021	18	1							241	10.1186/s12974-021-02274-0			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	WJ2YW	WOS:000708915300003	34666797	Green Published, gold			2022-02-06	
J	Marjani, S; Zirh, S; Sever-Bahcekapili, M; Cakir-Aktas, C; Muftuoglu, SF; Mut, M				Marjani, Saeid; Zirh, Selim; Sever-Bahcekapili, Melike; Cakir-Aktas, Canan; Muftuoglu, Sevda Fatma; Mut, Melike			Doxycycline alleviates acute traumatic brain injury by suppressing neuroinflammation and apoptosis in a mouse model	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Traumatic brain injury; Neuroinflammation; Microglia; Doxycycline	RECRUITMENT; FLUID; NEUROPROTECTION; EXPRESSION; BIOMARKERS; REDUCTION; MEDIATORS; HEALTH; DAMAGE	Traumatic brain injury (TBI) is one of the significant causes of death among young people worldwide. Doxycycline (DOX), an antibiotic with anti-inflammatory effects, has not been used as a therapeutic agent to modify the inflammatory response after the traumatic brain injury. In this study, intraperitoneal administration of DOX reduced significantly the acute inflammatory markers like IL-6 and CD3, microglial migration to the damaged area marked with Iba-1, and neuronal apoptosis assessed with TUNEL assay at 72 h after the trauma. The low dose, 10 mg/kg of DOX had a dominant anti-inflammatory effect; while the high dose, 100 mg/kg of DOX, was more effective in decreasing neuronal apoptosis. In early hours after the head trauma, use of a low dose (10 mg/ kg) of DOX for decreasing the acute form of inflammation followed by a high dose (100 mg/kg) for the antiapoptotic effects particularly in severe head traumas, would be a promising approach to alleviate the brain injury.	[Marjani, Saeid; Mut, Melike] Hacettepe Univ, Dept Neurosurg, Fac Med, Ankara, Turkey; [Zirh, Selim; Muftuoglu, Sevda Fatma] Hacettepe Univ, Dept Histol & Embryol, Fac Med, Ankara, Turkey; [Sever-Bahcekapili, Melike; Cakir-Aktas, Canan; Mut, Melike] Hacettepe Univ, Inst Neurol Sci & Psychiat, Ankara, Turkey		Mut, M (corresponding author), Hacettepe Univ, Dept Neurosurg, Fac Med, Ankara, Turkey.	melikem@hacettepe.edu.tr	Mut, Melike/E-9938-2013; ZIRH, Selim/AAP-4024-2020	Mut, Melike/0000-0002-9601-9907; ZIRH, Selim/0000-0002-7962-6078			Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; Balducci C, 2018, NEUROBIOL AGING, V70, P128, DOI 10.1016/j.neurobiolaging.2018.06.002; Bellizzi AM, 2020, HISTOPATHOLOGY, V76, P251, DOI 10.1111/his.13943; BOCKER R, 1981, ARZNEIMITTEL-FORSCH, V31-2, P2116; Brlek P, 2021, CLIN TRANSL ONCOL, V23, P1085, DOI 10.1007/s12094-020-02496-3; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chaudhry K, 2010, NEUROSCI LETT, V474, P109, DOI 10.1016/j.neulet.2010.03.020; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Cho Y, 2009, NEUROTOX RES, V16, P361, DOI 10.1007/s12640-009-9078-1; Clark WM, 1997, J MOL NEUROSCI, V9, P103, DOI 10.1007/BF02736854; CLARK WM, 1994, STROKE, V25, P1411, DOI 10.1161/01.STR.25.7.1411; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Di Caprio R, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/329418; Domercq M, 2004, TRENDS PHARMACOL SCI, V25, P609, DOI 10.1016/j.tips.2004.10.001; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Griffin MO, 2005, MOL CELL BIOCHEM, V270, P1, DOI 10.1007/s11010-005-2540-3; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; Lazzarini M, 2013, GLIA, V61, P1084, DOI 10.1002/glia.22496; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lucchetti J, 2019, J PHARMACOL EXP THER, V368, P32, DOI 10.1124/jpet.118.252064; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Malek AJ, 2020, J TRAUMA ACUTE CARE, V89, P435, DOI 10.1097/TA.0000000000002801; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Minagar A, 2008, ARCH NEUROL-CHICAGO, V65, P199, DOI 10.1001/archneurol.2007.41; Nelson ML, 2011, ANN NY ACAD SCI, V1241, P17, DOI 10.1111/j.1749-6632.2011.06354.x; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Ohsawa K, 2011, GLIA, V59, P1793, DOI 10.1002/glia.21238; Paldino E, 2020, MOL NEUROBIOL, V57, P1889, DOI 10.1007/s12035-019-01847-8; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Rana A, 2020, BRAIN INJURY, V34, P1039, DOI 10.1080/02699052.2020.1772508; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Santa-Cecilia FV, 2019, NEUROTOX RES, V35, P981, DOI 10.1007/s12640-019-00015-z; SCHACHVO.M, 1972, CHEMOTHERAPY, V17, P26, DOI 10.1159/000220836; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Soares HD, 1995, J NEUROSCI, V15, P8223; Song LM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00063; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Tam WY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07279; Tan WJ, 2016, J CLIN PATHOL, V69, P858, DOI 10.1136/jclinpath-2015-203590; Toshkezi G, 2018, J NEUROSURG, V129, P1286, DOI 10.3171/2017.7.JNS17878; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46	52	1	1	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	OCT 15	2021	359								577672	10.1016/j.jneuroim.2021.577672			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	UP2JQ	WOS:000695211500015	34364104				2022-02-06	
J	Walsh, DR; Ross, AM; Newport, DT; Zhou, Z; Kearns, J; Fearon, C; Lorigan, J; Mulvihill, JJE				Walsh, Darragh R.; Ross, Aisling M.; Newport, David T.; Zhou, Zhou; Kearns, Jamie; Fearon, Conor; Lorigan, Jennifer; Mulvihill, John J. E.			Mechanical characterisation of the human dura mater, falx cerebri and superior sagittal sinus	ACTA BIOMATERIALIA			English	Article						Traumatic brain injury (TBI); Biomechanics; Meninges; Collagen hybridizing peptide (CHP); Structural damage analysis	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODELS; BALLOON ANGIOPLASTY; 2ND-HARMONIC GENERATION; ARTERIAL TISSUE; LATERAL IMPACTS; HUMAN HEAD; QUANTIFICATION; VALIDATION; FRAMEWORK	The cranial meninges have been shown to play a pivotal role in traumatic brain injury mechanopathology. However, while the mechanical response of the brain and its many subregions have been studied extensively, the meninges have conventionally been overlooked. This paper presents the first comparative mechanical analysis of human dura mater, falx cerebri and superior sagittal sinus tissues. Biaxial tensile analysis identified that these tissues are mechanically heterogeneous, in contrast to the assumption that the tissues are mechanically homogeneous which is typically employed in FE model design. A thickness of 0.91 +/- 0.05 (standard error) mm for the falx cerebri was also identified. This data can aid in improving the biofidelity of the influential falx structure in FE models. Additionally, the use of a collagen hybridizing peptide on the superior sagittal sinus suggests this structure is particularly susceptible to the effects of circumf erential stretch, which may have important implications for clinical treatment of dural venous sinus pathologies. Collectively, this research progresses understanding of meningeal mechanical and structural characteristics and may aid in elucidating the behaviour of these tissues in healthy and diseased conditions.	[Walsh, Darragh R.; Ross, Aisling M.; Newport, David T.; Mulvihill, John J. E.] Univ Limerick, Bernal Inst, Limerick, Ireland; [Walsh, Darragh R.; Ross, Aisling M.; Newport, David T.; Mulvihill, John J. E.] Univ Limerick, Sch Engn, Limerick, Ireland; [Newport, David T.; Mulvihill, John J. E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland; [Zhou, Zhou] KTH Royal Inst Technol, Div Neuron Engn, Huddinge, Sweden; [Kearns, Jamie] Munster Rugby High Performance Ctr, Limerick, Ireland; [Fearon, Conor; Lorigan, Jennifer] Beaumont Hosp, Dept Neuropathol, Dublin Brain Bank, Dublin, Ireland; [Fearon, Conor] Beaumont Hosp, Dept Neuropathol, Dublin, Ireland		Mulvihill, JJE (corresponding author), Univ Limerick, Bernal Inst, Limerick, Ireland.	john.mulvihill@ul.ie					ANDREWS BT, 1989, NEUROSURGERY, V24, P514, DOI 10.1227/00006123-198904000-00005; Atsumi N, 2018, ANN BIOMED ENG, V46, P736, DOI 10.1007/s10439-018-1988-8; Aydin HE, 2019, J KOREAN NEUROSURG S, V62, P382, DOI 10.3340/jkns.2018.0130; Azzam D, 2018, WORLD NEUROSURG, V113, P244, DOI 10.1016/j.wneu.2018.01.115; Balik V, 2019, OPER NEUROSURG, V17, P88, DOI 10.1093/ons/opy287; Behera Sanjay K, 2015, Asian J Neurosurg, V10, P17, DOI 10.4103/1793-5482.151503; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHAN PDS, 1995, J NEUROSURG, V83, P522, DOI 10.3171/jns.1995.83.3.0522; Chauvet D, 2010, NEUROSURG REV, V33, P287, DOI 10.1007/s10143-010-0261-x; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Converse MI, 2018, ACTA BIOMATER, V67, P307, DOI 10.1016/j.actbio.2017.11.052; Cooney GM, 2015, J MECH BEHAV BIOMED, V41, P68, DOI 10.1016/j.jmbbm.2014.09.026; Danish SF, 2006, J NEUROSURG, V104, P16, DOI 10.3171/ped.2006.104.1.16; de Bruijn SFTM, 2001, J NEUROL NEUROSUR PS, V70, P105, DOI 10.1136/jnnp.70.1.105; De Kegel D, 2018, J MECH BEHAV BIOMED, V79, P122, DOI 10.1016/j.jmbbm.2017.12.023; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dtk M, 2008, ENG MECH, V16; Durgam S, 2020, TISSUE ENG PART C-ME, V26, P253, DOI [10.1089/ten.tec.2020.0032, 10.1089/ten.TEC.2020.0032]; Eilaghi A, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148467; Fehervary H, 2016, J MECH BEHAV BIOMED, V61, P135, DOI 10.1016/j.jmbbm.2016.01.011; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gaul RT, 2017, J MECH BEHAV BIOMED, V75, P359, DOI 10.1016/j.jmbbm.2017.07.036; Geest JPV, 2006, J BIOMECH, V39, P1324, DOI 10.1016/j.jbiomech.2005.03.003; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Gregory DE, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003327; Haimann MCJ, 1998, J ANAT, V192, P99; Herisson F, 2018, NAT NEUROSCI, V21, P1209, DOI 10.1038/s41593-018-0213-2; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Ho J, 2009, INT J CRASHWORTHINES, V14, P555, DOI 10.1080/13588260902895708; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hwang JM, 2017, ACTA BIOMATER, V53, P268, DOI 10.1016/j.actbio.2017.01.079; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Kapeliotis M, 2019, J BIOMECH, V92, P6, DOI 10.1016/j.jbiomech.2019.05.016; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lake SP, 2009, J ORTHOP RES, V27, P1596, DOI 10.1002/jor.20938; Levitt MR, 2016, AM J NEURORADIOL, V37, P1876, DOI 10.3174/ajnr.A4826; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Li XR, 2020, BEHAV RES METHODS, V52, P2657, DOI 10.3758/s13428-020-01360-0; Liao WH, 2015, NEURORADIOL J, V28, P177, DOI 10.1177/1971400915576633; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lu YC, 2019, ANN BIOMED ENG, V47, P1923, DOI 10.1007/s10439-019-02226-z; Maas SA, 2016, J MECH BEHAV BIOMED, V61, P499, DOI 10.1016/j.jmbbm.2016.04.012; MacManus DB, 2017, ACTA BIOMATER, V57, P384, DOI 10.1016/j.actbio.2017.05.022; Macrae RA, 2016, STRAIN, V52, P380, DOI 10.1111/str.12183; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MCGARVEY KA, 1984, BIOMATERIALS, V5, P109, DOI 10.1016/0142-9612(84)90011-5; Merkle A, 2014, INJURY BIOMECHANICS; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Muller-Schweinitzer E, 2009, ORGANOGENESIS, V5, P97, DOI 10.4161/org.5.3.9495; Mundt S, 2021, CELL, V184, P858, DOI 10.1016/j.cell.2021.01.040; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; O'Leary SA, 2014, J BIOMECH, V47, P1430, DOI 10.1016/j.jbiomech.2014.01.041; O'Leary SA, 2013, J BIOMECH, V46, P1955, DOI 10.1016/j.jbiomech.2013.05.003; Pasquesi SA, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4033883; Persson C, 2010, ANN BIOMED ENG, V38, P975, DOI 10.1007/s10439-010-9924-6; Piwowarczyk A, 2019, SCIENDO, V1, P819, DOI [10.2478/czoto- 2019-0105, DOI 10.2478/CZOTO-2019-0105]; Polindara C, 2016, J BIOMECH, V49, P2341, DOI 10.1016/j.jbiomech.2016.01.037; Qiu JL, 2020, SCI PROGRESS-UK, V103, DOI 10.1177/0036850420908750; Qiu MJ, 2017, CHINESE MED J-PEKING, V130, P879, DOI 10.4103/0366-6999.202736; Quaglini V, 2007, J APPL BIOMATER BIOM, V5, P34; Quinn KP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004205; Rai R, 2018, CUREUS, V10, DOI 10.7759/cureus.3079; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Rustenhoven J, 2021, CELL, V184, P1000, DOI 10.1016/j.cell.2020.12.040; Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671; Sacks MS, 1998, J BIOMECH ENG-T ASME, V120, P541, DOI 10.1115/1.2798027; Shazly T, 2015, EXP MECH, V55, P41, DOI 10.1007/s11340-014-9910-2; Shi ZD, 2009, BRIT J NEUROSURG, V23, P71, DOI 10.1080/02688690802582638; Stauber T, 2020, MATRIX BIOL, V85-86, P68, DOI 10.1016/j.matbio.2019.07.008; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tan LB, 2014, INT J NUMER METH BIO, V30, P1476, DOI 10.1002/cnm.2668; Teleb MS, 2015, J NEUROIMAGING, V25, P72, DOI 10.1111/jon.12072; Trotta A, 2020, INT J MECH SCI, V173, DOI 10.1016/j.ijmecsci.2020.105448; Tubbs R.S., 2020, ANATOMY, P9; van Noort R, 1981, Clin Phys Physiol Meas, V2, P197, DOI 10.1088/0143-0815/2/3/003; Walsh DR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78694-4; Walsh DR, 2021, J NEUROTRAUM, V38, P1748, DOI 10.1089/neu.2020.7288; Walsh DR, 2018, ACTA BIOMATER, V80, P237, DOI 10.1016/j.actbio.2018.09.004; Walsh MT, 2014, J BIOMECH, V47, P793, DOI 10.1016/j.jbiomech.2014.01.017; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Wismans, 1997, P 41 STAPP CAR CRASH, V41, P315, DOI DOI 10.4271/973338; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; YAMAMOTO Y, 1992, NEUROSURGERY, V30, P1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou Z, 2019, J NEUROTRAUM, V36, P2099, DOI 10.1089/neu.2018.6143; Zhou Z, 2020, J NEUROTRAUM, V37, P1074, DOI 10.1089/neu.2019.6634; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z; Zitnay JL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14913; Zwirner J, 2019, J MECH BEHAV BIOMED, V96, P38, DOI 10.1016/j.jmbbm.2019.04.035; Zwirner J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52836-9	108	1	1	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	OCT 15	2021	134						388	400		10.1016/j.actbio.2021.07.043			13	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	WK8EP	WOS:000709954800001	34314888				2022-02-06	
J	Chen, YH; Gong, K; Guo, LM; Zhang, BC; Chen, SF; Li, ZY; Xu, QH; Liu, W; Wang, ZX				Chen, Yuhua; Gong, Kai; Guo, Limin; Zhang, Bingchang; Chen, Sifang; Li, Zhangyu; Xu Quanhua; Liu, Wei; Wang, Zhanxiang			Downregulation of phosphoglycerate mutase 5 improves microglial inflammasome activation after traumatic brain injury	CELL DEATH DISCOVERY			English	Article							CELL-DEATH; PHOSPHATASE; NECROSIS	Traumatic brain injury (TBI) is considered as the most common cause of disability and death, and therefore an effective intervention of cascade pathology of secondary brain injury promptly can be a potential therapeutic direction for TBI prognosis. Further study of the physiological mechanism of TBI is urgent and important. Phosphoglycerate mutase 5 (Pgam5), a mitochondrial protein, mediate mitochondrial homeostasis, cellular senescence, and necroptosis. This study evaluated the effects of Pgam5 on neurological deficits and neuroinflammation of controlled cortical impact-induced TBI mouse model in vivo and LPS + ATP-induced microglia model in vitro. Pgam5 was overexpressed post-TBI. Pgam5 depletion reduced pyroptosis-related molecules and improved microglia activation, neuron damage, tissue lesion, and neurological dysfunctions in TBI mice. RNA-seq analysis and molecular biology experiments demonstrated that Pgam5 might regulate inflammatory responses by affecting the post-translational modification and protein expression of related genes, including Nlrp3, caspase1, Gsdmd, and Il-1 beta. In microglia, Pgam5-sh abrogated LPS + ATP-induced Il-1 beta secretion through Asc oligomerization-mediated caspase-1 activation, which was independent of Rip3. The data demonstrate the critical role Pgam5 plays in nerve injury in the progression of TBI, which regulates Asc polymerization and subsequently caspase1 activation, and thus reveals a fundamental mechanism linking microglial inflammasome activation to Asc/caspase1-generated Il-1 beta-mediated neuroinflammation. Thus, our data indicate Pgam5 worsens physiological and neurological outcomes post-TBI, which may be a potential therapeutic target to improve neuroinflammation after TBI.	[Chen, Yuhua; Liu, Wei] Xian Peihua Univ, Dept Cent Lab, Xian 710125, Peoples R China; [Chen, Yuhua; Gong, Kai; Guo, Limin; Zhang, Bingchang; Chen, Sifang; Li, Zhangyu; Liu, Wei; Wang, Zhanxiang] Xiamen Univ, Affiliated Hosp 1, Trauma Ctr, 55 Zhenhai Rd, Xiamen 361003, Fujian, Peoples R China; [Chen, Yuhua; Guo, Limin] Cent South Univ, Dept Anat & Neurobiol, 172 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China; [Gong, Kai; Zhang, Bingchang; Chen, Sifang; Li, Zhangyu; Liu, Wei; Wang, Zhanxiang] Xiamen Univ, Affiliated Hosp 1, Brain Ctr, Dept Neurosurg,Xiamen Key Lab, 55 Zhenhai Rd, Xiamen 361003, Fujian, Peoples R China; [Xu Quanhua] Bijie Tradit Chinese Med Hosp, Dept Neurosurg, Bijie 551700, Peoples R China		Liu, W (corresponding author), Xian Peihua Univ, Dept Cent Lab, Xian 710125, Peoples R China.; Liu, W; Wang, ZX (corresponding author), Xiamen Univ, Affiliated Hosp 1, Trauma Ctr, 55 Zhenhai Rd, Xiamen 361003, Fujian, Peoples R China.; Liu, W; Wang, ZX (corresponding author), Xiamen Univ, Affiliated Hosp 1, Brain Ctr, Dept Neurosurg,Xiamen Key Lab, 55 Zhenhai Rd, Xiamen 361003, Fujian, Peoples R China.	vincelau@sina.com; wangzx@xmu.edu.cn		Gong, Kai/0000-0002-2913-9714	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81901270, 82072229]	This study was supported by the National Natural Science Foundation of China (No. 81901270, No. 82072229).	Allan SM, 2000, P NATL ACAD SCI USA, V97, P5580, DOI 10.1073/pnas.090464197; Cai ZW, 2004, PEDIATR RES, V56, P377, DOI 10.1203/01.PDR.0000134249.92944.14; Chen G, 2014, MOL CELL, V54, P362, DOI 10.1016/j.molcel.2014.02.034; Chen YH, 2021, ANTIOXID REDOX SIGN, V34, P154, DOI 10.1089/ars.2019.7982; Chen YH, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00202; Chen YH, 2019, BRAIN RES, V1710, P163, DOI 10.1016/j.brainres.2019.01.005; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Dong XH, 2019, AM J TRANSL RES, V11, P499; Fan LW, 2010, NEUROSCIENCE, V168, P240, DOI 10.1016/j.neuroscience.2010.03.024; Feng J, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1064-1; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; He GW, 2017, GUT, V66, P716, DOI 10.1136/gutjnl-2015-311247; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Heuvel FO, 2019, BRAIN BEHAV IMMUN, V81, P228, DOI 10.1016/j.bbi.2019.06.019; Kang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8515; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Lu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147792; Ma KL, 2020, CELL DEATH DIFFER, V27, P1036, DOI 10.1038/s41418-019-0396-4; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McKenzie BA, 2018, P NATL ACAD SCI USA, V115, pE6065, DOI 10.1073/pnas.1722041115; Moriwaki K, 2016, J IMMUNOL, V196, P407, DOI 10.4049/jimmunol.1501662; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Phillips FC, 2016, GUT MICROBES, V7, P334, DOI 10.1080/19490976.2016.1182289; Shin N, 2019, ANTIOXID REDOX SIGN, V30, P1601, DOI 10.1089/ars.2017.7280; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Smith ED, 2014, J BIOL CHEM, V289, P20615, DOI 10.1074/jbc.M114.568659; Vay SU, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1261-y; Wang J, 2021, MOL NEUROBIOL, V58, P1052, DOI 10.1007/s12035-020-02171-2; Wang ZM, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00325-8; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Yamaguchi A, 2019, J BIOCHEM, V165, P19, DOI 10.1093/jb/mvy077; Yu B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16312-7; Zhou H, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12503; Zhu H, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101777	38	1	1	7	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2058-7716		CELL DEATH DISCOV	Cell Death Discov.	OCT 12	2021	7	1							290	10.1038/s41420-021-00686-8			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	WG1IP	WOS:000706752200002	34642327	Green Published, gold			2022-02-06	
J	Byard, RW				Byard, Roger W.			Vehicular Locard's principle and patterned tire markings	JOURNAL OF FORENSIC SCIENCES			English	Article; Early Access						head trauma; Locard's principle; motor vehicle injury; patterned injuries; pedestrian; tire markings		A 32-year-old man was found dead beside a road with severe complex traumatic brain injuries due to blunt craniocerebral trauma compatible with being run over by a vehicle. A subsequent review of closed-circuit television (CCTV) footage showed him to be unaccompanied and to fall over beside the road. At autopsy, distinctive black patterned markings were present on the left side of his face and head, which were not associated with significant underlying patterned bruising or abrasions. These corresponded to the pattern of tire tread taken from a vehicle identified by police as likely to have been involved in the incident. This case demonstrates an unusual form of tire track marking on the skin due to the transfer of oil/dirt/rubber from the projecting tread, that is, a vehicular form of Locard's principle where every contact leaves a trace. Although this may be extremely useful in linking a particular vehicle to a crash, the superficial nature of the residue renders it vulnerable to being wiped off by rubbing with a body bag during transport or washing if a body is cleaned. Careful photographic documentation of such tire markings at the scene will preserve this type of evidence and avoid it being subsequently compromised by body handling.	[Byard, Roger W.] Univ Adelaide, Forens Sci SA & Adelaide Med Sch, Adelaide, SA, Australia		Byard, RW (corresponding author), Univ Adelaide, Adelaide Sch Med, Level 2,Room N237,Helen Mayo North,Frome Rd, Adelaide, SA 5005, Australia.	roger.byard@sa.gov.au					Byard RW, 2016, J FORENSIC SCI, V61, P545, DOI 10.1111/1556-4029.12964; Byard RW, 2012, J FORENSIC LEG MED, V19, P419, DOI 10.1016/j.jflm.2012.02.002; Byard RW., 2010, SUDDEN DEATH YOUNG, V3, P16; Miranda M., TIRE MARKS THEIR ROL; Prahlow J., 2012, ATLAS FORENSIC PATHO, P472; Saukko P., 2016, KNIGHTS FORENSIC PAT, V4, P288; SUZUKI T, 1992, INT J LEGAL MED, V104, P355, DOI 10.1007/BF01369556; Thali MJ, 2000, FORENSIC SCI INT, V113, P281, DOI 10.1016/S0379-0738(00)00234-6; Xiao N, 2019, MED SCI LAW, V59, P4, DOI 10.1177/0025802418810102	9	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.												10.1111/1556-4029.14913		OCT 2021	3	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	WE7SX	WOS:000705822000001	34634136				2022-02-06	
J	Mason, HD; Johnson, AM; Mihelson, NA; Mastorakos, P; McGavern, DB				Mason, Hannah D.; Johnson, Alexis M.; Mihelson, Nicole A.; Mastorakos, Panagiotis; McGavern, Dorian B.			Glia limitans superficialis oxidation and breakdown promote cortical cell death after repetitive head injury	JCI INSIGHT			English	Article							TRAUMATIC BRAIN-INJURY; HYDROXYL RADICAL GENERATION; GREEN FLUORESCENT PROTEIN; ENCEPHALOPATHY; MICROGLIA; NEUROPROTECTION; ASTROCYTES; ACTIVATION; MONOCYTES; EXPOSURE	Repetitive mild traumatic brain injuries (mTBI) disrupt CNS barriers, the erosion of which has been linked to long-term neurodegenerative and psychiatric conditions. Although much attention has been devoted to CNS vasculature following mTBI, little is known about the glia limitans superficialis - a barrier of surface-associated astrocytes that helps protect the CNS parenchyma and maintain homeostasis. Here, we identify the glia limitans superficialis as a crucial barrier surface whose breakdown after acute repeat mTBI facilitates increased cell death and recruitment of peripheral myelomonocytic cells. Using intravital microscopy, we show that brain-resident microglia fortify this structure after a single mTBI, yet they fail to do so following secondary injury, which triggers massive recruitment of myelomonocytic cells from the periphery that contribute to further destruction of the glia limitans superficialis but not cortical cell death. We demonstrate, instead, that reactive oxygen species (ROS) generated in response to repetitive head injury are largely responsible for enhanced cortical cell death, and therapeutic administration of the antioxidant glutathione markedly reduces this cell death, preserves the glia limitans, and prevents myelomonocytic cells from entering the brain parenchyma. Collectively, our findings underscore the importance of preserving the glia limitans superficialis after brain injury and offer a therapeutic means to protect this structure and the underlying cortex.	[Mason, Hannah D.; Johnson, Alexis M.; Mihelson, Nicole A.; Mastorakos, Panagiotis; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Mastorakos, Panagiotis] NINDS, Dept Neurol Surg, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		McGavern, DB (corresponding author), NIH, Bldg 10,Room 5N240C, Bethesda, MD 20892 USA.	mcgavernd@mail.nih.gov	Mastorakos, Panagiotis/ABG-1157-2021	Mason, Hannah/0000-0003-1701-4655; Mihelson, Nicole/0000-0001-5051-0760; Mastorakos, Panagiotis/0000-0003-0505-6938	NINDS, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Defense Health Agency [310286-1.00-65642, 311661-5.00-66323]	This research was supported by the intramural program at the NINDS, NIH, and The Defense Health Agency (310286-1.00-65642 and 311661-5.00-66323).	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; ALTHAUS JS, 1993, MOL CHEM NEUROPATHOL, V20, P147, DOI 10.1007/BF02815368; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Faust N, 2000, BLOOD, V96, P719; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Horng S, 2017, J CLIN INVEST, V127, P3136, DOI 10.1172/JCI91301; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Keene CD, 2018, ACTA NEUROPATHOL, V135, P303, DOI 10.1007/s00401-017-1801-z; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liddelow SA, 2020, TRENDS IMMUNOL, V41, P820, DOI 10.1016/j.it.2020.07.006; Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manglani Monica, 2018, Curr Protoc Immunol, V120, DOI 10.1002/cpim.46; Mastorakos P, 2021, NAT NEUROSCI, V24, P245, DOI 10.1038/s41593-020-00773-6; Mastorakos P, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav0492; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rua R, 2019, NAT IMMUNOL, V20, P407, DOI 10.1038/s41590-019-0344-y; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Savarin C, 2010, J VIROL, V84, P4878, DOI 10.1128/JVI.00051-10; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Srinivasan R, 2016, NEURON, V92, P1181, DOI 10.1016/j.neuron.2016.11.030; Theadom A, 2013, EUR J NEUROL, V20, P1135, DOI 10.1111/ene.12099; Wang MW, 2020, NEUROCHEM RES, V45, P1097, DOI 10.1007/s11064-020-02987-3; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113	44	1	1	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA		2379-3708		JCI INSIGHT	JCI Insight	OCT 8	2021	6	19							e149229	10.1172/jci.insight.149229			14	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	WF7CE	WOS:000706458800001	34428178	Green Published, gold			2022-02-06	
J	Zauszniewski, JA; Burant, CJ; Martin, RJ; Sweetko, JS; DiFranco, E				Zauszniewski, Jaclene A.; Burant, Christopher J.; Martin, Richard J.; Sweetko, John S.; DiFranco, Evelina			Caregivers' Use of Personal and Social Resourcefulness: Differences by Care Recipient Condition	WESTERN JOURNAL OF NURSING RESEARCH			English	Article; Early Access						family caregivers; resourcefulness; chronic conditions	FAMILY CAREGIVERS; SUPPORT GROUP; DEMENTIA; BURDEN; DISTRESS; ADULTS; ANGER; LIFE	Although family caregivers who use both the personal and social resourcefulness skills have the best health outcomes, it is unknown whether their tendency toward personal or social resourcefulness varies by their care recipient's condition. This cross-sectional study of existing data from 234 caregivers of persons with various conditions examined five item pairs from the Resourcefulness Scale(C) with responses capturing personal and social resourcefulness in relation to anxiety, anger, sadness, indecision, and financial distress. Caregivers were categorized by the recipient's condition (amyotrophic lateral sclerosis, cancer, dementia, mental illness, Parkinson's disease, stroke, traumatic brain injury, other, or multiple conditions). Findings showed that across most groups, caregivers used both personal and social resourcefulness when angry, sad, or indecisive and personal resourcefulness when anxious or managing money. Caregivers of persons with cancer, traumatic brain injury, stroke, and mental illness differed. The findings provide a basis for future clinical trials across diverse caregiver groups.	[Zauszniewski, Jaclene A.; Burant, Christopher J.; Sweetko, John S.; DiFranco, Evelina] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 2120 Cornell Rd, Cleveland, OH 44106 USA; [Martin, Richard J.] Ursuline Coll, Breen Sch Nursing & Hlth Profess, Cleveland, OH USA		Zauszniewski, JA (corresponding author), Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 2120 Cornell Rd, Cleveland, OH 44106 USA.	jaz@case.edu		Zauszniewski, Jaclene A/0000-0002-1707-1193	Frances Payne Bolton School of Nursing research fund	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for the study was provided by the Frances Payne Bolton School of Nursing research fund to Dr Jaclene A. Zauszniewski.	AARP and National Alliance for Caregiving, 2020, CAR US 2020, DOI 10.26419/ppi.00103.001; Balfe M, 2016, PSYCHO-ONCOLOGY, V25, P1441, DOI 10.1002/pon.4079; Barutcu CD, 2016, HOLIST NURS PRACT, V30, P272, DOI 10.1097/HNP.0000000000000164; Casado BL, 2008, J HUM BEHAV SOC ENVI, V18, P269, DOI 10.1080/10911350802427514; Chu H, 2011, J AGING HEALTH, V23, P228, DOI 10.1177/0898264310381522; Chung ML, 2021, J CARDIOVASC NURS, V36, P206, DOI 10.1097/JCN.0000000000000717; Coon DW, 2003, GERONTOLOGIST, V43, P678, DOI 10.1093/geront/43.5.678; Crespo M, 2014, AGING MENT HEALTH, V18, P454, DOI 10.1080/13607863.2013.856857; Diehl J., 2003, DEMENTIA LONDON ENGL, V2, P151, DOI [DOI 10.1177/1471301203002002002, 10.1177/1471301203002002002]; DuBenske LL, 2014, HEALTH PSYCHOL, V33, P1261, DOI 10.1037/a0034216; Ferrell Betty R, 2017, J Adv Pract Oncol, V8, P494; Fox S., 2020, FAMILY CAREGIVERS AR; Gotze H, 2014, SUPPORT CARE CANCER, V22, P2775, DOI 10.1007/s00520-014-2257-5; Hasuo H, 2020, J PALLIAT MED, V23, P930, DOI 10.1089/jpm.2019.0257; Kang SY, 2021, J HUM BEHAV SOC ENVI, V31, P582, DOI 10.1080/10911359.2020.1799900; Knox L, 2016, NEUROPSYCHOL REHABIL, V26, P236, DOI 10.1080/09602011.2015.1019519; Lai DWL, 2012, SAGE OPEN, V2, DOI 10.1177/2158244012470467; Lee YJ, 2014, INT J AGING HUM DEV, V79, P302, DOI 10.1177/0091415015574181; Lewis M., 2000, AM J ALZHEIMERS DIS, V15, P361, DOI [https://doi.org/10.1177/153331750001500607, DOI 10.1177/153331750001500607]; Liu Y, 2019, GERONTOLOGIST, V59, pE512, DOI 10.1093/geront/gnz099; Liu Y, 2015, HEALTH PSYCHOL, V34, P729, DOI 10.1037/hea0000175; Mochari-Greenberger H, 2012, AM J HEALTH PROMOT, V27, P84, DOI 10.4278/ajhp.110606-QUAN-241; Moss KO, 2019, J HOSP PALLIAT NURS, V21, P14, DOI 10.1097/NJH.0000000000000489; Ng CKM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18062956; Pooyania Sepideh, 2016, Int J MS Care, V18, P122, DOI 10.7224/1537-2073.2015-023; Sabella SA, 2019, J HEAD TRAUMA REHAB, V34, P233, DOI 10.1097/HTR.0000000000000471; Schumacher KL, 2008, ONCOL NURS FORUM, V35, P49, DOI 10.1188/08.ONF.49-56; Sibalija J, 2020, AGING MENT HEALTH, V24, P765, DOI 10.1080/13607863.2018.1544223; Steffen AM, 2012, CLIN GERONTOLOGIST, V35, P205, DOI 10.1080/07317115.2012.657821; Thomas T, 2019, CLIN J ONCOL NURS, V23, P5, DOI 10.1188/19.CJON.S2.5-13; Truglio-Londrigan M, 2019, GERIATR NURS, V40, P257, DOI 10.1016/j.gerinurse.2018.10.015; Tschanz JT, 2013, AM J GERIAT PSYCHIAT, V21, P57, DOI 10.1016/j.jagp.2012.10.005; Turner RM, 2015, AM J ALZHEIMERS DIS, V30, P454, DOI 10.1177/1533317514566115; Wackerbarth SB, 2018, AGING MENT HEALTH, V22, P692, DOI 10.1080/13607863.2017.1292206; Watson B, 2019, GERONTOLOGIST, V59, pE597, DOI 10.1093/geront/gny049; Whitlatch C, 2008, AM J NURS, V108, P73, DOI 10.1097/01.NAJ.0000336426.65440.87; Zauszniewski J A, 1996, J Holist Nurs, V14, P223, DOI 10.1177/089801019601400305; Zauszniewski J.A., 2016, J FAMILY MED, V3, P1069; Zauszniewski J.A., 2018, ENCY NURSING RES, P632; Zauszniewski JA, 2006, J NURS MEAS, V14, P57, DOI 10.1891/jnum.14.1.57; Zauszniewski JA, 2020, ISSUES MENT HEALTH N, V42, P280, DOI 10.1080/01612840.2020.1800876; Zauszniewski JA, 2021, WESTERN J NURS RES, V43, P316, DOI 10.1177/0193945920948469; Zauszniewski JA, 2020, ISSUES MENT HEALTH N, V41, P486, DOI 10.1080/01612840.2019.1693670; Zauszniewski JA, 2016, WESTERN J NURS RES, V38, P1551, DOI 10.1177/0193945916665079; Zauszniewski JA, 2014, ARCH PSYCHIAT NURS, V28, P102, DOI 10.1016/j.apnu.2013.11.003; Zauszniewski Jaclene A, 2009, Issues Ment Health Nurs, V30, P142, DOI 10.1080/01612840802557204; Zhong YQ, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-019-1403-9	47	1	1	4	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-9459	1552-8456		WESTERN J NURS RES	West. J. Nurs. Res.											01939459211050951	10.1177/01939459211050951		OCT 2021	8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	WF0LK	WOS:000706006900001	34622720				2022-02-06	
J	Major, S; Gajovic-Eichelmann, N; Woitzik, J; Dreier, JP				Major, Sebastian; Gajovic-Eichelmann, Nenad; Woitzik, Johannes; Dreier, Jens P.			Oxygen-Induced and pH-Induced Direct Current Artifacts on Invasive Platinum/Iridium Electrodes for Electrocorticography	NEUROCRITICAL CARE			English	Article						Multimodal monitoring; Cytotoxic edema; Spreading depolarization; Electrocorticography; Aneurysmal subarachnoid hemorrhage; Traumatic brain injury; Platinum electrode	CORTICAL SPREADING DEPRESSION; ISCHEMIC NEUROLOGICAL DEFICITS; BLOOD-BRAIN-BARRIER; SUBARACHNOID HEMORRHAGE; CEREBRAL-ISCHEMIA; SODIUM-CHANNEL; MIGRAINE AURA; DEPOLARIZATION; STROKE; CORTEX	Background Spreading depolarization (SD) and the initial, still reversible phase of neuronal cytotoxic edema in the cerebral gray matter are two modalities of the same process. SD may thus serve as a real-time mechanistic biomarker for impending parenchyma damage in patients during neurocritical care. Using subdural platinum/iridium (Pt/Ir) electrodes, SD is observed as a large negative direct current (DC) shift. Besides SD, there are other causes of DC shifts that are not to be confused with SD. Here, we systematically analyzed DC artifacts in ventilated patients by observing changes in the fraction of inspired oxygen. For the same change in blood oxygenation, we found that negative and positive DC shifts can simultaneously occur at adjacent Pt/Ir electrodes. Methods Nurses and intensivists typically increase blood oxygenation by increasing the fraction of inspired oxygen at the ventilator before performing manipulations on the patient. We retrospectively identified 20 such episodes in six patients via tissue partial pressure of oxygen (p(ti)O(2)) measurements with an intracortical O-2 sensor and analyzed the associated DC shifts. In vitro, we compared Pt/Ir with silver/silver chloride (Ag/AgCl) to assess DC responses to changes in pO(2), pH, or 5-min square voltage pulses and investigated the effect of electrode polarization on pO(2)-induced DC artifacts. Results Hyperoxygenation episodes started from a p(ti)O(2) of 37 (30-40) mmHg (median and interquartile range) reaching 71 (50-97) mmHg. During a total of 20 episodes on each of six subdural Pt/Ir electrodes in six patients, we observed 95 predominantly negative responses in six patients, 25 predominantly positive responses in four patients, and no brain activity changes. Adjacent electrodes could show positive and negative responses simultaneously. In vitro, Pt/Ir in contrast with Ag/AgCl responded to changes in either pO(2) or pH with large DC shifts. In response to square voltage pulses, Pt/Ir falsely showed smaller DC shifts than Ag/AgCl, with the worst performance under anoxia. In response to pO(2) increase, Pt/Ir showed DC positivity when positively polarized and DC negativity when negatively polarized. Conclusions The magnitude of pO(2)-induced subdural DC shifts by approximately 6 mV was similar to that of SDs, but they did not show a sequential onset at adjacent recording sites, could be either predominantly negative or positive in contrast with the always negative DC shifts of SD, and were not accompanied by brain activity depression. Opposing polarities of pO(2)-induced DC artifacts may result from differences in baseline electrode polarization or subdural p(ti)O(2) inhomogeneities relative to subdermal p(ti)O(2) at the quasi-reference.	[Major, Sebastian; Dreier, Jens P.] Charite Univ Med Berlin, Campus Charite Mitte, Ctr Stroke Res Berlin, Charitepl 1, D-10117 Berlin, Germany; [Major, Sebastian; Dreier, Jens P.] Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany; [Major, Sebastian; Dreier, Jens P.] Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany; [Major, Sebastian; Dreier, Jens P.] Berlin Inst Hlth, Charitepl 1, D-10117 Berlin, Germany; [Major, Sebastian; Dreier, Jens P.] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany; [Major, Sebastian; Dreier, Jens P.] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Gajovic-Eichelmann, Nenad] Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc, Potsdam, Germany; [Woitzik, Johannes] Carl von Ossietzky Univ Oldenburg, Evangel Krankenhaus Oldenburg, Dept Neurosurg, Oldenburg, Germany; [Dreier, Jens P.] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany; [Dreier, Jens P.] Einstein Ctr Neurosci Berlin, Berlin, Germany		Dreier, JP (corresponding author), Charite Univ Med Berlin, Campus Charite Mitte, Ctr Stroke Res Berlin, Charitepl 1, D-10117 Berlin, Germany.; Dreier, JP (corresponding author), Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany.; Dreier, JP (corresponding author), Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany.; Dreier, JP (corresponding author), Berlin Inst Hlth, Charitepl 1, D-10117 Berlin, Germany.; Dreier, JP (corresponding author), Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany.; Dreier, JP (corresponding author), Charite Univ Med Berlin, Dept Neurol, Berlin, Germany.; Dreier, JP (corresponding author), Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany.; Dreier, JP (corresponding author), Einstein Ctr Neurosci Berlin, Berlin, Germany.	jens.dreier@charite.de		Major, Sebastian/0000-0003-0970-1308	DFG Deutsche Forschungsgemeinschaft (German Research Council)German Research Foundation (DFG) [DFG DR 323/5-1]; DFGGerman Research Foundation (DFG)European Commission [DR 323/10-1]; BMBF Bundesministerium fuer Bildung und Forschung (Era-Net Neuron EBio2) [BMBF 01EW2004]; Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL. This work was supported by grants from the: DFG Deutsche Forschungsgemeinschaft (German Research Council) (DFG DR 323/5-1) to JW and JPD, DFG DR 323/10-1 to JPD and BMBF Bundesministerium fuer Bildung und Forschung (Era-Net Neuron EBio2, with funds from BMBF 01EW2004) to JPD.	Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Burr HS., 1939, T AM NEUROL ASS, V65, P11; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Cain SM, 2017, P NATL ACAD SCI USA, V114, P2401, DOI 10.1073/pnas.1614447114; Carlson AP, 2019, J NEUROSURG, V131, P1773, DOI 10.3171/2018.7.JNS181478; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2007, EXP BIOL MED, V232, P204; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00373; Dreier JP, 2018, NEUROPHARMACOLOGY, V134, P189, DOI 10.1016/j.neuropharm.2017.09.027; Dreier JP, 2018, ANN NEUROL, V83, P295, DOI 10.1002/ana.25147; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Durst J, 2014, ENERG ENVIRON SCI, V7, P2255, DOI 10.1039/c4ee00440j; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; GOLDENSOHN ES, 1951, ELECTROEN CLIN NEURO, V3, P231, DOI 10.1016/0013-4694(51)90016-8; GOLDRING S, 1950, ELECTROEN CLIN NEURO, V2, P297, DOI 10.1016/0013-4694(50)90061-7; GOLDRING S, 1951, J NEUROPHYSIOL, V14, P275, DOI 10.1152/jn.1951.14.4.275; Gomez-Marin AM, 2019, ACS CATAL, V9, P2238, DOI 10.1021/acscatal.8b03351; Grimnes S., 2015, BIOIMPEDANCE BIOELEC, P179, DOI [10.1007/BF02464038, DOI 10.1007/BF02464038]; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; Hartings JA, 2019, NAT MATER, V18, P194, DOI 10.1038/s41563-018-0272-5; Hartings JA, 2017, BRAIN, V140, P2673, DOI 10.1093/brain/awx214; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1857, DOI 10.1177/0271678X16653135; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Helbok R, 2017, J CEREBR BLOOD F MET, V37, P1871, DOI 10.1177/0271678X16651269; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Jansen NA, 2020, ANN CLIN TRANSL NEUR, V7, P132, DOI 10.1002/acn3.50971; Jeffcote T, 2014, NEUROCRIT CARE, V20, P21, DOI 10.1007/s12028-013-9938-7; Jewell S, 2021, NEUROCRIT CARE, V35, P160, DOI 10.1007/s12028-021-01228-x; KEMPINSKY WH, 1954, ELECTROEN CLIN NEURO, V6, P375, DOI 10.1016/0013-4694(54)90052-8; Kirov SA., 2017, J CEREBR BLOOD F MET, V37, P1571, DOI [DOI 10.1177/0271678X16654495, 10.1177/0271678x16654495]; Kirov SA, 2020, CEREB CORTEX, V30, P5517, DOI 10.1093/cercor/bhaa134; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Lesser RP, 2010, CLIN NEUROPHYSIOL, V121, P1376, DOI 10.1016/j.clinph.2010.04.037; Li CY, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016008; Liu JYW, 2012, BRAIN, V135, P3115, DOI 10.1093/brain/aws147; Luckl J, 2018, BRAIN, V141, P1734, DOI 10.1093/brain/awy102; Major S, 2020, GEROSCIENCE, V42, P57, DOI 10.1007/s11357-019-00142-7; Maslarova A, 2011, STROKE, V42, P2917, DOI 10.1161/STROKEAHA.111.621581; Masvidal-Codina E, 2019, NAT MATER, V18, P280, DOI 10.1038/s41563-018-0249-4; Milakara D, 2017, NEUROIMAGE-CLIN, V16, P524, DOI 10.1016/j.nicl.2017.09.005; Mohammad LM, 2021, J NEUROSURG, V134, P1294, DOI 10.3171/2020.1.JNS192914; Montemore MM, 2018, CHEM REV, V118, P2816, DOI 10.1021/acs.chemrev.7b00217; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; Ndubuizu O, 2007, ANTIOXID REDOX SIGN, V9, P1207, DOI 10.1089/ars.2007.1634; Ohkuma H, 2000, STROKE, V31, P1621, DOI 10.1161/01.STR.31.7.1621; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Revankar G.S., 2017, SEIZURES CRITICAL CA, P77, DOI DOI 10.1007/978-3-319-49557-6_5; Rinaldo SG, 2014, ELECTROCATALYSIS-US, V5, P262, DOI 10.1007/s12678-014-0189-y; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Tallgren P, 2005, CLIN NEUROPHYSIOL, V116, P799, DOI 10.1016/j.clinph.2004.10.001; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; van Spronsen MA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00643-z; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Winkler MKL, 2017, J CEREBR BLOOD F MET, V37, P1841, DOI 10.1177/0271678X16641424; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Wolf Stefan, 2012, Acta Neurochir Suppl, V114, P161, DOI 10.1007/978-3-7091-0956-4_30	75	1	1	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2021	35	SUPPL 2		2	SI		146	159		10.1007/s12028-021-01358-2		OCT 2021	14	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL1AZ	WOS:000705759800001	34622418	hybrid, Green Published			2022-02-06	
J	Ayenew, LG; Hoelscher, MA; Emshoff, JG; Kidder, DP; Ellis, BA				Ayenew, Lisa G.; Hoelscher, Mary A.; Emshoff, James G.; Kidder, Daniel P.; Ellis, Barbara A.			Evaluation of the public health achievements made by projects supported by a federal contract mechanism at the Centers for Disease Control and Prevention (CDC), USA	EVALUATION AND PROGRAM PLANNING			English	Article						Evaluation; Program improvement; Public health; Research impact	RESEARCH IMPACT	In 2012, the Centers for Disease Control and Prevention (CDC) established the Achieving Public Health Impact through Research (APHIR) contract mechanism. APHIR provides CDC's Centers, Institute, and Offices (CIOs) a mechanism that supports multiyear, high impact public health research. Awarded projects supported research on a wide range of topics (e.g., cancer surveillance, HIV education programs, development of biological assays, and evaluation of traumatic brain injury prevention programs) and achieved diverse outcomes (e.g., contribution to the body of knowledge in their field, changes in practice and health service delivery, and capacity building). This article describes how existing impact frameworks and a variety of methods and tools (key informant interviews, online survey, bibliometric analysis, Altmetric and document reviews) were used to identify the outcomes achieved by awarded projects. The approach discussed in this paper can be used to evaluate projects that involve a diversity of activities and outcomes.	[Ayenew, Lisa G.] Ctr Dis Control & Prevent, Off Sci, Atlanta, GA 30333 USA; [Ayenew, Lisa G.] Ctr Dis Control & Prevent, Publ Hlth Sci & Surveillance, Atlanta, GA 30333 USA; [Hoelscher, Mary A.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Emshoff, James G.] EMSTAR Res Inc, Atlanta, GA 30307 USA; [Kidder, Daniel P.] Ctr Dis Control & Prevent, Program Performance & Evaluat Off, Off Associate Director Policy & Strategy, Atlanta, GA 30333 USA; [Ellis, Barbara A.] Ctr Dis Control & Prevent, Off Sci Qual, Off Sci, Publ Hlth Sci & Surveillance, Atlanta, GA 30333 USA		Ayenew, LG (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D72, Atlanta, GA 30333 USA.	mrq7@cdc.gov; mzr1@cdc.gov; jemshoff@gsu.edu; dtk8@cdc.gov; bae7@cdc.gov			Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA	This project was supported by funding from the Centers for Disease Control and Prevention (CDC) .	AEA Research Technology Development Topical Interest Group, 2015, EVALUATING OUTCOMES; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Banzi R, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-26; Centers for Disease Control and Prevention (CDC), 2018, DATA COLLECTION METH; Centers for Disease Control and Prevention (CDC), PROGR PERF EV OFF CD; Centers for Disease Control and Prevention (CDC), 2017, TABL 1 CDC SCI CIT E; Centers for Disease Control and Prevention (CDC), 2017, OFF ASS DIR SCI SCI; Centers for Disease Control and Prevention (CDC), 2016, CDC APPR EV; Centers for Disease Control and Prevention (CDC), 2012, IMPR US PROGR EV MAX; Centers for Disease Control and Prevention (CDC), 2018, PUBL HLTH SYST 10 ES; Cohen G, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/1478-4505-13-3; Commission on Evidence-Based Policymaking, 2017, PROMISE EVIDENCE BAS; Davison CM, 2009, N DIRECT EVAL, V2009, P75, DOI DOI 10.1002/EV.315; DeGroff A, 2010, EVAL PROGRAM PLANN, V33, P365, DOI 10.1016/j.evalprogplan.2010.02.003; Donovan C, 2011, RES EVALUAT, V20, P181, DOI 10.3152/095820211X13118583635756; Frank C., 2009, MAKING IMPACT PREFER; Glasgow RE, 2012, AM J PUBLIC HEALTH, V102, P1274, DOI 10.2105/AJPH.2012.300755; Graham KER, 2012, RES EVALUAT, V21, P354, DOI 10.1093/reseval/rvs027; Greenhalgh T, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0620-8; Hanney S, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0191-y; Higher Education Funding Council England, 2011, ASS FRAM GUID SUBM; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Ivankova Nataliya V., 2016, MIXED METHODS RES GU, DOI [10.4135/9781483398341, DOI 10.4135/9781483398341]; Kidder DP, 2018, PUBLIC HEALTH REP, V133, P356, DOI 10.1177/0033354918778034; Leinhos M, 2014, PUBLIC HEALTH REP, V129, P8, DOI 10.1177/00333549141296S403; Mayne J., 2011, EVALUATING COMPLEX, P53; Milstein B., 2002, NEW DIRECTIONS EVALU, V2002, P27, DOI [DOI 10.1002/EV.40, 10.1002/ev.40]; Morton S, 2015, RES EVALUAT, V24, P405, DOI 10.1093/reseval/rvv016; National Institutes of Health (NIH), 2018, FED REPORTER US MAN; National Science Foundation (NSF), 2017, TABL 3 FED OBL OUTL; Researchfish Ltd, NTR; Rivera SC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002370; Salazar LF., 2015, RES METHODS HLTH PRO, V2nd; US General Accounting Office (GAO), 2003, GAO03454; US General Services Administration (GSA), 2019, SUBP 8 4 FED SUPPL S; US Government Accountability Office (GAO), 2013, PROGRAM EVALUATION S; World Health Organization (WHO), 2012, KNOWLEDGE TRANSLATIO	37	1	1	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7189	1873-7870		EVAL PROGRAM PLANN	Eval. Program Plan.	OCT	2021	88								101949	10.1016/j.evalprogplan.2021.101949			9	Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Social Sciences - Other Topics	SQ6MG	WOS:000660466900009	34029890	hybrid			2022-02-06	
J	Biesterveld, BE; Siddiqui, AZ; O'Connell, RL; Remmer, H; Williams, AM; Shamshad, A; Smith, WM; Kemp, MT; Wakam, GK; Alam, HB				Biesterveld, Ben E.; Siddiqui, Ali Z.; O'Connell, Rachel L.; Remmer, Henriette; Williams, Aaron M.; Shamshad, Alizeh; Smith, William M.; Kemp, Michael T.; Wakam, Glenn K.; Alam, Hasan B.			Valproic Acid Protects Against Acute Kidney Injury in Hemorrhage and Trauma	JOURNAL OF SURGICAL RESEARCH			English	Article						VPA; AKI; Histone deacetylase; HDACI; Proteomics	ISCHEMIA-REPERFUSION INJURY; DEATHS; MODEL	Introduction: Trauma is the leading cause of death among young people. These patients have a high incidence of kidney injury, which independently increases the risk of mortality. As valproic acid (VPA) treatment has been shown to improve survival in animal models of lethal trauma, we hypothesized that it would also attenuate the degree of acute kidney injury. Methods: We analyzed data from two separate experiments where swine were subjected to lethal insults. Model 1 : hemorrhage (50% blood volume hemorrhage followed by 72-h damage control resuscitation). Model 2 : polytrauma (traumatic brain injury, 40% blood volume hemorrhage, femur fracture, rectus crush and grade V liver laceration). Animals were resuscitated with normal saline (NS) + /-VPA 150 mg/kg after a 1-h shock phase in both models ( n = 5-6/group). Serum samples were analyzed for creatinine (Cr) using colorimetry on a Liasys 330 chemistry analyzer. Proteomic analysis was performed on kidney tissue sampled at the time of necropsy. Results: VPA treatment significantly ( P < 0.05) improved survival in both models. (Model 1: 80% vs 20%; Model 2: 83% vs. 17%). Model 1 (Hemorrhage alone): Cr increased from a baseline of 1.2 to 3.0 in NS control animals ( P < 0.0001) 8 h after hemorrhage, whereas it rose only to 2.1 in VPA treated animals ( P = 0.004). Model 2 (Polytrauma): Cr levels increased from baseline of 1.3 to 2.5 mg/dL ( P = 0.01) in NS control animals 4 h after injury but rose to only 1.8 in VPA treated animals ( P = 0.02). Proteomic analysis of kidney tissue identified metabolic pathways were most affected by VPA treatment. Conclusions: A single dose of VPA (150 mg/kg) offers significant protection against acute kidney injury in swine models of polytrauma and hemorrhagic shock. (c) 2021 Elsevier Inc. All rights reserved.	[Biesterveld, Ben E.; Siddiqui, Ali Z.; O'Connell, Rachel L.; Williams, Aaron M.; Shamshad, Alizeh; Smith, William M.; Kemp, Michael T.; Wakam, Glenn K.; Alam, Hasan B.] Univ Michigan, Dept Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Remmer, Henriette] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [O'Connell, Rachel L.; Alam, Hasan B.] Northwestern Univ, Dept Surg, Chicago, IL USA		Biesterveld, BE (corresponding author), Univ Michigan, Dept Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	bbiester@med.umich.edu		Wakam, Glenn/0000-0002-0950-9554	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-17-C-0246]; National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM130010]	This work was supported by the US Army Medical Research and Materiel Command under award No. W81XWH-17-1-0701 and US Army Medical Research and Materiel Command under Contract No. W81XWH-17-C-0246 to Dr. Alam. The views, opinions and/or findings contained in this report are those of the author (s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation. In addition,Dr. Biesterveld was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number F32GM130010.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; [Anonymous], 2008, BIOTECHNOLOGY-PAKIST; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bhatti UF, 2019, TRAUMA SURG ACUTE CA, P4; Biesterveld B, 2020, J TRAUMA ACUTE CARE, V89, P1156, DOI 10.1097/TA.0000000000002918; Biesterveld B, 2020, J TRAUMA ACUTE CARE, V89, P932, DOI 10.1097/TA.0000000000002677; Biesterveld B, 2019, J TRAUMA ACUTE CARE, V87, P1133, DOI 10.1097/TA.0000000000002460; Bihorac A, 2010, ANN SURG, V252, P158, DOI 10.1097/SLA.0b013e3181deb6bc; Butler FK, 2017, WILD ENVIRON MED, V28, pS74, DOI 10.1016/j.wem.2016.12.007; Davis JS, 2014, J TRAUMA ACUTE CARE, V77, P213, DOI 10.1097/TA.0000000000000292; Dekker SE, 2021, SHOCK, V55, P110, DOI 10.1097/SHK.0000000000001605; DoVaIPa Disability, 2010, INJURIES VIOLENCE FA; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Georgoff PE, 2018, CLIN PHARMACOKINET, V57, P209, DOI 10.1007/s40262-017-0553-1; Gezginci-Oktayoglu S, 2016, PROTOPLASMA, V253, P127, DOI 10.1007/s00709-015-0796-3; Gomes E, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-1; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Harrois A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2265-9; Legouis D, 2020, NAT METAB, V2, P732, DOI 10.1038/s42255-020-0238-1; Levine MH, 2015, AM J TRANSPLANT, V15, P965, DOI 10.1111/ajt.13106; Liu B, 2014, PLOS ONE, P9; Nagata S, 2019, BIOL PHARM BULL, V42, P453, DOI 10.1248/bpb.b18-00785; Podoll AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077376; Qiao YL, 2014, J SURG RES, V187, P653, DOI 10.1016/j.jss.2013.08.028; Raza M, 1997, PHARMACOL RES, V35, P153, DOI 10.1006/phrs.1997.0134; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tian S, 2019, EBIOMEDICINE, V39, P83, DOI 10.1016/j.ebiom.2018.12.003; Van Beneden K, 2013, TOXICOL APPL PHARM, V271, P276, DOI 10.1016/j.taap.2013.05.013; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Wei QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106647; Williams AM, 2019, J TRAUMA ACUTE CARE, V87, P393, DOI 10.1097/TA.0000000000002281; Wu SY, 2015, ANESTHESIOLOGY, V122, P1327, DOI 10.1097/ALN.0000000000000618; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	35	1	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2021	266						222	229		10.1016/j.jss.2021.04.014			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TT3VU	WOS:000680279900026	34023578				2022-02-06	
J	Bongioanni, P; Del Carratore, R; Corbianco, S; Diana, A; Cavallini, G; Masciandaro, SM; Dini, M; Buizza, R				Bongioanni, Paolo; Del Carratore, Renata; Corbianco, Silvia; Diana, Andrea; Cavallini, Gabriella; Masciandaro, Silvia M.; Dini, Marco; Buizza, Roberto			Climate change and neurodegenerative diseases	ENVIRONMENTAL RESEARCH			English	Article						Climate change and health; Global warming; Neuroinflammation; Neurodegeneration; Oxidative stress; Excitoxicity	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; HEAT-STRESS; ALZHEIMERS-DISEASE; INCUBATION-TEMPERATURE; BODY-TEMPERATURE; OXIDATIVE STRESS; HYPERTHERMIA	The climate change induced global warming, and in particular the increased frequency and intensity of heat waves, have been linked to health problems. Among them, scientific works have been reporting an increased incidence of neurological diseases, encompassing also neurodegenerative ones, such as Dementia of Alzheimer's type, Parkinson's Disease, and Motor Neuron Diseases. Although the increase in prevalence of neurodegenerative diseases is well documented by literature reports, the link between global warming and the enhanced prevalence of such diseases remains elusive. This is the main theme of our work, which aims to examine the connection between high temperature exposure and neurode-generative diseases. Firstly, we evaluate the influence of high temperatures exposure on the pathophysiology of these disorders. Secondly, we discuss its effects on the thermoregulation, already compromised in affected pa-tients, and its interference with processes of excitotoxicity, oxidative stress and neuroinflammation, all of them related with neurodegeneration. Finally, we investigate chronic versus acute stressors on body warming, and put forward a possible interpretation of the beneficial or detrimental effects on the brain, which is responsible for the incidence or progression of neurological disorders.	[Bongioanni, Paolo] Azienda Osped Univ Pisana, Severe Acquired Brain Injuries Dpt Sect, Pisa, Italy; [Bongioanni, Paolo; Masciandaro, Silvia M.] NeuroCare Onlus, Pisa, Italy; [Del Carratore, Renata; Masciandaro, Silvia M.] Inst Clin Physiol, Natl Res Council, Pisa, Italy; [Corbianco, Silvia; Cavallini, Gabriella; Dini, Marco] Univ Pisa, Interdepat Res Ctr Biol & Pathol Aging, Pisa, Italy; [Corbianco, Silvia; Dini, Marco] Human Movement & Rehabil Res Lab, Pisa, Italy; [Diana, Andrea] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Buizza, Roberto] Scuola Super Sant Anna, Pisa, Italy; [Buizza, Roberto] Ctr Climate Change Studies & Sustainable Actions, Pisa, Italy		Del Carratore, R (corresponding author), Inst Clin Physiol, Natl Res Council, Pisa, Italy.	rdc@ifc.cnr.it	Buizza, Roberto/AAA-4304-2022				Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Akbarian A, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0097-5; Alinejad T., 2020, J ANAL PHARM RES, V9, P46, DOI [10.15406/japlr.2020.09.00350, DOI 10.15406/JAPLR.2020.09.00350]; Amiel JJ, 2017, ANIM COGN, V20, P117, DOI 10.1007/s10071-016-0993-2; Andrews O, 2018, LANCET PLANET HEALTH, V2, pE540, DOI 10.1016/S2542-5196(18)30240-7; Beckers L, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00136; Blunden J., 2020, B AM METEOROL SOC, V101, pS1, DOI [10.1175/2020BAMSStateoftheClimate.1, DOI 10.1175/2020BAMSSTATEOFTHECLIMATE.1, 10.1175/2020BAMSSTATEOFTHECLIMATE_INTRO.1]; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Calabrese V, 2018, FREE RADICAL BIO MED, V115, P80, DOI 10.1016/j.freeradbiomed.2017.10.379; Campanella C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092603; Carrettiero Daniel Carneiro, 2015, Temperature (Austin), V2, P491, DOI 10.1080/23328940.2015.1096438; Ceravolo R, 2013, MOVEMENT DISORD, V28, P1391, DOI 10.1002/mds.25585; Chauderlier A, 2017, METHODS MOL BIOL, V1523, P369, DOI 10.1007/978-1-4939-6598-4_25; Chauhan NR, 2017, NEUROSCIENCE, V358, P79, DOI 10.1016/j.neuroscience.2017.06.023; Chen HL, 2020, NEUROL SCI, V41, P1267, DOI 10.1007/s10072-019-04217-3; Cheshire WP, 2016, AUTON NEUROSCI-BASIC, V196, P91, DOI 10.1016/j.autneu.2016.01.001; Christoforidou E, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01822-4; Coogan AN, 2013, BIOL PSYCHIAT, V74, P333, DOI 10.1016/j.biopsych.2012.11.021; Coon E.A., 2020, SWEATING DISORDERS, V26, P116, DOI [10.1212/CON.0000000000000813, DOI 10.1212/CON.0000000000000813]; COP21, 2015, COP21; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; Dahl GE, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00116; Dantzer R, 2018, PHYSIOL REV, V98, P477, DOI 10.1152/physrev.00039.2016; Dayananda B, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0002; Della-Marta PM, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008510; Dentel C, 2013, BRAIN, V136, P483, DOI 10.1093/brain/aws274; Doppler K, 2014, ACTA NEUROPATHOL, V128, P99, DOI 10.1007/s00401-014-1284-0; Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3; Dukay B, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00920; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; El Oussini H, 2017, ANN NEUROL, V82, P444, DOI 10.1002/ana.25030; El-Orabi NF, 2011, J THERM BIOL, V36, P49, DOI 10.1016/j.jtherbio.2010.11.002; Ely Brett R, 2015, Temperature (Austin), V2, P51, DOI 10.4161/23328940.2014.992657; Eschbach J, 2013, HUM MOL GENET, V22, P3477, DOI 10.1093/hmg/ddt202; ESOT, 2019, EUR STAT CLIM 2019 S, DOI [10.24381/zw9t-hx58.https://climate.copernicus.eu/sites/default/files/2020-04/ESOTC2019, DOI 10.24381/ZW9T-HX58.HTTPS://CLIMATE.COPERNICUS.EU/SITES/DEFAULT/FILES/2020-04/ESOTC2019]; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Fragniere AMC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38296-7; Fukuoka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103130; Gelders G, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/4784268; Ghavami M, 2013, ACS CHEM NEUROSCI, V4, P375, DOI 10.1021/cn300205g; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Gorges M, 2017, J NEUROL NEUROSUR PS, V88, P1033, DOI 10.1136/jnnp-2017-315795; Gostimirovic M, 2020, ARCH ENVIRON OCCUP H, V75, P406, DOI 10.1080/19338244.2020.1742079; Gulcebi MI, 2021, EPILEPSY BEHAV, V116, DOI 10.1016/j.yebeh.2021.107791; Habibi L, 2014, BIOIMPACTS, V4, P167, DOI 10.15171/bi.2014.013; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Homma T, 2016, EXP CELL RES, V349, P128, DOI 10.1016/j.yexcr.2016.10.006; Huisman MHB, 2015, JAMA NEUROL, V72, P1155, DOI 10.1001/jamaneurol.2015.1584; Hunt AP, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01556; Iodice V, 2011, J NEUROL SCI, V310, P133, DOI 10.1016/j.jns.2011.07.014; IPCC (Intergovernmental Panel on Climate Change), 2014, 5 ASSESSMENT REPORT, P31; IPCC (Intergovernmental Panel on Climate Change), 2019, SPEC REP CLIM CHANG, P100; IPCC (Intergovernmental Panel on Climate Change), 2018, SPEC REP GLOB WARM 1, P25; Ji T, 2020, AGEING RES REV, V57, DOI 10.1016/j.arr.2019.100997; Jiang QJ, 2013, INT J HYPERTHER, V29, P219, DOI 10.3109/02656736.2013.786141; Jones DR, 2014, THER ADV NEUROL DISO, V7, P33, DOI 10.1177/1756285613493469; Kabir M.F., 2018, ENDOPLASMIC RETICULU, DOI [10.5772/intechopen.81381, DOI 10.5772/INTECHOPEN.81381]; Katschinski DA, 2004, NEWS PHYSIOL SCI, V19, P11, DOI 10.1152/nips.01403.2002; Keil G, 2015, BIOGERONTOLOGY, V16, P383, DOI 10.1007/s10522-015-9571-2; Kempuraj D., 2016, J NEUROL NEUROSURG S, V1, P1003; Kim Dana, 2014, Exp Neurobiol, V23, P352, DOI 10.5607/en.2014.23.4.352; Kim JA, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00027; Kingsbury AE, 2010, MOVEMENT DISORD, V25, P2508, DOI 10.1002/mds.23305; Kiyatkin Eugene A, 2019, Temperature (Austin), V6, P271, DOI 10.1080/23328940.2019.1691896; Konovalova J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236055; Laukkanen T, 2017, AGE AGEING, V46, P245, DOI 10.1093/ageing/afw212; Lee W, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0324-6; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111083; Lim KH, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00158; Liu GX, 2012, FUTUR NEUROL, V7, P145, DOI 10.2217/FNL.12.2; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Liu YH, 2012, MOL BIOL REP, V39, P3987, DOI 10.1007/s11033-011-1179-2; Logroscino G, 2018, LANCET NEUROL, V17, P1083, DOI 10.1016/S1474-4422(18)30404-6; Lu SH, 2010, J CLIN NURS, V19, P4, DOI 10.1111/j.1365-2702.2009.02945.x; Malyshev I., 2013, IMMUNITY TUMORS AGIN, V6, P113, DOI [10.1111/j.1365- 2702.2009.02945.x, DOI 10.1111/J.1365-2702.2009.02945.X]; Mecocci P, 2018, J ALZHEIMERS DIS, V64, pS397, DOI 10.3233/JAD-179903; Medinas DB, 2019, AGING-US, V11, P5, DOI 10.18632/aging.101705; Michaelson N, 2017, CYTOKINE GROWTH F R, V37, P81, DOI 10.1016/j.cytogfr.2017.05.001; Miller DJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00821; Mujahid Ahmad, 2007, Journal of Poultry Science, V44, P439, DOI 10.2141/jpsa.44.439; Neal M, 2018, BBA-MOL BASIS DIS, V1864, P432, DOI 10.1016/j.bbadis.2017.11.004; Nichols E, 2019, LANCET NEUROL, V18, P88, DOI 10.1016/S1474-4422(18)30403-4; O'Donnell S, 2018, SCI NAT-HEIDELBERG, V105, DOI 10.1007/s00114-017-1538-5; Orimo S, 2008, BRAIN, V131, P642, DOI 10.1093/brain/awm302; Othman M., 2020, GLOBAL WARMING NEURO, DOI [10.1101/2020.12.18.20248515, DOI 10.1101/2020.12.18.20248515]; Pallotta MM, 2017, J EXP ZOOL PART B, V328, P360, DOI 10.1002/jez.b.22736; Pasquinelli A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00102; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Podgorny PJ, 2016, PARKINSONISM RELAT D, V28, P94, DOI 10.1016/j.parkreldis.2016.04.033; Power JHT, 2017, BRAIN PATHOL, V27, P3, DOI 10.1111/bpa.12344; Qu LT, 2007, NEUROBIOL DIS, V27, P320, DOI 10.1016/j.nbd.2007.06.003; Qu Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35610-1; Rango M, 2014, J CEREBR BLOOD F MET, V34, P915, DOI 10.1038/jcbfm.2014.38; Reish HEA, 2015, J PARKINSON DIS, V5, P1, DOI 10.3233/JPD-140491; Ruszkiewicz JA, 2019, ENVIRON RES, V177, DOI 10.1016/j.envres.2019.108637; Salminen A, 2020, J MOL MED, V98, P633, DOI 10.1007/s00109-020-01904-z; Schar C, 2004, NATURE, V432, P559, DOI 10.1038/432559a; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Seminary ER, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00086; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Sharma HS, 2006, J NEURAL TRANSM, V113, P497, DOI 10.1007/s00702-005-0406-1; Sharma HS, 2003, INT J HYPERTHER, V19, P325, DOI 10.1080/0265673021000054621; Shi LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30161; Shi LH, 2015, NAT CLIM CHANGE, V5, P988, DOI 10.1038/NCLIMATE2704; Singh IS, 2013, INT J HYPERTHER, V29, P423, DOI 10.3109/02656736.2013.808766; Sinigaglia-Coimbra R, 2002, ACTA NEUROPATHOL, V103, P444, DOI 10.1007/s00401-001-0487-3; Slimen IB, 2014, INT J HYPERTHER, V30, P513, DOI 10.3109/02656736.2014.971446; Song K, 2016, SCIENCE, V353, P1393, DOI 10.1126/science.aaf7537; Stephenson J, 2018, IMMUNOLOGY, V154, P204, DOI 10.1111/imm.12922; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Sun G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061157; Suzuki K, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050401; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Tan CCS, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.201800468; Thornton C, 2017, BIOCHEM SOC T, V45, P1067, DOI 10.1042/BST20170017; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; UKMO (United Kingdom Met. Office), 2003, HEATW 2003 UK MET OF; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Valdinocci D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020469; Vandal M, 2016, NEUROBIOL AGING, V43, P47, DOI 10.1016/j.neurobiolaging.2016.03.024; Vercruysse P, 2016, BRAIN, V139, P1106, DOI 10.1093/brain/aww004; Vos T., 2020, GLOBAL BURDEN 369 DI; Waalen J, 2011, J GERONTOL A-BIOL, V66, P487, DOI 10.1093/gerona/glr001; Wang ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075044; Webers A, 2020, IMMUNOL CELL BIOL, V98, P28, DOI 10.1111/imcb.12301; Wei YG, 2019, ENVIRON INT, V126, P228, DOI 10.1016/j.envint.2018.12.054; White MG, 2012, J NEUROPHYSIOL, V108, P2203, DOI 10.1152/jn.00638.2011; Whittington RA, 2010, CURR ALZHEIMER RES, V7, P717; WMO, 2021, STAT GLOB CLIM 2020; Yan DY, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.574750; Yu TZ, 2015, FRONT BIOSCI-LANDMRK, V20, P229, DOI 10.2741/4306; Zammit C, 2021, EARLY HUM DEV, V155, DOI 10.1016/j.earlhumdev.2020.105217; Zanobetti A, 2013, EPIDEMIOLOGY, V24, P809, DOI 10.1097/01.ede.0000434432.06765.91; Zanobetti A, 2012, P NATL ACAD SCI USA, V109, P6608, DOI 10.1073/pnas.1113070109; Zlotnik A, 2010, ANESTH ANALG, V111, P1497, DOI 10.1213/ANE.0b013e3181fc0112; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	137	1	1	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	OCT	2021	201								111511	10.1016/j.envres.2021.111511			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	WC6LK	WOS:000704367500004	34126048				2022-02-06	
J	Cao, M; Luo, YY; Wu, ZY; Mazzola, CA; Catania, L; Alvarez, TL; Halperin, JM; Biswal, B; Li, XB				Cao, Meng; Luo, Yuyang; Wu, Ziyan; Mazzola, Catherine A.; Catania, Lori; Alvarez, Tara L.; Halperin, Jeffrey M.; Biswal, Bharat; Li, Xiaobo			Topological Aberrance of Structural Brain Network Provides Quantitative Substrates of Post-Traumatic Brain Injury Attention Deficits in Children	BRAIN CONNECTIVITY			English	Article						attention deficits; diffusion tensor imaging; graph theory; pediatric; traumatic brain injury	WHITE-MATTER; WORKING-MEMORY; EXECUTIVE FUNCTION; CORTICAL THICKNESS; POSTURAL CONTROL; MILD; CONNECTIVITY; MODERATE; PREDICTORS; DORSAL	Background: Traumatic brain injury (TBI)-induced attention deficits are among the most common long-term cognitive consequences in children. Most of the existing studies attempting to understand the neuropathological underpinnings of cognitive and behavioral impairments in TBI have utilized heterogeneous samples and resulted in inconsistent findings. The current research proposed to investigate topological properties of the structural brain network in children with TBI and their relationship with post-TBI attention problems in a more homogeneous subgroup of children who had severe post-TBI attention deficits (TBI-A).</p> Materials and Methods: A total of 31 children with TBI-A and 35 group-matched controls were involved in the study. Diffusion tensor imaging-based probabilistic tractography and graph theoretical techniques were used to construct the structural brain network in each subject. Network topological properties were calculated in both global level and regional (nodal) level. Between-group comparisons among the topological network measures and analyses for searching brain-behavioral were all corrected for multiple comparisons using Bonferroni method.</p> Results: Compared with controls, the TBI-A group showed significantly higher nodal local efficiency and nodal clustering coefficient in left inferior frontal gyrus and right transverse temporal gyrus, whereas significantly lower nodal clustering coefficient in left supramarginal gyrus and lower nodal local efficiency in left parahippocampal gyrus. The temporal lobe topological alterations were significantly associated with the post-TBI inattentive and hyperactive symptoms in the TBI-A group.</p> Conclusion: The results suggest that TBI-related structural re-modularity in the white matter subnetworks associated with temporal lobe may play a critical role in the onset of severe post-TBI attention deficits in children. These findings provide valuable input for understanding the neurobiological substrates of post-TBI attention deficits, and have the potential to serve as quantitatively measurable criteria guiding the development of more timely and tailored strategies for diagnoses and treatments to the affected individuals.</p> Impact statement This study provides a new insight into the neurobiological substrates associated with post-traumatic brain injury attention deficits (TBI-A) in children, by evaluating topological alterations of the structural brain network. The results demonstrated that relative to group-matched controls, the children with TBI-A had significantly altered nodal local efficiency and nodal clustering coefficient in temporal lobe, which strongly linked to elevated inattentive and hyperactive symptoms in the TBI-A group. These findings suggested that white matter structural re-modularity in subnetworks associated with temporal lobe may serve as quantitatively measurable biomarkers for early prediction and diagnosis of post-TBI attention deficits in children.</p>	[Cao, Meng; Luo, Yuyang; Alvarez, Tara L.; Biswal, Bharat; Li, Xiaobo] New Jersey Inst Technol, Dept Biomed Engn, 323 Martin Luther King Blvd,Fenster 613, Newark, NJ 07102 USA; [Wu, Ziyan; Li, Xiaobo] New Jersey Inst Technol, Dept Elect & Comp Engn, Newark, NJ USA; [Mazzola, Catherine A.] New Jersey Pediat Neurosci Inst, Morristown, NJ USA; [Catania, Lori] North Jersey Neurodev Ctr, N Haledon, NJ USA; [Halperin, Jeffrey M.] CUNY, Queens Coll, Dept Psychol, New York, NY 10021 USA		Li, XB (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, 323 Martin Luther King Blvd,Fenster 613, Newark, NJ 07102 USA.	xli.aecom@gmail.com			National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03MH109791, R15MH117368]; New Jersey Commission on Brain Injury Research [CBIR17PIL012]; New Jersey Institute of Technology Start-up Award	This work was partially supported by research grants from the National Institute of Mental Health (R03MH109791, R15MH117368), the New Jersey Commission on Brain Injury Research (CBIR17PIL012), and the New Jersey Institute of Technology Start-up Award.	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Arnott SR, 2011, NEUROSCI BIOBEHAV R, V35, P2162, DOI 10.1016/j.neubiorev.2011.04.005; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bathelt J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38894-z; Baum GL, 2017, CURR BIOL, V27, P1561, DOI 10.1016/j.cub.2017.04.051; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Chu SH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23051-9; Conners CK, 2008, CONNERS, V3rd; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; de Reus MA, 2013, NEUROIMAGE, V70, P402, DOI 10.1016/j.neuroimage.2012.12.066; Dennis EL, 2016, J NEUROTRAUM, V33, P840, DOI 10.1089/neu.2015.4012; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Diez I, 2017, NETW NEUROSCI, V1, P116, DOI [10.1162/NETN_a_00007, 10.1162/netn_a_00007]; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Faber J, 2016, BRAIN INJURY, V30, P1635, DOI 10.1080/02699052.2016.1199910; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Green GH, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1302; Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jolly AE, 2020, BRAIN, V143, P1158, DOI 10.1093/brain/awaa067; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Katsuki F, 2014, NEUROSCIENTIST, V20, P509, DOI 10.1177/1073858413514136; Kaufman J, 2000, J AM ACAD CHILD PSY, V39, P1208, DOI 10.1097/00004583-200010000-00002; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Kuceyeski AF, 2019, HUM BRAIN MAPP, V40, P4441, DOI 10.1002/hbm.24713; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Kurowski BG, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000432; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Le Fur C, 2020, ANN PHYS REHABIL MED, V63, P270, DOI 10.1016/j.rehab.2019.09.003; LeBlond E, 2019, J INT NEUROPSYCH SOC, V25, P740, DOI 10.1017/S1355617719000444; Lindsey HM, 2020, BRAIN IMAGING BEHAV, V14, P1626, DOI 10.1007/s11682-019-00093-9; Lipszyc J, 2014, ARCH CLIN NEUROPSYCH, V29, P289, DOI 10.1093/arclin/acu004; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mishra VR, 2019, HUM BRAIN MAPP, V40, P5108, DOI 10.1002/hbm.24761; Misic B, 2018, CEREB CORTEX, V28, P2655, DOI 10.1093/cercor/bhy101; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Molteni E, 2019, EUR J NEUROL, V26, P1183, DOI 10.1111/ene.13963; Narad ME, 2020, J HEAD TRAUMA REHAB, V35, pE271, DOI 10.1097/HTR.0000000000000550; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Polanczyk G, 2010, J AM ACAD CHILD PSY, V49, P210, DOI 10.1016/j.jaac.2009.12.014; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Raizman R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65948-4; Recanzone GH, 2010, BEHAV BRAIN RES, V206, P1, DOI 10.1016/j.bbr.2009.08.015; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Strazzer S, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/104282; TEASDALE G, 1974, LANCET, V2, P81; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Verhelst H, 2018, HUM BRAIN MAPP, V39, P2800, DOI 10.1002/hbm.24041; Voisin J, 2006, J NEUROSCI, V26, P273, DOI 10.1523/JNEUROSCI.2967-05.2006; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Watson CG, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101673; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yuan WH, 2017, J HEAD TRAUMA REHAB, V32, P378, DOI 10.1097/HTR.0000000000000318; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	103	1	1	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	OCT 1	2021	11	8					651	662		10.1089/brain.2020.0866			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WO1SZ	WOS:000712242600007	33765837	Green Submitted			2022-02-06	
J	Connolly, MG; Potter, OV; Sexton, AR; Kohman, RA				Connolly, Meghan G.; Potter, Opal, V; Sexton, Ashley R.; Kohman, Rachel A.			Effects of Toll-like receptor 4 inhibition on spatial memory and cell proliferation in male and female adult and aged mice	BRAIN BEHAVIOR AND IMMUNITY			English	Article						TLR4; Sex differences; TAK-242; Water maze; Ki67; Hippocampus; Granular cell layer; Restraint stress; Stress	TRAUMATIC BRAIN-INJURY; SEPTO-TEMPORAL AXIS; HIPPOCAMPAL NEUROGENESIS; SEX-DIFFERENCES; LEARNING INDEX; WATER MAZE; EXPRESSION; ANXIETY; LIPOPOLYSACCHARIDE; PERFORMANCE	Toll-like receptors (TLRs) participate in the response to infection, stress, and injury by initiating an innate immune response. In addition, these receptors are expressed in many neural cell types and under physiological conditions are implicated in modulating cognitive function and neural plasticity in the adult and aged brain. Knockout of the Toll-like receptor 4 (TLR4) subtype enhances spatial memory and adult hippocampal neurogenesis through increasing proliferation and neuronal differentiation. Currently unknown is whether pharmacological inhibition of TLR4 produces similar enhancements in cognitive function and cell proliferation. The present study evaluated water maze performance, cytokine expression, and cell proliferation in the hippocampus of young and aged male and female C57BL6/J mice following treatment with the TLR4 antagonist, TAK-242. Further, alterations in the response to an acute stressor were evaluated in TAK-242-treated mice. Results showed that TAK-242 selectively enhanced spatial learning and memory in young females. Additionally, TAK242 treatment reduced thigmotaxis in the water maze and lowered corticosterone levels following acute stress in females. TAK-242 decreased hippocampal interleukin (IL)-1 beta expression but had no effect on IL-6 or tumor necrosis factor-alpha (TNF alpha). Aged mice showed decreased cell proliferation compared to young mice, but TAK-242 administration had minimal effects on estimated Ki67 positive cell numbers. Findings indicate that pharmacological inhibition of TLR4 improves cognitive function in young females likely through attenuating stress reactivity.	[Connolly, Meghan G.; Potter, Opal, V; Sexton, Ashley R.; Kohman, Rachel A.] Univ North Carolina Wilmington, Dept Psychol, 601 S Coll Rd, Wilmington, NC 28409 USA		Kohman, RA (corresponding author), Univ North Carolina Wilmington, Dept Psychol, 601 S Coll Rd, Wilmington, NC 28409 USA.	mgc2598@uncw.edu; opalpotter88@gmail.com; ars8270@uncw.edu; kohmanr@uncw.edu			National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R15AG052935]	This work was supported by a grant from the National Institute on Aging [R15AG052935] awarded to RAK. Funding source had no involvement in the experimental design, interpretation of the results, or manuscript preparation.	Barak B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00272; Bastos GN, 2008, NEUROSCIENCE, V155, P454, DOI 10.1016/j.neuroscience.2008.06.020; Beiko J, 2004, BEHAV BRAIN RES, V151, P239, DOI 10.1016/j.bbr.2003.08.019; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Bonet I.J.M., 2021, J PAIN, DOI [10.1016/j.jpain.2021.03.152, DOI 10.1016/J.JPAIN.2021.03.152]; Braida D, 2004, BEHAV BRAIN RES, V153, P423, DOI 10.1016/j.bbr.2003.12.018; Chin PY, 2019, ENDOCRINOLOGY, V160, P2646, DOI 10.1210/en.2019-00493; Connolly MG, 2020, HIPPOCAMPUS, V30, P958, DOI 10.1002/hipo.23209; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Cui WG, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00444; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Donzis EJ, 2014, NEUROBIOL LEARN MEM, V115, P68, DOI 10.1016/j.nlm.2014.08.008; Doyle HH, 2017, J NEUROSCI, V37, P3202, DOI 10.1523/JNEUROSCI.2906-16.2017; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Femenia T, 2018, BRAIN BEHAV IMMUN, V69, P273, DOI 10.1016/j.bbi.2017.11.022; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Fields CT, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0166-x; Firmal P, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00807; Fu SN, 2019, PSYCHOPHARMACOLOGY, V236, P2173, DOI 10.1007/s00213-019-05210-6; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Garate I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-8; Garate I, 2013, BIOL PSYCHIAT, V73, P32, DOI 10.1016/j.biopsych.2012.07.005; Gemma C, 2005, EUR J NEUROSCI, V22, P1751, DOI 10.1111/j.1460-9568.2005.04334.x; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Heine VM, 2004, NEUROBIOL AGING, V25, P361, DOI 10.1016/S0197-4580(03)00090-3; Herrero AI, 2006, NEUROBIOL LEARN MEM, V86, P150, DOI 10.1016/j.nlm.2006.02.001; Hua F, 2015, J CEREBR BLOOD F MET, V35, P536, DOI 10.1038/jcbfm.2014.240; Jurgens HA, 2012, EXP NEUROL, V233, P40, DOI 10.1016/j.expneurol.2010.11.014; KAKIHANA R, 1976, PSYCHOPHARMACOLOGIA, V46, P301, DOI 10.1007/BF00421118; Kohman RA, 2013, BEHAV BRAIN RES, V242, P17, DOI 10.1016/j.bbr.2012.12.032; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Korgaonkar AA, 2020, BRAIN BEHAV IMMUN, V88, P381, DOI 10.1016/j.bbi.2020.03.035; Kranjac D, 2012, BRAIN BEHAV IMMUN, V26, P109, DOI 10.1016/j.bbi.2011.08.005; Lei CY, 2016, BRAIN RES, V1632, P1, DOI 10.1016/j.brainres.2015.11.045; Letiembre M, 2007, NEUROSCIENCE, V146, P248, DOI 10.1016/j.neuroscience.2007.01.004; Li CL, 2016, NEUROSCI BULL, V32, P127, DOI 10.1007/s12264-016-0015-z; Littlefield A, 2017, NEUROSCIENCE, V343, P106, DOI 10.1016/j.neuroscience.2016.11.027; Littlefield AM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0362-0; Loiarro M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/674363; Loram LC, 2012, PSYCHONEUROENDOCRINO, V37, P1688, DOI 10.1016/j.psyneuen.2012.02.018; Maei HR, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.004.2009; Maloney EA, 2014, WIRES COGN SCI, V5, P403, DOI 10.1002/wcs.1299; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Medina-Rodriguez EM, 2020, BRAIN BEHAV IMMUN, V89, P51, DOI 10.1016/j.bbi.2020.05.068; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moser VA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1340-0; Nelson RJ, 1997, HORM BEHAV, V31, P188, DOI 10.1006/hbeh.1997.1381; Nway NC, 2017, NEUROTOXICOLOGY, V63, P155, DOI 10.1016/j.neuro.2017.10.001; Okun E, 2014, BRAIN BEHAV IMMUN, V36, P90, DOI 10.1016/j.bbi.2013.10.013; Okun E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047522; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Pascual M, 2011, BRAIN BEHAV IMMUN, V25, pS80, DOI 10.1016/j.bbi.2011.02.012; Pereira IT, 2015, BEHAV NEUROSCI, V129, P533, DOI 10.1037/bne0000078; Potter OV, 2019, BRAIN BEHAV IMMUN, V76, P37, DOI 10.1016/j.bbi.2018.10.010; Pugh CR, 1998, BRAIN BEHAV IMMUN, V12, P212, DOI 10.1006/brbi.1998.0524; Rainer Q, 2012, INT J NEUROPSYCHOPH, V15, P321, DOI 10.1017/S1461145711000356; Rettew JA, 2009, ENDOCRINOLOGY, V150, P3877, DOI 10.1210/en.2009-0098; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Roberts BJ, 2013, EXP MOL PATHOL, V94, P58, DOI 10.1016/j.yexmp.2012.06.005; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Song Y, 2012, ARTERIOSCL THROM VAS, V32, P103, DOI 10.1161/ATVBAHA.111.236349; Sparkman NL, 2005, PHYSIOL BEHAV, V86, P244, DOI 10.1016/j.physbeh.2005.07.016; Sparkman NL, 2005, PHYSIOL BEHAV, V85, P278, DOI 10.1016/j.physbeh.2005.04.015; Takashima K, 2009, BRIT J PHARMACOL, V157, P1250, DOI 10.1111/j.1476-5381.2009.00297.x; Tanti A, 2013, NEUROSCIENCE, V252, P234, DOI 10.1016/j.neuroscience.2013.08.017; Tanti A, 2012, NEUROPHARMACOLOGY, V63, P374, DOI 10.1016/j.neuropharm.2012.04.022; Trotta T, 2014, J NEUROIMMUNOL, V268, P1, DOI 10.1016/j.jneuroim.2014.01.014; Wang YC, 2013, STROKE, V44, P2545, DOI 10.1161/STROKEAHA.113.001038; Wang YH, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/7254016; Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3; Ye YQ, 2014, INT J MOL SCI, V15, P12651, DOI 10.3390/ijms150712651; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhang DD, 2014, NEUROCHEM INT, V75, P11, DOI 10.1016/j.neuint.2014.05.003; Zhang K, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1525; Zhang ZL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1246-x	77	1	1	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2021	97						383	393		10.1016/j.bbi.2021.06.008			11	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	WA4TD	WOS:000702878400004	34343615				2022-02-06	
J	Crocker, KL; Marischuk, K; Rimkus, SA; Zhou, H; Yin, JCP; Boekhoff-Falk, G				Crocker, Kassi L.; Marischuk, Khailee; Rimkus, Stacey A.; Zhou, Hong; Yin, Jerry C. P.; Boekhoff-Falk, Grace			Neurogenesis in the adult Drosophila brain	GENETICS			English	Article						neuron; glia; stem cell; neuroblast; neural progenitor; penetrating traumatic brain injury; neurodegeneration	PAN-NEURAL GENE; NEUROBLAST LINEAGES; LOCOMOTOR-ACTIVITY; REACTIVE GLIOSIS; MUSHROOM BODY; STEM; PROLIFERATION; MELANOGASTER; PROTEIN; CELLS	Neurodegenerative diseases such as Alzheimer's and Parkinson's currently affect similar to 25 million people worldwide. The global incidence of traumatic brain injury (TBI) is estimated at similar to 70 million/year. Both neurodegenerative diseases and TBI remain without effective treatments. We are utilizing adult Drosophila melanogasterto investigate the mechanisms of brain regeneration with the long-term goal of identifying targets for neural regenerative therapies. We specifically focused on neurogenesis, i.e., the generation of new cells, as opposed to the regrowth of specific subcellular structures such as axons. Like mammals, Drosophila have few proliferating cells in the adult brain. Nonetheless, within 24 hours of a penetrating traumatic brain injury (PTBI) to the central brain, there is a significant increase in the number of proliferating cells. We subsequently detect both new glia and new neurons and the formation of new axon tracts that target appropriate brain regions. Glial cells divide rapidly upon injury to give rise to new glial cells. Other cells near the injury site upregulate neural progenitor genes including asense and deadpan and later give rise to the new neurons. Locomotor abnormalities observed after PTBI are reversed within 2 weeks of injury, supporting the idea that there is functional recovery. Together, these data indicate that adult Drosophila brains are capable of neuronal repair. We anticipate that this paradigm will facilitate the dissection of the mechanisms of neural regeneration and that these processes will be relevant to human brain repair.	[Crocker, Kassi L.; Marischuk, Khailee; Boekhoff-Falk, Grace] Univ Wisconsin, Sch Med & Publ Hlth, Genet Grad Training Program, Madison, WI 53705 USA; [Crocker, Kassi L.] Univ Wisconsin, Sch Med & Publ Hlth, Sci & Med Grad Res Scholars Program, Madison, WI 53705 USA; [Crocker, Kassi L.; Marischuk, Khailee; Rimkus, Stacey A.; Boekhoff-Falk, Grace] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53705 USA; [Zhou, Hong; Yin, Jerry C. P.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Genet, Madison, WI 53705 USA; [Rimkus, Stacey A.] Univ Wisconsin, Lab Genet, Madison, WI 53706 USA		Boekhoff-Falk, G (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Genet Grad Training Program, Madison, WI 53705 USA.; Boekhoff-Falk, G (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53705 USA.	grace.boekhoff@wisc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS102698, P40OD018537, T32 GM007133, NS090190]; University of Wisconsin Graduate School; Women in Science and Engineering Leadership Institute (WISELI)	The authors are grateful to Becky Katzenberger and Sarah Neuman for technical assistance; Bret Hanlon for assistance analyzing the locomotion data; Eduardo Moreno for sharing the pe rma-twin stocks; and Stanislava Chtarbanova for the ase and dpn primers. They also would like to thank Barry Ganetzky and David Wassarman for lively discussions that undoubtedly improved the science and Kent Mok, Cayla Guerra, Bailey Spiegelberg, and Shawn Ahern-Djamali for their contributions to the laboratory. The authors are grateful to the anonymous reviewers who insights improved the manuscript. The FasII, Elav, and Repo monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank (https://dshb.biology.uiowa.edu/), created by the National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242. Most of the Drosophila strains used in this study were obtained from the Bloomington Drosophila Stock Center (BDSC: https://bdsc.indiana.edu/; NIH P40OD018537). This work was supported by NIH T32 GM007133 (K.L.C. and K.M.); NIH NS090190 (G.B.F.); NIH NS102698 (G.B.F.); the University of Wisconsin Graduate School (G.B.F.); and the Women in Science and Engineering Leadership Institute (WISELI) (G.B.F.).	ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; An HP, 2017, J GENET GENOMICS, V44, P151, DOI 10.1016/j.jgg.2017.02.005; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Beaucher M, 2007, DEV BIOL, V301, P287, DOI 10.1016/j.ydbio.2006.09.019; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Chia W, 2008, J CELL BIOL, V180, P267, DOI 10.1083/jcb.200708159; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Fernandez-Hernandez I, 2013, CELL REP, V3, P1857, DOI 10.1016/j.celrep.2013.05.034; Gao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep22490; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Hu YH, 2013, G3-GENES GENOM GENET, V3, P1607, DOI 10.1534/g3.113.007021; Ihry RJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003085; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Kang KH, 2015, CELL TISSUE RES, V359, P33, DOI 10.1007/s00441-014-1914-9; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; Li GY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186653; Mabuchi I, 2016, NEUROSCI RES, V111, P25, DOI 10.1016/j.neures.2016.04.005; Martin JR, 1998, LEARN MEMORY, V5, P179; Moreno E, 2015, CURR BIOL, V25, P955, DOI 10.1016/j.cub.2015.02.014; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ramon y Cajal S, 1913, ESTUDIOS DEGENERACIO; Ramon y Cajal S., 1914, ESTUDIOS DEGENERACIO; Ramon-Canellas P, 2019, NEUROSCIENCE, V399, P39, DOI 10.1016/j.neuroscience.2018.12.014; Sanuki R, 2019, BRAIN BEHAV IMMUN, V80, P427, DOI 10.1016/j.bbi.2019.04.023; SEHGAL A, 1992, P NATL ACAD SCI USA, V89, P1423, DOI 10.1073/pnas.89.4.1423; Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060; Tyagi Vineet, 2016, Surg Neurol Int, V7, P78, DOI 10.4103/2152-7806.189296; Vishwakarma SK, 2014, J ADV RES, V5, P277, DOI 10.1016/j.jare.2013.04.005; von Trotha JW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-9; Weng M, 2011, CURR OPIN NEUROBIOL, V21, P36, DOI 10.1016/j.conb.2010.09.005; Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007; YOUNGERSHEPHERD S, 1992, CELL, V70, P911, DOI 10.1016/0092-8674(92)90242-5; Zhou CC, 2016, CURR STEM CELL RES T, V11, P177, DOI 10.2174/1574888X10666150531172108	57	1	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	2021	219	2							iyab092	10.1093/genetics/iyab092			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WI7CK	WOS:000708515000001	34117750	hybrid			2022-02-06	
J	Dickson, TJ; Terwiel, FA				Dickson, Tracey J.; Terwiel, F. Anne			Head injury and helmet usage trends for alpine skiers and snowboarders in western Canada during the decade 2008-9 to 2017-18	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Skiing; Snowboarding; Concussion; Helmets; Head injury	RISK-FACTORS; CONCUSSION	Objectives: This research explores snowsport head injury trends in western Canadian resorts over the decade 2008-2018. Design: Ecological study. Methods: Head-injury and participation data on alpine skiing and snowboarding (snowsports) was provided by the Canada West Ski Areas Association (CWSAA) for 2008-2018. Injury reports from the ski patrol of 52 western Canadian resorts were analysed. 29 resorts were included where there was both injury and participation data for at least 8 out of 10 seasons, resulting in analysis of 10,371 reports. Data was imported into SPSS 24 for analysis using descriptive statistics, chi-squared analysis, odds ratios and linear regression. Results: Over the decade: the head injury rate was 0.205 injuries per thousand skier days. Head injuries were 9-10% of all injuries, significantly lower for skiers (8.3%) than snowboarders (10.9%). There were no significant differences in helmet-usage rates of injured and non-injured populations. 80.6% of injured participants wore a helmet, those wearing a helmet were 8% more likely to report a head injury than those not wearing a helmet. There was little variation in the proportion of head injuries reported as concussion, but a 50% reduction in ambulance or helicopter transport, a head-injury severity proxy. There was a significant relationship between the proportion of snowsport participants who were snowboarders and the head-injury rate. Conclusions: Head injuries remain a rare event. There has been a decline in the severity of reported head injuries which may be a function of a decline in the proportion of snowboarders in snowsports. (c) 2020 Published by Elsevier Ltd on behalf of Sports Medicine Australia.	[Dickson, Tracey J.] Univ Canberra, Res Inst Sport & Exercise, Univ Ave, Canberra, ACT, Australia; [Terwiel, F. Anne] Thompson Rivers Univ, Fac Adventure Culinary Arts & Tourism, Kamloops, BC, Canada		Dickson, TJ (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Univ Ave, Canberra, ACT, Australia.	Tracey.Dickson@canberra.edu.au		Dickson, Tracey/0000-0002-9889-1512; Terwiel, Anne/0000-0003-4621-201X			ACIP, 2011, SOCIAL DETERMINANTS; Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; ASAA, 2017, PRESS REL HELM US CO; Audet O, 2019, BRIT J SPORT MED, V53, P19, DOI 10.1136/bjsports-2018-099166; Bailly N, 2018, WILD ENVIRON MED, V29, P151, DOI 10.1016/j.wem.2017.11.007; BC Coroners Service, 2017, WINT ACT DEATHS 2007; Canadian Ski Council, 2018, FACTS STATS SKI SNOW; Canadian Ski Council, 2019, HELM US DAT ALL CAN; Costa-Scorse B, 2011, HEAD INJURY PREVENTI; Costa-Scorse B.A., 2017, SNOW SPORTS TRAUMA S, P17; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Dickson TJ, 2017, SCAND J MED SCI SPOR, V27, P236, DOI 10.1111/sms.12642; Dickson TJ, J SCI MED SPORT; Dickson TJ, 2019, J SCI MED SPORT, V22, pS34, DOI 10.1016/j.jsams.2018.08.013; Dickson TJ, 2016, APPL ERGON, V53, P79, DOI 10.1016/j.apergo.2015.08.006; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ekeland A., 2017, SNOW SPORTS TRAUMA S, P3; Ekeland A, 2019, J SCI MED SPORT, V22, pS3, DOI 10.1016/j.jsams.2018.07.011; Fenerty L, 2016, INJURY PREV, V22, P176, DOI 10.1136/injuryprev-2015-041699; Hagel BE, 2004, INJURY PREV, V10, P275, DOI 10.1136/ip.2004.005546; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; NSAA, 2018, HELM US SAF FACT SHE; Petrone N, 2019, J SCI MED SPORT, V22, pS78, DOI 10.1016/j.jsams.2019.05.015; Porter ED, 2019, J TRAUMA ACUTE CARE, V87, P1205, DOI 10.1097/TA.0000000000002447; Shealy JE., 2015, SKIING TRAUMA SAFETY, V20th Volume, P22, DOI DOI 10.1520/STP158220140079; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Statistics Canada, 2018, HLTH FACTSHEETS; Sulheim S, 2011, BRIT J SPORT MED, V45, P1303, DOI 10.1136/bjsports-2011-090407; Waddington G, 2017, SNOW SPORTS TRAUMA S, P51	29	1	1	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	OCT	2021	24	10					1004	1009		10.1016/j.jsams.2020.01.009			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WC4UW	WOS:000704254800011	32111567				2022-02-06	
J	Ferre, AC; Towe, CW; Bachman, KC; Ho, VP				Ferre, Alexandra C.; Towe, Christopher W.; Bachman, Katelynn C.; Ho, Vanessa P.			Should Rib Fracture Patients be Treated at High Acuity Trauma Hospitals?	JOURNAL OF SURGICAL RESEARCH			English	Article						Rib fracture; Chest trauma; Blunt injury; Transfer criteria; Appropriate care	SURGICAL STABILIZATION; PAIN MANAGEMENT; GUIDELINE; MORBIDITY; MORTALITY; CARE	Background: It is well known that severely injured trauma patients have better outcomes when treated at centers that routinely treat high acuity trauma. The benefits of specialty treatment for chest trauma have not been shown. We hypothesized that patients with high risk rib fractures treated in centers that care for high acuity trauma would have better out-comes than patients treated in other centers. Methods: All rib fracture patients were identified via the 2016 National Inpatient Sample using ICD-10 codes; Abbreviated Injury Scales (AIS) and Elixhauser comorbidity scores were also extracted. Chest AIS was grouped as mild ( < 1) or severe ( > 2). All patients with AIS > 2 in another body region were excluded. High acuity trauma hospitals (TH) were defined as hospitals which transferred 0% of neurotrauma patients; all other hospitals were de -fined as non-trauma hospitals. Poor outcome was defined as any patient who died, had a tracheostomy, developed pneumonia, or had a length of stay in the longest decile. Logistic regression with an interaction term for hospital type and chest trauma severity was per -formed. Results: A total of 29,780 patients with rib fractures were identified (median age 64 (IQR 51-79), 60% male), of whom 22% had poor outcomes. Fifty-three percent of patients were treated at non-trauma hospitals. In unadjusted comparisons, poor outcomes occurred more often at TH (22.4% versus 21.4%, P = 0.03). However, after adjustment, severe chest trauma that was treated at non-trauma hospitals was associated with higher odds of poor outcomes (OR 1.6, < 0.001). Discussion: More than 20% of patients with severe chest trauma have a poor outcome. Severe chest trauma outcomes are improved at TH. Development of transfer criteria for chest injuries in high-risk patients may mitigate poor outcomes at hospitals without specialized trauma expertise. (c) 2021 Elsevier Inc. All rights reserved.	[Ferre, Alexandra C.; Ho, Vanessa P.] MetroHlth Med Ctr, Dept Surg, Div Trauma Crit Care Burns & Acute Care Surg, Cleveland, OH USA; [Ferre, Alexandra C.] Cleveland Clin Fdn, Dept Gen Surg, Digest Dis Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Towe, Christopher W.; Bachman, Katelynn C.] Univ Hosp, Dept Surg, Cleveland, OH USA; [Ho, Vanessa P.] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA		Ho, VP (corresponding author), Dept Surg, Div Trauma Crit Care Burns & Acute Care Surg, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	vho@metrohealth.org					Battle CE, 2012, INJURY, V43, P8, DOI 10.1016/j.injury.2011.01.004; Borczuk P, 2019, WEST J EMERG MED, V20, P307, DOI 10.5811/westjem.2018.12.39337; Bulger EM, 2000, J TRAUMA, V48, P1040, DOI 10.1097/00005373-200006000-00007; Chien CY, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0368-y; Clark David E, 2018, Inj Epidemiol, V5, P11, DOI 10.1186/s40621-018-0149-8; Dreizin D, 2012, RADIOGRAPHICS, V32, P609, DOI 10.1148/rg.323115099; Flarity K, 2017, AM SURGEON, V83, P1012; HCUP National Inpatient Sample (NIS), 2016, HEALTHC COST UT PROJ HEALTHC COST UT PROJ; He Z, 2019, J THORAC DIS, V11, pS1078, DOI 10.21037/jtd.2019.04.109; Ho AMH, 2011, CURR OPIN CRIT CARE, V17, P323, DOI 10.1097/MCC.0b013e328348bf6f; Kane ED, 2017, J TRAUMA ACUTE CARE, V83, P1047, DOI 10.1097/TA.0000000000001648; Kasotakis G, 2017, J TRAUMA ACUTE CARE, V82, P618, DOI [10.1097/TA.0000000000001350, 10.1097/TA.0000000000001389]; Lafferty PM, 2011, J BONE JOINT SURG AM, V93A, P97, DOI 10.2106/JBJS.I.00696; Liman ST, 2003, EUR J CARDIO-THORAC, V23, P374, DOI 10.1016/S1010-7940(02)00813-8; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Newgard CD, 2019, JAMA SURG, P154; Pieracci FM, 2018, J TRAUMA ACUTE CARE, V84, P1, DOI 10.1097/TA.0000000000001729; Pieracci FM, 2017, INJURY, V48, P307, DOI 10.1016/j.injury.2016.11.026; Rockne WY, 2021, AM J SURG, V221, P1076, DOI 10.1016/j.amjsurg.2020.09.033; Simon BJ, 2005, J TRAUMA, V59, P1256, DOI 10.1097/01.ta.0000178063.77946.f5; Sirmali M, 2003, EUR J CARDIO-THORAC, V24, P133, DOI 10.1016/S1010-7940(03)00256-2; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tignanelli CJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.1316; ZIEGLER DW, 1994, J TRAUMA, V37, P975, DOI 10.1097/00005373-199412000-00018	24	1	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2021	266						328	335		10.1016/j.jss.2021.02.040			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TT3VU	WOS:000680279900040	34058613				2022-02-06	
J	Marques, RSF; Antunes, C; Machado, MJ; Ramos, R; Duarte, N; Oliveira, L; Alegria, C; Sousa, N				Ferreira Marques, Renata Sofia; Antunes, Cristiano; Machado, Maria Joao; Ramos, Rui; Duarte, Nubelio; Oliveira, Leandro; Alegria, Carlos; Sousa, Nuno			Reappraising the need for a control CT in mild head injury patients on anticoagulation	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Head injury; Anticoagulated patients; Head CT; Control head CT	TRAUMATIC BRAIN-INJURY; RISK	Background Head injury is a frequent reason for admission to the emergency department. In parallel, there is a growing use of anticoagulants in an increasingly aging population, which renders this particular group of trauma patients more frequent. In several countries, including Portugal, a 24-h surveillance period followed by repetition of head computed tomography (CT) is the standard procedure for these patients. However, these recommendations have not been based on studies of prevalence of intracranial hemorrhages in control head CTs, namely in this group of anticoagulated patients. This study intends to evaluate the prevalence of de novo intracranial hemorrhages in control head CTs in anticoagulated patients. Method An observational study was carried out, which included patients admitted to Hospital de Braga between June 2017 and January 2018, victims of head injury and on anticoagulation therapy, whose admission head CT excluded intracranial hemorrhage. Results We collected a total of 201 patients, with a mean age of 81.6 years, and 57.5% of them were prescribed warfarin; 181 of these patients repeated the head CT 24 h later. Of these 181 patients, 3 (1.66%) exhibited intracranial hemorrhage in control CT, without surgical indication. All patients were followed up 1 month after the trauma, and there was no readmission requiring hospitalization, surgery or death. Conclusions In conclusion, de novo intracranial hemorrhage in control head CT of anticoagulated patients is rare. We propose that these patients may be discharged if the admission CT does not reveal intracranial hemorrhage, providing that they are accompanied by a caregiver and informed about red flags.	[Ferreira Marques, Renata Sofia; Antunes, Cristiano; Machado, Maria Joao; Ramos, Rui; Duarte, Nubelio; Oliveira, Leandro; Alegria, Carlos] Hosp Braga, Neurosurg Dept, Braga, Portugal; [Sousa, Nuno] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal; [Sousa, Nuno] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal		Marques, RSF (corresponding author), Hosp Braga, Neurosurg Dept, Braga, Portugal.	renatamarqes@gmail.com		Antunes, Cristiano/0000-0001-5517-8824			Beecham S, 2001, LANCET, V357, P771, DOI [10.1016/S0140-6736(00)04163-5, DOI 10.1016/S0140-6736(00)04163-5]; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Curtis N, 2001, ATHLET THER TODAY, V6, P42, DOI [10.1123/att.6.1.42, DOI 10.1123/ATT.6.1.42]; Cutler H. G., 1984, Proceedings of the Plant Growth Regulator Society of America, Eleventh Annual Meeting, 1984, P1; DGS, 1999, PROT NAC AB TRAUM CR, P1; Eades J, 2014, NURS TIMES, V81, P28; Haider AA, 2015, AM J SURG, V210, P1088, DOI 10.1016/j.amjsurg.2015.07.004; Huang JL, 2019, EUR J TRAUMA EMERG S, V45, P481, DOI 10.1007/s00068-018-0924-9; Kuczawski M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013742; Mann N, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0179-0; Mason SM., 2018, EMERG MED J, V36, P47; Mason S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014324; Matsushima K, 2016, J SURG RES, V205, P186, DOI 10.1016/j.jss.2016.06.042; McCammack KC, 2015, WEST J EMERG MED, V16, P43, DOI 10.5811/westjem.2014.10.19488; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	19	1	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2021	47	5			SI		1461	1466		10.1007/s00068-019-01172-8			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UW8UR	WOS:000700428900025	31209554	Green Published			2022-02-06	
J	Garcia-Vilana, S; Sanchez-Molina, D; Lluma, J; Galtes, I; Velazquez-Ameijide, J; Rebollo-Soria, MC; Arregui-Dalmases, C				Garcia-Vilana, Silvia; Sanchez-Molina, David; Lluma, Jordi; Galtes, Ignasi; Velazquez-Ameijide, Juan; Carmen Rebollo-Soria, M.; Arregui-Dalmases, Carlos			Viscoelastic Characterization of Parasagittal Bridging Veins and Implications for Traumatic Brain Injury: A Pilot Study	BIOENGINEERING-BASEL			English	Article						bridging veins; TBI; tissue characterization; biomechanics; strain rate dependent materials; viscoelasticity		Many previous studies on the mechanical properties of Parasagittal Bridging Veins (PSBVs) found that strain rate had a significant effect on some mechanical properties, but did not extensively study the viscoelastic effects, which are difficult to detect with uniaxial simple tensile tests. In this study, relaxation tests and tests under cyclic loading were performed, and it was found that PSBVs do indeed exhibit clear viscoelastic effects. In addition, a complete viscoelastic model for the PSBVs is proposed and data from relaxation, cyclic load and load-unload tests for triangular loads are used to find reference values that characterize the viscoelastic behavior of the PSBVs. Although such models have been proposed for other types of blood vessels, this is the first study that clearly demonstrates the existence of viscoelastic effects from an experimental point of view and also proposes a specific model to explain the data obtained. Finally, this study provides reference values for the usual viscoelastic properties, which would allow more accurate numerical simulation of PSBVs by means of computational models.</p>	[Garcia-Vilana, Silvia; Sanchez-Molina, David; Lluma, Jordi; Velazquez-Ameijide, Juan] Univ Politecn Cataluna, Escola Engn Barcelona Est, Av Eduard Maristany 16, Barcelona 08019, Spain; [Galtes, Ignasi] Inst Med Legal & Ciencies Forenses Catalunya, GV Corts Catalans 111, Barcelona 08014, Spain; [Galtes, Ignasi] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Barcelona 08193, Spain; [Carmen Rebollo-Soria, M.] Inst Med Legal Aragon, Irene Izarbez 22005, Huesca, Spain; [Arregui-Dalmases, Carlos] Ctr Zaragoza, Crtra 232,Km 273, Pedrola 50690, Spain		Sanchez-Molina, D (corresponding author), Univ Politecn Cataluna, Escola Engn Barcelona Est, Av Eduard Maristany 16, Barcelona 08019, Spain.	silvia.garcia.vilana@upc.edu; david.sanchez-molina@upc.edu; jordi.lluma@upc.edu; ignasigaltes@gmail.com; juan.velazquez@upc.edu; mcrebollos@aragon.es; carlos.arregui@centro-zaragoza.com	Sanchez-Molina, David/I-2149-2014; Galtes, Ignasi/K-3053-2014	Sanchez-Molina, David/0000-0002-0671-4106; Lluma, Jordi/0000-0002-4982-206X; Velazquez-Ameijide, Juan/0000-0001-6872-3609; Galtes, Ignasi/0000-0002-5758-2668; Garcia-Vilana, Silvia/0000-0002-8659-1985	Fundacio La Marato de TV3 (Barcelona) [289/C/2017, 201704.30]	This research was funded by Fundacio La Marato de TV3 (Barcelona, No. Grant 289/C/2017, 201704.30). The research was developed within the studies of the research project "Age Effects on Traumatic Brain Injuries".	Al-A'asam J.A., 2014, BAGHDAD SCI J, V11, P1274; Braess D, 2007, FINITE ELEMENTS THEO, V3rd; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Costa JMC, 2020, J MECH BEHAV BIOMED, V111, DOI 10.1016/j.jmbbm.2020.103976; Davis FM, 2012, ANN BIOMED ENG, V40, P2541, DOI 10.1007/s10439-012-0596-2; Delye H., 2006, SAE TECH PAP, V50, P1; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Doorly M.C., 2007, THESIS U COLL DUBLIN; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Fung Y.C., 2013, BIOMECHANICS MECH PR; Funk JR, 2000, J BIOMECH ENG-T ASME, V122, P15, DOI 10.1115/1.429623; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Iriarte YA, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12050870; Jin ZH, 2006, MATH MECH SOLIDS, V11, P216, DOI 10.1177/1081286504040401; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Komatsu K, 2007, J BIOMECH, V40, P634, DOI 10.1016/j.jbiomech.2006.01.026; LEE MC, 1992, J BIOMECH, V25, P925, DOI 10.1016/0021-9290(92)90232-P; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mauro JC, 2018, PHYSICA A, V506, P75, DOI 10.1016/j.physa.2018.04.047; Miller JD, 2014, J NEUROSURG, V120, P1378, DOI 10.3171/2013.10.JNS13272; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Monson KL, 2019, CLIN BIOMECH, V64, P98, DOI 10.1016/j.clinbiomech.2018.02.011; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Pascoletti G, 2020, MATERIALS, V13, DOI 10.3390/ma13173759; Pasquesi SA, 2017, ANN BIOMED ENG, V45, P1877, DOI 10.1007/s10439-017-1833-5; Raul JS, 2008, INT J LEGAL MED, V122, P337, DOI 10.1007/s00414-008-0242-6; Sanchez-Molina D, 2016, COMPUT METH PROG BIO, V136, P55, DOI 10.1016/j.cmpb.2016.08.007; Sanchez-Molina D, 2012, TRAFFIC INJ PREV, V13, P278, DOI 10.1080/15389588.2011.650803; Sanchez-Molina D, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10090831; Sanchez-Molina D, 2020, BIOMED ENG-APP BAS C, V32, DOI 10.4015/S1016237220500404; Soussou JE., 1970, T SOC RHEOL, V14, P573, DOI [10.1122/1.549179, https://doi.org/10.1122/1.549179, DOI 10.1122/1.549179]; Sun ZN, 2021, ACTA BIOMATER, V129, P188, DOI 10.1016/j.actbio.2021.05.021; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tapia-Romero Manuel Alejandro, 2020, Ing. invest. y tecnol., V21, pe1668, DOI 10.22201/fi.25940732e.2020.21n2.014; Tzikang C., 2000, DETERMINING PRONY SE; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wang Z., 2016, VISCOELASTIC VISCOPL; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Zhang K, 2009, J MECH BEHAV BIOMED, V2, P93, DOI 10.1016/j.jmbbm.2008.05.005; Zoghi-Moghadam M, 2009, COMPUT METHOD BIOMEC, V12, P1, DOI [10.1080/10255840802020420, 10.1080/10255840903064897]	44	1	1	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2306-5354		BIOENGINEERING-BASEL	Bioengineering-Basel	OCT	2021	8	10							145	10.3390/bioengineering8100145			15	Biotechnology & Applied Microbiology; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Engineering	WS3LV	WOS:000715087400001	34677218	gold, Green Published			2022-02-06	
J	Hazboun, R; Munoz, A; Krafft, PR; Harder, S; Vannix, R; Zouros, A; Kim, P; Baerg, J				Hazboun, Rajaie; Munoz, Amanda; Krafft, Paul R.; Harder, Sheri; Vannix, Rosemary; Zouros, Alexander; Kim, Paggie; Baerg, Joanne			Craniocervical Dissociation in Pediatric Patients Pearls and Pitfalls of Diagnosis and Management	PEDIATRIC EMERGENCY CARE			English	Article						cervical spine; cervical spine injuries; cervical spine radiographs; craniocervical dissociation	TRAUMATIC ATLANTOOCCIPITAL DISLOCATION; OCCIPITOVERTEBRAL RELATIONSHIPS; RADIOLOGIC-DIAGNOSIS; LATERAL RADIOGRAPHS; INJURY	Aims The aims of this study were to document the injury pattern in pediatric traumatic craniocervical dissociation (CCD) and identify features of survivors. Methods Pediatric traumatic CCDs, diagnosed between January 2004 and July 2016, were reviewed. Survivors and nonsurvivors were compared. Categorical and continuous variables were analyzed with Fisher exact and t tests, respectively. Results Twenty-seven children were identified; 10 died (37%). The median age was 60 months (ranges, 6-109 months [survivors], 2-98 months [nonsurvivors]). For survivors, the median follow-up was 13.4 months (range, 1-109 months). The median time to mortality was 1.5 days (range, 1-7 days). The injury modality was motor vehicle collision in 18 (67%), pedestrian struck in 8 (30%), and 1 shaken infant (3%). For nonsurvivors, CCD was equally diagnosed by plain radiograph and head/cervical spine computed tomography scan. For survivors, CCD was diagnosed by computed tomography in 7 (41%), magnetic resonance imaging in 10 (59%), and none by radiograph. Seven diagnosed by magnetic resonance imaging (41%) had nondiagnostic initial imaging but persistent neck pain. Magnetic resonance imaging was obtained and was diagnostic of CCD in all 7 (P < 0.01). Survivors required significantly less cardiopulmonary resuscitation (P < 0.01), had lower Injury Severity Scores (P < 0.01), higher Glasgow Coma Scale scores (P < 0.01), and shorter transport times (P < 0.01). Significantly more involved in motor vehicle collisions survived (P = 0.04). Nine (53%) had no disability at follow-up evaluation. Conclusions In pediatric CCD, high-velocity mechanism, cardiac arrest, high Injury Severity Score, and low Glasgow Coma Scale score are associated with mortality. If CCD is correctly managed in the absence of cardiac arrest or traumatic brain or spinal cord injury, children may survive intact.	[Hazboun, Rajaie; Munoz, Amanda; Vannix, Rosemary; Baerg, Joanne] Loma Linda Univ, Div Pediat Surg, Sch Med, Loma Linda, CA 92354 USA; [Krafft, Paul R.; Zouros, Alexander] Loma Linda Univ, Dept Pediat Neurosurg, Sch Med, Loma Linda, CA 92354 USA; [Harder, Sheri; Kim, Paggie] Loma Linda Univ, Sch Med, Dept Neuroradiol, Loma Linda, CA 92354 USA		Munoz, A (corresponding author), Loma Linda Univ, Div Pediat Surg, Childrens Hosp, Coleman Pavil 21111,11175 Campus St, Loma Linda, CA 92354 USA.	amamunoz@llu.edu	Shaheen, Ahmed/AAP-4054-2021	Shaheen, Ahmed/0000-0002-2216-1951			Astur N, 2014, J AM ACAD ORTHOP SUR, V22, P274, DOI 10.5435/JAAOS-22-05-274; Bertozzi JC, 2009, AM J ROENTGENOL, V192, P26, DOI 10.2214/AJR.08.1058; Blackwood NJ, 1908, ANN SURG, V47, P654, DOI 10.1097/00000658-190805000-00003; BULAS DI, 1993, RADIOLOGY, V188, P155, DOI 10.1148/radiology.188.1.8511290; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; HARRIS JH, 1994, AM J ROENTGENOL, V162, P881, DOI 10.2214/ajr.162.4.8141012; HARRIS JH, 1994, AM J ROENTGENOL, V162, P887, DOI 10.2214/ajr.162.4.8141013; HOSONO N, 1993, SPINE, V18, P786, DOI 10.1097/00007632-199305000-00023; Jiang SY, 2014, CRIT CARE MED, V42, pE242, DOI 10.1097/CCM.0000000000000017; Kenter K, 2001, J PEDIATR ORTHOPED, V21, P585, DOI 10.1097/00004694-200109000-00006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martinez-Lage JF, 2013, CHILD NERV SYST, V29, P187, DOI 10.1007/s00381-012-1915-5; Meoded A, 2011, AM J NEURORADIOL, V32, P1806, DOI 10.3174/ajnr.A2606; Saveika JA, 2006, AM J PHYS MED REHAB, V85, P1007, DOI 10.1097/01.phm.0000247654.44594.f1; Steinmetz MP, 2003, NEUROSURG FOCUS, V14, P1, DOI DOI 10.3171/foc.2003.14.2.11; TEASDALE G, 1974, LANCET, V2, P81; Vera M, 2007, CHILD NERV SYST, V23, P913, DOI 10.1007/s00381-007-0338-1	17	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	2021	37	10					E602	E608		10.1097/PEC.0000000000001721			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	WH4QK	WOS:000707664200015	30624426				2022-02-06	
J	Krishnamoorthy, V; Temkin, N; Barber, J; Foreman, B; Komisarow, J; Korley, FK; Laskowitz, DT; Mathew, JP; Hernandez, A; Sampson, J; James, ML; Bartz, R; Raghunathan, K; Goldstein, BA; Markowitz, AJ; Vavilala, MS				Krishnamoorthy, Vijay; Temkin, Nancy; Barber, Jason; Foreman, Brandon; Komisarow, Jordan; Korley, Fred K.; Laskowitz, Daniel T.; Mathew, Joseph P.; Hernandez, Adrian; Sampson, John; James, Michael L.; Bartz, Raquel; Raghunathan, Karthik; Goldstein, Benjamin A.; Markowitz, Amy J.; Vavilala, Monica S.		Transforming Clinical Res & Knowle	Association of Early Multiple Organ Dysfunction With Clinical and Functional Outcomes Over the Year Following Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study	CRITICAL CARE MEDICINE			English	Article						multiple organ dysfunction; outcomes; shock; trauma; traumatic brain injury	BLOOD-PRESSURE; HYPOTENSION; FAILURE; SEPSIS	OBJECTIVES: Traumatic brain injury is a leading cause of death and disability in the United States. While the impact of early multiple organ dysfunction syndrome has been studied in many critical care paradigms, the clinical impact of early multiple organ dysfunction syndrome in traumatic brain injury is poorly understood. We examined the incidence and impact of early multiple organ dysfunction syndrome on clinical, functional, and disability outcomes over the year following traumatic brain injury. DESIGN: Retrospective cohort study. SETTING: Patients enrolled in the Transforming Clinical Research and Knowledge in Traumatic Brain Injury study, an 18-center prospective cohort study of traumatic brain injury patients evaluated in participating level 1 trauma centers. SUBJECTS: Adult (age > 17 yr) patients with moderate-severe traumatic brain injury (Glasgow Coma Scale < 13). We excluded patients with major extracranial injury (Abbreviated Injury Scale score >= 3). INTERVENTIONS: Development of early multiple organ dysfunction syndrome, defined as a maximum modified Sequential Organ Failure Assessment score greater than 7 during the initial 72 hours following admission. MEASUREMENTS AND MAIN RESULTS: The main outcomes were: hospital mortality, length of stay, 6-month functional and disability domains (Glasgow Outcome Scale-Extended and Disability Rating Scale), and 1-year mortality. Secondary outcomes included: ICU length of stay, 3-month Glasgow Outcome Scale-Extended, 3-month Disability Rating Scale, 1-year Glasgow Outcome Scale-Extended, and 1-year Disability Rating Scale. We examined 373 subjects with moderate-severe traumatic brain injury. The mean (sd) Glasgow Coma Scale in the emergency department was 5.8 (3.2), with 280 subjects (75%) classified as severe traumatic brain injury (Glasgow Coma Scale 3-8). Among subjects with moderate-severe traumatic brain injury, 252 (68%) developed early multiple organ dysfunction syndrome. Subjects that developed early multiple organ dysfunction syndrome had a 75% decreased odds of a favorable outcome (Glasgow Outcome Scale-Extended 5-8) at 6 months (adjusted odds ratio, 0.25; 95% CI, 0.12-0.51) and increased disability (higher Disability Rating Scale score) at 6 months (adjusted mean difference, 2.04; 95% CI, 0.92-3.17). Subjects that developed early multiple organ dysfunction syndrome experienced an increased hospital length of stay (adjusted mean difference, 11.4 d; 95% CI, 7.1-15.8), with a nonsignificantly decreased survival to hospital discharge (odds ratio, 0.47; 95% CI, 0.18-1.2). CONCLUSIONS: Early multiple organ dysfunction following moderate-severe traumatic brain injury is common and independently impacts multiple domains (mortality, function, and disability) over the year following injury. Further research is necessary to understand underlying mechanisms, improve early recognition, and optimize management strategies.	[Krishnamoorthy, Vijay; Laskowitz, Daniel T.; Mathew, Joseph P.; James, Michael L.; Bartz, Raquel; Raghunathan, Karthik] Duke Univ, Dept Anesthesiol, Durham, NC 27708 USA; [Krishnamoorthy, Vijay; James, Michael L.; Bartz, Raquel; Raghunathan, Karthik] Duke Univ, Dept Anesthesiol, Crit Care & Perioperat Populat Hlth Res CAPER Uni, Durham, NC 27708 USA; [Krishnamoorthy, Vijay; Raghunathan, Karthik] Duke Univ, Dept Populat Hlth Sci, Durham, NC 27708 USA; [Temkin, Nancy; Barber, Jason] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Foreman, Brandon] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Komisarow, Jordan; Laskowitz, Daniel T.; Sampson, John] Duke Univ, Dept Neurosurg, Durham, NC USA; [Korley, Fred K.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Dept Neurol, Durham, NC USA; [Hernandez, Adrian] Duke Univ, Dept Med, Durham, NC USA; [James, Michael L.; Bartz, Raquel; Markowitz, Amy J.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Goldstein, Benjamin A.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA		Krishnamoorthy, V (corresponding author), Duke Univ, Dept Anesthesiol, Durham, NC 27708 USA.; Krishnamoorthy, V (corresponding author), Duke Univ, Dept Anesthesiol, Crit Care & Perioperat Populat Hlth Res CAPER Uni, Durham, NC 27708 USA.; Krishnamoorthy, V (corresponding author), Duke Univ, Dept Populat Hlth Sci, Durham, NC 27708 USA.; Markowitz, AJ (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.	vijay.krishnamoorthy@duke.edu; amymarkowitz@gmail.com		Komisarow, Jordan/0000-0003-3919-7931	National Institutes of Health (National Institute of Neurologic Disorders and Stroke)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS109274]	Supported, in part, by grant from National Institutes of Health (National Institute of Neurologic Disorders and Stroke): K23NS109274 (to Dr. Krishnamoorthy).	Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Casault C, 2019, NEUROCRIT CARE, V30, P22, DOI 10.1007/s12028-018-0522-z; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Fowler AA, 2019, JAMA-J AM MED ASSOC, V322, P1261, DOI 10.1001/jama.2019.11825; Frohlich M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0321-5; Javed A, 2017, J CRIT CARE, V42, P30, DOI 10.1016/j.jcrc.2017.06.024; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Lambden S, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2663-7; Lee S, 2019, J NEUROSURG, V131, P1931, DOI 10.3171/2018.8.JNS18676; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; McDonald SJ, 2020, J NEUROTRAUM, V37, P770, DOI 10.1089/neu.2019.6885; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Rahmatinejad Z, 2019, AM J EMERG MED, V37, P1237, DOI 10.1016/j.ajem.2018.09.011; Ramtinfar S, 2016, INDIAN J CRIT CARE M, V20, P575, DOI 10.4103/0972-5229.192042; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Schmidt B, 2009, J NEUROTRAUM, V26, P651, DOI 10.1089/neu.2008.0784; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Vasilevskis EE, 2016, CRIT CARE MED, V44, P138, DOI 10.1097/CCM.0000000000001375; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yeole U, 2020, CLIN NEUROL NEUROSUR, V196, DOI 10.1016/j.clineuro.2020.106017; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	29	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2021	49	10					1769	1778		10.1097/CCM.0000000000005055			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	US5RL	WOS:000697486100047	33935162				2022-02-06	
J	Kyyriainen, J; Kajevu, N; Banuelos, I; Lara, L; Lipponen, A; Balosso, S; Hamalainen, E; Das Gupta, S; Puhakka, N; Natunen, T; Ravizza, T; Vezzani, A; Hiltunen, M; Pitkanen, A				Kyyriainen, Jenni; Kajevu, Natallie; Banuelos, Ivette; Lara, Leonardo; Lipponen, Anssi; Balosso, Silvia; Hamalainen, Elina; Das Gupta, Shalini; Puhakka, Noora; Natunen, Teemu; Ravizza, Teresa; Vezzani, Annamaria; Hiltunen, Mikko; Pitkanen, Asla			Targeting Oxidative Stress with Antioxidant Duotherapy after Experimental Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						antioxidant treatment; cytokine; lateral fluid-percussion injury; N-acetylcysteine; oxidative stress; sulforaphane	NF-KAPPA-B; CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; RAT MODEL; GENE-EXPRESSION; ACETYLCYSTEINE; SULFORAPHANE; PROTECTS; ACTIVATION; EPILEPTOGENESIS	We assessed the effect of antioxidant therapy using the Food and Drug Administration-approved respiratory drug N-acetylcysteine (NAC) or sulforaphane (SFN) as monotherapies or duotherapy in vitro in neuron-BV2 microglial co-cultures and validated the results in a lateral fluid-percussion model of TBI in rats. As in vitro measures, we assessed neuronal viability by microtubule-associated-protein 2 immunostaining, neuroinflammation by monitoring tumor necrosis factor (TNF) levels, and neurotoxicity by measuring nitrite levels. In vitro, duotherapy with NAC and SFN reduced nitrite levels to 40% (p < 0.001) and neuroinflammation to -29% (p < 0.001) compared with untreated culture. The treatment also improved neuronal viability up to 72% of that in a positive control (p < 0.001). The effect of NAC was negligible, however, compared with SFN. In vivo, antioxidant duotherapy slightly improved performance in the beam walking test. Interestingly, duotherapy treatment decreased the plasma interleukin-6 and TNF levels in sham-operated controls (p < 0.05). After TBI, no treatment effect on HMGB1 or plasma cytokine levels was detected. Also, no treatment effects on the composite neuroscore or cortical lesion area were detected. The robust favorable effect of duotherapy on neuroprotection, neuroinflammation, and oxidative stress in neuron-BV2 microglial co-cultures translated to modest favorable in vivo effects in a severe TBI model.	[Kyyriainen, Jenni; Kajevu, Natallie; Banuelos, Ivette; Lara, Leonardo; Lipponen, Anssi; Hamalainen, Elina; Das Gupta, Shalini; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, FI-70211 Kuopio, Finland; [Lipponen, Anssi] Finnish Inst Hlth & Welf, Dept Hlth Secur, FI-70701 Kuopio, Finland; [Balosso, Silvia; Ravizza, Teresa; Vezzani, Annamaria] Mario Negri Inst Pharmacol Res IRCCS, Dept Neurosci, I-20156 Milan, Italy; [Natunen, Teemu; Hiltunen, Mikko] Univ Eastern Finland, Inst Biomed, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, FI-70211 Kuopio, Finland.	jenni.kyyriainen@uef.fi; natallie.kajevu@uef.fi; ivette.banuelos-cabrera@uef.fi; Leonardo.laravalderrabano@uef.fi; anssi.lipponen@uef.fi; silvia.balosso@marionegri.it; elina.hamalainen@uef.fi; shalini.gupta@uef.fi; noora.puhakka@uef.fi; teemu.natunen@uef.fi; teresa.ravizza@marionegri.it; annamaria.vezzani@marionegri.it; mikko.hiltunen@uef.fi; asla.pitkanen@uef.fi		Lara-Valderrabano, Leonardo/0000-0003-4617-2580; Pitkanen, Asla/0000-0002-8163-5416	FP7-HEALTH project [602102]; Sigrid Juselius FoundationSigrid Juselius Foundation; Strategic Neuroscience Funding of the University of Eastern Finland; Academy of FinlandAcademy of FinlandEuropean Commission [272249, 273909, 2285733-9, 307866]	This study was supported by the FP7-HEALTH project 602102 (EPITARGET) (A.P., A.V.), Sigrid Juselius Foundation (A.P., M.H.), Strategic Neuroscience Funding of the University of Eastern Finland and Academy of Finland (A.P.: grants 272249, 273909, and 2285733-9; M.H.: grant 307866).	Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Alshammari TK, 2020, BEHAV BRAIN RES, V377, DOI 10.1016/j.bbr.2019.112191; Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Brandenburg LO, 2010, INFLAMM RES, V59, P443, DOI 10.1007/s00011-009-0116-5; Brooke SM, 1999, NEUROSCI LETT, V267, P21, DOI 10.1016/S0304-3940(99)00315-8; Chang G, 2010, BIOL PHARM BULL, V33, P1477, DOI 10.1248/bpb.33.1477; Chao MW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32373; Checker R, 2015, J FUNCT FOODS, V19, P426, DOI 10.1016/j.jff.2015.08.030; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Clark RSB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180280; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cuadrado A, 2019, NAT REV DRUG DISCOV, V18, P295, DOI 10.1038/s41573-018-0008-x; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Eastman CL, 2020, NEUROPHARMACOLOGY, V172, DOI 10.1016/j.neuropharm.2019.107907; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gresa-Arribas N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045227; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hall ED, 2019, NEUROPHARMACOLOGY, V145, P247, DOI 10.1016/j.neuropharm.2018.08.005; He YX, 2019, NEUROREPORT, V30, P344, DOI 10.1097/WNR.0000000000001205; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Huang C, 2019, EUR J PHARMACOL, V853, P153, DOI 10.1016/j.ejphar.2019.03.010; Joseph B, 2018, J NEUROSCI RES, V96, P589, DOI 10.1002/jnr.24132; Juengst SB, 2017, EPILEPSY BEHAV, V73, P240, DOI 10.1016/j.yebeh.2017.06.001; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Krugel U, 2014, ARCH TOXICOL, V88, P853, DOI 10.1007/s00204-014-1203-0; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kyyriainen J, 2017, GLIA, V65, P322, DOI 10.1002/glia.23094; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lipponen A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215395; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markoutsa E, 2017, MOL PHARMACEUT, V14, P1591, DOI 10.1021/acs.molpharmaceut.6b01028; Martiskainen H, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0991-6; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Natunen TA, 2019, BASIC CLIN PHARMACOL, V124, P40, DOI 10.1111/bcpt.13094; Naziroglu M, 2014, CELL MOL NEUROBIOL, V34, P895, DOI 10.1007/s10571-014-0069-2; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Oka S, 2000, FEBS LETT, V472, P196, DOI 10.1016/S0014-5793(00)01464-2; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V130, P63, DOI 10.1111/j.1748-1716.1987.tb08112.x; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pauletti A, 2019, BRAIN, V142, pE38, DOI 10.1093/brain/awz128; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Pitkanen A, 2010, EPILEPSIA, V51, P2, DOI 10.1111/j.1528-1167.2010.02602.x; Porritt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041090; Qin SS, 2018, PHARMACOL RES, V133, P218, DOI 10.1016/j.phrs.2018.01.014; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Sangobowale MA, 2018, J NEUROTRAUM, V35, P907, DOI 10.1089/neu.2017.5348; Schwochow D, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-33; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Senol N, 2014, NEUROCHEM RES, V39, P685, DOI 10.1007/s11064-014-1255-9; Soane L, 2010, J NEUROSCI RES, V88, P1355, DOI 10.1002/jnr.22307; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Townsend BE, 2016, EXP GERONTOL, V73, P42, DOI 10.1016/j.exger.2015.11.004; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van Vliet EA, 2017, EPILEPSIA, V58, P2013, DOI 10.1111/epi.13915; Vomund S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122772; Wang H, 2011, J CHROMATOGR SCI, V49, P801, DOI 10.1093/chrsci/49.10.801; Webster KM, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112979; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu W, 2018, MOL MED REP, V17, P6647, DOI 10.3892/mmr.2018.8699; Wu XM, 2012, NEUROSCI BULL, V28, P509, DOI 10.1007/s12264-012-1273-z; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	89	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	OCT	2021	22	19							10555	10.3390/ijms221910555			29	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	WG5NQ	WOS:000707041800001	34638900	Green Published, gold			2022-02-06	
J	Levochkina, M; McQuillan, L; Awan, N; Barton, D; Maczuzak, J; Bianchine, C; Trombley, S; Kotes, E; Wiener, J; Wagner, A; Calcagno, J; Maza, A; Nierstedt, R; Ferimer, S; Wagner, A				Levochkina, Marina; McQuillan, Leah; Awan, Nabil; Barton, David; Maczuzak, John; Bianchine, Claudia; Trombley, Shannon; Kotes, Emma; Wiener, Joshua; Wagner, Audrey; Calcagno, Jason; Maza, Andrew; Nierstedt, Ryan; Ferimer, Stephanie; Wagner, Amy			Neutrophil-to-Lymphocyte Ratios and Infections after Traumatic Brain Injury: Associations with Hospital Resource Utilization and Long-Term Outcome	JOURNAL OF CLINICAL MEDICINE			English	Article						neutrophil-to-lymphocyte ratio; traumatic brain injury; hospital acquired infection; hospital resource utilization; inflammation; mechanical ventilation; Glasgow outcome scale	VENTILATOR-ASSOCIATED PNEUMONIA; LENGTH-OF-STAY; ORGAN DYSFUNCTION; INPATIENT REHABILITATION; ACQUIRED INFECTIONS; CARE; PROGNOSIS; MORTALITY; IMMUNE; COST	Traumatic brain injury (TBI) induces immune dysfunction that can be captured clinically by an increase in the neutrophil-to-lymphocyte ratio (NLR). However, few studies have characterized the temporal dynamics of NLR post-TBI and its relationship with hospital-acquired infections (HAI), resource utilization, or outcome. We assessed NLR and HAI over the first 21 days post-injury in adults with moderate-to-severe TBI (n = 196) using group-based trajectory (TRAJ), changepoint, and mixed-effects multivariable regression analysis to characterize temporal dynamics. We identified two groups with unique NLR profiles: a high (n = 67) versus a low (n = 129) TRAJ group. High NLR TRAJ had higher rates (76.12% vs. 55.04%, p = 0.004) and earlier time to infection (p = 0.003). In changepoint-derived day 0-5 and 6-20 epochs, low lymphocyte TRAJ, early in recovery, resulted in more frequent HAIs (p = 0.042), subsequently increasing later NLR levels (p <= 0.0001). Both high NLR TRAJ and HAIs increased hospital length of stay (LOS) and days on ventilation (p <= 0.05 all), while only high NLR TRAJ significantly increased odds of unfavorable six-month outcome as measured by the Glasgow Outcome Scale (GOS) (p = 0.046) in multivariable regression. These findings provide insight into the temporal dynamics and interrelatedness of immune factors which collectively impact susceptibility to infection and greater hospital resource utilization, as well as influence recovery.	[Levochkina, Marina; McQuillan, Leah; Awan, Nabil; Maczuzak, John; Bianchine, Claudia; Trombley, Shannon; Kotes, Emma; Wiener, Joshua; Wagner, Audrey; Calcagno, Jason; Maza, Andrew; Nierstedt, Ryan; Wagner, Amy] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Levochkina, Marina] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15213 USA; [Awan, Nabil] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15213 USA; [Barton, David] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA 15213 USA; [Ferimer, Stephanie] West Virginia Univ, Dept Orthopaed, Div Pediat Rehabil Med, Morgantown, WV 26506 USA; [Wagner, Amy] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Wagner, Amy] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15213 USA; [Wagner, Amy] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Wagner, Amy] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15213 USA		Wagner, A (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA.; Wagner, A (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA.; Wagner, A (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15213 USA.; Wagner, A (corresponding author), Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA.; Wagner, A (corresponding author), Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15213 USA.	msl66@pitt.edu; LEV23@pitt.edu; naa86@pitt.edu; bartond2@upmc.edu; JMM412@pitt.edu; CLB227@pitt.edu; tuo21498@temple.edu; erk74@pitt.edu; JMW264@pitt.edu; audreywa@buffalo.edu; jasoncalcagno12@gmail.com; andrewjmaza@pitt.edu; rnierstedt@oakland.edu; slf587@gmail.com; wagnerak@upmc.edu	Barton, David J/C-9282-2011	Barton, David J/0000-0003-0976-0383	 [NIDILRR-90DP004];  [DoDW81XWH19-2-0012];  [DoDW8 1XWH-071-0701];  [CDC-R49-CCR-323155];  [NIH R01 HD048162];  [NIH T32HL134615]	This work was supported, in part, by NIDILRR-90DP004, DoDW81XWH19-2-0012, DoDW8 1XWH-071-0701, CDC-R49-CCR-323155, NIH R01 HD048162, NIH T32HL134615.	Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Andraweera N, 2016, AUST HEALTH REV, V40, P114, DOI 10.1071/AH15062; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bassetti M, 2015, INTENS CARE MED, V41, P776, DOI 10.1007/s00134-015-3719-z; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/ERC.12.159, 10.1586/erc.12.159]; Binkowska AM, 2015, CENT EUR J IMMUNOL, V40, P206, DOI 10.5114/ceji.2015.52835; Brito A, 2019, J SURG RES, V244, P332, DOI 10.1016/j.jss.2019.06.071; Brochner AC, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-43; CHEADLE WG, 1993, J TRAUMA, V35, P844, DOI 10.1097/00005373-199312000-00007; Chen JG, 2019, NEUROCRIT CARE, V30, P334, DOI 10.1007/s12028-018-0622-9; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Dabrowski W, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56090469; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Doran SJ, 2020, CRIT CARE MED, V48, pE418, DOI 10.1097/CCM.0000000000004273; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Elzey BD, 2001, J IMMUNOL, V167, P3049, DOI 10.4049/jimmunol.167.6.3049; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Fabregas N, 2002, Minerva Anestesiol, V68, P285; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fischer R, 2015, ANTIBODIES, V4, P48, DOI 10.3390/antib4010048; Galvani AP, 2020, LANCET, V395, P524, DOI 10.1016/S0140-6736(19)33019-3; Girardot T, 2017, APOPTOSIS, V22, P295, DOI 10.1007/s10495-016-1325-3; Glance LG, 2011, ARCH SURG-CHICAGO, V146, P794, DOI 10.1001/archsurg.2011.41; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Gouel-Cheron A, 2012, CRIT CARE, V16, DOI 10.1186/cc11376; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Han S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1629-7; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Heffernan DS, 2012, CRIT CARE, V16, DOI 10.1186/cc11157; Hotchkiss RS, 2000, CRIT CARE MED, V28, P3207, DOI 10.1097/00003246-200009000-00016; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Hui X, 2013, J SURG RES, V184, P438, DOI 10.1016/j.jss.2013.05.072; Inanc Y, 2018, ANN ITAL CHIR, V89, P367; JENNETT B, 1975, LANCET, V1, P480; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; Kasmann L, 2017, LUNG, V195, P217, DOI 10.1007/s00408-017-9976-6; Kemp CD, 2008, AM SURGEON, V74, P866; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kopp MA, 2017, NEUROLOGY, V88, P892, DOI [10.1212/WNL.0000000000003652, 10.1212/wnl.0000000000003652]; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Kumar RG, 2020, J NEUROTRAUM, V37, P2198, DOI 10.1089/neu.2019.6577; Kumar RG, 2020, J TRAUMA ACUTE CARE, V88, P491, DOI 10.1097/TA.0000000000002562; Kutner M.H., 2005, APPL LINEAR STAT MOD, V5th edn; Lammermann T, 2016, J LEUKOCYTE BIOL, V100, P55, DOI 10.1189/jlb.1MR0915-403; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lowsby R, 2015, EMERG MED J, V32, P531, DOI 10.1136/emermed-2014-204071; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lv ZH, 2021, J CLIN LAB ANAL, V35, DOI 10.1002/jcla.23668; Manda-Handzlik A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121477; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Miller JM, 2018, CLIN INFECT DIS, V67, pE1, DOI 10.1093/cid/ciy381; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Penaloza HF, 2016, CYTOKINE GROWTH F R, V32, P17, DOI 10.1016/j.cytogfr.2016.07.003; R Core Team, 2015, RSTUDIO INT DEV ENV; Rakholia MV, 2019, J NEUROTRAUM, V36, P1156, DOI 10.1089/neu.2018.5782; Rebecca Killick K.H., 2016, R PACKAGE CHANGEPOIN; Reid L.D., 2020, HEALTHCARE COST UTIL; Robba C, 2020, CHEST, V158, P2292, DOI 10.1016/j.chest.2020.06.064; Robertson CM, 2006, MICROBES INFECT, V8, P1382, DOI 10.1016/j.micinf.2005.12.016; Sabouri E, 2020, WORLD NEUROSURG, V140, P142, DOI 10.1016/j.wneu.2020.04.185; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Schwab Karen A, 2015, Handb Clin Neurol, V128, P649, DOI 10.1016/B978-0-444-63521-1.00040-6; Seyit M, 2021, AM J EMERG MED, V40, P110, DOI 10.1016/j.ajem.2020.11.058; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Siwicka-Gieroba D, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091453; Sonneville R, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-15; Steeland S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051442; Strecker JK, 2017, NEUROCHEM INT, V107, P117, DOI 10.1016/j.neuint.2016.11.006; Szmydynger-Chodobska J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167677; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teh HS, 2000, J IMMUNOL, V165, P4814, DOI 10.4049/jimmunol.165.9.4814; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Valencic L., 2015, SANAMED, V10, P185, DOI [10.5937/sanamed1503185V, DOI 10.5937/SANAMED1503185V]; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; Weppner JL, 2021, PM&R, V13, P1227, DOI 10.1002/pmrj.12563; Wrathall Jonathan, 2017, EGEMS (Wash DC), V5, P4, DOI 10.13063/2327-9214.1279; Zhang Y, 2015, CLIN TRANSL ONCOL, V17, P810, DOI 10.1007/s12094-015-1310-2; Zheng J, 2017, CELL PHYSIOL BIOCHEM, V44, P967, DOI 10.1159/000485396; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	97	1	1	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	OCT	2021	10	19							4365	10.3390/jcm10194365			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WH6FS	WOS:000707771600001	34640381	Green Published, gold			2022-02-06	
J	Mangat, HS; Wu, X; Gerber, LM; Shabani, HK; Lazaro, A; Leidinger, A; Santos, MM; McClelland, PH; Schenck, H; Joackim, P; Ngerageza, JG; Schmidt, F; Stieg, PE; Hartl, R				Mangat, Halinder S.; Wu, Xian; Gerber, Linda M.; Shabani, Hamisi K.; Lazaro, Albert; Leidinger, Andreas; Santos, Maria M.; McClelland, Paul H.; Schenck, Hanna; Joackim, Pascal; Ngerageza, Japhet G.; Schmidt, Franziska; Stieg, Philip E.; Hartl, Roger			Severe traumatic brain injury management in Tanzania: analysis of a prospective cohort	JOURNAL OF NEUROSURGERY			English	Article						neurotrauma; global health; capacity building; traumatic brain injury; low-and middle-income countries	OF-HOSPITAL HYPOTENSION; EXTERNAL VALIDATION; INCOME COUNTRIES; DIRECT TRANSPORT; IMPACT MODELS; HEAD-INJURY; MORTALITY; NEUROSURGERY; PRESSURE; CARE	OBJECTIVE Given the high burden of neurotrauma in low-and middle-income countries (LMICs), in this observational study, the authors evaluated the treatment and outcomes of patients with severe traumatic brain injury (TBI) accessing care at the national neurosurgical institute in Tanzania. METHODS A neurotrauma registry was established at Muhimbili Orthopaedic Institute, Dar-es-Salaam, and patients with severe TBI admitted within 24 hours of injury were included. Detailed emergency department and subsequent medical and surgical management of patients was recorded. Two-week mortality was measured and compared with estimates of predicted mortality computed with admission clinical variables using the Corticoid Randomisation After Sig-nificant Head Injury (CRASH) core model. RESULTS In total, 462 patients (mean age 33.9 years) with severe TBI were enrolled over 4.5 years; 89% of patients were male. The mean time to arrival to the hospital after injury was 8 hours; 48.7% of patients had advanced airway management in the emergency department, 55% underwent cranial CT scanning, and 19.9% underwent surgical inter-vention. Tiered medical therapies for intracranial hypertension were used in less than 50% of patients. The observed 2-week mortality was 67%, which was 24% higher than expected based on the CRASH core model. CONCLUSIONS The 2-week mortality from severe TBI at a tertiary referral center in Tanzania was 67%, which was significantly higher than the predicted estimates. The higher mortality was related to gaps in the continuum of care of patients with severe TBI, including cardiorespiratory monitoring, resuscitation, neuroimaging, and surgical rates, along with lower rates of utilization of available medical therapies. In ongoing work, the authors are attempting to identify rea-sons associated with the gaps in care to implement programmatic improvements. Capacity building by twinning provides an avenue for acquiring data to accurately estimate local needs and direct programmatic education and interventions to reduce excess in-hospital mortality from TBI.	[Mangat, Halinder S.] Weill Cornell Brain & Spine Inst, Dept Neurol, New York, NY USA; [Mangat, Halinder S.; Leidinger, Andreas; Santos, Maria M.; McClelland, Paul H.; Schmidt, Franziska; Stieg, Philip E.; Hartl, Roger] Weill Cornell Brain & Spine Inst, Dept Neurol Surg, New York, NY USA; [Wu, Xian; Gerber, Linda M.] Weill Cornell Med, Healthcare Policy & Res, New York, NY USA; [Shabani, Hamisi K.; Lazaro, Albert; Leidinger, Andreas; Santos, Maria M.; Joackim, Pascal; Ngerageza, Japhet G.] Muhimbili Orthopaed Inst, Dept Neurol Surg, Dar Es Salaam, Tanzania; [Schenck, Hanna] Univ Maastricht, Maastricht, Netherlands		Mangat, HS (corresponding author), Weill Cornell Med, New York, NY 10021 USA.	hsm9001@med.cornell.edu		mangat, halinder/0000-0003-3426-2001	Clinical Translational Science Center, National Center for Advancing Translational Sciences [UL1-TR000457-06]	Xian Wu and Linda Gerber were partially funded by support from Clinical Translational Science Center, National Center for Advancing Translational Sciences, grant no. UL1-TR000457-06. We would like to acknowledge the Brain Trauma Foundation for providing the TBI-trac registry for this work.	[Anonymous], 2017, ATL COUNTR RES NEUR, V2nd; Bommakanti K, 2018, J SURG RES, V223, P72, DOI 10.1016/j.jss.2017.09.039; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; De Vloo P, 2018, WORLD NEUROSURG, V114, pE546, DOI 10.1016/j.wneu.2018.03.032; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Haas B, 2012, J TRAUMA ACUTE CARE, V72, P1510, DOI 10.1097/TA.0b013e318252510a; Haglund MM, 2017, NEUROSURGERY, V80, P656, DOI 10.1093/neuros/nyw159; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kabore AF, 2017, WORLD NEUROSURG, V107, P382, DOI 10.1016/j.wneu.2017.07.160; Krebs E, 2017, WORLD NEUROSURG, V102, P571, DOI 10.1016/j.wneu.2017.03.001; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; LaGrone L, 2016, B WORLD HEALTH ORGAN, V94, P585, DOI 10.2471/BLT.15.162214; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lund-Johansen M, 2017, WORLD NEUROSURG, V99, P403, DOI 10.1016/j.wneu.2016.12.051; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; Mowafi H, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001442; Nielsen K, 2012, PREHOSP EMERG CARE, V16, P381, DOI 10.3109/10903127.2012.664245; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reynolds TA, 2017, ANNU REV PUBL HEALTH, V38, P507, DOI 10.1146/annurev-publhealth-032315-021412; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; Santos MM, 2018, WORLD NEUROSURG, V113, P425, DOI 10.1016/j.wneu.2018.01.084; Schenck H, 2017, INTENS CARE MED EXP; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shackelford SA, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.9.FOCUS18404; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; St-Louis E, 2018, INJURY, V49, P2100, DOI 10.1016/j.injury.2018.10.007; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; WHO, 2017, WHO TECH REP SER, V1006, P1; WHO, 2014, INJ VIOL FACTS 2014	44	1	1	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2021	135	4					1190	1202		10.3171/2020.8.JNS201243			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WG4QS	WOS:000706981300004	33482641				2022-02-06	
J	McLean, AL; Jamjoom, AAB; Poon, MTC; Wang, DF; Phang, I; Okasha, M; Boissaud-Cooke, M; Williams, AP; Ahmed, AI				McLean, Aaron Lawson; Jamjoom, Aimun A. B.; Poon, Michael T. C.; Wang, Difei; Phang, Isaac; Okasha, Mohamed; Boissaud-Cooke, Matthew; Williams, Adam P.; Ahmed, Aminul, I		British Neurosurg Trainee Res Coll	Utility of image-guided external ventriculostomy: analysis of contemporary practice in the United Kingdom and Ireland	JOURNAL OF NEUROSURGERY			English	Article						brain injuries; traumatic; catheters; hydrocephalus; neuronavigation; neurosurgical procedures; stereotaxic techniques; ventriculostomy	CATHETER PLACEMENT; DRAIN PLACEMENT; STEREOTACTIC NAVIGATION; OMMAYA RESERVOIRS; ACCURACY; FRAMELESS; INSERTION; HYDROCEPHALUS; EFFICACY; GUIDANCE	OBJECTIVE Freehand external ventricular drain (EVD) insertion is associated with a high rate of catheter misplace-ment. Image-guided EVD placement with neuronavigation or ultrasound has been proposed as a safer, more accurate alternative with potential to facilitate proper placement and reduce catheter malfunction risk. This study aimed to deter-mine the impact of image-guided EVD placement on catheter tip position and drain functionality. METHODS This study is a secondary analysis of a data set from a prospective, multicenter study. Data were collated for EVD placements undertaken in the United Kingdom and Ireland from November 2014 to April 2015. In total, 21 large tertiary care academic medical centers were included. RESULTS Over the study period, 632 EVDs were inserted and 65.9% had tips lying free-floating in the CSF. Only 19.6% of insertions took place under image guidance. The use of image guidance did not significantly improve the position of the catheter tip on postoperative imaging, even when stratified by ventricular size. There was also no association between navigation use and drain blockage. CONCLUSIONS Image-guided EVD placement was not associated with an increased likelihood of achieving optimal catheter position or with a lower rate of catheter blockage. Educational efforts should aim to enhance surgeons' ability to apply the technique correctly in cases of disturbed cerebral anatomy or small ventricles to reduce procedural risks and facilitate effective catheter positioning.	[McLean, Aaron Lawson] Jena Univ Hosp, Dept Neurosurg, Jena, Germany; [Jamjoom, Aimun A. B.] NHS Lothian, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; [Poon, Michael T. C.] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland; [Wang, Difei] Univ Hosp Southampton NHS Fdn Trust, Southampton Gen Hosp, Wessex Neurol Ctr, Dept Neurosurg, Southampton, Hants, England; [Phang, Isaac] Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Dept Neurosurg, Preston, Lancs, England; [Okasha, Mohamed] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England; [Boissaud-Cooke, Matthew] Univ Hosp Plymouth NHS Trust, Derriford Hosp, Dept Neurosurg, Plymouth, Devon, England; [Williams, Adam P.] North Bristol NHS Trust, Southmead Hosp, Dept Neurosurg, Bristol, Avon, England; [Ahmed, Aminul, I] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, Dept Neurosurg, London, England		McLean, AL (corresponding author), Jena Univ Hosp, Jena, Germany.	aaron.lawsonmclean@med.uni-jena.de	Okasha, Mohamed/AAD-3951-2020; Poon, Michael/AAV-1914-2021	Okasha, Mohamed/0000-0002-8200-435X; Bulters, Diederik/0000-0001-9884-9050; Gray, William/0000-0001-7595-8887; Ahmed, Aminul/0000-0001-6670-0438; Mallucci, Conor/0000-0002-5509-0547			Abdoh MG, 2012, ACTA NEUROCHIR, V154, P153, DOI 10.1007/s00701-011-1136-9; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Ann JM, 2016, J KOREAN NEUROSURG S, V59, P322, DOI 10.3340/jkns.2016.59.3.322; BOGDAHN U, 1992, NEUROSURGERY, V31, P898, DOI 10.1227/00006123-199211000-00011; Chari A, 2018, ACTA NEUROCHIR, V160, P23, DOI 10.1007/s00701-017-3351-5; Cinibulak Z, 2016, ACTA NEUROCHIR, V158, P847, DOI 10.1007/s00701-016-2747-y; Eftekhar B, 2016, J NEUROSURG, V125, P754, DOI 10.3171/2015.6.JNS1588; Fried HI, 2016, NEUROCRIT CARE, V24, P61, DOI 10.1007/s12028-015-0224-8; Gray LD, 2013, ANAESTHESIA, V68, P3, DOI 10.1111/anae.12054; Greenfield JP, 2008, STEREOT FUNCT NEUROS, V86, P101, DOI 10.1159/000112431; Harrisson SE, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822d75af; Hepburn-Smith M, 2016, J NEUROSCI NURS, V48, P54, DOI 10.1097/JNN.0000000000000174; Hsieh CT, 2011, ACTA NEUROL BELG, V111, P22; Huyette DR, 2008, J NEUROSURG, V108, P88, DOI 10.3171/JNS/2008/108/01/0088; Jamjoom AAB, 2018, J NEUROL NEUROSUR PS, V89, P120, DOI 10.1136/jnnp-2017-316415; KHANNA RK, 1995, J NEUROSURG, V83, P791, DOI 10.3171/jns.1995.83.5.0791; Kim YB, 2006, J CLIN NEUROSCI, V13, P50, DOI 10.1016/j.jocn.2004.12.010; Krotz M, 2004, EUR RADIOL, V14, P227, DOI 10.1007/s00330-003-2134-y; Lemole GM, 2007, NEUROSURGERY, V61, P142, DOI 10.1227/01.neu.0000279734.22931.21; Li Y, 2019, J NEUROSURG, V131, P1599, DOI 10.3171/2018.4.JNS18124; Lollis SS, 2008, J NEUROSURG, V108, P269, DOI 10.3171/JNS/2008/108/2/0269; Mahan M, 2013, J CLIN NEUROSCI, V20, P1718, DOI 10.1016/j.jocn.2013.03.005; Manfield JH, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17148; Morgenstern PF, 2016, WORLD NEUROSURG, V93, P154, DOI 10.1016/j.wneu.2016.04.090; Morone PJ, 2017, OPER NEUROSURG, V13, P603, DOI 10.1093/ons/opx022; Muralidharan Rajanandini, 2015, Surg Neurol Int, V6, pS271, DOI 10.4103/2152-7806.157620; Nimsky C, 2017, NEUROSURG CLIN N AM, V28, P453, DOI 10.1016/j.nec.2017.05.001; O'Leary ST, 2000, J NEUROSURG, V92, P801, DOI 10.3171/jns.2000.92.5.0801; Patil V, 2015, STEREOT FUNCT NEUROS, V93, P50, DOI 10.1159/000368906; Patil V, 2013, ACTA NEUROCHIR, V155, P1773, DOI 10.1007/s00701-013-1769-y; Ruchholtz S, 1998, J TRAUMA, V45, P505, DOI 10.1097/00005373-199809000-00013; Saladino A, 2009, NEUROCRIT CARE, V10, P248, DOI 10.1007/s12028-008-9154-z; Saugel B, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1814-y; Schirmer CM, 2013, NEUROSURGERY, V73, P66, DOI 10.1227/NEU.0000000000000074; Shtaya A, 2019, J NEUROSURG, V130, P1268, DOI 10.3171/2017.11.JNS171892; Smit JM, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1989-x; Stangl AP, 1998, SURG NEUROL, V50, P77, DOI 10.1016/S0090-3019(97)00301-7; Strowitzki M, 2008, CHILD NERV SYST, V24, P65, DOI 10.1007/s00381-007-0410-x; Tai BL, 2015, J NEUROSURG, V123, P1070, DOI 10.3171/2014.12.JNS141867; Toma AK, 2009, NEUROSURGERY, V65, P1197, DOI 10.1227/01.NEU.0000356973.39913.0B; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Weiner GM, 2015, CLIN NEUROL NEUROSUR, V130, P61, DOI 10.1016/j.clineuro.2014.12.018; Whitehead WE, 2017, J NEUROSURG-PEDIATR, V19, P157, DOI 10.3171/2016.8.PEDS16229; Whitehead WE, 2013, J NEUROSURG-PEDIATR, V12, P565, DOI 10.3171/2013.9.PEDS1346; Yoon SY, 2017, J KOREAN NEUROSURG S, V60, P604, DOI 10.3340/jkns.2016.1011.004	45	1	1	1	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2021	135	4					1146	1154		10.3171/2020.8.JNS20321			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WF6SR	WOS:000706433600019	33513567				2022-02-06	
J	Miller, GF; Lyons, BH; Peterson, AB; Rice, KL; Holland, KM				Miller, Gabrielle F.; Lyons, Bridget H.; Peterson, Alexis B.; Rice, Ketra L.; Holland, Kristin M.			Reported History of Traumatic Brain Injury Among Suicide Decedents: National Violent Death Reporting System, 2003-2017	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							UNITED-STATES; OVERDOSE DEATHS; PREVALENCE; DISORDER; IDEATION; RISK; DRUG	Introduction: Traumatic brain injury is a major cause of death and disability in the U.S., and research shows that individuals who suffer traumatic brain injury have an increased risk for suicide. This study examines the characteristics of suicide decedents with a documented traumatic brain injury history using a database containing circumstantial data on suicides and examines the differ-ences in traumatic brain injury- and nontraumatic brain injury-related suicides within the general population and within individuals with a history of military service. Methods: Logistic regression models estimated AORs and 95% CIs of suicide among those with and without a previous traumatic brain injury using data from the 2003-2017 National Violent Death Reporting System (analyzed in 2020). Results: From 2003 to 2017, a total of 203,157 suicide decedents were identified, and 993 had a documented traumatic brain injury before suicide. Among those with a documented traumatic brain injury, a higher percentage were White non-Hispanic. Firearm injuries were the most com-mon method of suicide for both groups. Poisoning was more common among decedents with a pre-vious traumatic brain injury than among those without. Male individuals, those who were single, and those who served in the military were 1.4 times more likely to have a documented traumatic brain injury history before the suicide. Almost 1 in 5 suicides (18.9%) documenting traumatic brain injury occurred among individuals with a history of military service. Conclusions: Comprehensive suicide prevention approaches are imperative. Healthcare providers can play a role in assessing and identifying patients at increased risk of suicide, including those who have experienced falls or injuries that often result in traumatic brain injury, and provide tailored interventions or referrals. Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.	[Miller, Gabrielle F.; Peterson, Alexis B.; Rice, Ketra L.] Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway North East,Mailstop S106-08, Atlanta, GA 30341 USA; [Lyons, Bridget H.; Holland, Kristin M.] Ctr Dis Control & Prevent, Div Violence Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA		Miller, GF (corresponding author), Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway North East,Mailstop S106-08, Atlanta, GA 30341 USA.	ygm3@cdc.gov		Lyons, Bridget/0000-0003-1152-9439; Rice, Ketra/0000-0003-2921-4507	Intramural CDC HHS [CC999999] Funding Source: Medline		Adams RS, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6451; Agimi Y, 2019, MIL MED, V184, pE233, DOI 10.1093/milmed/usy313; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J CLIN PSYCHOL MED S, V18, P116, DOI 10.1007/s10880-011-9240-9; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Corrigan JD, 2019, ADDICT BEHAV, V90, P143, DOI 10.1016/j.addbeh.2018.10.030; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Greer N, 2020, J HEAD TRAUMA REHAB, V35, P1, DOI 10.1097/HTR.0000000000000478; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Perl DP, 2016, MILITARY TBI IS IT S; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Scholl L, 2019, MMWR-MORBID MORTAL W, V67, P1419; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Stone DM, 2017, PREVENTING SUICIDE T; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Traumatic Brain Injury Center of Excellence, TBI MIL	27	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	OCT	2021	61	4					501	508		10.1016/j.amepre.2021.04.034			8	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	WC6RP	WOS:000704383600015	34266711				2022-02-06	
J	Ramsey, KA; Vaughan, C; Wagner, BM; McGuire, JF; Gioia, GA				Ramsey, Kesley A.; Vaughan, Christopher; Wagner, Barry M.; McGuire, Joseph F.; Gioia, Gerard A.			Impact of Self-Efficacy and Affective Functioning on Pediatric Concussion Symptom Severity	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Children; Adolescents; Pediatric; mTBI; Self-confidence; Depression	TRAUMATIC BRAIN-INJURY; REVISED CHILD ANXIETY; DEPRESSION SCALE; INTERVENTION; MANAGEMENT	Objective: The purpose of this study was to examine whether self-efficacy predicted pediatric concussion symptom severity and explore whether affective mood states (e.g., depression) influenced this relationship. Method: Children (8-17 years) who were diagnosed with a concussion within 30 days of injury participated in the study (n = 105). Following a clinical assessment, participants and caregivers completed questionnaires that assessed overall concussion symptom severity and current depression symptoms. Participants also completed ratings capturing self-efficacy for managing concussion recovery. Results: Linear regression models revealed that greater levels of self-efficacy predicted lower parent- (R-2 = 0.10, p = .001) and youth-rated (R-2 = 0.23, p < .001) concussion symptom severity. Interestingly, depression symptoms moderated the relationship between self-efficacy and concussion symptom severity. Conclusions: Findings provide initial support for a relationship between self-efficacy and concussion outcomes and highlight the influence of depressive symptoms. Interventions that optimize youth's self-efficacy have the potential to increase treatment adherence, reduce concussion symptom severity, and improve recovery prognosis.	[Ramsey, Kesley A.; McGuire, Joseph F.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Child & Adolescent Psychiat, Baltimore, MD 21205 USA; [Vaughan, Christopher; Gioia, Gerard A.] Childrens Natl Hosp, Div Neuropsychol, Safe Concuss Outcome Recovery & Educ Score Progra, Rockville, MD USA; [Wagner, Barry M.] Catholic Univ Amer, Dept Psychol, Washington, DC 20064 USA		Ramsey, KA (corresponding author), Johns Hopkins Univ, Dept Psychiat & Behav Sci, 550 North Broadway,Suite 206, Baltimore, MD 21205 USA.	kramsey7@jhmi.edu		Ramsey, Kesley/0000-0002-3512-0913; McGuire, Joseph/0000-0002-6128-8138			[Anonymous], 2015, C TRAUM BRAIN INJ US; Armbrust W, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0125-1; Bandura A., 1997, SELF EFFICACY EXERCI; Belanger HG, 2015, MIL MED, V180, P192, DOI 10.7205/MILMED-D-14-00388; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chorpita BF, 2005, BEHAV RES THER, V43, P309, DOI 10.1016/j.brat.2004.02.004; DeMatteo CA, 2021, CLIN J SPORT MED, V31, pE406, DOI 10.1097/JSM.0000000000000800; Durish CL, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000343; Ebesutani C, 2010, J ABNORM CHILD PSYCH, V38, P249, DOI 10.1007/s10802-009-9363-8; Gioia GA., 2019, POSTCONCUSSION SYMPT; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Gornall A, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6235; Ho RA, 2020, BRAIN INJURY, V34, P520, DOI 10.1080/02699052.2020.1725841; Hwang V, 2014, J TRAUMA ACUTE CARE, V77, P117, DOI 10.1097/TA.0000000000000275; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maddux J.E., 2016, WILEY HDB POSITIVE C, P89, DOI [10.1002/9781118468197.ch7, DOI 10.1002/9781118468197.CH7]; Marks R, 2005, HEALTH PROMOT PRACT, V6, P148, DOI 10.1177/1524839904266792; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Scheenen ME, 2017, SOC SCI MED, V181, P184, DOI 10.1016/j.socscimed.2017.03.025; Schwarzer R, 2014, SELF EFFICACY THOUGH, P177; Steele MM, 2011, HEALTH EDUC BEHAV, V38, P596, DOI 10.1177/1090198110387514; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Zebracki K, 2004, CHILD HEALTH CARE, V33, P133, DOI 10.1207/s15326888chc3302_4; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	31	1	1	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2021	27	9					875	882	PII S1355617720001320	10.1017/S1355617720001320			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	XB3UP	WOS:000721257400005	33441215				2022-02-06	
J	Ru, DW; Yan, YF; Li, B; Shen, X; Tang, R; Wang, ES				Ru, Dewen; Yan, Yufeng; Li, Bing; Shen, Xiao; Tang, Ri; Wang, Ersong			BNP and NT-proBNP Concentrations in Paired cerebrospinal Fluid and Plasma Samples of Patients with Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Brain natriuretic peptide; Traumatic brain injury; Cerebrospinal fluid; Hyponatremia	NATRIURETIC-PEPTIDE; B-TYPE; CEREBRAL EDEMA; HYPONATREMIA; EXPRESSION; BARRIER; SYSTEM; IMPACT	Background: The aim of this study was to investigate the secretion pattems of brain natriuretic peptide (BNP) and N-terminal-proBNP (NT-proBNP) after traumatic brain injury (TBI) and to analyze the source of them in cerebrospinal fluid (CSF). Materials and methods: We synchronously measured BNP and NT-proBNP concentrations in paired CSF and plasma samples from 22 moderate to severe TBI patients and 40 healthy control patients. The CSF and/or plasma ratio of albumin (Q(Albumin)) was calculated daily. The BNP and NT-proBNP levels of CSF and plasma were compared between TBI patients and control patients. Results: CSF BNP and NT-proBNP levels peaked on day 3 after injury, as did the plasma BNP and NT-proBNP levels. The CSF BNP and NT-proBNP levels in TBI patients were elevated from day 1, which was significantly higher than control group (P < 0.05 and P < 0.01, respectively). However, in plasma, only NT-proBNP levels were significantly higher than in the control group from day 2 (P < 0.05). In addition, Q(BNP), defined as CSF BNP concentration and/or plasma BNP concentration, was significantly higher in TBI patients than in the control group (P < 0.01). However, Q(Albumin) remained within ranges of a mild to moderate dysfunction of blood-brain-barrier in TBI patients. Conclusions: CSF BNP concentrations are elevated and peak on day 3 after moderate to severe TBI. CSF BNP may originate from the brain and may be a potential biomarker of TBI. (C) 2021 Elsevier Inc. All rights reserved.	[Ru, Dewen; Yan, Yufeng; Shen, Xiao; Tang, Ri; Wang, Ersong] Fudan Univ, Jinshan Hosp, Dept Neurosurg, 1508 Longhang Rd, Shanghai 201508, Peoples R China; [Li, Bing] Fudan Univ, Jinshan Hosp, Clin Med Res Ctr, Shanghai, Peoples R China		Wang, ES (corresponding author), Fudan Univ, Jinshan Hosp, Dept Neurosurg, 1508 Longhang Rd, Shanghai 201508, Peoples R China.	wersong@sina.com			Shanghai Municipal Commis-sion of Health and Family Planning [20124339]; Shanghai Jin-shan District Commission of Health and Family Planning and Jinshan hospital of Fudan University [JSKJKTQN201814]	This study was funded by the Shanghai Municipal Commis-sion of Health and Family Planning (20124339) ; Shanghai Jin-shan District Commission of Health and Family Planning and Jinshan hospital of Fudan University (JSKJKTQN201814) .	Bu DW, 2013, PROTEIN EXPRES PURIF, V92, P203, DOI 10.1016/j.pep.2013.10.002; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Espiner EA, 2002, CLIN ENDOCRINOL, V56, P629, DOI 10.1046/j.1365-2265.2002.01285.x; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Fukui S, 2004, J CLIN NEUROSCI, V11, P507, DOI 10.1016/S0967-5868(03)00111-5; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Galton C, 2011, NEUROCRIT CARE, V14, P354, DOI 10.1007/s12028-011-9525-8; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hunt PJ, 1997, CLIN ENDOCRINOL, V47, P287, DOI 10.1046/j.1365-2265.1997.2361058.x; Hunt PJ, 1997, PEPTIDES, V18, P1475, DOI 10.1016/S0196-9781(97)00245-3; Hwang JJ, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0271-4; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; James ML, 2010, J NEUROTRAUM, V27, P217, DOI 10.1089/neu.2009.1022; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Lu DC, 2008, SURG NEUROL, V69, P226, DOI 10.1016/j.surneu.2007.02.051; McGirt MJ, 2004, NEUROSURGERY, V54, P1369, DOI 10.1227/01.NEU.0000125016.37332.50; McLean AS, 2003, CRIT CARE MED, V31, P2611, DOI 10.1097/01.CCM.0000094225.18237.20; Meng XF, 2016, J NEUROSURG ANESTH, V28, P21, DOI 10.1097/ANA.0000000000000192; Morley EJ, 2008, ANN EMERG MED, V52, P298, DOI 10.1016/j.annemergmed.2007.10.013; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Powner DJ, 2007, NEUROCRIT CARE, V7, P119, DOI 10.1007/s12028-007-0079-8; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; Rubattu S, 2008, AM J HYPERTENS, V21, P733, DOI 10.1038/ajh.2008.174; Ryu JH, 2013, NEUROCRIT CARE, V19, P222, DOI 10.1007/s12028-013-9824-3; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; SUDOH T, 1988, BIOCHEM BIOPH RES CO, V155, P726, DOI 10.1016/S0006-291X(88)80555-2; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; TAKAHASHI K, 1992, PEPTIDES, V13, P121, DOI 10.1016/0196-9781(92)90149-W; TAKAHASHI T, 1992, CIRC RES, V71, P9, DOI 10.1161/01.RES.71.1.9; TOGASHI K, 1991, CLIN CHIM ACTA, V201, P193, DOI 10.1016/0009-8981(91)90370-R; Tomida M, 1998, STROKE, V29, P1584, DOI 10.1161/01.STR.29.8.1584; Wiedemann K, 2000, EXP CLIN ENDOCR DIAB, V108, P5; Wu X, 2011, J TRAUMA, V71, P820, DOI 10.1097/TA.0b013e3182277b69; Zhang Y, 2017, AM J EMERG MED, V35, P1695, DOI 10.1016/j.ajem.2017.05.051	39	1	1	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2021	266						353	360		10.1016/j.jss.2021.04.018			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TT3VU	WOS:000680279900044	34087618				2022-02-06	
J	Wettervik, TSM; Engquist, H; Lenell, S; Howells, T; Hillered, L; Rostami, E; Lewen, A; Enblad, P				Svedung Wettervik, Teodor M.; Engquist, Henrik; Lenell, Samuel; Howells, Timothy; Hillered, Lars; Rostami, Elham; Lewen, Anders; Enblad, Per			Systemic Hyperthermia in Traumatic Brain Injury-Relation to Intracranial Pressure Dynamics, Cerebral Energy Metabolism, and Clinical Outcome	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral microdialysis; clinical outcome; energy metabolism; hyperthermia; neurointensive care; traumatic brain injury	HEAD-INJURY; NEUROINTENSIVE CARE; SECONDARY INSULTS; FEVER CONTROL; TEMPERATURE; REACTIVITY; MICRODIALYSIS; NORMOTHERMIA; PYREXIA; BURDEN	Background: Systemic hyperthermia is common after traumatic brain injury (TBI) and may induce secondary brain injury, although the pathophysiology is not fully understood. In this study, our aim was to determine the incidence and temporal course of hyperthermia after TBI and its relation to intracranial pressure dynamics, cerebral metabolism, and clinical outcomes. Materials and Methods: This retrospective study included 115 TBI patients. Data from systemic physiology (body temperature, blood pressure, and arterial glucose), intracranial pressure dynamics (intracranial pressure, cerebral perfusion pressure, compliance, and pressure reactivity), and cerebral microdialysis (glucose, pyruvate, lactate, glycerol, glutamate, and urea) were analyzed during the first 10 days after injury. Results: Overall, 6% of patients did not have hyperthermia (T>38 degrees C) during the first 10 days after injury, whereas 20% had hyperthermia for >50% of the time. Hyperthermia increased from 21% (+/- 27%) of monitoring time on day 1 to 36% (+/- 29%) on days 6 to 10 after injury. In univariate analyses, higher body temperature was not associated with higher intracranial pressure nor lower cerebral perfusion pressure, but was associated with lower cerebral glucose concentration (P=0.001) and higher percentage of lactate-pyruvate ratio>25 (P=0.02) on days 6 to 10 after injury. Higher body temperature and lower arterial glucose concentration were associated with lower cerebral glucose in a multiple linear regression analysis (P=0.02 for both). There was no association between hyperthermia and worse clinical outcomes. Conclusion: Hyperthermia was most common between days 6 and 10 following TBI, and associated with disturbances in cerebral energy metabolism but not worse clinical outcome.	[Svedung Wettervik, Teodor M.; Lenell, Samuel; Howells, Timothy; Hillered, Lars; Rostami, Elham; Lewen, Anders; Enblad, Per] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden; [Engquist, Henrik] Uppsala Univ, Dept Surg Sci Anesthesia & Intens Care, Uppsala, Sweden		Wettervik, TSM (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se		Lenell, Samuel/0000-0001-8914-5086	Department of Neuroscience, Uppsala University; Uppsala University Hospital (ALF grant, ie, Swedish Research Council funding for Clinical Research in Medicine)	Supported by the Department of Neuroscience, Uppsala University and the Uppsala University Hospital (ALF grant, ie, Swedish Research Council funding for Clinical Research in Medicine).	Ahlsson Fredrik, 2004, Pediatr Crit Care Med, V5, P89, DOI 10.1097/01.PCC.0000102396.02043.22; Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Alyagari V, 2007, J NEUROL SCI, V261, P39, DOI 10.1016/j.jns.2007.04.030; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Bohman LE, 2014, CURR OPIN CRIT CARE, V20, P182, DOI 10.1097/MCC.0000000000000070; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chmayssani M, 2015, NEUROCRIT CARE, V22, P265, DOI 10.1007/s12028-014-0076-7; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Diringer MN, 2011, TRANSL STROKE RES, V2, P517, DOI 10.1007/s12975-011-0119-8; Dyhrfort P, 2019, J NEUROTRAUM, V36, P2872, DOI 10.1089/neu.2018.6320; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Elf K, 2008, NEUROL RES, V30, P1097, DOI 10.1179/174313208X319125; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Hocker SE, 2013, JAMA NEUROL, V70, P1499, DOI 10.1001/jamaneurol.2013.4354; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Nyholm L, 2017, UPSALA J MED SCI, V122, P177, DOI 10.1080/03009734.2017.1319440; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rincon F, 2014, J NEUROSURG, V121, P950, DOI 10.3171/2014.7.JNS132470; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Salci Kontsantin, 2006, J Clin Monit Comput, V20, P25, DOI 10.1007/s10877-006-2864-x; Spiotta AM, 2008, NEUROSURGERY, V62, P864, DOI 10.1227/01.neu.0000316900.63124.ce; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Wang CX, 2009, INT J STROKE, V4, P274, DOI 10.1111/j.1747-4949.2009.00317.x; Wettervik TS, 2019, NEUROCRIT CARE, V31, P526, DOI 10.1007/s12028-019-00743-2; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	40	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2021	33	4					329	336		10.1097/ANA.0000000000000695			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	UR2BP	WOS:000696559100008	32433101				2022-02-06	
J	Vedin, T; Karlsson, M; Edelhamre, M; Bergenheim, M; Larsson, PA				Vedin, Tomas; Karlsson, Mathias; Edelhamre, Marcus; Bergenheim, Mikael; Larsson, Per-Anders			Features of urine S100B and its ability to rule out intracranial hemorrhage in patients with head trauma: a prospective trial	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Blood specimen collection; Urine specimen collection; Traumatic brain injuries; S100 calcium-binding protein beta subunit	BRAIN-INJURY; SERUM; PROTEIN; MILD; MORTALITY; UTILITY; S-100B; PH	Purpose Traumatic brain injury causes morbidity and mortality worldwide. S100B is the most documented emergency brain biomarker and its urine-assay might be advantageous because of easier sampling. The primary aim was to evaluate urine S100B's ability to rule out intracranial hemorrhage. Secondary aims included S100B temporal pattern for 48 h post-trauma and chemical properties of urine that affect urine S100B. Methods Patients with head trauma were sampled for serum and urine S100B. Patients who were admitted for intracranial hemorrhage were sampled for 48 h to assess S100B-level, renal function, urine-pH, etc. Results The negative predictive value of serum S100B was 97.0% [95% confidence interval (CI) 89.5-99.2%] and that of urine S100B was 89.1% (95% CI 85.5-91.9%). The specificity of serum S100B was 34.4% (95% CI 27.7-41.6%) and that of urine was 67.1% (95% CI 59.4-74.1%). Urine-pH correlated strongly with urine S100B during the first 6-h post-trauma. Trend-analysis of receiver operator characteristics of S100B in serum, urine the arithmetic difference between serum and urine S100B showed the largest area under the curve for arithmetic difference, which had a negative predictive value of 93.1% (95% CI 89.1-95.8%) and a specificity of 71.8% (95% CI 64.4-78.4%). Conclusion This study cannot support ruling out intracranial hemorrhage with urine S100B. Urine-pH might affect urine S100B and merits further studies. Serum and urine S100B have poor concordance and interchangeability. The arithmetic difference had a slightly better area under the curve and can be worth exploring in certain subgroups.	[Vedin, Tomas; Edelhamre, Marcus; Larsson, Per-Anders] Lund Univ, Dept Clin Sci, Svartbrodragranden 3-5, S-25187 Helsingborg, Sweden; [Karlsson, Mathias] Cent Sjukhuset, Dept Clin Chem, Karlstad, Sweden; [Karlsson, Mathias] Cent Sjukhuset, Ctr Clin Res, Karlstad, Sweden; [Bergenheim, Mikael] Karlstad Cent Hosp, Rosenborgsgatan 9, S-65230 Karlstad, Sweden		Vedin, T (corresponding author), Lund Univ, Dept Clin Sci, Svartbrodragranden 3-5, S-25187 Helsingborg, Sweden.	tvedin@gmail.com; mathias.karlsson@liv.se; marcus_e@telia.com; mikael.bergenheim@liv.se; p-a.larsson@telia.com		Vedin, Tomas/0000-0003-1913-7958			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; Anczykowski G, 2011, EJIFCC, V22, P66; Beaudeux JL, 2000, CLIN CHEM, V46, P989; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Hallen M, 2008, CLIN CHEM LAB MED, V46, P1025, DOI 10.1515/CCLM.2008.190; Hallen M, 2010, J TRAUMA, V69, P284, DOI 10.1097/TA.0b013e3181ca060b; Kamel KS, 2002, KIDNEY INT, V61, P988, DOI 10.1046/j.1523-1755.2002.00197.x; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; LTD R., 2014, EL S100 ASS PROM MAR; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Reagan WJ, 2007, VET CLIN PATH, V36, P73, DOI 10.1111/j.1939-165X.2007.tb00185.x; Risso FM, 2013, ACTA PAEDIATR, V102, pE467, DOI 10.1111/apa.12343; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2005, BRIT J NEUROSURG, V19, P43, DOI 10.1080/02688690500089381; Unden J, 2007, NEUROCRIT CARE, V6, P94, DOI 10.1007/s12028-007-0005-0; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Wolf H, 2015, J NEUROTRAUM, V32, P23, DOI 10.1089/neu.2013.3202; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	24	1	1	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2021	47	5			SI		1467	1475		10.1007/s00068-019-01201-6			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UW8UR	WOS:000700428900026	31388712	Green Published, hybrid			2022-02-06	
J	Wright, DK; Symons, GF; O'Brien, WT; McDonald, SJ; Zamani, A; Major, B; Chen, ZB; Costello, D; Brady, RD; Sun, MJ; Law, M; O'Brien, TJ; Mychasiuk, R; Shultz, SR				Wright, David K.; Symons, Georgia F.; O'Brien, William T.; McDonald, Stuart J.; Zamani, Akram; Major, Brendan; Chen, Zhibin; Costello, Daniel; Brady, Rhys D.; Sun, Mujun; Law, Meng; O'Brien, Terence J.; Mychasiuk, Richelle; Shultz, Sandy R.			Diffusion Imaging Reveals Sex Differences in the White Matter Following Sports-Related Concussion	CEREBRAL CORTEX			English	Article						biomarker; diffusion tensor imaging; fixel-based analysis; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; APPARENT FIBER DENSITY; HEAD IMPACTS; ABNORMALITIES; LOCALIZATION; RECOVERY; GENDER; RISK	Sports-related concussion (SRC) is a serious health concern. However, the temporal profile of neuropathophysiological changes after SRC and how these relate to biological sex are still poorly understood. This preliminary study investigated whether diffusion-weighted magnetic resonance imaging (dMRI) was sensitive to neuropathophysiological changes following SRC; whether these changes were sex-specific; and whether they persisted beyond the resolution of self-reported symptoms. Recently concussed athletes (n=14), and age- and education-matched nonconcussed control athletes (n=16), underwent MRI 24-48-h postinjury and again at 2-week postinjury (i.e., when cleared to return-to-play). Male athletes reported more symptoms and greater symptom severity compared with females. dMRI revealed white matter differences between athletes with SRC and their nonconcussed counterparts at 48-h postinjury. These differences were still present at 2-week postinjury, despite SRC athletes being cleared to return to play and may indicate increased cerebral vulnerability beyond the resolution of subjective symptoms. Furthermore, we identified sex-specific differences, with male SRC athletes having significantly greater white matter disruption compared with female SRC athletes. These results have important implications for the management of concussion, including guiding return-to-play decisions, and further improve our understanding regarding the role of sex in SRC outcomes.	[Wright, David K.; Symons, Georgia F.; O'Brien, William T.; McDonald, Stuart J.; Zamani, Akram; Major, Brendan; Chen, Zhibin; Brady, Rhys D.; Sun, Mujun; Law, Meng; O'Brien, Terence J.; Mychasiuk, Richelle; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia; [McDonald, Stuart J.] La Trobe Univ, Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia; [Chen, Zhibin; Costello, Daniel; Brady, Rhys D.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3010, Australia; [Chen, Zhibin] Monash Univ, Sch Publ Hlth & Prevent Med, Clin Epidemiol, Melbourne, Vic 3004, Australia; [Law, Meng] Monash Univ, Dept Elect & Comp Syst Engn, Clayton, Vic 3800, Australia; [Law, Meng] Univ Southern Calif, Dept Neurol Surg & Biomed Engn, Los Angeles, CA 90033 USA		Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia.; Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/L-8102-2013	McDonald, Stuart/0000-0001-5190-3179; O'Brien, Terence/0000-0002-7198-8621	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1174040, 1173565, 1141643, 1159645]	National Health and Medical Research Council (1174040 to D.K.W., 1173565 to R.M., and 1141643 and 1159645 to S.R.S.).	Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bastiani M, 2019, NEUROIMAGE, V184, P801, DOI 10.1016/j.neuroimage.2018.09.073; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gajamange S, 2018, NEUROIMAGE-CLIN, V17, P60, DOI 10.1016/j.nicl.2017.09.027; Giza CC, 2017, NEURON, V94, P1051, DOI 10.1016/j.neuron.2017.05.003; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Mayer C, 2010, P NATL ACAD SCI USA, V107, P22693, DOI 10.1073/pnas.1012406108; McDonald SJ, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-020-00256-7; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mito R, 2018, BRAIN, V141, P888, DOI 10.1093/brain/awx355; Povlishock JT, 2013, J NEUROTRAUM, V30, P1, DOI 10.1089/neu.2013.9942; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; Raffelt DA, 2015, NEUROIMAGE, V117, P40, DOI 10.1016/j.neuroimage.2015.05.039; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wright DK, 2021, J NEUROTRAUM, V38, P983, DOI 10.1089/neu.2019.6886; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730	36	1	1	6	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	OCT	2021	31	10					4411	4419		10.1093/cercor/bhab095			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UQ1BX	WOS:000695807700001	33860291				2022-02-06	
J	Xu, AL; Suresh, KV; Lee, RJ				Xu, Amy L.; Suresh, Krishna V.; Lee, R. Jay			Progress in Cheerleading Safety: Update on the Epidemiology of Cheerleading Injuries Presenting to US Emergency Departments, 2010-2019	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						cheerleading; closed head injury; concussion; emergency department; hospital admission	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; UNITED-STATES; TRENDS	Background: Although the athleticism required of cheerleaders has increased, the risks of cheerleading have been less studied as compared with other sports. Purpose: To update our understanding of the epidemiology of cheerleading-related injuries. Study Design: Descriptive epidemiology study. Methods: We analyzed the National Electronic Injury Surveillance System (NEISS) for cheerleading-related injuries presenting to nationally representative emergency departments (EDs) in the United States from January 2010 through December 2019. Extracted data included patient age and sex, injury characteristics (diagnosis, body region injured, time of year, and location where injury occurred), and hospital disposition. Using patient narratives, we recorded the cheerleading skills, settings, and mechanisms that led to injury. NEISS sample weights were used to derive national estimates (NEs) from actual case numbers. Results: From 2010 to 2019, a total of 9868 athletes (NE = 350,000; 95% CI, 250,000-450,000) aged 5-25 years presented to US EDs for cheerleading injuries. The annual number of injuries decreased by 15%, from 982 (NE = 35,000; 95% CI, 27,000-44,000) to 897 (NE = 30,000; 95% CI, 18,000-42,000) (P = .048), corresponding to a 27% decline in the injury rate per 100,000 cheerleaders (P < .01). The annual number of injuries caused by performing stunts decreased by 24%, from 240 (NE = 8700; 95% CI, 6700-11,000) to 216 (NE = 6600; 95% CI, 4000-9200) (P = .01), with a 36% decline in the corresponding injury rate per 100,000 cheerleaders (P < .01). Despite these decreases, annual incidence of concussions/closed head injuries increased by 44%, from 128 (NE = 3800; 95% CI, 2900-4700) to 171 (NE = 5500; 95% CI, 3400-7700) (P = .02), and patients requiring hospital admission increased by 118%, from 18 (NE = 330; 95% CI, 250-410) to 24 (NE = 720; 95% CI, 440-1000) (P < .01). The hospital admission rate increased by 9.0% (P = .02). Conclusion: The number of cheerleading-related injuries presenting to US EDs decreased from 2010 to 2019. However, the incidence of concussions/closed head injuries and hospital admissions increased, suggesting that further measures are needed to improve safety for cheerleaders.	[Xu, Amy L.; Suresh, Krishna V.; Lee, R. Jay] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Xu, Amy L.; Suresh, Krishna V.; Lee, R. Jay] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD USA		Lee, RJ (corresponding author), Johns Hopkins Univ, Dept Orthopaed Surg, 601 North Caroline St, Baltimore, MD 21287 USA.	editorialservices@jhmi.edu					American Association of Cheerleading Coaches and Administrators, 2018 2019 AACCA SCH; Amoo-Achampong K, 2017, PHYSICIAN SPORTSMED, V45, P239, DOI 10.1080/00913847.2017.1327304; Bagnulo Angela, 2012, J Can Chiropr Assoc, V56, P292; Boden Barry P, 2005, Curr Sports Med Rep, V4, P45; Boden BP, 2005, J AM ACAD ORTHOP SUR, V13, P445, DOI 10.5435/00124635-200511000-00004; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Buzzacott P, 2018, PUBLIC HEALTH, V155, P62, DOI 10.1016/j.puhe.2017.11.011; Currie DW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2447; Greenspan RE., SO WHY ISNT IT OFFIC; Homme JL, 2018, EMERG MED CLIN N AM, V36, P287, DOI 10.1016/j.emc.2017.12.015; Jacobson NA, 2012, J TRAUMA ACUTE CARE, V72, P521, DOI 10.1097/TA.0b013e31823f5fe3; Jones S, 2019, SPORTS MED, V49, P1901, DOI 10.1007/s40279-019-01182-x; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kilic O, 2017, EUR J SPORT SCI, V17, P765, DOI 10.1080/17461391.2017.1306114; LaBella CR, 2012, PEDIATRICS, V130, P966, DOI 10.1542/peds.2012-2480; Lemme NJ, 2018, PHYSICIAN SPORTSMED, V46, P503, DOI 10.1080/00913847.2018.1516478; Luckstead EF, 2002, PEDIATR CLIN N AM, V49, P581, DOI 10.1016/S0031-3955(02)00006-8; McCarthy MM, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119861812; Mueller FO, 2001, J ATHL TRAINING, V36, P312; Mueller FO., CATASTROPHIC SPORTS; Mueller FO, 2009, J ATHL TRAINING, V44, P565, DOI 10.4085/1062-6050-44.6.565; Naiyer N, 2017, CLIN PEDIATR, V56, P985, DOI 10.1177/0009922817702938; National Electronic Injury Surveillance System (NEISS) Online, EXPL NEISS EST OBT C; National Governing Body for Sport Cheering in the United States, US CHEERS POS PAP CH; Outdoor Foundation, 2019 OUTD PART REP; Pfirrmann D, 2016, J ATHL TRAINING, V51, P410, DOI 10.4085/1062-6050-51.6.03; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Schroeder T., NEISS SAMPLE DESIGN; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Sherman E., WHY DONT MORE PEOPLE; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Shields BJ, 2011, AM J EMERG MED, V29, P1003, DOI 10.1016/j.ajem.2010.05.014; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Shields BJ, 2009, J ATHL TRAINING, V44, P567, DOI 10.4085/1062-6050-44.6.567; Smith M., CHEERLEADING HAS CHA; Sports Fitness Industry Association, CHEERL PART REP 2020; Stracciolini A, 2015, CLIN J SPORT MED, V25, P30, DOI 10.1097/JSM.0000000000000105; Swain TA, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116671703; Tsushima WT, 2018, APPL NEUROPSYCH-CHIL, V7, P14, DOI 10.1080/21622965.2016.1220860; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; U.S. All Star Federation, USASF GLOSS 2015 16; U.S. All Star Federation, 2020 2021 USASF CHEE; Wells Elizabeth K, 2015, Int J Exerc Sci, V8, P256; Yau RK, 2019, SPORTS HEALTH, V11, P32, DOI 10.1177/1941738118807122; Young B., MORE MALE STUDENTS S; Young TE, 2016, J CHIROPR MED, V15, P204, DOI 10.1016/j.jcm.2016.04.002; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	50	1	1	3	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	OCT	2021	9	10							23259671211038895	10.1177/23259671211038895			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	WJ9LR	WOS:000709358500001	34676270	Green Published, gold			2022-02-06	
J	Xue, JQ; Zhang, Y; Zhang, JH; Zhu, ZJ; Lv, Q; Su, JH				Xue, Jianqin; Zhang, Yu; Zhang, Junhua; Zhu, Zhujun; Lv, Qi; Su, Jianhua			Astrocyte-derived CCL7 promotes microglia-mediated inflammation following traumatic brain injury	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Traumatic brain injury; CCL7; Inflammation; Microglia; Astrocytes	CONTRIBUTES; INHIBITION; EXPRESSION; RATS	Microglia are immune cells of the central nervous system that mediate neuroinflammation. It is widely known that microglia-mediated inflammation in the brain contribute to the widespread tissue damage and neurological deficits in traumatic brain injury (TBI). However, the mechanisms responsible for this inflammatory response remain elusive. Here, we investigated the role of astrocyte-derived chemokine (C-C motif) ligand 7 (CCL7) in microglial-controlled inflammation following TBI. Our results demonstrated that astrocyte-derived CCL7 induced microglial activation and the release of proinflammatory mediators in the cortex and serum of rats that underwent experimental TBI. Furthermore, CCL7 knockout improved microglia-controlled inflammation, brain morphology and neurological dysfunction following TBI. In vitro, CCL7-siRNA attenuated the LPS-induced expression of pro-inflammatory markers in the co-culture of microglia and astrocytes. Collectively, our findings uncover an important role for astrocyte-derived CCL7 in promoting microglia-mediated inflammation after TBI and suggests CCL7 could serve as a potential therapeutic strategy for attenuating TBI by inhibiting microglial activation.	[Xue, Jianqin; Zhang, Yu; Zhu, Zhujun; Lv, Qi] Jiangsu Univ, Jintan Hosp, Dept Rehabil Med, Changzhou 213200, Jiangsu, Peoples R China; [Zhang, Junhua; Su, Jianhua] Jiangsu Univ, Jintan Hosp, Neurol Dept, Changzhou 213200, Jiangsu, Peoples R China		Su, JH (corresponding author), 500 Jintan Ave, Changzhou 213200, Jiangsu, Peoples R China.	1000004299@ujs.edu.cn					Brunner PM, 2015, EXP DERMATOL, V24, P522, DOI 10.1111/exd.12709; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Cohen J, 2019, AGING CELL, V18, DOI 10.1111/acel.12937; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Guan FX, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1433-4; Han S, 2019, AM J TRANSL RES, V11, P442; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Huang TH, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0526-9; Imai S, 2013, BRAIN, V136, P828, DOI 10.1093/brain/aws330; Jin XX, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8090987; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kann AP, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.179259; Kano S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aar2124; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Kramer T.J., 2019, J NEUROINFLAMMATION, V16; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Lee EJ, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1363-6; Li J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42260; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Mercer PF, 2014, AM J RESP CELL MOL, V50, P144, DOI 10.1165/rcmb.2013-0142OC; Nam HY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1308-0; Crespo ART, 2007, BRAIN INJURY, V21, P441, DOI 10.1080/02699050701311125; Rodriguez-Gomez JA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071717; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Xiao X, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0501-0; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Zhang K, 2019, PHARMACOL RES, V139, P360, DOI 10.1016/j.phrs.2018.11.030; Zhang M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19973-6	40	1	1	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	OCT	2021	99								107975	10.1016/j.intimp.2021.107975			11	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	UL3EB	WOS:000692537400006	34293712				2022-02-06	
J	Yuan, D; Guan, SX; Wang, Z; Ni, HL; Ding, DL; Xu, WB; Li, GM				Yuan, Dong; Guan, ShuangXian; Wang, Zhen; Ni, HongLiang; Ding, DongLiang; Xu, WenBo; Li, GuoMin			HIF-1 alpha aggravated traumatic brain injury by NLRP3 inflammasome-mediated pyroptosis and activation of microglia	JOURNAL OF CHEMICAL NEUROANATOMY			English	Article						Traumatic brain injury; HIF-1 alpha; NLRP3 inflammasome; Pyroptosis; Microglia	BEHAVIORAL DEFICITS; NEUROPROTECTION; IMPACT; EDEMA; MODEL	Hypoxia inducible factor 1 alpha (HIF-1 alpha) is involved in regulating the biological functions of neuronal death after traumatic brain injury (TBI), and attaches importance in the inflammatory response, but its potential mechanism is still unknown. Our study aimed to explore the regulatory mechanism between HIF-1 alpha and NLRP3 inflammasome after TBI. Male mice underwent controlled cortical impact (CCI) or sham-operated procedures. Brain water content and blood-brain barrier permeability were measured at the indicated time after TBI. The behavioral performance, ELISA, immunofluorescence, and western blot analysis were used to determine whether HIF-1 alpha specifically targeted TBI-induced pymptosis. We discovered that TBI-induced brain injury caused by external mechanical forces is characterized by edema and blood-brain barrier disorder, and the release of IL-1 beta, IL-18, and LDH and upregulation of HIF-1 alpha expression, reaching the peak on the third day post-TBI. In addition, HIF-1 alpha accumulated NLRP3 inflammasome-mediated pymptosis and activation of microglia. The protein expressions of NLRP3, GSDMD, GSDMD-N, pro-caspase 1, and cleaved caspase 1 were markedly increased in the injured cortex, which were restored to normal levels by the interference of HIF-1 alpha. The inactivation of HIF-1 alpha conferred neumprotection and alleviated brain injury after TBI. HIF-1 alpha was implicated in TBI-induced brain injury, aggravated NLRP3 inflammasome -mediated pymptosis, and the activation of microglia, which provided a potential target for treating TBI.	[Yuan, Dong; Guan, ShuangXian; Wang, Zhen; Ni, HongLiang; Ding, DongLiang; Xu, WenBo; Li, GuoMin] Jiangsu Univ, Jintan Hosp, Emergency Dept, 500 Jintan Ave, Changzhou 213200, Jiangsu, Peoples R China		Li, GM (corresponding author), Jiangsu Univ, Jintan Hosp, Emergency Dept, 500 Jintan Ave, Changzhou 213200, Jiangsu, Peoples R China.	xyicu@163.com			Project of Science and Technology Bureau of Jintan District, Changzhou City, Jiangsu Province [KJ201923]	This study was supported by the Project of Science and Technology Bureau of Jintan District, Changzhou City, Jiangsu Province (No. KJ201923) .	An PP, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116599; Bok S, 2017, ONCOTARGET, V8, P111508, DOI 10.18632/oncotarget.22851; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen Y.R., 2020, J CLIN ONCOL, V38, P17028; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Fang XX, 2019, P NATL ACAD SCI USA, V116, P2672, DOI 10.1073/pnas.1821022116; Ge XT, 2018, BRAIN RES, V1697, P10, DOI 10.1016/j.brainres.2018.06.008; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Huang JJ, 2019, MOL MED REP, V20, P3424, DOI 10.3892/mmr.2019.10575; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang Q, 2020, NEUROSCIENCE, V448, P126, DOI 10.1016/j.neuroscience.2020.09.036; Jung Y., 2003, FASEB J; Kabba JA, 2018, CELL MOL NEUROBIOL, V38, P53, DOI 10.1007/s10571-017-0504-2; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; Lee SW, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1423-6; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu ZH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176291; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Merighi S, 2015, GLIA, V63, P1933, DOI 10.1002/glia.22861; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Qiu Z, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9743280; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Sen T, 2016, NEUROPHARMACOLOGY, V107, P79, DOI 10.1016/j.neuropharm.2016.03.009; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wang YM, 2017, NEUROSCIENCE, V361, P34, DOI 10.1016/j.neuroscience.2017.08.010; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yang HY, 2006, J NEUROTRAUM, V23, P721, DOI 10.1089/neu.2006.23.721; Yu LM, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4596368; Zeng C, 2020, REDOX BIOL, V34, DOI 10.1016/j.redox.2020.101523; Zeng XJ, 2020, J CELL MOL MED, V24, P7000, DOI 10.1111/jcmm.15361; Zhang JY, 2018, HEPATOLOGY, V67, P1872, DOI 10.1002/hep.29681; Zhang L, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6326517	41	1	1	8	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0891-0618	1873-6300		J CHEM NEUROANAT	J. Chem. Neuroanat.	OCT	2021	116								101994	10.1016/j.jchemneu.2021.101994			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	UO5JY	WOS:000694733000005	34166779				2022-02-06	
J	Kornyei, BS; Szabo, V; Perlaki, G; Balogh, B; Steigerwald, DKS; Nagy, SA; Toth, L; Buki, A; Doczi, T; Bogner, P; Schwarcz, A; Toth, A				Kornyei, Balint S.; Szabo, Viktor; Perlaki, Gabor; Balogh, Bendeguz; Steigerwald, Dorottya K. Szabo; Nagy, Szilvia A.; Toth, Luca; Buki, Andras; Doczi, Tamas; Bogner, Peter; Schwarcz, Attila; Toth, Arnold			Cerebral Microbleeds May Be Less Detectable by Susceptibility Weighted Imaging MRI From 24 to 72 Hours After Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						SWI MRI; traumatic brain injury; diffuse axonal injury; white matter; microbleeds; SWI; TMB	DIFFUSE AXONAL INJURY; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; AMYLOID ANGIOPATHY; LESIONS; MILD; EPIDEMIOLOGY; CLASSIFICATION; DIAGNOSIS; ROBUST	Purpose: A former rodent study showed that cerebral traumatic microbleeds (TMBs) may temporarily become invisible shortly after injury when detected by susceptibility weighted imaging (SWI). The present study aims to validate this phenomenon in human SWI. Methods: In this retrospective study, 46 traumatic brain injury (TBI) patients in various forms of severity were included and willingly complied with our strict selection criteria. Clinical parameters potentially affecting TMB count, Rotterdam and Marshall CT score, Mayo Clinic Classification, contusion number, and total volume were registered. The precise time between trauma and MRI [5 h 19 min to 141 h 54 min, including SWI and fluid-attenuated inversion recovery (FLAIR)] was individually recorded; TMB and FLAIR lesion counts were assessed. Four groups were created based on elapsed time between the trauma and MRI: 0-24, 24-48, 48-72, and > 72 h. Kruskal-Wallis, ANOVA, Chi-square, and Fisher's exact tests were used to reveal differences among the groups within clinical and imaging parameters; statistical power was calculated retrospectively for each comparison. Results: The Kruskal-Wallis ANOVA with Conover post hoc analysis showed significant (p = 0.01; 1-beta > 0.9) median TMB number differences in the subacute period: 0-24 h = 4.00 (n = 11); 24-48 h = 1 (n = 14); 48-72 h = 1 (n = 11); and 72 h <= 7.5 (n = 10). Neither clinical parameters nor FLAIR lesions depicted significant differences among the groups. Conclusion: Our results demonstrate that TMBs on SWI MRI may temporarily become less detectable at 24-72 h following TBI.	[Kornyei, Balint S.; Balogh, Bendeguz; Steigerwald, Dorottya K. Szabo; Bogner, Peter; Toth, Arnold] Univ Pecs, Sch Med, Dept Med Imaging, Pecs, Hungary; [Szabo, Viktor; Perlaki, Gabor; Toth, Luca; Buki, Andras; Doczi, Tamas; Schwarcz, Attila] Univ Pecs, Sch Med, Dept Neurosurg, Pecs, Hungary; [Perlaki, Gabor; Nagy, Szilvia A.] Pecs Diagnost Ctr, MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Nagy, Szilvia A.] Univ Pecs, Neurobiol Stress Res Grp, Szentagothai Res Ctr, Pecs, Hungary; [Nagy, Szilvia A.] Univ Pecs, Sch Med, Dept Lab Med, Pecs, Hungary; [Toth, Arnold] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary		Kornyei, BS (corresponding author), Univ Pecs, Sch Med, Dept Med Imaging, Pecs, Hungary.	balint.kornyei@gmail.com			New National Excellence Program of the Ministry for Innovation and Technology [UNKP-20-3-I-PTE-552, UNKP-20-5-PTE-794, UNKP-20-5-PTE-715, UNKP-20-5-PTE715]; Ministry of Innovation and Technology from the Development and Innovation Fund [KDP-2020-986041]; Janos Bolyai Scholarship of the Hungarian Academy of Science; PTE [AOK-KA-2020-08]; Janos Bolyai Research Scholarship of the Hungarian Academy of SciencesHungarian Academy of Sciences; Institutional Excellence Program for the Higher Education II; Hungarian Scientific Research FundOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [OTKA/K-120356]; Hungarian Brain Research Program [KTIA_NAP_13-2-2014-0019, 2017-1.2.1-NKP-2017-00002];  [EFOP-3.6.2-16-2017-00008]	BK was supported by the UNKP-20-3-I-PTE-552 New National Excellence Program of the Ministry for Innovation and Technology, and the manuscript was also prepared with the professional support of the doctoral student scholarship program of the Co-operative Doctoral Program of the Ministry of Innovation and Technology financed from the National Research, Development and Innovation Fund KDP-2020-986041. AT was supported by the UNKP-20-5-PTE-794 New National Excellence Program of the Ministry for Innovation and Technology. AT was supported by the Bolyai Scholarship of the Hungarian Academy of Science. SN was supported by the UNKP-20-5-PTE-715 New National Excellence Program of the Ministry for Innovation and Technology and Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences and PTE AOK-KA-2020-08. GP was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences and the Institutional Excellence Program for the Higher Education II within the framework of the 5th thematic program. This study was funded by the Hungarian Scientific Research Fund Grant No. OTKA/K-120356. Additionally, the study was also funded by EFOP-3.6.2-16-2017-00008 "The role of neuro-inflammation in neurodegeneration: from molecules to clinics" and supported by the UNKP20-3-I-PTE-552, UNKP-20-5-PTE-794, and UNKP-20-5-PTE715 New National Excellence Program of the Ministry for Innovation and Technology. This work was financially supported by Hungarian Brain Research Program (KTIA_NAP_13-2-2014-0019 and 2017-1.2.1-NKP-2017-00002).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akoudad S, 2016, JAMA NEUROL, V73, P934, DOI 10.1001/jamaneurol.2016.1017; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Andreasen SH, 2020, J NEUROTRAUM, V37, P581, DOI 10.1089/neu.2019.6608; Asano Y, 2012, NEUROL MED-CHIR, V52, P31, DOI 10.2176/nmc.52.31; Ayaz M, 2010, J MAGN RESON IMAGING, V31, P142, DOI 10.1002/jmri.22001; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Blitstein MK, 2007, AM J ROENTGENOL, V189, P720, DOI 10.2214/AJR.07.2249; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; de Haan S, 2017, NEURORADIOLOGY, V59, P963, DOI 10.1007/s00234-017-1898-8; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Di Leva A, 2015, J NEUROSURG, V123, P1463, DOI 10.3171/2015.1.JNS142349; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Ezaki Y, 2006, ACTA NEUROCHIR, V148, P547, DOI 10.1007/s00701-005-0692-2; Gennarelli T.A., 1986, NATO ASI SERIES A, V115, DOI [10.1007/978-1-4684-5203-7_2, DOI 10.1007/978-1-4684-5203-7_2]; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Haacke EM, 2007, AM J NEURORADIOL, V28, P316; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kallakuri S, 2015, J CLIN IMAG SCI, V5, DOI 10.4103/2156-7514.166354; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kim BJ, 2013, J STROKE, V15, P153, DOI 10.5853/jos.2013.15.3.153; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lawrence TP, 2017, NEUROSCI LETT, V655, P143, DOI 10.1016/j.neulet.2017.06.046; Lu J, 2005, ACT NEUR S, V95, P281; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Nakagami Y., 2014, EPILEPSY SEIZURE, V7, P23, DOI [10.3805/eands.7.23, DOI 10.3805/EANDS.7.23]; Nakata-Kudo Y, 2006, DEMENT GERIATR COGN, V22, P8, DOI 10.1159/000092958; Oh JH, 2008, CLIN NEUROL NEUROSUR, V110, P384, DOI 10.1016/j.clineuro.2007.12.001; Parizel PM, 2001, EUR RADIOL, V11, P1770, DOI 10.1007/s003300000800; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Ripoll MA, 2003, ACTA RADIOL, V44, P199, DOI 10.1034/j.1600-0455.2003.00038.x; Shams S, 2015, AM J NEURORADIOL, V36, P661, DOI 10.3174/ajnr.A4176; Sharma R, 2018, J MED IMAG RADIAT ON, V62, P451, DOI 10.1111/1754-9485.12726; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Toth A, 2019, J NEUROTRAUM, V36, P1670, DOI 10.1089/neu.2018.6004; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; van der Horn HJ, 2018, BRAIN IMAGING BEHAV, V12, P912, DOI 10.1007/s11682-017-9743-6; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Watanabe J, 2016, ACTA NEUROCHIR, V158, P1247, DOI 10.1007/s00701-016-2805-5; Yamauchi Y., 2016, CIRCULATION, V134; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	67	1	1	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 30	2021	15								711074	10.3389/fnins.2021.711074			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WJ5AA	WOS:000709056200001	34658762	Green Published, gold			2022-02-06	
J	Li, JR; Zhang, D; Guo, S; Zhao, CB; Wang, LY; Ma, SS; Guan, FX; Yao, MH				Li, Jinrui; Zhang, Dan; Guo, Shen; Zhao, Chengbin; Wang, Luyu; Ma, Shanshan; Guan, Fangxia; Yao, Minghao			Dual-enzymatically cross-linked gelatin hydrogel promotes neural differentiation and neurotrophin secretion of bone marrow-derived mesenchymal stem cells for treatment of moderate traumatic brain injury	INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES			English	Article						Injectable hydrogel; Neural differentiation; Neurotrophin secretion; Traumatic brain injury; Neurological function recovery	NERVE GROWTH-FACTOR; REPAIR; POLARIZATION; SCAFFOLD; PROLIFERATION; APOPTOSIS; BDNF	Traumatic brain injury (TBI) is one of the most devastating nervous injuries. Neural tissue engineering based on stem cells and bioactive scaffold is a promising but challenging approach for neural repair. A cutting-edge system with capability to control the fate of encapsulated stem cells is attractive to enhance neural regeneration after TBI. Herein, an injectable gelatin hydrogel dual-enzymatically cross-linked by horse radish peroxidase (HRP) and choline oxidase (ChOx) was performed as the neural scaffold to load murine bone marrow-derived mesenchymal stem cells (BMSC) for TBI treatment. The results of in vitro cellular experiments showed that low cross-linked gelatin hydrogel could obviously promote cellular viability, neural differentiation, and neurotrophins secretion of the loaded BMSC. In vivo tests on a TBI model of C57BL/6 mouse demonstrated that BMSC-laden gelatin hydrogel implants could significantly reduce the damaged area, ameliorate inflammation, attenuate neuronal apoptosis, facilitate survival and proliferation of endogenous neural cells, and promote the neurological function recovery of TBI mice. All data suggest that establishment of this three-dimensional (3D) gelatin hydrogel stem cell-loaded system is a promising therapeutic strategy for TBI or other neurological rehabilitation.	[Li, Jinrui; Zhang, Dan; Guo, Shen; Wang, Luyu; Ma, Shanshan; Guan, Fangxia; Yao, Minghao] Zhengzhou Univ, Sch Life Sci, 100 Sci Rd, Zhengzhou 450001, Peoples R China; [Guan, Fangxia] Zhengzhou Univ, Inst Neurosci, Zhengzhou 450000, Peoples R China; [Zhao, Chengbin] Zhengzhou Univ, Neurosurg Dept, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China		Yao, MH (corresponding author), Zhengzhou Univ, Sch Life Sci, 100 Sci Rd, Zhengzhou 450001, Peoples R China.; Guan, FX (corresponding author), Zhengzhou Univ, Inst Neurosci, Zhengzhou 450000, Peoples R China.	guanfangxia@126.com; yao453343550@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [U1804198, 31700820]; Zhongyuan Thousand Talents Project [204200510013]	This work was financially supported by the National Natural Science Foundation of China (U1804198 and 31700820) from Minghao Yao, and Zhongyuan Thousand Talents Project (204200510013) from Fangxia Guan. We also thank the facility support of the Center for Modern Analysis and Gene Sequencing, Zhengzhou University.	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050; Broguiere N, 2016, BIOMATERIALS, V99, P47, DOI 10.1016/j.biomaterials.2016.04.036; Carbonara M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00885; Chang C, 2021, ADV HEALTHC MATER, V10, DOI 10.1002/adhm.202001689; Chen MM, 2020, BIOACT MATER, V5, P880, DOI 10.1016/j.bioactmat.2020.05.004; Chen W, 2020, J TISSUE ENG REGEN M, V14, P412, DOI 10.1002/term.3002; Chiaretti A, 2017, BRAIN INJURY, V31, P1538, DOI 10.1080/02699052.2017.1376760; Das M, 2019, REV NEUROSCIENCE, V30, P839, DOI 10.1515/revneuro-2019-0002; Dasari R, 2021, NEUROCHEM INT, V142, DOI 10.1016/j.neuint.2020.104923; Devanney NA, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113310; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fan L, 2018, ACS APPL MATER INTER, V10, P17742, DOI 10.1021/acsami.8b05293; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fuhrmann T, 2016, BIOMATERIALS, V83, P23, DOI 10.1016/j.biomaterials.2015.12.032; Grayson B, 2015, BEHAV BRAIN RES, V285, P176, DOI 10.1016/j.bbr.2014.10.025; Guo YS, 2020, ACS OMEGA, V5, P29698, DOI 10.1021/acsomega.0c03285; Houlton J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00790; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang JP, 2020, BIOMATER SCI-UK, V8, P6362, DOI 10.1039/d0bm01116a; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Kinder HA, 2019, NEURAL REGEN RES, V14, P413, DOI 10.4103/1673-5374.245334; Kuan CY, 2019, J MATER CHEM B, V7, P4499, DOI 10.1039/c9tb00816k; Li JR, 2020, J TISSUE ENG REGEN M, V14, P1261, DOI 10.1002/term.3098; Li WQ, 2020, RSC ADV, V10, P17114, DOI 10.1039/d0ra01723j; Ma XT, 2020, BIOACT MATER, V5, P124, DOI 10.1016/j.bioactmat.2020.01.005; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Niu XL, 2018, MOL MED REP, V18, P4516, DOI 10.3892/mmr.2018.9465; Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Shokouhi G, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118049; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Wu HJ, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-020-02041-7; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Xu C, 2017, INT J NEUROSCI, V127, P1124, DOI 10.1080/00207454.2017.1325884; Yao MH, 2019, BIOMATER SCI-UK, V7, P4088, DOI 10.1039/c9bm00749k; Yin CC, 2020, ACTA BIOMATER, V102, P416, DOI 10.1016/j.actbio.2019.11.025; Zhang J, 2021, BIOMATER SCI-UK, V9, P745, DOI 10.1039/c9bm01446b; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g; Zhang ZC, 2020, MOL NEUROBIOL, V57, P997, DOI 10.1007/s12035-019-01777-5; Zhao R, 2019, NEUROSCIENCE, V422, P99, DOI 10.1016/j.neuroscience.2019.10.048; Zheng Y, 2019, BIOMATER SCI-UK, V7, P2037, DOI 10.1039/c8bm01449c; Zheng YT, 2021, BIOACT MATER, V6, P627, DOI 10.1016/j.bioactmat.2020.08.026	55	1	1	14	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0141-8130	1879-0003		INT J BIOL MACROMOL	Int. J. Biol. Macromol.	SEP 30	2021	187						200	213		10.1016/j.ijbiomac.2021.07.111			14	Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry; Polymer Science	UK2IX	WOS:000691799600007	34310990				2022-02-06	
J	Graham, NSN; Zimmerman, KA; Moro, F; Heslegrave, A; Maillard, SA; Bernini, A; Miroz, JP; Donat, CK; Lopez, MY; Bourke, N; Jolly, AE; Mallas, EJ; Soreq, E; Wilson, MH; Fatania, G; Roi, D; Patel, MC; Garbero, E; Nattino, G; Baciu, C; Fainardi, E; Chieregato, A; Gradisek, P; Magnoni, S; Oddo, M; Zetterberg, H; Bertolini, G; Sharp, DJ				Graham, Neil S. N.; Zimmerman, Karl A.; Moro, Federico; Heslegrave, Amanda; Maillard, Samia Abed; Bernini, Adriano; Miroz, John-Paul; Donat, Cornelius K.; Lopez, Maria Yanez; Bourke, Niall; Jolly, Amy E.; Mallas, Emma-Jane; Soreq, Eyal; Wilson, Mark H.; Fatania, Gavin; Roi, Dylan; Patel, Maneesh C.; Garbero, Elena; Nattino, Giovanni; Baciu, Camelia; Fainardi, Enrico; Chieregato, Arturo; Gradisek, Primoz; Magnoni, Sandra; Oddo, Mauro; Zetterberg, Henrik; Bertolini, Guido; Sharp, David J.			Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury	SCIENCE TRANSLATIONAL MEDICINE			English	Article							NEUROCHEMICAL AFTERMATH; MICROGLIAL ACTIVATION; RHESUS-MONKEY; DEGENERATION; CHAIN; INFLAMMATION; EXPRESSION; BIOMARKER; ATROPHY; PROTEIN	Axonal injury is a key determinant of long-term outcomes after traumatic brain injury (TBI) but has been difficult to measure clinically. Fluid biomarker assays can now sensitively quantify neuronal proteins in blood. Axonal components such as neurofilament light (NfL) potentially provide a diagnostic measure of injury. In the multicenter BIO-AX-TBI study of moderate-severe TBI, we investigated relationships between fluid biomarkers, advanced neuroimaging, and clinical outcomes. Cerebral microdialysis was used to assess biomarker concentrations in brain extracellular fluid aligned with plasma measurement. An experimental injury model was used to validate biomarkers against histopathology. Plasma NfL increased after TBI, peaking at 10 days to 6 weeks but remaining abnormal at 1 year. Concentrations were around 10 times higher early after TBI than in controls (patients with extracranial injuries). NfL concentrations correlated with diffusion MRI measures of axonal injury and predicted white matter neurodegeneration. Plasma TAU predicted early gray matter atrophy. NfL was the strongest predictor of functional outcomes at 1 year. Cerebral microdialysis showed that NfL concentrations in plasma and brain extracellular fluid were highly correlated. An experimental injury model confirmed a dose-response relationship of histopathologically defined axonal injury to plasma NfL. In conclusion, plasma NfL provides a sensitive and clinically meaningful measure of axonal injury produced by TBI. This reflects the extent of underlying damage, validated using advanced MRI, cerebral microdialysis, and an experimental model. The results support the incorporation of NfL sampling subacutely after injury into clinical practice to assist with the diagnosis of axonal injury and to improve prognostication.	[Graham, Neil S. N.; Zimmerman, Karl A.; Donat, Cornelius K.; Bourke, Niall; Jolly, Amy E.; Mallas, Emma-Jane; Soreq, Eyal; Sharp, David J.] Imperial Coll London, Dept Brain Sci, London W12 0NN, England; [Graham, Neil S. N.; Zimmerman, Karl A.; Bourke, Niall; Jolly, Amy E.; Mallas, Emma-Jane; Soreq, Eyal; Sharp, David J.] Imperial Coll London, UK DRI Ctr Care Res & Technol, London W12 0BZ, England; [Moro, Federico] Ist Ric Farmacol Mario Negri IRCCS, Lab Acute Brain Injury & Therapeut Strategies, Dept Neurosci, I-24126 Bergamo, Italy; [Heslegrave, Amanda] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England; [Heslegrave, Amanda] UK Dementia Res Inst UCL, London WC1N 3BG, England; [Maillard, Samia Abed; Bernini, Adriano; Miroz, John-Paul; Oddo, Mauro] CHUV Lausanne Univ Hosp, Dept Intens Care Med, Neurosci Crit Care Res Grp, CH-1011 Lausanne, Switzerland; [Maillard, Samia Abed; Bernini, Adriano; Miroz, John-Paul; Oddo, Mauro] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Lopez, Maria Yanez] Kings Coll London, Ctr Developing Brain, Sch Biomed Engn & Imaging Sci, London SE1 7EH, England; [Wilson, Mark H.] Imperial Coll Healthcare NHS Trust, Dept Neurosurg, London W6 8RF, England; [Wilson, Mark H.] Imperial Coll London, Fac Med, Dept Surg & Canc, London SW7 2AZ, England; [Fatania, Gavin; Roi, Dylan; Patel, Maneesh C.] Imperial Coll Healthcare NHS Trust, Dept Imaging, London W6 8RF, England; [Garbero, Elena; Nattino, Giovanni; Bertolini, Guido] Ist Ric Farmacol Mario Negri IRCCS, Lab Clin Epidemiol, I-24126 Bergamo, Italy; [Baciu, Camelia; Chieregato, Arturo] ASST Grande Osped Metropolitano Niguarda, Neurorianimaz, I-20162 Milan, Italy; [Fainardi, Enrico] Univ Firenze, Careggi Univ Hosp, Dept Expt & Clin Sci, I-50139 Florence, Italy; [Gradisek, Primoz] Univ Med Ctr, Clin Dept Anaesthesiol & Intens Therapy, Ljubljana 1000, Slovenia; [Magnoni, Sandra] Santa Chiara Hosp, Dept Anesthesia & Intens Care, I-38122 Trento, Italy; [Oddo, Mauro] CHUV Lausanne Univ Hosp, Med Direct, CH-1011 Lausanne, Switzerland; [Zetterberg, Henrik] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, S-43141 Molndal, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, S-43141 Molndal, Sweden; [Sharp, David J.] Imperial Coll London, Ctr Injury Studies, London SW7 2AZ, England; [Moro, Federico] Fdn IRCCS, Dipartimento Anestesia & Rianimaz, Ca Granda Osped Maggiore Policlin, I-20122 Milan, Italy		Sharp, DJ (corresponding author), Imperial Coll London, Dept Brain Sci, London W12 0NN, England.; Sharp, DJ (corresponding author), Imperial Coll London, UK DRI Ctr Care Res & Technol, London W12 0BZ, England.; Sharp, DJ (corresponding author), Imperial Coll London, Ctr Injury Studies, London SW7 2AZ, England.	david.sharp@imperial.ac.uk	Zimmerman, Karl/AAL-4988-2020; Moro, Federico/AAG-1731-2021; moro, federico/K-5644-2016; Magnoni, Sandra/AAC-7479-2022; Nattino, Giovanni/T-7306-2019; Mallas, Emma-Jane/ABE-3115-2020	Zimmerman, Karl/0000-0003-1239-3414; Moro, Federico/0000-0002-2682-5583; moro, federico/0000-0002-2682-5583; Magnoni, Sandra/0000-0002-1723-0844; Nattino, Giovanni/0000-0002-3034-6251; Mallas, Emma-Jane/0000-0002-4050-0208; Heslegrave, Amanda/0000-0002-7290-6405; Bernini, Adriano/0000-0003-0207-0064; Yanez Lopez, Maria/0000-0001-5187-2501	ERA-NET NEURON Cofund, European Research Projects on External Insults to the Nervous System call, within the Horizon 2020 [MR/R004528/1]; Alzheimer's Research UK Clinical Research Fellowship; U.K. Dementia Research Institute (DRI) Care Research and Technology Centre; National Institute of Health Research (NIHR) ProfessorshipNational Institute for Health Research (NIHR) [NIHR-RP-011-048]; NIHR Clinical Research Facility and Biomedical Research Centre (BRC) at Imperial College Healthcare NHS Trust; Medical Research Council Clinician Scientist FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Wallenberg Scholarship; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2018-02532]; European Research CouncilEuropean Research Council (ERC)European Commission [681712]; Swedish State Support for Clinical Research [ALFGBG-720931]; Alzheimer Drug Discovery Foundation (ADDF), USA [201809-2016862]; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [860197]; U.K. Dementia Research Institute at UCL; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31NE30_173675, 32003B_188501]	ERA-NET NEURON Cofund (MR/R004528/1), a part of the European Research Projects on External Insults to the Nervous System call, within the Horizon 2020 funding framework, provided the core funds for the project (PIs: D.J.S., H.Z., M.O., G.B., and S.M.), Alzheimer's Research UK Clinical Research Fellowship (N.S.N.G.), U.K. Dementia Research Institute (DRI) Care Research and Technology Centre (N.S.N.G., D.J.S., and K.A.Z.), National Institute of Health Research (NIHR) Professorship (NIHR-RP-011-048) (D.J.S.), the NIHR Clinical Research Facility and Biomedical Research Centre (BRC) at Imperial College Healthcare NHS Trust (D.J.S.), Medical Research Council Clinician Scientist Fellowship (D.J.S.), Wallenberg Scholarship (H.Z.), Swedish Research Council (no. 2018-02532) (H.Z.), the European Research Council (no. 681712) (H.Z.), Swedish State Support for Clinical Research (no. ALFGBG-720931) (H.Z.), Alzheimer Drug Discovery Foundation (ADDF), USA (no. 201809-2016862) (H.Z.), the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 860197 (MIRIADE) (H.Z.), the U.K. Dementia Research Institute at UCL (H.Z.), and the Swiss National Science Foundation (nos. 31NE30_173675 and 32003B_188501) (M.O.) Author contributions: Writing-original draft: N.S.N.G., K.A.Z., C.K.D., and D.J.S. Data curation	Agoston DV, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00092; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; Bacioglu M, 2016, NEURON, V91, P56, DOI 10.1016/j.neuron.2016.05.018; Barro C, 2018, BRAIN, V141, P2382, DOI 10.1093/brain/awy154; Bashir A, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113116; Bernick C, 2020, NEUROLOGY, V94, pE232, DOI 10.1212/WNL.0000000000008817; Cash DM, 2015, NEUROIMAGE, V123, P149, DOI 10.1016/j.neuroimage.2015.07.087; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donat CK, 2021, BRAIN, V144, P70, DOI 10.1093/brain/awaa336; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Gafson AR, 2020, BRAIN, V143, P1975, DOI 10.1093/brain/awaa098; Giorgi-Coll S, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6513; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Graham NSN, 2020, BRAIN, V143, P3685, DOI 10.1093/brain/awaa316; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Graham NSN, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042093; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Isensee F, 2019, HUM BRAIN MAPP, V40, P4952, DOI 10.1002/hbm.24750; Johnson EB, 2018, NEUROLOGY, V90, pE717, DOI 10.1212/WNL.0000000000005005; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jolly AE, 2021, BRAIN, V144, P92, DOI 10.1093/brain/awaa372; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martin-Aguilar L, 2021, J NEUROL NEUROSUR PS, V92, P70, DOI 10.1136/jnnp-2020-323899; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Millecamps S, 2007, J NEUROSCI, V27, P4947, DOI 10.1523/JNEUROSCI.5299-06.2007; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Palacios EM, 2017, AM J NEURORADIOL, V38, P537, DOI 10.3174/ajnr.A5025; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Sandelius A, 2018, NEUROLOGY, V90, pE518, DOI 10.1212/WNL.0000000000004932; SCHLAEPFER WW, 1977, J CELL BIOL, V74, P241, DOI 10.1083/jcb.74.1.241; SCHLAEPFER WW, 1974, BRAIN RES, V69, P203, DOI 10.1016/0006-8993(74)90002-X; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Simard M, 2003, J NEUROSCI, V23, P9254; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yeh FC, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116131; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784	69	1	1	6	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1946-6234	1946-6242		SCI TRANSL MED	Sci. Transl. Med.	SEP 29	2021	13	613							eabg9922	10.1126/scitranslmed.abg9922			15	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	WA6TI	WOS:000703016300005	34586833	Green Submitted			2022-02-06	
J	Shaikh, N; Theadom, A; Siegert, R; Hardaker, N; King, D; Hume, P				Shaikh, Nusratnaaz; Theadom, Alice; Siegert, Richard; Hardaker, Natalie; King, Doug; Hume, Patria			Rasch analysis of the Brain Injury Screening Tool (BIST) in mild traumatic brain injury	BMC NEUROLOGY			English	Article						Brain injury; Concussion; TBI; Screening; Assessment; Measurement; Rasch analysis	CONCUSSION SYMPTOMS QUESTIONNAIRE; NEW-ZEALAND	Objective To evaluate the psychometric properties of the Brain Injury Screening Tool (BIST) symptom scale in a sample of people with a mild Traumatic Brain Injury (mTBI) through Rasch analysis, and to obtain an interval level measurement score for potential clinical use. Materials and methods Data were obtained from 114 adults aged over 16 years, who had experienced at least one mTBI in the past 10 years. Participants were recruited via social media, concussion clinics and sports organisations over a 4-month period between May and September 2020. Participants were asked to compete the symptom scale of the BIST tool via an anonymous online questionnaire. Internal construct validity, dimensionality, person separation index, and differential item functioning of the BIST were examined with Rasch analysis. Results BIST in its original form produced a satisfactory item-trait interaction, and good reliability, but was found to be multi-dimensional. Rasch analysis of the full scale with three domains as subtests resulted in acceptable model fit (chi(2)(6) =3.8, p > 0.05), with good reliability (Person Separation Index = 0.84), and uni-dimensionality. Differential Item Functioning (DIF) analysis displayed no significant DIF effects for sex or age revealing that people responded consistently and similarly to the individual BIST items based on severity of symptom burden. Conclusions The 15-item symptom scale of the BIST tool is a psychometrically sound measure of symptom burden following mTBI. The findings provide support for use of both total and sub scale scores for clinical use. Ordinal to interval score conversions are recommended for use when using the scores for research purposes in mTBI.	[Shaikh, Nusratnaaz; Theadom, Alice; King, Doug; Hume, Patria] Auckland Univ Technol, TBI Network, Auckland, New Zealand; [Shaikh, Nusratnaaz; Theadom, Alice; Siegert, Richard] Auckland Univ Technol, Sch Clin Sci, Auckland, New Zealand; [Hardaker, Natalie] Accid Compensat Corp, Wellington, New Zealand; [Hardaker, Natalie; King, Doug; Hume, Patria] Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [King, Doug] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia		Shaikh, N (corresponding author), Auckland Univ Technol, TBI Network, Auckland, New Zealand.; Shaikh, N (corresponding author), Auckland Univ Technol, Sch Clin Sci, Auckland, New Zealand.	nusrat.shaikh@aut.ac.nz	Shaikh, Nusratnaaz/ABE-2407-2021	Shaikh, Nusratnaaz/0000-0001-8157-226X	TBI Network seeding project grant	Participant reimbursement was funded by a TBI Network seeding project grant. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrich D., 2012, RUMM 2030; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Forrest RHJ, 2018, J PRIM HEALTH CARE, V10, P159, DOI 10.1071/HC17071; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lee YK, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0066-y; Linacre J. M, 1994, RASCH MES T, V7, P328; Lingsma H., 2014, J NEUROTRAUM; Marais Ida, 2008, J Appl Meas, V9, P200; McGeown JP, 2020, SPORTS MED, V50, P1191, DOI 10.1007/s40279-019-01240-4; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nilsson AL, 2011, J REHABIL MED, V43, P884, DOI 10.2340/16501977-0871; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Reid D., 2018, REPORT 4 ACCIDENT CO; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Streiner D.L., 2015, HLTH MEASUREMENT SCA, V5th ed.; Tennant A., 2006, RASCH MEAS T, V20, P1048; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Theadom A, 2017, BRAIN IMPAIR, P1; Theadom A., 2021, PLOS ONE; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thissen D., 1993, DETECTION DIFFERENTI; Thomas M, 2018, BRAIN IMPAIR, V19, P166, DOI 10.1017/Brimp.2017.26	27	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	SEP 29	2021	21	1							376	10.1186/s12883-021-02410-6			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY7BD	WOS:000701673800002	34587927	Green Published, gold, Green Submitted			2022-02-06	
J	Heileson, JL; Anzalone, AJ; Carbuhn, AF; Askow, AT; Stone, JD; Turner, SM; Hillyer, LM; Ma, DWL; Luedke, JA; Jagim, AR; Oliver, JM				Heileson, Jeffery L.; Anzalone, Anthony J.; Carbuhn, Aaron F.; Askow, Andrew T.; Stone, Jason D.; Turner, Stephanie M.; Hillyer, Lyn M.; Ma, David W. L.; Luedke, Joel A.; Jagim, Andrew R.; Oliver, Jonathan M.			The effect of omega-3 fatty acids on a biomarker of head trauma in NCAA football athletes: a multi-site, non-randomized study	JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION			English	Article						Docosahexaenoic Acid; American Football; Neurofilament Light; Concussion; Brain; Eicosapentaenoic Acid	SERUM NEUROFILAMENT LIGHT; DEFAULT MODE NETWORK; ALPHA-LINOLENIC ACID; N-3 FATTY-ACIDS; DOCOSAHEXAENOIC ACID; BRAIN-INJURY; BLOOD-PRESSURE; OMEGA-3 INDEX; RISK; DISEASE	Background American-style football (ASF) athletes are at risk for cardiovascular disease (CVD) and exhibit elevated levels of serum neurofilament light (Nf-L), a biomarker of axonal injury that is associated with repetitive head impact exposure over the course of a season of competition. Supplementation with the w-3 fatty acid (FA) docosahexaenoic acid (DHA) attenuates serum Nf-L elevations and improves aspects of CVD, such as the omega-3 index (O3I). However, the effect of combining the w-3 FA eicosapentaenoic acid (EPA) and docosapentaenoic acid (DPA) with DHA on, specifically, serum Nf-L in ASF athletes is unknown. Therefore, this study assessed the effect of supplemental w-3 FA (EPA+DPA+DHA) on serum Nf-L, plasma w-3 FAs, the O3I, and surrogate markers of inflammation over the course of a season. Methods A multi-site, non-randomized design, utilizing two American football teams was employed. One team (n = 31) received supplementation with a highly bioavailablew-3 FA formulation (2000mg DHA, 560mg EPA, 320mg DPA, Mindset (R), Struct Nutrition, Missoula, MT) during pre-season and throughout the regular season, while the second team served as the control (n = 35) and did not undergo supplementation. Blood was sampled at specific times throughout pre- and regular season coincident w ith changes in intensity, physical contact, and changes in the incidence and severity of head impacts. Group differences were determined via a mixed-model between-within subjects ANOVA. Effect sizes were calculated using Cohen's dfor all between-group differences. Significance was set a priori at p< .05. Results Compared to the control group, ASF athletes in the treatment group experienced large increases in plasma EPA (p < .001, d = 1.71) and DHA (p < .001, d = 2.10) which contributed to increases in the O3I (p < .001, d = 2.16) and the EPA:AA ratio (p = .001, d = 0.83) and a reduction in the w-6: w-3 ratio (p < .001, d = 1.80). w-3 FA supplementation attenuated elevations in Nf-L (p = .024). The control group experienced a significant increase in Nf-L compared to baseline at several measurement time points (T2, T3, and T4 [p range < .001 - .005, drange = 0.59-0.85]). Conclusions These findings suggest a cardio- and neuroprotective effect of combined EPA+DPA+DHA w-3 FA supplementation in American-style football athletes.	[Heileson, Jeffery L.] Baylor Univ, Dept Hlth Human Performance & Recreat, Waco, TX 76798 USA; [Anzalone, Anthony J.] Wake Forest Sch Med, Winston Salem, NC 27101 USA; [Carbuhn, Aaron F.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Askow, Andrew T.] Univ Illinois, Nutr & Exercise Performance Lab, Champaign, IL USA; [Stone, Jason D.] West Virginia Univ, Rockefeller Neurosci Inst, Morgantown, WV 26506 USA; [Turner, Stephanie M.; Oliver, Jonathan M.] Texas Christian Univ, Dept Kinesiol, Ft Worth, TX 76129 USA; [Hillyer, Lyn M.; Ma, David W. L.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada; [Luedke, Joel A.] Univ Wisconsin, Athlet Dept, La Crosse, WI 54601 USA; [Jagim, Andrew R.] Mayo Clin Hlth Syst, Sports Med, Onalaska, WI USA		Anzalone, AJ (corresponding author), Wake Forest Sch Med, Winston Salem, NC 27101 USA.	aanzalon@wakehealth.edu		Askow, Andrew/0000-0002-0757-8943			Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Antonio J, 2021, JEPONLINE, V24, P6; Anzalone A, 2019, J ATHL TRAINING, V54, P7, DOI 10.4085/1062-6050-387-18; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Asselin PD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70604-y; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bernasconi AA, 2021, MAYO CLIN PROC, V96, P304, DOI 10.1016/j.mayocp.2020.08.034; Brenna JT, 2002, CURR OPIN CLIN NUTR, V5, P127, DOI 10.1097/00075197-200203000-00002; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Chang AY, 2009, AM J CARDIOL, V104, P805, DOI 10.1016/j.amjcard.2009.05.008; Cohen J, 1998, STAT POWER ANAL BEHA; Crouse SF, 2016, AM J CARDIOL, V117, P131, DOI 10.1016/j.amjcard.2015.09.049; Curfman G, 2020, JAMA-J AM MED ASSOC, V324, P2280, DOI 10.1001/jama.2020.22898; Davinelli S, 2021, CRIT REV FOOD SCI, V61, P259, DOI 10.1080/10408398.2020.1724871; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Fenton JI, 2016, PROSTAG LEUKOTR ESS, V112, P12, DOI 10.1016/j.plefa.2016.06.004; Guo XF, 2020, PROSTAG LEUKOTR ESS, V158, DOI 10.1016/j.plefa.2019.102033; Harris WS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22370-2; Harris WS, 2018, PROSTAG LEUKOTR ESS, V132, P34, DOI 10.1016/j.plefa.2018.03.003; Harris WS, 2017, ATHEROSCLEROSIS, V262, P51, DOI 10.1016/j.atherosclerosis.2017.05.007; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Heileson JL, 2020, NUTR REV, V78, P1001, DOI 10.1093/nutrit/nuaa034; Innes JK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020532; Kim JH, 2019, JAMA CARDIOL, V4, P1221, DOI 10.1001/jamacardio.2019.3909; Kim JH, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008620; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lewis NA, 2020, ADV NUTR, V11, P1300, DOI 10.1093/advances/nmaa050; Lombardi M, 2020, CURR ATHEROSCLER REP, V22, DOI 10.1007/s11883-020-00865-5; Lust CAC, 2020, APPL PHYSIOL NUTR ME, V45, P886, DOI 10.1139/apnm-2019-0555; Mason RP, 2019, CURR ATHEROSCLER REP, V21, DOI 10.1007/s11883-019-0762-1; Metherel AH, 2019, PROG LIPID RES, V76, DOI 10.1016/j.plipres.2019.101008; Metherel AH, 2019, AM J CLIN NUTR, V110, P823, DOI 10.1093/ajcn/nqz097; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Miura K, 2016, NUTR RES, V36, P1202, DOI 10.1016/j.nutres.2016.09.006; Mori TA, 2000, AM J CLIN NUTR, V71, P1085; Nelson JR, 2019, POSTGRAD MED, V131, P268, DOI 10.1080/00325481.2019.1607414; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Nocella C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061353; Norton K, 2001, SPORTS MED, V31, P763, DOI 10.2165/00007256-200131110-00001; Oliver JM, 2019, J NEUROSURG, V130, P1655, DOI 10.3171/2017.12.JNS172035; Oliver JM, 2018, SPORTS MED, V48, pS39, DOI 10.1007/s40279-017-0847-3; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Pu HJ, 2017, CELL TRANSPLANT, V26, P555, DOI [10.3727/096368916x693842, 10.3727/096368916X693842]; Rissanen T, 2000, CIRCULATION, V102, P2677, DOI 10.1161/01.CIR.102.22.2677; Ritz PP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228834; Rubin LH, 2019, BRAIN INJURY, V33, P456, DOI 10.1080/02699052.2019.1565895; Russell KL, 2013, PROSTAG LEUKOTR ESS, V89, P97, DOI 10.1016/j.plefa.2013.05.004; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; So J, 2021, ATHEROSCLEROSIS, V316, P90, DOI 10.1016/j.atherosclerosis.2020.11.018; Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Weiner RB, 2013, CIRCULATION, V128, P524, DOI 10.1161/CIRCULATIONAHA.113.003522; Wirsching A, 2019, J NEUROTRAUM, V36, P548, DOI 10.1089/neu.2018.5836; Wu AG, 2014, NEUROREHAB NEURAL RE, V28, P75, DOI 10.1177/1545968313498650; Zhu W, 2020, NEUROCHEM RES, V45, P1839, DOI 10.1007/s11064-020-03078-z; Zhu W, 2018, INFLAMMATION, V41, P1182, DOI 10.1007/s10753-018-0765-z	66	1	1	4	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1550-2783		J INT SOC SPORT NUTR	J. Int. Soc. Sport Nutr.	SEP 27	2021	18	1							65	10.1186/s12970-021-00461-1			13	Nutrition & Dietetics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics; Sport Sciences	UY0BG	WOS:000701198500001	34579748	Green Published, gold			2022-02-06	
J	Lassaren, P; Lindblad, C; Frostell, A; Carpenter, KLH; Guilfoyle, MR; Hutchinson, PJA; Helmy, A; Thelin, EP				Lassaren, Philipp; Lindblad, Caroline; Frostell, Arvid; Carpenter, Keri L. H.; Guilfoyle, Mathew R.; Hutchinson, Peter J. A.; Helmy, Adel; Thelin, Eric Peter			Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; Inflammation; Cytokines; IL1-ra; Human; Neuroinflammation; Infection	INTERLEUKIN-1 RECEPTOR ANTAGONIST; PROINFLAMMATORY CYTOKINES; CEREBROSPINAL-FLUID; INTENSIVE-CARE; MICRODIALYSIS; IMMUNE; BLOOD; SERUM; TOMOGRAPHY; CHEMOKINES	Background: Neuroinflammation following traumatic brain injury (TBI) has been shown to be associated with secondary injury development; however, how systemic inflammatory mediators affect this is not fully understood. The aim of this study was to see how systemic inflammation affects markers of neuroinflammation, if this inflammatory response had a temporal correlation between compartments and how different compartments differ in cytokine composition. Methods: TBI patients recruited to a previous randomised controlled trial studying the effects of the drug anakinra (Kineret (R)), a human recombinant interleukin-1 receptor antagonist (rhIL1ra), were used (n = 10 treatment arm, n = 10 control arm). Cytokine concentrations were measured in arterial and jugular venous samples twice a day, as well as in microdialysis-extracted brain extracellular fluid (ECF) following pooling every 6 h. C-reactive protein level (CRP), white blood cell count (WBC), temperature and confirmed systemic clinical infection were used as systemic markers of inflammation. Principal component analyses, linear mixed-effect models, cross-correlations and multiple factor analyses were used. Results: Jugular and arterial blood held similar cytokine information content, but brain-ECF was markedly different. No clear arterial to jugular gradient could be seen. No substantial delayed temporal associations between blood and brain compartments were detected. The development of a systemic clinical infection resulted in a significant decrease of IL1-ra, G-CSF, PDGF-ABBB, MIP-1b and RANTES (p < 0.05, respectively) in brain-ECF, even if adjusting for injury severity and demographic factors, while an increase in several cytokines could be seen in arterial blood. Conclusions: Systemic inflammation, and infection in particular, alters cytokine levels with different patterns seen in brain and in blood. Cerebral inflammatory monitoring provides independent information from arterial and jugular samples, which both demonstrate similar information content. These findings could present potential new treatment options in severe TBI patients, but novel prospective trials are warranted to confirm these associations.	[Lassaren, Philipp; Lindblad, Caroline; Frostell, Arvid; Thelin, Eric Peter] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Frostell, Arvid] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden; [Carpenter, Keri L. H.; Guilfoyle, Mathew R.; Hutchinson, Peter J. A.; Helmy, Adel; Thelin, Eric Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Carpenter, Keri L. H.; Hutchinson, Peter J. A.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Thelin, Eric Peter] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden		Thelin, EP (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.; Thelin, EP (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.; Thelin, EP (corresponding author), Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden.	Eric.thelin@ki.se	Frostell, Arvid/ABG-5167-2021; Thelin, Eric/K-2144-2012	Thelin, Eric/0000-0002-2338-4364; Helmy, Adel/0000-0002-0531-0556	Karolinska Institutet and Region Stockholm; National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Global Health Research Group on Neurotrauma a European Union Seventh Framework Program grant (Collaborative European NeuroTrauma Effectiveness Research in TBI [CENTER-TBI] [602150]; Royal College of Surgeons of England; Royal College of Surgeons of England Pump Priming Grant; MRC/Royal of Surgeons of England Clinical Research Training Fellowship [G0802251]; MRC GrantUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/R005036/1]; Swedish Society for Medical Research; StratNeuro; Region Stockholm; Swedish Brain Foundation; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986 ID79068]; Karolinska InstituteKarolinska Institutet	CL is supported by Karolinska Institutet and Region Stockholm. KLHC is supported by the National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). PJAH is supported by a Research Professorship from the National Institute for Health Research (NIHR), the NIHR Cambridge Biomedical Research Centre, the NIHR Global Health Research Group on Neurotrauma a European Union Seventh Framework Program grant (Collaborative European NeuroTrauma Effectiveness Research in TBI [CENTER-TBI]; grant no. 602150) and the Royal College of Surgeons of England. AH is supported by National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme), Royal College of Surgeons of England Pump Priming Grant, MRC/Royal of Surgeons of England Clinical Research Training Fellowship (G0802251) and MRC Grant (MR/R005036/1). EPT is supported by post-doctoral scholarships from the Swedish Society for Medical Research, StratNeuro, Region Stockholm (clinical research appointment) and the Swedish Brain Foundation. The Luminex 200 analyser was purchased with MRC funding (grant no. G0600986 ID79068). The funding bodies did not participate in the design of the study; collection, analysis, and interpretation of data; or writing of the article. Open Access funding provided by Karolinska Institute.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; [Anonymous], 2016, MED AFTAOA ABBREVIAT; Ao XP, 2006, METHODS, V38, P331, DOI 10.1016/j.ymeth.2005.11.012; Asai K, 2001, SHOCK, V16, P340, DOI 10.1097/00024382-200116050-00003; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Campuzano O, 2009, J NEUROSCI RES, V87, P2484, DOI 10.1002/jnr.22074; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chaudhry SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122580; Coutinho LG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-326; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Doran SJ, 2020, CRIT CARE MED, V48, pE418, DOI 10.1097/CCM.0000000000004273; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Galea J, 2018, J NEUROSURG, V128, P515, DOI 10.3171/2016.9.JNS16615; Hannestad J, 2012, NEUROIMAGE, V63, P232, DOI 10.1016/j.neuroimage.2012.06.055; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kox M, 2020, JAMA-J AM MED ASSOC, V324, P1565, DOI 10.1001/jama.2020.17052; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Li YT, 2020, NEUROCRIT CARE, V32, P272, DOI 10.1007/s12028-019-00773-w; Lindblad C, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03503-x; Lodewijk, 2016, GPLOTS VARIOUS R PRO; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Majetschak M, 2000, J TRAUMA, V48, P832, DOI 10.1097/00005373-200005000-00006; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Mellergard P, 2011, NEUROSURGERY, V68, P12, DOI 10.1227/NEU.0b013e3181ef2a40; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Pages J., 2004, REV COLOMB ESTAD, V27, P1; Park SE, 2019, J CLIN VIROL, V119, P11, DOI 10.1016/j.jcv.2019.08.006; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Pinheiro J., 2017, NLME LINEAR NONLINEA; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Rowland B, 2020, SHOCK, V53, P24, DOI 10.1097/SHK.0000000000001349; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Singh N, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-1; Stanstrup J, 2017, MASSAGER; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thompson HJ, 2020, J HEAD TRAUMA REHAB, V35, P324, DOI 10.1097/HTR.0000000000000606; Vlachogiannis P, 2019, WORLD NEUROSURG, V122, pE612, DOI 10.1016/j.wneu.2018.10.113; Warford J, 2017, CAN J NEUROL SCI, V44, P96, DOI 10.1017/cjn.2016.310; Wegner A, 2017, INNATE IMMUN-LONDON, V23, P432, DOI 10.1177/1753425917707026; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Zeiler FA, 2017, ACTA NEUROCHIR, V159, P2245, DOI 10.1007/s00701-017-3338-2; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00331; Zhao JY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42286-8; Zhou X, 2010, CURR OPIN CLIN NUTR, V13, P541, DOI 10.1097/MCO.0b013e32833cf3bc	70	1	1	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	SEP 25	2021	18	1							221	10.1186/s12974-021-02264-2			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	UU8EA	WOS:000699026400001	34563211	gold, Green Published			2022-02-06	
J	Herbenick, D; Fu, TC; Kawata, K; Eastman-Mueller, H; Guerra-Reyes, L; Rosenberg, M; Valdivia, DS				Herbenick, Debby; Fu, Tsung-Chieh; Kawata, Keisuke; Eastman-Mueller, Heather; Guerra-Reyes, Lucia; Rosenberg, Molly; Valdivia, Dubravka Svetina			Non-Fatal Strangulation/Choking During Sex and Its Associations with Mental Health: Findings from an Undergraduate Probability Survey	JOURNAL OF SEX & MARITAL THERAPY			English	Article; Early Access							INTIMATE-PARTNER VIOLENCE; CHOKING GAME; BEHAVIORS; RISK; CONCUSSION; DEPRESSION; ASPHYXIA; TRAUMA; CAMPUS	Choking/strangulation during sex is prevalent among young adults in the United States. We examined associations between having ever been choked and participants' current mental health symptoms (e.g., feeling depressed, anxious, sad, lonely) in the prior 30 days and in the prior year. Participants were 4352 randomly sampled undergraduates who completed a confidential online survey and reported lifetime partnered sexual activity. 33.6% of women and 6.0% of men reported having been choked more than five times. After adjusting for demographic characteristics, having been choked remained significantly associated with all four mental health outcomes, except for overwhelming anxiety among men.	[Herbenick, Debby; Fu, Tsung-Chieh; Eastman-Mueller, Heather; Guerra-Reyes, Lucia] Indiana Univ, Sch Publ Hlth, Dept Appl Hlth Sci, Bloomington, IN 47401 USA; [Herbenick, Debby; Fu, Tsung-Chieh; Eastman-Mueller, Heather; Guerra-Reyes, Lucia; Rosenberg, Molly] Indiana Univ, Sch Publ Hlth, Ctr Sexual Hlth Promot, PH 116, Bloomington, IN 47401 USA; [Kawata, Keisuke] Indiana Univ, Sch Publ Hlth, Dept Kinesiol, Bloomington, IN 47401 USA; [Kawata, Keisuke] Indiana Univ, Coll Arts & Sci, Div Clin & Translat Neurosci, Program Neurosci, Bloomington, IN 47401 USA; [Rosenberg, Molly] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN 47401 USA; [Valdivia, Dubravka Svetina] Indiana Univ, Sch Educ, Dept Counseling & Educ Psychol, Bloomington, IN 47401 USA		Herbenick, D (corresponding author), Indiana Univ, Sch Publ Hlth, Ctr Sexual Hlth Promot, PH 116, Bloomington, IN 47401 USA.	debby@indiana.edu	; Fu, Tsung-chieh/E-6136-2019	Herbenick, Debby/0000-0002-0352-2248; Fu, Tsung-chieh/0000-0003-2118-7225; Rosenberg, Molly/0000-0001-6679-6791	Indiana University School of Public Health	We are grateful to the Indiana University School of Public Health for support of our research.	American College Health Association, 2013, AM COLL HLTH ASS NAT; Anderson D.R., 2016, THESIS ALLIANT INT U; Beres M.A., 2020, YOUTH HLTH SAFE RELA; Bichard H, 2021, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1868537; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bridges AJ, 2010, VIOLENCE AGAINST WOM, V16, P1065, DOI 10.1177/1077801210382866; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bushnell CD, 2018, J CEREBR BLOOD F MET, V38, P2179, DOI 10.1177/0271678X18793324; Busse H, 2015, ARCH DIS CHILD, V100, P1106, DOI 10.1136/archdischild-2015-308187; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Cimino AN, 2019, J AGGRESS MALTREAT T, V28, P714, DOI 10.1080/10926771.2019.1587657; De Boos J, 2019, EMERG MED AUSTRALAS, V31, P302, DOI 10.1111/1742-6723.13243; Eastman-Mueller H, 2021, J AM COLL HEALTH, DOI 10.1080/07448481.2021.1905649; Engle G., 2020, MENS HLTH 0721; Fritz N, 2020, ARCH SEX BEHAV, V49, P3041, DOI 10.1007/s10508-020-01773-0; Glass N, 2008, J EMERG MED, V35, P329, DOI 10.1016/j.jemermed.2007.02.065; Gossett JL, 2002, GENDER SOC, V16, P689, DOI 10.1177/089124302236992; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hammers C, 2019, SIGNS, V44, P491, DOI 10.1086/699370; Herbenick D., ARCH SEX BEHAV; Herbenick D, 2021, J AM COLL HEALTH, DOI 10.1080/07448481.2021.1920599; Herbenick D, 2021, J SEX MED, V18, P1024, DOI 10.1016/j.jsxm.2021.03.006; Herbenick D, 2021, ARCH SEX BEHAV, V50, P1183, DOI 10.1007/s10508-021-01917-w; Herbenick D, 2020, J SEX MED, V17, P623, DOI 10.1016/j.jsxm.2020.01.013; Herbenick D, 2019, J SEX MARITAL THER, V45, P424, DOI 10.1080/0092623X.2018.1549634; Johnson L, 2022, J INTERPERS VIOLENCE, V37, pNP594, DOI 10.1177/0886260520916273; Joshi M, 2012, SOC WORK HEALTH CARE, V51, P798, DOI 10.1080/00981389.2012.692352; Keene S.M., 2019, THESIS VICTORIA U WE; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lee EM, 2015, ARCH SEX BEHAV, V44, P1751, DOI 10.1007/s10508-015-0575-4; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Linkletter M, 2010, CLIN PEDIATR, V49, P274, DOI 10.1177/0009922809339203; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Moore A., 2019, THE GUARDIAN 0302; Roma P, 2013, ARCH SEX BEHAV, V42, P895, DOI 10.1007/s10508-012-0035-3; Rothman EF, 2019, J FAM VIOLENCE, V34, P177, DOI 10.1007/s10896-018-9982-3; Sauvageau A, 2010, J FORENSIC SCI, V55, P1259, DOI 10.1111/j.1556-4029.2010.01459.x; Sendler DJ, 2018, J FORENSIC LEG MED, V56, P59, DOI 10.1016/j.jflm.2018.03.012; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Stansfield R, 2021, J INTERPERS VIOLENCE, V36, pNP5105, DOI 10.1177/0886260518795175; Strack GB, 2001, J EMERG MED, V21, P303, DOI 10.1016/S0736-4679(01)00399-7; Sun CF., 2017, SEXUALIZATION MEDIA, V3, P1; Thomas JN, 2020, SEXUALITIES, V23, P917, DOI 10.1177/1363460719861800; Triffin M., 2016, WOMENS HLTH 0323; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Wright PJ, 2015, COMMUN MONOGR, V82, P252, DOI 10.1080/03637751.2014.981558; Yardley E, 2021, VIOLENCE AGAINST WOM, V27, P1840, DOI 10.1177/1077801220966956; Zilkens RR, 2016, J FORENSIC LEG MED, V43, P1, DOI 10.1016/j.jflm.2016.06.005	48	1	1	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0092-623X	1521-0715		J SEX MARITAL THER	J. Sex Marital Ther.												10.1080/0092623X.2021.1985025		SEP 2021	13	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	WA1YR	WOS:000702689700001	34596011				2022-02-06	
J	Karr, JE; Iverson, GL; Isokuortti, H; Kataja, A; Brander, A; Ohman, J; Luoto, TM				Karr, Justin E.; Iverson, Grant L.; Isokuortti, Harri; Kataja, Anneli; Brander, Antti; Ohman, Juha; Luoto, Teemu M.			Preexisting conditions in older adults with mild traumatic brain injuries	BRAIN INJURY			English	Article						Brain concussion; head injuries; closed; aged; computed tomography; comorbidity	SPORTS-RELATED CONCUSSION; NEUROPSYCHOLOGICAL OUTCOMES; COGNITIVE IMPAIRMENT; ALCOHOL-CONSUMPTION; WHITE-MATTER; RISK-FACTOR; DEMENTIA; ANXIETY; IMPACT; MODERATE	Objective This study examined the prevalence of preexisting conditions that could affect premorbid brain health, cognition, and functional independence among older adults with mild traumatic brain injury (MTBI), and the relationship between preexisting conditions, injury characteristics, and emergency department (ED) discharge location (home versus continued care). Methods Older adults (N = 1,427; 55-104 years-old; 47.4% men) who underwent head computed tomography (CT) after acute head trauma were recruited from the ED. Researchers documented preexisting medical conditions retrospectively from hospital records. Results Multiple preexisting conditions increased in frequency with greater age, including circulatory and nervous system diseases and preexisting abnormalities on head CT. Psychiatric and substance use disorders (SUDs) decreased in frequency with greater age. Among participants with uncomplicated MTBI and GCS = 15, preexisting nervous system diseases and preexisting CT abnormalities were associated with higher odds of continued care for all participants, whereas psychiatric disorders and SUDs were only associated with higher odds of continued care among participants <70 years-old. Preexisting circulatory diseases, loss of consciousness, and amnesia were unassociated with discharge location. Conclusions Preexisting medical conditions that could affect brain and cognitive health occur commonly among older adults who sustain MTBIs. These conditions can confound research examining post-injury outcomes within this age group.	[Karr, Justin E.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Boston, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [Isokuortti, Harri] Helsinki Univ Cent Hosp, Neuroctr, Dept Neurol, Helsinki, Finland; [Kataja, Anneli; Brander, Antti] Tampere Univ Hosp, Med Imaging Ctr, Dept Radiol, Tampere, Finland; [Ohman, Juha] Tampere Univ, Dept Neurosurg, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ, Tampere, Finland		Karr, JE (corresponding author), Univ Kentucky, 171 Funkhouser Dr,012D Kastle Hall, Lexington, KY 40506 USA.	jkarr@uky.edu		Karr, Justin/0000-0003-3653-332X; Iverson, Grant/0000-0001-7348-9570	Finnish State Research Fund	This study was financially supported by the Finnish State Research Funding.	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Albrecht MA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00105; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Beaudreau SA, 2009, PSYCHOL AGING, V24, P507, DOI 10.1037/a0016035; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Cheng MH, 2017, J NURS SCHOLARSHIP, V49, P529, DOI 10.1111/jnu.12322; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; FUHRER R, 1992, PSYCHOL MED, V22, P159, DOI 10.1017/S0033291700032815; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Hicks AJ, 2019, J NEUROTRAUM, V36, P3191, DOI 10.1089/neu.2018.6346; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Huang L, 2006, CHINESE MED J-PEKING, V119, P1304, DOI 10.1097/00029330-200608010-00012; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Isokuortti H, 2016, J NEUROTRAUM, V33, P232, DOI 10.1089/neu.2015.3888; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Keary TA, 2008, EXP AGING RES, V34, P101, DOI 10.1080/03610730701876920; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Lecours A, 2012, J HEAD TRAUMA REHAB, V27, P379, DOI 10.1097/HTR.0b013e31823b2385; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; McIntyre RS, 2017, J CLIN PSYCHIAT, V78, P115, DOI 10.4088/JCP.16m10744; Modrego PJ, 2004, ARCH NEUROL-CHICAGO, V61, P1290, DOI 10.1001/archneur.61.8.1290; Mohlman J, 2009, PSYCHIAT RES-NEUROIM, V173, P121, DOI 10.1016/j.pscychresns.2008.09.010; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; Mukamal KJ, 2003, JAMA-J AM MED ASSOC, V289, P1405, DOI 10.1001/jama.289.11.1405; Peck KA, 2014, J TRAUMA ACUTE CARE, V77, P978, DOI 10.1097/TA.0000000000000356; Pfefferbaum A, 1997, ALCOHOL CLIN EXP RES, V21, P521, DOI 10.1111/j.1530-0277.1997.tb03798.x; Reitz C, 2007, ARCH NEUROL-CHICAGO, V64, P1734, DOI 10.1001/archneur.64.12.1734; Ristiluoma, 2012, TERVEYS TOIMINTAKYKY; Schroeter ML, 2011, J AFFECT DISORDERS, V134, P32, DOI 10.1016/j.jad.2010.11.008; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sinoff G, 2003, INT J GERIATR PSYCH, V18, P951, DOI 10.1002/gps.1004; Steffener J., 2017, CLIN NEUROPSYCHOL, V32, P1; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; Wolitzky-Taylor KB, 2010, DEPRESS ANXIETY, V27, P190, DOI 10.1002/da.20653; World Health Organization, 1992, ICD 10 CLASS MENT BE	48	1	1	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV 10	2021	35	12-13					1607	1615		10.1080/02699052.2021.1976419		SEP 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XP4FK	WOS:000698211600001	34546830				2022-02-06	
J	Cecchi, NJ; Domel, AG; Liu, YZ; Rice, E; Lu, R; Zhan, XH; Zhou, Z; Raymond, SJ; Sami, S; Singh, H; Rangel, I; Watson, LP; Kleiven, S; Zeineh, M; Camarillo, DB; Grant, G				Cecchi, Nicholas J.; Domel, August G.; Liu, Yuzhe; Rice, Eli; Lu, Rong; Zhan, Xianghao; Zhou, Zhou; Raymond, Samuel J.; Sami, Sohrab; Singh, Heer; Rangel, India; Watson, Landon P.; Kleiven, Svein; Zeineh, Michael; Camarillo, David B.; Grant, Gerald			Identifying Factors Associated with Head Impact Kinematics and Brain Strain in High School American Football via Instrumented Mouthguards	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Head impact sensor; Concussion; Brain injury; Head acceleration; Finite element model; Helmet	IN-VIVO; CONCUSSION; COLLEGIATE; EXPOSURE; EPIDEMIOLOGY; INJURIES; PLAYERS; LOCATION; SYSTEM	Repeated head impact exposure and concussions are common in American football. Identifying the factors associated with high magnitude impacts aids in informing sport policy changes, improvements to protective equipment, and better understanding of the brain's response to mechanical loading. Recently, the Stanford Instrumented Mouthguard (MiG2.0) has seen several improvements in its accuracy in measuring head kinematics and its ability to correctly differentiate between true head impact events and false positives. Using this device, the present study sought to identify factors (e.g., player position, helmet model, direction of head acceleration, etc.) that are associated with head impact kinematics and brain strain in high school American football athletes. 116 athletes were monitored over a total of 888 athlete exposures. 602 total impacts were captured and verified by the MiG2.0's validated impact detection algorithm. Peak values of linear acceleration, angular velocity, and angular acceleration were obtained from the mouthguard kinematics. The kinematics were also entered into a previously developed finite element model of the human brain to compute the 95th percentile maximum principal strain. Overall, impacts were (mean +/- SD) 34.0 +/- 24.3 g for peak linear acceleration, 22.2 +/- 15.4 rad/s for peak angular velocity, 2979.4 +/- 3030.4 rad/s(2) for peak angular acceleration, and 0.262 +/- 0.241 for 95th percentile maximum principal strain. Statistical analyses revealed that impacts resulting in Forward head accelerations had higher magnitudes of peak kinematics and brain strain than Lateral or Rearward impacts and that athletes in skill positions sustained impacts of greater magnitude than athletes in line positions. 95th percentile maximum principal strain was significantly lower in the observed cohort of high school football athletes than previous reports of collegiate football athletes. No differences in impact magnitude were observed in athletes with or without previous concussion history, in athletes wearing different helmet models, or in junior varsity or varsity athletes. This study presents novel information on head acceleration events and their resulting brain strain in high school American football from our advanced, validated method of measuring head kinematics via instrumented mouthguard technology.	[Cecchi, Nicholas J.; Domel, August G.; Liu, Yuzhe; Zhan, Xianghao; Zhou, Zhou; Raymond, Samuel J.; Watson, Landon P.; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Rice, Eli; Sami, Sohrab; Singh, Heer; Rangel, India] Stanford Univ, Stanford Ctr Clin Res, Stanford, CA 94305 USA; [Lu, Rong] Stanford Univ, Quantitat Sci Unit, Stanford, CA 94305 USA; [Kleiven, Svein] KTH Royal Inst Technol, Neuron Engn, Stockholm, Sweden; [Zeineh, Michael] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Grant, Gerald] Stanford Univ, Dept Neurosurg, Pediat Neurosurg, 300 Pasteur Dr Room R211,MC 5327, Stanford, CA 94305 USA		Grant, G (corresponding author), Stanford Univ, Dept Neurosurg, Pediat Neurosurg, 300 Pasteur Dr Room R211,MC 5327, Stanford, CA 94305 USA.	ggrant2@stanford.edu	Cecchi, Nicholas J/AAC-6547-2021	Cecchi, Nicholas J/0000-0001-9319-4163; Lu, Rong/0000-0003-4321-9144; Zhan, Xianghao/0000-0002-7058-2603	Taube Stanford Children's Concussion Initiative; Child Health Research Institute at Stanford; Harman Faculty Scholar Award; NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R24NS098518]; Pac12 Conference's Student-Athlete Health and Well-Being Initiative; NIH National Center for Advancing Translational Sciences [UL1TR003142]	This research was supported by the Taube Stanford Children's Concussion Initiative, Child Health Research Institute at Stanford, Harman Faculty Scholar Award, the NIH National Institute of Neurological Disorders and Stroke (Grant: R24NS098518), the Pac12 Conference's Student-Athlete Health and Well-Being Initiative, and the NIH National Center for Advancing Translational Sciences (Grant: UL1TR003142). We sincerely thank all the coaches, trainers, and players at the participating high schools for their willingness to enroll in these studies.	Alizadeh HV, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4049155; Asken BM, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01197-4; Bailey AM, 2020, ANN BIOMED ENG, V48, P2566, DOI 10.1007/s10439-020-02626-6; Bailey AM, 2020, ANN BIOMED ENG, V48, P2531, DOI 10.1007/s10439-020-02627-5; Bartsch AJ, 2020, ANN BIOMED ENG, V48, P2667, DOI 10.1007/s10439-020-02640-8; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Camarillo D. B., ANN BIOMED ENG, V2021; Campolettano ET, 2019, ANN BIOMED ENG, V47, P2086, DOI 10.1007/s10439-019-02309-x; Cecchi NJ, 2021, RES SPORTS MED, DOI 10.1080/15438627.2021.1929226; Cecchi NJ, 2020, P I MECH ENG P-J SPO, V234, P162, DOI 10.1177/1754337120901974; Cecchi NJ, 2019, SPORTS ENG, V22, DOI 10.1007/s12283-019-0311-8; Champagne AA, 2019, MED SCI SPORT EXER, V51, P2366, DOI 10.1249/MSS.0000000000002046; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dick R, 2007, J ATHL TRAINING, V42, P221; Domel AG, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87085-2; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Fahlstedt M, 2021, ANN BIOMED ENG, V49, P1097, DOI 10.1007/s10439-020-02703-w; Foss KDB, 2019, CLIN J SPORT MED, V29, P442, DOI 10.1097/JSM.0000000000000753; Fukuda T., 2019, J PHYS FIT SPORT MED, V8, P1, DOI [10.7600/jpfsm.8.1, DOI 10.7600/JPFSM.8.1]; Gabler LF, 2020, ANN BIOMED ENG, V48, P2599, DOI 10.1007/s10439-020-02654-2; Ghazi K, 2021, J NEUROTRAUM, V38, P1023, DOI 10.1089/neu.2020.7281; Gilchrist, 2013, 2013 IRCOBI C P INT, P525; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hajiaghamemar M, 2021, J NEUROTRAUM, V38, P144, DOI 10.1089/neu.2019.6791; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Joseph JR, 2020, J NEUROSURG, V133, P1886, DOI 10.3171/2019.7.JNS191272; Joseph JR, 2019, J NEUROSURG, V130, P1642, DOI 10.3171/2017.12.JNS172386; Kieffer EE, 2020, ANN BIOMED ENG, V48, P2613, DOI 10.1007/s10439-020-02647-1; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lessley DJ, 2020, ANN BIOMED ENG, V48, P2542, DOI 10.1007/s10439-020-02657-z; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; Macy JT, 2021, PUBLIC HEALTH REP, V136, P562, DOI 10.1177/0033354920976553; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McIlvain G, 2018, DEV COGN NEUROS-NETH, V34, P27, DOI 10.1016/j.dcn.2018.06.001; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Patton DA, 2020, ANN BIOMED ENG, V48, P2497, DOI 10.1007/s10439-020-02642-6; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Swartz EE, 2019, J SCI MED SPORT, V22, P1102, DOI 10.1016/j.jsams.2019.05.018; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Withnall, 2019, NFL LINEAR IMPACTOR; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Zhan XH, 2021, J R SOC INTERFACE, V18, DOI 10.1098/rsif.2021.0260; Zhan XH, 2021, IEEE T BIO-MED ENG, V68, P3424, DOI 10.1109/TBME.2021.3073380; Zhou Zhou, 2018, Stapp Car Crash J, V62, P293; Zimmerman KA, 2021, J BIOMECH, V118, DOI 10.1016/j.jbiomech.2021.110256; Zonner SW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00327; Zonner SW, 2019, JAMA OPHTHALMOL, V137, P265, DOI 10.1001/jamaophthalmol.2018.6193	64	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2814	2826		10.1007/s10439-021-02853-5		SEP 2021	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000698088100001	34549342				2022-02-06	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Acute and Chronic Effects of Multiple Concussions on Midline Brain Structures	NEUROLOGY			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; TENSOR IMAGING DETECTS; PROFESSIONAL FOOTBALL; TEMPORAL WINDOW; RECURRENT CONCUSSION; MIDCINGULATE CORTEX; VULNERABILITY; SPORTS; INJURY; PATHOPHYSIOLOGY	Background and Objectives To test the hypothesis that a history of concussion (HOC) causes greater disturbances in cerebral blood flow (CBF) and white matter microstructure of midline brain structures after subsequent concussions, during the acute and chronic phases of recovery. Methods In this longitudinal MRI study, 61 athletes with uncomplicated concussion (36 with HOC) were imaged at the acute phase of injury (1-7 days after injury), the subacute phase (8-14 days), medical clearance to return to play (RTP), 1 month after RTP, and 1 year after RTP. A normative group of 167 controls (73 with HOC) were also imaged. Each session assessed CBF of the cingulate cortex, along with fractional anisotropy (FA) and mean diffusivity (MD) of the corpus callosum. Linear mixed models tested for interactions of HOC with time since injury. The Sport Concussion Assessment Tool (SCAT) was also used to evaluate effects of HOC on symptoms, cognition, and balance. Results Athletes with HOC had significantly greater declines in midcingulate CBF subacutely (z = -3.29, p = 0.002) and greater declines in posterior cingulate CBF at 1 year after RTP (z = -2.42, p = 0.007). No significant effects of HOC were seen for FA, whereas athletes with HOC had higher MD of the splenium at RTP (z = 2.54, p = 0.008). These effects were seen in the absence of significant differences in SCAT domains (|z| <= 1.14, p >= 0.256) or time to RTP (z = 0.23, p = 0.818). Discussion Results indicate subacute and chronic effects of HOC on cingulate CBF and callosal microstructure in the absence of differences in clinical indices. These findings provide new insights into physiologic brain recovery after concussion, with cumulative effects of repeated injury detected among young, healthy athletes.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada		Schweizer, TA (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.; Schweizer, TA (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.; Schweizer, TA (corresponding author), Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada.; Schweizer, TA (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	tom.schweizer@unityhealth.to			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [RN294001-367456]; Canadian Institute for Military and Veterans Health Research [W7714145967]; Siemens Healthineers Canada	This work was supported by the Canadian Institutes of Health Research (grant RN294001-367456), the Canadian Institute for Military and Veterans Health Research (grant W7714145967), and Siemens Healthineers Canada.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bailey DM, 2011, EXP PHYSIOL, V96, P1196, DOI 10.1113/expphysiol.2011.060178; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2020, NEUROIMAGE-CLIN, V27, DOI 10.1016/j.nicl.2020.102258; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hoffstaedter F, 2014, HUM BRAIN MAPP, V35, P2741, DOI 10.1002/hbm.22363; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jarbo K, 2012, NEUROIMAGE, V59, P1988, DOI 10.1016/j.neuroimage.2011.09.056; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Vogt BA, 2016, J CHEM NEUROANAT, V74, P28, DOI 10.1016/j.jchemneu.2016.01.010; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	49	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 21	2021	97	12					E1170	E1181		10.1212/WNL.0000000000012580			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UZ7NM	WOS:000702388500016	34433678	Green Submitted			2022-02-06	
J	Campagno, KE; Lu, WN; Jassim, AH; Albalawi, F; Cenaj, A; Tso, HY; Clark, SP; Sripinun, P; Gomez, NM; Mitchell, CH				Campagno, Keith E.; Lu, Wennan; Jassim, Assraa Hassan; Albalawi, Farraj; Cenaj, Aurora; Tso, Huen-Yee; Clark, Sophia P.; Sripinun, Puttipong; Gomez, Nestor Mas; Mitchell, Claire H.			Rapid morphologic changes to microglial cells and upregulation of mixed microglial activation state markers induced by P2X7 receptor stimulation and increased intraocular pressure	JOURNAL OF NEUROINFLAMMATION			English	Article						Microglial M1; M2 activation; Neuroinflammation; Sholl analysis; Chemoattraction migration; ATP release; Intraocular pressure; Iba1; Glaucoma; Traumatic brain injury	RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; P2X(7) RECEPTOR; MOUSE MODEL; SUSTAINED ELEVATION; EXTRACELLULAR ATP; AXONAL DAMAGE; RELEASE; RAT; ANTAGONIST	Background The identification of endogenous signals that lead to microglial activation is a key step in understanding neuroinflammatory cascades. As ATP release accompanies mechanical strain to neural tissue, and as the P2X7 receptor for ATP is expressed on microglial cells, we examined the morphological and molecular consequences of P2X7 receptor stimulation in vivo and in vitro and investigated the contribution of the P2X7 receptor in a model of increased intraocular pressure (IOP). Methods In vivo experiments involved intravitreal injections and both transient and sustained elevation of IOP. In vitro experiments were performed on isolated mouse retinal and brain microglial cells. Morphological changes were quantified in vivo using Sholl analysis. Expression of mRNA for M1- and M2-like genes was determined with qPCR. The luciferin/luciferase assay quantified retinal ATP release while fura-2 indicated cytoplasmic calcium. Microglial migration was monitored with a Boyden chamber. Results Sholl analysis of Iba1-stained cells showed retraction of microglial ramifications 1 day after injection of P2X7 receptor agonist BzATP into mouse retinae. Mean branch length of ramifications also decreased, while cell body size and expression of Nos2, Tnfa, Arg1, and Chil3 mRNA increased. BzATP induced similar morphological changes in ex vivo tissue isolated from Cx3CR1(+/GFP) mice, suggesting recruitment of external cells was unnecessary. Immunohistochemistry suggested primary microglial cultures expressed the P2X7 receptor, while functional expression was demonstrated with Ca2+ elevation by BzATP and block by specific antagonist A839977. BzATP induced process retraction and cell body enlargement within minutes in isolated microglial cells and increased Nos2 and Arg1. While ATP increased microglial migration, this required the P2Y12 receptor and not P2X7 receptor. Transient elevation of IOP led to microglial process retraction, cell body enlargement, and gene upregulation paralleling changes observed with BzATP injection, in addition to retinal ATP release. Pressure-dependent changes were reduced in P2X7(-/-) mice. Death of retinal ganglion cells accompanied increased IOP in C57Bl/6J, but not P2X7(-/-) mice, and neuronal loss showed some association with microglial activation. Conclusions P2X7 receptor stimulation induced rapid morphological activation of microglial cells, including process retraction and cell body enlargement, and upregulation of markers linked to both M1- and M2-type activation. Parallel responses accompanied IOP elevation, suggesting ATP release and P2X7 receptor stimulation influence the early microglial response to increased pressure.	[Campagno, Keith E.; Lu, Wennan; Jassim, Assraa Hassan; Cenaj, Aurora; Tso, Huen-Yee; Clark, Sophia P.; Gomez, Nestor Mas; Mitchell, Claire H.] Univ Penn, Dept Basic & Translat Sci, 240 S 40th St, Philadelphia, PA 19104 USA; [Albalawi, Farraj; Sripinun, Puttipong] Univ Penn, Dept Orthodont, Philadelphia, PA 19104 USA; [Albalawi, Farraj] King Saud bin Abdulaziz Univ Hlth Sci, Coll Dent, Dept Prevent Dent Sci, Riyadh, Saudi Arabia; [Albalawi, Farraj] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Mitchell, Claire H.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Mitchell, Claire H.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA		Mitchell, CH (corresponding author), Univ Penn, Dept Basic & Translat Sci, 240 S 40th St, Philadelphia, PA 19104 USA.; Mitchell, CH (corresponding author), Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA.; Mitchell, CH (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	chm@upenn.edu			 [R01 EY015537];  [R01 EY013434];  [P30 EY001583];  [TL1TR001880];  [T32EY007035];  [T32NS043126]	This work was supported by grants R01 EY015537 (CHM), R01 EY013434 (CHM), core grant P30 EY001583 (CHM), TL1TR001880 (KC), T32EY007035 (KC), and T32NS043126 (AHJ). The funding bodies played no role in the design of the study and collection, analysis, or interpretation of data and in writing the manuscript.	Adinolfi E, 2018, BIOCHEM PHARMACOL, V151, P234, DOI 10.1016/j.bcp.2017.12.021; Akhmetzyanova E, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00037; Albalawi F, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00227; Beckel JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23877-3; Beckel JM, 2014, GLIA, V62, P1486, DOI 10.1002/glia.22695; Bell K, 2018, CURR NEUROPHARMACOL, V16, P942, DOI 10.2174/1570159X15666170720094529; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Bosco A, 2015, DIS MODEL MECH, V8, P443, DOI 10.1242/dmm.018788; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Bucolo C, 2011, PHARMACOL THERAPEUT, V130, P191, DOI 10.1016/j.pharmthera.2011.01.013; Burnstock G, 2018, PURINERG SIGNAL, V14, P1, DOI 10.1007/s11302-017-9593-0; Butovsky O, 2018, NAT REV NEUROSCI, V19, P622, DOI 10.1038/s41583-018-0057-5; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Campagno KE, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.645244; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Clapp C, 2019, ACTA DIABETOL, V56, P1031, DOI 10.1007/s00592-019-01343-4; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Crowston JG, 2015, EXP EYE RES, V141, P3, DOI 10.1016/j.exer.2015.03.006; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Dong LD, 2018, MOL MED REP, V17, P2289, DOI 10.3892/mmr.2017.8137; Fabbrizio P, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00249; Fletcher EL, 2019, DRUG DISCOV TODAY, V24, P1598, DOI 10.1016/j.drudis.2019.03.029; Fresta CG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239305; Galloway DA, 2019, GLIA, V67, P857, DOI 10.1002/glia.23576; Garcia-Bermudez MY, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.624983; Gomez NM, 2018, FASEB J, V32, P782, DOI 10.1096/fj.201700220RR; Guha S, 2013, FASEB J, V27, P4500, DOI 10.1096/fj.13-236166; Guzman-Martinez L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01008; Gyoneva S, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900453; He YB, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0904-8; Honore P, 2009, BEHAV BRAIN RES, V204, P77, DOI 10.1016/j.bbr.2009.05.018; Hu HL, 2010, EXP EYE RES, V91, P425, DOI 10.1016/j.exer.2010.06.017; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huang LQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-102; Janks L, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1353-8; Jassim AH, 2019, INVEST OPHTH VIS SCI, V60, P1, DOI 10.1167/iovs.18-24977; Jassim AH, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.699623; Kobashi S, 2020, MOL THER, V28, P254, DOI 10.1016/j.ymthe.2019.09.004; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Li A, 2011, EXP EYE RES, V93, P528, DOI 10.1016/j.exer.2011.06.020; Lian Hong, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.1989; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lim JC, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00270; Liu X, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1081-0; Lively S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00215; Lu WN, 2019, INVEST OPHTH VIS SCI, V60, P3046, DOI 10.1167/iovs.19-27241; Lu WN, 2017, J NEUROCHEM, V141, P436, DOI 10.1111/jnc.13998; Lu WN, 2015, INVEST OPHTH VIS SCI, V56, P3075, DOI 10.1167/iovs.14-15891; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Madry C, 2018, NEURON, V97, P299, DOI 10.1016/j.neuron.2017.12.002; Ventura ALM, 2019, BRAIN RES BULL, V151, P92, DOI 10.1016/j.brainresbull.2018.10.016; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Mitchell CH, 2009, PURINERG SIGNAL, V5, P241, DOI 10.1007/s11302-009-9142-6; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Notomi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053338; Ochocka N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22063027; de Lara MJP, 2019, BRAIN RES BULL, V150, P61, DOI 10.1016/j.brainresbull.2019.05.006; Platania CBM, 2019, BIOCHEM PHARMACOL, V168, P249, DOI 10.1016/j.bcp.2019.07.010; Platania CBM, 2017, BIOCHEM PHARMACOL, V138, P130, DOI 10.1016/j.bcp.2017.05.001; Ramirez AI, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00214; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Reigada D, 2008, NEUROSCIENCE, V157, P396, DOI 10.1016/j.neuroscience.2008.08.036; Rodrigues-Neves AC, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00016; Romano GL, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114199; ROQUE RS, 1993, CURR EYE RES, V12, P285, DOI 10.3109/02713689308999475; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Savio LEB, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00052; Shao XL, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122537; Sperlagh B, 2014, TRENDS PHARMACOL SCI, V35, P537, DOI 10.1016/j.tips.2014.08.002; Sterling JK, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108271; Stowell C, 2017, EXP EYE RES, V157, P13, DOI 10.1016/j.exer.2017.02.005; Sugiyama T, 2013, MOL VIS, V19, P2080; Szepesi Z, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00323; Tamm ER, 2017, EXP EYE RES, V157, P5, DOI 10.1016/j.exer.2017.02.006; Tehrani S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167364; Wang AYM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83669-0; Wei LY, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01304; Wilson JL, 2017, FREE RADICAL BIO MED, V104, P311, DOI 10.1016/j.freeradbiomed.2017.01.022; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104	83	1	1	5	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	SEP 20	2021	18	1							217	10.1186/s12974-021-02251-7			18	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	UT9RF	WOS:000698444300001	34544431	gold, Green Published			2022-02-06	
J	Filben, TM; Pritchard, NS; Hanes-Romano, KE; Miller, LE; Miles, CM; Urban, JE; Stitzel, JD				Filben, Tanner M.; Pritchard, N. Stewart; Hanes-Romano, Kathryn E.; Miller, Logan E.; Miles, Christopher M.; Urban, Jillian E.; Stitzel, Joel D.			Comparison of women's collegiate soccer header kinematics by play state, intent, and outcome	JOURNAL OF BIOMECHANICS			English	Article						Head impact exposure; Headers; Mouthpiece; Repetitive head impacts	EPIDEMIOLOGY; CONCUSSION; SCENARIO; EXPOSURE; IMPACTS	Although most head impacts in soccer are headers, limited knowledge exists about how header magnitude varies by on-field scenario. This study aimed to compare head kinematics during on-field headers by play state (i.e., corner kick, goal kick, free kick, throw-in, drill, or live ball), intent (i.e., pass, shot, or clearance), and outcome (i. e., successful or unsuccessful). Fifteen female collegiate soccer players were instrumented with mouthpiece-based head impact sensors during 72 practices and 24 games. A total of 336 headers were verified and contextualized via film review. Play state was associated with peak linear acceleration, rotational acceleration, and rotational velocity (all p < .001) while outcome was associated with peak linear acceleration (p < .010). Header intent was not significantly associated with any kinematic metric. Headers during corner kicks (22.9 g, 2189.3 rad/s(2), 9.87 rad/s), goal kicks (24.3 g, 2658.9 rad/s(2), 10.1 rad/s), free kicks (18.0 g, 1843.3 rad/s(2), 8.43 rad/s), and live balls (18.8 g, 1769.7 rad/s(2), 8.09 rad/s) each had significantly greater mean peak linear acceleration (all p < .050), rotational acceleration (all p < .001), and rotational velocity (all p < .001) than headers during drills (13.0 g, 982.4 rad/s(2), 5.28 rad/s). Headers during goal kicks also had a significantly greater mean rotational acceleration compared to headers during live ball scenarios (p < .050). Successful headers (18.3 g) had a greater mean peak linear acceleration compared to unsuccessful headers (13.8 g; p < .010). Results may help inform efforts to reduce head impact exposure in soccer.	[Filben, Tanner M.; Pritchard, N. Stewart; Miller, Logan E.; Miles, Christopher M.; Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA; [Filben, Tanner M.; Pritchard, N. Stewart; Miller, Logan E.; Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27101 USA; [Hanes-Romano, Kathryn E.; Miles, Christopher M.] Wake Forest Baptist Hlth, Sports Med, Winston Salem, NC USA; [Miles, Christopher M.] Wake Forest Sch Med, Dept Family & Community Med, Winston Salem, NC 27101 USA		Filben, TM (corresponding author), 575 N Patterson Ave,Suite 530, Winston Salem, NC 27101 USA.	tfilben@wakehealth.edu		Filben, Tanner/0000-0002-2572-0093	National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [2102417]; Childress Institute for Pediatric Trauma (Winston-Salem, NC, USA)	The authors would like to thank the women's soccer players for participating and the team athletic trainer and coaching staff for engaging with the study. The authors would also like to acknowledge Sarah Woods, Megan Hayden, and Emma Northrup for their assistance with data collection and film review. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. 2102417. Any opinion, findings, and con-clusions or recommendations expressed in this material are those of the authors (s) and do not necessarily reflect the views of the National Sci-ence Foundation. This work was also supported by the Childress Institute for Pediatric Trauma (Winston-Salem, NC, USA) . No sponsor institution was involved in the study design, data collection, analysis/interpretation, or authorship of this manuscript.	Caccese JB, 2019, MED SCI SPORT EXER, V51, P1355, DOI 10.1249/MSS.0000000000001905; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Dick R, 2007, J ATHL TRAINING, V42, P221; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Harriss A, 2019, MUSCULOSKEL SCI PRAC, V40, P53, DOI 10.1016/j.msksp.2019.01.009; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Miller LE, 2020, RES SPORTS MED, V28, P55, DOI 10.1080/15438627.2019.1590833; Miller LE, 2019, J NEUROTRAUM, V36, P1561, DOI 10.1089/neu.2018.6037; Nowak MK, 2020, JAMA OPHTHALMOL, V138, P350, DOI 10.1001/jamaophthalmol.2019.6128; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Quintero LM, 2020, J APPL BEHAV ANAL, V53, P237, DOI 10.1002/jaba.557; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Saunders TD, 2020, CLIN BIOMECH, V74, P14, DOI 10.1016/j.clinbiomech.2020.02.003; US Youth Soccer, 2016, US YOUTH SOCC POL PL; Wallace C, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000433; Wirsching A, 2019, J NEUROTRAUM, V36, P548, DOI 10.1089/neu.2018.5836; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	28	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	SEP 20	2021	126								110619	10.1016/j.jbiomech.2021.110619			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	WA0CQ	WOS:000702564800006	34325122				2022-02-06	
J	Kobeissy, FH; Shakkour, Z; El Hayek, S; Mohammad, W; Gold, MS; Wang, KKW				Kobeissy, Firas H.; Shakkour, Zaynab; El Hayek, Samer; Mohammad, Wael; Gold, Mark S.; Wang, Kevin K. W.			Elevation of Pro-inflammatory and Anti-inflammatory Cytokines in Rat Serum after Acute Methamphetamine Treatment and Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						IL-10; IL-6; IL-1 beta; Methamphetamine; Traumatic brain injury; Drug use	INDUCED BEHAVIORAL SENSITIZATION; SPECTRIN BREAKDOWN PRODUCTS; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; TISSUE INHIBITOR; GENE-EXPRESSION; INDUCED NEUROTOXICITY; NERVOUS-SYSTEM; MESSENGER-RNA; TNF-ALPHA	The use of methamphetamine (METH) is a growing worldwide epidemic that bears grave societal implications. METH is known to exert its neurotoxic effects on the dopaminergic and serotonergic systems of the brain. In addition to this classical studied mechanism of damage, findings from our laboratory and others have shown that acute METH treatment and mechanical injury, i.e. traumatic brain injury (TBI), share common cell injury mechanism(s). Since neuro-inflammation is a signature event in TBI, we hypothesize that certain cytokine levels might also be altered in rat brain exposed to an acute METH insult. In this study, using a cytokine antibody array chip, we evaluated the serum levels of 19 cytokines in rats 24 h after exposure to a 40 mg/kg acute regimen of METH. Data were compared to rats subjected to experimental TBI using the controlled cortical impact (CCI) injury model and saline controls. Sandwich ELISA method was used to further validate some of the findings obtained from the antibody cytokine array. We confirmed that three major inflammatory-linked cytokines (IL-1 beta, IL-6, and IL-10) were elevated in the METH and TBI groups compared to the saline group. Such finding suggests the involvement of an inflammatory process in these brain insults, indicating that METH use is, in fact, a stressor to the immune system where systemic involvement of an altered cytokine profile may play a major role in mediating chemical brain injury after METH use.	[Kobeissy, Firas H.; Shakkour, Zaynab] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon; [Kobeissy, Firas H.; Wang, Kevin K. W.] Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA; [Kobeissy, Firas H.; Wang, Kevin K. W.] Univ Florida, Dept Emergency Med, Gainesville, FL 32611 USA; [El Hayek, Samer] Amer Univ Beirut, Dept Psychiat, Beirut, Lebanon; [Mohammad, Wael] Menoufia Univ, Menoufia Med Sch, Clin Pharmacol Dept, Al Minufya, Egypt; [Mohammad, Wael] Int Islamic Univ Malaysia, Basic Med Sci Dept, Kulliyyah Med, Kuantan, Pahang, Malaysia; [Gold, Mark S.] Washington Univ, Inst Publ Hlth, Washington Univ Sch Med, Dept Psychiat, St Louis, MO USA; [Gold, Mark S.] Washington Univ, Inst Publ Hlth, Natl Council, St Louis, MO USA		Wang, KKW (corresponding author), Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA.; Wang, KKW (corresponding author), Univ Florida, Dept Emergency Med, Gainesville, FL 32611 USA.	kawangwang17@gmail.com	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944; El Hayek, Samer/0000-0002-7975-6104	Donald and Irene Dizney Eminent Scholar Chair; Department of Defense (DOD)United States Department of Defense [DAMD17-03-1-0066]	This study was supported in part by the Donald and Irene Dizney Eminent Scholar Chair, held by Mark Gold, M.D. Distinguished Professor, McKnight Brain Institute and also by the Department of Defense (DOD) grant #DAMD17-03-1-0066.	Akbari A, 2019, INT IMMUNOPHARMACOL, V66, P330, DOI 10.1016/j.intimp.2018.11.047; APUZZO MLJ, 1979, J NEUROSURG, V51, P317, DOI 10.3171/jns.1979.51.3.0317; Ares-Santos S, 2013, J INTERN MED, V273, P437, DOI 10.1111/joim.12049; Asanuma M, 2004, ANN NY ACAD SCI, V1025, P69, DOI 10.1196/annals.1316.009; Benveniste EN, 1998, CYTOKINE GROWTH F R, V9, P259, DOI 10.1016/S1359-6101(98)00015-X; Borgmann K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01143; Bowyer JF, 2007, NEUROSCIENCE, V144, P66, DOI 10.1016/j.neuroscience.2006.08.076; Bowyer JF, 2006, SYNAPSE, V60, P521, DOI 10.1002/syn.20324; Cadet JL, 1997, SYNAPSE, V25, P176; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Connor TJ, 2004, IMMUNOLOGY, V111, P357, DOI 10.1111/j.0019-2805.2004.01847.x; Courtney KE, 2014, DRUG ALCOHOL DEPEN, V143, P11, DOI 10.1016/j.drugalcdep.2014.08.003; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Czigner A, 2007, ACTA NEUROCHIR, V149, P281, DOI 10.1007/s00701-006-1095-8; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Dinarello Charles Anthony, 2014, Mol Med, V20 Suppl 1, pS43, DOI 10.2119/molmed.2014.00232; Du SH, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00409; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Eugenin EA, 2013, J INFECT DIS, V208, P699, DOI 10.1093/infdis/jit117; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Ginawi OT, 2005, REGUL TOXICOL PHARM, V41, P122, DOI 10.1016/j.yrtph.2004.10.005; Ginawi OT, 2004, J PHYSIOL PHARMACOL, V55, P357; Goncalves J, 2008, ANN NY ACAD SCI, V1139, P103, DOI 10.1196/annals.1432.043; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; Haskins WE, 2005, J NEUROTRAUM, V22, P629, DOI 10.1089/neu.2005.22.629; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hedegaard Holly, 2018, Natl Vital Stat Rep, V67, P1; Hirata H, 1997, J NEUROCHEM, V69, P780; Ho EL, 2009, NEUROCRIT CARE, V10, P295, DOI 10.1007/s12028-008-9177-5; HOUSE RV, 1994, IMMUNOPHARM IMMUNOT, V16, P1, DOI 10.3109/08923979409029897; Ikeda T, 2000, ACTA NEUROPATHOL, V100, P161, DOI 10.1007/s004019900162; Itzhak Y, 1996, J NEUROCHEM, V67, P1770; Jimenez A, 2004, TOXICOL APPL PHARM, V196, P223, DOI 10.1016/j.taap.2003.12.017; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kousik SM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00121; KRUEGER J, 1991, J CELL BIOCHEM, V45, P327, DOI 10.1002/jcb.240450404; Kuhn DM, 2006, ANN NY ACAD SCI, V1074, P31, DOI 10.1196/annals.1369.003; Ladenheim B, 2000, MOL PHARMACOL, V58, P1247, DOI 10.1124/mol.58.6.1247; Lai KSP, 2017, J NEUROL NEUROSUR PS, V88, P876, DOI 10.1136/jnnp-2017-316201; Lan KC, 1998, J FORMOS MED ASSOC, V97, P528; Lauw FN, 2000, J IMMUNOL, V165, P2783, DOI 10.4049/jimmunol.165.5.2783; LIU HM, 1988, FORENSIC SCI INT, V38, P285, DOI 10.1016/0379-0738(88)90174-0; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033822; Loftis JM, 2014, INT REV NEUROBIOL, V118, P165, DOI 10.1016/B978-0-12-801284-0.00007-5; LOTAN M, 1994, FASEB J, V8, P1026, DOI 10.1096/fasebj.8.13.7926367; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; Lwin T, 2021, PROG NEURO-PSYCHOPH, V111, DOI 10.1016/j.pnpbp.2020.110109; Mahajan SD, 2008, BRAIN RES, V1203, P133, DOI 10.1016/j.brainres.2008.01.093; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; Miyazaki M, 2013, INT J NEUROPSYCHOPH, V16, P1341, DOI 10.1017/S1461145712001356; Mizoguchi H, 2008, J PHARMACOL SCI, V106, P9, DOI 10.1254/jphs.FM0070139; Mizoguchi H, 2007, J NEUROCHEM, V102, P1548, DOI 10.1111/j.1471-4159.2007.04623.x; Mizoguchi H, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/681385; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Muller M, 2001, Eur J Ultrasound, V12, P203, DOI 10.1016/S0929-8266(00)00118-X; Najera JA, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0145-0; NSDUH-Report, 2006, METHAMPHETAMINE USE; Park M, 2013, J BIOL CHEM, V288, P33324, DOI 10.1074/jbc.M113.483487; Patel D, 2013, MBIO, V4, DOI 10.1128/mBio.00400-13; Perez JA, 1999, J EMERG MED, V17, P469, DOI 10.1016/S0736-4679(99)00009-8; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Pu CF, 1996, SYNAPSE, V23, P328, DOI 10.1002/(SICI)1098-2396(199608)23:4<328::AID-SYN11>3.0.CO;2-T; Ramirez SH, 2009, J CEREBR BLOOD F MET, V29, P1933, DOI 10.1038/jcbfm.2009.112; Rivera S, 1997, J NEUROSCI, V17, P4223; Robson MJ, 2013, EXP NEUROL, V247, P134, DOI 10.1016/j.expneurol.2013.04.009; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Sajja RK, 2016, J CEREBR BLOOD F MET, V36, P539, DOI 10.1177/0271678X15616978; SEIDEN LS, 1988, ANN NY ACAD SCI, V537, P161, DOI 10.1111/j.1749-6632.1988.tb42104.x; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; SIMAN R, 1989, J NEUROSCI, V9, P1579; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Sokolov BP, 2006, NEUROPSYCHOPHARMACOL, V31, P956, DOI 10.1038/sj.npp.1300891; Stahel PF, 1998, NEUROSCI LETT, V249, P123, DOI 10.1016/S0304-3940(98)00410-8; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Suwanjang W, 2012, NEUROSCI LETT, V526, P49, DOI 10.1016/j.neulet.2012.07.066; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theodore S, 2006, EXP NEUROL, V199, P490, DOI 10.1016/j.expneurol.2006.01.009; Tipton DA, 2010, TOXICOL IN VITRO, V24, P921, DOI 10.1016/j.tiv.2009.11.015; UNODC, 2019, WORLD DRUG REP; Vargas AM, 2020, MOL IMMUNOL, V121, P159, DOI 10.1016/j.molimm.2020.03.013; Wallace TL, 2003, NEUROSCIENCE, V116, P1063, DOI 10.1016/S0306-4522(02)00795-9; Warren MW, 2006, J ADDICT DIS, V25, P115, DOI 10.1300/J069v25n04_11; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; WARREN MW, 2006, INT J NEUROPSYCHOPH, P1; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; YAMAGUCHI T, 1991, NEUROSCI LETT, V128, P90, DOI 10.1016/0304-3940(91)90766-M; Yang TY, 2020, TOXICOL LETT, V333, P150, DOI 10.1016/j.toxlet.2020.07.028; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Yu QL, 2002, INT IMMUNOPHARMACOL, V2, P951, DOI 10.1016/S1567-5769(02)00047-4; Zheng LM, 1996, J EXP MED, V184, P579, DOI 10.1084/jem.184.2.579; Zhou Zheng, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P217	98	1	1	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JAN	2022	72	1					158	168		10.1007/s12031-021-01886-8		SEP 2021	11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	YF8DL	WOS:000698055100001	34542809				2022-02-06	
J	Carey, L; Terry, DP; McIntosh, AS; Stanwell, P; Iverson, GL; Gardner, AJ				Carey, Lauchlan; Terry, Douglas P.; McIntosh, Andrew S.; Stanwell, Peter; Iverson, Grant L.; Gardner, Andrew J.			Video Analysis and Verification of Direct Head Impacts Recorded by Wearable Sensors in Junior Rugby League Players	SPORTS MEDICINE-OPEN			English	Article						Head impacts; Rugby league; Wearable sensors; Accelerometer; Video review	HIGH-SCHOOL; CONCUSSION; FOOTBALL; YOUTH; RECOVERY; EXPOSURE; SPORTS; TEAM	Background Rugby league is a high-intensity collision sport that carries a risk of concussion. Youth athletes are considered to be more vulnerable and take longer to recover from concussion than adult athletes. Purpose To review head impact events in elite-level junior representative rugby league and to verify and describe characteristics of X-patch(TM)-recorded impacts via video analysis. Study Design Observational case series. Methods The X-patch(TM) was used on twenty-one adolescent players (thirteen forwards and eight backs) during a 2017 junior representative rugby league competition. Game-day footage, recorded by a trained videographer from a single camera, was synchronised with X-patch(TM)-recorded timestamped events. Impacts were double verified by video review. Impact rates, playing characteristics, and gameplay situations were described. Results The X-patch(TM)-recorded 624 impacts >= 20g between game start and finish, of which 564 (90.4%) were verified on video. Upon video review, 413 (73.2%) of all verified impacts >= 20g where determined to be direct head impacts. Direct head impacts >= 20g occurred at a rate of 5.2 impacts per game hour; 7.6 for forwards and 3.0 for backs (range = 0-18.2). A defender's arm directly impacting the head of the ball carrier was the most common event, accounting for 21.3% (n = 120) of all impacts, and 46.7% of all "hit-up" impacts. There were no medically diagnosed concussions during the competition. Conclusion The majority (90.4%) of head impacts >= 20g recorded by the X-patch(TM) sensor were verified by video. Double verification of direct head impacts in addition to cross-verification of sensor-recorded impacts using a secondary source such as synchronised video review can be used to ensure accuracy and validation of data.	[Carey, Lauchlan; Stanwell, Peter; Gardner, Andrew J.] Univ Newcastle, Fac Hlth, Ctr Stroke & Brain Injury, Sch Hlth Sci, Callaghan, NSW, Australia; [Terry, Douglas P.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Terry, Douglas P.; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] Home Base, Charlestown, MA USA; [McIntosh, Andrew S.] Edith Cowan Univ, Sch Engn, Perth, WA, Australia; [McIntosh, Andrew S.] Edith Cowan Univ, Australian Collaborat Res Injury Sport & Its Prev, Perth, WA, Australia; [Gardner, Andrew J.] Hunter New England Local Hlth Dist Sports Concuss, Waratah, NSW, Australia; [Gardner, Andrew J.] Sch Med & Publ Hlth, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Gardner, Andrew J.] Hunter Med Res Inst, New Lambtom Hts, NSW, Australia		Gardner, AJ (corresponding author), Univ Newcastle, Fac Hlth, Ctr Stroke & Brain Injury, Sch Hlth Sci, Callaghan, NSW, Australia.; Gardner, AJ (corresponding author), Hunter New England Local Hlth Dist Sports Concuss, Waratah, NSW, Australia.; Gardner, AJ (corresponding author), Sch Med & Publ Hlth, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW, Australia.; Gardner, AJ (corresponding author), Hunter Med Res Inst, New Lambtom Hts, NSW, Australia.	Andrew.Gardner@newcastle.edu.au	Stanwell, Peter/F-9136-2012	Stanwell, Peter/0000-0002-4780-0393; Gardner, Andrew/0000-0001-5031-5586	National Health and Medical Research Council (NHMRC) Early Career FellowshipNational Health and Medical Research Council of Australia; University of Newcastle's Priority Research Centre for Stroke and Brain Injury	Dr. Andrew Gardner acknowledges salary support from a National Health and Medical Research Council (NHMRC) Early Career Fellowship, research grant support from the University of Newcastle's Priority Research Centre for Stroke and Brain Injury, and unrestricted philanthropic support from the National Rugby League (NRL). Dr. Grant Iverson acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, ImPACT (R) Applications, Inc., the Spaulding Research Institute, and the National Rugby League.	Brennan J., 2016, ACCELEROMETERS ASSES; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Carey L, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0182-3; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gabbett TJ, 2005, J STRENGTH COND RES, V19, P749; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gissane C, 1997, Aust J Sci Med Sport, V29, P91; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kindschi Kari, 2017, BMJ Open Sport Exerc Med, V3, pe000165, DOI 10.1136/bmjsem-2016-000165; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King DA, 2018, J SCI MED SPORT, V21, P139, DOI 10.1016/j.jsams.2017.10.026; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McIntosh AS, 2019, J SCI MED SPORT, V22, P784, DOI 10.1016/j.jsams.2019.02.004; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Patton DA, 2020, ANN BIOMED ENG, V48, P2497, DOI 10.1007/s10439-020-02642-6; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Reyes J, 2020, AM J SPORT MED, V48, P1485, DOI 10.1177/0363546520912416; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	35	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open	SEP 16	2021	7	1							66	10.1186/s40798-021-00353-3			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	US5PG	WOS:000697480400002	34529180	gold, Green Published, Green Submitted			2022-02-06	
J	Engels, M; Kalia, M; Rahmati, S; Petersilie, L; Kovermann, P; van Putten, MJAM; Rose, CR; Meijer, HGE; Gensch, T; Fahlke, C				Engels, Miriam; Kalia, Manu; Rahmati, Sarah; Petersilie, Laura; Kovermann, Peter; van Putten, Michel J. A. M.; Rose, Christine R.; Meijer, Hil G. E.; Gensch, Thomas; Fahlke, Christoph			Glial Chloride Homeostasis Under Transient Ischemic Stress	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						intracellular chloride concentrations; chemical stress mimicking ischemia; fluorescence lifetime imaging microscopy; excitatory amino acid transporters; Na-K-2Cl cotransporter; K-Cl cotransporters	AMINO-ACID TRANSPORTER; CELL-VOLUME CONTROL; K-CL COTRANSPORTER; TEMPERATURE-DEPENDENCE; MOLECULAR PHYSIOLOGY; INTRACELLULAR PH; ASTROCYTES; CHANNELS; NEURONS; BRAIN	High water permeabilities permit rapid adjustments of glial volume upon changes in external and internal osmolarity, and pathologically altered intracellular chloride concentrations ([Cl-](int)) and glial cell swelling are often assumed to represent early events in ischemia, infections, or traumatic brain injury. Experimental data for glial [Cl-](int) are lacking for most brain regions, under normal as well as under pathological conditions. We measured [Cl-](int) in hippocampal and neocortical astrocytes and in hippocampal radial glia-like (RGL) cells in acute murine brain slices using fluorescence lifetime imaging microscopy with the chloride-sensitive dye MQAE at room temperature. We observed substantial heterogeneity in baseline [Cl-](int), ranging from 14.0 +/- 2.0 mM in neocortical astrocytes to 28.4 +/- 3.0 mM in dentate gyrus astrocytes. Chloride accumulation by the Na+-K+-2Cl(-) cotransporter (NKCC1) and chloride outward transport (efflux) through K+-Cl- cotransporters (KCC1 and KCC3) or excitatory amino acid transporter (EAAT) anion channels control [Cl-](int) to variable extent in distinct brain regions. In hippocampal astrocytes, blocking NKCC1 decreased [Cl-](int), whereas KCC or EAAT anion channel inhibition had little effect. In contrast, neocortical astrocytic or RGL [Cl-](int) was very sensitive to block of chloride outward transport, but not to NKCC1 inhibition. Mathematical modeling demonstrated that higher numbers of NKCC1 and KCC transporters can account for lower [Cl-](int) in neocortical than in hippocampal astrocytes. Energy depletion mimicking ischemia for up to 10 min did not result in pronounced changes in [Cl-](int) in any of the tested glial cell types. However, [Cl-](int) changes occurred under ischemic conditions after blocking selected anion transporters. We conclude that stimulated chloride accumulation and chloride efflux compensate for each other and prevent glial swelling under transient energy deprivation.	[Engels, Miriam; Rahmati, Sarah; Kovermann, Peter; Gensch, Thomas; Fahlke, Christoph] Forschungszentrum Julich, Inst Biol Informat Proc Mol & Zellphysiol IBI 1, Julich, Germany; [Kalia, Manu; Meijer, Hil G. E.] Univ Twente, Dept Appl Math, Appl Anal, Enschede, Netherlands; [Kalia, Manu; Petersilie, Laura; Rose, Christine R.] Heinrich Heine Univ Dusseldorf, Inst Neurobiol, Dusseldorf, Germany; [van Putten, Michel J. A. M.] Univ Twente, Dept Clin Neurophysiol, Enschede, Netherlands; [Rahmati, Sarah] Univ Bordeaux, Interdisciplinary Inst Neurosci IINS, Bordeaux, France		Engels, M; Fahlke, C (corresponding author), Forschungszentrum Julich, Inst Biol Informat Proc Mol & Zellphysiol IBI 1, Julich, Germany.	mi.engels@fz-juelich.de; c.fahlker@fz-juelich.de	Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952; Kovermann, Peter/0000-0001-5296-4918	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the Research Unit FOR 2795 (Synapses under stress)German Research Foundation (DFG) [Ro2327/12-1, Ro2327/14-1, FA 301/13-1]	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) to CR (Ro2327/12-1 and 14-1) and CF (FA 301/13-1) as part of the Research Unit FOR 2795 (Synapses under stress).	Abrahamsen B, 2013, J NEUROSCI, V33, P1068, DOI 10.1523/JNEUROSCI.3396-12.2013; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Auer T, 2020, NEUROPHARMACOLOGY, V162, DOI 10.1016/j.neuropharm.2019.107754; Benesova J, 2009, J NEUROSCI RES, V87, P96, DOI 10.1002/jnr.21828; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Berg Daniel A, 2018, F1000Res, V7, P277, DOI 10.12688/f1000research.12684.1; Bevensee MO, 1997, J GEN PHYSIOL, V110, P467, DOI 10.1085/jgp.110.4.467; Breithausen B, 2020, GLIA, V68, P918, DOI 10.1002/glia.23751; Brunne B, 2010, GLIA, V58, P1553, DOI 10.1002/glia.21029; CHAO AC, 1989, BIOPHYS J, V56, P1071, DOI 10.1016/S0006-3495(89)82755-9; Chivukula AS, 2020, HUM MUTAT, V41, P1892, DOI 10.1002/humu.24089; DALMARK M, 1972, J PHYSIOL-LONDON, V224, P583, DOI 10.1113/jphysiol.1972.sp009914; Deitmer JW, 2010, BRAIN RES REV, V63, P113, DOI 10.1016/j.brainresrev.2009.10.006; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 2021, AM J PHYSIOL-CELL PH, V320, pC324, DOI 10.1152/ajpcell.00566.2020; Delpire E, 2018, CURR TOP MEMBR, V81, P3, DOI 10.1016/bs.ctm.2018.08.001; Delpire E, 2016, ACS CHEM NEUROSCI, V7, P1624, DOI 10.1021/acschemneuro.6b00366; Delpire E, 2014, J PHYSIOL-LONDON, V592, P4099, DOI 10.1113/jphysiol.2014.275529; Dijkstra K, 2016, J NEUROSCI, V36, P11881, DOI 10.1523/JNEUROSCI.1934-16.2016; Eisner DA, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012826; Fahlke C, 2016, PFLUG ARCH EUR J PHY, V468, P491, DOI 10.1007/s00424-015-1768-3; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Flores B, 2019, NEUROCHEM INT, V123, P114, DOI 10.1016/j.neuint.2018.01.009; Funk K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-32; Gamba G, 2004, ADV EXP MED BIOL, V559, P55; GAMBA G, 1994, J BIOL CHEM, V269, P17713; GARAY RP, 1988, MOL PHARMACOL, V33, P696; Gerkau NJ, 2018, CEREB CORTEX, V28, P4264, DOI 10.1093/cercor/bhx280; Gerkau NJ, 2017, J NEUROSCI RES, V95, P2275, DOI 10.1002/jnr.23995; Gerkau NJ, 2019, J PHYSIOL-LONDON, V597, P5687, DOI 10.1113/JP278658; Gilbert D, 2007, INT J DEV NEUROSCI, V25, P479, DOI 10.1016/j.ijdevneu.2007.08.001; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Gillen CM, 1999, AM J PHYSIOL-CELL PH, V276, pC328, DOI 10.1152/ajpcell.1999.276.2.C328; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Hannemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017992; Hartmann Anna-Maria, 2011, BMC Res Notes, V4, P526, DOI 10.1186/1756-0500-4-526; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; Hertz L, 2015, J NEUROSCI RES, V93, P1019, DOI 10.1002/jnr.23499; Hiki K, 1999, J BIOL CHEM, V274, P10661, DOI 10.1074/jbc.274.15.10661; Hoshi Y, 2018, J NEUROSCI, V38, P5700, DOI 10.1523/JNEUROSCI.2888-17.2018; Jennings A, 2017, GLIA, V65, P447, DOI 10.1002/glia.23103; JENNINGS ML, 1990, J GEN PHYSIOL, V95, P1021, DOI 10.1085/jgp.95.6.1021; Jungblut M, 2012, GLIA, V60, P894, DOI 10.1002/glia.22322; Kafitz KW, 2008, J NEUROSCI METH, V169, P84, DOI 10.1016/j.jneumeth.2007.11.022; Kahle KT, 2015, TRENDS MOL MED, V21, P513, DOI 10.1016/j.molmed.2015.05.008; Kalia M, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009019; Kaneko H, 2002, CURR TOP MEMBR, V53, P167, DOI 10.1016/S1063-5823(02)53033-7; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kelly T, 2010, J NEUROCHEM, V115, P1123, DOI 10.1111/j.1471-4159.2010.07009.x; KETTENMANN H, 1988, GLIA, V1, P64, DOI 10.1002/glia.440010108; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Kirdajova DB, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00051; Kolbaev SN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75382-1; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; Koumangoye R, 2021, FUNCTION, V2, DOI 10.1093/function/zqaa028; Kourdougli N, 2017, ANN NEUROL, V81, P251, DOI 10.1002/ana.24870; Kovalchuk Yury, 2012, Cold Spring Harb Protoc, V2012, P778, DOI 10.1101/pdb.prot070037; Kovermann P, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa022; LACKO L, 1973, J CELL PHYSIOL, V82, P213, DOI 10.1002/jcp.1040820209; Lang F, 1998, CELL PHYSIOL BIOCHEM, V8, P285, DOI 10.1159/000016290; Langer J, 2017, GLIA, V65, P293, DOI 10.1002/glia.23092; Langer J, 2009, J PHYSIOL-LONDON, V587, P5859, DOI 10.1113/jphysiol.2009.182279; Lerchundi R, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00080; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; MacAulay N, 2010, NEUROSCIENCE, V168, P941, DOI 10.1016/j.neuroscience.2009.09.016; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; Maus M, 2001, ANAL CHEM, V73, P2078, DOI 10.1021/ac000877g; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Metzler, 2015, ADV TIME CORRELATED, P189, DOI DOI 10.1007/978-3-319-14929-5_4; Mongin AA, 2016, PFLUG ARCH EUR J PHY, V468, P421, DOI 10.1007/s00424-015-1765-6; Mongin Alexander A., 2001, Pathophysiology, V8, P77, DOI 10.1016/S0928-4680(01)00074-8; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Pasantes-Morales H, 2016, MOL PHARMACOL, V90, P358, DOI 10.1124/mol.116.104158; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Race JE, 1999, AM J PHYSIOL-CELL PH, V277, pC1210, DOI 10.1152/ajpcell.1999.277.6.C1210; Rakers C, 2017, GLIA, V65, P1550, DOI 10.1002/glia.23183; Ringel F, 2008, NEUROSCI LETT, V442, P219, DOI 10.1016/j.neulet.2008.07.017; Risher WC, 2012, GLIA, V60, P1709, DOI 10.1002/glia.22390; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; SCHAFER G, 1977, PLANT PHYSIOL, V60, P286, DOI 10.1104/pp.60.2.286; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt-Kastner R, 2015, NEUROSCIENCE, V309, P259, DOI 10.1016/j.neuroscience.2015.08.034; Shen MR, 2001, P NATL ACAD SCI USA, V98, P14714, DOI 10.1073/pnas.251388798; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Toft-Bertelsen TL, 2021, GLIA, V69, P28, DOI 10.1002/glia.23851; Untiet V, 2017, GLIA, V65, P388, DOI 10.1002/glia.23098; Uyanik G, 2006, NEUROLOGY, V66, P1044, DOI 10.1212/01.wnl.0000204181.31175.8b; Vardjan N, 2016, GLIA, V64, P1034, DOI 10.1002/glia.22981; VERKMAN AS, 1990, AM J PHYSIOL, V259, pC375, DOI 10.1152/ajpcell.1990.259.3.C375; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wilson CS, 2018, CURR TOP MEMBR, V81, P385, DOI 10.1016/bs.ctm.2018.07.006; Yan YP, 2001, BRAIN RES, V911, P43, DOI 10.1016/S0006-8993(01)02649-X; Ziemens D, 2019, J NEUROSCI, V39, P2620, DOI 10.1523/JNEUROSCI.2029-18.2019; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	100	1	1	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	SEP 16	2021	15								735300	10.3389/fncel.2021.735300			23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UZ2KJ	WOS:000702038800001	34602981	Green Published, gold			2022-02-06	
J	de la Tremblaye, PB; Wellcome, JL; Wiley, K; Lomahan, CA; Moschonas, EH; Cheng, JP; Bondi, CO; Kline, AE				de la Tremblaye, Patricia B.; Wellcome, JoDy L.; Wiley, Kaitlyn; Lomahan, Carolyn A.; Moschonas, Eleni H.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.			Chronic unpredictable stress during adolescence protects against adult traumatic brain injury-induced affective and cognitive deficits	BRAIN RESEARCH			English	Article						Cannabinoid receptor 1 (CB1); Chronic unpredictable stress (CUS); Controlled cortical impact (CCI); Early life stress (ELS); Endocannabinoids; Traumatic brain injury (TBI)	ENVIRONMENTAL ENRICHMENT; MALE RATS; RECOVERY; NEURONS; MEMORY; ENDOCANNABINOIDS; HALOPERIDOL; ACTIVATION; DISORDER; FEMALE	Pre-clinical early-life stress paradigms model early adverse events in humans. However, the long-term behavioral consequences of early-life adversities after traumatic brain injury (TBI) in adults have not been examined. In addition, endocannabinoids may protect against TBI neuropathology. Hence, the current study assessed the ef-fects of adverse stress during adolescence on emotional and cognitive performance in rats sustaining a TBI as adults, and how cannabinoid receptor 1 (CB1) activation impacts the outcome. On postnatal days (PND) 30-60, adolescent male rats were exposed to four weeks of chronic unpredictable stress (CUS), followed by four weeks of no stress (PND 60-90), or no stress at any time (Control), and then anesthetized and provided a cortical impact of moderate severity (2.8 mm tissue deformation at 4 m/s) or sham injury. TBI and Sham rats (CUS and Control) were administered either arachidonyl-2'-chloroethylamide (ACEA; 1 mg/kg, i.p.), a CB1 receptor agonist, or vehicle (VEH; 1 mL/kg, i.p.) immediately after surgery and once daily for 7 days. Anxiety-like behavior was assessed in an open field test (OFT) and learning and memory in novel object recognition (NOR) and Morris water maze (MWM) tasks. No differences were revealed among the Sham groups in any behavioral assessment and thus the groups were pooled. In the ACEA and VEH-treated TBI groups, CUS increased exploration in the OFT, enhanced NOR focus, and decreased the time to reach the escape platform in the MWM, suggesting decreased anxiety and enhanced learning and memory relative to the Control group receiving VEH (p < 0.05). ACEA also enhanced NOR and MWM performance in the Control + TBI group (p < 0.05). These data suggest that 4 weeks of CUS provided during adolescence may provide protection against TBI acquired during adulthood and/or induce adaptive behavioral responses. Moreover, CB1 receptor agonism produces benefits after TBI independent of CUS protection.	[de la Tremblaye, Patricia B.; Wellcome, JoDy L.; Wiley, Kaitlyn; Lomahan, Carolyn A.; Moschonas, Eleni H.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [de la Tremblaye, Patricia B.; Wellcome, JoDy L.; Wiley, Kaitlyn; Lomahan, Carolyn A.; Moschonas, Eleni H.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [de la Tremblaye, Patricia B.; Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15213 USA; [Moschonas, Eleni H.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15213 USA		Kline, AE (corresponding author), Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu		Wiley, Kaitlyn/0000-0002-3584-6722	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS084967, HD069620, NS099674, NS113810, NS094950, NS099683, NS110609, NS086749, NS07433]; University of Pittsburgh Physicians/UPMC Academic Foundation; UMPC Rehabilitation Institute	This work was supported, in part, by NIH grants NS084967, HD069620, NS099674, NS113810 (AEK), NS094950, NS099683, NS110609 (COB), the University of Pittsburgh Physicians/UPMC Academic Foundation, and the UMPC Rehabilitation Institute (COB). PBT was a Neurobiology of Neurological Disease T32 Postdoctoral Fellow (NIH NS086749) and EHM is a current Predoctoral Neuroscience T32 Fellow (NIH NS07433).	Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Arain M, 2015, ANN CLIN TRANSL NEUR, V2, P289, DOI 10.1002/acn3.163; Bai FH, 2017, MOL NEUROBIOL, V54, P1240, DOI 10.1007/s12035-016-9731-7; Bharne AP, 2016, HIPPOCAMPUS, V26, P1313, DOI 10.1002/hipo.22608; Bleimeister IH, 2019, BRAIN RES, V1714, P227, DOI 10.1016/j.brainres.2019.03.007; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Caltana L, 2015, J NEUROCHEM, V135, P616, DOI 10.1111/jnc.13288; Chaby LE, 2015, BEHAV BRAIN RES, V278, P492, DOI 10.1016/j.bbr.2014.09.003; Chaby LE, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00327; Chaby LE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00328; Chen YW, 2018, SYNAPSE, V72, DOI 10.1002/syn.22034; de la Tremblaye PB, 2018, NEUROSCI BIOBEHAV R, V85, P160, DOI 10.1016/j.neubiorev.2017.05.022; Diaz-Chavez A, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113318; Durand E, 2016, BRAIN INJURY, V30, P363, DOI 10.3109/02699052.2015.1131848; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Eidson LN, 2019, BRAIN BEHAV IMMUN, V81, P305, DOI 10.1016/j.bbi.2019.06.027; Farkas J, 2017, NEUROSCIENCE, V354, P11, DOI 10.1016/j.neuroscience.2017.04.019; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Free KE, 2017, EXP NEUROL, V296, P62, DOI 10.1016/j.expneurol.2017.07.004; Gorzalka BB, 2009, CURR TOP BEHAV NEURO, V1, P289, DOI 10.1007/978-3-540-88955-7_12; Gouirand AM, 2005, PHYSIOL BEHAV, V86, P21, DOI 10.1016/j.physbeh.2005.06.027; Hawley DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053126; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Jacqmain J, 2014, BEHAV BRAIN RES, V275, P201, DOI 10.1016/j.bbr.2014.08.056; Jenniches I, 2016, BIOL PSYCHIAT, V79, P858, DOI 10.1016/j.biopsych.2015.03.033; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Knowles MD, 2016, PROG NEURO-PSYCHOPH, V66, P8, DOI 10.1016/j.pnpbp.2015.10.010; Leishman E, 2018, BBA-MOL CELL BIOL L, V1863, P479, DOI 10.1016/j.bbalip.2018.02.001; Liu QR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249763; Ma L, 2018, NEUROPHARMACOLOGY, V135, P211, DOI 10.1016/j.neuropharm.2018.03.024; Ma L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12440; Magid L, 2019, J NEUROTRAUM, V36, P1836, DOI 10.1089/neu.2018.6063; Manole MD, 2021, EXP NEUROL, V335, DOI 10.1016/j.expneurol.2020.113522; McLaughlin RJ, 2013, BEHAV BRAIN RES, V237, P333, DOI 10.1016/j.bbr.2012.09.053; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Morena M, 2016, NEUROPSYCHOPHARMACOL, V41, P80, DOI 10.1038/npp.2015.166; Moschonas EH, 2021, BRAIN RES, V1751, DOI 10.1016/j.brainres.2020.147175; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Njoku I, 2019, EXP NEUROL, V315, P32, DOI 10.1016/j.expneurol.2019.01.019; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Palomba L, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061507; Paus Tomas, 2008, Nat Rev Neurosci, V9, P947, DOI 10.1038/nrn2513; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Rabner J, 2016, AM J ADDICTION, V25, P91, DOI 10.1111/ajad.12338; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Reich CG, 2013, J PSYCHOPHARMACOL, V27, P947, DOI 10.1177/0269881113499207; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Ruehle S, 2012, J PSYCHOPHARMACOL, V26, P23, DOI 10.1177/0269881111408958; Russell AL, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12641; Rusznak K, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00786; Santori A, 2019, PSYCHONEUROENDOCRINO, V108, P155, DOI 10.1016/j.psyneuen.2019.06.018; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Vrechi TA, 2018, NEUROTOX RES, V33, P846, DOI 10.1007/s12640-017-9839-1; Whittle S, 2014, AM J PSYCHIAT, V171, P564, DOI 10.1176/appi.ajp.2013.13070920; Yang S, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00338-3; Ye YL, 2019, BEHAV BRAIN RES, V362, P199, DOI 10.1016/j.bbr.2019.01.008; ZHANG Y, 2017, NEURAL PLAST, V2017, DOI DOI 10.1155/2017/9382797; Zimmermann T, 2018, CEREB CORTEX, V28, P4454, DOI 10.1093/cercor/bhy258	66	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 15	2021	1767								147544	10.1016/j.brainres.2021.147544			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UD5HV	WOS:000687238300008	34090883				2022-02-06	
J	Garcia, GP; De Gasperi, R; Tschiffely, AE; Sosa, MAG; Abutarboush, R; Kawoos, U; Statz, JK; Ciarlone, S; Reed, E; Jeyarajah, T; Perez, GM; Otero-Pagan, A; Pryor, D; Hof, PR; Cook, DG; Gandy, S; Elder, GA; Ahlers, ST				Garcia, Georgina Perez; De Gasperi, Rita; Tschiffely, Anna E.; Sosa, Miguel A. Gama; Abutarboush, Rania; Kawoos, Usmah; Statz, Jonathan K.; Ciarlone, Stephanie; Reed, Eileen; Jeyarajah, Theepica; Perez, Gissel M.; Otero-Pagan, Alena; Pryor, Dylan; Hof, Patrick R.; Cook, David G.; Gandy, Sam; Elder, Gregory A.; Ahlers, Stephen T.			Repetitive Low-Level Blast Exposure Improves Behavioral Deficits and Chronically Lowers A beta 42 in an Alzheimer Disease Transgenic Mouse Model	JOURNAL OF NEUROTRAUMA			English	Article						amyloid beta protein; Alzheimer disease; blast; transgenic mouse; traumatic brain injury	TRAUMATIC BRAIN-INJURY; BETA-AMYLOID PEPTIDE; A-BETA; GLYMPHATIC PATHWAY; ACCUMULATION; DEPOSITION; PROTEIN; CLEARANCE; SECRETASE; PATHOLOGY	Public awareness of traumatic brain injury (TBI) in the military increased recently because of the conflicts in Iraq and Afghanistan where blast injury was the most common mechanism of injury. Besides overt injuries, concerns also exist over the potential adverse consequences of subclinical blast exposures, which are common for many service members. A TBI is a risk factor for the later development of neurodegenerative diseases, including Alzheimer disease (AD)-like disorders. Studies of acute TBI in humans and animals have suggested that increased processing of the amyloid precursor protein (APP) toward the amyloid beta protein (A beta) may explain the epidemiological associations with AD. In a previous study, however, we found in both rat and mouse models of blast overpressure exposure that rather than increasing, rodent brain A beta 42 levels were decreased after acute blast exposure. Here we subjected APP/presenilin 1 transgenic mice (APP/PS1 Tg) to an extended sequence of repetitive low-level blast exposures (34.5 kPa) administered three times per week over eight weeks. If initiated at 20 weeks of age, these repetitive exposures, which were designed to mimic human subclinical blast exposures, reduced anxiety and improved cognition as well as social interactions in APP/PS1 Tg mice, returning many behavioral parameters in APP/PS1 Tg mice to levels of non-transgenic wild type mice. Repetitive low-level blast exposure was less effective at improving behavioral deficits in APP/PS1 Tg mice when begun at 36 weeks of age. While amyloid plaque loads were unchanged, A beta 42 levels and A beta oligomers were reduced in the brain of mice exposed to repetitive low-level blast exposures initiated at 20 weeks of age, although levels did not directly correlate with behavioral parameters in individual animals. These results have implications for understanding the nature of blast effects on the brain and their relationship to human neurodegenerative diseases.	[Garcia, Georgina Perez; De Gasperi, Rita; Perez, Gissel M.; Otero-Pagan, Alena; Pryor, Dylan; Gandy, Sam] James J Peters Dept Vet Affairs Med Ctr, Res & Dev Serv, Bronx, NY USA; [Sosa, Miguel A. Gama] James J Peters Dept Vet Affairs Med Ctr, Gen Med Res Serv, Bronx, NY USA; [Elder, Gregory A.] James J Peters Dept Vet Affairs Med Ctr, Neurol Serv, Bronx, NY USA; [Garcia, Georgina Perez; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [De Gasperi, Rita; Sosa, Miguel A. Gama; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Nash Family Dept Neurosci, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Care, New York, NY 10029 USA; [Hof, Patrick R.; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Mt Sinai Alzheimers Dis Res Ctr, New York, NY 10029 USA; [Hof, Patrick R.; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Gandy, Sam] Icahn Sch Med Mt Sinai, Barbara & Maurice A Deane Ctr Wellness & Cognit H, New York, NY 10029 USA; [Gandy, Sam] Icahn Sch Med Mt Sinai, Mt Sinai NFL Neurol Care Ctr, New York, NY 10029 USA; [Tschiffely, Anna E.; Abutarboush, Rania; Kawoos, Usmah; Statz, Jonathan K.; Ciarlone, Stephanie; Reed, Eileen; Jeyarajah, Theepica; Ahlers, Stephen T.] Naval Med Res Ctr, Dept Neurotrauma, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Tschiffely, Anna E.] Congress Directed Med Res Program, Detrick, MD USA; [Abutarboush, Rania; Kawoos, Usmah; Statz, Jonathan K.; Ciarlone, Stephanie; Jeyarajah, Theepica] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Reed, Eileen] Parsons Corp, San Antonio, TX USA; [Cook, David G.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Cook, David G.] Univ Washington, Dept Med, Seattle, WA USA		Ahlers, ST (corresponding author), Naval Med Res Ctr, Dept Neurotrauma, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.; Elder, GA (corresponding author), James J Peters VA Med Ctr, Neurol Serv 3E16, 130 West Kingsbridge Rd, Bronx, NY 10468 USA.	gregory.elder@va.gov; stephen.t.ahlers.civ@mail.mil			Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service AwardsUS Department of Veterans Affairs [1I01RX002660, 1I01RX000684, 1I01RX002333, 1I21RX003459, 121RX002876]; Department of Veterans Affairs Office of Research and Development Medical Research ServiceUS Department of Veterans Affairs [1I01BX004067, 1I01BX002311]; Defense Health Program (DHP) from Joint Program Committee 5 [603115HP.3520.001.A1411]; Alzheimer's Drug Discovery Foundation; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG005138, P30 AG066514]	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service Awards 1I01RX002660 (GE), 1I01RX000684 (SG), and 1I01RX002333 (SG), 1I21RX003459 (MAGS) and 121RX002876 (MAGS), the Department of Veterans Affairs Office of Research and Development Medical Research Service 1I01BX004067 (GE) and 1I01BX002311 (DC), by Defense Health Program (DHP) work unit number 603115HP.3520.001.A1411 from Joint Program Committee 5 (STA), the Alzheimer's Drug Discovery Foundation (SG) and by NIA P50 AG005138 and P30 AG066514 both to Mary Sano (SG, PRH).	Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Cernak I, 2017, BRAIN INJURY, V31, P1168, DOI 10.1080/02699052.2016.1274779; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Edwards KA, 2020, BRAIN INJURY, V34, P1213, DOI 10.1080/02699052.2020.1797171; Elder GA, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134294; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Fukumoto H, 1996, AM J PATHOL, V148, P259; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; HAASS C, 1993, J BIOL CHEM, V268, P3021; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P2716, DOI 10.1167/iovs.18-26353; Hoch E, 2019, P FIND EXP REC 7 DEP; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Maigler KC, 2021, J NEUROTRAUM, V38, P665, DOI 10.1089/neu.2020.6989; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Rein B, 2020, NAT PROTOC, V15, P3464, DOI 10.1038/s41596-020-0382-9; Saito S, 2016, CURR OPIN PSYCHIATR, V29, P168, DOI 10.1097/YCO.0000000000000239; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Steele JW, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-51; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Thangavelu B, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00620; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wang LM, 2019, BRAIN PATHOL, V29, P176, DOI 10.1111/bpa.12656; Wardlaw JM, 2020, NAT REV NEUROL, V16, P137, DOI 10.1038/s41582-020-0312-z; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Zhang B, 2021, J MOL NEUROSCI, V71, P1266, DOI 10.1007/s12031-020-01752-z; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001; Zuroff L, 2017, CELL MOL LIFE SCI, V74, P2167, DOI 10.1007/s00018-017-2463-7	64	1	1	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2021	38	22					3146	3173		10.1089/neu.2021.0184		SEP 2021	28	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WY7FJ	WOS:000696019300001	34353119				2022-02-06	
J	Lim, SW; Su, HC; Nyam, TTE; Chio, CC; Kuo, JR; Wang, CC				Lim, Sher-Wei; Su, Hui-Chen; Nyam, Tee-Tau Eric; Chio, Chung-Ching; Kuo, Jinn-Rung; Wang, Che-Chuan			Ceftriaxone therapy attenuates brain trauma in rats by affecting glutamate transporters and neuroinflammation and not by its antibacterial effects	BMC NEUROSCIENCE			English	Article						Traumatic brain injury; Ceftriaxone; Glutamate transporter; Glutamate receptor Neuroinflammation; Apoptosis	FLUID PERCUSSION; INJURY; PHARMACOKINETICS; GLT-1; MODEL; PATHOPHYSIOLOGY; EXPRESSION; APOPTOSIS	Background Ceftriaxone is a beta-lactam antibiotic used to treat central nervous system infections. Whether the neuroprotective effects of ceftriaxone after TBI are mediated by attenuating neuroinflammation but not its antibacterial actions is not well established. Methods Anesthetized male Sprague-Dawley rats were divided into sham-operated, TBI + vehicle, and TBI + ceftriaxone groups. Ceftriaxone was intraperitoneally injected at 0, 24, and 48 h with 50 or 250 mg/kg/day after TBI. During the first 120 min after TBI, we continuously measured heart rate, arterial pressure, intracranial pressure (ICP), and cerebral perfusion pressure. The infarct volume was measured by TTC staining. Motor function was measured using the inclined plane. Glutamate transporter 1 (GLT-1), neuronal apoptosis and TNF-alpha expression in the perilesioned cortex were investigated using an immunofluorescence assay. Bacterial evaluation was performed by Brown and Brenn's Gram staining. These parameters above were measured at 72 h after TBI. Results Compared with the TBI + vehicle group, the TBI + ceftriaxone 250 mg/kg group showed significantly lower ICP, improved motor dysfunction, reduced body weight loss, decreased infarct volume and neuronal apoptosis, decreased TBI-induced microglial activation and TNF-alpha expression in microglia, and increased GLT-1 expression in neurons and microglia. However, the grades of histopathological changes of antibacterial effects are zero. Conclusions The intraperitoneal injection of ceftriaxone with 250 mg/kg/day for three days may attenuate TBI by increasing GLT-1 expression and reducing neuroinflammation and neuronal apoptosis, thereby resulting in an improvement in functional outcomes, and this neuroprotective effect is not related to its antibacterial effects.	[Lim, Sher-Wei; Nyam, Tee-Tau Eric; Chio, Chung-Ching; Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan; [Su, Hui-Chen] Chi Mei Med Ctr, Dept Pharm, Tainan, Taiwan; [Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lim, Sher-Wei] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan		Wang, CC (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan.; Wang, CC (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Wang, CC (corresponding author), Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan.	wangchechuan@gmail.com					[Anonymous], 2009, MED MALADIES INFECT, V39, P356, DOI 10.1016/j.medmal.2009.02.037; Brain Trauma Foundation: American association of Neurological surgeons, 2007, J NEUROTRAUMA S1, V24, pS59; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Conti AC, 1998, J NEUROSCI, V18, P5663; Corsello SM, 2017, NAT MED, V23, P405, DOI 10.1038/nm.4306; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Hameed MQ, 2019, CEREB CORTEX, V29, P4506, DOI 10.1093/cercor/bhy328; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kuo JR, 2020, NEUROCHEM RES, V45, P1536, DOI 10.1007/s11064-020-03018-x; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Maragakis NJ, 2004, GLIA, V45, P133, DOI 10.1002/glia.10310; Marmarou A, 2003, ACT NEUR S, V86, P7; Matharu D, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9940-0; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; MOSKOVITZ BL, 1984, AM J MED, V77, P84; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; PATEL IH, 1981, ANTIMICROB AGENTS CH, V20, P634, DOI 10.1128/AAC.20.5.634; Persson M, 2012, AMINO ACIDS, V42, P207, DOI 10.1007/s00726-011-0865-7; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rao PSS, 2015, PSYCHOPHARMACOLOGY, V232, P2333, DOI 10.1007/s00213-015-3868-3; Ratti E, 2015, TOXICOL REP, V2, P1396, DOI 10.1016/j.toxrep.2015.09.010; Rice MW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00875; Rimmele TS, 2016, NEUROCHEM INT, V98, P19, DOI 10.1016/j.neuint.2016.04.010; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Sullins AK, 2013, PEDIATR DRUGS, V15, P93, DOI 10.1007/s40272-013-0017-5; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; Wang CC, 2016, J SURG RES, V200, P669, DOI 10.1016/j.jss.2015.10.005; Wang Y, 1997, J NEUROSCI, V17, P4341; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Yimer EM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00236; YUK JH, 1989, CLIN PHARMACOKINET, V17, P223, DOI 10.2165/00003088-198917040-00002; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857; Zwienenberg M, 1999, J NEUROTRAUM, V16, P1095, DOI 10.1089/neu.1999.16.1095	45	1	1	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	SEP 14	2021	22	1							54	10.1186/s12868-021-00659-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UQ2JJ	WOS:000695895500001	34521349	Green Published, gold			2022-02-06	
J	Rose, SC; Anderson, W; Feinberg, D; Ganesh, A; Green, L; Jaffee, M; Kaplen, M; Lorincz, M; De Luigi, A; Patel, D; Tsao, JW; Lee, E; Webb, A				Rose, Sean C.; Anderson, Wayne; Feinberg, Daniel; Ganesh, Aravind; Green, Lauren; Jaffee, Michael; Kaplen, Michael; Lorincz, Matthew; De Luigi, Arthur; Patel, Deepak; Tsao, Jack W.; Lee, Erin; Webb, Adam			Quality Improvement in Neurology Multiple Sclerosis Quality Measurement Set 2020 Update	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; POSITION STATEMENT; CONCUSSION; SPORTS; VISITS; YOUTH	Multiple sclerosis (MS) is a disabling immune-mediated disease of the CNS and considered one of the health conditions with the highest annual spending growth paid by both public and private insurance.(1) Health care spending in the United States for MS was reported as $13.9 billion in 2016.(1) The estimated cumulated (over 10 years) prevalence of MS among adults in the United States in 2010 was approximately 727,000.(2) In 2017, that number was substantially higher, approximately 914,000.(2,3) The prevalence is higher among women, with a female: male ratio of 2.8.(2) Improving high-quality care for these patients can lead to improved outcomes, reduced spending, and better quality of life.	[Rose, Sean C.] Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Rose, Sean C.] Ohio State Univ, Columbus, OH 43210 USA; [Feinberg, Daniel] Penn Hosp, Philadelphia, PA 19107 USA; [Ganesh, Aravind] Univ Calgary, Calgary, AB, Canada; [Green, Lauren] Univ Southern Calif, Los Angeles, CA 90007 USA; [Jaffee, Michael] Univ Florida, Gainesville, FL USA; [Kaplen, Michael] De Caro & Kaplen Esq, Pleasantville, NY USA; [Lorincz, Matthew] Univ Michigan, Ann Arbor, MI 48109 USA; [De Luigi, Arthur] Mayo Clin Arizona, Scottsdale, AZ USA; [Patel, Deepak] Rush Copley Med Grp, Aurora, IL USA; [Tsao, Jack W.] Univ Tennessee, Memphis, TN USA; [Lee, Erin] Amer Acad Neurol, Minneapolis, MN USA; [Webb, Adam] Emory Univ, Sch Med, Decatur, GA 30033 USA		Rose, SC (corresponding author), Nationwide Childrens Hosp, Columbus, OH 43205 USA.; Rose, SC (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.						Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Biegon A, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.576366; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Corwin DJ, 2020, CLIN J SPORT MED, V30, pE154, DOI 10.1097/JSM.0000000000000732; Daugherty J, 2020, J HEAD TRAUMA REHAB, V35, pE136, DOI 10.1097/HTR.0000000000000534; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Pavlov V, 2019, BRAIN INJURY, V33, P1151, DOI 10.1080/02699052.2019.1629022; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Robbins MS, 2020, NEUROLOGY, V95, P866, DOI 10.1212/WNL.0000000000010634; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Simpson TS., 2017, CLIN PRACT PEDIAT PS, V5, P248; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	28	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 14	2021	97	11					537	542		10.1212/WNL.0000000000012537			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UZ7WU	WOS:000702412700005	34321361	Bronze			2022-02-06	
J	Rong, YL; Ji, CY; Wang, ZH; Ge, XH; Wang, JX; Ye, W; Tang, PY; Jiang, DD; Fan, J; Yin, GY; Liu, W; Cai, WH				Rong, Yuluo; Ji, Chengyue; Wang, Zhuanghui; Ge, Xuhui; Wang, Jiaxing; Ye, Wu; Tang, Pengyu; Jiang, Dongdong; Fan, Jin; Yin, Guoyong; Liu, Wei; Cai, Weihua			Small extracellular vesicles encapsulating CCL2 from activated astrocytes induce microglial activation and neuronal apoptosis after traumatic spinal cord injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Spinal cord injury; Astrocyte; Small extracellular vesicles; CCL2; Microglia; Neuron	MONOCYTE CHEMOATTRACTANT PROTEIN-1; COGNITIVE DYSFUNCTION; NEUROPATHIC PAIN; BRAIN-INJURY; CELL-DEATH; NEUROINFLAMMATION; EXPRESSION; ALZHEIMERS; CONTRIBUTES; PATHOLOGY	Background Spinal cord injury (SCI) is a severe traumatic disease which causes high disability and mortality rates. The molecular pathological features after spinal cord injury mainly involve the inflammatory response, microglial and neuronal apoptosis, abnormal proliferation of astrocytes, and the formation of glial scars. However, the microenvironmental changes after spinal cord injury are complex, and the interactions between glial cells and nerve cells remain unclear. Small extracellular vesicles (sEVs) may play a key role in cell communication by transporting RNA, proteins, and bioactive lipids between cells. Few studies have examined the intercellular communication of astrocytes through sEVs after SCI. The inflammatory signal released from astrocytes is known to initiate microglial activation, but its effects on neurons after SCI remain to be further clarified. Methods Electron microscopy (TEM), nanoparticle tracking analysis (NTA), and western blotting were applied to characterize sEVs. We examined microglial activation and neuronal apoptosis mediated by astrocyte activation in an experimental model of acute spinal cord injury and in cell culture in vitro. Results Our results indicated that astrocytes activated after spinal cord injury release CCL2, act on microglia and neuronal cells through the sEV pathway, and promote neuronal apoptosis and microglial activation after binding the CCR2. Subsequently, the activated microglia release IL-1 beta, which acts on neuronal cells, thereby further aggravating their apoptosis. Conclusion This study elucidates that astrocytes interact with microglia and neurons through the sEV pathway after SCI, enriching the mechanism of CCL2 in neuroinflammation and spinal neurodegeneration, and providing a new theoretical basis of CCL2 as a therapeutic target for SCI.	[Rong, Yuluo; Ji, Chengyue; Wang, Zhuanghui; Ge, Xuhui; Wang, Jiaxing; Ye, Wu; Tang, Pengyu; Jiang, Dongdong; Fan, Jin; Yin, Guoyong; Liu, Wei; Cai, Weihua] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Nanjing 210029, Jiangsu, Peoples R China		Liu, W; Cai, WH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Nanjing 210029, Jiangsu, Peoples R China.	liuweiorth@njmu.edu.cn; caiwhspine@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81974335, 81902211]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20181490, BK20191061]; Jiangsu Province Six Talents Peak [TD-SWYY-010]; Wu Jieping Medical Foundation	This work was sponsored by the National Natural Science Foundation of China (grant No. 81974335, 81902211), the Natural Science Foundation of Jiangsu Province (grant No. BK20181490, BK20191061), the Jiangsu Province Six Talents Peak (grant No. TD-SWYY-010), and the Wu Jieping Medical Foundation (grant No.320-2745-16-117).	Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Alam Q, 2016, CURR PHARM DESIGN, V22, P541, DOI 10.2174/1381612822666151125000300; Bose S, 2013, ARCH PHARM RES, V36, P1039, DOI 10.1007/s12272-013-0161-z; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chaudhuri AD, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0369-4; Chen SB, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1193-6; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Delpech JC, 2019, TRENDS NEUROSCI, V42, P361, DOI 10.1016/j.tins.2019.02.007; Fan BY, 2018, CELL TRANSPLANT, V27, P853, DOI 10.1177/0963689718755778; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Gourmala NG, 1997, J NEUROIMMUNOL, V74, P35, DOI 10.1016/S0165-5728(96)00203-2; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Higashijima Y, 2013, AM J PHYSIOL-RENAL, V305, pF1412, DOI 10.1152/ajprenal.00249.2013; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; Ito S, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0303-18.2018; Jiang DD, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-00665-8; Jiang N, 2017, ACS NANO, V11, P7736, DOI 10.1021/acsnano.7b01087; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kawabata K, 2016, EUR J NEUROSCI, V43, P1499, DOI 10.1111/ejn.13247; Kawabata S, 2016, STEM CELL REP, V6, P1, DOI 10.1016/j.stemcr.2015.11.013; Kuang YN, 1996, J BIOL CHEM, V271, P3975; Liu W, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1726-7; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lv LL, 2018, J AM SOC NEPHROL, V29, P919, DOI 10.1681/ASN.2017050523; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Matyas JJ, 2017, J NEUROSCI, V37, P3956, DOI 10.1523/JNEUROSCI.3353-16.2017; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Men YQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11534-w; Meng C, 2019, J PAIN RES, V12, P1297, DOI 10.2147/JPR.S195117; Muessel MJ, 2002, MOL BRAIN RES, V103, P12, DOI 10.1016/S0169-328X(02)00158-4; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; O'Connor T, 2015, ENDOCR METAB IMMUNE, V15, P105, DOI 10.2174/1871530315666150316120920; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Patton MC, 2020, J CELL BIOCHEM, V121, P828, DOI 10.1002/jcb.29328; Pfisterer U, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.64; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rong YL, 2019, AGING-US, V11, P7723, DOI 10.18632/aging.102283; Rong YL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1571-8; Rong YL, 2019, BRAIN RES BULL, V148, P91, DOI 10.1016/j.brainresbull.2019.03.014; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Sheehan JJ, 2007, J NEUROSCI, V27, P1738, DOI 10.1523/JNEUROSCI.4987-06.2007; Skotland T, 2019, J LIPID RES, V60, P9, DOI 10.1194/jlr.R084343; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Song L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09720-x; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Tian DS, 2017, J NEUROSCI, V37, P7878, DOI 10.1523/JNEUROSCI.0315-17.2017; Waisman A, 2015, LANCET NEUROL, V14, P945, DOI 10.1016/S1474-4422(15)00141-6; Wang C, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1630-1; Wang JX, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-00630-5; Wang QQ, 2018, THERANOSTICS, V8, P4429, DOI 10.7150/thno.26717; Wang XJ, 2005, ACTA PHARMACOL SIN, V26, P934, DOI 10.1111/j.1745-7254.2005.00152.x; Xu JW, 2017, BEHAV BRAIN RES, V332, P145, DOI 10.1016/j.bbr.2017.05.066; Xu P, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02115-0; Yao Y, 2014, CELL MOL LIFE SCI, V71, P683, DOI 10.1007/s00018-013-1459-1; You Y, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2019.1706801; Zhang SS, 2016, BEHAV BRAIN RES, V298, P158, DOI 10.1016/j.bbr.2015.11.003; Zhang ZJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-136	60	1	1	5	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	SEP 12	2021	18	1							196	10.1186/s12974-021-02268-y			20	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	UP2KD	WOS:000695212800005	34511129	gold, Green Published			2022-02-06	
J	Lewin, AM; Fearnside, M; Kuru, R; Jonker, BP; Naylor, JM; Sheridan, M; Harris, IA				Lewin, A. M.; Fearnside, M.; Kuru, R.; Jonker, B. P.; Naylor, J. M.; Sheridan, M.; Harris, I. A.			Rates, costs, return to work and reoperation following spinal surgery in a workers' compensation cohort in New South Wales, 2010-2018: a cohort study using administrative data	BMC HEALTH SERVICES RESEARCH			English	Article						Spine; Spinal; Surgery; Workers' compensation; Outcomes; Cost; Return to work; Reoperation; Elective; Fusion; Decompression	LUMBAR FUSION; OUTCOMES; TRENDS; DISEASE	Background Internationally, elective spinal surgery rates in workers' compensation populations are high, as are reoperation rates, while return-to-work rates following spinal surgery are low. Little information is available from Australia. The aim of this study was to describe the rates, costs, return to work and reoperation following elective spinal surgery in the workers' compensation population in New South Wales (NSW), Australia. Methods This retrospective cohort study used administrative data from the State Insurance Regulatory Authority, the government organisation responsible for regulating and administering workers' compensation insurance in NSW. These data cover all workers' compensation-insured workers in New South Wales (over 3 million workers/year). We identified a cohort of insured workers who underwent elective spinal surgery (fusion or decompression) between January 1, 2010 and December 31, 2018. People who underwent surgery for spinal fracture or dislocation, or who had sustained a traumatic brain injury were excluded. The main outcome measures were annual spinal surgery rates, cost of the surgical episode, cumulative costs (surgical, hospital, medical and physical therapy) to 2 years post-surgery, and reoperation and return-to-work rates 2 years post-surgery. Results There were 9343 eligible claims (39.1 % fusion; 59.9 % decompression); claimants were predominantly male (75 %) with a mean age of 43 (range 18 to 75) years. Spinal surgery rates ranged from 15 to 29 surgeries per 100,000 workers per year, fell from 2011-12 to 2014-15 and rose thereafter. The average cost in Australian dollars for a surgical episode was $46,000 for a spinal fusion and $20,000 for a decompression. Two years post-fusion, only 19 % of people had returned to work at full capacity; 39 % after decompression. Nineteen percent of patients underwent additional spinal surgery within 2 years of the index surgery, to a maximum of 5 additional surgeries. Conclusion Rates of workers' compensation-funded spinal surgery did not rise significantly during the study period, but reoperation rates are high and return-to-work rates are low in this population at 2 years post- surgery. In the context of the poor evidence base supporting lumbar fusion surgery, the high cost, increasing rates, and the increased likelihood of poor outcomes in the workers' compensation population, we question the value of this procedure in this setting.	[Lewin, A. M.; Naylor, J. M.; Harris, I. A.] UNSW, South Western Sydney Clin Sch, Liverpool, Australia; [Lewin, A. M.; Naylor, J. M.; Harris, I. A.] Whitlam Orthopaed Res Ctr, Ingham Inst Appl Med Res, Liverpool, Australia; [Fearnside, M.] Westmead Hosp, Neurosurg, Westmead, NSW, Australia; [Kuru, R.] Lake Macquarie Med Ctr, Gateshead, Australia; [Jonker, B. P.] Royal Prince Alfred Hosp, Inst Acad Surg, Camperdown, NSW, Australia; [Sheridan, M.] Liverpool Hosp, Dept Neurosurg, Liverpool, Australia		Lewin, AM (corresponding author), UNSW, South Western Sydney Clin Sch, Liverpool, Australia.; Lewin, AM (corresponding author), Whitlam Orthopaed Res Ctr, Ingham Inst Appl Med Res, Liverpool, Australia.	adriane.lewin@unsw.edu.au		Lewin, Adriane/0000-0001-6258-3692	State Insurance Regulatory Authority of New South Wales	This study was funded in part by the State Insurance Regulatory Authority of New South Wales (ID: Workers Compensation Spine Surgery Audit). The funding source had no role in study design, data processing and analysis, interpretation of results, decision to publish, or preparation of the manuscript. Authors had full and complete access to the data at all times.	Anderson JT, 2018, J SURG ORTHOP ADV, V27, P209; [Anonymous], 2019, COMP PERF REV WORK C; [Anonymous], 2015, REL, V15; [Anonymous], 2 AUSTR ATLAS HEALTH; Cheriyan T, 2015, SPINE J, V15, P2564, DOI 10.1016/j.spinee.2015.09.033; de Moraes VY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050251; Faour M, 2017, SPINE, V42, P700, DOI 10.1097/BRS.0000000000001877; Grotle M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028743; Harris IA, 2020, PAIN, V161, pS95, DOI 10.1097/j.pain.0000000000001881; Harris IA, 2018, INTERN MED J, V48, P1430, DOI 10.1111/imj.14120; Harris IA, 2012, ANZ J SURG, V82, P625, DOI 10.1111/j.1445-2197.2012.06152.x; Harris IA, 2009, ANZ J SURG, V79, P783, DOI 10.1111/j.1445-2197.2009.05095.x; Huysmans E, 2018, SPINE J, V18, P1694, DOI 10.1016/j.spinee.2018.05.030; Imajo Y, 2015, J ORTHOP SCI, V20, P38, DOI 10.1007/s00776-014-0656-6; Kukreja S, 2015, CLIN NEUROL NEUROSUR, V135, P41, DOI 10.1016/j.clineuro.2015.04.012; Li Y, 2019, CLIN INTERV AGING, V14, P361, DOI 10.2147/CIA.S191449; Manson JF, 2015, SPINE, V40, P1620, DOI 10.1097/BRS.0000000000001096; Martin BI, 2019, SPINE, V44, P369, DOI 10.1097/BRS.0000000000002822; Nguyen TH, 2011, SPINE, V36, P320, DOI 10.1097/BRS.0b013e3181ccc220; Provaggi E, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011169; Sivasubramaniam V, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009011; Tabaraee E, 2015, SPINE, V40, P948, DOI 10.1097/BRS.0000000000000873; The Australian Commission on Safety and Quality in Health Care, 2016, PRIOR LIST CLIN DOM; Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe; Wheeler AJ, 2012, SPINE, V37, P605, DOI 10.1097/BRS.0b013e318226abf7; Wieser LM, 2016, J NEUROL SURG PART A, V77, P389, DOI 10.1055/s-0035-1570000	26	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6963		BMC HEALTH SERV RES	BMC Health Serv. Res.	SEP 11	2021	21	1							955	10.1186/s12913-021-06900-8			10	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	UP1LX	WOS:000695146800004	34511093	Green Published, gold			2022-02-06	
J	Hogan, C; Cornwell, P; Fleming, J; Man, DWK; Shum, DHK				Hogan, Christy; Cornwell, Petrea; Fleming, Jennifer; Man, David W. K.; Shum, David H. K.			Assessment of prospective memory after stroke utilizing virtual reality	VIRTUAL REALITY			English	Article; Early Access						Virtual reality; Memory; Stroke; Psychometrics; Neuropsychological test	MONTREAL COGNITIVE ASSESSMENT; TRAUMATIC BRAIN-INJURY; RETRIEVAL; PEOPLE; TASK; REHABILITATION; IMPAIRMENTS; REALIZATION; VERSION	Prospective Memory (PM) is the ability to remember to do something in the future. It is often impaired after stroke and can impact on an individual's level of independence and daily functioning. PM tasks have been criticized for their lack of ecological validity wherein test results may not be related to actual performance in daily life. With ecological validity in mind, the Virtual Reality Prospective Memory Shopping Task (VRPMST) was designed to assess two types of PM, time- and event-based. This study aimed to examine the ecological and convergent validity of the VRPMST in comparison to an experimental (Lexical Decision PM Task) and clinical measure of PM (Cambridge PM Test). Twelve individuals with stroke and 12 controls were administered three PM measures, three neuropsychological measures, and two user-friendliness questionnaires, one for the experimental PM measure and one for the VRPMST. Individuals with stroke showed impairments in PM compared to controls on all three PM measures, particularly time-based PM. Individuals with stroke were found to monitor time significantly less than controls on both the experimental PM measure and the VRPMST. The VRPMST was found to be sensitive in measuring PM, have better ecological validity when compared to the experimental PM measure, and good convergent validity. The findings of this study have helped to clarify that PM impairment does exist after stroke, possibly due to a problem in strategic monitoring. In addition, we have demonstrated how VR technology can be used to design a measure of cognitive function commonly impaired after stroke.	[Hogan, Christy] Griffith Univ, Sch Appl Psychol, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Hogan, Christy] Griffith Univ, Hopkins Ctr, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Menzies Hlth Inst Queensland, Sch Hlth Sci & Social Work, Prince Charles Hosp,Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Man, David W. K.; Shum, David H. K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Kowloon, Hong Kong, Peoples R China; [Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia		Man, DWK; Shum, DHK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Kowloon, Hong Kong, Peoples R China.; Shum, DHK (corresponding author), Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia.	david.shum@polyu.edu.hk	Shum, David H. K./A-3914-2008	Shum, David H. K./0000-0002-4810-9262; Hogan, Christy/0000-0001-7325-9695; Fleming, Jennifer/0000-0002-5603-2410	Griffith University Post-graduate ScholarshipGriffith University	This work was supported by a Griffith University Post-graduate Scholarship.	Andrews G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01032; Andrews G, 2014, BRAIN INJURY, V28, P442, DOI 10.3109/02699052.2014.888758; Barr A.C., 2011, THESIS U EDINBURGH; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Canty AL, 2017, NEUROPSYCHOL REHABIL, V27, P834, DOI 10.1080/09602011.2015.1052820; Canty AL, 2014, NEUROPSYCHOL REHABIL, V24, P238, DOI 10.1080/09602011.2014.881746; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cheng HD, 2010, BEHAV NEUROSCI, V124, P152, DOI 10.1037/a0018306; Cohen J, 1988, STAT POWER ANAL BEHA; Corporation IBM., 2017, IBM SPSS STAT VERS 2; Cumming TB, 2011, STROKE, V42, P2642, DOI 10.1161/STROKEAHA.111.619486; Debarnot U, 2015, NEUROBIOL AGING, V36, P2360, DOI 10.1016/j.neurobiolaging.2015.05.001; Desgranges B, 2014, INT J CHILD HLTH HUM, V7, P405; Dopping-Hepenstal S, 2014, M US MOD AD PERS DEN; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 1996, Q J EXP PSYCHOL-A, V49, P862, DOI 10.1080/027249896392333; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Hogan C, 2020, J INT NEUROPSYCH SOC, V26, P873, DOI 10.1017/S1355617720000405; Hogan C, 2016, BRAIN IMPAIR, V17, P123, DOI 10.1017/BrImp.2016.12; Kant N, 2014, NEUROPSYCHOLOGIA, V60, P77, DOI 10.1016/j.neuropsychologia.2014.05.015; Kim HJ, 2009, NEUROCASE, V15, P145, DOI 10.1080/13554790802709039; Kinsella GJ, 2009, BRAIN IMPAIR, V10, P45, DOI 10.1375/brim.10.1.45; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Knight RG, 2009, BRAIN IMPAIR, V10, P3, DOI 10.1375/brim.10.1.3; Kurtz MM, 2007, SCHIZOPHRENIA BULL, V33, P1162, DOI 10.1093/schbul/sbl039; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Kvavilashvili L, 2009, MEMORY, V17, P180, DOI 10.1080/09658210802194366; Man D, 2015, BRAIN INJURY, V29, P329, DOI 10.3109/02699052.2014.974672; Man DWK, 2018, NEUROPSYCHOL REHABIL, V28, P1197, DOI 10.1080/09602011.2016.1251949; Man DWK, 2015, NEUROPSYCHOL REHABIL, V25, P895, DOI 10.1080/09602011.2014.997253; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; Mitrovic A, 2016, J APPL RES MEM COGN, V5, P204, DOI 10.1016/j.jarmac.2016.03.006; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neulinger K., 2002, BRAIN IMPAIR, V3, P1, DOI [10.1375/brim.3.1.1, DOI 10.1375/BRIM.3.1.1]; Nolin, 2012, J CYBERTHERAPY REHAB, V5, P45; Nouri F. M., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Otani H, 1997, MEMORY, V5, P343, DOI 10.1080/741941393; RANKIN J, 1957, Scott Med J, V2, P200; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Reitan RM, 1992, TRAIL MAKING TEST MA; Rendell PG, 2009, BRAIN IMPAIR, V10, P14, DOI 10.1375/brim.10.1.14; Rose F, 2002, M INT C DIS VIRT REA; Rose FD, 1999, DISABIL REHABIL, V21, P548; Salkind NJ, 2010, ENCY RES DESIGN, P408, DOI DOI 10.4135/9781412961288; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Sweeney S, 2010, NEUROPSYCHOL REHABIL, V20, P239, DOI 10.1080/09602010903080531; Wechsler D., 2011, TEST PREMORBID FUNCT; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson~ BA, 2005, CAMBRIDGE TEST PROSP; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Yip BCB, 2013, NEUROREHABILITATION, V32, P103, DOI [10.3233/NRE-130827, 10.3233/NRE-30827]	57	1	1	10	10	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1359-4338	1434-9957		VIRTUAL REAL-LONDON	Virtual Real.												10.1007/s10055-021-00576-5		SEP 2021	14	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering; Imaging Science & Photographic Technology	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Imaging Science & Photographic Technology	UO6EQ	WOS:000694787000001		Green Published, hybrid			2022-02-06	
J	Moghadas, B; Bharadwaj, VN; Tobey, JP; Tian, YQ; Stabenfeldt, SE; Kodibagkar, VD				Moghadas, Babak; Bharadwaj, Vimala N.; Tobey, John P.; Tian, Yanqing; Stabenfeldt, Sarah E.; Kodibagkar, Vikram D.			GdDO3NI Enhanced Magnetic Resonance Imaging Allows Imaging of Hypoxia After Brain Injury	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article; Early Access						hypoxia; traumatic brain injury; GdDO3NI; targeted contrast agent	BARRIER BREAKDOWN; TUMOR HYPOXIA; MODEL; EPIDEMIOLOGY; SEQUELAE; IMPACT; MOUSE	Background Brain tissue hypoxia is a common consequence of traumatic brain injury (TBI) due to the rupture of blood vessels during impact and it correlates with poor outcome. The current magnetic resonance imaging (MRI) techniques are unable to provide a direct map of tissue hypoxia. Purpose To investigate whether GdDO3NI, a nitroimidazole-based T-1 MRI contrast agent allows imaging hypoxia in the injured brain after experimental TBI. Study Type Prospective. Animal Model TBI-induced mice (controlled cortical impact model) were intravenously injected with either conventional T-1 agent (gadoteridol) or GdDO3NI at 0.3 mmol/kg dose (n = 5 for each cohort) along with pimonidazole (60 mg/kg) at 1 hour postinjury and imaged for 3 hours following which they were euthanized. Field Strength/Sequence 7 T/T-2-weighted spin echo and T-1-weighted gradient echo. Assessment Injured animals were imaged with T-2-weighted spin-echo sequence to estimate the extent of the injury. The mice were then imaged precontrast and postcontrast using a T-1-weighted gradient-echo sequence for 3 hours postcontrast. Regions of interests were drawn on the brain injury region, the contralateral brain as well as on the cheek muscle region for comparison of contrast kinetics. Brains were harvested immediately post-imaging for immunohistochemical analysis. Statistical Tests One-way analysis of variance and two-sample t-tests were performed with a P < 0.05 was considered statistically significant. Results GdDO3NI retention in the injury region at 2.5-3 hours post-injection was significantly higher compared to gadoteridol (mean retention fraction 63.95% +/- 27.43% vs. 20.68% +/- 7.43% for gadoteridol at 3 hours) while it rapidly cleared out of the muscle region. Pimonidazole staining confirmed the presence of hypoxia in both gadoteridol and GdDO3NI cohorts, and the later cohort showed good agreement with MRI contrast enhancement. Data Conclusion GdDO3NI was successfully shown to visualize hypoxia in the brain post-TBI using T-1-weighted MRI at 2.5-3 hours postcontrast. Evidence Level 1 Technical Efficacy Stage 1	[Moghadas, Babak; Bharadwaj, Vimala N.; Tobey, John P.; Stabenfeldt, Sarah E.; Kodibagkar, Vikram D.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Tian, Yanqing] Southern Univ Sci & Technol, Dept Mat Sci & Engn, Shenzhen 518055, Guangdong, Peoples R China		Kodibagkar, VD (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	vikram.kodibagkar@asu.edu	Tian, Yanqing/N-1506-2019	Tian, Yanqing/0000-0002-1441-2431	National Science Foundation CAREER AwardNational Science Foundation (NSF) [1351992]; Fulton Schools of Engineering, ASU; FLINN Foundation [1976]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2HD084067]; Arizona State University Graduate College Completion Fellowship	This study was supported in part by a National Science Foundation CAREER Award#1351992 (V. D. K), a "Rising Stars in Engineering" seed grant from the Fulton Schools of Engineering, ASU (V.D.K., S.E.S.), a FLINN Foundation grant #1976 (S.E.S., V.D.K.), NIH 1DP2HD084067 (S.E.S.) and Arizona State University Graduate College Completion Fellowship (B.M. and V.N.B.). Imaging studies were performed at the Barrow-ASU Center for Preclinical Imaging, a part of the Biosciences Core Facilities at Arizona State University. The authors appreciate the assistance of Dr. Xiangxing Kong in contrast agent synthesis.	Agarwal S., 2017, MRI GUIDED ANAL CHAN, P181; Bardt TF, 1998, ACT NEUR S, V71, P153; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Boehm-Sturm P, 2018, RADIOLOGY, V286, P537, DOI 10.1148/radiol.2017170116; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Gulaka PK, 2014, J BIOL INORG CHEM, V19, P271, DOI 10.1007/s00775-013-1058-5; Guo BJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00335; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; JONKERS BW, 1984, J NEUROSCI METH, V12, P141, DOI 10.1016/0165-0270(84)90013-X; Kallehauge JF, 2014, ACTA ONCOL, V53, P1064, DOI 10.3109/0284186X.2014.937879; Kodibagkar VD, 2008, NMR BIOMED, V21, P899, DOI 10.1002/nbm.1279; Kording F, 2014, J MAGN RESON IMAGING, V40, P1310, DOI 10.1002/jmri.24513; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114173; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McDonald RJ, 2017, RADIOLOGY, V285, P536, DOI 10.1148/radiol.2017161594; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Mrozek S, 2016, BRAIN RES, V1646, P334, DOI 10.1016/j.brainres.2016.06.007; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Raleigh JA, 1996, SEMIN RADIAT ONCOL, V6, P37, DOI 10.1016/S1053-4296(96)80034-8; Rojas-Quijano FA, 2012, CHEM-EUR J, V18, P9669, DOI 10.1002/chem.201200266; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; SINHA RP, 1973, JAMA-J AM MED ASSOC, V224, P1258, DOI 10.1001/jama.224.9.1258; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Xie J, 2021, MAGN RESON MED, V85, P3370, DOI 10.1002/mrm.28664	35	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging												10.1002/jmri.27912		SEP 2021	8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	UO3ZK	WOS:000694635200001	34499791				2022-02-06	
J	Hellas, JA; Andrew, RD				Hellas, Julia A.; Andrew, R. David			Neuronal Swelling: A Non-osmotic Consequence of Spreading Depolarization	NEUROCRITICAL CARE			English	Article						Osmolar concentration; Osmolality; Ischemia; Cytotoxic cerebral edema; Brain edema; Water intoxication; Inappropriate ADH syndrome; SIADH; Stroke; Spreading depolarization	INTRINSIC OPTICAL SIGNALS; PRIMARY ASTROCYTE CULTURES; CEREBRAL-ARTERY OCCLUSION; ACUTE EXCITOTOXIC INSULT; RAT HIPPOCAMPAL SLICES; CENTRAL-NERVOUS-SYSTEM; CELL-VOLUME; WATER PERMEABILITY; CHLORIDE COTRANSPORTERS; GLUCOSE TRANSPORTERS	An acute reduction in plasma osmolality causes rapid uptake of water by astrocytes but not by neurons, whereas both cell types swell as a consequence of lost blood flow (ischemia). Either hypoosmolality or ischemia can displace the brain downwards, potentially causing death. However, these disorders are fundamentally different at the cellular level. Astrocytes osmotically swell or shrink because they express functional water channels (aquaporins), whereas neurons lack functional aquaporins and thus maintain their volume. Yet both neurons and astrocytes immediately swell when blood flow to the brain is compromised (cytotoxic edema) as following stroke onset, sudden cardiac arrest, or traumatic brain injury. In each situation, neuronal swelling is the direct result of spreading depolarization (SD) generated when the ATP-dependent sodium/potassium ATPase (the Na+/K+ pump) is compromised. The simple, and incorrect, textbook explanation for neuronal swelling is that increased Na+ influx passively draws Cl- into the cell, with water following by osmosis via some unknown conduit. We first review the strong evidence that mammalian neurons resist volume change during acute osmotic stress. We then contrast this with their dramatic swelling during ischemia. Counter-intuitively, recent research argues that ischemic swelling of neurons is non-osmotic, involving ion/water cotransporters as well as at least one known amino acid water pump. While incompletely understood, these mechanisms argue against the dogma that neuronal swelling involves water uptake driven by an osmotic gradient with aquaporins as the conduit. Promoting clinical recovery from neuronal cytotoxic edema evoked by spreading depolarizations requires a far better understanding of molecular water pumps and ion/water cotransporters that act to rebalance water shifts during brain ischemia.	[Hellas, Julia A.; Andrew, R. David] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada		Hellas, JA (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.	16jah6@queensu.ca					Aitken PG, 1998, PFLUG ARCH EUR J PHY, V436, P991, DOI 10.1007/s004240050734; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Andrew RD, 2017, J CEREBR BLOOD F MET, V37, P1735, DOI 10.1177/0271678X16657344; Andrew RD, 1999, METHODS, V18, P185, DOI 10.1006/meth.1999.0771; ANDREW RD, 1991, J NEUROL SCI, V101, P7, DOI 10.1016/0022-510X(91)90013-W; ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; Andrew RD, 1997, EXP NEUROL, V143, P300, DOI 10.1006/exnr.1996.6375; ANDREW RD, 1989, BRAIN RES, V498, P175, DOI 10.1016/0006-8993(89)90417-4; Andrew RD., 2016, MECH UNDERLYING NEUR; ARIEFF AI, 1973, J CLIN INVEST, V52, P571, DOI 10.1172/JCI107218; ASHTON D, 1990, BRAIN RES, V528, P212, DOI 10.1016/0006-8993(90)91660-9; Ayata RD., NEUROCRIT CARE, P2021; Ayus JC, 2008, AM J PHYSIOL-RENAL, V295, pF619, DOI 10.1152/ajprenal.00502.2007; Azouz R, 1997, J PHYSIOL-LONDON, V502, P175, DOI 10.1111/j.1469-7793.1997.175bl.x; BALLYK BA, 1991, J NEUROPHYSIOL, V65, P1055, DOI 10.1152/jn.1991.65.5.1055; Baraban SC, 1997, J PHYSIOL-LONDON, V498, P679, DOI 10.1113/jphysiol.1997.sp021892; Barone V, 2020, NEW YORK POST; Basavappa S, 1996, MOL NEUROBIOL, V13, P137, DOI 10.1007/BF02740638; Baslow M, 2008, AMINO ACID MOL UNPUB; Baslow MH, 1999, NEUROCHEM INT, V34, P77, DOI 10.1016/S0197-0186(98)00073-4; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Baslow MH, 2007, J MOL NEUROSCI, V32, P235, DOI 10.1007/s12031-007-0049-9; Biedermann J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2012843118; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bothwell JH, 2001, J NEUROCHEM, V77, P1632, DOI 10.1046/j.1471-4159.2001.00403.x; Brisson CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096585; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; Ch?vez-Castillo M., 2017, J NEUROLOGY NEUROSCI, V8, P193, DOI [10.21767/2171-6625.1000193, DOI 10.21767/2171-6625.1000193]; Chamma I, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00005; CHEBABO SR, 1995, BRAIN RES, V695, P203, DOI 10.1016/0006-8993(95)00778-O; CHEN W, 1993, P NATL ACAD SCI USA, V90, P9896, DOI 10.1073/pnas.90.21.9896; CHUNG HM, 1986, ARCH INTERN MED, V146, P333, DOI 10.1001/archinte.146.2.333; Ciura S, 2018, CELL REP, V23, P2245, DOI 10.1016/j.celrep.2018.04.090; COMBS DJ, 1990, STROKE, V21, P936, DOI 10.1161/01.STR.21.6.936; CZEH G, 1993, BRAIN RES, V632, P195, DOI 10.1016/0006-8993(93)91154-K; Davies ML, 2007, J NEUROSCI METH, V166, P203, DOI 10.1016/j.jneumeth.2007.07.012; Delpire E, 2014, J PHYSIOL-LONDON, V592, P4099, DOI 10.1113/jphysiol.2014.275529; Donkor ES, 2018, STROKE RES TREAT, V2018, DOI 10.1155/2018/3238165; Douglas HA, 2011, J NEUROPHYSIOL, V105, P1482, DOI 10.1152/jn.00817.2010; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; DUDEK FE, 1990, NEUROSCI LETT, V120, P267, DOI 10.1016/0304-3940(90)90056-F; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Farkas A., 2020, MALIGNANT ASTROCYTE; FERRIER IN, 1985, BRIT MED J, V291, P1594, DOI 10.1136/bmj.291.6509.1594; Fricker M, 2018, PHYSIOL REV, V98, P813, DOI 10.1152/physrev.00011.2017; FRIGERI A, 1995, J CELL SCI, V108, P2993; Fujio T, 2006, J NEUROENDOCRINOL, V18, P776, DOI 10.1111/j.1365-2826.2006.01476.x; GERHART DZ, 1994, MOL BRAIN RES, V25, P313, DOI 10.1016/0169-328X(94)90167-8; Greendyke RM, 1998, NEUROPSYCHOPHARMACOL, V18, P272; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hamann S, 2005, J PHYSIOL-LONDON, V568, P123, DOI 10.1113/jphysiol.2005.093526; HARIPRASAD MK, 1980, ARCH INTERN MED, V140, P1639, DOI 10.1001/archinte.140.12.1639; Hecimovic PM, 1997, PREPARATION USE BRAI, P23; Heiss WD, 1997, J CEREBR BLOOD F MET, V17, P388, DOI 10.1097/00004647-199704000-00004; HEISS WD, 1992, STROKE, V23, P1668, DOI 10.1161/01.STR.23.11.1668; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; Hernandez-Benitez R, 2014, CELL PHYSIOL BIOCHEM, V34, P2038, DOI 10.1159/000366399; Hirrlinger PG, 2008, J NEUROCHEM, V105, P1405, DOI 10.1111/j.1471-4159.2008.05243.x; HORN M, 1992, ACTA NEUROPATHOL, V85, P79, DOI 10.1007/BF00304636; Hoshi Y, 2018, J NEUROSCI, V38, P5700, DOI 10.1523/JNEUROSCI.2888-17.2018; Hui H, 2016, NEUROCHEM INT, V94, P23, DOI 10.1016/j.neuint.2016.02.002; Igarashi H, 2015, MAGN RESON MED SCI, V14, P13, DOI 10.2463/mrms.2014-0039; Jarvis CR, 1999, NEUROIMAGE, V10, P357, DOI 10.1006/nimg.1999.0473; Jha S K, 2003, Med J Armed Forces India, V59, P326, DOI 10.1016/S0377-1237(03)80147-8; Jourdain P, 2011, J NEUROSCI, V31, P11846, DOI 10.1523/JNEUROSCI.0286-11.2011; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Khmelinskii I, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65217-4; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; KIMELBERG HK, 1985, BRAIN RES, V361, P125, DOI 10.1016/0006-8993(85)91282-X; Kimelberg HK, 2000, NEUROSCIENTIST, V6, P14, DOI 10.1177/107385840000600110; Kirov SA, 1999, J NEUROSCI, V19, P2876; Kirov SA, 2020, CEREB CORTEX, V30, P5517, DOI 10.1093/cercor/bhaa134; Kreisman NR, 2003, NEUROSCIENCE, V120, P635, DOI 10.1016/S0306-4522(03)00359-2; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lauderdale K, 2015, ASN NEURO, V7, DOI 10.1177/1759091415605115; LEE JH, 1994, NEW ENGL J MED, V331, P439, DOI 10.1056/NEJM199408183310704; Lee K, 2020, CTR NEUROSCIENCE STU, P96; Leino RL, 1997, J NEUROSCI RES, V49, P617; Li H, 2016, P NATL ACAD SCI USA, V113, P5862, DOI 10.1073/pnas.1521038113; Lim JH, 2021, INT J MORPHOL, V39, P64; Macaulay N, 2004, NEUROSCIENCE, V129, P1031, DOI 10.1016/j.neuroscience.2004.06.045; MacAulay N, 2010, NEUROSCIENCE, V168, P941, DOI 10.1016/j.neuroscience.2009.09.016; MacAulay N, 2020, GLIA, V68, P2192, DOI 10.1002/glia.23824; Mao XY, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00512; Matsuda T, 2017, NAT NEUROSCI, V20, P230, DOI 10.1038/nn.4463; Mestre H, 2020, SCIENCE, V367, P1211, DOI 10.1126/science.aax7171; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Middleton SA, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0630-z; Moreira TJTP, 2009, J CEREBR BLOOD F MET, V29, P1273, DOI 10.1038/jcbfm.2009.50; Muller M, 1999, J NEUROPHYSIOL, V82, P1818, DOI 10.1152/jn.1999.82.4.1818; Murata Y, 2020, NEUROCHEM INT, V140, DOI 10.1016/j.neuint.2020.104848; Murphy TR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00275; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Noakes, 2012, WATERLOGGED SERIOUS, P429, DOI [10.5040/9781492596028, DOI 10.5040/9781492596028]; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Parisi M, 2007, J BIOL PHYS, V33, P331, DOI 10.1007/s10867-008-9064-5; Parkerson KA, 2003, AM J PHYSIOL-CELL PH, V284, pC1460, DOI 10.1152/ajpcell.00603.2002; Petrin D, 2019, J NEUROPHYSIOL, V121, P1650, DOI 10.1152/jn.00670.2018; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Polischuk TM, 1998, NEUROBIOL DIS, V4, P423, DOI 10.1006/nbdi.1998.0172; Pool AH, 2020, NATURE, V588, P112, DOI 10.1038/s41586-020-2821-8; Porcelli V., 2017, MCT2 EXPRESSION HYPO, P46; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Roberta A, 2010, CURR NEUROPHARMACOL, V8, P84, DOI 10.2174/157015910791233178; ROSEN AS, 1990, NEUROSCIENCE, V38, P579, DOI 10.1016/0306-4522(90)90052-6; ROSEN AS, 1991, BRAIN RES, V555, P58, DOI 10.1016/0006-8993(91)90859-T; Rosenberg GA, 1999, PROG CARDIOVASC DIS, V42, P209, DOI 10.1016/S0033-0620(99)70003-4; Rowntree LG, 1923, ARCH INTERN MED, V32, P157, DOI 10.1001/archinte.1923.00110200003001; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; Sager TN, 1999, J NEUROCHEM, V73, P807, DOI 10.1046/j.1471-4159.1999.0730807.x; Sahay Manisha, 2014, Indian J Endocrinol Metab, V18, P760, DOI 10.4103/2230-8210.141320; Sakoh M, 2000, J NEUROSURG, V93, P647, DOI 10.3171/jns.2000.93.4.0647; SALY V, 1993, J NEUROPHYSIOL, V69, P2200, DOI 10.1152/jn.1993.69.6.2200; Sannita M., 2016, BRAIN FUNCTION RESPO, VXI, P207; Sawant-Pokam PA, 2020, J CLIN INVEST, V130, P6005, DOI 10.1172/JCI134793; Shah S, 2016, SEMIN NEUROL, V36, P502, DOI 10.1055/s-0036-1592109; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Sperelakis N., 2001, CELL PHYSL SOURCE BO; Steffensen AB, 2015, J NEUROSCI, V35, P12172, DOI 10.1523/JNEUROSCI.0400-15.2015; STRANGE K, 1992, J AM SOC NEPHROL, V3, P12; Tasker JG, 2020, J NEUROENDOCRINOL, V32, DOI 10.1111/jne.12826; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; Toft-Bertelsen TL, 2021, GLIA, V69, P28, DOI 10.1002/glia.23851; Tomas-Camardiel M, 2004, J NEUROCHEM, V91, P891, DOI 10.1111/j.1471-4159.2004.02759.x; Tomioka S, 2012, NEUROREPORT, V23, P21, DOI 10.1097/WNR.0b013e32834da877; Urabe T, 1996, J NEUROCHEM, V67, P265; Vannucci SJ, 1998, DEV BRAIN RES, V107, P255, DOI 10.1016/S0165-3806(98)00021-2; Vargova L, 2001, J NEUROSCI RES, V65, P129, DOI 10.1002/jnr.1136; Verbalis JG, 2010, NEUROSCIENCE, V168, P862, DOI 10.1016/j.neuroscience.2010.03.042; Wang FS, 2017, BRAIN STRUCT FUNCT, V222, P1543, DOI 10.1007/s00429-016-1292-z; Wang Y, 2011, J NEUROSCI, V31, P10241, DOI 10.1523/JNEUROSCI.1462-11.2011; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zeuthen T, 1996, J PHYSIOL-LONDON, V497, P3, DOI 10.1113/jphysiol.1996.sp021745; Zhang SS, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01750-w; Zhang ZZ, 2003, NAT NEUROSCI, V6, P1021, DOI 10.1038/nn1124; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	145	1	1	3	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2021	35	SUPPL 2		2	SI		112	134		10.1007/s12028-021-01326-w		SEP 2021	23	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL1AZ	WOS:000693896700003	34498208	hybrid, Green Published			2022-02-06	
J	Bazarian, JJ; Welch, RD; Caudle, K; Jeffrey, CA; Chen, JY; Chandran, R; McCaw, T; Datwyler, SA; Zhang, HW; McQuiston, B				Bazarian, Jeffrey J.; Welch, Robert D.; Caudle, Krista; Jeffrey, Craig A.; Chen, James Y.; Chandran, Raj; McCaw, Tamara; Datwyler, Saul A.; Zhang, Hongwei; McQuiston, Beth			Accuracy of a rapid glial fibrillary acidic protein/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury	ACADEMIC EMERGENCY MEDICINE			English	Article							OVERUSE; ADULTS; RULE	Objective The objective was to determine the accuracy of a new, rapid blood test combining measurements of both glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) for predicting acute traumatic intracranial injury (TII) on head CT scan after mild traumatic brain injury (mTBI). Methods Analysis of banked venous plasma samples from subjects completing the Prospective Clinical Evaluation of Biomarkers of Traumatic Brain Injury (ALERT-TBI) trial, enrolled 2012-2014 at 22 investigational sites in the United States and Europe. All subjects were >= 18 years old, presented to an emergency department (ED) with a nonpenetrating head injury and Glasgow Coma Scale score (GCS) 9-15 (mild to moderate TBI), underwent head CT scanning as part of their clinical care, and had blood sampling within 12 h of injury. Plasma concentrations of GFAP and UCH-L1 were measured using i-STAT Alinity and TBI plasma cartridge and compared to acute TII on head CT scan. Results Of the 2011 subjects enrolled in ALERT-TBI, 1918 had valid CT scans and plasma specimens for testing and 1901 (99.1%) had GCS 13-15 (mTBI), for which the rapid test was intended. Among these subjects, the rapid test had a sensitivity of 0.958 (95% confidence interval [CI] = 0.906 to 0.982), specificity of 0.404 (95% CI = 0.382 to 0.427), negative predictive value of 0.993 (95% CI = 0.985 to 0.997), and positive predictive value of 0.098 (95% CI = 0.082 to 0.116) for acute TII. Conclusions A rapid i-STAT-based test had high sensitivity for prediction of acute TII, comparable to lab-based platforms. The speed, portability, and high accuracy of this test may facilitate clinical adoption of brain biomarker testing as an aid to head CT decision making in EDs.	[Bazarian, Jeffrey J.] Univ Rochester, Dept Emergency Med & Neurol, Rochester, NY USA; [Welch, Robert D.] Wayne State Univ, Dept Emergency, Sch Med, Detroit, MI 48201 USA; [Welch, Robert D.] Wayne State Univ, Biostat & Epidemiol Res Design Core, Detroit, MI USA; [Caudle, Krista] US Army Med Res & Dev Command, US Army Med Mat Dev Activ, Warfighter Brain Hlth Project Management Off, Ft Detrick, MD USA; [Jeffrey, Craig A.; McCaw, Tamara; Zhang, Hongwei] Abbott Point Care, Ottawa, ON, Canada; [Chen, James Y.] San Diego Vet Adm Med Ctr, Dept Radiol, La Jolla, CA USA; [Chen, James Y.] UC San Diego Hlth Syst, Dept Radiol, La Jolla, CA USA; [Datwyler, Saul A.; McQuiston, Beth] Abbott Diagnost, Abbott Pk, IL USA		Welch, RD (corresponding author), Wayne State Univ, Dept Emergency, Sch Med, Detroit, MI 48201 USA.	rwelch@med.wayne.edu			U.S. Army Medical Research and Materiel Command's U.S. Army Medical Materiel Development Activity [W81XWH-17-C-0079]	This work was supported by the U.S. Army Medical Research and Materiel Command's U.S. Army Medical Materiel Development Activity, contract no. W81XWH-17-C-0079. The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation. In the conduct of research where humans are the subjects, the investigator( s) adhered to the policies regarding the protection of human subjects as prescribed by Code of Federal Regulations (CFR) Title 45, Volume 1, Part 46; Title 32, Chapter 1, Part 219; and Title 21, Chapter 1, Part 50 (Protection of Human Subjects).	Advisory Board, 2015, NEW EV HEAD CT SCAN; [Anonymous], 2014, HEAD INJ ASS EARL MA; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1373/clinchem.2015.246280, 10.1136/bmj.h5527, 10.1148/radiol.2015151516]; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Cheng AHY, 2017, CAN J EMERG MED, V19, pS9, DOI 10.1017/cem.2017.1; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Gill J, 2018, NEUROLOGY, V90; HALDANE JBS, 1955, EVOLUTION, V9, P484, DOI 10.2307/2405484; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Lewis LM, 2020, J NEUROTRAUM, V37, P2624, DOI 10.1089/neu.2020.7071; Marion DW, 2006, NEUROSURGERY, V58, P655; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Michelson EA, 2018, WEST J EMERG MED, V19, P635, DOI 10.5811/westjem.2018.5.37293; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Okonkwo DO, 2020, J NEUROTRAUM, V37, P2460, DOI 10.1089/neu.2020.7140; Raja AS, 2017, WEST J EMERG MED, V18, P454, DOI 10.5811/westjem.2017.1.32677; Rogg JG, 2017, AM J EMERG MED, V35, P1510, DOI 10.1016/j.ajem.2017.04.059; Sharp AL, 2017, ACAD EMERG MED, V24, P393, DOI 10.1111/acem.13082; Sharp AL, 2017, ACAD EMERG MED, V24, P22, DOI 10.1111/acem.13061; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	32	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	NOV	2021	28	11					1308	1317		10.1111/acem.14366		SEP 2021	10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XC3JM	WOS:000695308100001	34358399	hybrid			2022-02-06	
J	Wearne, TA; Logan, JA; Trimmer, EM; Wilson, E; Filipcikova, M; Kornfeld, E; Rushby, JA; McDonald, S				Wearne, T. A.; Logan, J. A.; Trimmer, E. M.; Wilson, E.; Filipcikova, M.; Kornfeld, E.; Rushby, J. A.; McDonald, S.			Regulating emotion following severe traumatic brain injury: a randomized controlled trial of heart-rate variability biofeedback training	BRAIN INJURY			English	Article						traumatic brain injury; emotion regulation; anger; heart rate variability; biofeedback	ANXIETY STRESS SCALES; COGNITIVE PERFORMANCE; ASSOCIATION; DEPRESSION; TBI; INDIVIDUALS; EXPERIENCE; SYMPTOMS; BEHAVIOR; ADULTS	Background While difficulties regulating emotions are almost ubiquitous after traumatic brain injury (TBI), remediation techniques are limited. Heart-rate variability (HRV) is a physiological measure of emotion regulation and can be modified using biofeedback training. The aim of the current study was to evaluate the efficacy of repeated biofeedback training for improving emotion regulation difficulties following TBI. Design Fifty adults with severe TBI were allocated to either biofeedback or waitlist conditions. Treatment consisted of six biofeedback sessions whereby participants were taught to breathe at their resonant frequency. Outcomes included changes in physiological and subjective reactivity to anger-induction, emotional well-being, and physiology at rest, together with symptoms of psychological distress and sleep disturbances (ACTRN12618002031246). Results While biofeedback led to reduced skin conductance, it did not affect any other objective or subjective response to the mood induction procedure. Biofeedback led to fewer sleep disturbances, and reduced negative mood valence and depression during follow-up. Conclusions HRV biofeedback training is a feasible technique following TBI that transfers to improved symptoms of general emotional well-being, psychological distress, and sleep. Biofeedback does not transfer to a laboratory-based emotional provocation task. HRV biofeedback training may represent a novel adjunct for generalized emotional difficulties following injury.	[Wearne, T. A.; Logan, J. A.; Trimmer, E. M.; Wilson, E.; Filipcikova, M.; Kornfeld, E.; Rushby, J. A.; McDonald, S.] Univ New South Wales, Sch Psychol, Fac Sci, Sydney, NSW, Australia		Wearne, TA (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	t.wearne@unsw.edu.au	; McDonald, Skye/G-4118-2014	Wilson, Emily/0000-0002-1949-7657; McDonald, Skye/0000-0003-0723-6094; Wearne, Travis/0000-0002-7565-9163; Logan, Jodie/0000-0003-1198-487X	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1081923]	This project was funded by a National Health and Medical Research Council Project Grant (APP1081923).	Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Boucsein W., 1992, ELECTRODERMAL ACTIVI; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Buysse D J, 1989, Psychiatry Res, V28, P193; Camm AJ, 1996, CIRCULATION, V93, P1043; Campbell-Sills L., 2007, HDB EMOTION REGULATI, P542; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chalmers JA, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00080; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Dolcos S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00681; Ernst G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00240; Feldner MT, 2006, J BEHAV THER EXP PSY, V37, P171, DOI 10.1016/j.jbtep.2005.06.002; Francis HM, 2016, SOC NEUROSCI-UK, V11, P545, DOI 10.1080/17470919.2015.1115777; Francis HM, 2016, NEUROPSYCHOL REHABIL, V26, P103, DOI 10.1080/09602011.2014.1003246; Frasca Diana, 2013, Front Hum Neurosci, V7, P31, DOI 10.3389/fnhum.2013.00031; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Jester DJ, 2019, AGING MENT HEALTH, V23, P574, DOI 10.1080/13607863.2018.1432031; Jordan J, 2013, BRAIN INJURY, V27, P1063, DOI 10.3109/02699052.2013.794962; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.12.012, 10.1016/j.biopsych.2009.11.019]; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kim S, 2019, BRAIN INJURY, V33, P1012, DOI 10.1080/02699052.2019.1593506; Kim S, 2013, BRAIN INJURY, V27, P209, DOI 10.3109/02699052.2012.729292; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Lang P.J., 1997, NIMH CENTRAL STUDY E, P39; Lehrer PM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00756; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; Lin IM, 2019, CLIN PSYCHOPHARM NEU, V17, P222, DOI 10.9758/cpn.2019.17.2.222; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mathias CW, 2004, ARCH CLIN NEUROPSYCH, V19, P543, DOI 10.1016/j.acn.2003.08.001; Mennin DS, 2007, BEHAV THER, V38, P284, DOI 10.1016/j.beth.2006.09.001; Mohr DC, 2009, PSYCHOTHER PSYCHOSOM, V78, P275, DOI 10.1159/000228248; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Prinsloo GE, 2013, APPL PSYCHOPHYS BIOF, V38, P45, DOI 10.1007/s10484-012-9207-0; Prinsloo GE, 2011, APPL COGNITIVE PSYCH, V25, P792, DOI 10.1002/acp.1750; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Quintana DS, 2012, INT J PSYCHOPHYSIOL, V86, P168, DOI 10.1016/j.ijpsycho.2012.08.012; Reitan RM., 1992, TRAIL MAKING TEST RE; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Shields C, 2016, NEUROPSYCHOL REHABIL, V26, P410, DOI 10.1080/09602011.2015.1037772; Steffen PR, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00222; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Terry PC, 1999, J SPORT SCI, V17, P861, DOI 10.1080/026404199365425; Terry PC, 2003, PSYCHOL SPORT EXERC, V4, P125, DOI 10.1016/S1469-0292(01)00035-8; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thompson R A, 1994, Monogr Soc Res Child Dev, V59, P25, DOI 10.2307/1166137; Vaschillo E, 2002, APPL PSYCHOPHYS BIOF, V27, P1, DOI 10.1023/A:1014587304314; Vistisen ST, 2014, BRAIN INJURY, V28, P196, DOI 10.3109/02699052.2013.860477; Wearne T, 2019, BRAIN INJURY, V33, P12, DOI 10.1080/02699052.2018.1531300; Wearne TA, 2019, INT J PSYCHOPHYSIOL, V141, P76, DOI 10.1016/j.ijpsycho.2019.04.012; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wells R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046597; Winter L, 2018, BRAIN INJURY, V32, P593, DOI 10.1080/02699052.2018.1432895; Wolfe LF, 2018, NEUROREHABILITATION, V43, P257, DOI 10.3233/NRE-182583; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Zucker TL, 2009, APPL PSYCHOPHYS BIOF, V34, P135, DOI 10.1007/s10484-009-9085-2	67	1	1	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2021	35	11					1390	1401		10.1080/02699052.2021.1972337		SEP 2021	12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XO2HY	WOS:000693115500001	34487459				2022-02-06	
J	Morriss, NJ; Conley, GM; Hodgson, N; Boucher, M; Ospina-Mora, S; Fagiolini, M; Puder, M; Mejia, L; Qiu, JH; Meehan, W; Mannix, R				Morriss, Nicholas J.; Conley, Grace M.; Hodgson, Nathaniel; Boucher, Masen; Ospina-Mora, Sara; Fagiolini, Michaela; Puder, Mark; Mejia, Leo; Qiu, Jianhua; Meehan, William; Mannix, Rebekah			Visual Dysfunction after Repetitive Mild Traumatic Brain Injury in a Mouse Model and Ramifications on Behavioral Metrics	JOURNAL OF NEUROTRAUMA			English	Article						animal model; behavior; ERG; TBI; vision	MORRIS WATER MAZE; OPTIC-NERVE; AXONAL INJURY; PATTERN ELECTRORETINOGRAM; VESTIBULAR DYSFUNCTION; CONCUSSION; DEFICITS; DAMAGE; HEAD; RECOVERY	Mild traumatic brain injury (mTBI) is a major cause of morbidity and mortality with a poorly understood pathophysiology. Animal models have been increasingly utilized to better understand mTBI and recent research has identified visual deficits in these models that correspond to human literature. While visual impairment is being further characterized within TBI, the implications of impaired vision on behavioral tasks commonly utilized in animal models has not been well described thus far. Visual deficits may well confound behavioral tests that are believed to be isolated to cognitive functioning such as learning and memory. We utilized a mouse model of repetitive mTBI (rmTBI) to further characterize visual deficits using an optomotor task, electroretinogram, and visually evoked potential, and located likely areas of damage to the visual pathway. Mice were tested on multiple behavioral metrics, including a touchscreen conditional learning task to better identify the contribution of visual dysfunction to behavioral alterations. We found that rmTBI caused visual dysfunction resulting from damage distal to the retina that likely involves pathology within the optic nerve. Moreover, loss of vision led to poorer performance of rmTBI animals on classic behavioral tests such as the Morris water maze that would otherwise be attributed solely to learning and memory deficits. The touchscreen conditional learning task was able to differentiate rmTBI induced learning and memory dysfunction from visual impairment and is a valuable tool for elucidating subtle changes resulting from TBI.	[Morriss, Nicholas J.; Conley, Grace M.; Boucher, Masen; Ospina-Mora, Sara; Qiu, Jianhua; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Hodgson, Nathaniel; Fagiolini, Michaela; Mejia, Leo] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Puder, Mark] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Meehan, William] Boston Childrens Hosp, Sports Concuss Clin, Boston, MA 02115 USA; [Fagiolini, Michaela; Puder, Mark; Qiu, Jianhua; Meehan, William; Mannix, Rebekah] Harvard Med Sch, Boston, MA 02115 USA; [Meehan, William] Micheli Ctr Sports Injury Prevent, Boston, MA USA		Mannix, R (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	rebekah.mannix@childrens.harvard.edu			National Football League through the NFL LONG study; National Football League Players Association	The experiments described here were funded, in part, by the National Football League through the NFL LONG study and the National Football League Players Association. Part of the work was performed in the Animal Behavioral and Physiology Core at Boston Children's Hospital (CHB IDDRC, 1U54HD090255).	ASI H, 1992, CLIN VISION SCI, V7, P9; ASI H, 1992, DOC OPHTHALMOL, V79, P125, DOI 10.1007/BF00156572; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Benchorin G, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2218; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Blokland A, 2004, BEHAV BRAIN RES, V154, P71, DOI 10.1016/j.bbr.2004.01.022; BROWN KT, 1962, NATURE, V193, P958, DOI 10.1038/193958a0; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chou TH, 2018, METHODS MOL BIOL, V1695, P63, DOI 10.1007/978-1-4939-7407-8_6; Chou TH, 2012, INVEST OPHTH VIS SCI, V53, P8086, DOI 10.1167/iovs.12-10720; Desai A, 2020, J NEUROTRAUM, V37, P286, DOI 10.1089/neu.2019.6602; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Dong ZF, 2013, NEUROPHARMACOLOGY, V64, P65, DOI 10.1016/j.neuropharm.2012.06.027; Dratviman-Storobinsky O, 2008, MOL VIS, V14, P2171; Duarte CB, 1998, GEN PHARMACOL-VASC S, V30, P289, DOI 10.1016/S0306-3623(97)00360-1; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Frick KD, 2019, MIL MED, V184, pE338, DOI 10.1093/milmed/usy420; FURUKAWA TARO, 1955, JAPANESE JOUR PHYSIOL, V5, P289; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jacobs SM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0389-5; Jones Sherri M., 2009, Seminars in Hearing, V30, P231, DOI 10.1055/s-0029-1241124; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kolarik BS, 2016, NEUROPSYCHOLOGIA, V80, P90, DOI 10.1016/j.neuropsychologia.2015.11.013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JY, 1997, VISION RES, V37, P505, DOI 10.1016/S0042-6989(96)00159-9; Liu XX, 2017, J NEUROTRAUM, V34, P2445, DOI 10.1089/neu.2016.4823; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; Ma GX, 2019, NEUROSCIENCE, V421, P152, DOI 10.1016/j.neuroscience.2019.10.016; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meehan WP, 2011, CLIN SPORT MED, V30, pXVII, DOI 10.1016/j.csm.2010.09.008; Mei ZR, 2018, BEHAV BRAIN RES, V340, P195, DOI 10.1016/j.bbr.2017.04.017; NILSSON SEG, 1971, ACTA OPHTHALMOL, V49, P111; NOELL WK, 1954, AM J OPHTHALMOL, V38, P78, DOI 10.1016/0002-9394(54)90012-4; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Pasmanter N, 2020, VET OPHTHALMOL, V23, P418, DOI 10.1111/vop.12759; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; PEPPERBERG DR, 1978, BRAIN RES, V151, P194, DOI 10.1016/0006-8993(78)90964-2; Perlman I, 1995, WEBVISION ORG RETINA; Peterson MD, 2010, J HEAD TRAUMA REHAB, V25, P193, DOI 10.1097/HTR.0b013e3181dc82fa; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pinto LH, 2007, DOC OPHTHALMOL, V115, P127, DOI 10.1007/s10633-007-9064-y; Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SCHECHNER R, 1987, INVEST OPHTH VIS SCI, V28, P1605; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; SILLMAN AJ, 1969, VISION RES, V9, P1435, DOI 10.1016/0042-6989(69)90059-5; Soto A, 2004, NEUROSCIENCE, V123, P441, DOI 10.1016/j.neuroscience.2003.09.009; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Szentes N, 2019, GEROSCIENCE, V41, P631, DOI 10.1007/s11357-019-00059-1; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785; Tomiyama Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156927; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Trakkides TO, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8110548; Tzekov R, 2013, INVEST OPHTH VIS SCI, V54; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Vien L, 2017, OPTOMETRY VISION SCI, V94, P125, DOI 10.1097/OPX.0000000000000899; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Yue JK, 2019, NEUROL RES, V41, P609, DOI 10.1080/01616412.2019.1602312	84	1	1	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2881	2895		10.1089/neu.2021.0165		SEP 2021	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000693308900001	34375128				2022-02-06	
J	Abid, Z; Kuppermann, N; Tancredi, DJ; Dayan, PS				Abid, Zaynah; Kuppermann, Nathan; Tancredi, Daniel J.; Dayan, Peter S.			Risk of Traumatic Brain Injuries in Infants Younger than 3 Months With Minor Blunt Head Trauma	ANNALS OF EMERGENCY MEDICINE			English	Article							INTRACRANIAL INJURY; COMPUTED-TOMOGRAPHY; CHILDREN YOUNGER; SKULL FRACTURES; ASSOCIATION	Study objective: Infants with head trauma often have subtle findings suggestive of traumatic brain injury. Prediction rules for traumatic brain injury among children with minor head trauma have not been specifically evaluated in infants younger than 3 months old. We aimed to determine the risk of clinically important traumatic brain injuries, traumatic brain injuries on computed tomography (CT) images, and skull fractures in infants younger than 3 months of age who did and did not meet the age-specific Pediatric Emergency Care Applied Research Network (PECARN) low-risk criteria for children with minor blunt head trauma. Methods: We conducted a secondary analysis of infants <3 months old in the public use data set from PECARN's prospective observational study of children with minor blunt head trauma. Main outcomes included (1) clinically important traumatic brain injury, (2) traumatic brain injury on CT, and (3) skull fracture on CT. Results: Of 10,904 patients <2 years old, 1,081 (9.9%) with complete data were <3 months old; most (750/1081, 69.6%) sustained falls, and 633/1081 (58.6%) underwent CT scans. Of the 514/1081 (47.5%) infants who met the PECARN low-risk criteria, 1/514 (0.2%, 95% confidence interval [CI] 0.005% to 1.1%), 10/197 (5.1%, 2.5% to 9.1%), and 9/197 (4.6%, 2.1% to 8.5%) had clinically important traumatic brain injuries, traumatic brain injuries on CT, and skull fractures, respectively. Of 567 infants who did not meet the low-risk PECARN criteria, 24/567 (4.2%, 95% CI 2.7% to 6.2%), 94/436 (21.3%, 95% CI 17.6% to 25.5%), and 122/436 (28.0%, 95% CI 23.8% to 32.5%) had clinically important traumatic brain injuries, traumatic brain injuries, and skull fractures, respectively. Conclusion: The PECARN traumatic brain injury low-risk criteria accurately identified infants <3 months old at low risk of clinically important traumatic brain injuries. However, infants at low risk for clinically important traumatic brain injuries remained at risk for traumatic brain injuries on CT, suggesting the need for a cautious approach in these infants.	[Abid, Zaynah] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA; [Dayan, Peter S.] Columbia Univ, Irving Med Ctr, Dept Emergency Med, New York, NY USA; [Kuppermann, Nathan; Tancredi, Daniel J.] Univ Calif Sacramento, Davis Sch Med, Dept Emergency Med, Sacramento, CA USA; [Kuppermann, Nathan; Tancredi, Daniel J.] Univ Calif Sacramento, Davis Sch Med, Dept Pediat, Sacramento, CA USA		Abid, Z (corresponding author), Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA.	za2260@cumc.columbia.edu	Tancredi, Daniel/O-3381-2013	Tancredi, Daniel/0000-0002-3884-7907			Bressan S, 2019, ARCH DIS CHILD, V104, P664, DOI 10.1136/archdischild-2018-316066; Burns ECM, 2016, ACAD EMERG MED, V23, P576, DOI 10.1111/acem.12957; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Choi JY, 2020, PEDIATR EMERG CARE, V36, pE268, DOI 10.1097/PEC.0000000000001485; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Eapen N, 2020, J PAEDIATR CHILD H, V56, P764, DOI 10.1111/jpc.14736; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Magana JN, 2017, ACAD EMERG MED, V24, P382, DOI 10.1111/acem.13155; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Nishijima DK, 2015, JAMA PEDIATR, V169, P1141, DOI 10.1001/jamapediatrics.2015.2743; Parri N, 2018, J PEDIATR-US, V196, P230, DOI 10.1016/j.jpeds.2017.12.057; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Rabiner JE, 2013, PEDIATRICS, V131, pE1757, DOI 10.1542/peds.2012-3921; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schutzman SA, 2021, ACAD EMERG MED, V28, P92, DOI 10.1111/acem.14087; Sheridan DC, 2020, JACEP OPEN, V1, P965, DOI 10.1002/emp2.12113; Shin SS, 2018, J ULTRAS MED, V37, P1857, DOI 10.1002/jum.14547; van Wezel-Meijler G, 2010, SEMIN PERINATOL, V34, P28, DOI 10.1053/j.semperi.2009.10.002; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	32	1	1	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	SEP	2021	78	3					321	+		10.1016/j.annemergmed.2021.04.015			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UD4LJ	WOS:000687179100007	34148662	Bronze			2022-02-06	
J	Adams, RS; Corrigan, JD; Ritter, GA; Hagemeyer, A; Pliskin, MB; Reif, S				Adams, Rachel Sayko; Corrigan, John D.; Ritter, Grant A.; Hagemeyer, Abby; Pliskin, Madeline B.; Reif, Sharon			Association of Lifetime History of Traumatic Brain Injury With Prescription Opioid Use and Misuse Among Adults	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Ohio; opioid misuse; prescription opioids; traumatic brain injury	INPATIENT REHABILITATION; CHRONIC PAIN; MEDICATION USE; UNITED-STATES; USE DISORDERS; PREVALENCE; VETERANS; ALCOHOL; RELIABILITY; PATTERNS	Objective: To investigate associations of lifetime history of traumatic brain injury (TBI) with prescription opioid use and misuse among noninstitutionalized adults. Participants: Ohio Behavioral Risk Factor Surveillance System (BRFSS) participants in the 2018 cohort who completed the prescription opioid and lifetime history of TBI modules (n = 3448). Design: Secondary analyses of a statewide population-based cross-sectional survey. Main Measures: Self-report of a lifetime history of TBI using an adaptation of the Ohio State University TBI-Identification Method. Self-report of past year: (1) prescription pain medication use (ie, prescription opioid use); and (2) prescription opioid misuse, defined as using opioids more frequently or in higher doses than prescribed and/or using a prescription opioid not prescribed to the respondent. Results: In total, 22.8% of adults in the sample screened positive for a lifetime history of TBI. A quarter (25.5%) reported past year prescription opioid use, and 3.1% met criteria for prescription opioid misuse. A lifetime history of TBI was associated with increased odds of both past year prescription opioid use (adjusted odds ratio [AOR] = 1.52; 95% CI, 1.27-1.83; P < .01) and prescription opioid misuse (AOR = 1.65; 95% CI, 1.08-2.52; P < .05), controlling for sex, age, race/ethnicity, and marital status. Conclusion: Results from this study support the "perfect storm" hypothesis-that persons with a history of TBI are at an increased risk for exposure to prescription opioids and advancing to prescription opioid misuse compared with those without a history of TBI. Routine screening for a lifetime history of TBI may help target efforts to prevent opioid misuse among adults.	[Adams, Rachel Sayko; Reif, Sharon] Brandeis Univ, Inst Behav Hlth, Waltham, MA USA; [Ritter, Grant A.] Brandeis Univ, Schneider Inst Hlth Policy & Res, Waltham, MA 02254 USA; [Pliskin, Madeline B.] Brandeis Univ, Waltham, MA USA; [Adams, Rachel Sayko] Rocky Mt Mental Illness Res Educ & Clin Ctr, Vet Hlth Adm, Aurora, CO USA; [Corrigan, John D.] Ohio State Univ, Wexner Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Hagemeyer, Abby] Ohio Dept Hlth, Violence & Injury Prevent Sect, Columbus, OH 43266 USA		Adams, RS (corresponding author), Brandeis Univ, Inst Behav Hlth, Heller Sch Social Policy Management, 415 South St, Waltham, MA 02454 USA.	radams@brandeis.edu; johncorrigan1@me.com; ritter@brandeis.edu; Abby.Hagemeyer@odh.ohio.gov; madelinepliskin@brandeis.edu; reif@brandeis.edu			US Department ofHealth and Human Services (HHS), Administration for Community Living's (ACL) National Institute for Disability, Independent Living, and Rehabilitation Research (NIDILRR) [90DPGE0007]; Centers for DiseaseControl and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U17CE924827]; CDCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA	This research was supported by a grant from the USDepartment ofHealth and Human Services (HHS), Administration for Community Living's (ACL) National Institute for Disability, Independent Living, and Rehabilitation Research (NIDILRR) 90DPGE0007 (to Brandeis University, PI: Dr Reif). Dr Hagemeyer's effort on this project was funded in part by the Centers for DiseaseControl and Prevention (CDC) (U17CE924827). BRFSS data used in these analyses were obtained from the Ohio Department of Health (ODH), supported by theCDC. Use of these data does not imply that theODHorCDC agrees or disagrees with the analyses, interpretations, or conclusions in this publication. The contents of this article do not necessarily represent the policy of the NIDILRR, ACL, HHS, or the Veterans Health Administration, and you should not assume endorsement by the federal government.	Adams RS, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6451; Adams RS, 2019, MIL MED, V184, pE101, DOI 10.1093/milmed/usy162; Ashman TA, 2006, MT SINAI J MED, V73, P999; Beaulieu-Bonneau S, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000341; Bertenthal D, 2018, BRAIN INJURY, V32, P1188, DOI 10.1080/02699052.2018.1493535; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Byers AL, 2020, BRAIN INJURY, V34, P328, DOI 10.1080/02699052.2019.1701708; Cannella LA, 2019, EXP NEUROL, V317, P191, DOI 10.1016/j.expneurol.2019.03.003; CDC Wonder, 2020, WID RANG ONL DAT EP; Centers for Disease Control and Prevention, 2020, OP OV UND EP; Centers for Disease Control and Prevention, 2012, COMP DAT BRFSS 2011; Centers for Disease Control and Prevention, 2019, BEH RISK FACT SURV S; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2019, ADDICT BEHAV, V90, P143, DOI 10.1016/j.addbeh.2018.10.030; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Dahlhamer J, 2018, MMWR-MORBID MORTAL W, V67, P1001, DOI 10.15585/mmwr.mm6736a2; Dams-O'Connor K, 2018, BRAIN INJURY, V32, P431, DOI 10.1080/02699052.2018.1429024; Dowell D, 2017, JAMA-J AM MED ASSOC, V318, P2295, DOI 10.1001/jama.2017.15971; Edlund MJ, 2014, PAIN, V155, P2337, DOI 10.1016/j.pain.2014.08.033; Fonda JR, 2020, J HEAD TRAUMA REHAB, V35, P209, DOI 10.1097/HTR.0000000000000546; Gallagher M, 2019, NEUROPSYCHOL REHABIL, V29, P1, DOI 10.1080/09602011.2016.1258367; Gelman A, 2007, STAT SCI, V22, P153, DOI 10.1214/088342306000000691; Gros DF, 2017, COMPR PSYCHIAT, V78, P48, DOI 10.1016/j.comppsych.2017.07.004; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Hammond FM, 2020, J NEUROTRAUM, V37, P2507, DOI 10.1089/neu.2020.7038; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Han B, 2017, ANN INTERN MED, V167, P293, DOI 10.7326/M17-0865; Harrison JM, 2018, AM J PUBLIC HEALTH, V108, P788, DOI 10.2105/AJPH.2018.304349; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hostetter TA, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000489; Hudson TJ, 2018, PAIN MED, V19, P774, DOI 10.1093/pm/pnx208; Im JJ, 2015, J GEN INTERN MED, V30, P979, DOI 10.1007/s11606-015-3220-y; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Molero Y, 2021, J NEUROL NEUROSUR PS, V92, P519, DOI 10.1136/jnnp-2020-324353; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Shah A, 2017, MMWR-MORBID MORTAL W, V66, P265, DOI 10.15585/mmwr.mm6610a1; Stumbo SP, 2017, J SUBST ABUSE TREAT, V73, P47, DOI 10.1016/j.jsat.2016.11.003; The Ohio Brain Injury Program and the Brain Injury Advisory Committee, 2020, 2019 BIENN REP IMP T; US Department of Health and Human Services, 2019, HELP RES INF NAT OP; US Department of Health and Human Services, 2017, HHS ACTING SECRETARY; Valera EM, 2021, J HEAD TRAUMA REHAB, V36, pE1, DOI 10.1097/HTR.0000000000000652; Waltzman D, 2021, J HEAD TRAUMA REHAB, V36, pE40, DOI 10.1097/HTR.0000000000000603; Weil ZM, 2019, EXP NEUROL, V317, P284, DOI 10.1016/j.expneurol.2019.03.012; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Weiss RD, 2014, J SUBST ABUSE TREAT, V47, P140, DOI 10.1016/j.jsat.2014.03.004; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140	55	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		328	337		10.1097/HTR.0000000000000729			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300007	34489383	Bronze			2022-02-06	
J	Ashraf, AJ; Gilbert, TA; Holmer, HK; Cook, LJ; Carlson, KF				Ashraf, Alexandria J.; Gilbert, Tess A.; Holmer, Haley K.; Cook, Lawrence J.; Carlson, Kathleen F.			Receipt of Concurrent VA and Non-VA Opioid and Sedative-Hypnotic Prescriptions Among Post-9/11 Veterans With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						analgesics; benzodiazepines; *therapeutic use; brain injuries; drug overdose; epidemiology; drug prescriptions; statistics and numerical data; dual use; Iraq War; 2003-2011; opioid safety; opioid; *therapeutic use; traumatic; VA healthcare system; veterans; *statistics and numerical data	UNITED-STATES; PAIN; ASSOCIATION; AFGHANISTAN; DIAGNOSES; SYSTEM; IRAQ	Objective: Receipt of concurrent psychotropic prescription medications from both US Department of Veterans Affairs (VA) and non-VA healthcare providers may increase risk of adverse opioid-related outcomes among veterans with traumatic brain injury (TBI). Little is known about patterns of dual-system opioid or sedative-hypnotic prescription receipt in this population. We estimated the prevalence and patterns of, and risk factors for, VA/non-VA prescription overlap among post-9/11 veterans with TBI receiving opioids from VA providers in Oregon. Setting: Oregon VA and non-VA outpatient care. Participants: Post-9/11 veterans in Oregon with TBI who received an opioid prescription from VA providers between the years of 2014 and 2019. Design: Historical cohort study. Main Measures: Prescription overlap of VA opioids and non-VA opioids or sedative-hypnotics; proportions of veterans who received VA or non-VA opioid, benzodiazepine, and nonbenzodiazepine sedative-hypnotic prescriptions were also examined by year and by veteran characteristics. Results: Among 1036 veterans with TBI receiving opioids from the VA, 210 (20.3%) received an overlapping opioid prescription from a non-VA provider; 5.3% received overlapping benzodiazepines; and none received overlapping nonbenzodiazepine sedative-hypnotics. Proportions of veterans with prescription overlap tended to decrease over time. Veterans with other than urban versus urban addresses (OR = 1.4; 95% CI, 1.0-1.8), high versus medium average annual VA visits (OR = 1.7; 95% CI, 1.1-2.6), and VA service connection of 50% or more versus none/0% to 40% (OR = 4.3; 95% CI, 1.3-14.0) were more likely to have concurrent VA/non-VA prescriptions in bivariable analyses; other than urban remained associated with overlap in multivariable models. Similarly, veterans with comorbid posttraumatic stress disorder diagnoses were more likely to have concurrent VA/non-VA prescriptions in both bivariable and multivariable (OR = 2.1; 95% CI, 1.0-4.1) models. Conclusion: Among post-9/11 veterans with TBI receiving VA opioids, a considerable proportion had overlapping non-VA prescription medications. Providers and healthcare systems should consider all sources of psychotropic prescriptions, and risk factors for overlapping medications, to help mitigate potentially unsafe medication use among veterans with TBI.	[Ashraf, Alexandria J.; Gilbert, Tess A.; Holmer, Haley K.; Carlson, Kathleen F.] VA Portland Hlth Care Syst, VA HSR&D Ctr Improve Vet Involvement Care CIVIC, R&D 66,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Ashraf, Alexandria J.; Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Portland State Univ, Sch Publ Hlth, Portland, OR USA; [Cook, Lawrence J.] Univ Utah, Div Crit Care, Dept Pediat, Salt Lake City, UT USA		Ashraf, AJ (corresponding author), VA Portland Hlth Care Syst, VA HSR&D Ctr Improve Vet Involvement Care CIVIC, R&D 66,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	ajshraf777@gmail.com; Tess.Gilbert@va.gov; holmerh@ohsu.edu; Larry.Cook@hsc.Utah.edu; Kathleen.Carlson@va.gov			Veterans Health Administration, Office of Research andDevelopment, Health ServicesResearch andDevelopment Service [IIR15-091]	This work was supported by the Veterans Health Administration, Office of Research andDevelopment, Health ServicesResearch andDevelopment Service through grant IIR15-091 (Kathleen F. Carlson, Principal Investigator).	Adams RS, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6451; Adams RS, 2019, J HEAD TRAUMA REHAB, V34, P167, DOI 10.1097/HTR.0000000000000481; Becker WC, 2017, MED CARE, V55, pS33, DOI 10.1097/MLR.0000000000000722; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Bouaziz H, 1996, ANESTHESIOLOGY, V84, P143, DOI 10.1097/00000542-199601000-00017; Carico R, 2018, ANN INTERN MED, V169, P593, DOI 10.7326/M18-0852; Carlson KF, 2018, HEALTH SERV RES, V53, P5285, DOI 10.1111/1475-6773.13025; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Corrigan JD, 2019, ADDICT BEHAV, V90, P143, DOI 10.1016/j.addbeh.2018.10.030; Eibner C., 2015, CURRENT PROJECTED CH; Gellad WF, 2017, JAMA INTERN MED, V177, P611, DOI 10.1001/jamainternmed.2017.0147; Gellad WF, 2016, J GEN INTERN MED, V31, P153, DOI 10.1007/s11606-015-3492-2; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Haider A, 2019, CANCER-AM CANCER SOC, V125, P4525, DOI 10.1002/cncr.32484; Hardeman RR, 2020, HEALTH SERV RES, V55, P777, DOI 10.1111/1475-6773.13558; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hudson TJ, 2018, PAIN MED, V19, P774, DOI 10.1093/pm/pnx208; Hudson TJ, 2017, PAIN, V158, P1039, DOI 10.1097/j.pain.0000000000000874; Kang M., 2021, BENZODIAZEPINE TOXIC; Kim HS, 2017, AM J EMERG MED, V35, P458, DOI 10.1016/j.ajem.2016.11.054; Kumar RG, 2021, J NEUROTRAUM, V38, P2284, DOI 10.1089/neu.2020.7496; Larochelle MR, 2015, PHARMACOEPIDEM DR S, V24, P885, DOI 10.1002/pds.3776; Lin LWA, 2017, PAIN, V158, P833, DOI 10.1097/j.pain.0000000000000837; Military Health System, DOD TBI WORLDW NUMB; Musich S, 2020, POPUL HEALTH MANAG, V23, P286, DOI 10.1089/pop.2019.0128; Office of the Secretary HHS, 2009, Fed Regist, V74, P3328; Oregon Health Authority, 2020, RED OP OV MIS; Oregon Health Authority Oregon Prescription Drug Monitoring Program, 2019, 2018 ANN REP PDMP AD; Oregon Health Authority Prescription Drug Monitoring Program, PRESCR DRUG OV DASHB; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Shayegani R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190022; Suda KJ, 2017, J AM PHARM ASSOC, V57, P333, DOI 10.1016/j.japh.2017.02.018; Sun EC, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j760; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Umbricht A., 2021, TXB ADDICTION TREATM, P141, DOI [10.1007/978-3-030-36391-8_11, DOI 10.1007/978-3-030-36391-8_11]; US Centers for Disease Control and Prevention National Center for Health Statistics, 2017, INT CLASSIFICATION D; US Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2016, CDC COMP BENZ MUSCL; US Department of Agriculture Economic Research Service, 2016, DOC 2010 RUR URB COM; US Department of Veterans Affairs, SUMM VET ACC CHOIC A; US Department of Veterans Affairs, 2018, VA MISSION ACT NEW V; US Department of Veterans Affairs and US Department of Defense, 2016, VA DOD CLIN PRACT GU; US Department of Veterans Affairs. Office of Inspector General, 2017, HEALTHC INSP OP PRES; Weaver Michael F., 2015, Yale Journal of Biology and Medicine, V88, P247; Yoon J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2504-9	47	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		364	373		10.1097/HTR.0000000000000728			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300015	34489387				2022-02-06	
J	Bie, F; Wang, KY; Xu, T; Yuan, JS; Ding, H; Lv, B; Liu, YW; Lan, M				Bie, Fan; Wang, Kaiyang; Xu, Tao; Yuan, Jishan; Ding, Hua; Lv, Bin; Liu, Yuwen; Lan, Min			The potential roles of circular RNAs as modulators in traumatic spinal cord injury	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Circular RNA; Spinal cord injury; Mechanism; Regeneration	SIGNALING PATHWAY; EXPRESSION PROFILES; BRAIN; BIOGENESIS; REVEALS; ACTIVATION; ASTROCYTES; APOPTOSIS; MICRORNA; STRESS	Spinal cord injury (SCI) may cause long-term physical impairment and bring a substantial burden to both the individual patient and society. Existing therapeutic approaches for SCI have proven inadequate. This is mainly owing to the incomplete understanding of the cellular and molecular events post-injury. Circular RNAs (circRNAs) represent a new class of non-coding RNAs with a covalently closed annular structure that participates in regulating the transcription of certain genes and are linked to various biological processes and diseases. Mounting evidence is indicative that circRNAs are highly expressed in the spinal cord and they play key roles in multiple processes of neurological diseases. Recently, a role for circRNAs as effectors of SCI has emerged, leading to the continuity of relevant research. In this review, we presented current studies with regards to the abnormality of circRNAs mediating SCI by affecting mechanisms of autophagy, apoptosis, inflammation, and neural regeneration. Furthermore, the potential clinical value of circRNAs as therapeutic targets of SCI was also analyzed.	[Bie, Fan; Lan, Min] Jiangsu Univ, Affiliated Peoples Hosp, Dept Rehabil Med, Zhenjiang 212002, Jiangsu, Peoples R China; [Wang, Kaiyang] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthoped, Shanghai 200233, Peoples R China; [Xu, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, Nanjing 210029, Jiangsu, Peoples R China; [Yuan, Jishan; Ding, Hua; Lv, Bin] Jiangsu Univ, Affiliated Peoples Hosp, Dept Orthoped, Zhenjiang 212002, Jiangsu, Peoples R China; [Lv, Bin] Huazhong Univ Sci & Technol, Dept Orthoped, Union Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China; [Liu, Yuwen] Nanjing Med Univ, Childrens Hosp, Dept Orthoped, Nanjing 210008, Jiangsu, Peoples R China		Lan, M (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Rehabil Med, Zhenjiang 212002, Jiangsu, Peoples R China.; Lv, B (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Orthoped, Zhenjiang 212002, Jiangsu, Peoples R China.; Lv, B (corresponding author), Huazhong Univ Sci & Technol, Dept Orthoped, Union Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China.; Liu, YW (corresponding author), Nanjing Med Univ, Childrens Hosp, Dept Orthoped, Nanjing 210008, Jiangsu, Peoples R China.	529820889@qq.com; ortho_wang@163.com; xutaokrimo@126.com; ishan0926@hotmail.com; doctor_dh1973@163.com; dr_lvbin@sina.com; liuyuwen87629@sina.com; 908233440@qq.com			Scientific Research Projects of Jiangsu Commission of Health [Z2020003, Z20200058]; Clinical Medical Science and Technology Development Foundation of Jiangsu University [JLY2021010, JLY2021012]; Scientific Research Project of the Affiliated People's Hospital of Jiangsu University [Y2020011, Y 2020012, Y 2020013]	This work was sponsored by the Scientific Research Projects of Jiangsu Commission of Health (Grant No: Z2020003, Z20200058) and Clinical Medical Science and Technology Development Foundation of Jiangsu University, (Grant No: JLY2021010, JLY2021012),and the Scientific Research Project of the Affiliated People's Hospital of Jiangsu University (Grant No: Y2020011, Y 2020012 and Y 2020013).	Abdelmohsen K, 2017, RNA BIOL, V14, P361, DOI 10.1080/15476286.2017.1279788; Abe N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16435; Aktas T, 2017, NATURE, V544, P115, DOI 10.1038/nature21715; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bahn JH, 2015, CLIN CHEM, V61, P221, DOI 10.1373/clinchem.2014.230433; Bahrami Shahram, 2016, Advances in Biological Regulation, V62, P37, DOI 10.1016/j.jbior.2016.05.001; Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Barrett SP, 2016, DEVELOPMENT, V143, P1838, DOI 10.1242/dev.128074; Barrett SP, 2015, ELIFE, V4, DOI 10.7554/eLife.07540; Bolisetty MT, 2013, MOL CELL, V51, P705, DOI 10.1016/j.molcel.2013.09.012; Boutz PL, 2015, GENE DEV, V29, P63, DOI 10.1101/gad.247361.114; Broadbent KM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1603-4; Chen HL, 2017, EXP THER MED, V13, P861, DOI 10.3892/etm.2017.4049; Chen J, 2021, J COMP NEUROL, V529, P1456, DOI 10.1002/cne.25030; Chen W, 2016, TRENDS NEUROSCI, V39, P597, DOI 10.1016/j.tins.2016.06.006; Chen XL, 2018, INT IMMUNOPHARMACOL, V59, P287, DOI 10.1016/j.intimp.2018.04.020; Chen YG, 2017, MOL CELL, V67, P228, DOI 10.1016/j.molcel.2017.05.022; Chen ZH, 2019, EXP NEUROL, V313, P37, DOI 10.1016/j.expneurol.2018.12.003; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Di Cara F, 2018, IMMUNITY, V48, P832, DOI 10.1016/j.immuni.2018.03.035; Dichmann DS, 2012, GENE DEV, V26, P1351, DOI 10.1101/gad.187278.112; Diederichs S, 2014, TRENDS GENET, V30, P121, DOI 10.1016/j.tig.2014.01.004; Draijer S, 2019, PROG NEUROBIOL, V173, P41, DOI 10.1016/j.pneurobio.2018.05.007; Du WW, 2017, THERANOSTICS, V7, P4183, DOI 10.7150/thno.21299; Ebrahimi-Barough S, 2017, MOL NEUROBIOL, V54, P2547, DOI 10.1007/s12035-016-9828-z; Eger N, 2018, ADV EXP MED BIOL, V1087, P41, DOI 10.1007/978-981-13-1426-1_4; Esposito E, 2011, EXPERT OPIN THER TAR, V15, P943, DOI 10.1517/14728222.2011.581231; Esposito E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012170; Fang J, 2014, STEM CELLS DEV, V23, P2297, DOI 10.1089/scd.2013.0410; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Fu XD, 2018, CLIN EXP PHARMACOL P, V45, P68, DOI 10.1111/1440-1681.12856; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Guo Y, 2017, J CELL MOL MED, V21, P1013, DOI 10.1111/jcmm.13032; Han B, 2018, AUTOPHAGY, V14, P1164, DOI 10.1080/15548627.2018.1458173; Hansen TB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1458; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hawkins Lois A, 1800, J Cell Death, V6, P57, DOI 10.4137/JCD.S11037; He J, 2017, CANCER LETT, V396, P138, DOI 10.1016/j.canlet.2017.03.027; Huang H., 2019, CANCER BIOL THER, V20, P73, DOI DOI 10.1080/15384047.2018.1507254; Huang RR, 2017, AUTOPHAGY, V13, P1722, DOI 10.1080/15548627.2017.1356975; Hutson TH, 2019, NAT REV NEUROL, V15, P732, DOI 10.1038/s41582-019-0280-3; Ivanov A, 2015, CELL REP, V10, P170, DOI 10.1016/j.celrep.2014.12.019; Jazayeri SB, 2015, EUR SPINE J, V24, P905, DOI 10.1007/s00586-014-3424-6; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jeong SI, 2016, NEUROBIOL AGING, V44, P74, DOI 10.1016/j.neurobiolaging.2016.04.007; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Keller AV, 2019, EXP NEUROL, V318, P267, DOI 10.1016/j.expneurol.2019.03.006; Kelly S, 2015, J MOL BIOL, V427, P2414, DOI 10.1016/j.jmb.2015.02.018; Kim SY, 2008, BLOOD, V111, P5704, DOI 10.1182/blood-2007-12-129114; Kiraz Y, 2016, TUMOR BIOL, V37, P8471, DOI 10.1007/s13277-016-5035-9; Kristensen LS, 2018, RNA BIOL, V15, P280, DOI 10.1080/15476286.2017.1409931; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li XG, 2020, BIOL RES, V53, DOI 10.1186/s40659-020-00302-6; Li YN, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/239479; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liu CM, 2013, GENE DEV, V27, P1473, DOI 10.1101/gad.209619.112; Liu D, 2015, CELL MOL NEUROBIOL, V35, P483, DOI 10.1007/s10571-014-0142-x; Liu Y., 2020, SHOCK AUGUSTA GA; Liu Y., 2020, SHOCK AUGUSTA GA; Liu YD, 2020, J MOL NEUROSCI, V70, P1894, DOI 10.1007/s12031-020-01586-9; Liu Y, 2021, BIOCHEM BIOPH RES CO, V553, P126, DOI 10.1016/j.bbrc.2021.03.070; Lokody I, 2014, NAT REV GENET, V15, DOI 10.1038/nrg3847; Louw AM, 2016, NANOMED-NANOTECHNOL, V12, P643, DOI 10.1016/j.nano.2015.10.011; Lu D, 2016, FRONT GENET, V7, DOI [10.3389/fgene.2015.00053, 10.3389/fgene.2016.00053]; Lu GP, 2019, J CELL MOL MED, V23, P6720, DOI 10.1111/jcmm.14550; Lu YJ, 2019, NEUROSCI BULL, V35, P877, DOI 10.1007/s12264-019-00361-0; Mao KM, 2020, AGING CELL, V19, DOI 10.1111/acel.13163; Mao SS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2027-x; Marina N, 2016, ADV EXP MED BIOL, V903, P201, DOI 10.1007/978-1-4899-7678-9_14; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Martins D, 2017, DIS MODEL MECH, V10, P1253, DOI 10.1242/dmm.028571; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Meng XW, 2017, BRIEF BIOINFORM, V18, P547, DOI 10.1093/bib/bbw045; Minatohara K, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00078; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Paterniti I, 2017, MOL NEUROBIOL, V54, P5973, DOI 10.1007/s12035-016-0131-9; Paterniti I, 2010, FREE RADICAL RES, V44, P694, DOI 10.3109/10715761003742993; Peng P, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118039; Piwecka M, 2017, SCIENCE, V357, DOI 10.1126/science.aam8526; Ponti G, 2013, P NATL ACAD SCI USA, V110, pE1045, DOI 10.1073/pnas.1219563110; Qin C, 2019, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00497; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Santer L, 2019, MOL THER, V27, P1350, DOI 10.1016/j.ymthe.2019.07.001; Sato K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74372-7; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Shao L, 2021, FASEB J, V35, DOI 10.1096/fj.202001737RR; Shu BS, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082729; Sobrido-Camean D, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00101; Su YJ, 2019, J CELL PHYSIOL, V234, P14259, DOI 10.1002/jcp.28124; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Sun XY, 2016, FEBS LETT, V590, P3510, DOI 10.1002/1873-3468.12440; Szabo L, 2015, GENOME BIOL, V16, DOI [10.1186/s13059-016-1123-9, 10.1186/s13059-015-0690-5]; Tang CG, 2020, MOL CELL PROBE, V49, DOI 10.1016/j.mcp.2019.101478; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Van Nues R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00025-5; van Rossum D, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00074; Veno MT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0801-3; Vicens Q, 2014, CELL, V159, P13, DOI 10.1016/j.cell.2014.09.005; Wang GT, 2020, EBIOMEDICINE, V52, DOI 10.1016/j.ebiom.2020.102660; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Wang W., AGING CLIN EXP RES, V13; Wang WZ, 2021, NEURAL REGEN RES, V16, P2048, DOI 10.4103/1673-5374.308100; Wang WZ, 2019, AGING-US, V11, P2352, DOI 10.18632/aging.101919; Wang Y, 2015, RNA, V21, P172, DOI 10.1261/rna.048272.114; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; Wu RH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01303; Xu DD, 2016, NEUROCHEM RES, V41, P2086, DOI 10.1007/s11064-016-1921-1; Yang L, 2020, CIRCULATION, V142, P556, DOI 10.1161/CIRCULATIONAHA.120.045765; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Yao Y, 2020, BRAIN RES BULL, V164, P157, DOI 10.1016/j.brainresbull.2020.08.004; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Yue X, 2016, TUMOR BIOL, V37, P9789, DOI 10.1007/s13277-016-4877-5; Zhang JD, 2019, MOL NEUROBIOL, V56, P5586, DOI 10.1007/s12035-018-1464-3; Zhang K, 2018, EUR J PHARMACOL, V833, P63, DOI 10.1016/j.ejphar.2018.05.034; Zhang LL, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01224-3; Zhang P., 2017, Database J. Biol. Database. Curation, V2017; Zhang PP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36443-8; Zhang XO, 2016, GENOME RES, V26, P1277, DOI 10.1101/gr.202895.115; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zhao JW, 2020, BIOCHEM BIOPH RES CO, V528, P359, DOI 10.1016/j.bbrc.2020.02.108; Zhao YH, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120116; Zheng BB, 2016, J CELL MOL MED, V20, P1062, DOI 10.1111/jcmm.12761; Zhou ZB, 2019, J NEUROTRAUM, V36, P2287, DOI 10.1089/neu.2018.6366	133	1	1	7	7	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	SEP	2021	141								111826	10.1016/j.biopha.2021.111826			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	UO5CY	WOS:000694713300005	34328121	gold			2022-02-06	
J	Carrier, SL; Hicks, AJ; Ponsford, J; McKay, A				Carrier, Sarah L.; Hicks, Amelia J.; Ponsford, Jennie; McKay, Adam			Managing agitation during early recovery in adults with traumatic brain injury: An international survey	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Agitation; Inpatient care; Management; Post-traumatic amnesia; Rehabilitation; Traumatic brain injury	POSTTRAUMATIC AMNESIA; MANAGEMENT; OUTCOMES; PATIENT; CARE	Background: Managing agitation is a significant challenge in the early stages of recovery after traumatic brain injury (TBI), and research investigating current practice during this period is lacking. Objectives: This study examined how clinicians worldwide conceptualise, measure and manage agitation during early TBI recovery. Methods: A cross-sectional anonymous online survey was distributed via email, newsletters, conferences and social media to clinicians involved in early TBI care worldwide. Respondents were 331 clinicians (66% female) from 34 countries worldwide who worked in inpatient and outpatient settings in disciplines including medicine, nursing and allied health. Participants had an average of 13 years' clinical experience working specifically with an adult TBI population. Results: Agitated behaviour was commonly defined as aggression and restlessness. Three quarters of clinicians reported that their services measure agitation, and clinicians in North America more frequently use standardised assessment tools. Common non-pharmacological approaches used across all regions surveyed included providing familiarising information (85%) and environmental cues (82%), managing patients in single rooms (81%) and reducing noise levels (80%). Most clinicians (90%) reported pharmacology use, particularly atypical antipsychotic agents. Clinicians' mean rating of confidence in managing agitation was 7 out of 10 (10 being excellent) and was higher for services that provided staff with written guidelines for agitation management. Only half of clinicians reported sufficient training for managing agitation and 52% were satisfied with current agitation management practices. Conclusions: Despite high rates of agitation measurement and management, many clinicians reported dissatisfaction with current agitation management and insufficient training. This study supports the development of international guidelines and training to ensure consistent and effective agitation management in early TBI care. (C) 2021 Elsevier Masson SAS. All rights reserved.	[Carrier, Sarah L.; Hicks, Amelia J.; Ponsford, Jennie; McKay, Adam] Monash Univ, Turner Inst Brain & Mental Hlth, Sch Psychol Sci, Melbourne, Vic, Australia; [Carrier, Sarah L.; Hicks, Amelia J.; Ponsford, Jennie; McKay, Adam] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Australia; [Ponsford, Jennie; McKay, Adam] Epworth Healthcare, Rehabil & Mental Hlth Div, Melbourne, Vic, Australia		Carrier, SL (corresponding author), Monash Univ, Turner Inst Brain & Mental Hlth, Sch Psychol Sci, Clayton, Vic 3800, Australia.	sarah.carrier@monash.edu					Acquired Brain Injury Knowledge Uptake Strategy (ABIKUS) guideline development group, 2007, ABIKUS EVIDENCE BASE; [Anonymous], 2018, ERABI CLIN GUID; Barker E., 2007, NEUROSCIENCE NURSING; Becker C, 2012, REHABIL NURS, V37, P171, DOI 10.1002/rnj.50; BERROL S, 1988, ARCH PHYS MED REHAB, V69, P537; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Flanagan SR, 2009, PM&R, V1, P76, DOI 10.1016/j.pmrj.2008.10.013; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Giles GM, 2013, NEUROPSYCHOL REHABIL, V23, P732, DOI 10.1080/09602011.2013.805147; Harmsen M, 2004, BRAIN INJURY, V18, P787, DOI 10.1080/02699050410001671757; Herbel K, 1990, Rehabil Nurs, V15, P66; Hicks AJ, 2018, J NEUROTRAUM, V35, P2755, DOI 10.1089/neu.2018.5738; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Janzen S, 2014, BRAIN INJURY, V28, P318, DOI 10.3109/02699052.2013.860478; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Laursen SB, 2005, ACTA PSYCHIAT SCAND, V111, P324, DOI 10.1111/j.1600-0447.2004.00456.x; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; McKay A, 2021, J HEAD TRAUMA REHAB, V36, P149, DOI 10.1097/HTR.0000000000000614; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Mehta S, 2018, BRAIN INJURY, V32, P287, DOI 10.1080/02699052.2017.1419377; Nash RP, 2019, PSYCHOSOMATICS, V60, P139, DOI 10.1016/j.psym.2018.11.009; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Ponsford J., 2018, NEUROPSYCHOL REHABIL, V30, P1; Ponsford J, 2021, J NEUROTRAUM, V38, P1060, DOI 10.1089/neu.2020.7299; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Sherer M, 2020, ARCH PHYS MED REHAB, V101, P2041, DOI 10.1016/j.apmr.2020.06.021; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Wiart L, 2016, ANN PHYS REHABIL MED, V59, P31, DOI 10.1016/j.rehab.2015.12.001; Williamson D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029604	39	1	1	2	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	SEP	2021	64	5			SI				101532	10.1016/j.rehab.2021.101532			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	WG9RK	WOS:000707327800007	33933690				2022-02-06	
J	Chen, ZH; Wu, HY; Zhang, MQ				Chen, Zhuohui; Wu, Haiyue; Zhang, Mengqi			Long non-coding RNA: An underlying bridge linking neuroinflammation and central nervous system diseases	NEUROCHEMISTRY INTERNATIONAL			English	Article						Long non-coding RNAs; Neuroinflammation; Central nervous system; Microglia; Astrocyte; Therapeutic targets	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; INDUCED NEURONAL INJURY; INTRACEREBRAL HEMORRHAGE; INFLAMMATORY RESPONSE; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; MALAT1 CONTRIBUTES; NEUROPATHIC PAIN; MESSENGER-RNA	Central nervous system (CNS) diseases are responsible for a large proportion of morbidity and mortality worldwide. CNS diseases caused by intrinsic and extrinsic stimuli stimulate the resident immune cells including microglia and astrocyte, resulting in neuroinflammation that exacerbates the progression of diseases. Recent evidence reveals the aberrant expression patterns of long non-coding RNAs (lncRNAs) in the damaged tissues following CNS diseases. It was also proposed that lncRNAs possessed immune-modulatory activities by directly or indirectly affecting various effector proteins including transcriptional factor, acetylase, protein kinase, phosphatase, etc. In addition, lncRNAs can form a sophisticated network by interacting with other molecules to regulate the expression or activation of downstream immune response pathways. However, the major roles of lncRNAs in CNS pathophysiologies are still elusive, especially in neuroinflammation. Herein, we tend to review some potential roles of lncRNAs in modulating neuroinflammation based on current evidence in various CNS diseases, in order to provide novel explanations for the initiation and progression of CNS diseases and help to establish therapeutic strategies targeting neuroinflammation.	[Chen, Zhuohui; Wu, Haiyue; Zhang, Mengqi] Cent South Univ, Xiangya Hosp, Dept Neurol, 87 Xiangya Rd, Changsha 410008, Peoples R China		Zhang, MQ (corresponding author), Cent South Univ, Xiangya Hosp, Dept Neurol, 87 Xiangya Rd, Changsha 410008, Peoples R China.	zhangmengqi8912@163.com		Zhang, Mengqi/0000-0003-2090-6320	Key Research and Development Program of Hunan Province [2020SK2063]; Natural Science Foundations of Hunan Province [2020JJ4134]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501025]	This work was supported by the Key Research and Development Program of Hunan Province [grant numbers 2020SK2063] ; the Natural Science Foundations of Hunan Province [grant numbers 2020JJ4134] ; and the National Natural Science Foundation of China [grant numbers 81501025] .	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Ang CE, 2020, CURR OPIN GENET DEV, V65, P42, DOI 10.1016/j.gde.2020.05.006; Anjum A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207533; Barcia C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/357805; Bassani TB, 2015, ARQ NEURO-PSIQUIAT, V73, P616, DOI 10.1590/0004-282X20150057; Borlot F, 2019, SEIZURE-EUR J EPILEP, V67, P86, DOI 10.1016/j.seizure.2019.03.015; Cai LJ, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00656-8; Cai LJ, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105734; Cai M, 2018, INT J MOL MED, V42, P1741, DOI 10.3892/ijmm.2018.3736; Cain MD, 2019, NEURON, V103, P771, DOI 10.1016/j.neuron.2019.07.015; Cao BQ, 2018, NEUROSCIENCE, V388, P118, DOI 10.1016/j.neuroscience.2018.07.019; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen JX, 2020, BRAIN RES BULL, V162, P20, DOI 10.1016/j.brainresbull.2020.04.017; Chen JL, 2009, STROKE, V40, P2532, DOI 10.1161/STROKEAHA.108.545095; Chen LL, 2015, RNA BIOL, V12, P381, DOI 10.1080/15476286.2015.1020271; Chen YQ, 2021, INT IMMUNOPHARMACOL, V92, DOI 10.1016/j.intimp.2020.107339; Chen ZL, 2019, J CELL PHYSIOL, V234, P15647, DOI 10.1002/jcp.28213; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cui SY, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-020-02041-6; de Vries EE, 2016, NEUROSCI BIOBEHAV R, V63, P177, DOI 10.1016/j.neubiorev.2016.02.007; Deng YM, 2019, STROKE, V50, P1850, DOI 10.1161/STROKEAHA.118.023376; Ding XM, 2019, CHEM-BIOL INTERACT, V307, P73, DOI 10.1016/j.cbi.2019.04.017; Dobson R, 2019, EUR J NEUROL, V26, P27, DOI 10.1111/ene.13819; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Fan Y, 2021, NEUROCHEM RES, V46, P1019, DOI 10.1007/s11064-020-03222-9; Forloni G, 2018, J ALZHEIMERS DIS, V62, P1261, DOI 10.3233/JAD-170819; Gao S, 2021, LIFE SCI, V266, DOI 10.1016/j.lfs.2020.118863; Ghaiad HR, 2020, J ADV RES, V21, P141, DOI 10.1016/j.jare.2019.10.012; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gu EY, 2021, J MOL NEUROSCI, V71, P1256, DOI 10.1007/s12031-020-01751-0; Guan CJ, 2021, INFLAMMATION, V44, P923, DOI 10.1007/s10753-020-01387-7; Gupta M, 2019, MULT SCLER RELAT DIS, V36, DOI 10.1016/j.msard.2019.101407; Han CL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1139-z; Han D, 2019, IN VITRO CELL DEV-AN, V55, P501, DOI 10.1007/s11626-019-00375-y; Han YY, 2019, INT IMMUNOPHARMACOL, V76, DOI 10.1016/j.intimp.2019.105878; He C, 2021, YONSEI MED J, V62, P215, DOI 10.3349/ymj.2021.62.3.215; Hu JZ, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00050; Jang Y, 2018, SEIZURE-EUR J EPILEP, V58, P110, DOI 10.1016/j.seizure.2018.04.010; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jayaraj RL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1516-2; Jia H, 2021, J NEUROPATH EXP NEUR, V80, P254, DOI 10.1093/jnen/nlaa138; Jia H, 2019, J NEUROPATH EXP NEUR, V78, P268, DOI 10.1093/jnen/nly126; Jia JY, 2018, J CELL PHYSIOL, V233, P8839, DOI 10.1002/jcp.26798; Jia SL, 2019, INFECT GENET EVOL, V67, P88, DOI 10.1016/j.meegid.2018.10.027; Jin H, 2018, J CELL PHYSIOL, V233, P5847, DOI 10.1002/jcp.26376; Kaskow BJ, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029025; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kemanetzoglou E, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0742-1; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Kjell J, 2016, DIS MODEL MECH, V9, P1125, DOI 10.1242/dmm.025833; Kong S, 2020, CANCER LETT, V483, P59, DOI 10.1016/j.canlet.2020.04.006; Kuriakose D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207609; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Lasek-Bal A, 2019, J PHYSIOL PHARMACOL, V70, P209, DOI 10.26402/jpp.2019.2.04; Lee Y, 2017, WIRES NANOMED NANOBI, V9, DOI 10.1002/wnan.1450; Li JW, 2018, EUR REV MED PHARMACO, V22, P7614, DOI 10.26355/eurrev_201811_16375; Li RG, 2021, WORLD NEUROSURG, V147, pE293, DOI 10.1016/j.wneu.2020.12.049; Li YC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01237; Li Z, 2020, MOL MED, V26, DOI 10.1186/s10020-020-00235-6; Liang J, 2020, EXP NEUROL, V325, DOI 10.1016/j.expneurol.2019.113139; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Linnerbauer M, 2020, NEURON, V108, P608, DOI 10.1016/j.neuron.2020.08.012; Liu LP, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.106962; Liu NX, 2020, J BIOL REG HOMEOS AG, V34, P2255, DOI 10.23812/20-498-L; Liu RG, 2020, NEUROSCI LETT, V731, DOI 10.1016/j.neulet.2020.135060; Liu T, 2021, NEUROCHEM RES, V46, P230, DOI 10.1007/s11064-020-03157-1; Liu XM, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02156-5; Liu XM, 2018, CELL PHYSIOL BIOCHEM, V45, P1986, DOI 10.1159/000487975; Liu YJ, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20194486; Lu SH, 2019, NUCLEIC ACIDS RES, V47, P8111, DOI 10.1093/nar/gkz646; Lux AL, 2005, LANCET NEUROL, V4, P712, DOI 10.1016/S1474-4422(05)70199-X; Lv L, 2021, INT J NEUROSCI, V131, P1162, DOI 10.1080/00207454.2020.1782904; Ma NN, 2020, AGING-US, V12, P2897, DOI 10.18632/aging.102785; Ma PZ, 2019, CURR ALZHEIMER RES, V16, P596, DOI 10.2174/1567205016666190725130134; Ma XJ, 2020, INT J NEUROSCI, V130, P1215, DOI 10.1080/00207454.2020.1731508; Marques-Rocha JL, 2015, FASEB J, V29, P3595, DOI 10.1096/fj.14-260323; Masoumi F, 2019, J NEUROIMMUNOL, V328, P50, DOI 10.1016/j.jneuroim.2018.11.013; Massey JC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00410; Massone S, 2011, NEUROBIOL DIS, V41, P308, DOI 10.1016/j.nbd.2010.09.019; Matsui M, 2017, NAT REV DRUG DISCOV, V16, P167, DOI 10.1038/nrd.2016.117; Matsumoto A, 2017, NATURE, V541, P228, DOI 10.1038/nature21034; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Meinhardt J, 2021, NAT NEUROSCI, V24, P168, DOI 10.1038/s41593-020-00758-5; Meng J, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107141; Nath A, 2015, JAMA NEUROL, V72, P143, DOI 10.1001/jamaneurol.2014.3442; Ni XR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71411-1; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Orr MB, 2018, NEUROTHERAPEUTICS, V15, P541, DOI 10.1007/s13311-018-0631-6; Pan X, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/2094948; Pang HL, 2020, EUR J PHARMACOL, V868, DOI 10.1016/j.ejphar.2019.172880; Panicker N, 2015, J NEUROSCI, V35, P10058, DOI 10.1523/JNEUROSCI.0302-15.2015; Patel NA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1240-3; Peng CW, 2019, J CELL PHYSIOL, V234, P7292, DOI 10.1002/jcp.27487; Peng JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46577; Ponath G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00217; Potokar M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071121; PrabhuDas MR, 2017, J IMMUNOL, V198, P3775, DOI 10.4049/jimmunol.1700373; Qin C, 2019, NEUROSCI BULL, V35, P921, DOI 10.1007/s12264-019-00388-3; Radu BM, 2017, EPILEPSY RES, V131, P15, DOI 10.1016/j.eplepsyres.2017.02.003; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Rinaldi C, 2018, NAT REV NEUROL, V14, P9, DOI 10.1038/nrneurol.2017.148; Ritzel RM, 2015, NEUROBIOL AGING, V36, P2153, DOI 10.1016/j.neurobiolaging.2015.02.016; Robinson EK, 2020, BBA-GENE REGUL MECH, V1863, DOI 10.1016/j.bbagrm.2019.194419; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Ruan WC, 2019, CELL MOL NEUROBIOL, V39, P265, DOI 10.1007/s10571-018-00646-4; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Salvi V, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00148; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Sarlus H, 2017, J CLIN INVEST, V127, P3240, DOI 10.1172/JCI90606; Sawada H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134118; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schwartz M, 2014, NEUROSCIENTIST, V20, P343, DOI 10.1177/1073858413516799; Shao MH, 2020, INFLAMMATION, V43, P1536, DOI 10.1007/s10753-020-01230-z; Shen FJ, 2019, J CELL BIOCHEM, V120, P1000, DOI 10.1002/jcb.27466; Smith ES, 2018, J NEUROL, V265, P231, DOI 10.1007/s00415-017-8641-6; Sommer C, 2018, PAIN, V159, P595, DOI 10.1097/j.pain.0000000000001122; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sun DY, 2017, EMBO REP, V18, P1801, DOI 10.15252/embr.201643668; Sun WC, 2017, NEUROCHEM RES, V42, P3199, DOI 10.1007/s11064-017-2357-y; Tang L, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9642589; Tang Y, 2014, CELL DEATH DIFFER, V21, P369, DOI 10.1038/cdd.2013.159; Tang Y, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00154; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Nguyen TX, 2016, NANOMEDICINE-UK, V11, P1169, DOI 10.2217/nnm.16.9; Theofilopoulos AN, 2017, NAT IMMUNOL, V18, P716, DOI 10.1038/ni.3731; Tian JN, 2021, J BIOCHEM MOL TOXIC, V35, DOI 10.1002/jbt.22724; Tschoe C, 2020, J STROKE, V22, P29, DOI 10.5853/jos.2019.02236; Tu ZM, 2017, BIOMED PHARMACOTHER, V91, P899, DOI 10.1016/j.biopha.2017.05.016; Ule J, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032243; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Voet S, 2019, TRENDS MOL MED, V25, P112, DOI 10.1016/j.molmed.2018.11.005; Waisman A, 2015, ACTA NEUROPATHOL, V129, P625, DOI 10.1007/s00401-015-1402-7; Wan Y, 2020, CELL CYCLE, V19, P419, DOI 10.1080/15384101.2020.1711578; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wang F, 2021, CELL TISSUE RES, V384, P301, DOI 10.1007/s00441-020-03298-3; Wang HY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00215; Wang J, 2017, STROKE, V48, P2211, DOI 10.1161/STROKEAHA.117.017387; Wang L, 2020, J CELL PHYSIOL, V235, P6528, DOI 10.1002/jcp.29465; Wang LL, 2020, LIFE-BASEL, V10, DOI 10.3390/life10050064; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Wang Y, 2020, J CEREBR BLOOD F MET, V40, P747, DOI 10.1177/0271678X19836118; Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531; Wen J, 2018, EUR REV MED PHARMACO, V22, P2817, DOI 10.26355/eurrev_201805_14981; Wen YC, 2017, BIOCHEM BIOPH RES CO, V487, P923, DOI 10.1016/j.bbrc.2017.05.005; Wilkinson DA, 2018, NEUROPHARMACOLOGY, V134, P240, DOI 10.1016/j.neuropharm.2017.09.033; Wu JP, 2020, MOL MED REP, V21, P291, DOI 10.3892/mmr.2019.10829; Wu L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01934; Xia LX, 2018, J CELL PHYSIOL, V233, P7103, DOI 10.1002/jcp.26526; Xia X, 2020, CELL MOL NEUROBIOL, V40, P1383, DOI 10.1007/s10571-020-00824-3; Xiang WN, 2021, NEUROCHEM INT, V143, DOI 10.1016/j.neuint.2020.104929; Xie LJ, 2021, LIFE SCI, V267, DOI 10.1016/j.lfs.2020.118942; Xu S, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02824-z; Xu W, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106614; Xue ZY, 2019, CELL DEATH DIFFER, V26, P130, DOI 10.1038/s41418-018-0105-8; Yan XT, 2018, J CELL PHYSIOL, V233, P6098, DOI 10.1002/jcp.26453; Yang CJ, 2019, AM J PHYSIOL-CELL PH, V316, pC135, DOI 10.1152/ajpcell.00136.2018; Yang RC, 2016, SCI REP-UK, V6, DOI 10.1038/srep38903; Ye YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0821-5; Yi JP, 2019, J CELL BIOCHEM, V120, P18053, DOI 10.1002/jcb.29108; Yi M, 2020, INFLAMMATION, V43, P1832, DOI 10.1007/s10753-020-01257-2; Yu Q, 2020, NEUROCHEM RES, V45, P783, DOI 10.1007/s11064-019-02952-9; Yu YB, 2018, BIOCHEM BIOPH RES CO, V503, P1020, DOI 10.1016/j.bbrc.2018.06.111; Yu YH, 2017, BIOCHEM BIOPH RES CO, V491, P478, DOI 10.1016/j.bbrc.2017.07.021; Yue PJ, 2019, LIFE SCI, V233, DOI 10.1016/j.lfs.2019.116731; Zhai KH, 2020, HUM GENE THER, V31, P1274, DOI 10.1089/hum.2020.106; Zhang BP, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02278-z; Zhang DW, 2019, J CELL PHYSIOL, V234, P22234, DOI 10.1002/jcp.28790; Zhang F, 2018, J IMMUNOL, V200, P1618, DOI 10.4049/jimmunol.1601689; Zhang GL, 2021, NEUROCHEM RES, V46, P1280, DOI 10.1007/s11064-021-03265-6; Zhang JY, 2020, EUR REV MED PHARMACO, V24, P12034, DOI 10.26355/eurrev_202012_23992; Zhang JJ, 2021, EXP GERONTOL, V144, DOI 10.1016/j.exger.2020.111180; Zhang L, 2020, NEUROTOXICOLOGY, V78, P29, DOI 10.1016/j.neuro.2020.02.004; Zhang MQ, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.573143; Zhang QY, 2021, NEUROCHEM INT, V145, DOI 10.1016/j.neuint.2021.105001; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zhang T, 2021, NEURAL REGEN RES, V16, P772, DOI 10.4103/1673-5374.295335; Zhang X, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1464-x; Zhang YY, 2020, INFLAMMATION, V43, P1337, DOI 10.1007/s10753-020-01212-1; Zhang YW, 2021, GENE, V767, DOI 10.1016/j.gene.2020.145079; Zhang ZL, 2021, BRAIN RES BULL, V168, P110, DOI 10.1016/j.brainresbull.2020.12.005; Zhang ZY, 2021, EXP CELL RES, V399, DOI 10.1016/j.yexcr.2020.112435; Zhao JY, 2020, EXCLI J, V19, P1141, DOI 10.17179/excli2020-2286; Zhao PS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30359-z; Zheng HJ, 2019, EXP MOL PATHOL, V110, DOI 10.1016/j.yexmp.2019.104287; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhou BL, 2020, MOL MED REP, V22, P1489, DOI 10.3892/mmr.2020.11203; Zhou F, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1343-x; Zhou HJ, 2018, AM J PHYSIOL-CELL PH, V315, pC52, DOI 10.1152/ajpcell.00278.2017; Zhou JH, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01805-5; Zhou SF, 2020, IUBMB LIFE, V72, P2045, DOI 10.1002/iub.2344; Zhu SP, 2019, BIOSCI BIOTECH BIOCH, V83, P2049, DOI 10.1080/09168451.2019.1637245	195	1	1	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	SEP	2021	148								105101	10.1016/j.neuint.2021.105101			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	TM9LE	WOS:000675867400005	34139298				2022-02-06	
J	Cisneros, E; de Guise, E; Belleville, S; McKerral, M				Cisneros, Eduardo; de Guise, Elaine; Belleville, Sylvie; McKerral, Michelle			A controlled clinical efficacy trial of multimodal cognitive rehabilitation on episodic memory functioning in older adults with traumatic brain injury	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Traumatic brain injury; Aging; Cognitive rehabilitation; Episodic memory; Psychological well-being	IMPAIRMENT; INTERVENTIONS; COMPLAINT; ATTENTION; STRATEGY; MOCA	Objectives: This study aimed to evaluate the impact of a 12-week, 24-session multimodal group cognitive intervention, the Cognitive Enrichment Program (CEP), on episodic memory in older adults with traumatic brain injury (TBI) compared to an active control group that received usual care in the form of individual holistic rehabilitation. Methods: In total, 37 patients with a TBI who were 57 to 90 years old were assigned to experimental (n = 23) and control (n = 14) groups in a semi-randomized, controlled, before-after intervention trial with follow-up at 6 months, with blinded outcome measurement. The CEP's Memory module consisted of memory strategies to promote encoding. Efficacy was evaluated by using Face-name association, Word list recall, and Text memory measures, and generalization was assessed with the Self-Evaluation Memory Questionnaire (SEMQ), the Psychological General Well-Being Index, and a satisfaction questionnaire. Results: ANCOVA mixed model repeated-measures analysis revealed a strong group-by-time interaction, with the experimental group showing statistically significant improvement on the Face-name association test, with a large effect size. We also found a statistically significant group-by-time interaction on 3 dimensions of the SEMQ generalization measure: the experimental group showed increased memorization of the content of Conversations, reduced Slips of attention, and increased memory of Political and social events, with medium to large effect sizes. The group also showed clinically significant improvements in psychological well-being. Scores on the satisfaction questionnaire indicated a perceived positive impact on daily life habits requiring memory abilities. Conclusions: The CEP is a promising cognitive rehabilitation program for older individuals with TBI, showing high satisfaction in participants, that could improve their episodic memory functioning as well as enhance their psychological well-being. ClinicalTrials.gov Identifier: NCT04590911. (c) 2021 Elsevier Masson SAS. All rights reserved.	[Cisneros, Eduardo; de Guise, Elaine; McKerral, Michelle] CIUSSS Ctr Sud Ile Montreal, Ctr Interdisciplinary Res Rehabil Greater Montrea, IURDPM, 6363 Hudson Rd, Montreal, PQ H3S 1M9, Canada; [Cisneros, Eduardo; de Guise, Elaine; Belleville, Sylvie; McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [de Guise, Elaine] Univ Montreal, Ctr Hosp, Res Inst, Montreal, PQ, Canada; [Belleville, Sylvie] Inst Univ Geriatrie Montreal, Res Ctr, Montreal, PQ, Canada		Cisneros, E; McKerral, M (corresponding author), CIUSSS Ctr Sud Ile Montreal, Ctr Interdisciplinary Res Rehabil Greater Montrea, IURDPM, 6363 Hudson Rd, Montreal, PQ H3S 1M9, Canada.	eduardo.cisneros@umontreal.ca; michelle.mckerral@umontreal.ca			Fonds de recherche du Quebec - Sante (FRQS)Fonds de la Recherche en Sante du Quebec [22319]; Quebec Rehabilitation Research Network [09-10DS-06]; Lucie-Bruneau Rehabilitation Centre	This project was funded by the Fonds de recherche du Que?bec - Sante? (FRQS; research grant 22319 to MM and scholarship to EC) , the Quebec Rehabilitation Research Network (research grant 09-10DS-06 to MM) , the Lucie-Bruneau Rehabilitation Centre (research grant to EC and MM, and clinical research hours to EC) .	Ardila A, 2007, ARCH CLIN NEUROPSYCH, V22, P1003, DOI 10.1016/j.acn.2007.08.004; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Belleville S, 2006, DEMENT GERIATR COGN, V22, P486, DOI 10.1159/000096316; Belleville S, 2018, J AM GERIATR SOC, V66, P655, DOI 10.1111/jgs.15192; Belleville S, 2011, BRAIN, V134, P1623, DOI 10.1093/brain/awr037; Bigler E. D., 2012, PTSD MILD TRAUMATIC, P15; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; Bolduc F, 2012, BRAIN INJURY, V26, P533; Bottiroli S, 2008, ARCH GERONTOL GERIAT, V47, P277, DOI 10.1016/j.archger.2007.08.010; Bottiroli S, 2013, J EXP PSYCHOL-APPL, V19, P205, DOI 10.1037/a0034078; Bravo G, 1996, CAN J AGING, V15, P112, DOI 10.1017/S0714980800013325; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cavallini E, 2010, AGING CLIN EXP RES, V22, P314, DOI [10.1007/BF03337728, 10.3275/6704]; CHATELOIS J, 1993, CAN PSYCHOL, V34, P45, DOI 10.1037/h0078803; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cisneros E, 2021, ANN PHYS REHABIL MED, V64, DOI 10.1016/j.rehab.2021.101559; Clement F, 2008, J INT NEUROPSYCH SOC, V14, P222, DOI 10.1017/S1355617708080260; Craik FIM, 2007, J INT NEUROPSYCH SOC, V13, P132, DOI 10.1017/S1355617707070166; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Frenette LC, 2019, BRAIN INJURY, V33, P189, DOI 10.1080/02699052.2018.1542506; Jorge Ricardo E, 2015, Handb Clin Neurol, V128, P613, DOI 10.1016/B978-0-444-63521-1.00038-8; Kinsella GJ, 2011, BRAIN IMPAIR, V12, P71, DOI 10.1375/brim.12.1.71; Kirchhoff BA, 2009, NEUROSCIENTIST, V15, P166, DOI 10.1177/1073858408329507; Langlois AS, 2014, AGING NEUROPSYCHOL C, V21, P257, DOI 10.1080/13825585.2013.795928; McCullagh S., 2011, TRAUMATIC BRAIN INJU, P279; MORRIS RG, 1990, Q J EXP PSYCHOL-A, V42, P67, DOI 10.1080/14640749008401208; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pallant J., 2007, SURVIVAL MANUAL STEP; Potvin MJ, 2011, NEUROPSYCHOL REHABIL, V21, P899, DOI 10.1080/09602011.2011.630882; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Reijnders J, 2013, AGEING RES REV, V12, P263, DOI 10.1016/j.arr.2012.07.003; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; Sweet L, 2011, INT PSYCHOGERIATR, V23, P1582, DOI 10.1017/S1041610211001451; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Van der Linden M., 1989, QUESTIONNAIRE AUTO E; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Winocur G, 2007, J INT NEUROPSYCH SOC, V13, P153, DOI 10.1017/S135561770707018X; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	40	1	1	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	SEP	2021	64	5			SI				101563	10.1016/j.rehab.2021.101563			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WG9RK	WOS:000707327800004	34325040				2022-02-06	
J	Cisneros, E; Beausejour, V; de Guise, E; Belleville, S; McKerral, M				Cisneros, Eduardo; Beausejour, Veronique; de Guise, Elaine; Belleville, Sylvie; McKerral, Michelle			The impact of multimodal cognitive rehabilitation on executive functions in older adults with traumatic brain injury	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Traumatic brain injury; Aging; Cognitive rehabilitation; Executive functions; Self-awareness	INTERVENTIONS; METAANALYSIS; IMPAIRMENT; BEHAVIOR; OUTCOMES	Objectives: This study evaluated the impact of a 12-week, 24-session multimodal group cognitive rehabilitation intervention, the Cognitive Enrichment Program (CEP), on executive functioning and resumption of daily activities after traumatic brain injury (TBI) in older individuals as compared with an active control group that received individual holistic rehabilitation as usual care. Methods: In total, 37 patients with a TBI and aged 57 to 90 years were assigned to experimental (n = 23) and control (n = 14) groups in a semi-randomized, controlled, before-after intervention trial with follow-up at 6 months, with blinded outcome measurement. The CEP's executive function module included planning, problem solving, and goal management training as well as strategies focusing on self-awareness. Efficacy was evaluated by neuropsychological tests (Six Elements Task-Adapted [SET-A], D-KEFS Sorting test and Stroop four-color version); generalization was measured by self-reporting questionnaires about daily functioning (Dysexecutive Functioning Questionnaire, forsaken daily activities). Results: ANCOVA results showed significant group-by-time interactions; the experimental group showed a statistically significant improvement on Tackling the 6 subtasks and Avoiding rule-breaking measures of the SET-A, with medium effect sizes. The generalization measure, the Dysexecutive Functioning Questionnaire, showed a significant reduction in experimental patient-significant other difference on the Executive cognition subscale. The number of forsaken daily activities was reduced in the experimental versus control group, which was not significant immediately after the CEP but was significant 6 months later. Conclusions: Our study shows that older adults with TBI can improve their executive functioning, with a positive impact on everyday activities, after receiving multimodal cognitive training with the CEP. ClinicalTrials. gov Identifier: NCT04590911. (c) 2021 Elsevier Masson SAS. All rights reserved.	[Cisneros, Eduardo; Beausejour, Veronique; de Guise, Elaine; McKerral, Michelle] CIUSSS Ctr Sud De Ile De Montreal, Ctr Interdisciplinary Res Rehabil Greater Montrea, IURDPM, 6363 Hudson Rd, Montreal, PQ, Canada; [Cisneros, Eduardo; Beausejour, Veronique; de Guise, Elaine; Belleville, Sylvie; McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [de Guise, Elaine] Montreal Univ Hosp Ctr, Res Inst, Montreal, PQ, Canada; [Belleville, Sylvie] Inst Univ Geriatr Montreal, Res Ctr, Montreal, PQ, Canada		Cisneros, E; McKerral, M (corresponding author), CIUSSS Ctr Sud De Ile De Montreal, Ctr Interdisciplinary Res Rehabil Greater Montrea, IURDPM, 6363 Hudson Rd, Montreal, PQ, Canada.	eduardo.cisneros@umontreal.ca; michelle.mckerral@umontreal.ca			Fonds de recherche du Quebec Sante (FRQS) [22319]; Quebec Rehabilitation Research Network [09-10DS-06]; Lucie-Bruneau Rehabilitation Center	This project was funded by the Fonds de recherche du Quebec Sante (FRQS; research grant 22319 to MM and scholarship to EC), the Quebec Rehabilitation Research Network (research grant 09-10DS-06 to MM), the Lucie-Bruneau Rehabilitation Center (research grant to EC and MM, and clinical research hours to EC).	Acevedo A, 2007, J GERIATR PSYCH NEUR, V20, P239, DOI 10.1177/0891988707308808; Allain P, 2004, REV NEUROPSYCHOL, V14, P285; Basak C, 2020, PSYCHOL AGING, V35, P220, DOI 10.1037/pag0000442; Belleville S, 2006, DEMENT GERIATR COGN, V22, P486, DOI 10.1159/000096316; Belleville S, 2018, J AM GERIATR SOC, V66, P655, DOI 10.1111/jgs.15192; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chatelois J, STROOP FLEXIBILITE 4; Chung CSY, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008391.pub2; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cisneros E, 2002, ACT C INT READ TRAUM; Cisneros E, 2021, ANN PHYS REHABIL MED, V64, DOI 10.1016/j.rehab.2021.101563; Cisneros E, 2019, COGENT PSYCHOL, V6, DOI 10.1080/23311908.2019.1603614; Crepeau F, 1996, BRAIN COGNITION, V32, P266; Cristofori I, 2015, HDB CLIN NEUROLOGY, P197; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Delis DC., 2001, DELIS KAPLAN EXECUTI; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Goldstein F. C., 2005, REHABILITATION TRAUM, P235; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Nguyen L, 2019, PSYCHOL BULL, V145, P698, DOI 10.1037/bul0000196; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Oshima K, 2018, EMERG MED INT, V2018, DOI 10.1155/2018/2137658; Reagh Zachariah, 2017, F1000Res, V6, P491, DOI 10.12688/f1000research.10652.1; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spikman JM, BEHANDELING DISEXECU; Stamenova V, 2019, NEUROPSYCHOL REHABIL, V29, P1569, DOI 10.1080/09602011.2018.1438294; Stuss DT, 2007, J INT NEUROPSYCH SOC, V13, P120, DOI 10.1017/S1355617707070154; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Vaughan L, 2010, PSYCHOL AGING, V25, P343, DOI 10.1037/a0017729	41	1	1	3	3	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	SEP	2021	64	5			SI				101559	10.1016/j.rehab.2021.101559			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WG9RK	WOS:000707327800015	34303000				2022-02-06	
J	Corwin, DJ; Durbin, DR; Hayes, KL; Zonfrillo, MR				Corwin, Daniel J.; Durbin, Dennis R.; Hayes, Katie L.; Zonfrillo, Mark R.			Trends in Emergent Head Computed Tomography Utilization for Minor Head Trauma After Implementation of a Clinical Pathway	PEDIATRIC EMERGENCY CARE			English	Article						computed tomography; CT utilization; traumatic brain injury	RADIATION-EXPOSURE; CT	Objective The aims of this study were to evaluate trends over time in computed tomography (CT) scan utilization after implementation of a clinical pathway in a tertiary care children's hospital emergency department (ED), to determine how ED throughput differs by CT utilization, and to determine provider reasoning for obtaining head CT in low-risk patients. Methods This was a retrospective cohort study of patients 21 years or younger discharged from our ED with head trauma (Glasgow Coma Scale score >= 13 and a head trauma International Classification of Diseases code) over a 5-year period, starting 1 year after pathway implementation (January 2012 to December 2016). A manual chart review of 10% of patients who received a CT was performed to determine reasoning for CT utilization and guideline compliance. Results In total, 6.3% (95% confidence interval [CI], 5.9%-6.6%) of 21,129 discharged patients received a head CT, decreasing annually by an average of 0.9%. Pediatricians were more likely to obtain a CT than pediatric emergency medicine physicians after adjusting for acuity (odds ratio, 1.37; 95% CI, 1.02-1.82). Those who received a CT stayed 90 minutes longer (95% CI, 79-101 minutes) than those who did not after propensity score matching. Thirty percent of patients who received a CT in our manual chart review met low-risk Pediatric Emergency Care Applied Research Network criteria. Conclusions Head CT rates in patients with minor head trauma consistently decreased each year after guideline implementation. Children who received head CT did not have prolonged lengths of stay compared with those who did not. A minority of patients who received a CT and were discharged met low-risk criteria by standardized guidelines.	[Corwin, Daniel J.] Childrens Hosp Philadelphia, Div Emergency Med, Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Corwin, Daniel J.; Durbin, Dennis R.; Zonfrillo, Mark R.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Durbin, Dennis R.] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH USA; [Hayes, Katie L.] Childrens Hosp Philadelphia, Off Clin Qual Improvement, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Dept Pediat, Alpert Med Sch, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Providence, RI USA		Corwin, DJ (corresponding author), Childrens Hosp Philadelphia, Div Emergency Med, Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	corwind@email.chop.edu	Durbin, Dennis/AAD-7829-2022				Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Cheng CY., 2018, PEDIATR EMERG CARE; Farbman KS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4114; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Gilboy N, 2012, EMERGENCY SEVERITY I; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Magana JN, 2017, ACAD EMERG MED, V24, P382, DOI 10.1111/acem.13155; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Zonfrillo M., 2017, ED PATHWAY EVALUATIO; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696; Zonfrillo MR., 2015, CLIN PATHWAYS HEAD T, V7	17	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	SEP	2021	37	9					437	441		10.1097/PEC.0000000000001728			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	UO6LC	WOS:000694803800001	30672903				2022-02-06	
J	D'Amico, NR; Elbin, RJ; Sufrinko, A; Schatz, P; Mucha, A; Collins, MW; Kontos, AP				D'Amico, Nathan R.; Elbin, R. J.; Sufrinko, Alicia; Schatz, Philip; Mucha, Anne; Collins, Michael W.; Kontos, Anthony P.			Test Order Does Not Affect Vestibular/Ocular Motor Screening Item Scores in High School Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						VOMS; vestibular; ocular motor; concussion; baseline testing	CONCUSSION; RECOVERY; VOMS; RELIABILITY; PERFORMANCE; OCULOMOTOR; YOUTH	Objective: To compare VOMS item scores between a fixed and randomized administration order in a sample of nonconcussed high school athletes. Design: Post-test only, quasi-experimental design. Setting: Local high schools in a mid-west region of the United States. Patients: Fifty nonconcussed high school athletes (M = 15.64; SD = 1.12 years) completed the VOMS in a randomized testing order (RANDOM), and 49 (M = 15.64; SD = 1.12 years) completed the VOMS in the fixed testing order (FIXED). The groups were matched on age, sex, learning disorder, attention-deficit/hyperactivity disorder, concussion history, and baseline concussion symptoms. Interventions: The Vestibular/Ocular Motor Screening (VOMS) tool comprises pretest symptoms, smooth pursuit (SP), horizontal/vertical saccade (HSAC/VSAC), average near-point of convergence (NPC) distance, convergence symptoms, horizontal/vertical vestibular ocular reflex (HVOR/VVOR), and visual motion sensitivity (VMS). Main Outcome Measures: Mann-Whitney U tests were performed to examine differences between FIXED and RANDOM groups on VOMS items. RANDOM scores were rearranged in order of administration and combined with the FIXED group scores, and a Freidman test was performed for repeated measures. Results: There were no significant differences between FIXED and RANDOM groups on VOMS pretest symptoms (U = 1171, P = 0.57), SP (U = 1122.5, P = 0.35), HSAC (U = 1128.5, P = 0.44), VSAC (U = 1055.5, P = 0.16), convergence symptoms (U = 1129.0, P = 0.41), average NPC distance (U = 979.0, P = 0.06), HVOR (U = 1085.0, P = 0.25), VVOR (U = 1126.0, P = 0.41), and VMS scores (U = 1101.0, P = 0.32). When VOMS items were rearranged and the sample was combined, there were no differences for repeated measures [chi(2) (6) = 9.92, P = 0.13]. Conclusions: There were no significant differences on VOMS items between FIXED and RANDOM groups for repeated measures. The testing order of VOMS items does not affect VOMS scores in nonconcussed high school athletes.	[D'Amico, Nathan R.; Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Sufrinko, Alicia; Mucha, Anne; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, UPMC Sports Med Concuss Program, Dept Orthoped Surg, Pittsburgh, PA USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		D'Amico, NR (corresponding author), Univ Arkansas, Dept Hlth Human Performance & Recreat, 155 Stadium Dr, Fayetteville, AR 72701 USA.	nrdamico@uark.edu					Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Ledwidge PS, 2019, CLIN J SPORT MED, V29, P292, DOI 10.1097/JSM.0000000000000512; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	18	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2021	31	5					E240	E244		10.1097/JSM.0000000000000776			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3KG	WOS:000711670400005	31842048				2022-02-06	
J	Davis, SE; Roth, JR; Aljabi, Q; Hakim, AR; Savell, KE; Day, JJ; Arrant, AE				Davis, Skylar E.; Roth, Jonathan R.; Aljabi, Qays; Hakim, Ahmad R.; Savell, Katherine E.; Day, Jeremy J.; Arrant, Andrew E.			Delivering progranulin to neuronal lysosomes protects against excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; TRAUMATIC BRAIN-INJURY; ACTIVATED MICROGLIA; NEURITE OUTGROWTH; TNF RECEPTORS; HOST-DEFENSE; MOUSE MODEL; AUTOPHAGY; DEMENTIA; DEATH	Loss-of-function mutations in progranulin (GRN) are a major genetic cause of frontotemporal dementia (FTD), possibly due to loss of progranulin's neurotrophic and antiinflammatory effects. Progranulin promotes neuronal growth and protects against excitotoxicity and other forms of injury. It is unclear if these neurotrophic effects are mediated through cellular signaling or through promotion of lysosomal function. Progranulin is a secreted proprotein that may activate neurotrophic signaling through cell-surface receptors. However, progranulin is efficiently trafficked to lysosomes and is necessary for maintaining lysosomal function. To determine which of these mechanisms mediates progranulin's protection against excitotoxicity, we generated lentiviral vectors expressing progranulin (PGRN) or lysosome-targeted progranulin (L-PGRN). L-PGRN was generated by fusing the LAMP-1 transmembrane and cytosolic domains to the C-terminus of progranulin. L-PGRN exhibited no detectable secretion, but was delivered to lysosomes and processed into granulins. PGRN and L-PGRN protected against NMDA excitotoxicity in rat primary cortical neurons, but L-PGRN had more consistent protective effects than PGRN. L-PGRN's protective effects were likely mediated through the autophagy-lysosomal pathway. In control neurons, an excitotoxic dose of NMDA stimulated autophagy, and inhibiting autophagy with 3-methyladenine reduced excitotoxic cell death. L-PGRN blunted the autophagic response to NMDA and occluded the protective effect of 3-methyladenine. This was not due to a general impairment of autophagy, as L-PGRN increased basal autophagy and did not alter autophagy after nutrient starvation. These data show that progranulin's protection against excitotoxicity does not require extracellular progranulin, but is mediated through lysosomes, providing a mechanistic link between progranulin's lysosomal and neurotrophic effects.	[Davis, Skylar E.; Roth, Jonathan R.; Aljabi, Qays; Hakim, Ahmad R.; Arrant, Andrew E.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Davis, Skylar E.; Roth, Jonathan R.; Aljabi, Qays; Hakim, Ahmad R.; Savell, Katherine E.; Day, Jeremy J.; Arrant, Andrew E.] Univ Alabama Birmingham, Alzheimers Dis Ctr, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA; [Savell, Katherine E.; Day, Jeremy J.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Savell, Katherine E.] NIDA, Behav Neurosci Branch, Intramural Res Program, NIH, Baltimore, MD 20852 USA		Arrant, AE (corresponding author), Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA.; Arrant, AE (corresponding author), Univ Alabama Birmingham, Alzheimers Dis Ctr, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA.	andrewarrant@uabmc.edu		Day, Jeremy/0000-0002-7361-3399	Association for Frontotemporal Degeneration (Basic Science Pilot Grant); National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F31 AG064868, R00 AG056597, R21 AG068658]; UAB Alzheimer's Disease Center [P20 AG068024]; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [F31 DA042514]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH114990]	This work was supported by funding from The Association for Frontotemporal Degeneration (Basic Science Pilot Grant) to A. E. A., from the National Institute on Aging to J. R. R. (F31 AG064868), A. E. A. (R00 AG056597 and R21 AG068658), and the UAB Alzheimer's Disease Center (P20 AG068024), from the National Institute on Drug Abuse to K. E. S. (F31 DA042514), and from the National Institute of Mental Health to J. J. D. (R01 MH114990). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Almeida MR, 2016, NEUROBIOL AGING, V41, DOI 10.1016/j.neurobiolaging.2016.02.019; Altmann C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0132-1; Altmann C, 2016, NEUROBIOL DIS, V96, P294, DOI 10.1016/j.nbd.2016.09.010; Arrant AE, 2020, ANN CLIN TRANSL NEUR, V7, P2433, DOI 10.1002/acn3.51242; Arrant AE, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0872-6; Arrant AE, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0264-6; Arrant AE, 2018, J NEUROSCI, V38, P2341, DOI 10.1523/JNEUROSCI.3081-17.2018; Arrant AE, 2017, BRAIN, V140, P1447, DOI 10.1093/brain/awx060; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Beel S, 2017, HUM MOL GENET, V26, P2850, DOI 10.1093/hmg/ddx162; Borsello T, 2003, EUR J NEUROSCI, V18, P473, DOI 10.1046/j.1460-9568.2003.02757.x; Butler VJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008295; Butler VJ, 2019, BIOCHEMISTRY-US, V58, P2670, DOI 10.1021/acs.biochem.9b00275; Butlers VJ, 2019, J MOL BIOL, V431, P1038, DOI 10.1016/j.jmb.2019.01.027; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Chang MC, 2017, J EXP MED, V214, P2611, DOI 10.1084/jem.20160999; Chen X, 2013, J NEUROSCI, V33, P9202, DOI 10.1523/JNEUROSCI.5336-12.2013; Chen YH, 2018, J MOL MED, V96, P1359, DOI 10.1007/s00109-018-1703-0; Chitramuthu BP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174784; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; De Muynck L, 2013, NEUROBIOL AGING, V34, P2541, DOI 10.1016/j.neurobiolaging.2013.04.022; Descloux C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0916-z; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Finch N, 2011, NEUROLOGY, V76, P467, DOI 10.1212/WNL.0b013e31820a0e3b; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Gao X, 2010, PROTEIN CELL, V1, P552, DOI 10.1007/s13238-010-0067-1; Gass J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-33; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Ginet V, 2014, AUTOPHAGY, V10, P846, DOI 10.4161/auto.28264; Gotzl JK, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0281-5; Gotzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; Guo A, 2010, BRAIN RES, V1366, P1, DOI 10.1016/j.brainres.2010.09.099; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Holler CJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0100-17.2017; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Huin V, 2020, BRAIN, V143, P303, DOI 10.1093/brain/awz377; Hyung S, 2019, GLIA, V67, P360, DOI 10.1002/glia.23547; Kanazawa M, 2015, BRAIN, V138, P1932, DOI 10.1093/brain/awv079; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kleinberger G, 2016, NEUROBIOL AGING, V39, DOI 10.1016/j.neurobiolaging.2015.12.014; Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280; Krabbe G, 2017, P NATL ACAD SCI USA, V114, P5029, DOI 10.1073/pnas.1700477114; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Lee CW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0196-6; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mikulka CR, 2020, P NATL ACAD SCI USA, V117, P9032, DOI 10.1073/pnas.1917675117; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Neill T, 2016, J CELL BIOL, V215, P687, DOI 10.1083/jcb.201603079; Nguyen AD, 2013, TRENDS ENDOCRIN MET, V24, P597, DOI 10.1016/j.tem.2013.08.003; Nicholson AM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11992; Puyal J, 2012, NEUROSCIENTIST, V18, P224, DOI 10.1177/1073858411404948; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Sadasivan S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-21; Salazar DA, 2015, J NEUROSCI, V35, P9315, DOI 10.1523/JNEUROSCI.4808-14.2015; Savell KE, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3348; Savell KE, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0495-18.2019; Schmitz K, 2020, CELL MOL IMMUNOL, V17, P1077, DOI 10.1038/s41423-019-0274-5; Shacka JJ, 2007, NEUROSCI LETT, V414, P57, DOI 10.1016/j.neulet.2006.12.025; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Sheng JH, 2014, GENE, V542, P141, DOI 10.1016/j.gene.2014.03.041; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Suh HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035115; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tanaka Y, 2017, HUM MOL GENET, V26, P969, DOI 10.1093/hmg/ddx011; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Valdez C, 2020, HUM MOL GENET, V29, P716, DOI 10.1093/hmg/ddz229; Valdez C, 2017, HUM MOL GENET, V26, P4861, DOI 10.1093/hmg/ddx364; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2011, BRAIN, V134, P808, DOI 10.1093/brain/awr007; Voskobiynyk Y, 2020, ELIFE, V9, DOI 10.7554/eLife.57354; Wang C, 2018, CURR OPIN NEUROBIOL, V48, P52, DOI 10.1016/j.conb.2017.09.005; Wang WZ, 2011, BRAIN RES, V1389, P61, DOI 10.1016/j.brainres.2011.02.083; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x; Ward ME, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5642; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang JS, 2020, NATURE, V588, P459, DOI 10.1038/s41586-020-2709-7; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhou XL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212382; Zhou XL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0205-9; Zhou XL, 2017, ACTA NEUROPATHOL, V134, P151, DOI 10.1007/s00401-017-1719-5; Zhou XL, 2015, J CELL BIOL, V210, P991, DOI 10.1083/jcb.201502029; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	97	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100993	10.1016/j.jbc.2021.100993			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	WOS:000706361700009	34298019	Green Published, gold			2022-02-06	
J	Di Marco, R; Rubega, M; Lennon, O; Formaggio, E; Sutaj, N; Dazzi, G; Venturin, C; Bonini, I; Ortner, R; Bazo, HC; Tonin, L; Tortora, S; Masiero, S; Del Felice, A; Coyle, D; Guger, C; Menegatti, E; Fingleton, C; Guanziroli, E; Molteni, F; Pauletto, P; Faliero, F; Strausser, K				Di Marco, Roberto; Rubega, Maria; Lennon, Olive; Formaggio, Emanuela; Sutaj, Ngadhnjim; Dazzi, Giacomo; Venturin, Chiara; Bonini, Ilenia; Ortner, Rupert; Bazo, Humberto Cerrel; Tonin, Luca; Tortora, Stefano; Masiero, Stefano; Del Felice, Alessandra; Coyle, Damien; Guger, Christoph; Menegatti, Emanuele; Fingleton, Caitriona; Guanziroli, Eleonora; Molteni, Franco; Pauletto, Paolo; Faliero, Francesco; Strausser, Katherine		PRO GAIT Consortium	Experimental Protocol to Assess Neuromuscular Plasticity Induced by an Exoskeleton Training Session	METHODS AND PROTOCOLS			English	Article						rehabilitation; stroke; aging; EEG; EMG; neuromuscular plasticity; exoskeleton	CHRONIC STROKE; PARKINSONS-DISEASE; GAIT ASSESSMENT; ASSISTED GAIT; BARTHEL INDEX; LEG MUSCLES; BRAIN; SCALE; RELIABILITY; REHABILITATION	Exoskeleton gait rehabilitation is an emerging area of research, with potential applications in the elderly and in people with central nervous system lesions, e.g., stroke, traumatic brain/spinal cord injury. However, adaptability of such technologies to the user is still an unmet goal. Despite important technological advances, these robotic systems still lack the fine tuning necessary to adapt to the physiological modification of the user and are not yet capable of a proper human-machine interaction. Interfaces based on physiological signals, e.g., recorded by electroencephalography (EEG) and/or electromyography (EMG), could contribute to solving this technological challenge. This protocol aims to: (1) quantify neuro-muscular plasticity induced by a single training session with a robotic exoskeleton on post-stroke people and on a group of age and sex-matched controls; (2) test the feasibility of predicting lower limb motor trajectory from physiological signals for future use as control signal for the robot. An active exoskeleton that can be set in full mode (i.e., the robot fully replaces and drives the user motion), adaptive mode (i.e., assistance to the user can be tuned according to his/her needs), and free mode (i.e., the robot completely follows the user movements) will be used. Participants will undergo a preparation session, i.e., EMG sensors and EEG cap placement and inertial sensors attachment to measure, respectively, muscular and cortical activity, and motion. They will then be asked to walk in a 15 m corridor: (i) self-paced without the exoskeleton (pre-training session); (ii) wearing the exoskeleton and walking with the three modes of use; (iii) self-paced without the exoskeleton (post-training session). From this dataset, we will: (1) quantitatively estimate short-term neuroplasticity of brain connectivity in chronic stroke survivors after a single session of gait training; (2) compare muscle activation patterns during exoskeleton-gait between stroke survivors and age and sex-matched controls; and (3) perform a feasibility analysis on the use of physiological signals to decode gait intentions.	[Di Marco, Roberto; Rubega, Maria; Formaggio, Emanuela; Dazzi, Giacomo; Venturin, Chiara; Masiero, Stefano; Del Felice, Alessandra] Univ Padua, Dept Neurosci, Sect Rehabil, Via Belzoni 160, I-35121 Padua, Italy; [Lennon, Olive] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin 4, Ireland; [Sutaj, Ngadhnjim; Ortner, Rupert; Guger, Christoph] Gtec Med Engn GmbH, A-4521 Schiedlberg, Austria; [Bonini, Ilenia; Bazo, Humberto Cerrel] Osped Riabilitat Alta Specializzaz Motta Livenza, I-31045 Treviso, Italy; [Tonin, Luca; Tortora, Stefano] Univ Padua, Dept Informat Engn, I-35131 Padua, Italy; [Masiero, Stefano; Del Felice, Alessandra] Univ Padua, Padova Neurosci Ctr, I-35129 Padua, Italy; [Coyle, Damien] Ulster Univ, Coleraine, Londonderry, North Ireland; [Menegatti, Emanuele] Univ Padua, Padua, Italy; [Fingleton, Caitriona] Mater Misericordiae Univ Hosp, Dublin, Ireland; [Guanziroli, Eleonora; Molteni, Franco] Valduce Hosp, Villa Beretta Rehabil Ctr, Como, Italy; [Pauletto, Paolo; Faliero, Francesco] Osped Riabil Alta Specializzaz Motta Livenza, Motta Di Livenza, Italy; [Strausser, Katherine] Ekso Bion Inc, Richmond, CA USA		Di Marco, R; Rubega, M (corresponding author), Univ Padua, Dept Neurosci, Sect Rehabil, Via Belzoni 160, I-35121 Padua, Italy.	roberto.dimarco@unipd.it; maria.rubega@unipd.it; olive.lennon@ucd.ie; emanuela.formaggio@unipd.it; jimmy_sutaj@hotmail.com; giacomo.dazzi@studenti.unipd.it; chiara.venturin@studenti.unipd.it; ilenia.bonini.ib@gmail.com; ortner@gtec.at; HumbertoAntonio.CerrelBazo@ospedalemotta.it; luca.tonin@unipd.it; stefano.tortora@unipd.it; stef.masiero@unipd.it; alessandra.delfelice@unipd.it	Di Marco, Roberto/AAL-1586-2020; Formaggio, Emanuela/K-1555-2016	Di Marco, Roberto/0000-0002-3644-352X; Tonin, Luca/0000-0002-9751-7190; Tortora, Stefano/0000-0002-9918-1221; Rubega, Maria/0000-0002-0744-3109; Lennon, Olive/0000-0001-7005-3616; Masiero, Stefano/0000-0002-0361-4898; Formaggio, Emanuela/0000-0002-3417-0388	EUEuropean Commission [778043]; Italian Ministry for foreign Affairs and International CooperationMinistry of Foreign Affairs and International Cooperation (Italy) [PGR-01045]	This study has been supported by an EU-funded H2020 Research and Innovation Staff Exchange grant: PRO GAIT grant agreement No. 778043 (PRO GAIT project, www.progait.eu), and from the Italian Ministry for foreign Affairs and International Cooperation under grant No. PGR-01045 (SoftAct project). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androwis GJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00630; Artoni F, 2017, NEUROIMAGE, V159, P403, DOI 10.1016/j.neuroimage.2017.07.013; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Basmajian J.V., 1983, ELECTRODE PLACEMENT; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bhagat NA, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00122; Bisi MC, 2019, GAIT POSTURE, V68, P232, DOI 10.1016/j.gaitpost.2018.11.036; Blanc Y., 2010, OPEN REHABIL J, V3, P110, DOI [10.2174/1874943701003010110, DOI 10.2174/1874943701003010110]; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Borg G., 1975, PHYS WORK EFFORT, P39; Butt M, 2020, IEEE ENG MED BIO, P2841, DOI 10.1109/EMBC44109.2020.9175459; Calabro RS, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0268-4; Caliandro P, 2020, CLIN NEUROPHYSIOL, V131, P1775, DOI 10.1016/j.clinph.2020.04.158; Campanini I, 2007, J ELECTROMYOGR KINES, V17, P515, DOI 10.1016/j.jelekin.2006.06.001; Chowdhury A, 2017, PROCEEDINGS OF THE ADVANCES IN ROBOTICS (AIR'17), DOI 10.1145/3132446.3134909; Cincura C, 2009, CEREBROVASC DIS, V27, P119, DOI 10.1159/000177918; Colombo R, 2013, NEUROREHABILITATION, V33, P621, DOI 10.3233/NRE-131002; Contreras-Vidal JL, 2018, AM J PHYS MED REHAB, V97, P541, DOI 10.1097/PHM.0000000000000914; Damborska A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61264-z; De Luca A, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9142868; Dee M, 2020, DISABIL REHABIL, V42, P473, DOI 10.1080/09638288.2018.1501617; Delisle-Rodriguez D, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17122725; Demeyere N, 2016, J NEUROL, V263, P306, DOI 10.1007/s00415-015-7964-4; Donati ARC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30383; El-Gohary M, 2014, SENSORS-BASEL, V14, P356, DOI 10.3390/s140100356; Gandolfi M, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/8105480; Gandolla M, 2018, FRONT NEUROROBOTICS, V12, DOI 10.3389/fnbot.2018.00010; Gennaro F, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00039; Goffredo M, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.564067; Goffredo M, 2019, EUR J PHYS REHAB MED, V55, P710, DOI 10.23736/S1973-9087.19.05574-6; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; He YT, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaa8c0; He YT, 2014, IEEE ENG MED BIO, P3985, DOI 10.1109/EMBC.2014.6944497; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; Hornby TG, 2015, NEUROREHAB NEURAL RE, V29, P923, DOI 10.1177/1545968315572390; Hsueh IP, 2002, J NEUROL NEUROSUR PS, V73, P188, DOI 10.1136/jnnp.73.2.188; KALRA L, 1993, J AM GERIATR SOC, V41, P396, DOI 10.1111/j.1532-5415.1993.tb06947.x; Kilicarslan A, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026013; Knaepen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140626; Knight JF, 2006, TENTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P75; Knight JF, 2005, HUM FACTORS, V47, P77, DOI 10.1518/0018720053653875; Latt MD, 2009, J GERONTOL A-BIOL, V64, P700, DOI 10.1093/gerona/glp009; Lennon O, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00578; Lewis JR, 2018, INT J HUM-COMPUT INT, V34, P577, DOI 10.1080/10447318.2018.1455307; Merletti R, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.642257; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P320, DOI 10.1016/S0268-0033(98)00089-8; Molteni F, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11010104; Molteni F, 2020, AM J PHYS MED REHAB, V99, P694, DOI 10.1097/PHM.0000000000001395; Molteni F, 2017, EUR J PHYS REHAB MED, V53, P676, DOI 10.23736/S1973-9087.17.04591-9; Pasciuto I, 2017, J BIOMECH, V53, P84, DOI 10.1016/j.jbiomech.2017.01.005; Pascucci D, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007566; Paternostro-Sluga T, 2008, J REHABIL MED, V40, P665, DOI 10.2340/16501977-0235; Perry J, 1992, GAIT ANAL NORMAL PAT; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pierella C, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/ab9ada; Pirondini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13482-1; RANKIN J, 1957, Scott Med J, V2, P200; Rojek A, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01344; Rubega M, 2019, IEEE ENG MED BIO, P6438, DOI 10.1109/EMBC.2019.8856890; Rubega M, 2019, BRAIN TOPOGR, V32, P704, DOI 10.1007/s10548-018-0691-2; Rubega M., 2021, AGING BRAIN, V1, DOI [10.1016/j.nbas.2021.100013, DOI 10.1016/J.NBAS.2021.100013]; Rubega M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93556-3; Rubega M, 2021, ENTROPY-SWITZ, V23, DOI 10.3390/e23050592; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Scalona E, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8121495; Seeber M, 2015, NEUROIMAGE, V112, P318, DOI 10.1016/j.neuroimage.2015.03.045; Seeber M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00485; Shokur S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206464; Siragy T, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00387; Snyder KL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00639; Srivastava Shraddha, 2016, Int J Phys Med Rehabil, V4, DOI 10.4172/2329-9096.1000370; States RA, 2009, J NEUROL PHYS THER, V33, P179, DOI 10.1097/NPT.0b013e3181c29a8c; Strausser K. A., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P4911, DOI 10.1109/IROS.2011.6048674; Sylos-Labini F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00423; Tonin L, 2021, ANNU REV CONTR ROBOT, V4, P191, DOI 10.1146/annurev-control-012720-093904; Tortora S, 2020, FRONT NEUROROBOTICS, V14, DOI 10.3389/fnbot.2020.582728; Tortora S, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/ab9842; Van Criekinge T, 2020, DISABIL REHABIL, V42, P2836, DOI 10.1080/09638288.2019.1578421; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wagner J, 2012, NEUROIMAGE, V63, P1203, DOI 10.1016/j.neuroimage.2012.08.019; Ward NS, 2017, NAT REV NEUROL, V13, P244, DOI 10.1038/nrneurol.2017.34; Wheaton LA, 2007, EXP BRAIN RES, V180, P345, DOI 10.1007/s00221-007-0858-7; Winters C, 2015, NEUROREHAB NEURAL RE, V29, P614, DOI 10.1177/1545968314562115; Zhu FS, 2021, J NEURAL ENG, V18, DOI 10.1088/1741-2552/abf0d5	84	1	1	13	14	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2409-9279		METHOD PROTOCOL	Methods Protoc.	SEP	2021	4	3							48	10.3390/mps4030048			16	Biochemical Research Methods	Emerging Sources Citation Index (ESCI)	Biochemistry & Molecular Biology	UY8JF	WOS:000701763000001	34287357	Green Published, Green Submitted			2022-02-06	
J	Do, J; Blais, A; Feldman, B; Brandao, LR; Lougheed, J; Pohl, D; Klaassen, RJ; Johnston, DL; De Laat, D; Roth, J; Katz, SL; McCormick, A; Wright, FV; Macartney, G; McMillan, HJ; Venkateswaran, S; Sell, E; Doja, A; Matheson, K; Boafo, A; Longmuir, PE				Do, Jeffrey; Blais, Angelica; Feldman, Brian; Brandao, Leonardo R.; Lougheed, Jane; Pohl, Daniela; Klaassen, Robert J.; Johnston, Donna L.; De Laat, Denise; Roth, Johannes; Katz, Sherri Lynne; McCormick, Anna; Wright, F. Virginia; Macartney, Gail; McMillan, Hugh J.; Venkateswaran, Sunita; Sell, Erick; Doja, Asif; Matheson, Katherine; Boafo, Addo; Longmuir, Patricia E.			Characterization of physical literacy in children with chronicmedical conditions compared with healthy controls: a cross-sectional study	APPLIED PHYSIOLOGY NUTRITION AND METABOLISM			English	Article						physical activity; physical competence; pediatrics; children with disabilities	CANADIAN CHILDREN; FITNESS; PARTICIPATION; HEMOPHILIA; ARTHRITIS; EXERCISE; LIFE; ADOLESCENTS; CAPACITY; ASTHMA	To determine the physical literacy, defined as the capability for a physically active lifestyle, of children with medical conditions compared with healthy peers, this multicenter cross-sectional study recruited children with medical conditions from cardiology, neurology (including concussion), rheumatology, mental health, respirology, oncology, hematology, and rehabilitation (including cerebral palsy) clinics. Participants aged 8-12 years (N = 130; mean age: 10.0 6 1.44 years; 44% female) were randomly matched to 3 healthy peers from a normative database, based on age, gender, and month of testing. Total physical literacy was assessed by the Canadian Assessment of Physical Literacy, a validated assessment of physical literacy measuring physical competence, daily behaviour, knowledge/understanding, and motivation/confidence. Total physical literacy mean scores (/100) did not differ (t(498) = -0.67; p = 0.44) between participants (61.0 +/- 14.2) and matched healthy peers (62.0 +/- 10.7). Children with medical conditions had lower mean physical competence scores (/30; -6.5 [-7.44 to -5.51]; p < 0.001) but higher mean motivation/confidence scores (/30; 2.6 [1.67 to 3.63]; p < 0.001). Mean daily behaviour and knowledge/understanding scores did not differ from matches (/30; 1.8 [0.26 to 3.33]; p = 0.02;/10; -0.04 [-0.38 to 0.30]; p = 0.81; respectively). Children with medical conditions are motivated to be physically active but demonstrate impaired movement skills and fitness, suggesting the need for targeted interventions to improve their physical competence. Novelty: Physical literacy in children with diverse chronic medical conditions is similar to healthy peers. Children withmedical conditions have lower physical competence than healthy peers, but highermotivation and confidence. Physical competence (motor skill, fitness) interventions, rather than motivation or education, are needed for these youth.	[Do, Jeffrey; Blais, Angelica; Lougheed, Jane; Pohl, Daniela; Klaassen, Robert J.; Johnston, Donna L.; Roth, Johannes; Katz, Sherri Lynne; McCormick, Anna; McMillan, Hugh J.; Venkateswaran, Sunita; Sell, Erick; Doja, Asif; Matheson, Katherine; Boafo, Addo; Longmuir, Patricia E.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Do, Jeffrey; Lougheed, Jane; Pohl, Daniela; Klaassen, Robert J.; Johnston, Donna L.; Roth, Johannes; Katz, Sherri Lynne; McMillan, Hugh J.; Venkateswaran, Sunita; Sell, Erick; Doja, Asif; Matheson, Katherine; Boafo, Addo; Longmuir, Patricia E.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Blais, Angelica; McCormick, Anna; Macartney, Gail; Longmuir, Patricia E.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Feldman, Brian] Hosp Sick Children, Div Rheumatol, Toronto, ON, Canada; [Feldman, Brian; Brandao, Leonardo R.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Brandao, Leonardo R.] Hosp Sick Children, Div Hematol Oncol, Toronto, ON, Canada; [Lougheed, Jane] Childrens Hosp Eastern Ontario, Div Cardiol, Ottawa, ON, Canada; [Pohl, Daniela; McMillan, Hugh J.; Venkateswaran, Sunita; Sell, Erick; Doja, Asif] Childrens Hosp Eastern Ontario, Div Neurol, Ottawa, ON, Canada; [Klaassen, Robert J.; Johnston, Donna L.] Childrens Hosp Eastern Ontario, Div Hematol Oncol, Ottawa, ON, Canada; [De Laat, Denise; McCormick, Anna] Childrens Hosp Eastern Ontario, Div Dev Pediat & Rehabil Med, Ottawa, ON, Canada; [Roth, Johannes] Childrens Hosp Eastern Ontario, Div Dermatol & Rheumatol, Ottawa, ON, Canada; [Katz, Sherri Lynne] Childrens Hosp Eastern Ontario, Div Respirol, Ottawa, ON, Canada; [Wright, F. Virginia] Holland Bloorview Childrens Rehab Hosp, Toronto, ON, Canada; [Wright, F. Virginia] Univ Toronto, Dept Phys Therapy, Ottawa, ON, Canada; [Macartney, Gail] Univ Prince Edward Isl, Fac Nursing, Charlottetown, PE, Canada; [Matheson, Katherine; Boafo, Addo] Childrens Hosp Eastern Ontario, Div Psychiat, Ottawa, ON, Canada		Longmuir, PE (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada.; Longmuir, PE (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON, Canada.; Longmuir, PE (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada.	plongmuir@cheo.on.ca	McMillan, Hugh/AAA-1989-2021	McMillan, Hugh/0000-0001-8927-2018; Klaassen, Robert/0000-0002-6913-2808	Government of Ontario; Children's Hospital of Eastern Ontario Research Institute	This study was supported by the Government of Ontario and the Children's Hospital of Eastern Ontario Research Institute. The authors would like to thank all the families for their enthusiastic participation in the study. We would also like to thank Sophia Roubos, Kelly Hennessy, Clara Moore, Christelle-Jean Chow, Emil Prikryl, and Kevin Moncion who led the recruitment and data collection sessions for this research.	Belanger K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5897-4; Bjarnason-Wehrens B, 2007, CARDIOL YOUNG, V17, P487, DOI 10.1017/S1047951107001023; Boyer C, 2013, PEDIATR EXERC SCI, V25, P407, DOI 10.1123/pes.25.3.407; Braam KI, 2016, SUPPORT CARE CANCER, V24, P2259, DOI 10.1007/s00520-015-2993-1; Brna PM, 2017, EPILEPSY BEHAV, V73, P236, DOI 10.1016/j.yebeh.2017.05.012; Capovilla G, 2016, EPILEPSIA, V57, P6, DOI 10.1111/epi.13261; Cavallo S, 2015, J RHEUMATOL, V42, P1002, DOI 10.3899/jrheum.131377; Crosbie A, 2012, PEDIATR EXERC SCI, V24, P472, DOI 10.1123/pes.24.3.472; Edwards LC, 2017, SPORTS MED, V47, P113, DOI 10.1007/s40279-016-0560-7; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Elmesmari R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179429; Fortnum K, 2018, MENT HEALTH PHYS ACT, V15, P95, DOI 10.1016/j.mhpa.2018.10.001; Francis CE, 2016, J PHYS ACT HEALTH, V13, P214, DOI 10.1123/jpah.2014-0597; Giblin S, 2014, SPORTS MED, V44, P1177, DOI 10.1007/s40279-014-0205-7; Ginis KAM, 2016, HEALTH PSYCHOL REV, V10, P478, DOI 10.1080/17437199.2016.1198240; Goto M, 2016, J BLOOD MED, V7, P85, DOI 10.2147/JBM.S84848; Green D, 2009, DEV MED CHILD NEUROL, V51, P311, DOI 10.1111/j.1469-8749.2008.03242.x; Grimshaw SL, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28264; Harvey WJ, 2009, ADAPT PHYS ACT Q, V26, P131, DOI 10.1123/apaq.26.2.131; Hay JA., 1992, CLIN J SPORT MED, V2, P192, DOI [10.1097/00042752-199207000-00007, DOI 10.1097/00042752-199207000-00007]; Houghton K, 2012, PHYSICIAN SPORTSMED, V40, P77, DOI 10.3810/psm.2012.09.1979; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Khair K, 2017, HAEMOPHILIA, V23, P918, DOI 10.1111/hae.13323; Lloyd M, 2010, PEDIATR EXERC SCI, V22, P176, DOI 10.1123/pes.22.2.176; Longmuir PE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5902-y; Longmuir PE, 2017, J SPORT HEALTH SCI, V6, P231, DOI 10.1016/j.jshs.2015.11.004; Longmuir PE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2106-6; Martin C, 2018, BRIT J SPORT MED, V52, P214, DOI 10.1136/bjsports-2015-095317; Merlet AN, 2019, MED SCI SPORT EXER, V51, P4, DOI 10.1249/MSS.0000000000001757; Moola F, 2008, ADAPT PHYS ACT Q, V25, P49, DOI 10.1123/apaq.25.1.49; Moola FJ, 2011, PSYCHOL SPORT EXERC, V12, P599, DOI 10.1016/j.psychsport.2011.07.001; Nooijen C, 2014, J REHABIL MED, V46, P642, DOI 10.2340/16501977-1821; Norgaard M, 2019, ARTHRIT CARE RES, V71, P271, DOI 10.1002/acr.23795; Omwanghe OA, 2017, PEDIATR EXERC SCI, V29, P388, DOI 10.1123/pes.2016-0276; Philpott JF, 2010, CLIN J SPORT MED, V20, P167, DOI 10.1097/JSM.0b013e3181d2eddd; Pohl D, 2019, EPILEPSY BEHAV, V90, P260, DOI 10.1016/j.yebeh.2018.05.010; Race DL, 2016, J CHILD HEALTH CARE, V20, P428, DOI 10.1177/1367493516632616; Reijs RP, 2010, SEIZURE-EUR J EPILEP, V19, P467, DOI 10.1016/j.seizure.2010.06.003; Schaan CW, 2017, ARQ BRAS CARDIOL, V109, P357, DOI 10.5935/abc.20170125; Scott SN, 2013, MED SCI SPORT EXER, V45, P1139, DOI 10.1249/MSS.0b013e318281e4a8; Terrones-Munoz V, 2006, EUR J PEDIATR, V165, P427, DOI 10.1007/s00431-006-0087-2; Tremblay MS, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5903-x; Tremblay MS, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5891-x; Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pS311, DOI [10.1139/apnm-2016-0203, 10.1139/apnm-2016-0151]; Walker RG, 2015, PEDIATR EXERC SCI, V27, P219, DOI 10.1123/pes.2014-0074; West SL, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-018-1377-3; Williams B, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X515070; Wurz A, 2019, SUPPORT CARE CANCER, V27, P1153, DOI 10.1007/s00520-019-04669-5	48	1	1	2	4	CANADIAN SCIENCE PUBLISHING	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1715-5312	1715-5320		APPL PHYSIOL NUTR ME	Appl. Physiol. Nutr. Metab.	SEP	2021	46	9					1073	1082		10.1139/apnm-2020-0957			10	Nutrition & Dietetics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics; Physiology; Sport Sciences	UP5KE	WOS:000695418000008	33689492				2022-02-06	
J	Fortin, J; Grondin, S; Blanchet, S				Fortin, Julie; Grondin, Simon; Blanchet, Sophie			Event-related potentials of episodic encoding after traumatic brain injury in older adults	BRAIN RESEARCH			English	Article						Episodic memory; Electrophysiology; Aging; Head injury; Level of processing	DIVIDED ATTENTION; HEAD-INJURY; COGNITIVE IMPAIRMENT; ASSOCIATIVE DEFICIT; MEMORY PERFORMANCE; UNITED-STATES; RETRIEVAL; AGE; RECOGNITION; IMPACT	Episodic memory and attention impairments are frequently observed following a traumatic brain injury (TBI). Older adults are more affected than young adults after a TBI, partly because of the age-related neural and memory changes. Neural mechanisms underlying episodic memory deficits in older adults with chronic TBI remain to be investigated. The current study aimed to investigate the impact of TBI in older adults on the neural mechanisms of episodic encoding. Event-related potentials were recorded while 13 participants with mild-tosevere TBI and 14 matched controls were performing an episodic memory task in which the level of organizational strategy was manipulated through three encoding conditions. Participants were explicitly instructed to memorize words without any semantic relationship (Unrelated condition), words semantically related without any given strategies (Spontaneous condition) and words semantically related with provided category labels and organizational strategy (Guided condition). Behavioral performances indicated that older individuals with a TBI were impaired compared to matched controls whatever the condition. The electrophysiological findings showed a reduction of the P200 and LPC components amplitude in the TBI group relative to control group. Moreover, control participants without any neurological history showed a right frontal sustained activity only in the Spontaneous condition, whereas a right frontal asymmetry was observed in participants with chronic TBI whatever the encoding conditions. This was mainly the result of negative left frontal activity. These findings evidence neural dysfunctions underlying attentional and associative processes involved in memory strategies after a TBI sustained at an older age that are consistent with executive functions impairments.	[Fortin, Julie; Grondin, Simon; Blanchet, Sophie] Univ Laval, Ecole psychol, Quebec City, PQ, Canada; [Fortin, Julie; Grondin, Simon; Blanchet, Sophie] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Blanchet, Sophie] Univ Paris, Univ Paris Descartes, Inst Psychol, LMC2, Paris, France		Fortin, J (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.	julie.fortin.22@ulaval.ca; Simon.Grondin@psy.ulaval.ca; sophie.blanchet@parisdescartes.fr			Fonds de recherche du QuebecSante (FRQ-S); FRQ-S (Consortium program); Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [RGPIN201605028]	This study was supported by a scholarship from Fonds de recherche du QuebecSante (FRQ-S) to JF, by a research grant from FRQ-S (Consortium program) to SB, and by a research grant from the Natural Sciences and Engineering Research Council of Canada to SG [grant number RGPIN201605028] .	Anderson ND, 2000, J COGNITIVE NEUROSCI, V12, P775, DOI 10.1162/089892900562598; Anderson ND, 1998, PSYCHOL AGING, V13, P405, DOI 10.1037/0882-7974.13.3.405; Arenth PM, 2012, J CLIN EXP NEUROPSYC, V34, P333, DOI 10.1080/13803395.2011.633896; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Bartsch LM, 2018, MEM COGNITION, V46, P796, DOI 10.3758/s13421-018-0805-9; Bickford PC, 2017, EXP GERONTOL, V94, P4, DOI 10.1016/j.exger.2017.01.027; Blanchet S, 2002, REV NEUROPSYCHOL, V12, P319; Blanchet S, 2007, BRAIN RES, V1170, P59, DOI 10.1016/j.brainres.2007.07.024; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; Bolduc-Teasdale J, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9120343; Breed S, 2008, J HEAD TRAUMA REHAB, V23, P149, DOI 10.1097/01.HTR.0000319931.76966.ff; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cipolotti L, 2015, NEUROPSYCHOLOGIA, V75, P233, DOI 10.1016/j.neuropsychologia.2015.06.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Craik F I, 1990, Adv Neurol, V51, P201; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Craik FIM, 1977, HDB PSYCHOL AGING, P384; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Desrochers A., 2006, OMNILEX BASE DONNEES; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P601, DOI 10.1111/j.1469-8986.2010.01128.x; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Gaastra B, 2016, BRIT J NEUROSURG, V30, P221, DOI 10.3109/02688697.2015.1119240; Gagnon G, 2010, BRAIN RES, V1344, P148, DOI 10.1016/j.brainres.2010.04.041; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Gevins A, 1996, ELECTROEN CLIN NEURO, V98, P327, DOI 10.1016/0013-4694(96)00288-X; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Guez J, 2016, MEMORY, V24, P1091, DOI 10.1080/09658211.2015.1069852; Irimia A, 2018, NEUROBIOL AGING, V66, P158, DOI 10.1016/j.neurobiolaging.2018.02.026; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinjo H, 2011, PSYCHOL REP, V108, P405, DOI 10.2466/04.10.22.PR0.108.2.405-419; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lubitz AF, 2017, NEUROPSYCHOLOGIA, V106, P42, DOI 10.1016/j.neuropsychologia.2017.09.002; Luo L, 2008, CAN J PSYCHIAT, V53, P346, DOI 10.1177/070674370805300603; Makeig S., 2000, INTEGRATED HUMAN BRA; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Mangels JA, 2001, COGNITIVE BRAIN RES, V11, P77, DOI 10.1016/S0926-6410(00)00066-5; MAZZUCCHI A, 1992, J NEUROL, V239, P256; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; Meade ME, 2017, VIS COGN, V25, P825, DOI 10.1080/13506285.2017.1344341; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Naveh-Benjamin M, 2004, PSYCHON B REV, V11, P1067, DOI 10.3758/BF03196738; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037/0278-7393.26.5.1170; Naveh-Benjamin M, 2007, PSYCHOL AGING, V22, P202, DOI 10.1037/0882-7974.22.1.202; Nessler D, 2006, NEUROIMAGE, V30, P299, DOI 10.1016/j.neuroimage.2005.09.005; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Palermo D.S., 1970, PSYCHON MONOGR, V3, P107; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Pinal D, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00075; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schleepen TMJ, 2014, INT J PSYCHOPHYSIOL, V94, P319, DOI 10.1016/j.ijpsycho.2014.09.007; Schmidt M., 1996, HANDBOOK; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Tellez-Alanis B, 2004, NEUROREPORT, V15, P1819, DOI 10.1097/01.wnr.0000137075.4125798; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Troyer AK, 2000, CAN J EXP PSYCHOL, V54, P161, DOI 10.1037/h0087338; TULVING E, 1984, BEHAV BRAIN SCI, V7, P223, DOI 10.1017/S0140525X0004440X; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2011, WECHSLER ADULT INTEL; Wood RL, 2017, BRAIN INJURY, V31, P1270, DOI 10.1080/02699052.2017.1332387; Zacks R.T., 2006, LIFESPAN COGNITION M, P162, DOI [10.1093/acprof:oso/9780195169539.003.0011, DOI 10.1093/ACPROF:OSO/9780195169539.003.0011]; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008	90	1	1	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 1	2021	1766								147504	10.1016/j.brainres.2021.147504			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XC0OV	WOS:000721720800005	33910039				2022-02-06	
J	Gu, ZT; Li, L; Li, Q; Tan, HP; Zou, ZM; Chen, XY; Zhang, ZC; Zhou, YJ; Wei, DN; Liu, CY; Huang, QB; Maegele, M; Cai, DZ; Huang, MG				Gu, Zhengtao; Li, Li; Li, Qin; Tan, Hongping; Zou, Zhimin; Chen, Xueyong; Zhang, Zichen; Zhou, Yijun; Wei, Danian; Liu, Chengyong; Huang, Qiaobing; Maegele, Marc; Cai, Daozhang; Huang, Mingguang			Polydatin alleviates severe traumatic brain injury induced acute lung injury by inhibiting S100B mediated NETs formation	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Severe traumatic brain injury; Acute lung injury; NETs; Polydatin; S100B	SEVERE HEMORRHAGIC-SHOCK; MODEL; RATS; BIOMARKERS; PROTECTS; CELLS	Severe traumatic brain injury (sTBI)-induced acute lung injury (sTBI-ALI) is regarded as the most common complication of sTBI that is an independent predictor of poor outcomes in patients with sTBI and strongly increases sTBI mortality. Polydatin (PD) has been shown to have a potential therapeutic effect on sTBI-induced neurons injury and sepsis-induced acute lung injury (ALI), therefore, it is reasonable to believe that PD has a protective effect on sTBI-ALI. Here, to clarify the PD protective effect following sTBI-ALI, a rat brain injury model of lateral fluid percussion was established to mimic sTBI. As a result, sTBI induced ALI, and caused an increasing of wet/dry weight ratio and lung vascular permeability, as well as sTBI promoted oxidative stress response in the lung; sTBI caused inflammatory cytokines release, such as IL-6, IL-1 beta, TNF-alpha and MCP-1; and sTBI promoted NETs formation, mainly including an increasing expression of MPO, NE and CitH3. Simultaneously, sTBI induced a significant increase in the level of S100B; however, when inhibition of S100B, the expression of MPO, NE and CITH3 were significantly inhibited following sTBI. Inhibition of S100B also promoted lung vascular permeability recovery and alleviated oxidative stress response. Furthermore, PD treatment reduced the pathological lung damage, promoted lung vascular permeability recovery, alleviated oxidative stress response and inflammatory cytokines release; more importantly, PD inhibited the expression of S100B, and NETs formation in the lung following sTBI. These results indicate that PD alleviates sTBI-ALI by inhibiting S100B mediated NETs formation. Thus, PD may be valuable in sTBI-ALI treatment.	[Gu, Zhengtao; Huang, Mingguang] Southern Med Univ, Peoples Hosp Shunde 1, Dept Traumatol & Orthoped Surg, Shunde Hosp, Foshan, Guangdong, Peoples R China; [Gu, Zhengtao; Li, Li; Li, Qin; Zou, Zhimin; Chen, Xueyong; Zhang, Zichen; Wei, Danian; Liu, Chengyong; Huang, Qiaobing; Maegele, Marc; Cai, Daozhang] Southern Med Univ, Acad Orthoped, Guangdong Prov Key Lab Bone & Joint Degenerat Dis, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Gu, Zhengtao; Li, Li; Li, Qin; Zou, Zhimin; Chen, Xueyong; Zhang, Zichen; Wei, Danian; Liu, Chengyong; Huang, Qiaobing; Maegele, Marc] Southern Med Univ, Dept Treatment Ctr Traumat Injuries, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Gu, Zhengtao; Li, Li; Li, Qin; Zou, Zhimin; Chen, Xueyong; Zhang, Zichen; Huang, Qiaobing] Southern Med Univ, Dept Pathophysiol, Guangdong Prov Key Lab Shock & Microcirculat Res, Guangzhou, Peoples R China; [Tan, Hongping] Guangdong Sanjiu Brain Hosp, Dept Epilepsy Ctr, Guangzhou, Guangdong, Peoples R China; [Zhou, Yijun] South Cent Univ, Xiangya Med Coll, Guangde Clin Inst, Dept Orthopaed,Peoples Hosp Changde 1, Changde, Hunan, Peoples R China; [Maegele, Marc] Univ Witten Herdecke UW H, Cologne Merheim Med Ctr CMMC, Dept Traumatol & Orthoped Surg, Campus Cologne Merheim, Cologne, Germany; [Cai, Daozhang] Southern Med Univ, Acad Orthoped Guangdong Prov, Affiliated Hosp 3, Dept Orthoped,Ctr Orthopaed Surg, Guangzhou, Guangdong, Peoples R China		Huang, MG (corresponding author), Southern Med Univ, Peoples Hosp Shunde 1, Dept Traumatol & Orthoped Surg, Shunde Hosp, Foshan, Guangdong, Peoples R China.; Cai, DZ (corresponding author), Southern Med Univ, Acad Orthoped, Guangdong Prov Key Lab Bone & Joint Degenerat Dis, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China.; Cai, DZ (corresponding author), Southern Med Univ, Acad Orthoped Guangdong Prov, Affiliated Hosp 3, Dept Orthoped,Ctr Orthopaed Surg, Guangzhou, Guangdong, Peoples R China.	cdz@smu.edu.cn; MGHuang_n@163.com		Gu, zhengtao/0000-0001-8566-6634	Guangdong Natural Science Foundation of ChinaNational Natural Science Foundation of Guangdong Province [2020A1515010092, 2019A1515010295]; National Nature Science Fund of ChinaNational Natural Science Foundation of China (NSFC) [81901997]; Certificate of China Postdoctoral Science Foundation [2019M652960, 2019M652965]; Youth Scientific Research Staring Foundation for the Third Affiliated Hospital of Southern Medical University [2019Q006]; Scientific Research Staring Foundation for Southern Medical University [QD2018N024, QD2016N017]; Scientific Research Staring Foundation for Talent Introduction for Southern Medical University	This study was supported by Guangdong Natural Science Foundation of China [NO.2020A1515010092; NO.2019A1515010295], National Nature Science Fund of China [NO.81901997], Certificate of China Postdoctoral Science Foundation Grant [NO.2019M652960; NO.2019M652965], Youth Scientific Research Staring Foundation for the Third Affiliated Hospital of Southern Medical University [NO. 2019Q006], Scientific Research Staring Foundation for Southern Medical University [NO. QD2018N024; NO. QD2016N017], and Scientific Research Staring Foundation for Talent Introduction for Southern Medical University (to MM).	Chen B, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-77; Cheng CY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001468; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Gao YG, 2015, ANESTH ANALG, V121, P1251, DOI 10.1213/ANE.0000000000000977; Jung SS, 2020, NEUROMOL MED, V22, P31, DOI 10.1007/s12017-019-08560-8; Keshavarzi Z, 2014, IRAN J BASIC MED SCI, V17, P406; Kondrup M, 2020, BIOMED REP, V12, P204, DOI 10.3892/br.2020.1277; Lefrancais E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98178; Li L, 2019, NEURAL REGEN RES, V14, P1573, DOI 10.4103/1673-5374.255972; Li PY, 2015, EXPERT OPIN THER TAR, V19, P997, DOI 10.1517/14728222.2015.1054806; Li T, 2014, INT J CLIN EXP PATHO, V7, P8401; Liang YJ, 2018, EUR J PHARMACOL, V833, P432, DOI 10.1016/j.ejphar.2018.07.005; Lin HJ, 2017, CELL PHYSIOL BIOCHEM, V44, P1726, DOI 10.1159/000485778; Liu S, 2019, INFLAMMATION, V42, P387, DOI 10.1007/s10753-018-0903-7; Liu SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep37252; Loftis JM, 2018, ALCOHOL CLIN EXP RES, V42, P1466, DOI 10.1111/acer.13796; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Pedrazza L, 2017, J CELL PHYSIOL, V232, P3552, DOI 10.1002/jcp.25816; Piazza O, 2013, INT J IMMUNOPATH PH, V26, P383, DOI 10.1177/039463201302600211; Piazza O, 2011, PANMINERVA MED, V53, P203; Powell JR, 2020, J HEAD TRAUMA REHAB, V35, P300, DOI 10.1097/HTR.0000000000000598; Shao XF, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106175; Shi Y, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00409; Skrifvars MB, 2019, ACTA ANAESTH SCAND, V63, P200, DOI 10.1111/aas.13244; Tan HP, 2018, NEURAL REGEN RES, V13, P827, DOI 10.4103/1673-5374.232477; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang XM, 2013, EXPERT OPIN INV DRUG, V22, P169, DOI 10.1517/13543784.2013.748033; Wang YY, 2018, MED SCI MONITOR, V24, P4961, DOI 10.12659/MSM.908133; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Yamamura S, 2013, BRIT J PHARMACOL, V168, P1088, DOI 10.1111/j.1476-5381.2012.02132.x; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Zeng ZH, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1737185; Zeng ZH, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/965961; Zeng ZH, 2015, J SURG RES, V198, P192, DOI 10.1016/j.jss.2015.05.041; Zhang H, 2013, J CLIN INVEST, V123, P1019, DOI 10.1172/JCI64931; Zhang JH, 2018, J CELL BIOCHEM, V119, P8095, DOI 10.1002/jcb.26747	38	1	1	15	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	SEP	2021	98								107699	10.1016/j.intimp.2021.107699			12	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	UL7MA	WOS:000692829800001	34147911				2022-02-06	
J	Herrera, AV; Wastila, L; Brown, JP; Chen, HG; Gambert, SR; Albrecht, JS				Herrera, Anthony V.; Wastila, Linda; Brown, Jessica P.; Chen, Hegang; Gambert, Steven R.; Albrecht, Jennifer S.			Effects of Prescription Opioid Use on Traumatic Brain Injury Risk in Older Adults	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aged; analgesics; brain injuries; opioid; traumatic	UNITED-STATES; PSYCHOTROPIC-DRUGS; PERSISTENT PAIN; MEDICATION USE; CASE-CROSSOVER; FALLS; PEOPLE; FRACTURES; POPULATION; ANALGESICS	Objective: The objective of this study was to estimate the risk of traumatic brain injury (TBI) associated with opioid use among older adult Medicare beneficiaries. Setting: Five percent sample of Medicare administrative claims obtained for years 2011-2015. Participants: A total of 50 873 community-dwelling beneficiaries 65 years and older who sustained TBI. Design: Case-crossover study comparing opioid use in the 7 days prior to TBI with the control periods of 3, 6, and 9 months prior to TBI. Main Measures: TBI cases were identified using ICD-9 (International Classification of Diseases, Ninth Revision) and ICD-10 (International Classification of Diseases, Tenth Revision) codes. Prescription opioid exposure and concomitant nonopioid fall risk-increasing drug (FRID) use were determined by examining the prescription drug event file. Results: The 8257 opioid users (16.2%) were significantly younger (mean age 79.0 vs 80.8 years, P < .001). Relative to nonusers, opioid users were more likely to be women (77.0% vs 70.0%, P < .001) with a Charlson Comorbidity Index of 2 or more (43.7% vs 30.9%, P < .001) and higher concomitant FRID use (94.0% vs 82.7%, P < .001). Prescription opioid use independently increased the risk of TBI compared with nonusers (OR = 1.34; 95% CI, 1.28-1.40). In direct comparisons, we did not observe evidence of a significant difference in adjusted TBI risk between high- (>= 90 morphine milligram equivalents) and standard-dose opioid prescriptions (OR = 1.01; 95% CI, 0.90-1.14) or between acute and chronic (>= 90 days) opioid prescriptions (OR = 0.93; 95% CI, 0.84-1.02). Conclusions: Among older adult Medicare beneficiaries, prescription opioid use independently increased risk for TBI compared with nonusers after adjusting for concomitant FRID use. We found no significant difference in adjusted TBI risk between high-dose and standard-dose opioid use, nor did we find a significant difference in adjusted TBI risk between acute and chronic opioid use. This analysis can inform prescribing of opioids to community-dwelling older adults for pain management.	[Herrera, Anthony V.; Brown, Jessica P.; Chen, Hegang; Albrecht, Jennifer S.] Univ Maryland, Dept Epidemiol, Baltimore, MD 21201 USA; [Herrera, Anthony V.; Brown, Jessica P.; Chen, Hegang; Albrecht, Jennifer S.] Univ Maryland, Dept Publ Hlth, Baltimore, MD USA; [Herrera, Anthony V.; Brown, Jessica P.; Chen, Hegang; Albrecht, Jennifer S.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD USA; [Wastila, Linda] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD USA		Herrera, AV (corresponding author), Univ Maryland, Dept Epidemiol, Baltimore, MD 21201 USA.; Herrera, AV (corresponding author), Univ Maryland, Dept Publ Hlth, Baltimore, MD USA.; Herrera, AV (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD USA.	aherrera@som.umaryland.edu; lsimoniw@rx.umaryland.edu; JPBROWN@som.umaryland.edu; Hegang.Chen@som.umaryland.edu; sgambert@som.umaryland.edu; jalbrecht@som.umaryland.edu			National Institute on Aging at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32 AG00262]	Mr Herrera was supported by grants from the National Institute on Aging at the National Institutes of Health (grant no. T32 AG00262). For the remaining authors, none were declared. The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of data; in the preparation of the article; or in the review or approval of the article.	Axeen S, 2018, HEALTH SERV RES, V53, P3309, DOI 10.1111/1475-6773.12846; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bloch F, 2011, J AGING HEALTH, V23, P329, DOI 10.1177/0898264310381277; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Centers for Medicare Medicaid Service, 2018, OP MORPH EQ CONV FAC; Centers for Medicare Medicaid Services, RED OP MIS; Centers for Medicare & Medicaid Services, TRUST REP TRUST FUND; Centers for Medicare Medicaid Services, NEW D; Centers for Medicare Medicaid Services, OP CRIS AM; Chang CM, 2011, INT J GERIATR PSYCH, V26, P602, DOI 10.1002/gps.2569; Chiu MH, 2015, GERIATR GERONTOL INT, V15, P856, DOI 10.1111/ggi.12359; Davis MP, 2016, CURR ONCOL REP, V18, DOI 10.1007/s11912-016-0558-1; de Vries M, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.12.013; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Edlund MJ, 2010, CLIN J PAIN, V26, P1, DOI 10.1097/AJP.0b013e3181b99f35; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Ferrell B, 2009, J AM GERIATR SOC, V57, P1331, DOI 10.1111/j.1532-5415.2009.02376.x; French DD, 2006, CLIN THER, V28, P619, DOI 10.1016/j.clinthera.2006.04.011; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Goodwin JS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2318-9; Gray SL, 2020, J GERONTOL A-BIOL, V75, P1003, DOI 10.1093/gerona/glz270; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kelly KD, 2003, AGE AGEING, V32, P503, DOI 10.1093/ageing/afg081; Kennedy J, 2014, J PAIN, V15, P979, DOI 10.1016/j.jpain.2014.05.009; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Kuo YF, 2018, J AM GERIATR SOC, V66, P945, DOI 10.1111/jgs.15332; Kuo YF, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.10.002; Kuschel BM, 2015, EUR J PUBLIC HEALTH, V25, P527, DOI 10.1093/eurpub/cku120; Machado-Duque ME, 2018, INT PSYCHOGERIATR, V30, P941, DOI 10.1017/S1041610217002745; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Marr A., 2004, CENTRAL NERVOUS SYST; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Masud T, 2013, AGE AGEING, V42, P121, DOI 10.1093/ageing/afs118; Miller M, 2011, J AM GERIATR SOC, V59, P430, DOI 10.1111/j.1532-5415.2011.03318.x; Moden B, 2010, J EPIDEMIOL COMMUN H, V64, P440, DOI 10.1136/jech.2009.098947; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Office of Inspector General, 2018, TOOLK US DAT AN CALC, P25; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; ResDAC Data Dictionary, ID HOSP CLAIMS EM RO; Rolita L, 2013, J AM GERIATR SOC, V61, P335, DOI 10.1111/jgs.12148; Saunders KW, 2010, J GEN INTERN MED, V25, P310, DOI 10.1007/s11606-009-1218-z; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Seppala LJ, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.12.099; Seppala LJ, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.12.098; Soderberg KC, 2013, CNS DRUGS, V27, P155, DOI 10.1007/s40263-013-0038-1; Steinman MA, 2015, PAIN MED, V16, P319, DOI 10.1111/pme.12613; Takkouche B, 2007, DRUG SAFETY, V30, P171, DOI 10.2165/00002018-200730020-00006; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; United States Census Bureau, AM COMMUNITY SURVEY; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034	53	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		388	395		10.1097/HTR.0000000000000716			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300017	34489389	Green Accepted			2022-02-06	
J	Holmer, HK; Gilbert, TA; Ashraf, AJ; O'Neil, ME; Carlson, KF				Holmer, Haley K.; Gilbert, Tess A.; Ashraf, Alexandria J.; O'Neil, Maya E.; Carlson, Kathleen F.			Opioid and Sedative-Hypnotic Prescriptions Among Post-9/11 Veteran VA Users Nationwide With Traumatic Brain Injury, 2012-2020	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						health services; injury; opioids; rehabilitation; trauma; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; AFFAIRS POLYTRAUMA SYSTEM; UNITED-STATES; CHRONIC PAIN; CARE; HEALTH; ASSOCIATION; PREVALENCE; RISK; CONSEQUENCES	Objective: Many post-9/11 Veterans have received Department of Veterans Affairs (VA) healthcare for traumatic brain injury (TBI). Pain conditions are prevalent among these patients and are often managed with opioid analgesics. Opioids may impose unique risks to Veterans with a history of TBI, especially when combined with other psychotropic medications. We examined receipt of opioid and sedative-hypnotic prescriptions among post-9/11 Veterans with TBI who received VA care nationally between 2012 and 2020. Setting: Nationwide VA outpatient care. Participants: Veterans with, versus without, clinician-confirmed TBI based on the VA's Comprehensive TBI Evaluation (CTBIE) were followed up for subsequent years in which they received VA care. Design: A historical cohort study. Main Measures: Proportions of Veterans who received opioid, benzodiazepine, and nonbenzodiazepine sedative-hypnotic prescriptions were compared by CTBIE outcome (TBI yes/no) and by year; overlaps between medication classes, long-term opioid therapy, and high-dose opioid therapy were also examined. Among those with confirmed TBI, logistic regression was used to examine associations between veteran characteristics and likelihood of these potentially high-risk opioid use outcomes. Results: Among 69 752 Veterans with clinician-confirmed TBI, 26.9% subsequently received opioids. The prevalence receiving opioids each year increased from 2012 (16.7%) to 2014 (17.7%), and then decreased each of the following years through 2020 (5.8%). Among Veterans with TBI who received opioids, large proportions also received benzodiazepine (30.1%) and nonbenzodiazepine (36.0%) sedative-hypnotic prescriptions; these proportions also decreased in recent years. In both bivariable and multivariable regression models, Veterans' demographic, TBI, and clinical characteristics were associated with likelihood of potentially high-risk opioid use. Conclusions: VA opioid prescribing to Veterans with TBI has decreased in recent years but remains an important source of risk, particularly when considering coprescriptions of sedative-hypnotic medication. Understanding patterns of psychotropic prescription use among Veterans with TBI can highlight important healthcare and rehabilitation needs in this large patient cohort.	[Holmer, Haley K.; Gilbert, Tess A.; Ashraf, Alexandria J.; O'Neil, Maya E.; Carlson, Kathleen F.] VA Portland Hlth Care Syst, Ctr Improve Veteran Involvement Care CIVIC, Portland, OR USA; [Ashraf, Alexandria J.; Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Portland State Univ, Sch Publ Hlth, Portland, OR USA; [O'Neil, Maya E.; Carlson, Kathleen F.] VA Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res NCRAR, Portland, OR USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA		Carlson, KF (corresponding author), VA Portland Hlth Care Syst R&D 66, Ctr Improve Vet Involvement Care, 3715 SW US Vet Hosp Rd, Portland, OR 97239 USA.	holmerh@ohsu.edu; Tess.Gilbert@va.gov; ajshraf777@gmail.com; maya.oneil@va.gov; kathleen.carlson@va.gov			Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [N3197-P]	This work was supported by a grant from the VeteransHealth Administration, Office of Research and Development, Rehabilitation Research and Development Service (N3197-P). The opinions expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Adams RS, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6451; Adams RS, 2019, J HEAD TRAUMA REHAB, V34, P167, DOI 10.1097/HTR.0000000000000481; Altekruse SF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227966; Anderson KO, 2009, J PAIN, V10, P1187, DOI 10.1016/j.jpain.2009.10.002; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bertenthal D, 2018, BRAIN INJURY, V32, P1188, DOI 10.1080/02699052.2018.1493535; Carlson KF, 2018, HEALTH SERV RES, V53, P5285, DOI 10.1111/1475-6773.13025; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fonda JR, 2020, J HEAD TRAUMA REHAB, V35, P209, DOI 10.1097/HTR.0000000000000546; Gellad WF, 2017, JAMA INTERN MED, V177, P611, DOI 10.1001/jamainternmed.2017.0147; Golub A, 2013, SUBST USE MISUSE, V48, P811, DOI 10.3109/10826084.2013.796988; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greer N, 2020, J HEAD TRAUMA REHAB, V35, P1, DOI 10.1097/HTR.0000000000000478; Im JJ, 2015, J GEN INTERN MED, V30, P979, DOI 10.1007/s11606-015-3220-y; Jacotte-Simancas A, 2021, INT REV NEUROBIOL, V157, P195, DOI 10.1016/bs.irn.2020.09.003; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Krejci LP, 2014, MED CARE, V52, pS5, DOI 10.1097/MLR.0000000000000226; Kumar RG, 2021, J NEUROTRAUM, V38, P2284, DOI 10.1089/neu.2020.7496; Leelakanok N, 2017, J AM PHARM ASSOC, V57, P729, DOI 10.1016/j.japh.2017.06.002; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Li W, 2013, BRAIN RES, V1531, P58, DOI 10.1016/j.brainres.2013.07.036; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Lin LWA, 2017, PAIN, V158, P833, DOI 10.1097/j.pain.0000000000000837; Lucchetta RC, 2018, PHARMACOTHERAPY, V38, P1010, DOI 10.1002/phar.2170; Mattson CL, 2021, MMWR-MORBID MORTAL W, V70, P202, DOI 10.15585/mmwr.mm7006a4externalicon; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Office of the Secretary HHS, 2008, Fed Regist, V73, P49795; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rexing CJ, 2020, INJURY PREV, V26, P502, DOI 10.1136/injuryprev-2020-043941; Santoro TN, 2018, CUREUS, V10, DOI 10.7759/cureus.3733; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; United States Centers for Medicaid Medicare Services, 2020, 2021 ICD 10 CM; United States Department of Agriculture Economic Research Service, 2020, DOC 2010 RUR URB COM; United States Department of Veterans Affairs and Department of Defense Management of Concussion/mTBI Working Group, 2016, VA DOD CLIN PRACT GU; United States Department of Veterans Affairs Health Services Research & Development, 2014, CORP DAT WAR; United States Department of Veterans Affairs Pharmacy Benefits Management Services, 2021, VA NAT FORM FEBR 202; United States Department of Veterans Affairs Veterans Health Administration, 2017, VHA DIR 1184 SCREEN; United States Department of Veterans Affairs Veterans Health Administration Support Service Center, 2021, COMPR TBI EV VHA SUM; Upadhyay J, 2010, BRAIN, V133, P2098, DOI 10.1093/brain/awq138; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; Westanmo A, 2015, PAIN MED, V16, P1019, DOI 10.1111/pme.12699	48	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		354	363		10.1097/HTR.0000000000000712			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300013	34489386				2022-02-06	
J	Hoover, P; Johnson, D; Wu, T; French, LM; Caban, J				Hoover, Peter; Johnson, Dara; Wu, Tim; French, Louis M.; Caban, Jesus			Risk Factors Associated With the Prescription of Opioids Among Service Members Following a First Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						active-duty service members; mild traumatic brain injury; Military Health System; opioids	POSTTRAUMATIC-STRESS-DISORDER; HEALTH-CARE UTILIZATION; VETERANS; PATTERNS; IDENTIFICATION; COMORBIDITIES; PREVALENCE; PREDICTORS; SOLDIERS; PTSD	Objective: To evaluate factors impacting opioid receipt among active-duty service members (SMs) following a first mild traumatic brain injury (mTBI). Setting: Active-duty SMs receiving care within the Military Health System. Participants: In total, 14 757 SMs who have sustained an initial mTBI, as documented within electronic health records (EHRs), between 2016 and 2017. Design: A retrospective analysis of EHR metadata. Main Measures: Multivariable logistic regression assessed factors impacting opioid receipt and initiation. Factors include demographics, military characteristics, and preexisting clinical conditions, including prior opioid prescription. Results: Of the sample population, 33.4% (n = 4927) were prescribed opioids after their initial mTBI, of which, 60.6% (n = 2985) received opioids for the first time following injury. Significant risk factors associated with the increased probability of opioid receipt included age, gender, and preexisting behavioral health and musculoskeletal conditions. Military characteristics also exhibited changes in the probability of opioid receipt, both among initiation and new prescription. No changes were observed among race, nor among those with preexisting headaches or migraines. Conclusion: Despite concerns about the negative impact on recovery, the prescribing of opioids is common in this population of active-duty SMs first diagnosed with an mTBI. As several demographic and preexisting health conditions are factors in the receipt of opioids post-mTBI, the entire medical history of these patients should be considered prior to prescription. Understanding these factors may further inform policy for opioid use in the Military Health System.	[Hoover, Peter; Johnson, Dara; Wu, Tim; French, Louis M.; Caban, Jesus] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA		Hoover, P (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA.	peter.j.hoover2.civ@mail.mil; dara.y.johnson.ctr@mail.mil; timothy.t.wu.civ@mail.mil; louis.m.french.civ@mail.mil; jesus.j.caban.civ@mail.mil					Adams RS, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6451; Adams RS, 2019, MIL MED, V184, pE101, DOI 10.1093/milmed/usy162; [Anonymous], 2016, VADOD CLIN PRACT GUI; [Anonymous], 2020, DOD NUMB TRAUM BRAIN; Belsher BE, 2016, MED CARE, V54, P706, DOI 10.1097/MLR.0000000000000545; Bertenthal D, 2018, BRAIN INJURY, V32, P1188, DOI 10.1080/02699052.2018.1493535; Blanchard J, 2016, MIL MED, V181, P410, DOI 10.7205/MILMED-D-15-00009; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Corrigan JD, 2019, ADDICT BEHAV, V90, P143, DOI 10.1016/j.addbeh.2018.10.030; DeGraba TJ, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.580182; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Edwards-Stewart A, 2020, CLIN NEUROPSYCHOL, V34, P1124, DOI 10.1080/13854046.2020.1713399; Farmer Carrie M, 2017, Rand Health Q, V6, P11; Fonda JR, 2020, J HEAD TRAUMA REHAB, V35, P209, DOI 10.1097/HTR.0000000000000546; Ghahramanlou-Holloway M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040828; Harris MB, 2019, J HEAD TRAUMA REHAB, V34, P425, DOI 10.1097/HTR.0000000000000544; Health Services Research & Development Center, 2005, J HOPK ACG CAS MIX S; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hong CK, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0755-9; Hudson TJ, 2018, PAIN MED, V19, P774, DOI 10.1093/pm/pnx208; Hudson TJ, 2017, PAIN, V158, P1039, DOI 10.1097/j.pain.0000000000000874; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; John WS, 2019, DRUG ALCOHOL DEPEN, V194, P468, DOI 10.1016/j.drugalcdep.2018.11.011; Kasuske LM, 2021, MIL MED, V186, P567, DOI 10.1093/milmed/usaa320; Kazanis W, 2018, MIL MED, V183, pE157, DOI 10.1093/milmed/usx014; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lavasani Rebecca, 2020, Ment Health Clin, V10, P270, DOI 10.9740/mhc.2020.09.270; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Macey TA, 2011, PAIN MED, V12, P1502, DOI 10.1111/j.1526-4637.2011.01226.x; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Madsen C, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/9529257; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Meints SM, 2019, PAIN MANAG, V9, P317, DOI 10.2217/pmt-2018-0030; Merkel SF, 2017, NEUROSCI BIOBEHAV R, V77, P209, DOI 10.1016/j.neubiorev.2017.03.015; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pressman AR, 2021, HEADACHE, V61, P462, DOI 10.1111/head.14033; Rhon DI, 2020, J PRIM CARE COMMUNIT, V11, DOI 10.1177/2150132720957438; Rosenberg JM, 2018, PAIN MED, V19, P928, DOI 10.1093/pm/pnx203; Scott BR, 2020, HEADACHE, V60, P526, DOI 10.1111/head.13709; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Tam CC, 2020, DRUG ALCOHOL DEPEN, V216, DOI 10.1016/j.drugalcdep.2020.108311; Taylor B., 2012, FISCAL YEAR 2011 VA, P453; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343	50	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		345	353		10.1097/HTR.0000000000000711			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300012	34489385				2022-02-06	
J	Hunzinger, KJ; Caccese, JB; Costantini, KM; Swanik, CB; Buckley, TA				Hunzinger, Katherine J.; Caccese, Jaclyn B.; Costantini, Katelyn M.; Swanik, C. Buz; Buckley, Thomas A.			Age of First Exposure to Collision Sports Does Not Affect Patient Reported Outcomes in Women and Men Community Rugby Players	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						MILD TRAUMATIC BRAIN INJURY; REPETITIVE HEAD IMPACTS; WELL-BEING; CONCUSSION	HIGH-SCHOOL FOOTBALL; LATER-LIFE; CONCUSSION; HEALTH; BRAIN; PARTICIPATION; INJURY; RISK; RELIABILITY; COGNITION	Purpose This study aimed to determine the relationship between age of first exposure (AFE) to repetitive head impacts through contact/collision sports and patient-reported outcomes in community rugby players. Methods We recruited community rugby players older than 18 yr with at least 1 yr of contact rugby participation to complete an online survey. Participants completed the Brief Symptom Inventory-18 (BSI-18), Short-Form Health Survey 12 (SF-12), and Satisfaction with Life Scale (SWLS) via Qualtrics. We used generalized linear models to examine the association between AFE (continuous) and patient-reported outcomes by sex, while controlling for cumulative years contact/collision sport history, age, and concussion history (yes/no). In addition, we used Mann-Whitney U tests to compare patient-reported outcomes between AFE Results A total of 1037 rugby players (31.6 +/- 11.3 yr (range, 18-74 yr), 59.1% men) participated in this study. Whether analyzed continuously or dichotomously at age 12 yr, younger AFE was not associated with worse patient-reported outcomes for either men or women. Positive concussion history was a significant predictor of worse BSI-18 subscores, SF-12 subscores, and SWLS in women and worse BSI-18 subscores in men. Cumulative contact/collision sport history was a significant predictor of better BSI-18 Depression and SF-12 (Mental Component Summary) subscores in men only. In men and women, older age was a significant predictor of better BSI-18 Depression, Anxiety, and GSI subscores; better SWLS (in men only); and better SF-12 Mental Component Summary, but worse SF-12 (Physical Component Summary). Conclusions Younger AFE to contact/collision sport is not associated with worse patient-reported outcomes in early adult rugby players. Concussion history was predictive of worse patient-reported outcomes.	[Hunzinger, Katherine J.; Costantini, Katelyn M.; Swanik, C. Buz; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, 349 STAR Tower,100 Discovery Blvd, Newark, DE 19716 USA; [Hunzinger, Katherine J.; Swanik, C. Buz; Buckley, Thomas A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE USA; [Caccese, Jaclyn B.] Ohio State Univ, Sch Hlth & Rehabil Sci, Coll Med, Columbus, OH 43210 USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 349 STAR Tower,100 Discovery Blvd, Newark, DE 19716 USA.	khunzing@udel.edu; jaclyn.Caccese@osumc.edu; kcostan@udel.edu; cswanik@udel.edu; TBuckley@UDel.edu	Hunzinger, Katherine J./AAJ-6332-2020	Hunzinger, Katherine/0000-0002-4599-8543; Caccese, Jaclyn/0000-0003-2329-3603	University of Delaware Unidel Distinguished Graduate Scholars Fellowship	This publication was made possible and funded in part by the University of Delaware Unidel Distinguished Graduate Scholars Fellowship.	Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Andersen MH, 2019, SCAND J PUBLIC HEALT, V47, P832, DOI 10.1177/1403494818791405; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Bohr AD, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119868658; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Caccese JB, 2020, NEUROLOGY, V95, pE2935, DOI 10.1212/WNL.0000000000010672; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2020, INT J SPORTS MED, V41, P616, DOI 10.1055/a-1141-3553; Caccese JB, 2020, SPORTS MED, V50, P1377, DOI 10.1007/s40279-020-01261-4; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Davies MAM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12130-y; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; Deshpande SK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229978; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Dong EW, 2013, LEISURE STUD, V32, P219, DOI 10.1080/02614367.2012.748089; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gaulton TG, 2020, AM J EPIDEMIOL, V189, P592, DOI 10.1093/aje/kwz260; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Gouttebarge V, 2018, EUR J SPORT SCI, V18, P1004, DOI 10.1080/17461391.2018.1466914; Griffin SA, 2021, BRIT J SPORT MED, V55, P319, DOI 10.1136/bjsports-2020-102085; Guddal MH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028555; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hind K, 2020, SPORTS MED, V50, P2051, DOI 10.1007/s40279-020-01310-y; Howell DR, 2020, J ATHL TRAINING, V55, P1174, DOI 10.4085/1062-6050-0536.19; Hunzinger KJ, 2021, J SCI MED SPORT, V24, P368, DOI 10.1016/j.jsams.2020.10.013; Hunzinger KJ., 2020, BMJ MIL HLTH; Iverson GL., CLIN J SPORT MED; Iverson GL., J NEUROTRAUM, V38, P538; Iverson GL., CLIN J SPORT MED, DOI [10.1097/JSM.0000000000000898, DOI 10.1097/JSM.0000000000000898]; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lempke LB, 2021, HEALTH PROMOT PRACT, V22, P649, DOI 10.1177/1524839920920289; Manning KY, 2020, NEUROLOGY, V95, pE402, DOI 10.1212/WNL.0000000000009821; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Peck KY, 2013, SPORTS HEALTH, V5, P327, DOI 10.1177/1941738113487165; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stone Arthur A., 1999, SCI SELF REPORT IMPL; Symons GF, 2020, J NEUROTRAUM, V37, P792, DOI 10.1089/neu.2019.6884; Thomas ML, 2016, J CLIN PSYCHIAT, V77, pE1019, DOI 10.4088/JCP.16m10671; USA Rugby, 2019, USA RUGB MEMB STATS USA RUGB MEMB STATS; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; World Rugby, 2020, LAWS RUGB UN GAM LAWS RUGB UN GAM; World Rugby, 2017, WORLD RUGB YEAR REV; Zuckerman Scott L, 2020, Concussion, V5, pCNC75, DOI 10.2217/cnc-2020-0006	60	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	SEP	2021	53	9					1895	1902		10.1249/MSS.0000000000002657			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	TZ6KC	WOS:000684578600011	33731652				2022-02-06	
J	Jasinovic, T; Burma, JS; Cameron, B; Lun, V; van Rassel, CR; Sutter, B; Wiley, JP; Schneider, KJ				Jasinovic, Tin; Burma, Joel S.; Cameron, Ben; Lun, Victor; van Rassel, Cody R.; Sutter, Bonnie; Wiley, J. Preston; Schneider, Kathryn J.			The effect of high-intensity physical exertion on measures of cervical spine, vestibular/ocular-motor screening, and vestibulo-ocular reflex function in university level collision and combative sport athletes	PHYSICAL THERAPY IN SPORT			English	Article						Exertion; Cervical spine; Vestibular; ocular-motor screening; Vestibulo-ocular reflex	EXERCISE; CONCUSSION; CONVERGENCE; RELIABILITY; HEALTH; INJURY	Objectives: To examine how high-intensity physical exertion affects clinical measures of cervical spine (CSp), vestibular/ocular motor screen (VOMS), and vestibulo-ocular reflex (VOR) function. Design: Case series. Setting: Sports Medicine Centre. Participants: A total of 37 athletes consented to participate (22 rugby, 15 wrestling; 9 men, 28 women; median age = 19 years [range 17-23 years]). Main outcome measures: Outcome measures included tests of CSp (cervical flexor endurance, head perturbation test, cervical flexion rotation test and anterolateral strength), VOR (head thrust test and dynamic visual acuity [DVA]), and a quantified version of the VOMS. These metrics were assessed prior to and after completing the 30-15 Intermittent Fitness Test. Bland-Altman plots and Wilcoxon signed-rank tests were utilized to analyze the data using an alpha of p < 0.004. Results: Cervical anterolateral strength (kg) was reduced post-exertion on the left (z = 3.87; p < 0.001), but not on the right between conditions (z =-1.49; p = 0.14). Athletes reported increased dizziness (z =-3.55; p = 0.004) and had reduced DVA following exertion (z =-2.78; p 0.001). All other metrics were not significantly different following exertion (p 0.011). Conclusion: Reduced performance on DVA, decreased left-anterolateral strength, and increased dizziness occurred following high-intensity exertion in varsity collision and combative athletes, which has implications for sideline screening for sport-related concussion. (c) 2021 Published by Elsevier Ltd.	[Jasinovic, Tin; Cameron, Ben; Lun, Victor; Wiley, J. Preston] Univ Calgary, Cumming Sch Med, Dept Family Med, Calgary, AB, Canada; [Burma, Joel S.; van Rassel, Cody R.; Wiley, J. Preston; Schneider, Kathryn J.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Burma, Joel S.; Schneider, Kathryn J.] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada; [Cameron, Ben; Lun, Victor; Sutter, Bonnie; Wiley, J. Preston; Schneider, Kathryn J.] Univ Calgary, Sport Med Ctr, Fac Kinesiol, Calgary, AB, Canada; [Schneider, Kathryn J.] Alberta Childrens Hosp Res Inst, Cumming Sch Med, Calgary, AB, Canada		Schneider, KJ (corresponding author), Fac Kinesiol, Sport Injury Prevent Res Ctr, KNB 3300D,2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kjschnei@ucalgary.ca		Lun, Victor/0000-0002-3122-474X; Burma, Joel/0000-0001-9756-5793	Canadian Academy of Sport Medicine Research Fund	The study was supported by the Canadian Academy of Sport Medicine Research Fund [no grant number given].	Abraham Neethu G, 2015, Oman J Ophthalmol, V8, P14, DOI 10.4103/0974-620X.149856; Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; Ando S, 2013, EXERC SPORT SCI REV, V41, P87, DOI 10.1097/JES.0b013e318259ad37; Balasundaram AP, 2017, SCAND J MED SCI SPOR, V27, P2002, DOI 10.1111/sms.12844; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buchheit M, 2008, J STRENGTH COND RES, V22, P365, DOI 10.1519/JSC.0b013e3181635b2e; Burma JS, 2021, BRAIN INJURY, V35, P248, DOI 10.1080/02699052.2021.1871953; Burma JS, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14467; Burma JS, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14367; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Crosbie J, 2008, CLIN BIOMECH, V23, P184, DOI 10.1016/j.clinbiomech.2007.09.012; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eddy R, 2020, CLIN J SPORT MED, V30, P239, DOI 10.1097/JSM.0000000000000586; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Freitas SMSF, 2009, HUM MOVEMENT SCI, V28, P169, DOI 10.1016/j.humov.2009.01.003; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Hall TM, 2008, J MANIP PHYSIOL THER, V31, P293, DOI 10.1016/j.jmpt.2008.03.012; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Lindsey J., 2017, ATHLETIC TRAINING SP, V9, P177, DOI [10.3928/19425864-20170420-03, DOI 10.3928/19425864-20170420-03]; Matsuki K, 2011, J SHOULDER ELB SURG, V20, P659, DOI 10.1016/j.jse.2010.09.012; Millslagle D, 2005, PERCEPT MOTOR SKILL, V101, P657, DOI 10.2466/pms.101.2.657-664; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Myers K J, 1976, J Am Optom Assoc, V47, P515; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; R Core Team, R LANG ENV STAT COMP; Ratka J., 2020, BRAIN INJURY, V34, P110, DOI DOI 10.1080/02699052.2019.1682194; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Schneider KJ, 2019, MUSCULOSKEL SCI PRAC, V42, P140, DOI 10.1016/j.msksp.2019.05.007; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V48, P974, DOI 10.2519/jospt.2018.8258; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; *STATACORP, STATA STAT SOFTW REL; Susco TM, 2004, J ATHL TRAINING, V39, P241; Teyhen D. S., 2008, J ORTHOP SPORT PHYS, V38, pA1, DOI DOI 10.2519/jospt.2008.0303; Thomson K, 2009, J SPORT SCI MED, V8, P259; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Vera J, 2017, OPTOMETRY VISION SCI, V94, P797, DOI 10.1097/OPX.0000000000001105; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; WOODS RL, 1995, OPHTHAL PHYSL OPT, V15, P5, DOI 10.1046/j.1475-1313.1995.9592786.x	40	1	1	2	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	SEP	2021	51						36	44		10.1016/j.ptsp.2021.06.008			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	UL6XT	WOS:000692792500006	34225057				2022-02-06	
J	Lehrner, A; Hildebrandt, T; Bierer, LM; Flory, JD; Bader, HN; Makotkine, I; Yehuda, R				Lehrner, Amy; Hildebrandt, Tom; Bierer, Linda M.; Flory, Janine D.; Bader, Heather N.; Makotkine, Iouri; Yehuda, Rachel			A randomized, double-blind, placebo-controlled trial of hydrocortisone augmentation of Prolonged Exposure for PTSD in US combat veterans	BEHAVIOUR RESEARCH AND THERAPY			English	Article						Posttraumatic stress disorder; Cognitive behavioral therapy; Glucocorticoids; mTBI; Hydrocortisone	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PERIPHERAL MONONUCLEAR LEUKOCYTES; CORTISOL; ADULTS; GLUCOCORTICOIDS; PSYCHOTHERAPY; EXTINCTION; VALIDATION; RETENTION	Objective: Cognitive behavioral therapies such as Prolonged Exposure (PE) are considered first line treatments for posttraumatic stress disorder (PTSD). Nonetheless, many continue to experience significant symptoms following treatment and there is interest in enhancing treatment effectiveness. Glucocorticoid alterations in PTSD are well documented, and these steroids have been shown to enhance extinction learning. Methods: Augmentation of PE with the synthetic glucocorticoid hydrocortisone (HCORT) was tested in a randomized, double-blind, placebo-controlled trial in 60 veterans of wars in Iraq or Afghanistan with PTSD (NCT01525680). Participants ingested 30 mg oral HCORT or placebo 30 min prior to exposure sessions. Primary outcome measure: PTSD severity assessed by the CAPS; secondary outcome measures: self reported PTSD symptoms assessed by the PDS and depression assessed by the BDI; all administered at pretreatment, posttreatment, and 3-month follow up. Results: Across conditions, there was a robust effect of PE over time. An intent-to-treat analysis showed that HCORT did not measurably improve PTSD symptoms or secondary outcomes. However, exploratory analyses indicated that veterans with mild TBI exposure and current postconcussive symptoms showed a greater reduction in hyperarousal symptoms following PE treatment with HCORT augmentation. Additionally, veterans with higher baseline glucocorticoid sensitivity showed a greater reduction in avoidance symptoms with HCORT augmentation. Conclusions: Treatment matching based on cognitive or biological vulnerabilities might lead to greater efficacy of PE with glucocorticoid augmentation.	[Lehrner, Amy; Bierer, Linda M.; Flory, Janine D.; Bader, Heather N.; Makotkine, Iouri; Yehuda, Rachel] James J Peters Vet Affairs Med Ctr, Mental Hlth Patient Care Ctr, Bronx, NY 10468 USA; [Lehrner, Amy; Hildebrandt, Tom; Bierer, Linda M.; Flory, Janine D.; Bader, Heather N.; Makotkine, Iouri; Yehuda, Rachel] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA		Lehrner, A (corresponding author), James J Peters Vet Affairs Med Ctr, 130 West Kingsbridge Rd,526 OOMH PTSD, Bronx, NY 10468 USA.	amy.lehrner@va.gov			U.S. Department of DefenseUnited States Department of Defense [W81XWH1020072]	This work was supported by the U.S. Department of Defense (W81XWH1020072) .	Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bentz D, 2010, J ANXIETY DISORD, V24, P223, DOI 10.1016/j.janxdis.2009.10.011; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Blake DD, 1998, CLIN ADM PTSD SCAL D; Botella C, 2015, NEUROPSYCH DIS TREAT, V11, P2533, DOI 10.2147/NDT.S89542; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brueckner AH, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0455-0; Cusack K, 2016, CLIN PSYCHOL REV, V43, P128, DOI 10.1016/j.cpr.2015.10.003; Daskalakis NP, 2013, ENDOCRIN METAB CLIN, V42, P503, DOI 10.1016/j.ecl.2013.05.004; de Kleine RA, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21626; de Kleine RA, 2012, BIOL PSYCHIAT, V71, P962, DOI 10.1016/j.biopsych.2012.02.033; de Quervain D, 2019, PSYCHOPHARMACOLOGY, V236, P183, DOI 10.1007/s00213-018-5116-0; de Quervain D, 2017, NAT REV NEUROSCI, V18, P7, DOI 10.1038/nrn.2016.155; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Feingold A, 2015, J CONSULT CLIN PSYCH, V83, P157, DOI 10.1037/a0037721; Flanagan JC, 2018, J PSYCHIATR RES, V98, P64, DOI 10.1016/j.jpsychires.2017.12.014; Flory JD, 2015, BIOL PSYCHIAT, V78, pE5, DOI 10.1016/j.biopsych.2015.02.003; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Haagen JFG, 2015, CLIN PSYCHOL REV, V40, P184, DOI 10.1016/j.cpr.2015.06.008; Hamblen JL, 2019, PSYCHOTHERAPY, V56, P359, DOI 10.1037/pst0000231; Het S, 2005, PSYCHONEUROENDOCRINO, V30, P771, DOI 10.1016/j.psyneuen.2005.03.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hooper LM, 2011, J LOSS TRAUMA, V16, P258, DOI 10.1080/15325024.2011.572035; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; Kehle-Forbes SM, 2016, PSYCHOL TRAUMA-US, V8, P107, DOI 10.1037/tra0000065; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kircanski K, 2012, PSYCHOL SCI, V23, P1086, DOI 10.1177/0956797612443830; Kitchiner NJ, 2019, EUR J PSYCHOTRAUMATO, V10, DOI 10.1080/20008198.2019.1684226; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lee DJ, 2016, DEPRESS ANXIETY, V33, P792, DOI 10.1002/da.22511; Meuret AE, 2016, PSYCHONEUROENDOCRINO, V74, P197, DOI 10.1016/j.psyneuen.2016.09.008; Michopoulos V, 2017, PSYCHONEUROENDOCRINO, V83, P65, DOI 10.1016/j.psyneuen.2017.05.023; Morina N, 2014, CLIN PSYCHOL REV, V34, P249, DOI 10.1016/j.cpr.2014.03.002; Pineles SL, 2016, J ABNORM PSYCHOL, V125, P349, DOI 10.1037/abn0000138; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; Sheehan D., 2009, MINI INT NEUROPSYCHI; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; van Ast VA, 2013, PSYCHONEUROENDOCRINO, V38, P1874, DOI 10.1016/j.psyneuen.2013.06.012; van Gelderen MJ, 2020, PSYCHOTHER PSYCHOSOM, V89, P215, DOI 10.1159/000505977; Varker T, 2020, CLIN PSYCHOL-SCI PR, V27, DOI 10.1111/cpsp.12355; Wilcox RR, 2003, PSYCHOL METHODS, V8, P254, DOI 10.1037/1082-989X.8.3.254; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Yehuda R, 2004, BIOL PSYCHIAT, V55, P1110, DOI 10.1016/j.biopsych.2004.02.010; Yehuda R, 2003, J PSYCHIATR RES, V37, P471, DOI 10.1016/S0022-3956(03)00073-6; Yehuda R, 2015, PSYCHONEUROENDOCRINO, V51, P589, DOI 10.1016/j.psyneuen.2014.08.004; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x; Yehuda R, 2009, J PSYCHIATR RES, V43, P877, DOI 10.1016/j.jpsychires.2008.12.003	53	1	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-7967	1873-622X		BEHAV RES THER	Behav. Res. Ther.	SEP	2021	144								103924	10.1016/j.brat.2021.103924			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	TQ7VK	WOS:000678487900021	34298438				2022-02-06	
J	Levy, Y; Bian, KW; Patterson, L; Ouckama, R; Mao, HJ				Levy, Yanir; Bian, Kewei; Patterson, Luke; Ouckama, Ryan; Mao, Haojie			Head Kinematics and Injury Metrics for Laboratory Hockey-Relevant Head Impact Experiments	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Brain; Biomechanics; Mild traumatic brain injury; Concussion; Helmet; Impact; Sports	TRAUMATIC BRAIN-INJURY; STRAIN RESPONSES; AXONAL DAMAGE; PERFORMANCE; SYSTEM	Investigating head responses during hockey-related blunt impacts and hence understanding how to mitigate brain injury risk from such impacts still needs more exploration. This study used the recently developed hockey helmet testing methodology, known as the Hockey Summation of Tests for the Analysis of Risk (Hockey STAR), to collect 672 laboratory helmeted impacts. Brain strains were then calculated from the according 672 simulations using the detailed Global Human Body Models Consortium (GHBMC) finite element head model. Experimentally measured head kinematics and brain strains were used to calculate head/brain injury metrics including peak linear acceleration, peak rotational acceleration, peak rotational velocity, Gadd Severity Index (GSI), Head Injury Criteria (HIC15), Generalized Acceleration Model for Brain Injury Threshold (GAMBIT), Brain Injury Criteria (BrIC), Universal Brain Injury Criterion (UBrIC), Diffuse Axonal Multi-Axis General Equation (DAMAGE), average maximum principal strain (MPS) and cumulative strain damage measure (CSDM). Correlation analysis of kinematics-based and strain-based metrics highlighted the importance of rotational velocity. Injury metrics that use rotational velocity correlated highly to average MPS and CSDM with UBrIC yielding the strongest correlation. In summary, a comprehensive analysis for kinematics-based and strain-based injury metrics was conducted through a hybrid experimental (672 impacts) and computational (672 simulations) approach. The results can provide references for adopting brain injury metrics when using the Hockey STAR approach and guide ice hockey helmet designs that help reduce brain injury risks.	[Levy, Yanir; Mao, Haojie] Western Univ, Sch Biomed Engn, 1151 Richmond St, London, ON N6A 3K7, Canada; [Bian, Kewei; Patterson, Luke; Mao, Haojie] Western Univ, Fac Engn, Dept Mech & Mat Engn, 1151 Richmond St, London, ON N6A 3K7, Canada; [Ouckama, Ryan] Bauer Hockey Ltd, 60 Rue Jean Paul Cayer, Blainville, PQ J7C 0N9, Canada		Mao, HJ (corresponding author), Western Univ, Sch Biomed Engn, 1151 Richmond St, London, ON N6A 3K7, Canada.	hmao8@uwo.ca	Mao, Haojie/Q-7514-2018	Mao, Haojie/0000-0002-7563-9234	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); Bauer Hockey Ltd.; New Frontiers in Research Fund-Exploration (NFRF-E); Canada Research Chairs programCanada Research Chairs	We acknowledge NSERC and Bauer Hockey Ltd. for providing funding through the Engage program and the Discovery program, the New Frontiers in Research Fund-Exploration (NFRF-E) and the Canada Research Chairs program. We thank Mr. Marco Gallone for help with automating the kinematics processing pipeline. We thank Marie-Claude Genereux for proofreading and suggestions.	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Ashare A. B, 2000, CERTIFICATION PROTEC, P72; Bailey AM, 2020, ANN BIOMED ENG, V48, P2566, DOI 10.1007/s10439-020-02626-6; Bailey AM, 2020, ANN BIOMED ENG, V48, P2531, DOI 10.1007/s10439-020-02627-5; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bian KW, 2020, BIOMECH MODEL MECHAN, V19, P2323, DOI 10.1007/s10237-020-01341-4; Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Brodie I. K, 1993, SAFETY ICE HOCKEY 2; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fahlstedt M, 2021, ANN BIOMED ENG, V49, P1097, DOI 10.1007/s10439-020-02703-w; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; Gerber C, 2001, BRIT J SPORT MED, V35, P368; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T, 2008, J ASTM INT, V6, P1; Kleiven, 2002, FINITE ELEMENT MODEL; Knowles BM, 2017, ANN BIOMED ENG, V45, P2146, DOI 10.1007/s10439-017-1848-y; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mihalik JP, 2020, ANN BIOMED ENG, V48, P104, DOI 10.1007/s10439-019-02343-9; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Newman J.A., 1986, P INT IRCOBI C ZUR S; Nyquist GW, 1974, SAE T, V83, P398; Patrick L., 1963, 7 STAPP CAR CRASH C, P470; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yang J., 2005, INT J VEH SAF, V1, P100, DOI [10.1504/IJVS.2005.007540, 10.1504/ijvs.2005.007540]; Yao JF, 2008, SAFETY SCI, V46, P1103, DOI 10.1016/j.ssci.2007.06.021; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0	47	1	1	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2914	2923		10.1007/s10439-021-02855-3		SEP 2021	10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000691932900002	34472000				2022-02-06	
J	Liu, WX; Ye, QS; Xi, WH; Li, Y; Zhou, XH; Wang, Y; Ye, ZH; Hai, KR				Liu, Wenxun; Ye, Qingshan; Xi, Wenhua; Li, Yan; Zhou, Xiaohong; Wang, Yun; Ye, Zhenhai; Hai, Kerong			The ERK/CREB/PTN/syndecan-3 pathway involves in heparin-mediated neuro-protection and neuro-regeneration against cerebral ischemia-reperfusion injury following cardiac arrest	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Heparin; Cardiac arrest; Cerebral ischemia-reperfusion injury; PTN; ERK; CREB	MOLECULAR-WEIGHT HEPARIN; TRAUMATIC BRAIN-INJURY; PLEIOTROPHIN; RECOVERY; SURVIVAL; GROWTH	Background: Heparin, a commonly used anticoagulant, has been found to improve cerebral ischemia-reperfusion injury (CIR-CA) following cardiopulmonary resuscitation (CPR). Here, we aimed to explore the role of pleiotrophin (PTN)/syndecan-3 pathway in heparin therapy for CIR-CA. Materials and methods: The CA-CPR model was constructed in Sprague-Dawley (SD) rats, which were treated with low molecular weight heparin, and the neurological changes and brain histopathological changes were evaluated. For in-vitro experiments, the ischemic injury model of primary neurons was established by oxygen and glucose deprivation (OGD), and the neuron regeneration was detected via the Cell counting Kit-8 (CCK8) method, flow cytometry and microscopy. CREB antagonist (KG-501), ERK antagonist (PD98059) and si-PTN were used respectively to inhibit the expression of CREB, ERK and PTN in cells, so as to explore the role of heparin in regulating neuronal regeneration. Results: Compared with the sham rats, the neurological deficits and cerebral edema of CA-CPR rats were significantly improved after heparin treatment. Heparin also attenuated OGD-mediated neuronal apoptosis and promoted neurite outgrowth in vitro. Moreover, heparin attenuated CA-CPR-mediated neuronal apoptosis and microglial neuroinflammation. In terms of the mechanism, heparin upregulated the expression of ERK, CREB, NF200, BDNF, NGF, PTN and syndecan-3 in the rat brains. Inhibition of ERK, CREB and interference with PTN expression notably weakened the heparin-mediated neuroprotective effects and restrained the expression of ERK/CREB and PTN/syndecan-3 pathway. Conclusion: Heparin attenuates the secondary brain injury induced by CA-CPR through regulating the ERK/CREBmediated PTN/syndecan-3 pathway.	[Liu, Wenxun; Xi, Wenhua; Li, Yan] Ningxia Med Univ, Yinchuan 750004, Ningxia, Peoples R China; [Liu, Wenxun; Ye, Qingshan; Zhou, Xiaohong; Wang, Yun; Ye, Zhenhai; Hai, Kerong] Peoples Hosp Ningxia Hui Autonomous Reg, Dept Anesthesiol, Yinchuan 750002, Ningxia, Peoples R China; [Liu, Wenxun; Ye, Qingshan; Wang, Yun; Hai, Kerong] Ningxia Anesthesia Clinincal Med Res Ctr, Yinchuan 750002, Ningxia, Peoples R China		Hai, KR (corresponding author), Peoples Hosp Ningxia Hui Autonomous Reg, Dept Anesthesiol, Yinchuan 750002, Ningxia, Peoples R China.	haikerong119@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82060342]; Ningxia Natural Science Foundation of China [2020AAC03331]; Fourth Batch of Ningxia Youth Talents Supporting Program [TJGC2019087]	This work was supported by National Natural Science Foundation of China (No. 81760339) ; and National Natural Science Foundation of China (No. 82060342) ; and Ningxia Natural Science Foundation of China (No. 2020AAC03331) ; and The Fourth Batch of Ningxia Youth Talents Supporting Program (No. TJGC2019087) .	Arokiasamy S, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03031; Bartolotti N, 2019, BRAIN BEHAV IMMUN, V78, P9, DOI 10.1016/j.bbi.2019.01.004; Bertram S, 2019, EXP BRAIN RES, V237, P2983, DOI 10.1007/s00221-019-05644-6; Cherry Brandon H, 2015, World J Crit Care Med, V4, P1, DOI 10.5492/wjccm.v4.i1.1; Gaudier-Diaz MM, 2018, PHYSIOL BEHAV, V194, P437, DOI 10.1016/j.physbeh.2018.06.012; HALLENBECK JM, 1982, ANN NEUROL, V12, P145, DOI 10.1002/ana.410120204; Hida H, 2003, EUR J NEUROSCI, V17, P2127, DOI 10.1046/j.1460-9568.2003.02661.x; Jiang MR, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01933-y; Jonas S, 1997, ANN NY ACAD SCI, V825, P389, DOI 10.1111/j.1749-6632.1997.tb48449.x; Jou C, 2020, J INTENSIVE CARE MED, V35, P219, DOI 10.1177/0885066618817518; Karonova T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092518; Khattar NK, 2020, ACTA NEUROCHIR SUPPL, V127, P15, DOI 10.1007/978-3-030-04615-6_3; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Li T, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/5403045; Marchionini DM, 2007, BRAIN RES, V1147, P77, DOI 10.1016/j.brainres.2007.02.028; Mi YS, 2017, FASEB J, V31, P4998, DOI 10.1096/fj.201700400RR; Mokrushin AA, 2012, B EXP BIOL MED+, V152, P684, DOI 10.1007/s10517-012-1606-y; Nagata K, 2017, J TRAUMA ACUTE CARE, V83, P406, DOI 10.1097/TA.0000000000001590; Neigh GN, 2005, J CEREBR BLOOD F MET, V25, P1424, DOI 10.1038/sj.jcbfm.9600137; Onishi A, 2016, FRONT BIOSCI-LANDMRK, V21, P1372, DOI 10.2741/4462; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; Peysselon F, 2014, MATRIX BIOL, V35, P73, DOI 10.1016/j.matbio.2013.11.001; Sekhon MS, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1670-9; Simard JM, 2012, TRANSL STROKE RES, V3, pS155, DOI 10.1007/s12975-012-0166-9; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Tarantino G, 2013, ANN MED, V45, P348, DOI 10.3109/07853890.2013.770333; Tare RS, 2002, BIOCHEM BIOPH RES CO, V298, P324, DOI 10.1016/S0006-291X(02)02456-7; Teng L, 2019, WORLD NEUROSURG, V127, pE624, DOI 10.1016/j.wneu.2019.03.232; Torri G, 2018, MOLECULES, V23, DOI 10.3390/molecules23020293; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Walenga JM, 2013, CRIT REV ONCOL HEMAT, V88, P1, DOI 10.1016/j.critrevonc.2013.06.007; Wang XP, 2019, FRONT BIOSCI-LANDMRK, V24, P859, DOI 10.2741/4756; Wu B, 2006, BIOCHEM BIOPH RES CO, V347, P656, DOI 10.1016/j.bbrc.2006.06.117; Xiang YX, 2016, BIOMED REP, V5, P11, DOI 10.3892/br.2016.677; Xie WJ, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120270; Xu L, 2019, INT J MOL MED, V43, P1879, DOI 10.3892/ijmm.2019.4094; Ye QS, 2019, PHARM BIOL, V57, P519, DOI 10.1080/13880209.2019.1648524; Zhang BY, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106729; Zhao P, 2018, NEUROCHEM RES, V43, P1575, DOI 10.1007/s11064-018-2572-1; Zhong XM, 2019, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00772	41	1	1	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	SEP	2021	98								107689	10.1016/j.intimp.2021.107689			12	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	YP2ZH	WOS:000748494400005	34153666				2022-02-06	
J	Ma, SS; Zhou, JK; Huang, TJ; Zhang, ZK; Xing, Q; Zhou, XK; Zhang, K; Yao, MH; Cheng, T; Wang, XF; Wen, XJ; Guan, FX				Ma, Shanshan; Zhou, Jiankang; Huang, Tuanjie; Zhang, Zhenkun; Xing, Qu; Zhou, Xinkui; Zhang, Kun; Yao, Minghao; Cheng, Tian; Wang, Xiaofeng; Wen, Xuejun; Guan, Fangxia			Sodium alginate/collagen/stromal cell-derived factor-1 neural scaffold loaded with BMSCs promotes neurological function recovery after traumatic brain injury	ACTA BIOMATERIALIA			English	Article						Sustained release; Traumatic brain injury; Neurogenesis; Sodium alginate; collagen; stromal cell-derived factor1 hydrogel; Bone marrow-derived mesenchymal stem cells	MESENCHYMAL STEM-CELLS; INJECTABLE HYDROGEL; COLLAGEN SCAFFOLDS; TRANSPLANTATION; DIFFERENTIATION; THERAPY; NEUROPROTECTION; FACTOR-1-ALPHA; MIGRATION; ALGINATE	Stem cell therapy is promising for neural repair in devastating traumatic brain injury (TBI). However, the low survival and differentiation rates of transplanted stem cells are main obstacles to efficient stem cell therapy in TBI. Stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 are key factors that regulate the survival, recruitment, and differentiation of stem cells. Herein, we synthesized a sodium alginate (SA)/collagen type I (Col)/SDF-1 hydrogel and investigated whether the SA/Col/SDF-1 hydrogel loaded with bone marrow-derived mesenchymal stem cells (BMSCs) had therapeutic effects on a TBI model. Our results showed that the SA/Col/SDF-1 scaffold could stably release SDF-1 and provide biocompatible and biodegradable microenvironment for the survival, migration, and neuronal differentiation of BMSCs in vitro . In a rat model of TBI, the SA/Col/SDF-1 hydrogel loaded with BMSCs significantly ameliorated motor and cognition dysfunction and relieved anxiety and depressive-like behaviors. In addition, the BMSCs/SA/Col/SDF-1 scaffold reduced brain lesions and neuronal cell death and mitigated neuroinflammation. Further studies demonstrated that the BMSCs/SA/Col/SDF-1 hydrogel promoted the migration of BMSCs in the lesions and partly enhanced neurogenesis by activating the SDF-1/CXCR4-mediated FAK/PI3K/AKT pathway. Taken together, our results indicate that the SA/Col/SDF-1 scaffold loaded with BMSCs exerts neuroreparative effects in a TBI rat model, and thus, it may serve as an alternative neural regeneration scaffold for brain injury repair.	[Ma, Shanshan; Zhou, Jiankang; Huang, Tuanjie; Zhang, Zhenkun; Xing, Qu; Zhou, Xinkui; Zhang, Kun; Yao, Minghao; Guan, Fangxia] Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China; [Ma, Shanshan; Guan, Fangxia] Zhengzhou Univ, Inst Neurosci, Zhengzhou 450052, Henan, Peoples R China; [Cheng, Tian] Zhengzhou Univ, Affiliated Hosp 1, Ctr Stem Cell & Regenerat Med, Zhengzhou 450052, Henan, Peoples R China; [Wang, Xiaofeng] Zhengzhou Univ, Natl Ctr Int Res Micronano Molding Technol, Zhengzhou 450001, Henan, Peoples R China; [Wen, Xuejun] Virginia Commonwealth Univ, Sch Engn, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA		Ma, SS; Guan, FX (corresponding author), Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China.; Ma, SS; Guan, FX (corresponding author), Zhengzhou Univ, Inst Neurosci, Zhengzhou 450052, Henan, Peoples R China.	mashanshan84@163.com; guanfangxia@126.com			Training Plan for Young Excellent Teachers in Colleges and Universities of Henan [2020GGJS008]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [U2004201]; Central Plains Thousand People Plan of Henan Province [20420 0510 013]; Key R&D and Promotion Projects in Henan Province [202102310211]; Joint Fund for Fostering Talent of NCIR-MMT [MMT2017-04]; Joint Fund for Fostering Talent of HNKL-MMT [MMT2017-04]; Discipline Innovation and Wisdom Introduction Plan of Higher Education in Henan Province [CXJD2021002]	This study was supported by The Training Plan for Young Excellent Teachers in Colleges and Universities of Henan (2020GGJS008) , National Natural Science Foundation of China (U2004201) , Central Plains Thousand People Plan of Henan Province (20420 0510 013) , Key R&D and Promotion Projects in Henan Province (202102310211) , Joint Fund for Fostering Talents of NCIR-MMT & HNKL-MMT (MMT2017-04) , and Discipline Innova-tion and Wisdom Introduction Plan of Higher Education in Henan Province (CXJD2021002) .	Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Addington CP, 2017, MATRIX BIOL, V60-61, P206, DOI 10.1016/j.matbio.2016.09.007; Addington CP, 2015, BIOMATERIALS, V72, P11, DOI 10.1016/j.biomaterials.2015.08.041; Assinck P, 2017, NAT NEUROSCI, V20, P637, DOI 10.1038/nn.4541; Bagno L, 2018, MOL THER, V26, P1610, DOI 10.1016/j.ymthe.2018.05.009; Bittle GJ, 2018, CIRC RES, V123, P288, DOI 10.1161/CIRCRESAHA.117.311206; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Cheng X, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00590; Chu TC, 2017, NEUROSCIENTIST, V23, P627, DOI 10.1177/1073858416685690; Cui YB, 2017, BEHAV BRAIN RES, V320, P291, DOI 10.1016/j.bbr.2016.12.021; Desgres M, 2019, CELL STEM CELL, V25, P594, DOI 10.1016/j.stem.2019.10.001; Duan HM, 2016, ACTA BIOMATER, V45, P182, DOI 10.1016/j.actbio.2016.08.043; Fan BY, 2018, CELL TRANSPLANT, V27, P853, DOI 10.1177/0963689718755778; Fernandez-Serra R, 2020, NEURAL REGEN RES, V15, P783, DOI 10.4103/1673-5374.268891; Guan FX, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1433-4; Guan FX, 2019, PROG NEURO-PSYCHOPH, V95, DOI 10.1016/j.pnpbp.2019.109684; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guo XB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04153-2; Higuchi A, 2019, PROG MATER SCI, V103, P374, DOI 10.1016/j.pmatsci.2019.02.002; Hu TY, 2019, STEM CELL REP, V13, P545, DOI 10.1016/j.stemcr.2019.05.027; Janssens R, 2018, CYTOKINE GROWTH F R, V44, P51, DOI 10.1016/j.cytogfr.2018.10.004; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Li JR, 2020, J TISSUE ENG REGEN M, V14, P1261, DOI 10.1002/term.3098; Liu M, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.14; Ma JH, 2015, NEUROL RES, V37, P50, DOI 10.1179/1743132814Y.0000000399; Ma SS, 2020, ACS CHEM NEUROSCI, V11, P2590, DOI 10.1021/acschemneuro.0c00268; Madl CM, 2018, NATURE, V557, P335, DOI 10.1038/s41586-018-0089-z; Moshayedi P, 2016, BIOMATERIALS, V105, P145, DOI 10.1016/j.biomaterials.2016.07.028; Newsom JP, 2019, ACTA BIOMATER, V88, P32, DOI 10.1016/j.actbio.2019.02.011; Nih LR, 2018, NAT MATER, V17, P642, DOI 10.1038/s41563-018-0083-8; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Shen XF, 2016, BIOMATERIALS, V106, P205, DOI 10.1016/j.biomaterials.2016.08.023; Shi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep19077; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Shichinohe H, 2008, STROKE, V39, P660; Staff NP, 2019, MAYO CLIN PROC, V94, P892, DOI 10.1016/j.mayocp.2019.01.001; Toda T, 2019, MOL PSYCHIATR, V24, P67, DOI 10.1038/s41380-018-0036-2; Venkatesan J, 2015, INT J BIOL MACROMOL, V72, P269, DOI 10.1016/j.ijbiomac.2014.07.008; Wang XX, 2016, MOL CELLS, V39, P418, DOI 10.14348/molcells.2016.2345; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Xu L, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00498; Yu JR, 2020, ACTA BIOMATER, V108, P67, DOI 10.1016/j.actbio.2020.03.015; Yu Y, 2015, ARTHRITIS RHEUMATOL, V67, P1274, DOI 10.1002/art.39049; Zamani M, 2015, J COLLOID INTERF SCI, V451, P144, DOI 10.1016/j.jcis.2015.04.005; Zamproni LN, 2017, INT J PHARMACEUT, V519, P323, DOI 10.1016/j.ijpharm.2017.01.036; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g; Zhang SL, 2019, MOLECULES, V24, DOI 10.3390/molecules24183282; Zhang ZK, 2021, CELL TISSUE RES, V383, P809, DOI 10.1007/s00441-020-03321-7; Zhou JK, 2019, E-POLYMERS, V19, P87, DOI 10.1515/epoly-2019-0011	52	1	1	16	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	SEP 1	2021	131						185	197		10.1016/j.actbio.2021.06.038			13	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	UA6HD	WOS:000685260200002	34217903				2022-02-06	
J	Manivannan, S; Baskaran, R; Fisher, J; Tasker, I; Zaben, M				Manivannan, Susruta; Baskaran, Ravanth; Fisher, Jack; Tasker, Imogen; Zaben, Malik			Current Status of Websites Offering Information to Patients with Traumatic Brain Injury and Caregivers: Time for Reform?	WORLD NEUROSURGERY			English	Article						Health information; Information seeking; -Internet; Traumatic brain injury	WORLD-WIDE-WEB; HEALTH INFORMATION; QUALITY; ONLINE; CARE; INTERNET; ACCESS	OBJECTIVE: Traumatic brain injury (TBI) is a global public health problem, causing long-term burden to patients and caregivers. Patients and their families often resort to seeking online information regarding TBI management while awaiting formal health care consultations. Although this information is accessible and immediately available, little is known about the quality of online resources. We evaluated the accessibility, relevance, and readability of information regarding TBI from major online search engines. METHODS: TBI-related search terms were entered into 2 online search engines (Google and Yahoo), and the first 30 websites per search were assessed for eligibility. Quality (DISCERN score, JAMA Benchmark score) and readability (Flesch-Kincaid Grade Level, Flesch Reading Ease Score) were assessed. Associations between search ranking, quality, and readability were evaluated. RESULTS: In total, 202 websites were evaluated with mean DISCERN score 36.5 +/- 9.9/80, signifying poor global quality, and mean JAMA Benchmark score 2.8 +/- 1.1/4. The majority required 9-12 years of education (113/202; 55.9%) according to Flesch-Kincaid Grade Level and categorized as "Difficult" on Flesch Reading Ease Score (94/202; 46.5%). Website quality was not associated with search ranking or readability. CONCLUSIONS: There is a paucity of high-quality online resources for patients with TBI. Herein, we highlight: 1) the importance of guidance from healthcare professionals regarding online-information seeking; and 2) recommendations for the most useful online resources available.	[Manivannan, Susruta] Southampton Gen Hosp, Dept Neurosurg, Southampton, Hants, England; [Baskaran, Ravanth; Fisher, Jack] Cardiff Univ, Sch Med, Cardiff, Wales; [Tasker, Imogen] Univ Birmingham, Sch Biomed Sci, Birmingham, W Midlands, England; [Zaben, Malik] Cardiff Univ, Neurosci & Mental Hlth Res Inst NMHRI, Cardiff, Wales; [Zaben, Malik] Univ Hosp Wales, Dept Neurosurg, Cardiff, Wales		Zaben, M (corresponding author), Cardiff Univ, Neurosci & Mental Hlth Res Inst NMHRI, Cardiff, Wales.; Zaben, M (corresponding author), Univ Hosp Wales, Dept Neurosurg, Cardiff, Wales.	zabenm@cardiff.ac.uk		Baskaran, Ravanth/0000-0002-8012-0322; Fisher, Jack/0000-0001-8941-0951; Tasker, Imogen/0000-0002-3171-5944	Welsh Government through Health and Care Research Wales	Dr. Malik Zaben is a member of the BRAIN Unit, which is funded by the Welsh Government through Health and Care Research Wales.	Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Beck F, 2014, J MED INTERNET RES, V16, P193, DOI 10.2196/jmir.2934; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Cassidy JT, 2016, J BONE JOINT SURG AM, V98, P325, DOI 10.2106/JBJS.N.01189; Charnock D, 2004, HEALTH EDUC RES, V19, P440, DOI 10.1093/her/cyg046; Correa DJ, 2020, EPILEPSIA, V61, P528, DOI 10.1111/epi.16446; Cruz-Oliver DM, 2020, PATIENT EDUC COUNS, V103, P1677, DOI 10.1016/j.pec.2020.03.014; Dams-O'Connor K, 2018, BRAIN INJURY, V32, P431, DOI 10.1080/02699052.2018.1429024; Daraz L, 2019, J GEN INTERN MED, V34, P1884, DOI 10.1007/s11606-019-05109-0; Daraz L, 2018, AM J MED QUAL, V33, P487, DOI 10.1177/1062860617751639; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Engelen MM, 2020, J MED INTERNET RES, V22, DOI 10.2196/17422; Etnel JRG, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00025; Eysenbach G, 2002, BMJ-BRIT MED J, V324, P573, DOI 10.1136/bmj.324.7337.573; Farr JN, 1951, J APPL PSYCHOL, V35, P333, DOI 10.1037/h0062427; Rutten LJF, 2019, PUBLIC HEALTH REP, V134, P617, DOI 10.1177/0033354919874074; Gysels M, 2007, SUPPORT CARE CANCER, V15, P7, DOI 10.1007/s00520-006-0112-z; Haines KL, 2019, J SURG RES, V235, P131, DOI 10.1016/j.jss.2018.09.072; Hart T, 2018, BRAIN INJURY, V32, P1295, DOI 10.1080/02699052.2018.1493226; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Kaufman N, 2010, Int J Clin Pract Suppl, P41, DOI 10.1111/j.1742-1241.2009.02277.x; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Kutner M, 2006, 2006E483 NCES US DEP; Levine DM, 2016, JAMA-J AM MED ASSOC, V316, P538, DOI 10.1001/jama.2016.9124; Litsa T, 2018, IS IT IMPORTANT SEO; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Morahan-Martin JM, 2004, CYBERPSYCHOL BEHAV, V7, P497, DOI 10.1089/cpb.2004.7.497; Pellise F, 2009, EUR SPINE J, V18, pS395, DOI 10.1007/s00586-009-0973-1; Poulin V, 2019, DISABIL REHABIL, V41, P1955, DOI 10.1080/09638288.2018.1451560; Shepperd S, 1999, BMJ-BRIT MED J, V319, P764, DOI 10.1136/bmj.319.7212.764; Silberg WM, 1997, JAMA-J AM MED ASSOC, V277, P1244, DOI 10.1001/jama.277.15.1244; Srikesavan C, 2019, J TELEMED TELECARE, V25, P263, DOI 10.1177/1357633X18768400; Tan SSL, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.5729; Wang XH, 2021, HEALTH COMMUN, V36, P1163, DOI 10.1080/10410236.2020.1748829	35	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2021	153						E419	E427		10.1016/j.wneu.2021.06.140			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	UE5QP	WOS:000687942800036	34229103				2022-02-06	
J	Martin, AM; Almeida, EJ; Starosta, AJ; Hammond, FM; Hoffman, JM; Schwartz, DJ; Fann, JR; Bell, KR; Nakase-Richardson, R				Martin, Aaron M.; Almeida, Emily J.; Starosta, Amy J.; Hammond, Flora M.; Hoffman, Jeanne M.; Schwartz, Daniel J.; Fann, Jesse R.; Bell, Kathleen R.; Nakase-Richardson, Risa			The Impact of Opioid Medications on Sleep Architecture and Nocturnal Respiration During Acute Recovery From Moderate to Severe Traumatic Brain Injury: A TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						opioids; polysomnography; sleep apnea; sleep architecture; traumatic brain injury	AMERICAN ACADEMY; ACUTE-PHASE; APNEA; REHABILITATION; DISTURBANCES; DEPRIVATION; PREDICTORS; PAIN	Objectives: To describe patient and clinical characteristics associated with receipt of opioid medications and identify differences in sleep quality, architecture, and sleep-related respiration between those receiving and not receiving opioid medications. Setting: Acute inpatient rehabilitation care for moderate to severe traumatic brain injury (TBI). Participants: A total of 248 consecutive admissions for inpatient rehabilitation care following moderate to severe TBI (average age of 43.6 years), who underwent level 1 polysomnography (PSG) (average time since injury: 120 days) across 6 sites. Design: Cross-sectional, secondary analyses. Main Measures: The PSG sleep parameters included total sleep time (TST), sleep efficiency (SE), wake after sleep onset, rapid eye movement (REM) latency, sleep staging, and arousal and awakening indices. Respiratory measures included oxygen saturation, central apnea events per hour, obstructive apnea and hypopnea events per hour, and total apnea-hypopnea index. Results: After adjustment for number of prescribed medication classes, those receiving opioid medications on the day of PSG experienced increased TST relative to those not receiving opioid medications (estimated mean difference [EMD] = 31.58; 95% confidence interval [CI], 1.9-61.3). Other indices of sleep did not differ significantly between groups. Among respiratory measures those receiving opioids on the day of PSG experienced increased frequency of central sleep apnea events during total (EMD = 2.92; 95% CI, 0.8-5.0) and non-REM sleep (EMD = 3.37; 95% CI, 1.0-5.7) and higher frequency of obstructive sleep apnea events during REM sleep (EMD = 6.97; 95% CI, 0.1-13.8). Compared with those who did not, receiving opioids was associated with lower oxygen saturation nadir during total sleep (EMD = -3.03; 95% CI, -5.6 to -0.4) and a greater number of oxygen desaturations across REM (EMD = 8.15; 95% CI, 0.2-16.1), non-REM (EMD = 7.30; 95% CI, 0.3-14.4), and total sleep (EMD = 8.01; 95% CI, 0.8-15.2) Greater total apnea-hypopnea index was observed during REM (EMD = 8.13; 95% CI, 0.8-15.5) and total sleep (EMD = 7.26; 95% CI, 0.08-14.4) for those receiving opioids. Conclusion: Opioid use following moderate to severe TBI is associated with an increase in indicators of sleep-related breathing disorders, a modifiable condition that is prevalent following TBI. As sleep-wake disorders are associated with poorer rehabilitation outcomes and opioid medications may frequently be administered following traumatic injury, additional longitudinal investigations are warranted in determining whether a causal relation between opioids and sleep-disordered breathing in those following moderate to severe TBI exists. Given current study limitations, future studies can improve upon methodology through the inclusion of indication for and dosage of opioid medications in this population when examining these associations.	[Martin, Aaron M.; Nakase-Richardson, Risa] James Haley Vet Hosp, Mental Health& Behav Sci Serv, Bruce B Downs BLVD,Bldg 38,A-333, Tampa, FL 33612 USA; [Martin, Aaron M.; Schwartz, Daniel J.; Nakase-Richardson, Risa] Univ S Florida, Dept Psychiat, Div Pulm & SleepMed, Tampa, FL 33612 USA; [Martin, Aaron M.; Schwartz, Daniel J.; Nakase-Richardson, Risa] Univ S Florida, Dept Behav Neurosci, Tampa, FL 33620 USA; [Martin, Aaron M.; Schwartz, Daniel J.; Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Tampa, FL 33620 USA; [Nakase-Richardson, Risa] James Haley Vet Hosp, Def Hlth Agcy Traumat Brain Injury Ctr Excellence, Tampa, FL USA; [Almeida, Emily J.] Craig Hosp, Res Dept, Englewood, CO USA; [Starosta, Amy J.; Hoffman, Jeanne M.] Univ Washington, Dept Rehabil Med, Div Rehabil Psychol, Seattle, WA 98195 USA; [Hammond, Flora M.] Indiana Univ, Dept Physical Med & Rehabil, Indianapolis, IN USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Washington, DC USA; [Bell, Kathleen R.] Univ Texas, Southwestern Med Ctr, Dept Physical Med & Rehabil, Dallas, TX USA		Martin, AM (corresponding author), James Haley Vet Hosp, Mental Health& Behav Sci Serv, Bruce B Downs BLVD,Bldg 38,A-333, Tampa, FL 33612 USA.; Martin, AM (corresponding author), Univ S Florida, Dept Psychiat, Div Pulm & SleepMed, Tampa, FL 33612 USA.; Martin, AM (corresponding author), Univ S Florida, Dept Behav Neurosci, Tampa, FL 33620 USA.; Martin, AM (corresponding author), Univ S Florida, Dept Internal Med, Tampa, FL 33620 USA.	Aaron.Martin2@va.gov; EAlmeida@craighospital.org; starosta@uw.edu; flora.hammond@rhin.com; jeanneh@uw.edu; Daniel.Schwartz3@va.gov; fann@uw.edu; Kathleen.Bell@UTSouthwestern.edu; Risa.Richardson@va.gov			Patient-Centered Outcomes Research Institute (PCORI) AwardPatient-Centered Outcomes Research Institute - PCORI [CER-1511-33005]; VHA Central Office VA TBI Model Systems Program of Research; General Dynamics Information Technology from the Defense Health Agency TBI Center of Excellence [W91YTZ13-C-0015, HT0014-19-C-0004]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB0017]; National Institute on Disability, Independent Living, and Rehabilitation Research (University of Texas Southwestern Medical Center) [90DPTB0013-01-03]; National Institute on Disability, Independent Living, and Rehabilitation Research (Indiana University School of Medicine, Rehabilitation Hospital of Indiana) [90DRTB0002]; National Institute on Disability, Independent Living, and Rehabilitation Research (Division of Rehabilitation Psychology, Department of Rehabilitation Medicine) [90DPTB0008]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health & Human Services: National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)	Research reported in this article was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (CER-1511-33005). This research was sponsored by VHA Central Office VA TBI Model Systems Program of Research; Subcontract from General Dynamics Information Technology (W91YTZ13-C-0015; HT0014-19-C-0004) from the Defense Health Agency TBI Center of Excellence and the National Institute on Disability, Independent Living, and Rehabilitation Research (90DPTB0017; University of Texas Southwestern Medical Center, 90DPTB0013-01-03; Indiana University School of Medicine, Rehabilitation Hospital of Indiana, 90DRTB0002; and Division of Rehabilitation Psychology, Department of Rehabilitation Medicine, University of Washington School of Medicine, 90DPTB0008). The TBI Model Systems is a funded collaboration between the Department of Veterans Affairs and the Department of Health & Human Services: National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). Clinicaltrial.gov RegistrationNumber: NCT03033901.	Ahmad A, 2021, SLEEP MED REV, V58, DOI 10.1016/j.smrv.2021.101441; Alzoubaidi M, 2016, CURR OPIN PULM MED, V22, P545, DOI 10.1097/MCP.0000000000000319; Barshikar S, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0792-4; Beaulieu-Bonneau S, 2017, NEUROPSYCHOL REHABIL, V27, P983, DOI 10.1080/09602011.2016.1162176; Bomyea J, 2016, HEADACHE, V56, P699, DOI 10.1111/head.12799; Brown-Taylor L, 2021, PM&R, V13, P1169, DOI 10.1002/pmrj.12526; Corrigan JD, 2019, ADDICT BEHAV, V90, P143, DOI 10.1016/j.addbeh.2018.10.030; Cosano G, 2016, BRAIN INJURY, V30, P353, DOI 10.3109/02699052.2015.1118767; Dijk Derk-Jan, 2009, J Clin Sleep Med, V5, pS6; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Dimsdale JE, 2007, J CLIN SLEEP MED, V3, P33; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Eckert DJ, 2007, CHEST, V131, P595, DOI 10.1378/chest.06.2287; Fabius TM, 2019, SLEEP BREATH, V23, P57, DOI 10.1007/s11325-018-1654-2; Gavidia R, 2021, J CLIN SLEEP MED, V17, P55, DOI 10.5664/jcsm.8826; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Hassamal S, 2016, AM J ADDICTION, V25, P452, DOI 10.1111/ajad.12424; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P108, DOI 10.1097/HTR.0000000000000206; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Lowe A, 2020, DISABIL REHABIL, V42, P1041, DOI 10.1080/09638288.2018.1516819; Mantua J, 2018, SLEEP MED REV, V41, P61, DOI 10.1016/j.smrv.2018.01.004; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDermott CM, 2003, J NEUROSCI, V23, P9687; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Nakase-Richardson R, 2020, CHEST, V158, P1689, DOI 10.1016/j.chest.2020.03.083; Nakase-Richardson R, 2020, ARCH PHYS MED REHAB, V101, P283, DOI 10.1016/j.apmr.2019.09.019; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Noyes ET, 2021, REHABIL PSYCHOL, V66, P107, DOI 10.1037/rep0000366; Onen SH, 2005, CLIN J PAIN, V21, P422, DOI 10.1097/01.ajp.0000129757.31856.f7; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Pattinson KTS, 2008, BRIT J ANAESTH, V100, P747, DOI 10.1093/bja/aen094; Peever J, 2017, CURR BIOL, V27, pR1237, DOI 10.1016/j.cub.2017.10.026; Philips, 2016, SLEEPW G3 COMP PROGR; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Rosen IM, 2019, J CLIN SLEEP MED, V15, P1671, DOI 10.5664/jcsm.8062; Sandsmark DK, 2016, J HEAD TRAUMA REHAB, V31, P101, DOI 10.1097/HTR.0000000000000217; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; TBI Model Systems National Data and Statistical Center, TRAUMATIC BRAIN INJU; TEASDALE G, 1974, LANCET, V2, P81; Tripathi R, 2020, SLEEP MED, V67, P269, DOI 10.1016/j.sleep.2019.06.012; Vaughn BV, 2015, AASM MANUAL SCORING; Wang D, 2005, CHEST, V128, P1348, DOI 10.1378/chest.128.3.1348; Wang D, 2007, SLEEP MED REV, V11, P35, DOI 10.1016/j.smrv.2006.03.006; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wickwire EM, 2020, J CLIN SLEEP MED, V16, p5S, DOI 10.5664/jcsm.8872; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697	51	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		374	387		10.1097/HTR.0000000000000727			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300016	34489388				2022-02-06	
J	Mecca, CM; Chao, DM; Yu, GL; Feng, Y; Segel, I; Zhang, ZY; Rodriguez-Garcia, DM; Pawela, CP; Hillard, CJ; Hogan, QH; Pan, B				Mecca, Christina M.; Chao, Dongman; Yu, Guoliang; Feng, Yin; Segel, Ian; Zhang, Zhiyong; Rodriguez-Garcia, Dianise M.; Pawela, Christopher P.; Hillard, Cecilia J.; Hogan, Quinn H.; Pan, Bin			Dynamic Change of Endocannabinoid Signaling in the Medial Prefrontal Cortex Controls the Development of Depression After Neuropathic Pain	JOURNAL OF NEUROSCIENCE			English	Article						depression; endocannabinoid; medial prefrontal cortex; neuronal activity; neuropathic pain; synaptic transmission	PROTEIN-KINASE-C; RAT MODEL; BRAIN ACTIVITY; AXIS FUNCTION; RECEPTOR; ACTIVATION; STRESS; NEURONS; CONTRIBUTES; COMORBIDITY	Many patients with chronic pain conditions suffer from depression. The mechanisms underlying pain-induced depression are still unclear. There are critical links of medial prefrontal cortex (mPFC) synaptic function to depression, with signaling through the endocannabinoid (eCB) system as an important contributor. We hypothesized that afferent noxious inputs after injury compromise activity-dependent eCB signaling in the mPFC, resulting in depression. Depression-like behaviors were tested in male and female rats with traumatic neuropathy [spared nerve injury (SNI)], and neuronal activity in the mPFC was monitored using the immediate early gene c-fos and in vivo electrophysiological recordings. mPFC eCB Concentrations were determined using mass spectrometry, and behavioral and electrophysiological experiments were used to evaluate the role of alterations in eCB signaling in depression after pain. SNI-induced pain induced the development of depression phenotypes in both male and female rats. Pyramidal neurons in mPFC showed increased excitability followed by reduced excitability in the onset and prolonged phases of pain, respectively. Concentrations of the eCBs, 2-arachidonoylglycerol (2-AG) in the mPFC, were elevated initially after SNI, and our results indicate that this resulted in a loss of CB1R function on GABAergic interneurons in the mPFC. These data suggest that excessive release of 2-AG as a result of noxious stimuli triggers use -dependent loss of function of eCB signaling leading to excessive GABA release in the mPFC, with the final result being behavioral depression.	[Mecca, Christina M.; Chao, Dongman; Yu, Guoliang; Feng, Yin; Segel, Ian; Zhang, Zhiyong; Pawela, Christopher P.; Hogan, Quinn H.; Pan, Bin] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Mecca, Christina M.; Rodriguez-Garcia, Dianise M.; Hogan, Quinn H.; Pan, Bin] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Hillard, Cecilia J.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Pawela, Christopher P.; Hillard, Cecilia J.; Hogan, Quinn H.; Pan, Bin] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA		Pan, B (corresponding author), Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA.; Pan, B (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.; Pan, B (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA.	bpan@mcw.edu		Pan, Bin/0000-0002-5134-2508	National Institutes of Health at BethesdaUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS112194]; Brain & Behavior Research Foundation at New York [2510]; Advancing a Healthier Wisconsin Endowment [17262]	This work is supported by grant (R01NS112194) from National Institutes of Health at Bethesda, grant (#2510) from the Brain & Behavior Research Foundation at New York, and grant (#17262) from the Advancing a Healthier Wisconsin Endowment to B.P.	Abdallah Chadi G, 2017, Chronic Stress (Thousand Oaks), V1, DOI 10.1177/2470547017704763; Araque A, 2017, NEUROPHARMACOLOGY, V124, P13, DOI 10.1016/j.neuropharm.2017.06.017; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Barbas H, 2011, BIOL PSYCHIAT, V69, P1133, DOI 10.1016/j.biopsych.2010.08.008; Berrendero F, 2002, PSYCHOPHARMACOLOGY, V163, P111, DOI 10.1007/s00213-002-1144-9; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Bomholt SF, 2005, BRAIN RES, V1044, P216, DOI 10.1016/j.brainres.2005.03.005; Brodkin J, 2014, J NEUROSCI METH, V224, P48, DOI 10.1016/j.jneumeth.2013.12.010; Chao DM, 2020, PAIN, V161, P2872, DOI 10.1097/j.pain.0000000000001982; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Choi SK, 1997, J NEUROSCI, V17, P8613; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Descalzi G, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaj1549; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fischer G, 2014, GENE THER, V21, P44, DOI 10.1038/gt.2013.56; Fitzgerald JM, 2021, NEUROBIOL STRESS, V14, DOI 10.1016/j.ynstr.2021.100304; Garcia DE, 1998, J NEUROSCI, V18, P2834; Gerkin RC, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-38; Goffer Y, 2013, J NEUROSCI, V33, P19034, DOI 10.1523/JNEUROSCI.2454-13.2013; He XH, 2019, ACTA PHARMACOL SIN, V40, P365, DOI 10.1038/s41401-018-0059-x; Hill EL, 2007, J NEUROPHYSIOL, V97, P2580, DOI 10.1152/jn.00603.2006; Hill MN, 2011, J NEUROSCI, V31, P10506, DOI 10.1523/JNEUROSCI.0496-11.2011; Hill MN, 2009, TRENDS PHARMACOL SCI, V30, P484, DOI 10.1016/j.tips.2009.06.006; HILLARD CJ, 1994, BBA-MOL CELL RES, V1220, P163, DOI 10.1016/0167-4889(94)90131-7; Hogan Q, 2004, ANESTHESIOLOGY, V101, P476, DOI 10.1097/00000542-200408000-00030; Jensen KB, 2012, PAIN, V153, P1495, DOI 10.1016/j.pain.2012.04.010; Ji GC, 2011, J NEUROPHYSIOL, V106, P2642, DOI 10.1152/jn.00461.2011; Ji GC, 2010, J NEUROSCI, V30, P5451, DOI 10.1523/JNEUROSCI.0225-10.2010; Kelly CJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00133; Kim D, 2016, NEURON, V92, P902, DOI 10.1016/j.neuron.2016.09.023; Klein JC, 2010, NEUROIMAGE, V51, P555, DOI 10.1016/j.neuroimage.2010.02.062; Kremer M, 2021, EUR J NEUROSCI, V53, P236, DOI 10.1111/ejn.14686; Kummer KK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103440; Lee M, 2015, J NEUROSCI, V35, P5247, DOI 10.1523/JNEUROSCI.3494-14.2015; Li XY, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6402942; Lin XX, 2018, NEUROBIOL STRESS, V8, P92, DOI 10.1016/j.ynstr.2018.02.001; Liu X, 2010, J NERV MENT DIS, V198, P544, DOI 10.1097/NMD.0b013e3181e9daf7; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; Matos SC, 2015, J NEUROSCI, V35, P13244, DOI 10.1523/JNEUROSCI.0799-15.2015; McEwen BS, 2015, J ENDOCRINOL, V226, pT67, DOI 10.1530/JOE-15-0121; Mills C, 2012, J PAIN, V13, P519, DOI 10.1016/j.jpain.2012.02.009; Muhtz C, 2013, PAIN MED, V14, P498, DOI 10.1111/j.1526-4637.2012.01514.x; Norman GJ, 2010, MOL PSYCHIATR, V15, P404, DOI 10.1038/mp.2009.91; Pan B, 2011, J NEUROSCI, V31, P11244, DOI 10.1523/JNEUROSCI.1040-11.2011; Pan B, 2009, J PHARMACOL EXP THER, V331, P591, DOI 10.1124/jpet.109.158162; Pan B, 2008, J NEUROSCI, V28, P14018, DOI 10.1523/JNEUROSCI.4035-08.2008; Patel S, 2003, J PHARMACOL EXP THER, V306, P880, DOI 10.1124/jpet.103.054270; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Pawela CP, 2017, NEUROIMAGE, V147, P10, DOI 10.1016/j.neuroimage.2016.11.046; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Saab CY, 2012, TRENDS NEUROSCI, V35, P629, DOI 10.1016/j.tins.2012.06.002; Samat Ashish, 2008, Recent Pat Cardiovasc Drug Discov, V3, P187, DOI 10.2174/157489008786264014; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Seminowicz DA, 2017, J PAIN, V18, P1027, DOI 10.1016/j.jpain.2017.03.008; Sim-Selley LJ, 2006, MOL PHARMACOL, V70, P986, DOI 10.1124/mol.105.019612; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; Trinanes Y, 2015, PAIN PRACT, V15, P323, DOI 10.1111/papr.12186; Ulrich-Lai YM, 2006, PHYSIOL BEHAV, V88, P67, DOI 10.1016/j.physbeh.2006.03.012; Vachon-Presseau E, 2013, J NEUROSCI, V33, P6826, DOI 10.1523/JNEUROSCI.4584-12.2013; Volkow ND, 2014, P NATL ACAD SCI USA, V111, pE3149, DOI 10.1073/pnas.1411228111; Wang W, 2010, NEUROPSYCHOPHARMACOL, V35, P2249, DOI 10.1038/npp.2010.99; Wu DF, 2008, J NEUROCHEM, V104, P1132, DOI 10.1111/j.1471-4159.2007.05063.x; Wu HE, 2010, J PAIN, V11, P280, DOI 10.1016/j.jpain.2009.07.011; Yalcin I, 2014, CURR OPIN ANESTHESIO, V27, P520, DOI 10.1097/ACO.0000000000000116; Yalcin I, 2011, BIOL PSYCHIAT, V70, P946, DOI 10.1016/j.biopsych.2011.07.017; Zhang ZZ, 2015, CELL REP, V12, P752, DOI 10.1016/j.celrep.2015.07.001; Zhong P, 2014, NEUROPSYCHOPHARMACOL, V39, P1763, DOI 10.1038/npp.2014.24; Zhuo M, 2008, TRENDS NEUROSCI, V31, P199, DOI 10.1016/j.tins.2008.01.003; Zucker RS, 2005, NEURON, V45, P482, DOI 10.1016/j.neuron.2005.02.003	72	1	1	7	7	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	SEP 1	2021	41	35					7492	7508		10.1523/JNEUROSCI.3135-20.2021			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UL3HP	WOS:000692546600003	34244365				2022-02-06	
J	Migdady, I; Amin, M; Shoskes, A; Hassett, C; Rae-Grant, A; Snider, SB; Greer, DM; Cho, SM; George, P				Migdady, Ibrahim; Amin, Moein; Shoskes, Aaron; Hassett, Catherine; Rae-Grant, Alexander; Snider, Sam B.; Greer, David M.; Cho, Sung-Min; George, Pravin			Outcomes, Time-Trends, and Factors Associated With Ancillary Study Use for the Determination of Brain Death	CRITICAL CARE MEDICINE			English	Article						ancillary study; apnea test; brain death	TRANSCRANIAL DOPPLER; ANGIOGRAPHY; DIAGNOSIS	OBJECTIVES: Brain death determination often requires ancillary studies when clinical determination cannot be fully or safely completed. We aimed to analyze the results of ancillary studies, the factors associated with ancillary study performance, and the changes over time in number of studies performed at an academic health system. DESIGN: Retrospective cohort. SETTING: Multihospital academic health system. PATIENTS: Consecutive adult patients declared brain dead between 2010 and 2020. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of 140 brain death patients, ancillary studies were performed in 84 (60%). The false negative rate of all ancillary studies was 4% (5% of transcranial Doppler ultrasounds, 4% of nuclear studies, 0% of electroencephalograms, and 17% of CT angiography). In univariate analysis, ancillary study use was associated with female sex (odds ratio, 2.4; 95% CI, 1.21-5.01; p = 0.013) and the etiology of brain death being hypoxic-ischemic brain injury (odds ratio, 2.9; 95% CI, 1.43-5.88; p = 0.003), nontraumatic intracranial hemorrhage (odds ratio, 0.45; 95% CI, 0.21-0.96; p = 0.039), or traumatic brain injury (odds ratio, 0.22; 95% CI, 0.04-0.8; p = 0.031). In multivariable analysis, female sex (odds ratio, 5.7; 95% CI, 2.56-15.86; p = 0.004), the etiology of brain death being hypoxic-ischemic brain injury (odds ratio, 3.2; 95% CI, 1.3-8.8; p = 0.015), and the neurologists performing brain death declaration (odds ratio, 0.08; 95% CI, 0.004-0.64; p = 0.034) were factors independently associated with use of ancillary studies. Over the study period, the total number of ancillary studies performed each year did not significantly change; however, the number of electroencephalograms significantly decreased with time (odds ratio per 1-yr increase, 0.67; 95% CI, 0.49-0.90; p = 0.014). CONCLUSIONS: A large number of ancillary studies were performed despite a clinical determination of brain death; patients with hypoxic-ischemic brain injury are more likely to undergo ancillary studies for brain death determination, and neurologists were less likely to use ancillary studies for brain death. Recently, the use of electroencephalograms for brain death determination has decreased, likely reflecting significant concerns regarding its validity and reliability.	[Migdady, Ibrahim; Amin, Moein; Shoskes, Aaron; Rae-Grant, Alexander] Cleveland Clin, Dept Neurol, Neurol Inst, Cleveland, OH 44106 USA; [Migdady, Ibrahim] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Div Neurocrit Care, Boston, MA 02115 USA; [Hassett, Catherine; George, Pravin] Cleveland Clin, Dept Neurointens Care, Cerebrovasc Ctr, Cleveland, OH 44106 USA; [Snider, Sam B.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Greer, David M.] Boston Univ, Med Ctr, Dept Neurol, Boston, MA USA; [Cho, Sung-Min] Johns Hopkins Univ, Sch Med, Dept Neurol, Div Neurosci Crit Care, Baltimore, MD 21205 USA; [Cho, Sung-Min] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Div Neurosci Crit Care, Baltimore, MD 21205 USA; [Cho, Sung-Min] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Div Neurosci Crit Care, Baltimore, MD 21205 USA		Migdady, I (corresponding author), Cleveland Clin, Dept Neurol, Neurol Inst, Cleveland, OH 44106 USA.; Migdady, I (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Div Neurocrit Care, Boston, MA 02115 USA.	imigdady@mgh.harvard.edu					Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; Braksick SA, 2019, NEUROLOGY, V92, pE888, DOI 10.1212/WNL.0000000000007009; Chang JJ, 2016, AM J NEURORADIOL, V37, P408, DOI 10.3174/ajnr.A4548; Escalante JL., 1998, REV PORTUGUESA MED I, V7, P107; Escudero D, 2015, ANAESTHESIA, V70, P1130, DOI 10.1111/anae.13065; Fernandez-Torre JL, 2013, CLIN NEUROPHYSIOL, V124, P2362, DOI 10.1016/j.clinph.2013.05.028; Greer DM, 2020, JAMA-J AM MED ASSOC, V324, P1078, DOI 10.1001/jama.2020.11586; Greer DM, 2016, JAMA NEUROL, V73, P213, DOI 10.1001/jamaneurol.2015.3943; Greer DM, 2009, NEUROCRIT CARE, V11, P272, DOI 10.1007/s12028-009-9220-1; Joffe Ari R, 2010, J Intensive Care Med, V25, P53; Kramer AH, 2014, NEUROCRIT CARE, V21, P539, DOI 10.1007/s12028-014-9997-4; Lewis A, 2020, NEUROLOGY, V95, pE299, DOI 10.1212/WNL.0000000000009888; Li YQ, 2016, MED SCI MONITOR, V22, P1910, DOI 10.12659/MSM.899036; MacDougall BJ, 2014, NEUROCRIT CARE, V21, P383, DOI 10.1007/s12028-014-9975-x; Monteiro LM, 2006, INTENS CARE MED, V32, P1937, DOI 10.1007/s00134-006-0353-9; Sayan Halil Erkan, 2020, Rev. bras. ter. intensiva, V32, P405, DOI [10.5935/0103-507x.20200069, 10.5935/0103-507X.20200069]; Wijdicks EFM, 2013, NEUROL RES, V35, P169, DOI 10.1179/1743132812Y.0000000123; Wijdicks EFM, 2010, NEUROLOGY, V74, P1911, DOI 10.1212/WNL.0b013e3181e242a8	18	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2021	49	9					E840	E848		10.1097/CCM.0000000000005035			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD2HF	WOS:000687033000004	33852444				2022-02-06	
J	Muraoka, S; Lin, WW; Takamatsu-Yukawa, K; Hu, JQ; Ikezu, S; DeTure, MA; Dickson, DW; Emili, A; Ikezu, T				Muraoka, Satoshi; Lin, Weiwei; Takamatsu-Yukawa, Kayo; Hu, Jianqiao; Ikezu, Seiko; DeTure, Michael A.; Dickson, Dennis W.; Emili, Andrew; Ikezu, Tsuneya			Enrichment of Phosphorylated Tau (Thr181) and Functionally Interacting Molecules in Chronic Traumatic Encephalopathy Brain-derived Extracellular Vesicles	AGING AND DISEASE			English	Article						chronic traumatic encephalopathy; extracellular vesicles; microtubule-associated protein tau; plexin-A4; proteome; synaptosomal-associated protein 25; tauopathy; ubiquitin-like modifier-activating enzyme 1	DISEASE; TISSUES; CELL	Chronic Traumatic Encephalopathy (CTE) is a tauopathy that affects individuals with a history of mild repetitive brain injury. The initial neuropathologic changes of CTE include perivascular deposition of phosphorylated microtubule-associated protein tau (p-tau). Extracellular vesicles (EVs) are known to carry pathogenic molecules, such as tau in Alzheimer's disease and CTE suggesting their contribution in pathogenesis. We therefore examined the protein composition of EVs separated from CTE and an age-matched control brain tissues by tandem mass tag-mass spectrometry. The reporter ion intensity was used to quantify the identified molecules. A total of 516 common proteins were identified among three sets of experiments. Weighted protein co expression network analysis identified 18 unique modules of co-expressed proteins. Two modules were significantly correlated with total tau (t-tau) and p-tau protein in the isolated EVs and enriched in cellular components and biological processes for synaptic vesicle secretion and multivesicular body-plasma membrane fusion. The p-tau (Thr181) level is significantly higher in CTE EVs compared to control EVs and can distinguish the two groups with 73.6% accuracy. A combination of t-tau or p-tau (Thr181) with SNAP-25, PLXNA4 or UBA1, enhanced the accuracy to 96.3, 93.8 and 93.8%, respectively. Bioinformatic protein-protein interaction analysis revealed the functional interaction of SNAP-25 and PLXNA4 with tau, suggesting their interaction in CTE EVs. These data indicate the future application of identified EV proteins for monitoring the CTE risk assessments and understanding the EV-mediated disease progression mechanism.	[Muraoka, Satoshi; Takamatsu-Yukawa, Kayo; Hu, Jianqiao; Ikezu, Seiko; Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Lin, Weiwei; Emili, Andrew] Boston Univ, Dept Biochem, Boston, MA 02215 USA; [Lin, Weiwei; Emili, Andrew] Boston Univ, Ctr Network Syst Biol, Boston, MA 02215 USA; [DeTure, Michael A.; Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Ikezu, Tsuneya] Boston Univ, Ctr Syst Neurosci, Boston, MA 02215 USA; [Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Ikezu, Tsuneya] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA		Ikezu, T (corresponding author), Boston Univ, Sch Med, 72 East Concord St,L-606B, Boston, MA 02118 USA.	tikezu@bu.edu		Yukawa, Kayo/0000-0002-7507-1271	Aethlone Medical, Inc; Alzheimer's AssociationAlzheimer's Association [AARF-9550302678, DVT-14-320835]; Cure Alzheimer's Fund; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG066429, RF1 AG054199, R56 AG057469, R01AG67763, R21 NS104609]	The authors thank M. Ericsson (Electron Microscopy Facility, Harvard Medical School) for electron microscopic imaging services. This work is in part funded by Aethlone Medical, Inc (to T. I.), Alzheimer's Association AARF-9550302678 (SM), DVT-14-320835 (TI), Cure Alzheimer's Fund (TI), NIH R01 AG066429 (TI), NIH RF1 AG054199 (TI), NIH R56 AG057469 (TI), NIH R01AG67763 (TI) and NIH R21 NS104609 (TI).	Agliardi C, 2019, MOL NEUROBIOL, V56, P5792, DOI 10.1007/s12035-019-1501-x; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Aulston B, 2019, J ALZHEIMERS DIS, V72, P575, DOI 10.3233/JAD-190656; Bi BB, 2019, EXP NEUROBIOL, V28, P362, DOI 10.5607/en.2019.28.3.362; Botia JA, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0420-6; Brinkmalm A, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-53; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Cadonic C, 2016, MOL NEUROBIOL, V53, P6078, DOI 10.1007/s12035-015-9515-5; Deleo AM, 2018, J NEUROIMMUNE PHARM, V13, P292, DOI 10.1007/s11481-017-9768-z; Delpech JC, 2019, TRENDS NEUROSCI, V42, P361, DOI 10.1016/j.tins.2019.02.007; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Foote Molly, 2012, Int J Biochem Mol Biol, V3, P152; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Gabbouj S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00629; Groen EJN, 2015, TRENDS MOL MED, V21, P622, DOI 10.1016/j.molmed.2015.08.003; Guo M, 2020, BRAIN, V143, P1476, DOI 10.1093/brain/awaa090; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jun G, 2014, ANN NEUROL, V76, P379, DOI 10.1002/ana.24219; Kerr JS, 2017, TRENDS NEUROSCI, V40, P151, DOI 10.1016/j.tins.2017.01.002; Kobeissy FH, 2015, IGF 1 IGF R SIGNALIN; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Leyns CEG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0192-x; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Muraoka S, 2020, METHODS, V177, P35, DOI 10.1016/j.ymeth.2020.02.002; Muraoka S, 2020, ALZHEIMERS DEMENT, V16, P896, DOI 10.1002/alz.12089; Muraoka S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01059; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Picca A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040805; Salon ML, 2000, J NEUROSCI RES, V62, P302, DOI 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI 10.1586/EPR.09.17; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; You Y, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104512	41	1	1	1	1	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	SEP 1	2021	12	6					1376	1388		10.14336/AD.2020.1007			13	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	UQ8MP	WOS:000696313300003	34527416	Green Published, gold			2022-02-06	
J	Obukhov, YV; Kershner, IA; Tolmacheva, RA; Sinkin, MV; Zhavoronkova, LA				Obukhov, Yury Vladimirovich; Kershner, Ivan Andreevich; Tolmacheva, Renata Alekseevna; Sinkin, Mikhail Vladimirovich; Zhavoronkova, Ludmila Alekseevna			Wavelet Ridges in EEG Diagnostic Features Extraction: Epilepsy Long-Time Monitoring and Rehabilitation after Traumatic Brain Injury	SENSORS			English	Article						electroencephalogram; wavelet spectrum; ridge; segmentation; phase connectivity; epilepsy; traumatic brain injury	SEIZURE DETECTION; SIGNALS; TRANSFORM; REMOVAL	Interchannel EEG synchronization, as well as its violation, is an important diagnostic sign of a number of diseases. In particular, during an epileptic seizure, such synchronization occurs starting from some pairs of channels up to many pairs in a generalized seizure. Additionally, for example, after traumatic brain injury, the destruction of interneuronal connections occurs, which leads to a violation of interchannel synchronization when performing motor or cognitive tests. Within the framework of a unified approach to the analysis of interchannel EEG synchronization using the ridges of wavelet spectra, two problems were solved. First, the segmentation of the initial data of long-term monitoring of scalp EEG with various artifacts into fragments suspicious of epileptic seizures in order to reduce the total duration of the fragments analyzed by the doctor. Second, assessments of recovery after rehabilitation of cognitive functions in patients with moderate traumatic brain injury. In the first task, the initial EEG was segmented into fragments in which at least two channels were synchronized, and by the adaptive threshold method into fragments with a high value of the EEG power spectral density. Overlapping in time synchronized fragments with fragments of high spectral power density was determined. As a result, the total duration of the fragments for analysis by the doctor was reduced by more than 60 times. In the second task, the network of phase-related EEG channels was determined during the cognitive test before and after rehabilitation. Calculation-logical and spatial-pattern cognitive tests were used. The positive dynamics of rehabilitation was determined during the initialization of interhemispheric connections and connections in the frontal cortex of the brain.	[Obukhov, Yury Vladimirovich; Kershner, Ivan Andreevich; Tolmacheva, Renata Alekseevna] Kotelnikov Inst Radio Engn & Elect RAS, Mokhovaya St 11-7, Moscow 125009, Russia; [Sinkin, Mikhail Vladimirovich] Sklifosovsky Res Inst Emergency Med, Dept Neurosurg, Moscow Healthcare Dept, Bolshaya Sukharevskaya Sq 3, Moscow 129090, Russia; [Sinkin, Mikhail Vladimirovich] AI Yevdokimov Moscow State Univ Med & Dent, Lab Invas Neurointerfaces, Res Inst TechnoBioMed, Delegatskaya St 20 P1, Moscow 127473, Russia; [Zhavoronkova, Ludmila Alekseevna] Inst Higher Nervous Act & Neurophysiol RAS, Lab Gen & Clin Neurophysiol, Butlerova St 5a, Moscow 117485, Russia		Kershner, IA (corresponding author), Kotelnikov Inst Radio Engn & Elect RAS, Mokhovaya St 11-7, Moscow 125009, Russia.	yuvobukhov@mail.ru; ivan.kershner@gmail.com; tolmatcheva@yandex.ru; sinkinmv@sklif.mos.ru; lzhavoronkova@hotmail.com	Obukhov, Yury/AAO-6104-2021; Zhavoronkova, Ludmila/AAC-5787-2022; Sinkin, Mikhail/AAJ-3157-2021; Kershner, Ivan A/N-3856-2017	Sinkin, Mikhail/0000-0001-5026-0060; Kershner, Ivan A/0000-0001-8309-1582			Acharya UR, 2012, BIOMED SIGNAL PROCES, V7, P401, DOI 10.1016/j.bspc.2011.07.007; Ahmad Zeba Karin, 2019, 2019 2nd International Conference on Signal Processing and Communication (ICSPC). Proceedings, P258, DOI 10.1109/ICSPC46172.2019.8976487; Alotaiby TN, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-183; Arroyo-Ferrer A, 2021, J INTEGR NEUROSCI, V20, P449, DOI 10.31083/j.jin2002047; Bowyer S.M., 2016, NEUROPSYCHIATR ELECT, V2, P1, DOI 10.1186/s40810-015-0015-7; Cheng QQ, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21070698; Daubechies I., 1992, 10 LECT WAVELETS, V61, DOI 10.1063/14823127; DELPRAT N, 1992, IEEE T INFORM THEORY, V38, P644, DOI 10.1109/18.119728; Dhillon NS, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21082779; Euskai M., 1992, WAVELETS THEIR APPL; Guillemain P, 1996, P IEEE, V84, P561, DOI 10.1109/5.488700; Hampel F.R., 2011, ROBUST STAT APPROACH, V196; Haveman ME, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2656-6; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Hramov AE, 2015, WAVELETS NEUROSCIENC; Hussein R, 2019, CLIN NEUROPHYSIOL, V130, P25, DOI 10.1016/j.clinph.2018.10.010; Ianof Jéssica Natuline, 2017, Dement. neuropsychol., V11, P3, DOI 10.1590/1980-57642016dn11-010002; Islam MK, 2016, NEUROPHYSIOL CLIN, V46, P287, DOI 10.1016/j.neucli.2016.07.002; Khamis H, 2013, CLIN NEUROPHYSIOL, V124, P2317, DOI 10.1016/j.clinph.2013.05.015; Kharkevich A., 1961, PHYS TODAY, V14, P61, DOI [10.1063/1.3057619, DOI 10.1063/1.3057619]; Klatt J, 2012, EPILEPSIA, V53, P1669, DOI 10.1111/j.1528-1167.2012.03564.x; Kulaichev A., 2011, NEUROSCI BEHAV PHYSI, V41, P321, DOI [10.1007/s11055-011-9419-4, DOI 10.1007/S11055-011-9419-4]; Lai CQ, 2020, COMPUT INTEL NEUROSC, V2020, DOI 10.1155/2020/8923906; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Lee J, 2019, IEEE ACCESS, V7, P54550, DOI 10.1109/ACCESS.2019.2910869; Lilly JM, 2010, IEEE T INFORM THEORY, V57, P4135, DOI 10.1109/TIT.2010.2050935; Liu GD, 2021, FRONT SYST NEUROSCI, V15, DOI 10.3389/fnsys.2021.685387; Liu YX, 2012, IEEE T NEUR SYS REH, V20, P749, DOI 10.1109/TNSRE.2012.2206054; Mallat S., 1999, WAVELET TOUR SIGNAL, V1; MALLAT SG, 1989, IEEE T ACOUST SPEECH, V37, P2091, DOI 10.1109/29.45554; Mannan MMN, 2018, IEEE ACCESS, V6, P30630, DOI 10.1109/ACCESS.2018.2842082; Meyer Y., 1993, WAVELETS ALGORITHMS; Murashov DM, 2021, COMPUT OPT, V45, P301, DOI 10.18287/2412-6179-CO-798; Niknazar M, 2013, IEEE J BIOMED HEALTH, V17, P572, DOI 10.1109/JBHI.2013.2255132; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Obeid I, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00196; Pavlov AN, 2012, PHYS-USP+, V55, P845, DOI 10.3367/UFNe.0182.201209a.0905; Raghu S, 2020, NEUROCOMPUTING, V407, P385, DOI 10.1016/j.neucom.2020.04.144; Rana P, 2012, IEEE T BIO-MED ENG, V59, P1125, DOI 10.1109/TBME.2012.2184796; Rani T.P., 2021, INT J INF TECHNOL, V13, P423, DOI [10.1007/s41870-020-00524-7, DOI 10.1007/S41870-020-00524-7]; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279, DOI 10.1016/S1383-8121(01)80012-9; Rudrauf D, 2006, NEUROIMAGE, V31, P209, DOI 10.1016/j.neuroimage.2005.11.021; Runarsson TP, 2006, INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE FOR MODELLING, CONTROL & AUTOMATION JOINTLY WITH INTERNATIONAL CONFERENCE ON INTELLIGENT AGENTS, WEB TECHNOLOGIES & INTERNET COMMERCE, VOL 2, PROCEEDINGS, P673; Saminu S, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11050668; Tolmacheva RA, 2018, J COMMUN TECHNOL EL+, V63, P1070, DOI 10.1134/S1064226918090206; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Unser M, 1996, P IEEE, V84, P626, DOI 10.1109/5.488704; Vakman D. E., 1977, Soviet Physics - Uspekhi, V20, P1002, DOI 10.1070/PU1977v020n12ABEH005479; Wendling F, 2009, J NEUROSCI METH, V183, P9, DOI 10.1016/j.jneumeth.2009.04.021; Wong R., 2001, ASYMPTOTIC APPROXIMA; Wu J, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22020140; Xiong ZW, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21155145; Yoo J, 2013, IEEE J SOLID-ST CIRC, V48, P214, DOI 10.1109/JSSC.2012.2221220; Zhan Y, 2006, J NEUROSCI METH, V156, P322, DOI 10.1016/j.jneumeth.2006.02.013; Zhavoronkova L., 2017, DOES HUMAN BRAIN SIM, VVolume 59; Zhou WD, 2013, IEEE T BIO-MED ENG, V60, P3375, DOI 10.1109/TBME.2013.2254486	56	1	1	3	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	SEP	2021	21	18							5989	10.3390/s21185989			22	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	UX8BO	WOS:000701064100001	34577198	Green Published, gold			2022-02-06	
J	Ruiz-Perera, LM; Hoving, AL; Schmidt, KE; Cenan, S; Wohllebe, M; Greiner, JFW; Kaltschmidt, C; Simon, M; Knabbe, C; Kaltschmidt, B				Ruiz-Perera, Lucia M.; Hoeving, Anna L.; Schmidt, Kazuko E.; Cenan, Sule; Wohllebe, Max; Greiner, Johannes F. W.; Kaltschmidt, Christian; Simon, Matthias; Knabbe, Cornelius; Kaltschmidt, Barbara			Neuroprotection Mediated by Human Blood Plasma in Mouse Hippocampal Slice Cultures and in Oxidatively Stressed Human Neurons	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						human blood plasma; neuroprotection; oxidative stress-induced neuronal death; human serum albumin; human neural crest-derived stem cells	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; HUMAN SERUM-ALBUMIN; LARGE ANIMAL-MODEL; ANTIOXIDANT ACTIVITY; STEM-CELLS; EXCITOTOXICITY; RESUSCITATION; MECHANISMS; EXPRESSION	Neuroprotection from oxidative stress is critical during neuronal development and maintenance but also plays a major role in the pathogenesis and potential treatment of various neurological disorders and neurodegenerative diseases. Emerging evidence in the murine system suggests neuroprotective effects of blood plasma on the aged or diseased brain. However, little is known about plasma-mediated effects on human neurons. In the present study, we demonstrate the neuroprotective effect mediated by human plasma and the most abundant plasma-protein human serum albumin against oxidative stress in glutamatergic neurons differentiated from human neural crest-derived inferior turbinate stem cells. We observed a strong neuroprotective effect of human plasma and human serum albumin against oxidative stress-induced neuronal death on the single cell level, similar to the one mediated by tumor necrosis factor alpha. Moreover, we detected neuroprotection of plasma and human serum albumin against kainic acid-induced excitatory stress in ex vivo cultured mouse hippocampal tissue slices. The present study provides deeper insights into plasma-mediated neuroprotection ultimately resulting in the development of novel therapies for a variety of neurological and, in particular, neurodegenerative diseases.	[Ruiz-Perera, Lucia M.; Wohllebe, Max; Kaltschmidt, Barbara] Univ Bielefeld, Fac Biol, Mol Neurobiol, D-33615 Bielefeld, Germany; [Ruiz-Perera, Lucia M.; Hoeving, Anna L.; Schmidt, Kazuko E.; Wohllebe, Max; Knabbe, Cornelius] Ruhr Univ Bochum, Inst Lab & Transfus Med, Heart & Diabet Ctr NRW, D-32545 Bad Oeynhausen, Germany; [Hoeving, Anna L.; Schmidt, Kazuko E.; Cenan, Sule; Greiner, Johannes F. W.; Kaltschmidt, Christian; Kaltschmidt, Barbara] Univ Bielefeld, Fac Biol, Dept Cell Biol, D-33615 Bielefeld, Germany; [Greiner, Johannes F. W.; Kaltschmidt, Christian; Simon, Matthias; Knabbe, Cornelius; Kaltschmidt, Barbara] OWL FBMB eV, Forsch Verbund BioMed Bielefeld, D-33617 Bielefeld, Germany; [Simon, Matthias] Univ Med Sch OWL Bielefeld, Bethel Fdn, Dept Neurosurg, Protestant Hosp, D-33617 Bielefeld, Germany; [Ruiz-Perera, Lucia M.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Ruiz-Perera, Lucia M.] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10065 USA		Kaltschmidt, B (corresponding author), Univ Bielefeld, Fac Biol, Mol Neurobiol, D-33615 Bielefeld, Germany.; Hoving, AL (corresponding author), Ruhr Univ Bochum, Inst Lab & Transfus Med, Heart & Diabet Ctr NRW, D-32545 Bad Oeynhausen, Germany.; Hoving, AL; Kaltschmidt, B (corresponding author), Univ Bielefeld, Fac Biol, Dept Cell Biol, D-33615 Bielefeld, Germany.; Kaltschmidt, B (corresponding author), OWL FBMB eV, Forsch Verbund BioMed Bielefeld, D-33617 Bielefeld, Germany.	lucia.ruiz@uni-bielefeld.de; anna.hoeving@uni-bielefeld.de; k.schmidt10@uni-bielefeld.de; sule.evin@yahoo.de; max.wohllebe@uni-bielefeld.de; Johannes.Greiner@uni-bielefeld.de; dmabbe@hdz-nrw.de; matthias.simon@evkb.de; C.Kaltschmidt@uni-bielefeld.de; barbara.kaltschmidt@uni-bielefeld.de		Greiner, Johannes/0000-0002-0524-662X	University of Bielefeld; Heart and Diabetes Centre NRW	This work was funded by the University of Bielefeld and the Heart and Diabetes Centre NRW.	Albers DS, 2000, J NEURAL TRANSM-SUPP, P133; Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964; Austin JW, 2012, J NEUROCHEM, V122, P344, DOI 10.1111/j.1471-4159.2012.07789.x; Baierle M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/804198; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Candelario-Jalil E, 2001, J APPL TOXICOL, V21, P403, DOI 10.1002/jat.768; Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067; Cha MK, 1996, BIOCHEM BIOPH RES CO, V222, P619, DOI 10.1006/bbrc.1996.0793; Checkoway Harvey, 2011, IARC Sci Publ, P407; Chen X, 2016, NEUROSCIENCE, V324, P69, DOI 10.1016/j.neuroscience.2016.03.009; Chen XD, 2019, EXP NEUROL, V317, P244, DOI 10.1016/j.expneurol.2019.03.013; CHENG Y, 1994, NEUROCHEM RES, V19, P1557, DOI 10.1007/BF00969006; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Duport S, 1998, P NATL ACAD SCI USA, V95, P1840, DOI 10.1073/pnas.95.4.1840; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Greiner J F W, 2011, Eur Cell Mater, V22, P403; Greiner JFW, 2019, FEBS LETT, V593, P3338, DOI 10.1002/1873-3468.13606; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419; Henning L, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.660591; Hoving AL, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.662754; Hoving AL, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9120435; Hoving AL, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061472; Honoki K, 2017, WORLD J STEM CELLS, V9, P1, DOI 10.4252/wjsc.v9.i1.1; Imam A, 2015, J NEUROTRAUM, V32, P307, DOI 10.1089/neu.2014.3535; Jellinger KA, 2000, J NEURAL TRANSM-SUPP, P95; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Kawas CH, 2015, NEUROLOGY, V85, P535, DOI 10.1212/WNL.0000000000001831; Ke CL, 2011, FOOD CHEM TOXICOL, V49, P2670, DOI 10.1016/j.fct.2011.07.020; Leinonen JS, 2000, STROKE, V31, P33, DOI 10.1161/01.STR.31.1.33; Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Martin RH, 2016, STROKE, V47, P2355, DOI 10.1161/STROKEAHA.116.012825; Michaelis EK, 1998, PROG NEUROBIOL, V54, P369, DOI 10.1016/S0301-0082(97)00055-5; Milatovic D, 2002, BRAIN RES, V957, P330, DOI 10.1016/S0006-8993(02)03669-7; Montine TJ, 2002, FREE RADICAL BIO MED, V33, P620, DOI 10.1016/S0891-5849(02)00807-9; Muller J, 2015, STEM CELL TRANSL MED, V4, P31, DOI 10.5966/sctm.2014-0078; Muzio L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17524-7; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Ruiz-Perera LM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34394-8; Rusina E, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0337-20.2021; Sapojnikova N., 2012, ANTIOXID ENZYM, DOI [10.5772/50366, DOI 10.5772/50366]; Sarnatskaya VV, 2007, ARTIF CELL BLOOD SUB, V35, P287, DOI 10.1080/10731190701378618; Suarez Jose I, 2015, Acta Neurochir Suppl, V120, P287, DOI 10.1007/978-3-319-04981-6_48; SUN AY, 1992, PROG BRAIN RES, V94, P271; Teselkin YO, 1998, VOP MED KHIM, V44, P70; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Wang L, 2020, J CELL MOL MED, V24, P4061, DOI 10.1111/jcmm.15051; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411	60	1	1	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	SEP	2021	22	17							9567	10.3390/ijms22179567			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	UN9TY	WOS:000694350400001	34502475	Green Published, gold			2022-02-06	
J	Saba, ES; Karout, M; Nasrallah, L; Kobeissy, F; Darwish, H; Khoury, SJ				Saba, Esber S.; Karout, Mona; Nasrallah, Leila; Kobeissy, Firas; Darwish, Hala; Khoury, Samia J.			Long-term cognitive deficits after traumatic brain injury associated with microglia activation	CLINICAL IMMUNOLOGY			English	Article						Traumatic brain injury; Microglia; Cognition; Spatial memory; Infiltrating macrophages; Chronic inflammation	REVEALS; MILD; NEUROINFLAMMATION; INFLAMMATION; APOPTOSIS; SEVERITY; MODERATE; SUBSETS; MEMORY; MICE	Traumatic Brain Injury (TBI) is the most prevalent of all head injuries. Microglia play an essential role in homeostasis and diseases of the central nervous system. We hypothesize that microglia may play a beneficial or detrimental role in TBI depending on their state of activation and duration. In this study, we evaluated whether TBI results in a spatiotemporal change in microglia phenotype and whether it affects sensory-motor or learning and memory functions in male C57BL/6 mice. We used a panel of neurological and behavioral tests and a multi-color flow cytometry-based data analysis followed by unsupervised clustering to evaluate isolated microglia from injured brain tissue. We characterized several microglial phenotypes and their association with cognitive deficits. TBI results in a spatiotemporal increase in activated microglia that correlated negatively with spatial learning and memory at 35 days post-injury. These observations could define therapeutic windows and accelerate translational research to improve patient outcomes.	[Saba, Esber S.; Khoury, Samia J.] Amer Univ Beirut, Dept Expt Pathol Immunol & Microbiol, Fac Med, Beirut, Lebanon; [Karout, Mona; Nasrallah, Leila; Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Med Ctr, Beirut, Lebanon; [Darwish, Hala; Khoury, Samia J.] Amer Univ Beirut, Nehme & Therese Tohme Multiple Sclerosis Ctr, Fac Med, Med Ctr, Beirut, Lebanon; [Darwish, Hala] Amer Univ Beirut, Hariri Sch Nursing, Beirut, Lebanon		Khoury, SJ (corresponding author), Amer Univ Beirut, Abou Haidar Neurosci Inst, Fac Med, Med Ctr, POB 1107 2020, Beirut, Lebanon.; Darwish, H; Khoury, SJ (corresponding author), Amer Univ Beirut, Therese Tohme Multiple Sclerosis Ctr, Fac Med, Med Ctr, POB 1107 2020, Beirut, Lebanon.; Darwish, H (corresponding author), Amer Univ Beirut, Med Ctr, Hariri Sch Nursing, Fac Med, Beirut, Lebanon.	hd30@aub.edu.lb; sk88@aub.edu.lb	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944; Saba, Esber/0000-0003-1525-6394; Nasrallah, Leila/0000-0002-7358-4751			Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Alam A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02005-x; Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P627, DOI 10.1007/s004010000232; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Caplan HW, 2020, ASN NEURO, V12, DOI 10.1177/1759091420911770; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Darwish H, 2014, BRAIN INJURY, V28, P211, DOI 10.3109/02699052.2013.862737; du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000410; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Furman NT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68770-0; Geloso MC, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00242; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hanamsagar R, 2017, GLIA, V65, P1504, DOI 10.1002/glia.23176; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Hebda-Bauer EK, 2010, NEUROSCIENCE, V169, P645, DOI 10.1016/j.neuroscience.2010.05.033; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Ho MS, 2019, ADV EXP MED BIOL, V1175, P335, DOI 10.1007/978-981-13-9913-8_13; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lee Jae-Kyung, 2013, Methods Mol Biol, V1041, P17, DOI 10.1007/978-1-62703-520-0_3; Li Q, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00520; Lier J, 2020, INT J LEGAL MED, V134, P2187, DOI 10.1007/s00414-020-02308-x; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Martin E, 2017, JOVE-J VIS EXP, DOI 10.3791/55781; Martinez-Drudis L, 2021, BEHAV BRAIN RES, V400, DOI 10.1016/j.bbr.2020.113048; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nichols MR, 2019, J NEUROCHEM, V149, P562, DOI 10.1111/jnc.14674; Noristani HN, 2017, FRONT AGING NEUROSCI, V9, DOI [10.3389/fnagi.2017.00230, 10.3389/fnagi.2017.00227]; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Ritzel RM, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104713; Ritzel RM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0329-1; Skovira JW, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0769-2; Spijker S, 2011, NEUROMETHODS, V57, P13, DOI 10.1007/978-1-61779-111-6_2; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vorhees CV, 2014, ILAR J, V55, P310, DOI 10.1093/ilar/ilu013; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Wolf Y, 2018, EUR J IMMUNOL, V48, P1308, DOI 10.1002/eji.201847540; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Yeh H, 2019, TRENDS MOL MED, V25, P96, DOI 10.1016/j.molmed.2018.11.004; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	71	1	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1521-6616	1521-7035		CLIN IMMUNOL	Clin. Immunol.	SEP	2021	230								108815	10.1016/j.clim.2021.108815			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ8AX	WOS:000691503100012	34339843	Green Submitted			2022-02-06	
J	Shepherd, D; Heinonen-Guzejev, M; Heikkila, K; Landon, J; Theadom, A				Shepherd, Daniel; Heinonen-Guzejev, Marja; Heikkila, Kauko; Landon, Jason; Theadom, Alice			Sensitivity to Noise Following a Mild Traumatic Brain Injury: A Longitudinal Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mild traumatic brain injury; noise sensitivity; postconcussive symptoms	CONCUSSION SYMPTOMS QUESTIONNAIRE; HEAD-INJURY; NEW-ZEALAND; POPULATION; PREDICTORS; RECOVERY; VALIDITY; HEALTH	Objective: To describe changes in the prevalence and clinical correlates of noise sensitivity (NS) in mild traumatic brain injury (mTBI) across a 12-month period and to determine whether NS at an early stage of recovery has predictive value for later postconcussive symptoms. Setting: A mixed urban and rural region of New Zealand. Participants: Data for 341 adults (201 males, 140 females; age range from 16 to 91 years) were extracted from a 1-year TBI incidence, and outcomes study was conducted in New Zealand. Design: Secondary analysis of data from a community-based, longitudinal population study of an mTBI incidence cohort collected within 1 week of injury (baseline) and at 1, 6, and 12 months postinjury. Main Measures: Measures at baseline (within 2 weeks of the injury) and 1, 6, and 12 months included the Rivermead Post-concussion Symptoms Questionnaire and its NS item, the Hospital Depression and Anxiety Scale, and the computerized CNS-Vital Signs neurocognitive test. Results: NS progressively declined postinjury, from 45% at baseline to 28% at 12 months. In turn, NS showed itself as a significant predictor of future postconcussive symptoms. Conclusion: Taken together with previous research, the findings of the current study indicate that NS may have clinical utility in flagging vulnerability to persistent postconcussive symptoms.	[Shepherd, Daniel; Landon, Jason; Theadom, Alice] Auckland Univ Technol, Dept Psychol, Private Bag 92006, Auckland 1142, New Zealand; [Heinonen-Guzejev, Marja; Heikkila, Kauko] Univ Helsinki, Hjelt Inst, Dept Publ Hlth, Helsinki, Finland		Shepherd, D (corresponding author), Auckland Univ Technol, Dept Psychol, Private Bag 92006, Auckland 1142, New Zealand.	daniel.shepherd@aut.ac.nz; marja.heinonen@helsinki.fi; kauko.heikkila@helsinki.fi; jason.landon@aut.ac.nz; alice.theadom@aut.ac.nz	Heikkila, Kauko/E-5578-2019	Heikkila, Kauko/0000-0002-9256-8028			Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Allen P., 2019, SPSS STAT PRACTICAL, V4th ed.; Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Armann E., INTERNOISE NOISE CON, P1167; Assi H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28312-1; Attias J., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P117; Barker-Collo S, 2019, BRAIN INJURY, V33, P618, DOI 10.1080/02699052.2019.1570339; Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P422, DOI 10.1093/arclin/acu029; Callahan ML, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0867-x; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Cohen J., 2013, STAT POWER ANAL BEHA; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Fann JR., 2013, MANAG ADULTS TRAUMA, P195; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Forrest RHJ, 2018, J PRIM HEALTH CARE, V10, P159, DOI 10.1071/HC17071; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; IWATA O, 1984, JPN PSYCHOL RES, V26, P75, DOI 10.4992/psycholres1954.26.75; Karr JE, 2020, ACTA NEUROL SCAND, V141, P183, DOI 10.1111/ane.13190; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Landon J, 2012, NEUROPSYCHOL REHABIL, V22, P391, DOI 10.1080/09602011.2011.652496; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Miedema HME, 2003, J ACOUST SOC AM, V113, P1492, DOI 10.1121/1.1547437; NIVISON ME, 1993, J BEHAV MED, V16, P257, DOI 10.1007/BF00844759; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Olofsson A, 2020, SCAND J OCCUP THER, V27, P194, DOI 10.1080/11038128.2018.1495762; Shepherd D, 2019, BRAIN INJURY, V33, P1050, DOI 10.1080/02699052.2019.1606443; Shepherd D, 2016, J CLIN EXP NEUROPSYC, V38, P900, DOI 10.1080/13803395.2016.1176995; Shepherd D, 2015, INT J ENV RES PUB HE, V12, P5284, DOI 10.3390/ijerph120505284; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Somerville LH, 2010, BIOL PSYCHIAT, V68, P416, DOI 10.1016/j.biopsych.2010.04.002; Staner L, 2010, SLEEP MED REV, V14, P35, DOI 10.1016/j.smrv.2009.09.003; Stansfeld S.A, 1992, PSYCHOL MED        S, V22S, P1, DOI DOI 10.1017/S0264180100001119; STANSFELD SA, 1985, PSYCHOL MED, V15, P243, DOI 10.1017/S0033291700023527; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2018, BRAIN IMPAIR, V19, P119, DOI 10.1017/Brimp.2017.11; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thomas M, 2018, BRAIN IMPAIR, V19, P166, DOI 10.1017/Brimp.2017.26; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		E289	E301		10.1097/HTR.0000000000000645			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300001	33656468				2022-02-06	
J	Snyder, AR; Greif, SM; Clugston, JR; FitzGerald, DB; Yarrow, JF; Babikian, T; Giza, CC; Thompson, FJ; Bauer, RM				Snyder, Aliyah R.; Greif, Sarah M.; Clugston, James R.; FitzGerald, David B.; Yarrow, Joshua F.; Babikian, Talin; Giza, Christopher C.; Thompson, Floyd J.; Bauer, Russell M.			The Effect of Aerobic Exercise on Concussion Recovery: A Pilot Clinical Trial	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Neuropsychology; Return to Sport; Brain Injuries; Sports; Feasibility Studies; Public Health	TRAUMATIC BRAIN-INJURY; WHIPLASH-ASSOCIATED DISORDERS; SPORTS-RELATED CONCUSSION; MILD HEAD-INJURY; PHYSICAL-EXERCISE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; POSTURAL STABILITY; MEDICAL OUTCOMES; SYMPTOMS	Objective: The purpose of this study was to pilot safety and tolerability of a 1-week aerobic exercise program during the post-acute phase of concussion (14-25 days post-injury) by examining adherence, symptom response, and key functional outcomes (e.g., cognition, mood, sleep, postural stability, and neurocognitive performance) in young adults. Method: A randomized, non-blinded pilot clinical trial was performed to compare the effects of aerobic versus nonaerobic exercise (placebo) in concussion patients. The study enrolled three groups: 1) patients with concussion/mild traumatic brain injury (mTBI) randomized to an aerobic exercise intervention performed daily for 1-week, 2) patients with concussion/mTBI randomized to a non-aerobic (stretching and calisthenics) exercise program performed daily for 1-week, and 3) non-injured, no intervention reference group. Results: Mixed-model analysis of variance results indicated a significant decrease in symptom severity scores from pre- to post-intervention (mean difference = -7.44, 95% CI [-12.37, -2.20]) for both concussion groups. However, the pre- to post-change was not different between groups. Secondary outcomes all showed improvements by post-intervention, but no differences in trajectory between the groups. By three months post-injury, all outcomes in the concussion groups were within ranges of the non-injured reference group. Conclusions: Results from this study indicate that the feasibility and tolerability of administering aerobic exercise via stationary cycling in the post-acute time frame following post-concussion (14-25 days) period are tentatively favorable. Aerobic exercise does not appear to negatively impact recovery trajectories of neurobehavioral outcomes; however, tolerability may be poorer for patients with high symptom burden.	[Snyder, Aliyah R.; Babikian, Talin] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Snyder, Aliyah R.; Babikian, Talin; Giza, Christopher C.] Univ Calif Los Angeles, UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA 90095 USA; [Greif, Sarah M.; Bauer, Russell M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Greif, Sarah M.; Babikian, Talin] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL USA; [FitzGerald, David B.] Univ Florida, Dept Neurol, Gainesville, FL USA; [FitzGerald, David B.; Yarrow, Joshua F.; Thompson, Floyd J.; Bauer, Russell M.] North Florida South Georgia Vet Hlth Syst, Malcolm Randall VA Med Ctr, Res Serv, Gainesville, FL USA; [FitzGerald, David B.; Yarrow, Joshua F.; Thompson, Floyd J.; Bauer, Russell M.] North Florida South Georgia Vet Hlth Syst, Malcolm Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL USA; [Yarrow, Joshua F.] Univ Florida, Coll Med, Div Endocrinol Diabet & Metab, Gainesville, FL USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA; [Thompson, Floyd J.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Thompson, Floyd J.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA		Snyder, AR (corresponding author), Univ Calif Los Angeles, 760 Westwood Plaza,Room 18-240, Los Angeles, CA 90095 USA.	asnyder@mednet.ucla.edu		Snyder, Aliyah/0000-0003-1185-7424	NIH/NCATS Clinical and Translational Science AwardsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1 TR000066, UL1 TR000064]; UCLA Brain Injury Research Center; UCLA Steve Tisch BrainSPORT Program; UCLA Easton Labs for Brain Injury; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS09229]; VA Rehabilitation Research and Development ServiceUS Department of Veterans Affairs; American Psychological Association; American Psychological Foundation	This work supported was supported in part by the NIH/NCATS Clinical and Translational Science Awards to the University of Florida TL1 TR000066, UL1 TR000064 (A.R. Snyder & R.M. Bauer.); UCLA Brain Injury Research Center; UCLA Steve Tisch BrainSPORT Program; UCLA Easton Labs for Brain Injury; Stan and Patty Silver; NINDS NS09229; and VA Rehabilitation Research and Development Service (Bauer). This work was also supported in part by grants to the author from the American Psychological Association and the American Psychological Foundation.	Albanes D, 1990, Epidemiology, V1, P65, DOI 10.1097/00001648-199001000-00014; Allen RP, 2009, SLEEP MED, V10, P531, DOI 10.1016/j.sleep.2008.06.003; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; BENTON AL, 1969, J NEUROL SCI, V9, P39, DOI 10.1016/0022-510X(69)90057-4; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Boisgontier MP, 2016, NEUROSCI BIOBEHAV R, V68, P1004, DOI 10.1016/j.neubiorev.2016.05.034; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Chan JSY, 2019, J PSYCHOL, V153, P102, DOI 10.1080/00223980.2018.1470487; Charek DB, 2020, J HEAD TRAUMA REHAB, V35, P85, DOI 10.1097/HTR.0000000000000476; Chennaoui M, 2015, SLEEP MED REV, V20, P59, DOI 10.1016/j.smrv.2014.06.008; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Coelho FGD, 2013, ARCH GERONTOL GERIAT, V56, P10, DOI 10.1016/j.archger.2012.06.003; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Devine JM, 2009, PM&R, V1, P560, DOI 10.1016/j.pmrj.2009.03.015; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Elliott J, 2008, MANUAL THER, V13, P258, DOI 10.1016/j.math.2007.01.012; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Ferreira AFB, 2011, BRAIN RES, V1425, P111, DOI 10.1016/j.brainres.2011.10.004; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fogelman D, 2012, PM&R, V4, P908, DOI 10.1016/j.pmrj.2012.09.028; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Golding LA., 2000, YMCA FITNESS TESTING, V4th ed; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Halker RB, 2013, CURR PAIN HEADACHE R, V17, P337, DOI 10.1007/s11916-013-0337-8; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haynes, 2000, EVIDENCE BASED MED T; Hays RD, 2005, SLEEP MED, V6, P41, DOI 10.1016/j.sleep.2004.07.006; Heaton R.K., 1981, MANUAL WISCONSIN CAR, DOI [10.1016/j.jns.2004.09.003, DOI 10.1016/J.JNS.2004.09.003]; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Howell DR, 2020, J SCI MED SPORT, V23, P112, DOI 10.1016/j.jsams.2019.08.294; IBM Corp, 2019, IBM SPSS STAT WINDOW; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; Katz DA, 2002, J FAM PRACTICE, V51, P229; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly ME, 2014, AGEING RES REV, V16, P12, DOI 10.1016/j.arr.2014.05.002; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kreber LA, 2016, BRAIN RES, V1640, P152, DOI 10.1016/j.brainres.2016.01.016; Langvatn SA, 2020, STUD INT COURT TRIB, P1; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rockhill CM, 2010, BRAIN INJURY, V24, P1051, DOI 10.3109/02699052.2010.494586; RUFF RM, 1992, PERCEPT MOTOR SKILL, V75, P1311, DOI 10.2466/PMS.75.8.1311-1319; Sandoe CH, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0840-8; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Spielberger CD., 1970, STATE TRAIT ANXIETY; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Treleaven J, 2005, J REHABIL MED, V37, P219, DOI 10.1080/16501970410024299; van Belle G, 2011, STAT RULES THUMB, DOI [10.1002/9780470377963, DOI 10.1002/9780470377963]; Vanderbeken I, 2017, NEUROREHABILITATION, V40, P33, DOI 10.3233/NRE-161388; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Yoon KJ, 2018, ANN REHABIL MED-ARM, V42, P643, DOI 10.5535/arm.2018.42.5.643; Zafonte RD, 2018, HAND CLINIC, V158, P463, DOI 10.1016/B978-0-444-63954-7.00042-2	83	1	1	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2021	27	8					790	804		10.1017/S1355617721000886			15	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	UT9OA	WOS:000698436000006	34548116	Green Accepted			2022-02-06	
J	Steele, L; Klimas, N; Krengel, M; Quinn, E; Toomey, R; Little, D; Abreu, M; Aenlle, K; Killiany, R; Koo, BB; Janulewicz, P; Heeren, T; Clark, AN; Ajama, J; Cirillo, J; Buentello, G; Lerma, V; Coller, JK; Sullivan, K				Steele, Lea; Klimas, Nancy; Krengel, Maxine; Quinn, Emily; Toomey, Rosemary; Little, Deborah; Abreu, Maria; Aenlle, Kristina; Killiany, Ronald; Koo, Bang-Bon; Janulewicz, Patricia; Heeren, Timothy; Clark, Allison N.; Ajama, Joy; Cirillo, Joanna; Buentello, Gerardo; Lerma, Vanesa; Coller, Janet K.; Sullivan, Kimberly			Brain-Immune Interactions as the Basis of Gulf War Illness: Clinical Assessment and Deployment Profile of 1990-1991 Gulf War Veterans in the Gulf War Illness Consortium (GWIC) Multisite Case-Control Study	BRAIN SCIENCES			English	Article						Gulf War illness; brain-immune interactions; military exposures; pesticides; traumatic brain injury; case-control study	CHRONIC MULTISYMPTOM ILLNESS; PYRIDOSTIGMINE BROMIDE; HEALTH; EXPOSURES; SYMPTOMS; PREVALENCE; INSTRUMENT; PATTERNS; STATES; SARIN	The Boston University-based Gulf War Illness Consortium (GWIC) is a multidisciplinary initiative developed to provide detailed understanding of brain and immune alterations that underlie Gulf War illness (GWI), the persistent multisymptom disorder associated with military service in the 1990-1991 Gulf War. The core GWIC case-control clinical study conducted in-depth brain and immune evaluation of 269 Gulf War veterans (223 GWI cases, 46 controls) at three U.S. sites that included clinical assessments, brain imaging, neuropsychological testing, and analyses of a broad range of immune and immunogenetic parameters. GWI cases were similar to controls on most demographic, military, and deployment characteristics although on average were two years younger, with a higher proportion of enlisted personnel vs. officers. Results of physical evaluation and routine clinical lab tests were largely normal, with few differences between GWI cases and healthy controls. However, veterans with GWI scored significantly worse than controls on standardized assessments of general health, pain, fatigue, and sleep quality and had higher rates of diagnosed conditions that included hypertension, respiratory and sinus conditions, gastrointestinal conditions, and current or lifetime depression and post-traumatic stress disorder. Among multiple deployment experiences/exposures reported by veterans, multivariable logistic regression identified just two significant GWI risk factors: extended use of skin pesticides in theater (adjusted OR = 3.25, p = 0.005) and experiencing mild traumatic brain injury during deployment (OR = 7.39, p = 0.009). Gulf War experiences associated with intense stress or trauma (e.g., participation in ground combat) were not associated with GWI. Data and samples from the GWIC project are now stored in a repository for use by GWI researchers. Future reports will present detailed findings on brain structure and function, immune function, and association of neuroimmune measures with characteristics of GWI and Gulf War service.	[Steele, Lea; Buentello, Gerardo; Lerma, Vanesa] Baylor Coll Med, Dept Psychiat & Behav Sci, Beth K & Stuart C Yudofsky Div Neuropsychiat, Vet Hlth Res Program, Houston, TX 77030 USA; [Klimas, Nancy; Abreu, Maria; Aenlle, Kristina] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Inst Neuroimmune Med, Ft Lauderdale, FL 33314 USA; [Klimas, Nancy; Aenlle, Kristina] Miami VA Healthcare Syst, Dept Vet Affairs, Miami, FL 33125 USA; [Krengel, Maxine] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Quinn, Emily; Heeren, Timothy] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02118 USA; [Toomey, Rosemary] Boston Univ, Coll Arts & Sci, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Little, Deborah] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Killiany, Ronald; Koo, Bang-Bon; Janulewicz, Patricia; Ajama, Joy; Cirillo, Joanna; Sullivan, Kimberly] Boston Univ, Dept Environm Hlth, Sch Publ Hlth, Boston, MA 02118 USA; [Clark, Allison N.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Coller, Janet K.] Univ Adelaide, Sch Biomed, Discipline Pharmacol, Adelaide, SA 5005, Australia		Steele, L (corresponding author), Baylor Coll Med, Dept Psychiat & Behav Sci, Beth K & Stuart C Yudofsky Div Neuropsychiat, Vet Hlth Res Program, Houston, TX 77030 USA.; Sullivan, K (corresponding author), Boston Univ, Dept Environm Hlth, Sch Publ Hlth, Boston, MA 02118 USA.	Lea.Steele@bcm.edu; nklimas@nova.edu; mhk@bu.edu; eq@bu.edu; toomey@bu.edu; Deborah.M.Little@uth.tmc.edu; mabreu1@nova.edu; kaenlle@nova.edu; killiany@bu.edu; bbkoo@bu.edu; paj@bu.edu; tch@bu.edu; andark@bcm.edu; ajamajoy@bu.edu; jcirillo@bu.edu; buentellojerry@prahs.com; vanesa.lerma@bcm.edu; janet.coller@adelaide.edu.au; tty@bu.edu		Koo, Bang-bon/0000-0001-7423-5572; Heeren, Timothy/0000-0001-5643-3559; Sullivan, Kimberly/0000-0001-7940-6123	Congressionally-Directed Medical Research Program (CDMRP) Gulf War Illness Research Program, U.S. Department of Defense, through CDMRP consortium award [W81XWH-13-2-0072]	This research was funded by the Congressionally-Directed Medical Research Program (CDMRP) Gulf War Illness Research Program, U.S. Department of Defense, through CDMRP consortium award W81XWH-13-2-0072 to Kimberly Sullivan at Boston University. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense.	AbouDonia MB, 1996, J TOXICOL ENV HEALTH, V48, P35, DOI 10.1080/009841096161456; Anastasides N, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-018-0881-8; [Anonymous], 2020, SAS SOFTW V 9 4; Buysse D J, 1989, Psychiatry Res, V28, P193; Callahan, 1992, INVESTIGATION SUSPEC; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P443; Chao LL, 2018, MIL MED, V183, pE571, DOI 10.1093/milmed/usy109; Chao LDL, 2011, NEUROTOXICOLOGY, V32, P814, DOI 10.1016/j.neuro.2011.06.006; Cheng CH, 2020, BRAIN BEHAV IMMUN, V89, P281, DOI 10.1016/j.bbi.2020.07.006; Cherry N, 2001, OCCUP ENVIRON MED, V58, P299, DOI 10.1136/oem.58.5.299; Eisen SA, 2005, ANN INTERN MED, V142, P881, DOI 10.7326/0003-4819-142-11-200506070-00005; Fappiano CM, 2020, MIL MED, V185, pE1120, DOI 10.1093/milmed/usz471; First M., 2015, STRUCTURED CLIN INTE; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Gean EG, 2021, LIFE SCI, V275, DOI 10.1016/j.lfs.2021.119360; Gifford EJ, 2021, LIFE SCI, V278, DOI 10.1016/j.lfs.2021.119454; Guan Y, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110884; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P231, DOI 10.1001/jama.277.3.231; Hattiangady B, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00078; Heaton KJ, 2007, NEUROTOXICOLOGY, V28, P761, DOI 10.1016/j.neuro.2007.03.006; Janulewicz P, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8110198; Janulewicz PA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177121; Kaimal G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228574; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kazis LE., 2000, MED OUTCOMES TRUST M, V5, P1; Krengel M, 2021, LIFE SCI, V280, DOI 10.1016/j.lfs.2021.119623; Lacagnina MJ, 2021, BRAIN BEHAV IMMUN, V91, P418, DOI 10.1016/j.bbi.2020.10.022; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Michalovicz LT, 2020, NEUROPHARMACOLOGY, V171, DOI 10.1016/j.neuropharm.2020.108073; National Academy of Sciences Institute of Medicine, 2014, CHRON MULT ILLN GULF; Nisenbaum R, 2000, J NERV MENT DIS, V188, P259, DOI 10.1097/00005053-200005000-00002; Porter B, 2020, J OCCUP ENVIRON MED, V62, P4, DOI 10.1097/JOM.0000000000001716; Proctor S.P., DEV STRUCTURED NEURO; Research Advisory Committee on Gulf War Veterans' Illnesses, 2014, GULF WAR ILLNESS HLT; Research Advisory Committee on Gulf War Veterans' Illnesses, 2008, GULF WAR ILLNESS HLT, P560; Richardson RD, 2001, ARCH INTERN MED, V161, P1289, DOI 10.1001/archinte.161.10.1289; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Shuster JJ, 2009, STAT MED, V28, P2170, DOI 10.1002/sim.3581; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Steele L, 2012, ENVIRON HEALTH PERSP, V120, P112, DOI 10.1289/ehp.1003399; STRETCH RH, 1995, MIL MED, V160, P131, DOI 10.1093/milmed/160.3.131; Sullivan K, 2003, J PSYCHOPATHOL BEHAV, V25, P95, DOI 10.1023/A:1023342915425; Sullivan K, 2020, J WOMENS HEALTH, V29, P819, DOI 10.1089/jwh.2019.7705; Sullivan K, 2018, NEUROTOXICOL TERATOL, V65, P1, DOI 10.1016/j.ntt.2017.11.002; U.S. Department of Defense, 1992, COND PERS GULF WAR C; U.S. Department of Veterans Affairs Office of Research Development, GULF WAR RES STRAT P; Vojdani A, 2004, ENVIRON HEALTH PERSP, V112, P840, DOI 10.1289/ehp.6881; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Yee MK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070079; Zakirova Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119579; Zhang QW, 1999, CLIN DIAGN LAB IMMUN, V6, P6, DOI 10.1128/CDLI.6.1.6-13.1999; Zhang Y, 2020, NEUROTOXICOLOGY, V78, P71, DOI 10.1016/j.neuro.2020.02.006; Zundel CG, 2020, NEUROSCI INSIGHTS, V15, DOI 10.1177/2633105520952675	59	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	SEP	2021	11	9							1132	10.3390/brainsci11091132			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UV0LE	WOS:000699180900001	34573153				2022-02-06	
J	Stitt, D; Draper, N; Alexander, K; Kabaliuk, N				Stitt, Danyon; Draper, Nick; Alexander, Keith; Kabaliuk, Natalia			Laboratory Validation of Instrumented Mouthguard for Use in Sport	SENSORS			English	Article						instrumented mouthguard; head impacts; concussion; accelerations; sports	INJURY SURVEILLANCE SYSTEM; SCHOOL FOOTBALL PLAYERS; ICE HOCKEY INJURIES; HEAD IMPACTS; DESCRIPTIVE EPIDEMIOLOGY; RECURRENT CONCUSSION; RECOVERY-TIME; RUGBY LEAGUE; RISK; ASSOCIATION	Concussion is an inherent risk of participating in contact, combat, or collision sports, within which head impacts are numerous. Kinematic parameters such as peak linear and rotational acceleration represent primary measures of concussive head impacts. The ability to accurately measure and categorise such impact parameters in real time is important in health and sports performance contexts. The purpose of this study was to assess the accuracy of the latest HitIQ Nexus A9 instrumented mouthguard (HitIQ Pty. Ltd. Melbourne Australia) against reference sensors in an aluminium headform. The headform underwent drop testing at various impact intensities across the NOCSAE-defined impact locations, comparing the peak linear and rotational acceleration (PLA and PRA) as well as the shapes of the acceleration time-series traces for each impact. Mouthguard PLA and PRA measurements strongly correlated with (R-2 = 0.996 and 0.994 respectively), and strongly agreed with (LCCC = 0.997) the reference sensors. The root mean square error between the measurement devices was 1 +/- 0.6g for linear acceleration and 47.4 +/- 35 rad/s(2) for rotational acceleration. A Bland-Altman analysis found a systematic bias of 1% for PRA, with no significant bias for PLA. The instrumented mouthguard displayed high accuracy when measuring head impact kinematics in a laboratory setting.	[Stitt, Danyon; Alexander, Keith; Kabaliuk, Natalia] Univ Canterbury, Dept Mech Engn, Christchurch 8041, New Zealand; [Draper, Nick] Univ Canterbury Christchurch, Sch Hlth Sci, Christchurch 8041, New Zealand		Draper, N (corresponding author), Univ Canterbury Christchurch, Sch Hlth Sci, Christchurch 8041, New Zealand.	danyon.stitt@pg.canterbury.ac.nz; nick.draper@canterbury.ac.nz; keith.alexander@canterbury.ac.nz; natalia.kabaliuk@canterbury.ac.nz		Kabaliuk, Natalia/0000-0002-9899-3738; Stitt, Danyon/0000-0002-7139-3660			ACC, 2015, ACC NAT GUID; Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; ESTWANIK J J, 1984, Physician and Sportsmedicine, V12, P123; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fuller CW, 2017, BRIT J SPORT MED, V51, P1272, DOI 10.1136/bjsports-2016-097301; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gough C., 2019, COUNTRIES NUMBER REG; Greybe DG, 2020, SPORTS ENG, V23, DOI 10.1007/s12283-020-00324-z; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2019, J SCI MED SPORT, V22, P532, DOI 10.1016/j.jsams.2018.10.015; King D, 2017, ARC J RES SPORTS MED, V2, P9; King D, 2019, SPORTS MED, V49, P1559, DOI 10.1007/s40279-019-01151-4; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2018, J SCI MED SPORT, V21, P139, DOI 10.1016/j.jsams.2017.10.026; Klein R., BLAND ALTMAN CORRELA; Lange D., 2019, NUMBER PEOPLE PARTIC; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lock S., 2018, NUMBER PARTICIPANTS; Lock S., 2020, NUMBER PARTICIPANTS; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McBride, 2005, PROPOSAL STRENGTH AG; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; NOCSAE, 2017, IMP ATT TESTS; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Rugby W., 2017, GLOBAL RUGBY PARTICI; Schussler E, 2017, INT J SPORTS PHYS TH, V12, P592; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Silver D, 2018, J NEUROL SCI, V388, P40, DOI 10.1016/j.jns.2018.02.046; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448	57	1	1	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	SEP	2021	21	18							6028	10.3390/s21186028			13	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	UX9KC	WOS:000701153900001	34577235	Green Published, gold			2022-02-06	
J	Terry, DP; Reddi, PJ; Cook, NE; Seifert, T; Maxwell, BA; Zafonte, R; Berkner, PD; Iverson, GL				Terry, Douglas P.; Reddi, Preethi J.; Cook, Nathan E.; Seifert, Tad; Maxwell, Bruce A.; Zafonte, Ross; Berkner, Paul D.; Iverson, Grant L.			Acute Effects of Concussion in Youth With Pre-existing Migraines	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; migraine; traumatic brain injury; acute effects; cognition	SPORT-RELATED CONCUSSION; COGNITIVE FUNCTION; POSTTRAUMATIC MIGRAINE; HEADACHE; RECOVERY; CHILDREN; PREVALENCE; SEVERITY; VERTIGO; AGE	Objective: To examine associations between pre-existing migraines and postconcussion symptoms and cognitive performance acutely (within 72 hours) after a suspected concussion. Design: Nested case-control study. Setting: High schools in Maine, USA. Participants: From a sample of 39 161 adolescent athletes who underwent baseline preseason testing, 633 were assessed within 3 days of a suspected concussion. Of these, 59 reported a history of treatment for migraines at baseline (9.3%). These athletes were individually matched to 2 athletes who had a suspected concussion but denied preinjury migraines (total N = 177; age: M = 15.8, SD = 1.3). Assessment of Risk Factors: Self-reported history of treatment for migraines by a physician. Main Outcome Measures: Post-Concussion Symptom Scale total score, ImPACT composite scores, and individual symptom endorsement. Results: Individuals with a pre-existing migraine disorder endorsed greater symptom severity (M = 8.4, SD = 9.9) compared with controls (M = 4.5, SD = 6.5; Cohen's d = 0.47) at preinjury baseline and acutely after suspected injury (migraine: M = 26.0, SD = 25.5; controls: M = 16.7, SD = 15.4; d = 0.44). Acutely after a suspected concussion, greater proportions of athletes with migraine disorders reported mental fogginess (49.2% vs 33.9%) and memory problems (39.0% vs 24.6%; P < 0.05). Baseline ImPACT composite scores were similar between migraine and control groups (d = 0.04-0.13). Adolescents with pre-existing migraine disorders performed worse after a suspected concussion compared with the control participants on verbal memory (F = 4.32, P = 0.041) and visual memory (F = 3.95, P = 0.049). Conclusions: Individuals with pre-existing migraine disorders may be at higher risk for worse outcomes, including greater overall burden of symptoms and worse cognitive functioning in the memory domain, in the first 72 hours after concussion.	[Terry, Douglas P.; Cook, Nathan E.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Charlestown, MA USA; [Terry, Douglas P.; Cook, Nathan E.; Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Terry, Douglas P.; Cook, Nathan E.; Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Terry, Douglas P.; Zafonte, Ross; Iverson, Grant L.] Home Base, 79-96 Thirteenth St, Charlestown, MA 02129 USA; [Terry, Douglas P.; Cook, Nathan E.; Iverson, Grant L.] MassGen Hosp Children Sports Concuss Program, Boston, MA USA; [Reddi, Preethi J.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Seifert, Tad] Univ Louisville, Dept Neurol, Dept Sports Med, Norton Healthcare, Louisville, KY 40292 USA; [Seifert, Tad] Univ Louisville, Dept Sports Hlth, Dept Sports Med, Norton Healthcare, Louisville, KY 40292 USA; [Maxwell, Bruce A.] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Zafonte, Ross] Harvard Med Sch, Massachusetts Gen Hosp, Brigham & Womens Hosp, Spaulding Rehabil Hosp,Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA		Iverson, GL (corresponding author), Home Base, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu			National Football League	This study was funded in part by the National Football League for a program of research entitled "The Spectrum of Concussion: Predictors of Clinical Recovery, Treatment and Rehabilitation, and Possible Long-Term Effects." Unrestricted philanthropic support was provided by ImPACT Applications, Inc, the Mooney-Reed Charitable Foundation, Boston Bolts, the Heinz Family Foundation, and the Spaulding Research Institute.	Abu-Arafeh I, 2010, DEV MED CHILD NEUROL, V52, P1088, DOI 10.1111/j.1469-8749.2010.03793.x; Balatsouras DG, 2007, INT J PEDIATR OTORHI, V71, P487, DOI 10.1016/j.ijporl.2006.11.024; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Ferracini GN, 2014, HEADACHE, V54, P325, DOI 10.1111/head.12251; Gaist D, 2005, NEUROLOGY, V64, P600, DOI 10.1212/01.WNL.0000151858.15482.66; Gooch CL, 2017, ANN NEUROL, V81, P479, DOI 10.1002/ana.24897; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jelicic M, 2000, HEADACHE, V40, P715, DOI 10.1046/j.1526-4610.2000.00124.x; Kelman L, 2005, HEADACHE, V45, P904, DOI 10.1111/j.1526-4610.2005.05159.x; Kobor J, 2013, EUR J PAEDIATR NEURO, V17, P600, DOI 10.1016/j.ejpn.2013.05.006; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Le Pira F, 2000, CEPHALALGIA, V20, P475, DOI 10.1046/j.1468-2982.2000.00074.x; McCaslin DL, 2011, OTOLARYNG CLIN N AM, V44, P291, DOI 10.1016/j.otc.2011.01.003; McDevitt J, 2015, BRAIN INJURY, V29, P1674, DOI 10.3109/02699052.2015.1075252; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Mulder EJCM, 1999, CEPHALALGIA, V19, P557, DOI 10.1046/j.1468-2982.1999.019006557.x; Pearson AJ, 2006, CEPHALALGIA, V26, P74, DOI 10.1111/j.1468-2982.2005.01001.x; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Rist PM, 2013, HEADACHE, V53, P589, DOI 10.1111/head.12046; Smith MS, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e376; Terry DP, 2019, J NEUROTRAUM, V36, P142, DOI 10.1089/neu.2017.5443; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vos T., 2012, LANCET, V380, P2163, DOI [DOI 10.1016/S0140-6736(12)61729-2, 10.1016/S0140-6736(12)61729-2.Erratumin]; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	32	1	1	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2021	31	5					430	437		10.1097/JSM.0000000000000791			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3KG	WOS:000711670400020	31842054				2022-02-06	
J	Tham, SW; Palermo, TM; Chrisman, SPD; Groenewald, CB				Tham, See Wan; Palermo, Tonya M.; Chrisman, Sara P. D.; Groenewald, Cornelius B.			Prescription Opioid Misuse and Sports-Related Concussion Among High School Students in the United States	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescents; concussion; prescription opioid misuse	RISK-FACTORS; ADOLESCENTS; DEPRESSION; PREVALENCE; PAIN; SYMPTOMS; CHILDREN; INJURY; TRENDS; ABUSE	Study Objective: Concussion is highly prevalent in adolescents and associated with a higher risk of substance use. With the rising use of opioids among adolescents, one form of substance use of concern is the misuse of prescription opioids. This study aimed to examine the association between a history of sports-related concussion in the past year and current prescription opioid misuse among high school students in the United States. Setting: Secondary data analysis from the 2019 Youth Risk Behavior Survey. Participants: Nationally representative sample of high school students (n = 7314). Design: Cross-sectional study. Main Measures: Participants were asked whether they experienced any concussions related to sports or being physically active during the past 12 months and whether they had any prescription opioid misuse within the past 30 days. Results: Among this cohort, 14.0% reported sustaining a concussion in the past 12 months and 6% reported current prescription opioid misuse. The prevalence of prescription opioid misuse was higher among those with a history of concussion (9.9%) than among those without concussion (5.5%, P = .002). Controlling for covariates (sex, race/ethnicity, other substance use, depressive symptoms), the odds of prescription opioid misuse was 1.5 times higher for adolescents with concussion than those without (adjusted odds ratios [aOR] = 1.5; 95% CI, 1.0-2.3; P = .029). Conclusion: Concussion was associated with prescription opioid misuse among the US youth, even after accounting for depressive symptoms and other substance use. Longitudinal studies are needed to test causal relationships and understand biobehavioral mechanisms that underlie associations between concussion and opioid misuse in adolescents.	Seattle Childrens Hosp, Ctr Child Hlth Behav & Dev, Dept Anesthesiol & Pain Med, Seattle, WA USA; Univ Washington, Sch Med, Seattle, WA USA		Tham, SW (corresponding author), Seattle Childrens Hosp, Anesthesiol & Pain Med, M SMB 11-500-3 4800 Sand Point Way NE, Seattle, WA 98105 USA.	see.tham@seattlechildrens.org; tonya.palermo@seattlechildrens.org; sara.chrisman@seattlechildrens.org; cornelius.groenewald@seattlechildrens.org			National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [K23DK118111]; NationalHeart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL138155]	Dr Tham was supported by grant K23DK118111 from theNational Institute of Diabetes andDigestive and Kidney Diseases. DrGroenewald was supported by grantK23HL138155 from theNationalHeart, Lung, and Blood Institute. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by the NIH.	Cerda M, 2015, J PEDIATR-US, V167, P605, DOI 10.1016/j.jpeds.2015.04.071; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Clayton HB, 2019, AM J PREV MED, V57, P533, DOI 10.1016/j.amepre.2019.05.017; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Edlund MJ, 2015, DRUG ALCOHOL DEPEN, V152, P131, DOI 10.1016/j.drugalcdep.2015.04.010; Gaither JR, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6558; Gregorian R, 2020, J PAIN RES, V13, P987, DOI 10.2147/JPR.S242825; Groenewald CB, 2020, PAIN, V161, P742, DOI 10.1097/j.pain.0000000000001775; Haarbauer-Krupa J, 2021, ANN EPIDEMIOL, V54, P11, DOI 10.1016/j.annepidem.2020.11.006; Ho RA, 2020, BRAIN INJURY, V34, P520, DOI 10.1080/02699052.2020.1725841; Hudgins JD, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002922; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; Kelley-Quon LI, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2019.1750; Knell G, 2020, AM J SPORT MED, V48, P2534, DOI 10.1177/0363546520938776; Knight JR, 2002, ARCH PEDIAT ADOL MED, V156, P607, DOI 10.1001/archpedi.156.6.607; Lowry R, 2021, AM J PREV MED, V60, P352, DOI 10.1016/j.amepre.2020.10.018; Luciana M, 2018, DEV COGN NEUROS-NETH, V32, P67, DOI 10.1016/j.dcn.2018.02.006; McCabe SE, 2019, LANCET PSYCHIAT, V6, P840, DOI 10.1016/S2215-0366(19)30299-8; Meier A, 2014, AM J DRUG ALCOHOL AB, V40, P304, DOI 10.3109/00952990.2014.910519; Pontes NMH, 2020, NURS RES, V69, P176, DOI 10.1097/NNR.0000000000000424; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Shore J, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-0233-8; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Tham SW, 2013, J PAIN, V14, P1242, DOI 10.1016/j.jpain.2013.05.007; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Vaughn MG, 2016, J PSYCHIATR RES, V73, P17, DOI 10.1016/j.jpsychires.2015.11.003; Veliz P, 2021, SUBST ABUS, V42, P183, DOI 10.1080/08897077.2019.1671938; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Voepel-Lewis T, 2016, CLIN J PAIN, V32, P187, DOI 10.1097/AJP.0000000000000137; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Yang MN, 2019, AM J HEALTH BEHAV, V43, P258, DOI 10.5993/AJHB.43.2.3; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	36	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2021	36	5			SI		338	344		10.1097/HTR.0000000000000706			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UL1UK	WOS:000692444300010	34489384	Green Accepted			2022-02-06	
J	Wu, YJ; Rauen, K; Zeldovich, M; Voormolen, DC; Covic, A; Cunitz, K; Plass, AM; Polinder, S; Haagsma, JA; von Steinbuechel, N				Wu, Yi-Jhen; Rauen, Katrin; Zeldovich, Marina; Voormolen, Daphne C.; Covic, Amra; Cunitz, Katrin; Plass, Anne-Marie; Polinder, Suzanne; Haagsma, Juanita A.; von Steinbuechel, Nicole			Reference Values and Psychometric Properties of the Quality of Life After Traumatic Brain Injury-Overall Scale in Italy, The Netherlands, and the United Kingdom	VALUE IN HEALTH			English	Article						QOLIBRI-OS; HRQoL; reference values; measurement invariance; TBI	FIT INDEXES; HEALTH SURVEY; QOLIBRI; VALIDATION; SF-36; TRANSLATION; COUNTRIES; NORMS	Objectives: The Quality of Life after Brain Injury-Overall Scale (QOLIBRI-OS) is a short screening instrument for assessing disease-specific health-related quality of life (HRQoL) after traumatic brain injury. To date, no reference values are available for the QOLIBRI-OS in general populations. Thus, this study aimed to establish reference values for the QOLIBRIOS in general population samples from Italy, The Netherlands, and the United Kingdom. Methods: Data were collected using an online survey. The total sample comprised 11759 participants, consisting of 3549 Italian, 3564 Dutch, and 4646 British subjects. In this sample, 49% of the total sample did not report any health complaints, whereas 51% had at least 1 chronic health condition. Reference values were deduced for the QOLIBRI-OS for health-condition- related samples and total general population samples per country. To ensure the comparability of these values, measurement invariance was assessed using a multigroup confirmatory factor analysis. Covariates characterizing the reference values were selected with the help of regression analyses. Results: The confirmatory factor analysis confirmed that the QOLIBRI-OS scores measured the same traumatic brain injury- specific HRQoL construct across the 3 countries. Healthy individuals reported significantly higher HRQoL than individuals with at least 1 chronic health condition. Older age and higher education levels were significantly associated with higher HRQoL. Conclusions: Because the reference values displayed differences in terms of age and education level across the 3 countries, we recommend using country-specific reference values stratified by sociodemographic and health status in research and clinical practice.	[Wu, Yi-Jhen; Zeldovich, Marina; Covic, Amra; Cunitz, Katrin; Plass, Anne-Marie; von Steinbuechel, Nicole] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Waldweg 37, D-37073 Gottingen, Germany; [Rauen, Katrin] Univ Zurich, Psychiat Hosp Zurich, Dept Geriatr Psychiat, Zurich, Switzerland; [Rauen, Katrin] Ludwig Maximilians Univ Munchen, Univ Hosp ISD, Inst Stroke & Dementia Res, Munich, Germany; [Voormolen, Daphne C.; Polinder, Suzanne; Haagsma, Juanita A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Haagsma, Juanita A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Emergency Med, Rotterdam, Netherlands; [Voormolen, Daphne C.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands		von Steinbuechel, N (corresponding author), Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Waldweg 37, D-37073 Gottingen, Germany.	nvsteinbuechel@med.uni-goettingen.de			European Union's 7th Framework Programme (EC) [602150]; One Mind (USA); Integra LifeSciences Holdings Corporation (USA); NeuroTrauma Sciences, LLC (USA); Hannelore Kohl Stiftung (Germany)	CENTER-TBI was supported by the European Union's 7th Framework Programme (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), One Mind (USA), Integra LifeSciences Holdings Corporation (USA), and NeuroTrauma Sciences, LLC (USA).	Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x; Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; [Anonymous], OECD STAT; [Anonymous], POPULATION ED ATTAIN; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Black N, 2016, QUAL LIFE RES, V25, P1103, DOI 10.1007/s11136-015-1168-3; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; BROWNE MW, 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Bullock M Ross, 2002, Neurosurg Focus, V13, pECP1; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Costello A. B., 2005, PRACTICAL ASSESSMENT, V10; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Garratt AM, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0625-9; George D., 2010, SPSS WINDOWS STEP ST, V10th; Giustini M, 2014, FUNCT NEUROL, V29, P167, DOI 10.11138/FNeur/2014.29.3.167; Gorbunova A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072100; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Heiberg G, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1101-9; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Khan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132229; Konig HH, 2009, MED CARE, V47, P255, DOI 10.1097/MLR.0b013e318184759e; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Liegl G, 2019, EUR J CANCER, V107, P133, DOI 10.1016/j.ejca.2018.11.023; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Machin D, 2013, QUALITY LIFE ASSESSM; Maruish ME, 2011, USERS MANUAL SF36V2; Montazeri A, 2005, QUAL LIFE RES, V14, P875, DOI 10.1007/s11136-004-1014-5; Muehlan H, 2016, ASSESSMENT, V23, P124, DOI 10.1177/1073191115569844; Netuveli G, 2008, BRIT MED BULL, V85, P113, DOI 10.1093/bmb/ldn003; Oosterhuis HEM, 2016, ASSESSMENT, V23, P191, DOI 10.1177/1073191115580638; Parmenter BA, 2010, J INT NEUROPSYCH SOC, V16, P6, DOI 10.1017/S1355617709990750; Patricio B, 2014, SOC INDIC RES, V119, P1557, DOI 10.1007/s11205-013-0559-5; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; QOLIBRI, ONL HOM QOLIBRI; R Core Team, 2020, R LANG ENV STAT COMP; Rauen K, 2021, GEROSCIENCE, V43, P263, DOI 10.1007/s11357-020-00273-2; Revelle W., psych: Procedures for personality and psychological research. R package, version 1.8.12; Rose MS, 1999, J CLIN EPIDEMIOL, V52, P405, DOI 10.1016/S0895-4356(99)00014-1; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Skevington SM, 2002, QUAL LIFE RES, V11, P135, DOI 10.1023/A:1015013312456; Soberg HL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0589-9; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Steiger J. H., 1980, ANN SPRING M PSYCH S; Torrance N, 2009, J EVAL CLIN PRACT, V15, P328, DOI 10.1111/j.1365-2753.2008.01006.x; Truelle JL, 2017, NEUROPSYCHIATRY-LOND, V7; Uzark K, 2013, CONGENIT HEART DIS, V8, P211, DOI 10.1111/chd.12002; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; West SG., 2012, HDB STRUCTURAL EQUAT, P209; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Wong GKC, 2014, J CLIN NEUROSCI, V21, P954, DOI 10.1016/j.jocn.2013.09.010; Wu H, 2016, PSYCHOMETRIKA, V81, P1014, DOI 10.1007/s11336-016-9506-0	60	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	SEP	2021	24	9					1319	1327		10.1016/j.jval.2021.04.1282			9	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Business & Economics; Health Care Sciences & Services	UG5RC	WOS:000689308300012	34452712				2022-02-06	
J	Lu, LY; Zhang, J; Li, FF; Shang, SA; Chen, HY; Yin, XD; Gao, W; Chen, YC				Lu, Liyan; Zhang, Juan; Li, Fengfang; Shang, Song'an; Chen, Huiyou; Yin, Xindao; Gao, Wei; Chen, Yu-Chen			Aberrant Static and Dynamic Functional Network Connectivity in Acute Mild Traumatic Brain Injury with Cognitive Impairment	CLINICAL NEURORADIOLOGY			English	Article; Early Access						mTBI; Resting-state networks; Static connectivity; Dynamic connectivity; Acute stage	WORKING-MEMORY; ATTENTION; DEFICITS; SPEECH; FMRI	Purpose This study aimed to investigate differences in static and dynamic functional network connectivity (FNC) and explore their association with neurocognitive performance in acute mild traumatic brain injury (mTBI). Methods A total of 76 patients with acute mTBI and 70 age-matched and sex-matched healthy controls were enrolled (age 43.79 +/- 10.22 years vs. 45.63 +/- 9.49 years; male/female: 34/42 vs. 38/32; all p > 0.05) and underwent resting-state functional magnetic resonance imaging (fMRI) scan (repetition time/echo time = 2000/30 ms, 230 volumes). Independent component analysis was conducted to evaluate static and dynamic FNC patterns on the basis of nine resting-state networks, namely, auditory network (AUDN), dorsal attention network (dAN), ventral attention network (vAN), default mode network (DMN), left frontoparietal network (LFPN), right frontoparietal network (RFPN), somatomotor network (SMN), visual network (VN), and salience network (SN). Spearman's correlation among aberrances in FNC values, and Montreal cognitive assessment (MoCA) scores was further measured in mTBI. Results Compared with controls, patients with mTBI showed wide aberrances of static FNC, such as reduced FNC in DMN-vAN and VN-vAN pairs. The mTBI patients exhibited aberrant dynamic FNC in state 2, involving reduced FNC aberrance in the vAN with AUDN, VN with DMN and dAN, and SN with SMN and vAN. Reduced dFNC in the SN-vAN pair was negatively correlated with the MoCA score. Conclusion Our findings suggest that aberrant static and dynamic FNC at the acute stage may contribute to cognitive symptoms, which not only may expand knowledge regarding FNC cognition relations from the static perspective but also from the dynamic perspective.	[Lu, Liyan; Li, Fengfang; Shang, Song'an; Chen, Huiyou; Yin, Xindao; Gao, Wei; Chen, Yu-Chen] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China; [Zhang, Juan] Nanjing First Hosp, Yuhua Branch, Dept Neurol, Nanjing 210006, Peoples R China		Gao, W; Chen, YC (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China.	gao1974@yeah.net; chenyuchen1989@126.com		Chen, Yu-Chen/0000-0002-8539-7224	Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82102012, 82102006]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20201118]; 333 High-level Talents Training Project of Jiangsu Province [BRA2019122]	This work was supported by the Natural Science Foundation of China (No.82102012, 82102006), Natural Science Foundation of Jiangsu Province (No. BK20201118) and 333 High-level Talents Training Project of Jiangsu Province (No. BRA2019122).	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Chand GB, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00367; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; D'Souza MM, 2020, NEURORADIOL J, V33, P186, DOI 10.1177/1971400920901706; Du YH, 2016, SCHIZOPHR RES, V170, P55, DOI 10.1016/j.schres.2015.11.021; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Hou JM, 2017, J NEUROTRAUM, V34, P2456, DOI 10.1089/neu.2016.4851; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jerde TA, 2012, J NEUROSCI, V32, P17382, DOI 10.1523/JNEUROSCI.3810-12.2012; Jiang SF, 2020, EUR J RADIOL, V132, DOI 10.1016/j.ejrad.2020.109324; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kuiper JJ, 2020, HEARING RES, V396, DOI 10.1016/j.heares.2020.108078; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li FF, 2020, CNS NEUROSCI THER, V26, P1083, DOI 10.1111/cns.13430; Liu F, 2015, BRAIN TOPOGR, V28, P221, DOI 10.1007/s10548-014-0386-2; Liu J, 2019, J AFFECT DISORDERS, V252, P55, DOI 10.1016/j.jad.2019.04.033; Lu LY, 2020, BRAIN IMAGING BEHAV, V14, P941, DOI 10.1007/s11682-020-00288-5; Malhi GS, 2019, BRIT J PSYCHIAT, V215, P545, DOI 10.1192/bjp.2019.10; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Morillon B, 2010, P NATL ACAD SCI USA, V107, P18688, DOI 10.1073/pnas.1007189107; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Nourski KV, 2014, NEUROIMAGE, V101, P598, DOI 10.1016/j.neuroimage.2014.07.004; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Vergara VM, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.809; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Wang CL, 2020, NEURAL PLAST, V2020, DOI 10.1155/2020/8894868; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Widjaja E, 2013, AM J NEURORADIOL, V34, P2386, DOI 10.3174/ajnr.A3608; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	43	1	1	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1869-1439	1869-1447		CLIN NEURORADIOL	Clin. Neuroradiol.												10.1007/s00062-021-01082-6		AUG 2021	10	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	UK1BO	WOS:000691710100003	34463779				2022-02-06	
J	McCrea, MA; Cramer, SC; Okonkwo, DO; Mattke, S; Paadre, S; Bates, D; Nejadnik, B; Giacino, JT				McCrea, Michael A.; Cramer, Steven C.; Okonkwo, David O.; Mattke, Soeren; Paadre, Susan; Bates, Damien; Nejadnik, Bijan; Giacino, Joseph T.			Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury	EXPERT REVIEW OF NEUROTHERAPEUTICS			English	Article						Brain injuries; traumatic; Delphi technique; disability evaluation; humans; minimally clinically important difference	FUGL-MEYER ASSESSMENT; DISABILITY RATING-SCALE; QUALITY-OF-LIFE; CHRONIC STROKE; UNITED-STATES; RECOVERY; REHABILITATION; HEALTH; RESPONSIVENESS; IMPAIRMENT	Objective To determine minimally clinically important differences (MCIDs) for Disability Rating Scale (DRS), Fugl-Meyer Upper Extremity Subscale (FM-UE), Fugl-Meyer Lower Extremity Subscale (FM-LE), and Fugl-Meyer Motor Scale (FMMS) in patients with chronic motor deficits secondary to traumatic brain injury (TBI). Methods Retrospective analysis from the 1-year, double-blind, randomized, surgical sham-controlled, Phase 2 STEMTRA trial (NCT02416492), in which patients with chronic motor deficits secondary to TBI (N = 61) underwent intracerebral stereotactic implantation of modified bone marrow-derived mesenchymal stromal (SB623) cells. MCIDs for DRS, FM-UE, FM-LE, and FMMS were triangulated with distribution-based, anchor-based, and Delphi panel estimates. Results Triangulated MCIDs were: 1) -1.5 points for the Disability Rating Scale; 2) 6.2 points for the Fugl-Meyer Upper Extremity Subscale; 3) 3.2 points for the Fugl-Meyer Lower Extremity Subscale; and 4) 8.4 points for the Fugl-Meyer Motor Scale. Conclusions For the first time in the setting of patients with chronic motor deficits secondary to TBI, this study reports triangulated MCIDs for: 1) DRS, a measure of global outcome; and 2) Fugl-Meyer Scales, measures of motor impairment. These findings guide the use of DRS and Fugl-Meyer Scales in the assessment of global disability outcome and motor impairment in future TBI clinical trials.	[McCrea, Michael A.] Med Coll Wisconsin, Ctr Neurotrauma Res, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Cramer, Steven C.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Cramer, Steven C.] Calif Rehabil Inst, Res, Los Angeles, CA USA; [Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Neurotrauma Clin Trials Ctr, Pittsburgh, PA USA; [Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Mattke, Soeren] USC Dornsife, Ctr Improving Chron Illness Care, Los Angeles, CA USA; [Paadre, Susan] Biostat Consulting Inc, Biostat, Lexington, MA USA; [Bates, Damien] SanBio Inc, Mountain View, CA USA; [Nejadnik, Bijan] SanBio Inc, Regulatory Med Affairs Res & Clin Dev, Mountain View, CA USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Rehabil Neuropsychol, Charlestown, MA USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, SRN Disorders Consciousness Program, Charlestown, MA USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Spaulding Harvard TBI Model Syst, Charlestown, MA USA; [Giacino, Joseph T.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA		McCrea, MA (corresponding author), Med Coll Wisconsin, Ctr Neurotrauma Res, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; McCrea, MA (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mmccrea@mcw.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698	SanBio, Inc.; Dr. Anthony Stonehouse of Watson AMP; Stonehouse Enterprises, LLC	Funding for this study was provided by SanBio, Inc., This included funding of medical writing support, provided by Dr. Anthony Stonehouse of Watson & Stonehouse Enterprises, LLC.	Alves WM., 2017, HDB NEUROMERGENCY CL, P167; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Brigden A, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-1028-2; Chatham CH, 2018, AUTISM RES, V11, P270, DOI 10.1002/aur.1874; Conroy SS, 2011, ARCH PHYS MED REHAB, V92, P1754, DOI 10.1016/j.apmr.2011.06.016; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; Cramer SC, 2019, JAMA NEUROL, V76, P1079, DOI 10.1001/jamaneurol.2019.1604; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hung M, 2018, CLIN ORTHOP RELAT R, V476, P2027, DOI 10.1097/CORR.0000000000000419; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kawabori M, 2021, NEUROLOGY, V96, pE1202, DOI 10.1212/WNL.0000000000011450; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Leidy Nancy Kline, 2005, COPD, V2, P157; Lemay KR, 2019, J CARDIOPULM REHABIL, V39, pE6, DOI 10.1097/HCR.0000000000000379; Levy RM, 2016, NEUROREHAB NEURAL RE, V30, P107, DOI 10.1177/1545968315575613; Lin JH, 2009, PHYS THER, V89, P840, DOI 10.2522/ptj.20080285; Lo AC, 2009, NEUROREHAB NEURAL RE, V23, P775, DOI 10.1177/1545968309338195; Malec JF, 2020, ARCH PHYS MED REHAB, V101, P1090, DOI 10.1016/j.apmr.2019.12.008; Malec JF, 2017, J HEAD TRAUMA REHAB, V32, pE47, DOI 10.1097/HTR.0000000000000268; Mattke S, 2020, CURR MED RES OPIN, V36, P1999, DOI 10.1080/03007995.2020.1841616; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Myles PS, 2016, ANESTHESIOLOGY, V125, P39, DOI 10.1097/ALN.0000000000001158; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Page SJ, 2012, PHYS THER, V92, P791, DOI 10.2522/ptj.20110009; Page SJ, 2009, STROKE, V40, P551, DOI 10.1161/STROKEAHA.108.528760; Pandian S, 2016, TOP STROKE REHABIL, V23, P233, DOI 10.1179/1945511915Y.0000000003; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Ranson J, 2019, J NEUROTRAUM, V36, P2493, DOI 10.1089/neu.2018.5998; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; See J, 2013, NEUROREHAB NEURAL RE, V27, P732, DOI 10.1177/1545968313491000; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sharma B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00879; Smid DE, 2017, J AM MED DIR ASSOC, V18, P53, DOI 10.1016/j.jamda.2016.08.002; Steinberg GK, 2019, J NEUROSURG, V131, P1462, DOI 10.3171/2018.5.JNS173147; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; Turner D, 2010, J CLIN EPIDEMIOL, V63, P28, DOI 10.1016/j.jclinepi.2009.01.024; van der Lee JH, 2001, J REHABIL MED, V33, P110; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wu CY, 2012, PHYS THER, V92, P1006, DOI 10.2522/ptj.20110282	50	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1473-7175	1744-8360		EXPERT REV NEUROTHER	Expert Rev. Neurother.	SEP 2	2021	21	9					1051	1058		10.1080/14737175.2021.1968299		AUG 2021	8	Clinical Neurology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy	US3FS	WOS:000690598400001	34402352	hybrid			2022-02-06	
J	Libeson, L; Ross, P; Downing, M; Ponsford, J				Libeson, Lauren; Ross, Pamela; Downing, Marina; Ponsford, Jennie			Factors associated with employment stability following traumatic brain injury, in a sample who have received comprehensive vocational rehabilitation	DISABILITY AND REHABILITATION			English	Article; Early Access						Traumatic brain injury; vocational rehabilitation; employment; return to work; employment stability	RETURN-TO-WORK; PROGNOSTIC-FACTORS; MODERATE; PROGRAM	Purpose To quantify employment stability of individuals with traumatic brain injury (TBI) who received comprehensive vocational rehabilitation (VR) using different measures to identify difficulties experienced and factors associated with employment stability. Materials and methods 72 individuals with predominantly moderate-severe TBI were interviewed. Neuropsychological assessment scores were collected. Three employment stability measures were used: number of post-injury employers, duration with employer and average weekly hours. Descriptive and predictive analyses were performed. Results 90.2% remained employed at time of interview (Mean = 4.83 years post-injury). However, participants worked significantly fewer hours, 63.9% had changed roles or employers at least once and only 51% achieved their pre-injury level of responsibility. 61% reported a high level of employer support. Self-reported difficulties included physical sequelae, memory problems and fatigue. Post-injury testing found impaired memory (34.4%) and processing speed (49.2%). After accounting for time since injury, demographic and employment variables (older age, male gender, higher pre-injury skill-level, higher level of employer support), higher level of injury-related difficulties and lower level of cognitive function significantly predicted employment stability. Conclusion Injury-related difficulties impact employment long-term, necessitating ongoing work modifications. Individualised VR is important, not only to facilitate return to work but to support long-term employment stability after TBI.	[Libeson, Lauren; Downing, Marina; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Libeson, Lauren; Ross, Pamela; Downing, Marina; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Ross, Pamela] Epworth HealthCare, Richmond, Vic, Australia		Libeson, L (corresponding author), 2-70 Durrant St, Brighton, Vic 3186, Australia.	lauren.libeson@monash.edu	; Ponsford, Jennie/H-8341-2014	Downing, Marina/0000-0002-3126-6632; Ponsford, Jennie/0000-0003-0430-125X			Agency for Clinical Innovation, 2016, INVESTIGATION VOCATI; Agency for Clinical Innovation, 2016, INVESTIGATION VOCATI; Australian Bureau of Statistics, 2009, ANZSCO AUSTR NZ STAN, VANZSCO first edition revision 1; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Cogne M, 2017, BRAIN INJURY, V31, P655, DOI 10.1080/02699052.2017.1290827; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; DiSanto D, 2019, ARCH PHYS MED REHAB, V100, P412, DOI 10.1016/j.apmr.2018.06.022; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Donker-Cools BHPM, 2016, DISABIL REHABIL, V38, P733, DOI 10.3109/09638288.2015.1061608; Ellingsen KL., 2009, INT J DISABIL MANAG, V4, P1, DOI DOI 10.1375/JDMR.4.1.1; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Foy CML, 2014, J OCCUP REHABIL, V24, P533, DOI 10.1007/s10926-013-9488-z; Fraser EE, 2019, J NEUROTRAUM, V36, P2753, DOI 10.1089/neu.2019.6430; Gormley M, 2019, BRAIN INJURY, V33, P1567, DOI 10.1080/02699052.2019.1658222; Graham CW West MD Bourdon JL, CAMPBELL SYST REV, V12, P1; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hart T, 2019, REHABIL PSYCHOL, V64, P435, DOI 10.1037/rep0000290; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; Lexell J, 2016, BRAIN INJURY, V30, P969, DOI 10.3109/02699052.2016.1148196; Libeson L, 2020, NEUROPSYCHOL REHABIL, V30, P412, DOI 10.1080/09602011.2018.1470987; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Materne M, 2017, WORK, V56, P125, DOI 10.3233/WOR-162468; Moller Claire-Lynn, 2017, S. Afr. j. occup. ther., V47, P17, DOI 10.17159/2310-3833/2017/v47n3a4; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Possl O, 2001, BRAIN INJURY, V15, P15; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Schmidt M., 1996, REY AUDITORY VERBAL; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Watkin C, 2020, BRAIN INJURY, V34, P68, DOI 10.1080/02699052.2019.1681512; Wechsler, 1997, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Yousaf O, 2015, HEALTH PSYCHOL REV, V9, P264, DOI 10.1080/17437199.2013.840954	42	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.1965229		AUG 2021	8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	UF1LM	WOS:000688342800001	34498992				2022-02-06	
J	Van Houcke, J; Marien, V; Zandecki, C; Vanhunsel, S; Moons, L; Ayana, R; Seuntjens, E; Arckens, L				Van Houcke, Jolien; Marien, Valerie; Zandecki, Caroline; Vanhunsel, Sophie; Moons, Lieve; Ayana, Rajagopal; Seuntjens, Eve; Arckens, Lutgarde			Aging impairs the essential contributions of non-glial progenitors to neurorepair in the dorsal telencephalon of the Killifish Nothobranchius furzeri	AGING CELL			English	Article						aging; glial scar; inflammatory response; Killifish; neurodegenerative diseases; neuroregeneration; teleost; traumatic brain injury	ADULT NEUROGENESIS; NEURAL STEM; ZEBRAFISH; BRAIN; MODEL; REGENERATION; GENOME; INJURY	The aging central nervous system (CNS) of mammals displays progressive limited regenerative abilities. Recovery after loss of neurons is extremely restricted in the aged brain. Many research models fall short in recapitulating mammalian aging hallmarks or have an impractically long lifespan. We established a traumatic brain injury model in the African turquoise killifish (Nothobranchius furzeri), a regeneration-competent vertebrate that evolved to naturally age extremely fast. Stab-wound injury of the aged killifish dorsal telencephalon unveils an impaired and incomplete regeneration response when compared to young individuals. In the young adult killifish, brain regeneration is mainly supported by atypical non-glial progenitors, yet their proliferation capacity clearly declines with age. We identified a high inflammatory response and glial scarring to also underlie the hampered generation of new neurons in aged fish. These primary results will pave the way to unravel the factor age in relation to neurorepair, and to improve therapeutic strategies to restore the injured and/or diseased aged mammalian CNS.	[Van Houcke, Jolien; Marien, Valerie; Zandecki, Caroline; Ayana, Rajagopal; Arckens, Lutgarde] Katholieke Univ Leuven, Dept Biol, Lab Neuroplast & Neuroproteom, B-3000 Leuven, Belgium; [Zandecki, Caroline; Ayana, Rajagopal; Seuntjens, Eve] Katholieke Univ Leuven, Dept Biol, Dev Neurobiol Lab, Leuven, Belgium; [Vanhunsel, Sophie; Moons, Lieve] Katholieke Univ Leuven, Dept Biol, Lab Neural Circuit Dev & Regenerat, Leuven, Belgium; [Moons, Lieve; Seuntjens, Eve; Arckens, Lutgarde] KU Leuven Brain Inst, Leuven, Belgium		Arckens, L (corresponding author), Katholieke Univ Leuven, Dept Biol, Lab Neuroplast & Neuroproteom, B-3000 Leuven, Belgium.	lut.arckens@kuleuven.be		Zandecki, Caroline/0000-0002-7898-0550; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Arckens, Lutgarde/0000-0002-2909-8449; Ayana, R/0000-0002-9562-4638; Van houcke, Jolien/0000-0002-5072-6729; Seuntjens, Eve/0000-0002-0126-461X	Fonds Wetenschappelijk Onderzoek VlaanderenFWO [1S00318N, 1S16617N, G0C2618N]; KU LeuvenKU Leuven [KA-16-00745]	Fonds Wetenschappelijk Onderzoek Vlaanderen, Grant/Award Number: 1S00318N, 1S16617N and G0C2618N; KU Leuven, Grant/Award Number: KA-16-00745	Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ayari B, 2010, J NEUROTRAUM, V27, P959, DOI 10.1089/neu.2009.0972; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Bevan L, 2020, CARDIOVASC RES, V116, P1357, DOI 10.1093/cvr/cvz221; Bhattarai Prabesh, 2017, Neurogenesis (Austin), V4, pe1322666, DOI 10.1080/23262133.2017.1322666; CELIO MR, 1994, BRAIN RES REV, V19, P128, DOI 10.1016/0165-0173(94)90006-X; Chen JK, 2020, NAT NEUROSCI, V23, P1297, DOI 10.1038/s41593-020-0703-x; Choi HMT, 2016, DEVELOPMENT, V143, P3632, DOI 10.1242/dev.140137; CHOI HMT, 2018, DEVELOPMENT, V145, DOI DOI 10.1242/DEV.165753; Coolen M, 2020, CURR BIOL, V30, P736, DOI 10.1016/j.cub.2019.12.046; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Daynac M, 2017, RESULTS PROBL CELL D, V61, P375, DOI 10.1007/978-3-319-53150-2_17; de Keizer PLJ, 2017, TRENDS MOL MED, V23, P6, DOI 10.1016/j.molmed.2016.11.006; Deryckere A, 2021, ELIFE, V10, DOI 10.7554/eLife.69161; Dugger B. N., 2017, CSH PERSPECT BIOL, V9, DOI DOI 10.1101/CSHPERSPECT.A028035; Edelmann K, 2013, J COMP NEUROL, V521, P3099, DOI 10.1002/cne.23347; El-Hayek YH, 2019, J ALZHEIMERS DIS, V70, P321, DOI 10.3233/JAD-190426; Frik J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745294; Galvan V, 2007, CLIN INTERV AGING, V2, P605; Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x; Ghaddar B, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020391; Grade S, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0033-0; Grupp L, 2010, J COMP NEUROL, V518, P4277, DOI 10.1002/cne.22481; HARTIG W, 1992, NEUROREPORT, V3, P869; Hashimoto K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27990-1; Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Karp J.M., 2017, BIOL ENG STEM CELL N, P185, DOI [10.1016/B978-0-12-802734-9.00012-3, DOI 10.1016/B978-0-12-802734-9.00012-3]; Kawai H, 2001, GLIA, V36, P406, DOI 10.1002/glia.1126; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Marques IJ, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.167692; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Mu Y, 2019, CELL, V178, P27, DOI 10.1016/j.cell.2019.05.050; Polacik M, 2016, NAT PROTOC, V11, P1396, DOI 10.1038/nprot.2016.080; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Tozzini ET, 2012, AGING CELL, V11, P241, DOI 10.1111/j.1474-9726.2011.00781.x; Turnley AM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00029; Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048; Valenzano DR, 2015, CELL, V163, P1539, DOI 10.1016/j.cell.2015.11.008; Van Houcke J, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.619197; Verdugo CD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11739-z; Verheggen ICM, 2020, GEROSCIENCE, V42, P1183, DOI 10.1007/s11357-020-00211-2; Wahis J, 2021, CURR OPIN NEUROBIOL, V67, P174, DOI 10.1016/j.conb.2020.12.001; Zhao AD, 2016, BIOSCIENCE, V66, P735, DOI 10.1093/biosci/biw079; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021; ?zpolat D., 2020, I PROBE GENERATOR, DOI [10.5281/zenodo.4086058, DOI 10.5281/ZENODO.4086058]; Zupanc GKH, 2013, CURR TOP MICROBIOL, V367, P193, DOI 10.1007/82_2012_297	56	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1474-9718	1474-9726		AGING CELL	Aging Cell	SEP	2021	20	9							e13464	10.1111/acel.13464		AUG 2021	18	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	UQ1LU	WOS:000687776900001	34428340	Green Published, gold			2022-02-06	
J	Isung, J; Isomura, K; Larsson, H; Sidorchuk, A; Fernandez de la Cruz, L; Mataix-Cols, D				Isung, Josef; Isomura, Kayoko; Larsson, Henrik; Sidorchuk, Anna; Fernandez de la Cruz, Lorena; Mataix-Cols, David			Association of Tourette Syndrome and Chronic Tic Disorder With Cervical Spine Disorders and Related Neurological Complications	JAMA NEUROLOGY			English	Article							MOTOR TICS; MYELOPATHY; POPULATION; DISSECTION; REGISTER; BEHAVIOR; STROKE; RISK	IMPORTANCE Severe forms of Tourette syndrome or chronic tic disorder (TS/CTD) may involve repeated head jerking. Isolated case reports have described a spectrum of severe neck disorders in individuals with TS/CTD. However, the nature and prevalence of cervical spine disorders in TS/CTD are unknown. OBJECTIVE To establish if TS/CTD are associated with an increased risk of cervical spine disorders and related neurological complications compared with individuals from the general population. DESIGN, SETTING, AND PARTICIPANTS All individuals born from 1973 to 2013 and living in Sweden between 1997 and 2013 were identified. Individuals with a record of TS/CTD diagnosed in specialist settings were matched on age, sex, and county of birth with 10 unexposed individuals randomly selected from the general population. Cox proportional hazards regression models were used to estimate the risk of vascular and nonvascular cervical spine disorders among exposed individuals, compared with unexposed individuals. Models were adjusted for other known causes of cervical spine injury. Data were analyzed from March 19 to May 16, 2021. EXPOSURES International Statistical Classification of Diseases and Related Health Problems, Tenth Revision diagnoses of TS/CTD in the Swedish National Patient Register. Main Outcomes and Measures Records of cervical vascular disorders (ie, aneurysm, cerebral infarction, transitory cerebral ischemia) and cervical nonvascular disorders (ie, spondylosis, cervical disc disorders, fractures of the cervical spine, cervicalgia) and cervical surgeries. Covariates included rheumatic disorders, traffic injuries, fall- or sport-related injuries, and attention-deficit/hyperactivity disorder comorbidity. RESULTS A total of 6791 individuals with TS/CTD were identified (5238 [77.1%] were male; median [interquartile] age at first diagnosis, 15.6 [11.4-23.7] years) and matched to 67 910 unexposed individuals. Exposed individuals had a 39% increased risk of any cervical spine disorder (adjusted hazard ratio, 1.39; 95% CI, 1.22-1.59). Adjusted hazard ratios for cervical vascular and nonvascular disorders were 1.57 (95% CI, 1.16-2.13) and 1.38 (95% CI, 1.19-1.60), respectively. Risks were similar among men and women. CONCLUSIONS AND RELEVANCE Individuals with severe TS/CTD are at increased risk of cervical spine disorders. These outcomes are relatively rare but may lead to persistent disability in some individuals and thus require close monitoring to facilitate early interventions.	[Isung, Josef; Isomura, Kayoko; Sidorchuk, Anna; Fernandez de la Cruz, Lorena; Mataix-Cols, David] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Gavlegatan 22B, S-11330 Stockholm, Sweden; [Isung, Josef; Isomura, Kayoko; Sidorchuk, Anna; Fernandez de la Cruz, Lorena; Mataix-Cols, David] Reg Stockholm, Stockholm Hlth Care Serv, Stockholm, Sweden; [Larsson, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Larsson, Henrik] Orebro Univ, Sch Med Sci, Orebro, Sweden		Isung, J (corresponding author), Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Gavlegatan 22B, S-11330 Stockholm, Sweden.	josef.isung@ki.se					Bagheri MM, 1999, AM FAM PHYSICIAN, V59, P2263; Bajwa RJ, 2007, MOVEMENT DISORD, V22, P1346, DOI 10.1002/mds.21398; Billnitzer A, 2020, NEUROTHERAPEUTICS, V17, P1681, DOI 10.1007/s13311-020-00914-6; Brander G, 2018, MOL PSYCHIATR, V23, P1189, DOI 10.1038/mp.2017.31; Brander G, 2019, JAMA NEUROL, V76, P454, DOI 10.1001/jamaneurol.2018.4279; BRILL CB, 1981, ANN NEUROL, V9, P311, DOI 10.1002/ana.410090323; Brolin Karin, 2002, Inj Control Saf Promot, V9, P40, DOI 10.1076/icsp.9.1.40.3318; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Cheung MYC, 2007, MOVEMENT DISORD, V22, P1743, DOI 10.1002/mds.21599; Dobbs M, 2003, NEUROLOGY, V60, P1862, DOI 10.1212/01.WNL.0000064285.98285.CF; Eapen V, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00097; Fernandez de la Cruz L, 2017, BIOL PSYCHIAT, V82, P111, DOI 10.1016/j.biopsych.2016.08.023; Fullerton HJ, 2001, NEUROLOGY, V57, P1155, DOI 10.1212/WNL.57.7.1155; Kim Jonggil, 2019, Korean J Neurotrauma, V15, P199, DOI 10.13004/kjnt.2019.15.e24; Ko DY, 2013, CHILD NERV SYST, V29, P317, DOI 10.1007/s00381-012-1939-x; Krauss JK, 1996, MOVEMENT DISORD, V11, P563, DOI 10.1002/mds.870110512; Larsson H, 2013, BRIT J PSYCHIAT, V203, P103, DOI 10.1192/bjp.bp.112.120808; Lehman LL, 2011, NEUROLOGY, V77, P1706, DOI 10.1212/WNL.0b013e318238253c; Lin JJ, 2007, BRAIN DEV-JPN, V29, P61, DOI 10.1016/j.braindev.2006.05.009; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mataix-Cols D, 2018, MOL PSYCHIATR, V23, P1652, DOI 10.1038/mp.2017.215; Mataix-Cols D, 2021, MOVEMENT DISORD, V36, P188, DOI 10.1002/mds.28301; Mathews CA, 2004, J NEUROL NEUROSUR PS, V75, P1149, DOI 10.1136/jnnp.2003.020693; McGuire JF, 2015, BEHAV RES THER, V70, P56, DOI 10.1016/j.brat.2015.05.006; McGuire JF, 2013, PSYCHIAT RES, V210, P1198, DOI 10.1016/j.psychres.2013.09.021; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Nguyen Hoan Vu, 2004, Spine J, V4, P329; Patterson AL, 2016, PEDIATR NEUROL, V61, P99, DOI 10.1016/j.pediatrneurol.2016.05.008; Perez-Vigil A, 2018, JAMA NEUROL, V75, P1098, DOI 10.1001/jamaneurol.2018.1194; Perez-Vigil A, 2016, NEUROSCI BIOBEHAV R, V71, P542, DOI 10.1016/j.neubiorev.2016.09.025; Robertson MM, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2016.97; Ruck C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007520; Thygesen LC, 2014, EUR J EPIDEMIOL, V29, P551, DOI 10.1007/s10654-013-9873-0; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	36	1	1	4	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	OCT	2021	78	10					1205	1211		10.1001/jamaneurol.2021.2798		AUG 2021	7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WH1EW	WOS:000689744300002	34424277				2022-02-06	
J	Abeare, CA; An, K; Tyson, B; Holcomb, M; Cutler, L; May, N; Erdodi, LA				Abeare, Christopher A.; An, Kelly; Tyson, Brad; Holcomb, Matthew; Cutler, Laura; May, Natalie; Erdodi, Laszlo A.			The emotion word fluency test as an embedded performance validity indicator - Alone and in a multivariate validity composite	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						Verbal fluency; performance validity; embedded validity indicators	RECOGNITION MEMORY TEST; COMPLEX IDEATIONAL MATERIAL; TRAUMATIC BRAIN-INJURY; FALSE-POSITIVE RATES; RAW SCORE CUTOFFS; TOMM TRIAL 1; VERBAL FLUENCY; SYMPTOM VALIDITY; DIGIT SPAN; SEX-DIFFERENCES	Objective This project was designed to cross-validate existing performance validity cutoffs embedded within measures of verbal fluency (FAS and animals) and develop new ones for the Emotion Word Fluency Test (EWFT), a novel measure of category fluency. Method The classification accuracy of the verbal fluency tests was examined in two samples (70 cognitively healthy university students and 52 clinical patients) against psychometrically defined criterion measures. Results A demographically adjusted T-score of <= 31 on the FAS was specific (.88-.97) to noncredible responding in both samples. Animals T <= 29 achieved high specificity (.90-.93) among students at .27-.38 sensitivity. A more conservative cutoff (T <= 27) was needed in the patient sample for a similar combination of sensitivity (.24-.45) and specificity (.87-.93). An EWFT raw score <= 5 was highly specific (.94-.97) but insensitive (.10-.18) to invalid performance. Failing multiple cutoffs improved specificity (.90-1.00) at variable sensitivity (.19-.45). Conclusions Results help resolve the inconsistency in previous reports, and confirm the overall utility of existing verbal fluency tests as embedded validity indicators. Multivariate models of performance validity assessment are superior to single indicators. The clinical utility and limitations of the EWFT as a novel measure are discussed.	[Abeare, Christopher A.; Cutler, Laura; May, Natalie; Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Neuropsychol Track, Windsor, ON, Canada; [Tyson, Brad] Evergreen Hlth Med Ctr, Kirkland, WA USA; [Holcomb, Matthew] Jefferson Neurobehav Grp, New Orleans, LA USA		Erdodi, LA (corresponding author), 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com					Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; Abeare CA, 2021, CLIN NEUROPSYCHOL, V35, P1442, DOI 10.1080/13854046.2020.1779348; Abeare CA, 2017, J CLIN EXP NEUROPSYC, V39, P738, DOI 10.1080/13803395.2016.1259396; Abeare K., PERCEPT MOTOR SKILL; Abramson DA, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1774378; Ali S, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1760277; Alkhrisheh H., 2019, HUNGARIAN J APPL LIN, V19, P1; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Ashendorf L, 2019, CLIN NEUROPSYCHOL, V33, P1388, DOI 10.1080/13854046.2018.1543454; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bain KM, 2021, APPL NEUROPSYCH-ADUL, V28, P24, DOI 10.1080/23279095.2019.1585352; Barel E, 2018, ADV COGN PSYCHOL, V14, P51, DOI 10.5709/acp-0238-x; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Bodner T, 2019, J CLIN EXP NEUROPSYC, V41, P476, DOI 10.1080/13803395.2019.1579783; BOLLA KI, 1990, J CLIN PSYCHOL, V46, P623, DOI 10.1002/1097-4679(199009)46:5<623::AID-JCLP2270460513>3.0.CO;2-C; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Brickman AM, 2005, ARCH CLIN NEUROPSYCH, V20, P561, DOI 10.1016/j.acn.2004.12.006; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Chafetz MD, 2011, PSYCHOL INJ LAW, V4, P235, DOI 10.1007/s12207-011-9112-5; Chafetz MD, 2012, APPL NEUROPSYCH-ADUL, V19, P121, DOI 10.1080/09084282.2011.643953; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Cutler L, 2021, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2021.1884555; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Davis JJ, 2011, ARCH CLIN NEUROPSYCH, V26, P768, DOI 10.1093/arclin/acr079; Delis DC., 2001, DELIS KAPLAN EXECUTI; Denning JH, 2014, ARCH CLIN NEUROPSYCH, V29, P729, DOI 10.1093/arclin/acu051; Erdodi L.A., 2020, ARCH ASSESSMENT PSYC, V10, P45; Erdodi L.A., 2021, ASSESSMENT FEIGNED C, P218; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2020, ARCH CLIN NEUROPSYCH, V35, P188, DOI 10.1093/arclin/acz032; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P113, DOI 10.1007/s12207-019-09352-y; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P155, DOI 10.1007/s12207-019-09356-8; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P1029, DOI 10.1080/13854046.2017.1323119; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Erdodi LA, 2014, APPL NEUROPSYCH-ADUL, V21, P43, DOI 10.1080/09084282.2012.724036; Erdodi LA, 2010, J ATTEN DISORD, V14, P43, DOI 10.1177/1087054709347199; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Fuermaier ABM, 2017, PSYCHOL ASSESSMENT, V29, P1466, DOI 10.1037/pas0000534; Gawda B, 2019, J PSYCHOLINGUIST RES, V48, P1339, DOI 10.1007/s10936-019-09661-y; Grant AF, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1769097; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Gustavson DE, 2021, BEHAV GENET, V51, P99, DOI 10.1007/s10519-021-10048-w; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hurtubise J, 2020, APPL NEUROPSYCH-CHIL, V9, P337, DOI 10.1080/21622965.2020.1719409; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Jebahi F, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1821031; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kempler D, 1998, J INT NEUROPSYCH SOC, V4, P531, DOI 10.1017/S1355617798466013; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Kura K, 2013, INTELLIGENCE, V41, P512, DOI 10.1016/j.intell.2013.07.001; Lace JW, 2020, PSYCHOL INJ LAW, V13, P303, DOI 10.1007/s12207-020-09382-x; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2019, CLIN NEUROPSYCHOL, V33, P1354, DOI 10.1080/13854046.2019.1614227; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P127, DOI 10.1007/s12207-019-09354-w; Lindstrom W, 2011, CLIN NEUROPSYCHOL, V25, P302, DOI 10.1080/13854046.2010.537280; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Love CM, 2014, ASSESSMENT, V21, P618, DOI 10.1177/1073191114528028; Lupu T, 2018, APPL NEUROPSYCH-ADUL, V25, P532, DOI 10.1080/23279095.2017.1341410; MacAllister WS, 2019, CHILD NEUROPSYCHOL, V25, P1035, DOI 10.1080/09297049.2019.1569606; Maitland SB, 2004, MEM COGNITION, V32, P1160, DOI 10.3758/BF03196889; Martin P.K., 2021, ASSESSMENT FEIGNED C, P248; Martin PK, 2020, CLIN NEUROPSYCHOL, V34, P88, DOI 10.1080/13854046.2019.1637027; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McDaniel MA, 2006, INTELLIGENCE, V34, P607, DOI 10.1016/j.intell.2006.08.007; McDowell A., 2015, PSI CHI J PSYCHOL RE, V20, P228; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Merten T, 2017, BEHAV SCI LAW, V35, P97, DOI 10.1002/bsl.2274; Messa I., 2020, AUST J FORENSIC SCI, DOI [https://doi.org/10.1080/00450618.2020.1865457, DOI 10.1080/00450618.2020.1865457]; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Nie J, 2017, COMPR PSYCHIAT, V72, P114, DOI 10.1016/j.comppsych.2016.10.006; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Olla P, 2021, APPL NEUROPSYCH-ADUL, V28, P647, DOI 10.1080/23279095.2019.1681424; Pearson, 2009, ADV CLIN SOLUTIONS W; Piatt AL, 1999, J CLIN EXP NEUROPSYC, V21, P435, DOI 10.1076/jcen.21.4.435.885; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Rai JK, 2021, APPL NEUROPSYCH-ADUL, V28, P185, DOI 10.1080/23279095.2019.1613994; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; Ryan JJ, 2010, APPL NEUROPSYCHOL, V17, P246, DOI 10.1080/09084282.2010.499802; Scheuringer A, 2017, COGN PROCESS, V18, P407, DOI 10.1007/s10339-017-0801-1; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Siengthai B, 2008, J NUTR HEALTH AGING, V12, P641; Sirianni CD, 2021, PSYCHIAT RES, V298, DOI 10.1016/j.psychres.2020.113651; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Soble JR, 2020, PSYCHOL INJ LAW, V13, P44, DOI 10.1007/s12207-019-09370-w; Sokolowski A, 2020, ADV COGN PSYCHOL, V16, P92, DOI 10.5709/acp-0288-1; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Sullivan K, 2010, PSYCHIAT RES, V176, P75, DOI 10.1016/j.psychres.2008.07.013; Thilers PP, 2007, PHYSIOL BEHAV, V92, P105, DOI 10.1016/j.physbeh.2007.05.035; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wauters L, 2018, ARCH CLIN NEUROPSYCH, V33, P444, DOI 10.1093/arclin/acx063; Webber TA, 2018, PSYCHOL INJ LAW, V11, P325, DOI 10.1007/s12207-018-9335-9; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Weiss EM, 2006, J INT NEUROPSYCH SOC, V12, P502, DOI 10.1017/S1355617706060656; Whiteside DM, 2015, CLIN NEUROPSYCHOL, V29, P788, DOI 10.1080/13854046.2015.1093660; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P263, DOI 10.1093/arclin/acp034; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	130	1	1	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2021.1939027		AUG 2021	12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	UE0SD	WOS:000687607300001	34424798				2022-02-06	
J	Guo, SH; Wang, RM; Hu, JW; Sun, LP; Zhao, XR; Zhao, YF; Han, D; Hu, SQ				Guo, Sihan; Wang, Ruimin; Hu, Jiewei; Sun, Liping; Zhao, Xinru; Zhao, Yufeng; Han, Dong; Hu, Shuqun			Photobiomodulation Promotes Hippocampal CA1 NSC Differentiation Toward Neurons and Facilitates Cognitive Function Recovery Involving NLRP3 Inflammasome Mitigation Following Global Cerebral Ischemia	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						cognitive function; NLRP3 inflammasome; photobiomodulation; neurogenesis; global cerebral ischemia	LEVEL LASER THERAPY; TRAUMATIC BRAIN-INJURY; DENTATE GYRUS; LIGHT THERAPY; NEUROGENESIS; STROKE; CELLS; MECHANISMS; DISEASE; PROLIFERATION	Our recent study revealed that photobiomodulation (PBM) inhibits delayed neuronal death by preserving mitochondrial dynamics and function following global cerebral ischemia (GCI). In the current study, we clarified whether PBM exerts effective roles in endogenous neurogenesis and long-lasting neurological recovery after GCI. Adult male rats were treated with 808 nm PBM at 20 mW/cm(2) irradiance for 2 min on cerebral cortex surface (irradiance similar to 7.0 mW/cm(2), fluence similar to 0.8 J/cm(2) on the hippocampus) beginning 3 days after GCI for five consecutive days. Cognitive function was evaluated using the Morris water maze. Neural stem cell (NSC) proliferation, immature neurons, and mature neurons were examined using bromodeoxyuridine (BrdU)-, doublecortin (DCX)-, and NeuN-staining, respectively. Protein expression, such as NLRP3, cleaved IL1 beta, GFAP, and Iba1 was detected using immunofluorescence staining, and ultrastructure of astrocyte and microglia was observed by transmission electron microscopy. The results revealed that PBM exerted a markedly neuroprotective role and improved spatial learning and memory ability at 58 days of ischemia/reperfusion (I/R) but not at 7 days of reperfusion. Mechanistic studies revealed that PBM suppressed reactive astrocytes and maintained astrocyte regeneration at 7 days of reperfusion, as well as elevated neurogenesis at 58 days of reperfusion, as evidenced by a significant decrease in the fluorescence intensity of GFAP (astrocyte marker) but unchanged the number of BrdU-GFAP colabeled cells at the early timepoint, and a robust elevation in the number of DCX-NeuN colabeled cells at the later timepoint in the PBM-treated group compared to the GCI group. Notably, PBM treatment protected the ultrastructure of astrocyte and microglia cells at 58 days but not 7 days of reperfusion in the hippocampal CA1 region. Furthermore, PBM treatment significantly attenuated the GCI-induced immunofluorescence intensity of NLRP3 (an inflammasome component), cleaved IL1 beta (reflecting inflammasome activation) and Iba1, as well as the colocalization of NLRP3/GFAP or cleaved IL-1 beta/GFAP, especially in animals subjected to I/R at 58 days. Taken together, PBM treatment performed postischemia exerted a long-lasting protective effect on astrocytes and promoted endogenous neurogenesis in the hippocampal CA1 region, which might contribute to neurological recovery after GCI.	[Guo, Sihan; Sun, Liping; Zhao, Xinru; Zhao, Yufeng; Han, Dong; Hu, Shuqun] Xuzhou Med Univ, Sch Life Sci, Jiangsu Prov Inst Hlth Emergency, Xuzhou, Jiangsu, Peoples R China; [Wang, Ruimin; Hu, Jiewei] North China Univ Sci & Technol, Sch Publ Hlth, Neurobiol Inst, Tangshan, Peoples R China		Hu, SQ (corresponding author), Xuzhou Med Univ, Sch Life Sci, Jiangsu Prov Inst Hlth Emergency, Xuzhou, Jiangsu, Peoples R China.; Wang, RM (corresponding author), North China Univ Sci & Technol, Sch Publ Hlth, Neurobiol Inst, Tangshan, Peoples R China.	ruimin-wang@163.com; hushucm88@xzhmu.edu.cn					Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; ARSAC M, 1988, CURR MED RES OPIN, V11, P214, DOI 10.1185/03007998809114238; Babcock Kelsey R, 1800, Stem Cell Reports, V16, P681, DOI 10.1016/j.stemcr.2021.01.019; Bai N, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1715-x; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; Bathini M, 2020, CELL MOL NEUROBIOL, DOI 10.1007/s10571-020-01016-9; Berman MH, 2019, PHOTOBIOMOD PHOTOMED, V37, P623, DOI 10.1089/photob.2019.4685; Carmen J, 2007, PROG NEUROBIOL, V82, P151, DOI 10.1016/j.pneurobio.2007.03.001; Cope EC, 2019, CELL STEM CELL, V24, P690, DOI 10.1016/j.stem.2019.03.023; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; Dompe C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061724; Farfara D, 2015, J MOL NEUROSCI, V55, P430, DOI 10.1007/s12031-014-0354-z; Longo MGF, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17337; Gonzalez-Lima F, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00036; Greenhalgh AD, 2020, NAT REV NEUROSCI, V21, P139, DOI 10.1038/s41583-020-0263-9; Hamblin MR, 2017, AIMS BIOPHYS, V4, P337, DOI 10.3934/biophy.2017.3.337; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Hong CT, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000024191; Hong S, 2016, J NEUROTRAUM, V33, P362, DOI 10.1089/neu.2014.3860; Hwang MH, 2015, PHOTOCHEM PHOTOBIOL, V91, P403, DOI 10.1111/php.12415; Jablonska A, 2011, ACTA NEUROBIOL EXP, V71, P74; Jones ME, 2018, BRAIN BEHAV IMMUN, V67, P355, DOI 10.1016/j.bbi.2017.09.016; Koehl M, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00041; Kwon I, 2009, J NEUROSCI RES, V87, P668, DOI 10.1002/jnr.21877; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lee HI, 2017, J BIOPHOTONICS, V10, P1502, DOI 10.1002/jbio.201600244; Lee TK, 2019, NEURAL REGEN RES, V14, P1394, DOI 10.4103/1673-5374.253524; Lim W, 2015, J ORAL PATHOL MED, V44, P94, DOI 10.1111/jop.12204; Lindsay PJ, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1984-2; Liu JL, 1998, J NEUROSCI, V18, P7768; Liu YL, 2021, CHINESE MED J-PEKING, V134, P634, DOI 10.1097/CM9.0000000000001301; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Marques BL, 2019, SEMIN CELL DEV BIOL, V95, P98, DOI 10.1016/j.semcdb.2018.12.003; McAllister BB, 2020, HIPPOCAMPUS, V30, P623, DOI 10.1002/hipo.23185; Mezzasoma L, 2016, IMMUNOL RES, V64, P303, DOI 10.1007/s12026-015-8751-0; Moulaert VRMP, 2009, RESUSCITATION, V80, P297, DOI 10.1016/j.resuscitation.2008.10.034; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nakazawa K, 2006, NEURON, V50, P183, DOI 10.1016/j.neuron.2006.04.007; Nemirovich-Danchenko NM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00588; Nielsen N, 2011, INT J CARDIOL, V151, P333, DOI 10.1016/j.ijcard.2010.06.008; Nutma E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030600; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Radad K, 2017, CNS NEUROL DISORD-DR, V16, P740, DOI 10.2174/1871527316666170623094728; Ravera S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094347; Rietze R, 2000, J COMP NEUROL, V424, P397; Rolando C, 2016, CELL STEM CELL, V19, P653, DOI 10.1016/j.stem.2016.07.003; Saha B, 2016, CELL MOL GASTROENTER, V2, P302, DOI 10.1016/j.jcmgh.2015.12.005; Salazar-Colocho P, 2008, NEUROSCI RES, V61, P27, DOI 10.1016/j.neures.2008.01.008; Salehpour F, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040610; Fernandes KPS, 2015, J PHOTOCH PHOTOBIO B, V153, P344, DOI 10.1016/j.jphotobiol.2015.10.015; Schmidt W, 2002, NEUROSCI LETT, V334, P153, DOI 10.1016/S0304-3940(02)01072-8; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Song D, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-020-02059-x; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Tonchev AB, 2006, EXP NEUROL, V198, P101, DOI 10.1016/j.expneurol.2005.11.022; Tonchev AB, 2003, GLIA, V42, P209, DOI 10.1002/glia.10209; Tonchev AB, 2003, MOL CELL NEUROSCI, V23, P292, DOI 10.1016/S1044-7431(03)00058-7; Tucker LD, 2018, J MOL NEUROSCI, V65, P514, DOI 10.1007/s12031-018-1121-3; Vogel DDS, 2021, J BIOPHOTONICS, V14, DOI 10.1002/jbio.202000500; von Leden RE, 2013, LASER SURG MED, V45, P253, DOI 10.1002/lsm.22133; Wang Q, 2005, J NEUROSCI RES, V82, P138, DOI 10.1002/jnr.20610; Wang RM, 2019, MOL NEUROBIOL, V56, P1852, DOI 10.1007/s12035-018-1191-9; Wu KJ, 2017, CELL TRANSPLANT, V26, P1596, DOI 10.1177/0963689717721230; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Xuan WJ, 2016, J BIOPHOTONICS, V9, P1263, DOI 10.1002/jbio.201500336; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Zhou CF, 2011, NEUROCHEM INT, V59, P749, DOI 10.1016/j.neuint.2011.08.008	74	1	1	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	AUG 20	2021	15									10.3389/fncel.2021.731855			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UN4NH	WOS:000693992400001	34489645	Green Published, gold			2022-02-06	
J	Kersey, J; Terhorst, L; Heinemann, AW; Hammel, J; Baum, C; McCue, M; Skidmore, ER				Kersey, Jessica; Terhorst, Lauren; Heinemann, Allen W.; Hammel, Joy; Baum, Carolyn; McCue, Michael; Skidmore, Elizabeth R.			Construct validity of the enfranchisement scale of the community participation indicators	CLINICAL REHABILITATION			English	Article						Validity; patient-centred outcome measure; community participation	ITEM BANKS; SATISFACTION; INTEGRATION; PEOPLE; REHABILITATION; DISABILITY; VETERANS	Objective: This study examined the construct validity of the Enfranchisement scale of the Community Participation Indicators. Design: We conducted a secondary analysis of data collected in a cross-sectional study of rehabilitation outcomes. Subjects: The parent study included 604 community-dwelling adults with chronic traumatic brain injury, stroke, or spinal cord injury. The sample had a mean age of 64.1 years, was two-thirds male, and included a high proportion of racial minorities (n = 250, 41.4%). Main measures: The Enfranchisement scale contains two subscales: the Control subscale and the Importance subscale. We examined correlations between each Enfranchisement subscale and measures of participation, environment, and impairments. The current analyses included cases with at least 80% of items completed on each subscale (Control subscale: n = 391; Importance subscale: n = 219). Missing values were imputed using multiple imputation. Results: The sample demonstrated high scores, indicating poor enfranchisement (Control subscale: M = 51.7; Importance subscale: M = 43.0). Both subscales were most strongly associated with measures of participation (Control subscale: r = 0.56; Importance subscale: r = 0.52), and least strongly associated with measures of cognition (Control subscale: r = 0.03; Importance subscale: r = 0.03). The Importance subscale was closely associated with depression (r = 0.54), and systems, services, and policies (r = 0.50). Both subscales were associated with social attitudes (Control subscale: r = 0.44; Importance subscale: r = 0.44) and social support (Control subscale: r = 0.49; Importance subscale: r = 0.41). Conclusions: We found evidence of convergent validity between the Enfranchisement scale and measures of participation, and discriminant validity between the Enfranchisement scale and measures of disability-related impairments. The analyses also revealed the importance of the environment to enfranchisement outcomes.	[Kersey, Jessica; Terhorst, Lauren; Skidmore, Elizabeth R.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, 100 Technol Dr,Suite 370, Pittsburgh, PA 15219 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL USA; [Hammel, Joy] Univ Illinois, Dept Occupat Therapy, Chicago, IL USA; [Baum, Carolyn] Washington Univ, Program Occupat Therapy, St Louis, MO USA; [Baum, Carolyn] Washington Univ, Dept Neurol, St Louis, MO USA; [Baum, Carolyn] Washington Univ, Dept Social Work, St Louis, MO USA; [McCue, Michael] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Rehabil Sci & Technol, Pittsburgh, PA USA		Kersey, J (corresponding author), Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, 100 Technol Dr,Suite 370, Pittsburgh, PA 15219 USA.	jmk286@pitt.edu		Kersey, Jessica/0000-0001-9082-6962	National Institute of Disability, Independent Living, and Rehabilitation Research through a Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes grant [H133B090024]; National Institute on Disability and Rehabilitation Research [H133F140037]; University of Pittsburgh School of Health and Rehabilitation Sciences Dissertation Fund	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institute of Disability, Independent Living, and Rehabilitation Research through a Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes grant (H133B090024), the National Institute on Disability and Rehabilitation Research (H133F140037), and the University of Pittsburgh School of Health and Rehabilitation Sciences Dissertation Fund.	Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Chang FH, 2013, ARCH PHYS MED REHAB, V94, P771, DOI 10.1016/j.apmr.2012.10.031; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; DeVellis R., 2010, ARCH PHYS MED REHAB, V91, P60; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Fries JF, 2006, ANN RHEUM DIS, V65, P16, DOI 10.1136/ard.2006.059279; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Heinemann AW, 2016, ARCH PHYS MED REHAB, V97, P2113, DOI 10.1016/j.apmr.2016.05.021; Heinemann AW, 2015, J SPINAL CORD MED, V38, P397, DOI 10.1179/2045772315Y.0000000028; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Heinemann AW, 2011, ARCH PHYS MED REHAB, V92, P564, DOI 10.1016/j.apmr.2010.07.220; Heinemann AW, 2010, ARCH PHYS MED REHAB, V91, pS1, DOI 10.1016/j.apmr.2009.08.155; Kersey J, 2020, BRAIN INJURY, V34, P708, DOI 10.1080/02699052.2020.1757153; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; Magasi S., 2015, ARCH PHYS MED REHAB, V96, P6; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Moriarty H, 2015, J AM PSYCHIAT NURSES, V21, P195, DOI 10.1177/1078390315591879; Orff HJ, 2016, J REHABIL RES DEV, V53, P541, DOI 10.1682/JRRD.2014.11.0295; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tang E, 2019, QUAL LIFE RES, V28, P815, DOI 10.1007/s11136-018-2058-2; Tefertiller C, 2019, ARCH PHYS MED REHAB, V100, P1409, DOI 10.1016/j.apmr.2019.03.015; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Wu E, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000152; Yasui NY, 2009, DISABIL REHABIL, V31, P761, DOI 10.1080/09638280802306638	29	1	1	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	FEB	2022	36	2					263	271	02692155211040930	10.1177/02692155211040930		AUG 2021	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	YR0NQ	WOS:000686970500001	34414799				2022-02-06	
J	La Corte, V; Ferrieux, S; Abram, M; Bertrand, A; Dubois, B; Teichmann, M; Piolino, P				La Corte, Valentina; Ferrieux, Sophie; Abram, Maria; Bertrand, Anne; Dubois, Bruno; Teichmann, Marc; Piolino, Pascale			The role of semantic memory in prospective memory and episodic future thinking: new insights from a case of semantic dementia	MEMORY			English	Article						prospective memory; episodic future thinking; prospection; episodic memory; semantic dementia	MILD COGNITIVE IMPAIRMENT; AGE-RELATED DIFFERENCES; TRAUMATIC BRAIN-INJURY; MINI-MENTAL-STATE; AUTOBIOGRAPHICAL MEMORY; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; VIRTUAL-REALITY; TEST SCORE; PATTERNS	Prospective memory (PM), the ability to remember to execute planned actions, and episodic future thinking (EFT), the ability to imagine future personal events, are two core aspects of future-oriented cognition. The present study aimed for the first time at examining the role of semantic memory loss in PM and EFT in a single case patient (SL) at the early stage of semantic dementia. First, we investigated various types of PM as well as episodic memory of new events using a validated ecological assessment via virtual reality. Second, we examined EFT using a temporally extended version of the TEMPau task, which measures episodic aspects of remembering the past and imagining the future taking temporal distance into account. Patient SL was deficient in semantically linked event-based PM and was unable to provide any EFT for the most distant period but was preserved in other types of PM and near and intermediate EFT. These findings provide new evidence on the role of semantic memory in PM depending on the type of intention and in EFT depending on the temporal distance mirroring autobiographical memory. Finally, they point out a specific link between PM and near EFT in future-oriented cognition.	[La Corte, Valentina; Abram, Maria; Piolino, Pascale] Univ Paris, Lab Memoire Cerveau & Cognit MC2Lab, UR 7536, 71 Ave Edouard Vaillant, F-92774 Boulogne, Billancourt, France; [La Corte, Valentina; Ferrieux, Sophie; Dubois, Bruno; Teichmann, Marc] Hop La Pitie Salpetriere, AP HP, Inst Memoire & Maladie Alzheimer IM2A, Dept Neurol, Paris, France; [La Corte, Valentina; Ferrieux, Sophie; Dubois, Bruno; Teichmann, Marc] Hop La Pitie Salpetriere, AP HP, Ctr Reference Demences Rares Precoces, Paris, France; [Piolino, Pascale] Inst Univ France, Paris, France; [Bertrand, Anne; Dubois, Bruno; Teichmann, Marc] Sorbonne Univ, Hop Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, INSERM U1127, Paris, France		La Corte, V (corresponding author), Univ Paris, Lab Memoire Cerveau & Cognit MC2Lab, UR 7536, 71 Ave Edouard Vaillant, F-92774 Boulogne, Billancourt, France.	valentina.la-corte@parisdescartes.fr			ANR Research Fund grant (the Interplay between Memory and Temporality)French National Research Agency (ANR) [ANR-17-CE36-0009-01]	This research was supported by an ANR Research Fund grant (the Interplay between Memory and Temporality ANR-17-CE36-0009-01) awarded to PP.	Abichou K, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00058; Abram M, 2014, CONSCIOUS COGN, V29, P76, DOI 10.1016/j.concog.2014.07.011; Addis DR, 2008, PSYCHOL SCI, V19, P33, DOI 10.1111/j.1467-9280.2008.02043.x; Addis DR, 2018, J ROY SOC NEW ZEAL, V48, P64, DOI 10.1080/03036758.2018.1439071; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2660, DOI 10.1016/j.neuropsychologia.2009.05.018; Adlam ALR, 2009, NEUROPSYCHOLOGIA, V47, P1344, DOI 10.1016/j.neuropsychologia.2009.01.029; Altgassen M, 2017, CHILD NEUROPSYCHOL, V23, P536, DOI 10.1080/09297049.2016.1158247; Altgassen M, 2015, Q J EXP PSYCHOL, V68, P192, DOI 10.1080/17470218.2014.956127; Amado I, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00064; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Bozeat S, 2000, J NEUROL NEUROSUR PS, V69, P178, DOI 10.1136/jnnp.69.2.178; Brewer GA, 2010, COGN NEUROSCI-UK, V1, P81, DOI 10.1080/17588920903373960; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Chan D, 2001, ANN NEUROL, V49, P433, DOI 10.1002/ana.92.abs; Chapleau M, 2016, J ALZHEIMERS DIS, V54, P941, DOI 10.3233/JAD-160382; Chasteen AL, 2001, PSYCHOL SCI, V12, P457, DOI 10.1111/1467-9280.00385; Clement JP, 1997, ENCEPHALE, V23, P91; Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967; Crawford JR, 2006, NEUROPSYCHOLOGIA, V44, P666, DOI 10.1016/j.neuropsychologia.2005.06.001; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; d'Ydewalle G, 2001, AM J PSYCHOL, V114, P411, DOI 10.2307/1423688; Debarnot U, 2015, NEUROBIOL AGING, V36, P2360, DOI 10.1016/j.neurobiolaging.2015.05.001; Derouesne C, 1999, PRESSE MED, V28, P1141; Desgranges B, 2007, NEUROBIOL AGING, V28, P1904, DOI 10.1016/j.neurobiolaging.2006.08.006; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Duval C, 2012, NEUROPSYCHOLOGIA, V50, P254, DOI 10.1016/j.neuropsychologia.2011.11.019; Edan S, 2001, REV NEUROL-FRANCE, V157, P53; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galton CJ, 2001, NEUROLOGY, V57, P216, DOI 10.1212/WNL.57.2.216; Girardeau JC, 2020, CONSCIOUS COGN, V81, DOI 10.1016/j.concog.2020.102920; Godefroy O T, 2008, FONCTIONS EXECUTIVES, P179; Goodglass H., 2000, BOSTON DIAGNOSTIC AP; Gorno-Tempini M L, 2011, Neurology, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Graham KS, 2003, CORTEX, V39, P729, DOI 10.1016/S0010-9452(08)70861-X; Graham KS, 1997, NEUROPSYCHOLOGY, V11, P77, DOI 10.1037/0894-4105.11.1.77; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; Hannequin D., 1997, DO 80 TEST DENOMINAT; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Hodges JR, 2007, LANCET NEUROL, V6, P1004, DOI 10.1016/S1474-4422(07)70266-1; Hodges JR, 2001, PHILOS T R SOC B, V356, P1423, DOI 10.1098/rstb.2001.0943; Hodges JR, 2001, NEUROCASE, V7, P113, DOI 10.1076/neur.7.2.113.16260; Irish M, 2016, BRIT J CLIN PSYCHOL, V55, P49, DOI 10.1111/bjc.12090; Irish M, 2016, NEUROPSYCHOLOGIA, V81, P50, DOI 10.1016/j.neuropsychologia.2015.12.005; Irish M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00027; Irish M, 2012, NEUROPSYCHOLOGIA, V50, P3488, DOI 10.1016/j.neuropsychologia.2012.09.012; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Jebara Najate, 2014, Front Aging Neurosci, V6, P338, DOI 10.3389/fnagi.2014.00338; Kalpouzos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013304; Kamminga J, 2014, J ALZHEIMERS DIS, V38, P669, DOI 10.3233/JAD-131118; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Kliegel M., 2008, PROSPECTIVE MEMORY C; Kvavilashvili L, 1998, APPL COGNITIVE PSYCH, V12, P533, DOI 10.1002/(SICI)1099-0720(1998120)12:6<533::AID-ACP538>3.0.CO;2-1; Kvavilashvili L, 2020, REV GEN PSYCHOL, V24, P210, DOI 10.1177/1089268020918843; La Corte V, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00385; Landin-Romero R, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0219-5; Lecouvey G, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00241; Lecouvey G, 2017, SOCIOAFFECTIVE NEURO, V7, DOI 10.1080/20009011.2017.1304610; Maguire EA, 2010, NEUROPSYCHOLOGIA, V48, P123, DOI 10.1016/j.neuropsychologia.2009.08.020; Martinelli P, 2013, HUM BRAIN MAPP, V34, P1515, DOI 10.1002/hbm.22008; Matuszewski V, 2009, CORTEX, V45, P456, DOI 10.1016/j.cortex.2007.11.006; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; Mion M, 2010, BRAIN, V133, P3256, DOI 10.1093/brain/awq272; Mioni G, 2017, BRIT J CLIN PSYCHOL, V56, P130, DOI 10.1111/bjc.12126; Mullally SL, 2014, NEUROSCIENTIST, V20, P220, DOI 10.1177/1073858413495091; Neary, 1989, BEHAV NEUROL, V2, P167, DOI DOI 10.1093/NEUCAS/1.1.39-Y; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neroni MA, 2014, CONSCIOUS COGN, V23, P53, DOI 10.1016/j.concog.2013.12.001; Nestor PJ, 2002, NEUROPSYCHOLOGIA, V40, P633, DOI 10.1016/S0028-3932(01)00155-5; Nigro G, 2014, J EXP CHILD PSYCHOL, V127, P82, DOI 10.1016/j.jecp.2013.10.013; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Paraskevaides T, 2010, PSYCHOPHARMACOLOGY, V208, P301, DOI 10.1007/s00213-009-1731-0; Patterson, 1992, PYRAMID PALM TREES T; Pereira A, 2015, J CLIN EXP NEUROPSYC, V37, P863, DOI 10.1080/13803395.2015.1072499; Peron JA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00625; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Piolino P, 2003, COGN NEUROPSYCHOL, V20, P619, DOI 10.1080/02643290242000899; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Plancher G, 2012, NEUROPSYCHOLOGIA, V50, P592, DOI 10.1016/j.neuropsychologia.2011.12.013; Plancher G, 2010, NEUROPSYCHOLOGY, V24, P379, DOI 10.1037/a0018680; Rankin KP, 2005, COGN BEHAV NEUROL, V18, P28, DOI 10.1097/01.wnn.0000152225.05377.ab; Rendell PG, 2009, BRAIN IMPAIR, V10, P14, DOI 10.1375/brim.10.1.14; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Renoult L, 2019, TRENDS COGN SCI, V23, P1041, DOI 10.1016/j.tics.2019.09.008; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2017, CURR OPIN BEHAV SCI, V17, P41, DOI 10.1016/j.cobeha.2017.06.002; Schacter DL, 2016, MEM STUD, V9, P245, DOI 10.1177/1750698016645230; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; SNOWDEN J, 1994, COGNITIVE NEUROPSYCH, V11, P265, DOI 10.1080/02643299408251976; SNOWDEN JS, 1995, MEMORY, V3, P225, DOI 10.1080/09658219508253152; Snowden JS, 2001, J NEUROL NEUROSUR PS, V70, P323, DOI 10.1136/jnnp.70.3.323; Snowden JS, 1996, COGNITIVE NEUROPSYCH, V13, P1101, DOI 10.1080/026432996381674; Szpunar KK, 2014, P NATL ACAD SCI USA, V111, P18414, DOI 10.1073/pnas.1417144111; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; Terrett G, 2019, J EXP CHILD PSYCHOL, V178, P198, DOI 10.1016/j.jecp.2018.10.003; Terrett G, 2016, Q J EXP PSYCHOL, V69, P310, DOI 10.1080/17470218.2015.1054294; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Viard A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111046; Viard A, 2013, NEUROPSYCHOLOGIA, V51, P2620, DOI 10.1016/j.neuropsychologia.2013.08.007; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Weiler JA, 2010, HIPPOCAMPUS, V20, P685, DOI 10.1002/hipo.20695; Westmacott R, 2001, NEUROCASE, V7, P37, DOI 10.1093/neucas/7.1.37	109	1	1	9	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0965-8211	1464-0686		MEMORY	Memory	SEP 14	2021	29	8					943	962		10.1080/09658211.2021.1936069		AUG 2021	20	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	UP3UU	WOS:000686806600001	34412554				2022-02-06	
J	Thomas, CN; Bernardo-Colon, A; Courtie, E; Essex, G; Rex, TS; Blanch, RJ; Ahmed, Z				Thomas, Chloe N.; Bernardo-Colon, Alexandra; Courtie, Ella; Essex, Gareth; Rex, Tonia S.; Blanch, Richard J.; Ahmed, Zubair			Effects of intravitreal injection of siRNA against caspase-2 on retinal and optic nerve degeneration in air blast induced ocular trauma	SCIENTIFIC REPORTS			English	Article							GANGLION-CELL LOSS; AXON REGENERATION; BRAIN-INJURY; MOUSE MODEL; VISION LOSS; DNA-DAMAGE; DEATH; APOPTOSIS; ANTERIOR; GLOBE	Ocular repeated air blast injuries occur from low overpressure blast wave exposure, which are often repeated and in quick succession. We have shown that caspase-2 caused the death of retinal ganglion cells (RGC) after blunt ocular trauma. Here, we investigated if caspase-2 also mediates RGC apoptosis in a mouse model of air blast induced indirect traumatic optic neuropathy (b-ITON). C57BL/6 mice were exposed to repeated blasts of overpressure air (3 x 2 x 15 psi) and intravitreal injections of siRNA against caspase-2 (siCASP2) or against a control enhanced green fluorescent protein (siEGFP) at either 5 h after the first 2 x 15 psi ("post-blast") or 48 h before the first blast exposure ("pre-blast") and repeated every 7 days. RGC counts were unaffected by the b-ITON or intravitreal injections, despite increased degenerating ON axons, even in siCASP2 "post-blast" injection groups. Degenerating ON axons remained at sham levels after b-ITON and intravitreal siCASP2 "pre-blast" injections, but with less degenerating axons in siCASP2 compared to siEGFP-treated eyes. Intravitreal injections "post-blast" caused greater vitreous inflammation, potentiated by siCASP2, with less in "pre-blast" injected eyes, which was abrogated by siCASP2. We conclude that intravitreal injection timing after ocular trauma induced variable retinal and ON pathology, undermining our candidate neuroprotective therapy, siCASP2.	[Thomas, Chloe N.; Courtie, Ella; Essex, Gareth; Blanch, Richard J.; Ahmed, Zubair] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Neurosci & Ophthalmol, Birmingham, W Midlands, England; [Thomas, Chloe N.] Univ Birmingham, Coll Med & Dent Sci, Sch Biomed Sci, Inst Clin Sci, Birmingham, W Midlands, England; [Bernardo-Colon, Alexandra; Rex, Tonia S.] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN USA; [Courtie, Ella; Blanch, Richard J.] Univ Hosp Birmingham NHS Fdn Trust, Ophthalmol Dept, Birmingham, W Midlands, England; [Rex, Tonia S.] Vanderbilt Univ, Sch Med, Dept Ophthalmol & Visual Sci, Nashville, TN 37212 USA; [Blanch, Richard J.] Royal Ctr Def Med, Acad Dept Mil Surg & Trauma, Birmingham, W Midlands, England; [Blanch, Richard J.; Ahmed, Zubair] Univ Birmingham, Ctr Trauma Sci Res, Birmingham B15 2TT, W Midlands, England		Blanch, RJ; Ahmed, Z (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Neurosci & Ophthalmol, Birmingham, W Midlands, England.; Blanch, RJ (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Ophthalmol Dept, Birmingham, W Midlands, England.; Blanch, RJ (corresponding author), Royal Ctr Def Med, Acad Dept Mil Surg & Trauma, Birmingham, W Midlands, England.; Blanch, RJ; Ahmed, Z (corresponding author), Univ Birmingham, Ctr Trauma Sci Res, Birmingham B15 2TT, W Midlands, England.	r.j.blanch@bham.ac.uk; z.ahmed.1@bham.ac.uk			Fight for Sight PhD Studentship [1560/1561]; DoDUnited States Department of Defense [W81XWH-17-2-0055, W81XWH-15-1-0096]; NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30 EY008126, R01 EY022349, U24 EY029893]; Vanderbilt University Medical Center Cell Imaging Shared Resource core facility (Clinical and Translational Science Award from National Center for Research Resources) [UL1 RR024975]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Ret. Maj. General Stephen L. Jones, MD Fund; Ayers Research Fund in Regenerative Visual Neuroscience; Potoscnak Family-CSC Research Fund	This study was supported by Fight for Sight PhD Studentship, Grant Number 1560/1561 (RJB and ZA), DoD W81XWH-15-1-0096 (TSR), DoD W81XWH-17-2-0055 (TSR), NEI R01 EY022349 (TSR), NEI U24 EY029893 (TSR), NEI P30 EY008126 (VVRC), Vanderbilt University Medical Center Cell Imaging Shared Resource core facility (Clinical and Translational Science Award Grant UL1 RR024975 from National Center for Research Resources), Research to Prevent Blindness Unrestricted Funds (VEI), Ret. Maj. General Stephen L. Jones, MD Fund (TSR), Potoscnak Family-CSC Research Fund (TSR), and Ayers Research Fund in Regenerative Visual Neuroscience (TSR).	Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Azhdam AM, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.1.2; Ba J, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S86269; Bernardo-Colon A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00719; Bernardo-Colon A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1061-4; Blanch RJ, 2011, EYE, V25, P218, DOI 10.1038/eye.2010.190; Blanch R J, 2009, J R Army Med Corps, V155, P279; Bond WS, 2016, MOL THER, V24, P230, DOI 10.1038/mt.2015.198; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; Breeze J, 2020, OPHTHALMOLOGY, V127, P458, DOI 10.1016/j.ophtha.2019.10.014; Bricker-Anthony C, 2017, OPTOMETRY VISION SCI, V94, P20, DOI 10.1097/OPX.0000000000000898; Bricker-Anthony C, 2016, J OCUL PHARMACOL TH, V32, P286, DOI 10.1089/jop.2015.0104; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Chen F, 2011, INFECT IMMUN, V79, P2460, DOI 10.1128/IAI.00050-11; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cui Q, 2009, NEUROSCIENCE, V158, P1039, DOI 10.1016/j.neuroscience.2008.07.036; Dhillon A, 2020, EYE, V34, P2106, DOI 10.1038/s41433-020-1070-2; Dorstyn L, 2012, CELL DEATH DIFFER, V19, P1288, DOI 10.1038/cdd.2012.36; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Falavarjani KG, 2013, EYE, V27, P787, DOI 10.1038/eye.2013.107; Forsberg J, 2017, ONCOGENE, V36, P5441, DOI 10.1038/onc.2017.169; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hill LJ, 2015, INVEST OPHTH VIS SCI, V56, P3743, DOI 10.1167/iovs.14-15622; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; JONES NP, 1986, BRIT MED J, V292, P188, DOI 10.1136/bmj.292.6514.188; Kaplan HJ, 2010, INVEST OPHTH VIS SCI, V51; Kokona D, 2017, EXP EYE RES, V154, P159, DOI 10.1016/j.exer.2016.11.020; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Lidster K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079188; Mead B, 2016, EXP EYE RES, V151, P96, DOI 10.1016/j.exer.2016.08.006; Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110612; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Naguib S, 2021, EXP EYE RES, V202, DOI 10.1016/j.exer.2020.108369; Olsson M, 2015, ONCOGENE, V34, P1877, DOI 10.1038/onc.2014.139; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Pozueta J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2927; Ramos MS, 2021, OPHTHALMOL RETINA, V5, P625, DOI 10.1016/j.oret.2020.09.024; Rex TS, 2014, INVEST OPHTH VIS SCI, V55, P8342, DOI 10.1167/iovs.14-16135; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Scott RAH, 2015, TRAUMA, V17, P83, DOI 10.1177/1460408614539621; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; STOLL G, 1989, J NEUROSCI, V9, P2327; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Tao WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12225-6; Thomas CN, 2020, EXP EYE RES, V197, DOI 10.1016/j.exer.2020.108102; Thomas CN, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121517; Thomas CN, 2018, INVEST OPHTH VIS SCI, V59, P4453, DOI 10.1167/iovs.18-24045; Thomas CN, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.32; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Titze-de-Almeida R, 2017, PHARM RES-DORDR, V34, P1339, DOI 10.1007/s11095-017-2134-2; Troy CM, 2000, J NEUROSCI, V20, P1386; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Vigneswara V, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.44; Vigneswara V, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051259; Vigneswara V, 2014, BRAIN, V137, P1656, DOI 10.1093/brain/awu037; Vigneswara V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057861; Vigneswara V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053473; Vlasov Anton, 2015, J Trauma Acute Care Surg, V79, pS210, DOI 10.1097/TA.0000000000000666; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Williams RW, 1996, J NEUROSCI, V16, P7193; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zhao XH, 2016, NAT MED, V22, P1268, DOI 10.1038/nm.4199	79	1	1	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	AUG 19	2021	11	1							16839	10.1038/s41598-021-96107-y			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UC8JQ	WOS:000686768700080	34413361	Green Published, gold			2022-02-06	
J	Wanner, ZR; Southam, CG; Sanghavi, P; Boora, NS; Paxman, EJ; Dukelow, SP; Benson, BW; Montina, T; Metz, GAS; Debert, CT				Wanner, Zachary R.; Southam, Cormac G.; Sanghavi, Prachi; Boora, Naveenjyote S.; Paxman, Eric J.; Dukelow, Sean P.; Benson, Brian W.; Montina, Tony; Metz, Gerlinde A. S.; Debert, Chantel T.			Alterations in Urine Metabolomics Following Sport-Related Concussion: A H-1 NMR-Based Analysis	FRONTIERS IN NEUROLOGY			English	Article						sports-related concussion; urine metabolomics; H-1 NMR spectroscopy; diagnostic tool; biomarker	TRAUMATIC BRAIN-INJURY; ACETYL-L-CARNITINE; ALZHEIMERS-DISEASE; SERUM; BIOMARKERS; STRESS; METABOLITES; MECHANISMS; CARNOSINE; EFFICACY	Objective: Millions of sport-related concussions (SRC) occur annually in North America, and current diagnosis of concussion is based largely on clinical evaluations. The objective of this study was to determine whether urinary metabolites are significantly altered post-SRC compared to pre-injury. Setting: Outpatient sports medicine clinic. Participants: Twenty-six male youth sport participants. Methods: Urine was analyzed pre-injury and after SRC by H-1 NMR spectroscopy. Data were analyzed using multivariate statistics, pairwise t-test, and metabolic pathway analysis. Variable importance analysis based on random variable combination (VIAVC) was applied to the entire data set and resulted in a panel of 18 features. Partial least square discriminant analysis was performed exploring the separation between pre-injury and post-SRC groups. Pathway topography analysis was completed to identify biological pathway involvement. Spearman correlations provide support for the relationships between symptom burden and length of return to play and quantifiable metabolic changes in the human urinary metabolome. Results: Phenylalanine and 3-indoxysulfate were upregulated, while citrate, propylene glycol, 1-methylhistidine, 3-methylhistidine, anserine, and carnosine were downregulated following SRC. A receiver operator curve (ROC) tool constructed using the 18-feature classifier had an area under the curve (AUC) of 0.887. A pairwise t-test found an additional 19 altered features, 7 of which overlapped with the VIAVC analysis. Pathway topology analysis indicated that aminoacyl-tRNA biosynthesis and beta-alanine metabolism were the two pathways most significantly changed. There was a significant positive correlation between post-SRC 2-hydroxybutyrate and the length of return to play (rho = 0.482, p = 0.02) as well as the number of symptoms and post-SRC lactose (rho = 0.422, p = 0.036). Conclusion: We found that H-1 NMR metabolomic urinary analysis can identify a set of metabolites that can correctly classify SRC with an accuracy of 81.6%, suggesting potential for a more objective method of characterizing SRC. Correlations to both the number of symptoms and length of return to play indicated that 2-hydroxybutyrate and lactose may have potential applications as biomarkers for sport-related concussion.	[Wanner, Zachary R.; Southam, Cormac G.; Sanghavi, Prachi; Boora, Naveenjyote S.; Paxman, Eric J.; Metz, Gerlinde A. S.] Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB, Canada; [Southam, Cormac G.; Dukelow, Sean P.; Benson, Brian W.; Debert, Chantel T.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Dukelow, Sean P.; Debert, Chantel T.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Benson, Brian W.] Winsport Med Clin, Calgary, AB, Canada; [Montina, Tony] Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB, Canada		Metz, GAS (corresponding author), Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB, Canada.; Debert, CT (corresponding author), Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada.; Debert, CT (corresponding author), Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada.; Montina, T (corresponding author), Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB, Canada.	tony.montina@uleth.ca; gerlinde.metz@uleth.ca; chantel.debert@abertaheathservices.ca		Montina, Tony/0000-0002-9934-9856	Hotchkiss Brain Institute; Canadian Institutes of Health Research Project SchemeCanadian Institutes of Health Research (CIHR) [363195]; NSERC-CGS-MNatural Sciences and Engineering Research Council of Canada (NSERC); AIHS Studentship; CIHR-CGS-M	This research was funded by the Hotchkiss Brain Institute (CD, BB, TM, and GM) and the Canadian Institutes of Health Research Project Scheme Grant #363195 (GM) . ZW was supported by an NSERC-CGS-M, CS by an AIHS Studentship, and EP by a CIHR-CGS-M.	An MX, 2015, GENOM PROTEOM BIOINF, V13, P345, DOI 10.1016/j.gpb.2015.08.005; Anderson PE, 2011, METABOLOMICS, V7, P179, DOI 10.1007/s11306-010-0242-7; Bae ON, 2013, STROKE, V44, P205, DOI 10.1161/STROKEAHA.112.673954; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0957-1; BALES JR, 1984, CLIN CHEM, V30, P1631; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1056/NEJMra073096; Berton R, 2017, J SPORT SCI, V35, P1211, DOI 10.1080/02640414.2016.1218035; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bruno G, 1994, ALZHEIMER DIS ASS DI, V9, P128, DOI [10.1097/00002093-199500930-00002, DOI 10.1097/00002093-199500930-00002]; Buzatto AZ, 2014, ELECTROPHORESIS, V35, P1285, DOI 10.1002/elps.201300470; Chan A, 2008, AM J ALZHEIMERS DIS, V23, P571, DOI 10.1177/1533317508325093; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Dambinova SA, 2013, MIL MED, V178, P285, DOI 10.7205/MILMED-D-12-00368; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; Dawiskiba T, 2014, WORLD J GASTROENTERO, V20, P163, DOI 10.3748/wjg.v20.i1.163; Delaunay-Moisan A, 2017, ANTIOXID REDOX SIGN, V27, P1178, DOI 10.1089/ars.2017.7148; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fernstrom JD, 2005, J NUTR, V135, p1539S, DOI 10.1093/jn/135.6.1539S; Fukuhara K, 2013, J CLIN BIOCHEM NUTR, V52, P133, DOI 10.3164/jcbn.12-118; Glenn Thomas C, 2013, Acta Neurochir Suppl, V118, P115, DOI 10.1007/978-3-7091-1434-6_20; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jiang ZT, 2011, TALANTA, V84, P298, DOI 10.1016/j.talanta.2011.01.015; Jove M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kuratsune H, 2002, NEUROIMAGE, V17, P1256, DOI 10.1006/nimg.2002.1260; La Fountaine MF, 2016, J NEUROTRAUM, V33, P904, DOI 10.1089/neu.2015.3968; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mickiewicz B, 2013, AM J RESP CRIT CARE, V187, P967, DOI 10.1164/rccm.201209-1726OC; MINOTTI G, 1987, FREE RADICAL BIO MED, V3, P379, DOI 10.1016/0891-5849(87)90016-5; Pham N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117286; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Peng J, 2014, J PROTEOME RES, V13, P4457, DOI 10.1021/pr500828v; Percival Benita C, 2018, High Throughput, V8, DOI 10.3390/ht8010002; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Schulte S, 2013, EUR J APPL PHYSIOL, V113, P811, DOI 10.1007/s00421-012-2503-9; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P926, DOI 10.1001/jamaneurol.2014.1160; SPAGNOLI A, 1991, NEUROLOGY, V41, P1726, DOI 10.1212/WNL.41.11.1726; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; VITEK V, 1975, CLIN CHIM ACTA, V58, P109, DOI 10.1016/S0009-8981(75)80003-9; Vuille-Dit-Bille RN, 2012, AMINO ACIDS, V43, P1287, DOI 10.1007/s00726-011-1202-x; Wei CM, 2012, MOL BIOSYST, V8, P2197, DOI 10.1039/c2mb25105a; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wilson F, 2017, BR J SPORTS MED, V51, pA47, DOI [10.1136/bjsports-2016-097270.120, DOI 10.1136/BJSPORTS-2016-097270.120]; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wishart DS, 2008, TRAC-TREND ANAL CHEM, V27, P228, DOI 10.1016/j.trac.2007.12.001; Wolahan SM, 2015, BRAIN NEUROTRAUMA MO, P341; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320; Yun YH, 2015, METABOLOMICS, V11, P1539, DOI 10.1007/s11306-015-0803-x; Zanelli SA, 2005, ANN NY ACAD SCI, V1053, P153, DOI 10.1196/annals.1344.013; Zhang AH, 2013, ANAL BIOANAL CHEM, V405, P8143, DOI 10.1007/s00216-013-7061-4; Zhang R, 2012, INT J MOL SCI, V13, P2078, DOI 10.3390/ijms13022078	65	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 19	2021	12								645829	10.3389/fneur.2021.645829			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UI2PK	WOS:000690455800008	34489846	Green Published, gold			2022-02-06	
J	Wettervik, TS; Lewen, A; Enblad, P				Wettervik, Teodor Svedung; Lewen, Anders; Enblad, Per			Post-traumatic hydrocephalus - incidence, risk factors, treatment, and clinical outcome	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Early Access						Neurointensive care; post-traumatic hydrocephalus; traumatic brain injury; ventriculo-peritoneal shunt	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; VENTRICULAR ENLARGEMENT; SHUNT IMPLANTATION; PRESSURE; SCALE	Objectives Post-traumatic hydrocephalus (PTH) is well-known after traumatic brain injury (TBI), but there is limited evidence regarding patient selection for ventriculo-peritoneal (VP)-shunt treatment. In this study, we investigated the incidence and risk factors for PTH and the indication for and outcome after shunt treatment. Materials and methods In this retrospective study, 836 TBI patients, treated at our neurointensive care (NIC) unit at Uppsala university hospital, Sweden, between 2008 and 2018, were included. Demography, admission status, radiology, treatments, and outcome variables were evaluated. Results Post-traumatic ventriculomegaly occurred in 46% of all patients at NIC discharge. Twenty-nine (3.5%) patients received a VP-shunt. Lower GCS M at admission, greater amount of subarachnoid hemorrhage, meningitis, decompressive craniectomy (DC), and ventriculomegaly at NIC discharge were risk factors for receiving a VP-shunt. Fourteen of the PTH patients showed impeded recovery or low-pressure hydrocephalus symptoms, of whom 13 experienced subjective clinical improvement after shunt treatment. Five PTH patients showed deterioration in consciousness, of whom four improved following shunt treatment. Five DC patients received a shunt due to subdural hygromas (n =2) or external brain herniation (n = 3), of whom two patients improved following treatment. Five patients were vegetative with concurrent ventriculomegaly and these patients did not have any positive shunt response. Altogether, 19 (66%) PTH patients improved after shunt surgery. Conclusion Post-traumatic ventriculomegaly was common, but few developed symptomatic PTH and received a VP-shunt. Patients with low-pressure hydrocephalus symptoms had the best shunt response, whereas patients with suspected vegetative state exhibited a minimal shunt response.	[Wettervik, Teodor Svedung; Lewen, Anders; Enblad, Per] Uppsala Univ, Dept Neurosci, Sect Neurosurg, SE-75185 Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, SE-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se		Svedung Wettervik, Teodor/0000-0002-4556-5721	Department of Neuroscience, Uppsala University	The study was funded by the Department of Neuroscience, Uppsala University.	Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Bauer DF, 2011, NEUROSURGERY, V68, P85, DOI 10.1227/NEU.0b013e3181fd85f4; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P49, DOI 10.1016/j.clineuro.2012.04.012; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Dorai Z, 2003, NEUROSURGERY, V52, P763, DOI 10.1227/01.NEU.0000053222.74852.2D; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Guyot LL, 2000, NEUROL RES, V22, P25; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kowalsky RJ, 2018, J PHYS ACT HEALTH, V15, P788, DOI [10.1123/jpah.2017-0639, 10.3171/2017.7.JNS17555]; Lalou AD, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00184-6; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; Missori P, 2006, NEUROSURG REV, V29, P224, DOI 10.1007/s10143-006-0027-7; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Toma AK, 2011, NEUROSURGERY, V68, P245, DOI 10.1227/NEU.0b013e318214a809; Tribl G, 2000, BRAIN INJURY, V14, P345; Wang KW, 2005, SURG NEUROL, V64, P61, DOI 10.1016/j.surneu.2004.10.009; Wen L, 2009, BRAIN INJURY, V23, P61, DOI 10.1080/02699050802635265; Wettervik TS, 2021, WORLD NEUROSURG, V148, pE508, DOI 10.1016/j.wneu.2021.01.013; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu Y, 2007, NEUROSURGERY, V61, P557, DOI 10.1227/01.NEU.0000290903.07943.AF	34	1	1	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.												10.1080/02688697.2021.1967289		AUG 2021	7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UC8XR	WOS:000686805200001	34414834	Green Published			2022-02-06	
J	Bouton, C; Bhagat, N; Chandrasekaran, S; Herrero, J; Markowitz, N; Espinal, E; Kim, JW; Ramdeo, R; Xu, JQ; Glasser, MF; Bickel, S; Mehta, A				Bouton, Chad; Bhagat, Nikunj; Chandrasekaran, Santosh; Herrero, Jose; Markowitz, Noah; Espinal, Elizabeth; Kim, Joo-Won; Ramdeo, Richard; Xu, Junqian; Glasser, Matthew F.; Bickel, Stephan; Mehta, Ashesh			Decoding Neural Activity in Sulcal and White Matter Areas of the Brain to Accurately Predict Individual Finger Movement and Tactile Stimuli of the Human Hand	FRONTIERS IN NEUROSCIENCE			English	Article						neuroprosthetics; stereoelectroencephalography; sensorimotor; tactile stimuli; neural decoding	STEREOELECTROENCEPHALOGRAPHY; INTERFACE; SIGNALS	Millions of people worldwide suffer motor or sensory impairment due to stroke, spinal cord injury, multiple sclerosis, traumatic brain injury, diabetes, and motor neuron diseases such as ALS (amyotrophic lateral sclerosis). A brain-computer interface (BCI), which links the brain directly to a computer, offers a new way to study the brain and potentially restore impairments in patients living with these debilitating conditions. One of the challenges currently facing BCI technology, however, is to minimize surgical risk while maintaining efficacy. Minimally invasive techniques, such as stereoelectroencephalography (SEEG) have become more widely used in clinical applications in epilepsy patients since they can lead to fewer complications. SEEG depth electrodes also give access to sulcal and white matter areas of the brain but have not been widely studied in brain-computer interfaces. Here we show the first demonstration of decoding sulcal and subcortical activity related to both movement and tactile sensation in the human hand. Furthermore, we have compared decoding performance in SEEG-based depth recordings versus those obtained with electrocorticography electrodes (ECoG) placed on gyri. Initial poor decoding performance and the observation that most neural modulation patterns varied in amplitude trial-to-trial and were transient (significantly shorter than the sustained finger movements studied), led to the development of a feature selection method based on a repeatability metric using temporal correlation. An algorithm based on temporal correlation was developed to isolate features that consistently repeated (required for accurate decoding) and possessed information content related to movement or touch-related stimuli. We subsequently used these features, along with deep learning methods, to automatically classify various motor and sensory events for individual fingers with high accuracy. Repeating features were found in sulcal, gyral, and white matter areas and were predominantly phasic or phasic-tonic across a wide frequency range for both HD (high density) ECoG and SEEG recordings. These findings motivated the use of long short-term memory (LSTM) recurrent neural networks (RNNs) which are well-suited to handling transient input features. Combining temporal correlation-based feature selection with LSTM yielded decoding accuracies of up to 92.04 +/- 1.51% for hand movements, up to 91.69 +/- 0.49% for individual finger movements, and up to 83.49 +/- 0.72% for focal tactile stimuli to individual finger pads while using a relatively small number of SEEG electrodes. These findings may lead to a new class of minimally invasive brain-computer interface systems in the future, increasing its applicability to a wide variety of conditions.	[Bouton, Chad; Bhagat, Nikunj; Chandrasekaran, Santosh; Herrero, Jose; Espinal, Elizabeth; Ramdeo, Richard; Bickel, Stephan; Mehta, Ashesh] Feinstein Inst Med Res Northwell Hlth, New York, NY 10001 USA; [Bouton, Chad; Bhagat, Nikunj; Chandrasekaran, Santosh; Herrero, Jose; Markowitz, Noah; Espinal, Elizabeth; Ramdeo, Richard; Bickel, Stephan; Mehta, Ashesh] Feinstein Inst Med Res, Inst Bioelectron Med, New York, NY 10001 USA; [Bouton, Chad; Bickel, Stephan; Mehta, Ashesh] Hofstra Northwell, Med Sch, New York, NY 10001 USA; [Herrero, Jose; Bickel, Stephan; Mehta, Ashesh] Northwell Hlth, Dept Neurosurg, New York, NY USA; [Kim, Joo-Won; Xu, Junqian] Baylor Coll Med, Dept Radiol & Psychiat, Houston, TX 77030 USA; [Glasser, Matthew F.] Washington Univ, Dept Radiol & Neurosci, St Louis, MO 63110 USA; [Bickel, Stephan] Northwell Hlth, Dept Neurol, New York, NY USA		Bouton, C (corresponding author), Feinstein Inst Med Res Northwell Hlth, New York, NY 10001 USA.; Bouton, C (corresponding author), Feinstein Inst Med Res, Inst Bioelectron Med, New York, NY 10001 USA.; Bouton, C (corresponding author), Hofstra Northwell, Med Sch, New York, NY 10001 USA.	cbouton@northwell.edu	Xu, Junqian/D-2247-2009; Bhagat, Nikunj/AAW-1704-2021	Xu, Junqian/0000-0001-8438-2066; Bhagat, Nikunj/0000-0002-0158-2861; Bouton, Chad/0000-0002-6297-3890			Akbari H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37359-z; Armour BS, 2016, AM J PUBLIC HEALTH, V106, P1855, DOI 10.2105/AJPH.2016.303270; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Cardinale F, 2013, NEUROSURGERY, V72, P353, DOI 10.1227/NEU.0b013e31827d1161; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chandrasekaran S., 2020, MEDRXIV, DOI [10.1101/2020.11.06.20217372, DOI 10.1101/2020.11.06.20217372]; Chen C, 2014, NEUROSCI RES, V83, P1, DOI 10.1016/j.neures.2014.03.010; Chowdhury RH, 2020, ELIFE, V9, DOI 10.7554/eLife.48198; Flesher SN, 2021, SCIENCE, V372, P831, DOI 10.1126/science.abd0380; Flesher SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8083; Flint RD, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2560/14/1/016005; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Groppe DM, 2017, J NEUROSCI METH, V281, P40, DOI 10.1016/j.jneumeth.2017.01.022; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hosman T, 2019, I IEEE EMBS C NEUR E, P1066, DOI 10.1109/NER.2019.8717140; Huang WC, 2021, IEEE T BIO-MED ENG, V68, P2509, DOI 10.1109/TBME.2020.3047812; Huang WC, 2019, IEEE ENG MED BIO, P3062, DOI 10.1109/EMBC.2019.8857724; Jiang TX, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00100; Krusienski DJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025006; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; Li D., 2017, P INT IEEE EMBS C NE; Li GY, 2017, I IEEE EMBS C NEUR E, P375, DOI 10.1109/NER.2017.8008368; Melnik A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04757-8; Mercier MR, 2017, NEUROIMAGE, V147, P219, DOI 10.1016/j.neuroimage.2016.08.037; Murphy BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150359; Rule ME, 2020, ELIFE, V9, DOI 10.7554/eLife.51121; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Shewalkar A, 2019, J ARTIF INTELL SOFT, V9, P235, DOI 10.2478/jaiscr-2019-0006; Shih JJ, 2012, J NEUROSCI METH, V203, P311, DOI 10.1016/j.jneumeth.2011.10.012; Shin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047992; Stanslaski S, 2018, IEEE T BIOMED CIRC S, V12, P1230, DOI 10.1109/TBCAS.2018.2880148; Stricsek G., 2018, FUNCTIONAL NEUROSURG, P113; Vadera S, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.3.FOCUS1373; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Xu JQ, 2013, NEUROIMAGE, V83, P991, DOI 10.1016/j.neuroimage.2013.07.055; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang Mingming, 2018, Bioelectron Med, V4, P11, DOI 10.1186/s42234-018-0011-x	38	1	1	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 17	2021	15								699631	10.3389/fnins.2021.699631			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UL9QY	WOS:000692978400001	34483823	Green Published, gold			2022-02-06	
J	Ernst, N; Eagle, S; Trbovich, A; Kissinger-Knox, A; Bitzer, H; Kontos, AP				Ernst, Nathan; Eagle, Shawn; Trbovich, Alicia; Kissinger-Knox, Alicia; Bitzer, Hannah; Kontos, Anthony P.			Lower post-injury psychological resilience is associated with increased recovery time and symptom burden following sport-related concussion	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						Athlete; concussion; resiliency; recovery	CONNOR-DAVIDSON RESILIENCE; SCALE CD-RISC; TRAUMATIC BRAIN-INJURY; EXPLANATORY STYLE; ANXIETY; STRESS; RELIABILITY; BATTERY; INVARIANCE; ADVERSITY	The purpose of this study was to compare athletes with high and low resilience scores on concussion outcomes, and identify significant predictors associated with protracted recovery (>30 days). Forty-five adolescent and young adult athletes (28 males; aged 15.13 +/- 2.74; range of 11-22) were diagnosed with an SRC within 14 days of injury (M = 4.9 days) and grouped as high or low resilience based on score on the Connor-Davidson Resilience Scale-10 (CD-RISC-10). Primary dependent measures included days to full clearance, Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), Depression Anxiety and Stress Scale-21 (DASS-21), and Vestibular/Ocular Motor Screening (VOMS). The low resilience group (n = 22) had a longer recovery (36.0 +/- 27.6 vs 17.8 +/- 11.2 days), endorsed more mood symptoms (PCSS Affective cluster; 3.8 +/- 0.8 vs 0.9 +/- 0.7), and were more likely to have VOMS scores above cut off (p = 0.01-0.02), compared to those with high psychological resilience (n = 23). Logistic regression found low resilience scores was the only significant predictor for protracted recovery among injury characteristics and risk factors. Psychological resilience is a critical factor associated with recovery time following sport-related concussions. Low resilience was also associated with other poor clinical outcomes, greater subjective symptom report, more severe vestibular dysfunction, and elevated levels of mood symptoms following injury.	[Ernst, Nathan] West Virginia Univ, Dept Behav Med & Psychiat, Morgantown, WV 26506 USA; [Eagle, Shawn; Trbovich, Alicia; Kissinger-Knox, Alicia; Bitzer, Hannah; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthoped, Pittsburgh, PA USA; [Trbovich, Alicia; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Dept Orthoped, Pittsburgh, PA USA		Ernst, N (corresponding author), West Virginia Univ, Morgantown, WV 26506 USA.	nathan.ernst@wvumedicine.org					Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Burns RA, 2010, PERS INDIV DIFFER, V48, P527, DOI 10.1016/j.paid.2009.11.026; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Chmitorz A, 2018, CLIN PSYCHOL REV, V59, P78, DOI 10.1016/j.cpr.2017.11.002; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Durish CL, 2018, J INT NEUROPSYCH SOC, V24, P759, DOI 10.1017/S1355617718000437; Durish CL, 2018, BRAIN INJURY, V32, P1525, DOI 10.1080/02699052.2018.1502471; Fischer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111214; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Fletcher D, 2012, PSYCHOL SPORT EXERC, V13, P669, DOI 10.1016/j.psychsport.2012.04.007; Forbes S, 2018, REV GEN PSYCHOL, V22, P452, DOI 10.1037/gpr0000152; Galli N, 2008, SPORT PSYCHOL, V22, P316, DOI 10.1123/tsp.22.3.316; Galli N, 2015, INT J SPORT EXERC PS, V13, P243, DOI 10.1080/1612197X.2014.946947; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gonzalez SP, 2016, PSYCHOL SPORT EXERC, V23, P31, DOI 10.1016/j.psychsport.2015.10.005; Gucciardi DF, 2011, PSYCHOL SPORT EXERC, V12, P423, DOI 10.1016/j.psychsport.2011.02.005; Haddadi P, 2010, PROCD SOC BEHV, V5, P639, DOI 10.1016/j.sbspro.2010.07.157; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hartley MT, 2012, J COLL COUNS, V15, P37, DOI 10.1002/j.2161-1882.2012.00004.x; Hassett AL, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0567-7; Karoly P, 2006, PAIN, V123, P90, DOI 10.1016/j.pain.2006.02.014; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lebares CC, 2018, J AM COLL SURGEONS, V226, P80, DOI 10.1016/j.jamcollsurg.2017.10.010; Lee EE, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11776; Li YK, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00348; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Lowe SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125761; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Martin-Krumm CP, 2003, PERS INDIV DIFFER, V35, P1685, DOI 10.1016/S0191-8869(02)00390-2; Mealer M, 2012, INT J NURS STUD, V49, P292, DOI 10.1016/j.ijnurstu.2011.09.015; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; O'Rourke N, 2010, AGING MENT HEALTH, V14, P984, DOI 10.1080/13607863.2010.501063; Ong AD, 2010, PSYCHOL AGING, V25, P516, DOI 10.1037/a0019384; Osman A, 2012, J CLIN PSYCHOL, V68, P1322, DOI 10.1002/jclp.21908; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Poole JC, 2017, J AFFECT DISORDERS, V217, P144, DOI 10.1016/j.jad.2017.03.047; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Reid MW, 2018, J NEUROTRAUM, V35, P1146, DOI 10.1089/neu.2017.5424; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; SELIGMAN MEP, 1990, PSYCHOL SCI, V1, P143, DOI 10.1111/j.1467-9280.1990.tb00084.x; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Stonnington CM, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-015-0609-2; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Vaishnavi S, 2007, PSYCHIAT RES, V152, P293, DOI 10.1016/j.psychres.2007.01.006; van der Meulen E, 2019, PERS INDIV DIFFER, V144, P120, DOI 10.1016/j.paid.2019.03.006; Wagstaff CRD, 2013, PSYCHOL SPORT EXERC, V14, P476, DOI 10.1016/j.psychsport.2013.01.006; Wallhausser-Franke E, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/370307	64	1	1	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2021.1964966		AUG 2021	8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	UC3AA	WOS:000686401600001	34410842				2022-02-06	
J	Wehn, AC; Khalin, I; Duering, M; Hellal, F; Culmsee, C; Vandenabeele, P; Plesnila, N; Terpolilli, NA				Wehn, Antonia Clarissa; Khalin, Igor; Duering, Marco; Hellal, Farida; Culmsee, Carsten; Vandenabeele, Peter; Plesnila, Nikolaus; Terpolilli, Nicole Angela			RIPK1 or RIPK3 deletion prevents progressive neuronal cell death and improves memory function after traumatic brain injury	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Chronic posttraumatic brain damage; Magnetic resonance imaging; Necroptosis; Ferroptosis; Neuroprotection	CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC HYDROCEPHALUS; DECOMPRESSIVE CRANIECTOMY; CEREBRAL MICROBLEEDS; IN-VITRO; FERROPTOSIS; INFLAMMATION; NEURODEGENERATION; ACTIVATION; HEMORRHAGE	Traumatic brain injury (TBI) causes acute and subacute tissue damage, but is also associated with chronic inflammation and progressive loss of brain tissue months and years after the initial event. The trigger and the subsequent molecular mechanisms causing chronic brain injury after TBI are not well understood. The aim of the current study was therefore to investigate the hypothesis that necroptosis, a form a programmed cell death mediated by the interaction of Receptor Interacting Protein Kinases (RIPK) 1 and 3, is involved in this process. Neuron-specific RIPK1- or RIPK3-deficient mice and their wild-type littermates were subjected to experimental TBI by controlled cortical impact. Posttraumatic brain damage and functional outcome were assessed longitudinally by repetitive magnetic resonance imaging (MRI) and behavioral tests (beam walk, Barnes maze, and tail suspension), respectively, for up to three months after injury. Thereafter, brains were investigated by immunohistochemistry for the necroptotic marker phosphorylated mixed lineage kinase like protein(pMLKL) and activation of astrocytes and microglia. WT mice showed progressive chronic brain damage in cortex and hippocampus and increased levels of pMLKL after TBI. Chronic brain damage occurred almost exclusively in areas with iron deposits and was significantly reduced in RIPK1- or RIPK3-deficient mice by up to 80%. Neuroprotection was accompanied by a reduction of astrocyte and microglia activation and improved memory function. The data of the current study suggest that progressive chronic brain damage and cognitive decline after TBI depend on the expression of RIPK1/3 in neurons. Hence, inhibition of necroptosis signaling may represent a novel therapeutic target for the prevention of chronic post-traumatic brain damage.	[Wehn, Antonia Clarissa; Khalin, Igor; Duering, Marco; Hellal, Farida; Plesnila, Nikolaus; Terpolilli, Nicole Angela] Ludwig Maximilians Univ Munchen, LMU Klinikum, Inst Stroke & Dementia Res ISD, Feodor Lynen Str 17, D-81377 Munich, Germany; [Wehn, Antonia Clarissa; Khalin, Igor; Duering, Marco; Hellal, Farida; Plesnila, Nikolaus; Terpolilli, Nicole Angela] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Culmsee, Carsten] Univ Marburg, Biochem Pharmacol Ctr Marburg, Inst Pharmacol & Clin Pharm, Karl von Frisch Str 2, D-35032 Marburg, Germany; [Culmsee, Carsten] Univ Marburg, Marburg, Germany; [Vandenabeele, Peter] VIB UGent Ctr Inflammat Res, Mol Signaling & Cell Death Unit, UGent VIB Res Bldg FSVM,Technol Pk 71, B-9052 Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Plesnila, Nikolaus] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci GSN, Munich, Germany; [Terpolilli, Nicole Angela] Ludwig Maximilians Univ Munchen, Dept Neurosurg, LMU Klinikum, Munich, Germany; [Duering, Marco] Univ Basel, Dept Biomed Engn, Med Image Anal Ctr MIAC AG & Qbig, Basel, Switzerland		Plesnila, N; Terpolilli, NA (corresponding author), Ludwig Maximilians Univ Munchen, LMU Klinikum, Inst Stroke & Dementia Res ISD, Feodor Lynen Str 17, D-81377 Munich, Germany.; Plesnila, N; Terpolilli, NA (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.; Plesnila, N (corresponding author), Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci GSN, Munich, Germany.; Terpolilli, NA (corresponding author), Ludwig Maximilians Univ Munchen, Dept Neurosurg, LMU Klinikum, Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de; terpolilli@med.uni-muenchen.de	Vandenabeele, Peter/AAD-5793-2022; Culmsee, Carsten/ABC-3120-2021; Hellal, Farida/D-1834-2015	Vandenabeele, Peter/0000-0002-6669-8822; Culmsee, Carsten/0000-0002-5121-5015; Plesnila, Nikolaus/0000-0001-8832-228X; Hellal, Farida/0000-0002-9344-1846	Flemish grants (EOS MODEL-IDI, FWO)FWO [30826052]; FWOFWO [G.0E04.16N, G.0C76.18N, G.0B71.18N, G.0B96.20N]; Methusalem [BOF16/MET_V/007]; ATLANTIS [iBOF20/IBF/039]; Foundation against Cancer [FAFF/2016/865, F/2020/1505]; CRIG and GIGG consortia; VIB; Munich University; BMBFFederal Ministry of Education & Research (BMBF) [01EW1709]; Munich Cluster of Systems Neurology [EXC 2145/ID 390857198]	We want to thank Dr. Ulrike Schillinger for her support during the analysis of the MRI data. Research in the Vandenabeele group is supported by Flemish grants (EOS MODEL-IDI, FWO Grant 30826052), FWO research grants (G.0E04.16N, G.0C76.18N, G.0B71.18N, G.0B96.20N), Methusalem (BOF16/MET_V/007), iBOF20/IBF/039 ATLANTIS, Foundation against Cancer (FAFF/2016/865, F/2020/1505), CRIG and GIGG consortia, and VIB. The Plesnila group was funded by Munich University's Forder programm fur Forschung und Lehre (FoFoLe), by the BMBF-funded research consortium TRAINS (Project ID: 01EW1709) and by the Munich Cluster of Systems Neurology (SyNergy; Project ID EXC 2145/ID 390857198).	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Alghnam Suliman, 2017, Inj Epidemiol, V4, P29, DOI 10.1186/s40621-017-0126-7; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bhasin RR, 2002, ACTA NEUROCHIR SUPPL, V81, P249; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Conrad M, 2019, NAT CHEM BIOL, V15, P1137, DOI 10.1038/s41589-019-0408-1; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Derry PJ, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.603043; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Ganjam GK, 2018, CELL DEATH DIFFER, V25, P1394, DOI 10.1038/s41418-017-0046-7; Gawel K, 2019, N-S ARCH PHARMACOL, V392, P1, DOI 10.1007/s00210-018-1589-y; Ghosh M, 2015, ANN NEUROL, V78, P887, DOI 10.1002/ana.24512; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Guillen J, 2012, J AM ASSOC LAB ANIM, V51, P311; Guyot LL, 2000, NEUROL RES, V22, P25; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Hua Y, 2000, J NEUROSURG, V92, P1016, DOI 10.3171/jns.2000.92.6.1016; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Karperien A, 1999, FRACLAC IMAGEJ; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Krieg SM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00455; Lawrence TP, 2017, NEUROSCI LETT, V655, P143, DOI 10.1016/j.neulet.2017.06.046; LETARTE PB, 1993, J NEUROSURG, V79, P252, DOI 10.3171/jns.1993.79.2.0252; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mao X, 2020, J NEUROTRAUM, V37, P1331, DOI 10.1089/neu.2019.6510; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Ratan RR, 2020, CELL CHEM BIOL, V27, P479, DOI 10.1016/j.chembiol.2020.03.007; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takahashi N, 2014, NATURE, V513, P95, DOI 10.1038/nature13706; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; van der Horn HJ, 2018, BRAIN IMAGING BEHAV, V12, P912, DOI 10.1007/s11682-017-9743-6; Wan JR, 2019, STROKE VASC NEUROL, V4, P93, DOI 10.1136/svn-2018-000205; Young K, 2018, JOVE-J VIS EXP, DOI 10.3791/57648; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	68	1	1	5	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	AUG 17	2021	9	1							138	10.1186/s40478-021-01236-0			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC7RM	WOS:000686721200001	34404478	Green Published, gold			2022-02-06	
J	Yao, XL; Wang, SB; Chen, YC; Sheng, LQ; Li, HH; You, HC; Ye, JF; Zhang, Q; Li, J				Yao, Xiaolong; Wang, Shengbo; Chen, Yingchun; Sheng, Liuqing; Li, Huanhuan; You, Huichao; Ye, Jianfeng; Zhang, Qing; Li, Jun			Sodium houttuyfonate attenuates neurological defects after traumatic brain injury in mice via inhibiting NLRP3 inflammasomes	JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY			English	Article						HMGB1; IL4; NF-kappa B; NLRP3 inflammasome; sodium houttuyfonate; traumatic brain injury	ACTIVATION	Sodium houttuyfonate (SH) is a chemical compound synthesized by houttuynin and sodium bisulfite. As it has antinflammatory effects, SH has been widely used to treat autoimmune diseases, including post events following traumatic brain injury (TBI). Meanwhile, NOD-like receptor with pyrin domain containing-3 (NLRP3) inflammasomes in microglia may play a central role in TBI. But to date, the intracellular mechanisms involved in the anti-inflammatory effects of SH in TBI remain unknown, especially whether regulating NLRP3. To gain an insight into this possibility, we conducted cell culture and biochemical studies on the effect of SH on NLRP3 inflammasome in microglia. The results showed that SH inhibited TLR4 and NLRP3 inflammasome activation in the microglia cell. In parallel, phosphorylation of ERK and NF-kappa B p65, which play a key role in NLRP3 inflammasome formation, was decreased. Intraperitoneal injection of SH into TBI mice significantly reduced the modified neurological severity score (mNSS), as well as the degree of microglia apoptosis post-controlled cortical impact (CCI). Immunohistochemistry, Western blot analysis, and reverse-transcription polymerase chain reaction (RT-PCR) revealed that SH markedly reduced NLRP3 inflammasome activation, TLR4 activity, phosphorylation of ERK and NE-kappa B. Moreover, SH significantly inhibited microglia activation post-CCI, but effectively promoted the astrocyte activation and angiopoiesis. Taken together, our research provides evidence that SH attenuated neurological deficits post TBI through inhibiting NLRP3 inflammasome activation, via influencing the TLR4/NF-kappa B signaling pathway. These findings explain the intracellular mechanism of the anti-inflammatory activity caused by SH treatment following TBI.	[Yao, Xiaolong; Wang, Shengbo; Chen, Yingchun; Sheng, Liuqing; Li, Huanhuan; You, Huichao; Ye, Jianfeng; Zhang, Qing; Li, Jun] Third Peoples Hosp Hubei Prov, Dept Neurosurg, 26 Zhongshan Ave, Wuhan 433000, Hubei, Peoples R China		Li, J (corresponding author), Third Peoples Hosp Hubei Prov, Dept Neurosurg, 26 Zhongshan Ave, Wuhan 433000, Hubei, Peoples R China.	13006163722@163.com					Carranza-Aguilar CJ, 2020, CELL MOL NEUROBIOL, DOI 10.1007/s10571-020-00957-5; Chun JM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-234; Crupi R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040297; Da WY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00034; David L, 2020, MOL NEUROBIOL, V57, P4692; Du Q, 2020, J ETHNOPHARMACOL, V262, DOI 10.1016/j.jep.2020.113160; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Gensel John C, 2020, EXP NEUROL, V329; Hana S, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00649; Irrera N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176204; Ismail H, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100943; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Jeremy C.E, 2018, MOL NEUROBIOL, V55, P1977; Jerome B, 2019, FRONT NEUROSCI-SWITZ, V13, P1178; Ling LJ, 2020, PHYTOMEDICINE, V67, DOI 10.1016/j.phymed.2019.153150; Linlin L, 2020, J BIOCHEM MOL TOXIC, V34; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Mukherjee S, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01854-w; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Purvis GSD, 2020, BRIT J PHARMACOL, V177, P4416, DOI 10.1111/bph.15182; Sandall CF, 2020, MOLECULES, V25, DOI 10.3390/molecules25194572; Sekita Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2581876; Shingnaisui K, 2018, J ETHNOPHARMACOL, V220, P35, DOI 10.1016/j.jep.2018.03.038; Song N, 2017, MOL CELL, V68, P185, DOI 10.1016/j.molcel.2017.08.017; Sujatha K, 2019, EXP NEUROL, V320; Toth L, 2021, GEROSCIENCE, V43, P125, DOI 10.1007/s11357-020-00280-3; Wang WQ, 2017, MICROB PATHOGENESIS, V107, P12, DOI 10.1016/j.micpath.2017.03.011; Wang ZY, 2021, MOL IMMUNOL, V132, P82, DOI 10.1016/j.molimm.2021.01.028; Wen YJ, 2020, PHYTOMEDICINE, V79, DOI 10.1016/j.phymed.2020.153328; Xiang M, 2011, J IMMUNOL, V187, P4809, DOI 10.4049/jimmunol.1102093; Xu EQ, 2018, J NEUROIMMUNE PHARM, V13, P237, DOI 10.1007/s11481-018-9780-y; Yanarojana M, 2017, ANTICANCER RES, V37, P6619, DOI 10.21873/anticanres.12119; Yao XL, 2019, BIOCHEM BIOPH RES CO, V509, P624, DOI 10.1016/j.bbrc.2018.11.145; Yilmaz C, 2019, FRONT NEUROENDOCRIN, V55, DOI 10.1016/j.yfrne.2019.100788; Yin G, 2018, EXP NEUROL, V305, P129, DOI 10.1016/j.expneurol.2018.04.008; Zhao ZL, 2017, PROTEIN CELL, V8, P801, DOI 10.1007/s13238-017-0414-6; Zhou D, 2020, J ETHNOPHARMACOL, V258, DOI 10.1016/j.jep.2020.112826	37	1	1	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1095-6670	1099-0461		J BIOCHEM MOL TOXIC	J. Biochem. Mol. Toxicol.	SEP	2021	35	9							e22850	10.1002/jbt.22850		AUG 2021	10	Biochemistry & Molecular Biology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Toxicology	UQ0FH	WOS:000686365200001	34405489				2022-02-06	
J	Saber, M; Ortiz, JB; Valencia, LMR; Ma, XK; Tallent, BR; Adelson, PD; Rowe, RK; Qiu, SF; Lifshitz, J				Saber, Maha; Ortiz, J. Bryce; Rojas Valencia, Luisa M.; Ma, Xiaokuang; Tallent, Bret R.; Adelson, P. David; Rowe, Rachel K.; Qiu, Shenfeng; Lifshitz, Jonathan			Mice Born to Mothers with Gravida Traumatic Brain Injury Have Distorted Brain Circuitry and Altered Immune Responses	JOURNAL OF NEUROTRAUMA			English	Article						circuit connectivity; fetal development; gestational injury; immune response; intimate partner violence; maternal brain injury	SEX-DIFFERENCES; MATERNAL INFECTION; MOUSE MODELS; BIRTH-WEIGHT; ANIMAL TESTS; STRESS; CORTICOSTERONE; PREGNANCY; OUTCOMES; AGE	Intimate partner violence (IPV) increases risk of traumatic brain injury (TBI). Physical assaults increase in frequency and intensity during pregnancy. The consequences of TBI during pregnancy (gravida TBI; gTBI) on offspring development is unknown, for which stress and inflammation during pregnancy worsen fetal developmental outcomes. We hypothesized that gTBI would lead to increased anxiety- and depression-related behavior, altered inflammatory responses and gut pathology, and distorted brain circuitry in mixed-sex offspring compared to mice born to control mothers. Pregnant dams received either diffuse TBI or sham injury (control) 12 days post-coitum. We found that male gTBI offspring were principal drivers of the gTBI effects on health, physiology, and behavior. For example, male, but not female, gTBI offspring weighed significantly less at weaning compared to male control offspring. At post-natal day (PND) 28, gTBI offspring had significantly weaker intralaminar connectivity onto layer 5 pre-frontal pyramidal neurons compared to control offspring. Neurological performance on anxiety-like behaviors was decreased, with only marginal differences in depressive-like behaviors, for gTBI offspring compared to control offspring. At PND42 and PND58, circulating neutrophil and monocyte populations were significantly smaller in gTBI male offspring than control male offspring. In response to a subsequent inflammatory challenge at PND75, gTBI offspring had significantly smaller circulating neutrophil populations than control offspring. Anxiety-like behaviors persisted during the immune challenge in gTBI offspring. However, spleen immune response and gut histology showed no significant differences between groups. The results compel further studies to determine the full extent of gTBI on fetal and maternal outcomes.	[Saber, Maha; Ortiz, J. Bryce; Rojas Valencia, Luisa M.; Tallent, Bret R.; Adelson, P. David; Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Child Hlth, 475 North 5th St, Phoenix, AZ 85004 USA; [Ma, Xiaokuang; Qiu, Shenfeng] Univ Arizona, Coll Med Phoenix, Basic Med Sci, Phoenix, AZ USA; [Saber, Maha; Ortiz, J. Bryce; Rojas Valencia, Luisa M.; Tallent, Bret R.; Adelson, P. David; Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Ortiz, J. Bryce; Rojas Valencia, Luisa M.; Tallent, Bret R.; Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Rowe, Rachel K.] Univ Colorado Boulder, Dept Integrat Physiol, Boulder, CO USA		Lifshitz, J (corresponding author), Univ Arizona, Coll Med Phoenix, Child Hlth, 475 North 5th St, Phoenix, AZ 85004 USA.	jlifshitz@email.arizona.edu		Ma, Xiaokuang/0000-0001-7900-6779	Phoenix Children's Hospital; Arizona Alzheimer's Consortium; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32-AG044402]; Fraternal Order of Eagles	This research was funded, in part, by Phoenix Children's Hospital mission support, Arizona Alzheimer's Consortium, Fraternal Order of Eagles, and NIH T32-AG044402.	Alachkar A, 2018, MOL PSYCHIATR, V23, P282, DOI 10.1038/mp.2017.164; Aziz SHA, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9704607; Bailey BA, 2010, INT J WOMENS HEALTH, V2, P183, DOI 10.2147/ijwh.s8632; Baker S, 2008, BRAIN RES, V1213, P98, DOI 10.1016/j.brainres.2008.03.035; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Bialkowska AB, 2016, JOVE-J VIS EXP, DOI 10.3791/54161; Bilbo SD, 2018, EXP NEUROL, V299, P241, DOI 10.1016/j.expneurol.2017.07.002; Black M C., 2011, NATL INTIMATE PARTNE; Bowers SL, 2008, BRAIN BEHAV IMMUN, V22, P105, DOI 10.1016/j.bbi.2007.07.012; Brenhouse HC, 2019, FRONT NEUROENDOCRIN, V54, DOI 10.1016/j.yfrne.2019.100768; Brigida AL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071425; Brown AS, 2004, AM J PSYCHIAT, V161, P889, DOI 10.1176/appi.ajp.161.5.889; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; CDC, 2016, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention (CDC), 2010, TRAUMATIC BRAIN INJU; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Ribeiro MRC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170469; Coussons-Read ME, 2013, OBSTET MED, V6, P52, DOI 10.1177/1753495X12473751; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; EARLS F, 1987, PSYCHIAT DEV, V5, P1; Ellman LM, 2008, DEV PSYCHOBIOL, V50, P232, DOI 10.1002/dev.20293; Faravelli C, 2012, WORLD J PSYCHIATR, V2, P13, DOI 10.5498/wjp.v2.i1.13; Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0; Garcia-Flores V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01291; Genn RF, 2003, NEUROSCI BIOBEHAV R, V27, P155, DOI 10.1016/S0149-7634(03)00017-4; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Gunnar MR, 2019, P NATL ACAD SCI USA, V116, P23984, DOI 10.1073/pnas.1909699116; Halladay AK, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0019-y; Hantsoo L, 2019, BIOL PSYCHIAT, V85, P97, DOI 10.1016/j.biopsych.2018.08.018; Hava G, 2006, DEV PSYCHOBIOL, V48, P162, DOI 10.1002/dev.20116; Jasarevic E, 2019, FRONT NEUROENDOCRIN, V55, DOI 10.1016/j.yfrne.2019.100797; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Kazdoba TM, 2016, CURR TOP BEHAV NEURO, V28, P1, DOI 10.1007/7854_2015_5003; Khandaker GM, 2013, PSYCHOL MED, V43, P239, DOI 10.1017/S0033291712000736; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Kirsten TB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134565; Kiss ACI, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-21; Kumar KP, 2018, CELL TISSUE RES, V371, P551, DOI 10.1007/s00441-017-2753-2; Lake ET, 2015, HEALTH SERV RES, V50, P374, DOI 10.1111/1475-6773.12225; Lazaro MT, 2019, CELL REP, V27, P2567, DOI 10.1016/j.celrep.2019.05.006; Liu YZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00316; Lutgendorf MA, 2019, OBSTET GYNECOL, V134, P470, DOI 10.1097/AOG.0000000000003326; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Mackes NK, 2020, P NATL ACAD SCI USA, V117, P641, DOI 10.1073/pnas.1911264116; Mahic M, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00159-17, 10.1128/msphere.00159-17]; Mazina V, 2015, J DEV BEHAV PEDIATR, V36, P61, DOI 10.1097/DBP.0000000000000126; McKinney BC, 2005, AM J MED GENET B, V136B, P98, DOI 10.1002/ajmg.b.30183; Murphy SK, 2017, PSYCHIAT RES, V257, P102, DOI 10.1016/j.psychres.2017.07.025; Nyangahu DD, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0511-7; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Park SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08502; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Pitsillides CM, 2011, CYTOM PART A, V79A, P758, DOI 10.1002/cyto.a.21125; Plancikova D, 2021, EUR J TRAUMA EMERG S, V47, P2035, DOI 10.1007/s00068-020-01372-7; Qiu SF, 2011, J NEUROSCI, V31, P5855, DOI 10.1523/JNEUROSCI.6569-10.2011; Rasouli J, 2011, Einstein J Biol Med, V27, P74; Redelmeier DA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011972; Reed MD, 2020, NATURE, V577, P249, DOI 10.1038/s41586-019-1843-6; Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Rowe RK, 2021, J NEUROTRAUM, V38, P2301, DOI 10.1089/neu.2021.0022; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Saber M, 2021, J NEUROSCI RES, V99, P1136, DOI 10.1002/jnr.24771; Saber M, 2021, SHOCK, V55, P256, DOI 10.1097/SHK.0000000000001618; Saber M, 2020, EUR J NEUROSCI, V52, P2791, DOI 10.1111/ejn.14611; Schwartz DA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020194; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Siniscalco D, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11020056; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Spencer KM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.033.2009; Stephany CE, 2014, J NEUROSCI, V34, P11631, DOI 10.1523/JNEUROSCI.0545-14.2014; Su Q, 2015, PEDIATR NEONATOL, V56, P376, DOI 10.1016/j.pedneo.2015.02.002; Suter Benjamin A, 2010, Front Neural Circuits, V4, P100, DOI 10.3389/fncir.2010.00100; Taylor JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208846; Torche F, 2011, DEMOGRAPHY, V48, P1473, DOI 10.1007/s13524-011-0054-z; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; Wohleb ES, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00447; Wurbel H, 1997, ANIM BEHAV, V53, P891, DOI 10.1006/anbe.1996.0424; Yim YS, 2017, NATURE, V549, P482, DOI 10.1038/nature23909; Zerbo O, 2015, J AUTISM DEV DISORD, V45, P4002, DOI 10.1007/s10803-015-2579-2; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	94	1	1	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2862	2880		10.1089/neu.2021.0048		AUG 2021	19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000684632700001	34155930				2022-02-06	
J	Gao, JP; Li, YF; Song, R				Gao, Jinpeng; Li, Yunfeng; Song, Ran			SIRT2 inhibition exacerbates p53-mediated ferroptosis in mice following experimental traumatic brain injury	NEUROREPORT			English	Article						ferroptosis; protein 53; sirtuin 2; traumatic brain injury	MECHANISMS; ACETYLATION	Objective Ferroptosis plays an important role in traumatic brain injury (TBI). The p53 protein is a major mediator of ferroptosis. However, the role of p53-mediated ferroptosis in TBI has not been studied. Sirtuin 2 (SIRT2) exerts a protective effects role in TBI, although the underlying mechanism of this protection remains unclear. In the present study, we tested the hypothesis that that SIRT2 mitigates TBI by regulating p53-mediated ferroptosis. Methods and results To model TBI in mice, we used the controlled cortical impact (CCI) injury method. We found that ferroptosis was significantly activated by CCI, and peaked 3 days following CCI, as evidenced by upregulation of GPX4 and SLC7A11, increased content of decreases glutathione, lipid peroxidation, malondialdehyde and ferrous ion. Inhibition of ferroptosis significantly alleviated neurological indications and brain edema. In addition, knockout of p53 significantly blocked ferroptosis following CCI. Furthermore, we found that inhibition of SIRT2 upregulated the acetylation of p53, as well as p53 expression, and exacerbated ferroptosis following CCI. Interestingly, knockout of p53 rescued the SIRT2 inhibition-induced exacerbation of ferroptosis. Conclusions These findings indicate that p53-mediated ferroptosis contributes to the pathogenesis of TBI. Furthermore, we demonstrate that SIRT2 exerts a neuroprotective effect against TBI by suppressing p53-mediated ferroptosis.	[Gao, Jinpeng] Southern Med Univ, Affiliated Chenzhou Hosp, Peoples Hosp Chenzhou 1, Dept Neurosurg, Chenzhou, Peoples R China; [Li, Yunfeng] Second Peoples Hosp Chenzhou, Dept Crit Care Med, Chenzhou, Peoples R China; [Song, Ran] Southern Med Univ, Affiliated Chenzhou Hosp, Peoples Hosp Chenzhou 1, Dept Lab Med, 102 Luojiajing, Chenzhou 423000, Peoples R China		Song, R (corresponding author), Southern Med Univ, Affiliated Chenzhou Hosp, Peoples Hosp Chenzhou 1, Dept Lab Med, 102 Luojiajing, Chenzhou 423000, Peoples R China.	songrancz@163.com			Science and Technology Development Project of Chenzhou [zdyf201922]	This work was supported by the Science and Technology Development Project of Chenzhou (grant number: zdyf201922).	Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1; Chao CCK, 2015, CLIN CHIM ACTA, V438, P139, DOI 10.1016/j.cca.2014.08.015; Doll S, 2019, NATURE, V575, P693, DOI 10.1038/s41586-019-1707-0; Dong H, 2020, AGING-US, V12, P12943, DOI 10.18632/aging.103378; Zuo F, 2021, HUM CELL, V34, P177, DOI 10.1007/s13577-020-00431-w; Gnanapradeepan K, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00124; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Katare PB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75301-4; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Li Y, 2019, CELL DEATH DIFFER, V26, P2284, DOI 10.1038/s41418-019-0299-4; Liang C, 2019, ADV MATER, V31, DOI 10.1002/adma.201904197; Liu PF, 2020, CELL MOL BIOL LETT, V25, DOI 10.1186/s11658-020-00205-0; Liu XY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6039769; Liu YQ, 2019, J MOL CELL BIOL, V11, P564, DOI 10.1093/jmcb/mjz060; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Romeo-Guitart D, 2020, NEUROTHERAPEUTICS, V17, P1197, DOI 10.1007/s13311-020-00860-3; Shen LS, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00594; Stockwell BR, 2020, TRENDS CELL BIOL, V30, P478, DOI 10.1016/j.tcb.2020.02.009; Tang SC, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.590789; Tao NN, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9547127; Wang Y, 2020, MOL BIOL REP, V47, P381, DOI 10.1007/s11033-019-05141-7; Wu JR, 2018, J MOL NEUROSCI, V66, P197, DOI 10.1007/s12031-018-1155-6; Wu J, 2019, NATURE, V572, P402, DOI 10.1038/s41586-019-1426-6; Wu YN, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00115; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Xu DJ, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116639; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zhang YQ, 2020, EUR J PHARMACOL, V867, DOI 10.1016/j.ejphar.2019.172847; Zhao X, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6584-2	30	1	1	7	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 11	2021	32	12					1001	1008		10.1097/WNR.0000000000001679			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL2WE	WOS:000674716500006	34102645				2022-02-06	
J	Pan, DY; Li, YJ; Yang, FH; Lv, ZH; Zhu, SB; Shao, YX; Huang, Y; Ning, GZ; Feng, SQ				Pan, Dayu; Li, Yongjin; Yang, Fuhan; Lv, Zenghui; Zhu, Shibo; Shao, Yixin; Huang, Ying; Ning, Guangzhi; Feng, Shiqing			Increasing toll-like receptor 2 on astrocytes induced by Schwann cell-derived exosomes promotes recovery by inhibiting CSPGs deposition after spinal cord injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Schwann cell; Exosomes; Axonal regeneration; Spinal cord injury; Toll-like receptor 2; Astrocyte; CSPG (chondroitin sulfate proteoglycan)	CHONDROITIN SULFATE PROTEOGLYCANS; REACTIVE ASTROCYTES; FUNCTIONAL RECOVERY; NEURITE OUTGROWTH; SYNOVIAL TISSUE; INNATE IMMUNITY; SCAR FORMATION; AXON GROWTH; EXPRESSION; CNS	Background Traumatic spinal cord injury (SCI) is a severely disabling disease that leads to loss of sensation, motor, and autonomic function. As exosomes have great potential in diagnosis, prognosis, and treatment of SCI because of their ability to easily cross the blood-brain barrier, the function of Schwann cell-derived exosomes (SCDEs) is still largely unknown. Methods A T10 spinal cord contusion was established in adult female mice. SCDEs were injected into the tail veins of mice three times a week for 4 weeks after the induction of SCI, and the control group was injected with PBS. High-resolution transmission electron microscope and western blot were used to characterize the SCDEs. Toll-like receptor 2 (TLR2) expression on astrocytes, chondroitin sulfate proteoglycans (CSPGs) deposition and neurological function recovery were measured in the spinal cord tissues of each group by immunofluorescence staining of TLR2, GFAP, CS56, 5-HT, and beta-III-tublin, respectively. TLR2(f/f) mice were crossed to the GFAP-Cre strain to generate astrocyte specific TLR2 knockout mice (TLR2(-/-)). Finally, western blot analysis was used to determine the expression of signaling proteins and IKK beta inhibitor SC-514 was used to validate the involved signaling pathway. Results Here, we found that TLR2 increased significantly on astrocytes post-SCI. SCDEs treatment can promote functional recovery and induce the expression of TLR2 on astrocytes accompanied with decreased CSPGs deposition. The specific knockout of TLR2 on astrocytes abolished the decreasing CSPGs deposition and neurological functional recovery post-SCI. In addition, the signaling pathway of NF-kappa B/PI3K involved in the TLR2 activation was validated by western blot. Furthermore, IKK beta inhibitor SC-514 was also used to validate this signaling pathway. Conclusion Thus, our results uncovered that SCDEs can promote functional recovery of mice post-SCI by decreasing the CSPGs deposition via increasing the TLR2 expression on astrocytes through NF-kappa B/PI3K signaling pathway.	[Pan, Dayu; Li, Yongjin; Lv, Zenghui; Zhu, Shibo; Ning, Guangzhi; Feng, Shiqing] Tianjin Med Univ, Dept Orthoped, Gen Hosp, Tianjin 300052, Peoples R China; [Pan, Dayu; Li, Yongjin; Lv, Zenghui; Zhu, Shibo; Ning, Guangzhi; Feng, Shiqing] Tianjin Med Univ Gen Hosp, Tianjin Key Lab Spine & Spinal Cord Injury, Int Sci & Technol Cooperat Base Spinal Cord Injur, Dept Orthoped, Tianjin, Peoples R China; [Yang, Fuhan] Tongji Univ, Shanghai Tenth Peoples Hosp, Dept Urol, Shanghai 200072, Peoples R China; [Shao, Yixin; Huang, Ying] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA		Ning, GZ; Feng, SQ (corresponding author), Tianjin Med Univ, Dept Orthoped, Gen Hosp, Tianjin 300052, Peoples R China.; Ning, GZ; Feng, SQ (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Key Lab Spine & Spinal Cord Injury, Int Sci & Technol Cooperat Base Spinal Cord Injur, Dept Orthoped, Tianjin, Peoples R China.	ningguangzhi@foxmail.com; sqfeng@tmu.edu.cn	Pan, Dayu/ABB-6617-2021	Pan, Dayu/0000-0003-0284-9350	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772342, 82072439]; Key Program of Natural Science Foundation of Tianjin [19JCZDJC36300]; International Cooperation Program of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81620108018]	This work was supported by the following funding: National Natural Science Foundation of China (Project Number: 81772342, 82072439), Key Program of Natural Science Foundation of Tianjin (19JCZDJC36300), International Cooperation Program of National Natural Science Foundation of China (81620108018).	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Lopez-Verrilli MA, 2013, GLIA, V61, P1795, DOI 10.1002/glia.22558; Anderson MA, 2018, NATURE, V561, P396, DOI 10.1038/s41586-018-0467-6; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Assinck P, 2017, NAT NEUROSCI, V20, P637, DOI 10.1038/nn.4541; Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Boivin A, 2007, J NEUROSCI, V27, P12565, DOI 10.1523/JNEUROSCI.3027-07.2007; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Carrasco S, 2011, CLIN EXP RHEUMATOL, V29, P958; CELIO MR, 1993, NEUROSCI LETT, V162, P137, DOI 10.1016/0304-3940(93)90579-A; Cerqueira SR, 2018, BIOMATERIALS, V177, P176, DOI 10.1016/j.biomaterials.2018.05.049; Ching RC, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1017-8; Devaraj S, 2011, METABOLISM, V60, P256, DOI 10.1016/j.metabol.2010.01.005; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Fehlings MG, 2017, GLOB SPINE J, V7, p84S, DOI 10.1177/2192568217703387; Fregnan F, 2012, NEURAL REGEN RES, V7, P2259, DOI 10.3969/j.issn.1673-5374.2012.29.003; Freria CM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0579-6; Galindo LT, 2018, MOL NEUROBIOL, V55, P3185, DOI 10.1007/s12035-017-0565-8; Ururahy MAG, 2012, PEDIATR DIABETES, V13, P147, DOI 10.1111/j.1399-5448.2011.00794.x; Garcia-Rodriguez S, 2013, J EUR ACAD DERMATOL, V27, P242, DOI 10.1111/j.1468-3083.2011.04372.x; Goethals S, 2010, GLIA, V58, P1701, DOI 10.1002/glia.21041; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Henn A, 2011, J IMMUNOL, V186, P3237, DOI 10.4049/jimmunol.1002787; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373; Kawakami A, 2007, J RHEUMATOL, V34, P1019; Kerstetter AE, 2012, METHODS MOL BIOL, V814, P93, DOI 10.1007/978-1-61779-452-0_7; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kirchner M, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-9; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Kordjazy N, 2018, PHARMACOL RES, V129, P204, DOI 10.1016/j.phrs.2017.11.017; Kwok SK, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3780; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Lane RE, 2015, SCI REP-UK, V5, DOI 10.1038/srep07639; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Lee Sung Joong, 2002, Current Drug Targets - Inflammation and Allergy, V1, P181; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li L, 2019, BRAIN BEHAV IMMUN, V80, P328, DOI 10.1016/j.bbi.2019.04.010; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liu Y, 2014, CLIN REV ALLERG IMMU, V47, P136, DOI 10.1007/s12016-013-8402-y; Lopez-Verrilli MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00205; McDonough A, 2015, JOVE-J VIS EXP, DOI 10.3791/52318; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Osier N, 2018, MOL NEUROBIOL, V55, P9280, DOI 10.1007/s12035-018-1054-4; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Quraishe S, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/2952386; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Sofroniew MV, 2018, NATURE, V557, P343, DOI 10.1038/s41586-018-0068-4; Spachidou MP, 2007, CLIN EXP IMMUNOL, V147, P497, DOI 10.1111/j.1365-2249.2006.03311.x; Stirling DP, 2014, BRAIN, V137, P707, DOI 10.1093/brain/awt341; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; van Bon L, 2010, ANN RHEUM DIS, V69, P1539, DOI 10.1136/ard.2009.128207; Wasko NJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1540-2; Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037; Xu B, 2015, NEUROBIOL DIS, V73, P36, DOI 10.1016/j.nbd.2014.08.030	70	1	1	7	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	AUG 9	2021	18	1							172	10.1186/s12974-021-02215-x			14	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	UA3RU	WOS:000685079900004	34372877	Green Published, gold			2022-02-06	
J	Klinzing, S; Stretti, F; Pagnamenta, A; Bechir, M; Brandi, G				Klinzing, Stephanie; Stretti, Federica; Pagnamenta, Alberto; Bechir, Markus; Brandi, Giovanna			Transcranial color-coded duplex sonography assessment of cerebrovascular reactivity to carbon dioxide: an interventional study	BMC NEUROLOGY			English	Article						Transcranial color-coded duplex sonography; Intensive care ultrasound; CO2 reactivity; Traumatic brain injury; Cerebral blood flow measurements	CEREBRAL-BLOOD-FLOW; DOPPLER CO2 TEST; HEAD-INJURY; VELOCITY; PROPOFOL; HYPERVENTILATION; PRESSURE; ARTERY; VASOREACTIVITY; AUTOREGULATION	Background: The investigation of CO2 reactivity (CO2-CVR) is used in the setting of, e.g., traumatic brain injury (TBI). Transcranial color-coded duplex sonography (TCCD) is a promising bedside tool for monitoring cerebral hemodynamics. This study used TCCD to investigate CO2-CVR in volunteers, in sedated and mechanically ventilated patients without TBI and in sedated and mechanically ventilated patients in the acute phase after TBI. Methods: This interventional investigation was performed between March 2013 and February 2016 at the surgical ICU of the University Hospital of Zurich. Ten volunteers (group 1), ten sedated and mechanically ventilated patients (group 2), and ten patients in the acute phase (12-36 h) after severe TBI (group 3) were included. CO2-CVR to moderate hyperventilation (Delta CO2-5.5 mmHg) was assessed by TCCD. Results: CO2-CVR was 2.14 (1.20-2.70) %/mmHg in group 1, 2.03 (0.15-3.98) %/mmHg in group 2, and 3.32 (1.184.48)%/mmHg in group 3, without significant differences among groups. Conclusion: Our data did not yield evidence for altered CO2-CVR in the early phase after TBI examined by TCCD.	[Klinzing, Stephanie; Bechir, Markus; Brandi, Giovanna] Univ Hosp Zurich, Inst Intens Med, Raemistr 100, CH-8091 Zurich, Switzerland; [Stretti, Federica] Westmead Hosp, Intens Care Unit, Westmead, NSW, Australia; [Pagnamenta, Alberto] Reg Hosp Mendrisio, Intens Care Unit, Mendrisio, Switzerland; [Pagnamenta, Alberto] Ente Osped Cantonale, Clin Epidemiol Unit, Bellinzona, Switzerland; [Pagnamenta, Alberto] Univ Geneva, Div Pneumol, Geneva, Switzerland		Klinzing, S (corresponding author), Westmead Hosp, Intens Care Unit, Westmead, NSW, Australia.	stephanie.klinzing@usz.ch					BARTELS E, 1993, ULTRASCHALL MED, V14, P272, DOI 10.1055/s-2007-1005260; Brandi G, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2304-6; Dupont G, 2016, J NEUROSURG ANESTH, V28, P159, DOI 10.1097/ANA.0000000000000242; ENG C, 1992, ANESTHESIOLOGY, V77, P872, DOI 10.1097/00000542-199211000-00006; Froese L, 2021, NEUROCRIT CARE, V34, P325, DOI 10.1007/s12028-020-01003-4; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Harrison JM, 1999, BRIT J ANAESTH, V83, P839, DOI 10.1093/bja/83.6.839; Izumi Y, 1996, STROKE, V27, P1328, DOI 10.1161/01.STR.27.8.1328; KAISER L, 1989, STAT MED, V8, P1183, DOI 10.1002/sim.4780081002; Kastrup A, 1997, STROKE, V28, P2353, DOI 10.1161/01.STR.28.12.2353; KLINGELHOFER J, 1992, STROKE, V23, P962, DOI 10.1161/01.STR.23.7.962; Klinzing S, 2015, MINERVA ANESTESIOL, V81, P298; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Mariappan R, 2015, J NEUROSURG ANESTH, V27, P123, DOI 10.1097/ANA.0000000000000092; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; McCarville M Beth, 2008, Ultrasound Q, V24, P167, DOI 10.1097/RUQ.0b013e3181862b67; McMahon CJ, 2007, BRIT J NEUROSURG, V21, P21, DOI 10.1080/02688690701210539; Mirzai H, 2004, J NEUROSURG ANESTH, V16, P1, DOI 10.1097/00008506-200401000-00001; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Sakai K, 2000, ANESTH ANALG, V90, P377, DOI 10.1097/00000539-200002000-00026; STREBEL S, 1994, ANESTH ANALG, V78, P884; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; WIDDER B, 1986, EUR ARCH PSY CLIN N, V236, P162, DOI 10.1007/BF00380944; Zeiler FA, 2021, J NEUROTRAUM, V38, P272, DOI 10.1089/neu.2020.7249	30	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	AUG 7	2021	21	1							305	10.1186/s12883-021-02310-9			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TW8OW	WOS:000682653000001	34364365	Green Published, gold			2022-02-06	
J	Abujaber, A; Fadlalla, A; Gammoh, D; Al-Thani, H; El-Menyar, A				Abujaber, Ahmad; Fadlalla, Adam; Gammoh, Diala; Al-Thani, Hassan; El-Menyar, Ayman			Machine Learning Model to Predict Ventilator Associated Pneumonia in patients with Traumatic Brain Injury: The C.5 Decision Tree Approach	BRAIN INJURY			English	Article						Machine learning; ventilator-associated pneumonia; traumatic brain injury; C; 5; decision tree model	RISK-FACTORS; MORTALITY; IMPACT; METAANALYSIS; TRANSFUSION; INFECTIONS; NETWORK	Background There is paucity in the literature to predict the occurrence of Ventilator Associated Pneumonia (VAP) in patients with Traumatic Brain Injury (TBI). We aimed to build a C.5. Decision Tree (C.5 DT) machine learning model to predict VAP in patients with moderate to severe TBI. Methods This was a retrospective study including all adult patients who were hospitalized with TBI plus head abbreviated injury scale (AIS) >= 3 and were mechanically ventilated in a level 1 trauma center between 2014 and 2019. Results A total of 772 eligible patients were enrolled, of them 169 had VAP (22%). The C.5 DT model achieved moderate performance with 83.5% accuracy, 80.5% area under the curve, 71% precision, 86% negative predictive value, 43% sensitivity, 95% specificity and 54% F-score. Out of 24 predictors, C.5 DT identified 5 variables predicting occurrence of VAP post-moderate to severe TBI (Time from injury to emergency department arrival, blood transfusion during resuscitation, comorbidities, Injury Severity Score and pneumothorax). Conclusions This study could serve as baseline for the quest of predicting VAP in patients with TBI through the utilization of C.5. DT machine learning approach. This model helps provide timely decision support to caregivers to improve patient's outcomes.	[Abujaber, Ahmad] Hamad Med Corp, Nursing, Doha, Qatar; [Fadlalla, Adam] Qatar Univ, Management Informat Syst Business & Econ Fac, Doha, Qatar; [Gammoh, Diala] Univ Cent Florida, Ind Engn, Orlando, FL USA; [Al-Thani, Hassan] Hamad Med Corp, Dept Surg, Trauma Surg, Doha, Qatar; [El-Menyar, Ayman] Hamad Med Corp, Dept Surg, Clin Res, Trauma Surg, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Dept Clin Med, Doha, Qatar		El-Menyar, A (corresponding author), MD Weill Cornell Med Coll & Clin Res, Hamad Gen Hosp, Trauma Surg, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X			Ahmadi E, 2018, J AMB INTEL HUM COMP, V9, P999, DOI 10.1007/s12652-017-0499-z; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Apostolopoulou Eleni, 2003, Respir Care, V48, P681; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Arumugam SK, 2018, WORLD J EMERG MED, V9, P203, DOI 10.5847/wjem.j.1920-8642.2018.03.007; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Bochicchio GV, 2008, SURG INFECT, V9, P415, DOI 10.1089/sur.2006.069; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Cavalcanti M, 2006, CRIT CARE MED, V34, P1067, DOI 10.1097/01.CCM.0000206471.44161.A0; Chang L, 2017, CAN RESPIR J, V2017, DOI 10.1155/2017/7272080; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chen CJ, 2013, AM J CRIT CARE, V22, P506, DOI 10.4037/ajcc2013950; Dudeck MA, 2013, AM J INFECT CONTROL, V41, P1148, DOI 10.1016/j.ajic.2013.09.002; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Evans HL, 2010, ARCH SURG-CHICAGO, V145, P1041, DOI 10.1001/archsurg.2010.239; Garcia-Laencina PJ, 2015, COMPUT BIOL MED, V59, P125, DOI 10.1016/j.compbiomed.2015.02.006; Han J, 2012, MOR KAUF D, P1; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Kalanuria AA, 2014, CRIT CARE, V18, DOI 10.1186/cc13775; Kim OH, 2017, J TRAUMA ENG, V30, P131, DOI [10.20408/jti.2017.30.4.131, DOI 10.20408/JTI.2017.30.4.131]; Kollef MH, 2012, INFECT CONT HOSP EP, V33, P250, DOI 10.1086/664049; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Larsson J, 2017, J CRIT CARE, V37, P112, DOI 10.1016/j.jcrc.2016.09.003; Luckraz Heyman, 2018, J Intensive Care Soc, V19, P94, DOI 10.1177/1751143717740804; Mangram AJ, 2015, AM J SURG, V210, P1056, DOI 10.1016/j.amjsurg.2015.06.029; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Park Hyun Oh, 2017, Korean J Thorac Cardiovasc Surg, V50, P346, DOI 10.5090/kjtcs.2017.50.5.346; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Rau CS, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121203; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Shorr AF, 2004, CRIT CARE MED, V32, P666, DOI 10.1097/01.CCM.0000114810.30477.C3; Ustin J., 2019, WORLD J SURG; Wang CH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009165; Wiharto W, 2016, HEALTHC INFORM RES, V22, P186, DOI 10.4258/hir.2016.22.3.186; Wu DL, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00482; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763; Zolbanin HM, 2015, DECIS SUPPORT SYST, V74, P150, DOI 10.1016/j.dss.2015.04.003; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	39	1	1	8	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2021	35	9					1095	1102		10.1080/02699052.2021.1959060		AUG 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UN1JX	WOS:000682415600001	34357830				2022-02-06	
J	Kirkendall, DT; Krustrup, P				Kirkendall, Donald T.; Krustrup, Peter			Studying professional and recreational female footballers: A bibliometric exercise	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article; Early Access						association football; bibliometrics; females; professional players; soccer; VOSviewer		Objectives: Research directed at soccer has seen dramatic growth in the last decade. While published research on soccer has shown exponential growth, the proportion of articles addressing females is lagging behind research addressing males. The purpose of this paper is to explore how the literature on soccer, female soccer, and professional female soccer has changed over time. Methods: The Web of Science (WoS) was queried for all "articles" about soccer and association football from 1970 to 2019. This set of records was then queried to collect subsets of papers about females, professional/elite, and female professional/elite. Each of these data subsets was then queried for a number of characteristics and topics. The results were submitted to bibliometric analysis. Results: WoS returned 16,822 "articles" about soccer from 1970 to 2019, 3242 of which addressed females. A total of 5924 "articles" about professional players was found, of which 919 had a female focus. Articles about anterior cruciate ligament injuries and concussion were the topics with the highest proportion of papers involving females. Articles directed at selective areas of training and performance were relatively infrequent. Prominent journals, authors, affiliations, and influential papers are presented. Conclusions: A bibliometric analysis of the published research presents a high-level overview of trends in soccer research. Overall, studies about women accounted for around 20% of all soccer research and about 15% of studies on professional players. There were a number of topics where studies on females account for less than 10%-15% of the research on all professionals, and opens opportunities for future study.	[Kirkendall, Donald T.] Duke Hlth, James R Urbaniak Sports Sci Inst, Durham, NC USA; [Krustrup, Peter] Univ Southern Denmark, Fac Hlth Sci, SDU Sport & Hlth Sci Cluster SHSC, Dept Sports Sci & Clin Biomech, Odense, Denmark; [Krustrup, Peter] Univ Southern Denmark, Danish Inst Adv Study DIAS, Odense, Denmark; [Krustrup, Peter] Univ Exeter, Coll Life & Environm Sci, Sport & Hlth Sci, Exeter, Devon, England		Kirkendall, DT (corresponding author), 1121 Old Bramble Lane, Fuquay Varina, NC 27526 USA.	Kirkendall.ELS@gmail.com	Krustrup, Peter/D-2659-2019	Krustrup, Peter/0000-0002-1461-9838			ALI A, 1991, J SPORT MED PHYS FIT, V31, P82; [Anonymous], FIFA BIG COUNT 2006; BANGSBO J, 1991, CAN J SPORT SCI, V16, P110; BROOKES BC, 1985, J INFORM SCI, V10, P173, DOI 10.1177/016555158501000406; Caro B, 1970, J Sports Med Phys Fitness, V10, P100; Castagna C, 2001, J STRENGTH COND RES, V15, P420; Dvorak J, 2011, BRIT J SPORT MED, V45, P626, DOI 10.1136/bjsm.2010.079905; Federation Internationale de Football Association, GLOB CLUB FOOTB 2018 GLOB CLUB FOOTB 2018, P116; Reilly TT, 1976, J HUM MOV STUD, V2, P87; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; van Eck NJ., MEASURING SCHOLARLY, DOI [10.1007/978-3-319-10377-8_132014:285-320, DOI 10.1007/978-3-319-10377-8_132014:285-320]	11	1	1	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports												10.1111/sms.14019		AUG 2021	15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TW4DU	WOS:000682353700001	34363241	Bronze			2022-02-06	
J	Rubio, JE; Unnikrishnan, G; Sajja, VSSS; Van Albert, S; Rossetti, F; Skotak, M; Alay, E; Sundaramurthy, A; Subramaniam, DR; Long, JB; Chandra, N; Reifman, J				Rubio, Jose E.; Unnikrishnan, Ginu; Sajja, Venkata Siva Sai Sujith; Van Albert, Stephen; Rossetti, Franco; Skotak, Maciej; Alay, Eren; Sundaramurthy, Aravind; Subramaniam, Dhananjay Radhakrishnan; Long, Joseph B.; Chandra, Namas; Reifman, Jaques			Investigation of the direct and indirect mechanisms of primary blast insult to the brain	SCIENTIFIC REPORTS			English	Article							POSSIBLE DAMAGE MECHANISM; OXIDATIVE STRESS; INDUCED NEUROTRAUMA; RAT MODEL; INJURY; INFLAMMATION; CAVITATION; MICROGLIA; EXPOSURE; INCREASE	The interaction of explosion-induced blast waves with the head (i.e., a direct mechanism) or with the torso (i.e., an indirect mechanism) presumably causes traumatic brain injury. However, the understanding of the potential role of each mechanism in causing this injury is still limited. To address this knowledge gap, we characterized the changes in the brain tissue of rats resulting from the direct and indirect mechanisms at 24 h following blast exposure. To this end, we conducted separate blast-wave exposures on rats in a shock tube at an incident overpressure of 130 kPa, while using whole-body, head-only, and torso-only configurations to delineate each mechanism. Then, we performed histopathological (silver staining) and immunohistochemical (GFAP, Iba-1, and NeuN staining) analyses to evaluate brain-tissue changes resulting from each mechanism. Compared to controls, our results showed no significant changes in torso-only-exposed rats. In contrast, we observed significant changes in whole-body-exposed (GFAP and silver staining) and head-only-exposed rats (silver staining). In addition, our analyses showed that a head-only exposure causes changes similar to those observed for a whole-body exposure, provided the exposure conditions are similar. In conclusion, our results suggest that the direct mechanism is the major contributor to blast-induced changes in brain tissues.	[Rubio, Jose E.; Unnikrishnan, Ginu; Sundaramurthy, Aravind; Subramaniam, Dhananjay Radhakrishnan; Reifman, Jaques] ATTN FCMR TT, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr,US Army Med Res & D, 504 Scott St, Ft Detrick, MD 21702 USA; [Rubio, Jose E.; Unnikrishnan, Ginu; Sundaramurthy, Aravind; Subramaniam, Dhananjay Radhakrishnan] Henry M Jackson Fdn Adv Mil Med Inc, 6720A Rockledge Dr, Bethesda, MD 20817 USA; [Sajja, Venkata Siva Sai Sujith; Van Albert, Stephen; Rossetti, Franco; Skotak, Maciej; Long, Joseph B.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Div, 503 Robert Grant Dr, Silver Spring, MD 20910 USA; [Skotak, Maciej; Alay, Eren; Chandra, Namas] New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Dept Biomed Engn, 111 Lock St, Newark, NJ 07103 USA		Reifman, J (corresponding author), ATTN FCMR TT, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr,US Army Med Res & D, 504 Scott St, Ft Detrick, MD 21702 USA.	jaques.reifman.civ@mail.mil		Sundaramurthy, Aravind/0000-0002-0359-8680; Rubio, Jose/0000-0002-6320-2086; Sajja, Sujith/0000-0002-1992-9501	U.S. Department of Defense, Defense Health Program; U.S. Army Medical Research and Development Command [W81XWH20C0031]	We acknowledge support from the U.S. Department of Defense, Defense Health Program managed by the U.S. Army Military Operational Medicine Research Program Area Directorate (Fort Detrick, MD). This work is supported by the U.S. Army Medical Research and Development Command under Contract No. W81XWH20C0031.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Alay E, 2018, SHOCK WAVES, V28, P51, DOI 10.1007/s00193-017-0762-4; Bailey ZS, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00064; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Cernak I., 2015, BRAIN NEUROTRAUMA MO; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Chow Shein-Chung, 2002, J Biopharm Stat, V12, P441, DOI 10.1081/BIP-120016229; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kawa L, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00479; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Miller AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173167; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; R Core Team, 2020, R LANG ENV STAT COMP; Rao KVR, 2018, J NEUROTRAUM, V35, P2077, DOI 10.1089/neu.2017.5358; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Ritzel D. V., 2015, U.S. patent, Patent No. 9027383; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Rubio JE, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.573647; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2015, SHOCK, V44, P71, DOI 10.1097/SHK.0000000000000311; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sawyer TW, 2018, SHOCK WAVES, V28, P85, DOI 10.1007/s00193-017-0756-2; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Sidoryk-Wegrzynowicz M, 2011, TOXICOL PATHOL, V39, P115, DOI 10.1177/0192623310385254; Skotak M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01015; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Unnikrishnan G, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4049889; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang Y, 2017, J NEUROTRAUM, V34, P952, DOI 10.1089/neu.2016.4465	45	1	1	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	AUG 6	2021	11	1							16040	10.1038/s41598-021-95003-9			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TZ6CR	WOS:000684558800005	34362935	Green Published, gold			2022-02-06	
J	van Veen, E; van der Jagt, M; Citerio, G; Stocchetti, N; Gommers, D; Burdorf, A; Menon, DK; Maas, AIR; Kompanje, EJO; Lingsma, HF				van Veen, Ernest; van der Jagt, Mathieu; Citerio, Giuseppe; Stocchetti, Nino; Gommers, Diederik; Burdorf, Alex; Menon, David K.; Maas, Andrew I. R.; Kompanje, Erwin J. O.; Lingsma, Hester F.		CTR-TBI Investigators Participants	Occurrence and timing of withdrawal of life-sustaining measures in traumatic brain injury patients: a CENTER-TBI study	INTENSIVE CARE MEDICINE			English	Article						Traumatic brain injury; Critical care; Intensive care unit; WLSM	INTENSIVE-CARE UNITS; 1ST 72 HOURS; DECISION-MAKING; ORGAN DONATION; LARGE COHORT; END; SUPPORT; MULTICENTER; OUTCOMES; THERAPY	Background In patients with severe brain injury, withdrawal of life-sustaining measures (WLSM) is common in intensive care units (ICU). WLSM constitutes a dilemma: instituting WLSM too early could result in death despite the possibility of an acceptable functional outcome, whereas delaying WLSM could unnecessarily burden patients, families, clinicians, and hospital resources. We aimed to describe the occurrence and timing of WLSM, and factors associated with timing of WLSM in European ICUs in patients with traumatic brain injury (TBI). Methods The CENTER-TBI Study is a prospective multi-center cohort study. For the current study, patients with traumatic brain injury (TBI) admitted to the ICU and aged 16 or older were included. Occurrence and timing of WLSM were documented. For the analyses, we dichotomized timing of WLSM in early (< 72 h after injury) versus later (>= 72 h after injury) based on recent guideline recommendations. We assessed factors associated with initiating WLSM early versus later, including geographic region, center, patient, injury, and treatment characteristics with univariable and multivariable (mixed effects) logistic regression. Results A total of 2022 patients aged 16 or older were admitted to the ICU. ICU mortality was 13% (n = 267). Of these, 229 (86%) patients died after WLSM, and were included in the analyses. The occurrence of WLSM varied between regions ranging from 0% in Eastern Europe to 96% in Northern Europe. In 51% of the patients, WLSM was early. Patients in the early WLSM group had a lower maximum therapy intensity level (TIL) score than patients in the later WLSM group (median of 5 versus 10) The strongest independent variables associated with early WLSM were one unreactive pupil (odds ratio (OR) 4.0, 95% confidence interval (CI) 1.3-12.4) or two unreactive pupils (OR 5.8, CI 2.6-13.1) compared to two reactive pupils, and an Injury Severity Score (ISS) if over 41 (OR per point above 41 = 1.1, CI 1.0-1.1). Timing of WLSM was not significantly associated with region or center. Conclusion WLSM occurs early in half of the patients, mostly in patients with severe TBI affecting brainstem reflexes who were severely injured. We found no regional or center influences in timing of WLSM. Whether WLSM is always appropriate or may contribute to a self-fulfilling prophecy requires further research and argues for reluctance to institute WLSM early in case of any doubt on prognosis.	[van Veen, Ernest; Burdorf, Alex; Kompanje, Erwin J. O.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [van Veen, Ernest; van der Jagt, Mathieu; Gommers, Diederik] Erasmus MC Univ, Dept Intens Care Adults, Med Ctr, Rotterdam, Netherlands; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Monza, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Menon, David K.] Univ Cambridge, Dept Anaesthesia, Cambridge, England; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Kompanje, Erwin J. O.] Erasmus MC, Dept Med Eth & Hist Med, Rotterdam, Netherlands		van Veen, E (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.; van Veen, E (corresponding author), Erasmus MC Univ, Dept Intens Care Adults, Med Ctr, Rotterdam, Netherlands.	e.vanveen.1@erasmusmc.nl	Vande Vyvere, Thijs/AAB-5180-2022; Lagares, Alfonso/B-2969-2011; Posti, Jussi P./Y-2908-2019; Raj, Rahul/K-7693-2012; Ercole, Ari/B-6288-2009; van der Jagt, Mathieu/G-1905-2017; Gomez, Pedro/E-2411-2014	Vande Vyvere, Thijs/0000-0003-4032-5443; Lagares, Alfonso/0000-0003-3996-0554; Posti, Jussi P./0000-0002-5925-5193; Bragge, Peter/0000-0003-0745-5131; Van Essen, Thomas/0000-0003-4657-5283; Raj, Rahul/0000-0003-4243-9591; Dark, Paul/0000-0003-3309-0164; Radoi, Andreea/0000-0002-0677-3544; Zeiler, Frederick/0000-0003-1737-0510; Rossi, Sandra/0000-0002-9963-8121; van der Naalt, Joukje/0000-0001-9873-2418; Ercole, Ari/0000-0001-8350-8093; van der Jagt, Mathieu/0000-0003-2566-8325; Stewart, William/0000-0003-2199-2582; Coles, Jonathan/0000-0003-4013-679X; Gomez, Pedro/0000-0002-4185-5238	European UnionEuropean Commission [602150]; National Institute for Health Research (UK)National Institute for Health Research (NIHR)	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project, supported by the Framework 7 program of the European Union (602150). The funder had no role in the design of the study, the collection, analysis, and interpretation of data, or in writing the manuscript. David K. Menon was supported by a Senior Investigator Award from the National Institute for Health Research (UK). The funder had no role in the design of the study, the collection, analysis, and interpretation of data, or in writing the manuscript.	Azoulay E, 2009, INTENS CARE MED, V35, P623, DOI 10.1007/s00134-008-1310-6; Bornstein BH, 1999, SOC SCI MED, V49, P215, DOI 10.1016/S0277-9536(99)00117-3; Braverman JA, 2012, SOC SCI MED, V75, P186, DOI 10.1016/j.socscimed.2012.03.006; Broderick AR, 2016, CRIT CARE MED, V44, P352, DOI 10.1097/CCM.0000000000001384; Brody A, 2010, AM J SURG, V200, P728, DOI 10.1016/j.amjsurg.2010.09.002; Bulow HH, 2012, INTENS CARE MED, V38, P1126, DOI 10.1007/s00134-012-2554-8; Cheetham OV, 2016, RESUSCITATION, V101, P41, DOI 10.1016/j.resuscitation.2016.01.003; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Garland A, 2007, J PALLIAT MED, V10, P1298, DOI 10.1089/jpm.2007.0061; Guidet B, 2014, J CRIT CARE, V29, P896, DOI 10.1016/j.jcrc.2014.08.004; Huijben JA, 2020, INTENS CARE MED, V46, P995, DOI 10.1007/s00134-020-05965-z; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Joynt GM, 2015, J CRIT CARE, V30, P224, DOI 10.1016/j.jcrc.2014.10.011; Kapadia F, 2005, CRIT CARE MED, V33, P1272, DOI 10.1097/01.CCM.0000165557.02879.29; Keenan SP, 1998, CRIT CARE MED, V26, P245, DOI 10.1097/00003246-199802000-00018; Keenan SP, 1997, CRIT CARE MED, V25, P1324, DOI 10.1097/00003246-199708000-00019; Kowalski RG, 2021, JAMA NEUROL, V78, P548, DOI 10.1001/jamaneurol.2021.0084; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Manara AR, 2017, ANAESTHESIA, V72, P1179, DOI 10.1111/anae.13966; Mark NM, 2015, INTENS CARE MED, V41, P1572, DOI 10.1007/s00134-015-3810-5; McLean RF, 2000, CRIT CARE MED, V28, P100, DOI 10.1097/00003246-200001000-00016; Menon DK, 2017, BRIT J ANAESTH, V119, P1062, DOI 10.1093/bja/aex374; Mikolic A, 2021, J NEUROTRAUM, V38, P235, DOI 10.1089/neu.2020.7228; Morton V, 2003, BRIT MED J, V326, P1083, DOI 10.1136/bmj.326.7398.1083; Nedel Wagner Luis, 2016, Rev. bras. ter. intensiva, V28, P256, DOI 10.5935/0103-507X.20160050; Nesseler N, 2018, EUR J ANAESTH, V35, P511, DOI 10.1097/EJA.0000000000000783; Ouanes I, 2012, INTENS CARE MED, V38, P710, DOI 10.1007/s00134-012-2500-9; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Quill CM, 2014, CHEST, V146, P573, DOI 10.1378/chest.13-2529; Settervall Cristina Helena Costanti, 2011, Rev. Latino-Am. Enfermagem, V19, P1337; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Sprung CL, 2007, INTENS CARE MED, V33, P1732, DOI 10.1007/s00134-007-0693-0; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Togha M, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-9; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Veen E, 2020, J CRIT CARE, V58, P78, DOI 10.1016/j.jcrc.2020.04.001; Vedantam A, 2018, J NEUROSURG, V129, P234, DOI 10.3171/2017.3.JNS162720; White DB, 2007, ANN INTERN MED, V147, P34, DOI 10.7326/0003-4819-147-1-200707030-00006; White DB, 2006, CRIT CARE MED, V34, P2053, DOI 10.1097/01.CCM.0000227654.38708.C1; Wilkinson DJC, 2013, INTENS CARE MED, V39, P1128, DOI 10.1007/s00134-013-2871-6; Wunsch H, 2005, INTENS CARE MED, V31, P823, DOI 10.1007/s00134-005-2644-y	52	1	1	5	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	OCT	2021	47	10					1115	1129		10.1007/s00134-021-06484-1		AUG 2021	15	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XS0PP	WOS:000681565200001	34351445	Green Published, Green Accepted, hybrid			2022-02-06	
J	Sewalt, CA; Gravesteijn, BY; Menon, D; Lingsma, HF; Maas, AIR; Stocchetti, N; Venema, E; Lecky, FE				Sewalt, Charlie Aletta; Gravesteijn, Benjamin Yael; Menon, David; Lingsma, Hester Floor; Maas, Andrew I. R.; Stocchetti, Nino; Venema, Esmee; Lecky, Fiona E.		CENTER TBI Participants Investigat	Primary versus early secondary referral to a specialized neurotrauma center in patients with moderate/severe traumatic brain injury: a CENTER TBI study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Referral; Transfer; Trauma system	HEAD-INJURY; PREHOSPITAL MANAGEMENT; CARE; MORTALITY; OUTCOMES; EPIDEMIOLOGY; GUIDELINES; IMPACT; SYSTEM	Background Prehospital care for patients with traumatic brain injury (TBI) varies with some emergency medical systems recommending direct transport of patients with moderate to severe TBI to hospitals with specialist neurotrauma care (SNCs). The aim of this study is to assess variation in levels of early secondary referral within European SNCs and to compare the outcomes of directly admitted and secondarily transferred patients. Methods Patients with moderate and severe TBI (Glasgow Coma Scale < 13) from the prospective European CENTER-TBI study were included in this study. All participating hospitals were specialist neuroscience centers. First, adjusted between-country differences were analysed using random effects logistic regression where early secondary referral was the dependent variable, and a random intercept for country was included. Second, the adjusted effect of early secondary referral on survival to hospital discharge and functional outcome [6 months Glasgow Outcome Scale Extended (GOSE)] was estimated using logistic and ordinal mixed effects models, respectively. Results A total of 1347 moderate/severe TBI patients from 53 SNCs in 18 European countries were included. Of these 1347 patients, 195 (14.5%) were admitted after early secondary referral. Secondarily referred moderate/severe TBI patients presented more often with a CT abnormality: mass lesion (52% vs. 34%), midline shift (54% vs. 36%) and acute subdural hematoma (77% vs. 65%). After adjusting for case-mix, there was a large European variation in early secondary referral, with a median OR of 1.69 between countries. Early secondary referral was not associated with functional outcome (adjusted OR 1.07, 95% CI 0.78-1.69), nor with survival at discharge (1.05, 0.58-1.90). Conclusions Across Europe, substantial practice variation exists in the proportion of secondarily referred TBI patients at SNCs that is not explained by case mix. Within SNCs early secondary referral does not seem to impact functional outcome and survival after stabilisation in a non-specialised hospital. Future research should identify which patients with TBI truly benefit from direct transportation.	[Sewalt, Charlie Aletta; Gravesteijn, Benjamin Yael; Lingsma, Hester Floor; Venema, Esmee] Erasmus MC Med Ctr, Dept Publ Hlth, Postbus 2040, NL-3000 CA Rotterdam, Netherlands; [Gravesteijn, Benjamin Yael] Erasmus MC Med Ctr, Dept Anesthesiol, Rotterdam, Netherlands; [Menon, David] Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Cambridge, England; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Stocchetti, Nino] Milan Univ, Dept Pathophysiol & Transplantat, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci ICU, Milan, Italy; [Venema, Esmee] Erasmus MC Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Lecky, Fiona E.] Univ Sheffield, Ctr Urgent & Emergency Care Res CURE, Hlth Serv Res Sect, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England		Sewalt, CA (corresponding author), Erasmus MC Med Ctr, Dept Publ Hlth, Postbus 2040, NL-3000 CA Rotterdam, Netherlands.	c.sewalt@erasmusmc.nl	Lagares, Alfonso/B-2969-2011; Posti, Jussi P./Y-2908-2019; Vande Vyvere, Thijs/AAB-5180-2022; Gomez, Pedro/E-2411-2014; Raj, Rahul/K-7693-2012; Ercole, Ari/B-6288-2009	Lagares, Alfonso/0000-0003-3996-0554; Posti, Jussi P./0000-0002-5925-5193; Vande Vyvere, Thijs/0000-0003-4032-5443; Zeiler, Frederick/0000-0003-1737-0510; Radoi, Andreea/0000-0002-0677-3544; Parizel, Paul M./0000-0002-0221-2854; Gomez, Pedro/0000-0002-4185-5238; Stewart, William/0000-0003-2199-2582; Raj, Rahul/0000-0003-4243-9591; van der Naalt, Joukje/0000-0001-9873-2418; Gravesteijn, Benjamin/0000-0001-8096-5803; Coles, Jonathan/0000-0003-4013-679X; Ercole, Ari/0000-0001-8350-8093; Van Essen, Thomas/0000-0003-4657-5283; Rossi, Sandra/0000-0002-9963-8121	European Union 7th Framework program (EC Grant) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	CENTER-TBI was supported by the European Union 7th Framework program (EC Grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA).	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Citerio G, 2003, EUR J EMERG MED, V10, P68, DOI 10.1097/00063110-200303000-00020; Cnossen MC, 2019, J NEUROTRAUM, V36, P176, DOI 10.1089/neu.2018.5712; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Fuller G, 2011, J NEUROSURG ANESTH, V23, P198, DOI 10.1097/ANA.0b013e3182161816; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Gomes E, 2010, RESUSCITATION, V81, P440, DOI 10.1016/j.resuscitation.2009.12.014; Gravesteijn BY, 2021, J NEUROTRAUM, V38, P1842, DOI 10.1089/neu.2020.7218; Gravesteijn BY, 2021, PREHOSP EMERG CARE, V25, P629, DOI 10.1080/10903127.2020.1817210; GRIFFITH DA, 1989, ENVIRON PLANN A, V21, P1511, DOI 10.1068/a211511; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Helling TS, 2010, J TRAUMA, V69, P1362, DOI 10.1097/TA.0b013e3181d75250; Hoogmartens O, 2014, PREHOSP EMERG CARE, V18, P265, DOI 10.3109/10903127.2013.856506; Joosse P, 2012, J TRAUMA ACUTE CARE, V72, P487, DOI 10.1097/TA.0b013e318226ed59; Kunzmann K, 2021, J NEUROTRAUM, V38, P455, DOI 10.1089/neu.2019.6858; Lecky F, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20010; Lecky FE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016355; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; MENDELOFF JM, 1991, ANNU REV PUBL HEALTH, V12, P401; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Pickering A, 2015, J TRAUMA ACUTE CARE, V78, P164, DOI 10.1097/TA.0000000000000483; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; TEASDALE G, 1974, LANCET, V2, P81; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Walcott BP, 2014, J CLIN NEUROSCI, V21, P2107, DOI 10.1016/j.jocn.2014.05.016	41	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	AUG 4	2021	29	1							113	10.1186/s13049-021-00930-1			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TY0GK	WOS:000683462300002	34348784	Green Published, Green Accepted, gold			2022-02-06	
J	Zhang, LQ; Zhuang, QY; Wu, GQ; Yu, JH; Shi, ZF; Yuan, Q; Yu, J; Hu, J				Zhang, Liqiong; Zhuang, Qiyuan; Wu, Guoqing; Yu, Jinhua; Shi, Zhifeng; Yuan, Qiang; Yu, Jian; Hu, Jin			Combined Radiomics Model for Prediction of Hematoma Progression and Clinical Outcome of Cerebral Contusions in Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article; Early Access						TBI (traumatic brain injury); Cerebral contusions; Nomogram; Computational intelligence	INTRACEREBRAL HEMORRHAGE; MODERATE; CRANIECTOMY; MANAGEMENT; SPARSE; IMPACT	Background Traumatic brain injury is a common and devastating injury that is the leading cause of neurological disability and death worldwide. Patients with cerebral lobe contusion received conservative treatment because of their mild manifestations, but delayed intracranial hematoma may increase and even become life-threatening. We explored the noninvasive method to predict the prognosis of progression and Glasgow Outcome Scale (GOS) by using a quantitative radiomics approach and statistical analysis. Methods Eighty-eight patients who were pathologically diagnosed were retrospectively studied. The radiomics method developed in this work included image segmentation, feature extraction, and feature selection. The nomograms were established based on statistical analysis and a radiomics method. We conducted a comparative study of hematoma progression and GOS between the clinical factor alone and fusion radiomics features. Results Nineteen clinical factors, 513 radiomics features, and 116 locational features were considered. Among clinical factors, international normalized ratio, prothrombin time, and fibrinogen were enrolled for hematoma progression. As for GOS, treatment strategy, age, Glasgow Coma Scale score, and blood platelet were associated factors. Eight features for GOS and five features for hematoma progression were filtered by using sparse representation and locality preserving projection-combined method. Four nomograms were constructed. After fusion radiomics features, area under the curve of hematoma progression prediction increased from 0.832 to 0.899, whereas GOS prediction went from 0.794 to 0.844. Conclusions A radiomic-based model that merges radiomics and clinical features is a noninvasive approach to predict hematoma progression and clinical outcomes of cerebral contusions in traumatic brain injury.	[Zhang, Liqiong; Wu, Guoqing; Yu, Jinhua] Fudan Univ, Dept Elect Engn, Shanghai, Peoples R China; [Zhuang, Qiyuan; Shi, Zhifeng; Yuan, Qiang; Yu, Jian; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zhuang, Qiyuan; Shi, Zhifeng; Yuan, Qiang; Yu, Jian; Hu, Jin] Shanghai Brain Funct Restorat & Neural Regenerat, Shanghai, Peoples R China		Yuan, Q; Yu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.; Yuan, Q; Yu, J (corresponding author), Shanghai Brain Funct Restorat & Neural Regenerat, Shanghai, Peoples R China.	297260090@qq.com; lance2002@hotmail.com			Shanghai Municipal Science and Technology Major Project [2018SHZDZX01]; ZJLab, National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [91959127]; Natural Science FoundationNational Natural Science Foundation of China (NSFC) [16JC1420100]; Major Basic Research Program of Shanghai [16JC1420100]; Shanghai Muncipal Health Commission Project [2018ZHYL0107]; ZJLab	This study was supported by the Shanghai Municipal Science and Technology Major Project (No. 2018SHZDZX01) and ZJLab, National Natural Science Foundation of China (91959127), The Natural Science Foundation and Major Basic Research Program of Shanghai (16JC1420100), and Shanghai Muncipal Health Commission Project (2018ZHYL0107).	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Allison RZ, 2017, NEUROCRIT CARE, V26, P80, DOI 10.1007/s12028-016-0303-5; [Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Cepeda S, 2016, J NEUROTRAUM, V33, P1034, DOI 10.1089/neu.2015.4153; Chen L. C., 2014, COMPUT SCI, V4, P357, DOI DOI 10.1080/17476938708814211; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; de la Rosa E, 2018, RADIOMICS APPROACH T; Dong D, 2019, ANN ONCOL, V30, P431, DOI 10.1093/annonc/mdz001; Dong WS, 2011, IEEE I CONF COMP VIS, P1259, DOI 10.1109/ICCV.2011.6126377; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Farzaneh N, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00445-0; Gao L, 2013, WORLD NEUROSURG, V80, P879, DOI 10.1016/j.wneu.2013.01.020; Hale AT, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS17773; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kawano-Castillo J, 2014, STROKE, V45, P683, DOI 10.1161/STROKEAHA.113.003826; Lv J, IEEE INT S BIOM IM 2 IEEE INT S BIOM IM 2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martin RM, 2017, J NEUROSURG, V126, P796, DOI 10.3171/2016.3.JNS151781; Ronneberger O., 2015, INT C MEDICAL IMAGE, P234, DOI [10.1007/978-3-319-24574-4_28, DOI 10.1007/978-3-319-24574-4_28]; Ruckstiess T, 2011, SEQUENTIAL FEATURE S; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Suehiro E, 2014, CLIN NEUROL NEUROSUR, V127, P97, DOI 10.1016/j.clineuro.2014.10.007; Tang QS, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0961-8; Van de Zande N, 2019, NEUROSURG REV, V3, P195; Wibmer A, 2015, EUR RADIOL, V25, P2840, DOI 10.1007/s00330-015-3701-8; Wong H, 2017, J BLOOD MED, V8, P165, DOI 10.2147/JBM.S125209; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wu G., 2017, SM J BIOMED ENG, V3, P1012; Wu G., 2017, IEEE T IND ELECTRON, V99, P1; Xiaofeng Z., 2016, IEEE T BIOMED ENG, V26, P9; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108	35	1	1	4	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01320-2		AUG 2021	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TU7ED	WOS:000681194700001	34350554				2022-02-06	
J	Abeare, K; Romero, K; Cutler, L; Sirianni, CD; Erdodi, LA				Abeare, Kaitlyn; Romero, Kristoffer; Cutler, Laura; Sirianni, Christina D.; Erdodi, Laszlo A.			Flipping the Script: Measuring Both Performance Validity and Cognitive Ability with the Forced Choice Recognition Trial of the RCFT	PERCEPTUAL AND MOTOR SKILLS			English	Article						Rey Complex Figure Test; forced choice recognition; performance validity; embedded validity indicators	COMPLEX FIGURE TEST; TRAUMATIC BRAIN-INJURY; MEMORY MALINGERING TOMM; FALSE-POSITIVE RATES; VERBAL-LEARNING TEST; RAW SCORE CUTOFFS; SYMPTOM VALIDITY; CROSS-VALIDATION; CLASSIFICATION ACCURACY; DIGIT SPAN	In this study we attempted to replicate the classification accuracy of the newly introduced Forced Choice Recognition trial (FCR) of the Rey Complex Figure Test (RCFT) in a clinical sample. We administered the RCFTFCR and the earlier Yes/No Recognition trial from the RCFT to 52 clinically referred patients as part of a comprehensive neuropsychological test battery and incentivized a separate control group of 83 university students to perform well on these measures. We then computed the classification accuracies of both measures against criterion performance validity tests (PVTs) and compared results between the two samples. At previously published validity cutoffs (<= 16 & <= 17), the RCFTFCR remained specific (.84-1.00) to psychometrically defined non-credible responding. Simultaneously, the RCFTFCR was more sensitive to examinees' natural variability in visual-perceptual and verbal memory skills than the Yes/No Recognition trial. Even after being reduced to a seven-point scale (18-24) by the validity cutoffs, both RCFT recognition scores continued to provide clinically useful information on visual memory. This is the first study to validate the RCFTFCR as a PVT in a clinical sample. Our data also support its use for measuring cognitive ability. Replication studies with more diverse samples and different criterion measures are still needed before large-scale clinical application of this scale.	[Abeare, Kaitlyn; Romero, Kristoffer; Cutler, Laura; Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Windsor, ON, Canada; [Sirianni, Christina D.] Univ Windsor, Sch Social Work, Windsor, ON, Canada		Erdodi, LA (corresponding author), 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com	Cutler, Laura/AAI-6283-2021	Cutler, Laura/0000-0003-2957-8693; Romero, Kristoffer/0000-0002-3055-7112			Abeare C, 2021, PSYCHOL ASSESSMENT, V33, P90, DOI 10.1037/pas0000958; Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; Abeare CA, 2021, CLIN NEUROPSYCHOL, V35, P1442, DOI 10.1080/13854046.2020.1779348; Abeare CA, 2017, J CLIN EXP NEUROPSYC, V39, P738, DOI 10.1080/13803395.2016.1259396; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Arentsen TJ, 2013, CLIN NEUROPSYCHOL, V27, P1060, DOI 10.1080/13854046.2013.803603; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Bell-Sprinkel TL, 2013, CLIN NEUROPSYCHOL, V27, P516, DOI 10.1080/13854046.2012.744853; Benedict, 2001, HOPKINS VERBAL LEARN; Berger C, 2021, J ATTEN DISORD, V25, P1032, DOI 10.1177/1087054719864656; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boskovic I, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01195; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Chafetz MD, 2011, PSYCHOL INJ LAW, V4, P235, DOI 10.1007/s12207-011-9112-5; Conners K. C, 2015, CONNERS CONTINUOUS P; Cutler L, 2021, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2021.1884555; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Dandachi-FitzGerald B, 2016, PSYCHIAT RES, V239, P47, DOI 10.1016/j.psychres.2016.02.061; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; DeRight J, 2015, CLIN NEUROPSYCHOL, V29, P101, DOI 10.1080/13854046.2014.989267; Donders J, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1861659; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Egeland J, 2007, APPL NEUROPSYCHOL, V14, P113, DOI 10.1080/09084280701319953; Eglit GML, 2020, CLIN NEUROPSYCHOL, V34, P332, DOI 10.1080/13854046.2019.1643923; Erdal K, 2004, ARCH CLIN NEUROPSYCH, V19, P73; Erdodi, 2018, J PEDIAT NEUROPSYCHO, V4, P94, DOI [10.1007/s40817-018-0057-4, DOI 10.1007/s40817-018-0057-4, DOI 10.1007/S40817-018-0057-4]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2020, ARCH CLIN NEUROPSYCH, V35, P188, DOI 10.1093/arclin/acz032; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P113, DOI 10.1007/s12207-019-09352-y; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P155, DOI 10.1007/s12207-019-09356-8; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Fuermaier ABM, 2019, APPL NEUROPSYCH-ADUL, V26, P340, DOI 10.1080/23279095.2018.1429441; Fuermaier ABM, 2017, PSYCHOL ASSESSMENT, V29, P1466, DOI 10.1037/pas0000534; Giromini L, 2019, PSYCHOL INJ LAW, V12, P212, DOI 10.1007/s12207-019-09357-7; Giromini L, 2020, APPL NEUROPSYCH-ADUL, V27, P504, DOI 10.1080/23279095.2019.1570929; Giromini L, 2018, PSYCHOL INJ LAW, V11, P340, DOI 10.1007/s12207-018-9314-1; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Goworowski L, 2020, APPL NEUROPSYCH-ADUL, V27, P94, DOI 10.1080/23279095.2018.1488716; Grant AF, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1769097; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Guilliam TA, 2020, CRIT REV BIOCHEM MOL, V55, P469, DOI 10.1080/10409238.2020.1811630; Guise BJ, 2014, J NEUROPSYCHOL, V8, P20, DOI 10.1111/jnp.12002; Hand DJ, 2009, MACH LEARN, V77, P103, DOI 10.1007/s10994-009-5119-5; Harrison AG, 2017, PSYCHOL INJ LAW, V10, P138, DOI 10.1007/s12207-017-9291-9; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Hilsabeck RC, 2015, ARCH CLIN NEUROPSYCH, V30, P458, DOI 10.1093/arclin/acv037; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Hurtubise J, 2020, APPL NEUROPSYCH-CHIL, V9, P337, DOI 10.1080/21622965.2020.1719409; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Kura K, 2013, INTELLIGENCE, V41, P512, DOI 10.1016/j.intell.2013.07.001; Lace JW, 2020, PSYCHOL INJ LAW, V13, P303, DOI 10.1007/s12207-020-09382-x; Lafayette Instrument, 2015, GROOV PEGB US MAN; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lau L, 2017, CLIN NEUROPSYCHOL, V31, P1412, DOI 10.1080/13854046.2017.1318954; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Leon FR, 2014, INTELLIGENCE, V46, P291, DOI 10.1016/j.intell.2014.07.011; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P127, DOI 10.1007/s12207-019-09354-w; Lichtenstein JD, 2019, DEV NEUROPSYCHOL, V44, P159, DOI 10.1080/87565641.2019.1565535; Lichtenstein JD, 2018, CHILD NEUROPSYCHOL, V24, P247, DOI 10.1080/09297049.2016.1259402; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lindstrom W, 2011, CLIN NEUROPSYCHOL, V25, P302, DOI 10.1080/13854046.2010.537280; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Love CM, 2014, ASSESSMENT, V21, P618, DOI 10.1177/1073191114528028; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Lynn R, 2010, INTELLIGENCE, V38, P93, DOI 10.1016/j.intell.2009.07.004; Martin PK, 2020, CLIN NEUROPSYCHOL, V34, P88, DOI 10.1080/13854046.2019.1637027; Marzban C, 2004, WEATHER FORECAST, V19, P1106, DOI 10.1175/825.1; McWhirter L, 2020, CNS SPECTRUMS, V25, P511, DOI 10.1017/S1092852919001329; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Merten T, 2017, BEHAV SCI LAW, V35, P97, DOI 10.1002/bsl.2274; Merten T, 2013, J EXP PSYCHOPATHOL, V4, P20, DOI 10.5127/jep.023711; Messa I, 2021, AUST J FORENSIC SCI, DOI 10.1080/00450618.2020.1865457; Meyers JE., 1995, REY COMPLEX FIGURE T; Niesten IJM, 2017, PSYCHOL INJ LAW, V10, P368, DOI 10.1007/s12207-017-9303-9; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Ord AS, 2021, CLIN NEUROPSYCHOL, V35, P1426, DOI 10.1080/13854046.2020.1751301; Pearson, 2009, ADV CLIN SOLUTIONS W; Poreh A, 2016, APPL NEUROPSYCH-ADUL, V23, P155, DOI 10.1080/23279095.2015.1027343; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Poynter K, 2019, ARCH CLIN NEUROPSYCH, V34, P1367, DOI 10.1093/arclin/acy087; RAI J, 2019, APPL NEUROPSYCHOL, DOI DOI 10.1080/23279095.2019.161.1613994; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roberson CJ, 2013, CLIN NEUROPSYCHOL, V27, P495, DOI 10.1080/13854046.2012.737027; Roor JJ, 2016, APPL NEUROPSYCH-ADUL, V23, P172, DOI 10.1080/23279095.2015.1030018; Ross TP, 2016, ARCH CLIN NEUROPSYCH, V31, P97, DOI 10.1093/arclin/acv062; Roth R.M., 2020, PSYCHOL NEUROSCI, V13, P93, DOI [10.1037/pne0000185, DOI 10.1037/PNE0000185]; Roth RM, 2005, BRIEF A BEHAV RATING; ROULEAU I, 1992, BRAIN COGNITION, V18, P70, DOI 10.1016/0278-2626(92)90112-Y; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; Russeler J, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-37; Santos OA, 2014, ARCH CLIN NEUROPSYCH, V29, P609, DOI 10.1093/arclin/acu039; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Silk-Eglit GM, 2014, ARCH CLIN NEUROPSYCH, V29, P415, DOI 10.1093/arclin/acu028; Sirianni CD, 2021, PSYCHIAT RES, V298, DOI 10.1016/j.psychres.2020.113651; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith K, 2014, CLIN NEUROPSYCHOL, V28, P1048, DOI 10.1080/13854046.2014.931465; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Sugarman MA, 2016, APPL NEUROPSYCH-ADUL, V23, P105, DOI 10.1080/23279095.2015.1014557; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Sullivan K, 2010, PSYCHIAT RES, V176, P75, DOI 10.1016/j.psychres.2008.07.013; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; van Helvoort D, 2019, CLIN NEUROPSYCHOL, V33, P1069, DOI 10.1080/13854046.2018.1559359; Viglione DJ, 2019, J PERS ASSESS, V101, P653, DOI 10.1080/00223891.2018.1492413; Wald NJ, 2014, J MED SCREEN, V21, P51, DOI 10.1177/0969141313517497; Webber TA, 2018, PSYCHOL INJ LAW, V11, P325, DOI 10.1007/s12207-018-9335-9; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Weinborn M, 2012, CLIN NEUROPSYCHOL, V26, P832, DOI 10.1080/13854046.2012.686630; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Whitney KA, 2013, APPL NEUROPSYCH-ADUL, V20, P83, DOI 10.1080/09084282.2012.670167; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P263, DOI 10.1093/arclin/acp034; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	165	1	1	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0031-5125	1558-688X		PERCEPT MOTOR SKILL	Percept. Mot. Skills	AUG	2021	128	4					1373	1408		10.1177/00315125211019704			36	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	TG4UR	WOS:000671402200004	34024205	hybrid, Green Published			2022-02-06	
J	Alexopoulos, G; Quadri, N; Khan, M; Bazai, H; Pico, CF; Fraser, C; Kulkarni, N; Kemp, J; Coppens, J; Bucholz, R; Mercier, P				Alexopoulos, Georgios; Quadri, Nabiha; Khan, Maheen; Bazai, Henna; Pico, Carla Formoso; Fraser, Connor; Kulkarni, Neha; Kemp, Joanna; Coppens, Jeroen; Bucholz, Richard; Mercier, Philippe			Ballistic lobar trajectory outcomes in civilian firearm penetrating brain injury	JOURNAL OF NEUROSURGERY			English	Article						penetrating brain injury; ballistic trajectory; penetrating brain trauma; gunshot wound to the head; ballistic outcomes; traumatic brain injury	GUNSHOT WOUNDS; HEAD; PREDICTION; MORTALITY; SURVIVAL	OBJECTIVE Penetrating brain injury (PBI) is the most lethal of all firearm injuries, with reported survival rates of less than 20%. The projectile trajectory (PT) has been shown to impact mortality, but the significant lobar tracks have not been defined. The aim of this retrospective case-control study was to test for associations between distinct ballistic trajectories, missile types, and patient outcomes. METHODS A total of 243 patients who presented with a PBI to the Saint Louis University emergency department from 2008 through 2019 were identified from the hospital registry. Conventional CT scans combined with 3D CT reconstructions and medical records were reviewed for each patient to identify distinct PTs. RESULTS A total of 65 ballistic lobar trajectories were identified. Multivariable regression models were used, and the results were compared with those in the literature. Penetrating and perforating types of PBI associated with bitemporal (t-statistic = -2.283, p = 0.023) or frontal-to-contralateral parietal (t-statistic = -2.311, p = 0.025) projectile paths were universally found to be fatal. In the group in which the Glasgow Coma Scale (GCS) score at presentation was lower than 8, a favorable penetrating missile trajectory was one that involved a single frontal lobe (adjusted OR 0.02 [95% CI 0.000.38], p = 0.022) or parietal lobe (adjusted OR 0.15 [95% CI 0.02-0.97], p = 0.048). Expanding or fragmenting types of projectiles carry higher mortality rates (OR 2.53 [95% CI 1.32-4.83], p < 0.001) than do nondeformable missiles. Patient age was not associated with worse outcomes when controlled by other significant predictive factors. CONCLUSIONS Patients with penetrating or perforating types of PBI associated with bitemporal or frontal-to-contralateral parietal PTs should be considered as potential donor candidates. Trauma patients with penetrating missile trajectories involving a single frontal or parietal lobe should be considered for early neurosurgical intervention, especially in the circumstances of a low GCS score (< 8). Surgeons should not base their decision-making solely on advanced patient age to defer further treatment. Patients with PBIs caused by nondeformable types of projectiles can survive multiple simultaneous intracranial missile trajectories.	[Alexopoulos, Georgios; Quadri, Nabiha; Khan, Maheen; Kemp, Joanna; Coppens, Jeroen; Bucholz, Richard; Mercier, Philippe] St Louis Univ, Dept Neurosurg, St Louis, MO 63103 USA; [Alexopoulos, Georgios; Quadri, Nabiha; Khan, Maheen; Bazai, Henna; Pico, Carla Formoso; Fraser, Connor; Kulkarni, Neha; Kemp, Joanna; Coppens, Jeroen; Bucholz, Richard; Mercier, Philippe] St Louis Univ, Sch Med, St Louis, MO 63103 USA		Alexopoulos, G (corresponding author), St Louis Univ Hosp, St Louis, MO 63104 USA.	alexopoulos_george@hotmail.com		Alexopoulos, Georgios/0000-0002-6225-3033			AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; Alvis-Miranda Hernando Raphael, 2016, Bull Emerg Trauma, V4, P65; Bodanapally UK, 2015, J NEUROSURG, V122, P219, DOI 10.3171/2014.9.JNS14679; Can C, 2017, J ROY ARMY MED CORPS, V163, P211, DOI 10.1136/jramc-2016-000632; Cook A, 2017, INJURY, V48, P621, DOI 10.1016/j.injury.2017.01.044; Darwazeh R, 2018, WORLD NEUROSURG, V116, pE329, DOI 10.1016/j.wneu.2018.04.202; Dsouza LB, 2019, AM J EMERG MED, V37, P1818, DOI 10.1016/j.ajem.2018.12.036; Fowler KA, 2015, PREV MED, V79, P5, DOI 10.1016/j.ypmed.2015.06.002; Frosen J, 2019, ACTA NEUROCHIR, V161, P1285, DOI 10.1007/s00701-019-03952-y; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Hakki L, 2019, INJURY, V50, P1143, DOI 10.1016/j.injury.2019.01.033; Hazama A, 2018, WORLD NEUROSURG, V117, P309, DOI 10.1016/j.wneu.2018.06.132; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Jandial R, 2008, NEUROSURGERY, V62, P472, DOI 10.1227/01.neu.0000316015.05550.7a; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Karger B, 1997, INT J LEGAL MED, V110, P188, DOI 10.1007/s004140050065; Kegler Scott R., 2011, Morbidity and Mortality Weekly Report, V60, P573; Khan MB, 2014, WORLD NEUROSURG, V82, P14, DOI 10.1016/j.wneu.2013.01.026; Kim LH, 2020, J CLIN NEUROSCI, V75, P71, DOI 10.1016/j.jocn.2020.03.027; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; Maghin F, 2019, INT J LEGAL MED, V133, P1469, DOI 10.1007/s00414-019-02085-2; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; Nowinski Wieslaw L, 2018, Brain Inform, V5, P1, DOI 10.1186/s40708-018-0082-1; Nowinski WL, 2015, J NEUROSCI METH, V246, P65, DOI 10.1016/j.jneumeth.2015.02.012; Oehmichen M, 2003, ACTA NEUROPATHOL, V105, P570, DOI 10.1007/s00401-003-0683-4; Padrta JC, 1997, J TRAUMA, V43, P516, DOI 10.1097/00005373-199709000-00022; Puentes K, 2009, J FORENSIC LEG MED, V16, P407, DOI 10.1016/j.jflm.2009.04.003; Robinson LA, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000351; Skarupa DJ, 2019, AM J SURG, V218, P255, DOI 10.1016/j.amjsurg.2018.11.034; Tartaglione T, 2012, RADIOL MED, V117, P461, DOI 10.1007/s11547-011-0784-4; Turco L, 2017, WORLD NEUROSURG, V104, P653, DOI 10.1016/j.wneu.2017.05.068; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z	33	1	1	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2021	135	2					574	583		10.3171/2020.6.JNS201837			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UP9SW	WOS:000695714800029	33157538	Bronze			2022-02-06	
J	Baldassarro, VA; Sanna, M; Bighinati, A; Sannia, M; Gusciglio, M; Giardino, L; Lorenzini, L; Calza, L				Baldassarro, Vito Antonio; Sanna, Marco; Bighinati, Andrea; Sannia, Michele; Gusciglio, Marco; Giardino, Luciana; Lorenzini, Luca; Calza, Laura			A Time-Course Study of the Expression Level of Synaptic Plasticity-Associated Genes in Un-Lesioned Spinal Cord and Brain Areas in a Rat Model of Spinal Cord Injury: A Bioinformatic Approach	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						spinal cord injury; rat; transcriptomic; bioinformatic analysis	KEY GENES; REORGANIZATION; MECHANISMS; INSIGHTS; NEURONS	"Neuroplasticity" is often evoked to explain adaptation and compensation after acute lesions of the Central Nervous System (CNS). In this study, we investigated the modification of 80 genes involved in synaptic plasticity at different times (24 h, 8 and 45 days) from the traumatic spinal cord injury (SCI), adopting a bioinformatic analysis. mRNA expression levels were analyzed in the motor cortex, basal ganglia, cerebellum and in the spinal segments rostral and caudal to the lesion. The main results are: (i) a different gene expression regulation is observed in the Spinal Cord (SC) segments rostral and caudal to the lesion; (ii) long lasting changes in the SC includes the extracellular matrix (ECM) enzymes Timp1, transcription regulators (Egr, Nr4a1), second messenger associated proteins (Gna1, Ywhaq); (iii) long-lasting changes in the Motor Cortex includes transcription regulators (Cebpd), neurotransmitters/neuromodulators and receptors (Cnr1, Gria1, Nos1), growth factors and related receptors (Igf1, Ntf3, Ntrk2), second messenger associated proteins (Mapk1); long lasting changes in Basal Ganglia and Cerebellum include ECM protein (Reln), growth factors (Ngf, Bdnf), transcription regulators (Egr, Cebpd), neurotransmitter receptors (Grin2c). These data suggest the molecular mapping as a useful tool to investigate the brain and SC reorganization after SCI.	[Baldassarro, Vito Antonio; Bighinati, Andrea; Giardino, Luciana; Lorenzini, Luca] Univ Bologna, Dept Vet Med Sci, Via Tolara di Sopra 50, I-40064 Ozzano Dell Emilia, Italy; [Sanna, Marco; Sannia, Michele; Giardino, Luciana; Calza, Laura] Univ Bologna, Interdept Ctr Ind Res Life Sci & Technol, Via Tolara di Sopra 41-E, I-40064 Ozzano Dell Emilia, Italy; [Gusciglio, Marco; Giardino, Luciana] IRET Fdn, Via Tolara di Sopra 41-E, I-40064 Ozzano Dell Emilia, Italy; [Calza, Laura] Univ Bologna, Dept Pharm & BioTechnol, Via San Donato 15, I-40127 Bologna, Italy; [Calza, Laura] Montecatone Rehabil Inst, I-40026 Imola, Italy		Calza, L (corresponding author), Univ Bologna, Interdept Ctr Ind Res Life Sci & Technol, Via Tolara di Sopra 41-E, I-40064 Ozzano Dell Emilia, Italy.; Calza, L (corresponding author), Univ Bologna, Dept Pharm & BioTechnol, Via San Donato 15, I-40127 Bologna, Italy.; Calza, L (corresponding author), Montecatone Rehabil Inst, I-40026 Imola, Italy.	vito.baldassarro2@unibo.it; marco.sanna9@unibo.it; andrea.bighinati@unibo.it; michele.sannia2@unibo.it; marco.gusciglio@outlook.it; luciana.giardino@unibo.it; luca.lorenzini8@unibo.it; laura.calza@unibo.it	Sanna, Marco/ABE-8099-2021	Sanna, Marco/0000-0001-5709-5782; Baldassarro, Vito Antonio/0000-0003-1020-4261; Bighinati, Andrea/0000-0002-7584-1934	POR-FESR 2019-21, project "Mat2Rep", Emilia Romagna Region; Cluster Tecnologici Nazionali, project IRMI, MIURMinistry of Education, Universities and Research (MIUR); program "Alte Competenze" by Emilia Romagna Region; "Fondazione Montecatone", Imola (Italy)	This research was funded by the POR-FESR 2019-21, project "Mat2Rep", Emilia Romagna Region (L.C.) and by the Cluster Tecnologici Nazionali, project IRMI, MIUR (L.C.). Marco Sanna is receiving a fellowship from the program "Alte Competenze" by Emilia Romagna Region. The contribution of "Fondazione Montecatone", Imola (Italy) is also gratefully acknowledged.	Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; Alizadeh A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00035; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Azzarito M, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102221; Baek A, 2017, CELL TRANSPLANT, V26, P1286, DOI 10.1177/0963689717715822; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Baydyuk M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00254; Bazley FA, 2012, IEEE ENG MED BIO, P82, DOI 10.1109/EMBC.2012.6345876; Beauparlant J, 2013, BRAIN, V136, P3347, DOI 10.1093/brain/awt204; Bighinati A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041744; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byrnes KR, 2010, J MAGN RESON IMAGING, V32, P836, DOI 10.1002/jmri.22323; Carlson M., 2007, R Package Version, V3, DOI 10.18129/B9.bioc.GO.db; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chen XJ, 2013, EUR REV MED PHARMACO, V17, P2949; Christiansen L, 2018, NEUROTHERAPEUTICS, V15, P618, DOI 10.1007/s13311-018-0639-y; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; David G, 2019, NAT REV NEUROL, V15, P718, DOI 10.1038/s41582-019-0270-5; Deng WW, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.640255; Dietz V, 2004, BRAIN, V127, P2221, DOI 10.1093/brain/awh255; Dietz V, 2010, NAT REV NEUROL, V6, P167, DOI 10.1038/nrneurol.2009.227; Durieux LJA, 2021, EUR J NEUROSCI, DOI 10.1111/ejn.15110; Fang S, 2021, MOL NEUROBIOL, V58, P2643, DOI 10.1007/s12035-021-02289-x; Freund P, 2013, NEUROSCIENTIST, V19, P116, DOI 10.1177/1073858412449192; Gelfo F, 2011, NEUROREHAB NEURAL RE, V25, P243, DOI 10.1177/1545968310380926; Gong LL, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-6519; Grau JW, 2020, EXP NEUROL, V330, DOI 10.1016/j.expneurol.2020.113334; Hassannejad Z, 2019, NEUROSCIENCE, V402, P37, DOI 10.1016/j.neuroscience.2019.01.019; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Hilton BJ, 2016, J NEUROSCI, V36, P4080, DOI 10.1523/JNEUROSCI.3386-15.2016; Huber E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70805-5; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hutson TH, 2019, NAT REV NEUROL, V15, P732, DOI 10.1038/s41582-019-0280-3; Jacobi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088449; Kadoya K, 2016, NAT MED, V22, P479, DOI 10.1038/nm.4066; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kendziorski CM, 2003, BIOSTATISTICS, V4, P465, DOI 10.1093/biostatistics/4.3.465; Kjell J, 2016, DIS MODEL MECH, V9, P1125, DOI 10.1242/dmm.025833; Krucoff MO, 2019, NEUROSURGERY, V84, P30, DOI 10.1093/neuros/nyy128; Lai J, 2013, EUR REV MED PHARMACO, V17, P2941; Lee SY, 2020, OTOL NEUROTOL, V41, P986, DOI 10.1097/MAO.0000000000002691; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lim AFY, 2017, NEUROBIOL LEARN MEM, V138, P78, DOI 10.1016/j.nlm.2016.07.024; Matson K.J.E., 2021, SINGLE CELL ATLAS SP, P1, DOI [10.1101/2021.04.28.441862, DOI 10.1101/2021.04.28.441862]; Meis S, 2018, CEREB CORTEX, V28, P1195, DOI 10.1093/cercor/bhx032; Milich Lindsay M, 1800, J Exp Med, V218, DOI 10.1084/jem.20210040; Min YS, 2015, J NEUROTRAUM, V32, P1422, DOI 10.1089/neu.2014.3661; Mysoet J, 2015, BEHAV BRAIN RES, V290, P117, DOI 10.1016/j.bbr.2015.04.055; Ni Y, 2019, INT J NEUROSCI, V129, P856, DOI 10.1080/00207454.2019.1576661; Ohnishi Y, 2021, BRAIN COMMUN, V3, DOI 10.1093/braincomms/fcab058; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Poirier R, 2008, FRONT NEUROSCI-SWITZ, V2, P47, DOI 10.3389/neuro.01.002.2008; Qian J, 2019, J NEUROTRAUM, V36, P485, DOI 10.1089/neu.2018.5713; Ramsey JBG, 2010, J NEUROTRAUM, V27, P1709, DOI 10.1089/neu.2010.1382; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Sammons RP, 2015, CURR OPIN NEUROBIOL, V35, P136, DOI 10.1016/j.conb.2015.08.004; Serradj N, 2017, NEUROSCI LETT, V652, P94, DOI 10.1016/j.neulet.2016.12.003; Shah PK, 2011, BEHAV NEUROSCI, V125, P996, DOI 10.1037/a0026032; Shi LL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3532-x; Shin HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088215; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torres-Espin A, 2018, J NEUROTRAUM, V35, P1970, DOI 10.1089/neu.2018.5906; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vipin A, 2016, J NEUROTRAUM, V33, P2191, DOI 10.1089/neu.2015.4383; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Yokota K, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-018-0422-3; Zhang YH, 2017, MOL MED REP, V15, P1577, DOI 10.3892/mmr.2017.6192; Zhu J, 2017, JOVE-J VIS EXP, DOI 10.3791/55584	68	1	1	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	AUG	2021	22	16							8606	10.3390/ijms22168606			23	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	UG3VH	WOS:000689183900001	34445312	Green Published, gold			2022-02-06	
J	Caccese, JB; Eckner, JT; Franco-MacKendrick, L; Hazzard, JB; Ni, M; Broglio, SP; McAllister, TW; McCrea, MA; Pasquina, PF; Buckley, TA				Caccese, Jaclyn B.; Eckner, James T.; Franco-MacKendrick, Lea; Hazzard, Joseph B.; Ni, Meng; Broglio, Steven P.; McAllister, Thomas W.; McCrea, Michael A.; Pasquina, Paul F.; Buckley, Thomas A.			Interpreting Clinical Reaction Time Change and Recovery After Concussion: A Baseline Versus Norm-Based Cutoff Score Comparison	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury (mTBI); diagnosis; response time; evaluation; management	RELIABILITY	Context: Preseason testing can be time intensive and cost prohibitive. Therefore, using normative data for postconcussion interpretation in lieu of preseason testing is desirable. Objective: To establish the recovery trajectory for clinical reaction time (RTclin) and assess the usefulness of changes from baseline (comparison of postconcussion scores with individual baseline scores) and norm-based cutoff scores (comparison of postconcussion scores with a normative mean) for identifying impairments postconcussion. Design: Case-control study. Setting: Multisite clinical setting. Patients or Other Participants: An overlapping sample of 99 participants (age = 19.0 +/- 1.1 years) evaluated within 6 hours postconcussion, 176 participants (age = 18.9 +/- 1.1 years) evaluated at 24 to 48 hours postconcussion, and 214 participants (age = 18.9 +/- 1.1 years) evaluated once they were cleared to begin a return-to-play progression were included. Participants with concussion were compared with 942 control participants (age = 19.0 +/- 1.0 years) who did not sustain a concussion during the study period but completed preseason baseline testing at 2 points separated by 1 year (years 1 and 2). Main Outcome Measure(s): At each time point, follow-up RTclin (ie, postconcussion or year 2) was compared with the individual year 1 preseason baseline RTclin and normative baseline data (ie, sex and sport specific). Receiver operating characteristic curves were calculated to compare the sensitivity and specificity of RTclin change from baseline and norm-based cutoff scores. Results: Clinical reaction time performance declined within 6 hours (18 milliseconds, 9.2% slower than baseline). The decline persisted at 24 to 48 hours (15 milliseconds, 7.6% slower than baseline), but performance recovered by the time of return-to-play initiation. Within 6 hours, a change from baseline of 16 milliseconds maximized combined sensitivity (52%) and specificity (79%, area under the curve [AUC] = 0.702), whereas a norm-based cutoff score of 19 milliseconds maximized combined sensitivity (46%) and specificity ( 86%, AUC = 0.700). At 24 to 48 hours, a change from baseline of 2 milliseconds maximized combined sensitivity (64%) and specificity (61%, AUC = 0.666), whereas a norm-based cutoff score of 0 milliseconds maximized combined sensitivity (63%) and specificity (62%, AUC = 0.647). Conclusions: Norm-based cutoff scores can be used for interpreting RTclin scores postconcussion in collegiate athletes when individual baseline data are not available, although low sensitivity and specificity limit the use of RTclin as a stand-alone test.	[Caccese, Jaclyn B.] Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, 453 West 10th Ave, Columbus, OH 43210 USA; [Eckner, James T.; Franco-MacKendrick, Lea] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Hazzard, Joseph B.] Bloomsburg Univ, Dept Exercise Sci, Bloomsburg, PA USA; [Ni, Meng] Bloomsburg Univ, Inst Concuss Res & Serv, Bloomsburg, PA USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg & Neurol, Milwaukee, WI USA; [Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Pasquina, Paul F.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Buckley, Thomas A.] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE USA		Caccese, JB (corresponding author), Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, 453 West 10th Ave, Columbus, OH 43210 USA.	jaclyn.caccese@osumc.edu			Grand Alliance CARE Consortium - National Collegiate Athletic Association; US Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; US Department of Defense (Defense Health Program funds)United States Department of Defense	This study was supported in part by the Grand Alliance CARE Consortium, funded by the National Collegiate Athletic Association and the US Department of Defense. The US Army Medical Research Acquisition Activity, Fort Detrick, Maryland, is the awarding and administering acquisition office. This study was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under award W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the US Department of Defense (Defense Health Program funds).	[Anonymous], VA/DoD Clinical Practice Guidelines: Management of Opioid Therapy For Chronic Pain; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Caccese JB, 2020, J ATHL TRAINING, V55, P601, DOI 10.4085/1062-6050-164-19; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Cohen J, 2013, STAT POWER ANAL BEHA, P40; Eckner JT, 2015, PERCEPT MOTOR SKILL, V120, P841, DOI 10.2466/25.15.PMS.120v19x6; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2011, PM&R, V3, P1092, DOI 10.1016/j.pmrj.2011.04.022; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Lempke LB, 2020, SPORTS MED, V50, P1341, DOI 10.1007/s40279-020-01281-0; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb	20	1	1	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2021	56	8					851	859		10.4085/1062-6050-457-20			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TZ6NS	WOS:000684588100008	34375406	gold			2022-02-06	
J	Campolo, M; Crupi, R; Cordaro, M; Cardali, SM; Ardizzone, A; Casili, G; Scuderi, SA; Siracusa, R; Esposito, E; Conti, A; Cuzzocrea, S				Campolo, Michela; Crupi, Rosalia; Cordaro, Marika; Cardali, Salvatore Massimo; Ardizzone, Alessio; Casili, Giovanna; Scuderi, Sarah Adriana; Siracusa, Rosalba; Esposito, Emanuela; Conti, Alfredo; Cuzzocrea, Salvatore			Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; palmitoylethanolamide; luteolin; neurogenesis; mice; patients	MINI-MENTAL-STATE; HIPPOCAMPAL NEUROGENESIS; CELL-PROLIFERATION; SPATIAL MEMORY; DENTATE GYRUS; UP-REGULATION; PALMITOYLETHANOLAMIDE; LUTEOLIN; NEUROINFLAMMATION; NEUROPROTECTION	This study aimed to assess the neuro-regenerative properties of co-ultramicronized PEALut (Glialia(R)), composed of palmitoylethanolamide (PEA) and the flavonoid luteolin (Lut), in an in vivo model of traumatic brain injury (TBI) and patients affected by moderate TBI. An increase in neurogenesis was seen in the mice at 72 h and 7 d after TBI. The co-ultra PEALut treatment helped the neuronal reconstitution process to restore the basal level of both novel and mature neurons; moreover, it induced a significant upregulation of the neurotrophic factors, which ultimately led to progress in terms of memory recall during behavioral testing. Moreover, our preliminary findings in a clinical trial suggested that Glialia(R) treatment facilitated neural recovery on working memory. Thus, co-ultra PEALut (Glialia(R)) could represent a valuable therapeutic agent for intensifying the endogenous repair response in order to better treat TBI.	[Campolo, Michela; Crupi, Rosalia; Cordaro, Marika; Ardizzone, Alessio; Casili, Giovanna; Scuderi, Sarah Adriana; Siracusa, Rosalba; Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, I-98166 Messina, Italy; [Cardali, Salvatore Massimo] Univ Messina, Dept Neurosurg, I-98166 Messina, Italy; [Conti, Alfredo] Univ Bologna, Alma Mater Studiorum, Dipartimento Sci Biomed & Neuromotorie, I-40126 Bologna, Italy; [Conti, Alfredo] IRCCS Ist Sci Neurol Bologna, I-40139 Bologna, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA		Cuzzocrea, S (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, I-98166 Messina, Italy.; Cuzzocrea, S (corresponding author), St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	campolom@unime.it; rosalia.crupi@unime.it; marika.cordaro@unime.it; salvatore.cardali@unime.it; aleardizzone@unime.it; gcasili@unime.it; sarahadriana.scuderi@unime.it; rsiracusa@unime.it; eesposito@unime.it; alfredo.conti2@unibo.it	Conti, Alfredo/H-3022-2019; Casili, Giovanna/AAC-3740-2022; Siracusa, Rosalba/AAC-3110-2022; Ardizzone, Alessio/AAC-3715-2022; Cordaro, Marika/K-7329-2016	Conti, Alfredo/0000-0002-9408-2662; Casili, Giovanna/0000-0002-0552-1396; Siracusa, Rosalba/0000-0001-7868-2505; Ardizzone, Alessio/0000-0002-2293-0634; Cordaro, Marika/0000-0002-3980-0043; Cuzzocrea, Salvatore/0000-0001-6131-3690; Esposito, Emanuela/0000-0002-2663-6387			Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Ball TD, 2009, CLIN NEUROPSYCHOL, V23, P1037, DOI 10.1080/13854040902830203; Bhullar KS, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/891748; Blazquez C, 2015, CELL DEATH DIFFER, V22, P1618, DOI 10.1038/cdd.2015.11; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Caltagirone C, 2016, TRANSL STROKE RES, V7, P54, DOI 10.1007/s12975-015-0440-8; Campolo M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103596; Campolo M, 2018, METHODS MOL BIOL, V1727, P385, DOI 10.1007/978-1-4939-7571-6_30; Campolo M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0196-1; Casili G, 2018, J NEUROTRAUM, V35, P1437, DOI 10.1089/neu.2017.5260; Chen CC, 2004, MOL PHARMACOL, V66, P683; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cope EC, 2019, CELL STEM CELL, V24, P690, DOI 10.1016/j.stem.2019.03.023; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Crupi R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040297; Crupi R, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00047; de Guise E, 2011, APPL NEUROPSYCHOL, V18, P179, DOI 10.1080/09084282.2011.595444; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; Esposito E, 2013, CNS NEUROL DISORD-DR, V12, P55, DOI 10.2174/1871527311312010010; Esposito E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041880; Farr SA, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02009-7; Fidaleo M, 2014, CURR MED CHEM, V21, P2803, DOI 10.2174/0929867321666140303143455; Filippone A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145053; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fusco R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194845; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Gugliandolo E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00590; Guida F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00095; Gutierrez IL, 2018, ASN NEURO, V10, DOI 10.1177/1759091418784357; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kazanis I, 2009, BRAIN, V132, P2909, DOI 10.1093/brain/awp237; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempuraj D, 2021, BIOFACTORS, V47, P190, DOI 10.1002/biof.1687; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kumazawa Y, 2006, CURR PHARM DESIGN, V12, P4271, DOI 10.2174/138161206778743565; Lama A, 2021, BRIT J PHARMACOL, V178, P845, DOI 10.1111/bph.15071; Li Y, 2019, NEUROREPORT, V30, P1299, DOI 10.1097/WNR.0000000000001360; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lossi L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123999; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Manivannan S, 2021, NEUROPHARMACOLOGY, V183, DOI 10.1016/j.neuropharm.2020.108400; Mannelli LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128080; Moosavi F, 2016, DRUG DES DEV THER, V10, P23, DOI 10.2147/DDDT.S96936; Muccioli GG, 2008, NEUROPHARMACOLOGY, V54, P16, DOI 10.1016/j.neuropharm.2007.05.015; Mueller FJ, 2005, E SCHERING RES FDN W, V53, P83; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Paterniti I, 2014, CNS NEUROL DISORD-DR, V13, P1530, DOI 10.2174/1871527313666140806124322; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Patil SP, 2014, NEUROPHARMACOLOGY, V86, P192, DOI 10.1016/j.neuropharm.2014.07.012; Petrosino S, 2017, BRIT J PHARMACOL, V174, P1349, DOI 10.1111/bph.13580; Raad M, 2014, NEUROSCIENCE, V281, P16, DOI 10.1016/j.neuroscience.2014.08.045; Redell JB, 2020, EXP NEUROL, V331, DOI 10.1016/j.expneurol.2020.113372; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rolfe A, 2015, BRAIN NEUROTRAUMA MO; Russo E, 2013, EPILEPSY BEHAV, V28, P232, DOI 10.1016/j.yebeh.2013.05.002; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scuderi C, 2011, J CELL MOL MED, V15, P2664, DOI 10.1111/j.1582-4934.2011.01267.x; Selimi F, 2003, NEURON, V37, P813, DOI 10.1016/S0896-6273(03)00093-X; Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004; Siracusa R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00233; Siracusa R, 2016, MOL NEUROBIOL, V53, P3783, DOI 10.1007/s12035-015-9328-6; Siracusa R, 2015, CNS NEUROL DISORD-DR, V14, P1350, DOI 10.2174/1871527314666150821102823; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Skaper SD, 2014, IMMUNOLOGY, V141, P314, DOI 10.1111/imm.12170; Sophie Su Y, 2016, TRANSLATIONAL RES TR; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun GC, 2020, BRAIN RES BULL, V162, P84, DOI 10.1016/j.brainresbull.2020.05.009; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walter L, 2002, J BIOL CHEM, V277, P20869, DOI 10.1074/jbc.M110813200; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wilhelmsson U, 2019, BIOL CHEM, V400, P1147, DOI 10.1515/hsz-2019-0199; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Xie CC, 2015, BRAIN RES, V1602, P1, DOI 10.1016/j.brainres.2014.03.021; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yeung ST, 2014, NEUROSCIENCE, V259, P214, DOI 10.1016/j.neuroscience.2013.11.054; Yoo DY, 2013, NEUROL RES, V35, P813, DOI 10.1179/1743132813Y.0000000217; Yuan TF, 2015, STEM CELL REV REP, V11, P706, DOI 10.1007/s12015-015-9603-y; Zhao G, 2012, NEUROBIOL AGING, V33, P176, DOI 10.1016/j.neurobiolaging.2010.02.013; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	85	1	1	3	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	AUG	2021	22	16							8717	10.3390/ijms22168717			24	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	UG3AQ	WOS:000689130100001	34445417	gold, Green Published			2022-02-06	
J	Cardim, D; Robba, C; Schmidt, B; Donnelly, J; Schmidt, EA; Bohdanowicz, M; Smielewski, P; Czosnyka, M				Cardim, Danilo; Robba, Chiara; Schmidt, Bernhard; Donnelly, Joseph; Schmidt, Eric A.; Bohdanowicz, Michal; Smielewski, Peter; Czosnyka, Marek			Midline shift in patients with closed traumatic brain injury may be driven by cerebral perfusion pressure not intracranial pressure	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Intracranial pressure; Ultrasonography; Doppler; transcranial; Brain injuries; traumatic	TISSUE PRESSURE; HEAD-INJURY; GRADIENTS; AUTOREGULATION; ICP; ASYMMETRY; FLOW	BACKGROUND: In traumatic brain injury (TBI), swelling may disturb the potentially uniform pressure distribution in the brain, producing sustained intercompartmental pressure gradients which may associate with midline shift The presence of pressure gradients is often neglected since bilateral invasive intracranial pressure (ICP) monitoring is not usually considered because of risks and high costs. We evaluated the presence of interhemispheric pressure gradients using bilateral transcranial Doppler (TCD) as means for noninvasive ICP(nICP) monitoring in TBI patients presenting midline shift. METHODS: From a retrospective cohort of 97 TBI patients with arterial blood pressure (ABP), ICP and bilateral TCD monitoring, 24 presented unilateral lesion and midline shift confirmed by computer tomography. nICP and noninvasive cerebral perfusion pressure (nCPP) on the left and right brain hemispheres were retrospectively calculated using a mathematical model associating TCD-derived cerebral blood flow velocity and ABP. RESULTS: The nCPP difference was correlated with midline shift (R=-0.34, P<0.01) showing a tendency to record higher CPP at the side of expansion. Accordingly, nICP at the side of expansion was significantly lower in comparison to the compressed side (18.86 [+/- 5.71] mmHg [mean +/- standard deviation) versus 20.30 [+/- 6.78] mmHg for expansion and compressed sides, respectively). Subsequently, nCPP was greater on the side of brain expansion (79.48 +/- 7.84, 78.03 +/- 8.93 mmHg [P<0.01], for expansion and compressed sides, respectively). CONCLUSIONS: TCD-based interhemispheric nCPP difference showed significant correlation with midline shift. Cerebral perfusion pressure was greater on the side of brain expansion, acting as the driving force to shift brain structures.	[Cardim, Danilo; Donnelly, Joseph; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Robba, Chiara] Cambridge Univ NHS Fdn Trust, Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Robba, Chiara] Univ Genoa, Dept Neurosci, Genoa, Italy; [Schmidt, Bernhard] Univ Hosp Chemnitz, Dept Neurol, Chemnitz, Germany; [Schmidt, Eric A.] Toulouse Purpan Univ Hosp, Unit Neurosurg, Toulouse, France; [Bohdanowicz, Michal; Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Robba, C (corresponding author), Cambridge Univ NHS Fdn Trust, Addenbrookes Hosp, Brain Phys Lab, Neurosci Crit Care Unit,Div Neurosurg, Hills Rd, Cambridge, England.	kiarobba@gmail.com		Cardim, Danilo/0000-0002-9261-1321			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; ABE T, 1984, SURG NEUROL, V22, P477, DOI 10.1016/0090-3019(84)90306-9; Cardim D, 2016, ACTA NEUROCHIR, V158, P279, DOI 10.1007/s00701-015-2661-8; Cardim D, 2017, NEUROCRIT CARE, V26, P330, DOI 10.1007/s12028-016-0356-5; Cardim D, 2016, J NEUROTRAUM, V33, P792, DOI 10.1089/neu.2015.4134; Cardoso E R, 1992, Acta Neurochir Suppl (Wien), V55, P1; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chambers IR, 1998, ACT NEUR S, V71, P42; CONNER ES, 1984, J NEUROSURG, V61, P322, DOI 10.3171/jns.1984.61.2.0322; CORONEOS NJ, 1973, J NEUROL NEUROSUR PS, V36, P514, DOI 10.1136/jnnp.36.4.514; Coroneos NJ, 1972, INTRACRANIAL PRESSUR, P51; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; GAMBARDELLA G, 1992, NEUROSURGERY, V31, P918, DOI 10.1227/00006123-199211000-00014; IANNOTTI F, 1985, J NEUROSURG, V62, P83, DOI 10.3171/jns.1985.62.1.0083; KASUGA Y, 1987, J NEUROSURG, V66, P907, DOI 10.3171/jns.1987.66.6.0907; Kumar A, 2005, J NEUROL NEUROSUR PS, V76, P1570, DOI 10.1136/jnnp.2004.059493; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1986, INTRACRANIAL PRESSUR, P184; MILLER J D, 1987, Neurological Research, V9, P193; MINDERMANN T, 1992, ACTA NEUROCHIR, V116, P60, DOI 10.1007/BF01541255; Mindermann T, 1998, ACT NEUR S, V71, P56; Mindermann T, 1999, J CLIN NEUROSCI, V6, P464, DOI 10.1016/S0967-5868(99)90001-2; NORNES H, 1971, J NEUROSURG, V35, P541, DOI 10.3171/jns.1971.35.5.0541; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Qureshi AI, 1998, ACT NEUR S, V71, P354; Reulen HJ, 1975, INTRACRANIAL PRESSUR, P233; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; SYMON L, 1974, J NEUROL NEUROSUR PS, V37, P617, DOI 10.1136/jnnp.37.6.617; Turner JM, 1975, INTRACRANIAL PRESSUR, P397; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Varsos GV, 2014, NEUROCRIT CARE, V20, P142, DOI 10.1007/s12028-013-9868-4; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; WEAVER DD, 1982, J NEUROSURG, V56, P660, DOI 10.3171/jns.1982.56.5.0660; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolfla CE, 1997, J NEUROSURG, V86, P505, DOI 10.3171/jns.1997.86.3.0505; Wolfla CE, 1996, J NEUROSURG, V84, P642, DOI 10.3171/jns.1996.84.4.0642	42	1	1	1	2	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	AUG	2021	65	4					383	390		10.23736/S0390-5616.19.04604-6			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WA2OC	WOS:000702729800001	30724053	Green Submitted			2022-02-06	
J	Chen, XS; Gao, C; Yan, YN; Cheng, ZQ; Chen, G; Rui, TY; Luo, CL; Gao, Y; Wang, T; Chen, XP; Tao, LY				Chen, Xueshi; Gao, Cheng; Yan, Ya'nan; Cheng, Zhiqi; Chen, Guang; Rui, Tongyu; Luo, Chengliang; Gao, Yuan; Wang, Tao; Chen, Xiping; Tao, Luyang			Ruxolitinib exerts neuroprotection via repressing ferroptosis in a mouse model of traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Ferroptosis; Ruxolitinib; Neuroprotection; Lipid peroxidation	CELL-DEATH; LIPID-PEROXIDATION; COGNITIVE IMPAIRMENT; IN-VITRO; ACTIVATION; ABLATION; CYCLOOXYGENASE-2; INHIBITION; METABOLISM; PYROPTOSIS	Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Various forms of cells death are involved in the pathological process of TBI, without exception to ferroptosis, which is mainly triggered by irondependent lipid peroxidation. Although there have been studies on ferroptosis and TBI, the effect of ruxolitinib (Ruxo), one type of FDA approved drugs for treating myelofibrosis, on the process of ferroptosis post-TBI is remained non-elucidated. Therefore, using a controlled cortical impact device to establish the mouse TBI model, we examined the effect of Ruxo on TBI-induced ferroptosis, in which the inhibitor of ferroptosis, Ferrostatin-1 (Fer-1) was used as a positive control. Moreover, we also respectively explored the effects of these two interventions on neurological deficits caused by TBI. We firstly examined the expression patterns of ferroptosisrelated markers at protein level at different time points after TBI. And based on the expression changes of these markers, we chose 12 h post-TBI to prove the effect of Ruxo on ferroptosis. Importantly, we found the intensely inhibitory effect of Ruxo on ferroptosis, which is in parallel with the results obtained after Fer-1treatment. In addition, these two treatments both alleviated the content of brain water and degree of neurodegeneration in the acute phase of TBI. Finally, we further confirmed the neuroprotective effect of Ruxo or Fer-1 via the wire-grip test, Morris water maze and open field test, respectively. Thereafter, the lesion volume and iron deposition were also measured to certificate their effects on the long-term outcomes of TBI. Our results ultimately demonstrate that inhibiting ferroptosis exerts neuroprotection, and this is another neuroprotective mechanism of Ruxo on TBI.	[Chen, Xueshi; Gao, Cheng; Yan, Ya'nan; Cheng, Zhiqi; Chen, Guang; Rui, Tongyu; Luo, Chengliang; Gao, Yuan; Wang, Tao; Chen, Xiping; Tao, Luyang] Soochow Univ, Affiliated Guangji Hosp, Sch Basic Med & Biol Sci, Dept Forens Med, Suzhou, Peoples R China		Chen, XP; Tao, LY (corresponding author), Soochow Univ, Affiliated Guangji Hosp, Sch Basic Med & Biol Sci, Dept Forens Med, Suzhou, Peoples R China.	xipingchen@suda.edu.cn; taoluyang@suda.edu.cn			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971800, 81871536, 82072110]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the National Nature Science Foundation of China (Nos. 81971800, 81871536, and 82072110) , and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) .	Badgley MA, 2020, SCIENCE, V368, P85, DOI 10.1126/science.aaw9872; Bersuker K, 2019, NATURE, V575, P688, DOI 10.1038/s41586-019-1705-2; Chen B, 2019, BRAIN RES BULL, V153, P122, DOI 10.1016/j.brainresbull.2019.08.013; Chen PH, 2020, CELL DEATH DIFFER, V27, P1008, DOI 10.1038/s41418-019-0393-7; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Feng H, 2020, CELL REP, V30, P3411, DOI 10.1016/j.celrep.2020.02.049; Gao C, 2020, ACS CHEM NEUROSCI, V11, P4231, DOI 10.1021/acschemneuro.0c00517; Gunesch S, 2020, REDOX BIOL, V29, DOI 10.1016/j.redox.2019.101378; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021; Han W, 2014, DEV NEUROSCI-BASEL, V36, P64, DOI 10.1159/000357939; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Ke Y, 2007, PROG NEUROBIOL, V83, P149, DOI 10.1016/j.pneurobio.2007.07.009; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kumagai T, 2004, J BIOL CHEM, V279, P48389, DOI 10.1074/jbc.M409935200; Lang XT, 2019, CANCER DISCOV, V9, P1673, DOI 10.1158/2159-8290.CD-19-0338; Lee H, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0461-8; Li YZ, 2019, J NAT PROD, V82, P1002, DOI 10.1021/acs.jnatprod.9b00145; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mi Z., EXP NEUROL, V336; Miotto G, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101328; Naghavi M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l94; Park UJ, 2011, ACTA NEUROPATHOL, V121, P459, DOI 10.1007/s00401-010-0785-8; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qian ZM, 2019, BIOL REV, V94, P1672, DOI 10.1111/brv.12521; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Reimherr FW, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0859-6; Rui TY, 2021, J PINEAL RES, V70, DOI 10.1111/jpi.12704; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shen ZY, 2018, ACS NANO, V12, P11355, DOI 10.1021/acsnano.8b06201; Shichiri M, 2014, J CLIN BIOCHEM NUTR, V54, P151, DOI 10.3164/jcbn.14-10; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Svensson M, 2016, NEUROBIOL STRESS, V5, P8, DOI 10.1016/j.ynstr.2016.09.002; Tang DL, 2021, CELL RES, V31, P107, DOI 10.1038/s41422-020-00441-1; Tang SC, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.590789; Tuo QZ, 2017, MOL PSYCHIATR, V22, P1520, DOI 10.1038/mp.2017.171; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Ye Q, 2019, AM J TRANSL RES, V11, P875; Yoo SE, 2012, FREE RADICAL BIO MED, V52, P1820, DOI 10.1016/j.freeradbiomed.2012.02.043; Yu YY, 2020, BLOOD, V136, P726, DOI 10.1182/blood.2019002907; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Zilka O, 2017, ACS CENTRAL SCI, V3, P232, DOI 10.1021/acscentsci.7b00028; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609	54	1	1	4	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2021	342								113762	10.1016/j.expneurol.2021.113762			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SN4JI	WOS:000658257300004	33991524				2022-02-06	
J	Ellethy, H; Chandra, SS; Nasrallah, FA				Ellethy, Hanem; Chandra, Shekhar S.; Nasrallah, Fatima A.			The detection of mild traumatic brain injury in paediatrics using artificial neural networks	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Traumatic brain injury; PECARN; Machine learning; Artificial neural network; Random forest; mTBI	HEAD-INJURY; PREDICTION; CHILDREN	Head computed tomography (CT) is the gold standard in emergency departments (EDs) to evaluate mild traumatic brain injury (mTBI) patients, especially for paediatrics. Data-driven models for successfully classifying head CT scans that have mTBI will be valuable in terms of timeliness and cost-effectiveness for TBI diagnosis. This study applied two different machine learning (ML) models to diagnose mTBI in a paediatric population collected as part of the paediatric emergency care applied research network (PECARN) study between 2004 and 2006. The models were conducted using 15,271 patients under the age of 18 years with mTBI and had a head CT report. In the conventional model, random forest (RF) ranked the features to reduce data dimensionality and the top ranked features were used to train a shallow artificial neural network (ANN) model. In the second model, a deep ANN applied to classify positive and negative mTBI patients using the entirety of the features available. The dataset was divided into two subsets: 80% for training and 20% for testing using five-fold cross-validation. Accuracy, sensitivity, precision, and specificity were calculated by comparing the model's prediction outcome to the actual diagnosis for each patient. RF ranked ten clinical demographic features and twelve CT-findings; the hybrid RF-ANN model achieved an average specificity of 99.96%, sensitivity of 95.98%, precision of 99.25%, and accuracy of 99.74% in identifying positive mTBI from negative mTBI subjects. The deep ANN proved its ability to carry out the task efficiently with an average specificity of 99.9%, sensitivity of 99.2%, precision of 99.9%, and accuracy of 99.9%. The performance of the two proposed models demonstrated the feasibility of using ANN to diagnose mTBI in a paediatric population. This is the first study to investigate deep ANN in a paediatric cohort with mTBI using clinical and non-imaging data and diagnose mTBI with balanced sensitivity and specificity using shallow and deep ML models. This method, if validated, would have the potential to reduce the burden of TBI evaluation in EDs and aide clinicians in the decision-making process.	[Ellethy, Hanem; Nasrallah, Fatima A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Chandra, Shekhar S.] Univ Queensland, Sch Informat Technol & Elect Engn, St Lucia, Qld, Australia		Ellethy, H (corresponding author), Queensland Brain Inst, QBI Bldg 79, St Lucia, Qld 4072, Australia.	h.elwaseif@uq.edu.au			HRSA/MCHB/EMSCUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)	This manuscript was prepared using the Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study (STUDY) Data Set obtained from UTAH, and does not necessarily reflect the opinions or views of the STUDY investigators or the Health Resources Services Administration (HRSA) Maternal Child Health Bureau (MCHB) Emergency Medical Services for Children (EMSC). The PECARN was funded by the HRSA/MCHB/EMSC."Manuscripts and meeting abstracts may not use the name of the STUDY in the title, nor may the name of the STUDY or PECARN be included in the byline of the publication.	Alshayeji MH, 2018, COMPUT ELECTR ENG, V71, P191, DOI 10.1016/j.compeleceng.2018.07.020; Badawy MK, 2017, ACAD EMERG MED, V24, P595, DOI 10.1111/acem.13168; Bentley P, 2014, NEUROIMAGE-CLIN, V4, P635, DOI 10.1016/j.nicl.2014.02.003; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Chollet F., 2015, GITHUB REPOSITORY; Chong SL, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0015-0; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; de Sa Claudio Rebelo, 2019, Discovery Science. 22nd International Conference, DS 2019. Proceedings. Lecture Notes in Artificial Intelligence (LNAI 11828), P306, DOI 10.1007/978-3-030-33778-0_24; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Erickson BJ, 2017, RADIOGRAPHICS, V37, P505, DOI 10.1148/rg.2017160130; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Garner R, 2019, 2019 SPRING SIMULATION CONFERENCE (SPRINGSIM); Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Gregorutti B, 2017, STAT COMPUT, V27, P659, DOI 10.1007/s11222-016-9646-1; Guler I, 2009, EXPERT SYST APPL, V36, P10424, DOI 10.1016/j.eswa.2009.01.036; Gupta TK, 2019, MACHINE LEARNING IN BIO-SIGNAL ANALYSIS AND DIAGNOSTIC IMAGING, P159, DOI 10.1016/B978-0-12-816086-2.00007-2; Hale AT, 2019, J NEUROSURG-PEDIATR, V23, P219, DOI 10.3171/2018.8.PEDS18370; Hale AT, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS17773; Hassanipour S, 2019, INJURY, V50, P244, DOI 10.1016/j.injury.2019.01.007; Ibrahim H, 2019, INTELLIGENT MANUFACT, P12; Kashyap H., 2015, ARXIV PREPRINT ARXIV; Kibria MG, 2018, IEEE ACCESS, V6, P32328, DOI 10.1109/ACCESS.2018.2837692; Klement W, 2012, ARTIF INTELL MED, V54, P163, DOI 10.1016/j.artmed.2011.11.005; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; L'Heureux A, 2017, IEEE ACCESS, V5, P7776, DOI 10.1109/ACCESS.2017.2696365; Landry AP, 2019, J NEUROSURG, V131, P1235, DOI 10.3171/2018.6.JNS18607; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; Liu WB, 2017, NEUROCOMPUTING, V234, P11, DOI 10.1016/j.neucom.2016.12.038; Lu HY, 2015, J MED SYST, V39, DOI 10.1007/s10916-014-0187-x; Matsuo K, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6276; McNerney MW, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0187-y; Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548; Mhaskar H, 2017, THIRTY-FIRST AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2343; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Molaei S, 2016, IEEE ENG MED BIO, P2258, DOI 10.1109/EMBC.2016.7591179; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Patel UK, 2021, J NEUROL, V268, P1623, DOI 10.1007/s00415-019-09518-3; Peterson AB, 2014, SURVEILLANCE REPORT; Pourahmad S, 2016, METHOD INFORM MED, V55, P440, DOI 10.3414/ME15-01-0080; Power M. D., 2011, J MACH LEARN TECHNOL, V2, P37, DOI DOI 10.1038/S41598-021-86101-9; Qi YJ, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P307, DOI 10.1007/978-1-4419-9326-7_11; Rajkomar A, 2019, NEW ENGL J MED, V380, P1347, DOI 10.1056/NEJMra1814259; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Rughani AI, 2010, J NEUROSURG, V113, P585, DOI 10.3171/2009.11.JNS09857; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tang J, 2014, DATA CLASSIFICATION, P37, DOI 10.1201/b17320; Tolpadi AA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63395-9; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; Vergara VM, 2018, NEUROIMAGE-CLIN, V19, P30, DOI 10.1016/j.nicl.2018.03.017; Zhou QF, 2016, KNOWL-BASED SYST, V95, P1, DOI 10.1016/j.knosys.2015.11.010	58	1	1	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	AUG	2021	135								104614	10.1016/j.compbiomed.2021.104614			9	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	UE5WT	WOS:000687958800004	34229143				2022-02-06	
J	Fokin, A; Wycech, J; Shue, KC; Stalder, R; Lozada, J; Puente, I				Fokin, Alexander; Wycech, Joanna; Shue, Kyle Chin; Stalder, Ryan; Lozada, Jose; Puente, Ivan			Tracheostomy in trauma patients with rib fractures	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Tracheostomy; Rib fractures; Chest trauma; Rib fracture scoring systems	FLAIL CHEST INJURIES; SURGICAL STABILIZATION; MORTALITY; OUTCOMES; MORBIDITY	Purpose Patients with rib fractures (RF) may require prolonged mechanical ventilation and tracheostomy. Indications for tracheostomy in trauma patients with RF remain debatable. The goal was to delineate characteristics of patients who underwent tracheostomy due to thoracic versus extra-thoracic causes, such as maxillofacial-mandibular injury (MFM), traumatic brain injury (TBI), and cervical vertebrae trauma (CVT), and to analyze clinical outcomes. The predictive values of chest trauma scoring systems for tracheostomy were also evaluated. We hypothesized that tracheostomized patients were more severely injured with more ribs fractured and had more pulmonary co-injuries. Methods Retrospective review included 471 patients with RF admitted to two Level 1 trauma centers. Patients with tracheostomy (n = 124, 26.3%) were compared to patients with endotracheal intubation (n = 347, 73.7%). Analyzed variables included age, gender, injury severity score (ISS), Glasgow Coma Scale, number of ribs fractured, total fractures of ribs, prevalence of bilateral rib fractures, flail chest, clavicle fractures, MFM, TBI, CVT, co-injuries, comorbidities, RF treatment options, hospital length of stay (HLOS), intensive care unit LOS (ICULOS), duration of mechanical ventilation (DMV). Results Tracheostomized compared to intubated patients had statistically higher ISS, more ribs fractured, total fractures of the ribs, bilateral and clavicle fractures, MFM, spine, chest, and orthopedic co-injuries and longer HLOS, ICULOS and DMV. Tracheostomy for thoracic reasons was performed in 64 patients (51.6%) and for extra-thoracic reasons in 60 patients (48.4%). Mean tracheostomy timing was 9.9 days and was significantly shorter in the extra-thoracic compared to the thoracic group (8.0 versus 11.6 days, p < 0.001). All chest trauma scoring system values were significantly higher in tracheostomized patients. Predictive values of scoring systems for tracheostomy increased in patients with thoracic trauma only. Conclusions A quarter of mechanically ventilated patients with RF required tracheostomy. Tracheostomized compared to intubated patients were more severely injured with more ribs fractured and were intubated longer. An increased amount of RF was associated with an increase in tracheostomies, especially for thoracic reasons.	[Fokin, Alexander; Wycech, Joanna; Puente, Ivan] Delray Med Ctr, Div Trauma & Crit Care Serv, 5352 Linton Blvd, Delray Beach, FL 33484 USA; [Wycech, Joanna; Lozada, Jose; Puente, Ivan] Broward Hlth Med Ctr, Div Trauma & Crit Care Serv, 1600 S Andrews Ave, Ft Lauderdale, FL 33316 USA; [Shue, Kyle Chin; Puente, Ivan] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Surg, 777 Glades Rd, Boca Raton, FL 33431 USA; [Puente, Ivan] Florida Int Univ, Herbert Wertheim Coll Med, Dept Surg, 11200 SW 8th St, Miami, FL 33199 USA; [Stalder, Ryan] Wake Forest Univ, 1834 Wake Forest Rd, Winston Salem, NC 27109 USA		Fokin, A (corresponding author), Delray Med Ctr, Div Trauma & Crit Care Serv, 5352 Linton Blvd, Delray Beach, FL 33484 USA.	Alexander.Fokin@tenethealth.com	Wycech, Joanna/AAC-1162-2019	Wycech, Joanna/0000-0002-8869-8575			Alsherbini K, 2019, NEUROCRIT CARE, V30, P185, DOI 10.1007/s12028-018-0596-7; Althausen PL, 2011, J ORTHOP TRAUMA, V25, P641, DOI 10.1097/BOT.0b013e318234d479; Arabi Y, 2004, CRIT CARE, V8, pR347, DOI 10.1186/cc2924; Battle CE, 2012, INJURY, V43, P8, DOI 10.1016/j.injury.2011.01.004; Beks RB, 2019, EUR J TRAUMA EMERG S, V45, P631, DOI 10.1007/s00068-018-1020-x; Casamento A, 2018, J CRIT CARE, V44, P278, DOI 10.1016/j.jcrc.2017.11.034; Chapman BC, 2016, J TRAUMA ACUTE CARE, V80, P95, DOI 10.1097/TA.0000000000000867; Chelluri L, 2002, CHEST, V121, P549; Chen J, 2014, SURGERY, V156, P988, DOI 10.1016/j.surg.2014.06.045; Dehghan N, 2018, J ORTHOP TRAUMA, V32, P15, DOI 10.1097/BOT.0000000000000992; Dehghan N, 2014, J TRAUMA ACUTE CARE, V76, P462, DOI 10.1097/TA.0000000000000086; Easter, 2001, AM J CRIT CARE, V10, P320, DOI [10.4037/ajcc2001.10.5.320, DOI 10.4037/AJCC2001.10.5.320, DOI 10.4037/ajcc2001.10.5.320]; Emond M, 2015, ANN SURG, V262, P1115, DOI 10.1097/SLA.0000000000000952; Flagel BT, 2005, SURGERY, V138, P717, DOI 10.1016/j.surg.2005.07.022; Flores-Funes D, 2020, EUR J TRAUMA EMERG S, V46, P435, DOI 10.1007/s00068-018-1012-x; Fokin A, 2018, J SURG RES, V229, P1, DOI 10.1016/j.jss.2018.03.025; Fokin A, 2018, J ORTHOP TRAUMA, V32, P391, DOI 10.1097/BOT.0000000000001189; Fokin AA, 2019, J ORTHOP TRAUMA, V33, P3, DOI 10.1097/BOT.0000000000001330; Jones KM, 2011, AM J SURG, V202, P598, DOI 10.1016/j.amjsurg.2010.09.029; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Kane ED, 2018, J AM COLL SURGEONS, V226, P961, DOI 10.1016/j.jamcollsurg.2017.11.008; Miller C, 2019, AM J SURG, V218, P51, DOI 10.1016/j.amjsurg.2019.01.027; Pieracci FM, 2017, INJURY, V48, P307, DOI 10.1016/j.injury.2016.11.026; Pressley CM, 2012, AM J SURG, V204, P910, DOI 10.1016/j.amjsurg.2012.05.015; Shulzhenko NO, 2017, SURGERY, V161, P1083, DOI 10.1016/j.surg.2016.10.018; Sirmali M, 2003, EUR J CARDIO-THORAC, V24, P133, DOI 10.1016/S1010-7940(03)00256-2; Stahl Daniel, 2017, J Orthop Trauma, V31, P225, DOI 10.1097/BOT.0000000000000758; ZIEGLER DW, 1994, J TRAUMA, V37, P975, DOI 10.1097/00005373-199412000-00018	28	1	1	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2021	47	4			SI		965	974		10.1007/s00068-019-01149-7			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TS1QF	WOS:000679431900011	31119319	Bronze			2022-02-06	
J	Garcia, D; Rodriguez, GM; Lorenzo, NE; Coto, J; Blizzard, A; Farias, A; Smith, NDW; Kuluz, J; Bagner, DM				Garcia, Dainelys; Rodriguez, Gabriela M.; Lorenzo, Nicole E.; Coto, Jennifer; Blizzard, Angela; Farias, Alina; Smith, Nicholas David W.; Kuluz, John; Bagner, Daniel M.			Intensive Parent-Child Interaction Therapy for Children with Traumatic Brain Injury: Feasibility Study	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						accidents and injuries; behavior problems; evidence-based practice; parenting; parents	EXTERNALIZING BEHAVIOR PROBLEMS; RANDOMIZED-TRIAL; SKILL ACQUISITION; EFFICACY; RISK; INTERVENTION; PREDICTORS; OUTCOMES; IMPLEMENTATION; FAMILIES	Objective This study examined the feasibility and initial outcome of a time-limited and intensive format of Parent-Child Interaction Therapy (PCIT) for families of young children who have sustained a traumatic brain injury (TBI). Methods The nonrandomized open trial included 15 families with a child aged 2-5 years who had sustained a TBI and displayed clinically elevated levels of externalizing behavior problems. Families received clinic-based PCIT twice per week over an average of 6 weeks, with the exception of two families that received the same intensity and format of PCIT in the home. Results Ten of the 14 families who completed the baseline assessment (71%) completed the intervention and post and follow-up assessments. On average, caregivers completed homework practice on 52% of the days in between sessions. Caregivers reported high acceptability and satisfaction following the intervention, as well as decreases in child externalizing and internalizing behavior problems at the post-assessment and 2-month follow-up. Conclusions Results of this open trial provide preliminary support for the feasibility of a time-limited and intensive format of PCIT for families of young children who have sustained a TBI and have elevated levels of behavior problems. This study highlights a promising intervention approach for improving domains commonly affected by early childhood TBI and preventing the development of more severe and persistent problems.	[Garcia, Dainelys; Coto, Jennifer; Blizzard, Angela] Univ Miami, Miller Sch Med, Dept Pediat, 1601 NW 12th Ave, Miami, FL 33137 USA; [Rodriguez, Gabriela M.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN USA; [Lorenzo, Nicole E.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Farias, Alina] Nova Southeastern Univ, Coll Psychol, Ft Lauderdale, FL 33314 USA; [Smith, Nicholas David W.] Univ S Florida, Dept Psychol, Tampa, FL USA; [Kuluz, John] Nicklaus Childrens Hosp, Dept Pediat Neurosurg, Miami, FL USA; [Bagner, Daniel M.] Florida Int Univ, Dept Psychol, Miami, FL 33199 USA		Garcia, D (corresponding author), Univ Miami, Miller Sch Med, Dept Pediat, 1601 NW 12th Ave, Miami, FL 33137 USA.	ngarcia09@med.miami.edu	Lorenzo, Nicole/L-9716-2019	Lorenzo, Nicole/0000-0002-0799-3119; Rodriguez, Gabriela/0000-0003-4421-5372			Achenbach T. M., 2000, ASEBA PRESCHOOL FORM; Agnafors S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09283-3; Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Bagner DM, 2016, J ABNORM CHILD PSYCH, V44, P901, DOI 10.1007/s10802-015-0089-5; Bagner DM, 2016, BEHAV THER, V47, P184, DOI 10.1016/j.beth.2015.11.001; Bagner DM, 2013, COGN BEHAV PRACT, V20, P334, DOI 10.1016/j.cbpra.2012.08.001; Bagner DM, 2010, J DEV BEHAV PEDIATR, V31, P209, DOI 10.1097/DBP.0b013e3181d5a294; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Brestan EV, 1999, BEHAV THER, V30, P17, DOI 10.1016/S0005-7894(99)80043-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Cohen ML, 2012, J PEDIATR PSYCHOL, V37, P251, DOI 10.1093/jpepsy/jsr086; Comer JS, 2017, J CONSULT CLIN PSYCH, V85, P909, DOI 10.1037/ccp0000230; EISENSTADT TH, 1993, J CLIN CHILD PSYCHOL, V22, P42, DOI 10.1207/s15374424jccp2201_4; Eyberg S. M, 1993, INNOVATIONS CLIN PRA, V12, P380; Eyberg S. M., 2005, MANUAL DYADIC PARENT; Eyberg S. M., 2011, PARENT CHILD INTERAC; EYBERG SM, 1980, J CLIN PSYCHOL, V36, P492, DOI 10.1002/jclp.6120360218; Faul M, 2010, TRAUMATIC BRAIN INJU; Garcia D., 2016, EVIDENCEBASED PRACTI, V1, P40, DOI [10.1080/23794925.2016.1191977, DOI 10.1080/23794925.2016.1191977]; Garcia D, 2015, J CLIN CHILD ADOLESC, V44, P814, DOI 10.1080/15374416.2014.900718; Graziano PA, 2020, J CONSULT CLIN PSYCH, V88, P669, DOI 10.1037/ccp0000504; Graziano PA, 2015, J PSYCHOPATHOL BEHAV, V37, P38, DOI 10.1007/s10862-014-9435-0; Gross D, 2007, RES NURS HEALTH, V30, P213, DOI 10.1002/nur.20181; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kaminski JW, 2017, J CLIN CHILD ADOLESC, V46, P477, DOI 10.1080/15374416.2017.1310044; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; La Greca AM, 2009, J CONSULT CLIN PSYCH, V77, P373, DOI 10.1037/a0015954; Lyon AR, 2010, J CHILD FAM STUD, V19, P654, DOI 10.1007/s10826-010-9353-z; McCabe KM, 2020, PSYCHOL RES BEHAV MA, V13, P41, DOI 10.2147/PRBM.S230005; McHugh RK, 2010, AM PSYCHOL, V65, P73, DOI 10.1037/a0018121; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Narad ME, 2017, DIGIT HEALTH, V3, DOI 10.1177/2055207617719423; Nixon RDV, 2003, J CONSULT CLIN PSYCH, V71, P251, DOI 10.1037/0022-006X.71.2.251; Pincus, 1999, EYBERG CHILD BEHAV I; Pons J. I. J. I. J. I., 2008, REV PUERTORRIQUENA P, V19, P75; Ramos G, 2018, J CHILD FAM STUD, V27, P268, DOI 10.1007/s10826-017-0881-7; REIMERS TM, 1991, CHILD FAM BEHAV THER, V13, P53, DOI 10.1300/J019v13n02_04; Reyno SM, 2006, J CHILD PSYCHOL PSYC, V47, P99, DOI 10.1111/j.1469-7610.2005.01544.x; Ros R, 2016, BEHAV THER, V47, P1, DOI 10.1016/j.beth.2015.08.004; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Schuhmann EM, 1998, J CLIN CHILD PSYCHOL, V27, P34, DOI 10.1207/s15374424jccp2701_4; Shanley JR, 2010, J CLIN CHILD ADOLESC, V39, P282, DOI 10.1080/15374410903532627; Stokes JO, 2016, BEHAV THER, V47, P538, DOI 10.1016/j.beth.2016.04.004; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Vella K., 2007, BRIT J OCCUPATIONAL, V70, P154, DOI [https://doi.org/10.1177/030802260707000404, DOI 10.1177/030802260707000404]; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wechsler D., 2012, WECHSLER PRESCHOOL P; Wechsler D., 2011, WECHSLER ABBREVIATED; Williams TS, 2018, BRAIN INJURY, V32, P1386, DOI 10.1080/02699052.2018.1495844; Woods D. T., 2014, SOCIAL CARE NEURODIS, V5, P145, DOI 1108/SCN-03-2013-0006; Woods DT, 2012, NEUROREHABILITATION, V30, P189, DOI 10.3233/NRE-2012-0744; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zisser A., 2010, EVIDENCE BASED PSYCH, V2nd, P179, DOI DOI 10.1111/J.1467-8624.2010.01548.X	61	1	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	AUG	2021	46	7					844	855		10.1093/jpepsy/jsab040			12	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	WQ3BI	WOS:000713693800013	34015114				2022-02-06	
J	Haselmann, V; Schamberger, C; Trifonova, F; Ast, V; Froelich, MF; Strauss, M; Kittel, M; Jaruschewski, S; Eschmann, D; Neumaier, M; Neumaier-Probst, E				Haselmann, Verena; Schamberger, Christian; Trifonova, Feodora; Ast, Volker; Froelich, Matthias F.; Strauss, Maximilian; Kittel, Maximilian; Jaruschewski, Sabine; Eschmann, David; Neumaier, Michael; Neumaier-Probst, Eva			Plasma-based S100B testing for management of traumatic brain injury in emergency setting	PRACTICAL LABORATORY MEDICINE			English	Article						S100B; Traumatic brain injury; Mild traumatic brain injury; Mild head injury; Serum biomarker; Plasma; Integrated diagnostics	CT HEAD RULE; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; SERUM-LEVELS; PROTEIN; S-100B; BIOMARKERS; DAMAGE; ADULT	Background: Serum biomarker S100B has been explored for its potential benefit to improve clinical decision-making in the management of patients suffering from traumatic brain injury (TBI), especially as a pre-head computed-tomography screening test for patients with mild TBI. Although being already included into some guidelines, its implementation into standard care is still lacking. This might be explained by a turnaround time (TAT) too long for serum S100B to be used in clinical decision-making in emergency settings. Methods: S100B concentrations were determined in 136 matching pairs of serum and lithium heparin blood samples. The concordance of the test results was assessed by linear regression, Passing Pablok regression and Bland-Altman analysis. Bias and within- and between-run imprecision were determined by a 5 x 4 model using pooled patient samples. CT scans were performed as clinically indicated. Results: Overall, S100B levels between both blood constituents correlated very well. The suitability of S100B testing from plasma was verified according to ISO15189 requirements. Using a cut-off of 0.105 ng/ml, a sensitivity and negative predictive value of 100% were obtained for identifying patients with pathologic CT scans. Importantly, plasma-based testing reduced the TAT to 26 min allowing for quicker clinical decision-making. The clinical utility of integrating S100B in TBI management is highlighted by two case reports. Conclusions: Plasma-based S100B testing compares favorably with serum-based testing, substantially reducing processing times as the prerequisite for integrating S100B level into management of TBI patients. The proposed new clinical decision algorithm for TBI management needs to be validated in further prospective large-scale studies.	[Haselmann, Verena; Trifonova, Feodora; Ast, Volker; Strauss, Maximilian; Kittel, Maximilian; Neumaier, Michael] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Dept Clin Chem, Mannheim, Germany; [Schamberger, Christian; Eschmann, David] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Orthopaed Trauma Surg Ctr, Mannheim, Germany; [Froelich, Matthias F.] Heidelberg Univ, Univ Med Mannheim, Inst Clin Radiol & Nucl Med, Med Fac Mannheim, Mannheim, Germany; [Jaruschewski, Sabine] RWTH Univ Hosp Aachen, Lab Diagnost Ctr, Aachen, Germany; [Neumaier-Probst, Eva] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Dept Neuroradiol, Mannheim, Germany		Haselmann, V (corresponding author), Univ Med Ctr, Dept Clin Chem, Mannheim, Germany.	verena.haselmann@umm.de		Haselmann, Verena/0000-0002-8380-6581; Froelich, Matthias/0000-0001-8501-2147			[Anonymous], 2014, HEAD INJURY ASSESSME; Biberthaler P, 2002, EUR J MED RES, V7, P164; Cadamuro J, 2018, BIOCHEM MEDICA, V28, DOI 10.11613/BM.2018.010704; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cervellin G, 2012, CLIN BIOCHEM, V45, P408, DOI 10.1016/j.clinbiochem.2012.01.006; David A, 2017, DIAGN INTERV IMAG, V98, P551, DOI 10.1016/j.diii.2017.03.010; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Dummer R, 2010, ANN ONCOL, V21, pv194, DOI 10.1093/annonc/mdq188; Evans LR, 2017, POSTGRAD MED J, V93, P454, DOI 10.1136/postgradmedj-2016-134491; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Geyer LL, 2013, ACTA RADIOL, V54, P592, DOI 10.1177/0284185113475443; Gogas H, 2009, ANN ONCOL, V20, P8, DOI 10.1093/annonc/mdp251; Haeckel R, 2015, CLIN CHEM LAB MED, V53, P1161, DOI 10.1515/cclm-2014-0874; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Lippi Giuseppe, 2013, Recenti Progressi in Medicina, V104, P120, DOI 10.1701/1255.13861; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Moller MF, 2017, ANN CLIN BIOCHEM, V54, P593, DOI 10.1177/0004563216674030; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Ruan S, 2009, J NEUROTRAUM, V26, P1655, DOI 10.1089/neu.2009-0928; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stollhof LE, 2020, Z ORTHOP UNFALLCHIR, V158, P201, DOI 10.1055/a-0929-7820; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Tort ABL, 2003, CLIN BIOCHEM, V36, P629, DOI 10.1016/S0009-9120(03)00107-3; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Vedin T, 2021, EUR J TRAUMA EMERG S, V47, P1451, DOI 10.1007/s00068-019-01145-x; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	37	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2352-5517		PRACT LAB MED	Pract. Lab. Med.	AUG	2021	26								e00236	10.1016/j.plabm.2021.e00236			10	Medical Laboratory Technology	Emerging Sources Citation Index (ESCI)	Medical Laboratory Technology	UX0CT	WOS:000700517800005	34041343	Green Published, gold			2022-02-06	
J	Howell, DR; Seehusen, CN; Wingerson, MJ; Wilson, JC; Lynall, RC; Lugade, V				Howell, David R.; Seehusen, Corrine N.; Wingerson, Mathew J.; Wilson, Julie C.; Lynall, Robert C.; Lugade, Vipul			Reliability and Minimal Detectable Change for a Smartphone-Based Motor-Cognitive Assessment: Implications for Concussion Management	JOURNAL OF APPLIED BIOMECHANICS			English	Article						locomotion; dual-task; mobile assessment; accelerometer; mild traumatic brain injury; adolescent	TEST-RETEST RELIABILITY; TANDEM GAIT TEST; CONCURRENT VALIDITY; CONTROL DEFICITS; ADOLESCENTS; BALANCE; HEALTHY; RISK	Our purpose was to investigate the reliability and minimal detectable change characteristics of a smartphone-based assessment of single- and dual-task gait and cognitive performance. Uninjured adolescent athletes (n = 17; mean age = 16.6, SD = 1.3 y; 47% female) completed assessments initially and again 4 weeks later. The authors collected data via an automated smartphone-based application while participants completed a series of tasks under (1) single-task cognitive, (2) single-task gait, and (3) dual-task cognitive-gait conditions. The cognitive task was a series of continuous auditory Stroop cues. Average gait speed was consistent between testing sessions in single-task (0.98, SD = 0.21 vs 0.96, SD = 0.19 m/s; P = .60; r = .89) and dual-task (0.92, SD = 0.22 vs 0.89, SD = 0.22 m/s; P =.37; r =.88) conditions. Response accuracy was moderately consistent between assessments in singletask standing (82.3% accurate, SD = 17.9% vs 84.6% accurate, SD = 20.1%; P =.64; r = .52) and dual-task gait (89.4% accurate, SD = 15.9% vs 85.8% accurate, SD = 20.2%; P =.23; r = .81) conditions. Our results indicate automated motor-cognitive dualtask outcomes obtained within a smartphone-based assessment are consistent across a 1-month period. Further research is required to understand how this assessment performs in the setting of sport-related concussion. Given the relative reliability of values obtained, a smartphone-based evaluation may be considered for use to evaluate changes across time among adolescents, postconcussion.	[Howell, David R.; Seehusen, Corrine N.; Wingerson, Mathew J.; Wilson, Julie C.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Howell, David R.; Wilson, Julie C.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA; [Wilson, Julie C.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA; [Lugade, Vipul] Control One LLC, Atlanta, GA USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA.	David.Howell@CUAnschutz.edu	; Lynall, Robert/M-2888-2014	Howell, David/0000-0002-2955-0191; Lugade, Vipul/0000-0001-7226-6260; Lynall, Robert/0000-0002-0785-6640	Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; MINDSOURCE Brain Injury Network; Department of DefenseUnited States Department of Defense; National Operating Committee on Standards for Athletic Equipment; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952]	Research reported in this work was supported by the National Institute of Neurological Disorders and Stroke (R43NS108823Unrelated to this study, Dr D.R.H. has received research support from the National Institute of Neurological Disorders and Stroke (R01NS100952), the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560), and MINDSOURCE Brain Injury Network. Dr V.L. is the CEO of Control One LLC. Dr R.C.L. has received research support from the Department of Defense and National Operating Committee on Standards for Athletic Equipment. The remaining authors have no conflicts to disclose.	Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Brilliant AN, 2021, CLIN J SPORT MED, V31, P442, DOI 10.1097/JSM.0000000000000779; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Chakravorty A, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2663-4; Dugan EL, 2021, GAIT POSTURE, V83, P262, DOI 10.1016/j.gaitpost.2020.10.004; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Howell DR, 2019, J ATHL TRAINING, V54, P1254, DOI 10.4085/1062-6050-525-18; Howell DR, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab3552; Howell DR, 2020, PHYSICIAN SPORTSMED, V48, P75, DOI 10.1080/00913847.2019.1632155; Howell DR, 2021, CLIN J SPORT MED, V31, P133, DOI 10.1097/JSM.0000000000000722; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Johnson RS, 2021, J SPORT REHABIL, V30, P525, DOI 10.1123/jsr.2020-0080; Joseph ALC, 2021, PM&R, V13, P870, DOI 10.1002/pmrj.12478; Kuo AD, 2010, PHYS THER, V90, P157, DOI 10.2522/ptj.20090125; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; Lugade V, 2017, GAIT ANAL GAIT ANAL; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P377, DOI 10.1080/13803395.2017.1353590; Messerschmidt EL, 2021, J SPORT REHABIL, V30, P988, DOI 10.1123/jsr.2019-0331; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Ries JD, 2009, PHYS THER, V89, P569, DOI 10.2522/ptj.20080258; Safrit M. J., 1995, INTRO MEASUREMENT PH, V3rd; Silsupadol P, 2017, GAIT POSTURE, V58, P516, DOI 10.1016/j.gaitpost.2017.09.030; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Siu KC, 2008, AGING CLIN EXP RES, V20, P349, DOI 10.1007/BF03324867; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Van Deventer KA, 2021, J SPORT HEALTH SCI, V10, P131, DOI 10.1016/j.jshs.2020.08.005; Wingerson Mathew J, 2020, J Athl Train, DOI 10.4085/323-20; Wood TA, 2019, AM J PHYS MED REHAB, V98, P566, DOI 10.1097/PHM.0000000000001152; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	42	1	1	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	AUG	2021	37	4					380	387		10.1123/jab.2020-0391			8	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	TW6PI	WOS:000682518900013	34257159				2022-02-06	
J	Karr, JE; Garcia-Barrera, MA; Marsh, JM; Maxwell, BA; Berkner, PD; Iverson, GL				Karr, Justin E.; Garcia-Barrera, Mauricio A.; Marsh, Jacqueline M.; Maxwell, Bruce A.; Berkner, Paul D.; Iverson, Grant L.			Preseason Baseline Neurocognitive Performances and Symptom Reporting on Immediate Post-Concussion Assessment and Cognitive Testing: A Comparison of Adolescent Student-Athletes Tested in Spanish and English	JOURNAL OF ATHLETIC TRAINING			English	Article						cross-cultural comparison; neuropsychology; sports; concussion; postconcussion syndrome	EFFECT SIZE; ACCULTURATION; LANGUAGE; ASSOCIATION; EDUCATION; SCORES; IMPACT	Context: Student-athletes are commonly administered the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery at preseason baseline and postconcussion. The ImPACT is available in many languages, but few researchers have examined differences in cognitive performances and symptom ratings based on the language of administration. Objective: To examine differences in ImPACT neurocognitive composites and symptom reporting at preseason baseline testing between student-athletes who completed ImPACT in Spanish versus English. Design: Cross-sectional study. Setting: Preseason baseline testing for a high school concussion-management program in Maine. Patients or Other Participants: Adolescent student-athletes who completed testing in Spanish (n = 169) and English (n = 169) were matched on age, gender, and health and academic history. Language groups were compared on each outcome for the full sample and for gender-stratified subsamples. Main Outcome Measure(s): Neurocognitive composite scores and individual and total symptom severity ratings from the ImPACT battery. Results: Athletes tested in Spanish displayed lower levels of neurocognitive performance on 2 of 5 composite scores (visual motor speed: P,.001, d = 0.51; reaction time: P = .004, d = 0.33) and reported greater symptom severity (P,.001, r = 0.21). When the analyses were stratified by gender, similar visual motor speed differences were observed between language groups among boys (P =.001, d = 0.49) and girls (P = .001, d = 0.49), whereas reaction time showed a larger group difference for boys (P = .012, d = 0.42) than for girls (P = .128, d = 0.21). Language-group differences in symptom reporting were similar for boys (P = .003, r = 0.22) and girls (P = .008, r = 0.21), with more frequent endorsement of physical and affective symptoms by athletes tested in Spanish. Conclusions: Language-group differences in total symptom severity were small (r = 0.21) and in neurocognitive performances were small to medium (d = 0.05-0.51). Versus previous authors who compared athletes tested in Spanish and English with ImPACT, we observed smaller effects, which may be attributable to close matching on variables related to neurocognitive performances and symptom reporting.	[Karr, Justin E.] Univ Kentucky, Dept Psychol, 171 Funkhouser Dr,012D Kastle Hall, Lexington, KY 40506 USA; [Garcia-Barrera, Mauricio A.] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Marsh, Jacqueline M.] Harvard Med Sch, Dept Psychiat, Charlestown, MA USA; [Marsh, Jacqueline M.] Massachusetts Gen Hosp, Charlestown, MA USA; [Marsh, Jacqueline M.] Home Base, Charlestown, MA USA; [Maxwell, Bruce A.] Colby Coll, Dept Comp Sci, Waterville, ME USA; [Berkner, Paul D.] Univ New England, Coll Osteopath Med, Hlth Serv, Biddeford, ME USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children Sports Concuss Program, Boston, MA USA		Karr, JE (corresponding author), Univ Kentucky, Dept Psychol, 171 Funkhouser Dr,012D Kastle Hall, Lexington, KY 40506 USA.	jkarr@uky.edu	Garcia-Barrera, Mauricio A./AAO-9757-2021	Garcia-Barrera, Mauricio A./0000-0002-4302-4964; Karr, Justin/0000-0003-3653-332X			[Anonymous], 2011, IMM POSTC ASS COGN T; Arnold B. R., 1994, ASSESSMENT, V1, P239, DOI DOI 10.1177/107319119400100303; Bauer AM, 2012, GEN HOSP PSYCHIAT, V34, P323, DOI 10.1016/j.genhosppsych.2012.02.007; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Casaletto KB, 2016, J INT NEUROPSYCH SOC, V22, P364, DOI 10.1017/S135561771500137X; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D; Coffey DM, 2005, ARCH CLIN NEUROPSYCH, V20, P795, DOI 10.1016/j.acn.2005.04.009; Cohen J., 2013, STAT POWER ANAL BEHA; Cook NE, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00002; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Diaz-Venegas C., 2019, CONTEXTUALIZING HLTH, P85, DOI DOI 10.1007/978-3-030-00584-9_5; Duggan EC, 2019, ARCH CLIN NEUROPSYCH, V34, P657, DOI 10.1093/arclin/acy074; Escobar JI, 2010, J PSYCHOSOM RES, V69, P1, DOI 10.1016/j.jpsychores.2010.01.001; Escovar EL, 2018, J ANXIETY DISORD, V55, P39, DOI 10.1016/j.janxdis.2018.03.005; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Iverson GL, 2021, APPL NEUROPSYCH-CHIL, DOI 10.1080/21622965.2021.1881897; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jones NS, 2014, CLIN J SPORT MED, V24, P284, DOI 10.1097/JSM.0000000000000031; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; Ott S, 2014, ARCH CLIN NEUROPSYCH, V29, P152, DOI 10.1093/arclin/act091; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; Ryan C., 2010, LANGUAGE USE US 2011; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P894, DOI 10.1007/s40615-017-0437-y	28	1	1	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2021	56	8					879	886		10.4085/1062-6050-0345.20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TZ6NS	WOS:000684588100011	33237992	gold			2022-02-06	
J	Kelley, ME; Urban, JE; Jones, DA; Davenport, EM; Miller, LE; Snively, BM; Powers, AK; Whitlow, CT; Maldjian, JA; Stitzel, JD				Kelley, Mireille E.; Urban, Jillian E.; Jones, Derek A.; Davenport, Elizabeth M.; Miller, Logan E.; Snively, Beverly M.; Powers, Alexander K.; Whitlow, Christopher T.; Maldjian, Joseph A.; Stitzel, Joel D.			Analysis of longitudinal head impact exposure and white matter integrity in returning youth football players	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						diffusion tensor imaging; head acceleration; risk-weighted cumulative exposure; biomechanics; head impact frequency; trauma	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL FOOTBALL; BRAIN-INJURY; LATER-LIFE; CONCUSSION; CONNECTIVITY; SEASON; AGE	OBJECTIVE The objective of this study was to characterize changes in head impact exposure (HIE) across multiple football seasons and to determine whether changes in HIE correlate with changes in imaging metrics in youth football players. METHODS On-field head impact data and pre-and postseason imaging data, including those produced by diffusion tensor imaging (DTI), were collected from youth football athletes with at least two consecutive seasons of data. ANCOVA was used to evaluate HIE variations (number of impacts, peak linear and rotational accelerations, and risk-weighted cumulative exposure) by season number. DTI scalar metrics, including fractional anisotropy, mean diffusivity, and linear, planar, and spherical anisotropy coefficients, were evaluated. A control group was used to determine the number of abnormal white matter voxels, which were defined as 2 standard deviations above or below the control group mean. The difference in the number of abnormal voxels between consecutive seasons was computed for each scalar metric and athlete. Linear regression analyses were performed to evaluate relationships between changes in HIE metrics and changes in DTI scalar metrics. RESULTS There were 47 athletes with multiple consecutive seasons of HIE, and corresponding imaging data were available in a subsample (n = 19) of these. Increases and decreases in HIE metrics were observed among individual athletes from one season to the next, and no significant differences (all p > 0.05) in HIE metrics were observed by season number. Changes in the number of practice impacts, 50th percentile impacts per practice session, and 50th percentile impacts per session were significantly positively correlated with changes in abnormal voxels for all DTI metrics. CONCLUSIONS These results demonstrate a significant positive association between changes in HIE metrics and changes in the numbers of abnormal voxels between consecutive seasons of youth football. Reducing the number and frequency of head impacts, especially during practice sessions, may decrease the number of abnormal imaging findings from one season to the next in youth football.	[Kelley, Mireille E.; Urban, Jillian E.; Jones, Derek A.; Miller, Logan E.; Whitlow, Christopher T.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA; [Snively, Beverly M.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27101 USA; [Powers, Alexander K.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC 27101 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol Neuroradiol, Winston Salem, NC 27101 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Clin & Translat Sci Inst, Winston Salem, NC 27101 USA; [Kelley, Mireille E.; Urban, Jillian E.; Jones, Derek A.; Miller, Logan E.; Stitzel, Joel D.] Virginia Tech, Wake Forest Sch Biomed Engn & Sci, Winston Salem, NC 27101 USA; [Davenport, Elizabeth M.; Maldjian, Joseph A.] Univ Texas Southwestern, Dept Radiol, Dallas, TX USA		Urban, JE (corresponding author), Virginia Tech, Wake Forest Sch Biomed Engn & Sci, Winston Salem, NC 27101 USA.	jurban@wakehealth.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410, R01NS082453]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award numbers R01NS094410 and R01NS082453. The National Center for Advancing Translational Sciences, National Institutes of Health, supported Dr. Urban through grant KL2TR001421. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We give special thanks to the Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center for providing support for this study. We thank the youth football organization's board members, coaches, parents, and athletes whose support makes this research possible. We thank the athletic trainers for their support. We also thank all the research assistants who helped with data collection.	Asken BM, 2019, ANN BIOMED ENG, V47, P2094, DOI 10.1007/s10439-018-2088-5; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Davenport Elizabeth M, 2016, Concussion, V1, pCNC19, DOI 10.2217/cnc-2016-0003; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hulvershorn LA, 2011, BRAIN IMAGING BEHAV, V5, P307, DOI 10.1007/s11682-011-9134-3; Kelley ME, 2019, J NEUROSURG-PEDIATR, V23, P381, DOI 10.3171/2018.9.PEDS18314; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Messina R, 2015, CEPHALALGIA, V35, P1278, DOI 10.1177/0333102415578428; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Oishi K, 2011, J ALZHEIMERS DIS, V26, P287, DOI 10.3233/JAD-2011-0007; Rane P, 2015, HARVARD REV PSYCHIAT, V23, P223, DOI 10.1097/HRP.0000000000000072; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859	45	1	1	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2021	28	2					196	205		10.3171/2021.1.PEDS20586			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	TT3NL	WOS:000680257700001	34130257	Bronze			2022-02-06	
J	King, PR; Beehler, GP; Donnelly, K; Funderburk, JS; Wray, LO				King, Paul R., Jr.; Beehler, Gregory P.; Donnelly, Kerry; Funderburk, Jennifer S.; Wray, Laura O.			A Practical Guide to Applying the Delphi Technique in Mental Health Treatment Adaptation: The Example of Enhanced Problem-Solving Training (E-PST)	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						concussion; Delphi procedure; treatment adaptation; integrated primary care; veterans	LESSONS	Expert consensus methods, such as the Delphi procedure, are commonly employed in consumer, education, and health services research. However, the utility of this methodology has not widely been described in relation to mental health treatment adaptation efforts. This gap is noteworthy given that evidence-based treatments are often modified in terms of core intervention content, method of delivery, and target populations. Expert consensus methods such as the Delphi procedure offer multiple practical benefits (e.g., flexibility, resource-efficiency) for psychologists who need to adapt existing treatments to meet new research and clinical practice needs. The purpose of this article is to provide a brief overview of the Delphi procedure, and to offer a practical guide to using this method for treatment adaptation. An example is offered using our team's application of a three-round Delphi procedure to render content and context modifications to an existing problem-solving intervention to optimize its use with a new treatment population. Data were collected from Department of Veterans Affairs clinical subject matter experts. Round 1 utilized semi-structured interviews to determine necessary protocol features and modifications. Rounds 2-3 utilized a forced-choice survey and feedback loop to evaluate expert consensus. More than 91% of rated items reached consensus following Round 2, with the remainder following Round 3. Recommended modifications included minor structural and content edits, and rebalancing time allotments. We conclude that consensus methods may facilitate treatment adaptation efforts, enhance treatment feasibility, and promote content and ecological validity. Considerations for future Delphi-based treatment adaptations are offered.	[King, Paul R., Jr.; Beehler, Gregory P.; Funderburk, Jennifer S.; Wray, Laura O.] US Dept Vet Affairs, VA Ctr Integrated Healthcare, Buffalo, NY USA; [King, Paul R., Jr.; Donnelly, Kerry] Univ Buffalo, Grad Sch Educ, Dept Counseling Sch & Educ Psychol, Buffalo, NY USA; [Beehler, Gregory P.] Univ Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, Buffalo, NY USA; [Donnelly, Kerry] US Dept Vet Affairs, VA Western New York Healthcare Syst, Buffalo, NY USA; [Donnelly, Kerry] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA; [Funderburk, Jennifer S.] Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA; [Wray, Laura O.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Div Geriatr Gerontol, Buffalo, NY USA; [Wray, Laura O.] Univ Buffalo, Coll Arts & Sci, Dept Psychol, Buffalo, NY USA		King, PR (corresponding author), VA Ctr Integrated Healthcare, 3495 Bailey Ave, Buffalo, NY 14215 USA.	paul.king2@va.gov		King, Paul/0000-0003-4310-0282	United States (U.S.) Department of Veterans Affairs Rehabilitation R&D (Rehabilitation Research and Development) Service [IK2 RX002796]	The authors declare that there were no conflicts of interest with respect to the authorship or the publication of this article. This work was supported by Career Development/Capacity Building Award Number IK2 RX002796 from the United States (U.S.) Department of Veterans Affairs Rehabilitation R&D (Rehabilitation Research and Development) Service, as well as with the resources and use of facilities at the VA Center for Integrated Healthcare and the VA Western New York Healthcare System. The views expressed in this article are those of the authors and do not represent the position or policy of the Department of Veterans Affairs or the United States Government. All authors are full-time employees of the Department of Veterans Affairs, and the work performed was part of usual duties. We wish to thank Brenda Jeffries-Silmon for her assistance with data collection, and Carrie Pengelly for her assistance with manuscript preparation.	Aarts MJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-128; [Anonymous], 2015, ADM POLICY MENT HLTH, DOI [10.1007/s10488-013-0528-y, DOI 10.1007/s10488-013-0528-y]; Beehler GP, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-19; Biondo PD, 2008, SUPPORT CARE CANCER, V16, P935, DOI 10.1007/s00520-007-0348-2; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Dinos S, 2015, BJPSYCH BULL, V39, P153, DOI 10.1192/pb.bp.115.050872; Gale RC, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0853-y; Goodyear M, 2015, INT J MENT HEALTH NU, V24, P169, DOI 10.1111/inm.12120; Green B, 1999, HEALTH SOC CARE COMM, V7, P198, DOI 10.1046/j.1365-2524.1999.00176.x; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hill NTM, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-018-1995-1; Hsu C.C., 2007, PRACTICAL ASSESSMENT, V12, P10, DOI DOI 10.7275/PDZ9-TH90; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Jorm AF, 2015, AUST NZ J PSYCHIAT, V49, P887, DOI 10.1177/0004867415600891; Keeley T, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1356-7; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; MCKENNA HP, 1994, J ADV NURS, V19, P1221, DOI 10.1111/j.1365-2648.1994.tb01207.x; McMillan SS, 2016, INT J CLIN PHARM-NET, V38, P655, DOI 10.1007/s11096-016-0257-x; Miller S. A., 2015, PROBLEM SOLVING TRAI; Mulligan JA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1628-4; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Santaguida P, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0831-5; Skulmoski GJ, 2007, J INF TECHNOL EDUC-R, V6, P1; Stirman SW, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-65; Turner S, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0252-2; van der Linde H, 2005, J REHABIL RES DEV, V42, P693, DOI 10.1682/JRRD.2003.11.0172; Yotebieng M, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25218	29	1	1	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	AUG	2021	52	4					376	386		10.1037/pro0000371			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	TS5AE	WOS:000679660900009	34446984				2022-02-06	
J	Le, RK; Anderson, MN; Johnson, RS; Lempke, LB; Schmidt, JD; Lynall, RC				Le, Rachel K.; Anderson, Melissa N.; Johnson, Rachel S.; Lempke, Landon B.; Schmidt, Julianne D.; Lynall, Robert C.			On-field Characteristics and Head Impact Magnitude in Youth Tackle Football	PEDIATRIC NEUROLOGY			English	Article						Biomechanics; Head trauma; Triax system; Repetitive head impact exposure; mTBI; Sport safety	TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; PROFESSIONAL FOOTBALL; EXPOSURE; CONCUSSIONS; COLLEGIATE; EPIDEMIOLOGY; PLAYER; BIOMECHANICS; POSITION	Background: This study determined the effect of video-verified collision characteristics on head impact magnitudes in male youth tackle football. Methods: Participants (n = 23, age = 10.9 +/- 0.3 years, height = 150.0 +/- 8.3 cm, mass = 41.6 +/- 8.4 kg) wore Triax Sim-G sensors throughout the fall 2019 season. Ten filmed games were used to identify nine different collision characteristics: mechanism, preparedness, head direction, struck versus striking activity, stance, play type, closing distance, penalty, and quarter. Random-effects general linear models and Cohen d effect sizes were used to examine differences in log-transformed peak linear (PLA; g) and rotational (PRA; rad/s(2)) accelerations across characteristics. The 10 games produced 533 total video-verified impacts and 23.2 +/- 7.2 impacts per athlete. Results: PLA (P range: 0.107 to 0.923) and PRA (P range: 0.057 to 0.768) did not differ across characteristics. Struck players (3370 rads/s(2), 95% confidence interval [CI] = 2986 to 3808) had a small effect for higher PRA compared with striking players (3037 rads/s(2), 95% CI = 2713 to 3404, d = 0.251), but negligible effect for simultaneous struck-striking players (3340 rad/s(2), 95% CI = 2945 to 3792, d = 0.018). Fourth quarter impacts (3490 rads/s(2), 95% CI = 3083 to 3951) had a small effect for higher PRA compared with first (2945 rads/s(2), 95% CI = 2596 to 3337, d = 0.404), second (3196 rads/s(2), 95% CI = 2832 to 3604, d = 0.219), and third quarters (3241 rads/s(2), 95% CI = 2841 to 3699, d = 0.144). Conclusion: Youth tackle football characteristics did not significantly affect head impact magnitudes during games. More research is needed to explore additional factors that could be modified for sport safety rather than mitigating impact mechanism. (C) 2021 Elsevier Inc. All rights reserved.	[Le, Rachel K.; Anderson, Melissa N.; Johnson, Rachel S.; Lempke, Landon B.; Schmidt, Julianne D.; Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA		Le, RK (corresponding author), Univ Georgia, 330 River Rd, Athens, GA 30605 USA.	Rachel.Le@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640	National Operating Committee on Standards for Athletic Equipment	This study was funded in part by the National Operating Committee on Standards for Athletic Equipment.	Alois J, 2019, AM J SPORT MED, V47, P3498, DOI 10.1177/0363546519882034; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Bonnechere B, 2014, J SPORT SCI MED, V13, P423; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Cohen J., 2013, STAT POWER ANAL BEHA; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Karton C, 2016, 34 INT C BIOM SPORT 34 INT C BIOM SPORT; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; King D, 2012, RES SPORTS MED, V20, P86, DOI 10.1080/15438627.2012.660824; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Lynall RC, 2019, J NEUROTRAUM, V36, P1752, DOI 10.1089/neu.2018.6236; Lynall RC, 2017, J NEUROTRAUM, V34, P2684, DOI 10.1089/neu.2017.5032; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchesseault ER, 2018, PHYSICIAN SPORTSMED, V46, P324, DOI 10.1080/00913847.2018.1470888; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Oeur RA, 2016, 34 INT C BIOM SPORT 34 INT C BIOM SPORT; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; van der Kamp J, 2011, MOTOR CONTROL, V15, P342, DOI 10.1123/mcj.15.3.342; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	42	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	AUG	2021	121						33	39		10.1016/j.pediatrneurol.2021.04.005			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	TI1ZD	WOS:000672584500007	34146964				2022-02-06	
J	McGovern, AJ; Barreto, GE				McGovern, Andrew J.; Barreto, George E.			Network pharmacology identifies IL6 as an important hub and target of tibolone for drug repurposing in traumatic brain injury	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Traumatic brain injury; Tibolone; Inflammation; Cell proliferation; Apoptosis; Network pharmacology	ESTROGEN-RECEPTOR-BETA; REACTIVE ASTROGLIOSIS; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; PALMITIC ACID; TNF-ALPHA; EXPRESSION; ASTROCYTES; MICROGLIA; ESTRADIOL	Traumatic brain injury (TBI) is characterized by a complex network of signals mediating inflammatory, proliferative and apoptotic processes during its acute and chronic phases. Current therapies mitigate damage and are mainly for palliative care and there are currently no effective therapies for secondary damage. This suggests a need to discover a compound with a greater spectrum of action that can control various pathological aspects of TBI. Here we used a network pharmacology approach to explore the benefits of tibolone, an estrogen and androgen receptor agonist with broader actions in cells, as a possible repurposing drug for TBI therapy. Using different databases we retrieved the targets significantly associated to TBI and tibolone, obtaining 2700 and 652, respectively. The top 10 GO enriched terms were mostly related to cell proliferation, apoptosis and inflammation. Following protein-protein functional analysis, the top connected proteins were related to kinase activity (MAPK1/14/3, AKT1 PIK3R1), apoptosis (TP53, CASP3), growth factors (EGFR), estrogen signalling (ESR1) and inflammation (IL6, TNF), with IL6 as an important signalling hub belonging to the top GO categories. Thus, we identified IL6 as a cellular node which we then validated using molecular mechanics-generalized born surface area (MMGBSA) and docking to explore which tibolone metabolite might interact with this protein. Both 3 alpha and 3 beta-OH tibolone seemed to bind better to IL6 at important sites responsible for its binding to IL6R. In conclusion, our study demonstrates key hubs involved in TBI pathology which indicates IL6 as a target molecule of tibolone as drug repurposing for TBI therapy.	[McGovern, Andrew J.; Barreto, George E.] Univ Limerick, Dept Biol Sci, Limerick, Ireland; [Barreto, George E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland		Barreto, GE (corresponding author), Univ Limerick, Dept Biol Sci, Limerick, Ireland.	George.Barreto@ul.ie		McGovern, Andrew J./0000-0003-0890-5894			Abdi F, 2016, CLIMACTERIC, V19, P234, DOI 10.3109/13697137.2016.1164136; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Azcoitia I, 2019, FRONT NEUROENDOCRIN, V55, DOI 10.1016/j.yfrne.2019.100787; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; CAVANAGH JB, 1970, J ANAT, V106, P471; Clark LR, 2021, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.612749; Crespo-Castrillo A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1719-6; Crespo-Castrillo A, 2018, MOL NEUROBIOL, V55, P8651, DOI 10.1007/s12035-018-1008-x; Cruz NAE, 2019, EXP CLIN ENDOCR DIAB, V127, P396, DOI 10.1055/a-0659-9928; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; FRY DC, 1988, BIOCHEMISTRY-US, V27, P3588, DOI 10.1021/bi00410a009; Gameiro CM, 2010, MATURITAS, V67, P316, DOI 10.1016/j.maturitas.2010.08.003; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Garcia-Segura LM, 1998, NEUROREPORT, V9, P593, DOI 10.1097/00001756-199803090-00006; Gonzalez-Giraldo Y, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12768; Gonzalez-Giraldo Y, 2019, MOL CELL ENDOCRINOL, V486, P65, DOI 10.1016/j.mce.2019.02.017; Gonzalez-Giraldo Y, 2018, MOL NEUROBIOL, V55, P4453, DOI 10.1007/s12035-017-0667-3; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; Islam O, 2009, MOL BIOL CELL, V20, P188, DOI 10.1091/mbc.E08-05-0463; Jones KJ, 1997, J NEUROCYTOL, V26, P257, DOI 10.1023/A:1018596316465; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Lambrinoudaki I, 2013, CLIMACTERIC, V16, P258, DOI 10.3109/13697137.2012.668251; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Martin-Jimenez C, 2020, NEUROTOX RES, V38, P585, DOI 10.1007/s12640-020-00247-4; Martin-Jimenez C, 2019, NEUROENDOCRINOLOGY, V108, P142, DOI 10.1159/000495078; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Oscar H.-L., 2019, LIPOTOXICITY NEUROIN; Osorio D, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01410; Del Rio JP, 2020, TRENDS ENDOCRIN MET, V31, P742, DOI 10.1016/j.tem.2020.04.007; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Pinto-Almazan R, 2018, NEURAL REGEN RES, V13, P440, DOI 10.4103/1673-5374.228726; Rabbani O, 1997, EXP NEUROL, V146, P179, DOI 10.1006/exnr.1997.6516; Reis BF, 2016, HISTOL HISTOPATHOL, V31, P629, DOI 10.14670/HH-11-706; Rogers A, 2001, BONE, V29, P30, DOI 10.1016/S8756-3282(01)00468-9; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; de Medeiros ARS, 2012, REGUL PEPTIDES, V179, P55, DOI 10.1016/j.regpep.2012.08.015; Santos RS, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0151-9; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; Sukovich DA, 1998, ARTERIOSCL THROM VAS, V18, P1498, DOI 10.1161/01.ATV.18.9.1498; TAKAMIYA Y, 1988, DEV BRAIN RES, V38, P201, DOI 10.1016/0165-3806(88)90045-4; Tanzer L, 1997, EXP NEUROL, V146, P258, DOI 10.1006/exnr.1997.6529; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vural P, 2006, PHARMACOL RES, V53, P367, DOI 10.1016/j.phrs.2006.01.005; Wang ZJ, 2006, CHEM-BIOL INTERACT, V163, P207, DOI 10.1016/j.cbi.2006.08.005; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Zegeye MM, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0268-4; Zhao TZ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.449; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	61	1	1	5	8	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	AUG	2021	140								111769	10.1016/j.biopha.2021.111769			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	TE7QQ	WOS:000670203200003	34058440	gold, Green Published			2022-02-06	
J	Montazeri, K; Farhadi, M; Fekrazad, R; Akbarnejad, Z; Chaibakhsh, S; Mahmoudian, S				Montazeri, Katayoon; Farhadi, Mohammad; Fekrazad, Reza; Akbarnejad, Zeinab; Chaibakhsh, Samira; Mahmoudian, Saeid			Transcranial photobiomodulation in the management of brain disorders	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY			English	Article						Transcranial photobiomodulation; Low level laser therapy; Stroke; Parkinson; Alzheimer; Traumatic brain injury	LEVEL LASER THERAPY; NEUROTHERA EFFECTIVENESS; ISCHEMIC-STROKE; INFRARED LIGHT; LED THERAPY; INJURY; MODEL; DEFICITS; SAFETY; IMPROVEMENTS	Transcranial photobiomodulation (tPBM) is the process of delivering light photons through the skull to benefit from its modifying effect. Brain disorders are important health problems. The aim of this review was to determine the existing evidence of effectiveness, useful parameters, and safety of tPBM in the management of traumatic brain injury, stroke, Parkinson, and Alzheimer's disease as the common brain disorders. Four online databases, including Cochrane, Pub Med, Embase, and Google scholar were searched according to the Preferred Reporting Items for Systematic Reviews and meta-analyses (PRISMA) guidelines. 4728 articles were obtained in the initial search. Only those articles that were published until September 2020 and designed as randomized clinical trials (RCTs) or animal-controlled studies were included. 6 RCTs, 2 related supplementary articles, and 38 controlled animal studies met the inclusion criteria of this study. No RCTs were performed in the fields of Alzheimer's and Parkinson's diseases. The human RCTs and animal studies reported no adverse events resulted from the use of tPBM. Useful parameters of tPBM were identified according to the controlled animal studies. Since the investigated RCTs had no homogenous results, making an evidence-based decision for definite therapeutic application of tPBM is still unattainable. Altogether, these data support the need for large confirmatory well-designed RCTs for using tPBM as a novel, safe, and easy-to-administer treatment of brain disorders. Evidence before this study: High prevalence and complications of brain disorders and also side effects of neuropsychiatric medications have encouraged researchers to find alternative therapeutic techniques which tPBM can be one of them. In present review we tried to determine the existing evidence of effectiveness, useful parameters, and safety of tPBM in the management of traumatic brain injury, stroke, Alzheimer, and Parkinson's disease as common brain disorders. Four online databases, including "Cochrane", "Pub Med", "Embase", and "Google scholar" were searched. Only those articles that were published until September 2020 and designed as RCTs or animal-controlled studies were included. Search keywords were the followings: transcranial photobiomodulation" OR "transcranial low-level laser therapy" AND "stroke" OR "traumatic brain injury" OR "Alzheimer" OR "Parkinson". Several studies have confirmed effectiveness of tPBM in treatment of different brain disorders but the level of evidence of its effectiveness remain to be determined. Added value of this study: In this study we systematically reviewed human RCTs to determine the existing evidence of tPBM effectiveness in management of four mentioned brain disorders. Since the outcomes of the reviewed RCTs were not homogeneous, further well-designed RCTs are required to decide more definitively on the evidence of this noninvasive and probably safe therapeutic intervention. We hypothesized that non homogeneous outcomes could be due to inefficiency of PBM parameters. Controlled animal studies have the advantage of using objective tests to evaluate the results and compare them with the control group. We determined useful tPBM parameters based on these studies. Implications of all the available evidence: This research is part of our main project of tinnitus treatment using photobiomodulation (PBM). Evidence of central nervous system involvement in tinnitus led us to believe that treatment protocol of tinnitus should also include transcranial PBM. The determined useful parameters can be helpful in designing more efficient tPBM protocols in the management of brain disorders and tinnitus as a common debilitating symptom that can be associated with these disorders.	[Montazeri, Katayoon; Farhadi, Mohammad; Akbarnejad, Zeinab; Mahmoudian, Saeid] Iran Univ Med Sci IUMS, ENT & Head & Neck Res Ctr, Five Senses Hlth Einst, Tehran, Iran; [Fekrazad, Reza] AJA Univ Med Sci, Radiat Sci Res Ctr, Laser Res Ctr Med Sci, Tehran, Iran; [Chaibakhsh, Samira] Firoozgar Hosp, Neuromusculoskeletal Res Ctr, Tehran, Iran; [Chaibakhsh, Samira] Iran Univ Med Sci, Rassoul Akram Hosp, Eye Res Ctr, Tehran, Iran		Mahmoudian, S (corresponding author), Iran Univ Med Sci IUMS, Hazrat Rasoul Akram Hosp, ENT & Head & Neck Res Ctr, Five Senses Hlth Inst, Tehran, Iran.	mahmoudian.s@iums.ac.ir			Iran University of Medical Sciences, research Technology	We would like to show our gratitude to the all colleagues of auditory neuroscience core research, and ENT department for their valuable comments. Also, we appreciate Iran University of Medical Sciences, research & Technology deputy for funding this work by Ph.D. students' research program award. All authors had full access to all the data in this review and had final responsibility for the decision to submit for publication.	Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; [Anonymous], 2019, BRAIN STIMUL; Arbabshirani MR, 2017, NEUROIMAGE, V145, P137, DOI 10.1016/j.neuroimage.2016.02.079; Ashrafi F., 2020, INT CLIN NEUROSCI J, V7, P127, DOI DOI 10.34172/ICNJ.2020.13; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; Burns PB, 2011, PLAST RECONSTR SURG, V128, P305, DOI 10.1097/PRS.0b013e318219c171; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cho GM, 2020, J GERONTOL A-BIOL, V75, P631, DOI 10.1093/gerona/gly240; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Fonseca EGD, 2019, LASER MED SCI, V34, P1619, DOI 10.1007/s10103-019-02758-9; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Disner SG, 2016, BRAIN STIMUL, V9, P780, DOI 10.1016/j.brs.2016.05.009; Eltchechem CD, 2017, LASER MED SCI, V32, P749, DOI 10.1007/s10103-017-2156-3; Esenaliev RO, 2018, J NEUROTRAUM, V35, P1510, DOI 10.1089/neu.2017.5249; Longo MGF, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17337; Guptarak J, 2017, J NEUROTRAUM, V34, pA64; Hacke W, 2014, STROKE, V45, P3187, DOI 10.1161/STROKEAHA.114.005795; Hamblin MR, 2016, J BIOPHOTONICS, V9, P1122, DOI 10.1002/jbio.201670113; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Heiskanen V, 2018, PHOTOCH PHOTOBIO SCI, V17, P1003, DOI [10.1039/c8pp00176f, 10.1039/c8pp90049c]; Hemmen T., 2014, SAFETY TPA TRANSCRAN; Hennessy M, 2017, J OPTICS-UK, V19, DOI 10.1088/2040-8986/19/1/013003; Hillier S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-23; Huisa BN, 2013, INT J STROKE, V8, P315, DOI 10.1111/j.1747-4949.2011.00754.x; Isaac ML, 2014, MED CLIN N AM, V98, P1193, DOI 10.1016/j.mcna.2014.06.012; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Karu T.I., 2013, IEEE J SELECT TOP QU, V20, P143, DOI [10.1007/s00203-012-0847-5, DOI 10.1007/S00203-012-0847-5]; Kasner SE, 2013, STROKE, V44, P2025, DOI 10.1161/STROKEAHA.113.000870; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak PA, 2016, BRAIN RES, V1646, P125, DOI 10.1016/j.brainres.2016.04.039; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Lee HI, 2017, J BIOPHOTONICS, V10, P1502, DOI 10.1002/jbio.201600244; Lee JH, 2016, PEERJ, V4, DOI 10.7717/peerj.2252; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Malhi Gin S, 2006, Neuropsychiatr Dis Treat, V2, P165, DOI 10.2147/nedt.2006.2.2.165; Meyer DM, 2016, NEUROSCI LETT, V630, P254, DOI 10.1016/j.neulet.2016.06.038; Mitrofanis J, 2019, BIOL PSYCHIAT, V85, pS79, DOI 10.1016/j.biopsych.2019.03.206; Mocciaro E, 2020, J NEUROTRAUM, V37, P1108, DOI 10.1089/neu.2019.6534; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Norton R, 2019, BIOL PSYCHIAT, V85, pS245, DOI 10.1016/j.biopsych.2019.03.622; O'Brien JA, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9080381; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; Oueslati A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140880; Peoples C, 2012, PARKINSONISM RELAT D, V18, P469, DOI 10.1016/j.parkreldis.2012.01.005; Purushothuman S, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt232; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707; Reinhart F, 2017, NEUROSCI RES, V117, P42, DOI 10.1016/j.neures.2016.11.006; Saltmarche A.E., 2016, ALZHEIMERS DEMENTIA, V12, pP155; San Miguel M, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9100564; Strubakos CD, 2020, J CEREBR BLOOD F MET, V40, P833, DOI 10.1177/0271678X19845149; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Tian FH, 2016, LASER SURG MED, V48, P343, DOI 10.1002/lsm.22471; Uozumi Y, 2010, LASER SURG MED, V42, P566, DOI 10.1002/lsm.20938; Vogel DDS, 2021, J BIOPHOTONICS, V14, DOI 10.1002/jbio.202000287; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2016, J BIOPHOTONICS, V9, P1263, DOI 10.1002/jbio.201500336; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yang BC, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.201960117; Yang LD, 2018, EXP NEUROL, V299, P86, DOI 10.1016/j.expneurol.2017.10.013; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Zhang Z, 2020, AGING CELL, V19, DOI 10.1111/acel.13054; Zinchenko E, 2019, BIOMED OPT EXPRESS, V10, P4003, DOI 10.1364/BOE.10.004003; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	72	1	1	6	6	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1011-1344	1873-2682		J PHOTOCH PHOTOBIO B	J. Photochem. Photobiol. B-Biol.	AUG	2021	221								112207	10.1016/j.jphotobiol.2021.112207			9	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	UA2FL	WOS:000684979800004	34119804				2022-02-06	
J	Novack, TA; Zhang, Y; Kennedy, R; Rapport, LJ; Watanabe, TK; Monden, KR; Dreer, LE; Bergquist, T; Bombardier, C; Brunner, R; Goldin, Y; Marwitz, J; Niemeier, JP				Novack, Thomas A.; Zhang, Yue; Kennedy, Richard; Rapport, Lisa J.; Watanabe, Thomas K.; Monden, Kimberley R.; Dreer, Laura E.; Bergquist, Thomas; Bombardier, Charles; Brunner, Robert; Goldin, Yelena; Marwitz, Jennifer; Niemeier, Janet P.			Return to Driving After Moderate-to-Severe Traumatic Brain Injury: A Traumatic Brain Injury Model System Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Automobile driving; Brain injuries; Brain injuries; traumatic; Rehabilitation	COMMUNITY INTEGRATION; PREDICTORS; REHABILITATION; PERFORMANCE; IMPUTATION; EXPOSURE	Objective: Describe who is able to return to driving (RTD) after moderate-to-severe traumatic brain injury (TBI), when this occurs, who maintains that activity, and the association with outcome. Design: Cross-sectional descriptive study. Setting: Eight follow-up sites of the TBI Model Systems (TBIMS) program. Participants: 618 participants enrolled in the TBIMS and 88 caregivers (N=706). Interventions: Not applicable. Main Outcome Measures: A survey was completed from 1-30 years postinjury focusing on RTD. Descriptors included demographic information, injury severity, and current employment status. Outcome was assessed at the time of the interview, including depression, quality of life, functional status, and community participation. Results: Of 706 respondents, 78% (N = 552) RTD, but 14% (N = 77) of these did not maintain that activity. Of those who RTD, 43% (N = 192) did so within 6 months of the injury and 92% did so within 24 months postinjury. The percentage of people driving after TBI did not differ significantly based on age at time of injury or follow-up. There were significant differences between drivers and nondrivers with respect to severity of injury, seizures, race, education, employment, rural vs urban setting, marital status, and family income. We performed a multivariate logistic regression to examine the association between driving status and demographic variables, adjusting for other variables in the model. The strongest associations were with current employment, family income, race, seizures, and severity of injury. Driving was associated with greater community participation, better functional outcomes, fewer symptoms of depression, and greater life satisfaction. Conclusions: Over a span of 30 years, three-quarters of people experiencing moderate-to-severe TBI return to driving a personal vehicle, although not everyone maintains this activity. Employment, race, family income, and seizures are strongly associated with RTD. Archives of Physical Medicine and Rehabilitation 2021;102:1568-75 (c) 2021 by the American Congress of Rehabilitation Medicine	[Novack, Thomas A.; Brunner, Robert; Niemeier, Janet P.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35233 USA; [Zhang, Yue; Kennedy, Richard] Univ Alabama Birmingham, Div Gerontol, Dept Med, Integrat Ctr Aging Res, Birmingham, AL USA; [Rapport, Lisa J.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Watanabe, Thomas K.] Moss Rehab Elkins Pk Einstein Healthcare Network, Dept Phys Med & Rehabil, Elkins Pk, PA USA; [Monden, Kimberley R.] Craig Hosp, Res Dept, Englewood, CO USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL USA; [Bergquist, Thomas] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Bombardier, Charles] Univ Washington, Dept Phys Med & Rehabil, Seattle, WA USA; [Goldin, Yelena] JFK Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ USA; [Marwitz, Jennifer] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA		Novack, TA (corresponding author), Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35233 USA.	tnovack@uabmc.edu	Monden, Kimberley/AAE-9831-2020; Kennedy, Richard/K-1525-2018; Bombardier, Charles H./AAZ-3260-2021	Monden, Kimberley/0000-0002-5207-0452; Kennedy, Richard/0000-0003-4638-126X; Bombardier, Charles H./0000-0003-4758-6283; Rapport, Lisa/0000-0001-8014-9523	National Institute on Disability, Independent Living, and Rehabilitation Research, Administration of Community Living [90DPTB0015, 90DPTB0006, 90DPTB0004, 90DPTB00070, 90DPTB0014, 90DPTB0008, 90DPTB0005, 90DPTB0012]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research, Administration of Community Living (grant nos. 90DPTB0015, 90DPTB0006, 90DPTB0004, 90DPTB00070, 90DPTB0014, 90DPTB0008, 90DPTB0005, 90DPTB0012).	Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Erler KS, 2018, OTJR-OCCUP PART HEAL, V38, P143, DOI 10.1177/1539449218757739; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fisk GD, 1998, BRAIN INJURY, V12, P683; Galski T, 2000, J HEAD TRAUMA REHAB, V15, P895, DOI 10.1097/00001199-200006000-00004; George S, 2007, CLIN REHABIL, V21, P56, DOI 10.1177/0269215506071284; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Krellman JW, 2014, ARCH PHYS MED REHAB, V95, P633, DOI 10.1016/j.apmr.2013.10.016; Labbe DR, 2014, J HEAD TRAUMA REHAB, V29, P185, DOI 10.1097/HTR.0b013e3182795211; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Mcguckin N., 2018, SUMMARY TRAVEL TREND; McKay A, 2016, J HEAD TRAUMA REHAB, V31, pE44, DOI 10.1097/HTR.0000000000000209; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; R Core Team, R LANG ENV STAT COMP; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Ross PE, 2015, ARCH PHYS MED REHAB, V96, P440, DOI 10.1016/j.apmr.2014.09.027; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Santos A., 2011, SUMMARY TRAVEL TREND; Sommer M, 2010, ARCH CLIN NEUROPSYCH, V25, P99, DOI 10.1093/arclin/acp109; Therneau T.M., 2000, STAT BIOL HEALTH; Therneau TM, PACKAGE SURVIVAL ANA; van Buuren S, 2011, J STAT SOFTW, V45, P1; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	34	1	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2021	102	8					1568	1575		10.1016/j.apmr.2021.02.006			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	UL3LL	WOS:000692556700016	33705772				2022-02-06	
J	Posti, JP; Luoto, TM; Rautava, P; Kyto, V				Posti, Jussi P.; Luoto, Teemu M.; Rautava, Paivi; Kyto, Ville			Mortality After Trauma Craniotomy Is Decreasing in Older Adults-A Nationwide Population-Based Study	WORLD NEUROSURGERY			English	Article						Craniotomy; Elderly patients; Mortality; Outcome; Traumatic brain injury	CHRONIC SUBDURAL-HEMATOMA; BRAIN-INJURY; ELDERLY-PATIENTS; DECOMPRESSIVE CRANIECTOMY; EPIDEMIOLOGY; CLASSIFICATION; OUTCOMES	OBJECTIVE: No evidence-based guidelines are available for operative neurosurgical treatment of older patients with traumatic brain injuries (TBIs), and no population-based results of current practice have been reported. The objective of the present study was to investigate the rates of trauma craniotomy operations and later mortality in older adults with TBI in Finland. METHODS: Nationwide databases were searched for all admissions with a TBI diagnosis and after trauma craniotomy, and later deaths for persons aged >= 60 years from 2004 to 2018. RESULTS: The study period included 2166 patients (64% men; mean age, 70.3 years) who had undergone TBI-related craniotomy. The incidence rate of operations decreased with a concomitant decrease in adjusted mortality (30-day mortality, P < 0.001; 1-year mortality, P < 0.001) and increase in mean patient age (R-2 = 0.005; P < 0.001) during the study period. The cumulative mortality was 25% at 30 days and 38% at 1 year. The comorbidities increasing the hazard for 30-day mortality were diabetes, a history of malignancy, peripheral vascular disease, and a history of myocardial infarction. For 1-year mortality, the comorbidities were heart failure and a history of myocardial infarction. Evacuation of an epidural hematoma decreased the hazard for mortality. In contrast, evacuation of an intracerebral hematoma and decompressive craniectomy increased the risk at both 30 days and 1 year. CONCLUSIONS: Among older adults in Finland, the rate of trauma craniotomy and later mortality has been decreasing although the mean age of operated patients has been increasing. This can be expected to be related to an improved understanding of geriatric TBIs and, consequently, improved selection of patients for targeted therapy.	[Posti, Jussi P.] Univ Turku, Turku Brain Injury Ctr, Turku, Finland; [Posti, Jussi P.] Univ Turku, Dept Neurosurg, Neuroctr, Turku, Finland; [Rautava, Paivi] Univ Turku, Clin Res Ctr, Turku, Finland; [Kyto, Ville] Univ Turku, Heart Ctr, Turku, Finland; [Kyto, Ville] Univ Turku, Ctr Populat Hlth Res, Turku, Finland; [Kyto, Ville] Turku Univ Hosp, Ctr Populat Hlth Res, Turku, Finland; [Luoto, Teemu M.] Tampere Univ, Dept Neurosurg, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ Hosp, Tampere, Finland; [Kyto, Ville] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Kyto, Ville] Hosp Dist Southwest Finland, Administat Ctr, Turku, Finland		Posti, JP (corresponding author), Univ Turku, Turku Brain Injury Ctr, Turku, Finland.; Posti, JP (corresponding author), Univ Turku, Dept Neurosurg, Neuroctr, Turku, Finland.	jussi.posti@utu.fi	Posti, Jussi P./Y-2908-2019; Kyto, Ville/D-7971-2014	Posti, Jussi P./0000-0002-5925-5193; Luoto, Teemu/0000-0002-7329-3284; Kyto, Ville/0000-0002-4521-1093	Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Government's Special Financial Transfer tied to academic research in Health Sciences, Finland [11129]	Jussi P. Posti has received funding from the Academy of Finland (grant 17379), the Government's Special Financial Transfer tied to academic research in Health Sciences, Finland (grant 11129), and the Maire Taponen Foundation and has received speaker's fees from Finnish Medical Association. Ville Kyto received funding from the Finnish Government's Special Financial Transfer tied to academic research in Health Sciences, Finland and a grant from Finnish Cultural Foundation and Paulo Foundation. Teemu M. Luoto has received funding from the Government's Special Financial Transfer tied to academic research in Health Sciences, Finland and research grants from the Finnish Brain Foundation sr, the Emil Aaltonen Foundation sr, the Maire Taponen Foundation, the Science Fund of the City of Tampere, and the Finnish Medical Society Duodecim. Paivi Rautava has received speaker's fees from Pharmaceutical Information Centre Ltd.	Bus S, 2019, BRIT J NEUROSURG, V33, P51, DOI 10.1080/02688697.2018.1522418; Dang Q, 2015, J SURG RES, V198, P482, DOI 10.1016/j.jss.2015.03.092; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Evans LR, 2019, J NEUROTRAUM, V36, P517, DOI 10.1089/neu.2018.5829; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; IIGiovine Z, 2014, BRAIN INJURY, V28, P769; Kerezoudis P, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.7.FOCUS20439; Kinoshita T, 2016, WORLD NEUROSURG, V89, P187, DOI 10.1016/j.wneu.2016.01.071; Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163; Lindfors M, 2018, ACTA NEUROCHIR, V160, P2107, DOI 10.1007/s00701-018-3670-1; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; National Institute on Aging National Institutes of Health, WORLDS OLD POP GROWS WORLDS OLD POP GROWS; Nordic Medico-Statistical Committee, NOMESCO CLASS SURG P NOMESCO CLASS SURG P; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Posti JP, 2020, AGE AGEING, V49, P779, DOI 10.1093/ageing/afaa037; Posti JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41913-8; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Rauhala M, 2020, ACTA NEUROCHIR, V162, P1467, DOI 10.1007/s00701-020-04278-w; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Sipila JOT, 2017, ANN MED, V49, P310, DOI 10.1080/07853890.2016.1254350; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Tommiska P, 2021, AGE AGEING, V50, P815, DOI 10.1093/ageing/afaa193	31	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2021	152						E313	E320		10.1016/j.wneu.2021.05.090			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TS9LP	WOS:000679970700037	34082165	hybrid			2022-02-06	
J	Rhame, K; Le, D; Ventura, A; Horner, A; Andaluz, N; Miller, C; Stolz, U; Ngwenya, LB; Adeoye, O; Kreitzer, N				Rhame, Katherine; Le, Diana; Ventura, Amanda; Horner, Amy; Andaluz, Norberto; Miller, Christopher; Stolz, Uwe; Ngwenya, Laura B.; Adeoye, Opeolu; Kreitzer, Natalie			Management of the mild traumatic brain injured patient using a multidisciplinary observation unit protocol	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Mild traumatic brain injury; Observation medicine; Concussion	COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; HEAD-INJURY; LOW-RISK; STATES; NEED; DETERIORATION	Objectives: We developed an ED based multidisciplinary observation unit (OU) protocol for patients with mild traumatic brain injury (mTBI). We describe the cohort of patients who were placed in the ED OU and we evaluated if changes to our inclusion and exclusion criteria should be made. Methods: We conducted a retrospective cohort study to evaluate subjects who were admitted to the mTBI observation protocol. We included adults within 24 h of sustaining an mTBI with a Glasgow Coma Scale (GCS) of 14 or 15 who had pre-specified head CT findings, and did not meet exclusion criteria. Predictors of need for hospital admission after completing the OU protocol were determined using multivariable logistic regression analysis. Results: The mean age was 49 (SD 23), 58 (33%) were female, and 136 (78%) were Caucasian. No subjects discharged home required a surgical intervention or ICU admission, and there were no deaths in discharged or admitted subjects. 28 subjects (16%) were admitted to the hospital following their OU stay. Subjects admitted were older (mean age: 56 vs. 48, p = 0.1) and had a higher proportion of traumatic bleeds on head CT (85% vs. 76%, p = 0.3). In multivariable logistic regression, GCS of 15 (aOR 4.24), African-American race (aOR 5.84), and no comorbid cardiac disease predicted discharge home after the observation protocol (aOR 0.28). Conclusions: A period of observation for a pre-defined cohort of patients with mTBI provided a triage plan that could allow appropriate patient management without requiring admission in the majority of subjects. (c) 2020 Elsevier Inc. All rights reserved.	[Rhame, Katherine; Le, Diana] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Ventura, Amanda; Stolz, Uwe; Adeoye, Opeolu; Kreitzer, Natalie] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45221 USA; [Horner, Amy; Ngwenya, Laura B.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45221 USA; [Andaluz, Norberto] Univ Louisville, Dept Neurosurg, Louisville, KY 40292 USA; [Miller, Christopher] Case Western Reserve Univ, Sch Med, Univ Hosp, Cleveland, OH 44106 USA; [Ngwenya, Laura B.] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH 45221 USA; [Ngwenya, Laura B.] Univ Cincinnati, Collaborat Res Acute Neurol Injury, Cincinnati, OH 45221 USA; [Adeoye, Opeolu; Kreitzer, Natalie] Univ Cincinnati, Div Neurocrit Care, Cincinnati, OH 45221 USA		Kreitzer, N (corresponding author), Med Sci Bldg Room 1513,231 Albert Sabin Dive, Cincinnati, OH 45267 USA.	kreitzne@ucmail.uc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS047996] Funding Source: Medline		af Geijerstam JL, 2004, EMERG MED J, V21, P54, DOI 10.1136/emj.2003.003178; Choudhry OJ, 2013, NEUROSURGERY, V73, P753, DOI 10.1227/NEU.0000000000000105; Innocenti F, 2017, INTERN EMERG MED, V12, P81, DOI 10.1007/s11739-016-1421-y; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Norwood SH, 2002, J TRAUMA, V53, P503, DOI 10.1097/00005373-200209000-00018; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Rhame K, 2020, ACTA NEUROL SCAND, V141, P351, DOI 10.1111/ane.13199; Rosen Claire B, 2018, Trauma Surg Acute Care Open, V3, pe000129, DOI 10.1136/tsaco-2017-000129; Ross MA, 2013, HEALTH AFFAIR, V32, P2149, DOI 10.1377/hlthaff.2013.0662; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Stippler M, 2017, WORLD NEUROSURG, V105, P265, DOI 10.1016/j.wneu.2017.05.008; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Venkatesh AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024326; Welch RD, 2001, EMERG MED CLIN N AM, V19, P137, DOI 10.1016/S0733-8627(05)70172-3; Yun BJ, 2018, ACAD EMERG MED, V25, P769, DOI 10.1111/acem.13350	24	1	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	AUG	2021	46						176	182		10.1016/j.ajem.2020.06.088			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	TU8UX	WOS:000681307200034	33071105				2022-02-06	
J	Santana-Gomez, CE; Medel-Matus, JS; Rundle, BK				Santana-Gomez, Cesar E.; Medel-Matus, Jesus Servando; Rundle, Brian K.			Animal models of post-traumatic epilepsy and their neurobehavioral comorbidities	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						TBI; PTE; Comorbidities; Animal models	TRAUMATIC BRAIN-INJURY; RIGHT PARIETAL CORTEX; CONDITIONED FREEZING DEFICIT; CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; CEREBRAL-BLOOD-FLOW; COGNITIVE DEFICITS; HEAD-INJURY; RAT MODEL; SEIZURE PRECIPITANTS	Traumatic brain injury (TBI) is defined as a disturbance in brain functioning caused by an external force. The development of post traumatic epilepsy (PTE) is a serious risk associated with TBI. Indeed, other neurological impairments are also common following TBI. In this review, we analyze and discuss the most widely used and best validated rodent models of TBI, with a particular focus on their contribution to the understanding of the PTE development. Furthermore, we explore the importance of these models for the study of other neurobehavioral comorbidities associated with brain injury. The efficient and accurate diagnosis of epilepsy and other neuro-logical comorbidities as a consequence of brain trauma should improve the survival and quality of life of patients after TBI.	[Santana-Gomez, Cesar E.] UCLA, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Medel-Matus, Jesus Servando] UCLA, Dept Pediat, Neurol Div, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Rundle, Brian K.] Baylor Scott & White Res Inst, Dallas, TX USA		Santana-Gomez, CE (corresponding author), UCLA, Reed Neurol Res Ctr, Dept Neurol, David Geffen Sch Med, Suite 2155,710 Westwood Plaza, Los Angeles, CA 90095 USA.	csantanagomez@mednet.ucla.edu					Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Andrade P, 2019, J NEUROTRAUM, V36, P1890, DOI 10.1089/neu.2018.6107; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Badaut J, 2020, J NEUROSCI RES, V98, P129, DOI 10.1002/jnr.24415; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Becker C, 2019, EPILEPSIA, V60, P648, DOI 10.1111/epi.14692; Becker C, 2015, ANN NEUROL, V78, P128, DOI 10.1002/ana.24414; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Bruce-Keller AJ, 2009, BBA-MOL BASIS DIS, V1792, P395, DOI 10.1016/j.bbadis.2008.10.004; Castanon N, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00074; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Daglas M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00981; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; DASILVA AM, 1990, ACT NEUR S, V50, P48; de Kloet CS, 2007, PROG BRAIN RES, V167, P287, DOI 10.1016/S0079-6123(07)67025-3; Dudek FE, 1997, J CLIN NEUROPHYSIOL, V14, P90, DOI 10.1097/00004691-199703000-00002; DUNN LT, 1994, ANN ROY COLL SURG, V76, P147; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Frucht MM, 2000, EPILEPSIA, V41, P1534; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Goubert E, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00012; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Graber KD, 1999, ANN NEUROL, V46, P234, DOI 10.1002/1531-8249(199908)46:2<234::AID-ANA13>3.0.CO;2-Q; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Hogg S, 1998, BEHAV BRAIN RES, V93, P157, DOI 10.1016/S0166-4328(97)00145-9; Hogg S, 1998, J NEUROTRAUM, V15, P545, DOI 10.1089/neu.1998.15.545; Hou JM, 2017, J NEUROTRAUM, V34, P2456, DOI 10.1089/neu.2016.4851; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Joels M, 2009, EPILEPSIA, V50, P586, DOI 10.1111/j.1528-1167.2008.01902.x; Juengst SB, 2017, EPILEPSY BEHAV, V73, P240, DOI 10.1016/j.yebeh.2017.06.001; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Keith KA, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10010004; Kendirli MT, 2014, EPILEPSIA, V55, P1969, DOI 10.1111/epi.12854; Khalin I, 2016, NEURAL REGEN RES, V11, P630, DOI 10.4103/1673-5374.180749; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Lai LM, 2017, LANGMUIR, V33, P9018, DOI 10.1021/acs.langmuir.7b01516; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; LIN WJ, 2019, INT J ENV RES PUB HE, V16, P1; Liska GM, 2018, NEUROREPORT, V29, P939, DOI 10.1097/WNR.0000000000001056; Liu SY, 2011, CHIN J TRAUMATOL, V14, P100, DOI 10.3760/cma.j.issn.1008-1275.2011.02.007; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Miszczuk D, 2016, MOL NEUROBIOL, V53, P7010, DOI 10.1007/s12035-015-9578-3; Moshe S, 2008, EPILEPSIA, V49, P1451, DOI 10.1111/j.1528-1167.2008.01591.x; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Nakken KO, 2005, EPILEPSY BEHAV, V6, P85, DOI 10.1016/j.yebeh.2004.11.003; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Nita DA, 2006, J NEUROPHYSIOL, V95, P902, DOI 10.1152/jn.00742.2005; Barbosa JHO, 2015, MAGN RESON IMAGING, V33, P559, DOI 10.1016/j.mri.2015.02.021; Ostergard T, 2016, J NEUROSCI METH, V272, P50, DOI 10.1016/j.jneumeth.2016.03.023; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; PAYAN H, 1970, EPILEPSIA, V11, P81, DOI 10.1111/j.1528-1157.1970.tb03869.x; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Ping XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158231; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Reddy DS, 2002, J NEUROSCI, V22, P3795; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salazar Andres M, 2015, Handb Clin Neurol, V128, P525, DOI 10.1016/B978-0-444-63521-1.00033-9; Saletti PG, 2019, NEUROBIOL DIS, V123, P86, DOI 10.1016/j.nbd.2018.06.017; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Sandu RE, 2015, NEURAL REGEN RES, V10, P1349, DOI 10.4103/1673-5374.165208; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Sherman M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0641-4; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Sperling MR, 2008, SEIZURE-EUR J EPILEP, V17, P302, DOI 10.1016/j.seizure.2007.09.003; Sutula T, 2002, EPILEPSY RES, V50, P125, DOI 10.1016/S0920-1211(02)00074-8; SWANSON SJ, 1995, BRAIN, V118, P91, DOI 10.1093/brain/118.1.91; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Teutsch P, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/6037015; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Ueda Y, 2013, NEUROCHEM RES, V38, P1399, DOI 10.1007/s11064-013-1037-9; Uski J, 2018, NEUROLOGY, V91, pE878, DOI 10.1212/WNL.0000000000006077; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; Willmore LJ, 2012, EPILEPSY CURR, V12, P87, DOI 10.5698/1535-7511-12.3.87; WILLMORE LJ, 1978, SCIENCE, V200, P1501, DOI 10.1126/science.96527; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; Wu YP, 2015, NEUROL RES, V37, P959, DOI 10.1179/1743132815Y.0000000080; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036; Zweckberger K, 2009, NEUROSCI LETT, V454, P115, DOI 10.1016/j.neulet.2009.02.014	127	1	1	2	2	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	AUG	2021	90				SI		9	16		10.1016/j.seizure.2021.05.008			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TY1GR	WOS:000683532700003	34052088				2022-02-06	
J	Shchatsko, A; Purcell, LN; Tignanelli, CJ; Charles, A				Shchatsko, Anastasiya; Purcell, Laura N.; Tignanelli, Christopher J.; Charles, Anthony			The Effect of Organ System Surgery on Intensive Care Unit Mortality in a Cohort of Critically Ill Surgical Patients	AMERICAN SURGEON			English	Article						critical care severity and operative intervention; intensive care units prognosis in surgical patients; intensive care units and organ system surgery	TRAUMATIC BRAIN-INJURY; POSTOPERATIVE COMPLICATIONS; DECOMPRESSIVE CRANIECTOMY; EMERGENCY LAPAROTOMY; HOSPITAL MORTALITY; OUTCOMES; VENTILATION; SURVIVAL; SOCIETY	Background The critical illness burden in the United States is growing with an aging population obtaining surgical intervention despite age-related comorbidities. The effect of organ system surgical intervention on intensive care units (ICUs) mortality is unknown. Methods We performed an 8-year retrospective analysis of surgical ICU patients. Poisson regression analysis was performed assessing the relative risk of in-hospital mortality based on surgical intervention. Results Of 468 000 ICU patients included, 97 968 (20.9%) were surgical admissions and 97 859 (99.9%) had complete outcomes data. Nonsurvivors were older (68.8 +/- 15.4 vs. 62.7 +/- 15.8 years, P < .001) with higher Acute Physiology, Age, Chronic Health Evaluation (APACHE) III Scores (81.4 +/- 33.6 vs. 46.7 +/- 20.1, P < .001. Patients with gastrointestinal (GI) (n = 1,558, 7.8%), musculoskeletal (n = 277, 5.5%), and neurological (n = 884, 4.6%) system operations had the highest mortality. Upon Poisson regression model, patients undergoing emergent operative interventions on the neurologic system (RR 1.86, 95% CI 1.67-2.07, P < .001) had increased relative risk of mortality when compared to emergent operative interventions on the cardiovascular system after controlling for pertinent covariates. Elective operative interventions on the respiratory (RR 2.39, 95% CI 2.03-2.80, P < .001), GI (RR 2.34, 95% CI 2.10-2.61, P < .001), and skin and soft tissue (RR 2.26, 95% CI 1.77-2.89, P < .001) systems had increased risk of mortality when compared to elective cardiovascular system surgery after controlling for pertinent covariates. Conclusion We found significant differences in the risk of mortality based on organ system of operative intervention. The prognostication of critically ill patients undergoing surgical intervention is currently not accounted for in prognostic scoring systems.	[Shchatsko, Anastasiya] Cent Michigan Univ, Dept Surg, Coll Med, Saginaw, MI USA; [Purcell, Laura N.; Charles, Anthony] Univ N Carolina, Dept Surg, Chapel Hill, NC 27515 USA; [Tignanelli, Christopher J.] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA		Charles, A (corresponding author), UNC Sch Med, Dept Surg, 4008 Burnett Womack Bldg 101 Manning Dr, Chapel Hill, NC 27599 USA.	anthchar@med.unc.edu		Tignanelli, Christopher/0000-0002-8079-5565	department of surgery, the University of North Carolina at North Carolina; NIH Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW009340]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32GM008450-23]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the department of surgery, the University of North Carolina at North Carolina. LNP is funded by a grant from the NIH Fogarty International Center #D43TW009340. AC: Research reported in this manuscript was supported by the National Institute of Health under award NIH grant #5T32GM008450-23.	Abelha Fernando José, 2006, Rev. Bras. Anestesiol., V56, P34, DOI 10.1590/S0034-70942006000100005; Agostini P, 2010, THORAX, V65, P815, DOI 10.1136/thx.2009.123083; Allen CJ, 2018, AM SURGEON, V84, P443; Awad S, 2012, WORLD J SURG, V36, P2060, DOI 10.1007/s00268-012-1614-0; Barrett ML, 2014, HEALTHC COST UT PROJ; Boyd O, 2005, CRIT CARE, V9, P390, DOI 10.1186/cc3057; Centers for Disease Control, 2010, NAT HOSP DISCH SURV; Clarke A, 2011, EUR J ANAESTH, V28, P16, DOI 10.1097/EJA.0b013e32833f5389; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cove ME, 2016, ANN THORAC SURG, V102, P28, DOI 10.1016/j.athoracsur.2016.02.071; Deiner S, 2014, J AM GERIATR SOC, V62, P829, DOI 10.1111/jgs.12794; Feng Y, 2009, CHEST, V136, P759, DOI 10.1378/chest.09-0515; Garcea G, 2010, J SURG RES, V159, P729, DOI 10.1016/j.jss.2008.08.013; Goodney PP, 2005, ANN SURG, V241, P179; Hameed M., 2015, CRIT CARE, V19, pP519, DOI [10.1186/cc14599, DOI 10.1186/CC14599]; 심윤수, 2015, Acute and Critical Care, V30, P1; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Martini V, 2017, CRIT CARE RES PRACT, V2017, DOI 10.1155/2017/9852017; McNicol L, 2007, MED J AUSTRALIA, V186, P447, DOI 10.5694/j.1326-5377.2007.tb00994.x; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Morris RS, 2020, J TRAUMA ACUTE CARE, V88, P416, DOI 10.1097/TA.0000000000002569; Moussa WMM, 2017, NEUROSURG REV, V40, P115, DOI 10.1007/s10143-016-0743-6; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Pearse RM, 2006, CRIT CARE, V10, DOI 10.1186/cc4928; Raghavan A, 2020, WORLD NEUROSURG, V134, pE196, DOI 10.1016/j.wneu.2019.10.023; Reis P, 2019, SURG TODAY, V49, P836, DOI 10.1007/s00595-019-01805-w; Rose J, 2015, LANCET GLOB HEALTH, V3, pS13, DOI 10.1016/S2214-109X(15)70087-2; Saunders DI, 2012, BRIT J ANAESTH, V109, P368, DOI 10.1093/bja/aes165; Shahian DM, 2009, ANN THORAC SURG, V88, pS1, DOI 10.1016/j.athoracsur.2009.05.054; Sorensen LT, 2007, J GASTROINTEST SURG, V11, P903, DOI 10.1007/s11605-007-0165-4; St-Louis E, 2016, EUR J TRAUMA EMERG S, V42, P107, DOI 10.1007/s00068-015-0517-9; Taylor BL, 2019, NEUROLOGY, V92, pE1975, DOI 10.1212/WNL.0000000000007364; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Timmers TK, 2011, ANN SURG, V253, P151, DOI 10.1097/SLA.0b013e3181ff45df; Tobi KU, 2016, SOUTH AFR J ANAESTH, V22, P135, DOI 10.1080/22201181.2016.1206293; US Cenus, ANN EST RES POP SEL; Vester-Andersen M, 2014, BRIT J ANAESTH, V112, P860, DOI 10.1093/bja/aet487; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X	38	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	AUG	2021	87	8					1230	1237		10.1177/0003134820956353			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UQ3DD	WOS:000695947200007	33342251				2022-02-06	
J	Shibata, A; Matano, F; Saito, N; Fujiki, Y; Matsumoto, H; Mizunari, T; Morita, A				Shibata, Ami; Matano, Fumihiro; Saito, Nobuyuki; Fujiki, Yu; Matsumoto, Hisashi; Mizunari, Takayuki; Morita, Akio			Serum Glucose-To-Potassium Ratio as a Prognostic Predictor for Severe Traumatic Brain Injury	JOURNAL OF NIPPON MEDICAL SCHOOL			English	Article						head injury; prognostic predictor; traumatic brain injury; glucose-to-potassium ratio	EARLY MANAGEMENT; HEAD-INJURY; RISK-FACTOR; HYPOKALEMIA; CHILDREN; HYPERGLYCEMIA; COAGULATION	Background: Initial management of severe traumatic brain injury is important and includes treatment decision-making and prediction of prognosis. We examined whether biomarkers at admission could be useful prognostic predictors. We focused on electrolytes and blood glucose, which can be measured easily at any facility and for which results can be obtained promptly, before those of other biomarkers, such as D-dimer. Methods: All trauma patients with head injuries treated at Chiba Hokusoh Hospital between 2014 and 2017 were investigated. Cases of multiple trauma accompanied by fatal trauma, hemorrhagic shock, or cardiopulmonary arrest, and pediatric cases, were excluded from this study. Blood gas data at the initial hospital visit were reviewed retrospectively. A poor outcome was defined as death during hospitalization or a vegetative state due to head injury. Factors related to poor outcomes were analyzed. Results: Of the 185 male and 79 female patients studied, 34 had poor outcomes. Poor outcome was significantly correlated with potassium (P = 0.003), glucose (P < 0.001), and glucose-to-potassium ratio (P < 0.001) at arrival. The odds ratio was 4.079 for a glucose-to-potassium ratio of >= 50. Conclusions: We evaluated blood gas data at the initial hospital visit, as these results can be obtained more quickly than those of other biomarkers assessed previously. Serum glucose-to-potassium ratio at admission may be a potential predictor of prognosis for severe traumatic brain injury.	[Shibata, Ami] Nippon Med Sch, Dept Emergency & Crit Care Med, Tama Nagayama Hosp, Tama Ku, 1-7-1 Nagayama, Tokyo 2068512, Japan; [Matano, Fumihiro; Morita, Akio] Nippon Med Coll Hosp, Dept Neurol Surg, Tokyo, Japan; [Saito, Nobuyuki; Matsumoto, Hisashi] Chiba Hokusoh Hosp, Dept Emergency & Crit Care Med, Nippon Med Sch, Chiba, Japan; [Fujiki, Yu] Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Mizunari, Takayuki] Chiba Hokusoh Hosp, Dept Neurol Surg, Nippon Med Sch, Chiba, Japan		Shibata, A (corresponding author), Nippon Med Sch, Dept Emergency & Crit Care Med, Tama Nagayama Hosp, Tama Ku, 1-7-1 Nagayama, Tokyo 2068512, Japan.	068m1044@nms.ac.jp		Morita, Akio/0000-0002-2497-5772			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; BROWN MJ, 1983, NEW ENGL J MED, V309, P1414, DOI 10.1056/NEJM198312083092303; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Elkon B, 2014, PEDIATR CRIT CARE ME, V15, P623, DOI 10.1097/PCC.0000000000000170; Eskesen V, 2014, UGESKRIFT LAEGER, V176; Fujiki Y, 2017, J NEUROSURG, V6; Fukui S, 2002, NEUROLOGY, V59, P134, DOI 10.1212/WNL.59.1.134; JEEVANANDAM M, 1990, J TRAUMA, V30, P582, DOI 10.1097/00005373-199005000-00010; MacDonald JS, 2003, J TRAUMA, V54, P197, DOI 10.1097/00005373-200301000-00028; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Mees SMD, 2003, NEUROLOGY, V61, P1132, DOI 10.1212/01.WNL.0000090466.68866.02; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Ookuma T, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0103-6; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Rhine T, 2012, J TRAUMA ACUTE CARE, V73, pS248, DOI 10.1097/TA.0b013e31826b0062; ROLIH CA, 1995, MED CLIN N AM, V79, P211, DOI 10.1016/S0025-7125(16)30093-1; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salehpour F, 2011, J CRIT CARE, V26, P352, DOI 10.1016/j.jcrc.2010.12.005; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; Wafaisade A, 2013, J TRAUMA ACUTE CARE, V74, P387, DOI 10.1097/TA.0b013e31827e2410; Wu X, 2015, INJURY, V46, P35, DOI 10.1016/j.injury.2014.08.002; Yokota J, 2016, NIHON RINSHO, V74, P36	24	1	1	0	0	MEDICAL ASSOC NIPPON MEDICAL SCH	TOKYO	1-1-5, SENDAGI, TOKYO, 113-8602, JAPAN	1345-4676	1347-3409		J NIPPON MED SCH	J. Nippon Med. Sch.	AUG	2021	88	4					342	346		10.1272/jnms.JNMS.2021_88-506			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XC0SS	WOS:000721731700011	32999180	gold			2022-02-06	
J	Sullan, MJ; Crocker, LD; Thomas, KR; Orff, HJ; Davey, DK; Jurick, SM; Twamley, EW; Norman, SB; Schiehser, DM; Aupperle, R; Jak, AJ				Sullan, Molly J.; Crocker, Laura D.; Thomas, Kelsey R.; Orff, Henry J.; Davey, Delaney K.; Jurick, Sarah M.; Twamley, Elizabeth W.; Norman, Sonya B.; Schiehser, Dawn M.; Aupperle, Robin; Jak, Amy J.			Baseline sleep quality moderates symptom improvement in veterans with comorbid PTSD and TBI receiving trauma-focused treatment	BEHAVIOUR RESEARCH AND THERAPY			English	Article						Sleep; PTSD; TBI; Treatment; Cognitive symptoms; Neuropsychology	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; DISTURBANCES; INSOMNIA; CONSEQUENCES; DEPRESSION; MILITARY; CONTEXT	Poor sleep quality is common among Veterans with posttraumatic stress disorder (PTSD) and history of traumatic brain injury (TBI). However, the relationship between sleep quality and treatment outcomes following traumafocused interventions is less well-understood in this population. We sought to better understand whether 1) sleep quality changed as a result of trauma-focused treatment and 2) if baseline sleep quality moderated psychological and neurobehavioral treatment outcomes. Our sample consisted of 100 Iraq/Afghanistan era Veterans with PTSD and history of mild to moderate TBI who were randomized to one of two trauma-focused treatments: 1) Cognitive Processing Therapy (CPT) or 2) combined CPT and Cognitive Symptom Management and Rehabilitation Therapy (SMART-CPT). Self-reported sleep quality, psychiatric symptoms (PTSD and depression), and neurobehavioral concerns were assessed at multiple timepoints throughout the study. Multilevel modeling showed sleep quality did not improve, regardless of treatment condition. However, worse baseline sleep quality was associated with less improvement in PTSD symptoms and cognitive complaints. There was no effect of baseline sleep quality on change in depression symptoms. These findings suggest that more targeted treatments to address sleep quality either prior to or in conjunction with trauma-focused therapy may help to improve treatment outcomes for Veterans with comorbid PTSD and TBI history.	[Sullan, Molly J.; Norman, Sonya B.; Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Crocker, Laura D.; Orff, Henry J.; Jurick, Sarah M.; Twamley, Elizabeth W.; Norman, Sonya B.; Schiehser, Dawn M.; Jak, Amy J.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Crocker, Laura D.; Thomas, Kelsey R.; Orff, Henry J.; Davey, Delaney K.; Jurick, Sarah M.; Twamley, Elizabeth W.; Schiehser, Dawn M.] VA San Diego Healthcare Syst, Res Serv, 3350 La Jolla Village Dr,Bldg 13, San Diego, CA 92161 USA; [Sullan, Molly J.; Thomas, Kelsey R.; Orff, Henry J.; Jurick, Sarah M.; Twamley, Elizabeth W.; Norman, Sonya B.; Schiehser, Dawn M.; Jak, Amy J.] Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr, San Diego, CA 92093 USA; [Norman, Sonya B.] Natl Ctr PTSD, White River Jct, VT USA; [Aupperle, Robin] Laureate Inst Brain Res, Tulsa, OK USA; [Aupperle, Robin] Univ Tulsa, Sch Community Med, Tulsa, OK 74104 USA		Jak, AJ (corresponding author), 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ajak@health.ucsd.edu		Davey, Delaney/0000-0003-4784-8925; Twamley, Elizabeth/0000-0002-8693-8782; , Sarah/0000-0002-5573-6459	Department of DefenseUnited States Department of Defense [W81XWH1110641]; VA Rehabilitation Research & Development (RR&D) Service Career Development Awards [IK2 RX002459, IK2 RX00151201A2]; VA RRD MERIT [1 I01 RX001691]	Funding was provided by the Department of Defense (award W81XWH1110641) . During their work on the study, Laura Crocker and Henry Orff received salary support from the VA Rehabilitation Research & Development (RR&D) Service Career Development Awards (award IK2 RX002459 and IK2 RX00151201A2, respectively) , and Dawn Schiehser received salary support from VA RR&D MERIT (award 1 I01 RX001691) . None of these funding sources had a role in any aspect of the study, including study design, data collection, data analysis, interpretation of the data, writing of the manuscript, or in the decision to submit the article for publication. There are no conflicts of interest to report.	Adkins JW, 2008, J ANXIETY DISORD, V22, P1393, DOI 10.1016/j.janxdis.2008.02.002; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890423349; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brudey C, 2015, AM J PHYSIOL-REG I, V309, pR315, DOI 10.1152/ajpregu.00343.2014; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Colvonen PJ, 2019, PSYCHOL TRAUMA-US, V11, P107, DOI 10.1037/tra0000402; Colvonen PJ, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0916-9; Colvonen PJ, 2019, BEHAV SLEEP MED, V17, P524, DOI 10.1080/15402002.2018.1425869; Crocker LD, 2019, J PSYCHIATR RES, V116, P7, DOI 10.1016/j.jpsychires.2019.05.022; DoD, 2016, WORLDW NUMB TRAUM BR; Dyer AH, 2016, NEUROSCIENCE, V325, P89, DOI 10.1016/j.neuroscience.2016.03.056; Elliott JE, 2019, SLEEP, V42; Fink AM, 2018, CLIN AUTON RES, V28, P509, DOI 10.1007/s10286-018-0560-9; Galovski TE, 2009, J TRAUMA STRESS, V22, P197, DOI 10.1002/jts.20418; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Gloger EM, 2020, ARCH CLIN NEUROPSYCH, V35, P692, DOI 10.1093/arclin/acaa023; Gutner CA, 2013, BEHAV RES THER, V51, P817, DOI 10.1016/j.brat.2013.09.008; Haimov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061390; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; Jurick SM, 2020, J INT NEUROPSYCH SOC, V26, P108, DOI 10.1017/S1355617719000997; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lommen MJJ, 2016, DEPRESS ANXIETY, V33, P575, DOI 10.1002/da.22420; Lopez CM, 2017, J PSYCHOPATHOL BEHAV, V39, P755, DOI 10.1007/s10862-017-9618-6; Maher MJ, 2006, CNS DRUGS, V20, P567, DOI 10.2165/00023210-200620070-00003; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rajpathak SN, 2009, DIABETES-METAB RES, V25, P3, DOI 10.1002/dmrr.919; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Rusch HL, 2015, J CLIN SLEEP MED, V11, P615, DOI 10.5664/jcsm.4770; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schnurr PP, 2019, DEPRESS ANXIETY, V36, P162, DOI 10.1002/da.22871; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tapp ZM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00345; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; van Liempt S, 2013, PSYCHONEUROENDOCRINO, V38, P155, DOI 10.1016/j.psyneuen.2012.05.015; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Weathers F., 1994, PTSD CHECKL SPEC VER; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Woodard JL, 2017, NEUROPSYCHOLOGY, V31, P1020, DOI 10.1037/neu0000386	57	1	1	2	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-7967	1873-622X		BEHAV RES THER	Behav. Res. Ther.	AUG	2021	143								103892	10.1016/j.brat.2021.103892			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	ST1UV	WOS:000662237000007	34091276				2022-02-06	
J	Tang, AR; Reynolds, RA; Dallas, J; Chen, HD; Vance, EH; Bonfield, CM; Shannon, CN				Tang, Alan R.; Reynolds, Rebecca A.; Dallas, Jonathan; Chen, Heidi; Vance, E. Haley; Bonfield, Christopher M.; Shannon, Chevis N.			Admission trends in pediatric isolated linear skull fracture across the United States	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						children; skull fracture; transfer; traumatic brain injury; TBI; USA; trauma	TRAUMATIC BRAIN-INJURY; HEAD; CHILDREN; MANAGEMENT; NECESSITY; NEED	OBJECTIVE Pediatric isolated linear skull fractures commonly result from head trauma and rarely require surgery, yet patients are often admitted to the hospital-a costly care plan. In this study, the authors utilized a national database to investigate trends in admission for skull fractures across the United States. METHODS Children younger than 18 years with isolated linear skull fracture, according to ICD-9 diagnosis codes in the Kids' Inpatient Database of the Healthcare and Utilization Project (HCUP), who presented between 2003 and 2016 were included. HCUP collected data in 2003, 2006, 2009, 2012, and 2016. Children with a depressed skull fracture, multiple traumatic injuries, and acute intracranial findings were excluded. Sample-level data were translated into population-level data by using an HCUP-specific discharge weight. RESULTS Overall, 11,355 patients (64% males) were admitted to 1605 hospitals. National admissions decreased from 3053 patients in 2003 to 1203 in 2016. The mean +/- SD age at admission also decreased from 6.3 +/- 5.9 years to 1.2 +/- 3.0 years (p < 0.001). The proportion of patients in the lowest quartile of median household income increased by 9%, while that in the highest income quartile decreased by 7% (p < 0.001). Admission was generally more common in the summer months (June, July, and August) and on weekdays (68%). The mean +/- SD hospital length of stay decreased from 2.0 +/- 3.1 days to 1.4 +/- 1.4 days between 2003 and 2012, and then increased to 2.1 +/- 6.8 days in 2016 (p < 0.001). When adjusted for inflation, the mean total hospital charges increased from $13,099 to $21,204 (p < 0.001). The greatest proportion of admissions was in the South (35%), and the lowest was in the Northeast (17%). The proportion of patients admitted to large hospitals increased (59% to 72%, p < 0.001), which corresponded to a decrease in patients admitted to small hospitals (16% to 9%, p < 0.001). Overall, the total proportion of admissions to rural hospitals decreased by 6%, and that to urban teaching centers increased by 15% (p < 0.001). Since 2003, no child has undergone a neurosurgical procedure or died as an inpatient. CONCLUSIONS This study identified a general nationwide decrease in admissions for pediatric linear isolated skull fracture, but associated costs increased. Admissions became less common at smaller rural hospitals and more common at larger urban teaching hospitals. This patient population required no inpatient neurosurgical intervention after 2003.	[Tang, Alan R.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Tang, Alan R.; Reynolds, Rebecca A.; Dallas, Jonathan; Chen, Heidi; Vance, E. Haley; Bonfield, Christopher M.; Shannon, Chevis N.] Monroe Carell Jr Childrens Hosp Vanderbilt, Surg Outcomes Ctr Kids, Nashville, TN USA; [Reynolds, Rebecca A.; Vance, E. Haley; Bonfield, Christopher M.; Shannon, Chevis N.] Vanderbilt Univ, Dept Neurol Surg, Med Ctr, Nashville, TN USA; [Dallas, Jonathan] Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90007 USA; [Chen, Heidi] Vanderbilt Univ, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA		Reynolds, RA (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.	rebecca.a.kasl@vumc.org			Vanderbilt Institute for Clinical and Translational Research [5UL1TR002243-03]	This project was funded in part by the Vanderbilt Institute for Clinical and Translational Research (award no. 5UL1TR002243-03). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson GF, 2019, HEALTH AFFAIR, V38, P87, DOI 10.1377/hlthaff.2018.05144; [Anonymous], 2019, TBI REL EM DEP VIS H TBI REL EM DEP VIS H; [Anonymous], CPI INFL CALC; [Anonymous], Hospital adjusted expenses per inpatient day by ownership; Blackwood BP, 2016, J PEDIATR SURG, V51, P654, DOI 10.1016/j.jpedsurg.2015.08.064; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Bressan S, 2018, ANN EMERG MED, V71, P714, DOI 10.1016/j.annemergmed.2017.10.014; Dallas J, 2020, J NEUROSURG-PEDIATR, V25, P284, DOI 10.3171/2019.9.PEDS19203; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Donaldson K, 2019, PEDIATR EMERG CARE, V35, P301, DOI 10.1097/PEC.0000000000001814; Freeman MD, 2014, J FORENSIC LEG MED, V21, P64, DOI 10.1016/j.jflm.2013.08.005; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Hentzen AS, 2015, AM J SURG, V210, P322, DOI 10.1016/j.amjsurg.2014.11.011; Homme JL, 2018, EMERG MED CLIN N AM, V36, P287, DOI 10.1016/j.emc.2017.12.015; KID Overview, HEALTHC COST UT PROJ; Kommaraju K, 2019, PEDIATR NEUROSURG, V54, P21, DOI 10.1159/000495792; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lyons TW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3370; Mackel CE, 2018, J NEUROSURG-PEDIATR, V22, P375, DOI 10.3171/2018.5.PEDS182; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Metzger RR, 2014, J PEDIATR SURG, V49, P1856, DOI 10.1016/j.jpedsurg.2014.09.038; Northam W, 2019, J NEUROSURG-PEDIATR, V24, P489, DOI 10.3171/2019.5.PEDS18739; Orman G, 2015, J NEUROSURG-PEDIATR, V16, P426, DOI 10.3171/2015.3.PEDS1553; Plackett TP, 2015, J PEDIATR SURG, V50, P1758, DOI 10.1016/j.jpedsurg.2015.03.067; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Reuveni-Salzman A, 2016, CHILD NERV SYST, V32, P1669, DOI 10.1007/s00381-016-3175-2; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Snyder CW, 2019, J TRAUMA ACUTE CARE, V86, P92, DOI 10.1097/TA.0000000000002087; Stephens S, 2019, J CLIN NEUROSCI, V70, P27, DOI 10.1016/j.jocn.2019.09.008; Tunik MG, 2016, ANN EMERG MED, V68, P431, DOI 10.1016/j.annemergmed.2016.04.058; White IK, 2016, J NEUROSURG-PEDIATR, V17, P602, DOI 10.3171/2015.9.PEDS15352; Williams DC, 2018, PEDIATR EMERG CARE, V34, P403, DOI 10.1097/PEC.0000000000001324; Williams DC, 2017, PEDIATR EMERG CARE, V33, pE146, DOI 10.1097/PEC.0000000000001329	34	1	1	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2021	28	2					183	195		10.3171/2020.12.PEDS20659			13	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	TU9PW	WOS:000681362700004	34087799				2022-02-06	
J	Turner, JS; Tollison, AC; Hopkins, B; Poloskey, L; Fontaine, D				Turner, Jacob S.; Tollison, Andrew C.; Hopkins, Birgid; Poloskey, Leah; Fontaine, Dennis			Sport-Related Concussion Education and the Elaboration Likelihood Model: Need for Cognition as Mediator Between Health Literacy and Concussion Education Efficacy	COMMUNICATION & SPORT			English	Article						sports-related concussion education; elaboration likelihood model; need for cognition; health message matching; health literacy	SCHOOL FOOTBALL PLAYERS; ICE HOCKEY; INFORMATION; PREVENTION; MANAGEMENT; KNOWLEDGE; ATTITUDE; BRAIN; COMMUNICATION; DISCLOSURE	The current study examines the ways the elaboration likelihood model of persuasion can be applied to message design of concussion education programs. Results from a survey of collegiate athletes (N = 353) illustrate that it is not only students' generalized ability to understand health information (health literacy) that determines knowledge of concussion symptoms but also one's motivation to think deeply about concussion protocols (need for cognition [NFC]). Current results show that NFC mediated the relationship between health literacy and the collegiate athletes' knowledge of concussion symptoms. Collegiate athletes' concussion protocols aimed at increasing concussion reportage rates should be multimodal (rather than standardized textual lecture-based approaches) to be better fitting individualized approaches to cognitive processing of complex health-related messages and to begin to address the sociocultural contexts and complexities associated with athletes' stay-on-the-field bias, which makes the burden of behavioral change particularly difficult in concussion education efforts.	[Turner, Jacob S.; Tollison, Andrew C.; Hopkins, Birgid; Poloskey, Leah; Fontaine, Dennis] Merrimack Coll, 315 Turnpike St, N Andover, MA 01845 USA		Turner, JS (corresponding author), Merrimack Coll, 315 Turnpike St, N Andover, MA 01845 USA.	turnerjs@merrimack.edu					Bakker AB, 1999, AIDS EDUC PREV, V11, P150; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Belson Ken, 2017, NEW YORK TIMES; Braverman J, 2008, COMMUN RES, V35, P666, DOI 10.1177/0093650208321785; Brayton S, 2019, COMMUN SPORT, V7, P110, DOI 10.1177/2167479517740342; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Cacioppo JT, 1996, PSYCHOL BULL, V119, P197, DOI 10.1037/0033-2909.119.2.197; CACIOPPO JT, 1983, J PERS SOC PSYCHOL, V45, P805, DOI 10.1037/0022-3514.45.4.805; Cacioppo JT, 1985, PSYCHOL PROCESSES AD, P91; Cantu R., 2012, CONCUSSIONS OUR KIDS; Catlin JR, 2012, HEALTH COMMUN, V27, P264, DOI 10.1080/10410236.2011.578335; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Cranmer GA, 2018, INT J SPORT COMMUN, V11, P241, DOI 10.1123/ijsc.2017-0120; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Dean NA, 2019, SOCIOL SPORT J, V36, P22, DOI 10.1123/ssj.2018-0033; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Donovan-Kicken E, 2013, PATIENT EDUC COUNS, V90, P254, DOI 10.1016/j.pec.2012.10.007; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Gianotti S, 2007, NEUROREHABILITATION, V22, P181; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Gleadhill S., 2014, J FITNESS RES, V3, P8; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Harrington NG, 2006, MEDIA PSYCHOL, V8, P139, DOI 10.1207/s1532785xmep0802_5; Hayes A.F., 2012, PROCESS MACRO; Henning B, 2001, J COMMUN, V51, P100, DOI 10.1111/j.1460-2466.2001.tb02874.x; Ho SS, 2013, J HEALTH COMMUN, V18, P773, DOI 10.1080/10810730.2012.743624; Jhally Sut, 1984, CRIT SOCIOL, V12, P41; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Krezmien E, 2011, J HEALTH COMMUN, V16, P831, DOI 10.1080/10810730.2011.561909; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kutner M, 2006, HLTH LITERACY AM ADU; Latimer AE, 2005, J HEALTH COMMUN, V10, P137, DOI 10.1080/10810730500263364; Malcolm D, 2018, SOCIOL SPORT J, V35, P141, DOI 10.1123/ssj.2017-0113; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2012, J CLIN SPORT PSYCHOL, V6, P275, DOI 10.1123/jcsp.6.3.275; McMahon J, 2018, SOCIOL SPORT J, V35, P314, DOI 10.1123/ssj.2017-0186; NCAA, DIV DIFF HIST MULT C; NCAA , 2015, CONC SAFY BEST PRACT; Petty RE, 1986, COMMUNICATION PERSUA, V19, P123, DOI DOI 10.1016/S0065-2601(08)60214-2; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Ratzen SC, 2000, NATL LIB MED CURRENT; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rigby J, 2013, J ATHL TRAINING, V48, P636, DOI 10.4085/1062-6050-48.3.10; Rucker DD, 2006, J PUBLIC POLICY MARK, V25, P39, DOI 10.1509/jppm.25.1.39; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Sandvik MR, 2017, SOCIOL SPORT J, V34, P195, DOI 10.1123/ssj.2016-0073; Shah LC, 2010, J AM BOARD FAM MED, V23, P195, DOI 10.3122/jabfm.2010.02.070278; Shen L, 2009, COMMUN RES, V36, P104, DOI 10.1177/0093650208326466; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Tator CH, 2012, J CLIN SPORT PSYCHOL, V6, P293, DOI 10.1123/jcsp.6.3.293; Thomas JD, 2018, SOCIOL SPORT J, V35, P108, DOI 10.1123/ssj.2017-0181; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; Williams-Piehota P, 2006, HEALTH COMMUN, V19, P75, DOI 10.1207/s15327027hc1901_8; Williams-Piehota P, 2003, HEALTH COMMUN, V15, P375, DOI 10.1207/S15327027HC1504_01	63	1	1	7	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	AUG	2021	9	4					527	549		10.1177/2167479519875709			23	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	SX2SN	WOS:000665060300001					2022-02-06	
J	Weil, ZM; Karelina, K; Whitehead, B; Velazquez-Cruz, R; Oliverio, R; Pinti, M; Nwafor, DC; Nicholson, S; Fitzgerald, JA; Hollander, J; Brown, CM; Zhang, N; DeVries, AC				Weil, Zachary M.; Karelina, Kate; Whitehead, Bailey; Velazquez-Cruz, Ruth; Oliverio, Robin; Pinti, Mark; Nwafor, Divine C.; Nicholson, Samuel; Fitzgerald, Julie A.; Hollander, John; Brown, Candice M.; Zhang, Ning; DeVries, A. Courtney			Mild traumatic brain injury increases vulnerability to cerebral ischemia in mice	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Stroke; Metabolism; Vasculature; Inflammation; Reperfusion	OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL DYSFUNCTION; STROKE RISK; INSULIN; INFLAMMATION; BARRIER; PATHOPHYSIOLOGY; MICROVESSELS; CONCUSSION; DISRUPTION	Recent studies have reported that TBI is an independent risk factor for subsequent stroke. Here, we tested the hypothesis that TBI would exacerbate experimental stroke outcomes via alternations in neuroimmune and neurometabolic function. We performed a mild closed-head TBI and then one week later induced an experimental stroke in adult male mice. Mice that had previously experienced TBI exhibited larger infarcts, greater functional deficits, and more pronounced neuroinflammatory responses to stroke. We hypothesized that impairments in central metabolic physiology mediated poorer outcomes after TBI. To test this, we treated mice with the insulin sensitizing drug pioglitazone (Pio) after TBI. Pio prevented the exacerbation of ischemic outcomes induced by TBI and also blocked the induction of insulin insensitivity by TBI. However, tissue respiratory function was not improved by Pio. Finally, TBI altered microvascular responses including promoting vascular accumulation of serum proteins and significantly impairing blood flow during the reperfusion period after stroke, both of which were reversed by treatment with Pio. Thus, TBI appears to exacerbate ischemic outcomes by impairing metabolic and microvascular physiology. These data have important implications because TBI patients experience strokes at greater rates than individuals without a history of head injury, but these data suggest that those strokes may also cause greater tissue damage and functional impairments in that population.	[Weil, Zachary M.; Karelina, Kate; Whitehead, Bailey; Velazquez-Cruz, Ruth; Oliverio, Robin; Nwafor, Divine C.; Brown, Candice M.; Zhang, Ning] West Virginia Univ, WVU Rockefeller Neurosci Inst, Dept Neurosci, BMRC, 1 Med Ctr Dr,POB 9303, Morgantown, WV 26506 USA; [Pinti, Mark; Hollander, John] West Virginia Univ, Dept Exercise Physiol, Sch Med, 1 Med Ctr Dr, Morgantown, WV 26506 USA; [Pinti, Mark; Hollander, John] West Virginia Univ, Sch Med, Mitochondria Metab & Bioenerget Working Grp, 1 Med Ctr Dr, Morgantown, WV 26506 USA; [Nicholson, Samuel; Fitzgerald, Julie A.] Ohio State Univ, Dept Neurosci, 460 West 12th Ave, Columbus, OH 43210 USA; [DeVries, A. Courtney] West Virginia Univ, WVU Canc Inst, WVU Rockefeller Neurosci Inst, Dept Med,BMRC, 1 Med Ctr Dr,POB 9303, Morgantown, WV 26506 USA		Weil, ZM (corresponding author), West Virginia Univ, WVU Rockefeller Neurosci Inst, Dept Neurosci, BMRC, 1 Med Ctr Dr,POB 9303, Morgantown, WV 26506 USA.	zachary.weil@hsc.wvu.edu		Brown, Candice/0000-0001-5845-0221	American Heart AssociationAmerican Heart Association; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20GM109098, R01-HL-128485]; Community Foundation for the Ohio Valley Whipkey Trust; West Virginia University for Clinical and Translational Science Institute	This work supported by grants from American Heart Association, NIH P20GM109098 (to ZMW) and R01-HL-128485 (to JMH) and additional support was provided by Community Foundation for the Ohio Valley Whipkey Trust and the West Virginia University for Clinical and Translational Science Institute. The authors acknowledge the assistance of Connie Talbot at the John Hopkins Transcriptomics and Deep Sequencing facility. As well as the Mitochondria and Bioenergetics and Stroke core facilities at WVU.	Abcouwer SF, 2008, INVEST OPHTH VIS SCI, V49, P5581, DOI 10.1167/iovs.07-1032; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Albrecht JS, 2015, J HEAD TRAUMA REHAB, V30, pE62, DOI 10.1097/HTR.0000000000000035; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Arbel-Ornath M, 2013, ACTA NEUROPATHOL, V126, P353, DOI 10.1007/s00401-013-1145-2; Ashabi G, 2015, METAB BRAIN DIS, V30, P747, DOI 10.1007/s11011-014-9632-2; Badhwar A, 2017, J CEREBR BLOOD F MET, V37, P1120, DOI 10.1177/0271678X16655172; Bai J, 2015, INT J STROKE, V10, P143, DOI 10.1111/ijs.12434; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Blazquez E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00161; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; Dandona P, 2007, CURR OPIN CLIN NUTR, V10, P511, DOI 10.1097/MCO.0b013e3281e38774; Deng YB, 2020, GENES DIS, V7, P253, DOI 10.1016/j.gendis.2019.05.002; Duarte AI, 2006, DIABETES, V55, P2863, DOI 10.2337/db06-0030; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; El Amki M, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108260; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fried NT, 2014, AM J PHYSIOL-CELL PH, V307, pC1017, DOI 10.1152/ajpcell.00332.2013; Frith D, 2012, CURR OPIN ANESTHESIO, V25, P229, DOI 10.1097/ACO.0b013e3283509675; Garg R, 2006, STROKE, V37, P267, DOI 10.1161/01.STR.0000195175.29487.30; George PM, 2015, NEURON, V87, P297, DOI 10.1016/j.neuron.2015.05.041; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glenn MB, 2010, J HEAD TRAUMA REHAB, V25, P68, DOI 10.1097/HTR.0b013e3181be1eab; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Hanefeld M, 2001, INT J CLIN PRACT, P19; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Katakam PVG, 2009, J CEREBR BLOOD F MET, V29, P1955, DOI 10.1038/jcbfm.2009.177; Kobayashi T, 2007, INVEST OPHTH VIS SCI, V48, P2350, DOI 10.1167/iovs.06-1357; Kramer M, 2010, J NEUROSCI METH, V187, P84, DOI 10.1016/j.jneumeth.2009.12.020; Lassmann H, 2016, BBA-MOL BASIS DIS, V1862, P506, DOI 10.1016/j.bbadis.2015.09.018; Lee I, 2014, BBA-MOL BASIS DIS, V1842, P1579, DOI 10.1016/j.bbadis.2014.05.031; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Liu SW, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030230; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Morris NA, 2017, NEUROHOSPITALIST, V7, P122, DOI 10.1177/1941874416675796; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Ostergaard L, 2016, J CEREBR BLOOD F MET, V36, P302, DOI 10.1177/0271678X15606723; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Sun Q, 2014, WORLD J DIABETES, V5, P89, DOI 10.4239/wjd.v5.i2.89; Rhea EM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00521; Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schreiber S, 2012, J CEREBR BLOOD F MET, V32, P278, DOI 10.1038/jcbfm.2011.122; Schuh RA, 2011, J NEUROSCI RES, V89, P1979, DOI 10.1002/jnr.22650; Schwarzmaier SM, 2016, J NEUROTRAUM, V33, P1634, DOI 10.1089/neu.2015.4173; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SHUAIB A, 1995, NEUROSCIENCE, V67, P809, DOI 10.1016/0306-4522(95)00093-X; Smith Wade S, 2004, J Vasc Interv Radiol, V15, pS3; Soares BP, 2010, STROKE, V41, pE34, DOI 10.1161/STROKEAHA.109.568766; Sun YY, 2012, J NEUROSCI METH, V203, P122, DOI 10.1016/j.jneumeth.2011.09.029; Underwood E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69867-2; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; van Horssen J, 2013, MULT SCLER J, V19, P365; Vespa P, 2017, CURR OPIN NEUROL, V30, P563, DOI 10.1097/WCO.0000000000000506; Vicent D, 2003, J CLIN INVEST, V111, P1373, DOI 10.1172/JCI200315211; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	70	1	1	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2021	342								113765	10.1016/j.expneurol.2021.113765			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SN4JI	WOS:000658257300002	33992581				2022-02-06	
J	Zhang, L; Jackson, WJ; Bentil, SA				Zhang, Ling; Jackson, William J.; Bentil, Sarah A.			Deformation of an airfoil-shaped brain surrogate under shock wave loading	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						bTBI; Polydimethylsiloxane; PDMS; DIC; Shock wave; Brain surrogate	DIGITAL IMAGE CORRELATION; CONSTITUTIVE MODEL; OXIDATIVE STRESS; ELEMENT-ANALYSIS; STRAIN-RATE; TISSUE; PRESSURE; VALIDATION; RESPONSES; RUBBER	Improvised explosive devices (IEDs), during military operations, has increased the incidence of blast-induced traumatic brain injuries (bTBI). The shock wave is created following detonation of the IED. This shock wave propagates through the atmosphere and may cause bTBI. As a result, bTBI research has gained increased attention since this injury's mechanism is not thoroughly understood. To develop better protection and treatment against bTBI, further studies of soft material (e.g. brain and brain surrogate) deformation due to shock wave exposure are essential. However, the dynamic mechanical behavior of soft materials, subjected to high strain rates from shock wave exposure, remains unknown. Thus, an experimental approach was applied to study the interaction between the shock wave and an unconfined brain surrogate fabricated from a biomaterial (i.e. polydimethylsiloxane (PDMS)). The 1:70 ratio of curing agent-to-base determined the stiffness of the PDMS (Sylgard 184, Dow Corning Corporation). A stretched NACA 2414 (upper airfoil surface) geometry was utilized to resemble the shape of a porcine brain. Digital image correlation (DIC) technique was applied to measure the deformation on the brain surrogate's surface following shock wave exposure. A shock tube was utilized to create the shock wave and pressure transducers measured the pressure in the vicinity of the brain surrogate. A transient structural analysis using ANSYS Workbench was performed to predict the elastic modulus of 1:70 airfoil-shaped PDMS, at a strain rate on the order of 6 x 10(3) s(-1). Both compression and protrusion of the PDMS surface were found due to the shock wave exposure. Negative pressure was found in a semi-ring area, which was the cause of protrusion. Oscillation of the brain surrogate, due to the shock wave loading, was found. The frequency of oscillation does not depend on the geometry. This work will add to the limited data describing the dynamic behavior of soft materials due to shock wave loading.	[Zhang, Ling; Jackson, William J.; Bentil, Sarah A.] Iowa State Univ Sci & Technol, Dept Mech Engn, 2529 Union Dr, Ames, IA 50011 USA		Bentil, SA (corresponding author), Iowa State Univ Sci & Technol, Dept Mech Engn, 2529 Union Dr, Ames, IA 50011 USA.	sbentil@iastate.edu			Roy J. Carver Charitable Trust [18-5021]; Iowa State University	This research was financially supported by the Roy J. Carver Charitable Trust under Grant #18-5021 and is acknowledged gratefully. The research is also financially supported by Iowa State University through startup funds to SA. Bentil, for which the authors are grateful.	Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Begonia MT, 2010, ANN BIOMED ENG, V38, P3043, DOI 10.1007/s10439-010-0072-9; Bentil SA, 2016, EXP MECH, V56, P759, DOI 10.1007/s11340-015-0122-1; Bentil SA, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aab990; Bentil SA, 2014, J MECH BEHAV BIOMED, V30, P83, DOI 10.1016/j.jmbbm.2013.10.020; Budday S, 2017, J MECH BEHAV BIOMED, V74, P463, DOI 10.1016/j.jmbbm.2017.07.014; Cao R, 2019, J NEUROTRAUM, V36, P1526, DOI 10.1089/neu.2018.6062; Caruso MM, 2009, CHEM REV, V109, P5755, DOI 10.1021/cr9001353; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chanda A, 2018, MECH ADV MATER STRUC, V25, P1335, DOI 10.1080/15376494.2016.1143749; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; CLEMEDSON C. J., 1954, MILITARY SURGEON, V114, P424; CLEMEDSON CJ, 1956, ACTA PHYSIOL SCAND, V37, P202; Corning D., 2018, SYLGARD 184 SILICONE; Corning D, 2020, SYLGARD 184 SILICONE; Cristofolini, 2016, INT BIOMECH, V3, P1, DOI DOI 10.1080/23335432.2015.1117395; Evans SL, 2009, J STRAIN ANAL ENG, V44, P337, DOI 10.1243/03093247JSA488; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ghahfarolthi ZM, 2020, P I MECH ENG C-J MEC, V234, P3, DOI 10.1177/0954406219875771; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Grassi L, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4028415; Gurev V, 2015, BIOMECH MODEL MECHAN, V14, P829, DOI 10.1007/s10237-014-0639-8; Hokka M, 2015, J BIOMECH, V48, P2217, DOI 10.1016/j.jbiomech.2015.03.015; Holzapfel GA, 1996, INT J SOLIDS STRUCT, V33, P3019, DOI 10.1016/0020-7683(95)00263-4; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; Hossain S.G.M, 2010, MAT MODELING ANAL DE; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Iwaskiw AS, 2018, SHOCK WAVES, V28, P63, DOI 10.1007/s00193-017-0759-z; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Johnston ID, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/035017; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; KAUSCH HH, 1994, POLYMER, V35, P3848, DOI 10.1016/0032-3861(94)90267-4; Kohandel M, 2005, PHYS MED BIOL, V50, P2799, DOI 10.1088/0031-9155/50/12/005; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Lin IK, 2009, J MICROELECTROMECH S, V18, P1087, DOI 10.1109/JMEMS.2009.2029166; Lord JD, 2008, APPL MECH MATER, V13-14, P65, DOI 10.4028/www.scientific.net/AMM.13-14.65; Mahoney P, 2018, INT J LEGAL MED, V132, P519, DOI 10.1007/s00414-017-1737-9; Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2; McCarty AK, 2019, J MECH BEHAV BIOMED, V100, DOI 10.1016/j.jmbbm.2019.103380; Mediavilla Varas J., 2011, FRONT NEUROL, V2; Miller K, 1999, J BIOMECH, V32, P531, DOI 10.1016/S0021-9290(99)00010-X; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Mohammed MAP, 2014, SAINS MALAYS, V43, P451; Muller A, 2019, SOFT MATTER, V15, P779, DOI 10.1039/c8sm02105h; Ottenio M, 2015, J MECH BEHAV BIOMED, V41, P241, DOI 10.1016/j.jmbbm.2014.10.006; Payne T, 2014, PROCEDIA ENGINEER, V72, P533, DOI 10.1016/j.proeng.2014.06.092; Payne T, 2015, J MECH BEHAV BIOMED, V41, P336, DOI 10.1016/j.jmbbm.2014.09.018; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Rashid B., 2012, AM SOC MECH ENG, V45189, P921, DOI 10.1115/IMECE2012-85675; Rashid B, 2012, J MECH BEHAV BIOMED, V14, P113, DOI 10.1016/j.jmbbm.2012.04.005; Rashid B, 2012, COMP MATER SCI, V64, P295, DOI 10.1016/j.commatsci.2012.05.030; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Selvan V, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024132; Shergold OA, 2006, INT J IMPACT ENG, V32, P1384, DOI 10.1016/j.ijimpeng.2004.11.010; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tan X.G., 2016, ASME 2016 INT MECH E, P3, DOI [10.1115/IMECE2016-66218.V003T04A036, DOI 10.1115/IMECE2016-66218.V003T04A036]; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tung SH, 2010, OPT LASER ENG, V48, P636, DOI 10.1016/j.optlaseng.2009.09.011; Upadhyay K, 2020, INT J ENG SCI, V154, DOI 10.1016/j.ijengsci.2020.103314; Upadhyay K, 2020, J MECH PHYS SOLIDS, V135, DOI 10.1016/j.jmps.2019.103777; VIC3D, 2017, VIC 3D VERSION 8 REF; Voyiadjis GZ, 2018, J MECH BEHAV BIOMED, V83, P63, DOI 10.1016/j.jmbbm.2018.04.011; Wang Y, 2002, INT J SOLIDS STRUCT, V39, P3777, DOI 10.1016/S0020-7683(02)00176-2; Wang YQ, 2010, INJURY, V41, P707, DOI 10.1016/j.injury.2009.12.003; Wen P., 2003, Australasian Physical & Engineering Sciences in Medicine, V26, P115; WILCOX DC, 1988, AIAA J, V26, P1299, DOI 10.2514/3.10041; Zhang D, 2002, P ANN INT IEEE EMBS, P1276, DOI 10.1109/IEMBS.2002.1106385; Zhang HZ, 2007, BRAIN RES, V1132, P29, DOI 10.1016/j.brainres.2006.09.117; Zhang JT, 2016, COMPOS SCI TECHNOL, V130, P20, DOI 10.1016/j.compscitech.2016.05.002; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang L, 2019, J MECH BEHAV BIOMED, V95, P180, DOI 10.1016/j.jmbbm.2019.04.005; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518	82	1	1	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	AUG	2021	120								104513	10.1016/j.jmbbm.2021.104513			15	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	SU4YP	WOS:000663145300004	34010798	Green Submitted			2022-02-06	
J	Adler, C; Onur, OA; Braumann, S; Gramespacher, H; Bittner, S; Falk, S; Fink, GR; Baldus, S; Warnke, C				Adler, Christoph; Onur, Oezguer A.; Braumann, Simon; Gramespacher, Hannes; Bittner, Stefan; Falk, Steffen; Fink, Gereon R.; Baldus, Stephan; Warnke, Clemens			Absolute serum neurofilament light chain levels and its early kinetics predict brain injury after out-of-hospital cardiac arrest	JOURNAL OF NEUROLOGY			English	Article; Early Access						NFL; Cerebral hypoxia; Brain hypoxia; Hypoxic-ischemic brain injury	NEURON-SPECIFIC ENOLASE; EUROPEAN RESUSCITATION COUNCIL; INTENSIVE-CARE; LIFE; GUIDELINES; WITHDRAWAL; END	Objectives To test if the early kinetics of neurofilament light (NFL) in blood adds to the absolute values of NFL in the prediction of outcome, and to evaluate if NFL can discriminate individuals with severe hypoxic-ischemic brain injury (sHIBI) from those with other causes of poor outcome after out-of-hospital cardiac arrest (OHCA). Design and setting Monocentric retrospective study involving individuals following non-traumatic OHCA between April 2014 and April 2016. NFL concentrations were determined on a SiMoA HD-1 device using NF-Light Advantage Kits. Participants Of 73 patients screened, 53 had serum samples available for NFL measurement at three timepoints (after 3, 24, and 48 h of admission). Of these 53 individuals, 43.4% had poor neurologic outcome at discharge as assessed by Glasgow-Pittsburgh cerebral performance categories, and, according to a current prognostication algorithm, poor outcome due to sHIBI in 20.7%. Main outcome measure Blood NFL and its early kinetics for prognostication of outcome and prediction of sHIBI after OHCA. Results An absolute NFL > 508.6 pg/ml 48 h after admission, or a change in NFL > 494 pg/ml compared with an early baseline value predicted outcome, and discriminated severe sHIBI from other causes of unfavorable outcome after OHCA with high sensitivity (100%, 95%CI 70.0-100%) and specificity (91.7%, 95%CI 62.5-100%). Conclusions Not only absolute values of NFL, but also early changes in NFL predict the outcome following OHCA, and may differentiate sHIBI from other causes of poor outcome after OHCA with high sensitivity and specificity. Our study adds to published data, overall corroborating that NFL measured in blood should be implemented in prognostication algorithms used in clinical routine.	[Adler, Christoph; Braumann, Simon; Baldus, Stephan] Univ Cologne, Dept Internal Med 3, Div Cardiol Pneumol Angiol & Intens Care, D-50937 Cologne, Germany; [Onur, Oezguer A.; Gramespacher, Hannes; Fink, Gereon R.; Warnke, Clemens] Univ Cologne, Dept Neurol, Fac Med, D-50937 Cologne, Germany; [Onur, Oezguer A.; Gramespacher, Hannes; Fink, Gereon R.; Warnke, Clemens] Univ Cologne, Univ Hosp Cologne, D-50937 Cologne, Germany; [Fink, Gereon R.] Res Ctr Julich, Inst Neurosci & Med INM 3, Cognit Neurosci, Julich, Germany; [Bittner, Stefan; Falk, Steffen] Univ Med Ctr Mainz, Dept Neurol, Langenbeckstr 1, D-55131 Mainz, Germany; [Adler, Christoph] Fire Dept City Cologne, Inst Secur Sci & Rescue Technol, Cologne, Germany		Warnke, C (corresponding author), Univ Cologne, Dept Neurol, Fac Med, D-50937 Cologne, Germany.; Warnke, C (corresponding author), Univ Cologne, Univ Hosp Cologne, D-50937 Cologne, Germany.	clemens.warnke@uk-koeln.de	Fink, Gereon R./E-1616-2012	Fink, Gereon R./0000-0002-8230-1856; Gramespacher, Hannes/0000-0002-9980-4978; Warnke, Clemens/0000-0002-3510-9255	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL. None.	Adler C, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2042-9; Aghabarary M, 2016, J MED ETHICS HIST ME, V9; Bittner S, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102807; DAY INM, 1984, CLIN CHIM ACTA, V136, P219, DOI 10.1016/0009-8981(84)90295-X; Demertzi A, 2011, J NEUROL, V258, P1058, DOI 10.1007/s00415-010-5882-z; Dragancea I, 2017, RESUSCITATION, V117, P50, DOI 10.1016/j.resuscitation.2017.05.014; Huntgeburth M, 2014, NEUROCRIT CARE, V20, P358, DOI 10.1007/s12028-013-9848-8; Hunziker S, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03459-y; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Jox RJ, 2012, J MED ETHICS, V38, P540, DOI 10.1136/medethics-2011-100479; KAISER E, 1989, CLIN CHIM ACTA, V183, P13, DOI 10.1016/0009-8981(89)90268-4; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Langhelle A, 2005, RESUSCITATION, V66, P271, DOI 10.1016/j.resuscitation.2005.06.005; MARANGOS PJ, 1980, J NEUROCHEM, V34, P1254, DOI 10.1111/j.1471-4159.1980.tb09967.x; Moseby-Knappe M, 2019, JAMA NEUROL, V76, P64, DOI 10.1001/jamaneurol.2018.3223; Mulder M, 2014, CRIT CARE MED, V42, P2493, DOI 10.1097/CCM.0000000000000540; Nolan JP, 2021, RESUSCITATION, V161, P220, DOI 10.1016/j.resuscitation.2021.02.012; Rana OR, 2013, INT J CARDIOL, V168, P1322, DOI 10.1016/j.ijcard.2012.12.016; Sandroni C, 2020, INTENS CARE MED, V46, P1901, DOI 10.1007/s00134-020-06224-x; Schoerkhuber W, 1999, STROKE, V30, P1598, DOI 10.1161/01.STR.30.8.1598; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Uphaus T, 2019, STROKE, V50, P3077, DOI 10.1161/STROKEAHA.119.026410; Wihersaari L, 2021, INTENS CARE MED, V47, P39, DOI 10.1007/s00134-020-06218-9	24	1	1	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.												10.1007/s00415-021-10722-3		JUL 2021	8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TS4HZ	WOS:000679613600002	34328545	hybrid			2022-02-06	
J	Birg, T; Ortolano, F; Wiegers, EJA; Smielewski, P; Savchenko, Y; Ianosi, BA; Helbok, R; Rossi, S; Carbonara, M; Zoerle, T; Stocchetti, N				Birg, Tatiana; Ortolano, Fabrizio; Wiegers, Eveline J. A.; Smielewski, Peter; Savchenko, Yan; Ianosi, Bogdan A.; Helbok, Raimund; Rossi, Sandra; Carbonara, Marco; Zoerle, Tommaso; Stocchetti, Nino		CENTER TBI Investigators Parti	Brain Temperature Influences Intracranial Pressure and Cerebral Perfusion Pressure After Traumatic Brain Injury: A CENTER-TBI Study	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Neuromonitoring; Brain temperature; Fever; Hyperthermia; Intracranial pressure; Cerebral perfusion pressure	RECTAL TEMPERATURES; CRITICAL-CARE; FEVER; HEAD; HYPERTHERMIA; MULTICENTER; HYPOTHERMIA; GUIDELINES; PYREXIA; WORSENS	Background After traumatic brain injury (TBI), fever is frequent. Brain temperature (BT), which is directly linked to body temperature, may influence brain physiology. Increased body and/or BT may cause secondary brain damage, with deleterious effects on intracranial pressure (ICP), cerebral perfusion pressure (CPP), and outcome. Methods Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI), a prospective multicenter longitudinal study on TBI in Europe and Israel, includes a high resolution cohort of patients with data sampled at a high frequency (from 100 to 500 Hz). In this study, simultaneous BT, ICP, and CPP recordings were investigated. A mixed-effects linear model was used to examine the association between different BT levels and ICP. We additionally focused on changes in ICP and CPP during the episodes of BT changes (Delta BT >= 0.5 degrees C lasting from 15 min to 3 h) up or downward. The significance of ICP and CPP variations was estimated with the paired samples Wilcoxon test (also known as Wilcoxon signed-rank test). Results Twenty-one patients with 2,435 h of simultaneous BT and ICP monitoring were studied. All patients reached a BT of 38 degrees C and experienced at least one episode of ICP above 20 mm Hg. The linear mixed-effects model revealed an association between BT above 37.5 degrees C and higher ICP levels that was not confirmed for lower BT. We identified 149 episodes of BT changes. During BT elevations (n = 79) ICP increased, whereas CPP was reduced; opposite ICP and CPP variations occurred during episodes of BT reduction (n = 70). All these changes were of moderate clinical relevance (increase of ICP of 4.5 and CPP decrease of 7.5 mm Hg for BT rise, and ICP reduction of 1.7 and CPP elevation of 3.7 mm Hg during BT defervescence), even if statistically significant (p < 0.0001). It has to be noted, however, that a number of therapeutic interventions against intracranial hypertension was documented during those episodes. Conclusions Patients after TBI usually develop BT > 38 degrees C soon after the injury. BT may influence brain physiology, as reflected by ICP and CPP. An association between BT exceeding 37.5 degrees C and a higher ICP was identified but not confirmed for lower BT ranges. The relationship between BT, ICP, and CPP become clearer during rapid temperature changes. During episodes of temperature elevation, BT seems to have a significant impact on ICP and CPP.	[Birg, Tatiana; Ortolano, Fabrizio; Carbonara, Marco; Zoerle, Tommaso; Stocchetti, Nino] Fdn IRCCS, Ca Grand Osped Maggiore Policlin, Neurol Intens Care Unit, Milan, Italy; [Wiegers, Eveline J. A.] Erasmus Univ, Erasmus Univ Med Ctr, Ctr Med Decis Sci, Dept Publ Hlth, Rotterdam, Netherlands; [Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab,Div Neurosurg, Cambridge, England; [Savchenko, Yan] Burdenko Neurosurg Ctr, Neurointens Care Unit, Moscow, Russia; [Ianosi, Bogdan A.; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Rossi, Sandra] Parma Univ Hosp, Dept Anesthesia & Intens Care, Parma, Italy; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplant, Milan, Italy		Stocchetti, N (corresponding author), Fdn IRCCS, Ca Grand Osped Maggiore Policlin, Neurol Intens Care Unit, Milan, Italy.; Stocchetti, N (corresponding author), Univ Milan, Dept Pathophysiol & Transplant, Milan, Italy.	nino.stocchetti@policlinico.mi.it	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591; Radoi, Andreea/0000-0002-0677-3544; Rossi, Sandra/0000-0002-9963-8121; Savchenko, Ian/0000-0002-2292-8374; Zeiler, Frederick/0000-0003-1737-0510	Universita degli Studi di Milano within the CRUI-CARE Agreement; European Commission 7th Framework program [602,150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Neurotrauma Sciences (USA)	Open access funding provided by Universita degli Studi di Milano within the CRUI-CARE Agreement. This research is funded by the European Commission 7th Framework program (602,150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), from Integra LifeSciences Corporation (USA), and from Neurotrauma Sciences (USA). The funders had no role in the design of the study and collection, analysis, interpretation of data and in writing the article. The datasets used and/or analyzed during the current study are available via https://www.center-tbi.eu/data on reasonable request.	Bao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090956; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; Cairns Chris J S, 2002, Curr Opin Crit Care, V8, P106, DOI 10.1097/00075198-200204000-00003; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Childs Charmaine, 2010, Front Neurol, V1, P146, DOI 10.3389/fneur.2010.00146; CORK RC, 1983, ANESTH ANALG, V62, P211; Cormio M, 2000, INTENS CARE MED, V26, P552, DOI 10.1007/s001340051203; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Ethical approval in CENTER-TBI, ETH APPR; Flensner G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-27; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Heldt T, 2019, ANNU REV BIOMED ENG, V21, P523, DOI 10.1146/annurev-bioeng-060418-052257; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Huschak G, 2008, J NEUROSURG ANESTH, V20, P105, DOI 10.1097/ANA.0b013e31815f528c; KAZIS A, 1982, J NEUROL, V227, P1, DOI 10.1007/BF00313541; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; LANIER WL, 1995, J NEUROSURG ANESTH, V7, P216, DOI 10.1097/00008506-199507000-00021; Launey Y, 2020, JAMA NEUROL, V77, P339, DOI 10.1001/jamaneurol.2019.3854; Mangiacotti L., 2020, CRIT CARE, V24, DOI [10.1186/s13054-020-2772-3, DOI 10.1186/S13054-020-2772-3]; Mcilvoy Laura, 2007, J Neurosci Nurs, V39, P324; Nakagawa K, 2011, NEUROCRIT CARE, V15, P101, DOI 10.1007/s12028-010-9446-y; Nyholm L, 2017, UPSALA J MED SCI, V122, P177, DOI 10.1080/03009734.2017.1319440; O'Grady NP, 2008, CRIT CARE MED, V36, P1330, DOI 10.1097/CCM.0b013e318169eda9; Oddo M, 2009, STROKE, V40, P1913, DOI 10.1161/STROKEAHA.108.534115; Picetti E, 2019, J NEUROSURG ANESTH, V31, P399, DOI 10.1097/ANA.0000000000000536; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Rincon F, 2014, J NEUROSURG, V121, P950, DOI 10.3171/2014.7.JNS132470; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Spiotta AM, 2008, NEUROSURGERY, V62, P864, DOI 10.1227/01.neu.0000316900.63124.ce; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; TAKAGI K, 1994, AM J PHYSIOL-HEART C, V267, pH1770, DOI 10.1152/ajpheart.1994.267.5.H1770; VERLOOY J, 1995, ACTA NEUROCHIR, V134, P76, DOI 10.1007/BF01428508; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1	44	1	1	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2021	35	3					651	661		10.1007/s12028-021-01294-1		JUL 2021	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XS0FS	WOS:000679648100008	34331210	Green Published, hybrid, Green Submitted			2022-02-06	
J	Helmrich, IRAR; van Klaveren, D; Dijkland, SA; Lingsma, HF; Polinder, S; Wilson, L; von Steinbuechel, N; van der Naalt, J; Maas, AIR; Steyerberg, EW				Helmrich, Isabel R. A. Retel; van Klaveren, David; Dijkland, Simone A.; Lingsma, Hester F.; Polinder, Suzanne; Wilson, Lindsay; von Steinbuechel, Nicole; van der Naalt, Joukje; Maas, Andrew I. R.; Steyerberg, Ewout W.		CENTER TBI Collaborators	Development of prognostic models for Health-Related Quality of Life following traumatic brain injury	QUALITY OF LIFE RESEARCH			English	Article; Early Access						Prognostic model research; Traumatic brain injury; Health-related quality of life; SF-36; QOLIBRI	COPING STRATEGIES; CENTER-TBI; MILD; MODERATE; PREDICTORS; QOLIBRI; SCALE; SATISFACTION; OUTCOMES; ADULTS	Background Traumatic brain injury (TBI) is a leading cause of impairments affecting Health-Related Quality of Life (HRQoL). We aimed to identify predictors of and develop prognostic models for HRQoL following TBI. Methods We used data from the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Core study, including patients with a clinical diagnosis of TBI and an indication for computed tomography presenting within 24 h of injury. The primary outcome measures were the SF-36v2 physical (PCS) and mental (MCS) health component summary scores and the Quality of Life after Traumatic Brain Injury (QOLIBRI) total score 6 months post injury. We considered 16 patient and injury characteristics in linear regression analyses. Model performance was expressed as proportion of variance explained (R-2) and corrected for optimism with bootstrap procedures. Results 2666 Adult patients completed the HRQoL questionnaires. Most were mild TBI patients (74%). The strongest predictors for PCS were Glasgow Coma Scale, major extracranial injury, and pre-injury health status, while MCS and QOLIBRI were mainly related to pre-injury mental health problems, level of education, and type of employment. R-2 of the full models was 19% for PCS, 9% for MCS, and 13% for the QOLIBRI. In a subset of patients following predominantly mild TBI (N = 436), including 2 week HRQoL assessment improved model performance substantially (R-2 PCS 15% to 37%, MCS 12% to 36%, and QOLIBRI 10% to 48%). Conclusion Medical and injury-related characteristics are of greatest importance for the prediction of PCS, whereas patient-related characteristics are more important for the prediction of MCS and the QOLIBRI following TBI.	[Helmrich, Isabel R. A. Retel; van Klaveren, David; Dijkland, Simone A.; Lingsma, Hester F.; Polinder, Suzanne; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [van Klaveren, David] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Predict Analyt & Comparat Effectiveness Ctr, Boston, MA USA; [von Steinbuechel, Nicole] Georg August Univ, Dept Med Psychol & Med Sociol, D-37073 Gottingen, Germany; [van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling FK9 4LA, Scotland; [Maas, Andrew I. R.] Univ Hosp Antwerp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Steyerberg, Ewout W.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands; [Helmrich, Isabel R. A. Retel; van Klaveren, David; Dijkland, Simone A.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Univ Med Ctr, POB 2040, NL-3000 CA Rotterdam, Netherlands		Helmrich, IRAR (corresponding author), Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Univ Med Ctr Rotterdam, Rotterdam, Netherlands.; Helmrich, IRAR (corresponding author), Erasmus MC, Dept Publ Hlth, Univ Med Ctr, POB 2040, NL-3000 CA Rotterdam, Netherlands.	i.retelhelmrich@erasmusmc.nl; d.vanklaveren@erasmusmc.nl; s.dijkland@erasmusmc.nl; h.lingsma@erasmusmc.nl; s.polinder@erasmusmc.nl; l.wilson@stir.ac.uk; nvsteinbuechel@med.uni-goettingen.de; j.van.der.naalt@umcg.nl; Andrew.Maas@uza.be; e.steyerberg@erasmusmc.nl		van der Naalt, Joukje/0000-0001-9873-2418	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); One-Mind (USA); Integra LifeSciences Corporation (USA)	The research leading to these results was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement no 602150 (CENTER-TBI). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from One-Mind (USA), and from Integra LifeSciences Corporation (USA).	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Harrell Jr FE, 2012, RMS REGRESSION MODEL; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Kozlowski O., 2002, Annales de Readaptation et de Medecine Physique, V45, P466, DOI 10.1016/S0168-6054(02)00297-0; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maruish ME., 2011, USERS MANUAL SF 36V2; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Moons KGM, 2015, ADV ANAT PATHOL, V22, P303, DOI 10.1097/PAP.0000000000000072; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; R Core Team, 2020, R LANG ENV STAT COMP; Rainey EE, 2014, AM J SURG, V208, P517, DOI 10.1016/j.amjsurg.2014.05.016; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Steyerberg EW, 2008, CLIN PREDICTION MODE; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Summaka M, 2020, BRAIN INJURY, V34, P1229, DOI 10.1080/02699052.2020.1799435; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Warren L, 1996, J REHABIL RES DEV, V33, P404; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Wilson L, 2021, J NEUROL NEUROSUR PS, V92, P407, DOI 10.1136/jnnp-2020-324492; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	52	1	1	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.												10.1007/s11136-021-02932-z		JUL 2021	21	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	TS4CW	WOS:000679600300004	34331197	hybrid, Green Published			2022-02-06	
J	De Kegel, D; Musigazi, GU; Menichetti, A; Hellings, PW; Sciot, R; Demaerel, P; Famaey, N; Vander Sloten, J; Depreitere, B				De Kegel, Dries; Musigazi, Gracia Umuhire; Menichetti, Andrea; Hellings, Peter-William; Sciot, Raf; Demaerel, Philippe; Famaey, Nele; Vander Sloten, Jos; Depreitere, Bart			Investigation of tissue level tolerance for cerebral contusion in a controlled cortical impact porcine model	TRAFFIC INJURY PREVENTION			English	Article						Cerebral contusion; controlled cortical impact; traumatic brain injury; porcine model	BRAIN-INJURY; HEAD-INJURY; IN-VIVO	Objective Cerebral contusions (CC) represent a frequent lesion in traumatic brain injury, with potential morbidity from mass effect and tissue loss. Better understanding of the mechanical etiology will help to improve head protection. The goal of this study is to investigate the threshold for mechanical impact parameters to induce CC in an in vivo porcine controlled cortical impact model. Methods Thirty-four adult male pigs underwent craniotomy and controlled cortical impact with a hemispherical tip on intact dura under general anesthesia. Peak impact depth varied between 1.1 and 12.6 mm, and impact velocity between 0.4 and 2.2 m/s while the dwell time was kept at 200 ms. Two days following impact, the animals underwent magnetic resonance (MR) imaging of the brain, and were subsequently sacrificed for brain extraction. CC damage was investigated by magnetic resonance imaging and histology. Results All animals recovered from the impact without overt neurological deficit. Provoked injuries were histologically confirmed to be CC. Decreasing probability of cortical damage and white matter edema volume was observed with decreasing impact depth and velocity. No CC could be demonstrated below a product of impact depth and velocity of 0.8 mm*m/s, whereas the probability for CC was one third below 15 mm*m/s. The threshold for CC development as estimated from the current series of experiments, was situated at an impact depth of 2.0 mm and impact velocity of 0.4 m/s Conclusion Mechanical thresholds for CC development could be explored in the current porcine controlled cortical impact model. Findings will be used to further refine a cerebral contusion porcine model with volumetric histology data in light of future finite element cerebral contusion validation studies.	[De Kegel, Dries; Menichetti, Andrea; Hellings, Peter-William; Famaey, Nele; Vander Sloten, Jos] KULeuven, Biomech Sect, Heverlee, Belgium; [Musigazi, Gracia Umuhire; Depreitere, Bart] KULeuven, Expt Neurosurg & Neuroanat, Leuven, Belgium; [Sciot, Raf] KULeuven, Translat Cell & Tissue Res, Leuven, Belgium; [Demaerel, Philippe] KULeuven, Translat MRI, Leuven, Belgium		Depreitere, B (corresponding author), Expt Neurosurg & Neuroanat, Herestr 49, B-3000 Leuven, Belgium.	bart.depreitere@uzleuven.be		Famaey, Nele/0000-0002-7374-8912; Menichetti, Andrea/0000-0001-8042-0344	KULeuven grant [OT/12/071]; FWOFWO [G.0C67.13]	This research was funded by KULeuven grant OT/12/071 and FWO grant G.0C67.13. We wish to acknowledge Stephanie De Vleeschauwer, Dr Kris Meurrens (Animal Research Center, KULeuven), Marc Verbeek (Medical Technical Services, KULeuven), Piet Claus (Cardiovascular Imaging, KULeuven), Ronald Peeters, Walter Coudyzer (Radiology, University Hospitals Leuven) and An Van Damme (UCLouvain).	BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Dixon CE, 1994, ASTM STP, P154; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; GOLDSMITH W, 1981, J BIOMECH, V14, P883, DOI 10.1016/0021-9290(81)90016-6; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; HOFMAN MA, 1985, BRAIN BEHAV EVOLUT, V27, P28, DOI 10.1159/000118718; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Macmanus DB., 2020, BRAIN MULTIPHYS, V1, P100018, DOI [10.1016/j.brain.2020.100018, DOI 10.1016/J.BRAIN.2020.100018]; MADSEN FF, 1987, ACTA NEUROCHIR, V88, P65, DOI 10.1007/BF01400517; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Shreiber D.I., 1997, STAPP CAR CRASH J, V41, P277; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Viano D.C., 1999, J CRASH PREV INJ CON, V1, P35, DOI [10.1080/10286589908915739, DOI 10.1080/10286589908915739]; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	25	1	1	2	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	NOV 5	2021	22	8					616	622		10.1080/15389588.2021.1957856		JUL 2021	7	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	WQ4SA	WOS:000692272600001	34477471				2022-02-06	
J	Blass, BE; Gao, R; Blattner, KM; Gordon, JC; Pippin, DA; Canney, DJ				Blass, Benjamin E.; Gao, Rong; Blattner, Kevin M.; Gordon, John C.; Pippin, Douglas A.; Canney, Daniel J.			Design, synthesis, and evaluation of novel, selective gamma-butyrolactones sigma-2 ligands	MEDICINAL CHEMISTRY RESEARCH			English	Article						Sigma-2; Sigma-1; gamma-butyrolactone; Sigma receptor	RECEPTOR; IDENTIFICATION; INHIBITION; BINDING	Nearly 40 years after the first disclosure of sigma receptors, the sigma-2 (sigma 2) receptor was recently identified as the Transmembrane Protein 97 (TMEM97, also known as MAC30 (Meningioma-associated protein). This macromolecule has been associated with a number of disease states such as schizophrenia, Alzheimer's disease, neuropathic pain, traumatic brain injury, and cancer. We have recently identified a series of novel, functionalized gamma-butyrolactones that are potent sigma 2 receptor ligands that are drug-like and identified a potential candidate (9z) for future in vivo study. [GRAPHICS] .	[Blass, Benjamin E.; Gao, Rong; Gordon, John C.; Canney, Daniel J.] Temple Sch Pharm, Dept Pharmaceut Sci, Moulder Ctr Drug Discovery, Philadelphia, PA 19140 USA; [Blattner, Kevin M.; Pippin, Douglas A.] Praeventix Inc, 665 Stockton Dr,Suite 200H, Exton, PA 19341 USA		Blass, BE (corresponding author), Temple Sch Pharm, Dept Pharmaceut Sci, Moulder Ctr Drug Discovery, Philadelphia, PA 19140 USA.	Benjamin.Blass@Temple.edu		Blass, Benjamin/0000-0003-2449-4503	National Institute of Mental Health's Psychoactive Drug Screening ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [HHSN-271-2013-00017-C]	Ki determinations for compound binding to Sigma-1, and Sigma-2 were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program, Contract #HHSN-271-2013-00017-C (NIMH PDSP). The NIMH PDSP is directed by Bryan L. Roth at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda MD, USA. For experimental details please refer to the PDSP web site https://pdsp.unc.edu/ims/investigator/web/.The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. TPSA and cLogP values were generated using the Dotmatics software suite (Dotmatics LLC The Old Monastery, Windhill Bishops, Stortford Herts, CW23 2ND UK).	Abate C, 2018, FUTURE MED CHEM, V10, P1997, DOI 10.4155/fmc-2018-0072; Alon A, 2017, P NATL ACAD SCI USA, V114, P7160, DOI 10.1073/pnas.1705154114; Asong G, 2019, BIOORGAN MED CHEM, V27, P2629, DOI 10.1016/j.bmc.2019.04.012; Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Blass BE, 2018, EXPERT OPIN THER PAT, V28, P655, DOI 10.1080/13543776.2018.1519024; Bowen Wayne D., 1993, Molecular Neuropharmacology, V3, P117; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Ebrahimi-Fakhari D, 2016, HUM MOL GENET, V25, P3588, DOI 10.1093/hmg/ddw204; Gao R., 2013, DESIGN SYNTHESIS EVA; Gao R, 2014, MED CHEM RES, V23, P1023, DOI 10.1007/s00044-013-0692-3; Gao R, 2009, TETRAHEDRON LETT, V50, P5914, DOI 10.1016/j.tetlet.2009.08.016; Guo L, 2015, CURR MED CHEM, V22, P989, DOI 10.2174/0929867322666150114163607; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111898; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111899; KHAZAN N, 1984, NEUROPHARMACOLOGY, V23, P983, DOI 10.1016/0028-3908(84)90015-7; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; McMasters DR, 2007, J MED CHEM, V50, P3205, DOI 10.1021/jm0700060; Sahn JJ, 2017, ACS CHEM NEUROSCI, V8, P1801, DOI 10.1021/acschemneuro.7b00200; Schmidt HR, 2016, NATURE, V532, P527, DOI 10.1038/nature17391; SU TP, 1982, J PHARMACOL EXP THER, V223, P284; Vazquez-Rosa E, 2019, ACS CHEM NEUROSCI, V10, P1595, DOI 10.1021/acschemneuro.8b00543; VILNER BJ, 1995, CANCER RES, V55, P408; Yang JS, 2007, DRUG METAB DISPOS, V35, P501, DOI 10.1124/dmd.106.013359; Yi BN, 2017, J NEUROCHEM, V140, P561, DOI 10.1111/jnc.13917; Zeng CB, 2017, ADV EXP MED BIOL, V964, P49, DOI 10.1007/978-3-319-50174-1_5	27	1	1	3	3	SPRINGER BIRKHAUSER	NEW YORK	233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA	1054-2523	1554-8120		MED CHEM RES	Med. Chem. Res.	SEP	2021	30	9					1713	1727		10.1007/s00044-021-02771-0		JUL 2021	15	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	TY4PM	WOS:000678430200001		Green Submitted			2022-02-06	
J	Celian, C; Swanson, V; Shah, M; Newman, C; Fowler-King, B; Gallik, S; Reilly, K; Reinkensmeyer, DJ; Patton, J; Rafferty, MR				Celian, Courtney; Swanson, Veronica; Shah, Maahi; Newman, Caitlin; Fowler-King, Bridget; Gallik, Sarah; Reilly, Kaitlin; Reinkensmeyer, David J.; Patton, James; Rafferty, Miriam R.			A day in the life: a qualitative study of clinical decision-making and uptake of neurorehabilitation technology	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Rehabilitation technology; Occupational therapists; Physical therapists; Inpatient rehabilitation; Neurologic rehabilitation; Implementation	STROKE REHABILITATION; ACCEPTANCE	Background Neurorehabilitation engineering faces numerous challenges to translating new technologies, but it is unclear which of these challenges are most limiting. Our aim is to improve understanding of rehabilitation therapists' real-time decision-making processes on the use of rehabilitation technology (RT) in clinical treatment. Methods We used a phenomenological qualitative approach, in which three OTs and two PTs employed at a major, technology-encouraging rehabilitation hospital wrote vignettes from a written prompt describing their RT use decisions during treatment sessions with nine patients (4 with stroke, 2 traumatic brain injury, 1 spinal cord injury, 1 with multiple sclerosis). We then coded the vignettes using deductive qualitative analysis from 17 constructs derived from the RT literature and the Consolidated Framework for Implementation Research (CFIR). Data were synthesized using summative content analysis. Results Of the constructs recorded, the five most prominent are from CFIR determinants of: (i) relative advantage, (ii) personal attributes of the patients, (iii) clinician knowledge and beliefs of the device/intervention, (iv) complexity of the devices including time and setup, and (v) organizational readiness to implement. Therapists characterized candidate RT as having a relative disadvantage compared to conventional treatment due to lack of relevance to functional training. RT design also often failed to consider the multi-faceted personal attributes of the patients, including diagnoses, goals, and physical and cognitive limitations. Clinicians' comfort with RT was increased by their previous training but was decreased by the perceived complexity of RT. Finally, therapists have limited time to gather, setup, and use RT. Conclusions Despite decades of design work aimed at creating clinically useful RT, many lack compatibility with clinical translation needs in inpatient neurologic rehabilitation. New RT continue to impede the immediacy, versatility, and functionality of hands-on therapy mediated treatment with simple everyday objects.	[Celian, Courtney; Newman, Caitlin; Fowler-King, Bridget; Gallik, Sarah; Reilly, Kaitlin; Patton, James; Rafferty, Miriam R.] Shirley Ryan AbilityLab, 355 E Erie St, Chicago, IL 60611 USA; [Swanson, Veronica; Reinkensmeyer, David J.] Univ Calif Irvine, Henry Samueli Sch Engn, Dept Mech & Aerosp Engn, Engn Gateway 4200, Irvine, CA 92697 USA; [Shah, Maahi; Patton, James] Univ Illinois, Dept Bioengn, 851 S Morgan St, Chicago, IL 60607 USA; [Reinkensmeyer, David J.] Univ Calif Irvine, UC Irvine Sch Med, Dept Anat & Neurobiol, Irvine, CA 92617 USA; [Rafferty, Miriam R.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, 420 E Super St, Chicago, IL 60611 USA		Rafferty, MR (corresponding author), Shirley Ryan AbilityLab, 355 E Erie St, Chicago, IL 60611 USA.; Rafferty, MR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, 420 E Super St, Chicago, IL 60611 USA.	mrafferty@sralab.org		Rafferty, Miriam/0000-0002-3182-0314; Swanson, Veronica/0000-0003-4004-9397	U.S. Department of Health and Human Services, Administration on Community Living, National Institute on Disability, Independent Living and Rehabilitation Research [90REGE0010, 90REGE0005-01]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001414]; National Institutes of Health National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG059988]; United States Department of DefenseUnited States Department of Defense [W81XWH-20-1-0231]	This work was supported under Grant 90REGE0010 and 90REGE0005-01 from the U.S. Department of Health and Human Services, Administration on Community Living, National Institute on Disability, Independent Living and Rehabilitation Research, as well as by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR001414, National Institutes of Health National Institute on Aging (P30AG059988) and United States Department of Defense (W81XWH-20-1-0231). These contents, however, do not necessarily represent the policy or endorsement of any of the funding sources.	Bauer Mark S, 2015, BMC Psychol, V3, P32, DOI 10.1186/s40359-015-0089-9; Chen CC, 2011, AM J PHYS MED REHAB, V90, P415, DOI 10.1097/PHM.0b013e318214f5d8; Chua KSG, 2017, AM J PHYS MED REHAB, V96, pS150, DOI 10.1097/PHM.0000000000000799; Clark WE, 2019, J REHABIL ASSIST TER, V6, DOI 10.1177/2055668319863557; Cowan KE, 2019, MAYO CLIN PROC, V94, P2510, DOI 10.1016/j.mayocp.2019.04.018; Cramer SC, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.611453; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Friedman N, 2011, IEEE ENG MED BIO, P2359, DOI 10.1109/IEMBS.2011.6090659; Guillen-Climent S, 2021, J NEUROENG REHABIL, V18, DOI 10.1186/s12984-021-00837-z; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hughes AM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-124; Jones M, 2010, TOP STROKE REHABIL, V17, P323, DOI 10.1310/tsr1705-323; Liu LL, 2015, DISABIL REHABIL, V37, P447, DOI 10.3109/09638288.2014.923529; Medicare Program, INP REH FAC PROSP PA INP REH FAC PROSP PA; Pellerin MA, 2019, AUST OCCUP THER J, V66, P670, DOI 10.1111/1440-1630.12612; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010820.pub2; Reinkensmeyer DJ, 2007, 2007 VIRTUAL REHABILITATION, P42; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Wagner TH, 2011, STROKE, V42, P2630, DOI 10.1161/STROKEAHA.110.606442; Weber LM, 2018, NEUROREHABILITATION, V43, P99, DOI 10.3233/NRE-172408	20	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	JUL 28	2021	18	1							121	10.1186/s12984-021-00911-6			12	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Neurosciences & Neurology; Rehabilitation	TU2IE	WOS:000680863000002	34321036	gold, Green Published			2022-02-06	
J	Marincowitz, C; Gravesteijn, B; Sheldon, T; Steyerberg, E; Lecky, F				Marincowitz, Carl; Gravesteijn, Benjamin; Sheldon, Trevor; Steyerberg, Ewout; Lecky, Fiona			Performance of the Hull Salford Cambridge Decision Rule (HSC DR) for early discharge of patients with findings on CT scan of the brain: a CENTER-TBI validation study	EMERGENCY MEDICINE JOURNAL			English	Article; Early Access						trauma; head; research	INJURY GUIDELINES; HEAD-INJURY; EXTERNAL VALIDATION; COMPUTED-TOMOGRAPHY; RISK; LEVEL; MODEL; BIG	Background There is international variation in hospital admission practices for patients with mild traumatic brain injury (TBI) and injuries on CT scan. Only a small proportion of patients require neurosurgical intervention, while many guidelines recommend routine admission of all patients. We aim to validate the Hull Salford Cambridge Decision Rule (HSC DR) and the Brain Injury Guidelines (BIG) criteria to select low-risk patients for discharge from the emergency department. Method A cohort from 18 countries of Glasgow Coma Scale 13-15 patients with injuries on CT imaging was identified from the multicentre Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) Study (conducted from 2014 to 2017) for secondary analysis. A composite outcome measure encompassing need for ongoing hospital admission was used, including seizure activity, death, intubation, neurosurgical intervention and neurological deterioration. We assessed the performance of our previously derived prognostic model, the HSC DR and the BIG criteria at predicting deterioration in this validation cohort. Results Among 1047 patients meeting the inclusion criteria, 267 (26%) deteriorated. Our prognostic model achieved a C-statistic of 0.81 (95% CI: 0.78 to 0.84). The HSC DR achieved a sensitivity of 100% (95% CI: 97% to 100%) and specificity of only 4.7% (95% CI: 3.3% to 6.5%) for deterioration. Using the BIG criteria for discharge from the ED achieved a higher specificity (13.3%, 95% CI: 10.9% to 16.1%) and lower sensitivity (94.6%, 95% CI: 90.5% to 97%), with 12/105 patients recommended for discharge subsequently deteriorating, compared with 0/34 with the HSC DR. Conclusion Our decision rule would have allowed 3.5% of patients to be discharged, none of whom would have deteriorated. Use of the BIG criteria may select patients for discharge who have too high a risk of subsequent deterioration to be used clinically. Further validation and implementation studies are required to support use in clinical practice.	[Marincowitz, Carl] Univ Sheffield, Ctr Urgent & Emergency Care Res CURE, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England; [Gravesteijn, Benjamin] Erasmus MC, Dept Publ Hlth, Rotterdam, Zuid Holland, Netherlands; [Sheldon, Trevor] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Populat Hlth Sci, London, England; [Steyerberg, Ewout] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Zuid Holland, Netherlands; [Lecky, Fiona] Univ Sheffield, Salford Royal Hosp, Ctr Urgent & Emergency Care Res CURE, Sch Hlth & Related Res ScHARR,Emergency Dept, Sheffield, S Yorkshire, England; [Lecky, Fiona] Salford Royal Hosp, Sheffield, S Yorkshire, England		Marincowitz, C (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England.	c.marincowitz@sheffield.ac.uk		Marincowitz, Carl/0000-0003-3043-7564; Gravesteijn, Benjamin/0000-0001-8096-5803	European Union Seventh Framework Programme (EC) [602150]; One Mind (USA); Integra LifeSciences Corporation (USA); European Union Framework 7 Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (EC) [602150]; NHS Trusts 'Trauma Audit and Research Network; University of Sheffield; NIHRNational Institute for Health Research (NIHR); Hannelore Kohl Stiftung (Germany)	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project, with the support of the European Union Seventh Framework Programme (EC grant 602150). Full list of participants and investigators are provided in online supplemental material 9. Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), One Mind (USA) and Integra LifeSciences Corporation (USA). FL and ES were supported by the European Union Framework 7 Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (EC grant 602150). FL was also supported by the NHS Trusts 'Trauma Audit and Research Network-www.tarn.ac.uk'.CM is a National Institute for Health Research (NIHR) Clinical Lecturer in Emergency Medicine. This publication presents independent research funded by the NIHR and University of Sheffield.	Association for the Advancement of Automotive Medicine, 2018, ABBREVIATED INJURY S, V6th; Azim A, 2017, J TRAUMA ACUTE CARE, V83, P1200, DOI 10.1097/TA.0000000000001611; Battle CE, 2014, CRIT CARE, V18, DOI 10.1186/cc13873; Capron GK, 2017, AM J SURG, V214, P1182, DOI 10.1016/j.amjsurg.2017.09.002; Collins GS, 2016, STAT MED, V35, P214, DOI 10.1002/sim.6787; Collins GS, 2015, ANN INTERN MED, V162, P735, DOI 10.7326/L15-5093-2; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Marincowitz C, 2020, J NEUROTRAUM, V37, P324, DOI 10.1089/neu.2019.6652; Marincowitz Carl, 2018, Diagn Progn Res, V2, P6, DOI 10.1186/s41512-018-0027-4; Nguyen CD, 2017, EMERG THEMES EPIDEMI, V14, DOI 10.1186/s12982-017-0062-6; O'Keeffe ST, 2015, QJM-INT J MED, V108, P533, DOI 10.1093/qjmed/hcu246; Ross M, 2020, J NEUROSURG, V133, P1880, DOI 10.3171/2019.6.JNS19584; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Than M, 2013, INT J CARDIOL, V166, P752, DOI 10.1016/j.ijcard.2012.09.171; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i6	29	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.												10.1136/emermed-2020-210975		JUL 2021	7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XL7GA	WOS:000728309000001	34315761	Green Accepted, Green Submitted			2022-02-06	
J	Handiru, VS; Alivar, A; Hoxha, A; Saleh, S; Suviseshamuthu, ES; Yue, G; Allexandre, D				Handiru, Vikram Shenoy; Alivar, Alaleh; Hoxha, Armand; Saleh, Soha; Suviseshamuthu, Easter S.; Yue, Guang; Allexandre, Didier			Graph-theoretical analysis of EEG functional connectivity during balance perturbation in traumatic brain injury: A pilot study	HUMAN BRAIN MAPPING			English	Article						balance perturbation; EEG source localization; functional connectivity; graph theory; postural control; traumatic brain injury	DIFFUSE AXONAL INJURY; BOUNDARY-ELEMENT METHOD; WHITE-MATTER; POSTURAL CONTROL; BEHAVIOR RELATIONSHIPS; VOXELWISE ANALYSIS; NETWORKS; SEGREGATION; YOUNG; INTEGRATION	Traumatic brain injury (TBI) often results in balance impairment, increasing the risk of falls, and the chances of further injuries. However, the underlying neural mechanisms of postural control after TBI are not well understood. To this end, we conducted a pilot study to explore the neural mechanisms of unpredictable balance perturbations in 17 chronic TBI participants and 15 matched healthy controls (HC) using the EEG, MRI, and diffusion tensor imaging (DTI) data. As quantitative measures of the functional integration and segregation of the brain networks during the postural task, we computed the global graph-theoretic network measures (global efficiency and modularity) of brain functional connectivity derived from source-space EEG in different frequency bands. We observed that the TBI group showed a lower balance performance as measured by the center of pressure displacement during the task, and the Berg Balance Scale (BBS). They also showed reduced brain activation and connectivity during the balance task. Furthermore, the decrease in brain network segregation in alpha-band from baseline to task was smaller in TBI than HC. The DTI findings revealed widespread structural damage. In terms of the neural correlates, we observed a distinct role played by different frequency bands: theta-band modularity during the task was negatively correlated with the BBS in the TBI group; lower beta-band network connectivity was associated with the reduction in white matter structural integrity. Our future studies will focus on how postural training will modulate the functional brain networks in TBI.	[Handiru, Vikram Shenoy; Alivar, Alaleh; Hoxha, Armand; Saleh, Soha; Suviseshamuthu, Easter S.; Yue, Guang; Allexandre, Didier] Kessler Fdn, Ctr Mobil & Rehabil Engn Res, W Orange, NJ 07052 USA; [Handiru, Vikram Shenoy; Alivar, Alaleh; Saleh, Soha; Suviseshamuthu, Easter S.; Yue, Guang; Allexandre, Didier] Rutgers Univ New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA		Handiru, VS (corresponding author), Kessler Fdn, Ctr Mobil & Rehabil Engn Res, W Orange, NJ 07052 USA.	vshenoy@kesslerfoundation.org			New Jersey Commission on Brain Injury Research [CBIR15MIG004]	New Jersey Commission on Brain Injury Research, Grant/Award Number: CBIR15MIG004	ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alivar A, 2020, IEEE ENG MED BIO, P3256, DOI 10.1109/EMBC44109.2020.9176130; Allexandre D, 2019, IEEE ENG MED BIO, P1543, DOI 10.1109/EMBC.2019.8856645; Anderson JW, 2007, CONTEMP MATH, V432, P1; Babiloni C, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00020; Babiloni C, 2014, CLIN NEUROPHYSIOL, V125, P1936, DOI 10.1016/j.clinph.2014.04.021; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Benjamini Y, 2001, ANN STAT, V29, P1165; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; Boisgontier MP, 2017, NEUROBIOL AGING, V50, P47, DOI 10.1016/j.neurobiolaging.2016.10.024; Boshra R, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa063; Buchholz VN, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00446; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Chang CY, 2020, IEEE T BIO-MED ENG, V67, P1114, DOI 10.1109/TBME.2019.2930186; Chu CJ, 2015, NEUROIMAGE, V108, P23, DOI 10.1016/j.neuroimage.2014.12.033; Chung JW, 2017, NEUROIMAGE, V144, P164, DOI 10.1016/j.neuroimage.2016.10.008; Cohen JR, 2016, J NEUROSCI, V36, P12083, DOI 10.1523/JNEUROSCI.2965-15.2016; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Di Scala G, 2019, EXP AGING RES, V45, P41, DOI 10.1080/0361073X.2018.1560108; Diez I, 2017, NETW NEUROSCI, V1, P116, DOI [10.1162/NETN_a_00007, 10.1162/netn_a_00007]; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Douglas David B, 2018, Med Sci (Basel), V7, DOI 10.3390/medsci7010002; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Edwards AE, 2018, NEUROSCIENCE, V395, P35, DOI 10.1016/j.neuroscience.2018.10.040; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; Fallani FD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0521; Fuchs M, 1998, IEEE T BIO-MED ENG, V45, P980, DOI 10.1109/10.704867; Goel R, 2019, NEUROSCIENCE, V413, P135, DOI 10.1016/j.neuroscience.2019.05.063; Goossens N, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101881; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Handiru VS, 2018, IEEE SYST MAN CYBERN, V4, P14, DOI 10.1109/MSMC.2017.2778458; Hashim E, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00097; Hearne LJ, 2017, J NEUROSCI, V37, P8399, DOI 10.1523/JNEUROSCI.0485-17.2017; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Huang CY, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00096; Huang CY, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00420; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Klimesch W, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00118; Makeig S, 1996, ADV NEUR IN, V8, P145; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; Michel CM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00325; Mierau A, 2017, BRAIN TOPOGR, V30, P434, DOI 10.1007/s10548-017-0567-x; Miraglia F, 2018, NEURAL NETWORKS, V106, P168, DOI 10.1016/j.neunet.2018.07.005; Mullen TR, 2015, IEEE T BIO-MED ENG, V62, P2553, DOI 10.1109/TBME.2015.2481482; Munia TTK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17414-x; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nordin AD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41131-2; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; O'Reilly C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175870; Omlor W, 2011, J NEUROSCI, V31, P8037, DOI 10.1523/JNEUROSCI.4153-10.2011; Oostenveld R, 2002, HUM BRAIN MAPP, V17, P179, DOI 10.1002/hbm.10061; Owens JA, 2018, BRAIN INJURY, V32, P776, DOI 10.1080/02699052.2018.1451656; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Peterson SM, 2019, NEUROIMAGE, V198, P93, DOI 10.1016/j.neuroimage.2019.05.038; Peterson SM, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0207-18.2018; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Pilkar R, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00836; Pion-Tonachini L, 2019, NEUROIMAGE, V198, P181, DOI 10.1016/j.neuroimage.2019.05.026; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salimi-Khorshidi G, 2011, NEUROIMAGE, V54, P2006, DOI 10.1016/j.neuroimage.2010.09.088; Schelter B, 2006, J NEUROSCI METH, V152, P210, DOI 10.1016/j.jneumeth.2005.09.001; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Slobounov S, 2006, MOTOR CONTROL, V10, P69, DOI 10.1123/mcj.10.1.69; Slobounov SM, 2013, NEUROSCI LETT, V547, P6, DOI 10.1016/j.neulet.2013.05.001; Smith LGF, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.9.FOCUS19652; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Solis-Escalante T, 2019, NEUROIMAGE, V188, P557, DOI 10.1016/j.neuroimage.2018.12.045; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Surgent OJ, 2019, GAIT POSTURE, V71, P245, DOI 10.1016/j.gaitpost.2019.05.011; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Takakusaki K, 2017, J MOV DISORD, V10, P1, DOI 10.14802/jmd.16062; Talalay IV, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13269; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Uddin MN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39199-x; Van de Steen F, 2019, BRAIN TOPOGR, V32, P643, DOI 10.1007/s10548-016-0538-7; Varghese JP, 2019, NEUROSCIENCE, V401, P43, DOI 10.1016/j.neuroscience.2019.01.008; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Venkalesan UM, 2019, NEUROPSYCHOLOGY, V33, P893, DOI 10.1037/neu0000553; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wang BT, 2016, BEHAV BRAIN RES, V312, P238, DOI 10.1016/j.bbr.2016.06.037; Wittenberg E, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00170; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yoncheva YN, 2016, J AM ACAD CHILD PSY, V55, P137, DOI 10.1016/j.jaac.2015.11.011; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou YX, 2017, J MAGN RESON IMAGING, V46, P518, DOI 10.1002/jmri.25548	111	1	1	11	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	OCT 1	2021	42	14					4427	4447		10.1002/hbm.25554		JUL 2021	21	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	UL3NA	WOS:000679029800001	34312933	Green Published, Green Submitted, gold			2022-02-06	
J	Citerio, G; Robba, C; Rebora, P; Petrosino, M; Rossi, E; Malgeri, L; Stocchetti, N; Galimberti, S; Menon, DK				Citerio, Giuseppe; Robba, Chiara; Rebora, Paola; Petrosino, Matteo; Rossi, Eleonora; Malgeri, Letterio; Stocchetti, Nino; Galimberti, Stefania; Menon, David K.		Ctr-TBI Participants Investigators	Management of arterial partial pressure of carbon dioxide in the first week after traumatic brain injury: results from the CENTER-TBI study	INTENSIVE CARE MEDICINE			English	Article						Carbon dioxide; Hyperventilation; Traumatic brain injury; Intracranial pressure; Outcome	HEAD-INJURY; HYPERVENTILATION; GUIDELINES	Purpose To describe the management of arterial partial pressure of carbon dioxide (PaCO2) in severe traumatic brain-injured (TBI) patients, and the optimal target of PaCO2 in patients with high intracranial pressure (ICP). Methods Secondary analysis of CENTER-TBI, a multicentre, prospective, observational, cohort study. The primary aim was to describe current practice in PaCO2 management during the first week of intensive care unit (ICU) after TBI, focusing on the lowest PaCO2 values. We also assessed PaCO2 management in patients with and without ICP monitoring (ICPm), and with and without intracranial hypertension. We evaluated the effect of profound hyperventilation (defined as PaCO2 < 30 mmHg) on long-term outcome. Results We included 1100 patients, with a total of 11,791 measurements of PaCO2 (5931 lowest and 5860 highest daily values). The mean (+/- SD) PaCO2 was 38.9 (+/- 5.2) mmHg, and the mean minimum PaCO2 was 35.2 (+/- 5.3) mmHg. Mean daily minimum PaCO2 values were significantly lower in the ICPm group (34.5 vs 36.7 mmHg, p < 0.001). Daily PaCO2 nadir was lower in patients with intracranial hypertension (33.8 vs 35.7 mmHg, p < 0.001). Considerable heterogeneity was observed between centers. Management in a centre using profound hyperventilation (HV) more frequently was not associated with increased 6 months mortality (OR = 1.06, 95% CI = 0.77-1.45, p value = 0.7166), or unfavourable neurological outcome (OR 1.12, 95% CI = 0.90-1.38, p value = 0.3138). Conclusions Ventilation is manipulated differently among centers and in response to intracranial dynamics. PaCO2 tends to be lower in patients with ICP monitoring, especially if ICP is increased. Being in a centre which more frequently uses profound hyperventilation does not affect patient outcomes.	[Citerio, Giuseppe; Rebora, Paola; Galimberti, Stefania] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Citerio, Giuseppe] Azienda Sociosanitaria Terr Monza, Neurointens Care Unit, Osped San Gerardo, Monza, Italy; [Robba, Chiara] IRCCS Oncol & Neurosci, Policlin San Martino, Anesthesia & Intens Care, Genoa, Italy; [Robba, Chiara] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Rebora, Paola; Petrosino, Matteo; Galimberti, Stefania] Univ Milano Bicocca, Sch Med & Surg, Bicocca Bioinformat Biostat & Bioimaging Ctr B4, Milan, Italy; [Rossi, Eleonora] Univ Pavia, Dept Clin Surg Diagnost & Paediat Sci, Unit Anaesthesia & Intens Care, Pavia, Italy; [Malgeri, Letterio] Sch Med, Anesthesia & Intens Care, Messina, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Menon, David K.] Addenbrookes Hosp, Neurocrit Care Unit, Cambridge, England		Citerio, G (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Monza, Italy.; Citerio, G (corresponding author), Azienda Sociosanitaria Terr Monza, Neurointens Care Unit, Osped San Gerardo, Monza, Italy.	giuseppe.citerio@unimib.it	Vande Vyvere, Thijs/AAB-5180-2022; Posti, Jussi P./Y-2908-2019; Raj, Rahul/K-7693-2012	Vande Vyvere, Thijs/0000-0003-4032-5443; Posti, Jussi P./0000-0002-5925-5193; Van Essen, Thomas/0000-0003-4657-5283; Dark, Paul/0000-0003-3309-0164; van der Naalt, Joukje/0000-0001-9873-2418; Coles, Jonathan/0000-0003-4013-679X; Zeiler, Frederick/0000-0003-1737-0510; Raj, Rahul/0000-0003-4243-9591; Radoi, Andreea/0000-0002-0677-3544; Rossi, Sandra/0000-0002-9963-8121	Universita degli Studi di Milano - Bicocca within the CRUI-CARE Agreement; FW7 program of the European Union [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	Open access funding provided by Universita degli Studi di Milano -Bicocca within the CRUI-CARE Agreement. The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI study, registered at clinicaltrials.gov NCT02210221) was funded by the FW7 program of the European Union (602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and Integra LifeSciences Corporation (USA). The funder had no role in the design of the study, the collection, analysis, and interpretation of data, or in writing the manuscript.	Bien, 1949, ACTA PSYCHIAT SCAND, V34, P1; Bogossian EG, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.580859; Brandi G, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2304-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cnossen MC, 2018, CLIN EPIDEMIOL, V10, P841, DOI 10.2147/CLEP.S154500; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Godoy DA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00250; GORDON E, 1971, ACTA ANAESTH SCAND, V15, P193, DOI 10.1111/j.1399-6576.1971.tb05461.x; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Hoiland RL, 2019, COMPR PHYSIOL, V9, P1101, DOI 10.1002/cphy.c180021; Huijben JA, 2021, CRIT CARE, V25, DOI 10.1186/s13054-020-03370-y; Huijben JA, 2020, INTENS CARE MED, V46, P995, DOI 10.1007/s00134-020-05965-z; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Neumann JO, 2008, INTENS CARE MED, V34, P1676, DOI 10.1007/s00134-008-1123-7; Robba C, 2020, INTENS CARE MED, V46, P2397, DOI 10.1007/s00134-020-06283-0; Roberts I, 1997, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000566/abstract, DOI 10.1002/14651858.CD000566/ABSTRACT]; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; van Essen TA, 2019, ACTA NEUROCHIR, V161, P451, DOI 10.1007/s00701-019-03815-6; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	28	1	1	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	SEP	2021	47	9					961	973		10.1007/s00134-021-06470-7		JUL 2021	13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN3TP	WOS:000677224300001	34302517	Green Published, hybrid			2022-02-06	
J	Dang, YY; Ping, J; Guo, YK; Yang, Y; Xia, XY; Huang, RJ; Zhang, JN; He, JH				Dang, Yuanyuan; Ping, Jie; Guo, Yongkun; Yang, Yi; Xia, Xiaoyu; Huang, Ruijing; Zhang, Jianning; He, Jianghong			Cranioplasty for patients with disorders of consciousness	ANNALS OF PALLIATIVE MEDICINE			English	Article						Cranioplasty (CP); persistent vegetative state (persistent VS); traumatic brain injury (TBT); hydrocephalus; transcalvarial herniation (TCH)	GLASGOW OUTCOME SCALE; REVISED GOSE-R; DECOMPRESSIVE CRANIECTOMY; HYDROCEPHALUS; DIAGNOSIS; STATE; SHUNT	Background: Cranioplasty (CP) is necessary for patients with disorders of consciousness (DOC) and skull defects. However, due to the complexity of these conditions, the surgical indications are conservative, and there are few published reports. This study aimed to assess the outcomes and complications of CP in patients with DOC, and to optimize the management of transcalvarial herniation (TCH) and hydrocephalus. Methods: A total of 87 patients with DOC who underwent CP at our center between December 2016 and April 2019 were selected. The patients were divided into traumatic brain injury (TBI) and non-TBI groups, and the complications, outcomes, and costs were compared. Factors associated with prognosis and surgical complications were identified using multivariate logistic regression analysis. Results: Postoperative complications occurred in 18 patients (20.7%). The complication rate was higher in the TBI group than in the non-TBI group (P=0.031). Preoperative ventriculoperitoneal shunt (VPS) was identified as a risk factor for incision complication (P=0.032), and non-traumatic cause tended to be a protective factor against postoperative hydrocephalus (P=0.055). One year after CP, 25 patients (28.7%) regained full consciousness [Extended Glasgow Outcome Scale (GOSE) >= 3] and 10 patients (11.5%) achieved partial self-care (GOSE =4). Multivariate analyses revealed that minimally conscious state (MCS) vs. vegetative state/unresponsive wakefulness syndrome (VS/UWS) (P=0.000) and early CP (P=0.023) were potential indicators for the recovery of consciousness. Conclusions: Our findings suggest that CP is safe in patients with DOC and may be beneficial for the recovery of consciousness. Early surgery and surgery for MCS provide better results. Timely CP in patients with TCI I can help to reduce preoperative VPS, control incision complications, and detect and intervene in potential hydrocephalus.	[Dang, Yuanyuan; Xia, Xiaoyu; Huang, Ruijing] Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Med Ctr 7, Beijing, Peoples R China; [Ping, Jie] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Beijing, Peoples R China; [Guo, Yongkun] Zhengzhou Univ, Affiliated Hosp 5, Dept Neurosurg, Zhengzhou, Peoples R China; [Yang, Yi; He, Jianghong] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China; [Zhang, Jianning] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Neurosurg, 28 Fuxing Rd, Beijing 100853, Peoples R China		He, JH (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China.; Zhang, JN (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Neurosurg, 28 Fuxing Rd, Beijing 100853, Peoples R China.	he_jianghong2020@163.com; jnzhang2018@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771128]	This work was supported by the National Natural Science Foundation of China (No. 81771128).	Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Bjornson A, 2019, ACTA NEUROCHIR, V161, P467, DOI 10.1007/s00701-019-03820-9; Chen H, 2017, METAB BRAIN DIS, V32, P1427, DOI 10.1007/s11011-017-0008-2; Corallo F, 2015, TURK NEUROSURG, V25, P193, DOI 10.5137/1019-5149.JTN.10618-14.2; De Cola MC, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1106; Estraneo A, 2020, NEUROLOGY, V95, pE1488, DOI 10.1212/WNL.0000000000010254; Estraneo A, 2018, ARCH PHYS MED REHAB, V99, P2523, DOI 10.1016/j.apmr.2018.04.024; Finger T, 2017, CLIN NEUROL NEUROSUR, V153, P27, DOI 10.1016/j.clineuro.2016.12.001; Formisano R, 2018, J NEUROL SCI, V388, P22, DOI 10.1016/j.jns.2018.02.042; Formisano R, 2020, J NEUROSURG SCI, V64, P494, DOI 10.23736/S0390-5616.19.04789-1; Formisano R, 2019, BRAIN INJURY, V33, P974, DOI 10.1080/02699052.2019.1622785; Formisano R, 2019, EUR J PHYS REHAB MED, V55, P139, DOI 10.23736/S1973-9087.18.05441-2; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Han PY, 2008, J KOREAN NEUROSURG S, V43, P51, DOI 10.3340/jkns.2008.43.1.51; Kaushal Ashutosh, 2019, Asian J Neurosurg, V14, P52, DOI 10.4103/ajns.AJNS_147_17; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lilja-Cyron A, 2020, NEUROSURGERY, V86, P231, DOI 10.1093/neuros/nyz049; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Missori P, 2006, NEUROSURG REV, V29, P224, DOI 10.1007/s10143-006-0027-7; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Nasi D, 2018, WORLD NEUROSURG, V116, pE543, DOI 10.1016/j.wneu.2018.05.028; Ore CLD, 2018, J CRANIOFAC SURG, V29, P1862, DOI 10.1097/SCS.0000000000004706; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Posti JP, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00223; Septien S, 2018, SEMIN NEUROL, V38, P548, DOI 10.1055/s-0038-1667384; Shahid AH, 2018, J NEUROSURG, V128, P229, DOI 10.3171/2016.10.JNS16678; Neto ARS, 2019, CLIN NEUROL NEUROSUR, V182, P73, DOI 10.1016/j.clineuro.2019.05.003; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2019, J CLIN NEUROSCI, V63, P62, DOI 10.1016/j.jocn.2019.02.006; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu RH, 2019, BMC SURG, V19, DOI 10.1186/s12893-019-0489-5; Yang NR, 2018, WORLD NEUROSURG, V110, pE160, DOI 10.1016/j.wneu.2017.10.117; Zheng F, 2018, J INT MED RES, V46, P2503, DOI 10.1177/0300060518755148; Zheng RZ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00081; Zheng WJ, 2019, WORLD NEUROSURG, V127, pE1166, DOI 10.1016/j.wneu.2019.04.079; Zhu HF, 2018, WORLD NEUROSURG, V113, P198, DOI 10.1016/j.wneu.2018.02.080	37	1	1	1	1	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2224-5820	2224-5839		ANN PALLIAT MED	Ann. Pallliat. Med.	AUG	2021	10	8					8889	8899		10.21037/apm-21-1822		JUL 2021	11	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	UJ7WK	WOS:000682954800001	34488376	gold			2022-02-06	
J	Arun, P; Rossetti, F; Eken, O; Wilder, DM; Wang, Y; Long, JB				Arun, Peethambaran; Rossetti, Franco; Eken, Ondine; Wilder, Donna M.; Wang, Ying; Long, Joseph B.			Phosphorylated Neurofilament Heavy Chain in the Cerebrospinal Fluid is a Suitable Biomarker of Acute and Chronic Blast-Induced Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; blast exposure; cerebrospinal fluid; neurodegeneration; phosphorylated neurofilament heavy chain; traumatic brain injury	TIME-DEPENDENT CHANGES; NF-H; AXONAL-TRANSPORT; SERUM BIOMARKER; SUBUNITS; NEURONS; LIGHT	Blast-induced traumatic brain injury (bTBI) has been documented as a significant concern for both military and civilian populations in response to the increased use of improvised explosive devices. Identifying biomarkers that could aid in the proper diagnosis and assessment of both acute and chronic bTBI is in urgent need since little progress has been made towards this goal. Addressing this knowledge gap is especially important in military veterans who are receiving assessment and care often years after their last blast exposure. Neuron-specific phosphorylated neurofilament heavy chain protein (pNFH) has been successfully evaluated as a reliable biomarker of different neurological disorders, as well as brain trauma resulting from contact sports and acute stages of brain injury of different origin. In the present study, we have evaluated the utility of pNFH levels measured in the cerebrospinal fluid (CSF) as an acute and chronic biomarker of brain injury resulting from single and tightly coupled repeated blast exposures using experimental rats. The pNFH levels increased at 24 h, returned to normal levels at 1 month, but increased again at 6 months and 1 year post-blast exposures. No significant changes were observed between single and repeated blast-exposed groups. To determine whether the observed increase of pNFH in CSF corresponded with its levels in the brain, we performed fluorescence immunohistochemistry in different brain regions at the four time-points evaluated. We observed decreased pNFH levels in those brain areas at 24 h, 6 months, and 1 year. The results suggest that blast exposure causes axonal degeneration at acute and chronic stages resulting in the release of pNFH, the abundant neuronal cytoskeletal protein. Moreover, the changes in pNFH levels in the CSF negatively correlated with the neurobehavioral functions in the rats, reinforcing suggestions that CSF levels of pNFH can be a suitable biomarker of bTBI.	[Arun, Peethambaran; Rossetti, Franco; Eken, Ondine; Wilder, Donna M.; Wang, Ying; Long, Joseph B.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD USA; [Arun, Peethambaran] Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Arun, P (corresponding author), Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	peethambaran.arun.ctr@mail.mil			Military Operational Medicine Research Program at United States Army Medical Research and Development Command	This study was funded by the Military Operational Medicine Research Program at United States Army Medical Research and Development Command.	Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Arun P, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00438; Arun P, 2020, J NEUROTRAUM, V37, P647, DOI 10.1089/neu.2019.6591; Backstrom D, 2020, NEUROLOGY, V95, pE827, DOI 10.1212/WNL.0000000000010084; Boutte AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221036; Eikelenboom MJ, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/823176; Gao WY, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022363; Ghai V, 2020, J NEUROTRAUM, V37, P1418, DOI 10.1089/neu.2019.6826; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Harper MM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03374; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Jung C, 2000, CELL MOTIL CYTOSKEL, V47, P120, DOI 10.1002/1097-0169(200010)47:2<120::AID-CM3>3.0.CO;2-6; Jung CW, 1999, CELL MOTIL CYTOSKEL, V42, P230, DOI 10.1002/(SICI)1097-0169(1999)42:3<230::AID-CM6>3.0.CO;2-A; Kobeissy F.H, 2015, BRAIN NEUROTRAUMA MO; Kusnierova P, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.22948; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Laverse E, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa137; LEWIS SE, 1988, J CELL BIOL, V107, P2689, DOI 10.1083/jcb.107.6.2689; Ma WB, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/6612871; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shea TB, 2003, TRENDS NEUROSCI, V26, P397, DOI 10.1016/S0166-2236(03)00199-1; Shively SB, 2017, MIL MED, V182, P1461, DOI 10.7205/MILMED-D-16-00239; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Thompson JM, 2008, CAN FAM PHYSICIAN, V54, P1549; Tschiffely AE, 2020, J NEUROTRAUM, V37, P1091, DOI 10.1089/neu.2019.6512; Vajtr D, 2012, Soud Lek, V57, P7; Wang Y, 2017, J NEUROTRAUM, V34, P952, DOI 10.1089/neu.2016.4465; Xiong YL, 2021, EUR NEUROL, V84, P6, DOI 10.1159/000513008; Zheng YL, 2003, J BIOL CHEM, V278, P24026, DOI 10.1074/jbc.M303079200; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	43	1	1	11	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2801	2810		10.1089/neu.2021.0144		JUL 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000675018800001	34210150				2022-02-06	
J	Dennis, EL; Caeyenberghs, K; Hoskinson, KR; Merkley, TL; Suskauer, SJ; Asarnow, RF; Babikian, T; Bartnik-Olson, B; Bickart, K; Bigler, ED; Ewing-Cobbs, L; Figaji, A; Giza, CC; Goodrich-Hunsaker, NJ; Hodges, CB; Hovenden, ES; Irimia, A; Konigs, M; Levin, HS; Lindsey, HM; Max, JE; Newsome, MR; Olsen, A; Ryan, NP; Schmidt, AT; Spruiell, MS; Wade, BSC; Ware, AL; Watson, CG; Wheeler, AL; Yeates, KO; Zielinski, BA; Kochunov, P; Jahanshad, N; Thompson, PM; Tate, DF; Wilde, EA				Dennis, Emily L.; Caeyenberghs, Karen; Hoskinson, Kristen R.; Merkley, Tricia L.; Suskauer, Stacy J.; Asarnow, Robert F.; Babikian, Talin; Bartnik-Olson, Brenda; Bickart, Kevin; Bigler, Erin D.; Ewing-Cobbs, Linda; Figaji, Anthony; Giza, Christopher C.; Goodrich-Hunsaker, Naomi J.; Hodges, Cooper B.; Hovenden, Elizabeth S.; Irimia, Andrei; Konigs, Marsh; Levin, Harvey S.; Lindsey, Hannah M.; Max, Jeffrey E.; Newsome, Mary R.; Olsen, Alexander; Ryan, Nicholas P.; Schmidt, Adam T.; Spruiell, Matthew S.; Wade, Benjamin S. C.; Ware, Ashley L.; Watson, Christopher G.; Wheeler, Anne L.; Yeates, Keith Owen; Zielinski, Brandon A.; Kochunov, Peter; Jahanshad, Neda; Thompson, Paul M.; Tate, David F.; Wilde, Elisabeth A.			White Matter Disruption in Pediatric Traumatic Brain Injury Results From ENIGMA Pediatric Moderate to Severe Traumatic Brain Injury	NEUROLOGY			English	Article							BEHAVIOR RELATIONSHIPS; PSYCHIATRIC-DISORDERS; CORPUS-CALLOSUM; DIFFUSION MRI; CHILDREN; DTI; AGE; ADOLESCENCE; ANISOTROPY; CHILDHOOD	Objective Our study addressed aims (1) to test the hypothesis that moderate-severe traumatic brain injury (TBI) in pediatric patients is associated with widespread white matter (WM) disruption, (2) to test the hypothesis that age and sex affect WM organization after injury, and (3) to examine associations between WM organization and neurobehavioral outcomes. Methods Data from 10 previously enrolled, existing cohorts recruited from local hospitals and clinics were shared with the Enhancing NeuroImaging Genetics Through Meta-Analysis (ENIGMA) Pediatric Moderate/Severe TBI (msTBI) working group. We conducted a coordinated analysis of diffusion MRI (dMRI) data using the ENIGMA dMRI processing pipeline. Results Five hundred seven children and adolescents (244 with complicated msTBI and 263 controls) were included. Patients were clustered into 3 postinjury intervals: acute/subacute, <2 months; postacute, 2 to 6 months; and chronic, >= 6 months. Outcomes were dMRI metrics and postinjury behavioral problems as indexed by the Child Behavior Checklist. Our analyses revealed altered WM diffusion metrics across multiple tracts and all postinjury intervals (effect sizes range d = -0.5 to -1.3). Injury severity is a significant contributor to the extent of WM alterations but explained less variance in dMRI measures with increasing time after injury. We observed a sex-by-group interaction: female patients with TBI had significantly lower fractional anisotropy in the uncinate fasciculus than controls (beta = 0.043), which coincided with more parent-reported behavioral problems (beta = -0.0027). Conclusions WM disruption after msTBI is widespread, persistent, and influenced by demographic and clinical variables. Future work will test techniques for harmonizing neurocognitive data, enabling more advanced analyses to identify symptom clusters and clinically meaningful patient subtypes.	[Dennis, Emily L.; Merkley, Tricia L.; Bigler, Erin D.; Goodrich-Hunsaker, Naomi J.; Hovenden, Elizabeth S.; Lindsey, Hannah M.; Wade, Benjamin S. C.; Zielinski, Brandon A.; Tate, David F.; Wilde, Elisabeth A.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA; [Dennis, Emily L.; Goodrich-Hunsaker, Naomi J.; Lindsey, Hannah M.; Tate, David F.; Wilde, Elisabeth A.] George E Warden Vet Affairs Med Ctr, Salt Lake City, UT USA; [Caeyenberghs, Karen; Ryan, Nicholas P.] Deakin Univ, Sch Psychol, Cognit Neurosci Unit, Geelong, Vic, Australia; [Hoskinson, Kristen R.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Hoskinson, Kristen R.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Merkley, Tricia L.; Bigler, Erin D.; Goodrich-Hunsaker, Naomi J.; Hodges, Cooper B.; Lindsey, Hannah M.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Merkley, Tricia L.; Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Asarnow, Robert F.; Babikian, Talin] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Babikian, Talin; Bickart, Kevin; Giza, Christopher C.] Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Bartnik-Olson, Brenda] Loma Linda Univ, Med Ctr, Dept Radiol, Loma Linda, CA USA; [Bickart, Kevin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Ewing-Cobbs, Linda; Watson, Christopher G.] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Dept Pediat, Houston, TX 77030 USA; [Figaji, Anthony] Univ Cape Town, Div Neurosurg, Cape Town, South Africa; [Figaji, Anthony] Univ Cape Town, Neurosci Inst, Cape Town, South Africa; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat, Div Neurol, Mattel Childrens Hosp, Los Angeles, CA 90024 USA; [Hodges, Cooper B.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Irimia, Andrei] Univ Southern Calif, Ethel Percy Andrus Gerontol Ctr, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA; [Irimia, Andrei] Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA 90007 USA; [Konigs, Marsh] Univ Amsterdam, Amsterdam UMC, Emma Childrens Hosp, Emma Neurosci Grp, Amsterdam, Netherlands; [Levin, Harvey S.; Newsome, Mary R.; Spruiell, Matthew S.; Wilde, Elisabeth A.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey S.; Newsome, Mary R.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Max, Jeffrey E.] Rady Childrens Hosp, Dept Psychiat, San Diego, CA USA; [Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway; [Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Ryan, Nicholas P.] Univ Melbourne, Murdoch Childrens Res Inst, Dept Clin Sci, Melbourne, Vic, Australia; [Ryan, Nicholas P.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Schmidt, Adam T.] Texas Tech Univ, Dept Psychol Sci, Lubbock, TX 79409 USA; [Wade, Benjamin S. C.] Univ Calif Los Angeles, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90024 USA; [Ware, Ashley L.; Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Wheeler, Anne L.] Univ Toronto, Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON, Canada; [Wheeler, Anne L.] Univ Toronto, Physiol Dept, Toronto, ON, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Zielinski, Brandon A.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Kochunov, Peter] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA; [Jahanshad, Neda; Thompson, Paul M.] USC, Keck Sch Med, Stevens Neuroimaging & Informat Inst, Imaging Genet Ctr, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Ophthal, Los Angeles, CA USA		Dennis, EL (corresponding author), Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA.	emily.dennis@hsc.utah.edu	Jahanshad, Neda/ABD-5944-2021; Merkley, Tricia L./AAN-2989-2020; Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867; Dennis, Emily/0000-0001-7112-4009; Ryan, Nicholas/0000-0002-0878-8889; Wade, Benjamin/0000-0003-2461-6101; Babikian, Talin/0000-0002-2270-8566; Asarnow, Robert/0000-0002-4994-9642; Merkley, Tricia/0000-0002-0897-8391; Bartnik-Olson, Brenda/0000-0002-1137-9437; Suskauer, Stacy/0000-0002-5009-5584	National Health and Medical Research Council Career Development FellowshipNational Health and Medical Research Council of Australia; NRF SARChI Chair of Clinical Neurosciences; UCLA Easton Clinic for Brain Health, Stan and Patty Silver; UCLA Brain Injury Research Center [R01HD061504, K01HD083459, R01NS100973]; Department of DefenseUnited States Department of Defense [W81XWH-18-1-0413]; Hanson-Thorell Research Scholarship [R01HD088438, K12HD001097, K23HD06161, UL1TR001079, 1S10OD021648, U54EB020403, R01MH116147, R56AG058854, P41EB015922, R01MH111671, K99MH119314]; NARSADNARSAD [27786]; Ronald and Irene Ward Chair in Pediatric Brain Injury - Alberta Children's Hospital Foundation;  [K99NS096116];  [R61NS120249];  [R01NS05400]	Funding provided by K99NS096116 (E.L.D.); R61NS120249 (E.L.D., D.F.T., E.A.W.); R01NS05400 (B.B.-O.); National Health and Medical Research Council Career Development Fellowship (K.C.); NRF SARChI Chair of Clinical Neurosciences (A.F.); UCLA Easton Clinic for Brain Health, Stan and Patty Silver, UCLA Brain Injury Research Center, R01HD061504 (C.C.G.); K01HD083459 (K.R.H.); R01NS100973, Department of Defense contract W81XWH-18-1-0413 and a Hanson-Thorell Research Scholarship (A.I.); R01HD088438 (JEM); K12HD001097, K23HD06161, UL1TR001079, 1S10OD021648 (S.J.S.); U54EB020403, R01MH116147, R56AG058854, P41EB015922, R01MH111671 (P.M.T.); K99MH119314, NARSAD 27786 (B.S.C.W.); and Ronald and Irene Ward Chair in Pediatric Brain Injury, funded by the Alberta Children's Hospital Foundation (K.O.Y.).	Achenbach T.M., 1994, INTEGRATIVE GUIDE 19; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Dennis EL., BRAIN IMAGING YOUNG; Dennis EL, 2021, BRAIN IMAGING BEHAV, V15, P555, DOI 10.1007/s11682-020-00363-x; Dennis EL, 2022, HUM BRAIN MAPP, V43, P149, DOI 10.1002/hbm.25046; Dennis EL, 2021, MOL PSYCHIATR, V26, P4315, DOI 10.1038/s41380-019-0631-x; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Dennis EL, 2017, CHILD NERV SYST, V33, P1683, DOI 10.1007/s00381-017-3522-y; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Dhollander T., 2020, FIXEL BASED ANAL DIF, DOI [10.31219/osf.io/zu8fv, DOI 10.31219/OSF.IO/ZU8FV]; Ewing-Cobbs L, 2019, J NEUROTRAUM, V36, P1738, DOI 10.1089/neu.2018.6071; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Guo J, 2019, ACTA BIOMATER, V99, P433, DOI 10.1016/j.actbio.2019.08.036; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kelly S, 2018, Mol Psychiatry, V23, P1261, DOI 10.1038/mp.2017.170; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Kochunov P, 2022, HUM BRAIN MAPP, V43, P194, DOI 10.1002/hbm.24998; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lindsey HM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01296; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Molteni E, 2019, EUR J NEUROL, V26, P1183, DOI 10.1111/ene.13963; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Nolen-Hoeksema S., 1990, **DROPPED REF**, DOI DOI 10.1037/0033-2909.101.2.259; Raffelt DA, 2015, NEUROIMAGE, V117, P40, DOI 10.1016/j.neuroimage.2015.05.039; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Thompson PM, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0705-1; Watson CG, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101673; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2021, BRAIN IMAGING BEHAV, V15, P465, DOI 10.1007/s11682-021-00450-7; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092	50	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUL 20	2021	97	3					E298	E309		10.1212/WNL.0000000000012222			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UZ7MJ	WOS:000702385600025	34050006				2022-02-06	
J	Falk, H; Bechtold, KT; Peters, ME; Roy, D; Rao, V; Lavieri, M; Sair, H; Van Meter, TE; Korley, F				Falk, Hayley; Bechtold, Kathleen T.; Peters, Matthew E.; Roy, Durga; Rao, Vani; Lavieri, Mariel; Sair, Haris; Van Meter, Timothy E.; Korley, Frederick			A Prognostic Model for Predicting One-Month Outcomes among Emergency Department Patients with Mild Traumatic Brain Injury and a Presenting Glasgow Coma Scale of Fifteen	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						Glasgow Outcome Scale Extended; outcome prediction; prognostic model; traumatic brain injury	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; UNITED-STATES; AGE; DEPRESSION; PREVALENCE; DISORDERS; RECOVERY; COHORT; TBI	The lack of well-performing prognostic models for early prognostication of outcomes remains a major barrier to improving the clinical care of patients with mild traumatic brain injury (mTBI). We aimed to derive a prognostic model for predicting incomplete recovery at 1-month in emergency department (ED) patients with mTBI and a presenting Glasgow Coma Scale (GCS) score of 15 who were enrolled in the HeadSMART (Head Injury Serum Markers for Assessing Response to Trauma) study. The derivation cohort included 355 participants with complete baseline (day-of-injury) and follow-up data. The primary outcome measure was the Glasgow Outcome Scale Extended (GOSE) at 1-month and incomplete recovery was defined as a GOSE <8. At 1-month post-injury, incomplete recovery was present in 58% (n = 205) of participants. The final multi-variable logistic regression model included six variables: age in years (odds ratio [OR] = 0.98; 95% confidence interval [CI]: 0.97-1.00), positive head CT (OR = 4.42; 95% CI: 2.21-9.33), history of depression (OR = 2.59; 95% CI: 1.47-4.69), and self-report of moderate or severe headache (OR = 2.49; 95% CI: 1.49-4.18), difficulty concentrating (OR = 3.17; 95% CI: 1.53-7.04), and photophobia (OR = 4.17; 95% CI: 2.08-8.92) on the day-of-injury. The model was validated internally using bootstrap resampling (1000 resamples), which revealed a mean over-optimism value of 0.01 and an optimism-corrected area under the curve (AUC) of 0.79 (95% CI: 0.75-0.85). A prognostic model for predicting incomplete recovery among ED patients with mTBI and a presenting GCS of 15 using easily obtainable clinical and demographic variables has acceptable discriminative accuracy. External validation of this model is warranted.	[Falk, Hayley] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Lavieri, Mariel] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA; [Korley, Frederick] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Bechtold, Kathleen T.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD USA; [Peters, Matthew E.; Roy, Durga; Rao, Vani] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Sair, Haris] Johns Hopkins Univ, Dept Radiol & Radiol Sci, Baltimore, MD USA; [Van Meter, Timothy E.] BRAINBox Solut Inc, Richmond, VA USA		Falk, H (corresponding author), Dept Emergency Med, 24 Frank Lloyd Wright Dr,Suite H-3100, Ann Arbor, MI 48105 USA.	falkh@med.umich.edu			ImmunArray, Inc.	HeadSMART was supported by a grant from ImmunArray, Inc.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Booker J, 2019, BRAIN INJURY, V33, P1158, DOI 10.1080/02699052.2019.1629626; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Collins GS, 2015, CIRCULATION, V131, P211, DOI 10.1161/CIRCULATIONAHA.114.014508; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Harrell Jr FE., 2020, R PACKAGE VERSION, P6; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Korley FK, 2019, ACAD EMERG MED, DOI 10.1111/acem.13844; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Ma HP, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/4364592; Madhok DY, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050269; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mikolic A, 2021, J NEUROTRAUM, V38, P196, DOI 10.1089/neu.2020.7074; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Peters ME, 2018, BRAIN INJURY, V32, P1725, DOI 10.1080/02699052.2018.1520301; Peters ME, 2017, BRAIN INJURY, V31, P370, DOI 10.1080/02699052.2016.1231344; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Richey LN, 2020, INT REV PSYCHIATR, V32, P22, DOI 10.1080/09540261.2019.1657076; RStudio Team (2020), RSTUDIO INT DEV R RS RSTUDIO INT DEV R RS; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Steyerberg EW., 2019, CLIN PREDICTION MODE, V2nd ed; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Yue JK, 2018, NEUROL RES, V40, P972, DOI 10.1080/01616412.2018.1505416; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	63	1	1	4	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0137		JUL 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TL7EM	WOS:000675021200001	33957761				2022-02-06	
J	Kuusinen, V; Perakyla, J; Sun, LH; Ogawa, KH; Hartikainen, KM				Kuusinen, Venla; Perakyla, Jari; Sun, Lihua; Ogawa, Keith H.; Hartikainen, Kaisa M.			Emotional Modulation of Frontal Alpha Asymmetry - a Novel Biomarker of Mild Traumatic Brain Injury	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						mild traumatic brain injury (MTBI); frontal alpha asymmetry (FAA); emotion; threat; EEG; depression; post-concussion symptoms; biomarker	POSTTRAUMATIC-STRESS-DISORDER; ANTERIOR THALAMIC NUCLEI; POST-CONCUSSION SYNDROME; EEG ASYMMETRY; FUNCTIONAL CONNECTIVITY; DEPRESSIVE SYMPTOMS; STIMULI COMPETE; WORKING-MEMORY; HEAD-INJURY; ATTENTION	Objective findings of brain injury or dysfunction are typically lacking in mild traumatic brain injury (MTBI) despite prolonged post-concussion symptoms in some patients. Thus, there is a need for objective biomarkers of MTBI that reflect altered brain physiology underlying subjective symptoms. We have previously reported increased attention to threat-related stimuli in subjects with MTBI, suggesting a physiological vulnerability to depression. Vulnerability to depression has been linked with relatively greater activity of the right than left frontal cortex reflected in inverse pattern in frontal alpha with greater power on the left than right. We investigated whether patients with previous MTBI show this pattern of frontal activity reflected in more negative frontal alpha asymmetry (FAA) scores. Furthermore, in search for potential biomarkers of MTBI, we created a novel index, emotional modulation of FAA (eFAA) and investigated whether it correlates with subjective symptoms. EEG was recorded while subjects with previous MTBI and controls performed a computer-based reaction time task integrating different cognitive executive functions and containing either threat-related or emotionally neutral visual stimuli. Post-concussion symptoms and depression were assessed using the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) and Beck's depression inventory (BDI). Task-induced FAA was assessed and eFAA calculated by subtracting FAA in the context of neutral stimuli from FAA in the context of emotional stimuli. The MTBI group showed FAA scores reflecting relatively greater right-sided frontal activity compared to healthy controls. eFAA differentiated the symptomatic MTBI from non-symptomatic MTBI group and from healthy controls. eFAA also correlated with RPQ and BDI scores. In conclusion, FAA pattern previously linked with vulnerability to depression, was observed in patients with previous MTBI. Furthermore, eFAA has potential as a biomarker of altered affective brain functions in MTBI.	[Kuusinen, Venla; Perakyla, Jari; Sun, Lihua; Hartikainen, Kaisa M.] Tampere Univ Hosp, Behav Neurol Res Unit, Tampere, Finland; [Kuusinen, Venla; Perakyla, Jari; Hartikainen, Kaisa M.] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Sun, Lihua] Univ Turku, Turku PET Ctr, Turku, Finland; [Ogawa, Keith H.] St Marys Coll Calif, Dept Psychol, Moraga, CA USA		Hartikainen, KM (corresponding author), Tampere Univ Hosp, Behav Neurol Res Unit, Tampere, Finland.; Hartikainen, KM (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland.	kaisa.hartikainen@live.com		Sun, Lihua/0000-0002-9931-9497; Hartikainen, Kaisa/0000-0001-7278-9635	Academy of FinlandAcademy of FinlandEuropean Commission; Competitive Research Fund of Pirkanmaa Hospital District; Finnish Ministry of Social Affairs and Health from European Social Fund (ESF)/European Union Structural Fund (Sustainable Brain Health) [S21966]	This study was funded by the Academy of Finland, the Competitive Research Fund of Pirkanmaa Hospital District, Finnish Ministry of Social Affairs and Health from European Social Fund (ESF)/European Union Structural Fund (Sustainable Brain Health, S21966).	Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Allen JJB, 2015, CURR OPIN PSYCHOL, V4, P93, DOI 10.1016/j.copsyc.2014.12.017; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Banks SD, 2016, ARCH PHYS MED REHAB, V97, P1254, DOI 10.1016/j.apmr.2016.03.013; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bistricky SL, 2014, COGNITION EMOTION, V28, P470, DOI 10.1080/02699931.2013.837815; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Coan JA, 2006, BIOL PSYCHOL, V72, P198, DOI 10.1016/j.biopsycho.2005.10.003; Coan JA, 2003, PSYCHOPHYSIOLOGY, V40, P106, DOI 10.1111/1469-8986.00011; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; Erkkila M, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02556; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Foland-Ross LC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00489; Fox J., 2019, R COMPANION APPL REG, V3 rd; Gainotti G, 2019, NEUROSCIENTIST, V25, P258, DOI 10.1177/1073858418785342; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gotlib IH, 1998, COGNITION EMOTION, V12, P449, DOI 10.1080/026999398379673; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Hartikainen K., 2003, DETECTION CHANGE EVE, P99, DOI DOI 10.1007/978-1-4615-0294-4; Hartikainen KM, 2007, NEUROREPORT, V18, P1929, DOI 10.1097/WNR.0b013e3282f1ca18; Hartikainen KM, 2014, J CLIN EXP NEUROPSYC, V36, P540, DOI 10.1080/13803395.2014.913554; Hartikainen KM, 2012, J CLIN EXP NEUROPSYC, V34, P588, DOI 10.1080/13803395.2012.666231; Hartikainen KM, 2012, NEUROREPORT, V23, P447, DOI 10.1097/WNR.0b013e3283531e74; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hartikainen KM, 2010, NEUROREPORT, V21, P344, DOI 10.1097/WNR.0b013e328336eeb3; Hartikainen KM, 2000, NEUROPSYCHOLOGIA, V38, P1576, DOI 10.1016/S0028-3932(00)00072-5; HENRIQUES JB, 1991, J ABNORM PSYCHOL, V100, P535, DOI 10.1037/0021-843X.100.4.535; Jesulola E, 2015, BEHAV BRAIN RES, V292, P56, DOI 10.1016/j.bbr.2015.05.058; Joormann J, 2008, J ABNORM PSYCHOL, V117, P182, DOI 10.1037/0021-843X.117.1.182; Joormann J, 2010, CURR DIR PSYCHOL SCI, V19, P161, DOI 10.1177/0963721410370293; Karr JE, 2020, J NEUROTRAUM, V37, P1183, DOI 10.1089/neu.2019.6834; Keller AS, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0616-1; Keune PM, 2015, CLIN NEUROPHYSIOL, V126, P711, DOI 10.1016/j.clinph.2014.07.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Koster EHW, 2011, CLIN PSYCHOL REV, V31, P138, DOI 10.1016/j.cpr.2010.08.005; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuusinen V, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00437; Langner R, 2018, NEUROSCI BIOBEHAV R, V90, P400, DOI 10.1016/j.neubiorev.2018.04.022; Lawrence Michael A, 2016, CRAN; Letkiewicz AM, 2014, COGNITIVE THER RES, V38, P612, DOI 10.1007/s10608-014-9629-5; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Maki-Marttunen V, 2017, J NEUROTRAUM, V34, P400, DOI 10.1089/neu.2015.4390; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCuddy WT, 2018, NEUROIMAGE-CLIN, V19, P434, DOI 10.1016/j.nicl.2018.05.011; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Moore RD, 2016, BRAIN IMAGING BEHAV, V10, P1108, DOI 10.1007/s11682-015-9473-6; Nusslock R, 2011, J ABNORM PSYCHOL, V120, P497, DOI 10.1037/a0022940; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Perakyla J, 2017, J COGNITIVE NEUROSCI, V29, P2090, DOI 10.1162/jocn_a_01176; R Core Team, 2020, R LANG ENV STAT COMP; Revelle W., 2021, PSYCH PROCEDURES PSY; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Statz JK, 2019, BEHAV BRAIN RES, V368, P101, DOI 10.1016/j.bbr.2019.04.009; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stewart JL, 2014, PSYCHOPHYSIOLOGY, V51, P446, DOI 10.1111/psyp.12191; Stewart JL, 2011, J AFFECT DISORDERS, V129, P167, DOI 10.1016/j.jad.2010.08.029; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Sun LH, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00584; Sun LH, 2017, J CLIN EXP NEUROPSYC, V39, P954, DOI 10.1080/13803395.2017.1285869; Sun LH, 2015, NEUROPSYCHOLOGIA, V78, P88, DOI 10.1016/j.neuropsychologia.2015.10.001; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Thibodeau R, 2006, J ABNORM PSYCHOL, V115, P715, DOI 10.1037/0021-843X.115.4.715; van der Vinne N, 2017, NEUROIMAGE-CLIN, V16, P79, DOI 10.1016/j.nicl.2017.07.006; Vuilleumier P, 2001, NEUROREPORT, V12, P1119, DOI 10.1097/00001756-200105080-00014; Wang YL, 2018, NEUROREPORT, V29, P1288, DOI 10.1097/WNR.0000000000001109; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172; Zhang J, 2020, PERS INDIV DIFFER, V159, DOI 10.1016/j.paid.2020.109870	90	1	1	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JUL 20	2021	15								699947	10.3389/fnhum.2021.699947			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	TT6DR	WOS:000680437800001	34354578	Green Published, gold			2022-02-06	
J	Robinson, D; Kreitzer, N; Ngwenya, LB; Adeoye, O; Woo, D; Hartings, J; Foreman, B				Robinson, David; Kreitzer, Natalie; Ngwenya, Laura B.; Adeoye, Opeolu; Woo, Daniel; Hartings, Jed; Foreman, Brandon			Diffusion-Weighted Imaging Reveals Distinct Patterns of Cytotoxic Edema in Patients with Subdural Hematomas	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						ischemia; secondary insult; subdural hematoma	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; SPREADING DEPRESSION; DAMAGE; ABNORMALITIES; MODEL; MRI; DEPOLARIZATIONS; ASSOCIATION; PREVALENCE	Subdural hematomas (SDHs) are increasingly common and can cause ischemic brain injury. Previous work has suggested that this is driven largely by vascular compression from herniation, although this work was done before the era of magnetic resonance imaging (MRI). We thus sought to study SDH-related ischemic brain injury by looking at patterns of cytotoxic edema on diffusion-weighted MRI. To do so, we identified all SDH patients at a single institution from 2015 to 2019 who received an MRI within 2 weeks of presentation. We reviewed all MRIs for evidence of restricted diffusion consistent with cytotoxic edema. Cases were excluded if the restricted diffusion could have occurred as a result of alternative etiologies (e.g., cardioembolic stroke or diffuse axonal injury). We identified 450 SDH patients who received an MRI within 2 weeks of presentation. Twenty-nine patients (similar to 6.5% of all MRIs) had SDH-related cytotoxic edema, which occurred in two distinct patterns. In one pattern (N = 9), patients presented as comatose with severe midline shift and were found to have cytotoxic edema in the vascular territories of the anterior and posterior cerebral artery, consistent with herniation-related vascular compression. In the other pattern (N = 19), patients often presented as awake with less midline shift and developed cytotoxic edema in the cortex adjacent to the SDH outside of typical vascular territories (peri-SDH cytotoxic edema). Both patterns occurred in 1 patient. The peri-SDH cytotoxic edema pattern is a newly described type of secondary injury and may involve direct toxic effects of the SDH, spreading depolarizations, or other mechanisms.	[Robinson, David; Woo, Daniel; Foreman, Brandon] Univ Cincinnati, Dept Neurol & Rehabil Med, 231 Albert Sabin Way,Room 7101, Cincinnati, OH 45267 USA; [Kreitzer, Natalie] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45221 USA; [Ngwenya, Laura B.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45221 USA; [Ngwenya, Laura B.; Hartings, Jed; Foreman, Brandon] Collaborat Res Acute Neurol Injuries, Cincinnati, OH USA; [Adeoye, Opeolu; Foreman, Brandon] Washington Univ, Dept Emergency Med, St Louis, MO USA		Robinson, D (corresponding author), Univ Cincinnati, Dept Neurol & Rehabil Med, 231 Albert Sabin Way,Room 7101, Cincinnati, OH 45267 USA.	robin2dv@ucmail.uc.edu		Robinson, David/0000-0003-3221-3599	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5T32NS047996-14]	David Robinson reports relevant funding for his research time from the National Institute of Neurological Disorders and Stroke, 5T32NS047996-14. The funders had no role in the review or analysis of the data.	Abe M, 2003, SURG NEUROL, V59, P464, DOI 10.1016/S0090-3019(03)00078-8; Akgun B, 2018, TURK NEUROSURG, V28, P405, DOI 10.5137/1019-5149.JTN.19968-17.1; Anderson GB, 2000, AM J NEURORADIOL, V21, P1011; Baechli H, 2010, J CEREBR BLOOD F MET, V30, P576, DOI 10.1038/jcbfm.2009.230; Balser D, 2015, J NEUROSURG, V123, P1209, DOI 10.3171/2014.9.JNS141550; BIRSE SH, 1960, NEUROLOGY, V10, P101, DOI 10.1212/WNL.10.2.101; BRASS LM, 1994, J CEREBR BLOOD F MET, V14, pS91; Briellmann RS, 2005, EPILEPSIA, V46, P760, DOI 10.1111/j.1528-1167.2005.47604.x; Carlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; Cianfoni A, 2013, EUR J RADIOL, V82, P1964, DOI 10.1016/j.ejrad.2013.05.020; de Crespigny A, 1998, J CEREBR BLOOD F MET, V18, P1008, DOI 10.1097/00004647-199809000-00010; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dreier JP, 2018, NEUROPHARMACOLOGY, V134, P189, DOI 10.1016/j.neuropharm.2017.09.027; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 2002, ANN NEUROL, V52, P825, DOI 10.1002/ana.10383; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Flaherty M., 2010, EPIDEMIOLOGY INTRACE, P1; Forster A, 2012, CEREBROVASC DIS, V33, P104, DOI 10.1159/000332036; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; Hartings JA, 2019, J NEUROSURG, V130, P2095, DOI 10.3171/2018.6.JNS18235; INGLIS FM, 1990, ACT NEUR S, V51, P277; Jussen D, 2017, J NEUROTRAUM, V34, P906, DOI 10.1089/neu.2016.4464; Kim BJ, 2014, J STROKE, V16, P131, DOI 10.5853/jos.2014.16.3.131; Kim SE, 2017, SEIZURE-EUR J EPILEP, V48, P62, DOI 10.1016/j.seizure.2017.04.005; Kirov SA, 2020, CEREB CORTEX, V30, P5517, DOI 10.1093/cercor/bhaa134; Krenzlin H, 2019, J NEUROTRAUM, V36, P395, DOI 10.1089/neu.2018.5657; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lin DDM, 2001, AM J NEURORADIOL, V22, P1275; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Milligan TA, 2009, SEIZURE-EUR J EPILEP, V18, P104, DOI 10.1016/j.seizure.2008.07.004; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Mohammad LM, 2021, J NEUROSURG, V134, P1294, DOI 10.3171/2020.1.JNS192914; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Poulsen FR, 2016, PHARMACOEPIDEM DR S, V25, P1253, DOI 10.1002/pds.4058; Santos E, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2711-3; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Slotty PJ, 2013, J NEUROTRAUM, V30, P347, DOI 10.1089/neu.2012.2644; VANHARREVELD A, 1959, J CELL COMPAR PHYSL, V54, P65, DOI 10.1002/jcp.1030540108; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Weidauer S, 2008, NEURORADIOLOGY, V50, P1, DOI 10.1007/s00234-007-0294-1; Weimer JM, 2017, NEUROCRIT CARE, V26, P70, DOI 10.1007/s12028-016-0279-1; Yokobori S, 2018, BEHAV BRAIN RES, V340, P23, DOI 10.1016/j.bbr.2016.05.055	52	1	1	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0125		JUL 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TL7DP	WOS:000675018900001	34107754				2022-02-06	
J	Da Silva, K; Kumar, P; van Vuuren, SF; Pillay, V; Choonara, YE				Da Silva, Kate; Kumar, Pradeep; van Vuuren, Sandy F.; Pillay, Viness; Choonara, Yahya E.			Three-Dimensional Printability of an ECM-Based Gelatin Methacryloyl (GelMA) Biomaterial for Potential Neuroregeneration	ACS OMEGA			English	Article							EXTRACELLULAR-MATRIX; REACTIVE OXYGEN; GENIPIN; HYDROGELS; COLLAGEN; NEUROPROTECTION; APOPTOSIS; IMPACT; GROWTH; BIOINK	The current study introduces two novel, smart polymer three-dimensional (3D)-printable interpenetrating polymer network (IPN) hydrogel biomaterials with favorable chemical, mechanical, and morphological properties for potential applications in traumatic brain injury (TBI) such as potentially assisting in the restoration of neurological function through closure of the wound deficit and neural tissue regeneration. Additionally, removal of injury matter to allow for the appropriate scaffold grafting may assist in providing a TBI treatment. Furthermore, due to the 3D printability of the IPN biomaterials, complex structures can be designed and fabricated to mimic the native shape and structure of the injury sight, which can potentially assist with neural tissue regeneration after TBI. In this study, a peptide-only approach was employed, wherein collagen and elastin in a blend with gelatin methacryloyl were prepared and crosslinked using either Irgacure or Irgacure and Genipin to form either a semi or full IPN hydrogel 3D-printable neuromimicking platform system, respectively. The scaffolds displayed favorable thermal stability and were amorphous in nature with high full width at half-maximum values. Furthermore, no alteration to the peptide secondary structure was noted using Fourier transform infrared spectroscopy. The IPN biomaterials have a stiffness of around 600 Pa and are suitable for softer tissue engineering applications-that is, the brain. Scanning electron micrographs indicated that the IPN biomaterials had a morphological structure with a significant resemblance to the native rat cortex. Both biomaterial scaffolds were shown to support the growth of PC12 cells over a 72 h period. Furthermore, the increased nuclear eccentricity and nuclear area were shown to support the postulation that the IPN biomaterials maintain the cells in a healthy state encouraging cellular mitosis and proliferation. The Genipin component of the full IPN was further shown to exhibit antimicrobial properties and this suggests that Genipin can prevent the growth of pathogens associated with postsurgical brain infections. In addition to these findings, the study presents an anomaly, wherein the full IPN is found to be more brittle than the semi IPN, a finding that is in contradiction with the literature. This research, therefore, contributes to the collection of potential biomaterials for TBI applications coupled with 3D printing and can assist in the progression of neural treatments toward patient-specific scaffolds through the development of custom scaffolds.	[Da Silva, Kate; Kumar, Pradeep; Pillay, Viness; Choonara, Yahya E.] Univ Witwatersrand, Fac Hlth Sci, Wits Adv Drug Delivery Platform Res Unit, Sch Therapeut Sci,Dept Pharm & Pharmacol, ZA-2193 Johannesburg, South Africa; [van Vuuren, Sandy F.] Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Dept Pharm & Pharmacol, ZA-2193 Johannesburg, South Africa		Choonara, YE (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Wits Adv Drug Delivery Platform Res Unit, Sch Therapeut Sci,Dept Pharm & Pharmacol, ZA-2193 Johannesburg, South Africa.	yahya.choonara@wits.ac.za	Kumar, Pradeep/C-9424-2013	Kumar, Pradeep/0000-0002-8640-4350; Pillay, Viness/0000-0002-8119-3347	National Research Foundation (NRF) of South AfricaNational Research Foundation - South Africa; South African Medical Research Council (SAMRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); University of the Witwatersrand, Johannesburg	This work was supported by the National Research Foundation (NRF) of South Africa; the South African Medical Research Council (SAMRC); and the University of the Witwatersrand, Johannesburg.	Aldana AA, 2017, SOFT MATER, V15, P341, DOI 10.1080/1539445X.2017.1378677; Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; Archana D., 2012, INT J PHARM PHARM SC, V4, P389; Armstrong JPK, 2016, ADV HEALTHC MATER, V5, P1724, DOI 10.1002/adhm.201600022; Asma C, 2014, J CHIL CHEM SOC, V59, P2279, DOI 10.4067/S0717-97072014000100008; Bailey A J, 1978, J Clin Pathol Suppl (R Coll Pathol), V12, P49; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004; Bhardwaj V., 2012, INT J DRUG DEV RES, V4, P41; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Bozec L, 2011, BIOPHYS J, V101, P228, DOI 10.1016/j.bpj.2011.04.033; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; Caliari SR, 2016, NAT METHODS, V13, P405, DOI 10.1038/nmeth.3839; Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004; Chu XH, 2020, COLLOID SURFACE B, V190, DOI 10.1016/j.colsurfb.2020.110930; Cole DJ, 2009, PHYS CHEM CHEM PHYS, V11, P11395, DOI 10.1039/b816125a; Da Silva K, 2020, J BIOMED MATER RES A, V108, P2324, DOI 10.1002/jbm.a.36981; Da Silva K, 2019, TISSUE ENG PART C-ME, V25, P401, DOI [10.1089/ten.tec.2019.0052, 10.1089/ten.TEC.2019.0052]; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; El-Sherbiny Ibrahim M, 2013, Glob Cardiol Sci Pract, V2013, P316, DOI 10.5339/gcsp.2013.38; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Friedl P, 1998, CELL ADHES COMMUN, V6, P225, DOI 10.3109/15419069809004478; Gomez-Nicola D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/429231; Gu LL, 2020, REGEN BIOMATER, V7, P195, DOI 10.1093/rb/rbz050; Guvendiren M, 2016, ACS BIOMATER SCI ENG, V2, P1679, DOI 10.1021/acsbiomaterials.6b00121; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Haris P. I, 2013, ENCY BIOPHYSICS; Hoffman AS, 2004, BIOMATERIALS SCI INT, P107; Hong HY, 2007, BIOCHEM BIOPH RES CO, V362, P307, DOI 10.1016/j.bbrc.2007.07.165; Huber MD, 2007, J CELL BIOL, V179, P583, DOI 10.1083/jcb.200710156; Hughes RH, 2014, BRAIN RES, V1543, P308, DOI 10.1016/j.brainres.2013.11.020; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Hunsberger Joshua, 2009, Dialogues Clin Neurosci, V11, P333; Hussein MA, 2016, J THERM ANAL CALORIM, V124, P709, DOI 10.1007/s10973-016-5240-1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; ISHIGURO K, 1983, J NAT PROD, V46, P532, DOI 10.1021/np50028a018; Jenkins AD, 1996, PURE APPL CHEM, V68, P2287, DOI 10.1351/pac199668122287; Johnston D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/460936; Ju HK, 2002, J APPL POLYM SCI, V83, P1128, DOI 10.1002/app.10137; Katebi S, 2019, INT J NANOMED, V14, P2157, DOI 10.2147/IJN.S191878; Khan A, 2016, INNOV FOOD SCI EMERG, V35, P96, DOI 10.1016/j.ifset.2016.03.011; Khan Y, 2019, ENCYCLOPEDIA OF BIOMEDICAL ENGINEERING, VOL 1, P537, DOI 10.1016/B978-0-12-801238-3.99897-0; Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040; Kim BS, 2020, CHEM REV, V120, P10941, DOI 10.1021/acs.chemrev.9b00808; Kim TH, 2012, MOL MED, V18, P455, DOI 10.2119/molmed.2011.00308; Kim Y, 2016, INT NEUROUROL J, V20, pS23, DOI 10.5213/inj.1632600.318; Kirchmajer DM, 2015, J MATER CHEM B, V3, P4105, DOI 10.1039/c5tb00393h; Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011; Kumar P, 2017, CURR PHARM DESIGN, V23, P3538, DOI 10.2174/1381612823666170503144643; Lei ZY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03456-w; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Li JH, 2020, MAT SCI ENG R, V140, DOI 10.1016/j.mser.2020.100543; Liu CY, 2015, POLYM J, V47, P391, DOI 10.1038/pj.2015.2; Lohani A, 2014, J DRUG DELIV, V2014, DOI 10.1155/2014/583612; Lu BY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09003-5; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lambri ML, 2018, MATERIA-BRAZIL, V23, DOI [10.1590/s1517-707620180002.0424, 10.1590/S1517-707620180002.0424]; Mace SE, 2008, EMERG MED CLIN N AM, V26, P281, DOI 10.1016/j.emc.2008.02.002; Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042; Mok SW, 2016, J ORTHOP TRANSL, V6, P42, DOI 10.1016/j.jot.2016.04.003; Mu CD, 2013, J BIOMED MATER RES A, V101, P385, DOI 10.1002/jbm.a.34338; Nagai T., 2010, Food and Nutrition Sciences, V1, P59, DOI 10.4236/fns.2010.12010; Nagaraj P, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9120667; Nakamura M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014110; Nguyen AH, 2015, ACTA BIOMATER, V13, P101, DOI 10.1016/j.actbio.2014.11.028; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; Ozbolat IT, 2016, BIOMATERIALS, V76, P321, DOI 10.1016/j.biomaterials.2015.10.076; Parak A, 2019, DRUG DISCOV TODAY, V24, P198, DOI 10.1016/j.drudis.2018.09.012; Rahali K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122675; Rastegari A., 2020, INTERPENETRATING POL, P55; Resmi R Gelatin, 2002, GELATIN HYDROXYPROPY; Roland C. M., 2013, ENCY POLYM NANOMATER, P1, DOI [10.1007/978-3-642-36199-9_91-1, DOI 10.1007/978-3-642-36199-9_91-1]; Rutz AL, 2015, ADV MATER, V27, P1607, DOI 10.1002/adma.201405076; Samouillan V, 2004, BIOMACROMOLECULES, V5, P958, DOI 10.1021/bm034436t; Samouillan V, 2011, J FUNCT BIOMATER, V2, P230, DOI 10.3390/jfb2030230; Schoen F. J., 2004, BIOMATERIAL SCI INTR, V2nd, P260; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Seaman L, 2015, NUCLEUS-PHILA, V6, P408, DOI 10.1080/19491034.2015.1095432; Shao Y, 2015, BIOMATERIALS, V52, P26, DOI 10.1016/j.biomaterials.2015.01.078; Sonbol Hala Salim, 2018, J Microsc Ultrastruct, V6, P123, DOI 10.4103/JMAU.JMAU_4_18; Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108; Sun MY, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10111290; Tamayol A, 2015, ADV HEALTHC MATER, V4, P2146, DOI 10.1002/adhm.201500492; TJIA TL, 1985, J NEUROL NEUROSUR PS, V48, P853, DOI 10.1136/jnnp.48.9.853; Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d; Vasile C, 2020, MOLECULES, V25, DOI 10.3390/molecules25071539; Ventola C Lee, 2014, P T, V39, P704; VERAGRAZIANO R, 1995, J APPL POLYM SCI, V55, P1317, DOI 10.1002/app.1995.070550905; Yamamoto M, 2000, GASTROENTEROLOGY, V118, P380, DOI 10.1016/S0016-5085(00)70220-4; Yamazaki M, 2005, J HEALTH SCI, V51, P687, DOI 10.1248/jhs.51.687; Yang XC, 2018, MAT SCI ENG C-MATER, V83, P195, DOI 10.1016/j.msec.2017.09.002; Yannas I. V., 2004, BIOMATERIAL SCI INTR, V2nd, P127; Yoon HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163902; Yu SH, 2015, CARBOHYD POLYM, V126, P97, DOI 10.1016/j.carbpol.2015.02.068; Zhao X, 2016, ADV HEALTHC MATER, V5, P108, DOI 10.1002/adhm.201500005; Zhu MX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42186-x	97	1	1	8	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2470-1343			ACS OMEGA	ACS Omega	AUG 24	2021	6	33					21368	21383		10.1021/acsomega.1c01903		JUL 2021	16	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	UJ5BS	WOS:000691300900017	34471741	Green Published, gold			2022-02-06	
J	Toutonji, A; Mandava, M; Guglietta, S; Tomlinson, S				Toutonji, Amer; Mandava, Mamatha; Guglietta, Silvia; Tomlinson, Stephen			Chronic complement dysregulation drives neuroinflammation after traumatic brain injury: a transcriptomic study	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Complement system; Complement inhibition; Neuroinflammation; Traumatic brain injury; Gene expression; NanoString	MEMBRANE ATTACK COMPLEX; RAT MODEL; INHIBITION; ACTIVATION; EXPRESSION; RECEPTOR; MINOCYCLINE; RECOVERY; SYSTEM	Activation of the complement system propagates neuroinflammation and brain damage early and chronically after traumatic brain injury (TBI). The complement system is complex and comprises more than 50 components, many of which remain to be characterized in the normal and injured brain. Moreover, complement therapeutic studies have focused on a limited number of histopathological outcomes, which while informative, do not assess the effect of complement inhibition on neuroprotection and inflammation in a comprehensive manner. Using high throughput gene expression technology (NanoString), we simultaneously analyzed complement gene expression profiles with other neuroinflammatory pathway genes at different time points after TBI. We additionally assessed the effects of complement inhibition on neuropathological processes. Analyses of neuroinflammatory genes were performed at days 3, 7, and 28 post injury in male C57BL/6 mice following a controlled cortical impact injury. We also characterized the expression of 59 complement genes at similar time points, and also at 1- and 2-years post injury. Overall, TBI upregulated the expression of markers of astrogliosis, immune cell activation, and cellular stress, and downregulated the expression of neuronal and synaptic markers from day 3 through 28 post injury. Moreover, TBI upregulated gene expression across most complement activation and effector pathways, with an early emphasis on classical pathway genes and with continued upregulation of C2, C3 and C4 expression 2 years post injury. Treatment using the targeted complement inhibitor, CR2-Crry, significantly ameliorated TBI-induced transcriptomic changes at all time points. Nevertheless, some immune and synaptic genes remained dysregulated with CR2-Crry treatment, suggesting adjuvant anti-inflammatory and neurotropic therapy may confer additional neuroprotection. In addition to characterizing complement gene expression in the normal and aging brain, our results demonstrate broad and chronic dysregulation of the complement system after TBI, and strengthen the view that the complement system is an attractive target for TBI therapy.	[Toutonji, Amer; Mandava, Mamatha; Guglietta, Silvia; Tomlinson, Stephen] Med Univ South Carolina, Dept Microbiol & Immunol, 173 Ashley Ave,BSB 204,MSC 504, Charleston, SC 29425 USA; [Tomlinson, Stephen] Ralph Johnson VA Med Ctr, Charleston, SC 29401 USA		Guglietta, S; Tomlinson, S (corresponding author), Med Univ South Carolina, Dept Microbiol & Immunol, 173 Ashley Ave,BSB 204,MSC 504, Charleston, SC 29425 USA.	gugliett@musc.edu; tomlinss@musc.edu		tomlinson, stephen/0000-0002-6281-2122	Department of Veterans AffairsUS Department of Veterans Affairs [1BX004256, 1RX001141, IK6BX005235]	This work was supported by grants from the Department of Veterans Affairs (1BX004256, 1RX001141 and IK6BX005235) to S.T.	Alawieh A, 2021, J NEUROSCI, V41, P1830, DOI 10.1523/JNEUROSCI.1734-20.2020; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208; Bao WX, 2018, EXPERT REV MOL DIAGN, V18, P761, DOI 10.1080/14737159.2018.1471985; Benavente F, 2020, ELIFE, V9, DOI 10.7554/eLife.55732; Biggins PJC, 2017, J NEUROTRAUM, V34, P2075, DOI 10.1089/neu.2016.4701; Boone DR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214741; Brennan FH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.98254; Cevik S, 2019, CLIN NEUROL NEUROSUR, V183, DOI 10.1016/j.clineuro.2019.105380; Ciechanowska A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010045; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Gao TW, 2019, GLIA, V67, P1958, DOI 10.1002/glia.23678; Glavey SV, 2014, BLOOD, V124, P1765, DOI 10.1182/blood-2014-03-560862; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Grabinski TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120120; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Ignowski E, 2018, FREE RADICAL BIO MED, V124, P328, DOI 10.1016/j.freeradbiomed.2018.06.026; Kalia N, 2021, IMMUNOBIOLOGY, V226, DOI 10.1016/j.imbio.2021.152071; Kelsen J, 2019, J NEUROTRAUM, V36, P3253, DOI 10.1089/neu.2018.6369; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Ma YJ, 2015, J IMMUNOL, V195, P3365, DOI 10.4049/jimmunol.1500493; Mallah K, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01179-6; Manek R, 2018, MOL NEUROBIOL, V55, P6112, DOI 10.1007/s12035-017-0821-y; Mercurio D, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01041-1; Meythaler J, 2019, BRAIN INJURY, V33, P679, DOI 10.1080/02699052.2019.1566968; Rich MC, 2016, NEUROSCI LETT, V617, P188, DOI 10.1016/j.neulet.2016.02.025; Saha P, 2019, J NEUROTRAUM, V36, P3284, DOI 10.1089/neu.2019.6373; Sarkar C, 2020, AUTOPHAGY, V16, P466, DOI 10.1080/15548627.2019.1628538; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Sun MM, 2017, CANCER SCI, V108, P267, DOI 10.1111/cas.13128; Tchantchou F, 2018, J NEUROTRAUM, V35, P1192, DOI 10.1089/neu.2017.5401; Thelin EP, 2018, BEHAV BRAIN RES, V340, P71, DOI 10.1016/j.bbr.2016.08.058; Tsujimura A, 1998, BIOCHEM J, V330, P163, DOI 10.1042/bj3300163; Tucsek Z, 2017, GEROSCIENCE, V39, P385, DOI 10.1007/s11357-017-9981-y; Wang HC, 2021, LIFE SCI, V264, DOI 10.1016/j.lfs.2020.118631; Wang WZ, 2021, BIOCHEM BIOPH RES CO, V549, P47, DOI 10.1016/j.bbrc.2021.02.053; Winston CN, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01005; Wu YX, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01178-7; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Xie CB, 2020, AM J PATHOL, V190, P1138, DOI 10.1016/j.ajpath.2020.02.006; Xu L, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00498; Ye XC, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1693-z; Yin R, 2020, J PHARM PHARMACOL, V72, P539, DOI 10.1111/jphp.13233; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhang J, 2020, ELIFE, V9, DOI 10.7554/eLife.60908; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002; Zhou YY, 2020, NAT MED, V26, P131, DOI 10.1038/s41591-019-0695-9	55	1	1	3	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	JUL 19	2021	9	1							126	10.1186/s40478-021-01226-2			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TM8WR	WOS:000675827600001	34281628	gold, Green Published			2022-02-06	
J	Yuh, EL; Jain, S; Sun, XY; Pisica, D; Harris, MH; Taylor, SR; Markowitz, AJ; Mukherjee, P; Verheyden, J; Giacino, JT; Levin, HS; McCrea, M; Stein, MB; Temkin, NR; Diaz-Arrastia, R; Robertson, CS; Lingsma, HF; Okonkwo, DO; Maas, AIR; Manley, GT				Yuh, Esther L.; Jain, Sonia; Sun, Xiaoying; Pisica, Dana; Harris, Mark H.; Taylor, Sabrina R.; Markowitz, Amy J.; Mukherjee, Pratik; Verheyden, Jan; Giacino, Joseph T.; Levin, Harvey S.; McCrea, Michael; Stein, Murray B.; Temkin, Nancy R.; Diaz-Arrastia, Ramon; Robertson, Claudia S.; Lingsma, Hester F.; Okonkwo, David O.; Maas, Andrew I. R.; Manley, Geoffrey T.			Pathological Computed Tomography Features Associated With Adverse Outcomes After Mild Traumatic Brain Injury A TRACK-TBI Study With External Validation in CENTER-TBI	JAMA NEUROLOGY			English	Article							COMMON DATA ELEMENTS; ETHNIC DISPARITIES; PREDICTION; IDENTIFICATION; SCALE; CLASSIFICATION; CONCUSSION; RECOVERY; VALIDITY; MODELS	IMPORTANCE A head computed tomography (CT) with positive results for acute intracranial hemorrhage is the gold-standard diagnostic biomarker for acute traumatic brain injury (TBI). In moderate to severe TBI (Glasgow Coma Scale [GCS] scores 3-12), some CT features have been shown to be associated with outcomes. In mild TBI (mTBI; GCS scores 13-15), distribution and co-occurrence of pathological CT features and their prognostic importance are not well understood. OBJECTIVE To identify pathological CT features associated with adverse outcomes after mTBI. DESIGN, SETTING, AND PARTICIPANTS The longitudinal, observational Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study enrolled patients with TBI, including those 17 years and older with GCS scores of 13 to 15 who presented to emergency departments at 18 US level 1 trauma centers between February 26, 2014, and August 8, 2018, and underwent head CT imaging within 24 hours of TBI. Evaluations of CT imaging used TBI Common Data Elements. Glasgow Outcome Scale-Extended (GOSE) scores were assessed at 2 weeks and 3, 6, and 12 months postinjury. External validation of results was performed via the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER TBI) study. Data analyses were completed from February 2020 to February 2021. EXPOSURES Acute nonpenetrating head trauma. MAIN OUTCOMES AND MEASURES Frequency, co-occurrence, and clustering of CT features; incomplete recovery (GOSE scores <8 vs 8); and an unfavorable outcome (GOSE scores <5 vs >= 5) at 2 weeks and 3, 6, and 12 months. RESULTS In 1935 patients with mTBI (mean [SD] age, 41.5 [17.6] years; 1286 men [66.5%]) in the TRACK-TBI cohort and 2594 patients with mTBI (mean [SD] age, 51.8 [20.3] years; 1658 men [63.9%]) in an external validation cohort, hierarchical cluster analysis identified 3 major clusters of CT features: contusion. subarachnoid hemorrhage, and/or subdural hematoma; intraventricular and/or petechial hemorrhage; and epidural hematoma. Contusion, subarachnoid hemorrhage, and/or subdural hematoma features were associated with incomplete recovery (odds ratios [ORs] for GOSE scores <8 at 1 year: TRACK-TBI, 1.80 [95% CI, 1.39-2.33]; CENTER-TBI, 2.73 [95% CI, 2.18-3.41]) and greater degrees of unfavorable outcomes (ORs for GOSE scores <5 at 1 year: TRACK-TBI, 3.23 [95% CI, 1.59-6.58]; CENTER-TBI, 1.68 [95% CI, 1.13-2.49]) out to 12 months after injury, but epidural hematoma was not. Intraventricular and/or petechial hemorrhage was associated with greater degrees of unfavorable outcomes up to 12 months after injury (eg, OR for GOSE scores <5 at 1 year in TRACK-TBI: 3.47 [95% CI, 1.66-7.26]). Some CT features were more strongly associated with outcomes than previously validated variables (eg, ORs for GOSE scores <5 at 1year in TRACK-TBI: neuropsychiatric history, 1.43 [95% CI .98-2.10] vs contusion, subarachnoid hemorrhage, and/or subdural hematoma, 3.23 [95% CI 1.59-6.58]). Findings were externally validated in 2594 patients with mTBI enrolled in the CENTER-TBI study. CONCLUSIONS AND RELEVANCE In this study, pathological CT features carried different prognostic implications after mTBI to 1 year postinjury. Some patterns of injury were associated with worse outcomes than others. These results support that patients with mTBI and these CT features need TBI-specific education and systematic follow-up.	[Yuh, Esther L.; Harris, Mark H.; Taylor, Sabrina R.; Markowitz, Amy J.; Mukherjee, Pratik; Manley, Geoffrey T.] Brain & Spinal Injury Ctr, San Francisco, CA USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 185 Berry St Bldg B,Lobby 6,Ste 350, San Francisco, CA 94143 USA; [Jain, Sonia; Sun, Xiaoying] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, Biostat Res Ctr, La Jolla, CA 92093 USA; [Pisica, Dana] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Harris, Mark H.; Taylor, Sabrina R.; Markowitz, Amy J.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Verheyden, Jan] Icometrix, Res & Dev, Leuven, Belgium; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Stein, Murray B.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Temkin, Nancy R.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Pisica, Dana; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA		Yuh, EL (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 185 Berry St Bldg B,Lobby 6,Ste 350, San Francisco, CA 94143 USA.; Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	esther.yuh@ucsf.edu; manleyg@ucsf.edu	Posti, Jussi P./Y-2908-2019; Giacino, Joseph/AAF-1952-2021; Volovici, Victor/AAZ-8901-2020; Vande Vyvere, Thijs/AAB-5180-2022; Raj, Rahul/K-7693-2012; Belli, Antonio/I-3799-2015	Posti, Jussi P./0000-0002-5925-5193; Giacino, Joseph/0000-0002-7916-9698; Volovici, Victor/0000-0002-5798-5360; Vande Vyvere, Thijs/0000-0003-4032-5443; Raj, Rahul/0000-0003-4243-9591; Rossi, Sandra/0000-0002-9963-8121; Radoi, Andreea/0000-0002-0677-3544; Van Essen, Thomas/0000-0003-4657-5283; Belli, Antonio/0000-0002-3211-9933; van der Naalt, Joukje/0000-0001-9873-2418; Zeiler, Frederick/0000-0003-1737-0510; Badjatia, Neeraj/0000-0003-1509-9034; Dark, Paul/0000-0003-3309-0164; Stewart, William/0000-0003-2199-2582; Hemphill, Claude/0000-0003-4019-7525	US Department of Defense (TBI Endpoints Development Initiative grant)United States Department of Defense [W81XWH-14-2-0176]; National Institutes of Health/National Institute for Neurologic Disorders and Stroke [U01 NS1365885]; European Union Seventh Framework Program (EC) [602150]; Hannelore Kohl Stiftung; One Mind; Integra LifeSciences Corporation; NeuroTrauma Sciences; Jackson Family Foundation; Abbott LaboratoriesAbbott Laboratories	This Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) analysis was funded by the US Department of Defense (TBI Endpoints Development Initiative grant W81XWH-14-2-0176); TRACK-TBI was funded by the National Institutes of Health/National Institute for Neurologic Disorders and Stroke (grant U01 NS1365885), One Mind, NeuroTrauma Sciences, and Jackson Family Foundation; and Abbott Laboratories provides research support to the TRACK-TBI Network under a collaborative research agreement. Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) was funded by the European Union Seventh Framework Program (EC grant 602150) with additional funding from the Hannelore Kohl Stiftung, One Mind, the Integra LifeSciences Corporation, and NeuroTrauma Sciences. Patient travel expenses and stipends were supported by One Mind (Staglin Family and General Peter Chiarelli).	Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lell MM, 2020, INVEST RADIOL, V55, P8, DOI 10.1097/RLI.0000000000000601; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lingsma HF, 2017, LANCET NEUROL, V16, P494, DOI 10.1016/S1474-4422(17)30171-0; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; US Food and Drug Administration Center for Devices and Radiological Health, 2018, EV AUT CLASS 3 DES B; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vande Vyvere T, 2020, J NEUROTRAUM, V37, P1269, DOI 10.1089/neu.2019.6710; Voormolen DC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051525; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zheng BY, 2000, STAT MED, V19, P1265, DOI 10.1002/(SICI)1097-0258(20000530)19:10<1265::AID-SIM486>3.3.CO;2-L; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	44	1	1	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	SEP	2021	78	9					1137	1148		10.1001/jamaneurol.2021.2120		JUL 2021	12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UO4MJ	WOS:000676017800002	34279565	Green Published, hybrid			2022-02-06	
J	Marley, CJ; Owens, TS; Tsukamoto, H; Stacey, BS; Corkill, R; Bailey, DM				Marley, Christopher J.; Owens, Thomas S.; Tsukamoto, Hayato; Stacey, Benjamin S.; Corkill, Robin; Bailey, Damian M.			Impaired cerebral blood flow regulation and cognition in male football players	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						cerebral blood flow; cognition; football; soccer; traumatic brain injury	TRAUMATIC BRAIN-INJURY; STRESS	Football players are at increased risk of neurodegeneration, the likely consequence of repetitive mechanical trauma caused by heading the ball. However, to what extent a history of heading the ball affects cerebral blood flow (CBF) regulation and its potential relationship to cognitive impairment is unknown. To address this, we recruited 16 concussion-free male amateur football players (age: 25 +/- 6 y) with a history of heading the ball (18 +/- 6 y) and 18 sex, age, education, and activity-matched controls with no prior history of contact sport participation or concussion. Cerebral perfusion was measured at rest and in response to both hyper/hypocapnia to determine cerebrovascular reactivity to carbon dioxide (CVRCO2HYPER/HYPO) using transcranial Doppler ultrasound and capnography, with the sum reflecting the cerebral vasomotor range. Cognition and visuomotor coordination were assessed using the Montreal cognitive assessment (MoCA) and the Grooved Pegboard Dexterity Test (GPD), respectively. While no differences in cerebral perfusion were observed (p = 0.938), CVRCO2HYPER/HYPO (p = 0.038/p = 0.025), cerebral vasomotor range (p = 0.002), MoCA (p = 0.027), and GPD performance (dominant hand, P <= 0.001) were consistently lower in the players compared to controls. These findings are the first to demonstrate that CBF regulation and cognition are collectively impaired in male football players with history of heading the ball, which may contribute to neurodegeneration.	[Marley, Christopher J.; Owens, Thomas S.; Tsukamoto, Hayato; Stacey, Benjamin S.; Bailey, Damian M.] Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Pontypridd CF37 4AT, M Glam, Wales; [Tsukamoto, Hayato] Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan; [Corkill, Robin] Univ Wales Hosp, Dept Neurol, Cardiff, Wales		Bailey, DM (corresponding author), Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Pontypridd CF37 4AT, M Glam, Wales.	damian.bailey@southwales.ac.uk		Stacey, Benjamin S/0000-0003-1005-7038; Marley, Chris/0000-0002-6757-6448; Owens, Tom/0000-0003-0097-0616	Royal Society Wolfson Research Fellowship; JPR Williams Trust; University of South Wales; Royal Society International Exchanges Award; Japan Society for the Promotion of Science Research FellowshipMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science	Royal Society Wolfson Research Fellowship; JPR Williams Trust; University of South Wales; Royal Society International Exchanges Award; Japan Society for the Promotion of Science Research Fellowship	Bailey DM, 2019, J PHYSIOL-LONDON, V597, P611, DOI 10.1113/JP276898; Bailey DM, 2013, STROKE, V44, P3235, DOI 10.1161/STROKEAHA.113.002589; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Burley CV, 2020, EXP PHYSIOL, V105, P893, DOI 10.1113/EP087883; Canadian Society for Exercise Physiology, 2017, GET ACT QUEST; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; English Football Association, 2021, UPD HEAD GUID ANN YO; Gelman A, 2014, PERSPECT PSYCHOL SCI, V9, P641, DOI 10.1177/1745691614551642; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hunter LE, 2020, JAMA NEUROL, V77, P419, DOI 10.1001/jamaneurol.2019.4828; Krustrup P, 2018, SCAND J MED SCI SPOR, V28, P3, DOI 10.1111/sms.13220; Lafayette Instruments, 2002, GROOVED PEGBOARD TES; Lim EY, 2018, J ALZHEIMERS DIS, V65, P651, DOI 10.3233/JAD-180026; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Marley CJ, 2020, NEUROSCIENCE, V427, P58, DOI 10.1016/j.neuroscience.2019.12.008; Marley CJ, 2017, CLIN SCI, V131, P2807, DOI 10.1042/CS20171406; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Smirl JD, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00738; Soccer US., 2021, CONCUSSIONS HEAD INJ; Svaldi DO, 2020, BRAIN IMAGING BEHAV, V14, P164, DOI 10.1007/s11682-018-9983-0; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Woodside JDS, 2014, EXP PHYSIOL, V99, P1648, DOI 10.1113/expphysiol.2014.081265	28	1	1	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	OCT	2021	31	10					1908	1913		10.1111/sms.14018		JUL 2021	6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UP2NX	WOS:000673513900001	34233053				2022-02-06	
J	Chiang, HS; Shakal, S; Vanneste, S; Kraut, M; Hart, J				Chiang, Hsueh-Sheng; Shakal, Scott; Vanneste, Sven; Kraut, Michael; Hart, John, Jr.			Case Report: Improving Verbal Retrieval Deficits With High Definition Transcranial Direct Current Stimulation Targeting the Pre-Supplementary Motor Area in a Patient With Chronic Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						TBI; verbal retrieval; HD-tDCS; EEG; case report; verbal fluency; tDCS; word finding	COGNITIVE CONTROL; WORD RETRIEVAL; GO/NOGO TASK; REFLECTS; FLUENCY; SPEECH; CORTEX; GUIDE; SMA	We report a patient who has cognitive sequalae including verbal retrieval deficits after severe traumatic brain injury (TBI). The cortico-caudate-thalamic circuit involving the pre-Supplementary Motor Area (pre-SMA) has been proposed to underlie verbal retrieval functions. We hypothesized that High Definition-transcranial Direct Current Stimulation (HD-tDCS) targeting the pre-SMA would selectively modulate this circuit to remediate verbal retrieval deficits. After the patient underwent 10 sessions of 20 min of 1 mA HD-tDCS targeting the pre-SMA, we documented significant improvements for verbal fluency and naming, and for working memory and executive function tasks that involve the frontal lobes. The effects persisted for up to 14 weeks after completion of HD-tDCS treatment. We also demonstrated normalization of the event-related potentials suggesting modulation of the underlying neural circuit. Our study implicates that region-specific non-invasive brain stimulation, such as HD-tDCS, serves as a potential individualized therapeutic tool to treat cognitive deficits by inducing longer-lasting neuroplasticity even in the chronic phase of TBI.	[Chiang, Hsueh-Sheng; Hart, John, Jr.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Chiang, Hsueh-Sheng] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Shakal, Scott] Univ North Texas, Texas Coll Osteopath Med, Hlth Sci Ctr, Ft Worth, TX USA; [Vanneste, Sven] Trinity Coll Dublin, Dublin, Ireland; [Kraut, Michael] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA		Chiang, HS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.; Chiang, HS (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	hschiang@utdallas.edu		Chiang, Hsueh-Sheng/0000-0003-2211-6007; Vanneste, Sven/0000-0003-1513-5752	NINDS R25 under the UT Southwestern Integrated Program for the Advancement of Neuroscience Research Careers (UT SWANS) [NS09898702]; Berman Research Initiative at the University of Texas at Dallas in USA	H-SC was supported for his research time by NINDS R25 (NS09898702) under the UT Southwestern Integrated Program for the Advancement of Neuroscience Research Careers (UT SWANS). The study was funded by the Berman Research Initiative at the University of Texas at Dallas in USA.	Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Chhatbar PY, 2018, BRAIN STIMUL, V11, P727, DOI 10.1016/j.brs.2018.03.006; Chiang HS, 2013, NEUROREPORT, V24, P889, DOI 10.1097/WNR.0000000000000014; Das S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00550; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Fischer-Baum S, 2016, NEUROPSYCHOLOGY, V30, P791, DOI 10.1037/neu0000286; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fratantoni JM, 2017, J NEUROTRAUM, V34, P1017, DOI 10.1089/neu.2016.4651; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gill SK, 2014, APHASIOLOGY, V28, P155, DOI 10.1080/02687038.2013.802286; Giordano J, 2017, DOSE-RESPONSE, V15, DOI 10.1177/1559325816685467; Hamsher K., 1989, MULTILINGUAL APHASIA; Hart J, 2013, BRAIN LANG, V126, P89, DOI 10.1016/j.bandl.2012.08.002; Hart J, 2007, NEURAL BASIS OF SEMANTIC MEMORY, P331, DOI 10.1017/CBO9780511544965.014; Hertrich I, 2016, NEUROSCI BIOBEHAV R, V68, P602, DOI 10.1016/j.neubiorev.2016.06.030; Kaplan E, 1983, BOSTON NAMING TEST; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Kreutzer JS., 2011, ENCY CLIN NEUROPSYCH, DOI [10.1007/978-0-387-79948-3_4510, DOI 10.1007/978-0-387-79948-3_4510]; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Motes MA, 2020, J NEUROTRAUM, V37, P170, DOI 10.1089/neu.2018.6331; Mudar RA, 2015, BEHAV BRAIN RES, V287, P285, DOI 10.1016/j.bbr.2015.03.042; Reckow J, 2018, BRAIN STIMUL, V11, P991, DOI 10.1016/j.brs.2018.04.022; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Smith JL, 2007, CLIN NEUROPHYSIOL, V118, P343, DOI 10.1016/j.clinph.2006.09.027; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Thielscher A, 2015, IEEE ENG MED BIO, P222, DOI 10.1109/EMBC.2015.7318340; To WT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22730-x; Tremblay P, 2010, CORTEX, V46, P15, DOI 10.1016/j.cortex.2009.03.003; Tremblay P, 2009, BRAIN RES, V1268, P112, DOI 10.1016/j.brainres.2009.02.076; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Whiteside Douglas M, 2016, Appl Neuropsychol Adult, V23, P29, DOI 10.1080/23279095.2015.1004574; Woods AJ, 2016, CLIN NEUROPHYSIOL, V127, P1031, DOI 10.1016/j.clinph.2015.11.012	42	1	1	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 16	2021	12								678518	10.3389/fneur.2021.678518			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TS9LC	WOS:000679969200001	34335447	Green Published, gold			2022-02-06	
J	Eliasen, MH; Petersen, J; Benros, ME; Osler, M				Eliasen, Marie Holm; Petersen, Janne; Benros, Michael Eriksen; Osler, Merete			Number of traumatic brain injuries and temporal associations with depression: A register-based cohort study	ACTA PSYCHIATRICA SCANDINAVICA			English	Article						cohort study; depression; traumatic brain injury	RISK-FACTORS; HEAD-INJURY; DISORDERS	Objective To explore the association of the number of traumatic brain injuries (TBIs) and temporal associations with the subsequent risk of depression in the population. Methods National register-based cohort study on all individuals registered with TBI (ICD-10: S06, ICD-8: 85.0-85.5) from 1977 to 2015 in Denmark (n = 494,216) and a sex- and age-matched reference population (n = 499,505). The associations with the number of TBIs and time to depression (0-6, 7-12 and more than 12 months following TBI) were analyzed using Cox proportional hazard regression. Results During a follow-up of mean 14.5 (SD 11.3) years, a total of 27,873 (5.6%) individuals who had at least one TBI and 15,195 (3.0%) in the reference population were diagnosed with a depression. First-time TBI was associated with a higher risk of depression in both men (HR = 1.73 [95% CI:1.67-1.79]) and women (HR = 1.66 [95% CI:1.61-1.70]) after multiple adjustments for educational status and comorbidities including previous depression, and the association became stronger in a dose-response association with the number of TBIs (test for trend p < 0.01). The HRs for depression were highest the first 6 months after the TBI in both men (HR = 5.69 [95% CI:4.66-6.94]) and women (HR = 4.55 [95% CI:3.93-5.26]) and decreased gradually the following year but remained elevated from one year after TBI until end of follow-up independent of the number of TBIs (p < 0.01). The associations did not vary with age or calendar time. Conclusion Traumatic brain injury is associated with a higher risk of depression, especially in the first months after TBI and the risk increases with the number of TBIs.	[Eliasen, Marie Holm; Petersen, Janne; Osler, Merete] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Frederiksberg, Denmark; [Petersen, Janne] Univ Copenhagen, Sect Biostat, Dept Publ Hlth, Copenhagen, Denmark; [Benros, Michael Eriksen] Copenhagen Univ Hosp, Mental Hlth Ctr Copenhagen, Copenhagen Res Ctr Mental Hlth, Biol & Precis Psychiat, Copenhagen, Denmark; [Benros, Michael Eriksen] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Copenhagen, Denmark; [Osler, Merete] Univ Copenhagen, Sect Epidemiol, Dept Publ Hlth, Copenhagen, Denmark		Osler, M (corresponding author), Ctr Clin Res & Prevent, Nordre Fasanvej 57, DK-2000 Frederiksberg, Denmark.	Merete.osler@regionh.dk	Benros, Michael Eriksen/N-5868-2016	Benros, Michael Eriksen/0000-0003-4939-9465	Danish Health Fund [17-B-00033]	The study was funded by the Danish Health Fund (17-B-00033)	Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Conroy Susan K, 2020, Focus (Am Psychiatr Publ), V18, P150, DOI 10.1176/appi.focus.20200004; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Jorgensen TSH, 2016, JAMA PSYCHIAT, V73, P1032, DOI 10.1001/jamapsychiatry.2016.1932; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Malhi GS, 2018, LANCET, V392, P2299, DOI 10.1016/S0140-6736(18)31948-2; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Rabinowitz AR, 2020, J HEAD TRAUMA REHAB, V35, P76, DOI 10.1097/HTR.0000000000000537; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Ryttersgaard TO, 2020, SCAND J PSYCHOL, V61, P297, DOI 10.1111/sjop.12587; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Serafini G, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00149; Wadhawan A, 2019, J ALZHEIMERS DIS, V68, P1339, DOI 10.3233/JAD-181055	19	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-690X	1600-0447		ACTA PSYCHIAT SCAND	Acta Psychiatr. Scand.	OCT	2021	144	4					407	414		10.1111/acps.13347		JUL 2021	8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	UP3GU	WOS:000674050900001	34231201				2022-02-06	
J	Haque, A; Drasites, KP; Cox, A; Capone, M; Myatich, AI; Shams, R; Matzelle, D; Garner, DP; Bredikhin, M; Shields, DC; Vertegel, A; Banik, NL				Haque, Azizul; Drasites, Kelsey P.; Cox, April; Capone, Mollie; Myatich, Ali, I; Shams, Ramsha; Matzelle, Denise; Garner, Dena P.; Bredikhin, Mikhail; Shields, Donald C.; Vertegel, Alexey; Banik, Naren L.			Protective Effects of Estrogen via Nanoparticle Delivery to Attenuate Myelin Loss and Neuronal Death after Spinal Cord Injury	NEUROCHEMICAL RESEARCH			English	Article						Calpain; Gliosis; Myelination; Nanoparticle-estrogen; Neuronal death; Reactive oxygen species; Spinal cord injury	LYSOSOMAL THIOL REDUCTASE; TRAUMATIC BRAIN-INJURY; T-CELL RECOGNITION; SECONDARY DAMAGE; OXIDATIVE STRESS; NEUROPROTECTIVE AGENT; ASTROCYTE REACTIVITY; FUNCTIONAL RECOVERY; LOCOMOTOR FUNCTION; MELANOMA-CELLS	Spinal cord injury (SCI) is associated with devastating neurological deficits affecting more than 11,000 Americans each year. Although several therapeutic agents have been proposed and tested, no FDA-approved pharmacotherapy is available for SCI treatment. We have recently demonstrated that estrogen (E2) acts as an antioxidant and anti-inflammatory agent, attenuating gliosis in SCI. We have also demonstrated that nanoparticle-mediated focal delivery of E2 to the injured spinal cord decreases lesion size, reactive gliosis, and glial scar formation. The current study tested in vitro effects of E2 on reactive oxygen species (ROS) and calpain activity in microglia, astroglia, macrophages, and fibroblasts, which are believed to participate in the inflammatory events and glial scar formation after SCI. E2 treatment decreased ROS production and calpain activity in these glial cells, macrophages, and fibroblast cells in vitro. This study also tested the efficacy of fast- and slow-release nanoparticle-E2 constructs in a rat model of SCI. Focal delivery of E2 via nanoparticles increased tissue distribution of E2 over time, attenuated cell death, and improved myelin preservation in injured spinal cord. Specifically, the fast-release nanoparticle-E2 construct reduced the Bax/Bcl-2 ratio in injured spinal cord tissues, and the slow-release nanoparticle-E2 construct prevented gliosis and penumbral demyelination distal to the lesion site. These data suggest this novel E2 delivery strategy to the lesion site may decrease inflammation and improve functional outcomes following SCI.	[Haque, Azizul; Drasites, Kelsey P.; Capone, Mollie; Myatich, Ali, I; Shams, Ramsha; Banik, Naren L.] Med Univ South Carolina, Dept Microbiol & Immunol, 173 Ashley Ave, Charleston, SC 29425 USA; [Drasites, Kelsey P.; Cox, April; Capone, Mollie; Myatich, Ali, I; Shams, Ramsha; Matzelle, Denise; Shields, Donald C.; Banik, Naren L.] Med Univ South Carolina, Dept Neurosurg, 96 Jonathan Lucas St, Charleston, SC 29425 USA; [Drasites, Kelsey P.; Myatich, Ali, I; Shams, Ramsha; Garner, Dena P.] The Citadel, Dept Hlth & Human Performance, 171 Moultrie St, Charleston, SC 29409 USA; [Matzelle, Denise; Banik, Naren L.] Ralph H Johnson Vet Adm Med Ctr, 109 Bee St, Charleston, SC 29401 USA; [Bredikhin, Mikhail; Vertegel, Alexey] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Banik, Naren L.] Med Univ South Carolina, Dept Neurosurg & Neurol, 96 Jonathan Lucas St, Charleston, SC 29425 USA		Haque, A; Banik, NL (corresponding author), Med Univ South Carolina, Dept Microbiol & Immunol, 173 Ashley Ave, Charleston, SC 29425 USA.; Banik, NL (corresponding author), Med Univ South Carolina, Dept Neurosurg, 96 Jonathan Lucas St, Charleston, SC 29425 USA.; Banik, NL (corresponding author), Ralph H Johnson Vet Adm Med Ctr, 109 Bee St, Charleston, SC 29401 USA.; Banik, NL (corresponding author), Med Univ South Carolina, Dept Neurosurg & Neurol, 96 Jonathan Lucas St, Charleston, SC 29425 USA.	haque@musc.edu; baniknl@musc.edu		Haque, Azizul/0000-0002-6386-9390	Veterans AdministrationUS Department of Veterans Affairs [1IOBX001262, 1I01BX002349-01, 2I01 BX001262-05, 1I01 BX004269-01]; South Carolina State Spinal Cord Injury Research Fund [SCIRF-2015P-01, SCIRF-2015P-04, SCIRF-2015-I-01, 2016 I-03, 2018 I-01]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21NS118393-01]	This work was supported in part by funding from the Veterans Administration (1IOBX001262, 1I01BX002349-01, 2I01 BX001262-05, 1I01 BX004269-01), South Carolina State Spinal Cord Injury Research Fund (SCIRF-2015P-01, SCIRF-2015P-04, SCIRF-2015-I-01, SCIRF #2016 I-03, and SCIRF #2018 I-01). Contents do not necessarily represent the policy of the SCIRF and do not imply endorsement by the funding agency. This work was also supported in part by funding from the National Institutes of Health (1R21NS118393-01).	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Ardelt AA, 2012, BRAIN RES, V1461, P76, DOI 10.1016/j.brainres.2012.04.024; Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bracken MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001046.pub2; Bradbury EJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11707-7; Breslin K, 2012, PEDIATR EMERG CARE, V28, P1238, DOI 10.1097/PEC.0b013e3182724434; Cheng F, 2016, P NATL ACAD SCI USA, V113, pE4320, DOI 10.1073/pnas.1519197113; Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002; Cox A, 2021, J NEUROTRAUM, V38, P342, DOI 10.1089/neu.2020.7047; Cox A, 2015, J NEUROTRAUM, V32, P1413, DOI 10.1089/neu.2014.3730; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Cuzzocrea S, 2008, SHOCK, V29, P362, DOI 10.1097/shk.0b013e31814545dc; Das A, 2007, NEUROCHEM RES, V32, P1849, DOI 10.1007/s11064-007-9371-4; Das SK, 2014, INVEST OPHTH VIS SCI, V55, P4030, DOI 10.1167/iovs.13-13494; Datto JP, 2015, NEURAL REGEN RES, V10, P1533, DOI 10.4103/1673-5374.165213; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; dos Santos G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7574; Elkabes S, 2014, EXP NEUROL, V259, P28, DOI 10.1016/j.expneurol.2014.01.008; Evsen MS, 2013, EUR REV MED PHARMACO, V17, P1869; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gabizon A, 1997, DRUGS, V54, P15, DOI 10.2165/00003495-199700544-00005; Gatson JW, 2012, J NEUROTRAUM, V29, P2209, DOI 10.1089/neu.2011.2274; Ge XH, 2021, REDOX BIOL, V41, DOI 10.1016/j.redox.2021.101932; God JM, 2015, J IMMUNOL, V194, P1434, DOI 10.4049/jimmunol.1402382; Goldstein OG, 2008, CANCER IMMUNOL IMMUN, V57, P1461, DOI 10.1007/s00262-008-0483-8; Hall ED, 2003, J REHABIL RES DEV, V40, P81, DOI 10.1682/JRRD.2003.08.0081; Haque A, 2007, CELL IMMUNOL, V249, P20, DOI 10.1016/j.cellimm.2007.10.005; Haque A, 2007, CANCER IMMUNOL IMMUN, V56, P615, DOI 10.1007/s00262-006-0219-6; Haque A, 2017, NEUROCHEM RES, V42, P2777, DOI 10.1007/s11064-017-2291-z; Haque MA, 2002, J EXP MED, V195, P1267, DOI 10.1084/jem.20011853; Hathaway-Schrader JD, 2018, J CELL BIOCHEM, V119, P2212, DOI 10.1002/jcb.26383; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Perez-Alvarez MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-157; Jurzak M, 2014, ACTA POL PHARM, V71, P972; Kachadroka S, 2010, J NEUROTRAUM, V27, P611, DOI 10.1089/neu.2009.1069; Kamaly N, 2016, CHEM REV, V116, P2602, DOI 10.1021/acs.chemrev.5b00346; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Kipp M, 2012, J NEUROENDOCRINOL, V24, P62, DOI 10.1111/j.1365-2826.2011.02163.x; Kumar S, 2010, BBA-GEN SUBJECTS, V1800, P1127, DOI 10.1016/j.bbagen.2010.04.011; Lammertse DP, 2013, SPINAL CORD, V51, P2, DOI 10.1038/sc.2012.137; Leal-Filho Manoel Baldoino, 2011, Surg Neurol Int, V2, P112, DOI 10.4103/2152-7806.83732; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Lee JY, 2012, ENDOCRINOLOGY, V153, P3815, DOI 10.1210/en.2012-1068; Li HR, 2014, MOL THER, V22, P1839, DOI 10.1038/mt.2014.115; Li XY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9494352; Lidegaard O, 2002, CONTRACEPTION, V65, P187, DOI 10.1016/S0010-7824(01)00307-9; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Maximov VD, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/26/265103; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Nita M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3164734; O'Donnell PW, 2004, J IMMUNOL, V173, P731, DOI 10.4049/jimmunol.173.2.731; Okada S, 2018, NEUROSCI RES, V126, P39, DOI 10.1016/j.neures.2017.10.004; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Perot P L Jr, 1987, Cent Nerv Syst Trauma, V4, P149; Radwan FFY, 2012, LEUKEMIA LYMPHOMA, V53, P305, DOI 10.3109/10428194.2011.615423; Ritz MF, 2008, BRAIN RES, V1203, P177, DOI 10.1016/j.brainres.2008.01.091; Samantaray S, 2016, J NEUROCHEM, V136, P1064, DOI 10.1111/jnc.13464; Samantaray S, 2011, NEUROCHEM RES, V36, P1809, DOI 10.1007/s11064-011-0498-y; Samantaray S, 2010, ANN NY ACAD SCI, V1199, P90, DOI 10.1111/j.1749-6632.2009.05357.x; Sambandam Y, 2014, BONE, V61, P125, DOI 10.1016/j.bone.2014.01.004; Satishkumar R, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/50/505103; Schaufelberger SA, 2016, AM J PHYSIOL-ENDOC M, V310, pE313, DOI 10.1152/ajpendo.00418.2015; Schroeder GD, 2014, SPINE, V39, P971, DOI 10.1097/BRS.0000000000000297; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Shen Q, 2006, BRAIN RES, V1086, P9, DOI 10.1016/j.brainres.2006.02.116; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Siebert JR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/845323; Siriphorn A, 2012, J COMP NEUROL, V520, P2630, DOI 10.1002/cne.23056; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; Sribnick EA, 2004, NEUROCHEM RES, V29, P2007, DOI 10.1007/s11064-004-6874-0; Sribnick EA, 2003, ANN NY ACAD SCI, V993, P125, DOI 10.1111/j.1749-6632.2003.tb07521.x; Sribnick EA, 2010, J NEUROSCI RES, V88, P1738, DOI 10.1002/jnr.22337; Tripathi M, 2012, CELL ADHES MIGR, V6, P231, DOI 10.4161/cam.20419; Upadhyayula Pavan S, 2021, World J Stem Cells, V13, P168, DOI 10.4252/wjsc.v13.i2.168; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhao D, 2011, CELL IMMUNOL, V271, P392, DOI 10.1016/j.cellimm.2011.08.007; Zhou X, 2014, NEURAL REGEN RES, V9, P1787, DOI 10.4103/1673-5374.143423; Zhu P, 2015, GENET MOL RES, V14, P10490, DOI 10.4238/2015.September.8.10; Zlotnik A, 2012, INTENS CARE MED, V38, P137, DOI 10.1007/s00134-011-2401-3	90	1	1	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	NOV	2021	46	11					2979	2990		10.1007/s11064-021-03401-2		JUL 2021	12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	WA6QI	WOS:000673188200002	34269965				2022-02-06	
J	Anyaegbu, CC; Mao, YL; McGonigle, T; Raja, S; Clarke, T; Black, AMB; Solomon, T; Fuller, K; Fitzgerald, M				Anyaegbu, Chidozie C.; Mao, Yilin; McGonigle, Terry; Raja, Sushmitha; Clarke, Thomas; Black, Anna M. B.; Solomon, Tanya; Fuller, Kathy; Fitzgerald, Melinda			Simultaneous flow cytometric characterization of multiple cell types and metabolic states in the rat brain after repeated mild traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Neurotrauma; Repeated mild traumatic brain injury; Flow cytometry; Rat brain; Oxidative stress	ASTROCYTES; MICROGLIA; ADULT; DEGENERATION; PERFORMANCE	Background: Cellular responses at the sub-acute phase of mild traumatic brain injury (mTBI), and their contribution to ongoing damage, are unclear, complex and require simultaneous assessment of multiple cells to elucidate. New method: An 11-colour flow cytometry method for analysing brain cells was evaluated in a weight-drop rat model of repeated mTBI. Animals received sham, one, two or three mTBI delivered at 24 h intervals (n = 6/ group). Cerebrum homogenates were prepared 11 days after first mTBI, in two cohorts of n = 3/group to enable same-day staining of fresh tissue. Percentages of neurons, astrocytes, microglia, mature oligodendrocytes and NeuN + CC1+ cells, neutrophils, macrophages and non-myeloid leukocytes, and their immunoreactivity for cell damage indicators (inducible nitric oxide synthase; iNOS, proliferating cell nuclear antigen; PCNA, 8-Oxo-2 ' deoxyguanosine; 8OHDG and 4-hydroxynonenal; HNE), were assessed. Results: Median fluorescence intensity (MFI) of iNOS in activated microglia increased following two, but not one or three, mTBI (p = 0.04). However, there were differences between processing cohorts in terms of percentages and MFI of some PCNA+, iNOS+, 8OHDG + and HNE + cell populations. Comparison with existing methods: Previous applications of flow cytometry for rat brain analysis were typically limited to three or four markers. This method uses 11 markers to identify nine cell populations and evaluate their immunoreactivity to four metabolic indicators of cell damage. Conclusions: Flow cytometry can be useful for discerning injury-related changes in multiple rat brain cells. However, markers sensitive to subtle changes in experimental conditions must be identified in pilot experiments and subsequently analysed in the same tissue-processing cohort.	[Anyaegbu, Chidozie C.; Mao, Yilin; McGonigle, Terry; Raja, Sushmitha; Clarke, Thomas; Black, Anna M. B.; Solomon, Tanya; Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Belmont, WA, Australia; [Fuller, Kathy] Univ Western Australia, Sch Biomed Sci, Div Canc Biol, 35 Stirling Hwy, Nedlands, WA 6009, Australia; [Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia		Anyaegbu, CC (corresponding author), Curtin Univ, Ralph & Patricia Sarich Neurosci Res Inst, Curtin Hlth Innovat Res Inst, 8 Verdun St, Nedlands, WA 6009, Australia.	chidozie.anyaegbu@curtin.edu.au	Fuller, Kathy A/C-5454-2011; Fitzgerald, Melinda/C-4235-2011	Fuller, Kathy A/0000-0002-3462-7501; Solomon, Tanya/0000-0001-7762-9809; Anyaegbu, Chidozie/0000-0002-0618-3173; Fitzgerald, Melinda/0000-0002-4823-8179; RAJA, Sushmitha/0000-0002-2210-0593			Allen NJ, 2018, SCIENCE, V362, P181, DOI 10.1126/science.aat0473; Assis-Nascimento P, 2016, J NEUROSCI METH, V263, P57, DOI 10.1016/j.jneumeth.2016.01.025; Bai RJ, 2017, NEUROCHEM RES, V42, P2892, DOI 10.1007/s11064-017-2310-0; Barnett-Vanes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0142520; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Benoit A, 2018, J NEUROSCI METH, V304, P11, DOI 10.1016/j.jneumeth.2018.04.005; Bin JM, 2016, J NEUROCHEM, V139, P181, DOI 10.1111/jnc.13745; Calvo B, 2020, IBRO REP, V8, P36, DOI 10.1016/j.ibror.2019.12.004; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; Denker SP, 2007, J NEUROCHEM, V100, P893, DOI 10.1111/j.1471-4159.2006.04162.x; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Enam SF, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01860-y; Ero C, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00084; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Estevez FJM, 2019, JOVE-J VIS EXP, DOI 10.3791/60335; Fehily B, 2019, J NEUROCHEM, V149, P660, DOI 10.1111/jnc.14673; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Furman NT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68770-0; Gusel'nikova VV, 2015, ACTA NATURAE, V7, P42, DOI 10.32607/20758251-2015-7-2-42-47; Heimfarth L, 2013, NEUROTOXICOLOGY, V34, P175, DOI 10.1016/j.neuro.2012.10.015; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Intergovernmental Panel on Climate Change (IPCC), 2018, IPCC SPECIAL REPORT; Kato T.A, 2015, MATERNAL IMMUNE ACTI, DOI [10.3389/fncel.2015.00301, DOI 10.3389/FNCEL.2015.00301]; Lai JH, 2018, EMBO REP, V19, DOI 10.15252/embr.201846182; Lee C, 2008, CEREB CORTEX, V18, P2909, DOI 10.1093/cercor/bhn051; Legroux L, 2015, J NEUROSCI METH, V247, P23, DOI 10.1016/j.jneumeth.2015.03.021; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Mancarci BO, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0212-17.2017; Mao YL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113408; Martin D, 2017, ACS CHEM NEUROSCI, V8, P356, DOI 10.1021/acschemneuro.6b00374; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Moller Karoline, 2012, Exp Transl Stroke Med, V4, P20, DOI 10.1186/2040-7378-4-20; NSW Dept. of Health, 2011, CHILDREN INFANTS ACU; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Posel C, 2016, JOVE-J VIS EXP, DOI 10.3791/53658; Robinson AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107649; Roederer M, 2002, CURR PROTOC CYTOM, DOI [DOI 10.1002/0471142956.CY0114S22, 10.1002/0471142956.cy0114s22]; Taft JR, 2005, INT J NEUROSCI, V115, P1333, DOI 10.1080/00207450590934570; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Upreti D, 2016, ONCOL LETT, V11, P2199, DOI 10.3892/ol.2016.4209; Walz W, 1998, NEUROSCI LETT, V257, P127, DOI 10.1016/S0304-3940(98)00813-1; Wilson NM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178013; Yates NJ, 2017, EXP BRAIN RES, V235, P2133, DOI 10.1007/s00221-017-4958-8	52	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JUL 15	2021	359								109223	10.1016/j.jneumeth.2021.109223			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	SR7TP	WOS:000661249400010	34004202	hybrid			2022-02-06	
J	O'Donnell, JC; Purvis, EM; Helm, KVT; Adewole, DO; Zhang, QZ; Le, AD; Cullen, DK				O'Donnell, John C.; Purvis, Erin M.; Helm, Kaila V. T.; Adewole, Dayo O.; Zhang, Qunzhou; Le, Anh D.; Cullen, D. Kacy			An implantable human stem cell-derived tissue-engineered rostral migratory stream for directed neuronal replacement	COMMUNICATIONS BIOLOGY			English	Article							ADULT SUBVENTRICULAR ZONE; TRAUMATIC BRAIN-INJURY; FOREBRAIN NEUROGENESIS; NEUROBLAST MIGRATION; FUNCTIONAL RECOVERY; LIVING SCAFFOLDS; PROGENITOR CELLS; NEURAL STEM; PROLIFERATION; PRECURSORS	The rostral migratory stream (RMS) facilitates neuroblast migration from the subventricular zone to the olfactory bulb throughout adulthood. Brain lesions attract neuroblast migration out of the RMS, but resultant regeneration is insufficient. Increasing neuroblast migration into lesions has improved recovery in rodent studies. We previously developed techniques for fabricating an astrocyte-based Tissue-Engineered RMS (TE-RMS) intended to redirect endogenous neuroblasts into distal brain lesions for sustained neuronal replacement. Here, we demonstrate that astrocyte-like-cells can be derived from adult human gingiva mesenchymal stem cells and used for TE-RMS fabrication. We report that key proteins enriched in the RMS are enriched in TE-RMSs. Furthermore, the human TE-RMS facilitates directed migration of immature neurons in vitro. Finally, human TE-RMSs implanted in athymic rat brains redirect migration of neuroblasts out of the endogenous RMS. By emulating the brain's most efficient means for directing neuroblast migration, the TE-RMS offers a promising new approach to neuroregenerative medicine. O'Donnell et al. describe their Tissue-Engineered Rostral Migratory Stream (TE-RMS) comprised of human astrocyte-like cells that can be derived from adult gingival stem cells within one week, which reorganizes into bundles of bidirectional, longitudinally-aligned astrocytes to emulate the endogenous RMS. Establishing immature neuronal migration in vitro and in vivo, their study demonstrates surgical feasibility and proof-of-concept evidence for this nascent technology.	[O'Donnell, John C.; Purvis, Erin M.; Helm, Kaila V. T.; Adewole, Dayo O.; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [O'Donnell, John C.; Purvis, Erin M.; Helm, Kaila V. T.; Adewole, Dayo O.; Cullen, D. Kacy] Corporal Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA USA; [Purvis, Erin M.] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA; [Adewole, Dayo O.; Cullen, D. Kacy] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Zhang, Qunzhou; Le, Anh D.] Univ Penn, Sch Dent Med, Dept Oral & Maxillofacial Surg & Pharmacol, Philadelphia, PA 19104 USA; [Le, Anh D.] Univ Penn, Dept Oral & Maxillofacial Surg, Penn Med Hosp, Perelman Ctr Adv Med, Philadelphia, PA 19104 USA		Cullen, DK (corresponding author), Univ Penn, Dept Neurosurg, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.; Cullen, DK (corresponding author), Corporal Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA USA.; Cullen, DK (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.	dkacy@pennmedicine.upenn.edu		O'Donnell, John/0000-0001-8101-3783; Cullen, D. Kacy/0000-0002-5355-5216	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS117757, F32-NS103253]; National Science FoundationNational Science Foundation (NSF) [DGE-1845298]; Department of Veterans Affairs [BLRD Merit Review] [I01-BX003748]; RR&D Career Development Award [IK2-RX003376]; Michael J. Fox Foundation [9998]; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-16-1-0796]; Center for Undergraduate Research and Fellowships at the University of Pennsylvania	The authors thank Michael R. Grovola and Kevin D. Browne for technical assistance with these studies. Financial support was provided by the National Institutes of Health [R01-NS117757 (D.K.C.); F32-NS103253 (J.C.O'D.)], National Science Foundation [DGE-1845298 (E.M.P.)], Department of Veterans Affairs [BLR&D Merit Review I01-BX003748 (D.K.C.); RR&D Career Development Award IK2-RX003376 (J.C.O'D.)], Michael J. Fox Foundation [Therapeutic Pipeline Program #9998 (D.K.C.)], the U.S. Army Medical Research and Materiel Command [W81XWH-16-1-0796 (D.K.C.)], and the Center for Undergraduate Research and Fellowships at the University of Pennsylvania [K.V.T.H.]. The data that support the findings of this study are available from the corresponding author upon reasonable request. Opinions, interpretations, conclusions, and recommendations are those of the author(s) and are not necessarily endorsed by the National Institutes of Health, the National Science Foundation, the Department of Veterans Affairs, or the Department of Defense.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Adewole DO, 2019, WOODH PUBL SER BIOM, P3, DOI 10.1016/B978-0-08-102561-1.00001-4; Ajioka I, 2015, TISSUE ENG PT A, V21, P193, DOI [10.1089/ten.tea.2014.0080, 10.1089/ten.TEA.2014.0080]; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clark AR, 2016, STEM CELLS DEV, V25, P1109, DOI 10.1089/scd.2016.0069; Cleary MA, 2006, NEUROSCIENCE, V143, P851, DOI 10.1016/j.neuroscience.2006.08.028; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.tea.2011.0534, 10.1089/ten.TEA.2011.0534]; Dillen Y, 2020, TRANSL STROKE RES, V11, P60, DOI 10.1007/s12975-019-00717-8; Erlandsson A, 2011, EXP NEUROL, V230, P48, DOI 10.1016/j.expneurol.2010.05.018; Fon D, 2014, BIOMATERIALS, V35, P2692, DOI 10.1016/j.biomaterials.2013.12.016; Fujioka T, 2019, NEUROCHEM INT, V126, P69, DOI 10.1016/j.neuint.2019.03.001; Fujioka T, 2017, EBIOMEDICINE, V16, P195, DOI 10.1016/j.ebiom.2017.01.005; Ganz J, 2014, STEM CELL TRANSL MED, V3, P375, DOI 10.5966/sctm.2013-0074; Garcia-Marques J, 2010, GLIA, V58, P218, DOI 10.1002/glia.20918; Gengatharan A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00149; Grade S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055039; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gundelach J, 2018, EXP BRAIN RES, V236, P1181, DOI 10.1007/s00221-018-5209-3; Harris JP, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016019; Hayashi Y, 2018, J NEUROCHEM, V147, P584, DOI 10.1111/jnc.14557; Hickey K, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aaad82; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jinnou H, 2018, CELL STEM CELL, V22, P128, DOI 10.1016/j.stem.2017.11.005; Kaneko N, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aav0618; Kaneko N, 2017, J NEUROCHEM, V141, P835, DOI 10.1111/jnc.14002; Kaneko N, 2010, NEURON, V67, P213, DOI 10.1016/j.neuron.2010.06.018; Katiyar KS, 2019, J TISSUE ENG REGEN M, V13, P2040, DOI 10.1002/term.2955; Katiyar KS, 2018, JOVE-J VIS EXP, DOI 10.3791/55848; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Lim DA, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018820; Lindvall O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019034; Liu XS, 2009, J CEREBR BLOOD F MET, V29, P297, DOI 10.1038/jcbfm.2008.119; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lu JF, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5868632; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; Mason HA, 2001, J NEUROSCI, V21, P7654, DOI 10.1523/JNEUROSCI.21-19-07654.2001; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Motalleb R, 2018, J TISSUE ENG REGEN M, V12, pE2123, DOI 10.1002/term.2644; Nam SC, 2007, J COMP NEUROL, V505, P190, DOI 10.1002/cne.21473; O'Donnell JC, 2018, NEURAL REGEN RES, V13, P1327, DOI 10.4103/1673-5374.235215; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Ota H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5532; Panzer KV, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.580654; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Petraglia AL, 2010, NEUROSURGERY, V66, P165, DOI 10.1227/01.NEU.0000363148.49779.68; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Purvis EM, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00344; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rolfe A, 2015, BRAIN NEUROTRAUMA MO; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Serruya MD, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201701183; Struzyna LA, 2018, J TISSUE ENG REGEN M, V12, P1702, DOI 10.1002/term.2698; Struzyna LA, 2015, TISSUE ENG PT A, V21, P2744, DOI [10.1089/ten.tea.2014.0557, 10.1089/ten.TEA.2014.0557]; Struzyna LA, 2014, CURR OPIN SOLID ST M, V18, P308, DOI 10.1016/j.cossms.2014.07.004; Tang HD, 2009, NEUROBIOL AGING, V30, P299, DOI 10.1016/j.neurobiolaging.2007.06.004; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Wang ZF, 2020, STEM CELLS DEV, V29, P235, DOI 10.1089/scd.2019.0147; Winter CC, 2016, ACTA BIOMATER, V38, P44, DOI 10.1016/j.actbio.2016.04.021; Xiong LL, 2018, MOL NEUROBIOL, V55, P2696, DOI 10.1007/s12035-017-0551-1; Yamashita T, 2017, CELL TRANSPLANT, V26, P461, DOI 10.3727/096368916X692988; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yin XL, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0148-19.2019; Young CC, 2011, ANTIOXID REDOX SIGN, V14, P1877, DOI 10.1089/ars.2010.3435; Yu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081750; Zhang QZ, 2018, MOL NEUROBIOL, V55, P6965, DOI 10.1007/s12035-018-0913-3; Zhang QZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24888-w; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	85	1	1	2	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2399-3642		COMMUN BIOL	Commun. Biol.	JUL 15	2021	4	1							879	10.1038/s42003-021-02392-8			16	Biology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics	TM9CU	WOS:000675845200006	34267315	gold, Green Published			2022-02-06	
J	Yang, BX; Zhang, R; Sa, QR; Du, YL				Yang, Boxiao; Zhang, Rui; Sa, Qire; Du, Yanli			Rhamnazin Ameliorates Traumatic Brain Injury in Mice via Reduction in Apoptosis, Oxidative Stress, and Inflammation	NEUROIMMUNOMODULATION			English	Article; Early Access						Rhamnazin; Apoptosis; Oxidative stress; Inflammation	CELL-DEATH MECHANISMS; PATHOPHYSIOLOGY; MANAGEMENT	Background: Traumatic brain injury (TBI) is posing serious health challenges for people across the globe due to high morbidity and mortality. However, none of the agents prevents or limits the damage caused by TBI because of its multifactorial etiology. Thus, the discovery of novel agents which can act via several pathways could serve the purpose and afford favorable consequence against TBI. Therefore, in the present article, we intended to investigate the protective effect of rhamnazin (RMZ), a dimethoxyflavone against experimentally induced TBI in mice. Methods: The effect of RMZ was investigated on cerebral edema and grip test score after induction of experimental brain injury in rats. The effect of RMZ was also investigated on neuronal degeneration in brain tissues of the experimental mice via Nissl staining and flow cytometry analysis. The expression of Bax and Bcl-2 was also quantified using Western blot analysis. The level of inflammatory cytokines (TNF-alpha and IL-1 beta) and oxidative stress markers (malondialdehyde, superoxide dismutase, and glutathione peroxidase) was also determined using enzyme-linked immunosorbent assay. Results: RMZ showed a significant reduction in edema and improved grip strength. It also prevented neuronal degeneration via inhibition of neuronal apoptosis as shown by flow cytometry analysis. RMZ showed an antiapoptotic effect via reduction of Bax and increased the expression of Bcl-2 in Western blot analysis. It also showed to inhibit oxidative stress and inflammation compared to the TBI group. Conclusion: Collectively, our study is first to demonstrate the protective effect of RMZ against experimentally induced TBI in rats.	[Yang, Boxiao; Du, Yanli] Hulunbeier Peoples Hosp, Dept Neurosurg, Hulunbeier, Peoples R China; [Zhang, Rui] Hulunbeier Peoples Hosp, Dept Imaging, Hulunbeier, Peoples R China; [Sa, Qire] Hulunbeier Peoples Hosp, Dept Ophthalmol, Hulunbeier, Peoples R China		Du, YL (corresponding author), Hulunbeier Peoples Hosp, Dept Neurosurg, Hulunbeier, Peoples R China.	yang_dale@163.com					Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Bencheraiet R, 2011, REC NAT PROD, V5, P52; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dias DA, 2012, METABOLITES, V2, DOI 10.3390/metabo2020303; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dumitrescu L, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2406594; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Garcia-Saez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105; Goyal K., 2020, ACUTE NEURO CARE FOC, P139; Hashimoto Seiji, 2011, J Antibiot (Tokyo), V64, P697, DOI 10.1038/ja.2011.74; Hawas UW, 2019, NAT PROD RES, V33, P3364, DOI 10.1080/14786419.2018.1477153; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Katz L, 2016, J IND MICROBIOL BIOT, V43, P155, DOI 10.1007/s10295-015-1723-5; Kim YouJung, 2016, Journal of Nutrition and Health, V49, P288; Lee S, 2019, TRAUMATIC BRAIN INJU, P19, DOI [10.1007/978-981-10-5529-4_3, DOI 10.1007/978-981-10-5529-4_3]; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martini ND, 2004, J ETHNOPHARMACOL, V93, P207, DOI 10.1016/j.jep.2004.02.030; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mukhopadhyay S, 2014, APOPTOSIS, V19, P555, DOI 10.1007/s10495-014-0967-2; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Philchenkov A A, 2015, Ukr Biochem J, V87, P122; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shin SS, 2014, J NEUROSURG, V121, P1219, DOI 10.3171/2014.7.JNS131826; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wu GuoRong, 2017, Afr J Tradit Complement Altern Med, V14, P201, DOI 10.21010/ajtcam.v14i4.23; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu Y, 2018, RSC ADV, V8, P26696, DOI 10.1039/c8ra03159b; Yu Y, 2015, BIOCHEM BIOPH RES CO, V458, P913, DOI 10.1016/j.bbrc.2015.02.059; Zhang L, 2012, PHYTOCHEM LETT, V5, P104, DOI 10.1016/j.phytol.2011.11.003	44	1	1	1	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation												10.1159/000516927		JUL 2021	8	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	TK0XK	WOS:000673892300001	34265765				2022-02-06	
J	Gabler, LF; Dau, NZ; Park, G; Miles, A; Arbogast, KB; Crandall, JR				Gabler, Lee F.; Dau, Nathan Z.; Park, Gwansik; Miles, Alex; Arbogast, Kristy B.; Crandall, Jeff R.			Development of a Low-Power Instrumented Mouthpiece for Directly Measuring Head Acceleration in American Football	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						American football; Concussion; Head kinematics; Instrumented mouthpiece; Laboratory performance	IMPACT KINEMATICS; BRAIN-INJURY; SYSTEM; MOUTHGUARD; VALIDATION; CONCUSSION; SEVERITY; HELMET	Instrumented mouthpieces (IM) offer a means of measuring head impacts that occur in sport. Direct measurement of angular head kinematics is preferential for accuracy; however, existing IMs measure angular velocity and differentiate the measurement to calculate angular acceleration, which can limit bandwidth and consume more power. This study presents the development and validation of an IM that uses new, low-power accelerometers for direct measurement of linear and angular acceleration over a broad range of head impact conditions in American football. IM sensor accuracy for measuring six-degree-of-freedom head kinematics was assessed using two helmeted headforms instrumented with a custom-fit IM and reference sensor instrumentation. Head impacts were performed at 10 locations and 6 speeds representative of the on-field conditions associated with injurious and non-injurious impacts in American football. Sensor measurements from the IM were highly correlated with those from the reference instrumentation located at the maxilla and skull center of gravity. Based on pooled data across headform and impact location, R-2 >= 0.94, mean absolute error (AE) <= 7%, and mean relative impact angle <= 11 degrees for peak linear and angular acceleration and angular velocity while R-2 >= 0.90 and mean AE <= 7% for kinematic-based injury metrics used in helmet tests.	[Gabler, Lee F.; Dau, Nathan Z.; Park, Gwansik; Miles, Alex; Crandall, Jeff R.] Biomech Consulting & Res LLC, 1627 Quail Run Dr, Charlottesville, VA 22911 USA; [Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19146 USA		Gabler, LF (corresponding author), Biomech Consulting & Res LLC, 1627 Quail Run Dr, Charlottesville, VA 22911 USA.	lgabler@biocorellc.com			Football Research, Inc. (FRI); NFL	The research presented in this paper was made possible by a grant from Football Research, Inc. (FRI). FRI is a nonprofit corporation that receives funding from sources including the NFL and is dedicated to the research and development of novel methods to prevent, mitigate, and treat traumatic head injury. The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources.	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bailey A, 2020, SPORT BIOMECH, V19, P678, DOI 10.1080/14763141.2018.1513059; Bailey AM, 2020, ANN BIOMED ENG, V48, P2566, DOI 10.1007/s10439-020-02626-6; Bailey AM, 2020, ANN BIOMED ENG, V48, P2678, DOI 10.1007/s10439-020-02637-3; Bartsch A, 2020, MIL MED, V185, P190, DOI 10.1093/milmed/usz334; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Densford K, X2 BIOSYSTEMS UNVEIL; Funk JR, 2020, ANN BIOMED ENG, V48, P2652, DOI 10.1007/s10439-020-02632-8; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Holbourn AHS, 1943, LANCET, V2, P438; Jadischke R, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000362; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Joodaki H, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4043038; Kang YS, 2017, TRAFFIC INJ PREV, V18, pS129, DOI 10.1080/15389588.2017.1318210; Kang YS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005427; Kent R, 2020, J BIOMECH, V99, DOI 10.1016/j.jbiomech.2019.109551; Kieffer EE, 2020, ANN BIOMED ENG, V48, P2613, DOI 10.1007/s10439-020-02647-1; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Leong P, 1998, J NEUROSCI METH, V80, P191, DOI 10.1016/S0165-0270(97)00201-X; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; Martin PG, 1998, SHOCK VIB, V5, P211, DOI 10.1155/1998/134562; Myers B., 2009, SHOCK, V1, P54; Newman J.A., 2000, STAPP CAR CRASH J; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NFL, NFLPA RELEASE 2020 H; Park G, 2020, FOOTWEAR SCI, V12, P153, DOI 10.1080/19424280.2020.1769203; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rowson, 2018, VARSITY FOOTBALL HEL; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; SAE Mobilus, 2020, J2111 SAE MOB; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Thibault, 1999, JAMA-J AM MED ASSOC, V1000; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Withnall, 2017, NFL LINEAR IMPACTOR; Withnall C., 2010, SAE TECHNICAL PAPER; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	52	1	1	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2760	2776		10.1007/s10439-021-02826-8		JUL 2021	17	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000674132400001	34263384				2022-02-06	
J	Pu, HJ; Ma, C; Zhao, YF; Wang, YF; Zhang, WT; Miao, WY; Yu, F; Hu, XM; Shi, YJ; Leak, RK; Hitchens, TK; Dixon, CE; Bennett, MV; Chen, J				Pu, Hongjian; Ma, Cheng; Zhao, Yongfang; Wang, Yangfan; Zhang, Wenting; Miao, Wanying; Yu, Fang; Hu, Xiaoming; Shi, Yejie; Leak, Rehana K.; Hitchens, T. Kevin; Dixon, C. Edward; Bennett, Michael Vl; Chen, Jun			Intranasal delivery of interleukin-4 attenuates chronic cognitive deficits via beneficial microglial responses in experimental traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cognitive function; microglia polarization; long-term potentiation; PPAR gamma; DTI	LONG-TERM POTENTIATION; AMYLOID PRECURSOR PROTEIN; MICROGLIA/MACROPHAGE POLARIZATION; SPATIAL MEMORY; NEURONAL LOSS; WHITE-MATTER; SPINAL-CORD; ROSIGLITAZONE; ACTIVATION; IL-4	Traumatic brain injury (TBI) is commonly followed by long-term cognitive deficits that severely impact the quality of life in survivors. Recent studies suggest that microglial/macrophage (Mi/M phi) polarization could have multidimensional impacts on post-TBI neurological outcomes. Here, we report that repetitive intranasal delivery of interleukin-4 (IL-4) nanoparticles for 4 weeks after controlled cortical impact improved hippocampus-dependent spatial and non-spatial cognitive functions in adult C57BL6 mice, as assessed by a battery of neurobehavioral tests for up to 5 weeks after TBI. IL-4-elicited enhancement of cognitive functions was associated with improvements in the integrity of the hippocampus at the functional (e.g., long-term potentiation) and structural levels (CA3 neuronal loss, diffusion tensor imaging of white matter tracts, etc.). Mechanistically, IL-4 increased the expression of PPAR gamma and arginase-1 within Mi/M phi, thereby driving microglia toward a global inflammation-resolving phenotype. Notably, IL-4 failed to shift microglial phenotype after TBI in Mi/M phi-specific PPAR gamma knockout (mKO) mice, indicating an obligatory role for PPAR gamma in IL-4-induced Mi/M phi polarization. Accordingly, post-TBI treatment with IL-4 failed to improve hippocampal integrity or cognitive functions in PPAR gamma mKO mice. These results demonstrate that administration of exogenous IL-4 nanoparticles stimulates PPAR gamma-dependent beneficial Mi/M phi responses, and improves hippocampal function after TBI.	[Pu, Hongjian; Zhang, Wenting; Hu, Xiaoming; Shi, Yejie; Dixon, C. Edward; Chen, Jun] Vet Affairs Pittsburgh Hlth Care Syst, Educ & Clin Ctr, Geriatr Res, Univ Dr C, Pittsburgh, PA 15240 USA; [Pu, Hongjian; Ma, Cheng; Zhao, Yongfang; Wang, Yangfan; Zhang, Wenting; Miao, Wanying; Yu, Fang; Hu, Xiaoming; Shi, Yejie; Leak, Rehana K.; Chen, Jun] Univ Pittsburgh, Pittsburgh Inst Brain Disorders & Recovery, Sch Med, Pittsburgh, PA USA; [Pu, Hongjian; Ma, Cheng; Zhao, Yongfang; Wang, Yangfan; Zhang, Wenting; Miao, Wanying; Yu, Fang; Hu, Xiaoming; Shi, Yejie; Leak, Rehana K.; Chen, Jun] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Leak, Rehana K.] Duquesne Univ, Grad Sch Pharmaceut Sci, Sch Pharm, Pittsburgh, PA 15219 USA; [Hitchens, T. Kevin] Univ Pittsburgh, Anim Imaging Ctr, Sch Med, Pittsburgh, PA USA; [Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA; [Bennett, Michael Vl] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA		Chen, J (corresponding author), Vet Affairs Pittsburgh Hlth Care Syst, Educ & Clin Ctr, Geriatr Res, Univ Dr C, Pittsburgh, PA 15240 USA.	chenj2@upmc.edu	Leak, Rehana K/I-2607-2019; Yu, Fang/AAU-1944-2021; Shi, Yejie/E-5645-2015	Leak, Rehana K/0000-0003-2817-7417; Shi, Yejie/0000-0001-7502-9201	US Department of Veterans AffairsUS Department of Veterans Affairs [I01 BX003377]; Senior Research Career Scientist Award from the Department of Veterans AffairsUS Department of Veterans Affairs	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Merit Review grant (I01 BX003377) from the US Department of Veterans Affairs. JC is the Richard King Mellon Professor of Neurology at the University of Pittsburgh and also supported by the Senior Research Career Scientist Award from the Department of Veterans Affairs.	Anblagan D, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.838; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bliss TVP, 2006, SCIENCE, V313, P1058, DOI 10.1126/science.1132538; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolandzadeh N, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-126; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Cai W, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131355; Cai W, 2018, PROG NEUROBIOL, V163, P27, DOI 10.1016/j.pneurobio.2017.10.002; Caillaud M, 2020, J GERONTOL B-PSYCHOL, V75, P1382, DOI 10.1093/geronb/gbz120; Chadwick MJ, 2014, P NATL ACAD SCI USA, V111, P10720, DOI 10.1073/pnas.1319641111; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chen J, 2019, THERAPEUTIC INTRANAS; Cignarella F, 2020, ACTA NEUROPATHOL, V140, P513, DOI 10.1007/s00401-020-02193-z; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; du Sert NP, 2020, BRIT J PHARMACOL, V177, P3617, DOI [10.1111/bph.15193, 10.1177/0271678X20943823]; Eagle Andrew L, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.1821; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; GERNER R, 1975, ARCH GYNAKOL, V219, P454, DOI 10.1007/BF00669180; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Hu XM, 2014, PROG NEUROBIOL, V119, P60, DOI 10.1016/j.pneurobio.2014.06.002; Jiang L, 2020, J CEREBR BLOOD F MET, V40, pS81, DOI 10.1177/0271678X20902542; Kerr N, 2019, CNS NEUROSCI THER, V25, P1308, DOI 10.1111/cns.13267; Kozlovskaya L, 2014, J CONTROL RELEASE, V189, P133, DOI 10.1016/j.jconrel.2014.06.053; Kumar V, 2014, ROBBINS COTRAN PATHO, V9th; Liang XY, 2021, NEUROIMAGE-CLIN, V30, DOI 10.1016/j.nicl.2021.102621; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Litterst CM, 2001, J BIOL CHEM, V276, P45713, DOI 10.1074/jbc.M108132200; Liu H, 2016, BIOCHEM BIOPH RES CO, V472, P648, DOI 10.1016/j.bbrc.2016.03.003; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; Lyu JX, 2021, TRANSL STROKE RES, V12, P474, DOI 10.1007/s12975-020-00857-2; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Papp G, 2007, LEARN MEMORY, V14, P732, DOI 10.1101/lm.687407; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Poulin V, 2019, DISABIL REHABIL, V41, P1955, DOI 10.1080/09638288.2018.1451560; Pu HJ, 2021, J CEREBR BLOOD F MET, V41, P511, DOI 10.1177/0271678X20941393; Rolls ET, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00098; Shen CH, 1998, MOL CELL BIOL, V18, P3395, DOI 10.1128/MCB.18.6.3395; Shi LG, 2020, J CEREBR BLOOD F MET, V40, pS49, DOI 10.1177/0271678X20925655; Shie FS, 2009, CURR MED CHEM, V16, P643, DOI 10.2174/092986709787458399; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Sutcliffe JS, 2007, BEHAV BRAIN RES, V177, P117, DOI 10.1016/j.bbr.2006.10.029; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Thouennon E, 2015, J NEUROCHEM, V134, P463, DOI 10.1111/jnc.13152; Ting SM, 2020, J CEREBR BLOOD F MET, V40, P513, DOI 10.1177/0271678X19838189; Vandekar SN, 2019, J CEREBR BLOOD F MET, V39, P524, DOI 10.1177/0271678X17737692; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang RR, 2020, J CEREBR BLOOD F MET, V40, P720, DOI 10.1177/0271678X19888630; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Xiong XX, 2015, STROKE, V46, P2271, DOI 10.1161/STROKEAHA.115.008897; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Xu J, 2020, P NATL ACAD SCI USA, V117, P32679, DOI 10.1073/pnas.2018497117; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zhang QX, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000330; Zhang WT, 2019, CNS NEUROSCI THER, V25, P1329, DOI 10.1111/cns.13256; Zhao XR, 2015, J NEUROSCI, V35, P11281, DOI 10.1523/JNEUROSCI.1685-15.2015	66	1	1	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2021	41	11					2870	2886	0271678X211028680	10.1177/0271678X211028680		JUL 2021	17	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	WL1LL	WOS:000681036700001	34259069	hybrid, Green Published			2022-02-06	
J	Kant, A; Johnson, VE; Arena, JD; Dolle, JP; Smith, DH; Shenoy, VB				Kant, Aayush; Johnson, Victoria E.; Arena, John D.; Dolle, Jean-Pierre; Smith, Douglas H.; Shenoy, Vivek B.			Modeling links softening of myelin and spectrin scaffolds of axons after a concussion to increased vulnerability to repeated injuries	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						axonal cytoskeleton damage; repeated traumatic brain injuries; cytoskeletal load transfer mechanism	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; BREAKDOWN PRODUCTS; SURROGATE MARKERS; TAU PROTEINS; NEURONS; MICROTUBULES; BIOMECHANICS; DEGRADATION; MECHANISMS	Damage to the microtubule lattice, which serves as a rigid cytoskeletal backbone for the axon, is a hallmark mechanical initiator of pathophysiology after concussion. Understanding the mechanical stress transfer from the brain tissue to the axonal cytoskeleton is essential to determine the microtubule lattice's vulnerability to mechanical injury. Here, we develop an ultrastructural model of the axon's cytoskeletal architecture to identify the components involved in the dynamic load transfer during injury. Corroborative in vivo studies were performed using a gyrencephalic swine model of concussion via single and repetitive head rotational acceleration. Computational analysis of the load transfer mechanism demonstrates that the myelin sheath and the actin/spectrin cortex play a significant role in effectively shielding the microtubules from tissue stress. We derive failure maps in the space spanned by tissue stress and stress rate to identify physiological conditions in which the microtubule lattice can rupture. We establish that a softer axonal cortex leads to a higher susceptibility of the microtubules to failure. Immunohistochemical examination of tissue from the swine model of single and repetitive concussion confirms the presence of postinjury spectrin degradation, with more extensive pathology observed following repetitive injury. Because the degradation of myelin and spectrin occurs over weeks following the first injury, we show that softening of the myelin layer and axonal cortex exposes the microtubules to higher stress during repeated incidences of traumatic brain injuries. Our predictions explain how mechanical injury predisposes axons to exacerbated responses to repeated injuries, as observed in vitro and in vivo.	[Kant, Aayush; Shenoy, Vivek B.] Univ Penn, Ctr Engn Mechnobiol, Philadelphia, PA 19104 USA; [Kant, Aayush; Shenoy, Vivek B.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Johnson, Victoria E.; Arena, John D.; Dolle, Jean-Pierre; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Penn Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA		Shenoy, VB (corresponding author), Univ Penn, Ctr Engn Mechnobiol, Philadelphia, PA 19104 USA.; Shenoy, VB (corresponding author), Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.	vshenoy@seas.upenn.edu	Shenoy, Vivek/ABD-5075-2021	Arena, John/0000-0002-4322-4472	Paul Allen Family Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EB021293, NS038104, NS094003, NS092398]; Pennsylvania State Commonwealth Universal Research Enhancement (CURE) Award; NSF Center for Engineering Mechanobiology [CMMI-154857]	We gratefully acknowledge fruitful discussions with Pramod A. Pullarkat and Sushil Dubey (Raman Research Institute, India) with respect to modeling fidelity with their neuron stretch experiments. This work was supported by the Paul Allen Family Foundation; NIH Grants EB021293 (V.B.S. and D.H.S.), NS038104 (D.H.S.), NS094003 (D.H.S.), and NS092398 (D.H.S.); and a Pennsylvania State Commonwealth Universal Research Enhancement (CURE) Award. We thank the NSF Center for Engineering Mechanobiology (Grant CMMI-154857) for the computational resources used in the work and graphics support.	Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bruce CC, 2010, HORM BEHAV, V57, P56, DOI 10.1016/j.yhbeh.2009.06.004; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Rooij R, 2017, COMPUT MECH, V59, P523, DOI 10.1007/s00466-016-1359-y; de Rooij R, 2018, BIOPHYS J, V114, P201, DOI 10.1016/j.bpj.2017.11.010; Dillard DA, 2002, ADHESION SCIENCE AND ENGINEERING, VOL 1, P1; Dubey S, 2020, ELIFE, V9, DOI 10.7554/eLife.51772; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Hahn I, 2019, NEURAL DEV, V14, DOI 10.1186/s13064-019-0134-0; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; HOLLEY MC, 1990, J CELL SCI, V96, P283; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kim J, 2020, GLIA, V68, P2070, DOI 10.1002/glia.23827; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Krieg M, 2017, ELIFE, V6, DOI [10.7554/eLife.20172, 10.7554/elife.20172]; Krieg M, 2014, NAT CELL BIOL, V16, P224, DOI 10.1038/ncb2915; Kulbe JR, 2017, PROG NEUROBIOL, V158, P15, DOI 10.1016/j.pneurobio.2017.08.003; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nusholtz G. S., 1984, SAE T, V93, P800; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Ricketts SN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49236-4; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Siman R, 2001, J BIOL CHEM, V276, P44736, DOI 10.1074/jbc.M104092200; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Snaidero N, 2017, GLIA, V65, P1021, DOI 10.1002/glia.23116; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Wegmann S, 2011, J BIOL CHEM, V286, P20512, DOI 10.1074/jbc.M111.237875; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; YU WQ, 1994, J NEUROSCI, V14, P2818; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	52	1	1	1	1	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUL 13	2021	118	28							e2024961118	10.1073/pnas.2024961118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA3BB	WOS:000685036200014	34234016	hybrid, Green Published			2022-02-06	
J	Rehman, R; Tar, L; Olamide, AJ; Li, ZH; Kassubek, J; Bockers, T; Weishaupt, J; Ludolph, A; Wiesner, D; Roselli, F				Rehman, Rida; Tar, Lilla; Olamide, Adeyemi Jubril; Li, Zhenghui; Kassubek, Jan; Boeckers, Tobias; Weishaupt, Jochen; Ludolph, Albert; Wiesner, Diana; Roselli, Francesco			Acute TBK1/IKK-epsilon Inhibition Enhances the Generation of Disease-Associated Microglia-Like Phenotype Upon Cortical Stab-Wound Injury	FRONTIERS IN AGING NEUROSCIENCE			English	Article						TBK1; microglia; traumatic brain injury; amlexanox; neuroinflammation; stab wound injury	TRAUMATIC BRAIN-INJURY; IKK-EPSILON; TBK1; EPIDEMIOLOGY; NEURONS; SUBSET; LUNG	Traumatic brain injury has a poorer prognosis in elderly patients, possibly because of the enhanced inflammatory response characteristic of advanced age, known as "inflammaging." Recently, reduced activation of the TANK-Binding-Kinase 1 (Tbk1) pathway has been linked to age-associated neurodegeneration and neuroinflammation. Here we investigated how the blockade of Tbk1 and of the closely related IKK-epsilon by the small molecule Amlexanox could modify the microglial and immune response to cortical stab-wound injury in mice. We demonstrated that Tbk1/IKK-epsilon inhibition resulted in a massive expansion of microglial cells characterized by the TMEM119(+)/CD11c(+) phenotype, expressing high levels of CD68 and CD317, and with the upregulation of Cst7a, Prgn and Ccl4 and the decrease in the expression levels of Tmem119 itself and P2yr12, thus a profile close to Disease-Associated Microglia (DAM, a subset of reactive microglia abundant in Alzheimer's Disease and other neurodegenerative conditions). Furthermore, Tbk1/IKK-epsilon inhibition increased the infiltration of CD3(+) lymphocytes, CD169(+) macrophages and CD11c(+)/CD169(+) cells. The enhanced immune response was associated with increased expression of Il-33, Ifn-g, Il-17, and Il-19. This upsurge in the response to the stab wound was associated with the expanded astroglial scars and increased deposition of chondroitin-sulfate proteoglycans at 7 days post injury. Thus, Tbk1/IKK-epsilon blockade results in a massive expansion of microglial cells with a phenotype resembling DAM and with the substantial enhancement of neuroinflammatory responses. In this context, the induction of DAM is associated with a detrimental outcome such as larger injury-related glial scars. Thus, the Tbk1/IKK-epsilon pathway is critical to repress neuroinflammation upon stab-wound injury and Tbk1/IKK-epsilon inhibitors may provide an innovative approach to investigate the consequences of DAM induction.	[Rehman, Rida; Tar, Lilla; Olamide, Adeyemi Jubril; Li, Zhenghui; Kassubek, Jan; Weishaupt, Jochen; Ludolph, Albert; Wiesner, Diana; Roselli, Francesco] Ulm Univ, Dept Neurol, Ulm, Germany; [Tar, Lilla; Ludolph, Albert; Wiesner, Diana; Roselli, Francesco] German Ctr Neurodegenerat Dis DZNE Ulm, Ulm, Germany; [Olamide, Adeyemi Jubril] Ulm Univ, Translat & Mol Neurosci, Ulm, Germany; [Li, Zhenghui] Kaifeng Cent Hosp, Dept Neurosurg, Kaifeng, Peoples R China; [Boeckers, Tobias] Ulm Univ, Inst Anat & Cell Biol, Ulm, Germany; [Boeckers, Tobias; Weishaupt, Jochen; Ludolph, Albert; Wiesner, Diana; Roselli, Francesco] Neurozentrum Ulm, Ulm, Germany		Roselli, F (corresponding author), Ulm Univ, Dept Neurol, Ulm, Germany.; Roselli, F (corresponding author), German Ctr Neurodegenerat Dis DZNE Ulm, Ulm, Germany.; Roselli, F (corresponding author), Neurozentrum Ulm, Ulm, Germany.	francesco.roselli@uni-ulm.de	Rehman, Rida/AAR-4811-2020; Kassubek, Jan/O-1740-2019; Kassubek, Jan/F-2774-2015	Rehman, Rida/0000-0003-0518-5051; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; roselli, francesco/0000-0001-9935-6899; Adeyemi, Jubril Olamide/0000-0002-8063-6353	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [251293561]; BMBF as part of the ERANET-Micronet consortiumFederal Ministry of Education & Research (BMBF) [FKZ 01EW1705A]; Thierry Latran Foundation; Radala Foundation; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [SFB1149, 431995586, 446067541, 443642953]; Cellular and Molecular Mechanisms in Aging (CEMMA) Research Training Group; BMBFFederal Ministry of Education & Research (BMBF) [FKZ 01EW1705A]; Hannelore Kohl Foundation Award	This work was supported by the Deutsche Forschungsgemeinschaft in the context of the SFB1149 (FR; no. 251293561) and by BMBF (FKZ 01EW1705A) as part of the ERANET-Micronet consortium (FR). FR was also supported by the Thierry Latran Foundation (projects "Trials" and "Hypothals"), by the Radala Foundation, by the Deutsche Forschungsgemeinschaft (DFG) as part of the SFB1149 and with the individual grant nos. 431995586, 446067541, and 443642953, by the Cellular and Molecular Mechanisms in Aging (CEMMA) Research Training Group and by BMBF (FKZ 01EW1705A, as member of the ERANET-NEURON consortium "MICRONET"). RR is a member of the MICRONET consortium and is also independently funded by theHannelore Kohl Foundation Award.	Abbasi F., 2016, J CLIN EXP DENT, V18, P368, DOI [10.4317/jced.52540, DOI 10.4317/JCED.52540]; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Anderson SR, 2019, CELL REP, V27, P2002, DOI 10.1016/j.celrep.2019.04.062; Balka KR, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.056; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bogie JFJ, 2018, MULT SCLER J, V24, P290, DOI 10.1177/1352458517698759; Brenner D, 2019, J EXP MED, V216, P267, DOI 10.1084/jem.20180729; Bruno C, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa133; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cao ZJ, 2021, STROKE, V52, P687, DOI 10.1161/STROKEAHA.120.032402; Carr M, 2020, J CELL MOL MED, V24, P11573, DOI 10.1111/jcmm.15774; Chen JJ, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.566922; Chen SP, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01853-x; Cheng CP, 2018, THERANOSTICS, V8, P4633, DOI 10.7150/thno.26687; Cheng H, 2018, P NATL ACAD SCI USA, V115, P7611, DOI 10.1073/pnas.1800656115; Cignarella F, 2020, ACTA NEUROPATHOL, V140, P513, DOI 10.1007/s00401-020-02193-z; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; Dols-Icardo O, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000829; Duan WS, 2021, MOL NEUROBIOL, V58, P2435, DOI 10.1007/s12035-020-02235-3; Early AN, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01800-w; Ewers M, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012308; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Frigerio CS, 2019, CELL REP, V27, P1293, DOI 10.1016/j.celrep.2019.03.099; Frik J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745294; Gabande-Rodriguez E, 2020, J NEUROSCI RES, V98, P284, DOI 10.1002/jnr.24419; Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597; Gerbino V, 2020, NEURON, V106, P789, DOI 10.1016/j.neuron.2020.03.005; Gotzl JK, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809711; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Heuvel FO, 2019, BRAIN BEHAV IMMUN, V81, P228, DOI 10.1016/j.bbi.2019.06.019; Horiuchi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118640; Immig K, 2015, GLIA, V63, P611, DOI 10.1002/glia.22771; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jin J, 2012, NAT IMMUNOL, V13, P1101, DOI 10.1038/ni.2423; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim JY, 2013, P NATL ACAD SCI USA, V110, P12414, DOI 10.1073/pnas.1220674110; Koellhoffer EC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040769; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lafont E, 2018, NAT CELL BIOL, V20, P1389, DOI 10.1038/s41556-018-0229-6; Lee CYD, 2018, NEURON, V97, P1032, DOI 10.1016/j.neuron.2018.02.002; Lee SH, 2021, NEURON, V109, P1283, DOI 10.1016/j.neuron.2021.02.010; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Lewcock JW, 2020, NEURON, V108, P801, DOI 10.1016/j.neuron.2020.09.029; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Mathur V, 2017, NEURON, V96, P1290, DOI 10.1016/j.neuron.2017.11.032; Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179; Meilandt WJ, 2020, J NEUROSCI, V40, P1956, DOI 10.1523/JNEUROSCI.1871-19.2019; Mejias NH, 2018, J INFLAMM-LOND, V15, DOI 10.1186/s12950-018-0198-3; Mifflin L, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025102118; Moser CV, 2019, NEUROPHARMACOLOGY, V146, P198, DOI 10.1016/j.neuropharm.2018.12.004; Mogilenko DA, 2021, IMMUNITY, V54, P99, DOI 10.1016/j.immuni.2020.11.005; Mori D, 2015, MICROVASC RES, V98, P68, DOI 10.1016/j.mvr.2015.01.003; Muth C, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00181; Nugent AA, 2020, NEURON, V105, P837, DOI 10.1016/j.neuron.2019.12.007; O'Neill ASG, 2013, IMMUNOLOGY, V138, P198, DOI 10.1111/imm.12042; Ofengeim D, 2017, P NATL ACAD SCI USA, V114, pE8788, DOI 10.1073/pnas.1714175114; Oral EA, 2017, CELL METAB, V26, P157, DOI 10.1016/j.cmet.2017.06.006; Ostendorf L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89786-0; Ouali Alami Najwa, 2020, Life Sci Alliance, V3, DOI 10.26508/lsa.201900571; Ouali Alami N, 2018, EMBO J, V37, DOI 10.15252/embj.201798697; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Polyak MJ, 2013, FASEB J, V27, P2829, DOI 10.1096/fj.13-227868; Prabakaran T, 2018, EMBO J, V37, DOI 10.15252/embj.201797858; Quan MY, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1438-z; Quarta A, 2021, GLIA, V69, P326, DOI 10.1002/glia.23899; Raj D, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00206; Rangaraju S, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0254-8; Rawji KS, 2016, BRAIN, V139, P653, DOI 10.1093/brain/awv395; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Reinert LS, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136824; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; Safaiyan S, 2021, NEURON, V109, DOI 10.1016/j.neuron.2021.01.027; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Sato-Hashimoto M, 2019, ELIFE, V8, DOI 10.7554/eLife.42025; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; Sobue A, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-020-01099-x; Srinivasan K., 2019, 610345 BIORXIV, V610345, DOI [10.1101/610345, DOI 10.1101/610345]; Taetzsch T, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1446-z; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Wiesner D, 2018, EXP NEUROL, V299, P15, DOI 10.1016/j.expneurol.2017.09.011; Wilcz-Villega E, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201910491; Wlodarczyk A, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00523; Wojkowska DW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051000; Wu R, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0296-9; Xu DC, 2018, CELL, V174, P1477, DOI 10.1016/j.cell.2018.07.041; Yu JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7074; Yum S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100225118; Zhou Z, 2020, TOXICOLOGY, V444, DOI 10.1016/j.tox.2020.152579	97	1	1	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	JUL 13	2021	13								684171	10.3389/fnagi.2021.684171			20	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	TR6OU	WOS:000679082900001	34326766	gold, Green Published			2022-02-06	
J	Bailey, CR; Radhakrishna, S; Asanati, K; Dill, N; Hodgson, K; McKeown, C; Pawa, A; Plaat, F; Wilkes, A				Bailey, C. R.; Radhakrishna, S.; Asanati, K.; Dill, N.; Hodgson, K.; McKeown, C.; Pawa, A.; Plaat, F.; Wilkes, A.			Ergonomics in the anaesthetic workplace Guideline from the Association of Anaesthetists	ANAESTHESIA			English	Article						ergonomics; manual handling; musculoskeletal injuries	TRACHEAL INTUBATION; HAND DOMINANCE; TASK-ANALYSIS; COMMUNICATION; POSITION; EVENTS; BLOCK; HEAD	Ergonomics in relation to anaesthesia is the scientific study of the interaction between anaesthetists and their workspace environment in order to promote safety, performance and well-being. The foundation for avoiding pain or discomfort at work is to adopt and maintain a good posture, whether sitting or standing. Anaesthetists should aim to keep their posture as natural and neutral as possible. The successful practice of anaesthesia relies on optimisation of ergonomics and lack of attention to detail in this area is associated with impaired performance. The anaesthetic team should wear comfortable clothing, including appropriately-sized personal protective equipment where necessary. Temperature, humidity and light should be adequate at all times. The team should comply with infection prevention and control guidelines and monitoring as recommended by the Association of Anaesthetists. Any equipment or machinery that is mobile should be positioned where it is easy to view or reach without having to change the body or head position significantly when interacting with it. Patients who are supine should, whenever possible, be raised upwards to limit the need to lean towards them. Any item required during a procedure should be positioned on trays or trolleys that are close to the dominant hand. Pregnancy affects the requirements for standing, manually handling, applying force when operating equipment or moving machines and the period over which the individual might have to work without a break. Employers have a duty to make reasonable adjustments to accommodate disability in the workplace. Any member of staff with a physical impairment needs to be accommodated and this includes making provision for a wheelchair user who needs to enter the operating theatre and perform their work.	[Bailey, C. R.; Pawa, A.] Guys & St Thomas NHS Fdn Trust, Dept Anaesthesia, London, England; [Radhakrishna, S.] Univ Hosp Coventry & Warwickshire, Dept Anaesthesia, Coventry, W Midlands, England; [Asanati, K.] Imperial Coll London, London, England; [Dill, N.] British Anaesthet Resp Equipment Manufacturers As, Bromley, England; [Hodgson, K.] South East Scotland Sch Anaesthesia, Edinburgh, Midlothian, Scotland; [Hodgson, K.] Assoc Anaesthetists Training Comm, Edinburgh, Midlothian, Scotland; [McKeown, C.] Link Ergon, Nottingham, England; [Plaat, F.] Imperial Coll Healthcare NHS Trust, Dept Anaesthesia, London, England; [Plaat, F.] Royal Coll Anaesthetists, London, England; [Wilkes, A.] Dept Anaesthesia, Edinburgh, Midlothian, Scotland		Bailey, CR (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Anaesthesia, London, England.	craig.bailey@gstt.nhs.uk	Bailey, Craig R/E-8907-2010	Pawa, Amit/0000-0002-2404-9162; Bailey, Craig/0000-0002-7084-3842			Ahmad I, 2020, ANAESTHESIA, V75, P509, DOI 10.1111/anae.14904; Ajmal M, 2011, J CLIN ANESTH, V23, P35, DOI 10.1016/j.jclinane.2010.06.006; Ajmal M, 2009, EUR J ANAESTH, V26, P1037, DOI 10.1097/EJA.0b013e3283317dc9; American Society of Heating Refrigerating and Air-Conditioning Engineers, 2019, HUM CONTR EV PER CAR; Association of Anaesthetists, 2016, SAF VASC ACC; Association of Anaesthetists, 2020, INF PREV CONTR 2020; Association of Anaesthetists, 2012, AAGBI SAF GUID CHECK; Association of Surgical Technologists, 2017, GUIDELINES BEST PRAC; Bailey CR, 2019, ANAESTHESIA, V74, P778, DOI 10.1111/anae.14639; Broom MA, 2011, ANAESTHESIA, V66, P175, DOI 10.1111/j.1365-2044.2011.06623.x; Chartered Institution of Building Services Engineers, 2019, LG0219 LIGHT GUID 2; Cook TM, 2009, BRIT J ANAESTH, V102, P179, DOI 10.1093/bja/aen360; de Man FR, 2014, ANAESTHESIA, V69, P598, DOI 10.1111/anae.12640; Department of Health, 2013, 0402 HBN DEP HLTH; Department of Health, 2013, 0801 DEP HLTH; Department of Health, 2007, HEATING VENTILATION; Deris MS, 2017, INT J MECH PRODUCTIO, V5, P92; Edworthy J, 2013, ANAESTHESIA, V68, P791, DOI 10.1111/anae.12128; El-Orbany M, 2011, ANESTH ANALG, V113, P103, DOI 10.1213/ANE.0b013e31821c7e9c; European Committee for Standardization, 2019, 1379512019 EUR COMM; GARONZIK R, 1989, ERGONOMICS, V32, P1185, DOI 10.1080/00140138908966889; Grundgeiger T, 2015, ANAESTHESIA, V70, P1375, DOI 10.1111/anae.13190; Health and Safety Executive, 2000, DEAL SICK BUILD SYND; Health and Safety Executive, 2021, TEMP IS IT TOO HOT W; Health and Safety Executive, TEMP 6 BAS FACT; Health and Safety Executive, 2019, MAN HANDL MAN HANDL; Health and Safety Executive, 1997, LIGHT WORK; Health and Safety Executive, 2015, EL WORK REG 1989; Health and Safety Executive, 2013, MAN HLTH SAF HSG65; Higgs A, 2018, BRIT J ANAESTH, V120, P323, DOI 10.1016/j.bja.2017.10.021; International Electrotechnical Commission, 2012, 60601182006AMD12012; International Electrotechnical Commission, 2007, 623662007 IEC; International Organization for Standardization, 2020, 73762020 ISO; International Organization for Standardization, 2014, ISO110922014 INT ORG; ISO, 2005, 77302005 ISO; Jung HS, 2009, ERGONOMICS, V52, P1362, DOI 10.1080/00140130903067805; Karjalainen S, 2012, INDOOR AIR, V22, P96, DOI 10.1111/j.1600-0668.2011.00747.x; Katz JD, 2014, ANESTHESIOLOGY, V121, P894, DOI 10.1097/ALN.0000000000000319; Klein AA, 2021, ANAESTHESIA, V76, P1212, DOI 10.1111/anae.15501; Langford RA, 2009, ANAESTHESIA, V64, P845, DOI 10.1111/j.1365-2044.2009.05919.x; Legislation.gov.uk, 1999, MAN HLTH SAF WORK RE; Leifer S, 2019, ANAESTHESIA, V74, P285, DOI 10.1111/anae.14446; Li ES, 2015, J PERINATOL, V35, P142, DOI 10.1038/jp.2014.165; Liu D, 2010, ANESTH ANALG, V110, P1032, DOI 10.1213/ANE.0b013e3181d3e647; MacDonald JJ, 2012, ANAEST INTENS CARE M, V13, P528, DOI 10.1016/j.mpaic.2012.09.002; Moppett IK, 2015, ANAESTHESIA, V70, P1006, DOI 10.1111/anae.13162; Multidisciplinary Association of Spinal Cord Injury Professionals, 2009, MOV HANDL PAT ACT SU; National Institute for Health and Care Excellence, 2016, HYP PREV MAN AD HAV; Nayak Laba Kumar, 2019, Anesth Essays Res, V13, P535, DOI 10.4103/aer.AER_40_19; NHS Estates, 2004, HBN 26 FAC SURG PROC, V1; Pawa A, 2018, CURR OPIN ANESTHESIO, V31, P586, DOI 10.1097/ACO.0000000000000643; Roher K, 2015, ANASTH INTENSIV NOTF, V50, P504, DOI 10.1055/s-0041-103418; Royal College of Anaesthetists, 2019, GUID PROV AN SERV; Royal College of Physicians, 2012, BACK PAIN MYTHS MUST; Scottish Manual Handling Forum, 2014, SCOTT MAN HANDL PASS; Sites BD, 2007, REGION ANESTH PAIN M, V32, P107, DOI 10.1016/j.rapm.2006.11.006; Smith HM, 2012, REGION ANESTH PAIN M, V37, P441, DOI 10.1097/AAP.0b013e318257a551; Sohn HM, 2018, ANESTH ANALG, V126, P1349, DOI 10.1213/ANE.0000000000002534; Vargas-Prada S, 2019, ANAESTHESIA, V74, P274, DOI 10.1111/anae.14537; Wadhera RK, 2010, J THORAC CARDIOV SUR, V139, P312, DOI 10.1016/j.jtcvs.2009.10.048; Wahr JA, 2013, CIRCULATION, V128, P1139, DOI 10.1161/CIR.0b013e3182a38efa; Weldon SM, 2015, J ADV NURS, V71, P2763, DOI 10.1111/jan.12744; Wilson JMB, 2014, BRIT J ANAESTH, V113, P717, DOI 10.1093/bja/aeu324; Yamada NK, 2019, CHILDREN-BASEL, V6, DOI 10.3390/children6060074	64	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	DEC	2021	76	12					1635	1647		10.1111/anae.15530		JUL 2021	13	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	WR3AS	WOS:000671860700001	34251028	hybrid			2022-02-06	
J	Boulter, JHH; Shields, MMM; Meister, MRR; Murtha, G; Curry, BPP; Dengler, BAA				Boulter, Jason H. H.; Shields, Margaret M. M.; Meister, Melissa R. R.; Murtha, Gregory; Curry, Brian P. P.; Dengler, Bradley A. A.			The Expanding Role of Quantitative Pupillometry in the Evaluation and Management of Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						quantitative pupillometry; automated infrared pupillometry; pupillary examination; traumatic brain injury; coma; neurocritical care	COMA SCALE SCORE; DILATED PUPILS; HEAD-INJURY; HERNIATION	Traumatic brain injury is a rapidly increasing source of morbidity and mortality across the world. As such, the evaluation and management of traumatic brain injuries ranging from mild to severe are under active investigation. Over the last two decades, quantitative pupillometry has been increasingly found to be useful in both the immediate evaluation and ongoing management of traumatic brain injured patients. Given these findings and the portability and ease of use of modern pupillometers, further adoption and deployment of quantitative pupillometers into the preclinical and hospital settings of both resource rich and medically austere environments.	[Boulter, Jason H. H.; Meister, Melissa R. R.; Curry, Brian P. P.; Dengler, Bradley A. A.] Walter Reed Natl Mil Med Ctr, Div Neurosurg, Bethesda, MD 20814 USA; [Shields, Margaret M. M.; Murtha, Gregory] Uniformed Serv Univ Hlth Sci, Sch Med, Bethesda, MD USA		Boulter, JHH (corresponding author), Walter Reed Natl Mil Med Ctr, Div Neurosurg, Bethesda, MD 20814 USA.	jason.h.boulter.mil@mail.mil					Bower MM, 2021, J INTENSIVE CARE MED, V36, P383, DOI 10.1177/0885066619881124; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Capo-Aponte J.E., 2013, J SPINE, V4, DOI [10.4172/2165-7939.S4-004, DOI 10.4172/2165-7939.S4-004]; Center DaVsBI, 2020, DOD WORLDWIDE NUMBER; Chaudhuri K, 2009, INJURY, V40, P28, DOI 10.1016/j.injury.2008.09.004; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; El Ahmadieh TY, 2021, WORLD NEUROSURG, V145, pE163, DOI 10.1016/j.wneu.2020.09.152; Fischer VE, 2020, MIL MED, V185, P532, DOI 10.1093/milmed/usz409; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Joseph JR, 2020, J NEUROSURG, V133, P1886, DOI 10.3171/2019.7.JNS191272; Khokhar B, 2021, J NEUROTRAUM, V38, P210, DOI 10.1089/neu.2020.7176; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Larson MD, 2015, ANESTH ANALG, V120, P1242, DOI 10.1213/ANE.0000000000000314; Master CL, 2020, JAMA OPHTHALMOL, V138, P1135, DOI 10.1001/jamaophthalmol.2020.3466; Mauritz W, 2009, EUR J EMERG MED, V16, P153, DOI 10.1097/MEJ.0b013e32832a0864; McCrea M, 2001, J ATHL TRAINING, V36, P274; Nijboer JMM, 2010, INJURY, V41, P52, DOI 10.1016/j.injury.2009.05.030; Ong C, 2019, NEUROCRIT CARE, V30, P307, DOI 10.1007/s12028-018-0620-y; Oyegbile TO, 2020, BEHAV SLEEP MED, V18, P241, DOI 10.1080/15402002.2019.1578223; Papangelou A, 2018, MIL MED, V183, pE113, DOI 10.1093/milmed/usx018; Pearce AJ, 2018, BRAIN INJURY, V32, P498, DOI 10.1080/02699052.2018.1430376; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; van Dijck JTJM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216743	30	1	1	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 12	2021	12								685313	10.3389/fneur.2021.685313			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TR0ZH	WOS:000678701200001	34322081	gold, Green Published			2022-02-06	
J	Campolo, M; Casili, G; Lanza, M; Filippone, A; Cordaro, M; Ardizzone, A; Scuderi, SA; Cuzzocrea, S; Esposito, E; Paterniti, I				Campolo, Michela; Casili, Giovanna; Lanza, Marika; Filippone, Alessia; Cordaro, Marika; Ardizzone, Alessio; Scuderi, Sarah Adriana; Cuzzocrea, Salvatore; Esposito, Emanuela; Paterniti, Irene			The inhibition of mammalian target of rapamycin (mTOR) in improving inflammatory response after traumatic brain injury	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						apoptosis; astrogliosis; behavioural performance; KU0063794; mTOR; mTORC1; mTORC2; neuroinflammation; neuronal death; rapamycin; traumatic brain injury	NITRIC-OXIDE SYNTHASE; MICROGLIA; AUTOPHAGY; DEFICITS; RECEPTOR; PATHWAY	Traumatic brain injury (TBI) provokes primary and secondary damage on endothelium and brain parenchyma, leading neurons die rapidly by necrosis. The mammalian target of rapamycin signalling pathway (mTOR) manages numerous aspects of cellular growth, and it is up-regulated after moderate to severe traumatic brain injury (TBI). Currently, the significance of this increased signalling event for the recovery of brain function is unclear; therefore, we used two different selective inhibitors of mTOR activity to discover the functional role of mTOR inhibition in a mouse model of TBI performed by a controlled cortical impact injury (CCI). Treatment with KU0063794, a dual mTORC1 and mTORC2 inhibitor, and with rapamycin as well-known inhibitor of mTOR, was performed 1 and 4 hours subsequent to TBI. Results proved that mTOR inhibitors, especially KU0063794, significantly improved cognitive and motor recovery after TBI, reducing lesion volumes. Also, treatment with mTOR inhibitors ameliorated the neuroinflammation associated with TBI, showing a diminished neuronal death and astrogliosis after trauma. Our findings propose that the involvement of selective mTORC1/2 inhibitor may represent a therapeutic strategy to improve recovery after brain trauma.	[Campolo, Michela; Casili, Giovanna; Lanza, Marika; Filippone, Alessia; Cordaro, Marika; Ardizzone, Alessio; Scuderi, Sarah Adriana; Cuzzocrea, Salvatore; Esposito, Emanuela; Paterniti, Irene] Univ Messina, Dept Chem Biol Pharmacol & Environm Sci, Viale Ferdinando Stagno Dalcontres 31, I-98166 Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA		Paterniti, I (corresponding author), Univ Messina, Dept Chem Biol Pharmacol & Environm Sci, Viale Ferdinando Stagno Dalcontres 31, I-98166 Messina, Italy.	ipaterniti@unime.it	Lanza, Marika/AAC-3741-2022; Filippone, Alessia/AAC-3679-2022; Casili, Giovanna/AAC-3740-2022; Cordaro, Marika/K-7329-2016; Ardizzone, Alessio/AAC-3715-2022	Casili, Giovanna/0000-0002-0552-1396; Cordaro, Marika/0000-0002-3980-0043; Ardizzone, Alessio/0000-0002-2293-0634; Filippone, Alessia/0000-0002-9642-6844			Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; Casili G, 2020, MOL NEUROBIOL, V57, P4394, DOI 10.1007/s12035-020-02033-x; Casili G, 2018, J NEUROTRAUM, V35, P1437, DOI 10.1089/neu.2017.5260; Combs CK, 2001, J NEUROSCI, V21, P1179; Cordaro M, 2017, MOL NEUROBIOL, V54, P2415, DOI 10.1007/s12035-016-9827-0; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Cuzzocrea S, 2018, J NEUROTRAUM, V35, P1452, DOI 10.1089/neu.2017.5391; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kovesdi E, 2007, PROG BRAIN RES, V161, P81, DOI 10.1016/S0079-6123(06)61006-6; Lebrun-Julien F, 2014, J NEUROSCI, V34, P8432, DOI 10.1523/JNEUROSCI.1105-14.2014; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Lee SW, 2019, CLIN EXP EMERG MED, V6, P125, DOI 10.15441/ceem.18.019; Leker RR, 2002, ACTA NEUROCHIR SUPPL, V83, P49; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Mayorga AJ, 2001, J PHARMACOL EXP THER, V298, P1101; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Nogawa S, 1998, P NATL ACAD SCI USA, V95, P10966, DOI 10.1073/pnas.95.18.10966; Norrmen C, 2014, CELL REP, V9, P646, DOI 10.1016/j.celrep.2014.09.001; Robinson J, 2009, J PATHOL, V219, P35, DOI 10.1002/path.2562; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054918; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093	38	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	AUG	2021	25	16					7855	7866		10.1111/jcmm.16702		JUL 2021	12	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	TZ1DR	WOS:000671546000001	34245104	Green Published, gold			2022-02-06	
J	Bao, ZY; Liu, YL; Chen, BL; Miao, Z; Tu, YM; Li, C; Chao, HL; Ye, YF; Xu, XP; Sun, GC; Zhao, PZ; Liu, N; Liu, Y; Wang, XM; Lam, SM; Kagan, VE; Bayir, H; Ji, J				Bao, Zhongyuan; Liu, Yinlong; Chen, Binglin; Miao, Zong; Tu, Yiming; Li, Chong; Chao, Honglu; Ye, Yangfan; Xu, Xiupeng; Sun, Guangchi; Zhao, Pengzhan; Liu, Ning; Liu, Yan; Wang, Xiaoming; Lam, Sin Man; Kagan, Valerian E.; Bayir, Hulya; Ji, Jing			Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury	NATURE COMMUNICATIONS			English	Article							IN-VITRO; FERROPTOSIS; SENSITIZATION; EXPRESSION; MANAGEMENT; RECEPTOR; THERAPY; FBXO10	Prokineticin-2 (Prok2) is an important secreted protein likely involved in the pathogenesis of several acute and chronic neurological diseases through currently unidentified regulatory mechanisms. The initial mechanical injury of neurons by traumatic brain injury triggers multiple secondary responses including various cell death programs. One of these is ferroptosis, which is associated with dysregulation of iron and thiols and culminates in fatal lipid peroxidation. Here, we explore the regulatory role of Prok2 in neuronal ferroptosis in vitro and in vivo. We show that Prok2 prevents neuronal cell death by suppressing the biosynthesis of lipid peroxidation substrates, arachidonic acid-phospholipids, via accelerated F-box only protein 10 (Fbxo10)-driven ubiquitination, degradation of long-chain-fatty-acid-CoA ligase 4 (Acsl4), and inhibition of lipid peroxidation. Mice injected with adeno-associated virus-Prok2 before controlled cortical impact injury show reduced neuronal degeneration and improved motor and cognitive functions, which could be inhibited by Fbxo10 knockdown. Our study shows that Prok2 mediates neuronal cell deaths in traumatic brain injury via ferroptosis. Prokineticin-2 (Prok2) is a secreted protein involved in many physiological processes. Here, the authors show that Prok2 prevents neuronal cell ferroptosis after traumatic brain injury and its administration before cortical injury reduces neuronal degeneration, and motor and cognitive impairments.	[Bao, Zhongyuan; Chen, Binglin; Miao, Zong; Tu, Yiming; Li, Chong; Chao, Honglu; Ye, Yangfan; Xu, Xiupeng; Sun, Guangchi; Zhao, Pengzhan; Liu, Ning; Ji, Jing] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Peoples R China; [Liu, Yinlong] Nanjing Med Univ, Suzhou Municipal Hosp, Affiliated Suzhou Hosp, Dept Neurosurg, Suzhou, Peoples R China; [Liu, Yan] Nanjing Med Univ, Sch Pharm, Inst Stem Cell & Neural Regenerat, Nanjing, Peoples R China; [Wang, Xiaoming] Nanjing Med Univ, Dept Immunol, Nanjing, Peoples R China; [Lam, Sin Man] LipidALL Technol Co Ltd, Changzhou, Peoples R China; [Kagan, Valerian E.; Bayir, Hulya] Univ Pittsburgh, Ctr Free Rad & Antioxidant Heath, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Kagan, Valerian E.] IM Sechenov Moscow State Med Univ, Lab Nav Redox Lipid, Moscow, Russia; [Bayir, Hulya] Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bayir, Hulya] UPMC Childrens Hosp Pittsburgh, Childrens Neurosci Inst, Pittsburgh, PA USA		Ji, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Peoples R China.	jijing@njmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81972153, 81471269, 81901955]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [JX10231803]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20191066]	This study was supported by grants from National Natural Science Foundation of China (Grant Nos. 81972153, 81471269 and 81901955), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, Grant No. JX10231803), and Natural Science Foundation of Jiangsu Province (Grant No. BK20191066).	Abdalkader M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00466; Alim I, 2019, CELL, V177, P1262, DOI 10.1016/j.cell.2019.03.032; Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Arrazola MS, 2019, J NEUROSCI, V39, P3832, DOI 10.1523/JNEUROSCI.0881-18.2019; Bao ZY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00222; Beharier O, 2020, P NATL ACAD SCI USA, V117, P27319, DOI 10.1073/pnas.2009201117; Bersuker K, 2019, NATURE, V575, P688, DOI 10.1038/s41586-019-1705-2; Chao HL, 2019, J NEUROSCI, V39, P1930, DOI 10.1523/JNEUROSCI.3415-17.2018; Chao HL, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97677; Chao HL, 2018, BBA-MOL BASIS DIS, V1864, P2957, DOI 10.1016/j.bbadis.2018.06.006; Chen SJ, 2017, NEURON, V95, P153, DOI 10.1016/j.neuron.2017.06.001; Cheng MY, 2012, P NATL ACAD SCI USA, V109, P5475, DOI 10.1073/pnas.1113363109; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Chu B, 2019, NAT CELL BIOL, V21, P579, DOI 10.1038/s41556-019-0305-6; Dar HH, 2018, J CLIN INVEST, V128, P4639, DOI [10.1172/JCI99490, 10.1172/jci99490]; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S, 2019, NATURE, V575, P693, DOI 10.1038/s41586-019-1707-0; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Evankovich J, 2017, FASEB J, V31, P3894, DOI 10.1096/fj.201700031R; Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042; Gordon R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12932; Guida F, 2015, PHARMACOL RES, V91, P36, DOI 10.1016/j.phrs.2014.11.004; Guiney SJ, 2017, NEUROCHEM INT, V104, P34, DOI 10.1016/j.neuint.2017.01.004; Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021; Hironaka K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13104; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/NCHEMBIO.2238, 10.1038/nchembio.2238]; Kajarabille N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194968; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kojima K, 2019, BRAIN, V142, P322, DOI 10.1093/brain/awy331; Li Y, 2016, ONCOGENE, V35, P6223, DOI 10.1038/onc.2016.155; Li Y, 2019, CELL DEATH DIFFER, V26, P2284, DOI 10.1038/s41418-019-0299-4; Liu T, 2019, CANCER RES, V79, P1913, DOI 10.1158/0008-5472.CAN-18-3037; Masaldan S, 2018, REDOX BIOL, V14, P100, DOI 10.1016/j.redox.2017.08.015; Meng QM, 2014, J MOL NEUROSCI, V53, P262, DOI 10.1007/s12031-013-0215-1; Meng S, 2018, CIRCULATION, V138, P913, DOI [10.1161/CIRCULATIONAHA.118.033939, 10.1161/CIRCULATIONAHA.118.036328]; Monnier J, 2010, CANCER LETT, V296, P144, DOI 10.1016/j.canlet.2010.06.011; Mundim MV, 2019, MOL CELL NEUROSCI, V94, P1, DOI 10.1016/j.mcn.2018.10.004; Nagakannan P, 2019, CELL MOL NEUROBIOL, V39, P73, DOI 10.1007/s10571-018-0634-1; Neal M, 2018, GLIA, V66, P2137, DOI 10.1002/glia.23467; Negri L, 2018, PHYSIOL REV, V98, P1055, DOI 10.1152/physrev.00012.2017; Neitemeier S, 2017, REDOX BIOL, V12, P558, DOI 10.1016/j.redox.2017.03.007; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sakakibara Y, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0496-6; Severini C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15301; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Takashi Y, 2020, FREE RADICAL BIO MED, V161, P60, DOI 10.1016/j.freeradbiomed.2020.09.027; Timmons S. D., 2019, J NEUROSURG, V131, P1; Vellani V, 2006, J NEUROSCI, V26, P5109, DOI 10.1523/JNEUROSCI.3870-05.2006; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Wu JR, 2018, J MOL NEUROSCI, V66, P197, DOI 10.1007/s12031-018-1155-6; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhang YL, 2018, NAT CELL BIOL, V20, P1181, DOI 10.1038/s41556-018-0178-0; Zhou QY, 2006, MOL INTERV, V6, P330, DOI 10.1124/mi.6.6.6; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609	63	1	1	15	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2041-1723		NAT COMMUN	Nat. Commun.	JUL 9	2021	12	1							4220	10.1038/s41467-021-24469-y			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TK9PO	WOS:000674487100019	34244497	Green Published, gold			2022-02-06	
J	Azizi, S; Hier, DB; Allen, B; Obafemi-Ajayi, T; Olbricht, GR; Thimgan, MS; Wunsch, DC				Azizi, Sima; Hier, Daniel B.; Allen, Blaine; Obafemi-Ajayi, Tayo; Olbricht, Gayla R.; Thimgan, Matthew S.; Wunsch, Donald C., II			A Kinetic Model for Blood Biomarker Levels After Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						concussion; uncertainty analysis; mathematical modeling; sensitivity analysis; blood biomarkers; kinetics; mild traumatic brain injury	FIBRILLARY ACIDIC PROTEIN; TERMINAL HYDROLASE-L1; CEREBROSPINAL-FLUID; LYMPHATIC DRAINAGE; S100B PROTEIN; SERUM; TAU; PATHWAYS; UTILITY; ELIMINATION	Traumatic brain injury (TBI) imposes a significant economic and social burden. The diagnosis and prognosis of mild TBI, also called concussion, is challenging. Concussions are common among contact sport athletes. After a blow to the head, it is often difficult to determine who has had a concussion, who should be withheld from play, if a concussed athlete is ready to return to the field, and which concussed athlete will develop a post-concussion syndrome. Biomarkers can be detected in the cerebrospinal fluid and blood after traumatic brain injury and their levels may have prognostic value. Despite significant investigation, questions remain as to the trajectories of blood biomarker levels over time after mild TBI. Modeling the kinetic behavior of these biomarkers could be informative. We propose a one-compartment kinetic model for S100B, UCH-L1, NF-L, GFAP, and tau biomarker levels after mild TBI based on accepted pharmacokinetic models for oral drug absorption. We approximated model parameters using previously published studies. Since parameter estimates were approximate, we did uncertainty and sensitivity analyses. Using estimated kinetic parameters for each biomarker, we applied the model to an available post-concussion biomarker dataset of UCH-L1, GFAP, tau, and NF-L biomarkers levels. We have demonstrated the feasibility of modeling blood biomarker levels after mild TBI with a one compartment kinetic model. More work is needed to better establish model parameters and to understand the implications of the model for diagnostic use of these blood biomarkers for mild TBI.	[Azizi, Sima; Hier, Daniel B.; Allen, Blaine; Wunsch, Donald C., II] Missouri Univ Sci & Technol, Appl Computat Intelligence Lab, Dept Elect & Comp Engn, Rolla, MO 65409 USA; [Obafemi-Ajayi, Tayo] Missouri State Univ, Engn Program, Springfield, MO USA; [Olbricht, Gayla R.] Missouri Univ Sci & Technol, Dept Math & Stat, Rolla, MO USA; [Thimgan, Matthew S.] Missouri Univ Sci & Technol, Dept Biol Sci, Rolla, MO USA; [Wunsch, Donald C., II] Natl Sci Fdn, ECCS Div, Alexandria, VA USA		Azizi, S (corresponding author), Missouri Univ Sci & Technol, Appl Computat Intelligence Lab, Dept Elect & Comp Engn, Rolla, MO 65409 USA.	sacc5@mst.edu	Hier, Daniel/L-6409-2019	Hier, Daniel/0000-0002-6179-0793	Mary K. Finley Missouri Endowment; Missouri S&T Intelligent Systems Center; National Science FoundationNational Science Foundation (NSF); Leonard Wood Institute; U.S. Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-14-2-0034]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R15 GM117507-01A1]	Research was partially sponsored by the Mary K. Finley Missouri Endowment, the Missouri S&T Intelligent Systems Center, the National Science Foundation and the Leonard Wood Institute in cooperation with the U.S. Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-14-2-0034. Additional support came from NIH Award R15 GM117507-01A1. The views, opinions, findings, recommendations, or conclusions contained in this document are those of the authors and should not be interpreted as representing the views or official policies, either expressed or implied, of the Leonard Wood Institute, the Army Research Laboratory, the National Science Foundation or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation heron.	Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Albargothy NJ, 2018, ACTA NEUROPATHOL, V136, P139, DOI 10.1007/s00401-018-1862-7; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bacyinski A, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00101; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Boulton M, 1997, AM J PHYSIOL-REG I, V272, pR1613, DOI 10.1152/ajpregu.1997.272.5.R1613; BOX GEP, 1976, J AM STAT ASSOC, V71, P791, DOI 10.2307/2286841; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Centers for Disease Control and Prevention and others, 2003, REP C MILD TRAUM BRA REP C MILD TRAUM BRA; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Dadas Aaron, 2018, Concussion, V3, pCNC53, DOI 10.2217/cnc-2017-0019; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Elbarbry F., 2017, ABCS PHARMACOKINETIC; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; FELDSCHUH J, 1977, CIRCULATION, V56, P605, DOI 10.1161/01.CIR.56.4.605; Filley CM, 2020, NEUROLOGY, V95, P235, DOI 10.1212/WNL.0000000000009992; FITBIR, 2019, FED INT TRAUM BRAIN FED INT TRAUM BRAIN; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Hannocks MJ, 2018, J CEREBR BLOOD F MET, V38, P669, DOI 10.1177/0271678X17749689; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Huibregtse ME, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239507; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jones CMC, 2020, BRAIN INJURY, V34, P407, DOI 10.1080/02699052.2020.1725123; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; KNOPF PM, 1995, NEUROPATH APPL NEURO, V21, P175, DOI 10.1111/j.1365-2990.1995.tb01047.x; Layon AJ., 2017, CIVETTA TAYLOR KIRBY; Lei YM, 2017, PROG NEUROBIOL, V157, P230, DOI 10.1016/j.pneurobio.2015.12.007; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Li Y, 2015, J NEUROL SCI, V359, P280, DOI 10.1016/j.jns.2015.08.035; Lindblad C, 2020, J NEUROTRAUM, V37, P1381, DOI 10.1089/neu.2019.6741; Maas AIR, 2018, LANCET NEUROL, V17, P737, DOI 10.1016/S1474-4422(18)30275-8; Manivannan S, 2018, CLIN NEUROL NEUROSUR, V171, P6, DOI 10.1016/j.clineuro.2018.05.017; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Morris AWJ, 2016, ACTA NEUROPATHOL, V131, P725, DOI 10.1007/s00401-016-1555-z; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Nimmo J, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12070; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; Oliver JM, 2017, J NEUROTRAUM, V34, P3295, DOI 10.1089/neu.2017.5064; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2017, J NEUROTRAUM, V34, P2187, DOI 10.1089/neu.2017.5030; Partial Correlation, 2008, CONCISE ENCY STAT, DOI [10.1007/978-0-387-32833-1, DOI 10.1007/978-0-387-32833-1]; Pattinson CL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13191; Pattinson CL, 2020, J HEAD TRAUMA REHAB, V35, P66, DOI 10.1097/HTR.0000000000000485; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Rosenbaum SE., 2016, BASIC PHARMACOKINETI; Saltelli A, 2007, GLOBAL SENSITIVITY A, DOI [10.1002/9780470725184, DOI 10.1002/9780470725184]; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; WELLER RO, 1992, BRAIN PATHOL, V2, P277, DOI 10.1111/j.1750-3639.1992.tb00704.x; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	73	1	1	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 6	2021	12								668606	10.3389/fneur.2021.668606			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TK9IW	WOS:000674469200001	34295300	gold, Green Published			2022-02-06	
J	McCrea, MA; Giacino, JT; Barber, J; Temkin, NR; Nelson, LD; Levin, HS; Dikmen, S; Stein, M; Bodien, YG; Boase, K; Taylor, SR; Vassar, M; Mukherjee, P; Robertson, C; Diaz-Arrastia, R; Okonkwo, DO; Markowitz, AJ; Manley, GT				McCrea, Michael A.; Giacino, Joseph T.; Barber, Jason; Temkin, Nancy R.; Nelson, Lindsay D.; Levin, Harvey S.; Dikmen, Sureyya; Stein, Murray; Bodien, Yelena G.; Boase, Kim; Taylor, Sabrina R.; Vassar, Mary; Mukherjee, Pratik; Robertson, Claudia; Diaz-Arrastia, Ramon; Okonkwo, David O.; Markowitz, Amy J.; Manley, Geoffrey T.		TRACK-TBI Investigators	Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI Study	JAMA NEUROLOGY			English	Article							MIDDLE-CEREBRAL-ARTERY; COMMON DATA ELEMENTS; SEVERE HEAD-INJURY; DISABILITY; CONSCIOUSNESS; RECOMMENDATIONS; REHABILITATION; WITHDRAWAL; DISORDERS; MORTALITY	IMPORTANCE Moderate to severe traumatic brain injury (msTBI) is a major cause of death and disability in the US and worldwide. Few studies have enabled prospective, longitudinal outcome data collection from the acute to chronic phases of recovery after msTBI. OBJECTIVE To prospectively assess outcomes in major areas of life function at 2 weeks and 3, 6, and 12 months after msTBI. DESIGN, SETTING, AND PARTICIPANTS This cohort study, as part of the Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study, was conducted at 18 level 1 trauma centers in the US from February 2014 to August 2018 and prospectively assessed longitudinal outcomes, with follow-up to 12 months postinjury. Participants were patients with msTBI (Glasgow Coma Scale scores 3-12) extracted from a larger group of patients with mild, moderate, or severe TBI who were enrolled in TRACK-TBI. Data analysis took place from October 2019 to April 2021. EXPOSURES Moderate or severe TBI. MAIN OUTCOMES AND MEASURES The Glasgow Outcome Scale-Extended (GOSE) and Disability Rating Scale (DRS) were used to assess global functional status 2 weeks and 3, 6, and 12 months postinjury. Scores on the GOSE were dichotomized to determine favorable (scores 4-8) vs unfavorable (scores 1-3) outcomes. Neurocognitive testing and patient reported outcomes at 12 months postinjury were analyzed. RESULTS A total of 484 eligible patients were included from the 2679 individuals in the TRACK-TBI study. Participants with severe TBI (n = 362; 283 men [78.2%]; median [interquartile range] age, 35.5 [25-53] years) and moderate TBI (n = 122; 98 men [80.3%); median [interquartile range] age, 38 [25-53] years) were comparable on demographic and premorbid variables. At 2 weeks postinjury, 36 of 290 participants with severe TBI (12.4%) and 38 of 93 participants with moderate TBI (41%) had favorable outcomes (GOSE scores 4-8); 301of 322 in the severe TBI group (93.5%) and 81of 103 in the moderate TBI group (78.6%) had moderate disability or worse on the DRS (total score >= 4). By 12 months postinjury, 142 of 271with severe TBI (52.4%) and 54 of 72 with moderate TBI (75%) achieved favorable outcomes. Nearly 1 in 5 participants with severe TBI (52 of 270 [19.3%]) and 1 in 3 with moderate TBI (23 of 71 [32%]) reported no disability (DRS score 0) at 12 months. Among participants in a vegetative state at 2 weeks, 62 of 79 (78%) regained consciousness and 14 of 56 with available data (25%) regained orientation by 12 months. CONCLUSIONS AND RELEVANCE In this study, patients with msTBI frequently demonstrated major functional gains, including recovery of independence, between 2 weeks and 12 months postinjury. Severe impairment in the short term did not portend poor outcomes in a substantial minority of patients with msTBI. When discussing prognosis during the first 2 weeks after injury, clinicians should be particularly cautious about making early, definitive prognostic statements suggesting poor outcomes and withdrawal of life-sustaining treatment in patients with msTBI.	[McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA; [Giacino, Joseph T.; Bodien, Yelena G.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Giacino, Joseph T.; Bodien, Yelena G.] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Giacino, Joseph T.; Bodien, Yelena G.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Barber, Jason; Temkin, Nancy R.; Dikmen, Sureyya; Boase, Kim] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Levin, Harvey S.; Robertson, Claudia] Baylor Coll Med, Phys Med & Rehabil, Houston, TX USA; [Stein, Murray] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA USA; [Taylor, Sabrina R.; Vassar, Mary; Mukherjee, Pratik; Markowitz, Amy J.; Manley, Geoffrey T.] Univ Calif San Francisco, Neurol Surg, San Francisco, CA 94110 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Okonkwo, David O.] Univ Pittsburgh, Neurol Surg, Med Ctr, Pittsburgh, PA USA		McCrea, MA (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.; Markowitz, AJ (corresponding author), Univ Calif San Francisco, UCSF Brain & Spinal Injury Ctr, 1001 Potrero Ave, San Francisco, CA 94110 USA.	mmccrea@mcw.edu; amymarkowitz@gmail.com	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Hemphill, Claude/0000-0003-4019-7525; Badjatia, Neeraj/0000-0003-1509-9034	US National Institutes of Health, National Institute of Neurologic Disorders and Stroke [U01 NS1365885]; US Department of DefenseUnited States Department of Defense [W81XWH-14-2-0176]; One Mind (Staglin Family and General Peter Chiarelli)	The study was funded by the US National Institutes of Health, National Institute of Neurologic Disorders and Stroke (grant U01 NS1365885 [Dr Manley]) and supported by the US Department of Defense (grant W81XWH-14-2-0176 [Dr Manley]). Patient travel and stipend expenses were supported by One Mind (Staglin Family and General Peter Chiarelli).	Altman D.G., 1990, PRACTICAL STAT MED R; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention US Department of Health and Human Services Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Giacino JT, 2020, J NEUROTRAUM, V37, P357, DOI 10.1089/neu.2019.6429; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Griffin BA, 2014, TOOLKIT WEIGHTING AN; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kowalski RG, 2021, JAMA NEUROL, V78, P548, DOI 10.1001/jamaneurol.2021.0084; Kumar RG, 2020, J HEAD TRAUMA REHAB, V35, pE372, DOI 10.1097/HTR.0000000000000572; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P1603, DOI 10.1016/j.apmr.2012.04.003; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; O'Neil-Pirozzi TM, 2018, J HEAD TRAUMA REHAB, V33, P237, DOI 10.1097/HTR.0000000000000365; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Plaisier BR, 2002, AM SURGEON, V68, P159; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Schmidt M., 1996, REY AUDITORY VERBAL; Sigurdardottir S, 2020, J INT NEUROPSYCH SOC, V26, P654, DOI 10.1017/S1355617720000193; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vedantam A, 2018, J NEUROSURG, V129, P234, DOI 10.3171/2017.3.JNS162720; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilkins TE, 2019, J NEUROTRAUM, V36, P3158, DOI 10.1089/neu.2018.6153; Williamson T, 2020, JAMA SURG, V155, P723, DOI 10.1001/jamasurg.2020.1790; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yudofsky S., 2011, TXB TRAUMATIC BRAIN, DOI [10.1176/appi.books.9781585624201.js01, DOI 10.1176/APPI.BOOKS.9781585624201.JS01]; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	49	1	1	5	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	AUG	2021	78	8					982	992		10.1001/jamaneurol.2021.2043		JUL 2021	11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	TZ7HW	WOS:000671384900001	34228047				2022-02-06	
J	Wu, LM; Chan, ST; Edmiston, WJ; Jin, G; Levy, ES; Kwong, KK; Mannix, R; Meehan, WP; Chifamba, FF; Lipton, JO; Whalen, MJ; Chen, YCI				Wu, Limin; Chan, Suk-Tak; Edmiston, William J.; Jin, Gina; Levy, Emily S.; Kwong, Kenneth K.; Mannix, Rebekah; Meehan, William P.; Chifamba, Fortunate F.; Lipton, Jonathan O.; Whalen, Michael J.; Chen, Yin-Ching, I			Persistent CO2 reactivity deficits are associated with neurological dysfunction up to one year after repetitive mild closed head injury in adolescent mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Adolescent; cerebrovascular reactivity; fMRI; mild traumatic brain injury; neurological dysfunction	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; SENSING ION CHANNELS; CEREBRAL-BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; NERVOUS-SYSTEM; WORKING-MEMORY; IMPAIRMENT; STROKE	Cerebrovascular reactivity (CVR) deficits in adolescents with concussion may persist after resolution of neurological symptoms. Whether or not CVR deficits predict long term neurological function is unknown. We used adolescent mice closed head injury (CHI) models (54 g, 107 cm or 117 cm drop height), followed by blood oxygenation level dependent (BOLD)-functional MRI with CO2 challenge to assess CVR and brain connectivity. At one week, 3HD 107 cm mice showed delayed BOLD responses (p = 0.0074), normal striatal connectivity(,) and an impaired respiratory rate response to CO2 challenge (p = 0.0061 in Delta Rmax). The 107 cm group developed rotarod deficits at 6 months (p = 0.02) and altered post-CO2 brain connectivity (3-fold increase in striatum to motor cortex correlation coefficient) by one year, but resolved their CVR and respiratory rate impairments, and did not develop cognitive or circadian activity deficits. In contrast, the 117 cm group had persistent CVR (delay time: p = 0.016; washout time: p = 0.039) and circadian activity deficits (free-running period: 23.7 hr in sham vs 23.9 hr in 3HD; amplitude: 0.15 in sham vs 0.2 in 3HD; peak activity: 18 in sham vs 21 in 3HD) at one year. Persistent CVR deficits after concussion may portend long-term neurological dysfunction. Further studies are warranted to determine the utility of CVR to predict chronic neurological outcome after mild traumatic brain injury.	[Wu, Limin; Edmiston, William J.; Jin, Gina; Levy, Emily S.; Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02115 USA; [Chan, Suk-Tak; Kwong, Kenneth K.; Chen, Yin-Ching, I] Massachusetts Gen Hosp, A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA USA; [Chan, Suk-Tak; Kwong, Kenneth K.; Chen, Yin-Ching, I] Harvard Med Sch, Charlestown, MA USA; [Mannix, Rebekah; Meehan, William P.] Boston Childrens Hosp, Kirby Neurobiol Ctr, Dept Emergency Med, Boston, MA USA; [Chifamba, Fortunate F.; Lipton, Jonathan O.] Boston Childrens Hosp, Kirby Neurobiol Ctr, Dept Neurol, Boston, MA USA; [Meehan, William P.] Dept Orthoped, Div Sports Med, Boston, MA USA; [Lipton, Jonathan O.] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA		Chen, YCI (corresponding author), 149 13th St, Charlestown, MA 02129 USA.	ychen16@mgh.harvard.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096550]; National Football Players Association	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by NIH/NINDS R01NS096550 (MJW) and the National Football Players Association grant to Harvard College (MJW, WPM, RM).	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Amyot F, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102086; Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Barshikar S, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0792-4; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; Chan ST, 2015, BRAIN INJURY, V29, P403, DOI 10.3109/02699052.2014.974209; Chen YI, 2012, SYNAPSE, V66, P331, DOI 10.1002/syn.21516; Chen YI, 2010, DEV NEUROSCI-BASEL, V32, P125, DOI 10.1159/000286215; Chen YCI, 2001, J MAGN RESON IMAGING, V14, P517, DOI 10.1002/jmri.1215; Chen YI, 1999, NEUROREPORT, V10, P2881, DOI 10.1097/00001756-199909290-00001; Cheng H, 2021, INT J MED SCI, V18, P304, DOI 10.7150/ijms.49066; Chernomordikl V, 2016, BRAIN RES, V1639, P194, DOI 10.1016/j.brainres.2016.02.018; Churchill NW, 2019, J NEUROTRAUM, V36, P1518, DOI 10.1089/neu.2018.6024; Ding K, 2020, BRAIN RES, V1743, DOI 10.1016/j.brainres.2020.146924; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Dodd AB, 2020, J CEREBR BLOOD F MET, V40, P2491, DOI 10.1177/0271678X19896883; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Esposito E, 2020, NATURE, V582, P395, DOI 10.1038/s41586-020-2348-z; Faraci FM, 2019, CIRC RES, V125, P907, DOI 10.1161/CIRCRESAHA.119.315024; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Guyton, 1966, TXB MED PHYSL, pXXXIII; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hanlon FM., 2014, FUNCTIONAL MAGNETIC, DOI [10.1016/j.neubiorev.2014.11.016, DOI 10.1016/J.NEUBIOREV.2014.11.016]; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; KONTOS HA, 1977, STROKE, V8, P226, DOI 10.1161/01.STR.8.2.226; Kriz PK, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117737307; La Fountaine MF, 2018, INT J PSYCHOPHYSIOL, V132, P155, DOI 10.1016/j.ijpsycho.2017.11.016; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lavender AP, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00491; Li DP, 2016, CELL MOL NEUROBIOL, V36, P1045, DOI 10.1007/s10571-015-0295-2; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Mamet J, 2002, J NEUROSCI, V22, P10662; Mandeville JB, 2014, NEUROPHARMACOLOGY, V84, P65, DOI 10.1016/j.neuropharm.2014.02.018; Mannix R, 2020, J NEUROTRAUM, V37, P2029, DOI 10.1089/neu.2019.6956; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Marshall O, 2014, JAMA NEUROL, V71, P1275, DOI 10.1001/jamaneurol.2014.1668; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mazwi Nicole L, 2015, Handb Clin Neurol, V128, P553, DOI 10.1016/B978-0-444-63521-1.00035-2; Merzagora ACR, 2014, BRAIN IMAGING BEHAV, V8, P446, DOI 10.1007/s11682-013-9258-8; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Modell H, 2015, ADV PHYSIOL EDUC, V39, P259, DOI 10.1152/advan.00107.2015; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Obara M, 2008, NEUROCHEM INT, V52, P905, DOI 10.1016/j.neuint.2007.10.015; Poublanc J, 2013, CEREBROVASC DIS EXTR, V3, P55, DOI 10.1159/000348841; Ren JQ, 2009, SYNAPSE, V63, P764, DOI 10.1002/syn.20659; Richiardi J, 2015, NEUROBIOL AGING, V36, P33, DOI 10.1016/j.neurobiolaging.2014.07.020; RINGELSTEIN EB, 1988, STROKE, V19, P963, DOI 10.1161/01.STR.19.8.963; Siedlecki P, 2018, BRAIN INJURY, V32, P1824, DOI 10.1080/02699052.2018.1506945; Strohm J, 2014, RESP PHYSIOL NEUROBI, V197, P15, DOI 10.1016/j.resp.2014.03.003; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang YC, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0465-7; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wu LM, 2019, J CEREBR BLOOD F MET, V39, P2196, DOI 10.1177/0271678X18786633; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	68	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2021	41	12					3260	3272	0271678X211021771	10.1177/0271678X211021771		JUL 2021	13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	XL6CS	WOS:000680989200001	34229511				2022-02-06	
J	Chang, MC; Kwak, S				Chang, Min Cheol; Kwak, Soyoung			Videofluoroscopic Swallowing Study Findings Associated With Subsequent Pneumonia in Patients With Dysphagia Due to Frailty	FRONTIERS IN MEDICINE			English	Article						dysphagia; aspiration pneumonia; frailty; video fluoroscopic swallowing study; penetration-aspiration scale; functional dysphagia scale	ASPIRATION PNEUMONIA; PENETRATION; TOOL; STROKE; SCALE	Dysphagia in frailty or deconditioning without specific diagnosis that may cause dysphagia such as stroke, traumatic brain injury, or laryngeal pathology, has been reported in previous studies; however, little is known about which findings of the videofluoroscopic swallowing study (VFSS) are associated with subsequent pneumonia and how many patients actually develop subsequent pneumonia in this population. In this study, we followed 190 patients with dysphagia due to frailty or deconditioning without specific diagnosis that may cause dysphagia for 3 months after VFSS and analyzed VFSS findings for the risk of developing pneumonia. During the study period, the incidence of subsequent pneumonia was 24.74%; regarding the VFSS findings, (1) airway penetration (PAS 3) and aspiration (PAS 7 and 8) were associated with increased risk of developing pneumonia, and (2) the functional dysphagia scale (FDS) scores of the patients who developed subsequent pneumonia were higher than those of the patients who did not develop subsequent pneumonia. Our study findings might assist clinicians in making clinical decisions based on the VFSS findings in this population.	[Chang, Min Cheol; Kwak, Soyoung] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daegu, South Korea		Kwak, S (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daegu, South Korea.	sk315@ynu.ac.kr			National Research Foundation of Korea - Korean governmentNational Research Foundation of KoreaKorean Government [NRF-2019M3E5D1A02068106]; Gyeongsan Medichallenger program	This research was funded by Gyeongsan Medichallenger program. The present study was supported by a National Research Foundation of Korea grant funded by the Korean government (Grant no. NRF-2019M3E5D1A02068106).	Bahat G, 2019, J NUTR HEALTH AGING, V23, P571, DOI 10.1007/s12603-019-1191-0; Bock JM, 2017, LARYNGOSCOPE, V127, pS1, DOI 10.1002/lary.26854; Byun SE, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1382-x; Chen XJ, 2014, CLIN INTERV AGING, V9, P433, DOI 10.2147/CIA.S45300; Chun MH, 2017, INT J NEUROSCI, V127, P965, DOI 10.1080/00207454.2017.1282479; Daggett A, 2006, DYSPHAGIA, V21, P270, DOI 10.1007/s00455-006-9051-6; Farri A, 2007, Acta Otorhinolaryngol Ital, V27, P83; Hart TR, 2001, ARCH PHYS MED REHAB, V82, P677, DOI 10.1053/apmr.2001.21939; Kelly AM, 2007, LARYNGOSCOPE, V117, P1723, DOI 10.1097/MLG.0b013e318123ee6a; Kim DH, 2012, ANN REHABIL MED-ARM, V36, P791, DOI 10.5535/arm.2012.36.6.791; Kim L, 2011, ANN REHABIL MED-ARM, V35, P765, DOI 10.5535/arm.2011.35.6.765; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017; Lee JH, 2016, ANN REHABIL MED-ARM, V40, P440, DOI 10.5535/arm.2016.40.3.440; Mandell LA, 2019, NEW ENGL J MED, V380, P651, DOI 10.1056/NEJMra1714562; Martin-Harris B, 2008, DYSPHAGIA, V23, P392, DOI 10.1007/s00455-008-9185-9; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Molfenter SM, 2013, DYSPHAGIA, V28, P494, DOI 10.1007/s00455-013-9459-8; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; Payne M, 2018, J NUTR HEALTH AGING, V22, P562, DOI 10.1007/s12603-018-1033-5; Pikus L, 2003, AM J ROENTGENOL, V180, P1613, DOI 10.2214/ajr.180.6.1801613; Rodriguez AE, 2019, EXPERT REV CLIN PHAR, V12, P991, DOI 10.1080/17512433.2019.1663730; Rofes L, 2010, NEUROGASTROENT MOTIL, V22, P851, DOI 10.1111/j.1365-2982.2010.01521.x; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Ryu JS, 2009, ORAL ONCOL, V45, P665, DOI 10.1016/j.oraloncology.2008.10.005; Schmidt John, 1994, Dysphagia, V9, P7; Seo ZW, 2021, LUNG, V199, P55, DOI 10.1007/s00408-020-00413-7; Steele CM, 2017, DYSPHAGIA, V32, P601, DOI 10.1007/s00455-017-9809-z; Sura L, 2012, CLIN INTERV AGING, V7, P287, DOI 10.2147/CIA.S23404; Tomita S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197608; Wang TT, 2020, Int J Nurs Sci, V7, P318, DOI 10.1016/j.ijnss.2020.09.005; ZWEIG MH, 1993, CLIN CHEM, V39, P561	32	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	JUL 5	2021	8								690968	10.3389/fmed.2021.690968			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TK6IF	WOS:000674259100001	34291064	gold, Green Published			2022-02-06	
J	Stockbower, KA; Howell, DR; Seehusen, CN; Armento, AM; Walker, GA				Stockbower, Kathryn A.; Howell, David R.; Seehusen, Corrine N.; Armento, Aubrey M.; Walker, Gregory A.			Sport specialization, sleep, fatigue, and psychosocial ratings: do highly specialized athletes differ from their less specialized peers?	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						Early sport specialization; burnout; mental health; sleep; PROMIS (R)	QUALITY-OF-LIFE; INJURY; ASSOCIATION; ADOLESCENTS; DEPRESSION; CONCUSSION; RESPONSES; RISK	Objectives: To determine if sleep quality, fatigue, anxiety, depressive symptoms, or perceptions of sport participation differ between high-, moderate-, and low-specialized high school athletes with or without prior injuries. Methods: During pre-participation physical examinations (PPE), high school athletes completed questionnaires on sport specialization level, history of time-loss orthopedic injury, perceptions of sport participation, as well as sleep quality (Pittsburgh Sleep Quality Index (PSQI)), fatigue, anxiety, and depressive symptoms (Patient-Reported Outcomes Measurement Information System (PROMIS (R))). Athletes were grouped according to sport specialization level and history of prior time-loss orthopedic injury. Results: A total of 186 athletes completed the study: 49% (n = 92; mean age = 15.3 +/- 2.0 yrs; 50% female) were low specialized, 34% (n = 64; mean age = 15.3 +/- 1.3 yrs; 47% female) were moderately specialized, and 16% (n = 30; mean age = 15.7 +/- 1.1 yrs; 57% female) were highly specialized. Groups were similar for demographics, training volume, and injury history. Compared to the moderate-specialization group, highly specialized athletes reported higher levels of fatigue (3.1 +/- 3.7 vs. 1.5 +/- 2.2; p = 0.02), anxiety (3.6 +/- 4.1 vs. 1.8 +/- 2.6; p = 0.02), and depressive symptoms (2.4 +/- 4.0 vs. 0.8 +/- 2.0; p = 0.02). No differences in psychometric ratings, sleep quality, or perceptions of sport participation were observed between the low/moderate- or low/high-specialization groups. We did not observe any significant differences between groups who did and did not report a history of prior timeloss orthopedic injury. Conclusions: Highly specialized high school athletes report higher levels of fatigue, more anxiety symptoms, and more depressive symptoms than their moderately specialized peers, despite no differences in training volume or injury history. Low specialized athletes did not differ from moderately specialized or highly specialized athletes in the aforementioned domains, and there were no differences in sleep quality across specialization groups. These findings add to the current body of literature on early sport specialization by illustrating the distinctive psychosocial implications of sport specialization and demonstrating the need for further prospective research.	[Stockbower, Kathryn A.; Howell, David R.; Seehusen, Corrine N.; Armento, Aubrey M.; Walker, Gregory A.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Stockbower, Kathryn A.; Howell, David R.; Armento, Aubrey M.; Walker, Gregory A.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA		Stockbower, KA (corresponding author), Metropolitan Pediat, 9300 SE 91st Ave,Suite 200, Happy Valley, OR 97086 USA.	kstockbower@metropediatrics.com					[Anonymous], 2018 19 HIGH SCH ATH, P5; Bell DR, 2016, AM J SPORT MED, V44, P1469, DOI 10.1177/0363546516629943; Bell DR., 2018, PEDIATRICS, V142, P3; Brenner JS, 2019, J ATHL TRAINING, V54, P1021, DOI 10.4085/1062-6050-394-18; Brenner JS, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2148; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Dahab K, 2019, J ATHL TRAINING, V54, P1061, DOI 10.4085/1062-6050-361-18; Dampier C, 2016, PEDIATR BLOOD CANCER, V63, P1031, DOI 10.1002/pbc.25944; DiFiori JP, 2014, CLIN J SPORT MED, V24, P3, DOI 10.1097/JSM.0000000000000060; Frome D, 2019, CLIN J SPORT MED, V29, P368, DOI 10.1097/JSM.0000000000000643; Gagliardi Alexia G, 2020, J Clin Transl Res, V6, P54; Hall R, 2015, J SPORT REHABIL, V24, P31, DOI 10.1123/jsr.2013-0101; Healthy people 2020, SLEEP HEALTH; Hill G. M., 1989, Journal of Sport and Social Issues, V13, P1, DOI 10.1177/019372358901300101; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Jayanthi N, 2013, SPORTS HEALTH, V5, P251, DOI 10.1177/1941738112464626; Jayanthi NA, 2019, J ATHL TRAINING, V54, P1040, DOI 10.4085/1062-6050-380-18; Jayanthi NA, 2015, AM J SPORT MED, V43, P794, DOI 10.1177/0363546514567298; LaPrade RF, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116644241; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McGuine TA, 2017, AM J SPORT MED, V45, P2706, DOI 10.1177/0363546517710213; McLeod TCV, 2009, J ATHL TRAINING, V44, P603, DOI 10.4085/1062-6050-44.6.603; Meelissa J., 2016, AAP ENDORSES NEW REC; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; National Institute of Mental Health, MAJ DEPR; National Institute of Mental Health, ANY ANXIETY DISORDER; Owens J, 2014, PEDIATRICS, V134, pE921, DOI 10.1542/peds.2014-1696; Padaki AS, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118787159; Post EG, 2017, SPORTS HEALTH, V9, P518, DOI 10.1177/1941738117714160; Regestein Q, 2010, PSYCHIAT RES, V176, P34, DOI 10.1016/j.psychres.2008.11.006; Roberts RE, 2014, SLEEP, V37, P239, DOI 10.5665/sleep.3388; SMITH RE, 1986, J SPORT EXERCISE PSY, V8, P36, DOI 10.1123/jsp.8.1.36; StataCorp LLC, 2017, VERS 15; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; The Aspen Institute, STATE PLAY TRENDS DE, P3; Varni JW, 2014, QUAL LIFE RES, V23, P1233, DOI 10.1007/s11136-013-0544-0; Walker N, 2007, J R SOC PROMO HEALTH, V127, P174, DOI 10.1177/1466424007079494; Watson A, 2018, SPORTS HEALTH, V10, P244, DOI 10.1177/1941738118757422; Wilhelm Andrew, 2017, Orthop J Sports Med, V5, p2325967117728922, DOI 10.1177/2325967117728922	40	1	1	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2021.1947736		JUL 2021	6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	TE0SI	WOS:000669727500001	34171984				2022-02-06	
J	Vessey, JY; Shivapathasundram, G; Francis, N; Sheridan, M				Vessey, Johan Yusof; Shivapathasundram, Ganeshwaran; Francis, Nevenka; Sheridan, Mark			Is neurotrauma training in rural New South Wales still required following the implementation of the New South Wales State Trauma Plan?	ANZ JOURNAL OF SURGERY			English	Article						Gigli saw; Hudson brace; neurotrauma; regional; rural	ACUTE SUBDURAL-HEMATOMA; DECOMPRESSIVE CRANIECTOMY; EMERGENCY NEUROSURGERY; MAJOR TRAUMA; MORTALITY; METROPOLITAN; SURGEONS	BackgroundResults In New South Wales (NSW), Australia, trauma accounts for 6% of deaths. Trauma patients receiving definitive care in regional trauma centres are 34% more likely to have a fatal outcome compared to level 1 centres. Following the implementation of the NSW State Trauma Plan where patients with major trauma are fast tracked to regional trauma services, should NSW rural surgeons and retrieval doctors continue to receive surgical training in neurotrauma? Methods The study's primary objective was to ascertain which NSW regional and rural hospitals have the equipment to perform neurotrauma and when it was last used. The study also examined the outcome of those patients who had undergone an emergency neurosurgical procedure. Of the 149 regional and rural hospitals in NSW, 16 stored a Hudson brace, perforator, burr and Gigli saw sterile and ready to use in the operating theatre. Only one hospital utilised the equipment in the last year and 11 in the last 10 years. Of those patients who had undergone an emergency neurosurgical procedure, two patients died prior to transfer and three were confirmed deceased after transfer to a tertiary centre. Conclusion The implementation of the NSW State Trauma Plan has streamlined the trauma triage process and transport of neurotrauma patients to regional and major trauma services. However, it is likely that knowledge of how to perform burr hole and craniectomy for the evacuation of extradural haematoma remains a useful skill for the rural surgeon and retrieval doctor if transport is delayed.	[Vessey, Johan Yusof; Shivapathasundram, Ganeshwaran; Francis, Nevenka; Sheridan, Mark] Liverpool Hosp, Neurosurg Dept, Sydney, NSW, Australia; [Francis, Nevenka; Sheridan, Mark] Univ New South Wales, Fac Med, Sydney, NSW, Australia		Sheridan, M (corresponding author), Liverpool Hosp, Neurosurg Dept, Elizabeth St, Liverpool, NSW 2170, Australia.	marksheridan@bigpond.com		Yusof Vessey, Johan/0000-0002-1808-739X			Australian Bureau of Statistics, 2020, UND CAUS DEATH NEW S; Bishop CV, 2006, ANZ J SURG, V76, P53, DOI 10.1111/j.1445-2197.2006.03642.x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dinh MM, 2016, MED J AUSTRALIA, V205, P403, DOI 10.5694/mja16.00406; Fatovich DM, 2011, RESUSCITATION, V82, P886, DOI 10.1016/j.resuscitation.2011.02.040; Gilligan J, 2017, ANZ J SURG, V87, P80, DOI 10.1111/ans.13583; Gregson BA, 2015, HEALTH TECHNOL ASSES, V19, DOI 10.3310/hta19700; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Luck T, 2015, ANZ J SURG, V85, P610, DOI 10.1111/ans.13138; McMonagle MP, 2007, ANZ J SURG, V77, P241, DOI 10.1111/j.1445-2197.2007.04026.x; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Neurosurgical Society of Australasia, 2009, MAN AC NEUR RUR REM; NSW Institute of Trauma and Injury Management, NTR; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Treacy PJ, 2005, ANZ J SURG, V75, P852, DOI 10.1111/j.1445-2197.2005.03549.x; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	16	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	SEP	2021	91	9					1881	1885		10.1111/ans.16978		JUL 2021	5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UO4LG	WOS:000669747900001	34227205				2022-02-06	
J	Algattas, HN; McCarthy, D; Kujawski, B; Agarwal, N; Brown, J; Forsythe, RM; Leonardo, J; Walsh, K; Gross, BA; Friedlander, RM; Okonkwo, DO; Whiting, D; Miele, VJ				Algattas, Hanna N.; McCarthy, David; Kujawski, Brandon; Agarwal, Nitin; Brown, Joshua; Forsythe, Raquel M.; Leonardo, Jody; Walsh, Kevin; Gross, Bradley A.; Friedlander, Robert M.; Okonkwo, David O.; Whiting, Donald; Miele, Vincent J.			Impact of Coronavirus Disease 2019 Shutdown on Neurotrauma Volume in Pennsylvania	WORLD NEUROSURGERY			English	Article						COVID-19; Neurotrauma; Pennsylvania	1 TRAUMA CENTER; ORTHOPEDIC TRAUMA; COVID-19; SURGERY	-OBJECTIVE: The 2020 coronavirus disease 2019 (COVID19) pandemic resulted in state-specific quarantine protocols and introduced the concept of social distancing into modern parlance. We assess the impact of the COVID-19 pandemic on neurotrauma presentations in the first 3 months after shutdown throughout Pennsylvania. METHODS: The Pennsylvania Trauma Systems Foundation was queried for registry data from the Pennsylvania Trauma Outcomes Study between March 12 and June 5 in each year from 2017 to 2020. RESULTS: After the COVID-19 shutdown, there was a 27% reduction in neurotrauma volume, from 2680 cases in 2017 to 2018 cases in 2020, and a 28.8% reduction in traumatic brain injury volume. There was no significant difference in neurotrauma phenotype incurred relative to total cases. Injury mechanism was less likely to be motor vehicle collision and more likely caused by falls, gunshot wound, and recreational vehicle accidents (P < 0.05). Location of injury was less likely on roads and public locations and more likely at indoor private locations (P < 0.05). The proportion of patients with neurotrauma with blood alcohol concentration >0.08 g/dL was reduced in 2020 (11.4% vs. 9.0%; P < 0.05). Mortality was higher during 2020 compared with pre-COVID years (7.7% vs. 6.4%; P < 0.05). CONCLUSIONS: During statewide shutdown, neurotrauma volume and alcohol-related trauma decreased and low-impact traumas and gunshot wounds increased, with a shift toward injuries occurring in private, indoor locations. These changes increased mortality. However, there was not a change in the types of injuries sustained.	[Algattas, Hanna N.; McCarthy, David; Agarwal, Nitin; Gross, Bradley A.; Friedlander, Robert M.; Okonkwo, David O.; Miele, Vincent J.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Kujawski, Brandon; Leonardo, Jody; Walsh, Kevin; Whiting, Donald] Allegheny Gen Hosp, Dept Neurol Surg, Pittsburgh, PA 15212 USA; [Brown, Joshua; Forsythe, Raquel M.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA		Algattas, HN (corresponding author), Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15213 USA.	algattash@upmc.edu		Walsh, Kevin/0000-0002-6595-9461; Brown, Joshua/0000-0002-6936-035X			Balestrino Alberto, 2021, J Neurosurg Sci, DOI 10.23736/S0390-5616.21.05226-7; Bram JT, 2020, J PEDIATR ORTHOPED, V40, P373, DOI 10.1097/BPO.0000000000001600; Ceraudo M, 2021, WORLD NEUROSURG, V146, pE1079, DOI 10.1016/j.wneu.2020.11.088; Christey G, 2020, NEW ZEAL MED J, V133, P81; Ciancio A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238341; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Fontanella MM, 2020, J NEUROSURG SCI, V64, P383, DOI 10.23736/S0390-5616.20.04994-2; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Hassan K, 2020, ANN PLAS SURG, V85, pS161, DOI 10.1097/SAP.0000000000002459; Hecht N, 2020, ACTA NEUROCHIR, V162, P1795, DOI 10.1007/s00701-020-04437-z; Heim C, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-39; Hochstatter KR, 2021, AIDS BEHAV, V25, P354, DOI 10.1007/s10461-020-02976-1; Lechner WV, 2020, ADDICT BEHAV, V110, DOI 10.1016/j.addbeh.2020.106527; Leichtle SW, 2020, INJURY, V51, P2437, DOI 10.1016/j.injury.2020.08.014; Lubbe RJ, 2020, J ORTHOP TRAUMA, V34, pE343, DOI 10.1097/BOT.0000000000001890; Noronha KVMD, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00115320; Niles JK, 2021, POPUL HEALTH MANAG, V24, pS43, DOI 10.1089/pop.2020.0230; Placella G, 2020, INJURY, V51, P1403, DOI 10.1016/j.injury.2020.04.012; Probert AC, 2021, ANZ J SURG, V91, P68, DOI 10.1111/ans.16375; Rehm J, 2020, DRUG ALCOHOL REV, V39, P301, DOI 10.1111/dar.13074; Rhodes HX, 2020, CUREUS, V12, DOI 10.7759/cureus.10059; Sherman WF, 2021, CLIN ORTHOP RELAT R, V479, P266, DOI 10.1097/CORR.0000000000001484; Stoker S, 2020, J ORTHOP TRAUMA, V34, pE336, DOI 10.1097/BOT.0000000000001860; Wellons JC, 2020, J NEUROSURG-PEDIATR, V26, P1, DOI 10.3171/2020.3.PEDS20215; Zoia C, 2020, ACTA NEUROCHIR, V162, P1221, DOI 10.1007/s00701-020-04305-w	25	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2021	151						E178	E184		10.1016/j.wneu.2021.04.004			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	US6YO	WOS:000697573500010	33857673	Green Published			2022-02-06	
J	Battaglini, D; Gieroba, DS; Brunetti, I; Patroniti, N; Bonatti, G; Rocco, PRM; Pelosi, P; Robba, C				Battaglini, Denise; Gieroba, Dorota Siwicka; Brunetti, Iole; Patroniti, Nicolo; Bonatti, Giulia; Macedo Rocco, Patricia Rieken; Pelosi, Paolo; Robba, Chiara			Mechanical ventilation in neurocritical care setting: A clinical approach	BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY			English	Article						mechanical ventilation; acute brain injury; neurocritical care; tracheostomy; weaning	TRAUMATIC BRAIN-INJURY; END-EXPIRATORY PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY-ILL PATIENTS; ACUTE ISCHEMIC-STROKE; INTRACRANIAL-PRESSURE; SUBARACHNOID HEMORRHAGE; PREHOSPITAL VENTILATION; EXTUBATION FAILURE; TRACHEOSTOMY	Neuropatients often require invasive mechanical ventilation (MV). Ideal ventilator settings and respiratory targets in neuro patients are unclear. Current knowledge suggests maintaining protective tidal volumes of 6-8 ml/kg of predicted body weight in neuropatients. This approach may reduce the rate of pulmonary complications, although it cannot be easily applied in a neuro setting due to the need for special care to minimize the risk of secondary brain damage. Additionally, the weaning process from MV is particularly challenging in these patients who cannot control the brain respiratory patterns and protect airways from aspiration. Indeed, extubation failure in neuropatients is very high, while tracheostomy is needed in one-third of the patients. The aim of this manuscript is to review and describe the current management of invasive MV, weaning, and tracheostomy for the main four subpopulations of neuro patients: traumatic brain injury, acute ischemic stroke, subarachnoid hemorrhage, and intracerebral hemorrhage. (c) 2020 Elsevier Ltd. All rights reserved.	[Battaglini, Denise; Brunetti, Iole; Patroniti, Nicolo; Pelosi, Paolo; Robba, Chiara] San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Anesthesia & Intens Care, Genoa, Italy; [Gieroba, Dorota Siwicka] Univ Lublin, Dept Anesthesiol & Intens Care Med, PL-20954 Lublin, Poland; [Patroniti, Nicolo; Bonatti, Giulia; Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost DISC, Genoa, Italy; [Macedo Rocco, Patricia Rieken] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Pulm Invest, Rio De Janeiro, RJ, Brazil		Battaglini, D (corresponding author), San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Anesthesia & Intens Care, Genoa, Italy.	battaglini.denise@gmail.com; dsiw@wp.pl; brunettimed@gmail.com; npatroniti@gmail.com; giulia.bonatti@gmail.com; prmrocco@gmail.com; ppelosi@hotmail.com; kiarobba@gmail.com	bonatti, giulia/AAD-4989-2022; Rocco, Patricia/I-7460-2012; Battaglini, Denise/X-6446-2019	Rocco, Patricia/0000-0003-1412-7136; Battaglini, Denise/0000-0002-6895-6442; Siwicka-Gieroba, Dorota/0000-0002-1001-0080; , giulia/0000-0003-2290-7749			Asehnoune K, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1994-0; Asehnoune K, 2017, ANESTHESIOLOGY, V127, P338, DOI 10.1097/ALN.0000000000001725; Asehnoune K, 2017, INTENS CARE MED, V43, P957, DOI 10.1007/s00134-017-4764-6; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Baillard C, 2006, AM J RESP CRIT CARE, V174, P171, DOI 10.1164/rccm.200509-1507OC; Bosel J, 2017, STROKE, V48, P2638, DOI 10.1161/STROKEAHA.117.017794; Bosel J, 2013, STROKE, V44, P21, DOI 10.1161/STROKEAHA.112.669895; Boone MD, 2017, NEUROCRIT CARE, V26, P174, DOI 10.1007/s12028-016-0328-9; Borsellino B, 2016, EXPERT REV RESP MED, V10, P1123, DOI 10.1080/17476348.2017.1235976; Bouma G J, 1995, New Horiz, V3, P384; Briain DO, 2018, NEUROCRIT CARE, V29, P443, DOI 10.1007/s12028-018-0553-5; Cammarota G, 2021, J CLIN MONIT COMPUT, V35, P627, DOI 10.1007/s10877-020-00523-w; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang L, 2017, CAN RESPIR J, V2017, DOI 10.1155/2017/7272080; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; dos Reis HFC, 2017, J CRIT CARE, V42, P218, DOI 10.1016/j.jcrc.2017.07.051; Dasenbrock HH, 2018, NEUROCRIT CARE, V29, P326, DOI 10.1007/s12028-018-0619-4; Dastur CK, 2017, STROKE VASC NEUROL, V2, P21, DOI 10.1136/svn-2016-000047; Davies JD, 2016, RESP CARE, V61, P774, DOI 10.4187/respcare.04651; Della Torre V, 2017, J THORAC DIS, V9, P5368, DOI 10.21037/jtd.2017.11.03; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Dunn K, 2019, DYSPHAGIA, V34, P229, DOI 10.1007/s00455-018-9934-3; Edgerton CA, 2019, J CRIT CARE, V50, P118, DOI 10.1016/j.jcrc.2018.11.034; Elmer J, 2013, CRIT CARE MED, V41, P1992, DOI 10.1097/CCM.0b013e31828a3f4d; Enrichi C, 2017, RESP CARE, V62, P1255, DOI 10.4187/respcare.05470; Franco-Jimenez JA, 2020, CIR CIR, V88, P200, DOI 10.24875/CIRU.19001247; Friedman JA, 2003, NEUROSURGERY, V52, P1025, DOI 10.1227/01.NEU.0000058222.59289.F1; Gamberini L, 2019, J EMERG MED, V56, P657, DOI 10.1016/j.jemermed.2019.02.005; Godet T, 2017, ANESTHESIOLOGY, V126, P104, DOI 10.1097/ALN.0000000000001379; Hafner G, 2008, EUR ARCH OTO-RHINO-L, V265, P441, DOI 10.1007/s00405-007-0507-6; Hannawi Y, 2013, CEREBROVASC DIS, V35, P430, DOI 10.1159/000350199; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hosokawa K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1138-8; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Huttner HB, 2006, CEREBROVASC DIS, V21, P159, DOI 10.1159/000090527; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jenkins R, 2019, NEUROCRIT CARE, V30, P387, DOI 10.1007/s12028-018-0624-7; Kayambu G, 2013, CRIT CARE MED, V41, P1543, DOI 10.1097/CCM.0b013e31827ca637; Krishnamoorthy V, 2019, NEUROCRIT CARE, V30, P546, DOI 10.1007/s12028-019-00697-5; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Kumar RG, 2020, J TRAUMA ACUTE CARE, V88, P491, DOI 10.1097/TA.0000000000002562; Lahiri S, 2015, NEUROCRIT CARE, V23, P28, DOI 10.1007/s12028-014-0082-9; Lang M, 2018, ACTA ANAESTH SCAND, V62, P801, DOI 10.1111/aas.13093; Lee K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/207247; Lu Q, 2018, WORLD NEUROSURG, V112, pE324, DOI 10.1016/j.wneu.2018.01.043; Lu WC, 2019, J CRANIOFAC SURG, V30, P2168, DOI 10.1097/SCS.0000000000005721; Luoma A, 2013, BJA EDUC, V13, P52, DOI 10.1093/bjaceaccp/mks054; Marhong JD, 2014, NEUROCRIT CARE, V21, P178, DOI 10.1007/s12028-014-0014-8; Mayer SA, 2000, STROKE, V31, P2346, DOI 10.1161/01.STR.31.10.2346; Mazzeo AT, 2013, MINERVA ANESTESIOL, V79, P299; McCann MR, 2020, J NEUROSURG, V132, P87, DOI 10.3171/2018.7.JNS181345; McCredie V, 2017, NEUROCRIT CARE, V26, P14, DOI 10.1007/s12028-016-0297-z; McCredie VA, 2017, ANN AM THORAC SOC, V14, P85, DOI 10.1513/AnnalsATS.201608-620OC; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Nemer SN, 2011, J CRIT CARE, V26, P22, DOI 10.1016/j.jcrc.2010.04.015; Nemer SN, 2015, J CRIT CARE, V30, P1263, DOI 10.1016/j.jcrc.2015.07.019; Neto AS, 2015, CRIT CARE MED, V43, P2155, DOI 10.1097/CCM.0000000000001189; Ni YN, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0810-1; Patman S, 2009, INTENS CARE MED, V35, P258, DOI 10.1007/s00134-008-1278-2; Pelosi P, 2011, CRIT CARE, V15, DOI 10.1186/cc10259; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Picetti E, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02875-w; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Rhodes JK, 2016, ACTA NEUROCHIR SUPPL, V122, P9, DOI 10.1007/978-3-319-22533-3_2; Robba C, 2020, CHEST, V29, P443; Robba C, 2020, INTENS CARE MED, V46, P983, DOI 10.1007/s00134-020-05935-5; Robba C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2662-8; Roberts I, 2012, COCHRANE DB SYST REV, V2; Roch A, 2003, CRIT CARE MED, V31, P2651, DOI 10.1097/01.CCM.0000094222.57803.B4; Ruggieri F, 2017, J NEUROSURG ANESTH, V30, P1; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Sandsmark DK, 2012, STROKE, V43, P1440, DOI 10.1161/STROKEAHA.111.639906; Savi A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.07.079; Scheinhorn DJ, 2002, CRIT CARE CLIN, V18, P569, DOI 10.1016/S0749-0704(02)00016-7; Schirmer-Mikalsen K, 2016, NEUROCRIT CARE, V24, P332, DOI 10.1007/s12028-015-0208-8; Schonenberger S, 2016, NEUROCRIT CARE, V25, P94, DOI 10.1007/s12028-015-0235-5; Shibahashi K, 2017, BRIT J NEUROSURG, V31, P564, DOI 10.1080/02688697.2017.1302071; Smith CJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001307; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Suntrup-Krueger S, 2019, STROKE, V50, P1981, DOI 10.1161/STROKEAHA.118.024643; Szeder V, 2010, NEUROCRIT CARE, V13, P40, DOI 10.1007/s12028-010-9346-1; Tejerina E, 2017, J CRIT CARE, V38, P341, DOI 10.1016/j.jcrc.2016.11.010; Tiruvoipati R, 2018, JAMA NEUROL, V75, P818, DOI 10.1001/jamaneurol.2018.0123; Tomar GS, 2019, PHYS THER, V99, P388, DOI 10.1093/ptj/pzy141; Lopez H, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0533-8; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Zhang Y, 2016, ACTA NEUROCHIR SUPPL, V122, P205, DOI 10.1007/978-3-319-22533-3_41; Zhang Z, 2019, CURR OPIN ANESTHESIO, V32, P568, DOI 10.1097/ACO.0000000000000764	96	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1521-6896	1878-1608		BEST PRAC RES-CL ANA	Best Pract. Res.-Clin. Anaesth.	JUL	2021	35	2			SI		207	220		10.1016/j.bpa.2020.09.001			14	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	SH8AK	WOS:000654354500006	34030805				2022-02-06	
J	Bhowmick, S; Malat, A; Caruso, D; Ponery, N; D'Mello, V; Finn, C; Abdul-Muneer, PM				Bhowmick, Saurav; Malat, Anitha; Caruso, Danielle; Ponery, Nizmi; D'Mello, Veera; Finn, Christina; Abdul-Muneer, P. M.			Intercellular Adhesion Molecule-1-Induced Posttraumatic Brain Injury Neuropathology in the Prefrontal Cortex and Hippocampus Leads to Sensorimotor Function Deficits and Psychological Stress	ENEURO			English	Article						traumatic brain injury; ICAM-1 signaling; LFA-1 and Mac-1; cerebral blood flow; neuroinflammation; neurodegeneration	NEUTROPHIL ADHESION; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; ICAM-1; LFA-1; ACTIVATION; MECHANISMS; EXPRESSION; MODEL; MAC-1	Intercellular adhesion molecule-1 (ICAM-1) promotes adhesion and transmigration of circulating leukocytes across the blood-brain barrier (BBB). Traumatic brain injury (TBI) causes transmigrated immunocompetent cells to release mediators [function-associated antigen (LFA)-1 and macrophage-1 antigen (Mac-1)] that stimulate glial and endothelial cells to express ICAM-1 and release cytokines, sustaining neuroinflammation and neurodegeneration. Although a strong correlation exists between TBI-mediated inflammation and impairment in functional outcome following brain trauma, the role of ICAM-1 in impairing functional outcome by inducing neuroinflammation and neurodegeneration after TBI remains inconclusive. The experimental TBI was induced in vivo by fluid percussion injury (FPI; 10 and 20 psi) in wild-type (WT) and ICAM-1(-/-) mice and in vitro by stretch injury (3 psi) in brain endothelial cells. We manipulate ICAM-1 pharmacologically and genetically and conducted several biochemical analyses to gain insight into the mechanisms underlying ICAM-1-mediated neuroinflammation and performed rotarod, grid-walk, sucrose preference, and light-dark tests to assess functional outcome. TBI-induced ICAM-1-mediated neuroinflammation and cell death occur via LFA-1 or Mac-1 signaling pathways that rely on oxidative stress, matrix metalloproteinase (MMP), and vascular endothelial growth factor (VEGF) pathways. The deletion or blocking of ICAM-1 resulted in a better outcome in attenuating neuroinflammation and cell death as marked by the markers such as NF-kB, IL-1 beta, TNF-alpha, cleaved-caspase-3 (cl-caspase-3), Annexin V, and by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and Trypan blue staining. ICAM-1 deletion in TBI improves sensorimotor, depression, and anxiety-like behavior with significant upregulation of norepinephrine (NE), dopamine (DA) D1 receptor (DAD1R), serotonin (5-HT) 1AR, and neuropeptide Y (NPY). This study could establish the significance of ICAM-1 as a novel therapeutic target against the pathophysiology to establish functional recovery after TBI.	[Bhowmick, Saurav; Malat, Anitha; Caruso, Danielle; Ponery, Nizmi; D'Mello, Veera; Finn, Christina; Abdul-Muneer, P. M.] Hackensack Meridian Hlth JFK Univ, JFK Neurosci Inst, Lab CNS Injury & Mol Therapy, Med Ctr, Edison, NJ 08820 USA; [Abdul-Muneer, P. M.] Hackensack Meridian Sch Med, Dept Neurol, Nutley, NJ 07110 USA; [Caruso, Danielle] Environm & Occupat Hlth Sci Inst, 170 Frelinghuysen Rd, Piscataway, NJ 08854 USA; [Finn, Christina] Ctr Plast Surg, Mclean, VA USA; [D'Mello, Veera] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, 185 South Orange Ave, Newark, NJ 07103 USA		Abdul-Muneer, PM (corresponding author), Hackensack Meridian Hlth JFK Univ, JFK Neurosci Inst, Lab CNS Injury & Mol Therapy, Med Ctr, Edison, NJ 08820 USA.; Abdul-Muneer, PM (corresponding author), Hackensack Meridian Sch Med, Dept Neurol, Nutley, NJ 07110 USA.	mohammed.muneer@hmhn.org		Abdul-Muneer, P. M/0000-0001-8231-4385	New Jersey Commission on Brain Injury Research Grant [CBIR19PIL010]; Neuroscience Institute at JFK Medical Center	This work was supported by the New Jersey Commission on Brain Injury Research Grant CBIR19PIL010 and the Neuroscience Institute at JFK Medical Center (P.M.A.-M.).	aan het Rot M, 2009, CAN MED ASSOC J, V180, P305, DOI 10.1503/cmaj.080697; Abdul-Muneer PM, 2018, MOL NEUROBIOL, V55, P5901, DOI 10.1007/s12035-017-0812-z; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V62, P291, DOI 10.1016/j.bbi.2017.02.014; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Bankhead P, 2014, ANAL FLUORESCENCE MI; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.immunol.11.1.767; Bhowmick S, 2019, J MOL MED, V97, P1627, DOI 10.1007/s00109-019-01851-4; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; Boccella S, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00091; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Brigitta Bondy, 2002, Dialogues Clin Neurosci, V4, P7; Cole SW, 2008, BRAIN BEHAV IMMUN, V22, P1049, DOI 10.1016/j.bbi.2008.02.006; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; DEFOUGEROLLES AR, 1994, J EXP MED, V179, P619, DOI 10.1084/jem.179.2.619; Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Ding ZM, 1999, J IMMUNOL, V163, P5029; Dong AL, 2011, P NATL ACAD SCI USA, V108, P14614, DOI 10.1073/pnas.1012859108; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dunne JL, 2003, J IMMUNOL, V171, P6105, DOI 10.4049/jimmunol.171.11.6105; Dunne JL, 2002, BLOOD, V99, P336, DOI 10.1182/blood.V99.1.336; DUSTIN ML, 1988, IMMUNOL TODAY, V9, P213, DOI 10.1016/0167-5699(88)91216-9; Eaton K, 2007, CURR TOP MED CHEM, V7, P1645, DOI 10.2174/156802607782341037; Frank PG, 2008, AM J PHYSIOL-HEART C, V295, pH926, DOI 10.1152/ajpheart.00779.2008; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Goebel MU, 2000, PSYCHOSOM MED, V62, P664, DOI 10.1097/00006842-200009000-00010; Gonzalez H, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0201-8; Gray JA., 2000, NEUROPSYCHOLOGY ANXI; Hamai A, 2008, CANCER RES, V68, P9854, DOI 10.1158/0008-5472.CAN-08-0719; Hamon M, 2013, PROG NEURO-PSYCHOPH, V45, P54, DOI 10.1016/j.pnpbp.2013.04.009; Henderson RB, 2001, J EXP MED, V194, P219, DOI 10.1084/jem.194.2.219; Hogg N, 2001, J LEUKOCYTE BIOL, V69, P893; Hou XH, 2015, CELL BIOCHEM BIOPHYS, V72, P709, DOI 10.1007/s12013-015-0522-y; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Ksiazek K, 2010, INT J CANCER, V127, P293, DOI 10.1002/ijc.25036; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Landmesser U, 2007, ARTERIOSCL THROM VAS, V27, P943, DOI 10.1161/01.ATV.0000258415.32883.bf; Lindsberg PJ, 1996, CIRCULATION, V94, P939, DOI 10.1161/01.CIR.94.5.939; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Mannello F, 2005, APOPTOSIS, V10, P19, DOI 10.1007/s10495-005-6058-7; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mickey BJ, 2011, ARCH GEN PSYCHIAT, V68, P158, DOI 10.1001/archgenpsychiatry.2010.197; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Muneer PMA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-23; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; Romanova LY, 2011, CELL ADHES MIGR, V5, P457, DOI 10.4161/cam.5.6.18219; Salvador E, 2013, JOVE-J VIS EXP, DOI 10.3791/50928; Soares HD, 1995, J NEUROSCI, V15, P8223; SOBEL RA, 1990, AM J PATHOL, V136, P1309; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Sumagin R, 2011, AM J PHYSIOL-CELL PH, V301, pC804, DOI 10.1152/ajpcell.00135.2011; Trentini A, 2015, MULT SCLER J, V21, P1121, DOI 10.1177/1352458514560925; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Weaver LC, 2015, EXP NEUROL, V271, P409, DOI 10.1016/j.expneurol.2015.07.003; Wohleb ES, 2012, PSYCHONEUROENDOCRINO, V37, P1491, DOI 10.1016/j.psyneuen.2012.02.003; Wurm F, 2007, STROKE, V38, P2833, DOI 10.1161/STROKEAHA.107.485524; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Zhang Q, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.854	70	1	1	0	1	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	JUL-AUG	2021	8	4							0242-21.2021	10.1523/ENEURO.0242-21.2021			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XL8LU	WOS:000728393700002	34135004	Green Published, gold			2022-02-06	
J	Butler, EK; Killien, EY; Groner, JI; Arbabi, S; Vavilala, MS; Rivara, FP				Butler, Elissa K.; Killien, Elizabeth Y.; Groner, Jonathan, I; Arbabi, Saman; Vavilala, Monica S.; Rivara, Frederick P.			Optimal Timing of Tracheostomy in Injured Adolescents*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						pediatric; tracheostomy; tracheostomy timing; trauma	INTENSIVE-CARE-UNIT; TRAUMA PATIENTS; TRACHEOTOMY; CHILDREN; IMPACT; OUTCOMES	OBJECTIVES: To evaluate the optimal timing of tracheostomy for injured adolescents. DESIGN: Retrospective cohort study. SETTING: Trauma facilities in the United States. PATIENTS: Adolescents (age 12-17 yr) in the National Trauma Data Bank (2007-2016) who were ventilated for greater than 24 hours and survived to discharge. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: After stratifying by traumatic brain injury diagnosis, we compared ICU and hospital length of stay, pneumonia, and discharge disposition of patients with tracheostomy prior to three cut points (3, 7, and 14 d after admission) to 1) patients intubated at least as long as each cut point and 2) patients with tracheostomy on or after each cut point. Of 11,045 patients, 1,391 (12.6%) underwent tracheostomy. Median time to tracheostomy was 9 days (interquartile range, 6-13 d) for traumatic brain injury and 7 days (interquartile range, 3-12 d) for nontraumatic brain injury patients. Nontraumatic brain injury patients with tracheostomy prior to 7 days had 5.6 fewer ICU days (-7.8 to -3.5 d) and 5.7 fewer hospital days (-8.8 to -2.7 d) than patients intubated greater than or equal to 7 days and had 14.8 fewer ICU days (-19.6 to -10.0 d) and 15.3 fewer hospital days (-21.7 to -8.9 d) than patients with tracheostomy greater than or equal to 7 days. Similar differences were observed at 14 days but not at 3 days for both traumatic brain injury and nontraumatic brain injury patients. At the 3- and 7-day cut points, both traumatic brain injury and nontraumatic brain injury patients with tracheostomy prior to the cut point had lower risk of pneumonia and risk of discharge to a facility than those with tracheostomy after the cut point. CONCLUSIONS: For injured adolescents, tracheostomy less than 7 days after admission was associated with improved in-hospital outcomes compared with those who remained intubated greater than or equal to 7 days and with those with tracheostomy greater than or equal to 7 days. Tracheostomy between 3 and 7 days may be the optimal time point when prolonged need for mechanical ventilation is anticipated; however, unmeasured consequences of tracheostomy such as long-term complications and care needs must also be considered.	[Butler, Elissa K.; Killien, Elizabeth Y.; Arbabi, Saman; Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Butler, Elissa K.; Arbabi, Saman] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Butler, Elissa K.] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA; [Killien, Elizabeth Y.] Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA; [Killien, Elizabeth Y.; Rivara, Frederick P.] Seattle Childrens Hosp, Seattle, WA USA; [Groner, Jonathan, I] Nationwide Childrens Hosp, Ctr Pediat Trauma Res, Columbus, OH USA; [Groner, Jonathan, I] Nationwide Childrens Hosp, Dept Pediat Surg, Columbus, OH USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Div Gen Pediat, Seattle, WA 98195 USA		Butler, EK (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.; Butler, EK (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.; Butler, EK (corresponding author), SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA.	butlere@upstate.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH T-32 Pediatric Injury Research Training ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32HD057822-09]	Drs. Butler, Killien, Vavilala, and Rivara received support for article research from the National Institutes of Health (NIH). Drs. Killien's and Rivara's institutions received funding from the NIH. Drs. Butler and Killien were supported by the NIH T-32 Pediatric Injury Research Training Program (5T32HD057822-09). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Barquist ES, 2006, J TRAUMA, V60, P91, DOI 10.1097/01.ta.0000196743.37261.3f; Cai SQ, 2017, INJURY, V48, P866, DOI 10.1016/j.injury.2017.02.023; CDC Oid Ncezid, 2020, PNEUM VENT ASS VAP N PNEUM VENT ASS VAP N; Cohn EC, 2018, NEUROCRIT CARE, V28, P83, DOI 10.1007/s12028-017-0429-0; Diehl JL, 1999, AM J RESP CRIT CARE, V159, P383, DOI 10.1164/ajrccm.159.2.9707046; Dunham CM, 2006, AM SURGEON, V72, P276; Engoren M, 2005, AM SURGEON, V71, P123; Gilony D, 2005, OTOLARYNG HEAD NECK, V133, P366, DOI 10.1016/j.otohns.2005.04.025; Holloway Adrian J, 2015, Pediatr Crit Care Med, V16, pe52, DOI 10.1097/PCC.0000000000000336; Holscher CM, 2014, J PEDIATR SURG, V49, P590, DOI 10.1016/j.jpedsurg.2013.09.002; Hyde GA, 2015, INJURY, V46, P110, DOI 10.1016/j.injury.2014.08.049; Itamoto CH, 2010, BRAZ J OTORHINOLAR, V76, P326, DOI 10.1590/S1808-86942010000300010; Keenan JE, 2015, J SURG RES, V198, P475, DOI 10.1016/j.jss.2015.03.072; Lewarski Joseph S, 2005, Respir Care, V50, P534; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; McLaughlin C, 2019, J TRAUMA ACUTE CARE, V87, P818, DOI 10.1097/TA.0000000000002237; Moller MG, 2005, AM J SURG, V189, P293, DOI 10.1016/j.amjsurg.2005.01.002; Nieszkowska A, 2005, CRIT CARE MED, V33, P2527, DOI 10.1097/01.CCM.0000186898.58709.AA; October TW, 2020, PEDIATR CRIT CARE ME, V21, P136, DOI 10.1097/PCC.0000000000002109; Palmieri TL, 2002, CRIT CARE MED, V30, P922, DOI 10.1097/00003246-200204000-00036; Pizza A, 2017, MINERVA ANESTESIOL, V83, P836, DOI 10.23736/S0375-9393.17.11681-0; Raju A, 2010, AM SURGEON, V76, P276; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Rocha EP, 2000, J TRAUMA, V49, P483, DOI 10.1097/00005373-200009000-00016; Rogers S, 2017, J NURSING ED PRACTIC, V7, P23, DOI [10.5430/jnep. v7n11p23, DOI 10.5430/JNEP.V7N11P23]; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Sen S, 2015, BURNS, V41, P248, DOI 10.1016/j.burns.2014.10.005; Sheehan BM, 2020, J INTENSIVE CARE MED, V35, P1346, DOI 10.1177/0885066619870153; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059	30	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2021	22	7					629	641		10.1097/PCC.0000000000002681			13	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	TY5PH	WOS:000683835800011	34192728				2022-02-06	
J	Cochrane, GD; Christy, JB; Almutairi, A; Busettini, C; van Heyningen, HKK; Weise, KK; Swanson, MW; Gould, SJ				Cochrane, Graham D.; Christy, Jennifer B.; Almutairi, Anwar; Busettini, Claudio; van Heyningen, Hendrik K. Kits; Weise, Katherine K.; Swanson, Mark W.; Gould, Sara J.			Vestibular, Oculomotor, and Balance Functions in Children With and Without Concussion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						balance; concussion; oculomotor; pediatric; vestibular	MOTOR SCREENING VOMS; POSTURAL CONTROL; MATURATION; STABILITY; ADOLESCENTS; DISORDERS; DIZZINESS; RECOVERY; YOUTH	Objective: The main objective of this study was to assess whether objective vestibular, oculomotor, and balance functions were impaired in children with a current diagnosis of concussion with vestibular and/or ocular symptoms. Setting: Data were collected in a vestibular/ocular clinical laboratory. Patient participants were recruited from a concussion clinic in a children's hospital. Participants: Thirty-three children aged 8 to 17 years with a current diagnosis of concussion and vestibular and/or ocular symptoms and 30 children without concussion. Design: Cross-sectional single-visit study. Main Outcome Measures: Eye-tracking rotary chair oculomotor and vestibular measures, vestibular evoked potentials, and static posturography. Results: There were no statistically significant differences on any clinical measure between children with concussion and children without concussion. Younger children without concussion performed significantly worse on several rotary chair and balance measures compared with older children without concussion. Conclusions: No vestibular, oculomotor, or balance measures were significantly different between children with concussion and children without concussion, suggesting these measures may not be useful in the evaluation of a child with concussion and vestibular and/or oculomotor symptoms. Future research should investigate age effects and other vestibular and oculomotor tests to identify objective findings that better relate to vestibular and/or ocular symptoms in children with concussion.	[Cochrane, Graham D.] Univ Alabama Birmingham, Med Scientist Training Program, Sch Med, Birmingham, AL USA; [Cochrane, Graham D.; Christy, Jennifer B.] Univ Alabama Birmingham, Dept Phys Therapy, Sch Hlth Profess, Birmingham, AL USA; [Busettini, Claudio; Weise, Katherine K.; Swanson, Mark W.] Univ Alabama Birmingham, Sch Optometry, Birmingham, AL 35294 USA; [Gould, Sara J.] Univ Alabama Birmingham, Dept Surg, Div Orthoped, Birmingham, AL 35294 USA; [Almutairi, Anwar] Kuwait Univ, Allied Hlth Sci Ctr, Dept Phys Therapy, Sulibikhat, Kuwait; [Gould, Sara J.] Childrens Alabama, Concuss Clin, Birmingham, AL USA		Cochrane, GD (corresponding author), 625 19th Ct S, Birmingham, AL 35205 USA.	gcoch@uab.edu			NIH grants: NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 EY003039, GM008361]	Funding was obtained from 2 NIH grants: NIH P30 EY003039, GM008361 Medical Scientist Training Program.	Akin F W, 2001, J Am Acad Audiol, V12, P445; Alkathiry AA, 2019, SPORTS HEALTH, V11, P479, DOI 10.1177/1941738119865262; Alshehri MM, 2016, J VESTIBUL RES-EQUIL, V26, P439, DOI 10.3233/VES-160598; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Bin Zahid A, 2020, CLIN J SPORT MED, V30, P433, DOI 10.1097/JSM.0000000000000639; Brix GS, 2019, INT J PEDIATR OTORHI, V116, P49, DOI 10.1016/j.ijporl.2018.10.019; Brodsky JR, 2018, OTOLARYNG HEAD NECK, V159, P365, DOI 10.1177/0194599818770618; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Christy JB, 2019, J NEUROL PHYS THER, V43, P153, DOI 10.1097/NPT.0000000000000280; Cochrane GD, 2020, CLIN EXP OPTOM, V103, P929, DOI 10.1111/cxo.13045; Corwin DJ, 2019, AM J EMERG MED, V37, P1219, DOI 10.1016/j.ajem.2018.09.008; Corwin DJ, 2018, BRAIN INJURY, V32, P794, DOI 10.1080/02699052.2018.1458150; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Cumberworth VL, 2007, J LARYNGOL OTOL, V121, P449, DOI 10.1017/S0022215106004051; Debacker J, 2018, HAND CLINIC, V158, P145, DOI 10.1016/B978-0-444-63954-7.00015-X; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ferber-Viart C, 2007, INT J PEDIATR OTORHI, V71, P1041, DOI 10.1016/j.ijporl.2007.03.012; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Freeman L, 2018, J GERIATR PHYS THER, V41, P77, DOI 10.1519/JPT.0000000000000110; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; Kelly KM, 2019, J HEAD TRAUMA REHAB, V34, P176, DOI 10.1097/HTR.0000000000000437; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Mayer AR, 2018, J NEUROTRAUM, V35, P1178, DOI 10.1089/neu.2017.5340; Meyer N, 2015, INT J AUDIOL, V54, P143, DOI 10.3109/14992027.2014.971468; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Paquin H, 2018, HAND CLINIC, V158, P107, DOI 10.1016/B978-0-444-63954-7.00011-2; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Rochefort C, 2017, J SCI MED SPORT, V20, P970, DOI 10.1016/j.jsams.2017.04.008; Rochefort C, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117695507; Schubert P, 2014, GAIT POSTURE, V39, P518, DOI 10.1016/j.gaitpost.2013.09.001; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Sumrok VF, 2019, ARCH CLIN NEUROPSYCH, V34, P763, DOI 10.1093/arclin/acz026.33; Whitney SL, 2020, BRAIN INJURY, V34, P842, DOI 10.1080/02699052.2020.1755055; Whitney SL, 2019, J NEUROL PHYS THER, V43, pS31, DOI 10.1097/NPT.0000000000000272; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	42	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		264	273		10.1097/HTR.0000000000000651			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100013	33656474	Green Accepted			2022-02-06	
J	Cui, C; Zhang, DW; Sun, K; Li, HF; Xu, LQ; Lin, G; Guo, YB; Hu, JQ; Chen, JY; Nong, LD; Cai, YJ; Yu, DN; Yang, W; Wang, P; Sun, Y				Cui, Can; Zhang, Dengwen; Sun, Ke; Li, Haifeng; Xu, Liqian; Lin, Gen; Guo, Yuanbo; Hu, Jiaqi; Chen, Jieyuan; Nong, Lidan; Cai, Yujin; Yu, Dongnan; Yang, Wei; Wang, Peng; Sun, Yi			Propofol maintains Th17/Treg cell balance and reduces inflammation in rats with traumatic brain injury via the miR-145-3p/NFATc2/NF-kappa B axis	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						propofol; traumatic brain injury; microRNA-145-3p; nuclear factor of activated T cells c2; Th17; Treg; NF-&#954; B; inflammation	NF-KAPPA-B; MICRORNA; TREG; TH17; INVOLVEMENT; HEMORRHAGE; EXPRESSION; IMBALANCE; CYTOKINES; IL-17	Propofol is a commonly used intravenous anesthetic. The aim of the study was to examine the mechanism of propofol in traumatic brain injury (TBI) by regulating interleukin (IL)-17 activity and maintaining the Th17/Treg balance. A rat model with moderate TBI was established using the weight-drop method. Rats with TBI were regularly injected with propofol and their brain injuries were monitored. The peripheral blood of rats was collected to measure the Th17/Treg ratio. MicroRNA (miR)-145-3p expression was detected in the brain tissues of rats and antagomiR-145-3p was injected into the lateral ventricles of their brains to verify the effect of miR-145-3p on brain injury. The downstream target of miR-145-3p was predicted. The targeting relationship between miR-145-3p and nuclear factor of activated T cells c2 (NFATc2) was confirmed. NFATC2 expression and phosphorylation of NF-kappa B pathway-related proteins were measured. Propofol alleviated brain injury in rats with TBI and maintained the Th17/Treg balance. Propofol upregulated miR-145-3p expression in rat brains, while the inhibition of miR-145-3p reversed the effect of propofol on brain injury. A binding relationship was observed between miR-145-3p and NFATc2. Furthermore, propofol decreased the phosphorylation of p65 and I kappa B alpha, and inhibited activation of the NF-kappa B pathway in the brains of rats with TBI. In conclusion, propofol maintained Th17/Treg balance and reduced inflammation in the rats with TBI via the miR-145-3p/NFATc2/NF-kappa B axis.	[Cui, Can; Zhang, Dengwen; Sun, Ke; Li, Haifeng; Xu, Liqian; Lin, Gen; Guo, Yuanbo; Hu, Jiaqi; Chen, Jieyuan; Nong, Lidan; Cai, Yujin; Yu, Dongnan; Yang, Wei; Sun, Yi] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Anesthesiol, 96 Dongchuan Rd, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Peng] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Neurosurg, 96 Dongchuan Rd, Guangzhou 510080, Guangdong, Peoples R China		Sun, Y (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Anesthesiol, 96 Dongchuan Rd, Guangzhou 510080, Guangdong, Peoples R China.; Wang, P (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Neurosurg, 96 Dongchuan Rd, Guangzhou 510080, Guangdong, Peoples R China.	wangpeng_82@sina.com; sunnyuva2014@yahoo.com			Science and Technology Planning Project of Guangdong Province, China [2012B031800161]; Medical Scientific Research Foundation of Guangdong Province, China [A2016573, A2020038]; Natural Science Foundation of Guangdong Province, ChinaNational Natural Science Foundation of Guangdong Province [2018A0303130236, 2018A0303130297]; Science and Technology Program of Guangzhou, China [201904010080]; Project of Administration of Traditional Chinese Medicine of Guangdong Province, China [20191006]; Foundation for Basic and Applied Basic Research of Guangdong Province, China [2019A1515110063]	This study was supported by the Science and Technology Planning Project of Guangdong Province, China (2012B031800161), the Medical Scientific Research Foundation of Guangdong Province, China (A2016573), the Natural Science Foundation of Guangdong Province, China (2018A0303130236), the Natural Science Foundation of Guangdong Province, China (2018A0303130297); the Science and Technology Program of Guangzhou, China (201904010080), the Project of Administration of Traditional Chinese Medicine of Guangdong Province, China (20191006), the Foundation for Basic and Applied Basic Research of Guangdong Province, China (2019A1515110063), and the Medical Scientific Research Foundation of Guangdong Province, China (A2020038).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Baumgart S, 2016, MOL CANCER THER, V15, P491, DOI 10.1158/1535-7163.MCT-15-0309; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Chang JH, 2020, EXP MOL PATHOL, V112, DOI 10.1016/j.yexmp.2019.104327; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Choi MC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070734; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; FULTON B, 1995, DRUGS, V50, P636, DOI 10.2165/00003495-199550040-00006; Furman JL, 2016, J NEUROSCI, V36, P1502, DOI 10.1523/JNEUROSCI.1930-15.2016; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Gerlach K, 2012, CANCER RES, V72, P4340, DOI 10.1158/0008-5472.CAN-11-4155; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Guo HM, 2016, J INFECT CHEMOTHER, V22, P162, DOI 10.1016/j.jiac.2015.12.006; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Kustrimovic N, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1248-8; Kuwabara T, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3908061; Lee GR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030730; Li T, 2017, NEUROMOL MED, V19, P541, DOI 10.1007/s12017-017-8468-4; Li ZZ, 2017, AM J TRANSL RES, V9, P5653; Liu F, 2016, NEUROPEPTIDES, V58, P1, DOI 10.1016/j.npep.2016.03.004; Luo T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26767; Marik PE, 2005, PHARMACOTHERAPY, V25, p28S, DOI 10.1592/phco.2005.25.5_Part_2.28S; Mataki H, 2016, ONCOTARGET, V7, P72084, DOI 10.18632/oncotarget.12290; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Qi HY, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-0195-2; Qu J, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/6470957; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen Y, 2011, SCAND J IMMUNOL, V74, P176, DOI 10.1111/j.1365-3083.2011.02546.x; Shi SS, 2015, J MOL NEUROSCI, V57, P538, DOI 10.1007/s12031-015-0634-2; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Si LL, 2020, BIOCHEM BIOPH RES CO, V523, P527, DOI 10.1016/j.bbrc.2019.11.095; Wang DD, 2009, J NEUROIMMUNOL, V212, P17, DOI 10.1016/j.jneuroim.2009.04.007; Wang HW, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00635-0; Wang J, 2013, J NEUROIMMUNE PHARM, V8, P1287, DOI 10.1007/s11481-013-9498-9; Wang PC, 2020, INT J MED SCI, V17, P437, DOI 10.7150/ijms.39667; Yu SS, 2020, BIOFACTORS, V46, P934, DOI 10.1002/biof.1607; Yu Y, 2015, CHINESE MED J-PEKING, V128, P919, DOI 10.4103/0366-6999.154298; Zeng J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0895-5; Zhang Ying-Jun, 2005, Yaoxue Xuebao, V40, P299; Zheng LF, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9530951; Zheng XX, 2018, INFLAMMATION, V41, P11, DOI 10.1007/s10753-017-0658-6; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	47	1	1	1	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUL	2021	48	1							135	10.3892/ijmm.2021.4968			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	SH7JK	WOS:000654309800001	34036377	hybrid, Green Published			2022-02-06	
J	D'Souza, RS; Sexton, MA; Schulte, PJ; Pasternak, JJ; Abcejo, AS				D'Souza, Ryan S.; Sexton, Matthew A.; Schulte, Phillip J.; Pasternak, Jeffrey J.; Abcejo, Arnoley S.			Recent Preoperative Concussion and Postoperative Complications: A Retrospective Matched-cohort Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						concussion; anesthesia; treatment outcome; anesthesia recovery period; headache; postconcussion syndrome; sports; falls; traumatic brain injury	TRAUMATIC BRAIN-INJURY; AGITATION-SEDATION SCALE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORT HELD; ANESTHESIA; EXPOSURE; DELIRIUM; ENCEPHALOPATHY; EPIDEMIOLOGY	Background: Physiological alterations during the perianesthetic period may contribute to secondary neurocognitive injury after a concussion. Methods: Patients exposed to concussion and who received an anesthetic within 90 days were matched to unexposed patients without concussion. Intraoperative and postoperative events were compared. Subgroup analyses assessed relationships among patients with a concussion in the prior 30, 31 to 60, and 61 to 90 days and their respective unexposed matches. To facilitate identification of potential targets for further investigation, statistical comparisons are reported before, as well as after, correction for multiple comparisons. Results: Sixty concussion patients were matched to 176 unexposed patients. Before correction, 28.3% postconcussion versus 14.8% unexposed patients reported postanesthesia care unit pain score >= 7 (P=0.02); 16.7% concussion versus 6.5% unexposed patients reported headache within 90 days of anesthesia (P=0.02) and 23.5% of patients who received surgery and anesthesia within 30 days of concussion experienced headache within 90 days of anesthesia compared with 7.1% in the unexposed group (P=0.01). Patients who experienced concussion and had anesthesia between 31 and 60 days after injury had a postanesthesia care unit Richmond Agitation and Sedation Scale score of -1.61 +/- 1.29 versus a score of -0.2 +/- 0.45 in unexposed patients (P=0.002). After adjusting the P-value threshold for multiple comparisons, the P-value for significance was instead 0.0016 for the overall cohort. Our study revealed no significant associations with application of adjusted significance thresholds. Conclusions: There were no differences in intraoperative and postoperative outcomes in patients with recent concussion compared with unexposed patients. Before correction for multiple comparisons, several potential targets for further investigation are identified. Well-powered studies are warranted.	[D'Souza, Ryan S.; Sexton, Matthew A.; Pasternak, Jeffrey J.; Abcejo, Arnoley S.] Mayo Clin, Coll Med, Dept Anesthesiol & Perioperat Med, Rochester, MN 55905 USA; [Schulte, Phillip J.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA		Abcejo, AS (corresponding author), Mayo Clin, Coll Med, Dept Anesthesiol & Perioperat Med, Rochester, MN 55905 USA.	abcejo.arnoley@mayo.edu					Abcejo AS, 2017, MAYO CLIN PROC, V92, P1042, DOI 10.1016/j.mayocp.2017.03.012; [Anonymous], 2015, J AM COLL SURGEONS, V220, P136, DOI 10.1016/j.jamcollsurg.2014.10.019; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Matsota PK, 2017, J ANESTH, V31, P225, DOI 10.1007/s00540-016-2285-z; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sanchez A, 2019, TRIALS, V20, DOI 10.1186/s13063-018-3148-8; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sessler CN, 2001, SEMIN RESP CRIT CARE, V22, P211, DOI 10.1055/s-2001-13834; Sprung J, 2017, BRIT J ANAESTH, V119, P316, DOI 10.1093/bja/aex130; Sprung J, 2017, ANESTH ANALG, V124, P1277, DOI 10.1213/ANE.0000000000001725; Sprung J, 2016, MAYO CLIN PROC, V91, P273, DOI 10.1016/j.mayocp.2015.12.008; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vavilala MS, 2018, BRAIN INJURY, V32, P269, DOI 10.1080/02699052.2017.1408145; Warner DO, 2018, ANESTHESIOLOGY, V129, P89, DOI 10.1097/ALN.0000000000002232; WHO, 1992, INT STAT CLASS DIS R; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	39	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2021	33	3					221	229		10.1097/ANA.0000000000000654			9	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	ST1UR	WOS:000662236600006	31651548				2022-02-06	
J	Dar, PMUD; Gupta, P; Kaul, RP; Kumar, A; Gamangatti, S; Kumar, S; Gupta, A; Singhal, M; Sagar, S				Dar, P. M. U. D.; Gupta, P.; Kaul, R. P.; Kumar, A.; Gamangatti, S.; Kumar, S.; Gupta, A.; Singhal, M.; Sagar, S.			Haemorrhage control beyond Advanced Trauma Life Support (ATLS) protocol in life threatening maxillofacial trauma-experience from a level I trauma centre	BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY			English	Article						Haemorrhage; Facial Fracture; Embolisation	INJURIES	Maxillofacial injuries are usually not life-threatening and do not get priority over other associated injuries. However, some maxillofacial injuries with active oral or nasal bleeding need immediate management due to threatened airway and blood loss. In the case of major active vascular bleeding, measures such as local pressure, anterior nasal packing, posterior nasal packing, and balloon tamponade are ineffective. In these cases, angiography and transcatheter arterial embolisation (TAE) are used to treat life-threatening haemorrhage caused by maxillofacial trauma. We analysed the medical records of 39 patients with severe maxillofacial trauma and life-threatening haemorrhage that was a result of intractable oral or nasal bleeding. These patients were considered for TAE from January 2010 to December 2019. A total of 1668 patients was admitted, out of which 39 (2.3%) had severe maxillofacial injuries with life-threatening oral or nasal bleeding and underwent TAE. Out of a total of 39 patients, 38 were male and one female. Ages ranged from 16 to 65 years. Road traffic injury was the most common cause of injury (79.5%), Lefort I and II were the most common facial fractures, and traumatic brain injury was the most common associated injury. Embolisation and bleeding control were done successfully in all 39 patients with no procedure-related complications. A total of 17 deaths during the study period were due to severe traumatic brain injuries or haemorrhagic shock. (c) 2020 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.	[Dar, P. M. U. D.; Gupta, P.; Kaul, R. P.; Kumar, S.; Gupta, A.; Sagar, S.] All India Inst Med Sci AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Div Trauma Surg & Crit Care, New Delhi 110029, India; [Kumar, A.; Gamangatti, S.] All India Inst Med Sci AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Radio Diag, New Delhi 110029, India; [Singhal, M.] All India Inst Med Sci AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Plast & Reconstruct Surg, New Delhi 110029, India		Sagar, S (corresponding author), All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Room 229, New Delhi 110029, India.	sagar.sushma@gmail.com	Kaul, Ruchi Pathak/AAE-6222-2019	Kumar, Atin/0000-0001-5874-1336			American College of Surgeons Committee on Trauma, 1994, ADV TRAUM LIF SUPP M; ARDEKIAN L, 1993, J CRANIO MAXILL SURG, V21, P336, DOI 10.1016/S1010-5182(05)80493-7; Brooks B., 1930, MED J, V23, P100, DOI [10.1097/00007611-193002000-00004, DOI 10.1097/00007611-193002000-00004]; Bynoe RP, 2003, J TRAUMA, V55, P74, DOI 10.1097/01.TA.0000026494.22774.A0; Cogbill TH, 2008, J TRAUMA, V65, P994, DOI 10.1097/TA.0b013e318184ce12; Gamanagatti S, 2016, J MAXILLOFAC ORAL SU, V15, P59, DOI 10.1007/s12663-015-0792-3; Radhika N, 2017, T INDIAN I METALS, V70, P2233, DOI 10.1007/s12666-017-1061-6; SOKOLOFF J, 1974, RADIOLOGY, V111, P285, DOI 10.1148/111.2.285; STRUTZ J, 1990, ARCH OTOLARYNGOL, V116, P697	9	1	1	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0266-4356	1532-1940		BRIT J ORAL MAX SURG	Br. J. Oral Maxillofac. Surg.	JUL	2021	59	6					700	704		10.1016/j.bjoms.2020.09.012			5	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	TD9VW	WOS:000669667500014	34092410				2022-02-06	
J	Dong, ZH; Luces, JVS; Hirata, Y				Dong, Zonghao; Luces, Jose Victorio Salazar; Hirata, Yasuhisa			Control and Evaluation of Body Weight Support Walker for Overground Gait Training	IEEE ROBOTICS AND AUTOMATION LETTERS			English	Article						Legged locomotion; Robots; Training; Footwear; Instruments; Control systems; Medical treatment; Physically assistive devices; physical human-robot interaction	CHILDREN; STROKE; SYSTEM	Gait rehabilitation training under robot-assisted partial Body Weight Support (BWS) is a promising technique that helps patients who suffer from a traumatic or congenital brain injury like stroke or cerebral palsy to become independent in daily life activities. In recent years, robotic BWS systems have been widely studied, where the BWS is provided by the robot while the user walks on devices fixed to the environment such as treadmills, thereby gaining functional benefits such as improved gait symmetry and increased walking speed. On the other hand, mobile BWS robots that allow conventional overground walking with well-designed control strategies have been less researched, limiting the widespread adoption of robotic rehabilitation because of the cost effectiveness of fixed robotic devices and poor portability. To address this problem, in our previous study, we developed a mobile BWS walker that allows for overground walking under variable levels of BWS. In this letter, we introduce a system architecture that integrates the walker with a pair of instrumented shoes and discuss different system control strategies including static and variable BWS control. When walking under Static-BWS (SBWS), the subject walks while a constant portion of his/her weight is supported, which might cause an unnatural gait. Using a Variable-BWS (VBWS), the provided BWS can be adjusted according to human's gait events to provide a more natural gait. This letter describes the system architecture, as well as experiments with able subjects that demonstrate the effectiveness of both the SBWS and VBWS control algorithms in relieving part of the subjects' body weight. Specifically, by synchronizing the controlled BWS with human gait events, users were able to walk more naturally, particularly under a high level of BWS.	[Dong, Zonghao; Luces, Jose Victorio Salazar; Hirata, Yasuhisa] Tohoku Univ, Dept Robot, Sendai, Miyagi 9808579, Japan		Dong, ZH (corresponding author), Tohoku Univ, Dept Robot, Sendai, Miyagi 9808579, Japan.	z.dong@srd.mech.tohoku.ac.jp; j.salazar@srd.mech.tohoku.ac.jp; hirata@srd.mech.tohoku.ac.jp		Hirata, Yasuhisa/0000-0002-5931-0471	Japan Science and Technology Agency (JST)Japan Science & Technology Agency (JST) [JPMJMS2034]	This work was supported in part by Japan Science and Technology Agency (JST) [MoonshotR&DProgram] under Grant JPMJMS2034.	Agostini V, 2014, IEEE T NEUR SYS REH, V22, P946, DOI 10.1109/TNSRE.2013.2291907; Aoyagi D, 2007, IEEE T NEUR SYS REH, V15, P387, DOI 10.1109/TNSRE.2007.903922; BARBEAU H, 1987, MED BIOL ENG COMPUT, V25, P341, DOI 10.1007/BF02447435; Chen G., 2001, P 6 ANN GAIT CLIN MO, P25; Dietz V, 2004, J APPL PHYSIOL, V96, P1954, DOI 10.1152/japplphysiol.00942.2003; Dong ZH, 2021, IEEE/SICE I S SYS IN, P554, DOI 10.1109/IEEECONF49454.2021.9382656; Fasoli Susan E, 2012, Am J Phys Med Rehabil, V91, pS280, DOI 10.1097/PHM.0b013e31826bcff4; Franz JR, 2008, J BIOMECH, V41, P3116, DOI 10.1016/j.jbiomech.2008.09.007; Frey M, 2006, IEEE T NEUR SYS REH, V14, P311, DOI 10.1109/TNSRE.2006.881556; Gazzani F, 2000, IEEE T REHABIL ENG, V8, P506, DOI 10.1109/86.895954; Glauser M, 2010, IEEE T CONTR SYST T, V18, P480, DOI 10.1109/TCST.2009.2016953; Gorden K., 2008, U. S. Patent, Patent No. [7 381 163, 7381163]; Hatsukari T, 2009, 2008 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-4, P342, DOI 10.1109/ROBIO.2009.4913027; Kim JC, 2018, J EXERC REHABIL, V14, P1010, DOI 10.12965/jer.1836386.193; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Kurz MJ, 2013, PHYS OCCUP THER PEDI, V33, P353, DOI 10.3109/01942638.2013.771719; Kwak J, 2017, IEEE IND ELEC, P6739, DOI 10.1109/IECON.2017.8217177; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Lewis CL, 2017, ANAT REC, V300, P633, DOI 10.1002/ar.23552; Liao ZY, 2020, IEEE ROBOT AUTOM LET, V5, P5732, DOI 10.1109/LRA.2020.3010447; Luu TP, 2014, IEEE J TRANSL ENG HE, V2, DOI [10.1109/JTEHM.2014.2303807, 10.1109/1TEHM.2014.2303807]; Majnemer A, 2010, DEV MED CHILD NEUROL, V52, P1120, DOI 10.1111/j.1469-8749.2010.03732.x; Meyer-Heim A, 2013, SEMIN PEDIATR NEUROL, V20, P139, DOI 10.1016/j.spen.2013.06.006; Mikolajewska E., 2015, POLISH ANN MED, V22, P98, DOI [10.1016/j.poamed.2015.03.001, DOI 10.1016/J.POAMED.2015.03.001]; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Pohl M, 2002, STROKE, V33, P553, DOI 10.1161/hs0202.102365; Rad MH, 2017, RSI INT CONF ROBOT M, P69, DOI 10.1109/ICRoM.2017.8466140; Shibata Y, 2010, IEEE ENG MED BIO, P4468, DOI 10.1109/IEMBS.2010.5625972; Takeda M., 2020, ROBOMECH J, V7, P2197; Willoughby KL, 2010, ARCH PHYS MED REHAB, V91, P333, DOI 10.1016/j.apmr.2009.10.029; Wittmann F, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0182-1	31	1	1	7	14	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2377-3766			IEEE ROBOT AUTOM LET	IEEE Robot. Autom. Lett.	JUL	2021	6	3					4632	4639		10.1109/LRA.2021.3068691			8	Robotics	Science Citation Index Expanded (SCI-EXPANDED)	Robotics	RO0UL	WOS:000640765600027					2022-02-06	
J	Filev, AD; Silachev, DN; Ryzhkov, IA; Lapin, KN; Babkina, AS; Grebenchikov, OA; Pisarev, VM				Filev, Anton D.; Silachev, Denis N.; Ryzhkov, Ivan A.; Lapin, Konstantin N.; Babkina, Anastasiya S.; Grebenchikov, Oleg A.; Pisarev, Vladimir M.			Effect of Xenon Treatment on Gene Expression in Brain Tissue after Traumatic Brain Injury in Rats	BRAIN SCIENCES			English	Article						TBI; xenon; neuroinflammation; Nanostring; rat; gene expression	D-ASPARTATE RECEPTOR; NOBLE-GAS XENON; COMPETITIVE-INHIBITION; ANESTHETICS; SITE	The overactivation of inflammatory pathways and/or a deficiency of neuroplasticity may result in the delayed recovery of neural function in traumatic brain injury (TBI). A promising approach to protecting the brain tissue in TBI is xenon (Xe) treatment. However, xenon's mechanisms of action remain poorly clarified. In this study, the early-onset expression of 91 target genes was investigated in the damaged and in the contralateral brain areas (sensorimotor cortex region) 6 and 24 h after injury in a TBI rat model. The expression of genes involved in inflammation, oxidation, antioxidation, neurogenesis and neuroplasticity, apoptosis, DNA repair, autophagy, and mitophagy was assessed. The animals inhaled a gas mixture containing xenon and oxygen (phi Xe = 70%; phi O-2 25-30% 60 min) 15-30 min after TBI. The data showed that, in the contralateral area, xenon treatment induced the expression of stress genes (Irf1, Hmox1, S100A8, and S100A9). In the damaged area, a trend towards lower expression of the inflammatory gene Irf1 was observed. Thus, our results suggest that xenon exerts a mild stressor effect in healthy brain tissue and has a tendency to decrease the inflammation following damage, which might contribute to reducing the damage and activating the early compensatory processes in the brain post-TBI.	[Filev, Anton D.; Ryzhkov, Ivan A.; Lapin, Konstantin N.; Babkina, Anastasiya S.; Grebenchikov, Oleg A.; Pisarev, Vladimir M.] VA Negovsky Res Inst Gen Reanimatol, Fed Res & Clin Ctr Intens Care Med & Rehabilitol, Moscow 107031, Russia; [Filev, Anton D.] Res Ctr Med Genet RCMG, Moscow 115478, Russia; [Silachev, Denis N.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Phys Chem Biol, Leninskye Gory 1,Bldg 40, Moscow 119992, Russia		Filev, AD (corresponding author), VA Negovsky Res Inst Gen Reanimatol, Fed Res & Clin Ctr Intens Care Med & Rehabilitol, Moscow 107031, Russia.; Filev, AD (corresponding author), Res Ctr Med Genet RCMG, Moscow 115478, Russia.	anton.d.filev@gmail.com; silachevdn@genebee.msu.su; riamed21@gmail.com; k.n.lapin@gmail.com; asbabkina@gmail.com; oleg.grebenchikov@yandex.ru; vpisarev@gmail.com	Silachev, Denis/ABE-8515-2020; Ryzhkov, Ivan A/J-3491-2018; Pisarev, Vladimir/E-1373-2012	Ryzhkov, Ivan A/0000-0002-0631-5666; Filev, Anton/0000-0002-5962-0541; Pisarev, Vladimir/0000-0002-5729-9846	Ministry of Science and Higher Education of the Russian Federation [AAAA-A19-119032090049-0, AAAA-A19-119100990120-3]; RFBRRussian Foundation for Basic Research (RFBR) [1934-90072]	The study was funded by the Ministry of Science and Higher Education of the Russian Federation (No AAAA-A19-119032090049-0 and AAAA-A19-119100990120-3) and RFBR Grant No. 1934-90072.	AMANO T, 1982, J COMPUT ASSIST TOMO, V6, P923, DOI 10.1097/00004728-198210000-00010; Amer AR, 2018, PEDIATR NEUROL, V84, P5, DOI 10.1016/j.pediatrneurol.2018.02.009; Armstrong SP, 2012, ANESTHESIOLOGY, V117, P38, DOI 10.1097/ALN.0b013e31825ada2e; Bantel C, 2010, ANESTHESIOLOGY, V112, P623, DOI 10.1097/ALN.0b013e3181cf894a; Brehmer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049023; Breuer T, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1082-7; Campos-Pires R, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03373-9; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Fahlenkamp AV, 2011, J MOL NEUROSCI, V45, P48, DOI 10.1007/s12031-010-9432-z; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Gholami K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176368; Greco F, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1843-1; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Jin ZS, 2019, MINERVA ANESTESIOL, V85, P83, DOI 10.23736/S0375-9393.18.12909-9; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Khlusov I.A., 2003, VESTN ROS AKAD MED+, V9, P32; Lavaur J, 2017, J NEUROCHEM, V142, P14, DOI 10.1111/jnc.14041; LAWRENCE JH, 1947, J PHYSIOL-LONDON, V105, P197; Qiu XC, 2020, J NEUROTRAUM, V37, P950, DOI 10.1089/neu.2018.6170; Sun J, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1201-x; Sundaram VK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219440; Swijsen Ann, 2012, BMC Res Notes, V5, P685, DOI 10.1186/1756-0500-5-685; Veldeman M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00511; Wang C, 2019, NEUROSCI LETT, V699, P199, DOI 10.1016/j.neulet.2019.02.012; Wang YZ, 2019, MED GAS RES, V9, P80, DOI 10.4103/2045-9912.260649; Wright CJ, 2009, PEDIATR RES, V66, P3, DOI 10.1203/PDR.0b013e3181a2c184; Wu LZ, 2019, J ANESTH, V33, P321, DOI 10.1007/s00540-019-02623-7; Wyllie J, 2015, RESUSCITATION, V95, P249, DOI 10.1016/j.resuscitation.2015.07.029	32	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JUL	2021	11	7							889	10.3390/brainsci11070889			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TN7HA	WOS:000676400500001	34356124	gold, Green Published			2022-02-06	
J	Gracies, JM; Francisco, GE; Jech, R; Khatkova, S; Rios, CD; Maisonobe, P				Gracies, Jean-Michel; Francisco, Gerard E.; Jech, Robert; Khatkova, Svetlana; Rios, Carl D.; Maisonobe, Pascal		ENGAGE Study Grp	Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						botulinum toxins; exercise therapy; muscle spasticity; self-rehabilitation; self-stretching	INDUCED MOVEMENT THERAPY; UPPER EXTREMITY FUNCTION; TRAUMATIC BRAIN-INJURY; BOTULINUM TOXIN; RANDOMIZED-TRIAL; CHRONIC STROKE; REINFORCEMENT; INTENSITY; EFFICACY; ARM	Background and Purpose: Guided self-rehabilitation contracts (GSCs) are a diary-based rehabilitation strategy, wherein specific muscles are identified for prescription of high-load, home self-stretching techniques. We assessed the effect of GSCs combined with simultaneous upper limb (UL) and lower limb (LL) abobotulinumtoxinA injections on composite active range of motion (CXA) in adults with chronic spastic paresis. Methods: This was an international, prospective, single-arm, open-label study (ENGAGE, NCT02969356). Personalized GSCs were monitored by phone every other week, alongside 2 consecutive abobotulinumtoxinA injections (1500 U) across UL and LL, over 6 to 9 months. Primary outcomes were responder rates (CXA improvement >= 35 degrees [UL] or >= 5 degrees [LL]) at week 6 cycle 2. Secondary outcomes were active function (UL: Modified Frenchay Scale [MFS]; LL: 10-m barefoot maximal walking speed [WS]) and quality of life (12-item Short Form Health Survey, SF-12). Results: Of the 153 treated participants, 136 had primary endpoint data; 72.1% (95% confidence interval [CI], 64.0-78.9) were responders. Mean (SD) CXA changes from baseline to last study visit were +49.3 degrees (63.4) for UL and +20.1 degrees (27.6) for LL. Mean (95% CI) changes from baseline to week 12 cycle 2 were +0.55 (0.43-0.66) in MFS, +0.12 m/s (0.09-0.15) for WS, and +4.0 (2.8-5.2) for SF-12 physical scores. In the safety population (n = 157), 49.7% of participants reported treatment-emergent adverse events (AEs); 12.1% reported 25 serious AEs. Discussion and Conclusions: GSC combined with simultaneous UL and LL abobotulinumtoxinA injections led to improvements in CXA and function in both limbs, and quality-of-life physical scores. These results suggest the beneficial effect of combined GSC and abobotulinumtoxinA therapy in the management of spastic paresis. Video Abstract available for more insight from the authors (see the Supplementary Video, available at: ).	[Gracies, Jean-Michel] Univ Paris Est Creteil, Albert Chenevier Henri Mondor Hosp, Dept Neurorehabil, UR 7377 BIOTN, Creteil, France; [Francisco, Gerard E.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Francisco, Gerard E.] TIRR Mem Hermann, Neurorecovery Res Ctr, Houston, TX USA; [Jech, Robert] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Jech, Robert] Gen Fac Hosp, Prague, Czech Republic; [Khatkova, Svetlana] Ctr Minist Hlth & Social Dev Russian Federat, Fed State Hosp, Neurol Dept, Treatments & Rehabil, Moscow, Russia; [Rios, Carl D.; Maisonobe, Pascal] Ipsen Pharma, Boulogne, France		Gracies, JM (corresponding author), Univ Paris Est Creteil, Hosp Albert Chenevier Henri Mondor, Serv Reeduc Neurolocomotrice, UR 7377 BIOTN, F-94000 Creteil, France.	jean-michel.gracies@aphp.fr			IpsenIpsen	The authors thank all participants involved in the study, as well as their caregivers, care team, investigators of the ENGAGE study group, and research staff in participating institutions. The authors also thank Jacqueline Harte, BSc (Hons), of Watermeadow Medical, an Ashfield Company, for providing medical writing support, which was sponsored by Ipsen in accordance with Good Publication Practice guidelines.	Baude M, 2019, ANN PHYS REHABIL MED, V62, P426, DOI 10.1016/j.rehab.2018.10.004; Bayle N, 2016, ANN PHYS REHABIL MED, V59, pE59; Bayles N, 2020, CLIN REHABIL, V34, P803, DOI 10.1177/0269215520911970; Esquenazi A, 2008, AM J PHYS MED REHAB, V87, P305, DOI 10.1097/PHM.0b013e318168d36c; Feys H, 2004, STROKE, V35, P924, DOI 10.1161/01.STR.0000121645.44752.f7; Fleuren JFM, 2010, J NEUROL NEUROSUR PS, V81, P46, DOI 10.1136/jnnp.2009.177071; Gracies JM, 2015, ANN PHYS REHABIL MED, V58, P173, DOI 10.1016/j.rehab.2015.04.004; Gracies JM, 2010, EUR J PHYS REHAB MED, V46, P411; Gracies JM, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1257-y; Gracies JM, 2018, MUSCLE NERVE, V57, P245, DOI 10.1002/mus.25721; Gracies JM, 2017, NEUROLOGY, V89, P2245, DOI 10.1212/WNL.0000000000004687; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Gracies JM, 2009, ARCH PHYS MED REHAB, V90, P9, DOI 10.1016/j.apmr.2008.04.030; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; GRACIES JM, 2016, GUIDED SELF REHABILI; Gupta AD, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-017-0670-9; HANEL F, 1980, INT J REHABIL RES, V3, P505, DOI 10.1097/00004356-198012000-00004; Harris JE, 2007, PHYS THER, V87, P88, DOI 10.2522/ptj.20060065; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hu XL, 2007, ARCH PHYS MED REHAB, V88, P1022, DOI 10.1016/j.apmr.2007.05.006; Hutin E, 2018, TOP STROKE REHABIL, V25, P345, DOI 10.1080/10749357.2018.1460932; Knight C, 2002, BRAIN INJURY, V16, P75, DOI 10.1080/02699050110082188; Kulendran M, 2016, PSYCHOL HEALTH, V31, P1332, DOI 10.1080/08870446.2016.1204452; Kwakkel G, 1997, STROKE, V28, P1550, DOI 10.1161/01.STR.28.8.1550; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; Lenderking WR, 2008, CONTEMP CLIN TRIALS, V29, P867, DOI 10.1016/j.cct.2008.05.012; Leonard C T, 1998, J Stroke Cerebrovasc Dis, V7, P145, DOI 10.1016/S1052-3057(98)80142-0; McAllister PJ, 2019, J REHABIL MED, V51, P813, DOI 10.2340/16501977-2604; Meimoun M, 2015, REV NEUROL-FRANCE, V171, P130, DOI 10.1016/j.neurol.2014.09.011; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; NOLAND MP, 1989, RES Q EXERCISE SPORT, V60, P216, DOI 10.1080/02701367.1989.10607443; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Patel Atul T, 2020, JMIR Public Health Surveill, V6, pe17928, DOI 10.2196/17928; Patrick E, 2006, CLIN REHABIL, V20, P173, DOI 10.1191/0269215506cr922oa; Patten C, 2004, J REHABIL RES DEV, V41, P293, DOI 10.1682/JRRD.2004.03.0293; Pila O, 2018, INT J NEUROSCI, V128, P1030, DOI 10.1080/00207454.2018.1461626; PRADINES M, 2018, ANN PHYS REHABIL MED, V61, pE 440; Pradines M, 2019, NEUROREHAB NEURAL RE, V33, P245, DOI 10.1177/1545968319829455; Pradines M, 2018, PM&R, V10, P1020, DOI 10.1016/j.pmrj.2018.02.013; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; SKILBECK CE, 1983, J NEUROL NEUROSUR PS, V46, P5, DOI 10.1136/jnnp.46.1.5; Sun SF, 2010, NEUROREHAB NEURAL RE, V24, P34, DOI 10.1177/1545968309341060; SUNDERLAND A, 1992, J NEUROL NEUROSUR PS, V55, P530, DOI 10.1136/jnnp.55.7.530; Tyson SF, 2018, CLIN REHABIL, V32, P1145, DOI 10.1177/0269215518777789; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Vinti M, 2015, J NEURAL TRANSM, V122, P1089, DOI 10.1007/s00702-015-1379-3; Vinti M, 2013, CLIN NEUROPHYSIOL, V124, P528, DOI 10.1016/j.clinph.2012.08.010; Vinti M, 2012, MUSCLE NERVE, V46, P926, DOI 10.1002/mus.23427; Wagner JM, 2006, NEUROREHAB NEURAL RE, V20, P406, DOI 10.1177/1545968306286957; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Winstein CJ, 2003, NEUROREHAB NEURAL RE, V17, P137, DOI 10.1177/0888439003255511; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	53	1	1	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUL	2021	45	3					203	213		10.1097/NPT.0000000000000359			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	SZ9GX	WOS:000666866500002	34039905	hybrid, Green Published			2022-02-06	
J	Guan, RQ; Li, ZH; Dai, XH; Zou, W; Yu, XP; Liu, H; Chen, QX; Teng, W; Liu, P; Liu, XY; Dong, SS				Guan, Ruiqiao; Li, Zhihao; Dai, Xiaohong; Zou, Wei; Yu, Xueping; Liu, Hao; Chen, Qiuxin; Teng, Wei; Liu, Peng; Liu, Xiaoying; Dong, Shanshan			Electroacupuncture at GV20-GB7 regulates mitophagy to protect against neurological deficits following intracerebral hemorrhage via inhibition of apoptosis	MOLECULAR MEDICINE REPORTS			English	Article						intracerebral hemorrhage; electroacupuncture; autophagy; mitophagy; apoptosis	CEREBRAL ISCHEMIC-INJURY; TRAUMATIC BRAIN-INJURY; BCL-2 FAMILY-MEMBERS; CELL-DEATH; SUBARACHNOID HEMORRHAGE; SCALP ACUPUNCTURE; RAT MODEL; MITOCHONDRIAL DYSFUNCTION; AUTOPHAGY ACTIVATION; MEDIATED MITOPHAGY	The acupuncture penetrating line of Baihui (GV20) to Qubin (GB7) spans the parietal, frontal and temporal lobes. The present study aimed to elucidate the mechanism by which electroacupuncture (EA) at GV20-GB7 regulates mitophagy in intracerebral hemorrhage (ICH) and whether it serves a neuroprotective role. A whole blood-induced ICH model was used. Mitophagy-regulating proteins, including BCL/adenovirus E1B 19 kDa-interacting protein 3 (BNIP3), PTEN-induced putative kinase 1 (PINK1), Parkin and apoptosis-associated proteins were detected by western blotting; autophagy following ICH was evaluated by immunofluorescent techniques; morphological characteristics of mitophagy were observed using transmission electron microscopy; and TUNEL assay was performed to determine the number of apoptotic cells. Immunohistochemistry was used to detect p53 expression. The protective role of EA (GV20-GB7) via enhanced mitophagy and suppressed apoptosis in ICH was further confirmed by decreased modified neurological severity score. The results showed that EA (GV20-GB7) treatment upregulated mitochondrial autophagy following ICH and inhibited apoptotic cell death. The mechanism underlying EA (GV20-GB7) treatment may involve inhibition of p53, an overlapping protein of autophagy and apoptosis. EA (GV20-GB7) treatment decreased neurobehavioral deficits following ICH but pretreatment with 3-methyladenine counteracted the beneficial effects of EA (GV20-GB7) treatment. In conclusion, EA (GV20-GB7) improved recovery from ICH by regulating the balance between mitophagy and apoptosis.	[Guan, Ruiqiao] Fudan Univ, Zhongshan Hosp, Dept Integrated Chinese & Western Med, Shanghai 200032, Peoples R China; [Guan, Ruiqiao; Dai, Xiaohong; Zou, Wei; Yu, Xueping; Chen, Qiuxin; Teng, Wei; Liu, Peng; Liu, Xiaoying; Dong, Shanshan] Heilongjiang Univ Chinese Med, Dept Clin Med, Harbin 150040, Heilongjiang, Peoples R China; [Guan, Ruiqiao; Dai, Xiaohong; Zou, Wei; Yu, Xueping; Chen, Qiuxin; Teng, Wei; Liu, Peng; Liu, Xiaoying; Dong, Shanshan] Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Acupuncture & Moxibust 3, 26 Heping Rd, Harbin 150040, Heilongjiang, Peoples R China; [Guan, Ruiqiao; Chen, Qiuxin; Dong, Shanshan] Heilongjiang Univ Chinese Med, Clin Key Lab Integrated Chinese & Western Med, Harbin 150040, Heilongjiang, Peoples R China; [Guan, Ruiqiao] London South Bank Univ, Dept Tradit Chinese Med, London SE1 6RD, England; [Guan, Ruiqiao] London Confucius Inst Tradit Chinese Med, Clin Tradit Chinese Med, London SE1 0AA, England; [Li, Zhihao] Shanghai Univ Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Acupuncture & Moxibust, Shanghai 200437, Peoples R China; [Liu, Hao] Tongdc Hosp Zhejiang Prov, Dept Acupuncture & Moxibust, Hangzhou 315099, Zhejiang, Peoples R China		Zou, W (corresponding author), Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Acupuncture & Moxibust 3, 26 Heping Rd, Harbin 150040, Heilongjiang, Peoples R China.	visa4journals@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81473764, 81273824]; Key Program of Natural Science Foundation of Heilongjiang Province of China [ZD 201204]; Doctoral Fund of Ministry of Education of ChinaMinistry of Education, China [20102327110003]; Science Foundation for Young Scholars of Zhongshan Hospital, Fudan University [2020ZSQN65]	The present study was supported by the National Natural Science Foundation of China (grant no. 81473764,81273824), the Key Program of Natural Science Foundation of Heilongjiang Province of China (grant no. ZD 201204), the Doctoral Fund of Ministry of Education of China (grant no. 20102327110003) and the Science Foundation for Young Scholars of Zhongshan Hospital, Fudan University (grant no. 2020ZSQN65).	Baek SH, 2014, STROKE, V45, P2438, DOI 10.1161/STROKEAHA.114.005183; Belur PK, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1317; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Cao SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02679-z; CAPLAN LR, 1992, LANCET, V339, P656, DOI 10.1016/0140-6736(92)90804-C; Chen B, 2017, EXP CELL RES, V351, P163, DOI 10.1016/j.yexcr.2016.12.028; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen XL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01356; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2003, J CLIN IMMUNOL, V23, P355, DOI 10.1023/A:1025365432325; Choe SC, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0115-9; Colbert AP, 2011, J ACUPUNCT MERIDIAN, V4, P5, DOI 10.1016/S2005-2901(11)60002-2; COUNSELL C, 1995, CEREBROVASC DIS, V5, P26, DOI 10.1159/000107814; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Di Y, 2015, MOL MED, V21, P420, DOI 10.2119/molmed.2015.00038; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Feng X, 2011, EMBO J, V30, P3397, DOI 10.1038/emboj.2011.248; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Graef M, 2011, AUTOPHAGY, V7, P1245, DOI 10.4161/auto.7.10.16508; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guan RQ, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0487-4; Guo ZS, 2014, J NEUROSCI RES, V92, P1295, DOI 10.1002/jnr.23400; Han HJ, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/295475; Hanna Akram R., 2019, UC SAN DIEGO ELECT T, P12; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Health N., 1985, 1RR22135 NIH, P11; Hendgen-Cotta UB, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040687; Hoshino A, 2012, J MOL CELL CARDIOL, V52, P175, DOI 10.1016/j.yjmcc.2011.10.008; HUA X, 1987, Journal of Traditional Chinese Medicine, V7, P301; Jevtic G, 2016, PROG NEURO-PSYCHOPH, V66, P87, DOI 10.1016/j.pnpbp.2015.11.014; Jing CH, 2012, NEUROSCIENCE, V213, P144, DOI 10.1016/j.neuroscience.2012.03.055; Jittiwat J, 2017, J ACUPUNCT MERIDIAN, V10, P324, DOI 10.1016/j.jams.2017.08.003; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kim-Han JS, 2006, STROKE, V37, P2457, DOI 10.1161/01.STR.0000240674.99945.4e; Kissova I, 2006, J BIOL CHEM, V281, P36187, DOI 10.1074/jbc.M607444200; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Lang Yi, 2016, Zhongguo Zhong Xi Yi Jie He Za Zhi, V36, P294; Langevin HM, 2015, J ALTERN COMPLEM MED, V21, P113, DOI 10.1089/acm.2014.0186; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li HQ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7308261; Li J, 2014, BRAIN RES, V1573, P74, DOI 10.1016/j.brainres.2014.05.021; Li Q, 2014, BIOCHEM BIOPH RES CO, V444, P182, DOI 10.1016/j.bbrc.2014.01.032; Li XX, 2015, J HISTOCHEM CYTOCHEM, V63, P301, DOI 10.1369/0022155415574818; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Liu H, 2017, COMPLEMENT THER MED, V32, P85, DOI 10.1016/j.ctim.2017.03.014; Liu L, 2014, CELL RES, V24, P787, DOI 10.1038/cr.2014.75; Liu WL, 2016, INT J MOL MED, V37, P309, DOI 10.3892/ijmm.2015.2425; Liu XY, 2018, NEURAL REGEN RES, V13, P1425, DOI 10.4103/1673-5374.235298; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; [马洪涛 Ma Hongtao], 2017, [细胞与分子免疫学杂志, Chinese Journal of Cellular and Molecular Immunology], V33, P155; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Moll UM, 2001, FEBS LETT, V493, P65, DOI 10.1016/S0014-5793(01)02284-0; Morselli E, 2008, CELL CYCLE, V7, P3056, DOI 10.4161/cc.7.19.6751; Namas RA, 2011, SHOCK, V36, P196, DOI 10.1097/SHK.0b013e3182205e07; NEHLS DG, 1988, NEUROSURGERY, V23, P439, DOI 10.1227/00006123-198810000-00006; Ney PA, 2015, BBA-MOL CELL RES, V1853, P2775, DOI 10.1016/j.bbamcr.2015.02.022; Niu MM, 2017, TRANSL NEUROSCI, V8, P37, DOI 10.1515/tnsci-2017-0008; Shao AW, 2016, MOL NEUROBIOL, V53, P18, DOI 10.1007/s12035-014-8986-0; Shen Z, 2017, AUTOPHAGY, V13, P473, DOI 10.1080/15548627.2016.1274596; Shi RY, 2014, CNS NEUROSCI THER, V20, P1045, DOI 10.1111/cns.12325; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; SUN S, 1985, Journal of Traditional Chinese Medicine, V5, P167; Tan HY, 2015, PROTEOMICS, V15, P500, DOI 10.1002/pmic.201400171; Tang Y, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170803; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Wagner DC, 2011, BRAIN RES, V1381, P237, DOI 10.1016/j.brainres.2011.01.041; Wang C, 2016, PHARMACOL RES, V105, P164, DOI 10.1016/j.phrs.2016.01.028; Wang EY, 2013, HYPERTENSION, V62, P70, DOI 10.1161/HYPERTENSIONAHA.113.01028; Wang HQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005562; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wang WW, 2014, SCI REP-UK, V4, DOI 10.1038/srep03981; Wei HF, 2015, BBA-MOL CELL RES, V1853, P2784, DOI 10.1016/j.bbamcr.2015.03.013; Wu M, 2021, ACTA PHARMACOL SIN, V42, P199, DOI 10.1038/s41401-020-0480-9; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Wu YY, 2013, AUTOPHAGY, V9, P595, DOI 10.4161/auto.23641; Wu ZQ, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/9121597; Wu ZQ, 2015, MOL MED REP, V11, P4438, DOI 10.3892/mmr.2015.3253; Xia DY, 2013, BRAZ J MED BIOL RES, V46, P580, DOI 10.1590/1414-431X20133161; Yan J, 2006, BIOCHEM BIOPH RES CO, V346, P501, DOI 10.1016/j.bbrc.2006.05.160; Yang Y, 2010, BIOCHEM BIOPH RES CO, V395, P190, DOI 10.1016/j.bbrc.2010.03.155; Yin CS, 2008, RES VET SCI, V84, P159, DOI 10.1016/j.rvsc.2007.04.004; Yin Zheng-Lu, 2020, Zhongguo Zhen Jiu, V40, P918, DOI 10.13703/j.0255-2930.20190819-0001; Yuan Y, 2017, AUTOPHAGY, V13, P1754, DOI 10.1080/15548627.2017.1357792; Zhang B, 2018, NEURAL REGEN RES, V13, P1602, DOI 10.4103/1673-5374.237123; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang SH, 2015, STROKE, V46, P1301, DOI 10.1161/STROKEAHA.114.007659; Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132; Zheng GQ, 2011, J ALTERN COMPLEM MED, V17, P293, DOI 10.1089/acm.2010.0156; Zhou F, 2011, J APPL PHYSIOL, V111, P1877, DOI 10.1152/japplphysiol.00313.2011; Zhu Y, 2017, BRAIN RES BULL, V131, P123, DOI 10.1016/j.brainresbull.2017.04.003; Zou W, 2015, NEURAL REGEN RES, V10, P457, DOI 10.4103/1673-5374.153696; Zuo T, 2017, NEUROSCI LETT, V661, P41, DOI 10.1016/j.neulet.2017.06.043; Zuo W, 2014, NEUROPHARMACOLOGY, V86, P103, DOI 10.1016/j.neuropharm.2014.07.002	96	1	1	2	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JUL	2021	24	1							492	10.3892/mmr.2021.12131			15	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	SD6KR	WOS:000651484600001	33955500	hybrid, Green Published			2022-02-06	
J	He, R; Han, W; Song, XJ; Cheng, L; Chen, HS; Jiang, L				He, Rong; Han, Wei; Song, Xiaojie; Cheng, Li; Chen, Hengsheng; Jiang, Li			Knockdown of Lingo-1 by short hairpin RNA promotes cognitive function recovery in a status convulsion model	3 BIOTECH			English	Article						Status convulsion; Epilepsy; Epileptogenesis; Lingo-1; Cognitive function	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL MYELIN; RAT MODEL; IMPAIRMENT; EPILEPSY	The purpose of this study was to determine the dynamic changes of the Nogo-66 receptor 1 (NgR1) pathway during epileptogenesis and the potential beneficial of leucine-rich repeat and Ig-like domain-containing Nogo receptor interacting protein 1 (Lingo-1) inhibition on epilepsy rats. The hippocampal changes of the NgR1 pathway during epileptogenesis were determined by western blot analysis of multiple proteins, including neurite outgrowth inhibitor protein A (NogoA), myelin-associated glycoprotein (MAG), oligodendrocyte-myelin glycoprotein (OMgp), Lingo-1, ras homolog family member A (RhoA) and phosphorylated RhoA (p-RhoA). Lentivirus-mediated short hairpin RNA (shRNA) was used to knockdown the hippocampal expression of Lingo-1. Novel object recognition (NOR) test and Morris Water Maze (MWM) test were employed to determine the cognitive functions of rats. Hematoxylin and eosin (H&E) staining, protein expressions of RhoA, p-RhoA, and myelin basic protein (MBP), as well as convulsion susceptibility test were additionally performed. Our results showed that the NgR1 pathway was activated during epileptogenesis, characterized by up-regulation of NogoA, MAG, OMgp, and Lingo-1, which was especially significant at the chronic phase of epilepsy. The cognitive function, convulsion susceptibility and hippocampal neuronal survival of rats were impaired at the chronic phase of epileptogenesis but all improved by Lingo-1 inhibition; besides, the hippocampal protein expressions of p-RhoA and MBP were significantly decreased at the chronic phase of SC rats but increased after Lingo-1 inhibition. Our results demonstrated that Lingo-1 shRNA can improve epilepsy-induced cognitive impairment, which may be related with the pro-myelination and neuroprotection effects of Lingo-1 inhibition.	[He, Rong] Chongqing Hlth Ctr Women & Children, Dept Pediat, Chongqing 400013, Peoples R China; [Han, Wei; Song, Xiaojie; Jiang, Li] Chongqing Med Univ, Dept Neurol, Childrens Hosp, Chongqing 400014, Peoples R China; [Cheng, Li; Chen, Hengsheng] Chongqing Med Univ, Lab Neurol, Childrens Hosp, Chongqing, Peoples R China; [Jiang, Li] Minist Educ, China Int Sci & Technol Cooperat Base Child Dev &, Chongqing Key Lab Pediat, Key Lab Pediat,Natl Clin Res Ctr Child Hlth & Dis, Chongqing, Peoples R China		He, R (corresponding author), Chongqing Hlth Ctr Women & Children, Dept Pediat, Chongqing 400013, Peoples R China.; Jiang, L (corresponding author), Chongqing Med Univ, Dept Neurol, Childrens Hosp, Chongqing 400014, Peoples R China.; Jiang, L (corresponding author), Minist Educ, China Int Sci & Technol Cooperat Base Child Dev &, Chongqing Key Lab Pediat, Key Lab Pediat,Natl Clin Res Ctr Child Hlth & Dis, Chongqing, Peoples R China.	652055610@qq.com; li_jiang0920@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371452]; Chongqing Municipal Planning Commission of science and Research Fund [2015XMSB000712]	This work was supported by the grants from the National Natural Science Foundation of China (grant number 81371452) and Chongqing Municipal Planning Commission of science and Research Fund (grant number 2015XMSB000712).	Avanzini G, 2013, EPILEPSIA, V54, P14, DOI 10.1111/epi.12418; Borham LE, 2016, BRAIN RES, V1648, P418, DOI 10.1016/j.brainres.2016.07.046; Chen DL, 2014, J ETHNOPHARMACOL, V154, P206, DOI 10.1016/j.jep.2014.04.004; Collins C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4984; Dean DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163774; Drenthen GS, 2019, EPILEPSIA, V60, P1689, DOI 10.1111/epi.16280; Kesselmayer RF, 2020, DEV MED CHILD NEUROL, V62, P587, DOI 10.1111/dmcn.14477; Gao F, 2014, NEUROPSYCH DIS TREAT, V10, P2139, DOI 10.2147/NDT.S73210; Hei Y, 2019, BEHAV BRAIN RES, V365, P141, DOI 10.1016/j.bbr.2019.02.046; Holmes GL, 2015, EPILEPTIC DISORD, V17, P101, DOI 10.1684/epd.2015.0739; Kalemenev S V, 2015, Dokl Biol Sci, V463, P175, DOI 10.1134/S0012496615040055; Kavroulakis E, 2018, J MAGN RESON IMAGING, V47, P1359, DOI 10.1002/jmri.25849; Legriel S, 2010, CRIT CARE MED, V38, P2295, DOI 10.1097/CCM.0b013e3181f859a6; Li GM, 2013, NEUROL SCI, V34, P963, DOI 10.1007/s10072-012-1173-z; Lopes MW, 2016, EPILEPSY BEHAV, V55, P92, DOI 10.1016/j.yebeh.2015.12.001; Luo YY, 2015, BRAIN RES, V1627, P154, DOI 10.1016/j.brainres.2015.09.027; Ma L, 2015, BRAIN RES, V1622, P443, DOI 10.1016/j.brainres.2015.07.012; Ma T, 2019, EXP NEUROL, V321, DOI 10.1016/j.expneurol.2019.113034; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Mi S, 2013, CNS DRUGS, V27, P493, DOI 10.1007/s40263-013-0068-8; Niu HM, 2020, BRAIN RES, V1743, DOI 10.1016/j.brainres.2020.146902; Song XJ, 2018, NEUROCHEM RES, V43, P721, DOI 10.1007/s11064-018-2474-2; Starkey HDV, 2013, EUR J NEUROSCI, V37, P1643, DOI 10.1111/ejn.12165; Tan XQ, 2019, MED SCI MONITOR, V25, P2066, DOI 10.12659/MSM.912283; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Wu D., 2018, CNS NEUROL DISORD-DR, V16, P51, DOI [10.2174/1871527315666160915150754, DOI 10.2174/1871527315666160915150754]; Wu HF, 2013, BIOMATERIALS, V34, P1686, DOI 10.1016/j.biomaterials.2012.11.013; Zhou W, 2015, INT J CLIN EXP MED, V8, P16445; [朱孔江 Zhu Kongjiang], 2013, [第三军医大学学报, Journal of Third Military Medical University], V35, P1076	29	1	1	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2190-572X	2190-5738		3 BIOTECH	3 Biotech	JUL	2021	11	7							339	10.1007/s13205-021-02876-8			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	UJ7BU	WOS:000691437800005	34221810	Bronze			2022-02-06	
J	Hentig, J; Cloghessy, K; Hyde, DR				Hentig, James; Cloghessy, Kaylee; Hyde, David R.			Shuttle Box Assay as an Associative Learning Tool for Cognitive Assessment in Learning and Memory Studies using Adult Zebrafish	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article							TRAUMATIC BRAIN-INJURY; REGENERATION; SYSTEM; MODEL; GLIA; RISK	Cognitive deficits, including impaired learning and memory, are a primary symptom of various developmental and age-related neurodegenerative diseases and traumatic brain injury (TBI). Zebrafish are an important neuroscience model due to their transparency during development and robust regenerative capabilities following neurotrauma. While various cognitive tests exist in zebrafish, most of the cognitive assessments that are rapid examine non-associative learning. At the same time, associative-learning assays often require multiple days or weeks. Here, we describe a rapid associative-learning test that utilizes an adverse stimulus (electric shock) and requires minimal preparation time. The shuttle box assay, presented here, is simple, ideal for novice investigators, and requires minimal equipment. We demonstrate that, following TBI, this shuttle box test reproducibly assesses cognitive deficit and recovery from young to old zebrafish. Additionally, the assay is adaptable to examine either immediate or delayed memory. We demonstrate that both a single TBI and repeated TBI events negatively affect learning and immediate memory but not delayed memory. We, therefore, conclude that the shuttle box assay reproducibly tracks the progression and recovery of cognitive impairment.	[Hentig, James; Cloghessy, Kaylee; Hyde, David R.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Hentig, James; Cloghessy, Kaylee; Hyde, David R.] Univ Notre Dame, Ctr Zebrafish Res, Notre Dame, IN 46556 USA; [Hentig, James; Cloghessy, Kaylee; Hyde, David R.] Univ Notre Dame, Ctr Stem Cells & Regenerat Med, Notre Dame, IN 46556 USA		Hyde, DR (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Hyde, DR (corresponding author), Univ Notre Dame, Ctr Zebrafish Res, Notre Dame, IN 46556 USA.; Hyde, DR (corresponding author), Univ Notre Dame, Ctr Stem Cells & Regenerat Med, Notre Dame, IN 46556 USA.	dhyde@nd.edu			Center for Zebrafish Research at the University of Notre Dame; Center for Stem Cells and Regenerative Medicine at the University of Notre Dame; National Eye Institute of NIH [R01-EY018417]; National Science Foundation Graduate Research Fellowship ProgramNational Science Foundation (NSF); LTC Neil Hyland Fellowship of Notre Dame; Sentinels of Freedom Fellowship; Pat Tillman Scholarship	The authors would like to thank the Hyde lab members for their thoughtful discussions and the Freimann Life Sciences Center technicians for zebrafish care and husbandry. This work was supported by the Center for Zebrafish Research at the University of Notre Dame, the Center for Stem Cells and Regenerative Medicine at the University of Notre Dame, and grants from National Eye Institute of NIH R01-EY018417 (DRH), the National Science Foundation Graduate Research Fellowship Program (JTH), LTC Neil Hyland Fellowship of Notre Dame (JTH), Sentinels of Freedom Fellowship (JTH), and the Pat Tillman Scholarship (JTH). Figure 1 made with BioRender.com.	Bahl A, 2020, NAT NEUROSCI, V23, P94, DOI 10.1038/s41593-019-0534-9; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Bhattarai P, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000585; Hieu BTN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041464; Campbell LJ, 2021, GLIA, V69, P546, DOI 10.1002/glia.23912; Chanin S, 2012, ZEBRAFISH PROTOCOLS, V66; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gaspary KV, 2018, NEUROBIOL LEARN MEM, V155, P249, DOI 10.1016/j.nlm.2018.08.005; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Green LA, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000159; Hentig J., J VIS EXP; Hentig JT, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091445; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lahne M, 2020, ANNU REV VIS SCI, V6, P171, DOI 10.1146/annurev-vision-121219-081808; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lopez-Schier H, 2019, CURR OPIN NEUROBIOL, V54, P134, DOI 10.1016/j.conb.2018.10.004; Maheras AL, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0208-17.2017; Rea V, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.575575; Williams FE, 2002, BEHAV PROCESS, V58, P125, DOI 10.1016/S0376-6357(02)00025-6; Wu YJ, 2017, ZEBRAFISH, V14, P438, DOI 10.1089/zeb.2017.1446; Yu LL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000014; Zhdanova IV, 2008, BRAIN RES BULL, V75, P433, DOI 10.1016/j.brainresbull.2007.10.053; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	32	1	1	4	4	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUL	2021		173							e62745	10.3791/62745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TX0QO	WOS:000682796200079	34309605				2022-02-06	
J	Hughes, P; Alter, S; Greaves, S; Mazer, B; Solano, J; Shih, RC; Clayton, L; Trinh, N; Lottenberg, L; Hughes, M				Hughes, Patrick; Alter, Scott; Greaves, Spencer; Mazer, Benjamin; Solano, Joshua; Shih, Richard; Clayton, Lisa; Trinh, Nhat; Lottenberg, Lawrence; Hughes, Mary			Acute and delayed intracranial hemorrhage in head-injured patients on warfarin versus direct oral anticoagulant therapy	JOURNAL OF EMERGENCIES TRAUMA AND SHOCK			English	Article						Anticoagulants; direct oral anticoagulant; head injury; intracranial hemorrhage; warfarin	TRAUMATIC BRAIN-INJURY; PREINJURY WARFARIN; OLDER-ADULTS; LEVEL FALL; ANTIPLATELET; RISK; COMPLICATIONS	Introduction: Direct oral anticoagulant (DOAC) use for thrombosis treatment and prophylaxis is a popular alternative to warfarin. This study compares rates of traumatic intracranial hemorrhage (ICH) for patients on anticoagulant therapies and the effect of combined anticoagulant and antiplatelet therapies. Methods: A retrospective observational study of trauma patients was conducted at two level I trauma centers. Patients aged >= 18 years with preinjury use of an anticoagulant (warfarin, rivaroxaban, apixaban, or dabigatran) who sustained a blunt head injury within the past day were included. Patients were evaluated by head CT to evaluate for ICH. Results: Three hundred and eighty-eight patients were included (140 on warfarin, 149 on a DOAC, and 99 on combined anticoagulant and antiplatelet therapies). Seventy-nine patients (20.4%) had an acute ICH, while 16 patients (4.1%) had a delayed ICH found on routine repeat CT. Those on combination therapy were not at increased risk of acute ICH (relative risk [RR] 0.90, confidence interval [CI]: 0.56-1.44; P > 0.5) or delayed ICH (RR 2.19, CI: 0.84-5.69; P = 0.10) compared to anticoagulant use only. Those on warfarin were at increased risk of acute ICH (RR 1.75, CI: 1.10-2.78, P = 0.015), but not delayed ICH (RR 0.99, CI 0.27-3.59, P > 0.5), compared to those on DOACs. No delayed ICH patients died or required neurosurgical intervention. Conclusion: Patients on warfarin had a higher rate of acute ICH, but not delayed ICH, compared to those on DOACs. Given the low rate of delayed ICH with no resultant morbidity or mortality, routine observation and repeat head CT on patients with no acute ICH may not be necessary.	[Hughes, Patrick; Alter, Scott; Greaves, Spencer; Mazer, Benjamin; Solano, Joshua; Shih, Richard; Clayton, Lisa] Florida Atlantic Univ, Charles E Schmidt Coll Med, Div Emergency Med, Boca Raton, FL 33431 USA; [Trinh, Nhat] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Surg, Boca Raton, FL 33431 USA; [Lottenberg, Lawrence] St Marys Hosp, W Palm Beach, FL USA; [Lottenberg, Lawrence] Sparrow Hosp, Dept Emergency Med, Lansing, MI USA; [Hughes, Mary] Michigan State Univ, Coll Osteopath Med, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA		Hughes, P (corresponding author), Florida Atlantic Univ, Div Emergency Med, Bethesda Hlth, GME Suite,Lower Level,2815 South Seacrest Blvd, Boynton Beach, FL 33435 USA.	hughesp@health.fau.edu		Alter, Scott/0000-0003-3824-6308			Afaneh Amer, 2018, BMC Res Notes, V11, P183, DOI 10.1186/s13104-018-3291-z; Alrajhi KN, 2015, J EMERG MED, V48, P137, DOI 10.1016/j.jemermed.2014.08.016; Antoni A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111780; Barmparas G, 2019, AM J SURG, V217, P1051, DOI 10.1016/j.amjsurg.2018.10.016; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; Cohan CM, 2020, J SURG RES, V249, P114, DOI 10.1016/j.jss.2019.11.009; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Feeney JM, 2016, J TRAUMA ACUTE CARE, V81, P843, DOI 10.1097/TA.0000000000001245; Galliazzo S, 2019, THROMB RES, V174, P113, DOI 10.1016/j.thromres.2018.12.015; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Karni A, 2001, AM SURGEON, V67, P1098; Major J, 2009, EMERG MED J, V26, P871, DOI 10.1136/emj.2008.068643; Mason S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014324; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Minhas H, 2018, BRIT J HAEMATOL, V183, P119, DOI 10.1111/bjh.15509; Mowbray F, 2020, CAN J EMERG MED, V22, P74, DOI 10.1017/cem.2019.432; Nearing KI, 2017, NEUROL-CLIN PRACT, V7, P280, DOI 10.1212/CPJ.0000000000000385; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Scheetz LJ, 2015, INT EMERG NURS, V23, P162, DOI 10.1016/j.ienj.2014.09.003; Schoonman GG, 2014, EUR J NEUROL, V21, P1021, DOI 10.1111/ene.12429; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; Ting C, 2019, J AM COLL CARDIOL, V73, P526, DOI 10.1016/j.jacc.2018.11.024; Turcato G, 2019, J EMERG MED, V57, P817, DOI 10.1016/j.jemermed.2019.09.007; Uccella L, 2018, WORLD NEUROSURG, V110, pE339, DOI 10.1016/j.wneu.2017.10.173; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Verschoof MA, 2018, J NEUROL, V265, P315, DOI 10.1007/s00415-017-8701-y; Wiegele M, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2352-6	33	1	1	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	0974-2700	0974-519X		J EMERG TRAUMA SHOCK	J. Emerg. Trauma Shock	JUL-SEP	2021	14	3					123	127		10.4103/JETS.JETS_139_20			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	XG8ZA	WOS:000725035000002	34759629				2022-02-06	
J	Khalili, H; Kashkooli, NR; Niakan, A; Asadi-Pooya, AA				Khalili, Hosseinali; Kashkooli, Nima Rahimi; Niakan, Amin; Asadi-Pooya, Ali A.			Risk factors for post-traumatic epilepsy	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Epilepsy; Head injury; Seizure; Trauma	SEVERE HEAD-INJURY; SEIZURES	Purpose: The aim of the current study was to investigate the risk factors for post-traumatic epilepsy (PTE) in a large cohort of patients after severe non-penetrating civilian traumatic brain injury (TBI). Methods: This was a longitudinal study. All patients with a severe non-penetrating TBI, who were admitted at the neuro-intensive care unit of Shahid Rajaee Trauma Hospital, affiliated with Shiraz University of Medical Sciences, Shiraz, Iran, from 2015 until 2019, were studied. Severe TBI was defined as a Glasgow Coma Scale-Motor score below six. Post-traumatic epilepsy was defined as any seizures that occurred after being discharged from the hospital. Results: In total, 803 patients with severe non-penetrating TBI were studied; 82 patients (10.2%) reported any late post-traumatic seizures (PTSs). A higher Glasgow outcome scale (extended) at discharge was significantly inversely associated with PTE [Odds Ratio (OR)= 0.76, 95% Confidence Interval (CI): 0.65-0.87; p = 0.0001]. Depressed skull fracture (OR= 1.88, 95% CI: 0.92-3.80; p = 0.081), epi-dural hematoma (OR= 1.67, 95% CI: 0.93-2.97; p = 0.083), and sub-dural hematoma (OR= 1.64, 95% CI: 0.96-2.78; p = 0.068) were associated with PTE as trends. Conclusion: Our study adds to the literature on the risk of PTE after severe non-penetrating civilian TBI. Our large sample size and also the application of a logistic regression analysis model may suggest that other variables (e.g., depressed skull fracture and intracranial hematoma) are indeed associated with the Glasgow outcome scale (extended) at discharge and that is why they lost their significance in the model.	[Khalili, Hosseinali; Niakan, Amin] Shiraz Univ Med Sci, Dept Neurosurg, Shahid Rajaee Emtiaz Trauma Hosp, Trauma Res Ctr, Shiraz, Iran; [Kashkooli, Nima Rahimi] Shiraz Univ Med Sci, Shiraz Med Sch, Shiraz, Iran; [Asadi-Pooya, Ali A.] Shiraz Univ Med Sci, Epilepsy Res Ctr, Shiraz, Iran; [Asadi-Pooya, Ali A.] Thomas Jefferson Univ, Dept Neurol, Jefferson Comprehens Epilepsy Ctr, Philadelphia, PA 19107 USA		Asadi-Pooya, AA (corresponding author), Shiraz Univ Med Sci, Epilepsy Res Ctr, Shiraz, Iran.	aliasadipooya@yahoo.com			Shiraz University of Medical Sciences	This work was supported by Shiraz University of Medical Sciences. The funding source had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Chen W, 2017, NEUROPSYCH DIS TREAT, V13, P2301, DOI 10.2147/NDT.S141486; Engel J, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.107735; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Klein P, 2020, EPILEPSIA, V61, P359, DOI 10.1111/epi.16450; Lingsma HF, 2017, YOUMANS WINN TXB NEU, VSeventh, P2971; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Saletti PG, 2019, NEUROBIOL DIS, V123, P86, DOI 10.1016/j.nbd.2018.06.017; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Yeatts SD, 2020, J NEUROTRAUM, V37, P2674, DOI 10.1089/neu.2019.6969	12	1	1	4	5	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	JUL	2021	89						81	84		10.1016/j.seizure.2021.05.004			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TC2JZ	WOS:000668469100018	34023655				2022-02-06	
J	Knippenberg, E; Lamers, I; Timmermans, A; Spooren, A				Knippenberg, Els; Lamers, Ilse; Timmermans, Annick; Spooren, Annemie			Motivation, Usability, and Credibility of an Intelligent Activity-Based Client-Centred Training System to Improve Functional Performance in Neurological Rehabilitation: An Exploratory Cohort Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						client-centred; task-oriented; neurorehabilitation; technology; motivation	TRAUMATIC BRAIN-INJURY; VIRTUAL-REALITY; UPPER-LIMB; INTRINSIC MOTIVATION; MULTIPLE-SCLEROSIS; EXERCISE THERAPY; MOTOR IMPAIRMENT; STROKE; IMPACT; SURVIVORS	(1) Background: technology-based training systems are increasingly integrated in neurorehabilitation but are rarely combined with a client-centred task-oriented approach. To provide a low-cost client-centred task-oriented system, the intelligent activity-based client-centred task-oriented training (i-ACT) was developed. The objective was to evaluate the usability, credibility and treatment expectancy of i-ACT, and the motivation towards i-ACT use in rehabilitation over time. Additionally, this study will evaluate the upper limb treatment effects after training with i-ACT. (2) Methods: a mixed-method study was performed in four rehabilitation centres. Training with i-ACT was provided during six weeks, three times per week, forty-five minutes per day, additional to conventional care. (3) Results: seventeen persons with central nervous system diseases were included. High scores were seen in the system usability scale (score >= 73.8/100), credibility (score >= 22.0/27.0)/expectancy (score >= 15.8/27.0) questionnaire, and intrinsic motivation inventory (score >= 5.2/7.0), except the subscale pressure (score <= 2.0/7.0). Results from the interviews corroborate these findings and showed that clients and therapists believe in the i-ACT system as an additional training support system. Upper limb functional ability improved significantly (p < 0.05) over time on the Wolf motor function test. (4) Conclusion: i-ACT is a client-centred task-oriented usable and motivational system which has the potential to enhance upper limb functional training in persons with neurological diseases.	[Knippenberg, Els; Spooren, Annemie] PXL Univ Appl Sci & Arts, Ctr Expertise Innovat Care, Dept Healthcare, B-3500 Hasselt, Limburg, Belgium; [Knippenberg, Els; Lamers, Ilse; Timmermans, Annick; Spooren, Annemie] Hasselt Univ, Fac Rehabil Sci, REVAL, B-3590 Diepenbeek, Limburg, Belgium; [Lamers, Ilse] Noorderhart, Rehabil & MS Ctr, B-3900 Pelt, Limburg, Belgium		Knippenberg, E (corresponding author), PXL Univ Appl Sci & Arts, Ctr Expertise Innovat Care, Dept Healthcare, B-3500 Hasselt, Limburg, Belgium.; Knippenberg, E (corresponding author), Hasselt Univ, Fac Rehabil Sci, REVAL, B-3590 Diepenbeek, Limburg, Belgium.	Els.Knippenberg@PXL.be; Ilse.Lamers@Noorderhart.be; Annick.Timmermans@uhasselt.be; Annemie.Spooren@PXL.be		Lamers, Ilse/0000-0001-6147-4769; Knippenberg, Els/0000-0002-9676-8633; Timmermans, Annick/0000-0002-5461-947X			Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Bangor A, 2009, J USABILITY STUD, V4, P114; Bodiam C., 1999, BRIT J OCCUP THER, V62, P123, DOI [10.1177/030802269906200310, DOI 10.1177/030802269906200310]; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Chan C. C. H, 1997, OCCUP THER INT, V4, P231, DOI [10.1002/oti.58, DOI 10.1002/OTI.58]; Chen CC, 2010, ARCH PHYS MED REHAB, V91, P414, DOI 10.1016/j.apmr.2009.11.012; Chen L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7309272; DECI EL, 1994, J PERS, V62, P119, DOI 10.1111/j.1467-6494.1994.tb00797.x; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Dominguez-Tellez P, 2020, GAMES HEALTH J, V9, P1, DOI 10.1089/g4h.2019.0043; Duff M, 2013, NEUROREHAB NEURAL RE, V27, P306, DOI 10.1177/1545968312465195; Fasoli Susan E, 2004, Top Stroke Rehabil, V11, P11; Feys P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0043-3; Finley JM, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.577713; Gamito P, 2017, DISABIL REHABIL, V39, P385, DOI 10.3109/09638288.2014.934925; Jager J, 2017, MONOGR SOC RES CHILD, V82, P13, DOI 10.1111/mono.12296; Knippenberg E., 2016, AUSTIN J ROBOT AUTOM, V3, P1; Knippenberg E, 2020, TECHNOL HEALTH CARE, V28, P355, DOI 10.3233/THC-191854; Knippenberg E, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0270-x; Kos D, 2005, MULT SCLER, V11, P76, DOI 10.1191/1352458505ms1117oa; Kos D, 2003, ACTA NEUROL BELG, V103, P185; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; de Araujo AVL, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7106951; Lamers I, 2014, ARCH PHYS MED REHAB, V95, P1184, DOI 10.1016/j.apmr.2014.02.023; Laver KE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008349.pub4; Levin MF, 2012, NEUROL THER, V1, DOI 10.1007/s40120-012-0003-9; Lewis JR, 2009, LECT NOTES COMPUT SC, V5619, P94, DOI 10.1007/978-3-642-02806-9_12; Llorens R, 2015, ARCH PHYS MED REHAB, V96, P418, DOI 10.1016/j.apmr.2014.10.019; Lozano-Quilis JA, 2014, JMIR SERIOUS GAMES, V2, P43, DOI 10.2196/games.2933; Mehrholz J, 2020, J NEUROENG REHABIL, V17, DOI 10.1186/s12984-020-00715-0; Mubin Omar, 2019, JMIR Rehabil Assist Technol, V6, pe12010, DOI 10.2196/12010; Paquin K, 2016, DISABIL REHABIL, V38, P2144, DOI 10.3109/09638288.2015.1114155; de Heredia-Torres MP, 2020, EUR J PHYS REHAB MED, V56, P148, DOI 10.23736/S1973-9087.20.05914-6; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Prange GB, 2006, J REHABIL RES DEV, V43, P171, DOI 10.1682/JRRD.2005.04.0076; Rietberg MB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003980.pub2; RYAN RM, 1983, J PERS SOC PSYCHOL, V45, P736, DOI 10.1037/0022-3514.45.4.736; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Sin H, 2013, AM J PHYS MED REHAB, V92, P871, DOI 10.1097/PHM.0b013e3182a38e40; Smidt N, 2005, AUST J PHYSIOTHER, V51, P71, DOI 10.1016/S0004-9514(05)70036-2; Spooren AIF, 2011, SPINAL CORD, V49, P1049, DOI 10.1038/sc.2011.54; Spooren AIF, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-49; Stinear CM, 2020, LANCET NEUROL, V19, P348, DOI 10.1016/S1474-4422(19)30415-6; Timmermans AAA, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-45; Timmermans AAA, 2010, NEUROREHAB NEURAL RE, V24, P858, DOI 10.1177/1545968310368963; Tsigilis N, 2003, PERCEPT MOTOR SKILL, V97, P271, DOI 10.2466/PMS.97.4.271-280; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; Vanmulken DAMM, 2015, SPINAL CORD, V53, P547, DOI 10.1038/sc.2014.250; Veerbeek JM, 2017, NEUROREHAB NEURAL RE, V31, P107, DOI 10.1177/1545968316666957; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Verheyden G, 2006, SOUTH AFR J PHYSIOTH, V62, P23; Verheyden G, 2004, CLIN REHABIL, V18, P326, DOI 10.1191/0269215504cr733oa; Webster D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-108; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640	56	1	1	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JUL	2021	18	14							7641	10.3390/ijerph18147641			16	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	TN7WI	WOS:000676440300001	34300092	Green Published			2022-02-06	
J	Kontos, AP; Eagle, SR; Marchetti, G; Sinnott, A; Mucha, A; Port, N; Ferris, LM; Elbin, RJ; Clugston, JR; Ortega, J; Collins, MW				Kontos, Anthony P.; Eagle, Shawn R.; Marchetti, Gregory; Sinnott, Aaron; Mucha, Anne; Port, Nicholas; Ferris, Lyndsey M.; Elbin, R. J.; Clugston, James R.; Ortega, Justus; Collins, Michael W.			Discriminative Validity of Vestibular Ocular Motor Screening in Identifying Concussion Among Collegiate Athletes: A National Collegiate Athletic Association-Department of Defense Concussion Assessment, Research, and Education Consortium Study	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; athlete; vestibular; oculomotor; clinical cutoffs; VOMS; Vestibular; Ocular Motor Screening	POSTURAL STABILITY; VOMS; CONVERGENCE; RELIABILITY; PERFORMANCE; SYMPTOMS; RECOVERY; DEFICITS; YOUTH; RISK	Background: Vestibular and ocular motor screening tools, such as the Vestibular/Ocular Motor Screening (VOMS), are recognized as important components of a multifaceted evaluation of sport-related concussion. Previous research has supported the predictive utility of the VOMS in identifying concussion, but researchers have yet to examine the predictive utility of the VOMS among collegiate athletes in the first few days after injury. Purpose: To determine the discriminative validity of individual VOMS item scores and an overall VOMS score for identifying collegiate athletes with an acute sport-related concussion (<= 72 hours) from healthy controls matched by age, sex, and concussion history. Study Design: Case-control study; Level of evidence, 3. Methods: Participants (N = 570) aged 17 to 25 years were included from 8 institutions of the National Collegiate Athletic Association-Department of Defense CARE Consortium (Concussion Assessment, Research, and Education): 285 athletes who were concussed (per current consensus guidelines) and 285 healthy controls matched by age, sex, and concussion history. Participants completed the VOMS within 3 days of injury (concussion) or during preseason (ie, baseline; control). Symptoms are totaled for each VOMS item for an item score (maximum, 40) and totaled across items for an overall score (maximum, 280), and distance (centimeters) for near point of convergence (NPC) is averaged across 3 trials. Receiver operating characteristic analysis of the area under the curve (AUC) was performed on cutoff scores using Youden index (J) for each VOMS item, overall VOMS score, and NPC distance average. A logistic regression was conducted to identify which VOMS scores identified concussed status. Results: A symptom score >= 1 on each VOMS item and horizontal vestibular/ocular reflex >= 2 significantly discriminated concussion from control (AUC, 0.89-0.90). NPC distance did not significantly identify concussion from control (AUC, 0.51). The VOMS overall score had the highest accuracy (AUC, 0.91) for identifying sport-related concussion from control. Among the individual items, vertical saccades >= 1 and horizontal vestibular/ocular reflex >= 2 best discriminated concussion from control. Conclusion: The findings indicate that individual VOMS items and overall VOMS scores are useful in identifying concussion in collegiate athletes within 3 days of injury. Clinicians can use the cutoffs from this study to help identify concussion in collegiate athletes.	[Kontos, Anthony P.; Eagle, Shawn R.; Marchetti, Gregory; Sinnott, Aaron; Mucha, Anne; Port, Nicholas; Ferris, Lyndsey M.; Elbin, R. J.; Clugston, James R.; Ortega, Justus; Collins, Michael W.] Univ Pittsburgh, Pittsburgh, PA USA; [Kontos, Anthony P.; Eagle, Shawn R.; Sinnott, Aaron; Mucha, Anne; Collins, Michael W.] Univ Pittsburgh, Dept Orthoped Surg, UPMC Sports Med Concuss Program, Med Ctr, 3850 S Water St, Pittsburgh, PA 15203 USA; [Marchetti, Gregory] Duquesne Univ, Pittsburgh, PA 15219 USA; [Ferris, Lyndsey M.] Indiana Univ, Bloomington, IN USA; [Elbin, R. J.] Univ Arkansas, Fayetteville, AR 72701 USA; [Clugston, James R.] Univ Florida, Gainesville, FL USA; [Ortega, Justus] Humboldt State Univ, Arcata, CA 95521 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthoped Surg, UPMC Sports Med Concuss Program, Med Ctr, 3850 S Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Sinnott, Aaron/0000-0002-8887-759X; Clugston, James/0000-0002-2103-1039	Grand Alliance CARE Consortium (Concussion Assessment, Research, and Education) - National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense; US Army Medical Research Acquisition Activity; Office of the Assistant Secretary of Defense for Health Affairs, through the Combat Casualty Care Research Program; Department of Defense, through the Joint Program Committee 6/Combat Casualty Care Research Program-Psychological Health and Traumatic Brain Injury ProgramUnited States Department of Defense [W81XWH1420151]; National Football League for research through the University of Pittsburgh	The study was supported by the Grand Alliance CARE Consortium (Concussion Assessment, Research, and Education), funded in part by the National Collegiate Athletic Association and the Department of Defense. The US Army Medical Research Acquisition Activity is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Combat Casualty Care Research Program, and endorsed by the Department of Defense, through the Joint Program Committee 6/Combat Casualty Care Research Program-Psychological Health and Traumatic Brain Injury Program (award W81XWH1420151). M.W.C. was a shareholder and cofounder of ImPACT Applications Inc. A.P.K. and M.W.C. receive funding from the National Football League for research through the University of Pittsburgh and royalties from APA Books. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Sherry NS, 2021, CLIN J SPORT MED, V31, P244, DOI 10.1097/JSM.0000000000000740; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Trbovich AM, 2019, BRAIN INJURY, V33, P1545, DOI 10.1080/02699052.2019.1658131; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010	29	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2021	49	8					2211	2217		10.1177/03635465211012359			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	TC4KN	WOS:000668609500032	33979240				2022-02-06	
J	Lauby, RS; Cuenca, CM; Borgman, MA; Fisher, AD; Bebarta, VS; Moore, EE; Spinella, PC; Bynum, J; Schauer, SG				Lauby, Ryann S.; Cuenca, Camaren M.; Borgman, Matthew A.; Fisher, Andrew D.; Bebarta, Vikhyat S.; Moore, Earnest E.; Spinella, Philip C.; Bynum, James; Schauer, Steven G.			An analysis of outcomes for pediatric trauma warm fresh whole blood recipients in Iraq and Afghanistan	TRANSFUSION			English	Article						blood; military; pediatric; trauma; whole	MASSIVE TRANSFUSION; IMPROVED SURVIVAL; MILITARY; RESUSCITATION; HEMORRHAGE; APHERESIS	Background: Whole blood therapy-which contains the ideal balance of components, and particularly fresh whole blood-has been shown to be beneficial in adult trauma. It remains unclear whether there is potential benefit in the pediatric population. Study Design and Methods: This is a secondary analysis of previously published data analyzing pediatric casualties undergoing massive transfusion in the Department of Defense Trauma Registry. Pediatric patients with traumatic injury who were transfused at least one blood product were included in the analysis. We compared children who received component therapy exclusively to those who received any amount of warm fresh whole blood. Results: Of the 3439 pediatric casualties within our dataset, 1244 were transfused at least one blood product within the first 24 h. There were 848 patients without severe head injury. Within this cohort, 23 children received warm fresh whole blood overall, 20 of whom did not have severe head injury. In an adjusted analysis, the odds ratio (95% confidence interval [CI]) for survival for warm fresh whole blood recipients was 2.86 (0.40-20.45). After removing children with severe brain injury, there was an independent association with improved survival for warm fresh whole blood recipients with an odds ratio (95% CI) of 58.63 (2.70-1272.67). Discussion: Our data suggest that warm fresh whole blood may be associated with improved survival in children without severe head injury. Larger prospective studies are needed to assess the efficacy and safety of whole blood in children with severe traumatic bleeding.	[Lauby, Ryann S.; Cuenca, Camaren M.; Bynum, James; Schauer, Steven G.] US Army, Inst Surg Res, JBSA Ft Sam Houston, San Antonio, TX USA; [Borgman, Matthew A.; Schauer, Steven G.] Brooke Army Med Ctr, JBSA Ft Sam Houston, San Antonio, TX USA; [Borgman, Matthew A.; Schauer, Steven G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Fisher, Andrew D.] Univ New Mexico, Sch Med, Dept Surg, Albuquerque, NM 87131 USA; [Borgman, Matthew A.] Texas Army Natl Guard, Med Command, Austin, TX USA; [Fisher, Andrew D.; Bebarta, Vikhyat S.; Moore, Earnest E.] Univ Colorado, Dept Emergency Med, Ctr COMBAT Res, Anschutz Med Campus, Aurora, CO USA; [Spinella, Philip C.] Washington Univ, Dept Pediat, Div Crit Care, St Louis, MO 63130 USA		Schauer, SG (corresponding author), Steven Schauer 3698, Jbsa Ft Sam Houston, TX 78234 USA.	steven.g.schauer.mil@mail.mil	Fisher, Andrew/ABF-1845-2021; Spinella, Philip/AAV-8531-2021	Fisher, Andrew/0000-0003-1994-7774; Cuenca, Camaren/0000-0002-2528-4148			Barret JP, 1999, J TRAUMA, V47, P526, DOI 10.1097/00005373-199909000-00016; De Pascale MR, 2019, ANN I SUPER SANITA, V55, P351, DOI 10.4415/ANN_19_04_08; Fisher AD, 2020, J SPEC OPER MED, V20, P21; Fisher AD, 2020, J TRAUMA ACUTE CARE, V89, P834, DOI 10.1097/TA.0000000000002863; Glenn Michael Alan, 2008, J Trauma Nurs, V15, P181, DOI 10.1097/01.JTN.0000343323.47463.aa; Kaada SH, 2019, TRANSFUSION, V59, P1446, DOI 10.1111/trf.15184; Kendigelen P, 2016, ULUS TRAVMA ACIL CER, V22, P195, DOI 10.5505/tjtes.2015.40697; Le TD, 2016, J TRAUMA ACUTE CARE, V81, P114, DOI 10.1097/TA.0000000000001032; Leeper CM, 2019, J TRAUMA ACUTE CARE, V87, P49, DOI 10.1097/TA.0000000000002340; Leeper CM, 2018, JAMA PEDIATR, V172, P491, DOI 10.1001/jamapediatrics.2017.5238; National Academies of Sciences E Medicine., 2016, NATL TRAUMA CARE SYS; Naylor JF, 2020, MIL MED, V185, pE1903, DOI 10.1093/milmed/usaa197; Neff LP, 2015, J TRAUMA ACUTE CARE, V78, P22, DOI 10.1097/TA.0000000000000488; Nessen SC, 2013, TRANSFUSION, V53, p107S, DOI 10.1111/trf.12044; Nordin A, 2018, J PEDIATR SURG, V53, P130, DOI 10.1016/j.jpedsurg.2017.10.023; Nystrup KB, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0097-z; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Perkins JG, 2011, TRANSFUSION, V51, P242, DOI 10.1111/j.1537-2995.2010.02818.x; Repine TB, 2006, J TRAUMA, V60, pS59, DOI 10.1097/01.ta.0000219013.64168.b2; Robinson John B, 2016, US Army Med Dep J, P87; Schauer Stephen G, 2017, US Army Med Dep J, P92; Schauer SG, 2020, J TRAUMA ACUTE CARE, V89, pS185, DOI 10.1097/TA.0000000000002590; Schauer SG, 2020, AM J EMERG MED, V38, P895, DOI 10.1016/j.ajem.2019.07.007; Schauer SG, 2018, PREHOSP EMERG CARE, V22, P608, DOI 10.1080/10903127.2018.1428839; Schauer SG, 2018, PREHOSP EMERG CARE, V22, P624, DOI 10.1080/10903127.2018.1439130; Schauer SG, 2018, AM J EMERG MED, V36, P1540, DOI 10.1016/j.ajem.2018.01.014; Schauer SG, 2019, AM J EMERG MED, V37, P94, DOI 10.1016/j.ajem.2018.04.068; Spinella PC, 2008, CRIT CARE MED, V36, pS340, DOI 10.1097/CCM.0b013e31817e2ef9; Spinella PC, 2009, J TRAUMA, V66, pS69, DOI 10.1097/TA.0b013e31819d85fb; Warner Nicholas, 2018, J Spec Oper Med, V18, P15	30	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	JUL	2021	61			1	SI		S2	S7		10.1111/trf.16504			6	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	TK3EO	WOS:000674046200002	34269463	Bronze			2022-02-06	
J	Lempke, LB; Oh, J; Johnson, RS; Schmidt, JD; Lynall, RC				Lempke, Landon B.; Oh, Jeonghoon; Johnson, Rachel S.; Schmidt, Julianne D.; Lynall, Robert C.			Single- Versus Dual-Task Functional Movement Paradigms: A Biomechanical Analysis	JOURNAL OF SPORT REHABILITATION			English	Article						cognitive loading; concussion; sports medicine; human movement; return to sport	ERROR SCORING SYSTEM; LANDING BIOMECHANICS; NEUROMUSCULAR CONTROL; POSTURAL STABILITY; SUBSEQUENT INJURY; ENERGY-ABSORPTION; COGNITIVE TASK; RISK; JOINT; PERFORMANCE	Context: Laboratory-based movement assessments are commonly performed without cognitive stimuli (ie, single-task) despite the simultaneous cognitive processing and movement (ie, dual task) demands required during sport. Cognitive loading may critically alter human movement and be an important consideration for truly assessing functional movement and understanding injury risk in the laboratory, but limited investigations exist. Objective: To comprehensively examine and compare kinematics and kinetics between single- and dual-task functional movement among healthy participants while controlling for sex. Design: Cross-sectional study. Setting: Laboratory. Patients (or Other Participants): Forty-one healthy. physically active participants (49% female; 22.5 +/- 2.1 y; 172.5 +/- 11.9 cm; 71.0 +/- 13.7 kg) enrolled in and completed the study. Intervention(s): All participants completed the functional movement protocol under single- and dual-task (subtracting by 6s or 7s) conditions in a randomized order. Participants jumped forward from a 30-cm tall box and performed (1) maximum vertical jump landings and (2) dominant and (3) nondominant leg, single-leg 45 degrees cuts after landing. Main Outcome Measures: The authors used mixed-model analysis of variances (alpha = .05) to compare peak hip, knee, and ankle joint angles (degrees) and moments (N.m/BW) in the sagittal and frontal planes, and peak vertical ground reaction force (N/BW) and vertical impulse (Ns/BW) between cognitive conditions and sex. Results: Dual-task resulted in greater peak vertical ground reaction force compared with single-task during jump landing (mean difference = 0.06 N/BW; 95% confidence interval [CI]. 0.01 to 0.12; P = .025) but less force during dominant leg cutting (mean difference =-0.08 N/BW; 95% CL -0.14 to -0.02; P= .015). Less hip-flexion torque occurred during dual task than single task (mean difference = -0.09 N/BW; 95% CI, -0.17 to -0.02). No other outcomes were different between single and dual task (P >= .053). Conclusions: Slight, but potentially important. kinematic and kinetic differences were observed between single- and dual-task that may have implications for functional movement assessments and injury risk research. More research examining how various cognitive and movement tasks interact to alter functional movement among pathological populations is warranted before clinical implementation.	[Lempke, Landon B.; Oh, Jeonghoon; Johnson, Rachel S.; Schmidt, Julianne D.; Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Biomech Lab, Athens, GA 30602 USA; [Lempke, Landon B.; Johnson, Rachel S.; Schmidt, Julianne D.; Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA		Lynall, RC (corresponding author), Univ Georgia, Dept Kinesiol, UGA Biomech Lab, Athens, GA 30602 USA.; Lynall, RC (corresponding author), Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA.	rlynall@uga.edu	; Lynall, Robert/M-2888-2014	Oh, Jeonghoon/0000-0002-9185-7362; Lynall, Robert/0000-0002-0785-6640	University of Georgia Mary Frances Early College of Education	We would like to thank the following undergraduate and graduate students for their assistance in data processing: Aashka J. Sheth, Anoop S. Gundala, Ridge Maxson, Karsyn Archambeau, and Melissa N. Anderson, MS. This study was funded by the University of Georgia Mary Frances Early College of Education. The authors declare they have no potential conflicts of interest.	Almonroeder TG, 2018, J ORTHOP SPORT PHYS, V48, P381, DOI 10.2519/jospt.2018.7739; Ardakani MK, 2019, J ATHL TRAINING, V54, P1296, DOI 10.4085/1062-6050-550-17; Besier TF, 2001, MED SCI SPORT EXER, V33, P1176; Bodkin S, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117719041; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Dai BY, 2018, SPORT BIOMECH, V17, P192, DOI 10.1080/14763141.2016.1265579; Decker MJ, 2003, CLIN BIOMECH, V18, P662, DOI 10.1016/S0268-0033(03)00090-1; Delahunt E, 2006, J ORTHOP RES, V24, P1991, DOI 10.1002/jor.20235; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; DuPrey KM, 2016, AM J SPORT MED, V44, P1487, DOI 10.1177/0363546516629635; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Gulbrandsen M, 2019, J ATHL TRAINING, V54, P881, DOI 10.4085/1062-6050-144-18; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Holden S, 2016, SPORTS MED, V46, P241, DOI 10.1007/s40279-015-0416-6; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Kernozek TW, 2008, AM J SPORT MED, V36, P554, DOI 10.1177/0363546507308934; Kirsch AN, 2019, J ATHL TRAINING, V54, P1260, DOI 10.4085/1062-6050-266-18; Lapointe AP, 2018, INT J PSYCHOPHYSIOL, V132, P93, DOI 10.1016/j.ijpsycho.2017.08.003; Lawrence RK, 2008, CLIN BIOMECH, V23, P806, DOI 10.1016/j.clinbiomech.2008.02.009; Lee S, 2018, KOREAN J ANESTHESIOL, V71, P353, DOI 10.4097/kja.d.18.00242; Lempke LB, 2020, MED SCI SPORT EXER, V52, P1650, DOI 10.1249/MSS.0000000000002300; Lisman P, 2013, MED SCI SPORT EXER, V45, P636, DOI 10.1249/MSS.0b013e31827a1c4c; Lynall RC, 2019, J SCI MED SPORT, V22, P503, DOI 10.1016/j.jsams.2018.10.012; Lynall RC, 2018, ARCH PHYS MED REHAB, V99, P880, DOI 10.1016/j.apmr.2017.12.011; McLean SG, 2010, CLIN BIOMECH, V25, P563, DOI 10.1016/j.clinbiomech.2010.02.013; McPherson AL, 2020, SPORTS MED, V50, P1203, DOI 10.1007/s40279-020-01262-3; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Mohammadi-Rad S, 2016, J SPORT REHABIL, V25, P324, DOI 10.1123/jsr.2015-0012; Montalvo AM, 2019, BRIT J SPORT MED, V53, P1003, DOI 10.1136/bjsports-2016-096274; Moran RW, 2017, BRIT J SPORT MED, V51, P1661, DOI 10.1136/bjsports-2016-096938; Padua DA, 2018, J ATHL TRAINING, V53, P5, DOI 10.4085/1062-6050-99-16; Padua DA, 2015, J ATHL TRAINING, V50, P589, DOI 10.4085/1062-6050-50.1.10; Padua DA, 2009, AM J SPORT MED, V37, P1996, DOI 10.1177/0363546509343200; Plummer P, 2013, ARCH PHYS MED REHAB, V94, P2565, DOI 10.1016/j.apmr.2013.08.002; Prodromos CC, 2007, ARTHROSCOPY, V23, P1320, DOI 10.1016/j.arthro.2007.07.003; Rahnama L, 2010, J ORTHOP SPORT PHYS, V40, P180, DOI 10.2519/jospt.2010.3188; Schmitz RJ, 2010, J ATHL TRAINING, V45, P445, DOI 10.4085/1062-6050-45.5.445; Shinya M, 2011, GAIT POSTURE, V34, P55, DOI 10.1016/j.gaitpost.2011.03.011; Shultz SJ, 2015, J ATHL TRAINING, V50, P486, DOI 10.4085/1062-6050-49.5.08; Simon JE, 2020, PHYS THER SPORT, V41, P97, DOI 10.1016/j.ptsp.2019.12.002; Springer S, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1675-1; Talarico MK, 2017, J SPORT SCI, V35, P1118, DOI 10.1080/02640414.2016.1211307; Tukey JW, 1953, PROBLEM MULTIPLE COM; Wilkerson GB, 2017, CURR SPORT MED REP, V16, P419, DOI 10.1249/JSR.0000000000000430	48	1	1	3	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JUL	2021	30	5					774	785		10.1123/jsr.2020-0310			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	SU0XU	WOS:000662866100012	33494045				2022-02-06	
J	Mahncke, HW; DeGutis, J; Levin, H; Newsome, MR; Bell, MD; Grills, C; French, LM; Sullivan, KW; Kim, SJ; Rose, A; Stasio, C; Merzenich, MM				Mahncke, Henry W.; DeGutis, Joseph; Levin, Harvey; Newsome, Mary R.; Bell, Morris D.; Grills, Chad; French, Louis M.; Sullivan, Katherine W.; Kim, Sarah-Jane; Rose, Annika; Stasio, Catherine; Merzenich, Michael M.			A randomized clinical trial of plasticity-based cognitive training in mild traumatic brain injury	BRAIN			English	Article						concussion; traumatic brain injury; cognitive training; brain plasticity; randomized controlled trial	POSTTRAUMATIC-STRESS-DISORDER; EXECUTIVE FUNCTION; NORMATIVE DATA; OLDER-ADULTS; REHABILITATION; OUTCOMES; MEMORY; BLAST; SPEED; INTERVENTION	Clinical practice guidelines support cognitive rehabilitation for people with a history of mild traumatic brain injury (mTBI) and cognitive impairment, but no class I randomized clinical trials have evaluated the efficacy of self-administered computerized cognitive training. The goal of this study was to evaluate the efficacy of a self-administered computerized plasticity-based cognitive training programmes in primarily military/veteran participants with a history of mTBI and cognitive impairment. A multisite randomized double-blind clinical trial of a behavioural intervention with an active control was conducted from September 2013 to February 2017 including assessments at baseline, post-training, and after a 3-month follow-up period. Participants self-administered cognitive training (experimental and active control) programmes at home, remotely supervised by a healthcare coach, with an intended training schedule of 5 days per week, 1 h per day, for 13 weeks. Participants (149 contacted, 83 intent-to-treat) were confirmed to have a history of mTBI (mean of 7.2 years post-injury) through medical history/clinician interview and persistent cognitive impairment through neuropsychological testing and/or quantitative participant reported measure. The experimental intervention was a brain plasticity-based computerized cognitive training programme targeting speed/accuracy of information processing, and the active control was composed of computer games. The primary cognitive function measure was a composite of nine standardized neuropsychological assessments, and the primary directly observed functional measure a timed instrumental activities of daily living assessment. Secondary outcome measures included participant-reported assessments of cognitive and mental health. The treatment group showed an improvement in the composite cognitive measure significantly larger than that of the active control group at both the post-training [+6.9 points, confidence interval (CI) +1.0 to +12.7, P = 0.025, d = 0.555] and the follow-up visit (+7.4 points, CI +0.6 to +14.3, P = 0.039, d = 0.591). Both large and small cognitive function improvements were seen twice as frequently in the treatment group than in the active control group. No significant between-group effects were seen on other measures, including the directly-observed functional and symptom measures. Statistically equivalent improvements in both groups were seen in depressive and cognitive symptoms.	[Mahncke, Henry W.; Kim, Sarah-Jane; Rose, Annika; Stasio, Catherine; Merzenich, Michael M.] Posit Sci Corp, San Francisco, CA USA; [DeGutis, Joseph] VA Boston Healthcare Syst, Boston, MA USA; [DeGutis, Joseph] Harvard Med Sch, Boston, MA 02115 USA; [Levin, Harvey; Newsome, Mary R.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Levin, Harvey; Newsome, Mary R.] Baylor Coll Med, Houston, TX 77030 USA; [Bell, Morris D.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Bell, Morris D.] Yale Univ, Sch Med, West Haven, CT 06516 USA; [Grills, Chad] Desmond T Doss Hlth Clin, Oahu, HI USA; [French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [French, Louis M.; Sullivan, Katherine W.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Mahncke, HW (corresponding author), Posit Sci, 160 Pine St,Suite 200, San Francisco, CA 94111 USA.	henry.mahncke@positscience.com		Bell, Morris/0000-0003-0795-9196	CDMRP grant [PT100024]	The BRAVE study was funded by a CDMRP grant (PT100024) made to Posit Science as the coordinating centre, with subcontracts to each of the individual trial sites.	Allen CC, 1999, ASSESSMENT, V6, P43, DOI 10.1177/107319119900600105; Arrieux Jacques P, 2017, Concussion, V2, pCNC31, DOI 10.2217/cnc-2016-0021; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Belanger HG, 2015, MIL MED, V180, P192, DOI 10.7205/MILMED-D-14-00388; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Biagianti B, 2016, NEUROPSYCHOLOGY, V30, P998, DOI 10.1037/neu0000311; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Charvet LE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177177; Chiaravalloti ND, 2015, J HEAD TRAUMA REHAB, V30, P261, DOI 10.1097/HTR.0000000000000164; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Dams-O'Connor K, 2017, JAMA NEUROL, V74, P763, DOI 10.1001/jamaneurol.2017.0176; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; de Villers-Sidani E, 2010, P NATL ACAD SCI USA, V107, P13900, DOI 10.1073/pnas.1007885107; Dumas-Mallet E, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160254; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Edwards JD, 2018, NEUROSCI BIOBEHAV R, V84, P72, DOI 10.1016/j.neubiorev.2017.11.004; Eshel Inbal, 2019, Phys Med Rehabil Clin N Am, V30, P189, DOI 10.1016/j.pmr.2018.08.005; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Grace J, 2002, PSYCHOL ASSESSMENT R; Hallock H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00537; Haran FJ, 2016, BRAIN INJURY, V30, P280, DOI 10.3109/02699052.2015.1118766; Harvey PD, 2020, SCHIZOPHR RES-COGN, V19, DOI 10.1016/j.scog.2019.100150; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Lebowitz MS, 2012, J REHABIL RES DEV, V49, P1547, DOI 10.1682/JRRD.2011.07.0133; Lee HK, 2020, J GERONTOL B-PSYCHOL, V75, P1144, DOI 10.1093/geronb/gbz073; Lin F, 2016, J AM GERIATR SOC, V64, P1293, DOI 10.1111/jgs.14132; Lin FV, 2020, NEUROIMAGE, V213, DOI 10.1016/j.neuroimage.2020.116730; Lipset CH, 2014, NAT MED, V20, P231, DOI 10.1038/nm0314-231; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Malec J., 2005, MAYO PORTLAND ADAPTA; Man DWK, 2013, BRAIN INJURY, V27, P1016, DOI 10.3109/02699052.2013.794969; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Merzenich MM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00385; Monge ZA, 2016, NEUROSCI BIOBEHAV R, V69, P166, DOI 10.1016/j.neubiorev.2016.07.031; Nelson LA, 2013, NEUROPSYCHOLOGY, V27, P666, DOI 10.1037/a0034117; Politis AM, 2016, PERSPECT ASHA SPEC I, V1, P18; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Randolph C., 2012, REPEATABLE BATTERY A; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ross LA, 2019, J GERONTOL B-PSYCHOL, V74, P1152, DOI 10.1093/geronb/gby041; Schmidt M., 1996, REY AUDITORY VERBAL; Sharma B, 2017, DISABIL REHABIL, V39, P1380, DOI 10.1080/09638288.2016.1195453; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Strenziok M, 2014, NEUROIMAGE, V85, P1027, DOI 10.1016/j.neuroimage.2013.07.069; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; TALLAL P, 1973, NATURE, V241, P468, DOI 10.1038/241468a0; Tanielian T.L., 2008, INVISIBLE WOUNDS WAR, V1; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Von Ah D, 2012, BREAST CANCER RES TR, V135, P799, DOI 10.1007/s10549-012-2210-6; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D., 1997, WECHSLER MEMORY SCAL; Yon A, 2007, PSYCHOL AGING, V22, P4, DOI 10.1037/0882-7974.22.1.4; Young G, 2009, PSYCHOL INJ LAW, V2, P53, DOI 10.1007/s12207-009-9030-y; Zhou XM, 2015, P NATL ACAD SCI USA, V112, P2233, DOI 10.1073/pnas.1416582111	80	1	1	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JUL	2021	144		7				1994	2008		10.1093/brain/awab202			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WM3LW	WOS:000710991200017	34312662	hybrid, Green Published			2022-02-06	
J	Maulet, T; Pouplin, S; Bensmail, D; Zory, R; Roche, N; Bonnyaud, C				Maulet, Theo; Pouplin, Samuel; Bensmail, Djamel; Zory, Raphael; Roche, Nicolas; Bonnyaud, Celine			Self-rehabilitation combined with botulinum toxin to improve arm function in people with chronic stroke. A randomized controlled trial	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Stroke; Botulinum toxin injection; Upper limb function; Spasticity; Self-rehabilitation	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; UPPER-LIMB SPASTICITY; MOTOR FUNCTION-TEST; RELIABILITY; INTERVENTIONS; HEMIPARESIS; INJECTION; STRENGTH; PROGRAM	Background: Botulinum toxin injection (BTI) reduces muscle hyperactivity, but its effect on active upper-limb function is limited. Intensive rehabilitation could optimize the effects; however, outpatient post-stroke rehabilitation is usually not intensive. One solution could be self-rehabilitation. Objectives: The aim of this randomized controlled trial was to determine the effect of a self-rehabilitation program combined with BTI on upper-limb function in individuals with chronic hemiparesis. Methods: In total, 33 outpatients were randomly allocated to receive BTI + self-rehabilitation (R group: n = 17) or BTI alone (C group: n = 16). Outcomes evaluated just before the BTI and 4 weeks later included the Wolf Motor Function Test (WMFT time: primary outcome), Action Research Arm Test, fatigue and quality of life. Results: Change in WMFT did not differ between groups at 4 weeks (WMFT time: -14% for R group, -4% for C group. WFMT score: +12% for R group, 0% in C group). WFMT time and score improved significantly in the R group only (-14%, P= 0.01, and +12%, P= 0.02). In addition, the proportion of patients with improved WMFT time and score was higher in the R than C group (R group: 71% improved score, 77% improved time; C group: 43% improved score, 50% improved time). Also, passive range of shoulder flexion (P = 0.03) and wrist extension (P = 0.01) improved only in the R group. No other variables changed significantly. Compliance was excellent; average daily training time was greater than that prescribed. Conclusions: The addition of a self-rehabilitation program to BTI did not significantly improve functional outcomes more than BTI alone; however, movement quality and speed improved only in the self-rehabilitation group. Participants in the self-rehabilitation group trained more than they were asked to, which suggests that they found the program worthwhile. These clinically relevant findings justify larger-scale studies of the effects of self-rehabilitation to enhance the effects of BTI. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Maulet, Theo; Roche, Nicolas; Bonnyaud, Celine] Hop Raymond Poincare, AP HP, Physiol & Funct Explorat Dept, Garches, France; [Maulet, Theo; Bensmail, Djamel; Roche, Nicolas] UVSQ, INSERM, Unit 1179, End Icap Lab, Montigny Le Bretonneux, France; [Maulet, Theo; Pouplin, Samuel; Bensmail, Djamel; Bonnyaud, Celine] Paris Saclay Univ, UVSQ, Res Unit, ERPHAN, F-78000 Versailles, France; [Pouplin, Samuel] Hop Raymond Poincare, AP HP, New Technol Platform, Garches, France; [Bensmail, Djamel] Hop Raymond Poincare, AP HP, Phys & Rehabil Med Dept, Garches, France; [Zory, Raphael; Roche, Nicolas] Co Azur Univ, LAMHESS, Nice, France		Maulet, T (corresponding author), Hop Raymond Poincare, AP HP, Physiol & Funct Explorat Dept, Garches, France.; Maulet, T (corresponding author), UVSQ, INSERM, Unit 1179, End Icap Lab, Montigny Le Bretonneux, France.; Maulet, T (corresponding author), Paris Saclay Univ, UVSQ, Res Unit, ERPHAN, F-78000 Versailles, France.	theo.maulet@aphp.fr			AllerganAbbVieAllergan	This study was partly funded by Allergan. Allergan was not involved in the design, execution, analysis, or interpretation of results.	Ada L, 2006, AUST J PHYSIOTHER, V52, P241, DOI 10.1016/S0004-9514(06)70003-4; Aprile I, 2008, BRAIN INJURY, V22, P451, DOI 10.1080/02699050802060639; Bonnyaud C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020915; Bushnell C, 2015, CIRC-CARDIOVASC QUAL, V8, pS163, DOI 10.1161/CIRCOUTCOMES.115.002098; Cook CE, 2008, J MAN MANIP THER, V16, p82E, DOI 10.1179/jmt.2008.16.4.82E; Dhamoon MS, 2017, JAMA NEUROL, V74, P1439, DOI 10.1001/jamaneurol.2017.2802; Domholdt E, 2000, PHYS THERAPY RES PRI, V2nd, P338; Dorman PJ, 1997, STROKE, V28, P1876, DOI 10.1161/01.STR.28.10.1876; Eftekhar P, 2016, OCCUP THER INT, V23, P379, DOI 10.1002/oti.1440; Essery R, 2017, DISABIL REHABIL, V39, P519, DOI 10.3109/09638288.2016.1153160; Ghroubi S, 2020, PAN AFR MED J, V35, DOI 10.11604/pamj.2020.35.55.16091; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Graef P, 2016, BRAZ J PHYS THER, V20, P543, DOI 10.1590/bjpt-rbf.2014.0187; Gregson JM, 2000, AGE AGEING, V29, P223, DOI 10.1093/ageing/29.3.223; Haacke C, 2006, STROKE, V37, P193, DOI 10.1161/01.STR.0000196990.69412.fb; Harris JE, 2009, STROKE, V40, P2123, DOI 10.1161/STROKEAHA.108.544585; Krasny-Pacini A., 2013, Annals of Physical and Rehabilitation Medicine, V56, P212, DOI 10.1016/j.rehab.2013.02.002; Kwakkel G, 2006, DISABIL REHABIL, V28, P823, DOI 10.1080/09638280500534861; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lannin Natasha A, 2020, STROKE, V51, P556; Lecharte T, 2020, ANN PHYS REHABIL MED, V63, P222, DOI 10.1016/j.rehab.2019.12.003; Levy J, 2019, ANN PHYS REHABIL MED, V62, P234, DOI 10.1016/j.rehab.2018.05.1320; Lin KC, 2009, NEUROREHAB NEURAL RE, V23, P429, DOI 10.1177/1545968308331144; Meseguer-Henarejos AB, 2018, EUR J PHYS REHAB MED, V54, P576, DOI 10.23736/S1973-9087.17.04796-7; Natta DDN, 2015, ANN PHYS REHABIL MED, V58, P322, DOI 10.1016/j.rehab.2015.08.003; Nijland R, 2010, J REHABIL MED, V42, P694, DOI 10.2340/16501977-0560; Oujamaa L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P269, DOI 10.1016/j.rehab.2008.10.003; Ozyemisci-Taskiran O, 2019, TOP STROKE REHABIL, V26, P122, DOI 10.1080/10749357.2018.1550957; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010820.pub2; Raghavan P, 2015, PHYS MED REH CLIN N, V26, P599, DOI 10.1016/j.pmr.2015.06.008; Rensink M, 2009, J ADV NURS, V65, P737, DOI 10.1111/j.1365-2648.2008.04925.x; Roche N, 2015, J REHABIL MED, V47, P31, DOI 10.2340/16501977-1887; Salazar AP, 2019, ANN PHYS REHABIL MED, V62, P274, DOI 10.1016/j.rehab.2018.11.004; Takekawa T, 2012, INT J REHABIL RES, V35, P146, DOI 10.1097/MRR.0b013e3283527f4a; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; Volz LJ, 2015, NEUROIMAGE, V119, P44, DOI 10.1016/j.neuroimage.2015.05.101	39	1	1	3	3	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	JUL	2021	64	4							101450	10.1016/j.rehab.2020.10.004			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	TT0KV	WOS:000680041500002	33152520				2022-02-06	
J	Miller, KE; Ramsey, CM; Boland, EM; Klingaman, EA; Gehrman, P				Miller, Katherine E.; Ramsey, Christine M.; Boland, Elaine M.; Klingaman, Elizabeth A.; Gehrman, Philip			Identifying and characterizing longitudinal patterns of insomnia across the deployment cycle in active duty Army soldiers	SLEEP			English	Article						insomnia; deployment; soldiers; Army STARRS; veterans; mental health	ASSESS RISK; DEPRESSION; SLEEP; RESILIENCE; PTSD; IRAQ; PREVALENCE; PREDICTORS; SYMPTOMS; VETERANS	Study Objectives: The present study characterized a sample of 4,667 Army soldiers based on their patterns of insomnia before, during, and after deployment, and explored pre-deployment factors predictive of these patterns. Methods: Data were analyzed from the Army Study to Assess Risk and Resilience in Service members (STARRS)-Pre/Post Deployment Study (PPDS), using surveys that captured data approximately 1-2 months pre-deployment, and 3- and 9-month post-deployment from soldiers deployed to Afghanistan. Patterns of insomnia across time were examined. Theoretically derived variables linked to sleep disturbance were examined as predictors of the insomnia patterns. Results: Five longitudinal patterns of insomnia characterized the majority of the sample: "No Insomnia" (no insomnia symptoms at any timepoint; 31%), "Deployment-related Insomnia" (no pre-deployment insomnia, developed insomnia symptoms during deployment and recovered; 40%), "Incident Insomnia" (development insomnia during or shortly after deployment that did not remit; 14%), "Chronic Insomnia" (insomnia both pre- and post-deployment; 11%), and "Other Insomnia" (reported insomnia at >= 1 timepoint, but no clear pattern across the deployment cycle; 4%). Several pre-deployment factors were predictive of insomnia trajectories, including lifetime major depressive episodes, traumatic brain injury history, posttraumatic stress disorder, and past year personal life stressors. Conclusions: Distinct longitudinal patterns of insomnia were identified, with more than half of the sample reporting insomnia at some point in the deployment cycle. Identifying mental health conditions that are associated with different insomnia patterns prior to deployment can inform targeted interventions to reduce long-term sleep difficulty.	[Miller, Katherine E.; Ramsey, Christine M.; Boland, Elaine M.; Gehrman, Philip] Corporal Michael J Crescenz Vet Affairs Med Ctr, Mental Illness Res Educ & Clin Ctr, Philadelphia, PA 19104 USA; [Ramsey, Christine M.] Yale Sch Med, Yale Ctr Med Informat, New Haven, CT USA; [Miller, Katherine E.; Ramsey, Christine M.; Boland, Elaine M.; Klingaman, Elizabeth A.; Gehrman, Philip] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Klingaman, Elizabeth A.] VISN 5 Mental Illness Res Educ & Clin Ctr, Dept Vet Affairs, Baltimore, MD USA; [Klingaman, Elizabeth A.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA		Miller, KE (corresponding author), Corporal Michael J Crescenz Vet Affairs Med Ctr, Mental Illness Res Educ & Clin Ctr, Philadelphia, PA 19104 USA.	katherine.miller13@va.gov			Department of the Army; U.S. Department of Health and Human Services, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01MH087981]; U.S. Department of Defense (DoD)United States Department of Defense [HU0001-15-2-0004]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)	Data underlying this article were collected as part of the Army STARRS, sponsored by the Department of the Army and funded under cooperative agreement U01MH087981 with the U.S. Department of Health and Human Services, National Institutes of Health, and National Institute of Mental Health. Subsequently, STARRS-Longitudinal Study was sponsored and funded by the U.S. Department of Defense (DoD) (USUHS grant number HU0001-15-2-0004).	Adams RS, 2020, J HEAD TRAUMA REHAB, V35, P27, DOI 10.1097/HTR.0000000000000508; Babson KA, 2018, J CLIN SLEEP MED, V14, P931, DOI 10.5664/jcsm.7154; Bei B, 2018, J CONSULT CLIN PSYCH, V86, P282, DOI 10.1037/ccp0000282; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Cohen J, 1998, STAT POWER ANAL BEHA; DMDC, 2020, TABL ACT DUT FEM RAN; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2013, INT J METH PSYCH RES, V22, P267, DOI 10.1002/mpr.1401; Kessler RC, 2012, SLEEP, V35, P825, DOI 10.5665/sleep.1884; Kessler RC, 2010, SLEEP, V33, P1539, DOI 10.1093/sleep/33.11.1539; Klingaman EA, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12612; Koffel E, 2013, J ANXIETY DISORD, V27, P512, DOI 10.1016/j.janxdis.2013.07.003; Kucharczyk Erica R, 2012, Sleep Med Rev, V16, P547, DOI 10.1016/j.smrv.2012.01.005; Kyle SD, 2010, BEHAV SLEEP MED, V8, P123, DOI 10.1080/15402002.2010.487450; Lincoln ML, 2018, SLEEP HEALTH, V4, P377, DOI 10.1016/j.sleh.2018.05.005; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; SAS Institute Inc, 2011, SAS IML 9 3 US GUID; Seelig AD, 2016, SLEEP, V39, P1111, DOI 10.5665/sleep.5766; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Suh S, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0940-9; Taylor DJ, 2016, SLEEP, V39, P1795, DOI 10.5665/sleep.6156; Troxel W.M., 2015, RAND HLTH Q, V5, P19; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; Wang HHE, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy229; Weathers F.W., 1993, ANN M INT SOC TRAUM; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845	29	1	1	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	JUL	2021	44	7							zsab004	10.1093/sleep/zsab004			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UA5SI	WOS:000685221400005	33406270	hybrid, Green Published			2022-02-06	
J	Morris, SN; Chandran, A; Lempke, LB; Boltz, AJ; Robison, HJ; Collins, CL				Morris, Sarah N.; Chandran, Avinash; Lempke, Landon B.; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.			Epidemiology of Injuries in National Collegiate Athletic Association Men's Basketball: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						collegiate; sport-related; surveillance	SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY	Context: Basketball has remained a popular sport for players and spectators in the United States since before the first National Collegiate Athletic Association men's championship tournament in 1939. Background: Routine examinations of men's basketball injuries are important for identifying emerging temporal patterns. Methods: Exposure and injury data collected in the National Collegiate Athletic Association Injury Surveillance Program during 2014-2015 through 2018-2019 athletic seasons were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics, and injury rate ratios were used to examine differences in injury rates. Results: The overall injury rate was 7.28 per 1000 athlete exposures, with competition rates twice those of practices (injury rate ratio = 2.07; 95% CI = 1.93, 2.22). Injuries to the ankle (22.2%), knee (13.0%), head/face (11.3%), and hand/wrist (10.1%) accounted for most reported injuries, with sprains (30.4%), contusions (14.3%), and strains (13.9%) most commonly reported. Ankle sprain rates initially trended upward and decreased between 2017-2018 and 2018-2019; concussion rates remained relatively stable during 2014-2015 through 2018-2019. Conclusions: Findings suggest that common injury rates are trending downward relative to previous study findings.	[Morris, Sarah N.; Chandran, Avinash; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA; [Lempke, Landon B.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org			NCAA	The National Collegiate Athletic Association (NCAA) Injury Surveillance Program (ISP) was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many athletic trainers who have volunteered their time and efforts to submit data to the NCAA ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate student-athletes.	[Anonymous], High school participation survey archive; [Anonymous], Men's Final Four viewership, attendance by the numbers; [Anonymous], 2017 18 2018 19 MENS; [Anonymous], 2019, NCAA SPORTS SPONS PA NCAA SPORTS SPONS PA; [Anonymous], Men's basketball rules changes 2015-16 and 2016-17; [Anonymous], 2011 12 2012 13 MENS; Bahr R, 2020, BRIT J SPORT MED, V54, P372, DOI 10.1136/bjsports-2019-101969; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Clifton DR, 2018, J ATHL TRAINING, V53, P1025, DOI 10.4085/1062-6050-148-17; Dick R, 2007, J ATHL TRAINING, V42, P194; Dick R, 2007, J ATHL TRAINING, V42, P173; Drew MK, 2016, SPORTS MED, V46, P861, DOI 10.1007/s40279-015-0459-8; Edwards T, 2018, SPORTS, V6, DOI 10.3390/sports6010019; Finch CF, 1997, SPORTS MED, V24, P157, DOI 10.2165/00007256-199724030-00002; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; RYAN JB, 1991, AM J SPORT MED, V19, P299, DOI 10.1177/036354659101900316; Simon T, 2016, JOINT BONE SPINE, V83, P416, DOI 10.1016/j.jbspin.2015.07.013	18	1	1	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					681	687		10.4085/1062-6050-436-20			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700013	34280288	gold			2022-02-06	
J	Nedimyer, AK; Boltz, AJ; Robison, HJ; Collins, CL; Morris, SN; Chandran, A				Nedimyer, Aliza K.; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.; Chandran, Avinash			Epidemiology of Injuries in National Collegiate Athletic Association Women's Field Hockey: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						NCAA field hockey; injury surveillance; descriptive epidemiology	SURVEILLANCE SYSTEM; CONCUSSION; FOOTBALL	Context: The National Collegiate Athletic Association has sponsored women's field hockey since 1981, and team membership as well as student-athlete participation has grown over time. Background: Routine examinations of injuries sustained by athletes are important for identifying and understanding patterns that can be used to inform sport safety practices. Methods: Exposure and injury data collected in the National Collegiate Athletic Association Injury Surveillance Program from 2014-2015 through 2018-2019 were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics, and injury rate ratios were used to examine differential injury rates. Results: The overall injury rate was 6.27 per 1000 athlete-exposures (AEs). Head/face injuries (16.0%) and thigh injuries (12.3%) were the most commonly injured body parts during the 2014-2015 through 2018-2019 academic years. Concussion (8.6%) was the most commonly reported injury, and concussion rates notably decreased between 2017-2018 and 2018-2019. Summary: Study findings were generally consistent with the existing epidemiologic evidence. Incidence rates and trajectories of commonly observed injuries warrant particular attention in the future.	[Nedimyer, Aliza K.] Univ N Carolina, Dept Exercise & Sport Sci, Human Movement Sci Curriculum & Matthew Gfeller S, Chapel Hill, NC USA; [Nedimyer, Aliza K.] Univ N Carolina, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Sch Med, Chapel Hill, NC USA; [Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.; Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org			NCAA	The NCAA-ISP was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA-ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate studentathletes.	[Anonymous], 2019, STUDENT ATHELETE PAR STUDENT ATHELETE PAR; [Anonymous], Rules of hockey; [Anonymous], ORG CHART; [Anonymous], 2020, HIGH SCH FIELD HOCKE; Baugh CM, 2020, J ATHL TRAINING, V55, P573, DOI 10.4085/1062-6050-0463-19; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2019, SPORTS MED, V49, P1621, DOI 10.1007/s40279-019-01154-1; Dick R, 2007, J ATHL TRAINING, V42, P211; Dick R, 2007, J ATHL TRAINING, V42, P173; Finch CF, 1997, SPORTS MED, V24, P157, DOI 10.2165/00007256-199724030-00002; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lynall RC, 2018, J ATHL TRAINING, V53, P938, DOI 10.4085/1062-6050-173-17; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Woods C, 2002, BRIT J SPORT MED, V36, P436, DOI 10.1136/bjsm.36.6.436	20	1	1	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					636	642		10.4085/1062-6050-428-20			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700007	34280285	gold			2022-02-06	
J	Needham, EJ; Stoevesandt, O; Thelin, EP; Zetterberg, H; Zanier, ER; Al Nimer, F; Ashton, NJ; Outtrim, JG; Newcombe, VFJ; Mousa, HS; Simren, J; Blennow, K; Yang, ZH; Hutchinson, PJ; Piehl, F; Helmy, AE; Taussig, MJ; Wang, KKW; Jones, JL; Menon, DK; Coles, AJ				Needham, Edward J.; Stoevesandt, Oda; Thelin, Eric P.; Zetterberg, Henrik; Zanier, Elisa R.; Al Nimer, Faiez; Ashton, Nicholas J.; Outtrim, Joanne G.; Newcombe, Virginia F. J.; Mousa, Hani S.; Simren, Joel; Blennow, Kaj; Yang, Zhihui; Hutchinson, Peter J.; Piehl, Fredrik; Helmy, Adel E.; Taussig, Mike J.; Wang, Kevin K. W.; Jones, Joanne L.; Menon, David K.; Coles, Alasdair J.			Complex Autoantibody Responses Occur following Moderate to Severe Traumatic Brain Injury	JOURNAL OF IMMUNOLOGY			English	Article							SEVERE HEAD-INJURY; MICROGLIAL ACTIVATION; INFLAMMATION; ANTIBODIES; EFFICACY; TUBULIN; ADULTS	Most of the variation in outcome following severe traumatic brain injury (TBI) remains unexplained by currently recognized prognostic factors. Neuroinflammation may account for some of this difference. We hypothesized that TBI generated variable autoantibody responses between individuals that would contribute to outcome. We developed a custom protein microarray to detect autoantibodies to both CNS and systemic Ags in serum from the acute-phase (the first 7 d), late (6-12 mo), and long-term (6-13 y) intervals after TBI in human patients. We identified two distinct patterns of immune response to TBI. The first was a broad response to the majority of Ags tested, predominantly IgM mediated in the acute phase, then IgG dominant at late and long-term time points. The second was responses to specific Ags, most frequently myelin-associated glycopeptide (MAG), which persisted for several months post-TBI but then subsequently resolved. Exploratory analyses suggested that patients with a greater acute IgM response experienced worse outcomes than predicted from current known risk factors, suggesting a direct or indirect role in worsening outcome. Furthermore, late persistence of anti-MAG IgM autoantibodies correlated with raised serum neurofilament light concentrations at these time points, suggesting an association with ongoing neurodegeneration over the first year postinjury. Our results show that autoantibody production occurs in some individuals following TBI, can persist for many years, and is associated with worse patient outcome. The complexity of responses means that conventional approaches based on measuring responses to single antigenic targets may be misleading.	[Needham, Edward J.; Mousa, Hani S.; Jones, Joanne L.; Coles, Alasdair J.] Univ Cambridge, Dept Clin Neurosci, Level 3,A Block,Box 165,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Needham, Edward J.; Outtrim, Joanne G.; Newcombe, Virginia F. J.; Menon, David K.] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge, England; [Stoevesandt, Oda; Taussig, Mike J.] Cambridge Prot Arrays Ltd, Cambridge, England; [Thelin, Eric P.; Al Nimer, Faiez; Piehl, Fredrik] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Thelin, Eric P.] Karolinska Univ Hosp, Dept Neurovasc Dis, Stockholm, Sweden; [Thelin, Eric P.; Hutchinson, Peter J.; Helmy, Adel E.] Univ Cambridge, Div Acad Neurosurg, Dept Clin Neurosci, Cambridge, England; [Zetterberg, Henrik; Ashton, Nicholas J.; Simren, Joel; Blennow, Kaj] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL, Dept Neurodegenerat Dis, Inst Neurol, Queen Sq, London, England; [Zetterberg, Henrik] UCL, United Kingdom Dementia Res Inst, London, England; [Zanier, Elisa R.] Ist Ric Farmacol Mario Negri IRCCS, Dipartimento Ric Neurosci, Milan, Italy; [Newcombe, Virginia F. J.; Menon, David K.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; [Yang, Zhihui; Wang, Kevin K. W.] Univ Florida, Program Neurotrauma Neuroprote & Biomarker Res, Dept Emergency Med, McKnight Brain Inst, Gainesville, FL 32611 USA; [Yang, Zhihui; Wang, Kevin K. W.] Univ Florida, Program Neurotrauma Neuroprote & Biomarker Res, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Yang, Zhihui; Wang, Kevin K. W.] Univ Florida, Program Neurotrauma Neuroprote & Biomarker Res, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32611 USA		Needham, EJ (corresponding author), Univ Cambridge, Dept Clin Neurosci, Level 3,A Block,Box 165,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	edneedham@doctors.org.uk	Thelin, Eric Peter/K-2144-2012	Thelin, Eric Peter/0000-0002-2338-4364; Outtrim, Joanne/0000-0001-8118-6430; Helmy, Adel/0000-0002-0531-0556; Newcombe, Virginia/0000-0001-6044-9035; Zanier, Elisa/0000-0002-3011-8718; Jones, Joanne/0000-0003-4974-1371; Mousa, Hani S./0000-0002-8327-7114	Medical Research Council (U.K.) within ERANET NEURON; Ministero della Salute (Italy) within ERA-NET NEURON; National Institute for Health Research (NIHR) Senior Investigator AwardNational Institute for Health Research (NIHR); European Union 7th Framework program (European Commission) [602150]; Intensive Care Society Young Investigator Award; Addenbrooke's Charitable Trust; Cambridge University Hospitals Cambridge Clinical Research Fellowship; NIHR Health Technology Assessment Programme Brain Injury Healthcare Technology Co-operative Seedcorn funding; Region Stockholm (Clinical Research Appointment); Swedish Brain Foundation (Hjarnfonden); Swedish Society for Medical Research (Svenska Sallskapet for Medicinsk Forskning); Swedish Research Council FormasSwedish Research CouncilSwedish Research Council Formas [2018-02532]; European Research CouncilEuropean Research Council (ERC)European Commission [681712]; Swedish State Support for Clinical Research [ALFGBG-720931]; Centrum for Idrottsforskning [P2019-0198]; NIHR (Research Professorship and Cambridge Brain Repair Centre); Royal College of Surgeons of England; Wellcome TrustWellcome TrustEuropean Commission [RG79413]; Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship; Gates Cambridge Trust; Rosetrees TrustRosetrees Trust; Brain Research UK	E.J.N., A.E.H., A.J.C., P.J.H., and D.K.M. were supported by the Medical Research Council (U.K.) within the framework of ERANET NEURON. E.R.Z. is supported by the Ministero della Salute (Italy) within the framework of ERA-NET NEURON. D.K.M. is supported by a National Institute for Health Research (NIHR) Senior Investigator Award and European Union 7th Framework program (European Commission Grant 602150). E.J.N. is supported by the Intensive Care Society Young Investigator Award, Addenbrooke's Charitable Trust, Cambridge University Hospitals Cambridge Clinical Research Fellowship, and NIHR Health Technology Assessment Programme Brain Injury Healthcare Technology Co-operative Seedcorn funding. E.P.T. acknowledges funding from Region Stockholm (Clinical Research Appointment), the Swedish Brain Foundation (Hjarnfonden), and the Swedish Society for Medical Research (Svenska Sallskapet for Medicinsk Forskning). H.Z. is a Wallenberg Scholar supported by grants from the Swedish Research Council Formas (Grant 2018-02532), European Research Council (Grant 681712), Swedish State Support for Clinical Research (ALFGBG-720931), Centrum for Idrottsforskning (Grant P2019-0198), and U.K. Dementia Research Institute at University College London. P.J.H. is funded by the NIHR (Research Professorship and Cambridge Brain Repair Centre) and Royal College of Surgeons of England. J.L.J. is funded by the Wellcome Trust (Grant RG79413). V.F.J.N. is funded by an Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship. H.S.M. is supported by the Gates Cambridge Trust and Rosetrees Trust. E.J.N., V.F.J.N., A.J.C., and D.K.M. received support from Brain Research UK.	Absinta M, 2017, ELIFE, V6, DOI 10.7554/eLife.29738; Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Cox AL, 2006, J NEUROIMMUNOL, V174, P180, DOI 10.1016/j.jneuroim.2006.01.007; Cunningham ET, 2017, OCUL IMMUNOL INFLAMM, V25, P149, DOI 10.1080/09273948.2017.1305727; Gelfand JM, 2018, LANCET NEUROL, V17, P733, DOI 10.1016/S1474-4422(18)30279-5; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Guven E, 2014, J IMMUNOL METHODS, V403, P26, DOI 10.1016/j.jim.2013.11.014; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Iwata T, 2008, J IMMUNOL, V181, P5738, DOI 10.4049/jimmunol.181.8.5738; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1975, LANCET, V1, P480; Jeong JS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016253; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Ngankam L, 2011, ZH NEVROL PSIKHIATR, V111, P61; Palma J, 2018, CENT EUR J IMMUNOL, V43, P466, DOI 10.5114/ceji.2018.81354; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rodriguez-Zhurbenko N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00483; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Shamrei R K, 1969, Voen Med Zh, V4, P39; Skoda D, 2006, BRAIN RES BULL, V68, P213, DOI 10.1016/j.brainresbull.2005.05.032; Sorokina E G, 2009, Neurosci Behav Physiol, V39, P329, DOI 10.1007/s11055-009-9147-1; Stein TD, 2002, J NEUROPATH EXP NEUR, V61, P1100, DOI 10.1093/jnen/61.12.1100; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tiriveedhi V, 2013, J HEART LUNG TRANSPL, V32, P807, DOI 10.1016/j.healun.2013.06.003; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	46	1	1	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JUL 1	2021	207	1					90	100		10.4049/jimmunol.2001309			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XP9LE	WOS:000731178500010	34145056	Green Submitted			2022-02-06	
J	Oldham, JR; Master, CL; Walker, GA; Meehan, WP; Howell, DR				Oldham, Jessie R.; Master, Christina L.; Walker, Gregory A.; Meehan, William P., III; Howell, David R.			The Association between Baseline Eye Tracking Performance and Concussion Assessments in High School Football Players	OPTOMETRY AND VISION SCIENCE			English	Article							DEFICIT HYPERACTIVITY DISORDER; CONVERGENCE; RELIABILITY; POINT	SIGNIFICANCE Concussions are complex injuries that require a multifaceted testing battery. Vision impairments are common after concussion, but it is unknown exactly how eye tracking may be affected after injury and how it is associated with other clinical concussion assessments. PURPOSE This study aimed to (1) examine the relationship between eye tracking performance (BOX score) and other common concussion evaluations, (2) identify if eye tracking adds novel information that augments baseline concussion evaluations, and (3) examine the effect of age, concussion history, and attention-deficit/hyperactivity disorder on eye tracking and other ophthalmological measures. METHODS A total of 102 male high school football athletes (age, 16.0 years; 95% confidence interval, 15.8 to 16.2 years) completed a series of visual and neurocognitive tests during their pre-season baseline assessment. The main outcome measures were BOX score, near point of convergence (NPC) distance, binocular accommodative amplitude (BAA) distance, Standardized Assessment of Concussion score, and Immediate Post-Concussion Assessment and Cognitive Testing composite scores. RESULTS BOX score was not significantly associated with symptoms, Standardized Assessment of Concussion score, NPC distance, BAA distance, or any Immediate Post-Concussion Assessment and Cognitive Testing composite scores. Age, concussion history, attention-deficit/hyperactivity disorder, and number of prior years playing football were not significantly associated with BOX score or NPC distance, but there was a significant association between concussion history and greater BAA distance (beta = 1.60; 95% confidence interval = 0.19 to 3.01; P < .03). The BOX score cutoff of 10 resulted in a 12% false-positive rate. CONCLUSIONS Eye tracking was not significantly associated with the commonly used clinical concussion assessments. These results suggest that an objective eye tracking variable may be a valuable addition to the current concussion battery.	[Oldham, Jessie R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Oldham, Jessie R.; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Dept Orthoped, Boston, MA USA; [Master, Christina L.] Childrens Hosp Philadelphia, Div Orthoped, Sports Med & Performance Ctr, Philadelphia, PA USA; [Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA USA; [Walker, Gregory A.; Howell, David R.] Childrens Hosp Colorado, Ctr Sports Med, Aurora, CO USA; [Walker, Gregory A.; Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat & Orthoped Surg, Boston, MA USA		Oldham, JR (corresponding author), Micheli Ctr Sports Injury Prevent, Waltham, MA USA.; Oldham, JR (corresponding author), Boston Childrens Hosp, Div Sports Med, Dept Orthoped, Boston, MA USA.	Jessie.Oldham@childrens.harvard.edu; Masterc@email.chop.edu; Gregory.Walker@childrenscolorado.org; William.Meehan@childrens.harvard.edu; David.Howell@cuanschutz.edu			National Hockey League Alumni Association; National Football League; Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952, R41NS103698]; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; ElMindA Ltd.; Eastern Athletic Trainers Association, Inc.	The authors declare no conflicts of interest related to this study. WPM receives royalties from (1) ABC-CLIO publishing for the sale of his books, Kids, Sports, and Concussion: A Guide for Coaches and Parents, and Concussions; (2) Springer International for the book Head and Neck Injuries in Young Athlete; and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and the National Football League. DRH receives research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560) and the National Institute of Neurological Disorders and Stroke (R01NS100952 and R41NS103698) of the National Institutes of Health. He has previously received research support from a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center; ElMindA Ltd.; and the Eastern Athletic Trainers Association, Inc.	Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Bin Zahid A, 2020, CLIN J SPORT MED, V30, P433, DOI 10.1097/JSM.0000000000000639; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Clugston JR, 2019, J ATHL TRAINING, V54, P1247, DOI 10.4085/1062-6050-455-18; DeCarlo DK, 2016, OPTOMETRY VISION SCI, V93, P459, DOI 10.1097/OPX.0000000000000823; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Green W, 2010, OPTOMETRY, V81, P129, DOI 10.1016/j.optm.2009.07.015; Gronlund MA, 2007, EYE, V21, P494, DOI 10.1038/sj.eye.6702240; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howell DR, 2021, CLIN J SPORT MED, V31, P133, DOI 10.1097/JSM.0000000000000722; Howell DR, 2018, J CHILD NEUROL, V33, P794, DOI 10.1177/0883073818789320; Howell DR, 2020, CLIN J SPORT MED, V30, P444, DOI 10.1097/JSM.0000000000000630; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Maples WC, 2007, OPTOMETRY VISION SCI, V84, P224, DOI 10.1097/OPX.0b013e3180339f44; Marinides Zoe, 2015, Neurol Clin Pract, V5, P25, DOI 10.1212/CPJ.0000000000000060; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Medicine BPGL and BA of S and E, 2013, BRIT J SPORT MED, V47, P259; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; Raghuram A, 2019, AM J OPHTHALMOL, V206, P235, DOI 10.1016/j.ajo.2019.04.008; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Samadani Uzma, 2016, Concussion, V1, pCNC3, DOI 10.2217/cnc.15.3; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Santo AL, 2020, J SPORT REHABIL, V29, P1179, DOI 10.1123/jsr.2019-0428; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Zonner SW, 2019, JAMA OPHTHALMOL, V137, P265, DOI 10.1001/jamaophthalmol.2018.6193; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	36	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JUL	2021	98	7					826	832		10.1097/OPX.0000000000001737			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	TS1BM	WOS:000679391900020	34328459				2022-02-06	
J	Paredes, I; Navarro, B; Lagares, A				Paredes, Igor; Navarro, Blanca; Lagares, Alfonso			Sleep disorders in traumatic brain injury	NEUROCIRUGIA			Spanish	Article						Traumatic brain injury; Sleep disorder; Hypersomnolence; Insomnia; Sleep anatomy; Hypocretines	EXCESSIVE DAYTIME SLEEPINESS; COGNITIVE-BEHAVIORAL THERAPY; WAKE DISTURBANCES; INSOMNIA; PREVALENCE; MODAFINIL; TRIAL; MELATONIN; CROSSOVER; IMPROVE	The purpose of the review is to collect the most relevant current literature on the mechanisms of normal sleep and sleep disorders associated with traumatic brain injury (TBI), to discuss the most frequent conditions and the evidence on their possible treatments and future research. Sleep disorders are extremely prevalent after TBI (30-84%). Insomnia and circadian rhythm disorders are the most frequent disorders among the population that has suffered mild TBI, while hypersomnolence disorders are more frequent in populations that have suffered moderate and severe TBI. The syndrome of obstructive sleep apnea and restless leg syndrome are also very frequent in these patients; and patients exposed to multiple TBIs (war veterans) are especially susceptible to sleep disorders. The treatment of these disorders requires taking into account the particularities of these patients. In conclusion, diagnosis and treatment of sleep disorders should become part of routine clinical practice and cease to be anecdotal (as it is today) in patients with TBI. In addition, it is necessary to continue carrying out research that reveals the best therapeutic approach to these patients. (C) 2020 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Paredes, Igor; Lagares, Alfonso] Hosp Univ 12 Octubre, Serv Neurocirugia, Madrid, Spain; [Navarro, Blanca] Hosp Univ 12 Octubre, Serv Neurocirugia, Neuropsicol Clin, Madrid, Spain		Paredes, I (corresponding author), Hosp Univ 12 Octubre, Serv Neurocirugia, Madrid, Spain.	igorparedes@gmail.com	Paredes, Igor/AAW-6313-2021; Lang, Steven/AAE-8102-2021; Lagares, Alfonso/B-2969-2011	Paredes, Igor/0000-0002-3846-4164; Lang, Steven/0000-0003-1669-9146; Lagares, Alfonso/0000-0003-3996-0554			Albrecht JS, 2020, INT REV PSYCHIATR, V32, P31, DOI 10.1080/09540261.2019.1656176; [Anonymous], 2013, NEUROTRANSMITTER SYS; Aoun R, 2019, NAT SCI SLEEP, V11, P131, DOI 10.2147/NSS.S182158; Arrigoni E, 2016, J PHYSIOL-LONDON, V594, P5391, DOI 10.1113/JP271324; Aurora RN, 2010, J CLIN SLEEP MED, V6, P85; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bajaj S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00616; Barshikar S, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0792-4; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2016, SLEEP MED CLIN, V11, P19, DOI 10.1016/j.jsmc.2015.10.004; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, LANCET NEUROL, V4, P673, DOI 10.1016/S1474-4422(05)70196-4; Borghol Amne, 2018, Innov Clin Neurosci, V15, P17; Botchway EN, 2019, J NEUROTRAUM, V36, P669, DOI 10.1089/neu.2018.5743; Botchway EN, 2019, J HEAD TRAUMA REHAB, V34, P241, DOI 10.1097/HTR.0000000000000446; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Chiu HY, 2017, J NEUROSCI NURS, V49, P380, DOI 10.1097/JNN.0000000000000325; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Dhamapurkar SK, 2017, DISABIL REHABIL, V39, P2633, DOI 10.1080/09638288.2016.1236414; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Jang SH, 2016, SLEEP MED, V17, P124, DOI 10.1016/j.sleep.2015.09.020; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kazl C, 2019, SEMIN PEDIATR NEUROL, V30, P9, DOI 10.1016/j.spen.2019.03.003; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Killgore WDS, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104679; Kishi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136910; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lee Hsun-Hua, 2017, Acta Neurol Taiwan, V26, P13; Lowe A, 2020, DISABIL REHABIL, V42, P1041, DOI 10.1080/09638288.2018.1516819; Makley MJ, 2020, NEUROREHAB NEURAL RE, V34, P111, DOI 10.1177/1545968319895478; Martinez-Perez R, 2017, NEUROLOGIA, V32, P185, DOI 10.1016/j.nrl.2014.08.009; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mazwi Nicole L, 2015, Handb Clin Neurol, V128, P553, DOI 10.1016/B978-0-444-63521-1.00035-2; Menn SJ, 2014, J CLIN SLEEP MED, V10, P1181, DOI 10.5664/jcsm.4196; Morse AM, 2018, HAND CLINIC, V158, P127, DOI 10.1016/B978-0-444-63954-7.00013-6; Mumbower R, 2019, BRAIN INJURY, V33, P1624, DOI 10.1080/02699052.2019.1658133; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nardone R, 2011, J NEUROTRAUM, V28, P1165, DOI 10.1089/neu.2010.1748; O'Hara R, 2009, J REHABIL RES DEV, V46, P837, DOI 10.1682/JRRD.2008.10.0140; Oishi Y, 2017, NEUROSCI RES, V118, P66, DOI 10.1016/j.neures.2017.04.008; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Pedemonte M, 2010, FISIOLOGIA HUMANA, P166; Perez-Carbonell L, 2018, J THORAC DIS, V10, pS112, DOI 10.21037/jtd.2017.10.161; Postuma RB, 2012, NEUROLOGY, V79, P428, DOI 10.1212/WNL.0b013e31825dd383; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Ripley DL, 2018, NEUROREHABILITATION, V43, P255, DOI 10.3233/NRE-189001; Rosenberg Russell P, 2006, Ann Clin Psychiatry, V18, P49, DOI 10.1080/10401230500464711; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schenck CH, 1997, SLEEP, V20, P972, DOI 10.1093/sleep/20.11.972; Shan RSLP, 2004, AM J PHYS MED REHAB, V83, P421, DOI 10.1097/00002060-200406000-00003; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Tcheremissine Oleg V, 2017, Innov Clin Neurosci, V14, P11; Theadom A, 2018, CLIN REHABIL, V32, P619, DOI 10.1177/0269215517736671; Thomas A, 2018, NEUROREHABILITATION, V43, P355, DOI 10.3233/NRE-182535; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Wei L, 2020, J HEAD TRAUMA REHAB; Werner JK, 2017, SEMIN NEUROL, V37, P419, DOI 10.1055/s-0037-1604487; Wijemanne Subhashie, 2017, Pract Neurol, V17, P444, DOI 10.1136/practneurol-2017-001762; Wolfe LF, 2018, NEUROREHABILITATION, V43, P257, DOI 10.3233/NRE-182583	74	1	1	0	0	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473	2340-6305		NEUROCIRUGIA	Neurocirugia	JUL-AUG	2021	32	4					178	187		10.1016/j.neucir.2020.09.001			10	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TD7NR	WOS:000669509300004	34218878				2022-02-06	
J	Pastor, IS; Dumbrava, LP; Siserman, C; Stan, H; Para, I; Florian, IS				Pastor, Iulia-Sevastiana; Dumbrava, Lacrimioara Perju; Siserman, Costel; Stan, Horatiu; Para, Ioana; Florian, Ioan Stefan			Predictive factors of 30-day mortality in patients with traumatic subdural hematoma	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						acute subdural hematoma; traumatic brain injury; neurosurgery; predictive factors; mortality	DECOMPRESSIVE CRANIECTOMY; SURGICAL-MANAGEMENT; BRAIN-INJURY; CRANIOTOMY; OUTCOMES	In the present study, we aimed to assess and analyze the predictive factors of 30-day mortality in patients with acute subdural hematoma (ASDH) who underwent surgical intervention after traumatic brain injury (TBI). We conducted a retrospective study, which included a cohort of 135 consecutive patients diagnosed with ASDH who required surgical evacuation. We assessed the demographic and clinical data, the imaging data of the hematoma described by preoperative computed tomography (CT) and the type of neurosurgical intervention for hematoma evacuation via either craniectomy or craniotomy. The patients were followed up for 30 days after head trauma and the occurrence of death was noted. Death was recorded in 63 (46.6%) patients at 30 days after TBI. There was a significant number of deceased patients who underwent craniectomy (71.4%). The Glasgow Coma Scale (GCS) was statistically significantly lower in patients who died (P<0.001), with a cut-off value of <= 12, under which the probability of death increased [AUC 0.830 (95% CI, 0.756-0.889); Se 90.48% (95% CI, 80.4-96.4); Sp 66.7% (95% CI, 54.6-77.3); P<0.001]. The midline shift was statistically significantly higher in deceased patients (P=0.005), with a cut-off value of >7 mm, over which the probability of death increased [AUC 0.637 (95% CI, 0.550-0.718); Se 38.1% (95% CI, 26.1-51.2); Sp 86.1% (95% CI, 75.9-93.1); P=0.003]. There were significantly more deceased patients with intracranial hypertension, brain herniation, brain swelling, intraparenchymal hematoma and cranial fracture. In multivariate analysis only a Glasgow score <= 12 and a midline shift >7 mm were independently linked to mortality. Brain herniation and intraparenchymal hematoma were associated with a higher probability of dying, but the statistical threshold was slightly exceeded. The type of neurosurgery performed for patients with ASDH was not an independent predictive factor for 30-day mortality. However, craniectomy was associated with a higher mortality in patients with ASDH.	[Pastor, Iulia-Sevastiana; Stan, Horatiu; Florian, Ioan Stefan] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Dept Neurosurg, Cluj Napoca 400012, Romania; [Dumbrava, Lacrimioara Perju] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Dept Neurol 1, Cluj Napoca 400012, Romania; [Siserman, Costel] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Dept Legal Med, Cluj Napoca 400012, Romania; [Para, Ioana] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Dept Internal Med, 8 Victor Babes St, Cluj Napoca 400012, Romania		Para, I (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Fac Med, Dept Internal Med, 8 Victor Babes St, Cluj Napoca 400012, Romania.	ioana.para@yahoo.com	SISERMAN, COSTEL VASILE/AAF-1025-2019	SISERMAN, COSTEL VASILE/0000-0002-6124-8582			Alagoz F, 2017, TURK NEUROSURG, V27, P187, DOI 10.5137/1019-5149.JTN.15177-15.2; Baucher G, 2019, WORLD NEUROSURG, V126, pE944, DOI 10.1016/j.wneu.2019.02.194; Benedetto N, 2017, BRIT J NEUROSURG, V31, P244, DOI 10.1080/02688697.2016.1244249; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; D'Amato L, 2007, J Neurosurg Sci, V51, P107; Evans LR, 2019, J NEUROTRAUM, V36, P517, DOI 10.1089/neu.2018.5829; Gerard C, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0275-0; Godlewski B, 2013, NEUROL MED-CHIR, V53, P26, DOI 10.2176/nmc.53.26; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Jehan F, 2017, J TRAUMA ACUTE CARE, V83, P1148, DOI 10.1097/TA.0000000000001658; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Lavrador Jose Pedro, 2018, Asian J Neurosurg, V13, P565, DOI 10.4103/ajns.AJNS_51_16; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Phan K, 2017, WORLD NEUROSURG, V101, P677, DOI 10.1016/j.wneu.2017.03.024; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; TEASDALE G, 1974, LANCET, V2, P81; Van Essen TA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033513; van Essen TA, 2019, ACTA NEUROCHIR, V161, P435, DOI 10.1007/s00701-018-3761-z; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; Won YD, 2018, WORLD NEUROSURG, V111, pE120, DOI 10.1016/j.wneu.2017.12.025	25	1	1	3	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUL	2021	22	1							757	10.3892/etm.2021.10189			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	SG0HC	WOS:000653126400001	34035854	gold, Green Published			2022-02-06	
J	Radwan, TAM; Fahmy, RS; El Emady, MFM; Khedr, ASEDM; Osman, SH; ElSonbaty, MI; El-Kholy, BMB; Thabit, MA; Elkatatny, AM				Radwan, Tarek A. M.; Fahmy, Rania S.; El Emady, Mohamed F. M.; Khedr, Ahmed S. E. D. M.; Osman, Safinaz H.; ElSonbaty, Mohamed, I; El-Kholy, Badawy M. Badawy; Thabit, Mohamed A.; Elkatatny, Amr M.			Ischemia-modified Albumin as a Biomarker for Prediction of Poor Outcome in Patients With Traumatic Brain Injury: An Observational Cohort Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						albumin; ischemia-modified albumin; mortality; sensitivity; specificity; traumatic brain injury	MARKER	Background: Biomarkers can assist in outcome prediction and therapeutic decision making after traumatic brain injury (TBI). The aim of this study was to evaluate the role of ischemia-modified albumin (IMA) in the prediction of mortality in patients with TBI. Methods: In this observational study IMA was measured on admission to intensive care unit (D0) and 24 hours later (D1) in a cohort of patients with mixed TBI severity. The primary outcome was the correlation between IMA and 28-day mortality. Secondary outcomes included the incidence of elevated IMA, and the correlation between the severity of TBI and IMA, and between IMA and change in Glasgow coma score (GCS). The area under receiver operating characteristic curve analysis was performed to detect optimal IMA cut-off value for the detection of mortality. Results: Fifty-four patients were included in the study; IMA was elevated in 49 (90.7%) on admission to the intensive care unit. Of the 49 patients with elevated IMA, 22 had a decrease in IMA while 27 had an increase by 24 hours. IMA levels were higher at D0 and D1 (P<0.001 for both) in patients who died compared with those who survived. Twenty-one patients died (mortality rate 38.9%); all had elevated IMA on D0 and D1 and higher IMA levels at D1 compared with D0. Optimal cut-off values for IMA predicted mortality with 76.2% sensitivity and 81.8% specificity at D0 and with 100% sensitivity and specificity at D1. IMA values at D0 and D1 were correlated with D0 and D1 GCS, respectively (both P<0.001). Conclusion: IMA levels were elevated in patients following TBI, and can predict mortality with high sensitivity and specificity.	[Radwan, Tarek A. M.; Fahmy, Rania S.; El Emady, Mohamed F. M.; Khedr, Ahmed S. E. D. M.; Osman, Safinaz H.; ElSonbaty, Mohamed, I] Cairo Univ, Fac Med, Anesthesia Dept, Cairo, Egypt; [El-Kholy, Badawy M. Badawy] Cairo Univ, Fac Med, Chem & Clin Pathol Dept, Cairo, Egypt; [Thabit, Mohamed A.; Elkatatny, Amr M.] Cairo Univ, Fac Med, Neurosurg Dept, Cairo, Egypt		Fahmy, RS (corresponding author), Cairo Univ, Fac Med, Anesthesia Dept, Cairo, Egypt.	ransam98@gmail.com	Elkatatny, Amr A.A.Mostafa/AAC-8299-2020	Elkatatny, Amr A.A.Mostafa/0000-0001-7741-6096; Elsonbaty, Mohamed/0000-0001-9632-9289			Abboud H, 2007, CEREBROVASC DIS, V23, P216, DOI 10.1159/000097644; Bar-Or D, 2000, J EMERG MED, V19, P311, DOI 10.1016/S0736-4679(00)00255-9; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Coverdale JPC, 2018, PROSTAG LEUKOTR ESS, V135, P147, DOI 10.1016/j.plefa.2018.07.014; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Ertekin B, 2013, PAK J MED SCI, V29, P1003, DOI 10.12669/pjms.294.3176; Gordillo-Escobar E, 2016, MED INTENSIVA, V40, P105, DOI 10.1016/j.medin.2015.11.008; Gunduz A, 2008, AM J EMERG MED, V26, P874, DOI 10.1016/j.ajem.2007.11.023; Han K, 2012, MOL MED REP, V6, P621, DOI 10.3892/mmr.2012.961; Kara I, 2017, BRATISL MED J, V118, P112, DOI 10.4149/BLL_2017_023; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martinez BI, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0145-8; Montagnana M, 2006, CLIN BIOCHEM, V39, P913, DOI 10.1016/j.clinbiochem.2006.03.016; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Oran I, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/5692583; Piwowar A, 2008, DIS MARKERS, V24, P311, DOI 10.1155/2008/784313; Roy D, 2006, HEART, V92, P113, DOI 10.1136/hrt.2004.049643; Sbarouni E, 2008, HELL J CARDIOL, V49, P260; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610	20	1	1	4	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2021	33	3					254	257		10.1097/ANA.0000000000000647			4	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	ST1UR	WOS:000662236600010	31584483				2022-02-06	
J	Richards, J; Smithson, J; Moberly, NJ; Smith, A				Richards, Jenny; Smithson, Janet; Moberly, Nicholas J.; Smith, Alicia			"If It Goes Horribly Wrong the Whole World Descends on You": The Influence of Fear, Vulnerability, and Powerlessness on Police Officers' Response to Victims of Head Injury in Domestic Violence	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						domestic violence (DV); health consequences; psychological consequences; head injury; traumatic brain injury (TBI); police	INTIMATE PARTNER VIOLENCE; TRAUMATIC BRAIN-INJURY; HEALTH CONSEQUENCES; ATTITUDES; BARRIERS; OUTCOMES; MODEL	Domestic violence (DV) victims face significant barriers to accessing healthcare. This is particularly concerning in cases of brain injury (BI), which is difficult to diagnose and risks severe long-term consequences for DV victims. Police may be able to identify head injury (HI) and signpost victims to healthcare. This research investigated potential barriers to police supporting victim health needs by exploring police attitudes towards DV and considering how police interpret and respond to stories of HI in DV victims. Individual interviews were conducted with 12 police officers from forces in South and Central England. This included the use of a clinical vignette. Thematic analysis highlighted three global themes: 'seesaw of emotions', 'police vulnerability', and 'head injury is fearful'. Police officers' vulnerability to external blame was the predominant influence in their responses to HI.	[Richards, Jenny] Somerset NHS Fdn Trust, Taunton TA2 7PQ, Somerset, England; [Smithson, Janet; Moberly, Nicholas J.; Smith, Alicia] Univ Exeter, Dept Psychol, Exeter EX4 4QG, Devon, England		Richards, J (corresponding author), Somerset NHS Fdn Trust, Taunton TA2 7PQ, Somerset, England.	Jenny.Richards3@nhs.net; J.Smithson@exeter.ac.uk; n.j.moberly@exeter.ac.uk; A.Smith@exeter.ac.uk					Ard KL, 2011, J GEN INTERN MED, V26, P930, DOI 10.1007/s11606-011-1697-6; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Barton H, 2013, PUBLIC MONEY MANAGE, V33, P221, DOI 10.1080/09540962.2013.785709; Batson CD, 2009, SOC ISS POLICY REV, V3, P141, DOI 10.1111/j.1751-2409.2009.01013.x; Berger P. L., 1996, SOCIAL CONSTRUCTION; Black MC, 2011, AM J LIFESTYLE MED, V5, P428, DOI 10.1177/1559827611410265; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Caveney N, 2020, POLIC SOC, V30, P1210, DOI 10.1080/10439463.2019.1691549; Cornelius N, 2021, EQUAL DIVERS INCL, V40, P8, DOI 10.1108/EDI-07-2020-0199; Crank, 2014, UNDERSTANDING POLICE; Dlamini T., 2017, PSYCHOL BEHAV SCI IN, V6, DOI [10.19080/PBSIJ.2017.06.555680, DOI 10.19080/PBSIJ.2017.06.555680]; Dunn JL, 2005, SOCIOL INQ, V75, P1, DOI 10.1111/j.1475-682X.2005.00110.x; Eagly AH, 2007, SOC COGNITION, V25, P582, DOI 10.1521/soco.2007.25.5.582; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Fazio RH, 2007, SOC COGNITION, V25, P603, DOI 10.1521/soco.2007.25.5.603; Ferrari G, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.29890; Fugate M, 2005, VIOLENCE AGAINST WOM, V11, P290, DOI 10.1177/1077801204271959; Fylan F., 2005, HDB RES METHODS CLIN; Gawronski B, 2014, HANDBOOK OF RESEARCH METHODS IN SOCIAL AND PERSONALITY PSYCHOLOGY, SECOND EDITION, P283; Gergen K., 1996, MESSAGE SOCIAL PSYCH; Gergen K. J., 1985, SOCIAL CONSTRUCTION, P3, DOI 10.1007/978-1-4612-5076-0_1; Gergen KJ, 2008, SOC PSYCHOL QUART, V71, P331, DOI 10.1177/019027250807100403; Greig-Midlane J., 2019, THESIS CARDIFF U CAR; Heany J., 2005, THESIS U MISSOURI KA; Her Majesty's Inspectorate of Constabulary (HMIC), 2014, EV BUS IMPR POL RESP EV BUS IMPR POL RESP; Higbee M, 2019, J AGGRESS MALTREAT T, V28, P826, DOI 10.1080/10926771.2019.1653412; Hohl, 2012, JUST AUTHORITY TRUST; Home Office, 2013, INFORM LOCAL AREAS C, P1; Horwitz SH, 2011, J FAM VIOLENCE, V26, P617, DOI 10.1007/s10896-011-9396-y; Howarth C, 2004, J HEALTH PSYCHOL, V9, P229, DOI 10.1177/1359105304040889; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Johnson IM, 2007, J CRIM JUST, V35, P498, DOI 10.1016/j.jcrimjus.2007.07.003; Kaplowitz MD, 2000, QUAL QUANT, V34, P419, DOI 10.1023/A:1004844425448; Kaplowitz MD, 2001, ECOL ECON, V36, P237, DOI 10.1016/S0921-8009(00)00226-3; Krosnick J.A., 2015, HDB ATTITUDES ATTITU, P21; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Markowitz FE, 2015, CRIMINOLOGY, V53, P231, DOI 10.1111/1745-9125.12067; Merry S., 2012, INT J POLICE SCI MAN, V14, P118; Miers D., 1990, INT REV VICTIMOLOGY, V1, P219, DOI 10.1177/026975809000100301; Monahan K, 2019, FUTUR NEUROL, V14, DOI 10.2217/fnl-2018-0031; Monahan K, 2019, J AGGRESS MALTREAT T, V28, P807, DOI 10.1080/10926771.2019.1628154; Morgan M., 2015, REV DOMESTIC A UNPUB; National Audit Office, 2018, HC 1501 SESS 2017 20; Nolet AM, 2021, VIOLENCE AGAINST WOM, V27, P1630, DOI 10.1177/1077801220947169; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Office for National Statistics, DOM AB ENGL WAT YEAR; Othman S, 2014, J INTERPERS VIOLENCE, V29, P1497, DOI 10.1177/0886260513507136; Overstreet NM, 2013, BASIC APPL SOC PSYCH, V35, P109, DOI 10.1080/01973533.2012.746599; Patch M, 2018, J EMERG NURS, V44, P384, DOI 10.1016/j.jen.2017.12.001; Petty RE, 2007, SOC COGNITION, V25, P657, DOI 10.1521/soco.2007.25.5.657; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Potter J, 2007, PALGRAVE ADV, P160; Potter Jonathan, 1998, EUR REV SOC PSYCHOL, V9, P233; Quilter-Pinner H., 2019, THERE IS ALTERNATIVE, P1; Reiner R., 2018, HDB POLICING; Richards J., 2020, THESIS U EXETER; Rose D, 2011, BRIT J PSYCHIAT, V198, P189, DOI 10.1192/bjp.bp.109.072389; Ryan F, 2009, INT J THER REHABIL, V16, P309, DOI 10.12968/ijtr.2009.16.6.42433; Schwartz S. H., 2007, MEASURING ATTITUDES, P169; Shearson K., 2014, THESIS VICTORIA U ME; Shotter J., 1994, ANN INT COMMUNICATIO, V17, P3, DOI [https://doi.org/10.1080/23808985.1994.11678873, DOI 10.1080/23808985.1994.11678873]; Siangchokyoo N., 2012, AM SOC ENG MANAG, V2012, P714; Soukup B., 2013, LANGUAGE DE STANDARD, P251; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Strobl R., 2004, INT REV VICTIMOLOGY, V11, P295, DOI [10.1177/026975800401100206, DOI 10.1177/026975800401100206]; Vaismoradi M., 2016, J NURSING ED PRACTIC, V6, P100, DOI DOI 10.5430/JNEP.V6N5P100; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Walker Samuel, 2012, ST LOUIS U PUB L REV, V32, P88; Waring S., 2019, THESIS U LIVERPOOL; Wetherell, 1987, DISCOURSE SOCIAL PSY; Wire J., 2016, DOMESTIC ABUSE MATTE	72	1	1	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JUL	2021	18	13							7070	10.3390/ijerph18137070			17	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	TF8FK	WOS:000670951000001	34281006	gold, Green Published			2022-02-06	
J	Saadoun, S; Papadopoulos, MC				Saadoun, Samira; Papadopoulos, Marios C.			Acute, Severe Traumatic Spinal Cord Injury Monitoring from the Injury Site and Expansion Duraplasty	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Blood pressure; Critical care; Decompression; Duraplasty; Intraspinal pressure; Microdialysis; Spinal cord injury; Spinal cord perfusion pressure	EARLY SURGICAL DECOMPRESSION; INTRASPINAL PRESSURE; PERFUSION-PRESSURE; SURFACE MICRODIALYSIS; BRAIN-INJURY; VASOPRESSOR USAGE; MANAGEMENT; SURGERY; COMPRESSION; OUTCOMES		[Saadoun, Samira] St Georges Univ London, Acad Neurosurg Unit, Cranmer Terrace, London SW17 0RE, England; [Papadopoulos, Marios C.] St Georges Hosp NHS Fdn Trust, Dept Neurosurg, Atkinson Morley Wing,Blackshaw Rd, London SW17 0QT, England		Saadoun, S (corresponding author), St Georges Univ London, Acad Neurosurg Unit, Cranmer Terrace, London SW17 0RE, England.	ssaadoun@sgul.ac.uk			Wings for Life Spinal Cord Research Foundation; Neurosciences Research Foundation; UK Efficacy and Mechanism Evaluation (EME) Programme; Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); National Institute for Health Research (NIHR) partnershipNational Institute for Health Research (NIHR) [NIHR130048]	The authors thank the Wings for Life Spinal Cord Research Foundation and the Neurosciences Research Foundation for funding our research in spinal cord injury. The authors also thank the UK Efficacy and Mechanism Evaluation (EME) Programme, a Medical Research Council (MRC) and National Institute for Health Research (NIHR) partnership, for funding the DISCUS trial (NIHR130048). The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, NIHR, or the Department of Health and Social Care.	Abrahamsson P, 2012, CLIN PHYSIOL FUNCT I, V32, P99, DOI 10.1111/j.1475-097X.2011.01061.x; Abrahamsson P, 2011, CLIN PHYSIOL FUNCT I, V31, P175, DOI 10.1111/j.1475-097X.2010.00995.x; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Akesson O, 2020, J SURG RES, V245, P537, DOI 10.1016/j.jss.2019.07.060; Akesson O, 2016, J SURG RES, V204, P39, DOI 10.1016/j.jss.2016.04.001; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Chen SL, 2018, J NEUROTRAUM, V35, P2947, DOI 10.1089/neu.2018.5775; Chen SL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00493; Chen SL, 2017, J NEUROTRAUM, V34, P2941, DOI 10.1089/neu.2017.4982; Chen SL, 2016, J NEUROCHEM, V139, P700, DOI 10.1111/jnc.13854; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Czosnyka M, 2017, ACTA NEUROCHIR, V159, P2063, DOI 10.1007/s00701-017-3310-1; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; DONOVAN WH, 1994, PARAPLEGIA, V32, P375, DOI 10.1038/sc.1994.64; Falci SP, 2009, J NEUROSURG-SPINE, V11, P445, DOI 10.3171/2009.4.SPINE09333; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; FERNANDEZ E, 1985, ACTA NEUROCHIR, V76, P145, DOI 10.1007/BF01418478; Gallagher MJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64944-y; Gallagher MJ, 2019, J NEUROTRAUM, V36, P919, DOI 10.1089/neu.2018.5961; Gallagher MJ, 2018, CRIT CARE MED, V46, P1150, DOI 10.1097/CCM.0000000000003134; Hennekens CH, 2011, JAMA-J AM MED ASSOC, V305, P1134, DOI 10.1001/jama.2011.322; Hogg FRA, 2021, NEUROCRIT CARE, V34, P121, DOI 10.1007/s12028-020-00988-2; Hogg FRA, 2020, J NEUROTRAUM, V37, P1156, DOI 10.1089/neu.2019.6789; Hogg FRA, 2019, NEUROCRIT CARE, V30, P421, DOI 10.1007/s12028-018-0616-7; HUGHES JT, 1988, PARAPLEGIA, V26, P71, DOI 10.1038/sc.1988.15; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iannotti C, 2006, J NEUROTRAUM, V23, P853, DOI 10.1089/neu.2006.23.853; Inoue T, 2014, J NEUROTRAUM, V31, P284, DOI 10.1089/neu.2013.3061; Jalan D, 2017, J NEUROSURG-SPINE, V26, P62, DOI 10.3171/2016.6.SPINE16343; Jeffery ND, 2020, VET SURG, V49, P884, DOI 10.1111/vsu.13423; Kleindienst A, 2020, ACTA NEUROCHIR, V162, P2541, DOI 10.1007/s00701-020-04529-w; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Markatos K, 2018, WORLD NEUROSURG, V109, P338, DOI 10.1016/j.wneu.2017.10.047; Marketos SG, 1999, SPINE, V24, P1381, DOI 10.1097/00007632-199907010-00018; Oddo M, 2018, INTENS CARE MED, V44, P1945, DOI 10.1007/s00134-017-5031-6; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Piazza M, 2017, NEUROSURG CLIN N AM, V28, P31, DOI 10.1016/j.nec.2016.08.005; Readdy WJ, 2015, J NEUROSURG-SPINE, V23, P574, DOI 10.3171/2015.2.SPINE14746; Saadeh YS, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17428; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Saadoun S, 2017, J NEUROL NEUROSUR PS, V88, P452, DOI 10.1136/jnnp-2016-314600; Saadoun S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1490-3; Saadoun S, 2016, BRIT J NEUROSURG, V30, P582, DOI 10.3109/02688697.2016.1173191; Seth AK, 2015, J NEUROSCI, V35, P3293, DOI 10.1523/JNEUROSCI.4399-14.2015; Smith JS, 2010, J BONE JOINT SURG AM, V92A, P1206, DOI 10.2106/JBJS.I.00740; Squair JW, 2017, NEUROLOGY, V89, P1660, DOI 10.1212/WNL.0000000000004519; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; van Middendorp JJ, 2013, J NEUROTRAUM, V30, P1781, DOI 10.1089/neu.2013.2932; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Weiner MF, 2014, EUR NEUROL, V72, P363, DOI 10.1159/000365287; Werndle MC, 2016, ACTA NEUROCHIR SUPPL, V122, P323, DOI 10.1007/978-3-319-22533-3_64; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Wilcox Ruth K, 2003, J Orthop Sci, V8, P432, DOI 10.1007/s10776-003-0644-9; Zhang J, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0369-y; Zhu FZ, 2019, EUR SPINE J, V28, P2275, DOI 10.1007/s00586-019-06091-1	59	1	1	5	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2021	32	3			SI		365	376		10.1016/j.nec.2021.03.008			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SJ6RR	WOS:000655660300009	34053724				2022-02-06	
J	Semyachkina-Glushkovskaya, O; Postnov, D; Lavrova, A; Fedosov, I; Borisova, E; Nikolenko, V; Penzel, T; Kurths, J; Tuchin, V				Semyachkina-Glushkovskaya, Oxana; Postnov, Dmitry; Lavrova, Anastasia; Fedosov, Ivan; Borisova, Ekaterina; Nikolenko, Vladimir; Penzel, Thomas; Kurths, Juergen; Tuchin, Valery			Biophotonic Strategies of Measurement and Stimulation of the Cranial and the Extracranial Lymphatic Drainage Function	IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS			English	Article						The cranial and the extracranial lymphatics; brain diseases; photostimulation of the lymphatics	LEVEL LASER THERAPY; NEAR-INFRARED LIGHT; CEREBROSPINAL-FLUID ABSORPTION; RAT MESENTERIC LYMPHATICS; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; NITRIC-OXIDE; INTERSTITIAL FLUID; MOUSE MODEL; ALZHEIMERS-DISEASE	In this review, we discuss the crucial role of cranial and the extracranial lymphatics in keeping the central nervous system (CNS) health. We talk about the important lymphatic mechanism of removal of metabolites and toxins from the brain, which orchestrates the regenerative processes in CNS. We debate a novel knowledge about the lymphatic mechanism responsible for maintaining the balance between the exit and the entrance of molecules and cells from and into CNS. Finally, we highlight the pioneering technologies of biophotonic stimulation of lymphatic drainage function that can open a new era for the development of novel bedside, readily applicable and commercially viable technologies for the treatment of brain diseases.	[Semyachkina-Glushkovskaya, Oxana; Borisova, Ekaterina; Penzel, Thomas; Kurths, Juergen] Saratov NG Chernyshevskii State Univ, Dept Human & Anim Physiol, Saratov 83410012, Russia; [Semyachkina-Glushkovskaya, Oxana; Kurths, Juergen] Humboldt Univ, Dept Phys, D-12489 Berlin, Germany; [Postnov, Dmitry; Lavrova, Anastasia; Fedosov, Ivan; Tuchin, Valery] Saratov NG Chernyshevskii State Univ, Dept Opt & Biophoton, Saratov 410012, Russia; [Lavrova, Anastasia] St Petersburg State Res Inst Phthisiopulmonol, St Petersburg, Russia; [Lavrova, Anastasia] St Petersburg State Univ, St Petersburg, Russia; [Borisova, Ekaterina] Bulgarian Acad Sci, Inst Elect, Sofia 1784, Bulgaria; [Nikolenko, Vladimir] Sechenov Univ, NV Sklifosovsky Inst Clin Med, FSAEI HE IM Sechenov Moscow State Med Univ 1, Moscow 119435, Russia; [Nikolenko, Vladimir] Lomonosov Moscow State Univ, Moscow 119991, Russia; [Penzel, Thomas] Adv Sleep Res GmbH, D-12489 Berlin, Germany; [Penzel, Thomas] Charite Univ Med Berlin, Sleep Med Ctr, D-10117 Berlin, Germany; [Kurths, Juergen] Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; [Tuchin, Valery] Russian Acad Sci, Inst Precis Mech & Control, Saratov, Russia; [Tuchin, Valery] Tomsk State Univ, Tomsk, Russia		Semyachkina-Glushkovskaya, O (corresponding author), Saratov NG Chernyshevskii State Univ, Dept Human & Anim Physiol, Saratov 83410012, Russia.	glushkovskaya@mail.ru; postnov@info.sgu.ru; aurebours@googlemail.com; fedosov_optics@mail.ru; ekaterina.borisova@gmail.com; vn.nikolenko@yandex.ru; thomas.penzel@charite.de; juergen.kurths@pik-potsdam.de; Tuchinvv@mail.ru	Penzel, Thomas/M-2344-2014; Николенко, Владимир Николаевич/AAD-4696-2022; Tuchin, Valery V/C-7865-2013; Glushkovskaya, Oxana/D-9103-2013	Penzel, Thomas/0000-0002-4304-0112; Tuchin, Valery V/0000-0001-7479-2694; Glushkovskaya, Oxana/0000-0001-6753-7513	Russian Science FoundationRussian Science Foundation (RSF) [20-15-00090, 18-75-10033, 19-15-00201]; RFBRRussian Foundation for Basic Research (RFBR) [19-515-55016, 20-015-00308-a]; RF Government [075-15-2019-1885]	This work was supported in part by Grants of Russian Science Foundation: under Grant 20-15-00090, in part by th O.S-G. and J.K., Sections I, II, III, VI under Grant 18-75-10033, in part by the I.F.and M.K., Section V under Grant 19-15-00201, in part by the D.P. and A.L., Section VI RFBR under Grant 19-515-55016, 20-015-00308-a, and in part by the RF Government under Grant 075-15-2019-1885.	Abbott NJ, 2018, ACTA NEUROPATHOL, V135, P387, DOI 10.1007/s00401-018-1812-4; Agyeman A. A., 2020, MAYO CLIN P; Ahn JH, 2019, NATURE, V572, P62, DOI 10.1038/s41586-019-1419-5; Ajmani GS, 2016, ENVIRON HEALTH PERSP, V124, P1683, DOI 10.1289/EHP136; [Anonymous], 1991, VESTN OTORINOLARINGO; [Anonymous], 2010, METHOD YEAR 2010 OPT; [Anonymous], 2010, SCIENCE; Aragao MFVV, 2020, AM J NEURORADIOL, V41, P1703, DOI 10.3174/ajnr.A6675; Asgari M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38635; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bedussi B, 2018, J CEREBR BLOOD F MET, V38, P719, DOI 10.1177/0271678X17737984; Beeraka NM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.552925; Benedicenti S, 2008, PHOTOMED LASER SURG, V26, P451, DOI 10.1089/pho.2007.2218; Blatter C, 2016, SCI REP, V6, P1; Bohineust A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14810-2; Bohlen HG, 2009, AM J PHYSIOL-HEART C, V297, pH1337, DOI 10.1152/ajpheart.00171.2009; Bohlen HG, 2011, AM J PHYSIOL-HEART C, V301, pH1897, DOI 10.1152/ajpheart.00260.2011; Bohlen HG, 2009, AM J PHYSIOL-HEART C, V297, pH1319, DOI 10.1152/ajpheart.00039.2009; BOTEL C, 1994, LYMPHOLOGY, V27, P688; BRADBURY M, 1981, TRENDS NEUROSCI, V4, P100, DOI 10.1016/0166-2236(81)90032-1; BRADBURY MWB, 1980, J PHYSIOL-LONDON, V299, P353, DOI 10.1113/jphysiol.1980.sp013129; Brice G, 2013, CLIN GENET, V84, P378, DOI 10.1111/cge.12158; Briguglio M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00671; Bucchieri F, 2015, J ANAT, V227, P702, DOI 10.1111/joa.12381; Butler WE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187014; Butowt R, 2021, NEUROSCIENTIST, V27, P582, DOI 10.1177/1073858420956905; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; CASLEYSMITH JR, 1978, J PATHOL, V124, P13, DOI 10.1002/path.1711240104; CASLEYSMITH JR, 1976, BRIT J EXP PATHOL, V57, P179; Cassano Paolo, 2015, Psychiatry J, V2015, P352979, DOI 10.1155/2015/352979; Castorena-Gonzalez JA, 2018, CIRC RES, V123, P964, DOI 10.1161/CIRCRESAHA.117.312576; Caversaccio M, 1996, INTRACRANIAL AND INTRALABYRINTHINE FLUIDS, P123; Chakraborty S, 2015, SEMIN CELL DEV BIOL, V38, P55, DOI 10.1016/j.semcdb.2015.01.005; Chang J, 2018, NEUROPSYCHIATRY-LOND, V8, P477, DOI [DOI 10.4172/NEUROPSYCHIATRY.1000369, 10.4172/Neuropsychiatry.1000369]; Chen Y., 2004, J TRADIT CHIN MED, V24; CSERR HF, 1992, IMMUNOL TODAY, V13, P507, DOI 10.1016/0167-5699(92)90027-5; Czosnyka M, 2004, PEDIATRIC HYDROCEPHALUS, P47; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; de Leon MJ, 2017, J NUCL MED, V58, P1471, DOI 10.2967/jnumed.116.187211; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Diem AK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00475; DiMauro T. M., 2014, Patent US, Patent No. [8,734.498 B2, 8734498]; DIMMELER S, 1992, J BIOL CHEM, V267, P16771; Dirican A, 2011, SUPPORT CARE CANCER, V19, P685, DOI 10.1007/s00520-010-0888-8; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Dupont G, 2019, CLIN ANAT, V32, P117, DOI 10.1002/ca.23308; ELIAS RM, 1990, J APPL PHYSIOL, V68, P199, DOI 10.1152/jappl.1990.68.1.199; Eltchechem CD, 2017, LASER MED SCI, V32, P749, DOI 10.1007/s10103-017-2156-3; Engelhardt B, 2016, ACTA NEUROPATHOL, V132, P317, DOI 10.1007/s00401-016-1606-5; Ethell DW, 2014, J ALZHEIMERS DIS, V41, P1021, DOI 10.3233/JAD-130659; Farfara D, 2015, J MOL NEUROSCI, V55, P430, DOI 10.1007/s12031-014-0354-z; Fedosov I, 2016, HDB OPTICAL BIOMEDIC, V2, P688, DOI DOI 10.1117/3.2219603; Fedosov I. V., 2013, HDB COHERENT DOMAIN, P487; Fedosov IV, 2002, QUANTUM ELECTRON+, V32, P970, DOI 10.1070/QE2002v032n11ABEH002330; Fedosov IV, 2002, TECH PHYS LETT+, V28, P690, DOI 10.1134/1.1505552; FERGUSON MK, 1994, MICROVASC RES, V47, P308, DOI 10.1006/mvre.1994.1024; Ferrell RE, 2010, AM J HUM GENET, V86, P943, DOI 10.1016/j.ajhg.2010.04.010; Finegold DN, 2012, CLIN CANCER RES, V18, P2382, DOI 10.1158/1078-0432.CCR-11-2303; FOLDI M, 1968, EXPERIENTIA, V24, P1283, DOI 10.1007/BF02146675; Foldi M., 1968, LYMPH LYMPHATIC SYST, P169; Fultz NE, 2019, SCIENCE, V366, P628, DOI 10.1126/science.aax5440; Galanzha EI, 2008, CYTOM PART A, V73A, P884, DOI 10.1002/cyto.a.20587; Galanzha EI, 2007, WORLD J GASTROENTERO, V13, P192, DOI 10.3748/wjg.v13.i2.192; Gao YR, 2015, NEUROIMAGE, V115, P162, DOI 10.1016/j.neuroimage.2015.04.054; Gashev AA, 2002, J PHYSIOL-LONDON, V540, P1023, DOI 10.1113/jphysiol.2002.016642; Gasheva OY, 2006, J PHYSIOL-LONDON, V575, P821, DOI 10.1113/jphysiol.2006.115212; Geng X, 2016, DEV BIOL, V409, P218, DOI 10.1016/j.ydbio.2015.10.022; Gilani S, 2020, MED HYPOTHESES, V141, DOI 10.1016/j.mehy.2020.109757; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grillo SL, 2013, J PHOTOCH PHOTOBIO B, V123, P13, DOI 10.1016/j.jphotobiol.2013.02.015; Hadaczek P, 2006, MOL THER, V14, P69, DOI 10.1016/j.ymthe.2006.02.018; Hagendoorn J, 2004, CIRC RES, V95, P204, DOI 10.1161/01.RES.0000135549.72828.24; Hamblin M. R., 2018, LOW LEVEL LIGHT THER, P388; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; HARLINGBERG C, 1989, J NEUROIMMUNOL, V25, P185, DOI 10.1016/0165-5728(89)90136-7; Harvey NL, 2008, ANN NY ACAD SCI, V1131, P82, DOI 10.1196/annals.1413.007; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; His W., 1865, ZEITSCHR F WISS ZOOL, V15; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Hu XT, 2020, CELL RES, V30, P229, DOI 10.1038/s41422-020-0287-8; Huidobro N, 2018, NEUROSCI LETT, V664, P51, DOI 10.1016/j.neulet.2017.11.004; Huidobro N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00464; Huisa BN, 2013, INT J STROKE, V8, P315, DOI 10.1111/j.1747-4949.2011.00754.x; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Jackson DG, 2003, TRENDS CARDIOVAS MED, V13, P1, DOI 10.1016/S1050-1738(02)00189-5; JACKSON RT, 1979, ARCH OTOLARYNGOL, V105, P180; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Johnston Miles, 2004, Cerebrospinal Fluid Res, V1, P2, DOI 10.1186/1743-8454-1-2; Juratli MA, 2014, CANCERS, V6, P128, DOI 10.3390/cancers6010128; Kalchenko V, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.050502; Kanady JD, 2011, DEV BIOL, V354, P253, DOI 10.1016/j.ydbio.2011.04.004; Karimi-Galougahi M, 2020, ACAD RADIOL, V27, P1042, DOI 10.1016/j.acra.2020.04.030; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kiviniemi V, 2016, J CEREBR BLOOD F MET, V36, P1033, DOI 10.1177/0271678X15622047; Koh L, 2005, FLUIDS BARRIERS CNS, V2, DOI 10.1186/1743-8454-2-6; KOSTELJANETZ M, 1987, ACTA NEUROL SCAND, V75, P1; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kuan EL, 2015, J IMMUNOL, V194, P5200, DOI 10.4049/jimmunol.1500221; Landucci A, 2016, INT J ORAL MAX SURG, V45, P392, DOI 10.1016/j.ijom.2015.10.023; Lapchak PA, 2016, ACTA NEUROCHIR SUPPL, V121, P7, DOI 10.1007/978-3-319-18497-5_2; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; Liao S, 2015, SEMIN CELL DEV BIOL, V38, P83, DOI 10.1016/j.semcdb.2014.11.012; Liao S, 2011, P NATL ACAD SCI USA, V108, P18784, DOI 10.1073/pnas.1116152108; Liu C., 2009, INTRANASAL LOW INTEN; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lu YJ, 2017, NEUROBIOL AGING, V49, P165, DOI 10.1016/j.neurobiolaging.2016.10.003; Ma QL, 2019, ACTA NEUROPATHOL, V137, P151, DOI 10.1007/s00401-018-1916-x; Ma QL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01484-6; Mabil P, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00490; Mardal V. Vinje, 2019, SCI REP-UK, V9, P1; Markovic A, 2007, INT J ORAL MAX SURG, V36, P226, DOI 10.1016/j.ijom.2006.10.006; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Martinac AD, 2020, BIOMECH MODEL MECHAN, V19, P781, DOI 10.1007/s10237-019-01253-y; Meneguzzo D. T., 2017, LOW LEVEL LIGHT THER, P978; MESTER E, 1971, AM J SURG, V122, P532, DOI 10.1016/0002-9610(71)90482-X; Mester E., 1967, KISERL ORVOSTUD, V19; Mezey E, 2015, NATURE, V524, P415, DOI 10.1038/524415b; Mitchell UH, 2013, AM J PHYS MED REHAB, V92, P151, DOI 10.1097/PHM.0b013e318269d70a; Mohammed HS, 2016, LASER MED SCI, V31, P1651, DOI 10.1007/s10103-016-2033-5; Mollanji R, 2002, AM J PHYSIOL-REG I, V282, pR1593, DOI 10.1152/ajpregu.00695.2001; Mollanji R, 2001, AM J PHYSIOL-REG I, V280, pR1573, DOI 10.1152/ajpregu.2001.280.5.R1573; Montalvan V, 2020, CLIN NEUROL NEUROSUR, V194, DOI 10.1016/j.clineuro.2020.105921; Morries L. D., 2015, NEUROPSYCHIATRIC DIS, V11; Moshkovska T, 2005, POSTGRAD MED J, V81, P436, DOI 10.1136/pgmj.2004.027755; Murad F, 1999, ANGEW CHEM INT EDIT, V38, P1857, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1856::AID-ANIE1856>3.0.CO;2-D; Oreskovic D, 2018, NEUROSCIENCE, V392, P164, DOI 10.1016/j.neuroscience.2018.09.029; Oreskovic D, 2017, NEUROSCIENCE, V354, P69, DOI 10.1016/j.neuroscience.2017.04.025; Oron A, 2016, PHOTOMED LASER SURG, V34, P627, DOI 10.1089/pho.2015.4072; Ostergaard P, 2011, J MED GENET, V48, P251, DOI 10.1136/jmg.2010.085563; Ouares KA, 2019, EUR J NEUROSCI, V49, P6, DOI 10.1111/ejn.14251; Papaiconomou C, 2002, AM J PHYSIOL-REG I, V283, pR869, DOI 10.1152/ajpregu.00173.2002; Passarelli PC, 2020, AM J DENT, V33, P135; Pastrana E, 2011, NAT METHODS, V8, P24, DOI 10.1038/NMETH.F.323; Postnov DE, 2018, PROC SPIE, V10717, DOI 10.1117/12.2315196; Postnov DD, 2018, BIOMED OPT EXPRESS, V9, P6388, DOI 10.1364/BOE.9.006388; Printza A, 2020, EUR ARCH OTO-RHINO-L, V277, P2625, DOI 10.1007/s00405-020-06069-6; Purushothuman S, 2013, BRAIN RES, V1535, P61, DOI 10.1016/j.brainres.2013.08.047; Purushothurnan S, 2015, NEUROSCI LETT, V591, P155, DOI 10.1016/j.neulet.2015.02.037; Radjavi A, 2014, MOL PSYCHIATR, V19, P531, DOI 10.1038/mp.2013.79; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Salehpour F, 2020, REV NEUROSCIENCE, V31, P269, DOI 10.1515/revneuro-2019-0063; Salehpour F, 2018, MOL NEUROBIOL, V55, P6601, DOI 10.1007/s12035-017-0852-4; Samoilova KA, 2008, PHOTOMED LASER SURG, V26, P443, DOI 10.1089/pho.2007.2205; Scallan JP, 2010, J PHYSIOL-LONDON, V588, P243, DOI 10.1113/jphysiol.2009.179622; Schwalbe G., 1869, ZENTRALBL MED WISS, V7, P465; Semyachkina-Glushkovskaya O., 2020, TRANSL BIOPHOTONICS, V2, DOI [10.1002/tbio.201900036, DOI 10.1002/TBIO.201900036]; Semyachkina-Glushkovskaya O, 2020, BIOMED OPT EXPRESS, V11, P725, DOI 10.1364/BOE.383390; Semyachkina-Glushkovskaya O, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123818; Semyachkina-Glushkovskaya O, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201700287; Semyachkina-Glushkovskaya O, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.12.121719; Shepherd A. P., 1990, LASER DOPPLER BLOOD, P17; Shevrygin B. V., 2000, Vestnik Otorinolaringologii, P31; Shirasawa Y, 2000, AM J PHYSIOL-GASTR L, V278, pG551, DOI 10.1152/ajpgi.2000.278.4.G551; Silver I, 2002, NEUROPATH APPL NEURO, V28, P67, DOI 10.1046/j.1365-2990.2002.00373.x; Smith AJ, 2015, TRENDS NEUROSCI, V38, P331, DOI 10.1016/j.tins.2015.04.006; Smoot B, 2015, J CANCER SURVIV, V9, P287, DOI 10.1007/s11764-014-0411-1; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Song J, 2020, NEUROSCI LETT, V717, DOI 10.1016/j.neulet.2019.134698; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Sun BL, 2006, CLIN HEMORHEOL MICRO, V34, P227; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; SZENTISTVANYI I, 1984, AM J PHYSIOL, V246, pF835, DOI 10.1152/ajprenal.1984.246.6.F835; Tan P, 2017, TRENDS BIOTECHNOL, V35, P215, DOI 10.1016/j.tibtech.2016.09.002; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; TULEBAEV R K, 1989, Vestnik Otorinolaringologii, P46; Vega JL, 2003, J NEUROPATH EXP NEUR, V62, P848, DOI 10.1093/jnen/62.8.848; Volotovskaia A V, 2003, Vopr Kurortol Fizioter Lech Fiz Kult, P22; vonderWeid PY, 1996, J PHYSIOL-LONDON, V493, P563, DOI 10.1113/jphysiol.1996.sp021404; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Weed LH, 1914, J MED RES, V31, P51; WELLER RO, 1992, BRAIN PATHOL, V2, P277, DOI 10.1111/j.1750-3639.1992.tb00704.x; Weller RO, 1998, J NEUROPATH EXP NEUR, V57, P885, DOI 10.1097/00005072-199810000-00001; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; WIDNER H, 1988, SCAND J IMMUNOL, V28, P563, DOI 10.1111/j.1365-3083.1988.tb01488.x; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Xia ZL, 2003, CLIN HEMORHEOL MICRO, V29, P345; [肖学长 Xiao Xuechang], 2005, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V27, P418; XING CM, 1994, LYMPHOLOGY, V27, P742; Xu C., 2002, PRACTICE J MED PHARM, V19, P407; Xu C., 2001, QIAN WEI J MED PHARM, V18, P337; Xu YX, 2014, P NATL ACAD SCI USA, V111, P6371, DOI 10.1073/pnas.1319296111; Xu ZQ, 2017, MOL NEUROBIOL, V54, P4551, DOI 10.1007/s12035-016-9983-2; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Yanev P, 2020, J CEREBR BLOOD F MET, V40, P263, DOI 10.1177/0271678X18822921; Yokoyama Shin, 1993, American Journal of Physiology, V264; Zakharov A, 2004, MICROVASC RES, V67, P96, DOI 10.1016/j.mvr.2003.08.004; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707; Zhao PF, 2020, NANO LETT, V20, P5415, DOI 10.1021/acs.nanolett.0c01806; Zinchenko E, 2019, BIOMED OPT EXPRESS, V10, P4003, DOI 10.1364/BOE.10.004003	196	1	1	5	10	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1077-260X	1558-4542		IEEE J SEL TOP QUANT	IEEE J. Sel. Top. Quantum Electron.	JUL-AUG	2021	27	4							7400313	10.1109/JSTQE.2020.3045834			13	Engineering, Electrical & Electronic; Quantum Science & Technology; Optics; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Physics; Optics	QZ9YA	WOS:000631074200001					2022-02-06	
J	Sutherland, TC; Sefiani, A; Horvat, D; Huntington, TE; Lei, YJ; West, AP; Geoffroy, CG				Sutherland, Theresa C.; Sefiani, Arthur; Horvat, Darijana; Huntington, Taylor E.; Lei, Yuanjiu; West, A. Phillip; Geoffroy, Cedric G.			Age-Dependent Decline in Neuron Growth Potential and Mitochondria Functions in Cortical Neurons	CELLS			English	Article						mitochondria; aging; neurite growth; dysfunction; mitochondrial respiration; CNS Injury	SPINAL-CORD; OXIDATIVE STRESS; PROTEIN IMPORT; SKELETAL-MUSCLE; BIOENERGETICS; BIOGENESIS; BRAIN; GRIM-19; DNA; REGENERATION	The age of incidence of spinal cord injury (SCI) and the average age of people living with SCI is continuously increasing. However, SCI is extensively modeled in young adult animals, hampering translation of research to clinical applications. While there has been significant progress in manipulating axon growth after injury, the impact of aging is still unknown. Mitochondria are essential to successful neurite and axon growth, while aging is associated with a decline in mitochondrial functions. Using isolation and culture of adult cortical neurons, we analyzed mitochondrial changes in 2-, 6-, 12- and 18-month-old mice. We observed reduced neurite growth in older neurons. Older neurons also showed dysfunctional respiration, reduced membrane potential, and altered mitochondrial membrane transport proteins; however, mitochondrial DNA (mtDNA) abundance and cellular ATP were increased. Taken together, these data suggest that dysfunctional mitochondria in older neurons may be associated with the age-dependent reduction in neurite growth. Both normal aging and traumatic injury are associated with mitochondrial dysfunction, posing a challenge for an aging SCI population as the two elements can combine to worsen injury outcomes. The results of this study highlight this as an area of great interest in CNS trauma.	[Sutherland, Theresa C.; Sefiani, Arthur; Horvat, Darijana; Huntington, Taylor E.; Geoffroy, Cedric G.] Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Bryan, TX 77807 USA; [Lei, Yuanjiu; West, A. Phillip] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Bryan, TX 77807 USA		Geoffroy, CG (corresponding author), Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Bryan, TX 77807 USA.	tcsutherland@tamu.edu; sefiani@tamu.edu; d-horvat@tamu.edu; taylore.hunt94@tamu.edu; abbylei@tamu.edu; awest@tamu.edu; geoffroy@tamu.edu		Lei, Yuanjiu/0000-0002-7486-4261; Sefiani, Arthur/0000-0003-3226-8530; Sutherland, Theresa C./0000-0002-2919-1504; West, A. Phillip/0000-0003-2884-6895	Craig H. Neilsen Foundation [650332]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HL148153]	This research was funded by a Craig H. Neilsen Foundation Grant to Cedric Geoffroy (650332). Y.L. and A.P.W. were supported by NIH Grant R01HL148153.	[Anonymous], 2009, ONE DEGREE SEPARATIO, V2019; Brown MR, 2004, J BIOENERG BIOMEMBR, V36, P401, DOI 10.1023/B:JOBB.0000041775.10388.23; Chen Y, 2012, J BIOL CHEM, V287, P27227, DOI 10.1074/jbc.M112.340315; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; Demishtein-Zohary K, 2017, CELL TISSUE RES, V367, P33, DOI 10.1007/s00441-016-2486-7; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Filograna R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav9824; Formosa LE, 2018, NAT CELL BIOL, V20, P511, DOI 10.1038/s41556-018-0098-z; Fouad K, 2020, J NEUROTRAUM, V37, P831, DOI 10.1089/neu.2019.6674; Franco-Iborra S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1154-0; Geoffroy CG, 2017, NEUROSCI LETT, V652, P41, DOI 10.1016/j.neulet.2016.11.003; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343; Haas RH, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020048; Han Q, 2020, CELL METAB, V31, P623, DOI 10.1016/j.cmet.2020.02.002; Han SM, 2016, NEURON, V92, P1308, DOI 10.1016/j.neuron.2016.11.025; Hebert SL, 2015, J GERONTOL A-BIOL, V70, P1409, DOI 10.1093/gerona/glv086; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Islam MT, 2017, NEUROL RES, V39, P73, DOI 10.1080/01616412.2016.1251711; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jolivet Renaud, 2009, Front Neuroenergetics, V1, P4, DOI 10.3389/neuro.14.004.2009; Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327; Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x; Joseph AM, 2010, AM J PHYSIOL-CELL PH, V298, pC1308, DOI 10.1152/ajpcell.00644.2008; Kierans SJ, 2021, J PHYSIOL-LONDON, V599, P23, DOI 10.1113/JP280572; Kiryu-Seo S, 2019, NEUROSCI RES, V139, P42, DOI 10.1016/j.neures.2018.08.014; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; Lathrop Kira L, 2013, J Ocul Biol, V1, P9; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Lei YJ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe7548; Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8; Lin DT, 2007, NEUROBIOL AGING, V28, P99, DOI 10.1016/j.neurobiolaging.2005.11.004; Lopez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Manini TM, 2010, AGEING RES REV, V9, P1, DOI 10.1016/j.arr.2009.08.002; Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011; Mokranjac D, 2010, BBA-BIOENERGETICS, V1797, P1045, DOI 10.1016/j.bbabio.2010.01.026; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Murchison D, 2004, CELL CALCIUM, V36, P61, DOI 10.1016/j.ceca.2003.11.010; Murchison D, 2007, AGING CELL, V6, P297, DOI 10.1111/j.1474-9726.2007.00293.x; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; NSCIS, 2017, SPIN CORD INJ SCI FA; Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8; Pandya JD, 2016, NEUROBIOL AGING, V42, P25, DOI 10.1016/j.neurobiolaging.2016.02.027; Patron LA, 2016, NEURON, V92, P1152, DOI 10.1016/j.neuron.2016.12.007; Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022; Pfanner N, 1997, CURR BIOL, V7, pR100, DOI 10.1016/S0960-9822(06)00048-0; Porras CA, 2015, FRONT BIOSCI-LANDMRK, V20, P621, DOI 10.2741/4327; Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010; Rausser S., 2021, BIORXIV, DOI [10.1101/2020.10.16.342923, DOI 10.1101/2020.10.16.342923]; Ravera S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46749-w; Rubner M., 1916, JAMA-J AM MED ASSOC, V66; Schleiff E, 1998, BIOCHEMISTRY-US, V37, P13043, DOI 10.1021/bi9807456; Serviddio G, 2007, REDOX REP, V12, P91, DOI 10.1179/135100007X162112; Shetty PK, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00043; Shimokata H, 1993, Nihon Ronen Igakkai Zasshi, V30, P572; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sivandzade F, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3128; Smith ALM, 2020, NAT CANCER, V1, P976, DOI 10.1038/s43018-020-00112-5; Smith GM, 2018, DEV NEUROBIOL, V78, P221, DOI 10.1002/dneu.22546; Suen YK, 2000, APOPTOSIS, V5, P369, DOI 10.1023/A:1009691727077; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Sutherland TC, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00190; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; Tseng AM, 2019, ALCOHOL CLIN EXP RES, V43, P1414, DOI 10.1111/acer.14066; Vaarmann A, 2016, DEVELOPMENT, V143, P1981, DOI 10.1242/dev.128926; Vanhauwaert R, 2019, CURR OPIN NEUROBIOL, V57, P87, DOI 10.1016/j.conb.2019.01.015; VanHook A.M., 2013, SCI SIGNAL, V6, pEC50, DOI [10.1126/scisignal.2004095, DOI 10.1126/SCISIGNAL.2004095]; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939; Wang BY, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.650038; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Yamamoto H, 2011, P NATL ACAD SCI USA, V108, P91, DOI 10.1073/pnas.1014918108; Yaniv Y, 2013, TRENDS ENDOCRIN MET, V24, P495, DOI 10.1016/j.tem.2013.06.001; Yano H, 2014, NAT NEUROSCI, V17, P822, DOI 10.1038/nn.3721; Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28; Yonutas HM, 2015, J BIOENERG BIOMEMBR, V47, P149, DOI 10.1007/s10863-014-9593-5; Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209; Zhang RY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4287-0; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	87	1	1	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	JUL	2021	10	7							1625	10.3390/cells10071625			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	TO0YB	WOS:000676647600001	34209640	gold, Green Published			2022-02-06	
J	Teichner, EM; You, JC; Hriso, C; Wintering, NA; Zabrecky, GP; Alavi, A; Bazzan, AJ; Monti, DA; Newberg, AB				Teichner, Eric M.; You, Jason C.; Hriso, Chloe; Wintering, Nancy A.; Zabrecky, George P.; Alavi, Abass; Bazzan, Anthony J.; Monti, Daniel A.; Newberg, Andrew B.			Alterations in cerebral glucose metabolism as measured by F-18-fluorodeoxyglucose-PET in patients with persistent postconcussion syndrome	NUCLEAR MEDICINE COMMUNICATIONS			English	Article						concussion; cerebral glucose metabolism; cognition; F-18-fluorodeoxyglucose-PET; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NEUROIMAGING FINDINGS; PET; HYPOPERFUSION; DEPRESSION; EXCITATION; DEFICITS	Background Many patients who have traumatic brain injury experience a wide range of psychiatric and neurological symptoms (including impairment in functional status, cognition, and mood), and if persistent are referred to as persistent postconcussion syndrome (PCS). To our knowledge, this is the first study to broadly evaluate metabolic dysregulation in a heterogenous patient population meeting the criteria for PCS. Methods A total of 64 PCS patients and 37 healthy controls underwent F-18-fluorodeoxyglucose-PET (F-18-FDG-PET) scanning, and 70 brain structures (including left and right structures where appropriate) were analyzed in each subject. Results Compared to the brains of healthy controls, those of PCS patients demonstrated 15 hypermetabolic and 23 hypometabolic regions. Metabolic changes in the brains of PCS patients were subsequently correlated with various indices of symptom severity, mood, and physical/cognitive function. Among PCS patients, increased metabolism in the right cingulate gyrus correlated with the severity of postconcussion symptoms. Conversely, increased metabolism in the left temporal lobe was associated with both improved mood and measures of adaptability/rehabilitation. Furthermore, increased metabolism in the bilateral orbitofrontal regions correlated with improved working memory. Conclusions Overall, these findings suggest a complex pattern of cerebral metabolism in PCS patients, with a mixture of hypometabolic and hypermetabolic regions that correlate with various symptoms, highlighting both potential pathological and compensatory mechanisms in PCS. The findings also suggest that FDG PET is useful for providing neurophysiological information in the evaluation of patients with PCS and may help guide future targeted therapies.	[Teichner, Eric M.; Hriso, Chloe; Wintering, Nancy A.; Zabrecky, George P.; Bazzan, Anthony J.; Monti, Daniel A.; Newberg, Andrew B.] Thomas Jefferson Univ, Dept Integrat Med & Nutrit Sci, Marcus Inst Integrat Hlth, Philadelphia, PA 19107 USA; [You, Jason C.] Harvard Med Sch, Partners Neurol Massachusetts Gen Hosp & Brigham, Boston, MA 02115 USA; [Alavi, Abass] Univ Pennsylvania, Dept Radiol, Philadelphia, PA 19104 USA; [Newberg, Andrew B.] Thomas Jefferson Univ, Department Radiol, Philadelphia, PA 19107 USA		Newberg, AB (corresponding author), Thomas Jefferson Univ, Dept Integrat Med & Nutrit Sci, 925 Chestnut St,Suite 120, Philadelphia, PA 19107 USA.	Andrew.newberg@jefferson.edu		Teichner, Eric/0000-0001-6627-6550	Marcus Foundation	This study was funded by a grant from the Marcus Foundation.	Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; AZARI NP, 1992, BRAIN RES, V589, P279, DOI 10.1016/0006-8993(92)91288-P; Biagianti B, 2020, J AFFECT DISORDERS, V262, P71, DOI 10.1016/j.jad.2019.10.058; Bigler ED, 2016, SPORTS MED ARTHROSC, V24, pE42, DOI 10.1097/JSA.0000000000000119; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dubroff JG, 2010, PET CLIN, V5, P199, DOI 10.1016/j.cpet.2010.01.002; Eagle AL, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0104-18.2018; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GRASSO MG, 1994, STROKE, V25, P980, DOI 10.1161/01.STR.25.5.980; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; HORWITZ B, 1984, J CEREBR BLOOD F MET, V4, P484, DOI 10.1038/jcbfm.1984.73; Igelhorst BA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0194; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; MAYBERG HS, 1994, J NUCL MED, V35, P929; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ross DE, 2020, BRAIN INJURY, V34, P11, DOI 10.1080/02699052.2019.1669074; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Spielberger CD., 1970, STATE TRAIT ANXIETY; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Wahl OF, 2012, TRENDS COGN SCI, V16, P9, DOI 10.1016/j.tics.2011.11.002; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; WU JC, 1991, BIOL PSYCHIAT, V29, P1181, DOI 10.1016/0006-3223(91)90326-H; You JC, 2017, NAT MED, V23, P1377, DOI 10.1038/nm.4413	39	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0143-3636	1473-5628		NUCL MED COMMUN	Nucl. Med. Commun.	JUL	2021	42	7					772	781		10.1097/MNM.0000000000001397			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	SR7NV	WOS:000661233200009	33660691	Green Published, hybrid			2022-02-06	
J	Truong, EI; Stanley, SP; DeMario, BS; Tseng, ES; Como, JJ; Ho, VEP; Kelly, ML				Truong, Evelyn I.; Stanley, Samuel P.; DeMario, Belinda S.; Tseng, Esther S.; Como, John J.; Ho, Vanessa P.; Kelly, Michael L.			Variation in neurosurgical intervention for severe traumatic brain injury: The challenge of measuring quality in trauma center verification	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						TBI; craniotomy; craniectomy; intracranial pressure monitoring; trauma center	DECOMPRESSIVE CRANIECTOMY; CENTER DESIGNATION; AMERICAN-COLLEGE; SPLENIC INJURY; LEVEL 1; MORTALITY; OUTCOMES; REGIONALIZATION; GUIDELINES; MANAGEMENT	BACKGROUND: Intracranial pressure monitor (ICPm) procedure rates are a quality metric for American College of Surgeons trauma center verification. However, ICPm procedure rates may not accurately reflect the quality of care in TBI. We hypothesized that ICPm and craniotomy/craniectomy procedure rates for severe TBI vary across the United States by geography and institution. METHODS: We identified all patients with a severe traumatic brain injury (head Abbreviated Injury Scale, >= 3) from the 2016 Trauma Quality Improvement Program data set. Patients who received surgical decompression or ICPm were identified via International Classification of Diseases codes. Hospital factors included neurosurgeon group size, geographic region, teaching status, and trauma center level. Two multiple logistic regression models were performed identifying factors associated with (1) craniotomy with or without ICPm or (2) ICPm alone. Data are presented as medians (interquartile range) and odds ratios (ORs) (95% confidence interval). RESULTS: We identified 75,690 patients (66.4% male; age, 59 [36-77] years) with a median Injury Severity Score of 17 (11-25). Overall, 6.1% had surgical decompression, and 4.8% had ICPm placement. Logistic regression analysis showed that region of the country was significantly associated with procedure type: hospitals in the West were more likely to use ICPm (OR, 1.34 [1.20-1.50]), while Northeastern (OR, 0.80 [0.72-0.89]), Southern (OR, 0.84 [0.78-0.92]), and Western (OR, 0.88 [0.80-0.96]) hospitals were less likely to perform surgical decompression. Hospitals with small neurosurgeon groups (<3) were more likely to perform surgical intervention. Community hospitals are associated with higher odds of surgical decompression but lower odds of ICPm placement. CONCLUSION: Both geographic differences and hospital characteristics are independent predictors for surgical intervention in severe traumatic brain injury. This suggests that nonpatient factors drive procedural decisions, indicating that ICPm rate is not an ideal quality metric for American College of Surgeons trauma center verification.	[Truong, Evelyn I.; Stanley, Samuel P.; DeMario, Belinda S.; Tseng, Esther S.; Como, John J.; Ho, Vanessa P.] Metrohlth Med Ctr, Dept Surg, Cleveland, OH 44109 USA; [Ho, Vanessa P.] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA; [Kelly, Michael L.] Metrohlth Med Ctr, Dept Neurol Surg, 2500 MetroHlth Dr, Cleveland, OH 44109 USA		Kelly, ML (corresponding author), Metrohlth Med Ctr, Dept Neurol Surg, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	evelyn.truong@case.edu; sps81@case.edu; bsd39@case.edu; etseng@metrohealth.org; jcomo@metrohealth.org; vho@metrohealth.org; mkelly4@metrohealth.org			Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences component of the NIH [KL2TR002547]; NIH roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	V.P.H. is supported by the Clinical and Translational Science Collaborative of Cleveland (KL2TR002547) from the National Center for Advancing Translational Sciences component of the NIH and NIH roadmap forMedical Research. V.P.H. spouse is a consultant for Zimmer Biomet, Medtronic, Sig Medical, and Atricure.	Ahl R, 2019, J EMERG TRAUMA SHOCK, V12, P18, DOI 10.4103/JETS.JETS_59_18; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alice P, 2017, INJURY, V48, P1944, DOI 10.1016/j.injury.2017.04.033; American College of Surgeons, 2015, BEST PRACT MAN TRAUM, P1; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Birkmeyer JD, 2013, LANCET, V382, P1121, DOI 10.1016/S0140-6736(13)61215-5; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Committee on Trauma American College of Surgeons, 2014, RESOURCES OPTIMAL CA; De-Lima-Oliveira M, 2018, WORLD NEUROSURG, V113, P110, DOI 10.1016/j.wneu.2018.01.194; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Floyd SB, 2019, J ORTHOP SURG RES, V14, DOI 10.1186/s13018-018-1052-2; Goodney PR., 2014; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hamlat CA, 2012, ANN SURG, V255, P165, DOI 10.1097/SLA.0b013e31823840ca; Honeybul S, 2017, J CLIN NEUROSCI, V43, P11, DOI 10.1016/j.jocn.2017.04.032; Huetteman HE, 2019, PLAST RECONSTR SURG, V143, P159, DOI 10.1097/PRS.0000000000005088; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jones MD, 2020, J TRAUMA ACUTE CARE, V89, P920, DOI 10.1097/TA.0000000000002738; Kelly ML, 2015, J TRAUMA ACUTE CARE, V79, P372, DOI 10.1097/TA.0000000000000762; Kelly ML, 2015, J TRAUMA ACUTE CARE, V78, P715, DOI 10.1097/TA.0000000000000590; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Koval KJ, 2005, J ORTHOP TRAUMA, V19, P61, DOI 10.1097/00005131-200501000-00013; Malinoski DJ, 2012, J AM COLL SURGEONS, V215, P186, DOI 10.1016/j.jamcollsurg.2012.03.011; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rahmanian Abdolkarim, 2014, Bull Emerg Trauma, V2, P151; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Shafi S, 2008, J TRAUMA, V64, P599, DOI 10.1097/TA.0b013e31816533f9; Soni P, 2020, WORLD NEUROSURG, V137, pE263, DOI 10.1016/j.wneu.2020.01.151; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; van Essen TA, 2019, ACTA NEUROCHIR, V161, P435, DOI 10.1007/s00701-018-3761-z; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; Weyerbacher J, 2019, AM J SURG, V217, P509, DOI 10.1016/j.amjsurg.2018.10.033; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050; Zarzaur BL, 2011, J TRAUMA, V71, P1333, DOI 10.1097/TA.0b013e318224d0e4	41	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2021	91	1					114	120		10.1097/TA.0000000000003114			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	TC9ZM	WOS:000668996000032	33605705				2022-02-06	
J	Yang, MS; Xu, XJ; Zhang, B; Niu, F; Liu, BY				Yang, Meng-Shi; Xu, Xiao-Jian; Zhang, Bin; Niu, Fei; Liu, Bai-Yun			Comparative transcriptomic analysis of rat versus mouse cerebral cortex after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article							MEMBRANE ATTACK COMPLEX; EXPRESSION; NEUROINFLAMMATION; INHIBITOR; INFLAMMASOME; ACTIVATION; ENRICHMENT; PROTECTS; RECOVERY; GENES	The heterogeneity of traumatic brain injury (TBI)-induced secondary injury has greatly hampered the development of effective treatments for TBI patients. Targeting common processes across species may be an innovative strategy to combat debilitating TBI. In the present study, a cross-species transcriptome comparison was performed for the first time to determine the fundamental processes of secondary brain injury in Sprague-Dawley rat and C57/BL6 mouse models of TBI, caused by acute controlled cortical impact. The RNA sequencing data from the mouse model of TBI were downloaded from the Gene Expression Omnibus (ID: GSE79441) at the National Center for Biotechnology Information. For the rat data, peri-injury cerebral cortex samples were collected for transcriptomic analysis 24 hours after TBI. Differentially expressed gene-based functional analysis revealed that common features between the two species were mainly involved in the regulation and activation of the innate immune response, including complement cascades as well as Toll-like and nucleotide oligomerization domain-like receptor pathways. These findings were further corroborated by gene set enrichment analysis. Moreover, transcription factor analysis revealed that the families of signal transducers and activators of transcription (STAT), basic leucine zipper (BZIP), Rel homology domain (RHD), and interferon regulatory factor (IRF) transcription factors play vital regulatory roles in the pathophysiological processes of TBI, and are also largely associated with inflammation. These findings suggest that targeting the common innate immune response might be a promising therapeutic approach for TBI. The animal experimental procedures were approved by the Beijing Neurosurgical Institute Animal Care and Use Committee (approval No. 201802001) on June 6, 2018.	[Yang, Meng-Shi; Xu, Xiao-Jian; Zhang, Bin; Niu, Fei; Liu, Bai-Yun] Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Yang, Meng-Shi; Zhang, Bin; Liu, Bai-Yun] Capital Med Univ, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Yang, Meng-Shi; Zhang, Bin; Liu, Bai-Yun] Capital Med Univ, Beijing Neurosurg Inst, Dept Neurosurg, Beijing, Peoples R China; [Yang, Meng-Shi; Zhang, Bin; Liu, Bai-Yun] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China; [Liu, Bai-Yun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Liu, Bai-Yun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Neurosurg, Beijing, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China.; Liu, BY (corresponding author), Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China.; Liu, BY (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.	liubaiyun1212@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471238, 81771327]; Construction of Central Nervous System Injury Basic Science and Clinical Translational Research Platform, Budget of Beijing Municipal Health Commission 2020 [PXM2020_026280_000002]	This work was supported by the National Natural Science Foundation of China, Nos. 81471238, 81771327 (both to BYL), Construction of Central Nervous System Injury Basic Science and Clinical Translational Research Platform, Budget of Beijing Municipal Health Commission 2020, No. PXM2020_026280_000002 (to BYL).	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Assefa AT, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6721-y; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Breschi A, 2017, NAT REV GENET, V18, P425, DOI 10.1038/nrg.2017.19; Chen B, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00366; Chen ZH, 2019, EXP NEUROL, V313, P37, DOI 10.1016/j.expneurol.2018.12.003; Clervius H, 2019, NEURAL REGEN RES, V14, P1699, DOI 10.4103/1673-5374.255620; De Blasio D, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X18758881; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Ge XT, 2018, BRAIN RES, V1697, P10, DOI 10.1016/j.brainres.2018.06.008; Gerstein MB, 2014, NATURE, V512, P445, DOI 10.1038/nature13424; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Hato T, 2015, CLIN J AM SOC NEPHRO, V10, P1459, DOI 10.2215/CJN.04680514; Hu H, 2019, NUCLEIC ACIDS RES, V47, pD33, DOI 10.1093/nar/gky822; Hwang B, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0071-8; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jiang HS, 2018, CELL MOL NEUROBIOL, V38, P1009, DOI 10.1007/s10571-017-0570-5; Kar SP, 2017, BRIT J CANCER, V116, P524, DOI 10.1038/bjc.2016.426; Keifer J, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00069; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Krieg SM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00455; Lachmann A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03751-6; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Li D, 2020, INT J BIOL SCI, V16, P568, DOI 10.7150/ijbs.39769; Li XY, 2020, LIFE SCI, V241, DOI 10.1016/j.lfs.2019.117109; Liesz A, 2015, J NEUROSCI, V35, P583, DOI 10.1523/JNEUROSCI.2439-14.2015; Lipponen A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0519-z; Lodato S, 2015, ANNU REV CELL DEV BI, V31, P699, DOI 10.1146/annurev-cellbio-100814-125353; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Patel NA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1240-3; Prodromidou K, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00559; Reisinger SN, 2020, PSYCHONEUROENDOCRINO, V111, DOI 10.1016/j.psyneuen.2019.104480; Rich MC, 2016, NEUROSCI LETT, V617, P188, DOI 10.1016/j.neulet.2016.02.025; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Shi HJ, 2019, NEUROPHARMACOLOGY, V145, P259, DOI 10.1016/j.neuropharm.2018.07.022; Song YM, 2019, NEURAL REGEN RES, V14, P1796, DOI 10.4103/1673-5374.257534; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang YL, 2020, NEURAL REGEN RES, V15, P2262, DOI 10.4103/1673-5374.284996; Uosaki H, 2016, GENOM PROTEOM BIOINF, V14, P207, DOI 10.1016/j.gpb.2016.04.004; Vaibhav K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8847; Xu XJ, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12428; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Zakowski W, 2020, NEUROSCIENCE, V433, P1, DOI 10.1016/j.neuroscience.2020.02.049; Zhang B, 2019, BRAIN RES, V1725, DOI 10.1016/j.brainres.2019.146469; Zhang B, 2020, J NEUROTRAUM, V37, P262, DOI 10.1089/neu.2019.6556; Zhang Y, 2020, J CELL PHYSIOL, V235, P5511, DOI 10.1002/jcp.29261; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002; Zhou XHJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-232; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	64	1	1	1	26	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUL	2021	16	7					1235	1243		10.4103/1673-5374.301028			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	PG7UM	WOS:000599936100002	33318400	gold, Green Published			2022-02-06	
J	Zwirner, J; Anders, S; Bohnert, S; Burkhardt, R; Da Broi, U; Hammer, N; Pohlers, D; Tse, R; Ondruschka, E				Zwirner, Johann; Anders, Sven; Bohnert, Simone; Burkhardt, Ralph; Da Broi, Ugo; Hammer, Niels; Pohlers, Dirk; Tse, Rexson; Ondruschka, Enjamin			Screening for Fatal Traumatic Brain Injuries in Cerebrospinal Fluid Using Blood-Validated CK and CK-MB Immunoassays	BIOMOLECULES			English	Article						cerebrospinal fluid; creatine kinase; fatal traumatic brain injury; postmortem biochemistry	CREATINE-KINASE-BB; CARDIAC TROPONIN-I; ISOENZYME ACTIVITY; BIOMARKERS; DIAGNOSIS; MARKERS; SERUM; ACID	A single, specific, sensitive biochemical biomarker that can reliably diagnose a traumatic brain injury (TBI) has not yet been found, but combining different biomarkers would be the most promising approach in clinical and postmortem settings. In addition, identifying new biomarkers and developing laboratory tests can be time-consuming and economically challenging. As such, it would be efficient to use established clinical diagnostic assays for postmortem biochemistry. In this study, postmortem cerebrospinal fluid samples from 45 lethal TBI cases and 47 controls were analyzed using commercially available blood-validated assays for creatine kinase (CK) activity and its heart-type isoenzyme (CK-MB). TBI cases with a survival time of up to two hours showed an increase in both CK and CK-MB with moderate (CK-MB: AUC = 0.788, p < 0.001) to high (CK: AUC = 0.811, p < 0.001) diagnostic accuracy. This reflected the excessive increase of the brain-type CK isoenzyme (CK-BB) following a TBI. The results provide evidence that CK immunoassays can be used as an adjunct quantitative test aid in diagnosing acute TBI-related fatalities.	[Zwirner, Johann] Univ Otago, Dept Anat, Dunedin 9016, New Zealand; [Zwirner, Johann; Anders, Sven; Ondruschka, Enjamin] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, D-22529 Hamburg, Germany; [Zwirner, Johann] Univ Leipzig, Inst Legal Med, D-04103 Leipzig, Germany; [Bohnert, Simone] Univ Wurzburg, Inst Forens Med, D-97078 Wurzburg, Germany; [Burkhardt, Ralph] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany; [Da Broi, Ugo] Univ Udine, Dept Med, Forens Med, I-33100 Udine, Italy; [Hammer, Niels] Karl Franzens Univ Graz, Inst Macroscop & Clin Anat, A-8010 Graz, Austria; [Hammer, Niels] Univ Hosp Leipzig, Dept Trauma Orthoped & Plast Surg, D-04103 Leipzig, Germany; [Hammer, Niels] Fraunhofer Inst Machine Tools & Forming Technol, D-09126 Dresden, Germany; [Pohlers, Dirk] Klinikum Chemnitz, Ctr Diagnost, D-09116 Chemnitz, Germany; [Tse, Rexson] Auckland City Hosp, Dept Forens Pathol, LabPLUS, Auckland 1023, New Zealand		Zwirner, J (corresponding author), Univ Otago, Dept Anat, Dunedin 9016, New Zealand.; Zwirner, J; Ondruschka, E (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, D-22529 Hamburg, Germany.; Zwirner, J (corresponding author), Univ Leipzig, Inst Legal Med, D-04103 Leipzig, Germany.	medijo@gmx.de; s.anders@uke.de; simone.bohnert@uni-wuerzburg.de; ralph.burkhardt@ukr.de; ugo.dabroi@uniud.it; niels.hammer@medunigraz.at; d.pohlers@laborchemnitz.de; rexsont@adhb.govt.nz; b.ondruschka@uke.de	Tse, Rexson/Y-1939-2019	Tse, Rexson/0000-0002-1388-9537; Da Broi, Ugo/0000-0003-4100-2582			Anagnostopoulos D I, 1988, Br J Neurosurg, V2, P169, DOI 10.3109/02688698808992666; [Anonymous], 2009, ROCHE DIAGNOSTICS; Aydin S, 2019, VASC HEALTH RISK MAN, V15, P1, DOI 10.2147/VHRM.S166157; Banon R, 2019, FORENSIC SCI MED PAT, V15, P528, DOI 10.1007/s12024-019-00150-1; Barth JT, 2001, J ATHL TRAINING, V36, P253; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Cabaniss C.D., 1990, CLIN METHODS HIST PH; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; CHANDLER WL, 1986, AM J CLIN PATHOL, V86, P533, DOI 10.1093/ajcp/86.4.533; CHANDLER WL, 1984, CLIN CHEM, V30, P1804; Chen JH, 2015, LEGAL MED-TOKYO, V17, P343, DOI 10.1016/j.legalmed.2015.03.007; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coplin WM, 1999, ARCH NEUROL-CHICAGO, V56, P1348, DOI 10.1001/archneur.56.11.1348; HACKENBERRY LE, 1982, CRIT CARE MED, V10, P641; HANS P, 1983, J NEUROSURG, V58, P689, DOI 10.3171/jns.1983.58.5.0689; Hellewell SC, 2016, METHODS MOL BIOL, V1462, P253, DOI 10.1007/978-1-4939-3816-2_15; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; KARKELA JT, 1993, J FORENSIC SCI, V38, P603; KASTE M, 1981, J NEUROSURG, V55, P511, DOI 10.3171/jns.1981.55.4.0511; Lindblad C, 2020, J NEUROTRAUM, V37, P1381, DOI 10.1089/neu.2019.6741; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Maeda Hitoshi, 2009, Leg Med (Tokyo), V11 Suppl 1, pS46, DOI 10.1016/j.legalmed.2009.01.048; McDonald SJ, 2020, J NEUROTRAUM, V37, P770, DOI 10.1089/neu.2019.6885; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; OSUNA E, 1992, FORENSIC SCI INT, V52, P193, DOI 10.1016/0379-0738(92)90107-8; Palmiere C, 2012, INT J LEGAL MED, V126, P199, DOI 10.1007/s00414-011-0614-1; Peyron PA, 2019, CRIT REV CL LAB SCI, V56, P274, DOI 10.1080/10408363.2019.1619158; RABOW L, 1986, J NEUROSURG, V65, P625, DOI 10.3171/jns.1986.65.5.0625; SANCHEZRODRIGUEZ VF, 1995, AM J FOREN MED PATH, V16, P210, DOI 10.1097/00000433-199509000-00004; Subramanian A., 2013, ISRN EMERG MED, V2013, P1, DOI [10.1155/2013/241036, DOI 10.1155/2013/241036]; THOMPSON RJ, 1980, BRAIN RES, V201, P423, DOI 10.1016/0006-8993(80)91046-X; Tirschwell DL, 1997, NEUROLOGY, V48, P352, DOI 10.1212/WNL.48.2.352; Wang Q, 2011, LEGAL MED-TOKYO, V13, P226, DOI 10.1016/j.legalmed.2011.05.002; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Woydt L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31252-5; ZARGHAMI N, 1995, CLIN BIOCHEM, V28, P243, DOI 10.1016/0009-9120(95)00010-7; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhu Bao-Li, 2007, Legal Medicine, V9, P241, DOI 10.1016/j.legalmed.2007.01.010; Zhu BL, 2002, FORENSIC SCI INT, V125, P59, DOI 10.1016/S0379-0738(01)00617-X; Zwirner J., IL 6 GFAP COMPELLING	42	1	1	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-273X		BIOMOLECULES	Biomolecules	JUL	2021	11	7							1061	10.3390/biom11071061			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TO0ST	WOS:000676633800001	34356685	gold, Green Published			2022-02-06	
J	Arroyo-Ferrer, A; de Norena, D; Serrano, JI; Rios-Lago, M; Romero, JP				Arroyo-Ferrer, Aida; de Norena, David; Ignacio Serrano, Jose; Rios-Lago, Marcos; Pablo Romero, Juan			Cognitive rehabilitation in a case of traumatic brain injury using EEG-based neurofeedback in comparison to conventional methods	JOURNAL OF INTEGRATIVE NEUROSCIENCE			English	Article						Traumatic brain injury; Neurorehabilitation; Cognition; Neurofeedback; Virtual reality; Quantitative electroencephalography	WORKING-MEMORY; ALPHA; OSCILLATIONS; SYNCHRONIZATION; ATTENTION	Severe traumatic brain injury residual cognitive impairments significantly impact the quality of life. EEG-based neurofeedback is a technique successfully used in traumatic brain injury and stroke to rehabilitate cognitive and motor sequelae. There are not individualized comparisons of the effects of EEG-based neurofeedback versus conventional neuropsychological rehabilitation. We present a case study of a traumatic brain injury subject in whom eight sessions of a neuropsychological rehabilitation protocol targeting attention, executive functions, and working memory as compared with a personalized EEG-based neurofeedback protocol focused on the electrodes and bands that differed from healthy subjects (F3, F1, Fz, FC3, FC1, and FCz), targeting the inhibition of theta frequency band (3 Hz-7 Hz) in the same number of sessions. Quantitative EEG and neuropsy-chological testing were performed. Clear benefits of EEG-based neurofeedback were found in divided and sustained attention and several aspects related to visuospatial skills and the processing speed of motor-dependent tasks. Correlative quantitative EEG changes justify the results. EEG-based neurofeedback is probably an excellent complementary technique to be considered to enhance conventional neuropsychological rehabilitation.	[Arroyo-Ferrer, Aida; Pablo Romero, Juan] Francisco de Vitoria Univ, Fac Expt Sci, Madrid 28223, Spain; [de Norena, David; Rios-Lago, Marcos; Pablo Romero, Juan] Hosp Beata Maria Ana, Brain Damage Unit, Madrid 28007, Spain; [Ignacio Serrano, Jose] Spanish Natl Res Council, Ctr Automat & Robot, Neural & Cognit Engn Grp, Arganda Del Rey 28500, Spain; [Rios-Lago, Marcos] UNED, Basic Psychol Dept 2, Madrid 28040, Spain		Romero, JP (corresponding author), Francisco de Vitoria Univ, Fac Expt Sci, Madrid 28223, Spain.; Romero, JP (corresponding author), Hosp Beata Maria Ana, Brain Damage Unit, Madrid 28007, Spain.	p.romero.prof@ufv.es	Romero, Juan Pablo/Y-6765-2018; Rios-Lago, Marcos/P-6930-2019	Romero, Juan Pablo/0000-0002-3190-1296; Rios-Lago, Marcos/0000-0003-0187-5047; Arroyo, Aida/0000-0001-8704-242X			Bauer S, 2004, J PERS ASSESS, V82, P60, DOI 10.1207/s15327752jpa8201_11; Benedet M.J., 1998, TAVEC TEST APRENDIZA; Buriel Y, 2004, NEUROLOGIA, V19, P153; Byers AP., 1995, J NEUROTHERAPY, V1, P22; Caplan JB, 2003, J NEUROSCI, V23, P4726; Chang CY, 2020, IEEE T BIO-MED ENG, V67, P1114, DOI 10.1109/TBME.2019.2930186; Crespo-Garcia M, 2013, J COGNITIVE NEUROSCI, V25, P1343, DOI 10.1162/jocn_a_00379; Cubero NS, 1999, MANUAL TECNICO; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deschamps I, 2014, NEUROPSYCHOLOGIA, V53, P39, DOI 10.1016/j.neuropsychologia.2013.10.015; Galetto V, 2017, NEUROREHAB NEURAL RE, V31, P800, DOI 10.1177/1545968317723748; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Gorgoraptis N, 2019, NEUROREHABILITATION, V44, P321, DOI 10.3233/NRE-182618; Guez J, 2015, MEMORY, V23, P683, DOI 10.1080/09658211.2014.921713; Hsueh JJ, 2016, HUM BRAIN MAPP, V37, P2662, DOI 10.1002/hbm.23201; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Katyal N, 2020, CLIN NEUROL NEUROSUR, V198, DOI 10.1016/j.clineuro.2020.106145; Keller I, 2001, J NEUROTHERAPY, V5, P19; Klimesch W, 1999, INTELLIGENCE, V27, P347, DOI 10.1016/S0160-2896(99)00027-6; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2001, COGNITIVE BRAIN RES, V12, P33, DOI 10.1016/S0926-6410(01)00024-6; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kober SE, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0105-6; Lambregts SAM, 2018, BRAIN INJURY, V32, P230, DOI 10.1080/02699052.2017.1406990; May G, 2013, ANN CLIN PSYCHIATRY, V25, P289; Omejc N, 2019, BOSNIAN J BASIC MED, V19, P213, DOI 10.17305/bjbms.2018.3785; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pena-Casanova J., 2007, NEUROLOGIA CONDUCTA; Perianez JA, 2021, ARCH CLIN NEUROPSYCH, V36, P99, DOI 10.1093/arclin/acaa034; Prieto G, 2010, PAPEL PSICOL, V31, P67; Reddy RP, 2009, INDIAN J NEUROTRAUM, V6, P87, DOI 10.1016/S0973-0508(09)80037-3; Renton T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177290; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Riano-Garzon ME, 2018, J NEUROLOGY STROKE, V8, P4; Riley DS, 2017, J CLIN EPIDEMIOL, V89, P218, DOI 10.1016/j.jclinepi.2017.04.026; Roth, 2014, MILD TRAUMATIC BRAIN, P321; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Schretlen D, 1996, CLIN NEUROPSYCHOL, V10, P80, DOI 10.1080/13854049608406666; Silvoni S, 2011, CLIN EEG NEUROSCI, V42, P245, DOI 10.1177/155005941104200410; Sjolie D, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P869; Thornton KE, 2009, APPL PSYCHOPHYS BIOF, V34, P59, DOI 10.1007/s10484-009-9075-4; Vernon D, 2003, INT J PSYCHOPHYSIOL, V47, P75, DOI 10.1016/S0167-8760(02)00091-0; Vourvopoulos A, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00210; Walter M, 2009, HUM BRAIN MAPP, V30, P312, DOI 10.1002/hbm.20506; Wing K, 2001, Top Stroke Rehabil, V8, P45; Winkler I, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035013; Wu J, 2015, BRAIN, V138, P2359, DOI 10.1093/brain/awv156; Zhou RJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00597	49	1	1	7	10	IMR PRESS	ROBINSON	112 ROBINSON RD, ROBINSON, SINGAPORE	0219-6352	1757-448X		J INTEGR NEUROSCI	J. Integr. Neurosci.	JUN 30	2021	20	2					449	457		10.31083/j.jin2002047			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TI4XD	WOS:000672804800023	34258946	gold			2022-02-06	
J	Maissan, IM; Vlottes, B; Hoeks, S; Bosch, J; Stolker, RJ; den Hartog, D				Maissan, Iscander M.; Vlottes, Boris; Hoeks, Sanne; Bosch, Jan; Stolker, Robert Jan; den Hartog, Dennis			Ambulance deceleration causes increased intra cranial pressure in supine position: a prospective observational prove of principle study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Ambulance; Transportation; EMS; Traumatic brain injury; TBI; Intra cranial pressure; ICP; Optical nerve sheath diameter; ONSD; POCUS; Ultrasound	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; GUIDELINES; MANAGEMENT	BackgroundAmbulance drivers in the Netherlands are trained to drive as fluent as possible when transporting a head injured patient to the hospital. Acceleration and deceleration have the potential to create pressure changes in the head that may worsen outcome. Although the idea of fluid shift during braking causing intra cranial pressure (ICP) to rise is widely accepted, it lacks any scientific evidence. In this study we evaluated the effects of driving and deceleration during ambulance transportation on the intra cranial pressure in supine position and 30(degrees) upright position.MethodsParticipants were placed on the ambulance gurney in supine position. During driving and braking the optical nerve sheath diameter (ONSD) was measured with ultrasound. Because cerebro spinal fluid percolates in the optical nerve sheath when ICP rises, the diameter of this sheath will distend if ICP rises during braking of the ambulance. The same measurements were taken with the headrest in 30(degrees) upright position.ResultsMean ONSD in 20 subjects in supine position increased from 4.80 (IQR 4.80-5.00) mm during normal transportation to 6.00 (IQR 5.75-6.40) mm (p <0.001) during braking. ONSD's increased in all subjects in supine position.After raising the headrest of the gurney 30(<degrees>) mean ONSD increased from 4.80 (IQR 4.67-5.02) mm during normal transportation to 4.90 (IQR 4.80-5.02) mm (p =0.022) during braking. In 15 subjects (75%) there was no change in ONSD at all.ConclusionsONSD and thereby ICP increases during deceleration of a transporting vehicle in participants in supine position. Raising the headrest of the gurney to 30 degrees reduces the effect of breaking on ICP.	[Maissan, Iscander M.; Vlottes, Boris; Hoeks, Sanne; Stolker, Robert Jan] Dept Anesthesiol, Dr Molenwaterpl 40, NL-3015 GD Rotterdam, Netherlands; [Bosch, Jan] Reg Ambulancevoorziening Hollands Midden, Res & Dev, Vondellaan 43, NL-2332 AA Leiden, Netherlands; [den Hartog, Dennis] Dept Trauma Surg, Dr Molenwaterpl 40, NL-3015 GD Rotterdam, Netherlands		Maissan, IM (corresponding author), Dept Anesthesiol, Dr Molenwaterpl 40, NL-3015 GD Rotterdam, Netherlands.	i.maissan@erasmusmc.nl	Hoeks, Sanne/AAM-3313-2020				Advanced Life Support Group, 2017, PREH TRAUM LIF SUPP, V3; [Anonymous], DUTCH NATL AMBULANCE; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Goeres P, 2016, J CRIT CARE, V31, P168, DOI 10.1016/j.jcrc.2015.10.009; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Kim MS, 2014, J ENDOUROL, V28, P801, DOI 10.1089/end.2014.0019; Knauth M, 2017, NEUROIMAGE, V162, P151, DOI 10.1016/j.neuroimage.2017.08.062; Maissan IM, 2018, EUR J EMERG MED, V25, pE24, DOI 10.1097/MEJ.0000000000000490; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Petersen LG, 2016, AM J PHYSIOL-REG I, V310, pR100, DOI 10.1152/ajpregu.00302.2015; Petersen LG, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14039; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678	19	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JUN 30	2021	29	1							87	10.1186/s13049-021-00904-3			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TG2WR	WOS:000671271000002	34193207	Green Published, gold			2022-02-06	
J	Mohamed, AZ; Nestor, PJ; Cumming, P; Nasrallah, FA				Mohamed, Abdalla Z.; Nestor, Peter J.; Cumming, Paul; Nasrallah, Fatima A.			Traumatic brain injury fast-forwards Alzheimer's pathology: evidence from amyloid positron emission tomorgraphy imaging	JOURNAL OF NEUROLOGY			English	Article						Traumatic brain injury; Alzheimer's disease; Alzheimer's Disease Neuroimaging Initiative (ADNI); [F-18]-AV45 PET; Amyloid; Voxel-based morphometry	PITTSBURGH COMPOUND B; COGNITIVE IMPAIRMENT; CORTICAL THICKNESS; DEMENTIA; ONSET; BETA; ASSOCIATION; ACCUMULATION; METAANALYSIS; DEPOSITION	Purpose Traumatic brain injury (TBI) has been proposed as a risk factor for Alzheimer's disease (AD), although the mechanisms underlying the putative association are poorly understood. We investigated elderly individuals with a remote history of TBI, aiming to understand how this may have influenced amyloidosis, neurodegeneration, and clinical expression along the AD continuum. Methods Total of 241 individual datasets including amyloid beta (A beta) positron emission tomography ([F-18]-AV45), structural MRI, and neuropsychological measures, were obtained from the Alzheimer's Disease Neuroimaging Initiative. The data were stratified into groups with (TBI +) or without (TBI -) history of head injury, and by clinical dementia rating (CDR) scores, into subgroups with normal cognition (CDR = 0) and those with symptomatic cognitive decline (CDR >= 0.5). We contrasted the TBI + and TBI - subgroups with respect to the onset age and extent of cognitive decline, cortical thickness changes, and A beta standard uptake value (SUVr). Results Compared to the TBI -/CDR >= 0.5 subgroup, the TBI + /CDR >= 0.5 subgroup showed a 3-4 year earlier age of cognitive impairment onset (ACIO, p = 0.005). Among those participants on the AD continuum (A beta + , as defined by a cortical SUVr >= 1.23), irrespective of current CDR, a TBI + history was associated with greater A beta deposition and more pronounced cortical thinning. When matched for severity of cognitive status, the TBI + /CDR >= 0.5 group showed greater A beta burden, but earlier ACIO as compared to the TBI -/CDR >= 0.5, suggesting a more indolent clinical AD progression in those with TBI history. Conclusion Remote TBI history may alter the AD onset trajectory, with approximately 4 years earlier ACIO, greater amyloid deposition, and cortical thinning.	[Mohamed, Abdalla Z.; Nestor, Peter J.; Nasrallah, Fatima A.] Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia; [Mohamed, Abdalla Z.] Univ Sunshine Coast, Thompson Inst, Birtinya, Qld 4575, Australia; [Nestor, Peter J.] Mater Hosp, South Brisbane, Qld 4101, Australia; [Cumming, Paul] Bern Univ, Inselspital, Dept Nucl Med, Bern, Switzerland; [Cumming, Paul] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld, Australia		Nasrallah, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia.	f.nasrallah@uq.edu.au	Mohamed, Abdalla/ABG-8718-2021; Mohaned, Abdalla/AAL-8721-2020	Mohaned, Abdalla/0000-0003-4499-672X	Motor Accident Insurance Commission (MAIC); Queensland Government, Australia [2014000857]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [AG024904]; DOD ADNI (US Department of Defense)United States Department of Defense [W81XWH-12-2-0012]	This research was supported by Motor Accident Insurance Commission (MAIC), The Queensland Government, Australia (Grant number: 2014000857). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (US Department of Defense award number W81XWH-12-2-0012).	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Chapleau M, 2016, J ALZHEIMERS DIS, V54, P941, DOI 10.3233/JAD-160382; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Diaz-de-Grenu LZ, 2014, J ALZHEIMERS DIS, V38, P647, DOI 10.3233/JAD-130362; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Landau SM, 2013, J NUCL MED, V54, P70, DOI 10.2967/jnumed.112.109009; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Minkova L, 2017, HUM BRAIN MAPP, V38, P5890, DOI 10.1002/hbm.23772; Mohamed AZ, 2021, BIOL PSYCHIAT-COGN N, V6, P1100, DOI 10.1016/j.bpsc.2021.04.014; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Palmqvist S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01150-x; Pettigrew C, 2016, NEUROIMAGE-CLIN, V12, P116, DOI 10.1016/j.nicl.2016.06.010; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Schneider ALC, 2019, J NEUROTRAUM, V36, P2549, DOI 10.1089/neu.2018.6213; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; The Alzheimer's Disease Neuroimaging Inititive A, 2011, ALZH DIS NEUR IN 2 P; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wang ML, 2017, NEUROSCI LETT, V655, P115, DOI 10.1016/j.neulet.2017.06.055; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032	45	1	1	1	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	FEB	2022	269	2					873	884		10.1007/s00415-021-10669-5		JUN 2021	12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YL5DP	WOS:000668500600004	34191080				2022-02-06	
J	Garnier, E; Levard, D; Ali, C; Buendia, I; Hommet, Y; Gauberti, M; Crepaldi, T; Comoglio, P; Rubio, M; Vivien, D; Docagne, F; de Lizarrondo, SM				Garnier, Eugenie; Levard, Damien; Ali, Carine; Buendia, Izaskun; Hommet, Yannick; Gauberti, Maxime; Crepaldi, Tiziana; Comoglio, Paolo; Rubio, Marina; Vivien, Denis; Docagne, Fabian; Martinez de Lizarrondo, Sara			Factor XII protects neurons from apoptosis by epidermal and hepatocyte growth factor receptor-dependent mechanisms	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						apoptosis; contact pathway; intrinsic pathway; neuroprotection; thromboinflammation	COAGULATION-FACTOR-XII; TISSUE-PLASMINOGEN ACTIVATOR; BLOOD-BRAIN-BARRIER; NMDA RECEPTORS; CONTACT SYSTEM; ISCHEMIA; IMPACT; CELLS; ZINC; UPAR	Background Factor XII (FXII) is a serine protease that participates in the intrinsic coagulation pathway. Several studies have shown that plasma FXII exerts a deleterious role in cerebral ischemia and traumatic brain injury by promoting thrombo-inflammation. Nevertheless, the impact of FXII on neuronal cell fate remains unknown. Objectives We investigated the role of FXII and FXIIa in neuronal injury and apoptotic cell death. Methods We tested the neuroprotective roles of FXII and FXIIa in an experimental model of neuronal injury induced by stereotaxic intracerebral injection of N-methyl-D-aspartic acid (NMDA) in vivo and in a model of apoptotic death of murine primary neuronal cultures through serum deprivation in vitro. Results Here, we found that exogenous FXII and FXIIa reduce brain lesions induced by NMDA injection in vivo. Furthermore, FXII protects cultured neurons from apoptosis through a growth factor--like effect. This mechanism was triggered by direct interaction with epidermal growth factor (EGF) receptor and subsequent activation of this receptor. Interestingly, the "proteolytically" active and two-chain form of FXII, FXIIa, exerts its protective effects by an alternative signaling pathway. FXIIa activates the pro-form of hepatocyte growth factor (HGF) into HGF, which in turn activated the HGF receptor (HGFR) pathway. Conclusion This study describes two novel mechanisms of action of FXII and identifies neurons as target cells for the protective effects of single and two-chain forms of FXII. Therefore, inhibition of FXII in neurological disorders may have deleterious effects by preventing its beneficial effects on neuronal survival.	[Garnier, Eugenie; Levard, Damien; Ali, Carine; Buendia, Izaskun; Hommet, Yannick; Gauberti, Maxime; Rubio, Marina; Vivien, Denis; Docagne, Fabian; Martinez de Lizarrondo, Sara] Normandie Univ, Unicaen, INSERM, Physiopathol & Imaging Neurol Disorders PhIND, Caen, France; [Crepaldi, Tiziana; Comoglio, Paolo] Candiolo Canc Inst FPO IRCCS, Candiolo, Italy; [Crepaldi, Tiziana] Univ Torino, Med Sch, Dept Oncol, Candiolo, Italy; [Vivien, Denis] CHU Caen, CHU Caen Cote Nacre, Dept Clin Res, Caen, France		Buendia, I; Docagne, F; de Lizarrondo, SM (corresponding author), Ctr Cyceron, INSERM, U1237, Physiopathol & Imaging Neurol Disorders PhIND, BP5229, F-14074 Caen, France.	izaskunendia@hotmail.com; docagne@cyceron.fr; smartinez@cyceron.fr		Levard, Damien/0000-0002-7275-3170; Crepaldi, Tiziana/0000-0003-3410-947X	"Institut National de la Sante Et de la Recherche Medicale" (INSERM)Institut National de la Sante et de la Recherche Medicale (Inserm); "Etablisement Francais du Sang" (EFS); Normandy Regional Council; FISM Onlus-"Fondazione Italiana Sclerosi Multipla"	This work was supported by the "Institut National de la Sante Et de la Recherche Medicale" (INSERM) and the "Etablisement Francais du Sang" (EFS) and the Normandy Regional Council. T.C. and P.C were supported by FISM Onlus-"Fondazione Italiana Sclerosi Multipla".	Behrens MI, 1996, NEUROBIOL DIS, V3, P72, DOI 10.1006/nbdi.1996.0007; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Benchenane Karim, 2005, Stroke, V36, P1065; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Chen ZL, 2017, BLOOD, V129, P2547, DOI 10.1182/blood-2016-11-753202; Correa F, 2011, J EXP MED, V208, P1229, DOI 10.1084/jem.20101880; de Maat S, 2016, J THROMB HAEMOST, V14, P1498, DOI 10.1111/jth.13383; Finisguerra V, 2015, NATURE, V522, P349, DOI 10.1038/nature14407; Fredriksson L, 2017, SEMIN THROMB HEMOST, V43, P154, DOI 10.1055/s-0036-1586229; Gordon EM, 1996, P NATL ACAD SCI USA, V93, P2174, DOI 10.1073/pnas.93.5.2174; Hopp S, 2016, ANN NEUROL, V79, P970, DOI 10.1002/ana.24655; Ivanov I, 2017, BLOOD, V129, P1527, DOI 10.1182/blood-2016-10-744110; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P2391; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; Lemarchand E, 2016, CELL DEATH DIFFER, V23, P123, DOI 10.1038/cdd.2015.76; Liot G, 2006, J NEUROCHEM, V98, P1458, DOI 10.1111/j.1471-4159.2006.03982.x; Liu JP, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00043; Long AT, 2016, J THROMB HAEMOST, V14, P427, DOI 10.1111/jth.13235; Maas C, 2018, BLOOD, V131, P1903, DOI 10.1182/blood-2017-04-569111; Macrez R, 2016, BRAIN, V139, P2406, DOI 10.1093/brain/aww172; Mahdi F, 2002, BLOOD, V99, P3585, DOI 10.1182/blood.V99.10.3585; Nayeri F, 2008, GROWTH FACTORS, V26, P163, DOI 10.1080/08977190802128083; Permyakov, 2013, ENCY METALLOPROTEINS, P2565; Radak D, 2017, CURR VASC PHARMACOL, V15, P115, DOI 10.2174/1570161115666161104095522; Radi E, 2014, J ALZHEIMERS DIS, V42, pS125, DOI 10.3233/JAD-132738; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; SAMUEL M, 1992, J BIOL CHEM, V267, P19691; Schmaier AH, 2019, RES PRACT THROMB HAE, V3, P599, DOI 10.1002/rth2.12235; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; SHIMOMURA T, 1995, EUR J BIOCHEM, V229, P257, DOI 10.1111/j.1432-1033.1995.0257l.x; Stavrou E, 2010, THROMB RES, V125, P210, DOI 10.1016/j.thromres.2009.11.028; Stavrou EX, 2018, J CLIN INVEST, V128, P944, DOI 10.1172/JCI92880; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Vivien D, 2011, J CEREBR BLOOD F MET, V31, P2119, DOI 10.1038/jcbfm.2011.127; Vogel S, 2010, CELL MOL LIFE SCI, V67, P295, DOI 10.1007/s00018-009-0183-3; Wu QJ, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0357-8; YOKOYAMA M, 1986, NEUROSCI LETT, V71, P351, DOI 10.1016/0304-3940(86)90646-4; Zamolodchikov D, 2019, NEUROSCIENCE, V413, P294, DOI 10.1016/j.neuroscience.2019.05.040; Zamolodchikov D, 2015, P NATL ACAD SCI USA, V112, P4068, DOI 10.1073/pnas.1423764112	41	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	SEP	2021	19	9					2235	2247		10.1111/jth.15414		JUN 2021	13	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	UI7HH	WOS:000667704300001	34060720	Green Published			2022-02-06	
J	Loring, HS; Czech, VL; Icso, JD; O'Connor, L; Parelkar, SS; Byrne, AB; Thompson, PR				Loring, Heather S.; Czech, Victoria L.; Icso, Janneke D.; O'Connor, Lauren; Parelkar, Sangram S.; Byrne, Alexandra B.; Thompson, Paul R.			A phase transition enhances the catalytic activity of SARM1, an NAD(+) glycohydrolase involved in neurodegeneration	ELIFE			English	Article							CLEAVAGE ACTIVITY; PROTEIN; DEGENERATION; ACTIVATION; INJURY; EXPRESSION; DIFFUSION; LIQUID	Sterile alpha and toll/interleukin receptor (TIR) motif-containing protein 1 (SARM1) is a neuronally expressed NAD(+) glycohydrolase whose activity is increased in response to stress. NAD(+) depletion triggers axonal degeneration, which is a characteristic feature of neurological diseases. Notably, loss of SARM1 is protective in murine models of peripheral neuropathy and traumatic brain injury. Herein, we report that citrate induces a phase transition that enhances SARM1 activity by similar to 2000-fold. This phase transition can be disrupted by mutating a residue involved in multimerization, G601P. This mutation also disrupts puncta formation in cells. We further show that citrate induces axonal degeneration in C. elegans that is dependent on the C. elegans orthologue of SARM1 (TIR-1). Notably, citrate induces the formation of larger puncta indicating that TIR-1/SARM1 multimerization is essential for degeneration in vivo. These findings provide critical insights into SARM1 biology with important implications for the discovery of novel SARM1-targeted therapeutics.	[Loring, Heather S.; Icso, Janneke D.; Parelkar, Sangram S.; Thompson, Paul R.] UMass Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; [Loring, Heather S.; Icso, Janneke D.; Parelkar, Sangram S.; Thompson, Paul R.] UMass Med Sch, Program Chem Biol, Worcester, MA 01655 USA; [Czech, Victoria L.; O'Connor, Lauren; Byrne, Alexandra B.] UMass Med Sch, Dept Neurobiol, Worcester, MA USA		Thompson, PR (corresponding author), UMass Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.; Thompson, PR (corresponding author), UMass Med Sch, Program Chem Biol, Worcester, MA 01655 USA.	Paul.Thompson@umassmed.edu		Thompson, Paul/0000-0002-1621-3372	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS110936, R35 GM118112, F31 NS108610, T32 AI132152]	This work was supported in part by NIH grants R35 GM118112 (PRT), F31 NS108610 (HSL), and T32 AI132152 (JDI). The C. elegans work was supported in part by NIH R01 NS110936 (ABB).	An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; Bratkowski M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107999; Carlsson E, 2016, BBA-MOL CELL RES, V1863, P244, DOI 10.1016/j.bbamcr.2015.11.021; Chan CY, 2015, P NATL ACAD SCI USA, V112, P1368, DOI 10.1073/pnas.1423009112; Chen CY, 2011, J CELL BIOL, V193, P769, DOI 10.1083/jcb.201008050; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Costello Leslie C, 2013, J Regen Med Tissue Eng, V2; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Gadda G, 2018, BIOCHEMISTRY-US, V57, P3445, DOI 10.1021/acs.biochem.8b00232; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Hagen SJ, 2010, CURR PROTEIN PEPT SC, V11, P385; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Horsefield S, 2019, SCIENCE, V365, P793, DOI 10.1126/science.aax1911; Jiang YF, 2020, NATURE, V588, P658, DOI 10.1038/s41586-020-2862-z; Knuckley B, 2007, BIOCHEMISTRY-US, V46, P6578, DOI 10.1021/bi700095s; Knuckley B, 2010, BIOCHEMISTRY-US, V49, P4852, DOI 10.1021/bi100363t; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Loring HS, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2020.115644; Loring HS, 2020, BIOCHEMISTRY-US, V59, P933, DOI 10.1021/acs.biochem.9b01078; Loring HS, 2020, CELL CHEM BIOL, V27, P1, DOI 10.1016/j.chembiol.2019.11.002; Loring HS, 2018, BIOCHEMISTRY-US, V57, P5524, DOI 10.1021/acs.biochem.8b00775; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Massoll C, 2013, INVEST OPHTH VIS SCI, V54, P2771, DOI 10.1167/iovs.12-10973; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Peskett TR, 2018, MOL CELL, V70, P588, DOI 10.1016/j.molcel.2018.04.007; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sporny M, 2020, ELIFE, V9, DOI 10.7554/eLife.62021; Sporny M, 2019, J MOL BIOL, V431, P3591, DOI 10.1016/j.jmb.2019.06.030; Sulston J., 1988, METHODS NEMATODE C E; Summers DW, 2016, P NATL ACAD SCI USA, V113, pE6271, DOI 10.1073/pnas.1601506113; Ve T, 2017, NAT STRUCT MOL BIOL, V24, P743, DOI 10.1038/nsmb.3444; Wang JT, 2015, P NATL ACAD SCI USA, V112, P10093, DOI 10.1073/pnas.1508337112; Westergaard N, 2017, NEUROCHEM RES, V42, P1583, DOI 10.1007/s11064-016-2159-7	40	1	1	6	7	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	JUN 29	2021	10								e66694	10.7554/eLife.66694			33	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	TI2GE	WOS:000672605900001	34184985	gold, Green Submitted, Green Published			2022-02-06	
J	Zhuang, DZ; Sheng, JT; Peng, GY; Li, T; Cai, SR; Din, FX; Li, LJ; Huang, MD; Tian, F; Li, KS; Wang, SS; Chen, WQ				Zhuang, Dongzhou; Sheng, Jiangtao; Peng, Guoyi; Li, Tian; Cai, Shirong; Din, Faxiu; Li, Lianjie; Huang, Mindong; Tian, Fei; Li, Kangsheng; Wang, Shousen; Chen, Weiqiang			Neutrophil to lymphocyte ratio predicts early growth of traumatic intracerebral haemorrhage	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							EARLY HEMATOMA GROWTH; BRAIN-INJURY; NERVOUS-SYSTEM; BLEND SIGN; PROGRESSION; INFLAMMATION; COAGULATION; RESUSCITATION; TARGET	Objective The neutrophil to lymphocyte ratio (NLR) has been proposed to capture the inflammatory status of patients with various conditions involving the brain. This retrospective study aimed to explore the association between the NLR and the early growth of traumatic intracerebral haemorrhage (tICH) in patients with traumatic brain injury (TBI). Methods A multicentre, observational cohort study was conducted. Patients with cerebral contusion undergoing baseline computed tomography for haematoma volume analysis within 6 h after primary injury and follow-up visits within 48 h were included. Routine blood tests were performed upon admission, and early growth of tICH was assessed. Prediction accuracies of the NLR for the early growth of tICH and subsequent surgical intervention in patients were analysed. Results There were a total of 1077 patients who met the criteria included in the study cohort. Univariate analysis results showed that multiple risk factors were associated with the early growth of tICH and included in the following multivariate analysis models. The multivariate logistic regression analysis results revealed that the NLR was highly associated with the early growth of tICH (p < 0.001) while considering other risk factors in the same model. The prediction accuracy of the NLR for the early growth of tICH in patients is 82%. Interpretation The NLR is easily calculated and might predict the early growth of tICH for patients suffering from TBI.	[Zhuang, Dongzhou; Peng, Guoyi; Cai, Shirong; Din, Faxiu; Chen, Weiqiang] Shantou Univ, Affiliated Hosp 1, Med Coll, Dept Neurosurg, Shantou 515000, Guangdong, Peoples R China; [Sheng, Jiangtao; Li, Tian; Li, Kangsheng] Shantou Univ, Med Coll, Dept Microbiol & Immunol, 22 Xinling Rd, Shantou 515000, Guangdong, Peoples R China; [Sheng, Jiangtao; Li, Tian; Li, Kangsheng] Shantou Univ, Med Coll, Key Immunopathol Lab Guangdong Prov, 22 Xinling Rd, Shantou 515000, Guangdong, Peoples R China; [Li, Lianjie; Wang, Shousen] Xiamen Univ, Fuzhou Gen Hosp, Dept Neurosurg, Fuzhou 350025, Peoples R China; [Huang, Mindong] Jieyang Peoples Hosp, Dept Neurosurg, 107 Tianfu Rd, Jieyang, Peoples R China; [Tian, Fei] Shantou Univ, Affiliated Hosp 2, Med Coll, Dept Neurosurg, Dongxiabei Rd, Shantou 515000, Guangdong, Peoples R China		Wang, SS (corresponding author), Xiamen Univ, Fuzhou Gen Hosp, Dept Neurosurg, Fuzhou 350025, Peoples R China.; Chen, WQ (corresponding author), Shantou Univ, Med Coll, Dept Neurosurg, Affiliated Hosp 1, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China.	wshsen@xmu.edu.cn; wqchen@stu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471622, 81773976]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2018M633091]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2019A1515010649]; Medical Scientific Research Foundation of Guangdong Province, China [A2017168]; Clinical Improvement Program of Shantou University Medical College [201405]; Top-tier University Development Scheme for Research and Control of Infectious Diseases [2015026]	This study was supported by the National Natural Science Foundation of China (81471622 and 81773976); China Postdoctoral Science Foundation (2018M633091); the Natural Science Foundation of Guangdong Province (2019A1515010649); Medical Scientific Research Foundation of Guangdong Province, China (A2017168); Clinical Improvement Program of Shantou University Medical College (201405) and Top-tier University Development Scheme for Research and Control of Infectious Diseases (2015026).	Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Barlow KM, 2013, HAND CLINIC, V112, P891, DOI 10.1016/B978-0-444-52910-7.00011-8; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Chen WQ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0847-0; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Elkhatib THM, 2019, J STROKE CEREBROVASC, V28, P2177, DOI 10.1016/j.jstrokecerebrovasdis.2019.04.038; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; JENNETT B, 1975, LANCET, V1, P480; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Letourneau-Guillon L, 2013, AM J NEURORADIOL, V34, P773, DOI 10.3174/ajnr.A3309; Li Q, 2015, STROKE, V46, P2119, DOI 10.1161/STROKEAHA.115.009185; Liu JJ, 2019, EBIOMEDICINE, V43, P454, DOI 10.1016/j.ebiom.2019.04.040; Liu Lin-tao, 2006, Chin J Traumatol, V9, P249; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morotti A, 2016, STROKE, V47, P1473, DOI 10.1161/STROKEAHA.116.013176; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Schwartz M, 2001, J NEUROIMMUNOL, V113, P185, DOI 10.1016/S0165-5728(00)00447-1; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Woischneck D, 2010, Versicherungsmedizin, V62, P20; Yogendrakumar V, 2017, EUR STROKE J, V2, P257, DOI 10.1177/2396987317715836; Yuan L, 2020, CLIN NEUROL NEUROSUR, V189, DOI 10.1016/j.clineuro.2019.105625; Zhao JW, 2019, PEERJ, V7, DOI 10.7717/peerj.8324; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003; Zimmerman RD, 2006, AM J NEURORADIOL, V27, P666	34	1	1	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	AUG	2021	8	8					1601	1609		10.1002/acn3.51409		JUN 2021	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TY3JJ	WOS:000665033000001	34165245	Green Published, gold			2022-02-06	
J	Fisher, ER; Montroy, JJ; Duque, G; Cox, CS; Ewing-Cobbs, L				Fisher, Emily R.; Montroy, Janelle J.; Duque, Gerardo; Cox, Charles S., Jr.; Ewing-Cobbs, Linda			Post-Concussion and Post-Traumatic Stress Symptoms after Pediatric Traumatic Brain Injury: Shared Vulnerability Factors?	JOURNAL OF NEUROTRAUMA			English	Article						post-concussion symptoms; post-traumatic stress symptoms; traumatic brain injury	QUALITY-OF-LIFE; POSTCONCUSSIVE SYMPTOMS; RISK-FACTORS; MILD; CHILDREN; PREDICTORS; DISORDER; ASSOCIATION; RECOVERY; UPDATE	Following pediatric traumatic brain injury (TBI), post-concussion symptoms (PCS) and post-traumatic stress symptoms (PTSS) occur commonly; however, it is unknown to what degree they overlap. The study examined PCS and PTSS persisting 7 weeks after injury in children and adolescents ages 8-15 years with TBI (n = 89) or extracranial injury (EI; n = 40) after vehicle collisions. TBI was divided into mild, complicated-mild/moderate, and severe groups. Parents retrospectively rated children's pre-injury symptoms and behavior problems, and children completed self-report measures after injury. PCS and PTSS total scores were significantly correlated in TBI and EI groups, respectively, for child (r(s) = 0.75; r(s) = 0.44), and adolescent (r(s) = 0.61; r(s) = 0.67) cohorts. Generalized linear models examined whether injury type and severity, age, sex, and pre-injury symptom ratings predicted PCS and PTSS total scores and factor scores. Specific PCS and PTSS factor scores were elevated in different TBI severity groups, with most frequent problems following mild or severe TBI. PCS did not differ by age; however, girls had more emotional symptoms than boys. Only PTSS were predicted by pre-injury externalizing behavior. Significant age by sex interactions indicated that adolescent girls had more total, avoidance, and hyperarousal PTSS symptoms than younger girls or all boys. PCS and PTSS significantly overlapped in both TBI and EI groups, highlighting shared persistent symptoms after injury. Shared vulnerability factors included female sex, milder TBI, and poorer pre-injury adjustment. Older age was a unique vulnerability factor for PTSS. Psychological health interventions after injury should be customized to address comorbid symptoms.	[Fisher, Emily R.; Montroy, Janelle J.; Duque, Gerardo; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, McGovern Sch Med, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA; [Fisher, Emily R.; Montroy, Janelle J.; Duque, Gerardo; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, McGovern Sch Med, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Sch Med, Houston, TX 77030 USA		Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, McGovern Sch Med, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.; Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat, McGovern Sch Med, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS046308]; Nicole and Evan Katz Pediatric Neurodevelopmental Fund	This work was funded by the National Institutes of Health R01 NS046308 awarded to LEC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the granting institute. Support also was provided by the Nicole and Evan Katz Pediatric Neurodevelopmental Fund.	Achenbach TM., 1991, MANUAL CHILD BEHAV C; Al-Ozairi A, 2015, J HEAD TRAUMA REHAB, V30, P283, DOI 10.1097/HTR.0000000000000043; American Psychiatric Association, DIAGN STAT MAN MENT, V4a; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Beauchamp MH, 2019, J INT NEUROPSYCH SOC, V25, P375, DOI 10.1017/S1355617719000286; Biederman J, 2002, AM J PSYCHIAT, V159, P1556, DOI 10.1176/appi.ajp.159.9.1556; Brosbe MS, 2011, J PEDIATR PSYCHOL, V36, P718, DOI 10.1093/jpepsy/jsq115; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Donlon K, 2015, CHILD NEUROPSYCHOL, V21, P803, DOI 10.1080/09297049.2014.944491; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Gray M, 2020, PHYS THER SPORT, V42, P68, DOI 10.1016/j.ptsp.2020.01.001; Guo XY, 2017, NEUROPSYCHOLOGY, V31, P84, DOI 10.1037/neu0000305; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Howell DR, 2019, J CHILD NEUROL, V34, P256, DOI 10.1177/0883073818824000; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kassam-Adams N, 2013, JAMA PEDIATR, V167, P1158, DOI 10.1001/jamapediatrics.2013.2741; Kassam-Adams N, 2010, J AM ACAD CHILD PSY, V49, P616, DOI 10.1016/j.jaac.2010.02.011; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lu LH, 2019, NEUROREHABILITATION, V44, P511, DOI 10.3233/NRE-192702; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Lumba-Brown Angela, 2019, Concussion, V4, pCNC65, DOI 10.2217/cnc-2019-0005; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mayer AR, 2020, J NEUROTRAUM, V37, P1504, DOI 10.1089/neu.2019.6805; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Nixon RDV, 2013, PSYCHOL ASSESSMENT, V25, P1025, DOI 10.1037/a0033324; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Peixoto C, 2018, J PAIN RES, V11, P1927, DOI 10.2147/JPR.S165077; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Price J, 2016, J PEDIATR PSYCHOL, V41, P86, DOI 10.1093/jpepsy/jsv074; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rhine T, 2018, J HEAD TRAUMA REHAB, V33, P210, DOI 10.1097/HTR.0000000000000319; Russell JD, 2017, J AM ACAD CHILD PSY, V56, P669, DOI 10.1016/j.jaac.2017.05.021; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schreier H, 2005, J TRAUMA, V58, P353, DOI 10.1097/01.TA.0000152537.15672.B7; Segev S, 2016, NEUROPSYCHOLOGY, V30, P800, DOI 10.1037/neu0000299; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Snook ML, 2017, JAMA PEDIATR, V171, P879, DOI 10.1001/jamapediatrics.2017.1140; TEASDALE G, 1974, LANCET, V2, P81; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; von Steinb?chel, 2020, J CLIN MED, P9; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	52	1	1	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2021	38	18					2600	2609		10.1089/neu.2020.7541		JUN 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	US2IV	WOS:000664702200001	33899522				2022-02-06	
J	Saeedimasine, M; Montanino, A; Kleiven, S; Villa, A				Saeedimasine, Marzieh; Montanino, Annaclaudia; Kleiven, Svein; Villa, Alessandra			Elucidating Axonal Injuries Through Molecular Modelling of Myelin Sheaths and Nodes of Ranvier	FRONTIERS IN MOLECULAR BIOSCIENCES			English	Article						coarse grained model; molecular dynamics simulations (MD simulations); brain injury; axonal membrane; mechanoporation	COARSE-GRAINED MODEL; FORCE-FIELD; MEMBRANE INTERACTIONS; LIPID-COMPOSITION; SURFACE-CHARGE; NERVE MYELIN; SODIUM; AXOLEMMA; CHANNELS; DAMAGE	Around half of the traumatic brain injuries are thought to be axonal damage. Disruption of the cellular membranes, or alternatively cytoskeletal damage has been suggested as possible injury trigger. Here, we have used molecular models to have a better insight on the structural and mechanical properties of axon sub-cellular components. We modelled myelin sheath and node of Ranvier as lipid bilayers at a coarse grained level. We built ex-novo a model for the myelin. Lipid composition and lipid saturation were based on the available experimental data. The model contains 17 different types of lipids, distributed asymmetrically between two leaflets. Molecular dynamics simulations were performed to characterize the myelin and node-of-Ranvier bilayers at equilibrium and under deformation and compared to previous axolemma simulations. We found that the myelin bilayer has a slightly higher area compressibility modulus and higher rupture strain than node of Ranvier. Compared to the axolemma in unmyelinated axon, mechanoporation occurs at 50% higher strain in the myelin and at 23% lower strain in the node of Ranvier in myelinated axon. Combining the results with finite element simulations of the axon, we hypothesizes that myelin does not rupture at the thresholds proposed in the literature for axonal injury while rupture may occur at the node of Ranvier. The findings contribute to increases our knowledge of axonal sub-cellular components and help to understand better the mechanism behind axonal brain injury.	[Saeedimasine, Marzieh] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Montanino, Annaclaudia; Kleiven, Svein] KTH Royal Inst Technol, Div Neuron Engn, Stockholm, Sweden; [Villa, Alessandra] KTH Royal Inst Technol, PDC Ctr High Performance Comp, Stockholm, Sweden; [Saeedimasine, Marzieh] Stockholm Univ, Dept Mat & Environm Chem, Stockholm, Sweden		Villa, A (corresponding author), KTH Royal Inst Technol, PDC Ctr High Performance Comp, Stockholm, Sweden.	avilla@kth.se	Villa, Alessandra/A-1554-2010	Villa, Alessandra/0000-0002-9573-0326	Swedish Research CouncilSwedish Research CouncilEuropean Commission [VR-201605314, VR-2020-04496]; European Union 2020 Research and Innovation Framework Programme under the Marie Sklodowska-Curie [642662]; Swedish National Infrastructure for Computing [SNIC20171-491, SNIC2018-3-548]	The authors thank the Swedish Research Council (VR-201605314 and VR-2020-04496), the European Union Horizon 2020 Research and Innovation Framework Programme under the Marie Sklodowska-Curie (grant agreement No. 642662), and the Swedish National Infrastructure for Computing (SNIC20171-491 and SNIC2018-3-548) for the support.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bosio A, 1998, J NEUROCHEM, V70, P308; Bussi G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3073889; CAMEJO G, 1969, BIOCHIM BIOPHYS ACTA, V193, P247, DOI 10.1016/0005-2736(69)90186-2; CASPAR DLD, 1971, NATURE-NEW BIOL, V231, P46, DOI 10.1038/newbio231046a0; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Corradi V, 2018, ACS CENTRAL SCI, V4, P709, DOI 10.1021/acscentsci.8b00143; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; DEVRIES GH, 1981, J LIPID RES, V22, P208; DeVries GH, 1999, J NEUROSCI RES, V57, P670; Duflocq A, 2008, MOL CELL NEUROSCI, V39, P180, DOI 10.1016/j.mcn.2008.06.008; EVANS EA, 1976, BIOPHYS J, V16, P585, DOI 10.1016/S0006-3495(76)85713-X; Fitzpatrick MO, 1998, J NEUROL NEUROSUR PS, V64, P285, DOI 10.1136/jnnp.64.3.285; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hu H, 2014, NAT NEUROSCI, V17, P686, DOI 10.1038/nn.3678; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; INOUYE H, 1988, BIOPHYS J, V53, P247, DOI 10.1016/S0006-3495(88)83086-8; INOUYE H, 1988, BIOPHYS J, V53, P235, DOI 10.1016/S0006-3495(88)83085-6; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KIRSCHNER DA, 1989, J NEUROCHEM, V53, P1599, DOI 10.1111/j.1471-4159.1989.tb08558.x; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; Lukat G, 2013, J CHEM INF MODEL, V53, P2908, DOI 10.1021/ci400172g; MALO MS, 1994, CYTOGENET CELL GENET, V67, P178, DOI 10.1159/000133818; MANZOLI FA, 1970, FEBS LETT, V10, P317, DOI 10.1016/0014-5793(70)80462-8; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Min Y, 2009, P NATL ACAD SCI USA, V106, P3154, DOI 10.1073/pnas.0813110106; Montanino A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00025; Montanino A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00643; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Mu J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00217; Nakadate H., 2017, 61 STAPP CAR CRASH C, DOI [10.4271/2017-22-0003, DOI 10.4271/2017-22-0003]; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; OBRIEN JS, 1964, J LIPID RES, V5, P339; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Pandit SA, 2004, BIOPHYS J, V87, P1092, DOI 10.1529/biophysj.104.041939; Pandit SA, 2003, J CHEM PHYS, V119, P2199, DOI 10.1063/1.1582833; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pastor RW, 2011, J PHYS CHEM LETT, V2, P1526, DOI 10.1021/jz200167q; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Rasband MN, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P180; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Saeedimasine M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44318-9; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Singh S, 2015, BIOMECH MODEL MECHAN, V14, P1303, DOI 10.1007/s10237-015-0675-z; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; WANN KT, 1993, BRIT J ANAESTH, V71, P2, DOI 10.1093/bja/71.1.2; WAUGH R, 1979, BIOPHYS J, V26, P115, DOI 10.1016/S0006-3495(79)85239-X; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; WILLIAMS KA, 1993, CRIT REV CL LAB SCI, V30, P29, DOI 10.3109/10408369309084665; ZAMBRANO F, 1971, J MEMBRANE BIOL, V6, P289, DOI 10.1007/BF02116575	60	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-889X		FRONT MOL BIOSCI	Front. Mol. Biosci.	JUN 23	2021	8								669897	10.3389/fmolb.2021.669897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE5OJ	WOS:000670062100001	34250015	Green Published, gold			2022-02-06	
J	Wei, NL; Sun, ZX; Yu, JM; Jiat, YF; Zheng, PQ; Tang, HL; Chen, J				Wei, Naili; Sun, Zhenxing; Yu, Jimei; Jiat, Yanfei; Zheng, Peiqi; Tang, Hailiang; Chen, Jian			Immunological Responses to Transgene-Modified Neural Stem Cells After Transplantation	FRONTIERS IN IMMUNOLOGY			English	Article						neural stem cells; major histocompatibility complex; magnetotactic bacteria; immunological response; transgenic modification; mms6	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; STEM/PROGENITOR CELLS; CEREBRAL-ISCHEMIA; MHC EXPRESSION; CLASS-II; MICROGLIA; RATS; DIFFERENTIATION; MACROPHAGES	Neural stem cell (NSC) therapy is a promising therapeutic strategy for stroke. Researchers have frequently carried out genetic modification or gene editing of stem cells to improve survival or therapeutic function. However, NSC transplantation carries the risk of immune rejection, and genetic modification or gene-editing might further increase this risk. For instance, recent studies have reported on manipulating the stem cell genome and transplantation via the insertion of an exogenous gene derived from magnetotactic bacteria. However, whether transgene-modified stem cells are capable of inducing immunological reactions has not been explored. Although NSCs rarely express the major histocompatibility complex (MHC), they can still cause some immunological issues. To investigate whether transgene-modified NSCs aggravate immunological responses, we detected the changes in peripheral immune organs and intracerebral astrocytes, glial cells, and MHC-I and MHC-II molecules after the injection of GFP-labeled or mms6-GFP-labeled NSCs in a rat model. Xenogeneic human embryonic kidney (HEK-293T) cells were grafted as a positive control group. Our results indicated that xenogeneic cell transplantation resulted in a strong peripheral splenic response, increased astrocytes, enhanced microglial responses, and upregulation of MHC-I and MHC-II expression on the third day of transplantation. But they decreased obviously except Iba-1 positive cells and MHC-II expression. When injection of both mms6-GFP-labeled NSCs and GFP-labeled NSCs also induced similar responses as HEK-293T cells on the third days, but MHC-I and MHC-II expression decreased 3 weeks after transplantation. In addition, mms6 transgene-modified NSCs did not produce peripheral splenic response responses as well as astrocytes, microglial cells, MHC-I and MHC-II positive cells responses when compared with non-modified NSCs. The present study provides preliminary evidence that transgenic modification does not aggravate immunological responses in NSC transplantation.	[Wei, Naili; Zheng, Peiqi; Chen, Jian] Shantou Univ, Affiliated Hosp 1, Med Coll, Dept Neurosurg, Shantou, Guangdong, Peoples R China; [Sun, Zhenxing] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Neurosurg, Beijing, Peoples R China; [Yu, Jimei] Fudan Univ, Huashan Hosp North, Dept Nursing, Shanghai, Peoples R China; [Jiat, Yanfei] Lanzhou Univ, Hosp 2, Dept Neurosurg, Lanzhou, Peoples R China; [Tang, Hailiang] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China		Chen, J (corresponding author), Shantou Univ, Affiliated Hosp 1, Med Coll, Dept Neurosurg, Shantou, Guangdong, Peoples R China.; Tang, HL (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.	tangtang052105192@gmail.com; drchen@stu.edu.cn			National Nature Science FoundationNational Natural Science Foundation of China (NSFC) [82001447]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2020M682833]; Dengfeng Project for the construction of high-level hospitals in Guangdong Province; First Affiliated Hospital of Shantou University Medical College Supporting Funding [202003-29]; Beijing Tsinghua Changgung Hospital Fund [12015C1045]; 2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant [2020LKSFG11C]	This work was supported by grants from the National Nature Science Foundation (82001447), China Postdoctoral Science Foundation (2020M682833), Dengfeng Project for the construction of high-level hospitals in Guangdong Province, the First Affiliated Hospital of Shantou University Medical College Supporting Funding (202003-29), 2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant (2020LKSFG11C), and Beijing Tsinghua Changgung Hospital Fund (12015C1045).	Acosta SA, 2015, STROKE, V46, P2616, DOI 10.1161/STROKEAHA.115.009854; AKIYAMA H, 1988, J NEUROSCI RES, V20, P147, DOI 10.1002/jnr.490200202; Al Nimer F, 2004, NEUROREPORT, V15, P1871, DOI 10.1097/00001756-200408260-00007; Alam A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02005-x; Arakaki A, 2003, J BIOL CHEM, V278, P8745, DOI 10.1074/jbc.M211729200; Bakay RAE, 1998, CELL TRANSPLANT, V7, P109, DOI 10.1016/S0963-6897(97)00165-6; Barcia C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.17; Bauer S, 2003, J NEUROSCI, V23, P1792; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Chen ZG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014787, 10.1371/journal.pone.0028618]; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Elfick A, 2017, SCI REP-UK, V7, DOI 10.1038/srep39755; Fainstein N, 2013, GLIA, V61, P140, DOI 10.1002/glia.22420; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Hicks AU, 2009, EUR J NEUROSCI, V29, P562, DOI 10.1111/j.1460-9568.2008.06599.x; Hirata Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141785; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Kalladka D, 2016, LANCET, V388, P787, DOI 10.1016/S0140-6736(16)30513-X; Kazansky DB, 2008, J IMMUNOTOXICOL, V5, P369, DOI 10.1080/15476910802476708; Koh SH, 2017, TRANSL STROKE RES, V8, P3, DOI 10.1007/s12975-016-0460-z; Kokaia Z, 2011, TRANSL STROKE RES, V2, P272, DOI 10.1007/s12975-011-0100-6; Le Blon D, 2014, IMMUNOL CELL BIOL, V92, P650, DOI 10.1038/icb.2014.49; Leduc K, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094334; Lee JY, 2020, TRANSL STROKE RES, V11, P831, DOI 10.1007/s12975-019-00756-1; Liu MY, 2013, J NEUROIMMUNOL, V255, P32, DOI 10.1016/j.jneuroim.2012.10.013; Lyu JX, 2021, TRANSL STROKE RES, V12, P474, DOI 10.1007/s12975-020-00857-2; McLaren FH, 2001, J NEUROIMMUNOL, V112, P35, DOI 10.1016/S0165-5728(00)00410-0; Mirenda V, 2004, J AM SOC NEPHROL, V15, P987, DOI 10.1097/01.ASN.0000119575.98696.1D; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Perkey E, 2018, ANNU REV PATHOL-MECH, V13, P219, DOI 10.1146/annurev-pathol-020117-043720; Quan FS, 2016, EXP THER MED, V12, P1671, DOI 10.3892/etm.2016.3527; Radoul M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26550; Rohn W, 1999, J IMMUNOL, V162, P886; Sabir N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122725; Schartner JM, 2005, GLIA, V51, P279, DOI 10.1002/glia.20201; Smith DK, 2017, PROG NEUROBIOL, V157, P212, DOI 10.1016/j.pneurobio.2016.01.006; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Sun CR, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-77; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Vagaska B, 2016, SCI REP-UK, V6, DOI 10.1038/srep24251; Van den Eeckhout B, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.621931; Victorio SCS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-88; Vila-del Sol V, 2008, J IMMUNOL, V181, P4461, DOI 10.4049/jimmunol.181.7.4461; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wennersten A, 2006, EXP NEUROL, V199, P339, DOI 10.1016/j.expneurol.2005.12.035; WHITE LA, 1994, J NEUROIMMUNOL, V49, P135, DOI 10.1016/0165-5728(94)90189-9; Xu AL, 2020, NEURAL REGEN RES, V15, P78, DOI 10.4103/1673-5374.264465; Yu AC, 2017, J NEUROIMMUNOL, V307, P53, DOI 10.1016/j.jneuroim.2017.03.018; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0; Zhang XY, 2015, MOL IMAGING, V14, DOI 10.2310/7290.2014.00046; Zheng XS, 2007, BRAIN INJURY, V21, P275, DOI 10.1080/02699050701225754; Zurkiya O, 2008, MAGN RESON MED, V59, P1225, DOI 10.1002/mrm.21606	54	1	1	5	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	JUN 23	2021	12								697203	10.3389/fimmu.2021.697203			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TE8FX	WOS:000670243000001	34248998	gold, Green Published			2022-02-06	
J	Belanger, HG; Vincent, AS; Caserta, RJ; Biggs, AT; Yao, EF				Belanger, Heather G.; Vincent, Andrea S.; Caserta, Ryan J.; Biggs, Adam T.; Yao, Eveline F.			Automated neuropsychological assessment metrics (v4) military expanded battery: Normative data for special operations forces	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						military; ANAM; neuropsychological; assessment; concussion; special operations; cognitive; neurocognitive	TRAUMATIC BRAIN-INJURY; PERFORMANCE; ANAM	Objective: The Automated Neuropsychological Assessment Metrics (ANAM) has long been used to assess cognition in military samples before deployment and following injury. The purpose of this study was to explore the effects of various demographic factors on the ANAM4 Military Expanded (ANAM4 ME) performance of Special Operations Forces (SOF) and to provide regression-based normative data for clinicians working with SOF personnel. Method: The sample was a large active duty military sample of SOF and support personnel (n = 24,072) who were tested under a new baseline policy. Results: Performance differences based on demographic variables were generally small. In general, increasing age was associated with significantly worse performance, except on mathematical processing. Higher education level was associated with better performance on most subtests, as expected, but was associated with worse performance on spatial processing. Conclusion: This paper provides regression formulas for calculating adjusted scores based on the most relevant demographic variables, as well as base rates of obtaining one or more clearly above or below average scores across the entire ANAM4 ME battery.	[Belanger, Heather G.; Yao, Eveline F.] Special Operat Command SOCOM, Surg Gen Off, Tampa, FL 33621 USA; [Belanger, Heather G.] St Michaels Inc, Tampa, FL 33609 USA; [Belanger, Heather G.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vincent, Andrea S.] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73019 USA; [Vincent, Andrea S.] Vista LifeSci Inc, Denver, CO USA; [Caserta, Ryan J.] Special Operat Command SOCOM, Preservat Force & Family POTFF, Tampa, FL USA; [Caserta, Ryan J.] KBR, Houston, TX USA; [Biggs, Adam T.] Naval Special Warfare Command, Coronado, CA USA		Belanger, HG (corresponding author), Special Operat Command SOCOM, Surg Gen Off, Tampa, FL 33621 USA.; Belanger, HG (corresponding author), St Michaels Inc, Tampa, FL 33609 USA.; Belanger, HG (corresponding author), Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA.; Belanger, HG (corresponding author), Univ S Florida, Dept Psychol, Tampa, FL 33620 USA.	heather.belanger.ctr@socom.mil			Department of Defense (DoD)United States Department of Defense; St Michael's Inc.	The research reported here was supported by the Department of Defense (DoD) and St Michael's Inc. The views expressed herein are those of the authors and do not necessarily reflect the views of the Department of Health Affairs, the Department of Defense, nor the U.S. Government. Several authors are military service members or employees of the U.S. government. This work was prepared as part of their official duties. Title 17U.S.C. 105 provides that "Copyright protection under this title is not available for any work of the United States Government." Title 17U.S.C. 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person's official duties. The authors have no financial or non-financial competing interests in this manuscript.	Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Department of Defense Instruction 6490.13, 2017, COMPR POL TRAUM BRAI; Hair JF, 1995, MULTIVARIATE DATA AN; Heaton R. K., 2004, REVISED COMPREHENSIV; Holdnack J.A., 2013, WAIS 4 WMS 4 ACS; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Meyers JE, 2020, MIL MED, V185, pE1706, DOI 10.1093/milmed/usaa066; Proctor SP, 2015, MIL MED, V180, P660, DOI 10.7205/MILMED-D-14-00298; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Roebuck-Spencer TM, 2008, MIL PSYCHOL, V20, P187, DOI 10.1080/08995600802118825; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Royer SD, 2018, MIL MED, V183, pE341, DOI 10.1093/milmed/usy049; Rozencwajg P, 2010, LEARN INDIVID DIFFER, V20, P452, DOI 10.1016/j.lindif.2010.04.009; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2018, CLIN NEUROPSYCHOL, V32, P479, DOI 10.1080/13854046.2017.1368716; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Wilken JA, 2007, ARCH CLIN NEUROPSYCH, V22, pS127, DOI 10.1016/j.acn.2006.10.007	25	1	1	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2021.1933191		JUN 2021	13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	SX0DZ	WOS:000664884000001	34157935				2022-02-06	
J	Chen, L; Zhou, Y; Wang, JY; Li, K; Zhang, ZZ; Peng, M				Chen, Lei; Zhou, Ying; Wang, Jiayu; Li, Ke; Zhang, Zongze; Peng, Mian			The adenosine A(2A) receptor alleviates postoperative delirium-like behaviors by restoring blood cerebrospinal barrier permeability in rats	JOURNAL OF NEUROCHEMISTRY			English	Article						adenosine A(2A) receptor; blood cerebrospinal barrier; postoperative delirium; RhoA; rho-associated protein kinase 2	CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; TIGHT JUNCTION; CHOROID-PLEXUS; MICE; NEUROINFLAMMATION; DYSFUNCTION; CONTRIBUTES; LYMPHOCYTES	Postoperative delirium (POD) is a common post-operative complication in elderly patients that is associated with increased morbidity and mortality. However, the neuropathogenesis of this complication remains unknown. The blood-cerebrospinal fluid barrier (BCB) and brain-blood barrier (BBB) are composed of tight junctions between cells that form physical barriers, and BBB damage plays an important role in the neuropathogenesis of POD. Nevertheless, the role of BCB in POD remains to be elucidated. Herein, we investigated the effect of adenosine A(2A) receptor (A(2A)R), a key regulator of the permeability of barriers, on surgery-induced increased permeability of BCB and POD-like behaviors. Open field, buried food, and Y maze tests were used to evaluate behavioral changes in rats after surgery. Levels of tight junction proteins, adherens junction proteins, A(2A)R, GTP-RhoA, and ROCK2 in the choroid plexus were assessed by western blotting. The concentrations of NaFI and FITC-dextran in the cerebrospinal fluid (CSF) were detected by fluorescence spectrophotometry. Transmission electron microscopy was applied to observe the ultrastructure of the choroid plexus. Surgery/anesthesia decreased the levels of tight junction (e.g., ZO-1, occludin, and claudin1) proteins, increased concentrations of NaFI and FITC-dextran in CSF, damaged the ultrastructure of choroid plexus, and induced POD-like behaviors in rats. An A(2A)R antagonist alleviated POD-like behaviors in rats. Furthermore, the A(2A)R antagonist increased the levels of tight junction proteins and restored the permeability of BCB in rats with POD. Fasudil, a selective Rho-associated protein kinase 2 (ROCK2) inhibitor, ameliorated POD-like behaviors induced by A(2A)R activation. Moreover, fasudil also abolished the increased levels of GTP-RhoA/ROCK2, decreased levels of tight junction proteins, and increased permeability of BCB caused by A(2A)R activation. Our findings demonstrate that A(2A)R might participate in regulating BCB permeability in rats with POD via the RhoA/ROCK2 signaling pathway, which suggests the potential of A(2A)R as a therapeutic target for POD.	[Chen, Lei; Zhou, Ying; Wang, Jiayu; Li, Ke; Zhang, Zongze; Peng, Mian] Wuhan Univ, Zhongnan Hosp, Dept Anesthesiol, 169 Donghu Rd, Wuhan, Hubei, Peoples R China		Peng, M (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Anesthesiol, 169 Donghu Rd, Wuhan, Hubei, Peoples R China.	mianpeng@whu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371195, 81870851]; Outstanding Talented Young Doctor Program of Hubei Province [2019]	National Natural Science Foundation of China, Grant/Award Number: 81371195 and 81870851; a research grant from the Outstanding Talented Young Doctor Program of Hubei Province, Grant/Award Number: 2019	Aldecoa C, 2017, EUR J ANAESTH, V34, P192, DOI 10.1097/EJA.0000000000000594; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Bagewadi HG, 2015, J CLIN DIAGN RES, V9, pFF1, DOI 10.7860/JCDR/2015/13233.6287; Bahi A, 2014, DRUG DES DEV THER, V8, P627, DOI 10.2147/DDDT.S63088; Baruch K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8967; Bergen AA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2159-z; Bynoe MS, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0017-7; Castellani G, 2019, BRAIN BEHAV IMMUN, V81, P138, DOI 10.1016/j.bbi.2019.06.006; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Chen JF, 2014, INT REV NEUROBIOL, V119, P257, DOI 10.1016/B978-0-12-801022-8.00012-X; Chen L, 2020, MOL CARCINOGEN, V59, P390, DOI 10.1002/mc.23161; Chen L, 2019, BRAIN BEHAV IMMUN, V78, P188, DOI 10.1016/j.bbi.2019.01.020; Chen MH, 2013, EXPERT OPIN INV DRUG, V22, P537, DOI 10.1517/13543784.2013.778242; Cho SY, 2018, BLOOD, V131, P1931, DOI 10.1182/blood-2017-07-797209; da Silva SV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11915; Domenici MR, 2019, PHARMACOL RES, V147, DOI 10.1016/j.phrs.2019.104338; Du JY, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/3728752; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Ek CJ, 2003, J COMP NEUROL, V460, P451, DOI 10.1002/cne.10661; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Ennis SR, 2006, ACTA NEUROCHIR SUPPL, V96, P276; Ennis SR, 2006, J CEREBR BLOOD F MET, V26, P675, DOI 10.1038/sj.jcbfm.9600224; Evered L, 2018, BRIT J ANAESTH, V121, P1005, DOI 10.1016/j.bja.2017.11.087; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feng S, 2018, MOLECULES, V23, DOI 10.3390/molecules23092371; Fong TG, 2015, LANCET NEUROL, V14, P823, DOI 10.1016/S1474-4422(15)00101-5; Fredholm BB, 2007, PROG NEUROBIOL, V83, P263, DOI 10.1016/j.pneurobio.2007.07.005; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001; Gong P, 2020, J MOL NEUROSCI, V70, P71, DOI 10.1007/s12031-019-01402-z; Grant GA, 2003, J NEUROSURG, V98, P554, DOI 10.3171/jns.2003.98.3.0554; Hidaka C, 2018, NEUROPSYCH DIS TREAT, V14, P2255, DOI 10.2147/NDT.S170281; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hurtado-Alvarado G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167236; Inouye SK, 2016, ALZHEIMERS DEMENT, V12, P766, DOI 10.1016/j.jalz.2016.03.005; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; INOUYE SK, 2015, J AM COLL SURGEONS, V220, P136, DOI DOI 10.1016/J.JAMC0LLSURG.2014.10.019; Jeyaraj SC, 2012, AM J PHYSIOL-CELL PH, V303, pC499, DOI 10.1152/ajpcell.00461.2011; Johansson B, 1997, NEUROSCIENCE, V80, P1187, DOI 10.1016/S0306-4522(97)00143-7; Kaur C, 2016, J NEUROPATH EXP NEUR, V75, P198, DOI 10.1093/jnen/nlv030; Kawano T, 2018, J ANESTH, V32, P506, DOI 10.1007/s00540-018-2504-x; Kim J, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8080258; Kozler P, 2003, PHYSIOL RES, V52, P607; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P105, DOI 10.1007/978-1-4939-8994-2_10; Kwilasz AJ, 2018, BRAIN BEHAV IMMUN, V69, P470, DOI 10.1016/j.bbi.2018.01.005; Langford MB, 2020, CEREB CORTEX, V30, P3617, DOI 10.1093/cercor/bhz330; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; Liu Y, 2018, IMMUN INFLAMM DIS, V6, P72, DOI 10.1002/iid3.187; Lopes LV, 2004, BRIT J PHARMACOL, V141, P1006, DOI 10.1038/sj.bjp.0705692; Lu Q, 2010, AM J PHYSIOL-LUNG C, V298, pL755, DOI 10.1152/ajplung.00330.2009; Lu YY, 2020, AGING-US, V12, P844, DOI 10.18632/aging.102659; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Matos M, 2012, J ALZHEIMERS DIS, V31, P555, DOI 10.3233/JAD-2012-120469; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Mills JH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-193; Mills JH, 2012, J IMMUNOL, V188, P5713, DOI 10.4049/jimmunol.1200545; Mills JH, 2011, PURINERG SIGNAL, V7, P265, DOI 10.1007/s11302-011-9222-2; Mu ZH, 2016, CNS NEUROSCI THER, V22, P316, DOI 10.1111/cns.12500; Nie ZZ, 1999, MOL PHARMACOL, V56, P947, DOI 10.1124/mol.56.5.947; Orr AG, 2015, NAT NEUROSCI, V18, P423, DOI 10.1038/nn.3930; Ott BR, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00245; Paterniti I, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-31; Peng M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29874; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rajasundaram S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00402; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; Sanderson DJ, 2012, HIPPOCAMPUS, V22, P981, DOI 10.1002/hipo.20896; Santiago AR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/465694; Shansky RM, 2019, SCIENCE, V364, P825, DOI 10.1126/science.aaw7570; Sheth S, 2014, INT J MOL SCI, V15, P2024, DOI 10.3390/ijms15022024; Sonar SA, 2018, J LEUKOCYTE BIOL, V103, P839, DOI 10.1002/JLB.1RU1117-428R; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Subramaniyan S, 2019, ANESTH ANALG, V128, P781, DOI 10.1213/ANE.0000000000004053; Sun LL, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0913-7; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; Whitlock EL, 2011, MINERVA ANESTESIOL, V77, P448; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wyrobek J, 2017, BRIT J ANAESTH, V119, P324, DOI 10.1093/bja/aex103; Xiong C, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1292-4; Xue Y, 2019, BIOCHEM BIOPH RES CO, V509, P395, DOI 10.1016/j.bbrc.2018.12.144; Yamamoto M, 2019, J NEUROSCI, V39, P4179, DOI 10.1523/JNEUROSCI.2506-18.2019; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yang SM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00902; Zhou YQ, 2019, BRIT J PHARMACOL, V176, P2250, DOI 10.1111/bph.14673; Zhu YS, 2019, NEUROPATHOLOGY, V39, P30, DOI 10.1111/neup.12530; Zimmermann H, 2016, PURINERG SIGNAL, V12, P25, DOI 10.1007/s11302-015-9483-2	92	1	1	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2021	158	4					980	996		10.1111/jnc.15436		JUN 2021	17	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	UB8LG	WOS:000664350000001	34033116				2022-02-06	
J	Wu, ZR; Chen, C; Kang, SS; Liu, X; Gu, XH; Yu, SP; Keene, CD; Cheng, LM; Ye, KQ				Wu, Zhourui; Chen, Chun; Kang, Seong Su; Liu, Xia; Gu, Xiaohuan; Yu, Shan Ping; Keene, C. Dirk; Cheng, Liming; Ye, Keqiang			Neurotrophic signaling deficiency exacerbates environmental risks for Alzheimer's disease pathogenesis	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						sporadic Alzheimer's disease; C/EBP beta; delta-secretase; risk factors; AEP	GROWTH-FACTOR EXPRESSION; C/EBP-BETA; DELTA-SECRETASE; SEVERE OBESITY; BRAIN INSULIN; AXONAL INJURY; MOUSE MODEL; HEAD-INJURY; MEMORY LOSS; BDNF	The molecular mechanism of Alzheimer's disease (AD) pathogenesis remains obscure. Life and/or environmental events, such as traumatic brain injury (TBI), high-fat diet (HFD), and chronic cerebral hypoperfusion (CCH), are proposed exogenous risk factors for AD. BDNF/TrkB, an essential neurotrophic signaling for synaptic plasticity and neuronal survival, are reduced in the aged brain and in AD patients. Here, we show that environmental factors activate C/EBP beta, an inflammatory transcription factor, which subsequently up-regulates delta-secretase that simultaneously cleaves both APP and Tau, triggering AD neuropathological changes. These adverse effects are additively exacerbated in BDNF+/- or TrkB(+/-) mice. Strikingly, TBI provokes both senile plaque deposit and neurofibrillary tangles (NFT) formation in TrkB(+/-) mice, associated with augmented neuroinflammation and extensive neuronal loss, leading to cognitive deficits. Depletion of C/EBP beta inhibits TBI-induced AD-like pathologies in these mice. Remarkably, amyloid aggregates and NFT are tempospatially distributed in TrkB(+/-) mice brains after TBI, providing insight into their spreading in the progression of AD-like pathologies. Hence, our study revealed the roles of exogenous (TBI, HFD, and CCH) and endogenous (TrkB/BDNF) risk factors in the onset of AD-associated pathologies.	[Wu, Zhourui; Chen, Chun; Kang, Seong Su; Liu, Xia; Ye, Keqiang] Emory Univ, Dept Pathol & Lab Med, Sch Med, Atlanta, GA 30322 USA; [Wu, Zhourui; Cheng, Liming] Tongji Univ, Sch Med, Tongji Hosp, Div Spine,Dept Orthoped, Shanghai 200065, Peoples R China; [Wu, Zhourui; Cheng, Liming] Minist Educ, Key Lab Spine & Spinal Cord Injury Repair & Regen, Shanghai 200072, Peoples R China; [Gu, Xiaohuan; Yu, Shan Ping] Emory Univ, Dept Anesthesiol, Sch Med, Atlanta, GA 30322 USA; [Keene, C. Dirk] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98104 USA		Ye, KQ (corresponding author), Emory Univ, Dept Pathol & Lab Med, Sch Med, Atlanta, GA 30322 USA.; Cheng, LM (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Div Spine,Dept Orthoped, Shanghai 200065, Peoples R China.; Cheng, LM (corresponding author), Minist Educ, Key Lab Spine & Spinal Cord Injury Repair & Regen, Shanghai 200072, Peoples R China.	limingcheng@tongji.edu.cn; kye@emory.edu		Chen, Chun/0000-0003-3041-3263; Keene, Christopher/0000-0002-5291-1469; Ye, Keqiang/0000-0002-7657-8154	University of Washington ADRC [P50AG005136]; Kaiser Permanente Adult Changes in Thought Study (NIH) [U01 AG006781]; Rodent Behavioral Core - Emory University School of Medicine; Viral Vector Core of the Emory Neuroscience National Institute of Neurological Disorders and Stroke (NINDS) Core Facilities [P30NS055077]; Georgia Clinical & Translational Science Alliance of the NIH [UL1TR002378]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG051538, NS105982]; ADRC center grant [AG066511]; Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81810001048]; National Basic Research Program of ChinaNational Basic Research Program of China [2016YFA0100800]; Shanghai Pujiang ProgramShanghai Pujiang Program [19PJ1409200]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82071370]; Nancy and Buster Alvord Endowment	We thank the University of Washington ADRC (NIH Grant No. P50AG005136) and the Kaiser Permanente Adult Changes in Thought Study (NIH Grant No. U01 AG006781) research subjects and their families for brain donation, a tremendous gift to science. We thank Ms. Allison Beller for coordination of tissue requests, subject selection, and tissue transfer and Ms. Kim Howard for histological support. This study was supported in part by the Rodent Behavioral Core, which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities. Additional support was provided by the Viral Vector Core of the Emory Neuroscience National Institute of Neurological Disorders and Stroke (NINDS) Core Facilities (Grant No. P30NS055077). Further support was provided by the Georgia Clinical & Translational Science Alliance of the NIH under Award No. UL1TR002378. This work is supported by a grant from the NIH (RF1, Grant No. AG051538; RO1, Grant No. NS105982), and the ADRC center grant (P30, Grant No. AG066511) to K.Y., the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (NSFC) (Grant No. 81810001048), the National Basic Research Program of China (Grant No. 2016YFA0100800) to L.C., Shanghai Pujiang Program (Grant No. 19PJ1409200), and the National Natural Science Foundation of China (Grant No. 82071370) to Z.W. C.D.K. was supported by the Nancy and Buster Alvord Endowment.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Altieri M, 2004, NEUROLOGY, V62, P2193, DOI 10.1212/01.WNL.0000130501.79012.1A; Anderson JM, 2008, BRAIN, V131, P1736, DOI 10.1093/brain/awn119; Ando S, 2002, J NEUROSCI RES, V70, P519, DOI 10.1002/jnr.10443; Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Bambah-Mukku D, 2014, J NEUROSCI, V34, P12547, DOI 10.1523/JNEUROSCI.0324-14.2014; Bartoletti A, 2002, J NEUROSCI, V22, P10072; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Bordeleau M, 2016, ONCOTARGET, V7, P11864, DOI 10.18632/oncotarget.7689; Bussiere T, 2004, AM J PATHOL, V165, P987, DOI 10.1016/S0002-9440(10)63360-3; Calella AM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-4; Chakrabarti S, 2015, AGING DIS, V6, P282, DOI 10.14336/AD.2014.002; Chan CB, 2015, CHEM BIOL, V22, P355, DOI 10.1016/j.chembiol.2015.02.003; Cotman CW, 2005, NEUROCHEM RES, V30, P877, DOI 10.1007/s11064-005-6960-y; De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595; de la Torre JC, 2003, NEUROL RES, V25, P635, DOI 10.1179/016164103101201931; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Elder GA, 2010, MT SINAI J MED, V77, P69, DOI 10.1002/msj.20159; Farid K, 2011, J COMPUT ASSIST TOMO, V35, P1, DOI 10.1097/RCT.0b013e3181f56fda; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Ginsberg SD, 2019, HIPPOCAMPUS, V29, P422, DOI 10.1002/hipo.22802; Gorski JA, 2003, J NEUROSCI, V23, P6856; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kunzi MS, 1996, J INTERF CYTOK RES, V16, P919, DOI 10.1089/jir.1996.16.919; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Li Q, 2016, NEUROSCI BULL, V32, P153, DOI 10.1007/s12264-016-0023-z; Li RN, 2004, NEUROBIOL AGING, V25, P991, DOI 10.1016/j.neurobiolaging.2003.10.016; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Lukiw WJ, 2004, NEUROCHEM RES, V29, P1287, DOI 10.1023/B:NERE.0000023615.89699.63; MAGALINI A, 1995, CYTOKINE, V7, P753, DOI 10.1006/cyto.1995.0090; Marosi K, 2014, TRENDS ENDOCRIN MET, V25, P89, DOI 10.1016/j.tem.2013.10.006; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Meneilly GS, 2001, J GERONTOL A-BIOL, V56, pM5, DOI 10.1093/gerona/56.1.M5; Murer MG, 1999, NEUROSCIENCE, V88, P1015, DOI 10.1016/S0306-4522(98)00219-X; Nakagawa T, 2000, DIABETES, V49, P436, DOI 10.2337/diabetes.49.3.436; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Paquin A, 2005, J NEUROSCI, V25, P10747, DOI 10.1523/JNEUROSCI.2662-05.2005; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Samuelsson M, 2008, BIOCHEM BIOPH RES CO, V370, P619, DOI 10.1016/j.bbrc.2008.03.150; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Soga Y, 2003, NEUROSCI LETT, V337, P106, DOI 10.1016/S0304-3940(02)01315-0; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Strohmeyer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086617; SULLIVAN P, 1987, JAMA-J AM MED ASSOC, V257, P2289, DOI 10.1001/jama.1987.03390170045014; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Vandal M, 2015, FASEB J, V29, P4273, DOI 10.1096/fj.14-268482; Wang LX, 2016, EXP NEUROL, V283, P353, DOI 10.1016/j.expneurol.2016.07.006; Wang ZH, 2019, CELL REP, V28, P655, DOI 10.1016/j.celrep.2019.06.054; Wang ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04120-z; WEDEL A, 1995, IMMUNOBIOLOGY, V193, P171, DOI 10.1016/S0171-2985(11)80541-3; Wu ZR, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03270-7; Wu ZR, 2021, MOL PSYCHIATR, V26, P568, DOI 10.1038/s41380-020-0687-7; Wu ZR, 2020, PROG NEUROBIOL, V185, DOI 10.1016/j.pneurobio.2019.101730; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Zhang ZT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9762; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700	72	1	1	7	7	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUN 22	2021	118	25							e2100986118	10.1073/pnas.2100986118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TI4XQ	WOS:000672806300014	34140411	Green Published, Bronze			2022-02-06	
J	Zhang, JY; Zhang, YK; Zou, JT; Cao, F				Zhang, Jieyu; Zhang, Yongkang; Zou, Juntao; Cao, Fei			A meta-analysis of cohort studies: Traumatic brain injury and risk of Alzheimer's Disease	PLOS ONE			English	Article							HEAD-INJURY; DEMENTIA	Introduction Recently, some epidemiological studies have reported that cognitive disorders in elderly people is accelerated with traumatic brain injury. But the causal relationship between traumatic brain injury and AD is still an area of controversy. Aims Our review was conducted to estimate the relation between traumatic brain injury and risk of AD. Methods All longitudinal population-based studies comparing incidence of AD between subjects with and without traumatic brain injury from their inception to September 2020 were searched in The Cochrane Library, PubMed, Medline, Embase, Web of Science without restriction of language. The meta-analysis was conducted using Stata software. Results A total of 17 studies involving 4289,548 individuals were included. After pooling these 17 studies, subjects with traumatic brain injury had significant higher incidence of AD than those without traumatic brain injury (RR: 1.17, 95% CI: 1.05-1.29). When considering the severity of traumatic brain injury, this elevated risk of AD was still significant comparing subjects with moderate and severe traumatic brain injury and those with no traumatic brain injury (RR: 1.30, 95% CI: 1.01-1.59). Conclusion Traumatic brain injury, especially moderate and severe traumatic brain injury may be associated with increased risk of AD.	[Zhang, Jieyu; Zhang, Yongkang; Cao, Fei] Nanchang Univ, Fuzhou Med Coll, Fuzhou, Peoples R China; [Zou, Juntao] Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China		Cao, F (corresponding author), Nanchang Univ, Fuzhou Med Coll, Fuzhou, Peoples R China.	cdfycaofei@outlook.com					Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fischer P, 2008, DEMENT GERIATR COGN, V25, P501, DOI 10.1159/000128577; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Kumar A, 2015, PHARMACOL REP, V67, P195, DOI 10.1016/j.pharep.2014.09.004; Lacosta AM, 2017, J ALZHEIMERS DIS, V58, P661, DOI 10.3233/JAD-170163; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Luchini C, 2017, WORLD J META-ANAL, V5, P80, DOI 10.13105/wjma.v5.i4.80; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Rochoy M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220174; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Takanishi R, 2017, PROMOTING THE EDUCATIONAL SUCCESS OF CHILDREN AND YOUTH LEARNING ENGLISH: PROMISING FUTURES, P1, DOI 10.1111/pin.12520	17	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253206	10.1371/journal.pone.0253206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	WOS:000671691200030	34157045	Green Published, gold			2022-02-06	
J	Kaneko, R; Kurosaki, Y; Chin, M				Kaneko, Ryosuke; Kurosaki, Yoshitaka; Chin, Masaki			Removal of an Acute Subdural Hematoma Associated with High-Energy Trauma: Auxiliary Use of Emergency Trepanning and Endoscopy	INDIAN JOURNAL OF SURGERY			English	Article; Early Access						Acute subdural hematoma; Endoscopy; Traumatic brain injury; High-energy injury; Small craniotomy	EVACUATION; IRRIGATION; CRANIOTOMY	The endoscopic removal of subdural hematomas is well reported, but its use in high-energy trauma cases has not been completely elucidated. Moreover, questions persist regarding the need for an emergency puncture, craniotomy range, and the adaptation of endoscopic technique to clinical settings; this includes cases where brain swelling is expected. Here, we describe a novel technique of endoscopic hematoma removal in an elderly patient with an acute subdural hematoma associated with high-energy trauma.	[Kaneko, Ryosuke; Kurosaki, Yoshitaka; Chin, Masaki] Kurashiki Cent Hosp, Dept Neurosurg, 1-1-1 Miwa, Kurashiki, Okayama, Japan		Kurosaki, Y (corresponding author), Kurashiki Cent Hosp, Dept Neurosurg, 1-1-1 Miwa, Kurashiki, Okayama, Japan.	kurosaki0106@gmail.com		Kurosaki, Yoshitak/0000-0003-0738-760X; Kaneko, Ryosuke/0000-0002-6864-5628			Kawasaki T, 2018, ACTA NEUROCHIR, V160, P241, DOI 10.1007/s00701-017-3399-2; Marion DW, 2006, NEUROSURGERY, V58, P655; Nagasaka T, 2009, NEUROSURGERY, V65, P826, DOI 10.1227/01.NEU.0000350985.58062.3F; Otani N, 2010, ACTA NEUROCHIR SUPPL, V106, P257, DOI 10.1007/978-3-211-98811-4_48; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Yokosuka K, 2015, J NEUROSURG, V123, P1065, DOI 10.3171/2014.10.JNS14915	8	1	1	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0972-2068	0973-9793		INDIAN J SURG	Indian J. Surg												10.1007/s12262-021-03003-w		JUN 2021	5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SV7MS	WOS:000664004000001					2022-02-06	
J	Kumar, U; Li, L; Bragin, A; Engel, J				Kumar, Udaya; Li, Lin; Bragin, Anatol; Engel, Jerome, Jr.			Spike and wave discharges and fast ripples during posttraumatic epileptogenesis	EPILEPSIA			English	Article						biomarker; epilepsy; fast ripples; posttraumatic epilepsy; spike and wave discharges; traumatic brain injury	HIGH-FREQUENCY OSCILLATIONS; FLUID PERCUSSION INJURY; SPRAGUE-DAWLEY RATS; BRAIN-INJURY; EPILEPSY; PROGRESSION; HIPPOCAMPUS; GENERATION; NEOCORTEX; MODEL	Objective The goal of the present study was to determine whether spike and wave discharges (SWDs) and SWDs with superimposed fast ripples (SWDFRs) could be biomarkers of posttraumatic epileptogenesis. Methods Fluid percussion injury was conducted on 13-14-week old male Sprague Dawley rats. Immediately after traumatic brain injury (TBI), they were implanted with microelectrodes in the neocortex, hippocampus, and striatum bilaterally. Age-matched sham rats with the same electrode implantation montage acted as controls. Wideband brain electrical activity was recorded intermittently from Day 1 of TBI, and continued from 2 to 21 weeks after TBI. SWD and SWDFR analysis was performed during the first 2 weeks to investigate whether the occurrence of this pattern predicted development of epilepsy. The remaining 3-21 weeks were used for identifying which rats became epileptic (E+ group) and which did not (E- group). Results The E+ group (n = 9) showed a significant increase in SWD rate in prefrontal cortex during Weeks 1 and 2 after TBI. The E- group showed a significant increase in SWD rate only in the second week. One hundred percent of rats in the E+ group displayed SWDFRs beginning from the first week after TBI. The SWDFR pattern was observed in all recorded brain areas: prefrontal and perilesional cortices, hippocampus, and striatum. None of rats in the E- group showed coexistence of fast ripples with SWDs. Significance Occurrence of SWDFRs after TBI, but not an increase in the rate of SWDs, could be a noninvasive electroencephalographic biomarker of posttraumatic epileptogenesis.	[Kumar, Udaya; Li, Lin; Bragin, Anatol; Engel, Jerome, Jr.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Li, Lin] Univ North Texas, Dept Biomed Engn, Denton, TX 76203 USA; [Bragin, Anatol; Engel, Jerome, Jr.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA		Bragin, A; Engel, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	abragin@mednet.ucla.edu; engel@ucla.edu		Bragin, Anatol/0000-0003-1207-8481; LI, LIN/0000-0002-9996-9377; Kumar, Udaya/0000-0003-0725-0195	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS033310, R01NS065877, U54NS100064]	National Institutes of Health, Grant/Award Number: R01NS033310, R01NS065877 and U54NS100064	Andrade P, 2018, J NEUROSCI METH, V308, P330, DOI 10.1016/j.jneumeth.2018.08.028; Andrade P, 2017, J NEUROTRAUM, V34, P1482, DOI 10.1089/neu.2016.4675; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Bragin A, 2010, CURR OPIN NEUROL, V23, P151, DOI 10.1097/WCO.0b013e3283373ac8; BUZSAKI G, 1988, NEUROSCIENCE, V26, P735, DOI 10.1016/0306-4522(88)90095-4; BUZSAKI G, 1990, NEUROSCIENCE, V38, P323, DOI 10.1016/0306-4522(90)90031-X; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Engel Jerome Jr, 2018, Epilepsia Open, V3, P120, DOI 10.1002/epi4.12233; Engel J, 2019, NEUROBIOL DIS, V123, P3, DOI 10.1016/j.nbd.2018.04.002; Engel J, 2013, EPILEPSIA, V54, P61, DOI 10.1111/epi.12299; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Kandel A, 1997, J NEUROSCI, V17, P6783; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kobayashi K, 2011, EPILEPSIA, V52, P1812, DOI 10.1111/j.1528-1167.2011.03169.x; Leutgeb JK, 2019, ELIFE, V22, P8; Levesque M, 2018, NEUROSCI LETT, V667, P66, DOI 10.1016/j.neulet.2017.01.047; Li L, 2018, EPILEPSIA, V59, pE51, DOI 10.1111/epi.14041; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Pitkanen A, 1998, TRENDS PHARMACOL SCI, V19, P253; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Pitkanen A, 2010, EPILEPSIA, V51, P2, DOI 10.1111/j.1528-1167.2010.02602.x; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Sheybani L, 2018, J NEUROSCI, V38, P3776, DOI 10.1523/JNEUROSCI.2193-17.2018; Simonato M, 2021, NAT REV NEUROL, V17, P231, DOI 10.1038/s41582-021-00461-4; Staba RJ, 2002, J NEUROPHYSIOL, V88, P1743, DOI 10.1152/jn.2002.88.4.1743; Taylor JA, 2019, J NEUROSCI, V39, P4829, DOI 10.1523/JNEUROSCI.1167-18.2019; Taylor JA, 2017, J NEUROSCI, V37, P5861, DOI 10.1523/JNEUROSCI.3235-16.2017	37	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	AUG	2021	62	8					1842	1851		10.1111/epi.16958		JUN 2021	10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TU9RN	WOS:000663950400001	34155626				2022-02-06	
J	Ross, KA; Fried, JW; Bloom, DA; Gonzalez-Lomas, G				Ross, Keir A.; Fried, Jordan W.; Bloom, David A.; Gonzalez-Lomas, Guillem			The effect of specialization and level of competition on injury in elite male ice hockey players	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						Sports injury; specialization; ice hockey; overuse injury; concussion	ATHLETIC ASSOCIATION MENS; SPORT SPECIALIZATION; HIP; EPIDEMIOLOGY; CONCUSSION; KNOWLEDGE; RATES; RISK	Objective: Young players experience pressure to focus on ice hockey at the exclusion of other sports in order to improve chances of success. Early specialization in other sports has been associated with increased injury without the benefit of improved success. The objective of the current study was to investigate whether earlier specialization results in increased injury without higher rates of career success. This study also aimed to compare rates of injury in athletes at various levels of competition. Methods: An original survey was issued to men's ice hockey players at the junior A, collegiate, and professional levels. The survey consisted of 34 questions on various demographic, specialization, and injury variables. All participants were >18 years of age. Results: The survey was completed by 101 athletes. The mean age at specialization was 13 (+/- 4) overall and 14 (+/- 3), 13 (+/- 4), and 11(+/- 4) for professional, collegiate, and junior players, respectively. There was no difference in age at specialization between each group and professional players did not specialize earlier than the remainder of the cohort as a whole (p > 0.05). There was no significant correlation between age at specialization and total injuries (p > 0.05). There was no difference in concussions causing missed play time between groups (p > 0.05) but professional players had more overall concussions and underwent more surgeries due to hockey-related injuries (p = 0.01). Conclusions: Specializing exclusively in ice hockey earlier in life was not associated with playing professionally. Both collegiate and professional players do not tend to specialize prior to age 12. Age at specialization was not associated with overall number of injuries. Professional players with longer careers appear to sustain more concussions and undergo more surgery.	[Ross, Keir A.; Fried, Jordan W.; Bloom, David A.; Gonzalez-Lomas, Guillem] NYU, Dept Orthoped Surg, Sch Med, New York, NY 10003 USA		Ross, KA (corresponding author), NYU Langone Orthopaed Hosp, 301 E17 St Suite 1402, New York, NY 10003 USA.	keir.ross@nyulangone.org		Ross, Keir/0000-0003-1872-8481; Fried, Jordan/0000-0002-3519-4517; Bloom, David/0000-0002-1457-8378			Bell DR, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0657; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Black S, 2019, SPORTS HEALTH, V11, P64, DOI 10.1177/1941738118800446; Brenner JS, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2148; Brooks MA, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118769836; Chang R, 2009, SPORT BIOMECH, V8, P212, DOI 10.1080/14763140903229534; Dalton SL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116632692; Jayanthi N, 2013, SPORTS HEALTH, V5, P251, DOI 10.1177/1941738112464626; Jayanthi NA, 2015, AM J SPORT MED, V43, P794, DOI 10.1177/0363546514567298; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerbel YE, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118771676; LaPrade RF, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116644241; Lynall RC, 2018, J ATHL TRAINING, V53, P1129, DOI 10.4085/1062-6050-176-17; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McGuine TA, 2017, AM J SPORT MED, V45, P2706, DOI 10.1177/0363546517710213; McLeod TCV, 2011, J ATHL TRAINING, V46, P206, DOI 10.4085/1062-6050-46.2.206; Myer GD, 2015, SPORTS HEALTH, V7, P437, DOI 10.1177/1941738115598747; Padaki Ajay S, 2017, Orthop J Sports Med, V5, p2325967117729147, DOI 10.1177/2325967117729147; Padaki AS, 2017, SPORTS HEALTH, V9, P532, DOI 10.1177/1941738117734149; Pasulka J, 2017, PHYSICIAN SPORTSMED, V45, P344, DOI 10.1080/00913847.2017.1313077; Popkin CA, 2019, J AM ACAD ORTHOP SUR, V27, pE995, DOI 10.5435/JAAOS-D-18-00187; Post EG, 2017, AM J SPORT MED, V45, P1405, DOI 10.1177/0363546517690848; Rosene JM, 2017, AM J SPORT MED, V45, P2622, DOI 10.1177/0363546517710005; Sheppard M, 2020, J ATHL TRAINING, V55, P232, DOI 10.4085/1062-6050-0375-19; Stull JD, 2011, AM J SPORT MED, V39, p29S, DOI 10.1177/0363546511414012; USA Hockey, 2021, 2019 2020 ANN REP; USA Hockey, 2021, 2009 2010 ANN REP	27	1	1	3	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2021.1916786		JUN 2021	6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	SV9VE	WOS:000664165400001	33840376				2022-02-06	
J	Chrisman, SPD; Gomez, D; Kroshus, E; Mayer, CV; Garrett, K; Ramshaw, D; Glang, A				Chrisman, Sara P. D.; Gomez, Douglas; Kroshus, Emily; Mayer, Cecilia, V; Garrett, Kimberly; Ramshaw, Dane; Glang, Ann			Developing a conceptual model of coach concussion communication by adapting the theory of planned behavior and the social ecological model	JOURNAL OF AMERICAN COLLEGE HEALTH			English	Article; Early Access						Coach; sport; concussion; communication; reporting; college; qualitative	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; UNDERSTANDING CONCUSSION; BARRIERS; YOUTH	Objective: Acknowledging that coach communication about concussion increases the likelihood of athletes reporting concussive symptoms, the goal of this study was to examine factors affecting such communication, in order to develop a conceptual model that would inform the design of future educational interventions. Participants: Division I contact sport coaches. Methods: We conducted structured qualitative interviews with coaches and analyzed interviews using Thematic Analysis, viewed through the lens of the Theory of Planned Behavior nested within the Social Ecological Model. Results: Coaches had good knowledge of concussion and understood the dangers of playing with symptoms. However, they also discussed the lack of objective criteria for concussion diagnosis, and pressure to win in order to remain employed, both of which created barriers to concussion communication. Ultimately, most coaches reported not engaging in significant concussion communication as they did not feel this was their role, instead deferring to medical staff. Conclusions: Educational interventions might benefit from a focus on the importance of coach concussion safety-supportive coach communication, with a goal of increasing the likelihood of athlete concussion reporting.	[Chrisman, Sara P. D.; Kroshus, Emily; Mayer, Cecilia, V; Garrett, Kimberly] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,1920 Terry Ave,Cure 03, Seattle, WA 98145 USA; [Chrisman, Sara P. D.; Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Gomez, Douglas; Ramshaw, Dane; Glang, Ann] Univ Oregon, Ctr Brain Injury Res & Training, Eugene, OR USA		Chrisman, SPD (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,1920 Terry Ave,Cure 03, Seattle, WA 98145 USA.	sara.chrisman@seattlechildrens.org		Chrisman, Sara/0000-0001-5373-7223	Pac-12 Student Athlete Health and Well-Being Initiative	This work was made possible by a grant from the Pac-12 Student Athlete Health and Well-Being Initiative.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Goodman A, 2017, J ATHL TRAINING, V52, P23, DOI 10.4085/1062-6050-51.12.24; Holmes P, 2011, J SPORT ECON, V12, P157, DOI 10.1177/1527002510378820; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kuk HS, 2018, ADULT LEARN, V29, P150, DOI 10.1177/1045159518779138; Lininger MR, 2019, J ATHL TRAINING, V54, P21, DOI 10.4085/1062-6050-47-18; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; NCAA Sport Science Institute, 2020, CONC SAF PROT MAN CONC SAF PROT MAN; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2017, NEUROL CLIN, V35, P387, DOI 10.1016/j.ncl.2017.03.009; Scarneo SE, 2019, J ATHL TRAINING, V54, P356, DOI 10.4085/1062-6050-173-18; Slater MD, 2007, COMMUN THEOR, V17, P281, DOI 10.1111/j.1468-2885.2007.00296.x; Welsh DT, 2014, ACAD MANAGE J, V57, P723, DOI 10.5465/amj.2011.1009	27	1	1	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0744-8481	1940-3208		J AM COLL HEALTH	J. Am. Coll. Health												10.1080/07448481.2021.1944166		JUN 2021	8	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	TQ0BU	WOS:000677956200001	34398704				2022-02-06	
J	Moldovan, N; Blaga, II; Billa, S; Hossain, I; Gong, CG; Jones, CE; Murray, TA; Divan, R; Siddiqui, S; Arumugam, PU				Moldovan, Nicolaie; Blaga, Iuliu-Ioan; Billa, Sanjeev; Hossain, Imran; Gong, Chenggong; Jones, Claire E.; Murray, Teresa A.; Divan, Ralu; Siddiqui, Shabnam; Arumugam, Prabhu U.			Brain-implantable multifunctional probe for simultaneous detection of glutamate and GABA neurotransmitters	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Amperometry; Ultramicroelectrode; Neurotransmitter; Microfluidic; Glutamate; GABA	GAMMA-AMINOBUTYRIC-ACID; PERFORMANCE LIQUID-CHROMATOGRAPHY; IMPEDANCE SPECTROSCOPY; MICROELECTRODES; DOPAMINE; ZIRCONIA; SENSOR	Glutamate (GLU) and gamma-aminobutyric acid (GABA) are neurotransmitters (NTs) with an essential role in signal transmission in the brain. Brain disorders, such as epilepsy, Alzheimer?s and Parkinson?s diseases, and traumatic brain injury can be linked to imbalances in the GLU-GABA homeostasis that occurs in sub-second to seconds time frames. Current measurement techniques can detect these two NT concentrations simultaneously only in vitro. The present work reports on the fabrication of a silicon multifunctional biosensor microarray probe for sub-second simultaneous GLU-GABA detection in real-time, with excellent analyte sensitivity and selectivity and in vivo capabilities. The novel Si probes feature four surface-functionalized platinum ultramicroelectrodes (UMEs) for simultaneous amperometric detection of GLU and GABA with a sentinel, and a built-in microfluidic channel for the introduction of neurochemicals in the proximity of the UMEs. The microchannel also allows functioning of an On-Demand In-situ Calibrator that runs in-situ biosensor calibration. The probe exhibited excellent robustness at insertion in agarose-gel brain-tissue-mimicking test, and remarkably high hydrogen peroxide sensitivity (a by-product of GLU-GABA enzyme biosensor) with values on the order of 5000 nA ?M -1 cm -2 and maximum sensitivities of 204 ? 15 nA ?M -1 cm -2 and 37 ? 7 nA ?M -1 cm -2 for GLU and GABA, respectively. Furthermore, the limit of detection of the biosensors reached as low as 7 nM, 165 nM and 750 nM for H 2 O 2, GLU and GABA, respectively and a temporal resolution of hundreds of milliseconds during in vivo studies using freely moving rats.	[Moldovan, Nicolaie; Blaga, Iuliu-Ioan] Alcorix Co, Plainfield, IL 60544 USA; [Billa, Sanjeev; Hossain, Imran; Gong, Chenggong; Arumugam, Prabhu U.] Louisiana Tech Univ, Inst Micromfg IfM, Ruston, LA 71272 USA; [Jones, Claire E.; Murray, Teresa A.; Siddiqui, Shabnam; Arumugam, Prabhu U.] Louisiana Tech Univ, CBERS, Ruston, LA 71272 USA; [Divan, Ralu] Argonne Natl Lab, Ctr Nanoscale Mat, Lemont, IL 60439 USA; [Siddiqui, Shabnam] Louisiana State Univ, Dept Chem & Phys, Shreveport, LA 71115 USA		Moldovan, N (corresponding author), 14047 Franklin Ct, Plainfield, IL 60544 USA.	moldovanl@alcorix.com		Hossain, Md Imran/0000-0002-0308-6052; Murray, Teresa/0000-0002-8857-154X; Moldovan, Nicolaie/0000-0001-5715-4957	National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R41NS115282]; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF) [ECCS1542205]; Materials Research Science and Engineering CenterNational Science Foundation (NSF) [DMR1720139]; State of Illinois; U.S. Department of Energy, Office of Science, Office of Basic Energy SciencesUnited States Department of Energy (DOE) [DEAC0206CH11357]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) under Award Number R41NS115282. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work utilized Northwestern University Micro/Nano Fabrication Facility (NUFAB) , which is partially supported by Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF ECCS1542205) , the Materials Research Science and Engineering Center (DMR1720139) , the State of Illinois, and Northwestern University. The authors also acknowledge the use of the Center for Nanoscale Materials, an Office of Science user facility, supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DEAC0206CH11357.	Alan M.B, 1989, ANAL CHIRNICA ACTA, V216, P777; Amirudin A, 1995, PROG ORG COAT, V26, P1, DOI 10.1016/0300-9440(95)00581-1; Antec Scientific, 2013, 21302001 ANT SCI; Auteri M, 2015, CURR PHARM DESIGN, V21, P4996, DOI 10.2174/1381612821666150914121518; Baily B, 2017, THERMO SCI; Beloborodov IS, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235434; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Cahill PS, 1996, ANAL CHEM, V68, P3180, DOI 10.1021/ac960347d; CAUDILL WL, 1982, J CHROMATOGR, V227, P331, DOI 10.1016/S0378-4347(00)80387-4; de Florio DZ, 1999, SOLID STATE IONICS, V123, P301, DOI 10.1016/S0167-2738(99)00093-4; Doughty PT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69636-1; Dutta G, 2015, J ELECTROANAL CHEM, V756, P61, DOI 10.1016/j.jelechem.2015.08.016; GARGUILO MG, 1994, ANAL CHEM, V66, P2621, DOI 10.1021/ac00089a006; Hascup KN, 2007, FRONT NEUROENG, V1, P407; Hossain I, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00500; KEHR J, 1988, J NEUROCHEM, V51, P1308, DOI 10.1111/j.1471-4159.1988.tb03101.x; Mabrouk OS, 2018, ACS CHEM NEUROSCI, V9, P715, DOI 10.1021/acschemneuro.7b00294; Mazzei F, 1996, ANAL CHIM ACTA, V328, P41, DOI 10.1016/0003-2670(96)00089-X; Miller EM, 2015, J NEUROSCI METH, V252, P75, DOI 10.1016/j.jneumeth.2015.01.018; Monge-Acuna AA, 2009, J NEUROSCI METH, V183, P176, DOI 10.1016/j.jneumeth.2009.06.042; Niwa O, 1998, ANAL CHEM, V70, P89, DOI 10.1021/ac970740z; PAJKOSSY T, 1994, J ELECTROANAL CHEM, V364, P111, DOI 10.1016/0022-0728(93)02949-I; Pervin F., 2010, P SEM ANN C IND IND, P7; Pomfret R, 2013, ANN NEUROSCI, V20, P118, DOI 10.5214/ans.0972.7531.200309; Reinhoud NJ, 2013, ACS CHEM NEUROSCI, V4, P888, DOI 10.1021/cn400044s; Robinson DL, 2008, CHEM REV, V108, P2554, DOI 10.1021/cr068081q; Robinson DL, 2007, FRONT NEUROENG, V1, P17; ROWLEY HL, 1995, J NEUROSCI METH, V57, P93, DOI 10.1016/0165-0270(94)00132-Z; Sandberg S.G, 2010, ADV NEUROSCIENCE ADD, P101; Sekioka N, 2008, SENSOR ACTUAT B-CHEM, V129, P442, DOI 10.1016/j.snb.2007.08.040; Singh Sajal Sagar, 2016, Micro and Nano Systems Letters, V4, DOI 10.1186/s40486-016-0027-5; SMITH S, 1994, J CHROMATOGR B, V652, P228, DOI 10.1016/0378-4347(93)E0391-3; Steil MC, 1997, J ELECTROCHEM SOC, V144, P390, DOI 10.1149/1.1837416; STREIN TG, 1993, ANAL CHEM, V65, P1203, DOI 10.1021/ac00057a017; Tan C, 2020, J ELECTROCHEM SOC, V167, DOI 10.1149/1945-7111/ab6b0b; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; Wang MJ, 2004, BIOSENS BIOELECTRON, V19, P575, DOI 10.1016/S0956-5663(03)00252-5; Watson CJ, 2006, ANAL CHEM, V78, P1391, DOI 10.1021/ac0693722; Weltin A, 2014, BIOSENS BIOELECTRON, V61, P192, DOI 10.1016/j.bios.2014.05.014; Willuhn I, 2010, CURR TOP BEHAV NEURO, V3, P29, DOI 10.1007/7854_2009_27; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696	41	1	1	18	18	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND		0925-4005		SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	JUN 15	2021	337								129795	10.1016/j.snb.2021.129795			8	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Electrochemistry; Instruments & Instrumentation	UO7GS	WOS:000694862100006					2022-02-06	
J	Morledge, MD; Pories, WJ				Morledge, Michael D.; Pories, Walter J.			Bariatric surgery and cognitive impairment	OBESITY			English	Article							BODY-MASS; IMPROVEMENT; HEALTH	Bariatric surgery has been shown to improve cognition in patients with severe obesity. Bariatric surgery may improve mental function in patient populations with obesity and with cognitive impairment, including nonacquired, dementia, and traumatic brain injury, although studies have been limited. Bariatric surgery provides an opportunity to explore the effects of obesity, type 2 diabetes, dyslipidemias, and other expressions of metabolic syndrome on cognition. It offers the unusual opportunity to study patients with these chronic diseases and, later, those without them. This suggests the need for further studies into the effects of bariatric surgery on patient populations with obesity and with cognitive impairment to look at the effects of the continuing metabolic brain damage in people with severe obesity when earlier intervention could be considered.	[Morledge, Michael D.] East Carolina Univ, Dept Psychiat & Behav Med, Brody Sch Med, Greenville, NC 27858 USA; [Pories, Walter J.] East Carolina Univ, Brody Sch Med, Dept Surg, Greenville, NC 27858 USA		Pories, WJ (corresponding author), East Carolina Univ, Brody Sch Med, Dept Surg, Greenville, NC 27858 USA.	pories@ecu.edu		Morledge, Michael/0000-0001-6041-6954			Alosco ML, 2014, AM J SURG, V207, P870, DOI 10.1016/j.amjsurg.2013.05.018; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Cazzo E, 2018, SAO PAULO MED J, V136, P84, DOI 10.1590/1516-3180.2016.0299071216; Daigle CR, 2015, SURG OBES RELAT DIS, V11, P711, DOI 10.1016/j.soard.2015.02.014; Hammond JB, 2020, OBES SURG, V30, P2482, DOI 10.1007/s11695-020-04532-1; Liu, 2017, NEUROSCI BIOBEHAV R, V84; Makaronidis JM, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170910; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McGlennon TW, 2020, OBES SURG, V30, P4704, DOI 10.1007/s11695-020-05065-3; Morledge MD, 2020, OBESITY, V28, P689, DOI 10.1002/oby.22752; O'Brien PD, 2017, LANCET NEUROL, V16, P465, DOI 10.1016/S1474-4422(17)30084-4; Pedditizi E, 2016, AGE AGEING, V45, P14, DOI 10.1093/ageing/afv151; RIMMER JH, 1993, MENT RETARD, V31, P105; Rochette AD, 2016, OBESITY, V24, P1427, DOI 10.1002/oby.21514; Saindane AM, 2020, SURG OBES RELAT DIS, V16, P119, DOI 10.1016/j.soard.2019.09.076; Schmitt AM, 2016, CHANGE BODY MASS IND; Smith ME, 2019, SURG OBES RELAT DIS, V15, P1805, DOI 10.1016/j.soard.2019.08.002; Suemoto CK, 2015, INT J OBESITY, V39, P1383, DOI 10.1038/ijo.2015.83; Thiara G, 2017, PSYCHOSOMATICS, V58, P217, DOI 10.1016/j.psym.2017.02.004; Willeumier K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.67	20	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	AUG	2021	29	8					1239	1241		10.1002/oby.23187		JUN 2021	3	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	TR6GR	WOS:000661292500001	34128341				2022-02-06	
J	Ustaoglu, SG; Ali, MHM; Rakib, F; Blezer, ELA; Van Heijningen, CL; Dijkhuizen, RM; Severcan, F				Ustaoglu, Sebnem Garip; Ali, Mohamed H. M.; Rakib, Fazle; Blezer, Erwin L. A.; Van Heijningen, Caroline L.; Dijkhuizen, Rick M.; Severcan, Feride			Biomolecular changes and subsequent time-dependent recovery in hippocampal tissue after experimental mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; DIFFUSE AXONAL INJURY; IONIZING-RADIATION; FUNCTIONAL ALTERATIONS; HOMOGENATE MEMBRANES; BIOCHEMICAL-CHANGES; LIPID-PEROXIDATION; MODEL MEMBRANES; DAMAGE; RATS	Traumatic brain injury (TBI) is the main cause of disability and mortality in individuals under the age of 45 years. Elucidation of the molecular and structural alterations in brain tissue due to TBI is crucial to understand secondary and long-term effects after traumatic brain injury, and to develop and apply the correct therapies. In the current study, the molecular effects of TBI were investigated in rat brain at 24 h and 1 month after the injury to determine acute and chronic effects, respectively by Fourier transform infrared imaging. This study reports the time-dependent contextual and structural effects of TBI on hippocampal brain tissue. A mild form of TBI was induced in 11-week old male Sprague Dawley rats by weight drop. Band area and intensity ratios, band frequency and bandwidth values of specific spectral bands showed that TBI causes significant structural and contextual global changes including decrease in carbonyl content, unsaturated lipid content, lipid acyl chain length, membrane lipid order, total protein content, lipid/protein ratio, besides increase in membrane fluidity with an altered protein secondary structure and metabolic activity in hippocampus 24 h after injury. However, improvement and/or recovery effects in these parameters were observed at one month after TBI.	[Ustaoglu, Sebnem Garip] Altinbas Univ, Fac Med, Dept Med Biochem, Istanbul, Turkey; [Ali, Mohamed H. M.] Hamad Bin Khalifa Univ HBKU, Qatar Fdn QF, Diabet Res Ctr, Qatar Biomed Res Inst QBRI, POB 34110, Doha, Qatar; [Rakib, Fazle] Qatar Univ, Dept Chem & Earth Sci, Doha, Qatar; [Blezer, Erwin L. A.; Van Heijningen, Caroline L.; Dijkhuizen, Rick M.] Univ Med Ctr Utrecht, Ctr Image Sci, Biomed MR Imaging & Spect Grp, Utrecht, Netherlands; [Severcan, Feride] Altinbas Univ, Fac Med, Dept Biophys, Istanbul, Turkey; [Severcan, Feride] Middle East Tech Univ, Dept Biol Sci, Ankara, Turkey		Ustaoglu, SG (corresponding author), Altinbas Univ, Fac Med, Dept Med Biochem, Istanbul, Turkey.; Ali, MHM (corresponding author), Hamad Bin Khalifa Univ HBKU, Qatar Fdn QF, Diabet Res Ctr, Qatar Biomed Res Inst QBRI, POB 34110, Doha, Qatar.	sebnem.garip@altinbas.edu.tr; moaam@yahoo.com			Qatar National Research Fund (a member of The Qatar Foundation); NPRP Award [7-1648-3-420-4]	This study was supported by Qatar National Research Fund (a member of The Qatar Foundation) with a NPRP Award [7-1648-3-420-4].	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Ali MHM, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8122436; Ali MHM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00647; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Awayda MS, 2004, J GEN PHYSIOL, V123, P709, DOI 10.1085/jgp.200308983; Baloglu FK, 2015, ANALYST, V140, P2205, DOI [10.1039/c4an02008a, 10.1039/C4AN02008A]; Beljebbar A, 2008, ANAL CHEM, V80, P8406, DOI 10.1021/ac800990y; Boskey AL, 2016, J BONE MINER RES, V31, P1070, DOI 10.1002/jbmr.2759; Bozkurt O, 2010, ANALYST, V135, P3110, DOI 10.1039/c0an00542h; Cakmak G, 2016, INT J RADIAT BIOL, V92, P837, DOI 10.1080/09553002.2016.1230237; Cakmak G, 2012, ARCH BIOCHEM BIOPHYS, V520, P67, DOI 10.1016/j.abb.2012.02.012; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Demir P, 2015, APPL SPECTROSC, V69, P154, DOI 10.1366/13-07154; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Elibol-Can B, 2015, BRIT J NUTR, V113, P45, DOI 10.1017/S0007114514003432; Ercole A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00450; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Garip S, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.2.025008; Garip S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.111409; Garip S, 2010, J PHARMACEUT BIOMED, V52, P580, DOI 10.1016/j.jpba.2010.01.044; Gasper R, 2009, BBA-BIOMEMBRANES, V1788, P1263, DOI 10.1016/j.bbamem.2009.02.016; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Hackett MJ, 2016, ANAL CHEM, V88, P10949, DOI 10.1021/acs.analchem.6b02588; Haris PI, 1999, J MOL CATAL B-ENZYM, V7, P207, DOI 10.1016/S1381-1177(99)00030-2; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Heffernan ME, 2013, J NEUROTRAUM, V30, P1007, DOI 10.1089/neu.2012.2366; Heraud P, 2010, NEUROIMAGE, V49, P1180, DOI 10.1016/j.neuroimage.2009.09.053; Kneipp J, 2000, BBA-MOL BASIS DIS, V1501, P189, DOI 10.1016/S0925-4439(00)00021-1; Kumar D, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2019.134347; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Lakshmi RJ, 2002, RADIAT RES, V157, P175, DOI 10.1667/0033-7587(2002)157[0175:TRSFTS]2.0.CO;2; Leskovjan AC, 2010, ANAL CHEM, V82, P2711, DOI 10.1021/ac1002728; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Lou M, 2007, NEUROSCIENCE, V146, P555, DOI 10.1016/j.neuroscience.2007.01.046; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Morisaki S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.116011; Phillips LL, 2014, NEURAL REGEN RES, V9, P362, DOI 10.4103/1673-5374.128237; Rakib F, 2021, SPECTROCHIM ACTA A, V248, DOI 10.1016/j.saa.2020.119189; Redell JB, 2020, EXP NEUROL, V331, DOI 10.1016/j.expneurol.2020.113372; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Sen AN, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031409; Sen I, 2015, APPL SPECTROSC, V69, P679, DOI 10.1366/14-07443; Severcan F, 2005, BBA-BIOMEMBRANES, V1668, P215, DOI 10.1016/j.bbamem.2004.12.009; Severcan F, 1997, BIOSCIENCE REP, V17, P231, DOI 10.1023/A:1027341731230; Sinke MRT, 2021, J NEUROTRAUM, V38, P1642, DOI 10.1089/neu.2020.7151; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Surmacki JM, 2017, ANALYST, V142, P132, DOI 10.1039/c6an02238c; Szalontai B, 2000, BBA-BIOMEMBRANES, V1509, P409, DOI 10.1016/S0005-2736(00)00323-0; Tay LL, 2011, ANALYST, V136, P1620, DOI 10.1039/c0an00897d; Trivedi A, 2019, CELL MOL LIFE SCI, V76, P3141, DOI 10.1007/s00018-019-03176-4; Turker S, 2014, BBA-BIOMEMBRANES, V1838, P3088, DOI 10.1016/j.bbamem.2014.08.025; Ustaoglu SG, 2018, APPL SPECTROSC, V72, P689, DOI 10.1177/0003702817734617; Wang FL, 2019, LEGAL MED-TOKYO, V37, P76, DOI 10.1016/j.legalmed.2019.02.001; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Williamson MR, 2017, STROKE, V48, P195, DOI 10.1161/STROKEAHA.116.015404; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang TT, 2014, J FORENSIC SCI, V59, P231, DOI 10.1111/1556-4029.12290; Zhang J, 2015, J FORENSIC SCI, V60, P759, DOI 10.1111/1556-4029.12743; Zhang JY, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170036	64	1	1	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUN 14	2021	11	1							12468	10.1038/s41598-021-92015-3			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UR4XI	WOS:000696753700055	34127773	gold, Green Published			2022-02-06	
J	Fanelli, A; Ferlauto, L; Zollinger, EG; Brina, O; Reymond, P; Machi, P; Ghezzi, D				Fanelli, Adele; Ferlauto, Laura; Zollinger, Elodie Genevieve; Brina, Olivier; Reymond, Philippe; Machi, Paolo; Ghezzi, Diego			Transient Neurovascular Interface for Minimally Invasive Neural Recording and Stimulation	ADVANCED MATERIALS TECHNOLOGIES			English	Article; Early Access						endovascular device; neural interfaces; polymers; transient neurotechnology	SILICON MICROELECTRODE ARRAYS; BRAIN-TISSUE RESPONSE; ELECTRODE ARRAY; SYSTEMS; FABRICATION; GUIDELINES; POLYMERS; IMPLANTS; PROGRESS; SENSORS	Neural interfaces are used to mitigate the burden of traumatic injuries, neurodegenerative diseases, and mental disorders. However, the transient or permanent placement of an interface in close contact with the neural tissue requires invasive surgery, potentially entailing both short- and long-term complications. To tackle this problem, a transient neurovascular interface for neural recording and stimulation is developed. This endovascular array has been fabricated with facile molding techniques using solely polymeric materials. In vitro experiments have shown promising electrochemical performance for both recording and stimulation, together with a lack of cytotoxicity in cultured cells. The device is compatible with standard endovascular catheters and, once deployed, provide good apposition to a cylindrical structure mimicking a blood vessel. The advantage of this device is twofold. On the one hand, the exploitation of the cerebrovascular system as an access route to the neural tissue avoids invasive surgeries. On the other hand, a transient device may reduce the inflammatory reaction and avoid additional surgeries for removal or replacement. This neurovascular interface combines the benefits of both transient bioelectronics and stent technology in a single device to broaden the range of applications of neural interfaces from neurological diseases and mental disorders to bioelectronics medicine.	[Fanelli, Adele; Ferlauto, Laura; Zollinger, Elodie Genevieve; Ghezzi, Diego] Ecole Polytech Fed Lausanne, Medtron Chair Neuroengn, Ctr Neuroprosthet, Chemin Mines 9, CH-1202 Geneva, Switzerland; [Fanelli, Adele; Ferlauto, Laura; Zollinger, Elodie Genevieve; Ghezzi, Diego] Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Engn, Chemin Mines 9, CH-1202 Geneva, Switzerland; [Brina, Olivier; Reymond, Philippe; Machi, Paolo] Geneva Univ Hosp, Div Neuroradiol, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland		Ghezzi, D (corresponding author), Ecole Polytech Fed Lausanne, Medtron Chair Neuroengn, Ctr Neuroprosthet, Chemin Mines 9, CH-1202 Geneva, Switzerland.; Ghezzi, D (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Engn, Chemin Mines 9, CH-1202 Geneva, Switzerland.	diego.ghezzi@epfl.ch	Ghezzi, Diego/B-7218-2012; Ghezzi, Diego/ABG-7338-2021	Ghezzi, Diego/0000-0002-0554-7510; Ghezzi, Diego/0000-0002-0554-7510; Ferlauto, Laura/0000-0003-2131-6795	Ecole polytechnique federale de Lausanne; MedtronicMedtronic	This work was supported by Ecole polytechnique federale de Lausanne and Medtronic.	Abdalla S, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3458908; Aqrawe Z, 2018, SENSOR ACTUAT B-CHEM, V257, P753, DOI 10.1016/j.snb.2017.11.023; Biessmann L, 2018, ACS APPL MATER INTER, V10, P9865, DOI 10.1021/acsami.8b00446; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138; Bodart C, 2019, ACS APPL MATER INTER, V11, P17226, DOI 10.1021/acsami.9b03088; Boehler C, 2020, NAT PROTOC, V15, DOI 10.1038/s41596-020-0389-2; Borton D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005968; Brown PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026221; Charkhkar H, 2016, ACTA BIOMATER, V32, P57, DOI 10.1016/j.actbio.2015.12.022; Charlot B, 2013, MICROSYST TECHNOL, V19, P895, DOI 10.1007/s00542-012-1696-5; Chen TP, 2020, MATER CHEM PHYS, V242, DOI 10.1016/j.matchemphys.2019.122509; Chen WX, 2017, J BIOMECH, V63, P164, DOI 10.1016/j.jbiomech.2017.09.016; Chevion S., 2006, ANN NY ACAD SCI, V899, P308; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Connes P, 2016, BLOOD REV, V30, P111, DOI 10.1016/j.blre.2015.08.005; Cruz MFP, 2019, I IEEE EMBS C NEUR E, P924, DOI 10.1109/NER.2019.8717009; Dijk G, 2020, ADV MATER TECHNOL-US, V5, DOI 10.1002/admt.201900662; Dong XH, 2018, BIOMATERIALS, V181, P1, DOI 10.1016/j.biomaterials.2018.07.027; Eom SH, 2009, ORG ELECTRON, V10, P536, DOI 10.1016/j.orgel.2009.01.015; Fan JMZ, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00432; Ferlauto L, 2021, BIOMATERIALS, V274, DOI 10.1016/j.biomaterials.2021.120889; Garma LD, 2019, LAB CHIP, V19, P3776, DOI 10.1039/c9lc00636b; Gong F, 2018, PROG ORG COAT, V121, P89, DOI 10.1016/j.porgcoat.2018.04.006; Gong H, 2015, NANOSCALE, V7, P19282, DOI 10.1039/c5nr06081h; Gulino M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00689; Guo Y, 2016, ACS APPL MATER INTER, V8, P26998, DOI 10.1021/acsami.6b08036; Habib CA, 2013, J MAGN RESON IMAGING, V38, P641, DOI 10.1002/jmri.24003; Hakansson A, 2017, J POLYM SCI POL PHYS, V55, P814, DOI 10.1002/polb.24331; Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325; John SE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26457-7; Kang SK, 2016, NATURE, V530, P71, DOI 10.1038/nature16492; Khodagholy D, 2015, NAT NEUROSCI, V18, P310, DOI 10.1038/nn.3905; Khodagholy D, 2011, ADV MATER, V23, pH268, DOI 10.1002/adma.201102378; Kozai TDY, 2015, ACS CHEM NEUROSCI, V6, P48, DOI 10.1021/cn500256e; Li RF, 2018, BIOACT MATER, V3, P322, DOI 10.1016/j.bioactmat.2017.12.001; Lu BY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09003-5; Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007; McMahon S, 2018, PROG POLYM SCI, V83, P79, DOI 10.1016/j.progpolymsci.2018.05.002; Modarresi M, 2020, MACROMOLECULES, V53, P6267, DOI 10.1021/acs.macromol.0c00877; Opie NL, 2018, NAT BIOMED ENG, V2, P907, DOI 10.1038/s41551-018-0321-z; Oxley TJ, 2021, J NEUROINTERV SURG, V13, P102, DOI 10.1136/neurintsurg-2020-016862; Oxley TJ, 2016, NAT BIOTECHNOL, V34, P320, DOI 10.1038/nbt.3428; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Prodanov D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00011; Qiu TY, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00462; Sarode DN, 2019, EXPERT REV MED DEVIC, V16, P603, DOI 10.1080/17434440.2019.1627199; Saxena T, 2013, BIOMATERIALS, V34, P4703, DOI 10.1016/j.biomaterials.2013.03.007; Schander A, 2016, IEEE ENG MED BIO, P6174, DOI 10.1109/EMBC.2016.7592138; Schander A, 2016, SENSOR ACTUAT A-PHYS, V247, P125, DOI 10.1016/j.sna.2016.05.034; Schander A, 2019, IEEE SENS J, V19, P820, DOI 10.1109/JSEN.2018.2880833; Schiavone G, 2020, NEURON, V108, P238, DOI 10.1016/j.neuron.2020.10.010; Sethumadhavan V, 2020, COMMUN CHEM, V3, DOI 10.1038/s42004-020-00404-y; Sharma U, 2018, NAT MATER, V17, P96, DOI [10.1038/NMAT5016, 10.1038/nmat5016]; Shin JH, 2019, NAT BIOMED ENG, V3, P37, DOI 10.1038/s41551-018-0300-4; Someya T, 2016, NATURE, V540, P379, DOI 10.1038/nature21004; Su YC, 2019, TRENDS BIOTECHNOL, V37, P428, DOI 10.1016/j.tibtech.2018.10.009; Szymonowicz M, 2014, ACTA BIOENG BIOMECH, V16, P131, DOI 10.5277/ABB-00055-2014-03; Teo MY, 2019, ACS APPL MATER INTER, V11, P37069, DOI 10.1021/acsami.9b12069; Teplitzky BA, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026011; Thaning EM, 2010, J BIOMED MATER RES B, V93B, P407, DOI 10.1002/jbm.b.31597; Thiriet M., 2015, PANVASCULAR MED, P781, DOI [10.1007/978-3-642-37078-6_32, DOI 10.1007/978-3-642-37078-6_32]; Tzirtzilakis EE, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1978807; Venkatraman S, 2011, IEEE T NEUR SYS REH, V19, P307, DOI 10.1109/TNSRE.2011.2109399; Wang H.-W., 2021, SIGNALS, V2, P138, DOI [10.3390/signals2010012, DOI 10.3390/SIGNALS2010012]; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002	66	1	1	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2365-709X			ADV MATER TECHNOL-US	Adv. Mater. Technol.											2100176	10.1002/admt.202100176		JUN 2021	12	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	SR5ID	WOS:000661074100001		hybrid, Green Published			2022-02-06	
J	Zwirner, J; Lier, J; Franke, H; Hammer, N; Matschke, J; Trautz, F; Tse, R; Ondruschka, B				Zwirner, Johann; Lier, Julia; Franke, Heike; Hammer, Niels; Matschke, Jakob; Trautz, Florian; Tse, Rexon; Ondruschka, Benjamin			GFAP positivity in neurons following traumatic brain injuries	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Glial fibrillary acidic protein; Immunofluorescence; Immunohistochemistry; Neuron; Traumatic brain injury	FIBRILLARY ACIDIC PROTEIN; RADIAL GLIAL-CELLS; INTERMEDIATE-FILAMENTS; PLASMA-LEVELS; EXPRESSION; BIOMARKERS; LIPOFUSCIN; PATHOLOGY; NEUN; IDENTIFICATION	Glial fibrillary acidic protein (GFAP) is a well-established astrocytic biomarker for the diagnosis, monitoring and outcome prediction of traumatic brain injury (TBI). Few studies stated an accumulation of neuronal GFAP that was observed in various brain pathologies, including traumatic brain injuries. As the neuronal immunopositivity for GFAP in Alzheimer patients was shown to cross-react with non-GFAP epitopes, the neuronal immunopositivity for GFAP in TBI patients should be challenged. In this study, cerebral and cerebellar tissues of 52 TBI fatalities and 17 controls were screened for immunopositivity for GFAP in neurons by means of immunohistochemistry and immunofluorescence. The results revealed that neuronal immunopositivity for GFAP is most likely a staining artefact as negative controls also revealed neuronal GFAP staining. However, the phenomenon was twice as frequent for TBI fatalities compared to non-TBI control cases (12 vs. 6%). Neuronal GFAP staining was observed in the pericontusional zone and the ipsilateral hippocampus, but was absent in the contralateral cortex of TBI cases. Immunopositivity for GFAP was significantly correlated with the survival time (r = 0.306, P = 0.015), but no correlations were found with age at death, sex nor the post-mortem interval in TBI fatalities. This study provides evidence that the TBI-associated neuronal immunopositivity for GFAP is indeed a staining artefact. However, an absence post-traumatic neuronal GFAP cannot readily be assumed. Regardless of the particular mechanism, this study revealed that the artefact/potential neuronal immunopositivity for GFAP is a global, rather than a regional brain phenomenon and might be useful for minimum TBI survival time determinations, if certain exclusion criteria are strictly respected.	[Zwirner, Johann] Univ Otago, Dept Anat, Dunedin, New Zealand; [Zwirner, Johann; Ondruschka, Benjamin] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, Hamburg, Germany; [Zwirner, Johann; Trautz, Florian] Univ Leipzig, Inst Legal Med, Leipzig, Germany; [Lier, Julia] Univ Leipzig, Inst Anat, Leipzig, Germany; [Franke, Heike] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany; [Hammer, Niels] Karl Franzens Univ Graz, Inst Macroscop & Clin Anat, Graz, Austria; [Hammer, Niels] Univ Hosp Leipzig, Dept Trauma Orthoped & Plast Surg, Leipzig, Germany; [Hammer, Niels] Fraunhofer Inst Machine Tools & Forming Technol, Dresden, Germany; [Matschke, Jakob] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Tse, Rexon] Auckland City Hosp, Dept Forens Pathol, LabPLUS, Auckland, New Zealand		Zwirner, J (corresponding author), Univ Otago, Dept Anat, Dunedin, New Zealand.; Zwirner, J; Ondruschka, B (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, Hamburg, Germany.; Zwirner, J (corresponding author), Univ Leipzig, Inst Legal Med, Leipzig, Germany.	medijo@gmx.de; b.ondruschka@uke.de	Tse, Rexson/Y-1939-2019	Tse, Rexson/0000-0002-1388-9537; Zwirner, Johann/0000-0002-3560-3915	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.	Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; Andreiuolo F, 2009, NEUROPATHOLOGY, V29, P31, DOI 10.1111/j.1440-1789.2008.00936.x; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; BENDER BL, 1980, ULTRASTRUCT PATHOL, V1, P287, DOI 10.3109/01913128009141432; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Chan Y H, 2003, Singapore Med J, V44, P614; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Double KL, 2008, CELL MOL LIFE SCI, V65, P1669, DOI 10.1007/s00018-008-7581-9; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Emirandetti A, 2006, BRAIN RES, V1095, P35, DOI 10.1016/j.brainres.2006.04.021; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Franke H, IL 6 GFAP COMPELLING; GIMENEZ YRM, 2000, GLIA, V31, P69, DOI DOI 10.1002/(SICI)1098-1136(200007)31:1<69::AID-GLIA70>3.0.C0;2-W; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; GOYAL VK, 1982, EXP GERONTOL, V17, P481, DOI 10.1016/S0531-5565(82)80010-7; Gusel'nikova VV, 2015, ACTA NATURAE, V7, P42, DOI 10.32607/20758251-2015-7-2-42-47; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hernandez ML, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01238; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Li DR, 2009, HISTOL HISTOPATHOL, V24, P1113, DOI 10.14670/HH-24.1113; Li Dong-Ri, 2006, Legal Medicine, V8, P78, DOI 10.1016/j.legalmed.2005.09.002; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Lier J, 2020, INT J LEGAL MED, V134, P2187, DOI 10.1007/s00414-020-02308-x; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; Middeldorp J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007663; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Ondruschka B, 2019, INT J LEGAL MED, V133, P871, DOI 10.1007/s00414-018-1925-2; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Ottis P, 2012, PROTEOMICS, V12, P2445, DOI 10.1002/pmic.201100668; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; REMMELE W, 1987, PATHOLOGE, V8, P138; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Trautz F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48145-w; Trautz F, 2018, INT J LEGAL MED, V132, P1103, DOI 10.1007/s00414-017-1767-3; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; Woydt L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31252-5; ZELENIKA D, 1995, MOL BRAIN RES, V30, P251, DOI 10.1016/0169-328X(95)00010-P; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	55	1	1	3	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	NOV	2021	135	6					2323	2333		10.1007/s00414-021-02568-1		JUN 2021	11	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	WI7DG	WOS:000659793700001	34114049	hybrid, Green Published			2022-02-06	
J	Hogeveen, J; Aragon, DF; Rogge-Obando, K; Campbell, RA; Shuttleworth, CW; Avila-Rieger, RE; Yeo, RA; Wilson, JK; Fratzke, V; Brandt, E; Story-Remer, J; Gill, D; Mayer, AR; Cavanagh, JF; Quinn, DK				Hogeveen, Jeremy; Aragon, Denicia F.; Rogge-Obando, Kimberly; Campbell, Richard A.; Shuttleworth, C. William; Avila-Rieger, Rebecca E.; Yeo, Ronald A.; Wilson, J. Kevin; Fratzke, Violet; Brandt, Emma; Story-Remer, Jacqueline; Gill, Darbi; Mayer, Andrew R.; Cavanagh, James F.; Quinn, Davin K.			Ventromedial Prefrontal-Anterior Cingulate Hyperconnectivity and Resilience to Apathy in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						anterior cingulate cortex; apathy; hyperconnectivity; traumatic brain injury; ventromedial prefrontal cortex	FUNCTIONAL CONNECTIVITY; REWARD; CORTEX; AMYGDALA; MOTION; SEGMENTATION; STIMULATION; EXPECTATION; DEPRESSION; DOPAMINE	Apathy is a common and impairing sequela of traumatic brain injury (TBI). Yet, little is known about the neural mechanisms determining in which patients apathy does or does not develop post-TBI. We aimed to elucidate the impact of TBI on motivational neural circuits and how this shapes apathy over the course of TBI recovery. Resting-state functional magnetic resonance imaging data were collected in patients with subacute mild TBI (n = 44), chronic mild-to-moderate TBI (n = 26), and nonbrain-injured control participants (CTRL; n = 28). We measured ventromedial prefrontal cortex (vmPFC) functional connectivity (FC) as a function of apathy, using an a priori vmPFC seed adopted from a motivated decision-making study in an independent TBI study cohort. Patients reported apathy using a well-validated tool for assaying apathy in TBI. The vmPFC-to-wholebrain FC was contrasted between groups, and we fit regression models with apathy predicting vmPFC FC. Subacute and chronic TBI caused increased apathy relative to CTRL, replicating previous work suggesting that apathy has an enduring impact in TBI. The vmPFC was functionally connected to the canonical default network, and this architecture did not differ between subacute TBI, chronic TBI, and CTRL groups. Critically, in TBI, increased apathy scores predicted decreased vmPFC-dorsal anterior cingulate cortex (dACC) FC. Last, we subdivided the TBI group based on patients above versus below the threshold for "clinically significant apathy," finding that TBI patients with clinically significant apathy demonstrated comparable vmPFC-dACC FC to CTRLs, whereas TBI patients with subthreshold apathy scores demonstrated vmPFC-dACC hyperconnectivity relative to both CTRLs and patients with clinically significant apathy. Post-TBI vmPFC-dACC hyperconnectivity may represent an adaptive compensatory response, helping to maintain motivation and enabling resilience to the development of apathy after neurotrauma. Given the role of vmPFC-dACC circuits in value-based decision making, rehabilitation strategies designed to improve this ability may help to reduce apathy and improve functional outcomes in TBI.	[Hogeveen, Jeremy; Aragon, Denicia F.; Rogge-Obando, Kimberly; Avila-Rieger, Rebecca E.; Yeo, Ronald A.; Mayer, Andrew R.; Cavanagh, James F.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Hogeveen, Jeremy; Aragon, Denicia F.; Rogge-Obando, Kimberly; Avila-Rieger, Rebecca E.; Yeo, Ronald A.; Mayer, Andrew R.; Cavanagh, James F.] Univ New Mexico, Psychol Clin Neurosci Ctr, Albuquerque, NM 87131 USA; [Campbell, Richard A.; Fratzke, Violet; Story-Remer, Jacqueline; Gill, Darbi; Mayer, Andrew R.; Quinn, Davin K.] Univ New Mexico, Sch Med, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA; [Shuttleworth, C. William; Wilson, J. Kevin; Brandt, Emma] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Avila-Rieger, Rebecca E.; Fratzke, Violet] Clemson Univ, Coll Educ, Clemson, SC USA; [Story-Remer, Jacqueline] Rosalind Franklin Univ, Chicago Med Sch, N Chicago, IL USA; [Mayer, Andrew R.] Mind Res Network LBERI, Albuquerque, NM USA		Hogeveen, J (corresponding author), Univ New Mexico, Logan Hall,MSC03 2220, Albuquerque, NM 87131 USA.	jhogeveen@unm.edu			National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089]	This research was funded by the National Institute of General Medical Sciences (P20GM109089, PI: CWS).	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Broadway JM, 2019, CORTEX, V120, P240, DOI 10.1016/j.cortex.2019.06.011; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Camille N, 2011, J NEUROSCI, V31, P15048, DOI 10.1523/JNEUROSCI.3164-11.2011; Camus M, 2009, EUR J NEUROSCI, V30, P1980, DOI 10.1111/j.1460-9568.2009.06991.x; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Chong TTJ, 2015, CORTEX, V69, P40, DOI 10.1016/j.cortex.2015.04.003; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delgado MR, 2008, NAT NEUROSCI, V11, P880, DOI 10.1038/nn.2141; Drew DS, 2020, BRAIN, V143, P2502, DOI 10.1093/brain/awaa198; Esteban O., 2018, Software, DOI [10.5281/zenodo.852659, DOI 10.5281/ZENODO.852659]; Esteban O, 2019, NAT METHODS, V16, P111, DOI 10.1038/s41592-018-0235-4; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fonov V., 2009, NEUROIMAGE, V47, pS102; Gordon EM, 2017, NEURON, V95, P791, DOI 10.1016/j.neuron.2017.07.011; Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013; Gorgolewski KJ, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.44; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grace J, 2001, FRSBE FRONTAL SYSTEM; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Guild EB, 2015, J INT NEUROPSYCH SOC, V21, P650, DOI 10.1017/S1355617715000600; Heudiconv, DOCUMENTATION; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hogeveen J, 2018, BIOL PSYCHIAT, V84, P287, DOI 10.1016/j.biopsych.2018.01.015; Hogeveen J, 2017, CEREB CORTEX, V27, P1401, DOI 10.1093/cercor/bhv317; Howard JD, 2020, CURR BIOL, V30, P490, DOI 10.1016/j.cub.2019.12.007; Huntenburg J.M, 2014, 20 ANN M ORG HUM BRA; Husain M, 2018, NAT REV NEUROSCI, V19, P470, DOI 10.1038/s41583-018-0029-9; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kearney-Ramos TE, 2018, BIOL PSYCHIAT-COGN N, V3, P599, DOI 10.1016/j.bpsc.2018.03.016; Kirsch-Darrow L, 2011, J INT NEUROPSYCH SOC, V17, P1058, DOI 10.1017/S1355617711001068; Klein A, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005350; Klein-Flugge MC, 2016, J NEUROSCI, V36, P10002, DOI 10.1523/JNEUROSCI.0292-16.2016; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuhn M., PACKAGE CARET; Lanczos C., 1964, J SOC IND APPL MAT B, V1, P76, DOI [10.1137/0701007, DOI 10.1137/0701007]; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Le Heron C, 2018, NEUROPSYCHOLOGIA, V118, P54, DOI 10.1016/j.neuropsychologia.2017.07.003; Madhyastha T.M, 2017, FRONT NEUROINFORM, P11; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Muhammed K, 2016, BRAIN, V139, P2706, DOI 10.1093/brain/aww188; Nieto-Castanon A., NITRC CONN FUNCTIONA; Nieto-Castanon A., 2017, CONN FMRI FUNCTIONAL; Notter MP., 2018, NIPYPE SOFTWARE, DOI 10.5281/zenodo.596855; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Ray S, 2014, HUM BRAIN MAPP, V35, P6032, DOI 10.1002/hbm.22603; Satterthwaite TD, 2013, NEUROIMAGE, V83, P45, DOI 10.1016/j.neuroimage.2013.06.045; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Song, 2009, INSIGHT J, V2, P1; Starkstein SE, 2005, J NEUROL NEUROSUR PS, V76, P1070, DOI 10.1136/jnnp.2004.052795; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Taylor CT, 2014, SOC COGN AFFECT NEUR, V9, P1379, DOI 10.1093/scan/nst128; Team, 2013, R LANG ENV STAT COMP, V20; Treiber JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152472; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Worthington A, 2018, NEUROPSYCHOLOGIA, V118, P40, DOI 10.1016/j.neuropsychologia.2018.04.012; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	72	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2021	38	16					2264	2274		10.1089/neu.2020.7363		JUN 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TY0QY	WOS:000660114200001	33787328				2022-02-06	
J	Kureshi, N; Erdogan, M; Thibault-Halman, G; Fenerty, L; Green, RS; Clarke, DB				Kureshi, Nelofar; Erdogan, Mete; Thibault-Halman, Ginette; Fenerty, Lynne; Green, Robert S.; Clarke, David B.			Long-Term Trends in the Epidemiology of Major Traumatic Brain Injury	JOURNAL OF COMMUNITY HEALTH			English	Article						Traumatic brain injury; Epidemiology; Falls; Motor vehicle collisions		Traumatic brain injury (TBI) is a leading cause of death and disability among adults. Falls and motor vehicle collisions (MVCs) are the most common causes of TBI hospitalizations in Canada. The purpose of this study was to determine whether, at the provincial level, there have been significant changes in the injury rate and causes of major TBI. This was a retrospective cohort study of all patients in Nova Scotia who presented with major TBI (Abbreviated Injury Scale Head score >= 3) between 2002 and 2018. Prospectively entered data were collected from the Nova Scotia Trauma Registry. Annual injury rates were calculated based on 100,000 population (all ages) using population estimates from Statistics Canada. Linear regression was performed to analyze annual trends of major TBI within the province. There were 5590 major TBI patients in Nova Scotia during the 16-year study period. The overall annual rate of major TBI was 37 per 100,000 population. There was a 39% increase in the rate of major TBI over the study period (r = - 0.72, R2 = 0.51, p < 0.002). Patients had a mean age of 51 +/- 25 years; 72% were male. The proportion of TBIs in males decreased significantly from 76% in 2002 to 69% in 2017 (p < 0.001). Mechanisms of injury were predominantly falls (45%) and MVCs (29%); the proportion of violent injuries was 11.5%. The rate of fall-related TBIs more than doubled between 2002 and 2017, increasing from 9.1 to 20.5 injuries per 100,000 (p < 0.001). Our findings demonstrate an increasing incidence of major TBI over a 16-year period with a greater than two-fold increase in the rate of fall-related TBI. These results are important for targeting TBI prevention efforts in reducing falls, especially in older adults.	[Kureshi, Nelofar; Thibault-Halman, Ginette; Fenerty, Lynne; Clarke, David B.] Dalhousie Univ, Div Neurosurg, QEII Hlth Sci Ctr, Halifax, NS, Canada; [Erdogan, Mete; Green, Robert S.] Nova Scotia Hlth, Trauma Nova Scotia, Halifax, NS, Canada; [Green, Robert S.] Dalhousie Univ, Dept Crit Care Med, Halifax, NS, Canada; [Green, Robert S.] Dalhousie Univ, Dept Emergency Med, Halifax, NS, Canada; [Clarke, David B.] Dalhousie Univ, Brain Repair Ctr, Halifax, NS, Canada		Clarke, DB (corresponding author), Dalhousie Univ, Div Neurosurg, QEII Hlth Sci Ctr, Halifax, NS, Canada.; Clarke, DB (corresponding author), Dalhousie Univ, Brain Repair Ctr, Halifax, NS, Canada.	nelofar.kureshi@nshealth.ca; mete.erdogan@nshealth.ca; ginette.thibault-halman@nshealth.ca; lynne.fenerty@nshealth.ca; rsgreen@dal.ca; d.clarke@dal.ca					Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Phillips LA, 2009, CAN J NEUROL SCI, V36, P605, DOI 10.1017/S0317167100008118; Public Health Agency of Canada, 2020, INJ REV 2020 ED SPOT; Quaglio G, 2017, LANCET NEUROL, V16, P951, DOI 10.1016/S1474-4422(17)30370-8; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	15	1	1	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0094-5145	1573-3610		J COMMUN HEALTH	J. Community Health	DEC	2021	46	6					1197	1203		10.1007/s10900-021-01005-z		JUN 2021	7	Health Policy & Services; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	WY5UA	WOS:000659404400002	34106371				2022-02-06	
J	Mayer, AR; Ling, JM; Dodd, AB; Rannou-Latella, JG; Stephenson, DD; Dodd, RJ; Mehos, CJ; Patton, DA; Cullen, DK; Johnson, VE; Reddy, SP; Robertson-Benta, CR; Gigliotti, AP; Meier, TB; Vermillion, MS; Smith, DH; Kinsler, R				Mayer, Andrew R.; Ling, Josef M.; Dodd, Andrew B.; Rannou-Latella, Julie G.; Stephenson, David D.; Dodd, Rebecca J.; Mehos, Carissa J.; Patton, Declan A.; Cullen, D. Kacy; Johnson, Victoria E.; Pabbathi Reddy, Sharvani; Robertson-Benta, Cidney R.; Gigliotti, Andrew P.; Meier, Timothy B.; Vermillion, Meghan S.; Smith, Douglas H.; Kinsler, Rachel			Reproducibility and Characterization of Head Kinematics During a Large Animal Acceleration Model of Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; large animal model; dynamic acceleration; head kinematics; sensors; diffuse axonal injuries	AMYLOID PRECURSOR PROTEIN; DIFFUSE AXONAL INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; SWINE MODEL; MESSENGER-RNA; UP-REGULATION; INTRACRANIAL HEMORRHAGE; CEREBRAL CONCUSSION; IMPACT MODEL; BLOOD-FLOW	Acceleration parameters have been utilized for the last six decades to investigate pathology in both human and animal models of traumatic brain injury (TBI), design safety equipment, and develop injury thresholds. Previous large animal models have quantified acceleration from impulsive loading forces (i.e., machine/object kinematics) rather than directly measuring head kinematics. No study has evaluated the reproducibility of head kinematics in large animal models. Nine (five males) sexually mature Yucatan swine were exposed to head rotation at a targeted peak angular velocity of 250 rad/s in the coronal plane. The results indicated that the measured peak angular velocity of the skull was 51% of the impulsive load, was experienced over 91% longer duration, and was multi- rather than uni-planar. These findings were replicated in a second experiment with a smaller cohort (N = 4). The reproducibility of skull kinematics data was mostly within acceptable ranges based on published industry standards, although the coefficients of variation (8.9% for peak angular velocity or 12.3% for duration) were higher than the impulsive loading parameters produced by the machine (1.1 vs. 2.5%, respectively). Immunohistochemical markers of diffuse axonal injury and blood-brain barrier breach were not associated with variation in either skull or machine kinematics, suggesting that the observed levels of variance in skull kinematics may not be biologically meaningful with the current sample sizes. The findings highlight the reproducibility of a large animal acceleration model of TBI and the importance of direct measurements of skull kinematics to determine the magnitude of angular velocity, refine injury criteria, and determine critical thresholds.	[Mayer, Andrew R.; Ling, Josef M.; Dodd, Andrew B.; Rannou-Latella, Julie G.; Stephenson, David D.; Dodd, Rebecca J.; Pabbathi Reddy, Sharvani; Robertson-Benta, Cidney R.; Gigliotti, Andrew P.; Vermillion, Meghan S.] Lovelace Biomed Res Inst, Mind Res Network, Albuquerque, NM 87108 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Sch Med, Albuquerque, NM 87131 USA; [Mehos, Carissa J.] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Patton, Declan A.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Cullen, D. Kacy; Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cullen, D. Kacy; Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Penn Ctr Brain Injury & Repair, Perelman Sch Med, Philadelphia, PA 19104 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Kinsler, Rachel] US Army, Enroute Care Grp, Aeromed Res Lab, Ft Rucker, AL USA		Mayer, AR (corresponding author), Lovelace Biomed Res Inst, Mind Res Network, Albuquerque, NM 87108 USA.; Mayer, AR (corresponding author), Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA.; Mayer, AR (corresponding author), Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA.; Mayer, AR (corresponding author), Univ New Mexico, Dept Psychol, Sch Med, Albuquerque, NM 87131 USA.	amayer@mrn.org			Department of DefenseUnited States Department of Defense [W81XWH-17-2-0052]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of theNational Institutes of HealthGeneral Electric [P20GM109089]	This research was supported by a grant from the Department of Defense (W81XWH-17-2-0052) to AM. Histological analysis was performed by the Preclinical Core Facility at the University of New Mexico Center for Brain Recovery and Repair, which was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of theNational Institutes of Health under grant number P20GM109089.	Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Atlan LS, 2018, J NEUROSCI RES, V96, P536, DOI 10.1002/jnr.24108; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Byard RW, 2012, J FORENSIC SCI, V57, P973, DOI 10.1111/j.1556-4029.2012.02109.x; Byard Roger W, 2009, Leg Med (Tokyo), V11 Suppl 1, pS128, DOI 10.1016/j.legalmed.2009.02.001; Carstensen B, 2010, COMP CLIN MEASUREMEN, P107; Cecil KM, 1998, J NEUROCHEM, V70, P2038; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Clevenger AC, 2015, J NEUROTRAUM, V32, P120, DOI 10.1089/neu.2014.3570; Coats B, 2017, J NEUROTRAUM, V34, P235, DOI 10.1089/neu.2015.4352; Coats B, 2010, INVEST OPHTH VIS SCI, V51, P4792, DOI 10.1167/iovs.10-5211; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Eastmond DA, 2013, CRIT REV TOXICOL, V43, P611, DOI 10.3109/10408444.2013.822844; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; FAAS FH, 1968, J NEUROSURG, V28, P137, DOI 10.3171/jns.1968.28.2.0137; Finnie JW, 2003, AUST VET J, V81, P153, DOI 10.1111/j.1751-0813.2003.tb11078.x; Friess SH, 2012, LAB ANIM-UK, V46, P164, DOI 10.1258/la.2011.011084; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2015, J NEUROTRAUM, V32, P237, DOI 10.1089/neu.2014.3468; Friess SH, 2012, CRIT CARE MED, V40, P2400, DOI 10.1097/CCM.0b013e31825333e6; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Galgano M., 2015, J NEUROL NEUROBIOL, V2, P117, DOI [10. 16966/2379-7150.117, DOI 10.16966/2379-7150.117, 10.16966/2379-7150.117]; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gill J. L., 1978, Design and Analysis of Experiments in the Animal and Medical Sciences, V1; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; GRUBB RL, 1970, J NEUROSURG, V32, P320, DOI 10.3171/jns.1970.32.3.0320; Hajiaghamemar M, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4046393; Holbourn AHS, 1943, LANCET, V2, P438; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Ibrahim NG, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000956; Jaber SM, 2015, DEV NEUROPSYCHOL, V40, P34, DOI 10.1080/87565641.2014.969733; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; KANDA R, 1981, Neurologia Medico-Chirurgica, V21, P645; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Keating CE, 2020, J NEUROTRAUM, V37, P1918, DOI 10.1089/neu.2019.6738; Kilbaugh TJ, 2016, MITOCHONDRION, V26, P19, DOI 10.1016/j.mito.2015.11.001; Kilbaugh TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130927; Kimura H, 1996, J COMPUT ASSIST TOMO, V20, P540, DOI 10.1097/00004728-199607000-00007; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Masuda M., 2008, REPEATABILITY SENSIT; MASUZAWA H, 1976, Neurologia Medico-Chirurgica, V16, P77, DOI 10.2176/nmc.16pt1.77; Mayer AR., 2020, SHOCK, V2019, P24, DOI [10.1016/j.neubiorev.2019.06.024, DOI 10.1016/J.NEUBIOREV.2019.06.024]; McNamara EH, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113409; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sano K, 1967, Neurol Med Chir (Tokyo), V9, P21, DOI 10.2176/nmc.9.21; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Society of Automotive Engineers, 2014, J2111 SAE; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Van den Heuvel C, 2000, J NEUROTRAUM, V17, P1041, DOI 10.1089/neu.2000.17.1041; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van den Heuvel C, 2004, J NEUROTRAUM, V21, P1562, DOI 10.1089/0897715042441783; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; Van den Heuvel C, 2000, J CLIN NEUROSCI, V7, P140; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Vink R, 2008, ACTA NEUROCHIR SUPPL, V102, P189, DOI 10.1007/978-3-211-85578-2_37; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Wojnarowicz MW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00240; Wolf JA, 2017, J NEUROTRAUM, V34, P2303, DOI 10.1089/neu.2016.4848; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814	85	1	1	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 9	2021	12								658461	10.3389/fneur.2021.658461			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SY4AU	WOS:000665832900001	34177763	gold, Green Published			2022-02-06	
J	Carlsson, A; Horion, S; Davidsson, J; Schick, S; Linder, A; Hell, W; Svensson, MY				Carlsson, Anna; Horion, Stefan; Davidsson, Johan; Schick, Sylvia; Linder, Astrid; Hell, Wolfram; Svensson, Mats Y.			Dynamic Responses of Female Volunteers in Rear Impact Sled Tests at Two Head Restraint Distances	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						crash testing; females; soft tissue neck injury; rear impact; sled testing; vehicle safety; volunteers; whiplash	NECK; DUMMY	The objective of this study was to assess the biomechanical and kinematic responses of female volunteers with two different head restraint (HR) configurations when exposed to a low-speed rear loading environment. A series of rear impact sled tests comprising eight belted, near 50th percentile female volunteers, seated on a simplified laboratory seat, was performed with a mean sled acceleration of 2.1 g and a velocity change of 6.8 km/h. Each volunteer underwent two tests; the first test configuration, HR10, was performed at the initial HR distance similar to 10 cm and the second test configuration, HR15, was performed at similar to 15 cm. Time histories, peak values and their timing were derived from accelerometer data and video analysis, and response corridors were also generated. The results were separated into three different categories, HR10(C) (N = 8), HR15(C) (N = 6), and HR15(N)(C) (N = 2), based on: (1) the targeted initial HR distance [10 cm or 15 cm] and (2) whether the volunteers' head had made contact with the HR [Contact (C) or No Contact (NC)] during the test event. The results in the three categories deviated significantly. The greatest differences were found for the average peak head angular displacements, ranging from 10 degrees to 64 degrees. Furthermore, the average neck injury criteria (NIC) value was 22% lower in HR10(C) (3.9 m(2)/s(2)), and 49% greater in HR15(N)(C) (7.4 m(2)/s(2)) in comparison to HR15(C) (5.0 m(2)/s(2)). This study supplies new data suitable for validation of mechanical or mathematical models of a 50th percentile female. A model of a 50th percentile female remains to be developed and is urgently required to complement the average male models to enhance equality in safety assessments. Hence, it is important that future protection systems are developed and evaluated with female properties taken into consideration too. It is likely that the HR15 test configuration is close to the limit for avoiding HR contact for this specific seat setup. Using both datasets (HR15(C) and HR15(N)(C)), each with its corresponding HR contact condition, will be possible in future dummy or model evaluation.	[Carlsson, Anna] Chalmers Ind Technol Chalmers Ind Tekn, Gothenburg, Sweden; [Horion, Stefan; Schick, Sylvia; Hell, Wolfram] Ludwig Maximilian Univ LMU, Inst Legal Med, Munich, Germany; [Davidsson, Johan; Linder, Astrid; Svensson, Mats Y.] Chalmers Univ Techno, Vehicle Safety Div, Gothenburg, Sweden; [Linder, Astrid] Swedish Natl Rd & Transport Res Inst VTI, Gothenburg, Sweden		Carlsson, A (corresponding author), Chalmers Ind Technol Chalmers Ind Tekn, Gothenburg, Sweden.	anna.carlsson@chalmers.se		Carlsson, Anna/0000-0002-3216-8145	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [233904]; European Union Horizon 2020 Research and Innovation Programme [768960]; Folksams Forskningsstiftelse, Sweden	This study was part of the ADSEAT (Adaptive Seat to Reduce Neck Injuries for Female and Male Occupants) project funded by the European Commission, Project No. 233904. The data was adapted for evaluation tasks in the project VIRTUAL (Open Access Virtual Testing Protocols for Enhanced Road User Safety) that has received funding from the European Union Horizon 2020 Research and Innovation Programme under Grant Agreement No. 768960. The writing of this paper was funded by Folksams Forskningsstiftelse, Sweden.	Bostrom O, 2000, ACCIDENT ANAL PREV, V32, P321, DOI 10.1016/S0001-4575(99)00105-0; Carlsson A, 2012, THESIS CHALMERS U TE; Carlsson A, 2017, TRAFFIC INJ PREV, V18, P398, DOI 10.1080/15389588.2016.1217522; Carlsson A, 2014, TRAFFIC INJ PREV, V15, P855, DOI 10.1080/15389588.2014.885647; Carlsson A, 2012, TRAFFIC INJ PREV, V13, P378, DOI 10.1080/15389588.2012.659362; Carlsson A, 2011, TRAFFIC INJ PREV, V12, P347, DOI 10.1080/15389588.2011.585408; Carstensen TBW, 2012, EUR J PAIN, V16, P49, DOI 10.1016/j.ejpain.2011.06.002; Chapline JF, 2000, ACCIDENT ANAL PREV, V32, P287, DOI 10.1016/S0001-4575(99)00126-8; Davidsson J., 1999, P 43 STAPP CAR CRASH P 43 STAPP CAR CRASH; Davidsson J., 1998, P IRCOBI C GOT; Gustafsson M, 2015, TRAFFIC INJ PREV, V16, P353, DOI 10.1080/15389588.2014.940459; Haland Y., 1996, P IRCOBI C, P123; Jakobsson L, 2000, ACCIDENT ANAL PREV, V32, P307, DOI 10.1016/S0001-4575(99)00107-4; Kihlberg J.K., 1969, P 13 AAAM C MINN MN; Krafft M., 2002, TRAFFIC INJ PREV, V3, P141, DOI [10.1080/15389580212001, DOI 10.1080/15389580212001]; Krafft Maria, 2003, Traffic Inj Prev, V4, P136, DOI 10.1080/15389580309862; Kullgren A., 2020, P IRCOBI C 2020; Kullgren A., 2010, P IRCOBI C HAN; Kullgren A., 2007, P 20 ESV C LYON, DOI [10.1080/15389580212001, DOI 10.1080/15389580212001]; Linder A, 2019, INTERDISCIPL SCI REV, V44, P140, DOI 10.1080/03080188.2019.1603870; Linder A, 2008, TRAFFIC INJ PREV, V9, P592, DOI 10.1080/15389580802384669; Mordaka J., 2003, ACTA POLITECHNICA, V43, P47; Morris AP, 1996, STAPP CAR C, VP-30, P317; Moss S., 2000, SAE TECHNICAL PAPER; ONEILL B, 1972, AM J PUBLIC HEALTH N, V62, P399, DOI 10.2105/AJPH.62.3.399; Ono K., 2006, IRCOBI C MADR; OTREMSKI I, 1989, INJURY, V20, P349, DOI 10.1016/0020-1383(89)90011-9; Park J, 2018, TRAFFIC INJ PREV, V19, P825, DOI 10.1080/15389588.2018.1524889; Philippens M, 2002, Stapp Car Crash J, V46, P461; Robbins D.H, 1983, UMTRI 83533; Robbins D.H., 1983, UMTRI83532; Schick S., 2008, P 2 INT C TUV SUD WH; Schneider L.W., 1983, UMTRI83531; Siegmund G.P., 1997, P 41 STAPP CAR CRASH; Siegmund GP, 2003, J BIOMECH, V36, P473, DOI 10.1016/S0021-9290(02)00458-X; Storvik Steven G, 2009, Biomed Sci Instrum, V45, P244; Temming J., 1998, P IRCOBI C GOT; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Viano David C, 2003, Traffic Inj Prev, V4, P228, DOI 10.1080/15389580309880; Welsh R., 2001, P 45 AAAM C SAN ANT	40	1	1	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	JUN 8	2021	9								684003	10.3389/fbioe.2021.684003			11	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	SV6JD	WOS:000663925700001	34169067	gold, Green Published			2022-02-06	
J	Huang, L; He, SL; Cai, Q; Li, F; Wang, SW; Tao, K; Xi, Y; Qin, HZ; Gao, GD; Feng, DY				Huang, Lu; He, Shulei; Cai, Qing; Li, Fei; Wang, Siwei; Tao, Kai; Xi, Ye; Qin, Huaizhou; Gao, Guodong; Feng, Dayun			Polydatin alleviates traumatic brain injury: Role of inhibiting ferroptosis	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Polydatin; Ferroptosis; TBI; GPx4		Secondary injury is the main cause of high mortality and poor prognosis of TBI, which has recently been suggested to be related to ferroptosis. Polydatin, a monocrystalline compound extracted from the rhizome of Polygonum, has been shown to exert potential neuroprotective effects. However, its role and mechanism in the secondary injury of TBI has not been elucidated. In this study, the inhibition of Polydatin on ferroptosis was observed both in the hemoglobin treated Neuro2A cells in vitro and in TBI mouse model in vivo, characterized by reversion of accumulation or deposition of free Fe-2(+), increased content of MDA, decreased activity of key REDOX enzyme GPx4, cell death and tissues loss. Although Polydatin corrected the increased mRNA levels of ferroptosis signaling molecules GPX4, SLC7A11, PTGS2, and ATP5G3 after TBI, TBI and Polydatin treatment had no significant effect on their protein expression. Notably, Polydatin could completely reverse the decrease of GPx4 activity after TBI in vivo and in vitro, and the effect was stronger than that of the classical ferroptosis inhibitor FER-1 in vitro. Further, Polydatin has been shown to reduce the severity of acute neurological impairment and significantly improve subacute motor dysfunction in TBI mice. Our findings provided translational insight into neuroprotection with Polydatin in TBI by inhibiting ferroptosis mainly depending on the maintenance of GPx4 activity. (C) 2021 Published by Elsevier Inc.	[Huang, Lu; He, Shulei; Cai, Qing; Li, Fei; Qin, Huaizhou; Gao, Guodong; Feng, Dayun] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Peoples R China; [Wang, Siwei] Xian Univ Sci & Technol, Sch Safety Sci & Engn, Xian 710038, Peoples R China; [Tao, Kai] Gen Hosp Western Theater Command, Dept Emergency, Chengdu 610083, Peoples R China; [Xi, Ye] Fourth Mil Med Univ, Sch Basic Med, Dept Neurobiol, Xian 710038, Peoples R China		Qin, HZ; Gao, GD; Feng, DY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Peoples R China.	tdfengdy@fmmu.edu.cn	XI, YE/AAU-9149-2021		National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [819711229, 81771245]	This work was supported by the National Science Foundation of China [grant number: 819711229 and 81771245].	Angeli JPF, 2017, TRENDS PHARMACOL SCI, V38, P489, DOI 10.1016/j.tips.2017.02.005; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Forcina GC, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800311; Friedman-Levi Y, 2021, EXP NEUROL, V338, DOI 10.1016/j.expneurol.2021.113604; Gong WY, 2017, FREE RADICAL BIO MED, V106, P393, DOI 10.1016/j.freeradbiomed.2017.03.003; Guo WZ, 2021, CANCER RES, V81, P552, DOI 10.1158/0008-5472.CAN-20-0617; Heidari M, 2016, MOL PSYCHIATR, V21, P1599, DOI 10.1038/mp.2015.192; Ji H, 2012, BRAIN RES BULL, V87, P50, DOI 10.1016/j.brainresbull.2011.09.021; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang XJ, 2021, NAT REV MOL CELL BIO, V22, P266, DOI 10.1038/s41580-020-00324-8; Li YF, 2020, NEUROPATH APPL NEURO, V46, P519, DOI 10.1111/nan.12615; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mohan S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00556; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Seibt TM, 2019, FREE RADICAL BIO MED, V133, P144, DOI 10.1016/j.freeradbiomed.2018.09.014; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shen ZY, 2018, ACS NANO, V12, P11355, DOI 10.1021/acsnano.8b06201; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sun ZC, 2020, BIOORG CHEM, V94, DOI 10.1016/j.bioorg.2019.103485; Tang DL, 2021, CELL RES, V31, P107, DOI 10.1038/s41422-020-00441-1; Tang JS, 2021, BRAIN RES BULL, V170, P1, DOI 10.1016/j.brainresbull.2021.01.023; Tang SC, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.590789; Uchida Y, 2020, NEUROLOGY, V95, pE1188, DOI 10.1212/WNL.0000000000010148; Ursini F, 2020, FREE RADICAL BIO MED, V152, P175, DOI 10.1016/j.freeradbiomed.2020.02.027; Vijayalakshmi S, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090375; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Yan YD, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01229-6; Yang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40358; Zeng ZH, 2016, EXPERT OPIN THER TAR, V20, P645, DOI 10.1080/14728222.2016.1177023; Zhang CT, 2019, NEUROPHARMACOLOGY, V160, DOI 10.1016/j.neuropharm.2019.107777; Zhang LJ, 2020, ARCH BIOCHEM BIOPHYS, V682, DOI 10.1016/j.abb.2020.108302	33	1	1	4	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JUN 4	2021	556						149	155		10.1016/j.bbrc.2021.03.108			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	RK4FJ	WOS:000638253000001	33839410				2022-02-06	
J	Scrimgeour, AG; Condlin, ML; Loban, A; DeMar, JC				Scrimgeour, Angus G.; Condlin, Michelle L.; Loban, Andrei; DeMar, James C.			Omega-3 Fatty Acids and Vitamin D Decrease Plasma T-Tau, GFAP, and UCH-L1 in Experimental Traumatic Brain Injury	FRONTIERS IN NUTRITION			English	Article						mild traumatic brain injury; exercise; omega-3 fatty acids; vitamin D-3; neurotrauma biomarkers	DOCOSAHEXAENOIC ACID; NEUROFILAMENT-LIGHT; AXONAL INJURY; VOLUNTARY EXERCISE; COGNITIVE FUNCTION; TEMPORAL PROFILES; LIVER CONVERSION; VASOPRESSIN V-1A; OXIDATIVE STRESS; HEAD-INJURY	Traumatic brain injury (TBI) results in neuronal, axonal and glial damage. Interventions targeting neuroinflammation to enhance recovery from TBI are needed. Exercise is known to improve cognitive function in TBI patients. Omega-3 fatty acids and vitamin D reportedly reduce inflammation, and in combination, might improve TBI outcomes. This study examined how an anti-inflammatory diet affected plasma TBI biomarkers, voluntary exercise and behaviors following exposure to mild TBI (mTBI). Adult, male rats were individually housed in cages fitted with running wheels and daily running distance was recorded throughout the study. A modified weight drop method induced mTBI, and during 30 days post-injury, rats were fed diets supplemented with omega-3 fatty acids and vitamin D-3 (AIDM diet), or non-supplemented AIN-76A diets (CON diet). Behavioral tests were periodically conducted to assess functional deficits. Plasma levels of Total tau (T-tau), glial fibrillary acidic protein (GFAP), ubiquitin c-terminal hydrolase L1 (UCH-L1) and neurofilament light chain (NF-L) were measured at 48 h, 14 days, and 30 days post-injury. Fatty acid composition of food, plasma, and brain tissues was determined. In rats exposed to mTBI, NF-L levels were significantly elevated at 48 h post-injury (P < 0.005), and decreased to levels seen in uninjured rats by 14 days post-injury. T-tau, GFAP, and UCH-L1 plasma levels did not change at 48 h or 14 days post-injury. However, at 30 days post-injury, T-tau, GFAP and UCH-L1 all significantly increased in rats exposed to mTBI and fed CON diets (P < 0.005), but not in rats fed AIDM diets. Behavioral tests conducted post-injury showed that exercise counteracted cognitive deficits associated with mTBI. The AIDM diets significantly increased docosahexaenoic acid levels in plasma and brain tissue (P < 0.05), and in serum levels of vitamin D (P < 0.05). The temporal response of the four injury biomarkers examined is consistent with studies by others demonstrating acute and chronic neural tissue damage following exposure to TBI. The anti-inflammatory diet significantly altered the temporal profiles of plasma T-tau, GFAP, and UCH-L1 following mTBI. Voluntary exercise protected against mTBI-induced cognitive deficits, but had no impact on plasma levels of neurotrauma biomarkers. Thus, the prophylactic effect of exercise, when combined with an anti-inflammatory diet, may facilitate recovery in patients with mTBI.	[Scrimgeour, Angus G.; Condlin, Michelle L.; Loban, Andrei] US Army, Mil Nutr Div, Res Inst Environm Med, Natick, MA 01760 USA; [DeMar, James C.] Walter Reed Army Inst Res WRAIR, Ctr Mil Psychiat & Neurosci Res, Blast Induced Neurotrauma Branch, Silver Spring, MD USA		Scrimgeour, AG (corresponding author), US Army, Mil Nutr Div, Res Inst Environm Med, Natick, MA 01760 USA.	angus.g.scrimgeour.civ@mail.mil					Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bauer I, 2014, HUM PSYCHOPHARM CLIN, V29, P133, DOI 10.1002/hup.2379; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Belayev L, 2017, CELL DEATH DIFFER, V24, P1091, DOI 10.1038/cdd.2017.55; Bernick C, 2018, J NEUROTRAUM, V35, P2351, DOI 10.1089/neu.2017.5553; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Cekic M, 2011, NEUROBIOL AGING, V32, P864, DOI 10.1016/j.neurobiolaging.2009.04.017; Chen CT, 2013, J LIPID RES, V54, P2410, DOI 10.1194/jlr.M038505; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; Cui D, 2021, LIFE SCI, V264, DOI 10.1016/j.lfs.2020.118683; Cui D, 2020, ASN NEURO, V12, DOI 10.1177/1759091420960550; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Di Pietro V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030260; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Eto M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219465; Farooqui AA, 2012, CURR MED CHEM, V19, P532; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grimm MOW, 2011, J BIOL CHEM, V286, P14028, DOI 10.1074/jbc.M110.182329; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Howe P, 2014, MIL MED, V179, P138, DOI 10.7205/MILMED-D-14-00154; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Huang M, 2009, J AOAC INT, V92, P1327; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Igarashi M, 2007, J LIPID RES, V48, P152, DOI 10.1194/jlr.M600396-JLR200; Igarashi M, 2006, J LIPID RES, V47, P1812, DOI 10.1194/jlr.M600030-JLR200; James S.L., 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30415-0, DOI 10.1016/S1474-4422(18)30415-0]; Jourdan C, 2012, DEV MED CHILD NEUROL, V54, P624, DOI 10.1111/j.1469-8749.2012.04291.x; Kalm M, 2017, BRAIN RES, V1668, P12, DOI 10.1016/j.brainres.2017.05.011; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Kulbe JR, 2017, PROG NEUROBIOL, V158, P15, DOI 10.1016/j.pneurobio.2017.08.003; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Lopez-Vicario C, 2016, EUR J PHARMACOL, V785, P133, DOI 10.1016/j.ejphar.2015.03.092; Losurdo M, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10040229; Lucke-Wold BP, 2018, NUTR NEUROSCI, V21, P79, DOI [10.1080/1028415x.2016.1236174, 10.1080/1028415X.2016.1236174]; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahan MY, 2019, WORLD NEUROSURG, V128, pE434, DOI 10.1016/j.wneu.2019.04.170; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou Christina R., 2009, P393, DOI 10.1007/978-1-60327-185-1_34; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McGeown JP, 2021, J NEUROSCI RES, V99, P573, DOI 10.1002/jnr.24746; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; National Research Council, 2011, GUIDE CARE USE LAB A; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pham L, 2021, NEUROBIOL DIS, V148, DOI 10.1016/j.nbd.2020.105151; Pu HJ, 2017, CELL TRANSPLANT, V26, P555, DOI [10.3727/096368916x693842, 10.3727/096368916X693842]; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Rao JS, 2007, MOL PSYCHIATR, V12, P151, DOI 10.1038/sj.mp.4001887; Rauen K, 2020, J NEUROTRAUM, V37, P665, DOI 10.1089/neu.2019.6653; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rosenfeld CS, 2014, JOVE-J VIS EXP, DOI 10.3791/51194; Rubenstein R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00124; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Schober ME, 2016, J NEUROTRAUM, V33, P390, DOI 10.1089/neu.2015.3945; Scrimgeour AG, 2018, J NEUROTRAUM, V35, P2495, DOI 10.1089/neu.2017.5614; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shriki J, 2021, EMERG MED CLIN N AM, V39, P203, DOI 10.1016/j.emc.2020.09.012; Silva DD, 2011, ACTA CIR BRAS, V26, P94, DOI 10.1590/S0102-86502011000200004; Smith DH, 2020, NAT REV NEUROL, V16, P457, DOI 10.1038/s41582-020-0382-y; Soltani N, 2020, CELL MOL NEUROBIOL, V40, P555, DOI 10.1007/s10571-019-00753-w; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Tang HL, 2015, BRAIN INJURY, V29, P1165, DOI 10.3109/02699052.2015.1035330; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhu W, 2018, INFLAMMATION, V41, P1182, DOI 10.1007/s10753-018-0765-z	102	1	1	4	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-861X			FRONT NUTR	Front. Nutr.	JUN 4	2021	8								685220	10.3389/fnut.2021.685220			15	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	ST8GX	WOS:000662677400001	34150829	Green Published, gold			2022-02-06	
J	Zhang, J; Emami, Z; Safar, K; McCunn, P; Richardson, JD; Rhind, SG; da Costa, L; Jetly, R; Dunkley, BT				Zhang, Jing; Emami, Zahra; Safar, Kristina; McCunn, Patrick; Richardson, J. Don; Rhind, Shawn G.; da Costa, Leodante; Jetly, Rakesh; Dunkley, Benjamin T.			Teasing apart trauma: neural oscillations differentiate individual cases of mild traumatic brain injury from post-traumatic stress disorder even when symptoms overlap	TRANSLATIONAL PSYCHIATRY			English	Article							BETA-OSCILLATIONS; HIPPOCAMPAL FUNCTION; PREFRONTAL CORTEX; MODEL SYSTEMS; PTSD; CONNECTIVITY; MAGNETOENCEPHALOGRAPHY; DEPRESSION; SEVERITY; CONCUSSION	Post-traumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI) are highly prevalent and closely related disorders. Affected individuals often exhibit substantially overlapping symptomatology - a major challenge for differential diagnosis in both military and civilian contexts. According to our symptom assessment, the PTSD group exhibited comparable levels of concussion symptoms and severity to the mTBI group. An objective and reliable system to uncover the key neural signatures differentiating these disorders would be an important step towards translational and applied clinical use. Here we explore use of MEG (magnetoencephalography)-multivariate statistical learning analysis in identifying the neural features for differential PTSD/mTBI characterisation. Resting state MEG-derived regional neural activity and coherence (or functional connectivity) across seven canonical neural oscillation frequencies (delta to high gamma) were used. The selected features were consistent and largely confirmatory with previously established neurophysiological markers for the two disorders. For regional power from theta, alpha and high gamma bands, the amygdala, hippocampus and temporal areas were identified. In line with regional activity, additional connections within the occipital, parietal and temporal regions were selected across a number of frequency bands. This study is the first to employ MEG-derived neural features to reliably and differentially stratify the two disorders in a multi-group context. The features from alpha and beta bands exhibited the best classification performance, even in cases where distinction by concussion symptom profiles alone were extremely difficult. We demonstrate the potential of using 'invisible' neural indices of brain functioning to understand and differentiate these debilitating conditions.	[Zhang, Jing; Emami, Zahra; Safar, Kristina; McCunn, Patrick; Dunkley, Benjamin T.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada; [Zhang, Jing; Emami, Zahra; Safar, Kristina; McCunn, Patrick; Dunkley, Benjamin T.] SickKids Res Inst, Neurosci & Mental Hlth, Toronto, ON, Canada; [Richardson, J. Don] St Josephs London OSI, London, ON, Canada; [Richardson, J. Don] MacDonald Franklin OSI Res Ctr, London, ON, Canada; [Rhind, Shawn G.] Def Res & Dev Canada, Toronto, ON, Canada; [da Costa, Leodante] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [da Costa, Leodante] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Jetly, Rakesh] Canadian Forces Hlth Serv HQ, Ottawa, ON, Canada; [Jetly, Rakesh] Univ Ottawa, Dept Psychiat, Fac Med, Ottawa, ON, Canada; [Jetly, Rakesh] Dalhousie Univ, Dept Psychiat, Fac Med, Halifax, NS, Canada; [Dunkley, Benjamin T.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada		Zhang, J (corresponding author), Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada.; Zhang, J (corresponding author), SickKids Res Inst, Neurosci & Mental Hlth, Toronto, ON, Canada.	jzhangcad@gmail.com	; Richardson, J Don/X-5123-2018	Rhind, Shawn/0000-0003-2300-0620; Richardson, J Don/0000-0002-2927-6735; Dunkley, Ben/0000-0001-6173-1171	Defence Research and Development Canada (DRDC); Canadian Institute for Military and Veteran Health Research (CIMVHR); Innovation for Defence Excellence and Security (IDEaS) program	The study is funded by Defence Research and Development Canada (DRDC), Canadian Institute for Military and Veteran Health Research (CIMVHR), and Innovation for Defence Excellence and Security (IDEaS) program.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Amen DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129659; Arakaki X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188101; Averill LA, 2017, NEUROSCI LETT, V649, P147, DOI 10.1016/j.neulet.2016.11.064; Badura-Brack AS, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00205; Ben-Zion Z, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00898-z; Berlim MT, 2014, CAN J PSYCHIAT, V59, P487, DOI 10.1177/070674371405900905; Bertram Edward H., 2010, J NEUROOPHTHALMOL, V30, P110; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Bzdok D, 2018, BIOL PSYCHIAT-COGN N, V3, P223, DOI 10.1016/j.bpsc.2017.11.007; Caccese J. B, SPORTS MED, DOI [10.1007/s40279-020-01415-4(2021, DOI 10.1007/S40279-020-01415-4(2021]; Chiba T, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00233; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Colclough GL, 2016, NEUROIMAGE, V138, P284, DOI 10.1016/j.neuroimage.2016.05.070; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Delgado D, 2010, PA NURSE, V65, P3; Dewey M, 2007, J MAGN RESON IMAGING, V26, P1322, DOI 10.1002/jmri.21147; Dieter JN, 2019, NEUROSCI INSIGHTS, V14, DOI 10.1177/1179069519892933; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Dunkley BT, 2014, NEUROIMAGE-CLIN, V5, P377, DOI 10.1016/j.nicl.2014.07.017; Esterman M, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz9343; Figueiredo T, 2020, MOL NEUROBIOL, V57, P23, DOI 10.1007/s12035-019-01753-z; Foss L, 2020, SETTING NATL CONSENS, DOI [10.25561/81286, DOI 10.25561/81286]; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Gordon E, 2010, CLIN EEG NEUROSCI, V41, P178, DOI 10.1177/155005941004100404; GRIGSBY JP, 1986, INT J CLIN NEUROPSYC, V8, P65; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Huang M.-X, HUM BRAIN MAPP, DOI [10.1002/hbm.25340(2021, DOI 10.1002/HBM.25340(2021]; Huang MX, 2020, CEREB CORTEX, V30, P283, DOI 10.1093/cercor/bhz087; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2020, NEUROIMAG CLIN N AM, V30, P175, DOI 10.1016/j.nic.2020.02.003; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Iljazi A, 2020, NEUROL SCI, V41, P2737, DOI 10.1007/s10072-020-04458-7; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jeon S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59815-5; Kaltiainen H, 2019, J NEUROTRAUM, V36, P2222, DOI 10.1089/neu.2018.6306; Kim EJ, 2015, LEARN MEMORY, V22, P411, DOI 10.1101/lm.037291.114; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langdon S, 2020, SPORTS MED, V50, P1829, DOI 10.1007/s40279-020-01321-9; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; Lanius RA, 2012, DEPRESS ANXIETY, V29, P701, DOI 10.1002/da.21889; Lee RR, 2014, PROG NEUROL SURG, V28, P94, DOI 10.1159/000358768; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; Lumba-Brown Angela, 2019, Concussion, V4, pCNC65, DOI 10.2217/cnc-2019-0005; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Misic B, 2016, J NEUROSCI, V36, P419, DOI 10.1523/JNEUROSCI.1506-15.2016; Moyer A, 2016, RADIOL TECHNOL, V87, P649; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Olff M, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1351204; Pervez M, 2018, NEUROIMAG CLIN N AM, V28, P1, DOI 10.1016/j.nic.2017.09.010; Popescu M, 2016, CLIN NEUROPHYSIOL, V127, P3075, DOI 10.1016/j.clinph.2016.06.004; Rangaprakash D, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00803; Ratliff WA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59252-4; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rosen V, 2020, NEUROSCI INSIGHTS, V15, DOI 10.1177/2633105520907895; Rossiter HE, 2014, NEUROIMAGE, V91, P360, DOI 10.1016/j.neuroimage.2014.01.012; Rowland JA, 2017, BRAIN CONNECT, V7, P45, DOI 10.1089/brain.2015.0406; Schmidt R, 2019, J NEUROSCI, V39, P8231, DOI 10.1523/JNEUROSCI.1163-19.2019; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Shim M, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102001; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shipton OA, 2014, P NATL ACAD SCI USA, V111, P15238, DOI 10.1073/pnas.1405648111; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slone L. B, 2017, HDB PTSD SCI PRACTIC, P685; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Vaiva G, 2006, AM J PSYCHIAT, V163, P1446, DOI 10.1176/appi.ajp.163.8.1446; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Van Praag DLG, 2019, J NEUROTRAUM, V36, P3220, DOI 10.1089/neu.2018.5759; van Rooij SJH, 2014, J PSYCHIATR NEUROSCI, V39, P330, DOI 10.1503/jpn.130223; Voss JL, 2017, TRENDS COGN SCI, V21, P577, DOI 10.1016/j.tics.2017.05.008; Wang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27131; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yasen AL, 2018, J NEUROPHYSIOL, V120, P1318, DOI 10.1152/jn.00896.2017; Zaman S, 2020, CLIN NEUROL NEUROSUR, V196, DOI 10.1016/j.clineuro.2020.105981; Zemla R, 2017, CURR OPIN NEUROBIOL, V43, P187, DOI 10.1016/j.conb.2017.04.005; Zhang J, 2020, J NEUROPHYSIOL, V124, P1948, DOI 10.1152/jn.00333.2020; Zhang J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62713-5; Zhang J, 2016, J INTEGR BIOINFORMAT, V13, DOI 10.2390/biecoll-jib-2016-306; Zhang L, 2012, ACTA NEUROPSYCHIATR, V24, P34, DOI 10.1111/j.1601-5215.2011.00580.x; Zoellner LA, 2000, J TRAUMA STRESS, V13, P635, DOI 10.1023/A:1007810200460	93	1	1	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2158-3188			TRANSL PSYCHIAT	Transl. Psychiatr.	JUN 4	2021	11	1							345	10.1038/s41398-021-01467-8			14	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	SR2BB	WOS:000660847800001	34088901	Green Published, gold			2022-02-06	
J	Adams, T; Greathouse, K				Adams, Tori; Greathouse, Kasey			Evaluation of Time to Administration, Benzodiazepine Use, and Safety of Intravenous Push Levetiracetam in a Neuro-Spine Intensive Care Unit	NEUROCRITICAL CARE			English	Article						Levetiracetam; Intravenous; Antiepileptics	INFUSION	Purpose The purpose of this study was to evaluate the time to medication administration, clinical effect, and safety of a recent Pharmacy and Therapeutics Committee-approved change in the administration of levetiracetam from intravenous piggyback (IVPB) over 15 min to undiluted intravenous push (IVP) over 2-5 min at a large academic medical center. Methods The primary outcome was the time from order verification to the administration of IVP levetiracetam versus IVPB levetiracetam. The secondary outcome was any benzodiazepine administered in the time between levetiracetam order verification and administration in both groups. Adult patients admitted to the neuro-spine intensive care unit in the 6 months prior to and after the policy change, and who received at least one dose of 1000 mg or higher of IVP or IVPB levetiracetam for active seizures, were included in this retrospective, observational, institutional review board-approved study. Data were analyzed using descriptive statistics, chi(2), and the Mann-Whitney U-test as appropriate. Results Of the 2055 hospital-wide levetiracetam doses ordered within the study period, 316 doses were screened for enrollment and 160 were enrolled with 60 and 100 patients assigned to the IVP and IVPB groups, respectively. There were no differences between the groups at baseline. The majority of the population was male, 57 years old, had no significant renal dysfunction (defined as a creatinine clearance of less than 60 ml/min), and had a seizure etiology of malignancy or traumatic brain injury. A significant reduction in the time to administration of levetiracetam was found with IVP compared with IVPB administration (28 vs. 80 min, p < 0.0001). A subsequent reduction in patients who received benzodiazepines in the interim of levetiracetam order verification and administration was also associated with IVP compared with IVPB (2% vs. 13%, p = 0.042). There were no differences found in the rates of adverse effects between groups. Conclusions Administration of levetiracetam doses up to 2000 mg via IVP is a safe method of administration that results in a reduction of time to medication administration and a reduction of benzodiazepine use.	[Adams, Tori] Univ Iowa Hosp & Clin, 200 Hawkins Dr, Iowa City, IA 52242 USA; [Greathouse, Kasey] Northwestern Mem Hosp, Chicago, IL 60611 USA		Adams, T (corresponding author), Univ Iowa Hosp & Clin, 200 Hawkins Dr, Iowa City, IA 52242 USA.	tradams31@gmail.com					Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Burakgazi E, 2014, CLIN EEG NEUROSCI, V45, P89, DOI 10.1177/1550059413496777; Cramer JA, 2003, EPILEPSY BEHAV, V4, P124, DOI 10.1016/S1525-5050(03)00005-2; Morgan O, 2020, NEUROCRIT CARE, V32, P131, DOI 10.1007/s12028-019-00708-5; Ramael S, 2006, EPILEPSIA, V47, P1128, DOI 10.1111/j.1528-1167.2006.00586.x; US Food and Drug Administration, FDA APPR DRUGS; Wheless JW, 2009, J CHILD NEUROL, V24, P946, DOI 10.1177/0883073808331351	7	1	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2021	35	3					789	793		10.1007/s12028-021-01237-w		JUN 2021	5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XS0FS	WOS:000657551600001	34081297				2022-02-06	
J	Ogwang, R; Ningwa, A; Akun, P; Bangirana, P; Anguzu, R; Mazumder, R; Salamon, N; Henning, OJ; Newton, CR; Abbo, C; Mwaka, AD; Marsh, K; Idro, R				Ogwang, Rodney; Ningwa, Albert; Akun, Pamela; Bangirana, Paul; Anguzu, Ronald; Mazumder, Rajarshi; Salamon, Noriko; Henning, Oliver Johannes; Newton, Charles R.; Abbo, Catherine; Mwaka, Amos Deogratius; Marsh, Kevin; Idro, Richard			Epilepsy in Onchocerca volvulus Sero-Positive Patients From Northern Uganda-Clinical, EEG and Brain Imaging Features	FRONTIERS IN NEUROLOGY			English	Article						seizures; MRI; EEG; onchocerciasis; epilepsy	SUB-SAHARAN AFRICA; NODDING SYNDROME; EPIDEMIOLOGY; PREVALENCE; DIAGNOSIS; REGIONS; STIGMA	Globally, epilepsy is the most common chronic neurological disorder. The incidence in sub-Saharan Africa is 2-3 times higher than that in high income countries. Infection by Onchocerca volvulus may be an underlying risk factor for the high burden and based upon epidemiological associations, has been proposed to cause a group of disorders-Onchocerca associated epilepsies (OAE) like nodding syndrome (NS). To improve our understanding of the disease spectrum, we described the clinical, electroencephalographic (EEG) and magnetic resonance imaging (MRI) features of children with epilepsy and sero-positive for Onchocerca volvulus (possible OAEs other than nodding syndrome). Twenty-nine children and adolescents with non-nodding syndrome OAE in northern Uganda were enrolled. A diagnosis of OAE was made in patients with epilepsy and seizure onset after age 3 years, no reported exposure to perinatal severe febrile illness or traumatic brain injury, no syndromic epilepsy diagnosis and a positive Ov-16 ELISA test. Detailed clinical evaluation including psychiatric, diagnostic EEG, a diagnostic brain MRI (in 10 patients) and laboratory testing were performed. Twenty participants (69%) were male. The mean age was 15.9 (standard deviation [SD] 1.9) years while the mean age at seizure onset was 9.8 (SD 2.9) years. All reported normal early childhood development. The most common clinical presentation was a tonic-clonic seizure. The median number of seizures was 2 (IQR 1-4) in the previous month. No specific musculoskeletal changes, or cranial nerve palsies were reported, neither were any vision, hearing and speech difficulties observed. The interictal EEG was abnormal in the majority with slow wave background activity in 52% (15/29) while 41% (12/29) had focal epileptiform activity. The brain MRI showed mild to moderate cerebellar atrophy and varying degrees of atrophy of the frontal, parietal and occipital lobes. The clinical spectrum of epilepsies associated with Onchocerca may be broader than previously described. In addition, focal onset tonic-clonic seizures, cortical and cerebellar atrophy may be important brain imaging and clinical features.	[Ogwang, Rodney; Ningwa, Albert; Akun, Pamela; Bangirana, Paul; Anguzu, Ronald; Abbo, Catherine; Mwaka, Amos Deogratius; Idro, Richard] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Ogwang, Rodney; Newton, Charles R.] Ctr Geog Med Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Ogwang, Rodney; Ningwa, Albert; Akun, Pamela; Anguzu, Ronald; Idro, Richard] Ctr Trop Neurosci, Kitgum, Uganda; [Anguzu, Ronald] Med Coll Wisconsin, Div Epidemiol, Inst Hlth & Equ, Milwaukee, WI 53226 USA; [Mazumder, Rajarshi] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Salamon, Noriko] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Henning, Oliver Johannes] Oslo Univ Hosp, Natl Ctr Epilepsy, Div Clin Neurosci, Oslo, Norway; [Newton, Charles R.] Univ Oxford, Dept Psychiat, Oxford, England; [Marsh, Kevin; Idro, Richard] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England		Idro, R (corresponding author), Makerere Univ, Coll Hlth Sci, Kampala, Uganda.; Idro, R (corresponding author), Ctr Trop Neurosci, Kitgum, Uganda.; Idro, R (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.	ridro1@gmail.com	Yue, Yuhang/AAW-9279-2021		Medical Research Council, UK (DFID/MRC) African Research Leadership grantUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/M025489/1]; DELTAS Africa Initiative [DEL-15-003]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome TrustWellcome TrustEuropean Commission [107769/Z/10/Z]; UK government; European UnionEuropean Commission	This study was funded by a Medical Research Council, UK (DFID/MRC) African Research Leadership grant, MR/M025489/1. The award is part of the EDCTP2 programme supported by the European Union. RO was supported through the DELTAS Africa Initiative [DEL-15-003]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [107769/Z/10/Z] and the UK government.	Anguzu R, 2021, EPILEPSY BEHAV, V114, DOI 10.1016/j.yebeh.2020.107584; Anguzu R, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1431362; Ba-Diop A, 2014, LANCET NEUROL, V13, P1029, DOI 10.1016/S1474-4422(14)70114-0; Baskind R, 2005, EPILEPSY BEHAV, V7, P68, DOI 10.1016/j.yebeh.2005.04.009; Beghi E, 2020, NEUROEPIDEMIOLOGY, V54, P185, DOI 10.1159/000503831; Bennuru S, 2020, J INFECT DIS, V221, P1805, DOI 10.1093/infdis/jiz307; Burton Adrian, 2016, Lancet Neurol, V15, P30, DOI 10.1016/S1474-4422(15)00350-6; Casis-Sacre G, 1938, B SALUBR HIG MEX, V1, P11; Colebunders Robert, 2017, Epilepsia Open, V2, P145, DOI 10.1002/epi4.12054; Colebunders R, 2018, TRENDS PARASITOL, V34, P208, DOI 10.1016/j.pt.2017.11.009; De Marco FA, 2003, SEIZURE-EUR J EPILEP, V12, P312, DOI 10.1016/S1059-1311(02)00267-4; Dowell SF, 2013, EMERG INFECT DIS, V19, P1374, DOI 10.3201/eid1909.130401; Druet-Cabanac M, 2004, NEUROEPIDEMIOLOGY, V23, P144, DOI 10.1159/000075958; Fink DL, 2011, J CLIN MICROBIOL, V49, P42, DOI 10.1128/JCM.01697-10; Foger K, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005201; Galovic M, 2019, JAMA NEUROL, V76, P1230, DOI 10.1001/jamaneurol.2019.1708; Gumisiriza N, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-0628-3; Harkin LA, 2007, BRAIN, V130, P843, DOI 10.1093/brain/awm002; Hotterbeekx A, 2018, SEIZURE-EUR J EPILEP, V60, P205, DOI 10.1016/j.seizure.2018.01.006; Hotterbeekx A, 2019, BRAIN RES BULL, V145, P39, DOI 10.1016/j.brainresbull.2018.08.024; Idro R, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1256-z; Idro R, 2018, EPILEPTIC DISORD, V20, P508, DOI 10.1684/epd.2018.1012; Idro R, 2016, INT J INFECT DIS, V45, P112, DOI 10.1016/j.ijid.2016.03.002; Idro R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002540; Jeliffe DB, 1962, TROP GEOGR MED, V14, P96; Johnson TP, 2020, ANNU REV PATHOL-MECH, V15, P395, DOI 10.1146/annurev-pathmechdis-012419-032748; Kaiser C, 1996, B WORLD HEALTH ORGAN, V74, P361; Kaiser C, 1998, EPILEPSY RES, V30, P247, DOI 10.1016/S0920-1211(98)00007-2; Kaiser C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002147; Kamuyu G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002908; Kipp W, 1996, AM J TROP MED HYG, V54, P80, DOI 10.4269/ajtmh.1996.54.80; Levick B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005732; Melchers NVSV, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0481-9; Moog JC, 2017, SEIZURE-EUR J EPILEP, V44, P108, DOI 10.1016/j.seizure.2016.11.032; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Nutman TB., 2020, HUNTERS TROPICAL MED, P864, DOI [10.1016/B978-0-323-55512-8.00116-2, DOI 10.1016/B978-0-323-55512-8.00116-2]; Ogwang R, 2021, EPILEPSIA OPEN, V6, P297, DOI 10.1002/epi4.12463; Ogwang R, 2018, ACTA TROP, V188, P27, DOI 10.1016/j.actatropica.2018.08.023; Olum S, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa037; Owolabi LF, 2020, ACTA NEUROL SCAND, V142, P3, DOI 10.1111/ane.13246; Oyegbile TO, 2011, EPILEPSIA, V52, P698, DOI 10.1111/j.1528-1167.2010.02937.x; Reik Lul, 2012, Morbidity and Mortality Weekly Report, V61, P52; Salinsky MC, 2002, EPILEPSIA, V43, P482, DOI 10.1046/j.1528-1157.2002.22501.x; Sejvar JJ, 2013, LANCET NEUROL, V12, P166, DOI 10.1016/S1474-4422(12)70321-6; Tumwine JK, 2012, AFR HEALTH SCI, V12, P242, DOI 10.4314/ahs.v12i3.1; Udall DN, 2007, CLIN INFECT DIS, V44, P53, DOI 10.1086/509325; WHO, 2004, EPILEPSY WHO AFRICAN; Wilmshurst JM, 2014, EPILEPSIA, V55, P1322, DOI 10.1111/epi.12602; Winkler AS, 2008, EPILEPSIA, V49, P2008, DOI 10.1111/j.1528-1167.2008.01671.x; World Health Organization, 2019, WHO EPILEPSY PUBLIC; World Health Organization (WHO), 2019, EPILEPSY	52	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 3	2021	12								687281	10.3389/fneur.2021.687281			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ST1CQ	WOS:000662188100001	34149607	Green Published, gold			2022-02-06	
J	Seidenfaden, SC; Kjerulff, JL; Juul, N; Kirkegaard, H; Moller, MF; Munster, AMB; Botker, MT				Seidenfaden, Sophie-Charlott; Kjerulff, Julie Linding; Juul, Niels; Kirkegaard, Hans; Moller, Mette Fogh; Munster, Anna-Marie Bloch; Botker, Morten Thingemann			Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study"	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Biomarker; S100B; GFAP; Diagnostic accuracy; Prehospital triage; Emergency medical service	MINOR HEAD-INJURY; FIBRILLARY ACIDIC PROTEIN; INTRACRANIAL HEMORRHAGE; COMPUTED-TOMOGRAPHY; CT; GUIDELINES; MANAGEMENT; PATTERNS; UTILITY; DAMAGE	Background: The biomarker serum S100 calcium-binding protein B (S100B) is used in in-hospital triage of adults with mild traumatic brain injury to rule out intracranial lesions. The biomarker glial fibrillary acidic protein (GFAP) is suggested as a potential diagnostic biomarker for traumatic brain injury. The aim of this study was to investigate the diagnostic accuracy of early prehospital S100B and GFAP measurements to rule out intracranial lesions in adult patients with mild traumatic brain injury. Methods: Prehospital and in-hospital blood samples were drawn from 566 adult patients with mild traumatic brain injury (Glasgow Coma Scale Score 14-15). The index test was S100B and GFAP concentrations. The reference standard was endpoint adjudication of the traumatic intracranial lesion based on medical records. The primary outcome was prehospital sensitivity of S100B in relation to the traumatic intracranial lesion. Results: Traumatic intracranial lesions were found in 32/566 (5.6%) patients. The sensitivity of S100B > 0.10 mu g/L was 100% (95%CI: 89.1;100.0) in prehospital samples and 100% (95% CI 89.1;100.0) in in-hospital samples. The specificity was 15.4% (95%CI: 12.4;18.7) in prehospital samples and 31.5% (27.5;35.6) in in-hospital samples. GFAP was only detected in less than 2% of cases with the assay used. Conclusion: Early prehospital and in-hospital S100B levels < 0.10 mu g/L safely rules out traumatic intracranial lesions in adult patients with mild traumatic brain injury, but specificity is lower with early prehospital sampling than with in-hospital sampling. The very limited cases with values detectable with our assay do not allow conclusions to be draw regarding the diagnostic accuracy of GFAP.	[Seidenfaden, Sophie-Charlott; Kjerulff, Julie Linding; Kirkegaard, Hans; Botker, Morten Thingemann] Cent Denmark Reg, Prehosp Emergency Med Serv, Res & Dev, Olof Palmes Alle 34 2, Aarhus, Denmark; [Seidenfaden, Sophie-Charlott; Kirkegaard, Hans; Botker, Morten Thingemann] Aarhus Univ, Dept Clin Med, Incuba Skejby, Bld 2,Palle Juul Jensens Blvd 82, Aarhus, Denmark; [Juul, Niels] Aarhus Univ Hosp, Dept Anaesthesiol & Intens Care, Neurointens Care Unit, Sect North, Palle Jull Jensens Blvd 161, Aarhus, Denmark; [Kirkegaard, Hans] Aarhus Univ Hosp, Res Ctr Emergency Med, Palle Juul Jensens Blvd 99, Aarhus, Denmark; [Moller, Mette Fogh] Reg Hosp West Jutland, Dept Clin Biochem, Gl Landevej 61, Herning, Denmark; [Munster, Anna-Marie Bloch] Hosp South West Jutland, Dept Clin Biochem, Finsensgade 35, Esbjerg, Denmark; [Botker, Morten Thingemann] Reg Hosp Randers, Dept Anaesthesiol, Skovlyvej 15, Randers, Denmark		Seidenfaden, SC (corresponding author), Cent Denmark Reg, Prehosp Emergency Med Serv, Res & Dev, Olof Palmes Alle 34 2, Aarhus, Denmark.; Seidenfaden, SC (corresponding author), Aarhus Univ, Dept Clin Med, Incuba Skejby, Bld 2,Palle Juul Jensens Blvd 82, Aarhus, Denmark.	soseid@rm.dk		Munster, Anna-Marie Bloch/0000-0002-3398-3977	A.P. Moller and Chastine Mc-Kinney Moller Foundation for General Purposes (Medical Foundation); Holger and Ruth Hesse Memorial Foundation; Central Denmark Region Health Research Foundation; Radet for Offerfonden; Regional Scientific Ethical Committee System	The study was entirely initiated by the research group. No commercial companies were involved in the design or initiation of the study. Salary for the primary investigator amounts to a regular PhD salary throughout the study period. The project was financially supported by external foundations: The A.P. Moller and Chastine Mc-Kinney Moller Foundation for General Purposes (Medical Foundation) (DKK 60.000) Holger and Ruth Hesse Memorial Foundation (DKK 64.000), Central Denmark Region Health Research Foundation (DKK 480.000) and Radet for Offerfonden (DKK 600.000). The Regional Scientific Ethical Committee System was notified of all funding during the study period.	AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Anandalwar SP, 2016, J NEUROSURG, V125, P667, DOI 10.3171/2015.9.JNS151379; Ananthaharan A, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0193-2; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1373/clinchem.2015.246280, 10.1136/bmj.h5527, 10.1148/radiol.2015151516]; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; DeAngelis J, 2017, WEST J EMERG MED, V18, P821, DOI 10.5811/westjem.2017.6.33685; Eskesen V, 2014, UGESKR LAEGER, V176, P2; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kjerulff JL, 2020, J NEUROTRAUM, V37, P1864, DOI 10.1089/neu.2019.6907; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P247, DOI 10.1007/978-3-211-98811-4_46; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Minkkinen M, 2019, J NEUROTRAUM, V36, P2904, DOI 10.1089/neu.2018.6351; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Roche Diagnostics GmbH M Germany, 2015, COB S100 KIT INS; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Thaler HW, 2015, J NEUROSURG, V123, P1202, DOI 10.3171/2014.12.JNS142276; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	29	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JUN 2	2021	29	1							75	10.1186/s13049-021-00891-5			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SM2LE	WOS:000657440600002	34078435	gold, Green Published			2022-02-06	
J	Zahedi, H; Hosseinzadeh-Attar, MJ; Shadnoush, M; Sahebkar, A; Barkhidarian, B; Sadeghi, O; Najafi, A; Hosseini, S; Qorbani, M; Ahmadi, A; Ardehali, SH; Norouzy, A				Zahedi, Hoda; Hosseinzadeh-Attar, Mohammad Javad; Shadnoush, Mahdi; Sahebkar, Amirhossein; Barkhidarian, Bahareh; Sadeghi, Omid; Najafi, Atabak; Hosseini, Saeed; Qorbani, Mostafa; Ahmadi, Arezoo; Ardehali, Seyed Hossein; Norouzy, Abdolreza			Effects of curcuminoids on inflammatory and oxidative stress biomarkers and clinical outcomes in critically ill patients: A randomized double-blind placebo-controlled trial	PHYTOTHERAPY RESEARCH			English	Article						curcuminoids; inflammation; oxidative stress; traumatic brain injuries	TRAUMATIC BRAIN-INJURY; IN-VITRO; SUPPLEMENTATION; COUNTERACTS; PLASTICITY; PIPERINE; THERAPY; ROLES; SPICE; RATS	Experimental studies have suggested the beneficial effects of curcuminoids as natural polyphenols against traumatic brain injury (TBI). The aim of this study was to investigate the effects of supplementation with curcuminoids on inflammatory and oxidative stress biomarkers, clinical outcomes and nutritional status in critically ill patients with TBI. A total of 62 ICU-admitted adult patients with TBI were randomly allocated to receive either a daily dose of 500 mg curcuminoids or matched placebo via enteral nutrition for 7 consecutive days based on stratified block randomization by age and sex. Inflammatory and oxidative stress as well as clinical outcomes and nutritional status of the patients were measured at baseline and at the end of the study. There were no overall group effects regarding to all dependent variables. Compared with baseline, serum levels of IL-6, TNF-alpha, MCP-1 and CRP were significantly reduced in patients receiving curcuminoids (p < .05) without any significant changes in placebo group; however, changes in the activities of GPx and SOD in serum were not significant between two groups. Moreover, APACHEII and NUTRIC score were significantly improved following curcuminoids consumption in comparison with placebo (p < .05). The findings of this study suggest that short-term supplementation with curcuminoids may have beneficial effects on inflammation, clinical outcomes and nutritional status of critically ill patients with TBI.	[Zahedi, Hoda; Hosseinzadeh-Attar, Mohammad Javad; Barkhidarian, Bahareh; Hosseini, Saeed] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, Tehran, Iran; [Shadnoush, Mahdi] Semnan Univ Med Sci, Fac Med, Semnan, Iran; [Shadnoush, Mahdi] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Dept Clin Nutr, Tehran, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran; [Sadeghi, Omid] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran; [Najafi, Atabak; Ahmadi, Arezoo] Univ Tehran Med Sci, Sina Hosp, Fac Med, Dept Anesthesiol & Crit Care Med, Tehran, Iran; [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran; [Ardehali, Seyed Hossein] Shahid Beheshti Univ Med Sci, Shohadaye Tajrish Hosp, Dept Anesthesiol & Crit Care, Tehran, Iran; [Norouzy, Abdolreza] Mashhad Univ Med Sci, Dept Nutr, Mahshad, Iran		Norouzy, A (corresponding author), Mashhad Med Sch, Dept Nutr, Azadi Sq, Mashhad, Razavi Khorasan, Iran.	norouzya@mums.ac.ir	Zahedi, Hoda/AAO-9339-2021; Hosseinzadeh-Attar, Mohammad Javad/E-9358-2018	Zahedi, Hoda/0000-0003-4431-7459; Hosseinzadeh-Attar, Mohammad Javad/0000-0002-5787-4089	Tehran University of Medical Sciences and Health ServicesTehran University of Medical Sciences [96-04-161-37823]	Tehran University of Medical Sciences and Health Services, Grant/Award Number: 96-04-161-37823	Al-Naama Lamia M, 2015, Qatar Med J, V2015, P14, DOI 10.5339/qmj.2015.14; Basnet P, 2011, MOLECULES, V16, P4567, DOI 10.3390/molecules16064567; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; Durackova Z, 2010, PHYSIOL RES, V59, P459, DOI 10.33549/physiolres.931844; Exner M, 2004, TRANSPLANTATION, V77, P538, DOI 10.1097/01.TP.0000113467.36269.F8; Faiz-ul Hassan, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00514; Fakharian E, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.23869; Farkhondeh T., 2019, RECENT PATENTS FOOD, V10, P1; Gao TL, 2018, BIOCHEM BIOPH RES CO, V497, P430, DOI 10.1016/j.bbrc.2018.02.102; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; He Y, 2015, MOLECULES, V20, P9183, DOI 10.3390/molecules20059183; Hewlings SJ, 2017, FOODS, V6, DOI 10.3390/foods6100092; Heyland DK, 2011, CRIT CARE, V15, DOI 10.1186/cc10546; Kamarudin TA, 2012, EXCLI J, V11, P226; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Lucke-Wold BP, 2018, NUTR NEUROSCI, V21, P79, DOI [10.1080/1028415x.2016.1236174, 10.1080/1028415X.2016.1236174]; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mohammadi A, 2019, J NUTR BIOCHEM, V66, P1, DOI 10.1016/j.jnutbio.2018.12.005; Pagano E, 2018, PHARMACOL RES, V134, P79, DOI 10.1016/j.phrs.2018.06.007; Panahi Y, 2015, DRUG RES, V65, P567, DOI 10.1055/s-0034-1389986; Panahi Y, 2019, J CELL BIOCHEM, V120, P15989, DOI 10.1002/jcb.28877; Panahi Y, 2017, INFLAMMOPHARMACOLOGY, V25, P25, DOI 10.1007/s10787-016-0301-4; Panahi Y, 2016, BIOMED PHARMACOTHER, V82, P578, DOI 10.1016/j.biopha.2016.05.037; Panahi Y, 2012, ANN CLIN BIOCHEM, V49, P580, DOI 10.1258/acb.2012.012040; Panahi Y, 2012, BRIT J NUTR, V108, P1272, DOI 10.1017/S0007114511006544; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Priyadarsini KI, 2003, FREE RADICAL BIO MED, V35, P475, DOI 10.1016/S0891-5849(03)00325-3; Qin S, 2018, NUTR RES, V60, P1, DOI 10.1016/j.nutres.2018.08.003; Rahimnia AR, 2015, DRUG RES, V65, P521, DOI 10.1055/s-0034-1384536; Sahebkar A, 2016, PHARMACOL RES, V107, P234, DOI 10.1016/j.phrs.2016.03.026; Sahebkar A, 2014, PHYTOTHER RES, V28, P633, DOI 10.1002/ptr.5045; Scheff SW, 2017, J NEUROTRAUM, V34, P1491, DOI 10.1089/neu.2016.4718; Selvi NMK, 2015, INDIAN J CLIN BIOCHE, V30, P180, DOI 10.1007/s12291-014-0436-2; Shafabakhsh R, 2019, PHARMACOL RES, V147, DOI 10.1016/j.phrs.2019.104353; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Suresh D, 2007, FOOD CHEM TOXICOL, V45, P1437, DOI 10.1016/j.fct.2007.02.002; Tabrizi R, 2019, PHYTOTHER RES, V33, P253, DOI 10.1002/ptr.6226; Tiyaboonchai W, 2007, INT J PHARMACEUT, V337, P299, DOI 10.1016/j.ijpharm.2006.12.043; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wongcharoen W, 2009, INT J CARDIOL, V133, P145, DOI 10.1016/j.ijcard.2009.01.073; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706	48	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	AUG	2021	35	8					4605	4615		10.1002/ptr.7179		JUN 2021	11	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	UA0GE	WOS:000657332200001	34080237				2022-02-06	
J	Algahtany, MA				Algahtany, Mubarak Ali			Secular Trend, Seasonal Variation, Epidemiological Pattern, and Outcome of Traumatic Head Injuries Due to Road Traffic Accidents in Aseer, Saudi Arabia	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						road traffic accident; traumatic head injury; trend; seasonal variation; Saudi Arabia	BRAIN-INJURY	Road traffic accidents (RTAs) are a leading cause of traumatic head injury (THI) and are regarded as a public health problem in Saudi Arabia. This hospital-based retrospective study aims to provide data on the frequency, type, and distribution of RTA-related THIs over the past decade; demonstrate their time trend and seasonality; and decipher age and sex differences in RTA-related THIs and their outcome. The results showed a decline in the number of RTA-related THIs between 2010 and 2019. The patients had a mean age of 26.16 +/- 16.27 years, and the male-to-female ratio was 10.8:1. Head injury with multiple lesions was the most common diagnosis, followed by cerebral contusion and skull fracture (32.1%, 12.9%, and 11.2%, respectively). Subdural hematoma (SDH) and skull fracture were significantly more common in patients aged >= 60 years (standard residual > 1.96), and significantly less common in those aged <= 17 years (standard residual < 1.96), compared to other age groups. Males experienced significantly more SDHs than females (standard residual = -2.8, p = 0.029). The length of hospital stay was positively correlated with age (Spearman's rho = 0.057, p = 0.046). No seasonal variation was found.	[Algahtany, Mubarak Ali] King Khalid Univ, Div Neurosurg, Dept Surg, Coll Med, Abha 625122291, Saudi Arabia		Algahtany, MA (corresponding author), King Khalid Univ, Div Neurosurg, Dept Surg, Coll Med, Abha 625122291, Saudi Arabia.	mbalgahtany@kku.edu.sa		Algahtany, Mubarak/0000-0001-8524-9769			Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Al-Habib A, 2013, ANN SAUDI MED, V33, P351, DOI 10.5144/0256-4947.2013.351; Al-Hajj S, 2021, NEUROEPIDEMIOLOGY, V55, P20, DOI 10.1159/000511554; Al-Kuwaiti A, 2012, ULUS TRAVMA ACIL CER, V18, P213, DOI 10.5505/tjtes.2012.03710; Aldawood AS, 2012, ANN SAUDI MED, V32, P498, DOI 10.5144/0256-4947.2012.498; Alghnam S, 2017, ANN SAUDI MED, V37, P1, DOI 10.5144/0256-4947.2017.1; Alhabdan S, 2013, ANN SAUDI MED, V33, P52, DOI 10.5144/0256-4947.2013.52; Alnaami Ibrahim, 2019, Neurosci J, V2019, P2782146, DOI 10.1155/2019/2782146; [Anonymous], 2020, GLOBAL BURDEN DIS ES; Barrimah I, 2012, INT J HEALTH SCI-IJH, V6, P31, DOI 10.12816/0005971; Dahim Mohammed A H, 2018, Int J Pediatr Adolesc Med, V5, P103, DOI 10.1016/j.ijpam.2018.08.002; Eom Ki Seong, 2020, Korean J Neurotrauma, V16, P28, DOI 10.13004/kjnt.2020.16.e2; Faul M, 2010, TRAUMATIC BRAIN INJU; General Authority for Statistics, 2019, STAT YB; Haghparast-Bidgoli H, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-281; Hefny AF, 2012, ACCIDENT ANAL PREV, V49, P245, DOI 10.1016/j.aap.2011.05.003; James SL, 2020, INJURY PREV, V26, P46, DOI 10.1136/injuryprev-2019-043302; Karacasu M, 2011, PROCD SOC BEHV, V20, DOI 10.1016/j.sbspro.2011.08.085; Khan MAB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062135; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Kudryavtsev AV, 2013, INT J INJ CONTROL SA, V20, P349, DOI 10.1080/17457300.2012.745576; Livingston Kristin S, 2016, Open Orthop J, V10, P550; Matsui Yasuhiro, 2013, Stapp Car Crash J, V57, P201; Ministry of Municipal Rural Affairs and Housing, ABH CIT PROF ABH TOU, P64; Ostermann RC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0975-y; Pape-Kohler CIA, 2014, INJURY, V45, pS93, DOI 10.1016/j.injury.2014.08.027; Taylor MS, 2020, TRAFFIC INJ PREV, V21, P55, DOI 10.1080/15389588.2019.1666981; World Health Organization, 2018, Global status report on alcohol and health 2018	28	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JUN	2021	18	12							6623	10.3390/ijerph18126623			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	SY7SQ	WOS:000666083500001	34202974	gold, Green Published			2022-02-06	
J	Attye, A; Renard, F; Baciu, M; Roger, E; Lamalle, L; Dehail, P; Cassoudesalle, H; Calamante, F				Attye, Arnaud; Renard, Felix; Baciu, Monica; Roger, Elise; Lamalle, Laurent; Dehail, Patrick; Cassoudesalle, Helene; Calamante, Fernando			TractLearn: A geodesic learning framework for quantitative analysis of brain bundles	NEUROIMAGE			English	Article						Diffusion MRI; Fiber tractography; Precision medicine; Manifold learning	FIBER DENSITY; DIFFUSION; SUBJECT; INJURY; QUANTIFICATION	Deep learning-based convolutional neural networks have recently proved their efficiency in providing fast segmentation of major brain fascicles structures, based on diffusion-weighted imaging. The quantitative analysis of brain fascicles then relies on metrics either coming from the tractography process itself or from each voxel along the bundle. Statistical detection of abnormal voxels in the context of disease usually relies on univariate and multivariate statistics models, such as the General Linear Model (GLM). Yet in the case of high-dimensional low sample size data, the GLM often implies high standard deviation range in controls due to anatomical variability, despite the commonly used smoothing process. This can lead to difficulties to detect subtle quantitative alterations from a brain bundle at the voxel scale. Here we introduce TractLearn, a unified framework for brain fascicles quantitative analyses by using geodesic learning as a data-driven learning task. TractLearn allows a mapping between the image high-dimensional domain and the reduced latent space of brain fascicles using a Riemannian approach. We illustrate the robustness of this method on a healthy population with test-retest acquisition of multi-shell diffusion MRI data, demonstrating that it is possible to separately study the global effect due to different MRI sessions from the effect of local bundle alterations. We have then tested the efficiency of our algorithm on a sample of 5 age-matched subjects referred with mild traumatic brain injury. Our contributions are to propose: 1/ A manifold approach to capture controls variability as standard reference instead of an atlas approach based on a Euclidean mean. 2/ A tool to detect global variation of voxels' quantitative values, which accounts for voxels' interactions in a structure rather than analyzing voxels independently. 3/ A ready-to-plug algorithm to highlight nonlinear variation of diffusion MRI metrics. With this regard, TractLearn is a ready-to-use algorithm for precision medicine.	[Attye, Arnaud; Renard, Felix; Baciu, Monica; Roger, Elise] Grenoble Alpes Univ Hosp, Neuroradiol & MRI, Grenoble, France; [Attye, Arnaud; Calamante, Fernando] Univ Sydney, Sch Biomed Engn, Sydney, NSW 2006, Australia; [Lamalle, Laurent] Univ Grenoble Alpes, Grenoble, France; [Lamalle, Laurent] IRMaGe, CNRS UMS 3552, Inserm US 17, Grenoble, France; [Dehail, Patrick; Cassoudesalle, Helene] Univ Hosp Bordeaux, Phys & Rehabil Med Dept, Bordeaux, France; [Dehail, Patrick; Cassoudesalle, Helene] Univ Bordeaux, HACS 2EA4136, Bordeaux, France; [Calamante, Fernando] Univ Sydney, Sydney Imaging, Sydney, NSW, Australia		Attye, A (corresponding author), Grenoble Alpes Univ Hosp, Neuroradiol & MRI, Grenoble, France.; Attye, A (corresponding author), Univ Sydney, Sch Biomed Engn, Sydney, NSW 2006, Australia.	arnaudattye@gmail.com	; ATTYE, Arnaud/W-3497-2018	Lamalle, Laurent/0000-0002-8930-7337; Cassoudesalle, Helene/0000-0002-9384-5410; Baciu, Monica/0000-0002-6842-1317; ROGER, Elise/0000-0003-1542-751X; ATTYE, Arnaud/0000-0002-0233-0367	Agence Nationale de la RechercheFrench National Research Agency (ANR)European Commission [ANR-12-EMMA-0056]; Alain Rahmouni grants of the French Society of Radiology; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Australian Research CouncilAustralian Research Council	The computation server used benefitted from the ERATRANIRMA project, by Agence Nationale de la Recherche [grant ANR-12-EMMA-0056] . We would like to acknowledge the funding from the Alain Rahmouni grants of the French Society of Radiology. This work was also supported by funding from the National Health and Medical Research Council of Australia and the Australian Research Council.	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Archdeacon T.J., 1994, CORRELATION REGRESSI; Barajas RF, 2013, AM J NEURORADIOL, V34, P1319, DOI 10.3174/ajnr.A3400; Batchelor PG, 2003, MAGN RESON MED, V49, P1143, DOI 10.1002/mrm.10491; Bender B, 2014, J MAGN RESON IMAGING, V40, P334, DOI 10.1002/jmri.24367; Bozzali M, 2011, NEUROIMAGE, V54, P2045, DOI 10.1016/j.neuroimage.2010.08.069; Calamante F, 2016, AM J NEURORADIOL, V37, P1066, DOI 10.3174/ajnr.A4721; Calamante F, 2017, MAGN RESON MATER PHY, V30, P317, DOI 10.1007/s10334-017-0608-1; Calamante F, 2015, NEUROIMAGE, V117, P284, DOI 10.1016/j.neuroimage.2015.05.070; Calamante F, 2012, NEUROIMAGE, V59, P2494, DOI 10.1016/j.neuroimage.2011.08.099; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Delgado R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222916; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; Fuster A., 2014, COMPUTATIONAL DIFFUS, P97, DOI [10.1007/978-3-319-02475-2_9, DOI 10.1007/978-3-319-02475-2_9]; Goh A, 2011, NEUROIMAGE, V56, P1181, DOI 10.1016/j.neuroimage.2011.01.053; Hao X, 2014, MED IMAGE ANAL, V18, P161, DOI 10.1016/j.media.2013.10.007; Hauberg S, 2015, LECT NOTES COMPUT SC, V9349, P597, DOI 10.1007/978-3-319-24553-9_73; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Khurd P, 2007, LECT NOTES COMPUT SC, V4584, P581; Kumar K, 2018, NEUROIMAGE, V183, P212, DOI 10.1016/j.neuroimage.2018.08.006; Kumar K, 2017, NEUROIMAGE, V158, P242, DOI 10.1016/j.neuroimage.2017.06.083; Nguyen LH, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006907; Lyksborg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095540; Mandelstam SA, 2012, AM J NEURORADIOL, V33, P1204, DOI 10.3174/ajnr.A2652; McInnes L., 2018, ARXIV180203426CSSTAT; Miller MI, 2004, NEUROIMAGE, V23, pS19, DOI 10.1016/j.neuroimage.2004.07.021; Mito R, 2018, BRAIN, V141, P888, DOI 10.1093/brain/awx355; Pannek K, 2011, NEUROIMAGE, V55, P133, DOI 10.1016/j.neuroimage.2010.12.010; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Raffelt D, 2012, MAGN RESON MED, V67, P844, DOI 10.1002/mrm.23058; Raffelt D, 2011, NEUROIMAGE, V56, P1171, DOI 10.1016/j.neuroimage.2011.02.014; Ronneberger O, 2015, LECT NOTES COMPUT SC, P234, DOI DOI 10.1007/978-3-319-24574-4_28; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Sun ZY, 2017, J PSYCHIATR NEUROSCI, V42, P27, DOI 10.1503/jpn.150291; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tilquin F, 2019, INT CONF ACOUST SPEE, P2867, DOI 10.1109/ICASSP.2019.8682472; Titsias M.K., 2004, P 16 INV C ADV NEUR; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Vik T, 2007, IEEE T PATTERN ANAL, V29, P901, DOI 10.1109/TPAMI.2007.1028; Wasserthal J, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101559; Wasserthal J, 2018, NEUROIMAGE, V183, P239, DOI 10.1016/j.neuroimage.2018.07.070; Willats L, 2014, NEUROIMAGE, V87, P18, DOI 10.1016/j.neuroimage.2013.11.016; Zhu B, 2018, NATURE, V555, P487, DOI 10.1038/nature25988; Ziegler E, 2014, NEUROIMAGE, V99, P498, DOI 10.1016/j.neuroimage.2014.06.033	51	1	1	2	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JUN	2021	233								117927	10.1016/j.neuroimage.2021.117927			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	RZ2MC	WOS:000648431300010	33689863	Green Submitted, Green Published, gold			2022-02-06	
J	Babenko, VA; Silachev, DN; Danilina, TI; Goryunov, KV; Pevzner, IB; Zorova, LD; Popkov, VA; Chernikov, VP; Plotnikov, EY; Sukhikh, GT; Zorov, DB				Babenko, Valentina A.; Silachev, Denis N.; Danilina, Tatyana I.; Goryunov, Kirill V.; Pevzner, Irina B.; Zorova, Ljubava D.; Popkov, Vasily A.; Chernikov, Valery P.; Plotnikov, Egor Y.; Sukhikh, Gennady T.; Zorov, Dmitry B.			Age-Related Changes in Bone-Marrow Mesenchymal Stem Cells	CELLS			English	Article						mitochondria; aging; senescence; stem; mesenchymal stromal cells; proliferation; glycolysis; oxidative phosphorylation; glucose utilization; traumatic brain injury; therapy	MITOCHONDRIAL PERMEABILITY TRANSITION; MECHANISMS; FRAGMENTATION; ISCHEMIA; BEHAVIOR; NEURONS; HEALTH; DEATH; ROS	The use of stem cells is part of a strategy for the treatment of a large number of diseases. However, the source of the original stem cells for use is extremely important and determines their therapeutic potential. Mesenchymal stromal cells (MSC) have proven their therapeutic effectiveness when used in a number of pathological models. However, it remains an open question whether the chronological age of the donor organism affects the effectiveness of the use of MSC. The asymmetric division of stem cells, the result of which is some residential stem cells acquiring a non-senile phenotype, means that stem cells possess an intrinsic ability to preserve juvenile characteristics, implying an absence or at least remarkable retardation of senescence in stem cells. To test whether residential MSC senesce, we evaluated the physiological changes in the MSC from old rats, with a further comparison of the neuroprotective properties of MSC from young and old animals in a model of traumatic brain injury. We found that, while the effect of administration of MSC on lesion volume was minimal, functional recovery was remarkable, with the highest effect assigned to fetal cells; the lowest effect was recorded for cells isolated from adult rats and postnatal cells, having intermediate potency. MSC from the young rats were characterized by a faster growth than adult MSC, correlating with levels of proliferating cell nuclear antigen (PCNA). However, there were no differences in respiratory activity of MSC from young and old rats, but young cells showed much higher glucose utilization than old ones. Autophagy flux was almost the same in both types of cells, but there were remarkable ultrastructural differences in old and young cells.	[Babenko, Valentina A.; Silachev, Denis N.; Danilina, Tatyana I.; Pevzner, Irina B.; Zorova, Ljubava D.; Popkov, Vasily A.; Plotnikov, Egor Y.; Zorov, Dmitry B.] Lomonosov Moscow State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia; [Babenko, Valentina A.; Silachev, Denis N.; Goryunov, Kirill V.; Pevzner, Irina B.; Zorova, Ljubava D.; Popkov, Vasily A.; Plotnikov, Egor Y.; Sukhikh, Gennady T.; Zorov, Dmitry B.] VI Kulakov Natl Med Res Ctr Obstet Gynecol & Peri, Moscow 117997, Russia; [Chernikov, Valery P.] Res Inst Human Morphol, Moscow 117418, Russia		Zorov, DB (corresponding author), Lomonosov Moscow State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia.; Sukhikh, GT; Zorov, DB (corresponding author), VI Kulakov Natl Med Res Ctr Obstet Gynecol & Peri, Moscow 117997, Russia.	nucleus-90@yandex.ru; silachevdn@belozersky.msu.ru; danilina.tatyana2010@yandex.ru; kirishgor@gmail.com; irinapevzner@mail.ru; lju_2003@list.ru; popkov.vas@gmail.com; 1200555@mail.ru; plotnikov@belozersky.msu.ru; gtsukhikh@mail.ru; zorov@belozersky.msu.ru	Silachev, Denis/ABE-8515-2020; Plotnikov, Egor Y/F-8592-2019; Zorova, Ljubava/AAC-7286-2022; Goryunov, Kirill/AAE-5774-2020; Zorov, Dmitry B./AAB-1738-2019	Plotnikov, Egor Y/0000-0003-2838-3704; Goryunov, Kirill/0000-0002-8776-7196; Zorov, Dmitry B./0000-0003-0863-8490	Russian Foundation for basic researchRussian Foundation for Basic Research (RFBR) [19-29-04090]	This research was funded by the Russian Foundation for basic research, grant number 19-29-04090.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Ahmed Abu Shufian Ishtiaq, 2017, World J Exp Med, V7, P1, DOI 10.5493/wjem.v7.i1.1; Anderlini P, 2017, BONE MARROW TRANSPL, V52, P15, DOI 10.1038/bmt.2016.201; Andrianova NV, 2020, AGING-US, V12, P18693, DOI 10.18632/aging.103960; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Fafian-Labora JA, 2019, WORLD J STEM CELLS, V11, P337, DOI 10.4252/wjsc.v11.i6.337; Aon MA, 2016, CLIN SCI, V130, P1285, DOI 10.1042/CS20160002; Babenko VA, 2018, MOLECULES, V23, DOI 10.3390/molecules23030687; Babenko VA, 2015, STEM CELL TRANSL MED, V4, P1011, DOI 10.5966/sctm.2015-0010; Fafian-Labora J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16765; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Galkin F, 2019, AGEING RES REV, V49, P104, DOI 10.1016/j.arr.2018.11.008; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Huffman DM, 2016, EXP GERONTOL, V86, P73, DOI 10.1016/j.exger.2016.05.012; HUNTER GR, 1969, BIOCHIM BIOPHYS ACTA, V180, P81, DOI 10.1016/0005-2728(69)90196-0; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Jazwinski SM, 2012, SUBCELL BIOCHEM, V57, P79, DOI 10.1007/978-94-007-2561-4_4; Jitschin R, 2019, LEUKEMIA, V33, P1783, DOI 10.1038/s41375-018-0376-6; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Karantalis V, 2015, CIRC RES, V116, P1413, DOI 10.1161/CIRCRESAHA.116.303614; Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384; Knorre DA, 2018, MECH AGEING DEV, V176, P24, DOI 10.1016/j.mad.2018.09.001; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Lo Furno D, 2018, J CELL PHYSIOL, V233, P3982, DOI 10.1002/jcp.26192; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Ma SM, 2015, CELL METAB, V22, P332, DOI 10.1016/j.cmet.2015.07.005; Mantovani C, 2012, EXP CELL RES, V318, P2034, DOI 10.1016/j.yexcr.2012.05.008; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Merry TL, 2020, AM J PHYSIOL-ENDOC M, V319, pE659, DOI 10.1152/ajpendo.00249.2020; MYRON DR, 1971, J CELL BIOL, V48, P291, DOI 10.1083/jcb.48.2.291; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Plotnikov EY, 2008, FEBS LETT, V582, P3117, DOI 10.1016/j.febslet.2008.08.002; Popkov VA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32801-8; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rottenberg H, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010079; Rottenberg H, 2017, AGING CELL, V16, P943, DOI 10.1111/acel.12650; Schallert T, 2000, CONT NEUROS, P131; Sheng GJ, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0094-5; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Silachev DN, 2009, B EXP BIOL MED+, V147, P269, DOI 10.1007/s10517-009-0489-z; Skulachev VP, 2002, ANN NY ACAD SCI, V959, P214, DOI 10.1111/j.1749-6632.2002.tb02095.x; Tompkins BA, 2017, J GERONTOL A-BIOL, V72, P1513, DOI 10.1093/gerona/glx137; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Weng SL, 2011, TAIWAN J OBSTET GYNE, V50, P447, DOI 10.1016/j.tjog.2011.10.009; Zorov DB, 1997, BIOSCIENCE REP, V17, P507, DOI 10.1023/A:1027304122259; ZOROV DB, 1992, J BIOENERG BIOMEMBR, V24, P119, DOI 10.1007/BF00769538; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020175; Zorov DB, 2017, J GERONTOL A-BIOL, V72, P1171, DOI 10.1093/gerona/glw184	55	1	1	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	JUN	2021	10	6							1273	10.3390/cells10061273			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	SX8NT	WOS:000665455100001	34063923	gold, Green Published			2022-02-06	
J	Berard, JA; Walker, LAS				Berard, Jason A.; Walker, Lisa A. S.			Increasing the Clinical Utility of the Paced Auditory Serial Addition Test: Normative Data for Standard, Dyad, and Cognitive Fatigability Scoring	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						PASAT; normative data; cognitive fatigability; fatigue	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; MINIMAL ASSESSMENT; SELF-REPORT; FATIGUE; PERFORMANCE; TASK; MECHANISMS; SCALE	Background: No normative data currently exist that would allow clinicians to decide whether the degree of cognitive fatigability (CF) experienced in individuals with neurologic disease is greater than expected when compared with a healthy population. Objective: To establish discrete and regression-based normative data for CF as defined by an objective decrement in performance over the course of a cognitive task; namely, the Paced Auditory Serial Addition Test (PASAT). In addition, to develop discrete and regression-based normative data for PASAT performance scores-dyad and percent dyad-for which data do not currently exist. Method: One hundred and seventy-eight healthy individuals completed the PASAT as part of a larger neuropsychological battery. PASAT performance scores including total correct responses, total dyads, and percent dyad were calculated. CF scores were calculated by comparing the individuals' performance on the first half (or third) of the test to their performance on the last half (or third) in order to capture any within-task performance decrements over time. Results: Both age- and education-based discrete normative data and demographically adjusted (sex, age, and education) regression-based formulas were established for the PASAT performance scores and the CF scores. Conclusion: The development of these normative data will allow for greater interpretation of an individual's performance on the PASAT, beyond just the total correct score, through the use of dyad and percent dyad scores. With respect to CF, these data will allow clinicians to objectively quantify decrements in cognitive performance over time better in individuals with neurologic diseases.	[Berard, Jason A.; Walker, Lisa A. S.] Ottawa Hosp Res Inst, Dept Psychol, Ottawa, ON, Canada; [Walker, Lisa A. S.] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada; [Walker, Lisa A. S.] Carleton Univ, Dept Psychol, Ottawa, ON, Canada		Berard, JA (corresponding author), Ottawa Hosp Res Inst, 501 Smyth Rd,Suite 7300, Ottawa, ON K1H 8L6, Canada.	jberard@ohri.ca	Walker, Lisa/AAH-7842-2019	Walker, Lisa/0000-0001-5865-7257	Multiple Sclerosis Society of Canada; University of Ottawa Brain and Mind Research Institute; Bayer HealthCare PharmaceuticalsBayer AGBayer Healthcare Pharmaceuticals	Supported in part by the Multiple Sclerosis Society of Canada, University of Ottawa Brain and Mind Research Institute, and Bayer HealthCare Pharmaceuticals.	Amtmann D, 2012, REHABIL PSYCHOL, V57, P159, DOI 10.1037/a0027890; Bailey A, 2007, MULT SCLER J, V13, P73, DOI 10.1177/1352458506071162; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; Berard JA, 2019, ARCH CLIN NEUROPSYCH, V34, P31, DOI 10.1093/arclin/acy014; Berard Jason A, 2018, Int J MS Care, V20, P55, DOI 10.7224/1537-2073.2016-106; Braley TJ, 2010, SLEEP, V33, P1061, DOI 10.1093/sleep/33.8.1061; Brassington JC, 1998, NEUROPSYCHOL REV, V8, P43, DOI 10.1023/A:1025621700003; Bryant D, 2004, REHABIL PSYCHOL, V49, P114, DOI 10.1037/0090-5550.49.2.114; Cleare AJ, 2003, ENDOCR REV, V24, P236, DOI 10.1210/er.2002-0014; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; De Doncker W, 2018, J NEUROL NEUROSUR PS, V89, P287, DOI 10.1136/jnnp-2017-316007; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Fisk JD, 2001, J INT NEUROPSYCH SOC, V7, P363, DOI 10.1017/S1355617701733103; Forwell SJ., 2008, INT J MS CARE, V10, P14; Fuchs TA, 2019, MULT SCLER RELAT DIS, V27, P298, DOI 10.1016/j.msard.2018.11.005; Ghajarzadeh M, 2013, ACTA NEUROL BELG, V113, P411, DOI 10.1007/s13760-013-0198-2; Gonzalez R, 2006, CLIN NEUROPSYCHOL, V20, P396, DOI 10.1080/13854040590967559; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Heesen C, 2006, J NEUROL NEUROSUR PS, V77, P34, DOI 10.1136/jnnp.2005.065805; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Linnhoff S, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9050100; Lorist MM, 2009, BRAIN RES, V1270, P95, DOI 10.1016/j.brainres.2009.03.015; Michael KM, 2006, REHABIL NURS, V31, P210, DOI 10.1002/j.2048-7940.2006.tb00137.x; Moller MC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00496; Morrow SA, 2015, COGN BEHAV NEUROL, V28, P27, DOI 10.1097/WNN.0000000000000050; Parmenter BA, 2003, MULT SCLER, V9, P111, DOI 10.1191/1352458503ms859oa; Parmenter BA, 2010, J INT NEUROPSYCH SOC, V16, P6, DOI 10.1017/S1355617709990750; Paul RH, 1998, APPL NEUROPSYCHOL, V5, P143, DOI 10.1207/s15324826an0503_5; Penner IK, 2009, MULT SCLER J, V15, P1509, DOI 10.1177/1352458509348519; Prak RF, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01919; Sandry J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00214; Schwid SR, 2002, J REHABIL RES DEV, V39, P211; Strober LB, 2005, ARCH CLIN NEUROPSYCH, V20, P631, DOI 10.1016/j.acn.2005.04.002; Tartaglia MC, 2004, ARCH NEUROL-CHICAGO, V61, P201, DOI 10.1001/archneur.61.2.201; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Walker LAS, 2012, J NEUROL SCI, V316, P86, DOI 10.1016/j.jns.2012.01.021; Walker LAS, 2017, CAN J NEUROL SCI, V44, P547, DOI 10.1017/cjn.2017.199; Wylie GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08846-6; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	44	1	1	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	JUN	2021	34	2					107	116		10.1097/WNN.0000000000000268			10	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	SK4NN	WOS:000656194400003	34074865				2022-02-06	
J	Bolus, MF; Willats, AA; Rozell, CJ; Stanley, GB				Bolus, M. F.; Willats, A. A.; Rozell, C. J.; Stanley, G. B.			State-space optimal feedback control of optogenetically driven neural activity	JOURNAL OF NEURAL ENGINEERING			English	Article						closed-loop; control; estimation; optogenetics; state space; thalamus; firing rate; in vivo	CLOSED-LOOP; MODEL; DYNAMICS; PROBES; LIGHT	Objective. The rapid acceleration of tools for recording neuronal populations and targeted optogenetic manipulation has enabled real-time, feedback control of neuronal circuits in the brain. Continuously-graded control of measured neuronal activity poses a wide range of technical challenges, which we address through a combination of optogenetic stimulation and a state-space optimal control framework implemented in the thalamocortical circuit of the awake mouse. Approach. Closed-loop optogenetic control of neurons was performed in real-time via stimulation of channelrhodopsin-2 expressed in the somatosensory thalamus of the head-fixed mouse. A state-space linear dynamical system model structure was used to approximate the light-to-spiking input-output relationship in both single-neuron as well as multi-neuron scenarios when recording from multielectrode arrays. These models were utilized to design state feedback controller gains by way of linear quadratic optimal control and were also used online for estimation of state feedback, where a parameter-adaptive Kalman filter provided robustness to model-mismatch. Main results. This model-based control scheme proved effective for feedback control of single-neuron firing rate in the thalamus of awake animals. Notably, the graded optical actuation utilized here did not synchronize simultaneously recorded neurons, but heterogeneity across the neuronal population resulted in a varied response to stimulation. Simulated multi-output feedback control provided better control of a heterogeneous population and demonstrated how the approach generalizes beyond single-neuron applications. Significance. To our knowledge, this work represents the first experimental application of state space model-based feedback control for optogenetic stimulation. In combination with linear quadratic optimal control, the approaches laid out and tested here should generalize to future problems involving the control of highly complex neural circuits. More generally, feedback control of neuronal circuits opens the door to adaptively interacting with the dynamics underlying sensory, motor, and cognitive signaling, enabling a deeper understanding of circuit function and ultimately the control of function in the face of injury or disease.	[Bolus, M. F.; Willats, A. A.; Stanley, G. B.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Bolus, M. F.; Willats, A. A.; Stanley, G. B.] Emory Univ, Atlanta, GA 30332 USA; [Rozell, C. J.] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA		Stanley, GB (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Stanley, GB (corresponding author), Emory Univ, Atlanta, GA 30332 USA.	garrett.stanley@bme.gatech.edu		Stanley, Garrett/0000-0003-2039-7706	NIH/NINDS Collaborative Research in Computational Neuroscience (CRCNS)/BRAIN [R01NS115327]; NIH/NINDS BRAIN [R01NS104928]; NSF Graduate Research FellowshipNational Science Foundation (NSF) [DGE1650044]; J. Norman and Rosalyn Wells Fellowship; NIH/NIDA GT/Emory Computational Neuroscience Training Grant [T90DA032466]; NSF GrantNational Science Foundation (NSF) [CCF-1409422]; James S. McDonnell Foundation [220020399]	This work was supported by the NIH/NINDS Collaborative Research in Computational Neuroscience (CRCNS)/BRAIN Grant R01NS115327 (GBS and CJR) and NIH/NINDS BRAIN Grant R01NS104928 (GBS). MFB was supported by an NSF Graduate Research Fellowship Grant DGE1650044 and the J. Norman and Rosalyn Wells Fellowship. AAW was supported by the NIH/NIDA GT/Emory Computational Neuroscience Training Grant T90DA032466. CJR was additionally supported by NSF Grant CCF-1409422, and James S. McDonnell Foundation Grant 220020399.	Ahmadian Y, 2011, J NEUROPHYSIOL, V106, P1038, DOI 10.1152/jn.00427.2010; Archer E. W., 2014, ADV NEURAL INFORM PR, V27, P343; Astrom K. J., 2008, FEEDBACK SYSTEMS INT; Bavdekar VA., 2013, IFAC P, V46, P184, DOI [10.3182/20131218-3-IN-2045.00175, DOI 10.3182/20131218-3-IN-2045.00175]; Bolus MF, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaa506; Boyd S., 2018, INTRO APPL LINEAR AL, DOI [10.1017/9781108583664, DOI 10.1017/9781108583664]; Britten KH, 1999, J NEUROSCI, V19, P5074; Chen Z., 2018, DYNAMIC NEUROSCIENCE, DOI [10.1007/978-3-319-71976-4, DOI 10.1007/978-3-319-71976-4]; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Ching SN, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00054; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Ehrens D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00058; Eleryan Ahmed, 2014, Front Neuroeng, V7, P23, DOI 10.3389/fneng.2014.00023; Estebanez L, 2012, NAT NEUROSCI, V15, P1691, DOI 10.1038/nn.3258; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fong MF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7339; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Harris KD., 2016, P ADV NEUR INF PROC, V29, P4448, DOI DOI 10.1101/061481; Hell F, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00314; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Iolov A, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046004; Jun JJ, 2017, NATURE, V551, P232, DOI 10.1038/nature24636; Kalm R.E., 1960, J BASIC ENG-T ASME, V82D, P35, DOI [DOI 10.1115/1.3662552, 10.1115/1.3662552]; Kozak G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06684-0; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Latchoumane CFV, 2017, NEURON, V95, P424, DOI 10.1016/j.neuron.2017.06.025; Linder SP, 1997, PROCEEDINGS OF THE 1997 IEEE INTERNATIONAL CONFERENCE ON CONTROL APPLICATIONS, P475, DOI 10.1109/CCA.1997.627699; Liu JB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045002; Macke JH., 2011, ADV NEURAL INFORM PR, V24, P1350; McFarland JM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003143; Millard DC, 2015, J NEUROSCI, V35, P15702, DOI 10.1523/JNEUROSCI.5045-14.2015; Nandi A, 2016, P AMER CONTR CONF, P5779, DOI 10.1109/ACC.2016.7526575; Nawrot MP, 2008, J NEUROSCI METH, V169, P374, DOI 10.1016/j.jneumeth.2007.10.013; Newman JP, 2015, ELIFE, V4, DOI 10.7554/eLife.07192; O'Connor DH, 2013, NAT NEUROSCI, V16, P958, DOI 10.1038/nn.3419; Okun M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151180; Oweiss KG, 2010, STATISTICAL SIGNAL PROCESSING FOR NEUROSCIENCE AND NEUROTECHNOLOGY, P1; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Paninski L, 2010, J COMPUT NEUROSCI, V29, P107, DOI 10.1007/s10827-009-0179-x; Park M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002219; Patel YA, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005430; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Rawlings JB, 2000, IEEE CONTR SYST MAG, V20, P38, DOI 10.1109/37.845037; Sahani M., 2003, ADV NEURAL INFORM PR, P125; Sanderson C., 2016, J OPEN SOURCE SOFTW, V1, P26, DOI [DOI 10.21105/JOSS.00026, 10.21105/joss.00026]; Santaniello S, 2011, IEEE T NEUR SYS REH, V19, P15, DOI 10.1109/TNSRE.2010.2081377; Schiff SJ, 2010, PHILOS T R SOC A, V368, P2269, DOI 10.1098/rsta.2010.0050; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Sederberg AJ, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006716; Shafai B., 1995, Proceedings of the Third European Control Conference. ECC 95, P520; Shanechi MM, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004730; Shumway R. H., 1982, Journal of Time Series Analysis, V3, P253, DOI 10.1111/j.1467-9892.1982.tb00349.x; Smith AC, 2003, NEURAL COMPUT, V15, P965, DOI 10.1162/089976603765202622; Srinivasan SS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07721-w; Stanley GB, 2013, NAT NEUROSCI, V16, P259, DOI 10.1038/nn.3330; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; Stujenske JM, 2015, CELL REP, V12, P525, DOI 10.1016/j.celrep.2015.06.036; Todorov E, 2005, P AMER CONTR CONF, P300, DOI 10.1109/ACC.2005.1469949; Trautmann EM, 2019, NEURON, V103, P292, DOI 10.1016/j.neuron.2019.05.003; Ullah G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.040901; Van Overschee P., 1996, SUBSPACE IDENTIFICAT, DOI [10.1007/978-1-4613-0465-4, DOI 10.1007/978-1-4613-0465-4]; Wang Q, 2010, NAT NEUROSCI, V13, P1534, DOI 10.1038/nn.2670; Wu F, 2015, NEURON, V88, P1136, DOI 10.1016/j.neuron.2015.10.032; Yang WJ, 2017, NAT METHODS, V14, P349, DOI 10.1038/nmeth.4230; Yang YX, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aad1a8; Zhang ZH, 2018, NAT METHODS, V15, P1037, DOI 10.1038/s41592-018-0183-z; Zoltowski DM, 2018, ADV NEUR IN, V31	70	1	1	1	2	IOP Publishing Ltd	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	JUN	2021	18	3							036006	10.1088/1741-2552/abb89c			23	Engineering, Biomedical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	YC2LR	WOS:000739528200001	32932241	Green Accepted, Green Submitted			2022-02-06	
J	Cohn, JE; Melley, LE; Lafferty, D; Othman, S; Stucker, FJ; Bundrick, P				Cohn, Jason E.; Melley, Lauren E.; Lafferty, David; Othman, Sammy; Stucker, Fred J.; Bundrick, Paige			Adult Maxillofacial Trauma Patterns in American Football	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Facial trauma; football; maxillofacial trauma; NEISS; otolaryngology	PSYCHOLOGICAL SEQUELAE; FACIAL TRAUMA; HIGH-SCHOOL; INJURIES; CONCUSSION; EPIDEMIOLOGY; DIAGNOSIS; SPORTS	Introduction: The authors aimed to identify and categorize adult maxillofacial trauma patterns in the setting of American football. Methods: The National Electronic Injury Surveillance System was accessed to identify adult patients presenting with football-related head and facial injuries from 2009 to 2018. Data surrounding each event were collected including age, injury type, injury location, and disposition of the patient. Chi-squared testing was performed to compare categorical variables, with a Bonferroni correction applied. Results: During the study period, 1784 total patients (national estimate = 65,052) were identified. The average age for this cohort was 27.26 (SD +/- 8.49), with young adults (86.1%) and males (87.9%) sustaining the majority of injuries. Lacerations were the most common injury type (43.1%). Maxillofacial fractures comprised 15.8% of the sample, with nasal bone (52.8%) being the most common subtype. Female patients were significantly more likely to present with head injuries than men (46.8% versus 29.0%, P < 0.001). Young and middle-aged adults combined were more likely to be discharged from the emergency department, whereas the elderly were significantly less likely (P = 0.002). Patients with fractures were significantly more likely to be admitted to the hospital compared to all other types of injuries (P < 0.001). Conclusions: An understanding of maxillofacial injuries while participating in American football is important in developing safety initiatives. To address these, it is crucial that providers understand the patterns of craniofacial injuries as they relate to American football trauma.	[Cohn, Jason E.; Stucker, Fred J.; Bundrick, Paige] Ochsner LSU Hlth, Div Facial Plast Reconstruct Surg, Dept Otolaryngol Head & Neck Surg, 1501 Kings Highway, Shreveport, LA 71103 USA; [Melley, Lauren E.] Philadelphia Coll Osteopath Med, 4190 City Line Ave, Philadelphia, PA USA; [Lafferty, David] Philadelphia Coll Osteopath Med, Dept Otolaryngol Head & Neck Surg, 4190 City Line Ave, Philadelphia, PA USA; [Othman, Sammy] Drexel Univ, Coll Med, 2900 West Queen Lane, Philadelphia, PA 19104 USA		Cohn, JE (corresponding author), Ochsner LSU Hlth, Div Facial Plast Reconstruct Surg, Dept Otolaryngol Head & Neck Surg, 1501 Kings Highway, Shreveport, LA 71103 USA.	jcohn@lsuhsc.edu					Bartley JH., 2017, ORTHOP J SPORTS MED, V5, P1; Bisson JI, 1997, J TRAUMA, V43, P496, DOI 10.1097/00005373-199709000-00018; Bobian MR, 2016, ANN OTO RHINOL LARYN, V125, P992, DOI 10.1177/0003489416668195; Carniol ET, 2015, OTOLARYNG HEAD NECK, V153, P957, DOI 10.1177/0194599815602668; Chorney SR, 2017, LARYNGOSCOPE, V127, P1296, DOI 10.1002/lary.26441; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Fuentes E, 2017, AN ACAD BRAS CIENC, V89, P285, DOI 10.1590/0001-3765201720160487; Glynn SM, 2010, ORAL MAXIL SURG CLIN, V22, P217, DOI 10.1016/j.coms.2010.01.008; Gough C., 2020, NFL MONDAY NIGHT FOO; Gough C., 2020, NFL REVENUE YEAR; Grabow H, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01963; Guys NP, 2018, INT J PEDIATR OTORHI, V111, P153, DOI 10.1016/j.ijporl.2018.06.009; Harmon KJ., 2018, INJURY EPIDEMIOLOGY; Hojjat H, 2016, ANN OTO RHINOL LARYN, V125, P652, DOI 10.1177/0003489416644617; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Kellman RM, 2014, FACIAL PLAST SURG CL, V22, P559, DOI 10.1016/j.fsc.2014.07.009; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Lawrence LA, 2015, LARYNGOSCOPE, V125, P589, DOI 10.1002/lary.24893; Lock S., 2020, TACKLE FOOTBALL NUMB; Mendelson B, 2012, AESTHET PLAST SURG, V36, P753, DOI 10.1007/s00266-012-9904-3; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Norman J., 2018, FOOTBALL STILL AM FA; Othman S, 2019, CRANIOMAX TRAUM REC, V12, P266, DOI 10.1055/s-0039-1679930; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Perkins S W, 2000, Ear Nose Throat J, V79, P632; Plawecki A, 2017, JAMA FACIAL PLAST SU, V19, P453, DOI 10.1001/jamafacial.2017.0332; Povolotskiy R, 2019, ANN OTO RHINOL LARYN, V128, P516, DOI 10.1177/0003489419830114; Romeo SJ, 2005, PHYSICIAN SPORTSMED, V33, P45, DOI 10.3810/psm.2005.04.73; Scheffler P, 2019, INT J PEDIATR OTORHI, V121, P6, DOI 10.1016/j.ijporl.2019.02.036; Shannon-Missal L., 2016, PRO FOOTBALL STILL A; Sproule DW, 2017, P I MECH ENG P-J SPO, V231, P317, DOI 10.1177/1754337117703019; Vondracek SF, 2009, CLIN INTERV AGING, V4, P121; Williams RJ, 2001, AM J SPORT MED, V29, P55, DOI 10.1177/03635465010290011401; Wu BW, 2020, J ORAL MAXIL SURG, V78, P588, DOI 10.1016/j.joms.2019.11.031	39	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1567	1570		10.1097/SCS.0000000000007399			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100107	33405450				2022-02-06	
J	Converse, MI; Monson, KL				Converse, Matthew, I; Monson, Kenneth L.			Biaxial softening of isolated cerebral arteries following axial overstretch	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Traumatic brain injury; Arterial softening; Overstretch; Passive biaxial mechanical properties	BRAIN-INJURY; MECHANICAL-BEHAVIOR; SUBFAILURE INJURY; FAILURE; DAMAGE; ANGIOPLASTY; RELAXATION; RECOVERY; COLLAGEN; LIGAMENT	Arteries play a critical role in carrying essential nutrients and oxygen throughout the brain; however, vessels can become damaged in traumatic brain injury (TBI), putting neural tissue at risk. Even in the absence of hemorrhage, large deformations can disrupt both the physiological and mechanical behavior of the cerebral vessels. Our group recently reported the effect of vessel overstretch on axial mechanics; however, that work did not address possible changes in circumferential mechanics that are critical to the regulation of blood flow. In order to address this in the present work, ovine middle cerebral arteries were isolated and overstretched axially to 10, 20, or 40% beyond the in vivo configuration. Results showed a statistically significant decrease in circumferential stiffness and strain energy, as well as an increase in vessel diameter following 40% overstretch (p < 0.05). These passive changes would lead to a decrease in vascular resistance and likely play a role in previous reports of cellular dysfunction. We anticipate that our findings will both increase understanding of vessel softening phenomena and also promote improved modeling of cerebrovascular mechanics following head trauma.	[Converse, Matthew, I; Monson, Kenneth L.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA; [Monson, Kenneth L.] Univ Utah, Dept Biomed Engn, Salt Lake City, UT 84112 USA		Monson, KL (corresponding author), Univ Utah, Mech Engn, 1495 E 100 S MEK 1550, Salt Lake City, UT 84112 USA.	ken.monson@utah.edu		Monson, Ken/0000-0002-8461-6034	Integrated Sciences Award from the Primary Children's Medical Center Foundation	This work was supported by an Integrated Sciences Award from the Primary Children's Medical Center Foundation. The funding sources were not involved in the study design, in the collection, analysis, and interpretation article. We thank Gary's Meats in Payson, Utah for supply of sheep heads.	Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Armstead WM, 1999, EXP TOXICOL PATHOL, V51, P137, DOI 10.1016/S0940-2993(99)80087-6; Bell ED, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039625; Bell ED, 2017, J MECH BEHAV BIOMED, V65, P627, DOI 10.1016/j.jmbbm.2016.09.028; Bell ED, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00002; Bell ED, 2013, J BIOMECH, V46, P91, DOI 10.1016/j.jbiomech.2012.10.015; Converse MI, 2018, ACTA BIOMATER, V67, P307, DOI 10.1016/j.actbio.2017.11.052; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Dixon DA, 1996, ENVIRONMENTAL GEOTECHNICS, VOL 1, P43; Duenwald SE, 2009, ANN BIOMED ENG, V37, P1131, DOI 10.1007/s10439-009-9687-0; Duenwald-Kuehl S., 2012, ANN BIOMED ENG, P1; Emery JL, 1997, J BIOMECH ENG-T ASME, V119, P6, DOI 10.1115/1.2796067; Faul M, 2010, TRAUMATIC BRAIN INJU; Gregersen H, 1998, ANN BIOMED ENG, V26, P850, DOI 10.1114/1.109; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hayenga HN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00420; Humphrey JD, 1995, CRIT REV BIOMED ENG, V23, P1; itny R., 2010, B APPL MECH, V6, P1, DOI DOI 10.1007/978-3-642-13039-7_194; JAMAL A, 1992, ARTERIOSCLER THROMB, V12, P307, DOI 10.1161/01.ATV.12.3.307; LANGFITT TW, 1977, ANN SURG, V186, P411, DOI 10.1097/00000658-197710000-00002; Maher E, 2012, J MECH BEHAV BIOMED, V12, P9, DOI 10.1016/j.jmbbm.2012.03.001; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Meaney D.F., 1990, P 1990 INT IRCOBI C, P215; Monson K. L. V., 2001, MECH FAILURE PROPERT; Monson KL, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002935; Monson KL, 2008, ANN BIOMED ENG, V36, P2028, DOI 10.1007/s10439-008-9578-9; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Oktay H.S., 1993, CONTINUUM DAMAGE MEC; Panjabi MM, 1996, J ORTHOP RES, V14, P216, DOI 10.1002/jor.1100140208; Panjabi MM, 1999, CLIN BIOMECH, V14, P24, DOI 10.1016/S0268-0033(98)00046-1; Panjabi MM, 2001, CLIN BIOMECH, V16, P334, DOI 10.1016/S0268-0033(01)00007-9; Pollock RG, 2000, J SHOULDER ELB SURG, V9, P427, DOI 10.1067/mse.2000.108388; Provenzano PP, 2002, J APPL PHYSIOL, V92, P362, DOI 10.1152/jappl.2002.92.1.362; Quinn K.P., 2007, LOADING; Sliker CW, 2008, RADIOGRAPHICS, V28, P1689, DOI 10.1148/rg.286085521; Stemper BD, 2005, J BIOMECH, V38, P2491, DOI 10.1016/j.jbiomech.2004.10.021; VANLOON P, 1977, BIORHEOLOGY, V14, P181; Weisbecker H, 2013, J BIOMECH, V46, P1859, DOI 10.1016/j.jbiomech.2013.04.025; Weisbecker H, 2012, J MECH BEHAV BIOMED, V12, P93, DOI 10.1016/j.jmbbm.2012.03.012; Wicker BK, 2008, COMPUT METHOD BIOMEC, V11, P539, DOI 10.1080/10255840801949793; YAMAMOTO Y, 1992, NEUROSURGERY, V30, P1; ZOLLIKOFER CL, 1984, RADIOLOGY, V153, P369, DOI 10.1148/radiology.153.2.6237385; ZUBKOV Y, 1993, DEVEL NEUR, V8, P325	45	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JUN	2021	118								104447	10.1016/j.jmbbm.2021.104447			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	RY2QI	WOS:000647761600004	33725523				2022-02-06	
J	Correll, EA; Ramser, BJ; Knott, MV; McCullumsmith, RE; McGuire, JL; Ngwenya, LB				Correll, Erika A.; Ramser, Benjamin J.; Knott, Maxon, V; McCullumsmith, Robert E.; McGuire, Jennifer L.; Ngwenya, Laura B.			Deficits in pattern separation and dentate gyrus proliferation after rodent lateral fluid percussion injury	IBRO NEUROSCIENCE REPORTS			English	Article						Traumatic brain injury; Adult neurogenesis; Hippocampus	TRAUMATIC BRAIN-INJURY; ADULT HIPPOCAMPAL NEUROGENESIS; INDUCED CELL-PROLIFERATION; COGNITIVE RECOVERY; SURVIVAL; PHOSPHORYLATION; INHIBITION; NEURONS; MEMORY; BLAST	It has been demonstrated that adult born granule cells are generated after traumatic brain injury (TBI). There is evidence that these newly generated neurons are aberrant and are poised to contribute to poor cognitive function after TBI. Yet, there is also evidence that these newly generated neurons are important for cognitive recovery. Pattern separation is a cognitive task known to be dependent on the function of adult generated granule cells. Performance on this task and the relation to dentate gyrus dysfunction after TBI has not been previously studied. Here we subjected Sprague Dawley rats to lateral fluid percussion injury or sham and tested them on the dentate gyrus dependent task pattern separation. At 2 weeks after injury, we examined common markers of dentate gyrus function such as GSK3 beta phosphorylation, Ki-67 immunohistochemistry, and generation of adult born granule cells. We found that injured animals have deficits in pattern separation. We additionally found a decrease in proliferative capacity at 2 weeks indicated by decreased phosphorylation of GSK3 beta and Ki-67 immunopositivity as compared to sham animals. Lastly we found an increase in numbers of new neurons generated during the pattern separation task. These findings provide evidence that dentate gyrus dysfunction may be an important contributor to TBI pathology.	[Correll, Erika A.; McGuire, Jennifer L.; Ngwenya, Laura B.] Univ Cincinnati, Dept Neurosurg, 231 Albert Sabin Way,MSB 5251, Cincinnati, OH 45267 USA; [Ramser, Benjamin J.] Univ Cincinnati, Coll Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Knott, Maxon, V] Univ Cincinnati, 2600 Clifton Ave, Cincinnati, OH 45221 USA; [McCullumsmith, Robert E.] Univ Toledo, Coll Med & Life Sci, 2801W Bancroft St, Toledo, OH 43606 USA; [McCullumsmith, Robert E.] ProMed Toledo Hosp, 1 ProMed Pkwy, Toledo, OH 43606 USA; [Ngwenya, Laura B.] Univ Cincinnati, Dept Neurol & Rehabil Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Correll, Erika A.] Univ Massachusetts, Neurosci & Behav Grad Program, 230 Stockbridge Rd, Amherst, MA 01003 USA		Ngwenya, LB (corresponding author), Univ Cincinnati, Dept Neurosurg, 231 Albert Sabin Way,MSB 5251, Cincinnati, OH 45267 USA.	laura.ngwenya@uc.edu		McGuire, Jennifer/0000-0003-3058-5241; Correll, Erika/0000-0002-4761-1955	University of Cincinnati Gardner Neurosciences Institute Neurobiology Research Center Pilot Grant; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS110988]	This research was supported by a University of Cincinnati Gardner Neurosciences Institute Neurobiology Research Center Pilot Grant (LBN) and by NIH/NINDS K08NS110988 (LBN).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Berron D, 2016, J NEUROSCI, V36, P7569, DOI 10.1523/JNEUROSCI.0518-16.2016; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Encinas JM, 2012, BEHAV BRAIN RES, V227, P433, DOI 10.1016/j.bbr.2011.10.010; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Hagihara Hideo, 2009, J Vis Exp, DOI 10.3791/1543; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kirshner ZZ, 2018, MOL CELL ENDOCRINOL, V473, P156, DOI 10.1016/j.mce.2018.01.015; Korgaonkar AA, 2020, BRAIN BEHAV IMMUN, V88, P381, DOI 10.1016/j.bbi.2020.03.035; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; McGuire JL, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104611; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Morris AM, 2012, NEUROBIOL LEARN MEM, V97, P326, DOI 10.1016/j.nlm.2012.02.005; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Ngwenya LB, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01014; Ngwenya LB, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/4209821; Ngwenya LB, 2005, J HISTOCHEM CYTOCHEM, V53, P821, DOI 10.1369/jhc.4A6605.2005; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Pardo M, 2016, GENES BRAIN BEHAV, V15, P348, DOI 10.1111/gbb.12283; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Shapiro LA, 2017, CELL TRANSPLANT, V26, P1314, DOI 10.1177/0963689717714099; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toth Z, 1997, J NEUROSCI, V17, P8106; Van KC, 2016, METHODS MOL BIOL, V1462, P231, DOI 10.1007/978-1-4939-3816-2_14; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang YS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00413; Wu XM, 2013, INT J CLIN EXP PATHO, V6, P1282; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	53	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2667-2421			IBRO NEUROSCI REP	IBRO Neurosci. Rep.	JUN	2021	10	1					31	41		10.1016/j.ibneur.2020.11.005			11	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	SP9EN	WOS:000659965500005	33861814	gold, Green Published			2022-02-06	
J	Cournoyer, J; Koncan, D; Gilchrist, MD; Hoshizaki, TB				Cournoyer, Janie; Koncan, David; Gilchrist, Michael D.; Hoshizaki, T. Blaine			The Influence of Neck Stiffness on Head Kinematics and Maximum Principal Strain Associated With Youth American Football Collisions	JOURNAL OF APPLIED BIOMECHANICS			English	Article						neckform; brain injury; helmet testing	MUSCLE STRENGTH; IMPACT EXPOSURE; ACCELERATION; SIMULATIONS; CONCUSSION; CHILDREN; PLAYERS; GENDER	Understanding the relationship between head mass and neck stiffness during direct head impacts is especially concerning in youth sports where athletes have higher proportional head mass to neck strength. This study compared 2 neck stiffness conditions for peak linear and rotational acceleration and brain tissue deformations across 3 impact velocities, 3 impact locations, and 2 striking masses. A pendulum fitted with a nylon cap was used to impact a fifth percentile hybrid III headform equipped with 9 accelerometers and fitted with a youth American football helmet. The 2 neck stiffness conditions consisted of a neckform with and without resistance in 3 planes, representing the upper trapezius, the splenius capitis, and the sternocleidomastoid muscles. Increased neck stiffness resulted in significant changes in head kinematics and maximum principal strain specific to impact velocity, impact location, and striking mass.	[Cournoyer, Janie; Koncan, David; Hoshizaki, T. Blaine] Univ Ottawa, Neurotrauma Impact Sci Lab, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Dept Mech Engn, Dublin, Ireland		Cournoyer, J (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, Ottawa, ON, Canada.	jcournoy@uottawa.ca			National Operating Committee on Sport Safety Equipment	This study was funded by the National Operating Committee on Sport Safety Equipment. The authors would like to thank Riddell for providing the helmets used in this study.	Campolettano Eamon T, 2018, Proc Int IRCOBI Conf Biomech Impacts, V2018, P326; Chenoweth L, 1937, SCH HLTH PROBLEMS; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; DeGoede KM, 2003, J BIOMECH, V36, P413, DOI 10.1016/S0021-9290(02)00396-2; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Hager-Ross C, 2002, ACTA PAEDIATR, V91, P617, DOI 10.1080/080352502760068990; Hamilton DF, 2012, BONE JOINT RES, V1, P152, DOI 10.1302/2046-3758.17.2000079; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Huelke DF, 1998, P ANN C ASS, P93; Jin X, 2017, J BIOMED ENG, V139, P1; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; NELLHAUS G, 1968, PEDIATRICS, V41, P106; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Post A, 2017, SPORTS ENG, V20, P111, DOI 10.1007/s12283-016-0219-5; Rousseau Philippe, 2010, Stapp Car Crash J, V54, P37; Sandler R, 2001, J BIOMECH ENG-T ASME, V123, P590, DOI 10.1115/1.1408940; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Vickers VS, 1943, J PEDIATR-US, V22, P155, DOI 10.1016/S0022-3476(43)80074-3; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	27	1	1	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	JUN	2021	37	3					288	295		10.1123/jab.2020-0070			8	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	SH8HX	WOS:000654374000017	33690168				2022-02-06	
J	DeVience, SJ; Lu, X; Proctor, JL; Rangghran, P; Medina, JA; Melhem, ER; Gullapalli, RP; Fiskum, G; Mayer, D				DeVience, Stephen J.; Lu, Xin; Proctor, Julie L.; Rangghran, Parisa; Medina, Juliana A.; Melhem, Elias R.; Gullapalli, Rao P.; Fiskum, Gary; Mayer, Dirk			Enhancing Metabolic Imaging of Energy Metabolism in Traumatic Brain Injury Using Hyperpolarized [1-C-13]Pyruvate and Dichloroacetate	METABOLITES			English	Article						traumatic brain injury; magnetic resonance spectroscopic imaging; hyperpolarized metabolic imaging; pyruvate dehydrogenase; controlled cortical impact	IN-VIVO; PYRUVATE; LACTATE; RAT	Hyperpolarized magnetic resonance spectroscopic imaging (MRSI) of [1-C-13]pyruvate metabolism has previously been used to assess the effects of traumatic brain injury (TBI) in rats. Here, we show that MRSI can be used in conjunction with dichloroacetate to measure the phosphorylation state of pyruvate dehydrogenase (PDH) following mild-to-moderate TBI, and that measurements can be repeated in a longitudinal study to monitor the course of injury progression and recovery. We found that the level of C-13-bicarbonate and the bicarbonate-to-lactate ratio decreased on the injured side of the brain four hours after injury and continued to decrease through day 7. Levels recovered to normal by day 28. Measurements following dichloroacetate administration showed that PDH was inhibited equally by PDH kinase (PDK) on both sides of the brain. Therefore, the decrease in aerobic metabolism is not due to inhibition by PDK.	[DeVience, Stephen J.; Lu, Xin; Melhem, Elias R.; Gullapalli, Rao P.; Mayer, Dirk] Univ Maryland, Dept Diagnost Radiol & Nucl Med, Sch Med, Baltimore, MD 21201 USA; [DeVience, Stephen J.; Lu, Xin; Melhem, Elias R.; Gullapalli, Rao P.; Mayer, Dirk] Univ Maryland, Ctr Metab Imaging & Therapeut, Med Ctr, Baltimore, MD 21201 USA; [Proctor, Julie L.; Rangghran, Parisa; Medina, Juliana A.; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Proctor, Julie L.; Rangghran, Parisa; Medina, Juliana A.; Fiskum, Gary] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [DeVience, Stephen J.] Scalar Magnet LLC, 3 Harolwood Ct Apt C, Windsor Mill, MD 21244 USA; [Lu, Xin] Univ Oklahoma, Dept Radiol Sci, Coll Med, Oklahoma City, OK 73104 USA		Mayer, D (corresponding author), Univ Maryland, Dept Diagnost Radiol & Nucl Med, Sch Med, Baltimore, MD 21201 USA.; Mayer, D (corresponding author), Univ Maryland, Ctr Metab Imaging & Therapeut, Med Ctr, Baltimore, MD 21201 USA.	stephen@scalarmag.com; xin-lu@ouhsc.edu; jproctor@som.umaryland.edu; prangghran@som.umaryland.edu; jmedina@som.umaryland.edu; emelhem@umm.edu; rgullapalli@som.umaryland.edu; gfiskum@som.umaryland.edu; dmayer@som.umaryland.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS096575]	This research was funded by the National Institutes of Health, grant number R21 NS096575.	Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; DeVience SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01736-x; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Guglielmetti C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17758-4; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hurd RE, 2010, MAGN RESON MED, V63, P1137, DOI 10.1002/mrm.22364; Ikeda K, 2016, RESUSCITATION, V105, P138, DOI 10.1016/j.resuscitation.2016.04.024; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Mayer D, 2010, J MAGN RESON, V204, P340, DOI 10.1016/j.jmr.2010.03.005; McKenna MC, 2015, NEUROCHEM RES, V40, P2527, DOI 10.1007/s11064-015-1600-7; Park JM, 2013, NEURO-ONCOLOGY, V15, P433, DOI 10.1093/neuonc/nos319; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Randle P.J., 1976, METABOLIC INTERCONVE, P136, DOI [10.1007/978-3-642-66461-8_17, DOI 10.1007/978-3-642-66461-8_17]; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun YY, 2016, ONCOTARGET, V7, P31708, DOI 10.18632/oncotarget.9150; Sutendra G, 2013, ONCOGENE, V32, P1638, DOI 10.1038/onc.2012.198; Wang ML, 2018, AM J NEURORADIOL, V39, P1650, DOI 10.3174/ajnr.A5737; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739	28	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-1989		METABOLITES	Metabolites	JUN	2021	11	6							335	10.3390/metabo11060335			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	SZ0FW	WOS:000666253600001	34073714	gold, Green Published			2022-02-06	
J	Ding, HQ; Liao, LX; Zheng, XM; Wang, QS; Liu, Z; Xu, GH; Li, X; Liu, L				Ding, Huaqiang; Liao, Luoxing; Zheng, Xiaomei; Wang, Qisheng; Liu, Zhi; Xu, Guanghui; Li, Xing; Liu, Liang			beta-Blockers for traumatic brain injury: A systematic review and meta-analysis	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; beta-blocker; catecholamine; paroxysmal sympathetic; hyperactivity	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; EARLY PROPRANOLOL; HEAD-INJURY; CATECHOLAMINES; BLOCKADE; SURVIVAL; MANAGEMENT; DISRUPTION; PREINJURY; EXPOSURE	BACKGROUND Paroxysmal sympathetic hyperactivity (PSH) and catecholamine surge, which are associated with poor outcome, may be triggered by traumatic brain injury (TBI). beta Adrenergic receptor blockers (beta -blockers), as potential therapeutic agents to prevent paroxysmal sympathetic hyperactivity and catecholamine surge, have been shown to improve survival after TBI. The principal aim of this study was to investigate the effect of beta -blockers on outcomes in patients with TBI. METHODS For this systematic review and meta-analysis, we searched MEDLINE, EMBASE, and Cochrane Library databases from inception to September 25, 2020, for randomized controlled trials, nonrandomized controlled trials, and observational studies reporting the effect of beta -blockers on the following outcomes after TBI: mortality, functional measures, and cardiopulmonary adverse effects of beta -blockers (e.g., hypotension, bradycardia, and bronchospasm). With use of random-effects model, we calculated pooled estimates, confidence intervals (CIs), and odds ratios (ORs) of all outcomes. RESULTS Fifteen studies with 12,721 patients were included. Exposure to beta -blockers after TBI was associated with a significant reduction in adjusted in-hospital mortality (OR, 0.39; 95% CI, 0.30-0.51; I-2 = 66.3%; p < 0.001). beta-Blockers significantly improved the long-term (>= 6 months) functional outcome (OR, 1.75; 95% CI, 1.09-2.80; I-2 = 0%; p = 0.02). Statistically significant difference was not seen for cardiopulmonary adverse events (OR, 0.91; 95% CI, 0.55-1.50; I-2 = 25.9%; p = 0.702). CONCLUSION This meta-analysis demonstrated that administration of beta -blockers after TBI was safe and effective. Administration of beta -blockers may therefore be suggested in the TBI care. However, more high-quality trials are needed to investigate the use of beta -blockers in the management of TBI. LEVEL OF EVIDENCE Systematic review and meta-analysis, level III.	[Ding, Huaqiang; Liu, Zhi] Chongqing Yubei Dist Peoples Hosp, Dept Neurosurg, Chongqing, Peoples R China; [Liao, Luoxing] Nanan Dist Peoples Hosp Chongqing, Dept Neurosurg, Chongqing, Peoples R China; [Wang, Qisheng] Peoples Hosp Hejiang City, Dept Neurosurg, Luzhou, Peoples R China; [Liao, Luoxing; Xu, Guanghui; Li, Xing; Liu, Liang] Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, 25 Taiping St, Luzhou 646000, Peoples R China; [Zheng, Xiaomei; Xu, Guanghui] Southwest Med Univ, Affiliated Hosp, Dept Neurol, Luzhou, Peoples R China; [Liu, Liang] Neurosurg Clin Med Res Ctr Sichuan Prov, Luzhou, Peoples R China; [Liu, Liang] Academician Expert Workstat Sichuan Prov, Luzhou, Peoples R China; [Liu, Liang] Neurol Dis & Brain Funct Lab, Luzhou, Peoples R China		Liu, L (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, 25 Taiping St, Luzhou 646000, Peoples R China.	275345382@qq.com; 1179300707@qq.com; zxmlst@163.com; 372638777@qq.com; dinghuaqiang2009@sina.com; 326686323@qq.com; 541874379@qq.com; liulst@163.com					Ahl R, 2017, EUR J TRAUMA EMERG S, V43, P783, DOI 10.1007/s00068-017-0779-5; Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; Alofisan TO, 2019, PEDIATR CRIT CARE ME, V20, P252, DOI 10.1097/PCC.0000000000001811; Ammar MA, 2018, SAUDI J ANAESTH, V12, P514, DOI 10.4103/sja.SJA_33_18; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Bukur M, 2012, J TRAUMA ACUTE CARE, V72, P1013, DOI 10.1097/TA.0b013e318241bc5b; Chen ZF, 2017, J CRIT CARE, V41, P240, DOI 10.1016/j.jcrc.2017.05.035; CHIOLERO RL, 1989, CRIT CARE MED, V17, P328, DOI 10.1097/00003246-198904000-00006; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; CRUICKSHANK JM, 1987, LANCET, V2, P585, DOI 10.1016/s0140-6736(87)92984-9; Davanzo JR, 2017, SURG CLIN N AM, V97, P1237, DOI 10.1016/j.suc.2017.08.001; Edavettal M, 2016, AM SURGEON, V82, P1203; El-Menyar A, 2018, J NEUROSURG, V129, P1541, DOI 10.3171/2017.7.JNS17675; El-Menyar A, 2017, CARDIOL REV, V25, P279, DOI 10.1097/CRD.0000000000000167; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Genet GF, 2018, J TRAUMA ACUTE CARE, V84, P89, DOI 10.1097/TA.0000000000001708; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Hendrick LE, 2016, AM SURGEON, V82, P575; Huang GY, 2012, INT ORTHOP, V36, P887, DOI 10.1007/s00264-011-1423-3; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Khalili H, 2020, WORLD J SURG, V44, P1844, DOI 10.1007/s00268-020-05391-8; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Koskinen LOD, 2014, NEUROSCIENCE, V283, P245, DOI 10.1016/j.neuroscience.2014.06.039; Lewis PR, 2016, J TRAUMA ACUTE CARE, V80, P643, DOI 10.1097/TA.0000000000000957; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Lump D, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0494-0; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Mohseni S, 2015, WORLD J SURG, V39, P2076, DOI 10.1007/s00268-015-3039-z; Mohseni S, 2014, J TRAUMA ACUTE CARE, V76, P804, DOI 10.1097/TA.0000000000000139; Murry JS, 2016, J SURG RES, V200, P221, DOI 10.1016/j.jss.2015.06.045; Neideen T, 2008, J TRAUMA, V65, P1016, DOI 10.1097/TA.0b013e3181897eac; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Schroeppel TJ, 2020, AM SURGEON, V86, P1124, DOI 10.1177/0003134820943648; Schroeppel TJ, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000307; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Zangbar B, 2016, J SURG RES, V200, P586, DOI 10.1016/j.jss.2015.08.020; Zeeshan M, 2019, J TRAUMA ACUTE CARE, V87, P1140, DOI 10.1097/TA.0000000000002484; Zheng RZ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00081	62	1	1	2	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2021	90	6					1077	1085		10.1097/TA.0000000000003094			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	TC0GW	WOS:000668324000036	33496547				2022-02-06	
J	Farre-Alins, V; Palomino-Antolin, A; Narros-Fernandez, P; Lopez-Rodriguez, AB; Decouty-Perez, C; Munoz-Montero, A; Zamorano-Fernandez, J; Mansilla-Fernandez, B; Giner-Garcia, J; Garcia-Feijoo, P; Saez-Alegre, M; Palpan-Flores, AJ; Roda-Frade, JM; Carabias, CS; Rosa, JM; Civantos-Martin, B; Yus-Teruel, S; Gandia, L; Lagares, A; Hernandez-Garcia, BJ; Egea, J				Farre-Alins, Victor; Palomino-Antolin, Alejandra; Narros-Fernandez, Paloma; Lopez-Rodriguez, Ana Belen; Decouty-Perez, Celine; Munoz-Montero, Alicia; Zamorano-Fernandez, Jorge; Mansilla-Fernandez, Beatriz; Giner-Garcia, Javier; Garcia-Feijoo, Pablo; Saez-Alegre, Miguel; Palpan-Flores, Alexis J.; Roda-Frade, Jose Maria; Carabias, Cristina S.; Rosa, Juliana M.; Civantos-Martin, Belen; Yus-Teruel, Santiago; Gandia, Luis; Lagares, Alfonso; Hernandez-Garcia, Borja J.; Egea, Javier			Serum Amyloid A1/Toll-Like Receptor-4 Axis, an Important Link between Inflammation and Outcome of TBI Patients	BIOMEDICINES			English	Article						traumatic brain injury; neuroinflammation; prognosis; biomarkers; immunomodulation	TRAUMATIC BRAIN-INJURY; TOLL-LIKE RECEPTORS; PATHOPHYSIOLOGY; EXPRESSION; MECHANISMS; BIOMARKERS; MOUSE	Traumatic brain injury (TBI) is one of the leading causes of mortality and disability worldwide without any validated biomarker or set of biomarkers to help the diagnosis and evaluation of the evolution/prognosis of TBI patients. To achieve this aim, a deeper knowledge of the biochemical and pathophysiological processes triggered after the trauma is essential. Here, we identified the serum amyloid A1 protein-Toll-like receptor 4 (SAA1-TLR4) axis as an important link between inflammation and the outcome of TBI patients. Using serum and mRNA from white blood cells (WBC) of TBI patients, we found a positive correlation between serum SAA1 levels and injury severity, as well as with the 6-month outcome of TBI patients. SAA1 levels also correlate with the presence of TLR4 mRNA in WBC. In vitro, we found that SAA1 contributes to inflammation via TLR4 activation that releases inflammatory cytokines, which in turn increases SAA1 levels, establishing a positive proinflammatory loop. In vivo, post-TBI treatment with the TLR4-antagonist TAK242 reduces SAA1 levels, improves neurobehavioral outcome, and prevents blood-brain barrier disruption. Our data support further evaluation of (i) post-TBI treatment in the presence of TLR4 inhibition for limiting TBI-induced damage and (ii) SAA1-TLR4 as a biomarker of injury progression in TBI patients.	[Farre-Alins, Victor; Palomino-Antolin, Alejandra; Narros-Fernandez, Paloma; Lopez-Rodriguez, Ana Belen; Decouty-Perez, Celine; Rosa, Juliana M.; Egea, Javier] Hosp Univ Princesa, Hosp Univ Santa Cristina, Mol Neuroinflammat & Neuronal Plast Res Lab, Res Unit,Inst Invest Sanitaria, Madrid 28009, Spain; [Farre-Alins, Victor; Palomino-Antolin, Alejandra; Narros-Fernandez, Paloma; Lopez-Rodriguez, Ana Belen; Decouty-Perez, Celine; Munoz-Montero, Alicia; Gandia, Luis; Egea, Javier] UAM, Fac Med, Dept Farmacol & Terapeut, Inst Teofilo Hernando, Madrid 28029, Spain; [Zamorano-Fernandez, Jorge; Mansilla-Fernandez, Beatriz; Giner-Garcia, Javier; Garcia-Feijoo, Pablo; Saez-Alegre, Miguel; Palpan-Flores, Alexis J.; Roda-Frade, Jose Maria; Hernandez-Garcia, Borja J.] Hosp Univ La Paz, Serv Neurocirug, Madrid 28046, Spain; [Carabias, Cristina S.; Lagares, Alfonso] Univ Complutense Madrid, Hosp Univ 12 Octubre, imas12, Serv Neurocirug, Madrid 28041, Spain; [Civantos-Martin, Belen; Yus-Teruel, Santiago] Hosp Univ La Paz, Serv Med Intens, Madrid 28046, Spain; [Rosa, Juliana M.] Hosp Nacl Paraplejicos, Expt Neurophysiol & Neuronal Circuits Lab, SESCAM, Toledo 45004, Spain		Egea, J (corresponding author), Hosp Univ Princesa, Hosp Univ Santa Cristina, Mol Neuroinflammat & Neuronal Plast Res Lab, Res Unit,Inst Invest Sanitaria, Madrid 28009, Spain.; Egea, J (corresponding author), UAM, Fac Med, Dept Farmacol & Terapeut, Inst Teofilo Hernando, Madrid 28029, Spain.	victorfarre@hotmail.com; alejandra.palominoantolin@gmail.com; palomanf22@gmail.com; lopezrodr.ab@gmail.com; celinedecouty96@gmail.com; alimunozmontero@gmail.com; teveosabio@gmail.com; beatrizmf25@gmail.com; Javier.giner.garcia@gmail.com; g.feijoo.neurosurgery@gmail.com; miksaezalegre@gmail.com; alexispalpan@hotmail.com; josem.roda@salud.madrid.org; csanchezcarabias@gmail.com; juli.martins.rosa@gmail.com; bcivantos@hotmail.com; santiagoyus@gmail.com; luis.gandia@uam.es; Algadoc@yahoo.com; borjajhega@gmail.com; javier.egea@inv.uam.es	Lagares, Alfonso/B-2969-2011; Rosa, Juliana M/P-6969-2017; Zamorano-Fernandez, Jorge/K-5769-2018	Lagares, Alfonso/0000-0003-3996-0554; Rosa, Juliana M/0000-0003-0857-3746; Zamorano-Fernandez, Jorge/0000-0001-5091-9689; FARRE ALINS, VICTOR/0000-0002-6908-1705	Fundacion Mutua Madrilena and Fondo de Investigaciones Sanitarias (FIS) (ISCIII/FEDER) [CP14/00008, CPII19/00005, PI16/00735, PI19/00082, RYC2019-026870-I, PI18/01387]	This work was supported by grants from Fundacion Mutua Madrilena and Fondo de Investigaciones Sanitarias (FIS) (ISCIII/FEDER) (Programa Miguel Servet CP14/00008; CPII19/00005; PI16/00735; PI19/00082) to JE, RYC2019-026870-I to JMR and PI18/01387 to AL.	Agoston DV, 2019, J NEUROTRAUM, V36, P1724, DOI 10.1089/neu.2018.6261; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Brea D, 2011, J CEREBR BLOOD F MET, V31, P1424, DOI 10.1038/jcbfm.2010.231; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Carabias CS, 2020, J INTENSIVE CARE MED, V35, P1180, DOI 10.1177/0885066619837913; Chitnis T, 2017, J CLIN INVEST, V127, P3577, DOI 10.1172/JCI90609; de Seny D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066769; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Hahn A, 2020, J CACHEXIA SARCOPENI, V11, P103, DOI 10.1002/jcsm.12491; Han S, 2016, J DERMATOL SCI, V84, P107, DOI 10.1016/j.jdermsci.2016.07.010; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hirai K, 2019, J DENT RES, V98, P117, DOI 10.1177/0022034518796456; Jang S, 2019, TRANSGENIC RES, V28, P499, DOI 10.1007/s11248-019-00166-x; Jang WY, 2017, BRAIN RES, V1654, P55, DOI 10.1016/j.brainres.2016.09.003; Janssens S, 2003, CLIN MICROBIOL REV, V16, P637, DOI 10.1128/CMR.16.4.637-646.2003; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Kindy Mark S., 1999, J Alzheimers Dis, V1, P155; Labzin LI, 2018, ANNU REV MED, V69, P437, DOI 10.1146/annurev-med-050715-104343; Lagerstedt L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175572; Li W, 2015, MOL MED, V21, P515, DOI 10.2119/molmed.2015.00109; Mahan MY, 2019, WORLD NEUROSURG, V128, pE434, DOI 10.1016/j.wneu.2019.04.170; Manivannan S, 2018, CLIN NEUROL NEUROSUR, V171, P6, DOI 10.1016/j.clineuro.2018.05.017; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Parada E, 2015, MOL NUTR FOOD RES, V59, P1690, DOI 10.1002/mnfr.201500279; Passey SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146882; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rodriguez-Yanez M, 2012, J NEUROIMMUNOL, V247, P75, DOI 10.1016/j.jneuroim.2012.03.019; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Sevenich L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00697; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Vaure C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00316; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Yu N, 2015, CLIN EXP IMMUNOL, V179, P344, DOI 10.1111/cei.12458; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhang DD, 2014, NEUROCHEM INT, V75, P11, DOI 10.1016/j.neuint.2014.05.003; Zhang YK, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-112; Zhang ZY, 2019, CLIN CHIM ACTA, V497, P6, DOI 10.1016/j.cca.2019.07.008	40	1	1	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	JUN	2021	9	6							599	10.3390/biomedicines9060599			18	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	SX7ME	WOS:000665383400001	34070533	Green Published, gold			2022-02-06	
J	Fiester, P; Rao, D; Andreou, S; Soule, E; Patel, J				Fiester, Peter; Rao, Dinesh; Andreou, Sonia; Soule, Erik; Patel, Jeet			Pediatric Retroclival Epidural Hematoma in the Acute Trauma Setting: A Sign of Tectorial Membrane Stripping Injury	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						craniocervical junction; MRI; pediatric; retroclival epidural hematoma; tectorial membrane	CRANIOCERVICAL JUNCTION; CLIVUS; FRACTURES	OBJECTIVE. A traumatic retroclival epidural hematoma is a rare imaging finding of severe cervical flexion-extension injury in the pediatric population. The purpose of our study was to identify pediatric patients with a retroclival epidural hematoma, record the hematoma size and extent, and examine the major craniocervical ligaments for injury. MATERIALS AND METHODS. Pediatric patients who suffered a retroclival epidural hematoma were identified retrospectively using the keywords "clivus," "epidural hematoma," and "retroclival" included in head CT reports between 2012 and 2019. The cervical and brain MRI examinations for these patients were reviewed for craniocervical ligament injury by two certified neuroradiologists. Detailed descriptions of patient injuries were recorded along with demographic information, clinical history, patient management, and outcome. RESULTS. Eleven pediatric patients were identified with an acute posttraumatic retroclival epidural hematoma with a mean anteroposterior dimension of 4.4 mm and craniocaudal dimension of 4.3 cm. All patients with a retroclival epidural hematoma who underwent subsequent cervical MRI had a stripping injury of the tectorial membrane (TM). Disruption of additional major craniocervical ligaments on MRI (alar ligament, transverse ligament, longitudinal ligaments, and ligamentum flavum) was relatively rare with the most common associated ligamentous injuries involving the anterior atlantooccipital membrane, apical ligament, and interspinous ligaments. None of the patients suffered a cervical cord or severe intracranial injury. The majority of the patients were managed conservatively with excellent clinical outcomes. CONCLUSION. A posttraumatic retroclival epidural hematoma in the pediatric population is a rare injury often identified initially by head CT and easily overlooked by the radiologist. We propose that a retroclival epidural hematoma in the pediatric population is a direct result of a significant flexion-extension force, with a subsequent stripping injury of the TM from the posterior clivus. Pediatric patients with a posttraumatic retroclival epidural hematoma on initial head CT should undergo a cervical MRI to evaluate the integrity of the TM and other craniocervical ligaments.	[Fiester, Peter; Rao, Dinesh; Andreou, Sonia; Soule, Erik; Patel, Jeet] Univ Florida Hlth Jacksonville, Dept Neuroradiol, 655 8th St, Jacksonville, FL 32209 USA		Andreou, S (corresponding author), Univ Florida Hlth Jacksonville, Dept Neuroradiol, 655 8th St, Jacksonville, FL 32209 USA.	sonia.andreou@jax.ufl.edu					ANGEL K R, 1989, Arthroscopy, V5, P197; Azizyan A, 2015, J NEUROSURG, V123, P808, DOI 10.3171/2014.12.JNS14445; Calli C, 1998, J NEURORADIOLOGY, V25, P229; Caroli E, 2005, EUR SPINE J, V14, P487, DOI 10.1007/s00586-004-0832-z; Farley FA, 2005, J SPINAL DISORD TECH, V18, P136, DOI 10.1097/01.bsd.0000154460.55090.8a; Fiester P, 2019, EMERG RADIOL, V26, P615, DOI 10.1007/s10140-019-01710-2; FRANK C, 1988, CLIN ORTHOP RELAT R, P279; Nguyen HS, 2016, CHILD NERV SYST, V32, P1749, DOI 10.1007/s00381-016-3098-y; Izumida T, 2017, BMJ CASE REP, V2017; Junewick JJ, 2011, AM J ROENTGENOL, V196, P1003, DOI 10.2214/AJR.10.6051; Kjaer M, 2015, PROG MOL BIOL TRANSL, V135, P259, DOI 10.1016/bs.pmbts.2015.07.008; Koshy J, 2014, CHILD NERV SYST, V30, P835, DOI 10.1007/s00381-014-2369-8; Kwon TH, 2008, NEUROL MED-CHIR, V48, P347, DOI 10.2176/nmc.48.347; Langford S, 2015, NEURORADIOLOGY, V57, P1263, DOI 10.1007/s00234-015-1584-7; Magnusson SP, 2016, ADV EXP MED BIOL, V920, P11, DOI 10.1007/978-3-319-33943-6_2; Marks SM, 1997, BRIT J NEUROSURG, V11, P245; Menku A, 2004, NEUROSURG REV, V27, P194, DOI 10.1007/s10143-004-0320-2; Meoded A, 2011, AM J NEURORADIOL, V32, P1806, DOI 10.3174/ajnr.A2606; Mizushima H, 1998, J NEUROSURG, V88, P590, DOI 10.3171/jns.1998.88.3.0590; Narvid J, 2016, J NEUROSURG, V124, P716, DOI 10.3171/2015.2.JNS142221; PAPADOPOULOS SM, 1991, NEUROSURGERY, V28, P574, DOI 10.1227/00006123-199104000-00015; Phuntsok R, 2019, J NEUROSURG-SPINE, V31, P501, DOI 10.3171/2019.4.SPINE181488; Radcliff KE, 2015, SPINE J, V15, P1618, DOI 10.1016/j.spinee.2015.02.004; Ratilal B, 2006, SURG NEUROL, V66, P200, DOI 10.1016/j.surneu.2005.11.030; Silvera VM, 2014, PEDIATR RADIOL, V44, P621, DOI 10.1007/s00247-014-3170-2; Singh AK, 2017, AM J NEURORADIOL, V38, P2380, DOI 10.3174/ajnr.A5400; Sridhar K, 2010, NEUROL INDIA, V58, P131, DOI 10.4103/0028-3886.73756; Tubbs RS, 2007, CLIN ANAT, V20, P382, DOI 10.1002/ca.20334; Tubbs RS, 2010, NEUROSURGERY, V67, P404, DOI 10.1227/01.NEU.0000372085.70895.E7; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014	30	1	1	0	0	AMER ROENTGEN RAY SOC	LEESBURG	44211 SLATESTONE CT, LEESBURG, VA USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	JUN	2021	216	6					1641	1648		10.2214/AJR.20.22957			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	XE5NZ	WOS:000723435500036	33826356				2022-02-06	
J	Figueroa, JM; Berry, K; Boddu, J; Kader, M; Silva, M; Luther, E; Ayala, V; Starke, RM; Jagid, J; Benveniste, R				Figueroa, Javier M.; Berry, Katherine; Boddu, James; Kader, Michael; Silva, Michael; Luther, Evan; Ayala, Veronica; Starke, Robert M.; Jagid, Jonathan; Benveniste, Ronald			Treatment strategies for patients with concurrent blunt cerebrovascular and traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						TBI; BCVI; Intracranial hemorrhage; Dissection; Pseudoaneurysm	ARTERY DISSECTION; CAROTID INJURIES; INFARCTION; SURGERY; THERAPY	Patients who present with traumatic brain injury (TBI) combined with blunt cerebrovascular injuries (BCVI) are difficult to manage, in part because treatment for each entity may exacerbate the other. It is necessary to develop a treatment paradigm that ensures maximum benefit while mitigating the opposing risks. A cohort of 150 patients from 2015 to present, with either internal carotid artery (ICA) and/or vertebral artery (VA) dissections or pseudoaneurysms, was cross-referenced with those who had sustained TBI. Of the 38 patients identified with both TBI and BCVI, 25 suffered ICA injuries, 10 had VA injuries and 3 had combined ICA/VA injuries. Unilateral BCVI occurred in 30 patients, while 8 had bilateral BCVI. Two patients required surgical intervention for TBI, and 5 patients required endovascular intervention for BCVI. Positive emboli detection studies (EDS) on transcranial dopplers (TCD) were demonstrated in 19 patients, with 9 patients having radiographic evidence of stroke. Anti-platelet therapy was initiated in 32 patients, and anti-coagulation in 10 patients, without new or worsening intracranial hemorrhages (ICH). Overall, 76% of patients were able to be discharged home or to rehabilitation, with good recovery demonstrated in 73% of the patients who had appropriate follow-up. In the setting of concurrent TBI and BCVI, use of anti-platelet/coagulation to prevent stroke can be safe if monitored closely. Here we describe a treatment paradigm which weighs the risk and benefits of therapies based on severity of ICH and stroke prevention, which tended to result in good disposition and recovery. (c) 2021 Elsevier Ltd. All rights reserved.	[Figueroa, Javier M.; Berry, Katherine; Boddu, James; Kader, Michael; Silva, Michael; Luther, Evan; Ayala, Veronica; Starke, Robert M.; Jagid, Jonathan; Benveniste, Ronald] Univ Miami, Miller Sch Med, Dept Neurosurg, Coral Gables, FL 33124 USA		Figueroa, JM (corresponding author), Lois Pope Life Ctr, 1095 NW 14th Terrace, Miami, FL 33136 USA.	Javier.Figueroa@jhsmiami.org					Arthurs ZM, 2008, INJURY, V39, P1232, DOI 10.1016/j.injury.2008.02.042; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Bok APL, 1996, J TRAUMA, V40, P968, DOI 10.1097/00005373-199606000-00017; DuBose J, 2008, J TRAUMA, V65, P1561, DOI 10.1097/TA.0b013e31817fd954; Edwards NM, 2007, J AM COLL SURGEONS, V204, P1007, DOI 10.1016/j.jamcollsurg.2006.12.041; Esnault P, 2017, J NEUROSURG, V127, P16, DOI 10.3171/2016.4.JNS152600; Fleck SK, 2011, NEUROSURGERY, V69, P615, DOI 10.1227/NEU.0b013e31821a8701; Fleck SK, 2010, ACTA NEUROCHIR, V152, P1679, DOI 10.1007/s00701-010-0685-7; Foreman PM, 2015, J NEUROSURG-SPINE, V23, P665, DOI 10.3171/2015.1.SPINE141174; Geddes AE, 2016, AM J SURG, V212, P1167, DOI 10.1016/j.amjsurg.2016.09.016; Griffin RL, 2019, J NEUROSURG, V130, P1520, DOI 10.3171/2017.12.JNS172284; Gupta AN, 2020, NEUROINTERVENTION; Ho AL, 2020, WORLD NEUROSURG, V137, pE315, DOI 10.1016/j.wneu.2020.01.191; Kastrau F, 2005, STROKE, V36, P825, DOI 10.1161/01.STR.0000157595.93115.70; Koennecke HC, 1997, STROKE, V28, P593, DOI 10.1161/01.STR.28.3.593; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Nally MC, 2019, J VASC SURG, V69, P1704, DOI 10.1016/j.jvs.2018.09.051; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Redekop GJ, 2008, CAN J NEUROL SCI, V35, P146, DOI 10.1017/S0317167100008556; Schicho A, 2018, THER CLIN RISK MANAG, V14, P173, DOI 10.2147/TCRM.S148176; Seth R, 2013, AM J NEURORADIOL, V34, P1219, DOI 10.3174/ajnr.A3337; Srinivasan J, 1996, STROKE, V27, P1226, DOI 10.1161/01.STR.27.7.1226; Tao WD, 2012, STROKE, V43, P2060, DOI 10.1161/STROKEAHA.112.652420; Tsai YH, 2010, NEURORADIOLOGY, V52, P1011, DOI 10.1007/s00234-009-0651-3; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; van Wessem KJP, 2011, EUR J TRAUMA EMERG S, V37, P147, DOI 10.1007/s00068-010-0032-y; Wahl WL, 2002, J TRAUMA, V52, P896, DOI 10.1097/00005373-200205000-00012; Zurcher E, 2019, J STROKE CEREBROVASC, V28, P710, DOI 10.1016/j.jstrokecerebrovasdis.2018.11.016	28	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUN	2021	88						243	250		10.1016/j.jocn.2021.03.044			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SD5ZM	WOS:000651455000041	33992192				2022-02-06	
J	Frondelli, MJ; Levison, SW				Frondelli, Michelle J.; Levison, Steven W.			Leukemia Inhibitory Factor Is Required for Subventricular Zone Astrocyte Progenitor Proliferation and for Prokineticin-2 Production after a Closed Head Injury in Mice	NEUROTRAUMA REPORTS			English	Article						astrogliosis; cell proliferation; cytokines; neurotrauma; stem cells	CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELL; NEURONAL PRECURSORS; SUBEPENDYMAL ZONE; OLFACTORY-BULB; BRAIN-INJURY; MIGRATE; EXPRESSION; DIFFERENTIATE; FOREBRAIN	Astrogliosis is one of the hallmarks of brain injury, and after a mild injury activated astrocytes subserve neuroprotective and pro-regenerative functions. We previously found that the astroglial response to closed head injury (CHI) was blunted in mice that were haplodeficient in leukemia inhibitory factor (LIF); therefore, the goal of these studies was to determine if the delayed astrogliosis was due to decreased recruitment of subventricular zone (SVZ) progenitors. CHI's were performed on post-natal day 20 on LIF heterozygous (Het) and wild-type (WT) mice. At 48 h post-CHI, astrocyte progenitor proliferation within the SVZ increased similar to 250% in WT mice but was reduced by similar to 200% in LIF Het mice compared with sham controls. Using neurospheres to model the SVZ, LIF increased the percentage of proliferating astrocyte progenitors by 2-fold compared with controls but had no effect on neural stem cell proliferation. To rule out the involvement of other cytokines, 105 cytokines were analyzed using a multi-plex array and with targeted validation on injured LIF Het versus WT neocortex. Of the cytokines analyzed, only prokineticin-2 (ProK2) required LIF signaling. Correspondingly, LIF-treated neurospheres expressed higher levels of ProK2, the ProK1 and ProK2 receptors (ProKR1 and ProKR2). Using in situ hybridization, ProK2 messenger RNA (mRNA) was most abundant in neocortical neurons and highly expressed within the SVZ. However, in contrast to LIF, ProK2 decreased astrocyte progenitor proliferation 2-fold. Altogether, these data demonstrate that LIF is necessary for astrocyte progenitor proliferation after injury and reveal a new role for LIF as an essential regulator of the neurotrophic factor ProK2.</p>	[Frondelli, Michelle J.; Levison, Steven W.] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, New Jersey Med Sch, 205 S Orange Ave, Newark, NJ 07103 USA		Levison, SW (corresponding author), Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, New Jersey Med Sch, 205 S Orange Ave, Newark, NJ 07103 USA.	levisosw@njms.rutgers.edu			New Jersey Commission on Brain Injury Research [CBIR19FELO14, CBIR13IRG0170]	Research reported in this article was supported by the New Jersey Commission on Brain Injury Research under award numbers CBIR19FELO14 to M.J.F. and CBIR13IRG0170 to S.W.L.	Adams KL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16028-8; Allen NJ, 2017, NEURON, V96, P697, DOI 10.1016/j.neuron.2017.09.056; Ayari B, 2010, J NEUROTRAUM, V27, P959, DOI 10.1089/neu.2009.0972; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Buono KD, 2015, J NEUROSCI, V35, P8855, DOI 10.1523/JNEUROSCI.2868-12.2015; Buono KD, 2012, DEV NEUROSCI-BASEL, V34, P449, DOI 10.1159/000345155; Butzkueven H, 2006, GLIA, V53, P696, DOI 10.1002/glia.20321; CAMMER W, 1992, J COMP NEUROL, V321, P33, DOI 10.1002/cne.903210104; Cheng MY, 2012, P NATL ACAD SCI USA, V109, P5475, DOI 10.1073/pnas.1113363109; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; De Marchis S, 2004, J COMP NEUROL, V476, P290, DOI 10.1002/cne.20217; Deverman BE, 2012, J NEUROSCI, V32, P2100, DOI 10.1523/JNEUROSCI.3803-11.2012; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; Felling RJ, 2016, J NEUROSCI RES, V94, P1531, DOI 10.1002/jnr.23929; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Frondelli M.J., 2020, OLIGODENDROCYTE PROG, DOI [10.1101/2020.12.09.418343, DOI 10.1101/2020.12.09.418343]; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Goodus MT, 2016, J NEUROTRAUM, V33, P1522, DOI 10.1089/neu.2015.4234; Goodus MT, 2015, DEV NEUROSCI-BASEL, V37, P29, DOI 10.1159/000367784; Gordon R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12932; Gresle MM, 2015, GLIA, V63, P1005, DOI 10.1002/glia.22798; Gresle MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047379; Haroon F, 2011, J IMMUNOL, V186, P6521, DOI 10.4049/jimmunol.1001135; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Hill SA, 2019, ELIFE, V8, DOI 10.7554/eLife.45545; HUPPES W, 1992, J NEUROCYTOL, V21, P129, DOI 10.1007/BF01189011; Kakita A, 2003, J COMP NEUROL, V458, P381, DOI 10.1002/cne.10597; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kirschenbaum B, 1999, J NEUROSCI, V19, P2171; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Kubota Y, 2008, J CLIN INVEST, V118, P2393, DOI 10.1172/JCI34882; Landucci E, 2016, NEUROPHARMACOLOGY, V108, P39, DOI 10.1016/j.neuropharm.2016.04.043; Langley M, 2017, ANTIOXID REDOX SIGN, V27, P1048, DOI 10.1089/ars.2016.6905; Levison SW, 2000, DEV NEUROSCI-BASEL, V22, P106, DOI 10.1159/000017432; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; LEVISON SW, 1993, DEVELOPMENT, V119, P611; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Lim DA, 1997, P NATL ACAD SCI USA, V94, P14832, DOI 10.1073/pnas.94.26.14832; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; Melchiorri D, 2001, EUR J NEUROSCI, V13, P1694, DOI 10.1046/j.1460-9568.2001.01549.x; Mundim MV, 2019, MOL CELL NEUROSCI, V94, P1, DOI 10.1016/j.mcn.2018.10.004; Neal M, 2018, GLIA, V66, P2137, DOI 10.1002/glia.23467; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Niimi Y, 2018, PEDIATR RES, V83, P385, DOI 10.1038/pr.2017.261; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Paylor JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep37580; Prusac, 2015, NEURAL SURFACE ANTIG, P175; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Severini C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15301; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Thomas LB, 1996, GLIA, V17, P1; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294; Wanner IB, 2012, METHODS MOL BIOL, V814, P189, DOI 10.1007/978-1-61779-452-0_14; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	58	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	JUN 1	2021	2	1					285	302		10.1089/neur.2020.0063			18	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WO9SL	WOS:000712784600001	34223558	gold, Green Published			2022-02-06	
J	Hammond, FM; Davis, CS; Hirsch, MA; Snow, JM; Kropf, ME; Schur, L; Kruse, D; Ball, AM				Hammond, Flora M.; Davis, Christine S.; Hirsch, Mark A.; Snow, Julia M.; Kropf, Martha E.; Schur, Lisa; Kruse, Douglas; Ball, Andrew M.			Qualitative Examination of Voting Empowerment and Participation Among People Living With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Community participation; Politics; Qualitative research; Rehabilitation	DISABILITY; MAIL; INDIVIDUALS; COVID-19; TURNOUT	Objective: To examine political participation after traumatic brain injury (TBI). Design: Qualitative, participatory research via interviews and observations. Each participant was interviewed to discuss their experience of voting in 2007 or 2008. Data were coded using Grounded Theory to develop themes, metacodes, and theories. Setting: Community. Participants: A total of 57 individuals with history of TBI and 28 family members (NZ85). Main Outcome Measures: Not applicable. Results: Four themes emerged from the data: (1) people with TBI have barriers to voting; (2) the voting process can be improved for people with TBI; (3) voting is the responsibility of members of society; and (4) voting is one way we have a voice in society. Conclusions: The data support the importance of voting as an American right regardless of the presence of disability. While persons with TBI report voting represents their freedom and voice, there may be barriers that can threaten or limit their voice. Archives of Physical Medicine and Rehabilitation 2021;102:1091-9 (c) 2021 by the American Congress of Rehabilitation Medicine	[Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Hammond, Flora M.; Davis, Christine S.; Hirsch, Mark A.; Ball, Andrew M.] Atrium Hlth, Dept Phys Med & Rehabil, Carolinas Rehabil, Charlotte, NC USA; [Davis, Christine S.; Snow, Julia M.] Univ N Carolina, Dept Commun Studies, Charlotte, NC USA; [Kropf, Martha E.] Univ N Carolina, Dept Polit Sci & Publ Adm, Charlotte, NC USA; [Schur, Lisa; Kruse, Douglas] Rutgers State Univ, Sch Management & Labor Relat, New Brunswick, NJ USA; [Ball, Andrew M.] NxtGen Inst, Atlanta, GA USA; [Ball, Andrew M.] Myopain Seminars, Bethesda, MD USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	Flora.hammond@rhin.com			Carolinas HealthCare Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21HD055202-01]; National Institutes of Health American Recovery and Reinvestment Act of 2009 administrative supplement grant [3R21HD055202-02S1]	Supported by the Carolinas HealthCare Foundation and by a "Community participation in research grant" by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Institute of Mental Health to Carolinas Medical Center (PI: Mark A. Hirsch) (grant no. #R21HD055202-01) and a National Institutes of Health American Recovery and Reinvestment Act of 2009 administrative supplement grant (grant no. 3R21HD055202-02S1). The contents of this publication do not necessarily represent the policy of the Department of Health and Human Services, and you should not assume endorsement by the Federal Government.	AAPD, REG ED VOT US YOUR P; Abrams A., 2020, TIME; Davis CS, 2010, STRAIGHT TALK COMMUN; Ehde DM, 2013, ARCH PHYS MED REHAB, V94, pS30, DOI 10.1016/j.apmr.2012.10.025; Election Assistance Commission, EL ADM VOT SURV; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Gaventa J., 2010, IDS WORK PAP, DOI [DOI 10.1111/J.2040-0209.2010.00347_2.X, 10.1111/j.2040-0209.2010.00347_2.x]; Glaser B., 1967, DISCOVERY GROUNDED T; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Gordon WA, 2005, AM J PHYS MED REHAB, V84, P999, DOI 10.1097/01.phm.0000187851.96774.27; Gronke P, 2012, AM POLIT RES, V40, P976, DOI 10.1177/1532673X12457809; Hammond FM, 2020, ARCH PHYS MED REHAB, V101, P1101, DOI 10.1016/j.apmr.2020.03.005; Hammond FM, VOTING TIPS PEOPLE L; Hawley LA, 2016, J SOC WORK DISABIL R, V15, P201, DOI 10.1080/1536710X.2016.1220885; Heron J, 2002, HDB ACTION RES PARTI, P179; Hirsch MA, 2019, WORLD MED HEALTH POL, V11, P24, DOI 10.1002/wmh3.296; Human Systems Integration Division Electronic Systems Laboratory Georgia Tech Research Institute Georgia Institute of Technology, 2012, CONS VOT ACC INJ OIF; Jagosh J, 2012, MILBANK Q, V90, P311, DOI 10.1111/j.1468-0009.2012.00665.x; Karlawish JH, 2004, JAMA-J AM MED ASSOC, V292, P1345, DOI 10.1001/jama.292.11.1345; Kim Saerom, 2015, J Prev Med Public Health, V48, P18, DOI 10.3961/jpmph.14.031; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; Leighley Jan E., 2014, WHO VOTES NOW DEMOGR; Lindlof T.L., 2002, QUALITATIVE COMMUNIC; Link JN, 2012, ELECT LAW J, V11, P52, DOI 10.1089/elj.2011.0121; Lockhart M, 2020, P NATL ACAD SCI USA, V117, P24640, DOI 10.1073/pnas.2008023117; McCullough J, 2020, TEXAS TRIBUNE   1102; McIntyre A, 2008, PARTICIPATORY ACTION, P15; McReyonlds A, 2020, HILL; Miller P, 2016, AM POLIT RES, V44, P28, DOI 10.1177/1532673X15586618; Niebler S, 2020, SOCIETY, V57, P547, DOI 10.1007/s12115-020-00531-1; Patton M. Q., 2014, QUALITATIVE RES EVAL, V4th; Persily N, 2020, 10 REC ENS HLTH TRUS; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reason P, 2002, HDB ACTION RES PARTI, P1; Sabatino Charles P., 2007, MCGEORGE LAW REV, V38, P843; Sade RM, 2015, J LAW MED ETHICS, P406; Schur L, 2002, POLIT RES QUART, V55, P167, DOI 10.1177/106591290205500107; Schur L, FACT SHEET DISABILIT; SCHUR L, 1998, J DISABIL POLICY STU, V9, P3, DOI DOI 10.1177/104420739800900202; Schur LA, 2000, SOC SCI QUART, V81, P571; Schur L, 2017, SOC SCI QUART, V98, P1374, DOI 10.1111/ssqu.12373; Schur L, 2014, CAMB STUD ELECT LAW, P188; SHIELDS TG, 1998, J DISABILITY POLICY, V0009; Smith D, 2018, J NATL MED ASSOC, V110, P304, DOI 10.1016/j.jnma.2018.07.002; Strauss A., 1990, BASICS QUALITATIVE R; US Department of Justice, AM DIS ACT OTH FED L; US Elections Project, 2020 GEN EL EARL VOT; US Government Accountability Office, VOT DIS OBS POLL PLA; Yamazaki H, 2009, BIOSCI TRENDS, V3, P202; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	52	1	1	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2021	102	6					1091	1101		10.1016/j.apmr.2020.12.016			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	SM2ZC	WOS:000657477200006	33493439	Green Submitted, Bronze			2022-02-06	
J	Hwang, I; Tang, D; Paik, J				Hwang, Inah; Tang, Deanna; Paik, Jihye			Oxidative stress sensing and response in neural stem cell fate	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Neural stem cells; Reactive oxygen species; Oxidative stress; Cell fate; Redox signaling; Cysteine sulfenylation	NF-KAPPA-B; PEROXIDE-MEDIATED OXIDATION; TUMOR-SUPPRESSOR PTEN; ACTIVE-SITE CYSTEINE; REACTIVE OXYGEN; REDOX REGULATION; REVERSIBLE INACTIVATION; HYDROGEN-PEROXIDE; MITOCHONDRIAL DYNAMICS; MOLECULAR-MECHANISM	Neural stem/progenitor cells (NSPCs) contribute to the physiological cellular turnover of the adult brain and make up its regenerative potential. It is thus essential to understand how different factors influence their proliferation and differentiation to gain better insight into potential therapeutic targets in neurodegenerative diseases and traumatic brain injuries. Recent evidences indicate the roles of redox stress sensing and coping mechanisms in mediating the balance between NSPC self-renewal and differentiation. Such mechanisms involve direct cysteine modification, signaling and metabolic reprogramming, epigenetic alterations and transcription changes leading to adaptive responses like autophagy. Here, we discuss emerging findings on the involvement of redox sensors and effectors and their mechanisms in influencing changes in cellular redox potential and NSPC fate.	[Hwang, Inah] OneCureGEN Co Ltd, R&D Ctr, Daejeon 34141, South Korea; [Tang, Deanna] Univ Chicago, Chicago, IL 60637 USA; [Hwang, Inah; Paik, Jihye] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10021 USA		Paik, J (corresponding author), Weill Cornell Med, 1300 York Ave,Box 69, New York, NY 10021 USA.	jep2025@med.cornell.edu	Hwang, Inah/AAZ-5420-2021	Hwang, Inah/0000-0002-4479-9374; Tang, Deanna/0000-0003-1585-1679	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG048284]	We apologize to authors whose work has not been cited due to space limitations and to limitations of our knowledge. This work was supported by National Institutes of Health Grant AG048284 (to J.P.) .	Adane B, 2019, CELL REP, V27, P238, DOI 10.1016/j.celrep.2019.03.009; Adusumilli V.S., 2020, CELL STEM CELL; Allen DR, 2001, GENE DEV, V15, P554, DOI 10.1101/gad.869001; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bahat A, 2019, J BIOL CHEM, V294, P13852, DOI 10.1074/jbc.REV118.000828; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Beckervordersandforth Ruth, 2017, Brain Plast, V3, P73, DOI 10.3233/BPL-170044; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006; Brandes MS, 2020, ASN NEURO, V12, DOI 10.1177/1759091419899782; Byrne DP, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax2713; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Carrica L, 2019, NEUROBIOL LEARN MEM, V157, P79, DOI 10.1016/j.nlm.2018.12.002; Casares-Crespo L, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00339; Cedervall T, 2005, BIOCHEMISTRY-US, V44, P684, DOI 10.1021/bi049232r; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Chen CH, 2015, NEUROBIOL DIS, V76, P13, DOI 10.1016/j.nbd.2014.12.027; Chesnokova V, 2016, BRAIN BEHAV IMMUN, V58, P1, DOI 10.1016/j.bbi.2016.01.017; Chui A, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.184150; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Conway ME, 2004, BIOCHEMISTRY-US, V43, P7356, DOI 10.1021/bi0498050; Corenblum MJ, 2016, AGING CELL, V15, P725, DOI 10.1111/acel.12482; Cotto-Rios XM, 2012, CELL REP, V2, P1475, DOI 10.1016/j.celrep.2012.11.011; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Crump KE, 2012, EUR J IMMUNOL, V42, P2152, DOI 10.1002/eji.201142289; Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Doiron B, 1996, J BIOL CHEM, V271, P5321, DOI 10.1074/jbc.271.10.5321; Dotsey EY, 2015, CHEM BIOL, V22, P619, DOI 10.1016/j.chembiol.2015.04.013; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Fang CC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8495160; Fawal MA, 2018, EPIGENETICS INSIGHTS, V11, DOI 10.1177/2516865718820946; Fawal MA, 2018, CELL REP, V23, P2864, DOI 10.1016/j.celrep.2018.05.005; Fernandez-Irigoyen J, 2008, BIOCHEM J, V411, P457, DOI 10.1042/BJ20071569; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Forsberg K, 2013, J NEUROSCI, V33, P14318, DOI 10.1523/JNEUROSCI.1056-13.2013; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Gambhir L, 2015, TOXICOL APPL PHARM, V289, P297, DOI 10.1016/j.taap.2015.09.014; Godat E, 2008, BIOL CHEM, V389, P1123, DOI 10.1515/BC.2008.109; Gruning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017; Guillaumet-Adkins A, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9175806; Guo Z, 2010, CELL CYCLE, V9, P4805, DOI 10.4161/cc.9.24.14323; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hamilton LK, 2015, CELL STEM CELL, V17, P397, DOI 10.1016/j.stem.2015.08.001; He M, 2013, MOL MED REP, V8, P942, DOI 10.3892/mmr.2013.1566; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Heppner DE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06790-1; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Huang TT, 2012, SEMIN CELL DEV BIOL, V23, P738, DOI 10.1016/j.semcdb.2012.04.003; Hwang I, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20839-0; Hwang I, 2018, AGING CELL, V17, DOI 10.1111/acel.12701; Innes BT, 2015, BBA-MOL BASIS DIS, V1852, P905, DOI 10.1016/j.bbadis.2014.12.025; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; Kaiserova K, 2006, J BIOL CHEM, V281, P15110, DOI 10.1074/jbc.M600837200; Kato I, 2013, MOL CELL BIOL, V33, P340, DOI 10.1128/MCB.01350-12; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Khacho M, 2018, DEV DYNAM, V247, P47, DOI 10.1002/dvdy.24538; Khacho M, 2017, HUM MOL GENET, V26, P3327, DOI 10.1093/hmg/ddx217; Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015; Kim DY, 2015, CELL DEATH DIFFER, V22, P2034, DOI 10.1038/cdd.2015.123; Kim DY, 2014, CELL MOL LIFE SCI, V71, P4221, DOI 10.1007/s00018-014-1686-0; Kim H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10025; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Korn SH, 2001, J BIOL CHEM, V276, P35693, DOI 10.1074/jbc.M104321200; Koundouros N, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00160; Kreuz S, 2016, EPIGENOMICS-UK, V8, P843, DOI 10.2217/epi-2016-0002; Kruger A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001959; Kulathu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2567; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; L'Episcopo F, 2013, J NEUROSCI, V33, P1462, DOI 10.1523/JNEUROSCI.3206-12.2013; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee B.H, 2020, INT J MOL SCI, V21; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Legler PM, 2008, BIOCHEMISTRY-US, V47, P9592, DOI 10.1021/bi8010016; Lei H, 2009, J BIOL CHEM, V284, P6329, DOI 10.1074/jbc.M808426200; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Li L, 2014, J NEUROSCI, V34, P16713, DOI 10.1523/JNEUROSCI.4590-13.2014; LiCausi F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051544; Lingappan Krithika, 2018, Current Opinion in Toxicology, V7, P81, DOI 10.1016/j.cotox.2017.11.002; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu J, 2008, MOL IMMUNOL, V45, P3984, DOI 10.1016/j.molimm.2008.06.012; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Luanpitpong S, 2013, MOL BIOL CELL, V24, P858, DOI 10.1091/mbc.E12-10-0747; Lupo G, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519829040; Ma CY, 2014, DEVELOPMENT, V141, P4697, DOI 10.1242/dev.117937; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Maller C, 2011, ANTIOXID REDOX SIGN, V14, P49, DOI 10.1089/ars.2010.3149; Marchetti B, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101664; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011; Mews P, 2017, NATURE, V546, P381, DOI 10.1038/nature22405; Morales Y, 2015, J BIOL CHEM, V290, P14915, DOI 10.1074/jbc.M115.651380; Morgado AL, 2015, MOL NEUROBIOL, V51, P1168, DOI 10.1007/s12035-014-8794-6; Movafagh S, 2015, J CELL BIOCHEM, V116, P696, DOI 10.1002/jcb.25074; Nadeau PJ, 2009, MOL BIOL CELL, V20, P3628, DOI 10.1091/mbc.E09-03-0211; Nagahara N, 2005, J BIOL CHEM, V280, P34569, DOI 10.1074/jbc.M505643200; Nakajima S, 2013, FREE RADICAL BIO MED, V65, P162, DOI 10.1016/j.freeradbiomed.2013.06.020; NAKAMURA K, 1993, ONCOGENE, V8, P3133; Nayernia Z, 2017, REDOX BIOL, V13, P82, DOI 10.1016/j.redox.2017.04.026; Nelson KJ, 2018, J BIOL CHEM, V293, P16376, DOI 10.1074/jbc.RA118.004613; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Niwa K, 2003, ANTIOXID REDOX SIGN, V5, P713, DOI 10.1089/152308603770380016; Oeing CU, 2020, CIRC RES, V127, P522, DOI 10.1161/CIRCRESAHA.119.315714; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Ranaghan MJ, 2013, J BIOL CHEM, V288, P36160, DOI 10.1074/jbc.M113.524355; Ray S, 2018, CELL TRANSPLANT, V27, P589, DOI 10.1177/0963689718774030; Reichenbach J, 1999, CLIN EXP IMMUNOL, V117, P535; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Rharass T, 2014, J BIOL CHEM, V289, P27937, DOI 10.1074/jbc.M114.573519; Rhee SG, 2018, ANTIOXID REDOX SIGN, V28, P537, DOI 10.1089/ars.2017.7167; Robledinos-Anton N, 2017, REDOX BIOL, V13, P393, DOI 10.1016/j.redox.2017.06.010; Salminen A, 2013, INT J MOL SCI, V14, P3834, DOI 10.3390/ijms14023834; Santo EE, 2018, CURR TOP DEV BIOL, V127, P105, DOI 10.1016/bs.ctdb.2017.10.002; Sato A, 2014, STEM CELL RES, V12, P119, DOI 10.1016/j.scr.2013.09.012; Schaffner I, 2018, NEURON, V99, P1188, DOI 10.1016/j.neuron.2018.08.017; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Schweitzer JS, 2020, NEW ENGL J MED, V382, P1926, DOI 10.1056/NEJMoa1915872; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Stoll EA, 2015, STEM CELLS, V33, P2306, DOI 10.1002/stem.2042; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Suzuki T, 2019, CELL REP, V28, P746, DOI 10.1016/j.celrep.2019.06.047; Tao LL, 2020, ELIFE, V9, DOI 10.7554/eLife.57837; Ulianov SV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09185-y; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Walton NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035264; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Wetzel MA, 2014, MAR ENVIRON RES, V99, P125, DOI 10.1016/j.marenvres.2014.04.008; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Xavier JM, 2014, ANTIOXID REDOX SIGN, V21, P1009, DOI 10.1089/ars.2013.5417; Yan LJ, 2013, FREE RADICAL RES, V47, P123, DOI 10.3109/10715762.2012.752078; Yazdankhah M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.358; Ye CQ, 2017, MOL CELL, V66, P180, DOI 10.1016/j.molcel.2017.02.026; Ye ZW, 2015, BBA-GEN SUBJECTS, V1850, P1607, DOI 10.1016/j.bbagen.2014.11.010; Yeo H, 2013, EMBO J, V32, P2589, DOI 10.1038/emboj.2013.186; Yoshida S, 2011, J BIOL CHEM, V286, P32651, DOI 10.1074/jbc.M111.238014; Yoshikawa Y, 2019, NEUROSCIENCE, V398, P193, DOI 10.1016/j.neuroscience.2018.11.046; Zhang Y., 2012, FRONT BIOL, V7; Zhou WJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1434-3; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685	163	1	1	7	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	JUN	2021	169						74	83		10.1016/j.freeradbiomed.2021.03.043			10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	SF8UK	WOS:000653023500002	33862161				2022-02-06	
J	Jalloul, D; Hajjar, H; Asdikian, R; Maawie, M; Nasrallah, L; Medlej, Y; Darwich, M; Karnib, N; Lawand, N; Rassoul, RA; Wang, KKW; Kobeissy, F; Darwish, H; Obeid, M				Jalloul, Dounya; Hajjar, Helene; Asdikian, Rita; Maawie, Mariam; Nasrallah, Leila; Medlej, Yasser; Darwich, Mouhamad; Karnib, Nabil; Lawand, Nada; Abdel Rassoul, Ronza; Wang, Kevin K. W.; Kobeissy, Firas; Darwish, Hala; Obeid, Makram			Potentiating Hemorrhage in a Periadolescent Rat Model of Closed-Head Traumatic Brain Injury Worsens Hyperexcitability but Not Behavioral Deficits	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						controlled cortical impact; hemorrhage; hyperexcitable; astrocyte; adolescent; spike; behavior; epilepsy	CONTROLLED CORTICAL IMPACT; FLUID-PERCUSSION INJURY; POSTTRAUMATIC EPILEPSY; ANIMAL-MODELS; RISK-FACTORS; SEIZURE SUSCEPTIBILITY; ADULT RATS; EEG; SPIKES; ELECTROENCEPHALOGRAPHY	Post-traumatic epilepsy (PTE) and neurocognitive deficits are devastating sequelae of head injuries that are common in adolescents. Investigating desperately needed treatments is hindered by the difficulties in inducing PTE in rodents and the lack of established immature rat models of pediatric PTE. Hemorrhage is a significant risk factor for PTE, but compared to humans, rats are less prone to bleeding because of their rapid blood coagulation system. In this study, we promoted bleeding in the controlled cortical impact (CCI) closed-head injury model with a 20 min pre-impact 600 IU/kg intraperitoneal heparin injection in postnatal day 35 (P35) periadolescent rats, given the preponderance of such injuries in this age group. Temporo-parietal CCI was performed post-heparin (HTBI group) or post-saline (TBI group). Controls were subjected to sham procedures following heparin or saline administration. Continuous long-term EEG monitoring was performed for 3 months post-CCI. Sensorimotor testing, the Morris water maze, and a modified active avoidance test were conducted between P80 and P100. Glial fibrillary acidic protein (GFAP) levels and neuronal damage were also assessed. Compared to TBI rats, HTBI rats had persistently higher EEG spiking and increased hippocampal GFAP levels (p < 0.05). No sensorimotor deficits were detected in any group. Compared to controls, both HTBI and TBI groups had a long-term hippocampal neuronal loss (p < 0.05), as well as contextual and visuospatial learning deficits (p < 0.05). The hippocampal astrogliosis and EEG spiking detected in all rats subjected to our hemorrhage-promoting procedure suggest the emergence of hyperexcitable networks and pave the way to a periadolescent PTE rat model.	[Jalloul, Dounya; Hajjar, Helene; Asdikian, Rita; Medlej, Yasser; Karnib, Nabil; Lawand, Nada; Darwish, Hala; Obeid, Makram] Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Beirut 11072020, Lebanon; [Maawie, Mariam; Abdel Rassoul, Ronza] Lebanese Univ, Neurosci Res Ctr, Fac Med Sci, POB 6573-14, Hadath, Lebanon; [Nasrallah, Leila; Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut 11072020, Lebanon; [Darwich, Mouhamad; Obeid, Makram] Amer Univ Beirut Med Ctr, Div Child Neurol, Dept Pediat & Adolescent Med, Beirut 1107, Lebanon; [Lawand, Nada] Amer Univ Beirut, Dept Neurol, Med Ctr, Beirut 1107, Lebanon; [Wang, Kevin K. W.; Kobeissy, Firas] Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL 32608 USA; [Wang, Kevin K. W.; Kobeissy, Firas] Univ Florida, Dept Emergency Med, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL 32608 USA; [Darwish, Hala] Amer Univ Beirut, Rafic Hariri Sch Nursing, Beirut 1107, Lebanon		Darwish, H; Obeid, M (corresponding author), Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Beirut 11072020, Lebanon.; Kobeissy, F (corresponding author), Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut 11072020, Lebanon.; Obeid, M (corresponding author), Amer Univ Beirut Med Ctr, Div Child Neurol, Dept Pediat & Adolescent Med, Beirut 1107, Lebanon.; Kobeissy, F (corresponding author), Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL 32608 USA.; Kobeissy, F (corresponding author), Univ Florida, Dept Emergency Med, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL 32608 USA.; Darwish, H (corresponding author), Amer Univ Beirut, Rafic Hariri Sch Nursing, Beirut 1107, Lebanon.	dfj04@mail.aub.edu; helenehajjar@outlook.com; rha69@mail.aub.edu; mariam_ma96@hotmail.com; ln23@aub.edu.lb; yasser.medlej@uks.eu; mouhamad.el.darwich@gmail.com; nkarnib0@gmail.com; n108@aub.edu.lb; ronza.abdelrassoul@gmail.com; kawangwang17@gmail.com; firasko@gmail.com; hd30@aub.edu.lb; mo21@aub.edu.lb	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944; Obeid, Makram/0000-0003-4349-674X; Wang, Kevin/0000-0002-9343-6473; Hajjar, Helene/0000-0001-9558-4237; Nasrallah, Leila/0000-0002-7358-4751	American University of Beirut, Medical Practice Plan Award [320150]; Citizens United for Research in Epilepsy (CURE) foundation; United States Army Medical Research and Materiel Command, Department of Defense (DoD), through the Psychological Health and Traumatic Brain Injury Research Program [W81XWH-152-0069]	This research work was supported by the American University of Beirut, Medical Practice Plan Award No. 320150 to M.O., H.D., and F.K. The work is also supported in part by Citizens United for Research in Epilepsy (CURE) foundation grant to K.W. and F.K., received from the United States Army Medical Research and Materiel Command, Department of Defense (DoD), through the Psychological Health and Traumatic Brain Injury Research Program under Award No. W81XWH-152-0069. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense.	Abdelmalik PA, 2005, EPILEPSIA, V46, P356, DOI 10.1111/j.0013-9580.2005.34204.x; Assi L, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0467-0; Bergstrom RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01483; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Cotter D, 2017, SEIZURE-EUR J EPILEP, V46, P53, DOI 10.1016/j.seizure.2017.02.002; Dadas A, 2019, NEUROBIOL DIS, V123, P20, DOI 10.1016/j.nbd.2018.06.022; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fedele DE, 2005, BRAIN, V128, P2383, DOI 10.1093/brain/awh555; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Glushakov AV, 2016, METHODS MOL BIOL, V1462, P481, DOI 10.1007/978-1-4939-3816-2_27; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Hwang SY, 2019, BRAIN INJURY, V33, P1420, DOI 10.1080/02699052.2019.1641625; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kandratavicius L, 2014, NEUROPSYCH DIS TREAT, V10, P1693, DOI 10.2147/NDT.S50371; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Keret A, 2017, J NEUROSURG-PEDIATR, V20, P64, DOI 10.3171/2017.2.PEDS16585; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Korkmaz K, 2013, EUR REV MED PHARMACO, V17, P522; Lapinlampi N, 2020, EPILEPSIA, V61, P2035, DOI 10.1111/epi.16632; Levesque M, 2016, J NEUROSCI METH, V260, P45, DOI 10.1016/j.jneumeth.2015.03.009; Li Q, 2018, NEUROCHEM RES, V43, P2343, DOI 10.1007/s11064-018-2659-8; Medlej Y, 2019, METHODS MOL BIOL, V2011, P429, DOI 10.1007/978-1-4939-9554-7_25; Medlej Y, 2019, METHODS MOL BIOL, V2011, P345, DOI 10.1007/978-1-4939-9554-7_20; Medlej Y, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0490-z; Medlej Y, 2019, EPILEPSY BEHAV, V92, P332, DOI 10.1016/j.yebeh.2019.01.023; Obeid M, 2010, EPILEPSY BEHAV, V19, P278, DOI 10.1016/j.yebeh.2010.07.023; Obeid M, 2009, EUR J PAEDIATR NEURO, V13, P102, DOI 10.1016/j.ejpn.2008.05.007; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pitkanen A., 2012, Jasper's Basic Mechanisms of the Epilepsies, V4th ed.; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Robel S, 2016, NAT NEUROSCI, V19, P28, DOI 10.1038/nn.4184; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Salah H, 2021, FRONT BEHAV NEUROSCI, V15, DOI 10.3389/fnbeh.2021.682927; Salah H, 2019, METHODS MOL BIOL, V2011, P413, DOI 10.1007/978-1-4939-9554-7_24; Sarkisian MR, 2001, EPILEPSY BEHAV, V2, P201, DOI 10.1006/ebeh.2001.0193; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Shakkour Z, 2021, NEUROSCIENTIST, V27, P620, DOI 10.1177/1073858420961078; Shandra O, 2019, J NEUROSCI, V39, P1944, DOI 10.1523/JNEUROSCI.1067-18.2018; Sharma S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00007; SHERWOOD NM, 1970, STEREOTAXIC ATLAS DE; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Siller-Matula JM, 2008, THROMB HAEMOSTASIS, V100, P397, DOI 10.1160/TH08-02-0103; Smith D, 2018, EPILEPSY RES, V147, P87, DOI 10.1016/j.eplepsyres.2018.09.005; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Staley K, 2005, NEUROSCIENTIST, V11, P272, DOI 10.1177/1073858405278239; Staley KJ, 2011, NEUROSCI LETT, V497, P247, DOI 10.1016/j.neulet.2011.03.070; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Sun GC, 2020, BRAIN RES BULL, V162, P84, DOI 10.1016/j.brainresbull.2020.05.009; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; White A, 2010, EPILEPSIA, V51, P371, DOI 10.1111/j.1528-1167.2009.02339.x; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026	61	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN	2021	22	12							6456	10.3390/ijms22126456			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	TA7NV	WOS:000667433800001	34208666	gold, Green Published			2022-02-06	
J	Kim, M; Moeller, E; Thaller, SR				Kim, Minji; Moeller, Ellie; Thaller, Seth R.			Sports-Related Craniofacial Injuries Among Pediatric and Adolescent Females: A National Electronic Injury Surveillance System Database Study	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Athletes; craniofacial injuries; female athletes; fractures; sports-related injuries	FACIAL TRAUMA; FRACTURES; CONCUSSION; PREVENTION; DEPRESSION; ANXIETY; GENDER; TRENDS	Background: Number of female athletes continues to exponentially increase in all sports; however, available literature detailing craniofacial injuries remains scarce. Compared to male athletes, female athletes may experience different types of injuries. These may be related to sex differences such as craniofacial pain and dimensions. Thus, this study assesses the type of sport and craniofacial injuries that pediatric and adolescent female athletes sustain. Methods: National Electronic Injury Surveillance System was analyzed for all hospital admissions for young female athletes (5-24 years old) experiencing a sports-related craniofacial injury. These included contusions and abrasions, lacerations, fractures, and hematomas. Following sports were analyzed for craniofacial injury: basketball, golf, soccer, ice skating, swimming, softball, horseback riding, volleyball, field hockey, and football. Results: Most of the sports-related craniofacial injury occurred in female athletes who are between 10 and 19 years old. Across all age groups, softball (34.9%), basketball (28.1%), and soccer (15.6%) caused majority of the craniofacial injuries. The most common presenting craniofacial injury types were contusions and abrasions as well as lacerations. Conclusions: There is a need for improved protective gear, such as face shields and low-impact balls, especially in softball and basketball. Physicians should consider the differences in female versus male and child versus adult injury pattern when treating female athletes in order to prevent long-term complications, such as scarring and depression. Overall, sports-related craniofacial injuries among female athletes need to be further examined as the epidemiology of their injuries and their health needs are unique.	[Kim, Minji; Moeller, Ellie] Univ Miami, Miller Sch Med, 1600 NW 10th Ave 1140, Miami, FL 33136 USA; [Thaller, Seth R.] Univ Miami, Div Plast Aesthet & Reconstruct Surg, Miami, FL 33136 USA		Kim, M (corresponding author), Univ Miami, Miller Sch Med, 1600 NW 10th Ave 1140, Miami, FL 33136 USA.	minji.kim@med.miami.edu		Kim, Minji/0000-0002-2339-4538			Appaneal RN, 2009, J SPORT EXERCISE PSY, V31, P60, DOI 10.1123/jsep.31.1.60; Bak MJ, 2004, J ORAL MAXIL SURG, V62, P1209, DOI 10.1016/j.joms.2004.06.034; Black AM, 2017, CLIN SPORT MED, V36, P257, DOI 10.1016/j.csm.2016.11.002; Brennan MJ, 2021, J CRANIOFAC SURG, V32, P1561, DOI 10.1097/SCS.0000000000007136; Cairns BE, 2007, HEADACHE, V47, P319, DOI 10.1111/j.1526-4610.2006.00708.x; Choi SH, 2016, J CRANIOFAC SURG, V27, P1682, DOI 10.1097/SCS.0000000000002916; Costello JT, 2014, EUR J SPORT SCI, V14, P847, DOI 10.1080/17461391.2014.911354; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Emery CA, 2006, CLIN J SPORT MED, V16, P514, DOI 10.1097/01.jsm.0000251179.90840.58; Frank RM, 2017, JBJS REV, V5, DOI 10.2106/JBJS.RVW.17.00017; Gandy JR, 2016, LARYNGOSCOPE, V126, P1054, DOI 10.1002/lary.25584; Islam S, 2010, INJURY, V41, P92, DOI 10.1016/j.injury.2009.07.012; Levine E, 2005, ANN PLAS SURG, V54, P502, DOI 10.1097/01.sap.0000155282.48465.94; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; MacIsaac ZM, 2013, PLAST RECONSTR SURG, V131, P1339, DOI 10.1097/PRS.0b013e31828bd191; Matthews HS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22752-5; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Murphy C, 2015, J CRANIOFAC SURG, V26, P2120, DOI 10.1097/SCS.0000000000002109; National Federation of State High School Association, 2019, PART HIGH SCH SPORTS; National Women's Law Center, 2011, BATTL GEND EQ ATHL C; Othman S, 2019, CRANIOMAX TRAUM REC, V12, P266, DOI 10.1055/s-0039-1679930; Prashanth N T, 2015, J Int Oral Health, V7, P94; Pueringer J, 2021, PHYSICIAN SPORTSMED, V49, P64, DOI 10.1080/00913847.2020.1768451; Reehal P, 2010, CURR SPORT MED REP, V9, P27, DOI 10.1249/JSR.0b013e3181cd2c04; Reich JS, 2021, J CRANIOFAC SURG, V32, P1564, DOI 10.1097/SCS.0000000000006984; Romeo Sam J, 2007, Curr Sports Med Rep, V6, P155, DOI 10.1007/s11932-007-0022-y; Sallis RE, 2001, INT J SPORTS MED, V22, P420, DOI 10.1055/s-2001-16246; Scheffler P, 2019, INT J PEDIATR OTORHI, V121, P6, DOI 10.1016/j.ijporl.2019.02.036; Schwarb AW., 2018, Number of NCAA college athletes reaches all-time high; Singh DJ, 2004, CLIN PLAST SURG, V31, P499, DOI 10.1016/j.cps.2004.03.012; Svider PF, 2016, INT J PEDIATR OTORHI, V87, P78, DOI 10.1016/j.ijporl.2016.05.025; Taner L, 2019, TURK J ORTHOD, V32, P59, DOI 10.5152/TurkJOrthod.2019.18031; Tebble NJ, 2004, J ADV NURS, V47, P417, DOI 10.1111/j.1365-2648.2004.03123.x; Valier ARS, 2020, J ATHL TRAINING, V55, P188, DOI 10.4085/1062-6050-105-19; Wheeler J, 2011, CRANIOMAX TRAUM REC, V4, P43, DOI 10.1055/s-0031-1272901	36	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1603	1606		10.1097/SCS.0000000000007586			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100118	33654046				2022-02-06	
J	Laeke, T; Tirsit, A; Kassahun, A; Sahlu, A; Yesehak, B; Getahun, S; Zenebe, E; Deyassa, N; Moen, BE; Lund-Johansen, M; Sundstrom, T				Laeke, Tsegazeab; Tirsit, Abenezer; Kassahun, Azarias; Sahlu, Abat; Yesehak, Betelehem; Getahun, Samuel; Zenebe, Eyob; Deyassa, Negussie; Moen, Bente E.; Lund-Johansen, Morten; Sundstrom, Terje			Prospective Study of Surgery for Traumatic Brain Injury in Addis Ababa, Ethiopia: Surgical Procedures, Complications, and Postoperative Outcomes	WORLD NEUROSURGERY			English	Article						Low- and middle-income countries; Neurotrauma; Surgical outcome; Traumatic brain injury	MANAGEMENT; NEUROTRAUMA; EPIDEMIOLOGY; NEUROSURGERY; GUIDELINES; MORTALITY; CARE	BACKGROUND: Traumatic brain injury (TBI) is an important cause of trauma-related mortality and morbidity in Ethiopia. There are significant resource limitations along the entire continuum of care, and little is known about the neurosurgical activity and patient outcomes. METHODS: All surgically treated TBI patients at the 4 teaching hospitals in Addis Ababa, Ethiopia were prospectively registered from October 2012 to December 2016. Data registration included surgical procedures, complications, reoperations, discharge outcomes, and mortality. RESULTS: A total of 1087 patients were included. The most common procedures were elevation of depressed skull fractures (49.5%) and craniotomies (47.9%). Epidural hematoma was the most frequent indication for a craniotomy (74.7%). Most (77.7%) patients were operated within 24 hours of admission. The median hospital stay for depressed skull fracture operations or craniotomies was 4 days. Decompressive craniectomy was only done in 10 patients. Postoperative complications were seen in 17% of patients, and only 3% were reoperated. Cerebrospinal fluid leak was the most common complication (7.9%). The overall mortality was 8.2%. Diagnosis, admission Glasgow Coma Scale (GCS) score, surgical procedure, and complications were significant predictors of discharge GCS score (P < 0.01). Age, admission GCS score, and length of hospital stay were significantly associated with mortality (P <= 0.005). CONCLUSIONS: The injury panorama, surgical activity, and outcome are significantly influenced by patient selection due to deficits within both prehospital and hospital care. Still, the neurosurgical services benefit a large number of patients in the greater Addis region and are qualitatively comparable with reports from high-income countries.	[Laeke, Tsegazeab; Tirsit, Abenezer; Kassahun, Azarias; Sahlu, Abat; Yesehak, Betelehem; Getahun, Samuel; Zenebe, Eyob] Addis Ababa Univ, Coll Hlth Sci, Surg Dept, Neurosurg Unit, Addis Ababa, Ethiopia; [Deyassa, Negussie] Addis Ababa Univ, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Laeke, Tsegazeab; Tirsit, Abenezer; Lund-Johansen, Morten; Sundstrom, Terje] Univ Bergen, Fac Med, Dept Clin Med, Ctr Int Hlth, Bergen, Norway; [Moen, Bente E.] Univ Bergen, Fac Med, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Lund-Johansen, Morten; Sundstrom, Terje] Haukeland Hosp, Neurosurg, Bergen, Norway		Laeke, T (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Surg Dept, Neurosurg Unit, Addis Ababa, Ethiopia.; Laeke, T (corresponding author), Univ Bergen, Fac Med, Dept Clin Med, Ctr Int Hlth, Bergen, Norway.	tselaeke@gmail.com	Moen, BE/P-9329-2017	Moen, Bente Elisabeth/0000-0002-0435-3124; Laeke, Tsegazeab/0000-0003-4287-1413			Ahmad S, 2018, PAK J MED SCI, V34, P130, DOI 10.12669/pjms.341.13184; Alkire BC, 2015, LANCET GLOB HEALTH, V3, pE316, DOI 10.1016/S2214-109X(15)70115-4; Azaj A., 2013, East and Central African Journal of Surgery, V18, P108; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chrastina J, 2020, EUR J TRAUMA EMERG S, V46, P347, DOI 10.1007/s00068-019-01077-6; Compagnone C, 2005, NEUROSURGERY, V57, P1183; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; El Khamlichi Abdeslam, 2005, Clin Neurosurg, V52, P214; El-Fiki M, 2011, WORLD NEUROSURG, V75, P458, DOI 10.1016/j.wneu.2010.10.057; El-Fiki M, 2010, WORLD NEUROSURG, V73, P254, DOI 10.1016/j.wneu.2010.02.012; Elahi C, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.7.FOCUS19316; Ethiopia Central Statistical Agency, 2014, MIN DEM HLTH SURV 20; Hunchak Cheryl, 2015, BMC Res Notes, V8, P605, DOI 10.1186/s13104-015-1592-z; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kelly ML, 2018, WORLD NEUROSURG, V118, pE974, DOI 10.1016/j.wneu.2018.07.124; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Laeke T, 2020, MANAGEMENT SEVERE TR, P9; Laeke T, WORLD NEUROSURG, DOI [10.1016/j.wneu.2021.02, DOI 10.1016/J.WNEU.2021.02]; Laeke T, 2019, WORLD NEUROSURG, V127, pE186, DOI 10.1016/j.wneu.2019.03.044; Laghari Altaf Ali, 2018, Asian J Neurosurg, V13, P1053, DOI 10.4103/ajns.AJNS_195_17; Lund-Johansen M, 2017, WORLD NEUROSURG, V99, P403, DOI 10.1016/j.wneu.2016.12.051; Ohaegbulam Samuel C, 2011, Surg Neurol Int, V2, P182, DOI 10.4103/2152-7806.91137; Quinones-Hinojosa A., 2012, SCHIMEDIK SWEET OPER, V2, P1526; Qureshi JS, 2013, INT J SURG, V11, P265, DOI 10.1016/j.ijsu.2013.01.011; Rolekar Nikita G, 2014, IJMHS, V3, DOI [10.5455/ijmsph.2014.271020141, DOI 10.5455/IJMSPH.2014.271020141]; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Salia SM, 2018, WORLD NEUROSURG, V114, pE833, DOI 10.1016/j.wneu.2018.03.095; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Solano EE, 2017, E CENTRAL AFRICAN J, V22, P98; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Stein SC, 2019, WORLD NEUROSURG, V121, P186, DOI 10.1016/j.wneu.2018.10.045; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Surgeons ACo, 2018, ATLS ADV TRAUM LIF S; Tadesse S, 2016, J OCCUP MED TOXICOL, V11, DOI 10.1186/s12995-016-0107-8; Tallon JM, 2008, CAN J SURG, V51, P339; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; World Health Organization, 2009, GLOB STAT REP ROAD S	44	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2021	150						E316	E323		10.1016/j.wneu.2021.03.004			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SM8GR	WOS:000657837500033	33706016				2022-02-06	
J	Lee, SI; Adans-Dester, CP; OBrien, AT; Vergara-Diaz, GP; Black-Schaffer, R; Zafonte, R; Dy, JG; Bonato, P				Lee, Sunghoon I.; Adans-Dester, Catherine P.; OBrien, Anne T.; Vergara-Diaz, Gloria P.; Black-Schaffer, Randie; Zafonte, Ross; Dy, Jennifer G.; Bonato, Paolo			Predicting and Monitoring Upper-Limb Rehabilitation Outcomes Using Clinical and Wearable Sensor Data in Brain Injury Survivors	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Task analysis; DC motors; Wearable sensors; Accelerometers; Monitoring; Data models; Thumb; Gaussian Process Regression; Machine Learning; Precision Rehabilitation; Stroke; Traumatic Brain Injury; Wearable Technology	MOTOR FUNCTION-TEST; STROKE SURVIVORS; PROPORTIONAL RECOVERY; IMPAIRMENT; STIMULATION; RELIABILITY; EXTREMITIES	Objective: Rehabilitation specialists have shown considerable interest for the development of models, based on clinical data, to predict the response to rehabilitation interventions in stroke and traumatic brain injury survivors. However, accurate predictions are difficult to obtain due to the variability in patients' response to rehabilitation interventions. This study aimed to investigate the use of wearable technology in combination with clinical data to predict and monitor the recovery process and assess the responsiveness to treatment on an individual basis. Methods: Gaussian Process Regression-based algorithms were developed to estimate rehabilitation outcomes (i.e., Functional Ability Scale scores) using either clinical or wearable sensor data or a combination of the two. Results: The algorithm based on clinical data predicted rehabilitation outcomes with a Pearson's correlation of 0.79 compared to actual clinical scores provided by clinicians but failed to model the variability in responsiveness to the intervention observed across individuals. In contrast, the algorithm based on wearable sensor data generated rehabilitation outcome estimates with a Pearson's correlation of 0.91 and modeled the individual responses to rehabilitation more accurately. Furthermore, we developed a novel approach to combine estimates derived from the clinical data and the sensor data using a constrained linear model. This approach resulted in a Pearson's correlation of 0.94 between estimated and clinician-provided scores. Conclusion: This algorithm could enable the design of patient-specific interventions based on predictions of rehabilitation outcomes relying on clinical and wearable sensor data. Significance: This is important in the context of developing precision rehabilitation interventions.	[Lee, Sunghoon I.; Adans-Dester, Catherine P.; OBrien, Anne T.; Vergara-Diaz, Gloria P.; Black-Schaffer, Randie; Zafonte, Ross] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Lee, Sunghoon I.] Univ Massachusetts Amherst, Coll Informat & Comp Sci, Amherst, MA USA; [Dy, Jennifer G.] Northeastern Univ, Elect & Comp Engn, Boston, MA 02115 USA; [Bonato, Paolo] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Bonato, Paolo] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA		Bonato, P (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA.; Bonato, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	pbonato@ieee.org	Black-Schaffer, Randie/AAY-4671-2021; Bonato, Paolo/AAH-6111-2019	Bonato, Paolo/0000-0002-1818-1714; Adans-Dester, Catherine/0000-0001-6816-0586; Black-Schaffer, Randie/0000-0002-1250-1502	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24HD050821, R24HD065688]	This work was partially supported by the Grant number R24HD050821 (Engineering for Neurologic Rehabilitation) and the Grant number R24HD065688 (Improving Outcome Measurement for Medical Rehabilitation Clinical Trials) awarded by the National Institutes of Health.	Acler M, 2009, RESTOR NEUROL NEUROS, V27, P277, DOI 10.3233/RNN-2009-0477; Bailey RR, 2015, NEUROREHAB NEURAL RE, V29, P969, DOI 10.1177/1545968315583720; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Bradley CL, 2019, NEUROREHAB NEURAL RE, V33, P331, DOI 10.1177/1545968319837289; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Byblow WD, 2015, ANN NEUROL, V78, P848, DOI 10.1002/ana.24472; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; Del Din S, 2011, IEEE ENG MED BIO, P5839, DOI 10.1109/IEMBS.2011.6091444; Dobkin BH, 2011, NEUROREHAB NEURAL RE, V25, P788, DOI 10.1177/1545968311425908; Duff SV, 2015, NEUROREHAB NEURAL RE, V29, P436, DOI 10.1177/1545968314553030; Feng WW, 2015, ANN NEUROL, V78, P860, DOI 10.1002/ana.24510; Ford GA, 2019, LANCET NEUROL, V18, P530, DOI 10.1016/S1474-4422(19)30147-4; Groisser BN, 2014, NEUROREHAB NEURAL RE, V28, P751, DOI 10.1177/1545968314521896; Hall MA, 1999, CORRELATION BASED FE; Hayward KS, 2016, BRAIN IMPAIR, V17, P16, DOI 10.1017/BrImp.2015.21; Hope TMH, 2013, NEUROIMAGE-CLIN, V2, P424, DOI 10.1016/j.nicl.2013.03.005; Ingemanson ML, 2019, NEUROLOGY, V92, pE1098, DOI 10.1212/WNL.0000000000007041; Inouye M, 2000, AM J PHYS MED REHAB, V79, P513, DOI 10.1097/00002060-200011000-00007; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kim WS, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0489-9; Krakauer JW, 2015, ANN NEUROL, V78, P845, DOI 10.1002/ana.24537; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Lang CE, 2016, ANN NEUROL, V80, P342, DOI 10.1002/ana.24734; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lee S. I., 2016, ARCH PHYS MED REHAB, V97; Lee SI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212484; Lee SI, 2016, IEEE J BIOMED HEALTH, V20, P91, DOI 10.1109/JBHI.2014.2372777; Leuenberger K, 2017, MED BIOL ENG COMPUT, V55, P141, DOI 10.1007/s11517-016-1496-7; McCabe J, 2015, ARCH PHYS MED REHAB, V96, P981, DOI 10.1016/j.apmr.2014.10.022; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Nijland R, 2010, J REHABIL MED, V42, P694, DOI 10.2340/16501977-0560; Oubre B, 2020, IEEE T NEUR SYS REH, V28, P601, DOI 10.1109/TNSRE.2020.2966950; Patel S, 2016, IEEE ENG MED BIO, P5997, DOI 10.1109/EMBC.2016.7592095; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Patel S, 2010, P IEEE, V98, P450, DOI 10.1109/JPROC.2009.2038727; Pietilainen V, 2010, THESIS AALTO U ESPOO; Prabhakaran S, 2008, NEUROREHAB NEURAL RE, V22, P64, DOI 10.1177/1545968307305302; Rand D, 2012, NEUROREHAB NEURAL RE, V26, P76, DOI 10.1177/1545968311408918; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Reinkensmeyer DJ, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0148-3; Rosser N, 2008, ARCH PHYS MED REHAB, V89, P1633, DOI 10.1016/j.apmr.2008.02.030; Sapienza S, 2017, 2017 IEEE/ACM SECOND INTERNATIONAL CONFERENCE ON CONNECTED HEALTH - APPLICATIONS, SYSTEMS AND ENGINEERING TECHNOLOGIES (CHASE), P284, DOI 10.1109/CHASE.2017.104; Stegle O, 2008, IEEE T BIO-MED ENG, V55, P2143, DOI 10.1109/TBME.2008.923118; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Thrane G, 2011, J REHABIL MED, V43, P299, DOI 10.2340/16501977-0676; Tran DA, 2016, AM J PHYS MED REHAB, V95, P459, DOI 10.1097/PHM.0000000000000438; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Miranda JGV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29470-y; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Ward NS, 2019, J NEUROL NEUROSUR PS, V90, P498, DOI 10.1136/jnnp-2018-319954; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winstein C, 2018, NEUROREHABILITATION, V43, P3, DOI 10.3233/NRE-172412; Wolf SL, 2006, ARCH PHYS MED REHAB, V87, P443, DOI 10.1016/j.apmr.2005.10.006; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Yu L, 2016, COMPUT METH PROG BIO, V128, P100, DOI 10.1016/j.cmpb.2016.02.012; Zarshenas S, 2019, ARCH PHYS MED REHAB, V100, P1274, DOI 10.1016/j.apmr.2018.11.023	59	1	1	8	9	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	JUN	2021	68	6					1871	1881		10.1109/TBME.2020.3027853			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	SF5LA	WOS:000652795800013	32997621	Green Accepted, Bronze			2022-02-06	
J	Sarti, THM; Paz, DD; Diniz, JM; Kim, IHT; Rodrigues, TP; Cavalheiro, S; Suriano, IC				Martins Sarti, Talita Helena; Paz, Daniel de Araujo; Diniz, Juliete Melo; Kim, Isaque Hyung Tong; Rodrigues, Thiago Pereira; Cavalheiro, Sergio; Suriano, Italo Capraro			External cranioplasty for the syndrome of the trephined - Case report	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Cranioplasty; Plastered helmet; Syndrome of the trephined		Background: The syndrome of the trephined was described in 1939 by Grant and Norcross and is defined as a progressive neurological deterioration after craniectomy. Commonly, it is associated with sinking of the skin near the bone-free area. The symptoms and signs improve after cranioplasty. This report intends to describe an uncommon case of a patient who presented to the hospital with the syndrome of the trephined and was temporarily treated with a plastered helmet. Case description: 45-year old male was submitted to a decompressive craniectomy due to severe traumatic brain injury. After one month, he was diagnosed with the syndrome of the trephined. Once he was in sepsis, cranioplasty could not be done. An alternative treatment was proposed and the patient improved in both clinical and radiological cenarios. Conclusion: The external cranioplasty made with plastered helmet proved to be an effective technique that can be safely applied to patients with the syndrome of the trephined who cannot be promptly treated with surgery.	[Martins Sarti, Talita Helena; Paz, Daniel de Araujo; Kim, Isaque Hyung Tong; Rodrigues, Thiago Pereira; Cavalheiro, Sergio; Suriano, Italo Capraro] Univ Fed Sao Paulo UNIFESP, Dept Neurosurg, Sao Paulo, Brazil; [Diniz, Juliete Melo] Inst Assistencia Med Servidor Publ Estadual Sao P, Sao Paulo, Brazil		Paz, DD (corresponding author), Dept Neurosurg, Rua Napoleo de Barros 715,6th Floor, Sao Paulo, Brazil.	talita.helena.ms@hotmail.com					Bijlenga P, 2007, J NEUROL NEUROSUR PS, V78, P430, DOI 10.1136/jnnp.2006.099242; Dillen WL, 2018, WORLD NEUROSURG, V120, P200, DOI 10.1016/j.wneu.2018.08.153; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Faleiro RM, 2015, BRAZ NEUROSURG, V34, P338, DOI 10.1055/s-0035-1564823; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; GUIDO LJ, 1976, J NEUROSURG, V45, P348, DOI 10.3171/jns.1976.45.3.0348; Kato Akihito, 2016, No Shinkei Geka, V44, P755, DOI 10.11477/mf.1436203372; Kim M., 2017, OPER NEUROSURG HAGER, V13, P28, DOI [10.1093/ons/opx036, DOI 10.1093/ONS/OPX036]; Langfitt T.W, 1968, CLIN NEUROSURG, V16, P436; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43	10	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	JUN	2021	24								101065	10.1016/j.inat.2020.101065			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RC2VY	WOS:000632664000001		gold			2022-02-06	
J	Mazurkiewicz, A; Xu, S; Frei, H; Banton, R; Piehler, T; Petel, OE				Mazurkiewicz, Ashley; Xu, Sheng; Frei, Hanspeter; Banton, Rohan; Piehler, Thuvan; Petel, Oren E.			Impact-Induced Cortical Strain Concentrations at the Sulcal Base and Its Implications for Mild Traumatic Brain Injury	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							AXONAL INJURY; ANIMAL-MODELS; SCALING LAW; IMAGE; ENCEPHALOPATHY; PLATFORM	This study investigated impact-induced strain fields within brain tissue surrogates having different cortical gyrification. Two elastomeric surrogates, one representative of a lissencephalic brain and the other of a gyrencephalic brain, were drop impacted in unison at four different heights and in two different orientations. Each surrogate contained a radiopaque speckle pattern that was used to calculate strain fields. Two different approaches, digital image correlation (DIC) and a particle tracking method, enabled comparisons of full-field and localized strain responses. The DIC results demonstrated increased localized deviations from the mean strain field in the surrogate with a gyrified cortex. Particle tracking algorithms, defining four-node quadrilateral elements, were used to investigate the differences in the strain response of three regions: the base of a sulcus, the adjacent gyrus, and the internal capsule of the surrogates. The results demonstrated that the strains in the cortex were concentrated at the sulcal base. This mechanical mechanism of increased strain is consistent with neurodegenerative markers observed in postmortem analyses, suggesting a potential mechanism of local damage due to strain amplification at the sulcal bases in gyrencephalic brains. This strain amplification mechanism may be responsible for cumulative neurodegeneration from repeated subconcussive impacts. The observed results suggest that lissencephalic animal models, such as rodents, would not have the same modes of injury present in a gyrencephalic brain, such as that of a human. As such, a shift toward representative mild traumatic brain injury animal models having gyrencephalic cortical structures should be strongly considered.	[Mazurkiewicz, Ashley; Xu, Sheng; Frei, Hanspeter; Petel, Oren E.] Carleton Univ, Dept Mech & Aerosp Engn, Ottawa, ON K1S 5B6, Canada; [Banton, Rohan; Piehler, Thuvan] US Army, Res Lab, Aberdeen, MD 21005 USA; [Piehler, Thuvan] US Army, Med Res & Dev Command, Ft Detrick, MD 21702 USA		Petel, OE (corresponding author), Carleton Univ, Dept Mech & Aerosp Engn, Ottawa, ON K1S 5B6, Canada.	oren.petel@carleton.ca		Mazurkiewicz, Ashley/0000-0003-3505-2823	Canada Foundation for InnovationCanada Foundation for InnovationCGIAR [39233]; U.S. Army [WP911F-17-2-0222]	Canada Foundation for Innovation (Grant No. 39233; Funder ID: 10.13039/501100001805). U.S. Army (Grant No. WP911F-17-2-0222; Funder ID: 10.13039/100006751).	Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Blaber J, 2015, EXP MECH, V55, P1105, DOI 10.1007/s11340-015-0009-1; Bottlang M, 2007, J NEUROTRAUM, V24, P1068, DOI 10.1089/neu.2006.3772; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Ganpule S, 2018, SHOCK WAVES, V28, P127, DOI 10.1007/s00193-017-0791-z; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Horstemeyer MF, 2019, ANN BIOMED ENG, V47, P1873, DOI 10.1007/s10439-019-02294-1; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Kalcioglu ZI, 2013, J BIOMECH, V46, P1583, DOI 10.1016/j.jbiomech.2013.03.011; Lauret C, 2009, MED ENG PHYS, V31, P392, DOI 10.1016/j.medengphy.2008.05.004; Magnan S., 2018, THESIS CARLETON U OT, DOI [10.22215/etd/2018-13242, DOI 10.22215/ETD/2018-13242]; Malkus, 2007, CONCEPTS APPL FINITE; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Ouellet S, 2018, SHOCK WAVES, V28, P19, DOI 10.1007/s00193-017-0771-3; Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Patestas M., 2006, TXB NEUROANATOMY; Piehler T, 2018, SHOCK WAVES, V28, P37, DOI 10.1007/s00193-017-0744-6; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Sawyer TW, 2018, SHOCK WAVES, V28, P85, DOI 10.1007/s00193-017-0756-2; Sawyer TW, 2018, J NEUROTRAUM, V35, P174, DOI 10.1089/neu.2016.4961; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tallinen T, 2014, P NATL ACAD SCI USA, V111, P12667, DOI 10.1073/pnas.1406015111; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thielen P, 2018, SHOCK WAVES, V28, P115, DOI 10.1007/s00193-017-0769-x; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	44	1	1	2	2	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	JUN 1	2021	143	6							061015	10.1115/1.4050283			12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	RX3OO	WOS:000647136700015	33625494				2022-02-06	
J	Medel-Matus, JS; Shin, D; Sankar, R; Mazarati, A				Medel-Matus, Jesus-Servando; Shin, Don; Sankar, Raman; Mazarati, Andrey			Diversity of kindling of limbic seizures after lateral fluid percussion injury in the rat	EPILEPSIA OPEN			English	Article						epileptogenesis; post-traumatic epilepsy; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC EPILEPSY; EPILEPTOGENESIS; MODELS	Lateral fluid percussion injury (LFPI) in rats is used to model post-traumatic epilepsy (PTE), with spontaneous seizures occurring in up to 1/2 of the subjects. Using the kindling paradigm, we examined whether animals without detectable seizures had an altered seizure susceptibility. Male Sprague Dawley rats were subjected to LFPI. Seven-nine months later, spontaneous seizures were monitored for two weeks. Afterward, the animals underwent kindling of basolateral amygdala. For kindling outcomes, the animals were categorized based on the 95% confidence intervals of mean number trials to kindling (ie 3 consecutive stage 4-5 seizures). Spontaneous seizures were detected in 7 out of 24 rats. There was no correlation between the severity of LFPI and either baseline afterdischarge properties, or kindling rates. Six LFPI rats kindled at a rate comparable to those in sham-LFPI (n = 10) and in naive (n = 7) subjects. Ten LFPI rats kindled faster and 8-slower than controls. None of slow-kindling rats had spontaneous seizures during the prekindling monitoring. During the same period, six fast-kindling and three normal-kindling rats had been seizure-free. Thus, kindling reveals a diversity to seizure susceptibility after LFPI beyond an overt seizure symptomatology, ranging from the increased susceptibility to the increased resistance.	[Medel-Matus, Jesus-Servando; Shin, Don; Sankar, Raman; Mazarati, Andrey] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Sankar, Raman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Sankar, Raman; Mazarati, Andrey] Univ Calif Los Angeles, Childrens Discovery & Innovat Inst, Los Angeles, CA USA		Mazarati, A (corresponding author), Univ Calif Los Angeles, D Geffen Sch Med, Dept Pediat, Neurol Div, BOX 951752,22-474 MDCC, Los Angeles, CA 90095 USA.	mazarati@ucla.edu					Becker C, 2015, ANN NEUROL, V78, P128, DOI 10.1002/ana.24414; Beretta S, 2017, CELL TRANSPLANT, V26, P1247, DOI 10.1177/0963689717714107; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brevard ME, 2006, EPILEPSIA, V47, P745, DOI 10.1111/j.1528-1167.2006.00502.x; Chandel S, 2016, REV NEUROSCIENCE, V27, P329, DOI 10.1515/revneuro-2015-0050; Eslami M, 2016, NEUROL RES, V38, P269, DOI 10.1179/1743132815Y.0000000086; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; Hesam S, 2018, NEUROCHEM RES, V43, P1978, DOI 10.1007/s11064-018-2619-3; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kotloski RJ, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01286; Medel-Matus Jesus-Servando, 2018, Epilepsia Open, V3, P290, DOI 10.1002/epi4.12114; Medel-Matus JS, 2017, EPILEPSY BEHAV, V77, P33, DOI 10.1016/j.yebeh.2017.10.001; Medel-Matus JS, 2017, EPILEPSIA, V58, pE122, DOI 10.1111/epi.13826; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Ono Tomonori, 2018, Epilepsia Open, V3, P90, DOI 10.1002/epi4.12260; Pan GJ, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00048; PAXINOS G, 1986, RAT BRAIN STEREOTAX; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Smith D, 2018, EPILEPSY RES, V147, P87, DOI 10.1016/j.eplepsyres.2018.09.005; Sutula TP, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P813, DOI 10.1016/B978-0-12-804066-9.00055-9; Xapelli Sara, 2006, Recent Pat CNS Drug Discov, V1, P315, DOI 10.2174/157488906778773689	27	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2470-9239		EPILEPSIA OPEN	Epilepsia Open	JUN	2021	6	2					413	418		10.1002/epi4.12472			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SO1KF	WOS:000658737800015	34033249	Green Published, gold			2022-02-06	
J	Naylor, RM; Dodin, RE; Henry, KA; De la Pena, NM; Jarvis, TL; Labott, JR; Van Gompel, JJ				Naylor, Ryan M.; Dodin, Rakan E.; Henry, Katharine A.; De la Pena, Nicole M.; Jarvis, Tyler L.; Labott, Joshua R.; Van Gompel, Jamie J.			Timing of Restarting Anticoagulation and Antiplatelet Therapies After Traumatic Subdural Hematoma-A Single Institution Experience	WORLD NEUROSURGERY			English	Article						Anticoagulation; Antiplatelet medication; Subdural hematoma; Thromboembolism; Thrombosis; Traumatic brain injury	INTRACRANIAL HEMORRHAGE; MANAGEMENT; DISCONTINUATION; THROMBOEMBOLISM; STROKE; RISK	BACKGROUND: There is a paucity of information regarding the optimal timing of restarting antiplatelet therapy (APT) and anticoagulation therapy (ACT) after traumatic subdural hematoma (tSDH). Therefore, we sought to report our experience at a single level 1 trauma center with regard to restarting APT and/or ACT after tSDH. METHODS: A total of 456 consecutive records were reviewed for unplanned hematoma evacuation within 90 days of discharge and thrombotic/thromboembolic events before restarting APT and/or ACT. - RESULTS: There was no difference in unplanned hematoma evacuation rate in patients not receiving APT or ACT (control) compared with those necessitating APT and/or ACT (6.4% control, 6.9% APT alone, 5.8% ACT alone, 5.4% APT and ACT). There was an increase in post-tSDH thrombosis/thromboembolism in patients needing to restart ACT (1.9% APT alone, P = 0.53 vs. control; 5.8% ACT alone, P = 0.04 vs. control; 16% APT and ACT; P < 0.001 vs. control). Subgroup analysis revealed that patients with coronary artery disease necessitating APT and patients with atrial fibrillation necessitating ACT had higher thrombosis/thromboembolism rates compared with controls (1.0% control vs. 6.1% coronary artery disease, P = 0.02; 1.0% control vs. 10.1% atrial fibrillation, P < 0.001). The median restart time of ACT was approximately 1 month after trauma; APT was restarted 2-4 weeks after trauma depending on clinical indication. CONCLUSIONS: Patients requiring reinitiation of APT and/or ACT after tSDH were at elevated risk of thrombotic/thromboembolic events but not unplanned hematoma evacuation. Therefore, patients should be followed closely until APT and/or ACT are restarted, and consideration for earlier reinitiation of blood thinners should be given on a case-by-case basis.	[Naylor, Ryan M.; Van Gompel, Jamie J.] Mayo Clin, Dept Neurosurg, Rochester, MN 55905 USA; [Labott, Joshua R.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Labott, Joshua R.] Mayo Clin, Alix Sch Med, Rochester, MN USA; [Dodin, Rakan E.] Univ North Dakota, Sch Med & Hlth Sci, Grand Forks, ND USA; [Henry, Katharine A.; De la Pena, Nicole M.; Jarvis, Tyler L.] Mayo Clin, Alix Sch Med, Scottsdale, AZ USA		Van Gompel, JJ (corresponding author), Mayo Clin, Dept Neurosurg, Rochester, MN 55905 USA.	Vangompel.jamie@mayo.edu		De La Pena, Nicole/0000-0002-1302-6299; Jarvis, Tyler/0000-0002-6358-1290; Henry, Katharine/0000-0002-7673-2019			Chan YH, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008150; Crawley F, 2000, J NEUROL NEUROSUR PS, V69, P396, DOI 10.1136/jnnp.69.3.396; Diamond T, 1988, Br J Neurosurg, V2, P351, DOI 10.3109/02688698809001006; Hawryluk GWJ, 2010, J THROMB HAEMOST, V8, P1500, DOI 10.1111/j.1538-7836.2010.03882.x; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Murthy SB, 2020, STROKE, V51, P1464, DOI 10.1161/STROKEAHA.119.028510; NAGANO N, 1991, Neurologia Medico-Chirurgica, V31, P743, DOI 10.2176/nmc.31.743; Nielsen PB, 2015, CIRCULATION, V132, P517, DOI 10.1161/CIRCULATIONAHA.115.015735; Perry LA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012144.pub2; Phan TG, 2000, ARCH NEUROL-CHICAGO, V57, P1710, DOI 10.1001/archneur.57.12.1710; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Puckett Y, 2018, CUREUS, V10, DOI 10.7759/cureus.2920; Salman RAS, 2019, LANCET, V393, P2613, DOI 10.1016/S0140-6736(19)30840-2; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Shen X, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000077; Spano PJ, 2020, J TRAUMA ACUTE CARE, V88, P454, DOI 10.1097/TA.0000000000002580; Tykocki T, 2016, WORLD NEUROSURG, V89, P497, DOI 10.1016/j.wneu.2016.01.063; Wijdicks EFM, 1998, NEUROSURGERY, V42, P769, DOI 10.1097/00006123-199804000-00053; Wijdicks EFM, 1999, NEUROLOGY, V52, P676	20	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2021	150						E203	E208		10.1016/j.wneu.2021.02.135			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SM8GR	WOS:000657837500023	33684586				2022-02-06	
J	Ndode-Ekane, XE; Perez, MDP; Di Sapia, R; Lapinlampi, N; Pitkanen, A				Ndode-Ekane, Xavier Ekolle; Perez, Maria del Mar Puigferrat; Di Sapia, Rossella; Lapinlampi, Niina; Pitkanen, Asia			Reorganization of Thalamic Inputs to Lesioned Cortex Following Experimental Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						axonal injury; hyperexcitation; lateral fluid-percussion injury; perilesional cortex; thalamo-cortical projection; traumatic brain injury	AXONAL INJURY; RAT; MODEL; PROJECTIONS; ACTIVATION; INTEGRITY; RECOVERY; NEURONS; INFLAMMATION; CONNECTIVITY	Traumatic brain injury (TBI) disrupts thalamic and cortical integrity. The effect of post-injury reorganization and plasticity in thalamocortical pathways on the functional outcome remains unclear. We evaluated whether TBI causes structural changes in the thalamocortical axonal projection terminals in the primary somatosensory cortex (S1) that lead to hyperexcitability. TBI was induced in adult male Sprague Dawley rats with lateral fluid-percussion injury. A virus carrying the fluorescent-tagged opsin channel rhodopsin 2 transgene was injected into the ventroposterior thalamus. We then traced the thalamocortical pathways and analyzed the reorganization of their axonal terminals in S1. Next, we optogenetically stimulated the thalamocortical relays from the ventral posterior lateral and medial nuclei to assess the post-TBI functionality of the pathway. Immunohistochemical analysis revealed that TBI did not alter the spatial distribution or lamina-specific targeting of projection terminals in S1. TBI reduced the axon terminal density in the motor cortex by 44% and in S1 by 30%. A nematic tensor-based analysis revealed that in control rats, the axon terminals in layer V were orientated perpendicular to the pial surface (60.3 degrees). In TBI rats their orientation was more parallel to the pial surface (5.43 degrees, difference between the groups p < 0.05). Moreover, the level of anisotropy of the axon terminals was high in controls (0.063) compared with TBI rats (0.045, p < 0.05). Optical stimulation of the sensory thalamus increased alpha activity in electroencephalography by 312% in controls (p > 0.05) and 237% (p > 0.05) in TBI rats compared with the baseline. However, only TBI rats showed increased beta activity (33%) with harmonics at 5 Hz. Our findings indicate that TBI induces reorganization of thalamocortical axonal terminals in the perilesional cortex, which alters responses to thalamic stimulation.	[Ndode-Ekane, Xavier Ekolle; Perez, Maria del Mar Puigferrat; Di Sapia, Rossella; Lapinlampi, Niina; Pitkanen, Asia] Univ Eastern Finland, AI Virtanen Inst Mol Sci, FI-70211 Kuopio, Finland		Ndode-Ekane, XE (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, FI-70211 Kuopio, Finland.	xavier.ekollendode-ekane@uef.fi; mariadelmar.pupe@gmail.com; rossella.disapia@marionegri.it; niina.lapinlampi@uef.fi; asla.pitkanen@uef.fi	Di Sapia, Rossella/ABF-8823-2021	Di Sapia, Rossella/0000-0001-7481-5198; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632; Lapinlampi, Niina/0000-0003-3210-6312	Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909, 2285733-9]; Sigrid Juselius FoundationSigrid Juselius Foundation	This study was supported by the Medical Research Council of the Academy of Finland (Grants 272249, 273909, and 2285733-9) (AP), and the Sigrid Juselius Foundation (AP).	Agostinelli C., 2017, R PACKAGE CIRCULAR C; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Begic D, 2001, INT J PSYCHOPHYSIOL, V40, P167, DOI 10.1016/S0167-8760(00)00153-7; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; Colella P, 2018, MOL THER-METH CLIN D, V8, P87, DOI 10.1016/j.omtm.2017.11.007; DeNardo LA, 2015, NAT NEUROSCI, V18, P1687, DOI 10.1038/nn.4131; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hareendran S, 2013, REV MED VIROL, V23, P399, DOI 10.1002/rmv.1762; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Huttunen JK, 2018, J NEUROTRAUM, V35, P2708, DOI 10.1089/neu.2017.5308; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Jones E.G., 1985, THALAMUS; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kemppainen S, 2002, HIPPOCAMPUS, V12, P735, DOI 10.1002/hipo.10020; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuramoto E, 2009, CEREB CORTEX, V19, P2065, DOI 10.1093/cercor/bhn231; Landisman CE, 2007, CEREB CORTEX, V17, P2853, DOI 10.1093/cercor/bhm025; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Ndode-Ekane XE, 2018, RESTOR NEUROL NEUROS, V36, P485, DOI 10.3233/RNN-170811; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Oda S, 2004, NEUROSCI LETT, V367, P394, DOI 10.1016/j.neulet.2004.06.042; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Petrosyan HA, 2014, GENE THER, V21, P991, DOI 10.1038/gt.2014.74; Pitkanen A, 2000, AMYGDALA FUNCTIONAL, P31; Presson N, 2015, MIL MED, V180, P109, DOI 10.7205/MILMED-D-14-00413; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reeves TM, 2016, EXP NEUROL, V283, P188, DOI 10.1016/j.expneurol.2016.06.011; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; RStudio Team, 2016, RSTUDIO INT DEV R RS; Salo RA, 2018, NEUROIMAGE, V172, P404, DOI 10.1016/j.neuroimage.2018.01.087; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; Van KC, 2016, METHODS MOL BIOL, V1462, P231, DOI 10.1007/978-1-4939-3816-2_14; Viaene AN, 2011, J NEUROPHYSIOL, V105, P279, DOI 10.1152/jn.00747.2010; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Yasuno F, 2014, BRAIN COGNITION, V84, P63, DOI 10.1016/j.bandc.2013.11.005; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	65	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN	2021	22	12							6329	10.3390/ijms22126329			22	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	SZ3RA	WOS:000666485400001	34199241	Green Published, gold			2022-02-06	
J	Ngo, MT; Harley, BAC				Ngo, Mai T.; Harley, Brendan A. C.			Progress in mimicking brain microenvironments to understand and treat neurological disorders	APL BIOENGINEERING			English	Article								Neurological disorders including traumatic brain injury, stroke, primary and metastatic brain tumors, and neurodegenerative diseases affect millions of people worldwide. Disease progression is accompanied by changes in the brain microenvironment, but how these shifts in biochemical, biophysical, and cellular properties contribute to repair outcomes or continued degeneration is largely unknown. Tissue engineering approaches can be used to develop in vitro models to understand how the brain microenvironment contributes to pathophysiological processes linked to neurological disorders and may also offer constructs that promote healing and regeneration in vivo. In this Perspective, we summarize features of the brain microenvironment in normal and pathophysiological states and highlight strategies to mimic this environment to model disease, investigate neural stem cell biology, and promote regenerative healing. We discuss current limitations and resulting opportunities to develop tissue engineering tools that more faithfully recapitulate the aspects of the brain microenvironment for both in vitro and in vivo applications.	[Ngo, Mai T.; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Harley, Brendan A. C.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Harley, Brendan A. C.] Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA		Harley, BAC (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.; Harley, BAC (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.; Harley, BAC (corresponding author), Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA.	bharley@illinois.edu		Harley, Brendan/0000-0001-5458-154X; Ngo, Mai/0000-0002-2459-1701	National Cancer Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA197488]; National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [DGE 1144245]; Department of Chemical and Biomolecular Engineering; Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana-Champaign	This work was funded by the National Cancer Institute of the National Institutes of Health (No. R01 CA197488) and the National Science Foundation Graduate Research Fellowship (No. DGE 1144245 to M.T.N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or NSF. The authors gratefully acknowledge additional funding from the Department of Chemical and Biomolecular Engineering and the Carl R. Woese Institute for Genomic Biology at the University of Illinois at Urbana-Champaign.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Addington CP, 2017, MATRIX BIOL, V60-61, P206, DOI 10.1016/j.matbio.2016.09.007; Addington CP, 2015, BIOMATERIALS, V72, P11, DOI 10.1016/j.biomaterials.2015.08.041; Adil MM, 2018, STEM CELL REP, V10, P1481, DOI 10.1016/j.stemcr.2018.03.007; Adil MM, 2017, BIOMATERIALS, V136, P1, DOI 10.1016/j.biomaterials.2017.05.008; Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005; Anderson JM, 2009, ACS NANO, V3, P3447, DOI 10.1021/nn900884n; Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Arulmoli J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08499; Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x; Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Baisiwala S, 2017, J BIOMATER TISS ENG, V7, P868, DOI 10.1166/jbt.2017.1644; Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050; Barnes JM, 2017, J CELL SCI, V130, P71, DOI 10.1242/jcs.191742; Blatchley MR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7518; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Boulet T, 2011, J NEUROSCI METH, V201, P296, DOI 10.1016/j.jneumeth.2011.08.019; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Calhoun MA, 2019, ACS BIOMATER SCI ENG, V5, P3964, DOI 10.1021/acsbiomaterials.8b01390; Caliari SR, 2016, INTEGR BIOL-UK, V8, P720, DOI 10.1039/c6ib00027d; Campisi M, 2018, BIOMATERIALS, V180, P117, DOI 10.1016/j.biomaterials.2018.07.014; Cha J, 2017, FRONT MATER, V4, DOI 10.3389/fmats.2017.00045; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chatterjee K, 2020, J NEUROSCI METH, V333, DOI 10.1016/j.jneumeth.2019.108541; Chaudhuri O, 2016, NAT MATER, V15, P326, DOI [10.1038/nmat4489, 10.1038/NMAT4489]; Chen JWE, 2018, FRONT MATER, V5, DOI 10.3389/fmats.2018.00039; Chen JWE, 2018, BIOMATER SCI-UK, V6, P854, DOI 10.1039/c7bm01195d; Chen JWE, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201700018; Chen X, 2018, NEURON, V100, P799, DOI 10.1016/j.neuron.2018.09.046; Chitforoushzadeh Z, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad3373; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Collingridge DR, 1999, RADIOTHER ONCOL, V53, P127, DOI 10.1016/S0167-8140(99)00121-8; Cook DJ, 2017, J CEREBR BLOOD F MET, V37, P1030, DOI 10.1177/0271678X16649964; Corbett DC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb9062; Cruz-Acuna R, 2017, NAT CELL BIOL, V19, P1326, DOI 10.1038/ncb3632; Darmanis S, 2017, CELL REP, V21, P1399, DOI 10.1016/j.celrep.2017.10.030; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; De Waele J, 2015, BIOMATERIALS, V41, P122, DOI 10.1016/j.biomaterials.2014.11.025; DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Di Lullo E, 2017, NAT REV NEUROSCI, V18, P573, DOI 10.1038/nrn.2017.107; Egawa EY, 2011, BIOMATERIALS, V32, P4737, DOI 10.1016/j.biomaterials.2011.03.033; Eggermont LJ, 2014, TRENDS BIOTECHNOL, V32, P456, DOI 10.1016/j.tibtech.2014.06.007; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Faiz M, 2015, CELL STEM CELL, V17, P624, DOI 10.1016/j.stem.2015.08.002; Fan X, 2009, BRAIN RES REV, V62, P99, DOI 10.1016/j.brainresrev.2009.09.006; Farris AL, 2016, J MATER CHEM B, V4, P3422, DOI 10.1039/c5tb02635k; Felderhoff-Mueser U, 2004, NEUROBIOL DIS, V17, P273, DOI 10.1016/j.nbd.2004.07.019; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; Fichman G, 2014, ACTA BIOMATER, V10, P1671, DOI 10.1016/j.actbio.2013.08.013; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Fon D, 2014, ADV HEALTHC MATER, V3, P761, DOI 10.1002/adhm.201300287; Freimann FB, 2013, NMR BIOMED, V26, P1534, DOI 10.1002/nbm.2987; Galarza S, 2020, ADV HEALTHC MATER, V9, DOI 10.1002/adhm.201901419; Galindo LT, 2018, MOL NEUROBIOL, V55, P3185, DOI 10.1007/s12035-017-0565-8; Garcion E, 2001, DEVELOPMENT, V128, P2485; Gardner L, 2012, CURR OPIN CHEM BIOL, V16, P292, DOI 10.1016/j.cbpa.2012.04.010; Ghuman H, 2018, ACTA BIOMATER, V80, P66, DOI 10.1016/j.actbio.2018.09.020; Gilchrist AE, 2020, INTEGR BIOL-UK, V12, P175, DOI 10.1093/intbio/zyaa013; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grim JC, 2018, ACS CENTRAL SCI, V4, P909, DOI 10.1021/acscentsci.8b00325; Guillamo JS, 2001, J NEURO-ONCOL, V52, P205, DOI 10.1023/A:1010620420241; Gutowski NJ, 1999, NEUROPATH APPL NEURO, V25, P207; Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792; Hall PE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-71; Handley A, 2015, MOL CELL, V58, P621, DOI 10.1016/j.molcel.2015.04.024; Heffernan JM, 2015, ANN BIOMED ENG, V43, P1965, DOI 10.1007/s10439-014-1223-1; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Herland A, 2020, NAT BIOMED ENG, DOI 10.1038/s41551-019-0498-9; Herland A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150360; Herrera-Perez RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194183; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Householder KT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49028-w; Hu B, 2008, J BIOL CHEM, V283, P24848, DOI 10.1074/jbc.M801433200; Huang Y, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01667-4; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Hwang B, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0071-8; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Irintchev A, 2005, CEREB CORTEX, V15, P950, DOI 10.1093/cercor/bhh195; Jacob RS, 2015, BIOMATERIALS, V54, P97, DOI 10.1016/j.biomaterials.2015.03.002; Jain A, 2014, NAT MATER, V13, P309, DOI [10.1038/nmat3878, 10.1038/NMAT3878]; Janes KA, 2017, INTEGR BIOL-UK, V9, P574, DOI 10.1039/c7ib00014f; Janes KA, 2015, CELL, V163, P1566, DOI 10.1016/j.cell.2015.12.010; Jeon JS, 2015, P NATL ACAD SCI USA, V112, P214, DOI 10.1073/pnas.1417115112; Jeon JS, 2014, INTEGR BIOL-UK, V6, P555, DOI 10.1039/c3ib40267c; Jin Y, 2018, NAT BIOMED ENG, V2, P522, DOI 10.1038/s41551-018-0260-8; Kalaria RN, 1995, BRAIN RES, V705, P349, DOI 10.1016/0006-8993(95)01250-8; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kang PH, 2020, MOL BIOL CELL, V31, P386, DOI 10.1091/mbc.E19-11-0602; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Kearns SM, 2003, EXP NEUROL, V182, P240, DOI 10.1016/S0014-4886(03)00124-9; Kelava I, 2016, DEV BIOL, V420, P199, DOI 10.1016/j.ydbio.2016.06.037; Kerever A, 2014, STEM CELL RES, V12, P492, DOI 10.1016/j.scr.2013.12.009; Keung AJ, 2011, STEM CELLS, V29, P1886, DOI 10.1002/stem.746; Kievit FM, 2014, BIOMATERIALS, V35, P9137, DOI 10.1016/j.biomaterials.2014.07.037; Kim SN, 2014, DEVELOPMENT, V141, P3233, DOI 10.1242/dev.106039; Kim Y, 2014, MOL CANCER RES, V12, P1416, DOI 10.1158/1541-7786.MCR-13-0629; Kingsmore KM, 2018, APL BIOENG, V2, DOI 10.1063/1.5023503; Kingsmore KM, 2016, INTEGR BIOL-UK, V8, P1246, DOI 10.1039/c6ib00167j; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Koh I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22681-3; Kolesky DB, 2016, P NATL ACAD SCI USA, V113, P3179, DOI 10.1073/pnas.1521342113; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Koutsopoulos S, 2013, ACTA BIOMATER, V9, P5162, DOI 10.1016/j.actbio.2012.09.010; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Lampe KJ, 2010, TISSUE ENG PT A, V16, P1857, DOI 10.1089/ten.TEA.2009.0509; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lau LW, 2012, ANN NEUROL, V72, P419, DOI 10.1002/ana.23599; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; LEBLOND CP, 1989, AM J ANAT, V185, P367, DOI 10.1002/aja.1001850403; Lee HP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08465-x; Lee HP, 2017, NAT MATER, V16, P1243, DOI [10.1038/nmat4993, 10.1038/NMAT4993]; Lee SWL, 2020, ADV HEALTHC MATER, V9, DOI 10.1002/adhm.201901486; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; LeValley PJ, 2020, J AM CHEM SOC, V142, P4671, DOI 10.1021/jacs.9b11564; Lewis DM, 2017, NAT PROTOC, V12, P1620, DOI 10.1038/nprot.2017.059; LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136; Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151; Li Y, 2017, J ALZHEIMERS DIS, V57, P395, DOI 10.3233/JAD-160804; Liao H, 2008, J BIOL CHEM, V283, P27927, DOI 10.1074/jbc.M804764200; LIESI P, 1984, EMBO J, V3, P683, DOI 10.1002/j.1460-2075.1984.tb01867.x; Lim TC, 2013, FASEB J, V27, P1023, DOI 10.1096/fj.12-221515; Lin Q, 2017, INT J PHARMACEUT, V517, P383, DOI 10.1016/j.ijpharm.2016.12.028; Lindahl U., 2015, ESSENTIALS GLYCOBIOL, P207, DOI DOI 10.1101/GLYCOBIOLOGY.3E.017; Logun MT, 2016, J MATER CHEM B, V4, P6052, DOI [10.1039/c6tb01083k, 10.1039/C6TB01083K]; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Maclean FL, 2017, ACS BIOMATER SCI ENG, V3, P2542, DOI 10.1021/acsbiomaterials.7b00524; Madl CM, 2017, NAT MATER, V16, P1233, DOI [10.1038/NMAT5020, 10.1038/nmat5020]; Mahadik BP, 2015, BIOMATERIALS, V67, P297, DOI 10.1016/j.biomaterials.2015.07.042; Mahadik BP, 2014, ADV HEALTHC MATER, V3, P449, DOI 10.1002/adhm.201300263; Makihara N, 2015, EXP NEUROL, V264, P127, DOI 10.1016/j.expneurol.2014.12.007; Manfrin A, 2019, NAT METHODS, V16, P640, DOI 10.1038/s41592-019-0455-2; Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127; Maoz BM, 2018, NAT BIOTECHNOL, V36, P865, DOI 10.1038/nbt.4226; Marchini A, 2019, P NATL ACAD SCI USA, V116, P7483, DOI 10.1073/pnas.1818392116; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007; Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Milner R, 2007, J IMMUNOL, V178, P8158, DOI 10.4049/jimmunol.178.12.8158; Mirabella T, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0083; Miroshnikova YA, 2016, NAT CELL BIOL, V18, P1336, DOI 10.1038/ncb3429; Moriarty N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15970-w; Moshayedi P, 2016, BIOMATERIALS, V105, P145, DOI 10.1016/j.biomaterials.2016.07.028; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Munson JM, 2013, CANCER RES, V73, P1536, DOI 10.1158/0008-5472.CAN-12-2838; Murphy MC, 2019, NEUROIMAGE, V187, P176, DOI 10.1016/j.neuroimage.2017.10.008; Murphy MC, 2016, NEUROIMAGE-CLIN, V10, P283, DOI 10.1016/j.nicl.2015.12.007; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; MURTOMAKI S, 1992, J NEUROSCI RES, V32, P261, DOI 10.1002/jnr.490320216; Nam S, 2019, BIOMATERIALS, V200, P15, DOI 10.1016/j.biomaterials.2019.02.004; NEAME PJ, 1993, EXPERIENTIA, V49, P393, DOI 10.1007/BF01923584; Ngo MT, 2020, INTEGR BIOL-UK, V12, P139, DOI 10.1093/intbio/zyaa010; Ngo MT, 2019, BIOMATERIALS, V198, P122, DOI 10.1016/j.biomaterials.2018.06.013; Ngo MT, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700687; Nichols E, 2019, LANCET NEUROL, V18, P88, DOI 10.1016/S1474-4422(18)30403-4; Nih LR, 2018, NAT MATER, V17, P642, DOI 10.1038/s41563-018-0083-8; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; Obermeyer JM, 2019, TISSUE ENG PT A, V25, P1175, DOI [10.1089/ten.tea.2018.0215, 10.1089/ten.TEA.2018.0215]; Offeddu GS, 2019, BIOMATERIALS, V212, P115, DOI 10.1016/j.biomaterials.2019.05.022; Offeddut GS, 2020, CURR OPIN BIOMED ENG, V13, P119, DOI 10.1016/j.cobme.2019.12.011; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Osaki T, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5847; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Papadimitriou C, 2018, DEV CELL, V46, P85, DOI 10.1016/j.devcel.2018.06.005; Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4; Park TE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10588-0; Patel AP, 2019, LANCET NEUROL, V18, P376, DOI 10.1016/S1474-4422(18)30468-X; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Patel AK, 2016, CURR OPIN SOLID ST M, V20, P202, DOI 10.1016/j.cossms.2016.02.002; Pedron S, 2013, J BIOMED MATER RES A, V101, P3404, DOI 10.1002/jbm.a.34637; Pedron S, 2019, BIOMATERIALS, V219, DOI 10.1016/j.biomaterials.2019.119371; Pedron S, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700529; Pedron S, 2013, BIOMATERIALS, V34, P7408, DOI 10.1016/j.biomaterials.2013.06.024; Peers C, 2009, ANN NY ACAD SCI, V1177, P169, DOI 10.1111/j.1749-6632.2009.05026.x; Perez CMR, 2015, ANN BIOMED ENG, V43, P501, DOI 10.1007/s10439-014-1166-6; Pham MT, 2018, NEUROREPORT, V29, P588, DOI 10.1097/WNR.0000000000001014; Pickford CE, 2011, STEM CELLS, V29, P629, DOI 10.1002/stem.610; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Qazi H, 2013, INTEGR BIOL-UK, V5, P1334, DOI 10.1039/c3ib40057c; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Ranga A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5324; Ranga A, 2016, P NATL ACAD SCI USA, V113, pE6831, DOI 10.1073/pnas.1603529113; Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j; Rao SS, 2013, BIOMATERIALS, V34, P5181, DOI 10.1016/j.biomaterials.2013.03.069; Rifes P, 2020, NAT BIOTECHNOL, V38, P1265, DOI 10.1038/s41587-020-0525-0; Rosales AM, 2017, ANGEW CHEM INT EDIT, V56, P12132, DOI 10.1002/anie.201705684; Rouleau N, 2020, MACROMOL BIOSCI, V20, DOI 10.1002/mabi.202000004; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Sadtler K, 2019, BIOMATER SCI-UK, V7, P4472, DOI 10.1039/c9bm00349e; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Saldin LT, 2017, ACTA BIOMATER, V49, P1, DOI 10.1016/j.actbio.2016.11.068; Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112; Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Shadish JA, 2019, NAT MATER, V18, P1005, DOI 10.1038/s41563-019-0367-7; Shiba M, 2014, TRANSL STROKE RES, V5, P238, DOI 10.1007/s12975-014-0333-2; Shin Y, 2019, ADV SCI, V6, DOI 10.1002/advs.201900962; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; Skene NG, 2018, NAT GENET, V50, P825, DOI 10.1038/s41588-018-0129-5; Sobel RA, 2001, J NEUROPATH EXP NEUR, V60, P1198, DOI 10.1093/jnen/60.12.1198; Sood D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54248-1; Sood D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12420-1; Stephenson EL, 2018, BRAIN, V141, DOI 10.1093/brain/awy033; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stoffels JMJ, 2013, BRAIN, V136, P116, DOI 10.1093/brain/aws313; Stone SE, 2017, CURR OPIN CHEM BIOL, V36, P50, DOI 10.1016/j.cbpa.2016.12.026; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Stukel JM, 2016, TISSUE ENG PART B-RE, V22, P173, DOI [10.1089/ten.teb.2015.0380, 10.1089/ten.TEB.2015.0380]; SU JH, 1992, NEUROSCIENCE, V51, P801, DOI 10.1016/0306-4522(92)90521-3; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050; Suttkus A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.25; Tang M, 2021, SMALL, V17, DOI 10.1002/smll.202006050; Tang M, 2020, CELL RES, V30, P833, DOI 10.1038/s41422-020-0338-1; Tape CJ, 2014, MOL CELL PROTEOMICS, V13, P1866, DOI 10.1074/mcp.O113.037119; Tate CC, 2007, J NEUROTRAUM, V24, P226, DOI 10.1089/neu.2006.0043; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tham M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015341; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Tonge DA, 2012, BRAIN RES, V1453, P8, DOI 10.1016/j.brainres.2012.03.024; Twiss F, 2013, CELL MOL LIFE SCI, V70, P4101, DOI 10.1007/s00018-013-1329-x; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; van der Goes A, 2001, FASEB J, V15, P1852, DOI 10.1096/fj.00-0881fje; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Vega LJCM, 2016, J MATER CHEM B, V4, P6803, DOI [10.1039/c6tb01814a, 10.1039/C6TB01814A]; Velasco S, 2019, NATURE, V570, P523, DOI 10.1038/s41586-019-1289-x; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Wang C, 2019, BIOMATERIALS, V202, P35, DOI 10.1016/j.biomaterials.2019.02.024; Wang C, 2014, MOL PHARMACEUT, V11, P2115, DOI 10.1021/mp5000828; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wang TY, 2016, BIOMATERIALS, V74, P89, DOI 10.1016/j.biomaterials.2015.09.039; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Winkler F, 2009, GLIA, V57, P1306, DOI 10.1002/glia.20850; Wolf KJ, 2019, ACS BIOMATER SCI ENG, V5, P3753, DOI 10.1021/acsbiomaterials.8b01268; Wolf KJ, 2018, APL BIOENG, V2, DOI 10.1063/1.5021059; Wu C, 2009, NAT MED, V15, P519, DOI 10.1038/nm.1957; Wu DL, 2011, JOVE-J VIS EXP, DOI 10.3791/2899; Wu Y, 2017, CELL TRANSPLANT, V26, P1224, DOI 10.1177/0963689717714090; Xiao WK, 2020, MATRIX BIOL, V85-86, P128, DOI 10.1016/j.matbio.2019.04.003; Xiao WK, 2018, CANCER RES, V78, P1358, DOI 10.1158/0008-5472.CAN-17-2429; Xie K, 2013, NEUROBIOL AGING, V34, P2389, DOI 10.1016/j.neurobiolaging.2013.04.013; Xu Jiaquan, 2018, NCHS Data Brief, P1; Yao Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4413; Yi HG, 2019, NAT BIOMED ENG, V3, P509, DOI 10.1038/s41551-019-0363-x; Zambuto SG, 2020, MRS COMMUN, V10, P83, DOI 10.1557/mrc.2019.159; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang DW, 2014, BIOMATERIALS, V35, P1420, DOI 10.1016/j.biomaterials.2013.11.028; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025; Zhang ZN, 2016, P NATL ACAD SCI USA, V113, P3185, DOI 10.1073/pnas.1521255113; Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958; Ziu M, 2006, J NEURO-ONCOL, V79, P125, DOI 10.1007/s11060-006-9121-5	276	1	1	7	7	AIP Publishing	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2473-2877			APL BIOENG	APL Bioeng.	JUN 1	2021	5	2							020902	10.1063/5.0043338			19	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	RJ9NP	WOS:000637927100001	33869984	Green Published, gold			2022-02-06	
J	O'Hara, NN; Kringos, DS; Slobogean, GP; Degani, Y; Klazinga, NS				O'Hara, Nathan N.; Kringos, Dionne S.; Slobogean, Gerard P.; Degani, Yasmin; Klazinga, Niek S.			Patients Place More of an Emphasis on Physical Recovery Than Return to Work or Financial Recovery	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							DISCRETE-CHOICE EXPERIMENTS; HEALTH-CARE; DISORDER; DECISION; OUTCOMES; INJURY	Background Value-based healthcare models aim to incentivize healthcare providers to offer interventions that address determinants of health. Understanding patient priorities for physical and socioeconomic recovery after injury can help determine which services and resources are most useful to patients. Questions/purposes (1) Do trauma patients consistently identify a specific aspect/domain of recovery as being most important at 6 weeks, 6 months, and 12 months after an injury? (2) Does the relative importance of those domains change within the first year after injury? (3) Are differences in priorities greater between patients than for a given patient over time? (4) Are different recovery priorities associated with identifiable biopsychosocial factors? Methods Between June 2018 and December 2018, 504 adult patients with fractures of the extremities or pelvis were surgically treated at the study site. For this prospective longitudinal study, we purposefully sampled patients from 6 of the 12 orthopaedic attendings' postoperative clinics. The participating surgeons surgically treated 243 adult patients with fractures of the extremities or pelvis. Five percent (11 of 243) of patients met inclusion criteria but missed their appointments during the 6-week recruitment window and could not be consented. We excluded 4% (9 of 243) of patients with a traumatic brain injury, 1% (2) of patients with a spinal cord injury, and 5% (12) of non-English-speaking patients (4% Spanish speaking [10]; 1% other languages [2]). Eighty-six percent of eligible patients (209 of 243) were approached for consent, and 5% (11 of 209) of those patients refused to participate. All remaining 198 patients consented and completed the baseline survey; 83% (164 of 198 patients) completed at least 6 months of follow-up, and 68% (134 of 198 patients) completed the 12-month assessment. The study participants' mean age was 44 +/- 17 years, and 63% (125 of 198) were men. The primary outcome was the patient's recovery priorities, assessed at 6 weeks, 6 months, and 12 months after fracture using a discrete choice experiment. Discrete choice experiments are a well-established method for eliciting decisional preferences. In this technique, respondents are presented with a series of hypothetical scenarios, described by a set of plausible attributes or outcomes, and asked to select their preferred scenario. We used hierarchical Bayesian modeling to calculate individual-level estimates of the relative importance of physical recovery, work-related recovery, and disability benefits, based on the discrete choice experiment responses. The hierarchical Bayesian model improves upon more commonly used regression techniques by accounting for the observed response patterns of individual patients and the sequence of scenarios presented in the discrete choice experiment when calculating the model estimates. We computed the coefficient of variation for the three recovery domains and compared the between-patient versus within-patient differences using asymptotic tests. Separate prognostic models were fit for each of the study's three recovery domains to assess marginal changes in the importance of the recovery domain based on patient characteristics and factors that remained constant over the study (such as sex or preinjury work status) and patient characteristics and factors that varied over the study (including current work status or patient-reported health status). We previously published the 6-week results. This paper expands upon the prior publication to evaluate longitudinal changes in patient recovery priorities. Results Physical recovery was the respondents' main priority at all three timepoints, representing 60% +/- 9% of their overall concern. Work-related recovery and access to disability benefits were of secondary importance and were associated with 27% +/- 6% and 13% +/- 7% of the patients' concern, respectively. The patients' concern for physical recovery was 6% (95% CrI 4% to 7%) higher at 12 months after fracture that at 6 weeks postfracture. The mean concern for work-related recovery increased by 7% (95% CrI 6% to 8%) from 6 weeks to 6 months after injury. The mean importance of disability benefits increased by 2% (95% CrI 1% to 4%) from 6 weeks to 6 months and remained 2% higher (95% CrI 0% to 3%) at 12 months after the injury. Differences in priorities were greater within a given patient over time than between patients as measured using the coefficient of variation (physical recovery [245% versus 7%; p < 0.001], work-related recovery [678% versus 12%; p < 0.001], and disability benefits [620% versus 33%; p < 0.001]. There was limited evidence that biopsychosocial factors were associated with variation in recovery priorities. Patients' concern for physical recovery was 2% higher for every 10-point increase in their Patient-reported Outcome Measure Information System (PROMIS) physical health status score (95% CrI 1% to 3%). A 10-point increase in the patient's PROMIS mental health status score was associated with a 1% increase in concern for work-related recovery (95% CrI 0% to 2%). Conclusion Work-related recovery and accessing disability benefits were a secondary concern compared with physical recovery in the 12 months after injury for patients with fractures. However, the importance of work-related recovery was elevated after the subacute phase. Priorities were highly variable within a given patient in the year after injury compared with between-patient differences. Given this variation, orthopaedic surgeons should consider assessing and reassessing the socioeconomic well-being of their patients throughout their continuum of care.	[O'Hara, Nathan N.; Slobogean, Gerard P.; Degani, Yasmin] Univ Maryland, Sch Med, Dept Orthopaed, 110 S Paca St,Suite 300, Baltimore, MD 21201 USA; [O'Hara, Nathan N.; Kringos, Dionne S.; Klazinga, Niek S.] Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam UMC, Amsterdam, Netherlands		O'Hara, NN (corresponding author), Univ Maryland, Sch Med, Dept Orthopaed, 110 S Paca St,Suite 300, Baltimore, MD 21201 USA.	nohara@som.umaryland.edu	Kringos, Dionne/ABE-2290-2020	Kringos, Dionne/0000-0003-2711-4713			Bachrach D., ENABLING SUSTAINA BL; Bhashyam AR, 2019, J BONE JOINT SURG AM, V101, P1245, DOI 10.2106/JBJS.18.01114; Brinkley DR., FAMILY MED LEAVE ACT; Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9; Ioannou L, 2018, INJURY, V49, P990, DOI 10.1016/j.injury.2018.03.013; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kalofonos I, 2019, NEW ENGL J MED, V381, P1985, DOI 10.1056/NEJMp1811661; Kesternich I, 2013, J HEALTH ECON, V32, P1313, DOI 10.1016/j.jhealeco.2012.11.006; Kreuter M, 2020, HEALTH AFFAIR, V39, P679, DOI 10.1377/hlthaff.2019.01256; Kuehn BM, 2019, JAMA-J AM MED ASSOC, V321, P822, DOI 10.1001/jama.2018.21476; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Livingston EH, 2012, ARCH SURG-CHICAGO, V147, P110, DOI 10.1001/archsurg.2011.2169; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; MacKenzie EJ, 2006, J TRAUMA, V61, P688, DOI 10.1097/01.ta.0000195985.56153.68; McFadden D., 1973, FRONTIERS ECONOMETRI; MCPHERSON K, 1981, SOC SCI MED-MED SOC, V15, P273, DOI 10.1016/0271-7123(81)90011-0; Mueller MW., ILLUSION STABLE PREF; O'Hara NN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227907; O'Hara NN, 2019, J ORTHOP TRAUMA, V33, pS16, DOI 10.1097/BOT.0000000000001621; O'Hara NN, 2019, INJURY, V50, P1353, DOI 10.1016/j.injury.2019.05.029; O'Toole RV, 2008, J BONE JOINT SURG AM, V90A, P1206, DOI 10.2106/JBJS.G.00492; Perlman M., 1974, EC HLTH MED CARE, P162; Ryan M, 2004, BMJ-BRIT MED J, V328, P360, DOI 10.1136/bmj.328.7436.360; Ryan M, 2008, ECON NON-MARK GOOD, V11, P1, DOI 10.1007/978-1-4020-5753-3; Shrime MG, 2018, VALUE HEALTH, V21, P95, DOI 10.1016/j.jval.2017.07.006; Simske NM., 2019, OTA INT, P045; van Buuren S, 2011, J STAT SOFTW, V45, P1; Zatzick DF, 2001, MED CARE, V39, P327, DOI 10.1097/00005650-200104000-00004; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8	29	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUN	2021	479	6					1333	1343		10.1097/CORR.0000000000001583			11	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	WN3NB	WOS:000711677700030	33239518				2022-02-06	
J	Palominos, E; Levett-Jones, T; Power, T; Alcorn, N; Martinez-Maldonado, R				Palominos, Evelyn; Levett-Jones, Tracy; Power, Tamara; Alcorn, Nadine; Martinez-Maldonado, Roberto			Measuring the impact of productive failure on nursing students? learning in healthcare simulation: A quasi-experimental study	NURSE EDUCATION TODAY			English	Article						Direct instruction; Learning from errors; Learning outcomes; Nursing education; Productive failure; Simulation-based learning	EXPERIENCES; INSTRUCTION; MATTER	Background: Previous research suggests that making errors in a non-threatening simulated environment can facilitate learning. Productive failure, which combines problem-solving tasks followed by instruction, enables students to learn from making mistakes. This teaching approach has demonstrated improved learning outcomes such as explanatory knowledge and transfer of knowledge compared to a direct instruction approach where students receive instruction prior to problem-solving tasks. However, no previous studies have examined the impact of productive failure on nursing students? learning in manikin-based simulation. Objective: To measure the impact of productive failure on nursing students? declarative knowledge, explanatory knowledge, and transfer of knowledge compared to a direct instruction approach in a paediatric closed head injury simulation. Methods: Second year undergraduate nursing students (n = 349) from one Australian university were invited to participate in the study. Consenting participants (n = 344) were randomised into two groups: productive failure and direct instruction. The intervention consisted of two paediatric closed head injury simulations separated by a simulation debrief. Knowledge tests were administered before and immediately after the simulation. Results: Data from 331 participants were analysed. The productive failure group outperformed the direct instruction group in the post-test (p < 0.001). Learning gains for participants in the productive failure group were significantly higher than the direct instruction group for both explanatory knowledge (p < 0.001) and the ability to apply learning to solve novel clinical problems (p < 0.001). The difference in the median scores for declarative knowledge was not significant (p = 0.096). Conclusion: This study demonstrated that a productive failure simulation that leads learners to make mistakes before receiving instruction can facilitate deeper levels of explanatory knowledge and enable the transfer of learning to new clinical situations. These results suggest the need for further exploration of pedagogies that foster learning from errors in simulation-based learning.	[Palominos, Evelyn; Levett-Jones, Tracy; Power, Tamara; Alcorn, Nadine] Univ Technol Sydney, Fac Hlth, 235 Jones St, Ultimo, NSW 2007, Australia; [Martinez-Maldonado, Roberto] Monash Univ, Fac Informat Technol, Clayton, Vic, Australia		Palominos, E (corresponding author), Univ Technol Sydney, Fac Hlth, 235 Jones St, Ultimo, NSW 2007, Australia.	evelyn.m.palominosletelier@student.uts.edu.au		Levett-Jones, Tracy/0000-0003-4279-8957	Australian Government Research Training Program (RTP) Stipend Scholarship	The first author received an Australian Government Research Training Program (RTP) Stipend Scholarship.	Cao L., 2020, ANN M AM ED RES ASS, P1; Coleman EB, 1998, J LEARN SCI, V7, P387, DOI 10.1207/s15327809jls0703&4_5; Cook DA, 2009, ADV HEALTH SCI EDUC, V14, P79, DOI 10.1007/s10459-007-9089-8; Dubovi I, 2018, NURS EDUC TODAY, V69, P67, DOI 10.1016/j.nedt.2018.07.001; FOLLMANN D, 1994, J STAT PLAN INFER, V39, P1, DOI 10.1016/0378-3758(94)90108-2; Helyar S. M., 2013, JOURNAL OF NURSING E, V4, P11, DOI [10.5430/jnep.v4n2p11, DOI 10.5430/JNEP.V4N2P11]; Hoffman K., 2017, CLIN REASONING LEARN, P136; Hughes C., 2014, BR J MIDWIFERY, V22, P201, DOI 10.12968/bjom.2014.22.3.201; Jacobson MJ, 2020, LEARN INSTR, V65, DOI 10.1016/j.learninstruc.2019.101222; Jacobson MJ, 2017, LEARN INSTR, V52, P1, DOI 10.1016/j.learninstruc.2017.03.007; Kapur M., 2015, LEARN RES PRACT, V1, P51, DOI DOI 10.1080/23735082.2015.1002195; Kapur M, 2014, COGNITIVE SCI, V38, P1008, DOI 10.1111/cogs.12107; Kapur M, 2012, J LEARN SCI, V21, P45, DOI 10.1080/10508406.2011.591717; Kirschner PA, 2006, EDUC PSYCHOL-US, V41, P75, DOI 10.1207/s15326985ep4102_1; Kulasegaram Kulamakan, 2018, Acad Med, V93, pS37, DOI 10.1097/ACM.0000000000002378; Lendahls L, 2017, NURS EDUC TODAY, V50, P12, DOI 10.1016/j.nedt.2016.12.005; Loibl K, 2019, LEARN INSTR, V62, P1, DOI 10.1016/j.learninstruc.2019.03.002; Loibl K, 2017, EDUC PSYCHOL REV, V29, P693, DOI 10.1007/s10648-016-9379-x; Loibl K, 2014, LEARN INSTR, V34, P74, DOI 10.1016/j.learninstruc.2014.08.004; LYNN MR, 1986, NURS RES, V35, P382; Nestel D, 2017, HEALTHCARE SIMULATIO; New South Wales Health, 2016, STAND PAED OBS CHART; Ohlsson S., 1996, LEARNING HUMANS MACH, P37; Palominos E, 2019, NURS EDUC TODAY, V77, P32, DOI 10.1016/j.nedt.2019.02.013; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Song I.H., 2015, INT J BIOSCIENCE BIO, V7, P147, DOI DOI 10.14257/IJBSBT.2015.7.3.15; Stefaniak JE, 2014, SIMUL HEALTHC, V9, P15, DOI 10.1097/SIH.0b013e3182a8336f; Sweller J, 2011, EXPLOR LEARN SCI, P155; Yockey J, 2019, CLIN SIMUL NURS, V29, P29, DOI 10.1016/j.ecns.2018.12.004; Young JE, 2016, ADV HEALTH SCI EDUC, V21, P63, DOI 10.1007/s10459-015-9611-3; Zendejas B, 2010, J SURG EDUC, V67, P432, DOI 10.1016/j.jsurg.2010.05.001	31	1	1	2	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0260-6917	1532-2793		NURS EDUC TODAY	Nurse Educ. Today	JUN	2021	101								104871	10.1016/j.nedt.2021.104871			7	Education, Scientific Disciplines; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Nursing	RS3IP	WOS:000643673700005	33773221				2022-02-06	
J	Reich, JS; Cohn, JE; Othman, S; Shokri, T; Ducic, Y; Sokoya, M				Reich, Jeremy S.; Cohn, Jason E.; Othman, Sammy; Shokri, Tom; Ducic, Yadranko; Sokoya, Mofiyinfolu			Volleyball-related Adult Maxillofacial Trauma Injuries: A NEISS Database Study	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Craniofacial trauma; maxillofacial trauma; NEISS; sports injuries; volleyball	DESCRIPTIVE EPIDEMIOLOGY; WOMENS VOLLEYBALL; HIGH-SCHOOL; COLLEGIATE; SPORTS; BASKETBALL; PLAYERS; PROGRAM; HOCKEY; SOCCER	Introduction: Craniofacial trauma among athletes of various sports has been well detailed and described. Despite this research, there is a dearth of literature describing the nature of facial trauma secondary to volleyball, despite its global popularity. Methods: A cross-sectional analysis of volleyball-related facial trauma was conducted using the National Electronic Injury Surveillance System (NEISS) database from 2009 to 2018. Patient demographics (age, sex, and race), medical injury information (injury type and location), and disposition (observed and discharged, admitted, deceased) were collected and analyzed. chi(2) testing was performed to compare categorical variables. Results: A total of 235 volleyball-related facial traumas were recorded with an estimated 10,424 visits occurring nationally. The majority of injuries were among young adults aged 20 to 29 years (52.3%) and was evenly distributed for men and women. Lacerations were the most frequent injury type (37.9%), whereas the face was the most common site of injury (41.7%). The majority of fractures involved the nose (71.4%) and among individuals aged 20 through 49 (90.5%). Males had significantly more lacerations than females (75.3% vs 24.7%), whereas females had significantly more contusions/abrasions (64.5% vs 35.5%) and concussions (72.9% vs 27.1%). Conclusions: Volleyball-related craniofacial injuries can vary depending on patient demographics. This information can help with the development of safety and preventative measures for individuals participating in the sport.	[Reich, Jeremy S.] Philadelphia Coll Osteopath Med, Philadelphia, PA USA; [Cohn, Jason E.] Louisiana State Univ, Hlth Sci Ctr, Div Facial Plast Reconstruct Surg, Dept Otolaryngol Head & Neck Surg, 1501 Kings Highway, Shreveport, LA 71103 USA; [Othman, Sammy] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Shokri, Tom] Penn State Hershey Med Ctr, Dept Otolaryngol Head & Neck Surg, Hershey, PA USA; [Ducic, Yadranko] Otolaryngol & Facial Plast Surg Associates, Ft Worth, TX USA; [Sokoya, Mofiyinfolu] Univ Arizona, Coll Med, Dept Otolaryngol Head & Neck Surg, Tucson, AZ USA		Cohn, JE (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Div Facial Plast Reconstruct Surg, Dept Otolaryngol Head & Neck Surg, 1501 Kings Highway, Shreveport, LA 71103 USA.	jcohn@lsuhsc.edu					Agel J, 2007, J ATHL TRAINING, V42, P295; [Anonymous], 2019, STUD ATHL PART 1981; Baugh CM, 2018, SPORTS HEALTH, V10, P60, DOI 10.1177/1941738117733685; Beard A., 2015, LOOK BACK NBA PLAYER; Bere T, 2015, BRIT J SPORT MED, V49, P1132, DOI 10.1136/bjsports-2015-094959; Bobian MR, 2016, ANN OTO RHINOL LARYN, V125, P992, DOI 10.1177/0003489416668195; Boden BP, 2017, SPORTS HEALTH, V9, P444, DOI 10.1177/1941738117712425; Carniol ET, 2015, OTOLARYNG HEAD NECK, V153, P957, DOI 10.1177/0194599815602668; Chouinard AF, 2016, CURR TRAUMA REP, V2, P55, DOI 10.1007/s40719-016-0040-4; Foss KDB, 2014, PHYSICIAN SPORTSMED, V42, P146, DOI 10.3810/psm.2014.05.2066; Fowell CJ, 2013, BRIT J SPORT MED, V47, P654, DOI 10.1136/bjsports-2012-091697; Fraser MA, 2017, J ATHL TRAINING, V52, P698, DOI 10.4085/1062-6050-52.3.10; Goiato MC, 2012, J CRANIOFAC SURG, V23, P1201, DOI 10.1097/SCS.0b013e31824e240e; Hwang K, 2020, J CRANIOFAC SURG, V31, pE179, DOI 10.1097/SCS.0000000000006132; KUJALA UM, 1995, BRIT MED J, V311, P1465, DOI 10.1136/bmj.311.7018.1465; Lawrence LA, 2015, LARYNGOSCOPE, V125, P589, DOI 10.1002/lary.24893; Migliorini F, 2019, SPORT SCI HLTH, V15, P281, DOI 10.1007/s11332-019-00549-x; Mizoguchi Yasuaki, 2019, J Phys Ther Sci, V31, P675, DOI 10.1589/jpts.31.675; National Federation of State High School Associations (NFHS), ANN REPORT; Nikolaidis PT, 2015, KINESIOLOGY, V47, P75; Othman S, 2019, CRANIOMAX TRAUM REC, V12, P266, DOI 10.1055/s-0039-1679930; Piras A, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/189268; Pollard KA, 2011, CLIN PEDIATR, V50, P844, DOI 10.1177/0009922811406262; Povolotskiy R, 2019, ANN OTO RHINOL LARYN, V128, P516, DOI 10.1177/0003489419830114; Reeser J., 2008, VOLLEYBALL OLYMPIC H, P1; Reeser JC, 2015, SPORTS HEALTH, V7, P504, DOI 10.1177/1941738115600143; Reeser JC, 2010, PM&R, V2, P27, DOI 10.1016/j.pmrj.2009.11.010; Romeo SJ, 2005, PHYSICIAN SPORTSMED, V33, P45, DOI 10.3810/psm.2005.04.73; Verhagen EALM, 2005, BRIT J SPORT MED, V39, P111, DOI 10.1136/bjsm.2003.011031	29	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1564	1567		10.1097/SCS.0000000000006984			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100106	32897977				2022-02-06	
J	Shah, EJ; Gurdziel, K; Ruden, DM				Shah, Ekta J.; Gurdziel, Katherine; Ruden, Douglas M.			Sex-Differences in Traumatic Brain Injury in the Absence of Tau in Drosophila	GENES			English	Article						TBI; sex-differences; gene expression; Tau-KO	NEUROINFLAMMATION	Traumatic brain injuries, a leading cause of death and disability worldwide, are caused by a severe impact to the head that impairs physiological and psychological function. In addition to severity, type and brain area affected, brain injury outcome is also influenced by the biological sex of the patient. Traumatic brain injury triggers accumulation of Tau protein and the subsequent development of Tauopathies, including Alzheimer's disease and Chronic traumatic encephalopathy. Recent studies report differences in Tau network connections between healthy males and females, but the possible role of Tau in sex-dependent outcome to brain injury is unclear. Thus, we aimed to determine if Tau ablation would alleviate sex dependent outcomes in injured flies. We first assessed motor function and survival in tau knock-out flies and observed sex-differences in climbing ability, but no change in locomotor activity in either sex post-injury. Sex differences in survival time were also observed in injured tau deficient flies with a dramatically higher percent of female death within 24 h than males. Additionally, 3 ' mRNA-Seq studies in isolated fly brains found that tau deficient males show more gene transcript changes than females post-injury. Our results suggest that sex differences in TBI outcome and recovery are not dependent on the presence of Tau in Drosophila.	[Shah, Ekta J.; Ruden, Douglas M.] Wayne State Univ, Dept Pharmacol, Sch Med, Detroit, MI 48201 USA; [Gurdziel, Katherine] Wayne State Univ, Res, Detroit, MI 48201 USA; [Ruden, Douglas M.] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48201 USA; [Ruden, Douglas M.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA		Ruden, DM (corresponding author), Wayne State Univ, Dept Pharmacol, Sch Med, Detroit, MI 48201 USA.; Gurdziel, K (corresponding author), Wayne State Univ, Res, Detroit, MI 48201 USA.; Ruden, DM (corresponding author), Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48201 USA.; Ruden, DM (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA.	ejshah@med.wayne.edu; gurdziel@wayne.edu; douglasr@wayne.edu	Ruden, Douglas/ABE-1418-2021	Ruden, Douglas/0000-0002-0070-437X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01ES012933, 5P30ES020957, 1UG3OD023285, 1S10OD025170-01]; Office of the Vice President for Research at Wayne State University	This work was funded by the National Institutes of Health {Grant Nos. 5R01ES012933 (DR), 5P30ES020957 (DR), 1UG3OD023285 (DR) and 1S10OD025170-01 (DR)}. In addition, the Office of the Vice President for Research at Wayne State University supports K.G. and provided pilot funds for D.M.R.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bolkan BJ, 2014, DEV NEUROBIOL, V74, P1210, DOI 10.1002/dneu.22199; Buckley RF, 2019, JAMA NEUROL, V76, P542, DOI 10.1001/jamaneurol.2018.4693; Burnouf S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23102; Casimir M, 2009, BIOCHEM J, V424, P459, DOI 10.1042/BJ20090729; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Cheng Y, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00163; Ciuffreda KJ., 2016, ADV OPHTHALMOL OPTOM, V1, P307, DOI [10.1016/j.yaoo.2016.03.013, DOI 10.1016/J.YAOO.2016.03.013]; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; DeVos SL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0481; Ding LG, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006359; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edwards G, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6348; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fresno C, 2013, BIOINFORMATICS, V29, P2810, DOI 10.1093/bioinformatics/btt487; Fuller GW, 2016, NEUROEPIDEMIOLOGY, V47, P1, DOI 10.1159/000445997; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hanamsagar R, 2016, J STEROID BIOCHEM, V160, P127, DOI 10.1016/j.jsbmb.2015.09.039; Harbison ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-281; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Jara C, 2018, REDOX BIOL, V18, P279, DOI 10.1016/j.redox.2018.07.010; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Ke Yazi D, 2012, Int J Alzheimers Dis, V2012, P873270, DOI 10.1155/2012/873270; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Lei P, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-29; Li X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164237; Maphis N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00196; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Novak P, 2017, LANCET NEUROL, V16, P123, DOI [10.1016/S1474-4422(16)30331-3, 10.1016/s1474-4422(16)30331-3]; Papanikolopoulou K, 2019, J NEUROSCI, V39, P8315, DOI 10.1523/JNEUROSCI.0391-19.2019; R Core Team, 2019, R LANG ENV STAT COMP; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shah EJ, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.628777; Shah EJ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00511; Shokouhi S, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12016; Silaidos C, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0193-7; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Tan SY, 2020, CANCER RES, V80, P1130, DOI 10.1158/0008-5472.CAN-19-2332; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; West C, 2017, CELL, V169, P188, DOI 10.1016/j.cell.2017.03.032; Zhao CH, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23112	59	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4425		GENES-BASEL	Genes	JUN	2021	12	6							917	10.3390/genes12060917			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TB3UY	WOS:000667873500001	34198629	gold, Green Published			2022-02-06	
J	Singer, KE; Wallen, TE; Jalbert, T; Wakefield, D; Spuzzillo, A; Sharma, S; Earnest, R; Heh, V; Foreman, B; Goodman, MD				Singer, Kathleen E.; Wallen, Taylor E.; Jalbert, Timothy; Wakefield, Devin; Spuzzillo, Anthony; Sharma, Sameer; Earnest, Ryan; Heh, Victor; Foreman, Brandon; Goodman, Michael D.			Efficacy of Noninvasive Technologies in Triaging Traumatic Brain Injury and Correlating With Intracranial Pressure: A Prospective Study	JOURNAL OF SURGICAL RESEARCH			English	Article						Austere environment; Noninvasive intracranial pressure; Optic sheath nerve diameter; Pupillometry; Transcranial Doppler		Background: There is interest in methods of measuring noninvasive intracranial pressure (ICP), including pupillometry, ultrasonographic transcranial Doppler (TCD), and optic nerve sheath diameter (ONSD), for diagnosing traumatic brain injury (TBI) in limited resource environments. Whether these technologies have diagnostic agreement is unknown. We hypothesized that ONSD, pupillometry, and TCD could both distinguish severe TBI and correlate with ICP. Methods: A prospective study of 135 patients was conducted at a level 1 trauma center. Four test groups were established: nontrauma patients with ICP monitoring, trauma patients without TBI, trauma patients with mild TBI, and trauma patients with severe TBI with ICP monitoring. All patients underwent daily measurements of ONSD, pupillometry, and TCD with both CX50 Sonosite and the Spencer ST3 Yi Pencil probe. Results: ONSD differed significantly in patients with severe TBI compared with patients with mild and no TBI, but did not correlate with ICP. Pupillometric constriction velocity, dilation velocity, and percent change in pupil diameter were significantly different in patients with severe TBI, but also did not correlate with ICP. TCD did not differ among TBI severities, but middle cerebral artery peak systolic velocity, middle cerebral artery flow velocity, and carotid flow velocity correlated with ICP. Conclusions: This is a novel study of four noninvasive tests to screen for severity of TBI and measure ICP. Our analysis indicates that no single device can do both. However, ONSD and pupillometry may be used as a supplementary screening tool for severe TBI, whereas TCD could be used to estimate and follow ICP in patients with severe TBI. (c) 2020 Elsevier Inc. All rights reserved.	[Singer, Kathleen E.; Wallen, Taylor E.; Jalbert, Timothy; Wakefield, Devin; Spuzzillo, Anthony; Earnest, Ryan; Heh, Victor; Goodman, Michael D.] Univ Cincinnati, Dept Gen Surg, Cincinnati, OH 45267 USA; [Sharma, Sameer; Foreman, Brandon] Univ Cincinnati, Dept Neurol, Cincinnati, OH 45267 USA		Goodman, MD (corresponding author), Univ Cincinnati, Dept Surg, Sect Gen Surg, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.	goodmamd@ucmail.uc.edu		Goodman, Michael/0000-0001-7218-4855; Jalbert, Timothy/0000-0002-0500-3441	USAF [G102123-6263608307-1]; AFIMSC [MSC-2020-0190]	USAF G102123-6263608307-1.; AFIMSC Case#: MSC-2020-0190.	Agrawal D, 2020, CRIT CARE MED; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bouzat P, 2016, ANESTHESIOLOGY, V125, P346, DOI 10.1097/ALN.0000000000001165; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Carlson K, 2009, ASSESSMENT TREATMENT; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chen LM, 2019, BRIT J OPHTHALMOL, V103, P437, DOI 10.1136/bjophthalmol-2018-312934; Das SK, 2017, POL J RADIOL, V82, P240, DOI 10.12659/PJR.900196; Fatima Nida, 2019, Asian J Neurosurg, V14, P626, DOI 10.4103/ajns.AJNS_42_19; Glaser Jacob, 2016, Trauma Surg Acute Care Open, V1, pe000019, DOI 10.1136/tsaco-2016-000019; Gurney JM, 2020, MIL MED, V185, P148, DOI 10.1093/milmed/usz361; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Kansagara D., 2013, COMPLICATIONS MILD T; Le Roux P., 2016, TRANSLATIONAL RES TR; Moreno J A, 2000, Neurosurg Focus, V8, pe8; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Mutschler M, 2014, EMERG MED J, V31, P35, DOI 10.1136/emermed-2012-202130; Naqvi J, 2013, INT J VASC MED, V2013, DOI 10.1155/2013/629378; Prevention C.o.D.C.a, 2019, TBI REL EM DEP VIS H; Rajajee V, 2012, CRIT CARE, V16, DOI [10.1186/cc11336, 10.1186/CC11336]; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Romagnosi F, 2020, CURR OPIN CRIT CARE, V26, P115, DOI 10.1097/MCC.0000000000000710; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Wang JX, 2020, J NEUROSURG, V133, P514, DOI 10.3171/2019.4.JNS183297	28	1	1	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN	2021	262						27	37		10.1016/j.jss.2020.12.042			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	RM0CB	WOS:000639329000006	33540153				2022-02-06	
J	Solomon, NP; Brungart, DS; Wince, JR; Abramowitz, JC; Eitel, MM; Cohen, J; Lippa, SM; Brickell, TA; French, LM; Lange, RT				Solomon, Nancy Pearl; Brungart, Douglas S.; Wince, Jessica R.; Abramowitz, Jordan C.; Eitel, Megan M.; Cohen, Julie; Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.; Lange, Rael T.			Syllabic Diadochokinesis in Adults With and Without Traumatic Brain Injury: Severity, Stability, and Speech Considerations	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ALTERNATING MOTION RATE; FIXED-TARGET TASK; ORAL DIADOCHOKINESIS; SPEAKING RATE; MOTOR; DYSARTHRIA; IMPAIRMENT; DISORDERS; APRAXIA	Purpose: Syllabic diadochokinesis (DDK) is a standard assessment task for motor speech disorders. This study aimed to compare rate and regularity of DDK according to the presence or absence of traumatic brain injury (TBI) and severity of TBI, examine the stability of DDK over time, and explore associations between DDK and extemporaneous speech. Method: Military service members and veterans were categorized into three groups: no history of TBI (control), uncomplicated mild TBI (mTBI), and moderate through severe (including penetrating) TBI (msTBl). Participants produced rapid alternating-motion and sequential-motion syllable repetitions during one or two sessions. A semi-automated protocol determined syllabic rate and regularity. Perceptual ratings of selected participants' connected speech samples were compared to DDK results. Results: Two hundred sixty-three service members and veterans provided data from one session and 69 from two sessions separated by 1.9 years (SD = 1.0). DDKs were significantly slower overall for mTBI and msTBI groups compared to controls. Regularity of productions did not differ significantly across groups. A significant Group x Task interaction revealed that the msTBI group produced sequential-motion syllable repetitions but not alternating-motion repetitions with greater regularity, whereas the opposite occurred for control and mTBI groups. DDK results did not differ significantly between sessions. Perceptual speech analysis for 30 participants, including 20 with atypical or questionable DDK performance, revealed two participants with mildly abnormal speech. Conclusions: Overall, DDK productions are slower than normal in adults with moderate, severe, and penetrating TBI and are stable over time. Regularity of productions did not differentiate groups, although this result differed according to task. There were surprisingly few people identified with disordered speech, making comparisons to DDK data tenuous, and indicating that dysarthria is a rare complication in a population of adults with mostly uncomplicated mTBI who are not selected from referrals to a speech-language pathology clinic.	[Solomon, Nancy Pearl; Brungart, Douglas S.; Wince, Jessica R.; Abramowitz, Jordan C.; Eitel, Megan M.; Cohen, Julie; Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA; [Solomon, Nancy Pearl; Brungart, Douglas S.; Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Wince, Jessica R.] Towson Univ, Baltimore, MD USA; [Abramowitz, Jordan C.; Cohen, Julie] Univ Maryland, College Pk, MD 20742 USA; [Eitel, Megan M.; Cohen, Julie] Henry M Jackson Fdn, Rockville, MD USA; [Eitel, Megan M.; Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.; Lange, Rael T.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.; Lange, Rael T.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; Lange, Rael T.] Gen Dynam Informat Technol, Falls Church, VA USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Solomon, NP (corresponding author), Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA.; Solomon, NP (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	nancy.p.solomon.civ@mail.mil		french, louis/0000-0002-9451-0604; Solomon, Nancy/0000-0002-5018-7569	Defense and Veterans Brain Injury Center 15-Year Longitudinal TBI studies [Sec721 NDAA FY2007]; Oak Ridge Institute for Science and Engineering summer internship program; Department of Army/Navy/Air Force, Department of Defense; DHA Contracting Office [HT0014-19C-0004, HT0014]; U.S. Government	This work was supported by the Defense and Veterans Brain Injury Center 15-Year Longitudinal TBI studies (Sec721 NDAA FY2007). We are also grateful for the support provided by the Oak Ridge Institute for Science and Engineering summer internship program. This article is based on a poster presentation at the Twentieth Biennial Conference on Motor Speech in Santa Barbara, CA (February 19-23, 2020). The identification of specific products or scientific instrumentation is considered an integral part of the scientific endeavor and does not constitute endorsement or implied endorsement on the part of the authors, U.S. Department of Defense, or any component agency. The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Army/Navy/Air Force, Department of Defense, or U.S. Government. This work was prepared under Contract HT0014-19C-0004 with DHA Contracting Office HT0014 and, therefore, is defined as U.S. Government work under Title 17 U.S.C. 101. Per Title 17 U.S.C. 105, copyright protection is not available for any work of the U.S. Government. For more information, please contact dha.DVBICinfo@mail.mil.	ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; Banks R. E, 2019, THESIS MICHIGAN STAT; BLUMBERGER J, 1995, BRAIN INJURY, V9, P797, DOI 10.3109/02699059509008235; Brendel B, 2015, J NEUROL, V262, P21, DOI 10.1007/s00415-014-7511-8; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cummins N, 2015, SPEECH COMMUN, V71, P10, DOI 10.1016/j.specom.2015.03.004; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; Elbourn E, 2019, BRAIN INJURY, V33, P143, DOI 10.1080/02699052.2018.1539246; Enderby P., 2008, FRENCHAY DYSARTHRIA; Ergun A, 2008, BRAIN INJURY, V22, P773, DOI 10.1080/02699050802372182; Eshghi M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01288; Haley KL, 2012, J SPEECH LANG HEAR R, V55, pS1502, DOI 10.1044/1092-4388(2012/11-0318); Helfer BS, 2014, INTERSPEECH, P485; Karlsson F, 2019, FOLIA PHONIATR LOGO, V71, P251, DOI 10.1159/000498851; KENT RD, 1987, J SPEECH HEAR DISORD, V52, P367, DOI 10.1044/jshd.5204.367; KENT RD, 1991, J SPEECH HEAR RES, V34, P1269, DOI 10.1044/jshr.3406.1269; Knuijt S, 2019, INT J SPEECH-LANG PA, V21, P56, DOI 10.1080/17549507.2017.1380227; Lange RT, 2020, NEUROPSYCHOL REHABIL, V30, P1762, DOI 10.1080/09602011.2019.1604385; Mefferd AS, 2012, J COMMUN DISORD, V45, P35, DOI 10.1016/j.jcomdis.2011.09.002; Myers J. R., 2020, ANAL DISCOURSE UNPUB; Nishio M, 2000, CLIN LINGUIST PHONET, V14, P485; Nishio M, 2006, FOLIA PHONIATR LOGO, V58, P114, DOI 10.1159/000089612; Peiffer-Lapid T, 2016, MOTOR SPEECH RATES C; PORTNOY RA, 1982, J SPEECH HEAR DISORD, V47, P324, DOI 10.1044/jshd.4703.324; Rong PY, 2020, J SPEECH LANG HEAR R, V63, P59, DOI 10.1044/2019_JSLHR-19-00178; Rong PY, 2020, AMYOTROPH LAT SCL FR, V21, P34, DOI 10.1080/21678421.2019.1681454; Rong PY, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/183027; Rusz J, 2018, MULT SCLER RELAT DIS, V19, P62, DOI 10.1016/j.msard.2017.11.007; Rusz J, 2016, J NEURAL TRANSM, V123, P379, DOI 10.1007/s00702-016-1515-8; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Salvatore A. P., 2019, CLIN ARCH COMMUN DIS, V4, P214, DOI [10.21849/cacd.2019.00150, DOI 10.21849/CACD.2019.00150]; Solomon NP, 2017, AM J SPEECH-LANG PAT, V26, P951, DOI 10.1044/2017_AJSLP-16-0144; Staiger A, 2017, NEUROPSYCHOLOGIA, V95, P40, DOI 10.1016/j.neuropsychologia.2016.12.010; Stubbs E, 2018, BRAIN INJURY, V32, P167, DOI 10.1080/02699052.2017.1291989; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang YT, 2004, CLIN LINGUIST PHONET, V18, P57, DOI 10.1080/02699200310001596160; Wang YT, 2009, FOLIA PHONIATR LOGO, V61, P1, DOI 10.1159/000184539; Xu Y, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02469; Zarshenas S, 2019, ARCH PHYS MED REHAB, V100, P1274, DOI 10.1016/j.apmr.2018.11.023; Ziegler W, 1996, NEUROLOGY, V47, P208, DOI 10.1212/WNL.47.1.208; Ziegler W, 2002, BRAIN LANG, V80, P556, DOI 10.1006/brln.2001.2614; Ziegler W, 2017, J SPEECH LANG HEAR R, V60, P1516, DOI 10.1044/2017_JSLHR-S-16-0336	44	1	1	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	JUN	2021	30	3		S	SI		1400	1409		10.1044/2020_AJSLP-20-00158			10	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	SU7QV	WOS:000663328000008	33630660				2022-02-06	
J	Stanbouly, D; Stanbouly, R; Lee, KC; Chuang, SK				Stanbouly, Dani; Stanbouly, Rami; Lee, Kevin C.; Chuang, Sung-Kiang			Prevalence of Dentofacial Injuries and Concussions Among College Athletes and Their Perceptions of Mouthguards	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Dental trauma; maxillofacial trauma; trauma prevention	DENTAL TRAUMA; CUSTOM-MADE; PREVENTION; SPORTS; EPIDEMIOLOGY	Purpose: The purpose of this study was to determine the rates of dento-facial injuries and concussions among National Collegiate Athletic Association (NCAA) division 1 college athletes and their perceptions of mouth-guards and their protection role in injury prevention. Materials and methods: A specific survey regarding the experiences of dento-facial injuries and concussions, attitudes towards the mouthguards, and knowledge of dental first aid was distributed to 682 NCAA division I college athletes registered at Columbia University. The independent predictor variable was sport type (contact versus noncontact). The dependent outcome variables were dental injury rate, facial injury rate, concussion rate, mouthguard use, knowledge of dental first aid. Chi-squared and independent sample tests were used for statistical analysis. Results: The mean age of the athletes was 19.4 years (range: 17 to 22). 107 (47.6%) athletes were male. Only 62 (27.6%) athletes reported mouthguard use during gameplay. The most popular choice of mouthguard was the mouth-molded type (56.7%). Mouthguard use was significantly more prevalent among contact sport athletes (43.3% versus 1.2%; P < 0.01). Contact sport athletes were more likely to experience dental injuries (14.3% versus 0.0%; P < 0.01)., facial injuries (35.0% versus 6.2%; p < 0.01), and concussions (32.6% versus 2.4%; P < 0.01) relative to noncontact sport athletes. No significant difference was identified between contact and noncontact sport athletes with regards to knowledge of dental first aid. Conclusions: Contact sport athletes are significantly more inclined to suffer dento-facial injuries and concussions relative to noncontact sport athletes. Thus, mouthguard use and knowledge of dental first aid should be particularly reinforced amongst contact sport athletes.	[Stanbouly, Dani] Columbia Univ, Coll Dent Med, 630 West 168th St, New York, NY 10032 USA; [Stanbouly, Rami] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Lee, Kevin C.] Columbia Univ, Irving Med Ctr, New York Presbyterian, Div Oral & Maxillofacial Surg, New York, NY USA; [Chuang, Sung-Kiang] Univ Penn, Dept Oral & Maxillofacial Surg, Philadelphia, PA 19104 USA; [Chuang, Sung-Kiang] Good Samaritan Hosp, Dept Oral & Maxillofacial Surg, Brockton Oral & Maxillofacial Surg Inc, Brockton, MA USA		Stanbouly, D (corresponding author), Columbia Univ, Coll Dent Med, 630 West 168th St, New York, NY 10032 USA.	ds3840@cumc.columbia.edu					ADA, 2006, J AM DENT ASSOC, V137, P1712; Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; Eroglu E, 2006, DENT TRAUMATOL, V22, P193, DOI 10.1111/j.1600-9657.2006.00385.x; Galic T, 2018, DENT TRAUMATOL, V34, P175, DOI 10.1111/edt.12394; Gawlak D, 2014, DENT TRAUMATOL, V30, P306, DOI 10.1111/edt.12085; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Levin L, 2012, DENT TRAUMATOL, V28, P49, DOI 10.1111/j.1600-9657.2011.01060.x; McBain K, 2012, BRIT J SPORT MED, V46, P169, DOI 10.1136/bjsm.2010.080929; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Parker K, 2017, BRIT DENT J, V222, P629, DOI 10.1038/sj.bdj.2017.365; Pieter W, 2005, MED SPORT SCI, V48, P59, DOI 10.1159/000084283; Polmann H, 2020, DENT TRAUMATOL, V36, P124, DOI 10.1111/edt.12508; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Sepet E, 2014, DENT TRAUMATOL, V30, P391, DOI 10.1111/edt.12105; Vucic S, 2016, BRIT J SPORT MED, V50, P298, DOI 10.1136/bjsports-2015-094896; WEI SH, 1974, INT DENT J, V24, P30	19	1	1	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1600	1603		10.1097/SCS.0000000000007615			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100117	33710051				2022-02-06	
J	von Steinbuechel, N; Rauen, K; Bockhop, F; Covic, A; Krenz, U; Plass, AM; Cunitz, K; Polinder, S; Wilson, L; Steyerberg, EW; Maas, AIR; Menon, D; Wu, YJ; Zeldovich, M				Steinbuechel, Nicole von; Rauen, Katrin; Bockhop, Fabian; Covic, Amra; Krenz, Ugne; Plass, Anne Marie; Cunitz, Katrin; Polinder, Suzanne; Wilson, Lindsay; Steyerberg, Ewout W.; Maas, Andrew I. R.; Menon, David; Wu, Yi-Jhen; Zeldovich, Marina		CTR-TBI Participants Investi	Psychometric Characteristics of the Patient-Reported Outcome Measures Applied in the CENTER-TBI Study	JOURNAL OF CLINICAL MEDICINE			English	Article						psychometric properties; patient-reported outcome measures; traumatic brain injury; classical test theory	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; POST-CONCUSSION SYMPTOMS; POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; RISK-FACTORS; VALIDITY; QOLIBRI; SCALE; QUESTIONNAIRE	Traumatic brain injury (TBI) may lead to impairments in various outcome domains. Since most instruments assessing these are only available in a limited number of languages, psychometrically validated translations are important for research and clinical practice. Thus, our aim was to investigate the psychometric properties of the patient-reported outcome measures (PROM) applied in the CENTER-TBI study. The study sample comprised individuals who filled in the six-months assessments (GAD-7, PHQ-9, PCL-5, RPQ, QOLIBRI/-OS, SF-36v2/-12v2). Classical psychometric characteristics were investigated and compared with those of the original English versions. The reliability was satisfactory to excellent; the instruments were comparable to each other and to the original versions. Validity analyses demonstrated medium to high correlations with well-established measures. The original factor structure was replicated by all the translations, except for the RPQ, SF-36v2/-12v2 and some language samples for the PCL-5, most probably due to the factor structure of the original instruments. The translation of one to two items of the PHQ-9, RPQ, PCL-5, and QOLIBRI in three languages could be improved in the future to enhance scoring and application at the individual level. Researchers and clinicians now have access to reliable and valid instruments to improve outcome assessment after TBI in national and international health care.	[Steinbuechel, Nicole von; Bockhop, Fabian; Covic, Amra; Krenz, Ugne; Plass, Anne Marie; Cunitz, Katrin; Wu, Yi-Jhen; Zeldovich, Marina] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Waldweg 37A, D-37073 Gottingen, Germany; [Rauen, Katrin] Univ Zurich, Psychiat Hosp Zurich, Dept Geriatr Psychiat, Minervastr 145, CH-8032 Zurich, Switzerland; [Rauen, Katrin] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Stroke & Dementia Res ISD, Feodor Lynen Str 17, D-81377 Munich, Germany; [Polinder, Suzanne; Steyerberg, Ewout W.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling FK9 4LJ, Scotland; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, NL-2333 RC Leiden, Netherlands; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, B-2650 Edegem, Belgium; [Menon, David] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 157, Cambridge CB2 0QQ, England		von Steinbuechel, N (corresponding author), Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Waldweg 37A, D-37073 Gottingen, Germany.	nvsteinbuechel@med.uni-goettingen.de; katrin.rauen@uzh.ch; fabian.bockhop@med.uni-goettingen.de; amra.covic@med.uni-goettingen.de; ugne.krenz@med.uni-goettingen.de; annemarie.plass@med.uni-goettingen.de; katrin.cunitz@med.uni-goettingen.de; s.polinder@erasmusmc.nl; l.wilson@stir.ac.uk; e.steyerberg@erasmusmc.nl; andrew.maas@uza.be; dkm13@cam.ac.uk; yi-jhen.wu@med.uni-goettingen.de; marina.zeldovich@med.uni-goettingen.de	Cunitz, Katrin/AAS-8176-2020; Posti, Jussi P./Y-2908-2019; Steyerberg, Ewout/C-1509-2018	Cunitz, Katrin/0000-0001-5530-8190; Posti, Jussi P./0000-0002-5925-5193; Wilson, Lindsay/0000-0003-4113-2328; Rauen, Katrin/0000-0003-4555-6697; Takala, Riikka/0000-0001-6342-0043; Steyerberg, Ewout/0000-0002-7787-0122	Seventh Framework ProgrammeEuropean Commission [602150] Funding Source: Medline; Integra LifeSciences Corporation (USA) Funding Source: Medline; Hannelore Kohl Stiftung (Germany) Funding Source: Medline; OneMind (USA) Funding Source: Medline		Acquadro C., 2012, LINGUISTIC VALIDATIO; Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; Ashbaugh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161645; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Biehn TL, 2013, PSYCHOL INJ LAW, V6, P290, DOI 10.1007/s12207-013-9177-4; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown TA., 2015, CONFIRMATORY FACTOR, V2; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bujang MA, 2018, MALAYS J MED SCI, V25, P85, DOI 10.21315/mjms2018.25.6.9; Bulmer, 1979, PRINCIPLES STAT; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castano-Leon AM, 2018, EVAL HEALTH PROF, V41, P456, DOI 10.1177/0163278717702696; Cho E, 2015, ORGAN RES METHODS, V18, P207, DOI 10.1177/1094428114555994; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donders J, 2017, BRAIN INJURY, V31, P1871, DOI 10.1080/02699052.2017.1334962; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Geier TJ, 2020, J TRAUMA STRESS, V33, P218, DOI 10.1002/jts.22478; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gorbunova A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072100; Hair JF., 2014, MULTIVARIATE DATA AN, V7; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kunzmann K, 2021, J NEUROTRAUM, V38, P455, DOI 10.1089/neu.2019.6858; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Machin D, 2013, QUALITY LIFE ASSESSM; Maruish ME., 2011, USERS MANUAL SF 36V2; Maydeu-Olivares A, 2017, STRUCT EQU MODELING, V24, P495, DOI 10.1080/10705511.2017.1289816; Maydeu-Olivares A, 2009, BEHAV RES METHODS, V41, P295, DOI 10.3758/BRM.41.2.295; McDonald R, 1999, TEST THEORY UNIFIED; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller MW, 2013, PSYCHOL TRAUMA-US, V5, P501, DOI 10.1037/a0029730; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; R Core Team, 2021, R LANG ENV STAT COMP; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rauen K, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01391-3; Revelle W., 2020, PSYCH PROCEDURES PSY; Rockwood TH, 1997, SOCIOL METHOD RES, V26, P118, DOI 10.1177/0049124197026001004; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Steinbuechel N., J CLIN MED; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; TEASDALE G, 1974, LANCET, V2, P81; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Teymoori A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030873; Teymoori A, 2020, J AFFECT DISORDERS, V262, P278, DOI 10.1016/j.jad.2019.10.035; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; von Steinbuchel N, 2020, J NEUROTRAUM, V37, P1242, DOI 10.1089/neu.2019.6627; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Ware J., 2007, USERS MANUAL 36V2 HL; Ware J. E., 2009, USERS MANUAL SF12V2; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Wolf EJ, 2013, EDUC PSYCHOL MEAS, V73, P913, DOI 10.1177/0013164413495237; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260; Wu Y.-J., 2021, VALUE HEALTH; Yurdugul H, 2008, HACET UNIV EGIT FAK, P397; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172	83	1	1	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUN	2021	10	11							2396	10.3390/jcm10112396			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SQ2UC	WOS:000660211600001	34071667	Green Published, gold			2022-02-06	
J	Szenasi, A; Amrein, K; Czeiter, E; Szarka, N; Toth, P; Koller, A				Szenasi, Annamaria; Amrein, Krisztina; Czeiter, Endre; Szarka, Nikolett; Toth, Peter; Koller, Akos			Molecular Pathomechanisms of Impaired Flow-Induced Constriction of Cerebral Arteries Following Traumatic Brain Injury: A Potential Impact on Cerebral Autoregulation	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						hemodynamic forces; diameter; autoregulation; arachidonic acid; CYP450 4A; TXA(2) receptors	CA2+-ACTIVATED K+ CHANNEL; MYOGENIC CONSTRICTION; 20-HYDROXYEICOSATETRAENOIC ACID; UNITED-STATES; 20-HETE; RAT; PRESSURE; RESPONSES; MODEL; DYSFUNCTION	(1) Background: Traumatic brain injury (TBI) frequently occurs worldwide, resulting in high morbidity and mortality. Here, we hypothesized that TBI impairs an autoregulatory mechanism, namely the flow-induced constriction of isolated rat middle cerebral arteries (MCAs). (2) Methods: TBI was induced in anaesthetized rats by weight drop model, and then MCAs were isolated and transferred into a pressure-flow chamber. The internal diameter was measured by a video-microscopy. (3) Results: In MCAs from intact rats, increases in flow and pressure + flow elicited constrictions (-26 +/- 1.9 mu m and -52 +/- 2.8 mu m, p < 0.05), which were significantly reduced after TBI or in the presence of thromboxane-prostanoid (TP receptor) antagonist SQ 29,548. Flow-induced constrictions were significantly reduced by HET0016, inhibitor of cytochrome P450 4A (CYP450 4A). Arachidonic acid, (AA, 10(-7) M), and CYP-450 4A metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) elicited constrictions of intact MCA (-26 +/- 2.3% and -31 +/- 3.6%), which were significantly reduced after TBI (to 11 +/- 1.3% and -16 +/- 2.5%). The TP receptor agonist U46619 (10(-7) M) elicited substantial constrictions of MCA from intact rats (-21 +/- 3.3%), which were also significantly reduced, after TBI (to -16 +/- 2.4%). (4) Conclusions: Flow-induced constrictor response of MCA is impaired by traumatic brain injury, likely due to the reduced ability of cytochrome P450 4A to convert arachidonic acid to constrictor prostaglandins and the mitigated sensitivity of thromboxane-prostanoid receptors.	[Szenasi, Annamaria; Koller, Akos] Semmelweis Univ, Fac Med, Dept Translat Med, H-1085 Budapest, Hungary; [Szenasi, Annamaria; Koller, Akos] Semmelweis Univ, Fac Hlth Sci, Dept Morphol & Physiol, H-1085 Budapest, Hungary; [Amrein, Krisztina; Czeiter, Endre; Toth, Peter] Univ Pecs, Dept Neurosurg, Med Sch, H-7623 Pecs, Hungary; [Amrein, Krisztina; Czeiter, Endre; Toth, Peter] Univ Pecs, Szentagothai Res Ctr, Med Sch, H-7623 Pecs, Hungary; [Szarka, Nikolett; Toth, Peter] MTA PTE Clin Neurosci MR Res Grp, H-7623 Pecs, Hungary; [Koller, Akos] Univ Phys Educ, Res Ctr Sports Physiol, H-1123 Budapest, Hungary; [Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA		Koller, A (corresponding author), Semmelweis Univ, Fac Med, Dept Translat Med, H-1085 Budapest, Hungary.; Koller, A (corresponding author), Semmelweis Univ, Fac Hlth Sci, Dept Morphol & Physiol, H-1085 Budapest, Hungary.; Koller, A (corresponding author), Univ Phys Educ, Res Ctr Sports Physiol, H-1123 Budapest, Hungary.; Koller, A (corresponding author), New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA.	ancsi.szenasi@gmail.com; tina.amrein84@gmail.com; endre.czeiter@aok.pte.hu; nikiszarka@gmail.com; petitoth@gmail.com; akos.koller@gmail.com		Czeiter, Endre/0000-0002-9578-6944	National Research, Development and Innovation Office FundNational Research, Development & Innovation Office (NRDIO) - Hungary [OTKA K 132596, NKFIFK123798, TKP2020-NKA-17]; Semmelweis University; National Bionika Program, Hungary [ED_17-1-2017-0009]; National Competitiveness and Excellence Program Project [NVKP 16-1-2016-0051, EFOP-3.6.3-VEKOP-16-2017-00009]	National Research, Development and Innovation Office Fund, OTKA K 132596, NKFIFK123798 and TKP2020-NKA-17 Institutional Excellence Program at University of Physical Education, Semmelweis University and the National Bionika Program ED_17-1-2017-0009, Hungary, National Competitiveness and Excellence Program Project NVKP 16-1-2016-0051, EFOP-3.6.3-VEKOP-16-2017-00009.	Chennupati R, 2019, ELIFE, V8, DOI 10.7554/eLife.49374; Cipolla M.J., 2009, CEREBRAL CIRCULATION; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Czigler A, 2020, PROSTAG OTH LIPID M, V146, DOI 10.1016/j.prostaglandins.2019.106389; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; DORA E, 1984, J CEREBR BLOOD F MET, V4, P447, DOI 10.1038/jcbfm.1984.64; ESCALANTE B, 1989, J PHARMACOL EXP THER, V248, P229; GARCIAROLDAN JL, 1990, CIRC RES, V66, P1445, DOI 10.1161/01.RES.66.5.1445; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Gebremedhin D, 2008, AM J PHYSIOL-HEART C, V294, pH107, DOI 10.1152/ajpheart.01416.2006; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; Harder DR, 2011, AM J PHYSIOL-HEART C, V300, pH1557, DOI 10.1152/ajpheart.01097.2010; HARDER DR, 1994, AM J PHYSIOL, V266, pH2098, DOI 10.1152/ajpheart.1994.266.5.H2098; Hayashida M, 2003, ANESTH ANALG, V97, P1340, DOI 10.1213/01.ANE.0000083369.63589.A5; Henrion D, 2005, ARCH MAL COEUR VAISS, V98, P913; Iadecola C, 1997, J NEUROPHYSIOL, V78, P651, DOI 10.1152/jn.1997.78.2.651; Johnson MB, 2021, ACCIDENT ANAL PREV, V152, DOI 10.1016/j.aap.2021.105987; Jukic I, 2021, AM J PHYSIOL-HEART C, V320, pH1609, DOI 10.1152/ajpheart.00620.2020; Keller J, 2011, ENDOCRINOLOGY, V152, P4927, DOI 10.1210/en.2011-1424; Koller A, 2012, J VASC RES, V49, P375, DOI 10.1159/000338747; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Lapi D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnuls.2016.00470; Mandala M, 2012, ACTA PHYSIOL, V205, P363, DOI 10.1111/j.1748-1716.2011.02406.x; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Menyhart A, 2015, NEUROBIOL AGING, V36, P3269, DOI 10.1016/j.neurobiolaging.2015.08.014; Nemeth Z, 2020, AM J PHYSIOL-HEART C, V319, pH42, DOI 10.1152/ajpheart.00126.2020; Osol G, 2002, AM J PHYSIOL-HEART C, V283, pH2260, DOI 10.1152/ajpheart.00634.2002; Poloyac SM, 2005, J NEUROSCI METH, V144, P257, DOI 10.1016/j.jneumeth.2004.11.015; Racz A, 2010, ATHEROSCLEROSIS, V208, P43, DOI 10.1016/j.atherosclerosis.2009.06.014; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schaller B, 2005, J TRAUMA, V59, P1521, DOI 10.1097/01.ta.0000197402.20180.6b; SCHWARTZMAN ML, 1989, J BIOL CHEM, V264, P11658; Shekhar Shashank, 2017, J Pharm Sci Exp Pharmacol, V2017, P21; Szarka N, 2018, J NEUROTRAUM, V35, P930, DOI 10.1089/neu.2017.5056; Szarka N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133223; Szarka N, 2017, J NEUROTRAUM, V34, P2315, DOI 10.1089/neu.2016.4962; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Toth P, 2014, J CEREBR BLOOD F MET, V34, P1887, DOI 10.1038/jcbfm.2014.156; Toth P, 2013, AM J PHYSIOL-HEART C, V305, pH1698, DOI 10.1152/ajpheart.00377.2013; Toth P, 2013, J CEREBR BLOOD F MET, V33, P1732, DOI 10.1038/jcbfm.2013.143; Toth P, 2011, J CEREBR BLOOD F MET, V31, P2096, DOI 10.1038/jcbfm.2011.74; Ungvari Z, 1999, STROKE, V30, P1949, DOI 10.1161/01.STR.30.9.1949; Yu M, 2004, EUR J PHARMACOL, V486, P297, DOI 10.1016/j.ejphar.2004.01.009; Zou AP, 1996, AM J PHYSIOL-REG I, V270, pR228, DOI 10.1152/ajpregu.1996.270.1.R228	46	1	1	5	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN	2021	22	12							6624	10.3390/ijms22126624			12	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	SZ0SR	WOS:000666286900001	34205652	gold, Green Published			2022-02-06	
J	van der Vlegel, M; Polinder, S; Mikolic, A; Kaplan, R; von Steinbuechel, N; Plass, AM; Zeldovich, M; van Praag, D; Bockhop, F; Cunitz, K; Mueller, I; Haagsma, JA				van der Vlegel, Marjolein; Polinder, Suzanne; Mikolic, Ana; Kaplan, Rana; von Steinbuechel, Nicole; Plass, Anne Marie; Zeldovich, Marina; van Praag, Dominique; Bockhop, Fabian; Cunitz, Katrin; Mueller, Isabelle; Haagsma, Juanita A.		CENTER-TBI Participants Investiga	The Association of Post-Concussion and Post-Traumatic Stress Disorder Symptoms with Health-Related Quality of Life, Health Care Use and Return-to-Work after Mild Traumatic Brain Injury	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury (TBI); post-concussion symptoms; Rivermead Post-Concussion Symptoms Questionnaire (RPQ); post-traumatic stress disorder; health-related quality of life; TBI outcome	CENTER-TBI; PREDICTORS	Patients with mild traumatic brain injury (mTBI) are at risk for post-concussion (PC) symptoms and post-traumatic stress disorder (PTSD). The co-occurrence of PC and PTSD symptoms after mTBI in relation to health-related quality of life (HRQoL), health care utilization, and return to work has not yet been investigated. PC and PTSD symptoms were measured six months post-TBI by respectively the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) and the Post-Traumatic Stress Disorder Checklist for DSM-5 (PCL-5). Of the 1566 individuals after mTBI who met the inclusion criteria, 26.1% experienced PC symptoms (RPQ >= 16). Additionally, 9.8% experienced PTSD symptoms (PCL-5 >= 33), of which the vast majority (81%) also reported experiencing PC symptoms. Differences between patients with no/mild symptoms, with only PC, only PTSD, and both PC and PTSD symptoms in HRQoL, return to work, and rehabilitation were analyzed using logistic and linear regression analyses. Patients with PC and/or PTSD symptoms reported lower HRQoL, higher rates of rehabilitation, and lower return to work rates compared to patients with no/mild symptoms. Patients with both PC and PTSD symptoms reported significantly lower HRQoL (B = -2.73, CI = -4.65; -0.83, p < 0.001) compared to those with only PC symptoms, while there were no significant differences in their ongoing rehabilitation care (OR = 1.39, CI = 0.77-2.49, p = 0.272) and return to work rates (OR = 0.49, CI = 0.15-1.63, p = 0.246) at six months. These results underline the importance of the diagnosis and appropriate treatment of patients with mTBI, experiencing PC and/or PTSD symptoms.	[van der Vlegel, Marjolein; Polinder, Suzanne; Mikolic, Ana; Kaplan, Rana; Haagsma, Juanita A.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [von Steinbuechel, Nicole; Plass, Anne Marie; Zeldovich, Marina; Bockhop, Fabian; Cunitz, Katrin; Mueller, Isabelle] Georg August Univ, Univ Med Ctr Gottingen UMG, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany; [van Praag, Dominique] Univ Antwerp, Antwerp Univ Hosp, Dept Psychol, B-2650 Edegem, Belgium		van der Vlegel, M (corresponding author), Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands.	m.vandervlegel@erasmusmc.nl; s.polinder@erasmusmc.nl; a.mikolic@erasmusmc.nl; z.kaplan@erasmusmc.nl; nvsteinbuechel@med.uni-goettingen.de; annemarie.plass@med.uni-goettingen.de; marina.zeldovich@med.uni-goettingen.de; Dominique.VanPraag@uza.be; fabian.bockhop@med.uni-goettingen.de; katrin.cunitz@med.uni-goettingen.de; isabelle.mueller@med.uni-goettingen.de; j.haagsma@erasmusmc.nl	Cunitz, Katrin/AAS-8176-2020	Cunitz, Katrin/0000-0001-5530-8190; van der Vlegel, Marjolein/0000-0002-0217-9484; Mueller, Isabelle/0000-0001-7511-6647; Van Praag, Dominique/0000-0002-4279-6532	European Union 7th Framework program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Neurotrauma Sciences (USA)	CENTER-TBI was supported by the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), from Integra LifeSciences Corporation (USA) and from Neurotrauma Sciences (USA).	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; Arango-Lasprilla JC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9062007; Ashbaugh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161645; Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Blevins C.A., PTSD CHECKLIST DSM 5; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; COHEN J, 1988, APPL PSYCH MEAS, V12, P425, DOI 10.1177/014662168801200410; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P750, DOI 10.1002/da.20767; Gennarelli TA., 2008, ABBREVIATED INJURY S; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Karr JE, 2020, BRAIN INJURY, V34, P26, DOI 10.1080/02699052.2019.1669825; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kraemer HC, 2003, J AM ACAD CHILD PSY, V42, P1524, DOI 10.1097/00004583-200312000-00022; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mackenzie A, 2015, J REHABIL, V81, P9; Mahar C., 2012, INT J DISABILITY MAN, V6, P49, DOI [10.1375/jdmr.6.1.49, DOI 10.1375/JDMR.6.1.49]; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Molina R.T., 2012, J PSYCHOL PSYCHOTHER, V5, P2161, DOI [10.4172/2161-0487.1000231, DOI 10.4172/2161-0487.1000231]; Mols F, 2009, QUAL LIFE RES, V18, P403, DOI 10.1007/s11136-009-9455-5; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Snell DL., 2016, J BEHAV BRAIN SCI, V6, P227, DOI [10.4236/jbbs.2016.66023, DOI 10.4236/JBBS.2016.66023]; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; TEASDALE G, 1974, LANCET, V2, P81; Thompson C., 2016, BRAIN INJURY; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Van Praag DLG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231857; Van Praag DLG, 2019, J NEUROTRAUM, V36, P3220, DOI 10.1089/neu.2018.5759; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287	50	1	1	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUN	2021	10	11							2473	10.3390/jcm10112473			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SQ1QS	WOS:000660135000001	34199591	gold, Green Published			2022-02-06	
J	Wallace, JS; Mannix, RC				Wallace, Jessica S.; Mannix, Rebekah C.			Racial Disparities in Diagnosis of Concussion and Minor Head Trauma and Mechanism of Injury in Pediatric Patients Visiting the Emergency Department	JOURNAL OF PEDIATRICS			English	Article							BRAIN-INJURY; UNITED-STATES; KNOWLEDGE; PREVALENCE; ATTITUDES; EDUCATION; CHILDREN	Objective To determine if racial/ethnic differences exist in the diagnosis and mechanism of injury among children and adolescents visiting the emergency department (ED) for concussion and minor head trauma (MHT). Study design A retrospective, cross-sectional study of patient (age <= 19 years) visits to the ED for concussion between 2010-2015, using the National Hospital Ambulatory Medical Care Survey, was completed. The primary study exposure was race/ethnicity. Outcome measures included ED visits that resulted in a concussion/MHT diagnosis and mechanism of injury. Mechanism categories included sport, motor vehicle collision, fall, assault, and other mechanism. A multivariable logistic regression and multinomial logistic regression were conducted to assess relationships between race/ethnicity and outcomes. Findings were weighted to reflect population estimates. Results In total, 1263 child/adolescent visits for concussion/MHT were identified, representing an estimated 6.6 million child/adolescent visits nationwide. Compared with non-Hispanic White pediatric patients, non-Hispanic Black patients were least likely to have an ED visit for a concussion/ MHT (P < .001; OR, 0.66; 95% CI, 0.52-0.83) The odds of non-Hispanic Black children/adolescents (OR, 3.80; 95% CI, 1.68-8.55) and children/adolescents of other race/ethnicity (OR, 4.93; 95% CI, 1.09-22.23) sustaining a concussion/MHT resulting from assault vs sport was higher. Conclusions Amid the emerging focus on sport-related concussion, these ethnic/racial differences in ED diagnosis of concussion/MHT demonstrate sociodemographic differences that warrant further attention. Assault may be a more common mechanism of concussion among children/adolescents of a racial minority.	[Wallace, Jessica S.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Wallace, Jessica S.] Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane,2106 Capital Hall, Tuscaloosa, AL 35487 USA; [Mannix, Rebekah C.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Mannix, Rebekah C.] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Mannix, Rebekah C.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA		Wallace, JS (corresponding author), Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane,2106 Capital Hall, Tuscaloosa, AL 35487 USA.	jswallace1@ua.edu					Alpern ER, 2014, ACAD EMERG MED, V21, P365, DOI 10.1111/acem.12347; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Carter PM, 2017, ACAD EMERG MED, V24, P803, DOI 10.1111/acem.13200; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Donnell Z, 2018, J SAFETY RES, V64, P163, DOI 10.1016/j.jsr.2017.12.001; Hanson Holly R, 2019, Inj Epidemiol, V6, P23, DOI 10.1186/s40621-019-0207-x; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Johnston LD, 2007, AM J PREV MED, V33, pS195, DOI 10.1016/j.amepre.2007.07.015; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lyons TW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00690; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Ni H, 2002, INJURY PREV, V8, P60, DOI 10.1136/ip.8.1.60; Richmond TK, 2006, PEDIATRICS, V117, P2158, DOI 10.1542/peds.2005-1920; Sheats KJ, 2018, AM J PREV MED, V55, P462, DOI 10.1016/j.amepre.2018.05.017; Singichetti B, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000397; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1	24	1	1	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JUN	2021	233						249	+		10.1016/j.jpeds.2021.01.057			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	SJ1BU	WOS:000655264900050	33524386				2022-02-06	
J	Walton, SR; Kerr, ZY; Brett, BL; Chandran, A; DeFreese, JD; Smith-Ryan, AE; Stoner, L; Echemendia, RJ; McCrea, M; Meehan, WP; Guskiewicz, KM				Walton, Samuel R.; Kerr, Zachary Y.; Brett, Benjamin L.; Chandran, Avinash; DeFreese, J. D.; Smith-Ryan, Abbie E.; Stoner, Lee; Echemendia, Ruben J.; McCrea, Michael; Meehan III, William P.; Guskiewicz, Kevin M.			Health-promoting behaviours and concussion history are associated with cognitive function, mood-related symptoms and emotional-behavioural dyscontrol in former NFL players: an NFL-LONG Study	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						concussion; american football; diet; exercise; Sleep	QUALITY-OF-LIFE; PROFESSIONAL FOOTBALL PLAYERS; DEPRESSIVE SYMPTOMS; RECURRENT CONCUSSION; SLEEP DURATION; LEAGUE PLAYERS; BRAIN ATROPHY; ITEM BANKS; RISK; EXERCISE	Objectives To examine the relationships among self-reported sport-related concussion (SRC) history and current health-promoting behaviours (exercise frequency, diet quality and sleep duration) with self-reported measures of brain health (cognitive function, symptoms of depression and anxiety and emotional-behavioural dyscontrol) in former NFL players. Methods In this cross-sectional study, a questionnaire was sent to former NFL players. Respondents reported SRC history (categorical: 0; 1-2; 3-5; 6-9; 10+ concussions), number of moderate-to-vigorous aerobic and resistance exercise sessions per week, diet quality (Rapid Eating Assessment for Participants-Shortened) and average nightly sleep duration. Outcomes were Patient-Reported Outcomes Measurement Information System Cognitive Function, Depression, and Anxiety, and Neuro-QoL Emotional-Behavioral Dyscontrol domain T-scores. Multivariable linear regression models were fit for each outcome with SRC history, exercise frequency, diet quality and sleep duration as explanatory variables alongside select covariates. Results Multivariable regression models (n=1784) explained approximately 33%-38% of the variance in each outcome. For all outcomes, SRC history (0.144 <=|beta|<= 0.217) was associated with poorer functioning, while exercise frequency (0.064 <=|beta|<= 0.088) and diet quality (0.057 <=|beta|<= 0.086) were associated with better functioning. Sleeping under 6 hours per night (0.061 <=|beta|<= 0.093) was associated with worse depressive symptoms, anxiety and emotional-behavioural dyscontrol. Conclusion Several variables appear to be associated with mood and perceived cognitive function in former NFL players. SRC history is non-modifiable in former athletes; however, the effects of increasing postplaying career exercise frequency, making dietary improvements, and obtaining adequate sleep represent important potential opportunities for preventative and therapeutic interventions.	[Walton, Samuel R.; Kerr, Zachary Y.; Chandran, Avinash; DeFreese, J. D.; Smith-Ryan, Abbie E.; Stoner, Lee; Guskiewicz, Kevin M.] Univ N Carolina, Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Brett, Benjamin L.; McCrea, Michael] Med Coll Wisconsin, Neurosurg Neurol, Milwaukee, WI 53226 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, NCAA Injury Surveillance Program, Indianapolis, IN USA; [Echemendia, Ruben J.] Univ Missouri, Psychol, Kansas City, MO 64110 USA; [Echemendia, Ruben J.] Univ Orthoped Ctr Concuss Clin, Neuropsychol, State Coll, PA USA; [Meehan III, William P.] Boston Childrens Hosp, Sports Med, Boston, MA USA; [Meehan III, William P.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA		Kerr, ZY (corresponding author), Univ N Carolina, Exercise & Sport Sci, Chapel Hill, NC 27515 USA.	zkerr@email.unc.edu	Stoner, Lee/C-8504-2011	Stoner, Lee/0000-0002-0682-2270; Kerr, Zachary/0000-0003-1423-1259; Walton, Samuel/0000-0003-2647-5701; Brett, Benjamin/0000-0003-2849-4658; Echemendia, Ruben/0000-0001-6116-8462	National Football League; Boston Children's Hospital	Funding for this research project comes from the National Football League and Boston Children's Hospital.	Adamson BC, 2015, ARCH PHYS MED REHAB, V96, P1329, DOI 10.1016/j.apmr.2015.01.005; Alles B, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081808; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Baker JG, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000420; Barbosa Filho V. Cordeiro, 2018, Rev Andal Med Deporte, V11, P23, DOI 10.1016/j.ramd.2016.02.010; Batista C, 2013, J CARDIOL, V61, P440, DOI 10.1016/j.jjcc.2013.01.011; Bellou V, 2017, ALZHEIMERS DEMENT, V13, P406, DOI 10.1016/j.jalz.2016.07.152; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Brett BL, 2019, J NEUROPSYCH CLIN N, V31, P17, DOI 10.1176/appi.neuropsych.18040080; Brinkworth GD, 2009, ARCH INTERN MED, V169, P1873, DOI 10.1001/archinternmed.2009.329; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Erickson Kirk I, 2013, Dialogues Clin Neurosci, V15, P99; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fields L, 2020, ARCH CLIN NEUROPSYCH, V35, P233, DOI 10.1093/arclin/acz008; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Gildner TE, 2019, ARCH GERONTOL GERIAT, V83, P161, DOI 10.1016/j.archger.2019.04.014; Gildner TE, 2014, J CLIN SLEEP MED, V10, P613, DOI 10.5664/jcsm.3782; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hair JF, 1995, MULTIVARIATE DATA AN; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hays RD, 2018, QUAL LIFE RES, V27, P1885, DOI 10.1007/s11136-018-1842-3; Hinton PS, 2011, PHYSICIAN SPORTSMED, V39, P11, DOI 10.3810/psm.2011.09.1916; Iverson GL, 2019, J NEUROPSYCH CLIN N, V31, P328, DOI 10.1176/appi.neuropsych.18110280; JC L., 2014, SLEEP, V37, P821; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Lai JS, 2014, PSYCHO-ONCOLOGY, V23, P1133, DOI 10.1002/pon.3522; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Liu YR, 2018, BEHAV BRAIN RES, V347, P292, DOI 10.1016/j.bbr.2018.03.032; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Matthews KA, 2019, ALZHEIMERS DEMENT, V15, P17, DOI 10.1016/j.jalz.2018.06.3063; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Plessow F, 2020, J NEUROTRAUM, V37, P1021, DOI 10.1089/neu.2019.6661; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Richards A, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw029; Roberts AL, 2021, J NEUROTRAUM, V38, P189, DOI 10.1089/neu.2020.7070; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Ruiter KI, 2019, CLIN NEUROPHYSIOL, V130, P111, DOI 10.1016/j.clinph.2018.10.013; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Segal-Isaacson CJ, 2004, DIABETES EDUCATOR, V30, P774, DOI 10.1177/014572170403000512; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Turner AP, 2000, BRIT J SPORT MED, V34, P332, DOI 10.1136/bjsm.34.5.332; Weber A, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014355; Webner D, 2016, BRAIN INJURY, V30, P1718, DOI 10.1080/02699052.2016.1202451; Whitlock EL, 2017, JAMA INTERN MED, V177, P1146, DOI 10.1001/jamainternmed.2017.1622; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000423; Willeumier K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.67; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	65	1	1	6	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN	2021	55	12					683	+		10.1136/bjsports-2020-103400			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TA4SP	WOS:000667240100012	33397673				2022-02-06	
J	Werner, JK; Shahim, P; Pucci, JU; Lai, C; Raiciulescu, S; Gill, JM; Nakase-Richardson, R; Diaz-Arrastia, R; Kenney, K				Werner, J. Kent, Jr.; Shahim, Pashtun; Pucci, Josephine U.; Lai, Chen; Raiciulescu, Sorana; Gill, Jessica M.; Nakase-Richardson, Risa; Diaz-Arrastia, Ramon; Kenney, Kimbra			Poor sleep correlates with biomarkers of neurodegeneration in mild traumatic brain injury patients: a CENC study	SLEEP			English	Article						traumatic brain injury; sleep disorders; military health; dementia; neurofilament; tau; amyloid	AMYLOID-BETA; NEUROFILAMENT LIGHT; CEREBROSPINAL-FLUID; QUALITY INDEX; PLASMA TAU; DEMENTIA; VALIDITY; RISK; TBI; DISTURBANCES	Study Objectives: Sleep disorders affect over half of mild traumatic brain injury (mTBI) patients. Despite evidence linking sleep and neurodegeneration, longitudinal TBI-related dementia studies have not considered sleep. We hypothesized that poor sleepers with mTBI would have elevated markers of neurodegeneration and lower cognitive function compared to mTBI good sleepers and controls. Our objective was to compare biomarkers of neurodegeneration and cognitive function with sleep quality in warfighters with chronic mTBI. Methods: In an observational warfighters cohort (n = 138 mTBI, 44 controls), the Pittsburgh Sleep Quality Index (PSQI) was compared with plasma biomarkers of neurodegeneration and cognitive scores collected an average of 8 years after injury. Results: In the mTBI cohort, poor sleepers (PSQI >= 10, n = 86) had elevated plasma neurofilament light (NfL, (x) over bar = 11.86 vs 7.91 pg/mL, p = 0.0007, d = 0.63) and lower executive function scores by the categorical fluency ((x) over bar = 18.0 vs 21.0, p = 0.0005, d = -0.65) and stop-go tests ((x) over bar = 30.1 vs 31.1, p = 0.024, d = -0.37). These findings were not observed in controls (n = 44). PSQI predicted NfL (beta = 0.22, p = 0.00002) and tau (beta = 0.14, p = 0.007), but not amyloid beta 42. Poor sleepers showed higher obstructive sleep apnea (OSA) risk by STOP-BANG scores ((x) over bar = 3.8 vs 2.7, p = 0.0005), raising the possibility that the PSQI might be partly secondary to OSA. Conclusions: Poor sleep is linked to neurodegeneration and select measures of executive function in mTBI patients. This supports implementation of validated sleep measures in longitudinal studies investigating pathobiological mechanisms of TBI related neurodegeneration, which could have therapeutic implications.	[Werner, J. Kent, Jr.; Pucci, Josephine U.; Raiciulescu, Sorana; Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Shahim, Pashtun; Lai, Chen; Gill, Jessica M.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Werner, J. Kent, Jr.; Shahim, Pashtun] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Nakase-Richardson, Risa] Univ S Florida, Sleep & Pulm Div, Dept Internal Med, Tampa, FL 33620 USA; [Nakase-Richardson, Risa] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Diaz-Arrastia, Ramon] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA		Werner, JK (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	kent.werner@usuhs.edu		Werner, Kent/0000-0001-9858-2931	U.S. Army Medical Research and Material Command, Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]; VHA Central Office VA TBI Model Systems Program of Research/DHA Contracting Office (CO-NCR) [W91YTZ-13-C-0015/HT0014-19-C-0004, HT0014]	This work was supported by grant funding from the U.S. Army Medical Research and Material Command, Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095, and Department of Veterans Affairs CENC Award I01 CX001135. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was also supported under Contract W91YTZ-13-C-0015/HT0014-19-C-0004 with VHA Central Office VA TBI Model Systems Program of Research/DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as U.S. Government work under Title 17 U.S.C. 101. Per Title 17 U.S.C. 105, copyright protection is not available for any work of the U.S. Government. This work was completed at Uniformed Services University of Health Sciences, Bethesda, MD.	Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Benedict C, 2020, NEUROLOGY, V94, pE1181, DOI 10.1212/WNL.0000000000008866; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caldwell JA, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz112; Chang WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078655; Christensen J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63022-7; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; de Wolfa F, 2020, BRAIN, V143, P1220, DOI 10.1093/brain/awaa054; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Diaz-Roman M, 2021, SLEEP, V44, DOI 10.1093/sleep/zsaa133; Didonna A, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0318-4; Dobrowolska JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089998; Fortea J, 2018, LANCET NEUROL, V17, P860, DOI 10.1016/S1474-4422(18)30285-0; Geary EK, 2011, J INT NEUROPSYCH SOC, V17, P709, DOI 10.1017/S1355617711000646; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Holth JK, 2019, SCIENCE, V363, P880, DOI 10.1126/science.aav2546; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Ju YE, 2019, ANN NEUROL, V85, P291, DOI 10.1002/ana.25408; Ju YE, 2017, BRAIN, V140, P2104, DOI 10.1093/brain/awx148; Ju YE, 2016, ANN NEUROL, V80, P154, DOI 10.1002/ana.24672; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kennedy JE, 2019, MIL MED, V184, P148, DOI 10.1093/milmed/usy321; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Lequerica A, 2014, NEUROREHABILITATION, V35, P485, DOI 10.3233/NRE-141141; Lim MM, 2019, JAMA NEUROL, V76, P114, DOI 10.1001/jamaneurol.2018.3738; Lutsey PL, 2016, SLEEP, V39, P309, DOI 10.5665/sleep.5434; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Matsangas P, 2018, MIL PSYCHOL, V30, P360, DOI 10.1080/08995605.2018.1478547; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; Motamedi V, 2018, SLEEP MED, V43, P71, DOI 10.1016/j.sleep.2017.11.1121; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; O'Hara R, 2005, NEUROLOGY, V65, P642, DOI 10.1212/01.wnl.0000173055.75950.bf; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Ooms S, 2014, JAMA NEUROL, V71, P971, DOI 10.1001/jamaneurol.2014.1173; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Riemann D, 2015, LANCET NEUROL, V14, P547, DOI 10.1016/S1474-4422(15)00021-6; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sprecher KE, 2017, NEUROLOGY, V89, P445, DOI 10.1212/WNL.0000000000004171; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115	57	1	1	2	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	JUN	2021	44	6							zsaa272	10.1093/sleep/zsaa272			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TG7HU	WOS:000671572000006	33280032	Green Published, hybrid			2022-02-06	
J	Wolfe, EM; Pierrot, RG; Slavin, BR; Plotsker, EL; Samaha, GJ; Gishen, K; Thaller, SR				Wolfe, Erin M.; Pierrot, Randall G.; Slavin, Benjamin R.; Plotsker, Ethan L.; Samaha, Georges J.; Gishen, Kriya; Thaller, Seth R.			Rolling With the Punches: A National Electronic Injury Surveillance System Database Study of Craniofacial Injuries in Boxing	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Boxing; craniofacial injuries; facial trauma	BOXERS	Introduction: Boxing is a popular combat sport in which competitors may sustain high impact blows to the face. For this reason, they are at high risk for craniofacial injuries; however, data on facial injuries specific to boxing remains sparse. Studies on safety measures, such as headgear, to prevent such injuries in boxing have been inconclusive. Boxing is popular with a wide audience. However, there is no consensus on safety measures across different populations involved in boxing due to lack of data. The objective of this study is to characterize the demography and incidence of injury types of patients presenting to emergency departments with boxing-related craniofacial injuries on a national scale in order to facilitate the establishment of evidence-based safety guidelines for prevention of boxing-related injuries. Methods: The National Electronic Injury Surveillance System database was searched for boxing-related craniofacial injuries from the last 10 years (2010-2019). Injuries involving boxing were isolated and organized into 5-year age groups. Information on demographics and injury type was extracted from the National Electronic Injury Surveillance System database. Statistical analysis was performed between different age and gender groups. Results: A total of 749 boxing-related craniofacial injuries treated in US emergency departments between 2010 and 2019 were recorded. The 19 to 34-year-old age group had the highest number of cases (54%), followed by the 12 to 18-year-old age group (31%). The most common injury types within both of these age groups were concussions and lacerations. This difference was found to be significant when compared to other craniofacial injury types (P < 0.05). The majority of athletes in these age groups were male (93% and 91%, respectively). Analysis of sex differences demonstrated concussions were more common in females compared to other injury types, whereas lacerations in males were more common compared to other injury types; these differences were found to be significant (P < 0.05). Conclusions: The high incidence of boxing-related craniofacial injuries such as concussions and lacerations incurred in young adults (19-34 years) and adolescents (12-18 years) indicate that protective measures such as community-based safety interventions and revised guidelines for protective equipment may be indicated in these groups to protect against craniofacial injuries such as lacerations and concussions. Further studies are required to develop algorithms for management of boxing-related craniofacial injuries and to evaluate the safety and efficacy of protective equipment such as boxing headgear on concussions.	[Wolfe, Erin M.; Pierrot, Randall G.; Slavin, Benjamin R.; Plotsker, Ethan L.; Samaha, Georges J.; Gishen, Kriya; Thaller, Seth R.] Univ Miami, Miller Sch Med, Dewitt Daughtry Dept Surg, Div Plast Surg, Miami, FL 33136 USA		Wolfe, EM (corresponding author), Univ Miami, Miller Sch Med, 1600 NW 10th Ave 1140, Miami, FL 33136 USA.	ewolfe@med.miami.edu		Slavin, Benjamin/0000-0002-6755-2358			American Academy of Pediatrics, 2010, COUNC SPORTS MED FIT; [Anonymous], 2014, OR HLTH PREV CRAN IN; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bochnig MS, 2017, DENT TRAUMATOL, V33, P205, DOI 10.1111/edt.12324; Dickinson P, 2016, SPORTS MED-OPEN, V2, DOI 10.1186/s40798-016-0043-2; Esomnofu A., 2019, GOVERNING BODY DROPS; Frazier J., 2005, BOX PROS, P24; Gillespie K., 2016, PROS CONS BOXING HEA; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; GUTTMANN A, 1981, J SPORT HIST, V8, P5; Hojjat H, 2016, ANN OTO RHINOL LARYN, V125, P652, DOI 10.1177/0003489416644617; Keay J, 2000, INDIA A HIST; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; MEADOW D, 1984, Pediatric Dentistry, V6, P248; Mendoza-Puente M, 2014, ARCH PHYS MED REHAB, V95, P1977, DOI 10.1016/j.apmr.2014.06.011; Moeller EA., 2020, J CRANIOFAC SURG; Paradis E, 2012, BODY SOC, V18, P82, DOI 10.1177/1357034X12440829; Parva Samayapalana, SAMAYAPALANA PARVA, V4; Sprau AC, 2020, J CRANIOFAC SURG; Thompson DC., 2000, COCHRANE DB SYST REV, V1999; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Wang SS, 2013, WALL STR J	23	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1576	1580		10.1097/SCS.0000000000007640			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100110	33741888				2022-02-06	
J	Yang, S; Yu, CX; Yang, ZF; Cui, H; Wu, Y; Liang, Z; Liu, Y; Shi, X; Shao, F; Zhao, S; Tang, ZR				Yang, Song; Yu, Changxiao; Yang, Zhengfei; Cui, Hao; Wu, Yang; Liang, Zhen; Liu, Ying; Shi, Xian; Shao, Fei; Zhao, Shen; Tang, Ziren			DL-3-n-butylphthalide-induced neuroprotection in rat models of asphyxia-induced cardiac arrest followed by cardiopulmonary resuscitation	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						asphyxia-induced cardiac arrest model; hippocampal neuron; L-3-n-butylphthalide; neuroprotection	TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; TAU-PROTEIN; APOPTOSIS; DISEASE; PATHWAY; ANTIOXIDANT; CELLS; NBP	Most patients that resuscitate successfully from cardiac arrest (CA) suffer from poor neurological prognosis. DL-3-n-butylphthalide (NBP) is known to have neuroprotective effects via multiple mechanisms. This study aimed to investigate whether NBP can decrease neurological impairment after CA. We studied the protective role of NBP in the hippocampus of a rat model of cardiac arrest induced by asphyxia. Thirty-nine rats were divided randomly into sham, control, and NBP groups. Rats in control and NBP groups underwent cardiopulmonary resuscitation (CPR) 6 min after asphyxia. NBP or vehicle (saline) was administered intravenously 10 min after the return of spontaneous circulation (ROSC). Ultrastructure of hippocampal neurons was observed under transmission electron microscope. NBP treatment improved neurological function up to 72 h after CA. The ultrastructural lesion in mitochondria recovered in the NBP-treated CA model. In conclusion, our study demonstrated multiple therapeutic benefits of NBP after CA.	[Yang, Song; Yu, Changxiao; Cui, Hao; Wu, Yang; Liang, Zhen; Liu, Ying; Shi, Xian; Shao, Fei; Tang, Ziren] Capital Med Univ, Beijing Chaoyang Hosp, Dept Emergency Med, Beijing, Peoples R China; [Yang, Zhengfei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Emergency Med, Guangzhou, Peoples R China; [Yang, Song; Shi, Xian] Beijing Huairou Hosp, Dept Emergency Med, Beijing, Peoples R China; [Zhao, Shen] Fujian Med Univ, Fujian Inst Emergency Med, Fujian Prov Hosp, Dept Emergency Med, Fuzhou, Peoples R China; [Tang, Ziren] Beijing Chaoyang Hosp, Beijing Key Lab Cardiopulm Cerebral Resuscitat, Beijing, Peoples R China		Zhao, S (corresponding author), Fujian Prov Hosp, Dept Emergency Med, 134 Dongjie Rd, Fuzhou 350001, Peoples R China.; Tang, ZR (corresponding author), Beijing Chaoyang Hosp, Dept Emergency Med, 8 Workers Stadium South Rd, Beijing 100020, Peoples R China.	jzkzhaoshen@163.com; tangziren1970@163.com					Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Arora K, 2015, J BIOL CHEM, V290, P21409, DOI 10.1074/jbc.M114.634162; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Chen JM, 2019, J INTEGR NEUROSCI, V18, P277, DOI 10.31083/j.jin.2019.03.174; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Cho H, 2016, NEUROLOGY, V87, P375, DOI 10.1212/WNL.0000000000002892; Gao M, 2019, NEUROL RES, V41, P1024, DOI 10.1080/01616412.2019.1672387; Gutierrez Salomon Hernandez, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P153, DOI 10.2174/187152908784533702; He WF, 2011, NEURAL REGEN RES, V6, P2773, DOI 10.3969/j.issn.1673-5374.2011.35.009; Horstmann A, 2010, NEUROLOGY, V74, P306, DOI 10.1212/WNL.0b013e3181cbcd6f; Jiang WB, 2017, MOL BIOSYST, V13, P1863, DOI 10.1039/c7mb00246g; Kaltschmidt C, 2019, CANCERS, V11, DOI 10.3390/cancers11050655; Li J, 2018, CLIN EXP PHARMACOL P, V45, P525, DOI 10.1111/1440-1681.12918; Liao W, 2019, EUR REV MED PHARMACO, V23, P144, DOI 10.26355/eurrev_201908_18641; Liu Yumei, 2017, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V29, P1122, DOI 10.3760/cma.j.issn.2095-4352.2017.12.014; Moulaert VRM, 2017, NEUROREHAB NEURAL RE, V31, P530, DOI 10.1177/1545968317697032; Niu XL, 2019, J CELL PHYSIOL, V234, P12604, DOI 10.1002/jcp.27332; Pirscoveanu DFV, 2017, ROM J MORPHOL EMBRYO, V58, P1141; Qi YY, 2019, EUR REV MED PHARMACO, V23, P4474, DOI 10.26355/eurrev_201905_17959; Qin C, 2019, J CEREBR BLOOD F MET, V39, P2011, DOI 10.1177/0271678X18776833; Thomas SN, 2012, ACTA NEUROPATHOL, V123, P105, DOI 10.1007/s00401-011-0893-0; Wang CY, 2016, NEUROBIOL AGING, V38, P32, DOI 10.1016/j.neurobiolaging.2015.10.024; Wang HM, 2013, CELL PHYSIOL BIOCHEM, V32, P235, DOI 10.1159/000350139; Wang L, 2019, J TOXICOL SCI, V44, P523, DOI 10.2131/jts.44.523; Wang P, 2018, TRANSL RES, V194, P68, DOI 10.1016/j.trsl.2018.01.002; Wang S, 2018, CNS NEUROL DISORD-DR, V17, P338, DOI 10.2174/1871527317666180612125843; Wei X, 2015, CELL PHYSIOL BIOCHEM, V36, P1527, DOI 10.1159/000430316; Xiong NA, 2012, NEUROBIOL AGING, V33, P1777, DOI 10.1016/j.neurobiolaging.2011.03.007; Yang J, 2018, ADV EXP MED BIOL, V1087, P309, DOI 10.1007/978-981-13-1426-1_25; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805; Zhang Le, 2016, Adv Exp Med Biol, V923, P31, DOI 10.1007/978-3-319-38810-6_4; Zhang Y, 2006, J PHARMACOL EXP THER, V317, P973, DOI 10.1124/jpet.105.098517; Zhao YY, 2017, NEUROCHEM INT, V111, P82, DOI 10.1016/j.neuint.2017.03.017; Zhu W, 2018, NEUROSCIENCE, V379, P281, DOI 10.1016/j.neuroscience.2018.03.029	34	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	NOV	2021	236	11					7464	7472		10.1002/jcp.30442		JUN 2021	9	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	WJ4WV	WOS:000656617000001	34061993				2022-02-06	
J	Yokobori, S; Saito, K; Sasaki, K; Kanaya, T; Fujiki, Y; Yamaguchi, M; Satoh, S; Watanabe, A; Igarashi, Y; Suzuki, G; Kaneko, J; Nakae, R; Onda, H; Ishinokami, S; Takayama, Y; Naoe, Y; Sato, H; Unemoto, K; Fuse, A; Yokota, H				Yokobori, Shoji; Saito, Ken; Sasaki, Kazuma; Kanaya, Takahiro; Fujiki, Yu; Yamaguchi, Masahiro; Satoh, Shin; Watanabe, Akihiro; Igarashi, Yutaka; Suzuki, Go; Kaneko, Junya; Nakae, Ryuta; Onda, Hidetaka; Ishinokami, Saori; Takayama, Yasuhiro; Naoe, Yasutaka; Sato, Hidetaka; Unemoto, Kyoko; Fuse, Akira; Yokota, Hiroyuki			Treatment of Geriatric Traumatic Brain Injury: A Nationwide Cohort Study	JOURNAL OF NIPPON MEDICAL SCHOOL			English	Article						traumatic brain injury; Glasgow Outcome Scale; intraventricular hemorrhage; intracranial pressure	ELDERLY-PATIENTS; OLDER-ADULTS; GUIDELINES; MANAGEMENT; OUTCOMES	Background: Because of the aging of the Japanese population, traumatic brain injuries (TBI) have increased in elderly adults. However, the effectiveness and prognosis of intensive treatment for geriatric TBI have not yet been determined. Thus, we used nationwide data from the Japan Neurotrauma Data Bank (JNTDB) projects to analyze prognostic factors for intensive and aggressive treatments. Methods: We analyzed 1,879 geriatric TBI cases (age >= 6.5 years) registered in four JNTDB projects: Project 1998 (P1998) to Project 2015 (P2015). Clinical features, use of aggressive treatment, and 6-month outcomes on the Glasgow Outcome Scale (GOS) were compared among study projects. Logistic regression was used to identify prognostic factors in aggressively treated patients. Results: The percentage of geriatric TBI cases significantly increased with time-P1998: 30.1%; Project 2004 (P2004): 34.6%; Project 2009 (P2009): 43.9%; P2015: 53.6%, p<0.0001). Use of aggressive treatment also significantly increased, from 67.0% in P1998 to 69.3% in P2015 (p<0.0001). Less invasive methods, such as trepanation and normothermic targeted temperature management, were more often chosen for geriatric patients. These efforts resulted in a significant decrease in the 6-month mortality rate, from 76.2% in P1998 to 63.1% in P2015 (p=0.0003), although the percentage of severely disabled patients increased, from 8.9% in P1998 to 11.1% in P2015 (p=0.0003). Intraventricular hemorrhage was the factor most strongly associated with unfavorable 6-month outcomes (OR 3.79, 95% CI 1.78-8.06, p<0.0001). Conclusions: Less invasive treatments reduced mortality in geriatric TBI but did not improve functional outcomes. Patient age was not the strongest prognostic factor; thus, physicians should consider characteristics other than age.	[Yokobori, Shoji; Saito, Ken; Sasaki, Kazuma; Kanaya, Takahiro; Fujiki, Yu; Yamaguchi, Masahiro; Satoh, Shin; Watanabe, Akihiro; Igarashi, Yutaka; Suzuki, Go; Kaneko, Junya; Nakae, Ryuta; Onda, Hidetaka; Ishinokami, Saori; Takayama, Yasuhiro; Naoe, Yasutaka; Sato, Hidetaka; Unemoto, Kyoko; Fuse, Akira; Yokota, Hiroyuki] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan		Yokobori, S (corresponding author), Nippon Med Sch, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	shoji@nms.ac.jp					Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Maurice-Williams RS, 1975, J NEUROL NEUROSUR PS, V38; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; The Japaese society of neurotraumatology, 2019, TOB CHIR KANR NO GAI TOB CHIR KANR NO GAI, P47; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Yokobori S, 2016, WORLD NEUROSURG, V86, P127, DOI 10.1016/j.wneu.2015.09.105; Yokobori S, 2011, NEUROL MED-CHIR, V51, P265, DOI 10.2176/nmc.51.265; Yokota H, 2007, NEUROL MED-CHIR, V47, P383, DOI 10.2176/nmc.47.383	17	1	1	0	0	MEDICAL ASSOC NIPPON MEDICAL SCH	TOKYO	1-1-5, SENDAGI, TOKYO, 113-8602, JAPAN	1345-4676	1347-3409		J NIPPON MED SCH	J. Nippon Med. Sch.	JUN	2021	88	3					194	203		10.1272/jnms.JNMS.2021_88-404			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TT7IS	WOS:000680518900006	32612015	gold			2022-02-06	
J	Fraser, EE; Downing, MG; Ponsford, JL				Fraser, Elinor E.; Downing, Marina G.; Ponsford, Jennie L.			Survey on the experiences, attitudes, and training needs of Australian healthcare professionals related to sexuality and service delivery in individuals with acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Brain injuries; Rehabilitation; Sexuality; Neurosexuality; Training	REHABILITATION	Following acquired brain injury (ABI), sexuality, self-esteem and practices are often negatively impacted. Whilst sexuality is recognized as an essential part of a person's life regardless of medical condition, it is poorly understood in the ABI rehabilitation context. This study examined current assessment and treatment practices for sexual health and wellbeing in ABI rehabilitation, including perceived barriers and facilitators to discussing sexuality with individuals after ABI. We also assessed the need for further education and training in this area. Two hundred and thirty-nine Australian healthcare professionals predominantly working with both traumatic brain injury (TBI) and stroke populations completed an online survey comprising thirty-four questions. The 12-item sexuality attitudes and beliefs survey (SABS) was included as an additional objective outcome measure. Findings suggest that healthcare professionals infrequently raise sexuality with individuals with ABI. Inadequate education and training, not knowing whose role it is and when to raise the topic, and the view that individuals with ABI will ask for the information were all identified as key barriers contributing to poor sexuality management after ABI. More education and training opportunities with greater access to resources are needed to facilitate the incorporation of sexuality into routine practice across the continuum of ABI care.	[Fraser, Elinor E.; Downing, Marina G.; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Downing, Marina G.; Ponsford, Jennie L.] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Fraser, EE (corresponding author), Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, 18 Innovat Walk, Clayton, Vic 3800, Australia.	elinor.fraser@monash.edu	; Ponsford, Jennie/H-8341-2014	Downing, Marina/0000-0002-3126-6632; Ponsford, Jennie/0000-0003-0430-125X; Fraser, Elinor/0000-0001-5679-4362	Transport Accident Commission	This research was funded by the Transport Accident Commission.	Aloni R., 2003, SEXUAL DIFFICULTIES; [Anonymous], 2016, ROYAL COLL PHYS UK N; Barrett C., 2011, ELECT J APPL PSYCHOL, V7, P31, DOI [DOI 10.7790/ejap.v7i1.233, DOI 10.7790/EJAP.V7I1.233]; Barrett C., 2014, SEXUALITY STROKE SOX; Better Health Channel, 2018, BRAIN INJ SEX ISS; Bezeau SC, 2004, BRAIN INJURY, V18, P299, DOI 10.1080/02699050310001617398; Brainline, 2008, SEX DYSF FOLL INJ TI; Calabro RS, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1389; Arango-Lasprilla J, 2017, SEX DISABIL, V35, P473, DOI 10.1007/s11195-017-9503-y; Arango-Lasprilla JC, 2017, BRAIN INJURY, V31, P1605, DOI 10.1080/02699052.2017.1332784; Cellek S, 2012, NAT REV UROL, V9, P537, DOI 10.1038/nrurol.2012.134; Chambon X, 2011, SEXOLOGIES, V20, P102, DOI 10.1016/j.sexol.2010.10.005; Connell KM, 2014, BURNS TRAUMA, V2, DOI 10.4103/2321-3868.130189; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Deschenes PM, 2019, SEX DISABIL, V37, P297, DOI 10.1007/s11195-019-09576-5; Dogan S, 2008, INT PSYCHOGERIATR, V20, P1019, DOI 10.1017/S1041610208007229; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Dyer K, 2014, DISABIL REHABIL, V36, P1431, DOI 10.3109/09638288.2013.859747; Eisenberg N.W., 2015, CURR SEX HEALTH REP, V7, P19, DOI [DOI 10.1007/s11930-014-0037-3, https://doi.org/10.1007/s11930-014-0037-3, DOI 10.1007/S11930-014-0037-3]; Forbat L, 2012, BJU INT, V109, P98, DOI 10.1111/j.1464-410X.2011.10257.x; Fraser EE, 2020, ARCH PHYS MED REHAB, V101, P2080, DOI 10.1016/j.apmr.2020.06.028; Fronek P, 2005, SEX DISABIL, V23, P51, DOI 10.1007/s11195-005-4669-0; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Haesler E, 2016, NURS EDUC TODAY, V40, P57, DOI 10.1016/j.nedt.2016.02.012; Headway-The Brain Injury Association, 2017, SEX SEX BRAIN INJ; Kaczmirek L., 2011, EUROPEAN ASS METHODO, P11; Katz S, 1999, INT J REHABIL RES, V22, P45, DOI 10.1097/00004356-199903000-00006; Kimura M, 2001, COMPR PSYCHIAT, V42, P217, DOI 10.1053/comp.2001.23141; Magnan Morris A, 2005, Medsurg Nurs, V14, P282; Marwick C, 1999, JAMA-J AM MED ASSOC, V281, P2173, DOI 10.1001/jama.281.23.2173; Mayring P., 2004, COMPANION QUALITATIV, V1st, P166; McGrath M, 2019, J REHABIL MED, V51, P352, DOI 10.2340/16501977-2548; McLaughlin J, 2005, SEX DISABIL, V23, P213, DOI 10.1007/s11195-005-8929-9; Mellor RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078802; Model Systems Knowledge Translation Center, 2011, SEX TRAUM BRAIN INJ; Moreno A, 2015, NEUROREHABILITATION, V37, P99, DOI 10.3233/NRE-151243; National Stroke Foundation, 2013, SEX REL STROK; Northcott R., 2000, BRIT J OCCUP THER, V63, P412, DOI [https://doi.org/10.1177/030802260006300902, DOI 10.1177/030802260006300902]; Overall C., 2006, NWSA J, P126, DOI [10.1353/nwsa.2006.0016, DOI 10.1353/NWSA.2006.0016]; Post MWM, 2008, SEX DISABIL, V26, P3, DOI 10.1007/s11195-007-9068-2; Prior S, 2019, HEALTHCARE-BASEL, V7, DOI 10.3390/healthcare7010025; Rees PM, 2007, LANCET, V369, P512, DOI 10.1016/S0140-6736(07)60238-4; Reynolds KE, 2005, CLIN NURSE SPEC, V19, P255, DOI 10.1097/00002800-200509000-00009; Richards A, 2016, DISABIL REHABIL, V38, P1471, DOI 10.3109/09638288.2015.1106595; Russell EB, 2012, FAM J, V20, P94, DOI 10.1177/1066480711430196; Sander A.M., 2011, SEXUAL FUNCTIONING S; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sansom J, 2015, INT J THER REHABIL, V22, P21, DOI 10.12968/ijtr.2015.22.1.21; Schmitz MA, 2010, TOP STROKE REHABIL, V17, P204, DOI 10.1310/tsr1703-204; Shears S., 2010, SOC CARE NEURODISABI, V1, P4, DOI [10.5042/scn.2010.0597, DOI 10.5042/SCN.2010.0597]; Simpson G., 1999, YOU ME GUIDE SEX SEX; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; Simpson G, 1999, YOU ME ED PROGRAMME; Simpson G, 2006, CLIN REHABIL, V20, P847, DOI 10.1177/0269215506072180; Spector R., 2004, CULTURAL DIVERSITY H; Stroke Association, 2021, SEX INT REL STROK; Synapse-Australia's Brain Injury Association, EFF BRAIN INJ SEX CH; Vikan JK, 2019, J REHABIL MED, V51, P361, DOI 10.2340/16501977-2552; World Health Organization, 2006, DEF SEX HLTH REP TEC	59	1	1	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1934486		MAY 2021	21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	SJ8LU	WOS:000655780400001	34044727				2022-02-06	
J	Chrisman, SPD; Mendoza, JA; Zhou, C; Palermo, TM; Gogue-Garcia, T; Janz, KF; Rivara, FP				Chrisman, Sara P. D.; Mendoza, Jason A.; Zhou, Chuan; Palermo, Tonya M.; Gogue-Garcia, Tierra; Janz, Kathleen F.; Rivara, Frederick P.			Pilot Study of Telehealth Delivered Rehabilitative Exercise for Youth With Concussion: The Mobile Subthreshold Exercise Program (MSTEP)	FRONTIERS IN PEDIATRICS			English	Article						brain concussion; child; fear-avoidance; pain; exercise; physical activity; traumatic brain injury; sport	QUALITY-OF-LIFE; PATIENT HEALTH QUESTIONNAIRE-9; GENERALIZED ANXIETY DISORDER; CHRONIC MUSCULOSKELETAL PAIN; POSTCONCUSSIVE SYMPTOMS; FEAR-AVOIDANCE; ACTIVE REHABILITATION; CHILDREN; DEPRESSION; ADOLESCENTS	Background: Concussion is common, and up to 30% of youth develop persistent symptoms. Preliminary data suggests treatment with rehabilitative exercise is beneficial, but most programs require frequent in-person visits, which is challenging for youth in rural areas, and has been made more difficult for all youth during the COVID-19 pandemic. We have adapted an exercise intervention to be delivered via telehealth using Zoom and personal fitness devices, which could ensure access to this type of treatment. Objective: The goal of this study was to assess feasibility and acceptability of a telehealth delivered exercise intervention for concussion, the Mobile Subthreshold Exercise Program (MSTEP), and collect pilot data regarding efficacy. Materials and Methods: All youth received the 6-week MSTEP intervention which included wearing a Fitbit and setting exercise heartrate and duration goals weekly over Zoom with the research assistant. Youth completed standardized measures of concussive symptoms (Health Behavior Inventory, HBI), fear-avoidance (Fear of Pain Questionnaire, FOPQ) and health-related quality of life (Pediatric Quality of life Assessment, PedsQL), as well as a structured qualitative exit interview. We examined change in measures over time using mixed effects modeling, controlling for age, sex, prior concussion and duration of symptoms. We coded qualitative interviews using Thematic analysis. Results: We recruited 19 subjects, 79% female with average age 14.3 (SD 2.2) and mean duration of symptoms 75.6 days (SD 33.7). Participants wore the Fitbit on 80% of days, and completed 94% of surveys and 96% of Zoom calls. Concussive symptoms (HBI) decreased significantly over the 6 week intervention (-10.6, 95%CI: -16.0 to -5.1) as did fear-avoidance (-21.6, 95%CI: -29.8 to -13.5). PedsQL improved significantly during the same time period (+15.1, 95%CI: 8.6-21.6). Approximately three-quarters (76%) of youth rated their care as "excellent." Participants appreciated the structure of the guided exercise program and the support of the RA. They also enjoyed being able to track their progress with the Fitbit. Conclusion: This study provides evidence for the feasibility and acceptability of a telehealth delivered rehabilitative exercise intervention for youth with concussion. Further research utilizing a randomized controlled trial is needed to assess efficacy.	[Chrisman, Sara P. D.; Mendoza, Jason A.; Zhou, Chuan; Palermo, Tonya M.; Gogue-Garcia, Tierra; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98101 USA; [Chrisman, Sara P. D.; Mendoza, Jason A.; Zhou, Chuan; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Mendoza, Jason A.] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA; [Palermo, Tonya M.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Janz, Kathleen F.] Univ Iowa, Dept Hlth & Human Physiol, Iowa City, IA USA; [Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA		Chrisman, SPD (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98101 USA.; Chrisman, SPD (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	sara.chrisman@seattlechildrens.org			Satterberg Foundation; Institute for Child Health, Behavior and Development, Seattle Children's Research Institute	The support for this research was provided by the Satterberg Foundation in addition to internal funds from the Institute for Child Health, Behavior and Development, Seattle Children's Research Institute. Neither organization had any involvement in the study design, analysis, or reporting of results.	Allor KM, 2000, PEDIATR EXERC SCI, V12, P284, DOI 10.1123/pes.12.3.284; Asmundson GJG, 2012, PAIN RES MANAG, V17, P397, DOI 10.1155/2012/908061; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bailey Kristen M., 2010, Cognitive Behaviour Therapy, V39, P46, DOI 10.1080/16506070902980711; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Braun V., 2012, ENCY CRITICAL PSYCHO, DOI [10.1037/13620-000, DOI 10.1037/13620-004]; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SPD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00623; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Essner B, 2015, BEHAV SLEEP MED, V13, P296, DOI 10.1080/15402002.2014.896253; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gauvin-Lepage J, 2020, CLIN J SPORT MED, V30, P423, DOI 10.1097/JSM.0000000000000634; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Howell DR, 2019, MED SCI SPORT EXER, V51, P647, DOI 10.1249/MSS.0000000000001829; Hsing JC, 2020, PEDIATR CLIN N AM, V67, P773, DOI 10.1016/j.pcl.2020.04.014; Krist AH, 2020, ANN FAM MED, V18, P349, DOI 10.1370/afm.2557; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Maizels M, 2006, HEADACHE, V46, pS98, DOI 10.1111/j.1526-4610.2006.00561.x; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mendoza JA, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26660; Moran LM, 2011, J HEAD TRAUMA REHAB, V26, P348, DOI 10.1097/HTR.0b013e3181f8d32e; National Institutes of Health, COMMON DATA ELEMENTS; Palermo TM, 2016, PAIN, V157, P174, DOI 10.1097/j.pain.0000000000000348; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; R Core Team, 2021, R LANG ENV STAT COMP; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Russell K, 2019, J NEUROSURG-PEDIATR, V23, P455, DOI 10.3171/2018.8.PEDS18356; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Schoenfelder Erin, 2017, Prev Med Rep, V6, P210, DOI 10.1016/j.pmedr.2017.03.003; Shigekawa E, 2018, HEALTH AFFAIR, V37, P1975, DOI 10.1377/hlthaff.2018.05132; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Simons LE, 2011, J PAIN, V12, P677, DOI 10.1016/j.jpain.2010.12.008; SIMONSMORTON BG, 1988, ANNU REV PUBL HEALTH, V9, P403, DOI 10.1146/annurev.pu.09.050188.002155; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Turk DC, 2010, CURR PAIN HEADACHE R, V14, P88, DOI 10.1007/s11916-010-0094-x; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Wilson AC, 2011, PAIN RES MANAG, V16, P178, DOI 10.1155/2011/296298; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	57	1	1	4	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	MAY 28	2021	9								645814	10.3389/fped.2021.645814			12	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	SQ0OI	WOS:000660060300001	34123963	gold, Green Published			2022-02-06	
J	Hou, YX; Xu, LX; Song, SR; Fan, WJ; Wu, QL; Tong, XG; Yan, H				Hou, Yongxin; Xu, Lixia; Song, Sirong; Fan, Weijia; Wu, Qiaoli; Tong, Xiaoguang; Yan, Hua			Oral Administration of Brain Protein Combined With Probiotics Induces Immune Tolerance Through the Tryptophan Pathway	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						TBI; immune tolerance; probiotics; tryptophan; IDO; 5-HT	ARYL-HYDROCARBON RECEPTOR; INTESTINAL PERMEABILITY; GUT MICROBIOTA; INJURY; INFLAMMATION; BARRIER; BACTERIA; AXIS	Excessive inflammation leads to secondary immune damage after traumatic brain injury (TBI). The intestinal mucosa is a key component of immune tolerance due to gut-brain axis regulation, but the curative effect is not optimal. Intestinal dysfunction impairs the establishment of immune tolerance in patients with TBI. Therefore, we orally administered brain protein (BP) combined with probiotics to induce immune tolerance and explored the mechanism by which the homeostasis of the microbiota contributes to the enhancement of curative effects by BPs. Herein, we demonstrated that patients with TBI and surgical brain injury (SBI) models of rats had obvious dysbiosis. Notably, the intestinal barrier, proinflammatory cytokines, and activation of microglia demonstrated that excessive inflammatory damage was better controlled in the combined group (oral administration of BP combined with probiotics) than in the BP group (oral administration of BP). Fundamentally, tandem mass tag (TMT)-based quantitative proteomics analysis revealed that BP and probiotics preferentially affect Try-related pathways. A series of experiments further confirmed that Indoleamine 2,3 dioxygenase (IDO)/Kynurenine (Kyn)/Aryl hydrocarbon receptor (AhR) expression was high in the BP group, while Tryptophan hydroxylase 1(TpH1)/5-hydroxytryptamine (5-HT) only changed in the combined group. This study suggests that probiotics can enhance the efficacy of oral BP-induced immune tolerance through the Try pathway.	[Hou, Yongxin] Nankai Univ, Sch Med, Tianjin, Peoples R China; [Xu, Lixia; Fan, Weijia; Wu, Qiaoli; Tong, Xiaoguang; Yan, Hua] Tianjin Huanhu Hosp, Tianjin Neurosurg Inst, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China; [Song, Sirong] Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China; [Tong, Xiaoguang; Yan, Hua] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin, Peoples R China		Tong, XG; Yan, H (corresponding author), Tianjin Huanhu Hosp, Tianjin Neurosurg Inst, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China.; Tong, XG; Yan, H (corresponding author), Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin, Peoples R China.	yanhua20042007@sina.com; tongxg@yahoo.com			Tianjin Municipal Science and Technology Commission [18JCZDJC35600]; Tianjin Huanhu Hospital [HHYYKY202004]; Tianjin Health and Science Technology Project [KJ20045]	This study was financially supported by a grant from the Tianjin Municipal Science and Technology Commission (No. 18JCZDJC35600), Tianjin Huanhu Hospital (No. HHYYKY202004), and Tianjin Health and Science Technology Project (No. KJ20045).	Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Alexeev EE, 2018, AM J PATHOL, V188, P1183, DOI 10.1016/j.ajpath.2018.01.011; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Caricilli Andrea Moro, 2014, World J Gastrointest Pathophysiol, V5, P18, DOI 10.4291/wjgp.v5.i1.18; Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794; Chen X, 2017, CELL PHYSIOL BIOCHEM, V42, P1713, DOI 10.1159/000479439; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; de Punder K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00223; Dickson RP, 2016, LANCET RESP MED, V4, P59, DOI 10.1016/S2213-2600(15)00427-0; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fan Xuejiao, 2014, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V28, P377; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Guillemin GJ, 2005, NEUROPATH APPL NEURO, V31, P395, DOI 10.1111/j.1365-2990.2005.00655.x; Hormann N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113080; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Hubbard TD, 2015, DRUG METAB DISPOS, V43, P1522, DOI 10.1124/dmd.115.064246; Hubbard TD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12689; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; Kelly JR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00392; Kennedy PJ, 2017, NEUROPHARMACOLOGY, V112, P399, DOI 10.1016/j.neuropharm.2016.07.002; Kharrazian D, 2015, ALTERN THER HEALTH M, V21, P28; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lamprecht M, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-45; Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Palin K, 2008, NEUROBIOL DIS, V30, P19, DOI 10.1016/j.nbd.2007.11.012; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Tian Z, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00743; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142561; Wang Q, 2001, AM J PHYSIOL-REG I, V281, pR1013, DOI 10.1152/ajpregu.2001.281.3.R1013; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yu XY, 2011, NUTRITION, V27, P100, DOI 10.1016/j.nut.2010.01.010; Yue JK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080093; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	47	1	1	8	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	MAY 28	2021	14								634631	10.3389/fnmol.2021.634631			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SP8KX	WOS:000659913100001	34122006	gold, Green Published			2022-02-06	
J	Kanser, RJ; Rapport, LJ; Hanks, RA; Patrick, SD				Kanser, Robert J.; Rapport, Lisa J.; Hanks, Robin A.; Patrick, Sarah D.			Utility of WAIS-IV Digit Span indices as measures of performance validity in moderate to severe traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						Traumatic brain injury; Digit Span; performance validity; malingering	MALINGERED NEUROCOGNITIVE DYSFUNCTION; INDICATORS; TESTS	Objective: The addition of Sequencing to WAIS-IV Digit Span (DS) brought about new Reliable Digit Span (RDS) indices and an Age-Corrected Scaled Score that includes Sequencing trials. Reports have indicated that these new performance validity tests (PVTs) are superior to the traditional RDS; however, comparisons in the context of known neurocognitive impairment are sparse. This study compared DS-derived PVT classification accuracies in a design that included adults with verified TBI. Methods: Participants included 64 adults with moderate-to-severe TBI (TBI), 51 healthy adults coached to simulate TBI (SIM), and 78 healthy comparisons (HC). Participants completed the WAIS-IV DS subtest in the context of a larger test battery. Results: Kruskal-Wallis tests indicated that all DS indices differed significantly across groups. Post hoc contrasts revealed that only RDS Forward and the traditional RDS differed significantly between SIM and TBI. ROC analyses indicated that RDS variables were comparable predictors of SIM vs. HC; however, the traditional RDS showed the highest sensitivity when approximating 90% specificity for SIM vs. TBI. A greater percentage of TBI scored RDS Sequencing < 1 compared to SIM and HC. Conclusion: In the context of moderate-to-severe TBI, the DS-derived PVTs showed comparable discriminability. However, the Greiffenstein et al. traditional RDS demonstrated the best classification accuracy with respect to specificity/sensitivity balance. This relative superiority may reflect that individuals with verified TBI are more likely to perseverate on prior instructions during DS Sequencing. Findings highlight the importance of including individuals with verified TBI when evaluating and developing PVTs.	[Kanser, Robert J.; Rapport, Lisa J.; Patrick, Sarah D.] Wayne State Univ, Dept Psychol, 5057 Woodward Ave, Detroit, MI 48202 USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave, Detroit, MI 48202 USA.	rapport@wayne.edu		Kanser, Robert/0000-0001-8229-1857; Hanks, Robin/0000-0002-3432-4789; Rapport, Lisa/0000-0001-8014-9523	National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90IFOO92, 90DPTB0006]; Wayne State University Graduate School Thesis and Dissertation grants	This research was supported by grants from the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR; L.J.R., 90IFOO92; R.A.H., 90DPTB0006) and Wayne State University Graduate School Thesis and Dissertation grants (R.J.K., Bashem).	An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bender SD, 2004, ARCH CLIN NEUROPSYCH, V19, P49, DOI 10.1016/S0887-6177(02)00165-8; Bodner T, 2019, J CLIN EXP NEUROPSYC, V41, P476, DOI 10.1080/13803395.2019.1579783; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush, 2012, MILD TRAUMATIC BRAIN, P57; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hosmer DW., 2000, APPL LOGISTIC REGRES; Hurtubise J, 2020, APPL NEUROPSYCH-CHIL, V9, P337, DOI 10.1080/21622965.2020.1719409; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kanser RJ, 2020, NEUROPSYCHOLOGY, V34, P308, DOI 10.1037/neu0000613; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; NCS Pearson Inc, 2009, ADV CLIN SOLUTIONS W; Neudecker JJ, 2009, ARCH CLIN NEUROPSYCH, V24, P59, DOI 10.1093/arclin/acp008; Ovsiew GP, 2020, J CLIN EXP NEUROPSYC, V42, P473, DOI 10.1080/13803395.2020.1758635; Patrick SD, 2021, CLIN NEUROPSYCHOL, V35, P1154, DOI 10.1080/13854046.2020.1716997; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Rosenthal R., 1994, HDB RES SYNTHESIS, P231, DOI DOI 10.7758/9781610441377.20; Ruchinskas R, 2019, CLIN NEUROPSYCHOL, V33, P1436, DOI 10.1080/13854046.2019.1585574; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Suchy Y, 2019, CLIN NEUROPSYCHOL, V33, P1349, DOI 10.1080/13854046.2019.1672334; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Svingos AM, 2019, J CLIN EXP NEUROPSYC, V41, P775, DOI 10.1080/13803395.2019.1620695; Tabachnick BG., 2007, USING MULTIVARIATE S, V5, P481; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; TOMBAUGH TN, 1997, CLIN NEUROPSYCHOL, V9, P260, DOI DOI 10.1037/1040-3590.9.3.260; WEBBER TA, 2018, PSYCHOL ASSESSMENT, V32, P657, DOI DOI 10.1080/13854046.2017.1415374; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D, 1981, WECHSLER ADULT INTEL; WODUSHEK TR, 2017, CLIN NEUROPSYCHOL, V23, P214, DOI DOI 10.1097/PRA.0000000000000233; YOUNG JC, 2012, J PSYCHIATR PRACT, V26, P147, DOI DOI 10.1080/13854046.2011.647083	47	1	1	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2021.1921277		MAY 2021	14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	SJ8MZ	WOS:000655783500001	34044725				2022-02-06	
J	Huovinen, A; Marinkovic, I; Isokuortti, H; Korvenoja, A; Maki, K; Nybo, T; Raj, R; Melkas, S				Huovinen, Antti; Marinkovic, Ivan; Isokuortti, Harri; Korvenoja, Antti; Maki, Kaisa; Nybo, Taina; Raj, Rahul; Melkas, Susanna			Traumatic Microbleeds in Mild Traumatic Brain Injury Are Not Associated with Delayed Return to Work or Persisting Post-Concussion Symptoms	JOURNAL OF NEUROTRAUMA			English	Article						functional recovery; mild traumatic brain injury; post-concussion symptoms; return to work; traumatic microbleeds	DIFFUSE AXONAL INJURY; COMMON DATA ELEMENTS; HEAD-INJURY; IMPACT	The main objective of this prospective cohort study was to evaluate whether traumatic microbleeds (TMBs) are a significant prognostic factor of return to work (RTW), post-traumatic symptoms, and overall recovery in patients with mild traumatic brain injury (mTBI). One hundred and thirteen patients with mTBI were recruited from the Helsinki University Hospital emergency units. All patients underwent multi-contrast 3T magnetic resonance imaging (MRI) 3-17 days after mTBI. Patients were evaluated in the Traumatic Brain Injury Outpatient Clinic of Helsinki University Hospital 1 month after injury. Post-concussion symptoms were assessed with the Post-Concussion Symptom Questionnaire (RPQ) and overall recovery was assessed with the Glasgow Outcome Scale Extended (GOS-E). Their time to RTW was continuously measured up to 1 year after TBI. Median RTW was 9 days (interquartile range [IQR] 4-30) after mTBI and full RTW rate after 1 year was 98%. Patients with TMBs (n = 22) did not have more post-concussion symptoms (median RPQ 10.0 vs. 7.0, p = 0.217) or worse overall recovery (58% vs. 56% with GOS-E = 8, p = 0.853) than patients without TMBs (n = 91). There was no significant difference in time to RTW (13.5 vs. 7.0 days, p = 0.063). In this study, patients with TMBs did not have delayed RTW or more post-concussion symptoms than other patients with mTBI. TMBs in mTBI do not seem to be a significant prognostic factor of RTW.	[Huovinen, Antti; Marinkovic, Ivan; Isokuortti, Harri; Melkas, Susanna] Univ Helsinki, Dept Neurol, Helsinki, Finland; [Korvenoja, Antti] Univ Helsinki, HUS Med Imaging Ctr, Radiol Radiol, Helsinki, Finland; [Maki, Kaisa; Nybo, Taina] Univ Helsinki, Dept Neuropsychol, Helsinki, Finland; [Raj, Rahul] Univ Helsinki, Dept Neurosurg, Helsinki, Finland; [Raj, Rahul] Helsinki Univ Hosp, Helsinki, Finland		Huovinen, A (corresponding author), Univ Helsinki, Neurol, Traumat Brain Injury Outpatient Clin, Paciuksenkatu 21,POB 302, Helsinki 00029, Finland.; Huovinen, A (corresponding author), Helsinki Univ Hosp, Paciuksenkatu 21,POB 302, Helsinki 00029, Finland.	antti.huovinen@helsinki.fi	Korvenoja, Antti/C-2292-2009; Huovinen, Antti/F-8786-2015; Raj, Rahul/K-7693-2012	Korvenoja, Antti/0000-0003-4348-0449; Huovinen, Antti/0000-0001-9964-8218; Raj, Rahul/0000-0003-4243-9591; Maki, Kaisa/0000-0002-6439-1560; Marinkovic, Ivan/0000-0002-0950-8623	Dorothea, Jarl Walter and Karl Walter Perklen's foundation; Paivikki and Sakari Sohlberg's foundation; Maire Taponen foundation; Helsinki University Hospital (HUS) Neurocenter	This study was supported by grants from Dorothea, Jarl Walter and Karl Walter Perkle ' n's foundation, Paivikki and Sakari Sohlberg's foundation, the Maire Taponen foundation, and the Helsinki University Hospital (HUS) Neurocenter. This manuscript was written as part of Mr. Huovinen's doctoral thesis.	Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Bigler ED, 2015, BRAIN NEUROTRAUMA MO, P1; Bloom B, 2018, BRAIN INJURY, V32, P1623, DOI 10.1080/02699052.2018.1532111; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Chien DK, 2017, ACCIDENT ANAL PREV, V98, P101, DOI 10.1016/j.aap.2016.09.025; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Moe H.K., 2019, J NEUROSURG; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Studerus-Germann AM, 2016, INT J NEUROSCI, V126, P289, DOI 10.3109/00207454.2015.1033620; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; van Eijck M, 2018, J NEUROTRAUM, V35, P2357, DOI 10.1089/neu.2018.5650; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193	30	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2021	38	17					2400	2406		10.1089/neu.2021.0055		MAY 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UK1GM	WOS:000655202500001	33847170				2022-02-06	
J	Iverson, GL; Howell, DR; Van Patten, R; Bloomfield, P; Gardner, AJ				Iverson, Grant L.; Howell, David R.; Van Patten, Ryan; Bloomfield, Paul; Gardner, Andrew J.			Sport Concussion Assessment Tool-5th Edition (SCAT5): Normative Reference Values for the National Rugby League Women's Premiership	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						rugby league; brain concussion; head injuries; baseline survey; clinical assessment; women athletes	ASSESSMENT TOOL-3RD EDITION; BASE-LINE VALUES; MANAGEMENT; INJURY	Objective: To establish normative reference values for the Sport Concussion Assessment Tool-5th Edition (SCAT5) for the new National Rugby League Women's Premiership. Methods: Preseason SCAT5 baseline testing was administered individually to all National Rugby League Women's Premiership players (N = 117). Testing was completed by the medical staff. Normative reference values were calculated for the components of the SCAT5, including the Standardized Assessment of Concussion, modified Balance Error Scoring System, and the Symptom Scale. A small case series of players who sustained concussions were included to illustrate the use of the new normative data. Results: The median Standardized Assessment of Concussion total score was 27.0 (M = 26.9, SD = 2.1). The median modified Balance Error Scoring System score was 2.0 (M = 2.4, SD = 2.2). The median number of symptoms score was 1.0 (M = 3.2, SD = 4.7) and the median symptom severity score was 2.0 (M = 5.4, SD = 8.2). The most common baseline symptom was fatigue or low energy (33%), followed by trouble sleeping (24%), headache (23%), neck pain (22%), and difficulty remembering (21%). In the total sample, 41% reported no symptoms. The clinical interpretation of these new normative data to a case series of women with concussions is provided. Conclusions: Normative reference values are provided for the SCAT5 for women who are professional rugby league players. Using these normative data will improve clinical interpretation of SCAT5 scores following a concussion.	[Iverson, Grant L.; Van Patten, Ryan] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Van Patten, Ryan] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.; Van Patten, Ryan] MassGeneral Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Bloomfield, Paul] Natl Rugby League, Moore Pk, NSW, Australia; [Gardner, Andrew J.] Hunter New England Local Hlth Dist Sports Concuss, Newcastle, NSW, Australia; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Calvary Mater Hosp, Ctr Stroke & Brain Injury, Waratah, NSW, Australia		Gardner, AJ (corresponding author), Hunter New England Local Hlth Dist Sports Concuss, Newcastle, NSW, Australia.; Gardner, AJ (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Calvary Mater Hosp, Ctr Stroke & Brain Injury, Waratah, NSW, Australia.	andrew.gardner@newcastle.edu.au			National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; Priority Research Center for Stroke and Brain Injury; Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03HD094560, R01NS100952, R43NS108823]; MINDSOURCE Brain Injury Network; Tai Foundation	AG and GI acknowledge unrestricted philanthropic support from the National Rugby League. GI acknowledges unrestricted philanthropic support from ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, Boston Bolts, Heinz Family Foundation, and the Spaulding Research Institute. AG was supported by the National Health and Medical Research Council (NHMRC) early career fellowship and the Priority Research Center for Stroke and Brain Injury. DH acknowledges research support fromthe Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560), the National Institute of Neurological Disorders And Stroke (R01NS100952, R03HD094560, and R43NS108823), the MINDSOURCE Brain Injury Network, and the Tai Foundation. The entities above, with the exception of the National Rugby League, were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication.	Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Yong JPCP, 2020, CLIN J SPORT MED, V30, P353, DOI 10.1097/JSM.0000000000000605; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuller GW, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-019-0231-y; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Fuller GW, 2020, CLIN J SPORT MED, V30, pE150, DOI 10.1097/JSM.0000000000000713; Gabbett TJ, 2005, J SPORT SCI, V23, P961, DOI 10.1080/02640410400023381; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; King D, 2010, INT J PERF ANAL SPOR, V10, P241, DOI 10.1080/24748668.2010.11868519; Lee JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727261; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; O'Connor KL, 2018, MIL MED, V183, pE580, DOI 10.1093/milmed/usx130; Petit Kyle M, 2020, Int J Exerc Sci, V13, P1143; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Tucker R, 2021, J SCI MED SPORT, V24, P122, DOI 10.1016/j.jsams.2020.07.006; Tucker R, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-020-00265-8; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th, DOI [10.1037/t15169-000, DOI 10.1037/T15169-000]; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	32	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	MAY 26	2021	3								653743	10.3389/fspor.2021.653743			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	WF2KP	WOS:000706140100001	34124655	gold, Green Published			2022-02-06	
J	Uluk, D; Lindner, T; Dahne, M; Bickelmayer, JW; Beyer, K; Slagman, A; Jahn, F; Willy, C; Mockel, M; Gerlach, UA				Uluk, Deniz; Lindner, Tobias; Dahne, Michael; Bickelmayer, Jens Werner; Beyer, Kassandra; Slagman, Anna; Jahn, Friedrich; Willy, Christian; Mockel, Martin; Gerlach, Undine A.			E-scooter incidents in Berlin: an evaluation of risk factors and injury patterns	EMERGENCY MEDICINE JOURNAL			English	Article; Early Access						trauma; accidental; emergency department; musculoskeletal	ACCIDENTS	Background E-scooters have emerged as a frequently used vehicle in German cities due to their high availability and easy access. However, investigations about the causes and mechanisms of E-scooter incidents and their trauma-specific consequences are rare. Methods We analysed all patients involved in E-scooter incidents from June to December 2019 who presented to four inner-city EDs in Berlin. The prospective data included patient-related and incident-related data, information on injury patterns and therapy, responses in a voluntary questionnaire concerning E-scooter use and general traffic experience. Results 248 patients (129 males; median age 29 years (5-81)) were included: 41% were tourists and 4% were children. Most incidents (71%) occurred between July and September 2019, the majority occurring at weekends (58%). The injury pattern was mostly multifocal, affecting the lower (42%) and upper limbs (37%) and the head (40%). Traumatic brain injury was associated with alcohol consumption. Inpatient admission was recorded in 25%, surgery in 23%. Conclusion This study has defined the incidence of injury related to E-scooter use in a major European city. Stricter laws governing the use of E-scooters, the wearing of helmets and technical modifications to the E-scooter platforms might decrease E-scooter-associated incidents and resulting injuries in the future.	[Uluk, Deniz; Lindner, Tobias; Slagman, Anna; Mockel, Martin; Gerlach, Undine A.] Charite Univ Med Berlin, Dept Emergency Med, Berlin, Germany; [Uluk, Deniz; Beyer, Kassandra] Charite Univ Med Berlin, Dept Surg, Berlin, Germany; [Dahne, Michael] Charite, Trauma & Reconstruct Surg, Berlin, Germany; [Bickelmayer, Jens Werner] Bundeswehr Hosp Berlin, Dept Anesthesia Intens Care Pain Therapy & Emerge, Berlin, Germany; [Jahn, Friedrich] Evangelical Elisabeth Clin Berlin Mitte, Orthopaed & Trauma Surg, Berlin, Germany; [Willy, Christian] Bundeswehr Hosp Berlin, Orthopaed & Trauma Surg, Berlin, Germany		Uluk, D (corresponding author), Charite Univ Med Berlin, Dept Surg, Campus Mitte, Charitepl, D-110115 Berlin, Germany.	deniz.uluk@charite.de		Uluk, Deniz/0000-0001-6395-0845; Mockel, Martin/0000-0002-7691-3709			Beck S, 2020, EMERG MED AUSTRALAS, V32, P409, DOI 10.1111/1742-6723.13419; Bekhit MNZ, 2020, INJURY, V51, P271, DOI 10.1016/j.injury.2019.10.026; Blomberg Stig Nikolaj Fasmer, 2019, BMJ Open, V9, pe033988, DOI 10.1136/bmjopen-2019-033988; Campbell A, 2019, NEW ZEAL MED J, V132, P57; Clewlow R., 2018, MICRO MOBILITY REVOL; Commission E, 2018, COMMISSION E DIRECTO; Ishmael CR, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.19.00390; Juhra C, 2012, INJURY, V43, P2026, DOI 10.1016/j.injury.2011.10.016; Mayhew LJ, 2019, J MED IMAG RADIAT ON, V63, P461, DOI 10.1111/1754-9485.12889; Mitchell G, 2019, EMERG MED AUSTRALAS, V31, P930, DOI 10.1111/1742-6723.13356; Moftakhar T, 2021, ARCH ORTHOP TRAUM SU, V141, P1207, DOI 10.1007/s00402-020-03589-y; Namiri NK, 2020, JAMA SURG, V155, P357, DOI 10.1001/jamasurg.2019.5423; Oksanen E, 2020, J ORAL MAXIL SURG, V78, P2273, DOI 10.1016/j.joms.2020.05.038; Puzio TJ, 2020, TRAFFIC INJ PREV, V21, P175, DOI 10.1080/15389588.2019.1709176; Statistischer Bericht, EINWOHNERINNEN EINWO; Stormann P, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051569; Trivedi B, 2019, J ORAL MAXIL SURG, V77, P2292, DOI 10.1016/j.joms.2019.07.014; Trivedi TK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7381; Uluk D, 2020, NOTFALL RETTUNGSMED, V23, P293, DOI 10.1007/s10049-019-00678-3; Wuster J, 2021, CRANIOMAX TRAUM REC, V14, P43, DOI 10.1177/1943387520940180	20	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.												10.1136/emermed-2020-210268		MAY 2021	6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XL6TO	WOS:000728276600001	34099458				2022-02-06	
J	Lance, EI; Faulcon, LM; Fu, ZM; Yang, J; Whyte-Stewart, D; Strouse, JJ; Barron-Casella, E; Jones, K; Van Eyk, JE; Casella, JF; Everett, AD				Lance, Eboni, I; Faulcon, Lisa M.; Fu, Zongming; Yang, Jun; Whyte-Stewart, Donna; Strouse, John J.; Barron-Casella, Emily; Jones, Kimberly; Van Eyk, Jennifer E.; Casella, James F.; Everett, Allen D.			Proteomic discovery in sickle cell disease: Elevated neurogranin levels in children with sickle cell disease	PROTEOMICS CLINICAL APPLICATIONS			English	Article						neurogranin; sickle cell disease; silent cerebral infarction; stroke	SILENT CEREBRAL INFARCTS; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; L-SELECTIN; PROTEIN; PLASMA; STROKE; SERUM; IDENTIFICATION	Purpose Sickle cell disease (SCD) is an inherited hemoglobinopathy that causes stroke and silent cerebral infarct (SCI). Our aim was to identify markers of brain injury in SCD. Experimental Design Plasma proteomes were analyzed using a sequential separation approach of hemoglobin (Hb) and top abundant plasma protein depletion, followed by reverse phase separation of intact proteins, trypsin digestion, and tandem mass spectrometry. We compared plasma proteomes of children with SCD with and without SCI in the Silent Cerebral Infarct Multi-Center Clinical Trial (SIT Trial) to age-matched, healthy non-SCD controls. Results From the SCD group, 1172 proteins were identified. Twenty-five percent (289/1172) were solely in the SCI group. Twenty-five proteins with enriched expression in the human brain were identified in the SCD group. Neurogranin (NRGN) was the most abundant brain-enriched protein in plasma of children with SCD. Using a NRGN sandwich immunoassay and SIT Trial samples, median NRGN levels were higher at study entry in children with SCD (0.28 ng/mL, N = 100) compared to control participants (0.12 ng/mL, N = 25, p < 0.0004). Conclusions and Clinical Relevance NRGN levels are elevated in children with SCD. NRGN and other brain-enriched plasma proteins identified in plasma of children with SCD may provide biochemical evidence of neurological injury.	[Lance, Eboni, I] Kennedy Krieger Inst, Dept Neurodev Med, 801 North Broadway, Baltimore, MD 21205 USA; [Lance, Eboni, I] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Faulcon, Lisa M.] Food & Drug Adm, Silver Spring, MD USA; [Fu, Zongming; Whyte-Stewart, Donna; Strouse, John J.; Barron-Casella, Emily; Jones, Kimberly; Casella, James F.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD 21205 USA; [Yang, Jun; Everett, Allen D.] Johns Hopkins Univ, Dept Pediat, Div Pediat Cardiol, Sch Med, Baltimore, MD USA; [Strouse, John J.] Duke Univ, Dept Med, Div Hematol, Sch Med, Durham, NC USA; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Dept Internal Med, Div Cardiol, Sch Med, Baltimore, MD USA; [Van Eyk, Jennifer E.] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA		Lance, EI (corresponding author), Kennedy Krieger Inst, Dept Neurodev Med, 801 North Broadway, Baltimore, MD 21205 USA.	lance@kennedykrieger.org	Strouse, John/A-2690-2008	Strouse, John/0000-0003-0341-1457	National Institutes of Health National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL133455, K12-HL087169-07, R34HL108756, U54HL090515, R01HL091759]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01-NS-042804 9]; Johns Hopkins ITCR/CTSA Biomarker Development Center - National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54RR023561]	We gratefully acknowledge the Monoclonal Antibody Core Facility (MACF) at Johns Hopkins University, Department of Neuroscience. This work was supported by grants from the National Institutes of Health National Heart, Lung and Blood Institute [grants K23HL133455 (PI E.I.L.) K12-HL087169-07 (E.I.L. and PI J.F.C.), R34HL108756 (J.F.C.), U54HL090515 (E.B.C., PI J.F.C., subproject PI A.D.E.), R01HL091759 (PIs J.F.C. and A.D.E.)], from the National Institute of Neurological Disorders and Stroke (NINDS) U01-NS-042804 9 (PI DeBaun, J.F.C. Co-investigator and Vice Chair), and the Johns Hopkins ITCR/CTSA Biomarker Development Center funded in part by National Institutes of Health (NIH) grant U54RR023561 (J.V.E.). The current affiliation for LMF is the Food and Drug Administration, Silver Spring, MD. Although the author is a FDA/CTP employee, this work was not done as part his/her official duties. This publication reflects the views of the author and should not be construed to reflect the FDA/CTP's views or policies. The current affiliation for JJS is Division of Hematology, Duke University School of Medicine, Durham, NC. The current affiliation of J.V.E. is Biostatistics and Informatics Core, Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, USA.	Abner EL, 2016, ANN CLIN TRANSL NEUR, V3, P399, DOI 10.1002/acn3.309; Adams RJ, 2005, NEW ENGL J MED, V353, P2769; Adams RJ, 1998, CONTROL CLIN TRIALS, V19, P110, DOI 10.1016/S0197-2456(97)00099-8; Alvarez O, 2006, PEDIATR NEPHROL, V21, P533, DOI 10.1007/s00467-006-0033-6; Antinucci P, 2013, CELL REP, V5, P582, DOI 10.1016/j.celrep.2013.09.045; Armstrong FD, 1996, PEDIATRICS, V97, P864; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Biancone L, 2004, J IMMUNOL, V173, P5268, DOI 10.4049/jimmunol.173.8.5268; Broadbelt K, 2006, SCHIZOPHR RES, V87, P6, DOI 10.1016/j.schres.2006.04.028; Brown AJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01248; Casella JF, 2010, PEDIATR HEMAT ONCOL, V27, P69, DOI 10.3109/08880010903360367; Chau BN, 2000, MOL CELL, V6, P31, DOI 10.1016/S1097-2765(00)00005-8; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; de Arrieta CM, 1999, ENDOCRINOLOGY, V140, P335, DOI 10.1210/en.140.1.335; De Vos A, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0945-8; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; DeBaun MR, 2016, BLOOD, V127, P829, DOI 10.1182/blood-2015-09-618579; DeBaun MR, 2012, BLOOD, V119, P4587, DOI 10.1182/blood-2011-02-272682; Di Domenico F, 2011, J PROTEOMICS, V74, P1091, DOI 10.1016/j.jprot.2011.03.033; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Ermert D, 2016, IMMUNOL LETT, V169, P82, DOI 10.1016/j.imlet.2015.11.014; Faulcon LM, 2013, BRIT J HAEMATOL, V162, P421, DOI 10.1111/bjh.12374; GLAUSER TA, 1995, J CHILD NEUROL, V10, P88, DOI 10.1177/088307389501000203; Gong QZ, 1999, J NEUROTRAUM, V16, P893, DOI 10.1089/neu.1999.16.893; Huang FL, 2006, J NEUROSCI, V26, P6230, DOI 10.1523/JNEUROSCI.1182-06.2006; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Kakhniashvili DG, 2005, EXP BIOL MED, V230, P787, DOI 10.1177/153537020523001102; Kato GJ, 2005, BRIT J HAEMATOL, V130, P943, DOI 10.1111/j.1365-2141.2005.05701.x; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Kawadler JM, 2016, DEV MED CHILD NEUROL, V58, P672, DOI 10.1111/dmcn.13113; Kimura T, 2010, J BIOL CHEM, V285, P38692, DOI 10.1074/jbc.M110.136630; Korolainen MA, 2010, J NEUROCHEM, V112, P1386, DOI 10.1111/j.1471-4159.2009.06558.x; Krug A, 2013, SCHIZOPHRENIA BULL, V39, P141, DOI 10.1093/schbul/sbr076; Lance EI, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28076; Lance EI, 2014, PROTEOM CLIN APPL, V8, P813, DOI 10.1002/prca.201400069; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Martinez-Vargas M, 2006, NEUROSCI LETT, V400, P21, DOI 10.1016/j.neulet.2006.02.010; Michibata H, 2009, STEM CELLS DEV, V18, P629, DOI 10.1089/scd.2008.0215; Miller ST, 2001, J PEDIATR-US, V139, P385, DOI 10.1067/mpd.2001.117580; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Moser FG, 1996, AM J NEURORADIOL, V17, P965; Ning MM, 2011, STROKE, V42, P37, DOI 10.1161/STROKEAHA.110.585703; Odreman F, 2005, J PROTEOME RES, V4, P698, DOI 10.1021/pr0498180; Pak JH, 2000, P NATL ACAD SCI USA, V97, P11232, DOI 10.1073/pnas.210184697; Parker CL, 2002, MOL IMMUNOL, V39, P453, DOI 10.1016/S0161-5890(02)00121-9; Pegelow CH, 2002, BLOOD, V99, P3014, DOI 10.1182/blood.V99.8.3014; Perestenko PV, 2010, FEBS J, V277, P5174, DOI 10.1111/j.1742-4658.2010.07935.x; Prichard L, 1999, J BIOL CHEM, V274, P7689, DOI 10.1074/jbc.274.12.7689; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Savage WJ, 2011, AM J HEMATOL, V86, P427, DOI 10.1002/ajh.21995; Savage WJ, 2011, ACTA HAEMATOL-BASEL, V125, P103, DOI 10.1159/000321791; Schatz J, 2001, NEUROLOGY, V56, P1109, DOI 10.1212/WNL.56.8.1109; Schwartz J., 2014, CRIT CARE MED S, V42, pA1488, DOI [10.1097/01.ccm.0000458030.91776.65, DOI 10.1097/01.CCM.0000458030.91776.65]; Shen YC, 2012, SCHIZOPHR RES, V137, P7, DOI 10.1016/j.schres.2012.01.011; Sheng S, 2011, METHODS MOL BIOL, V728, P29, DOI 10.1007/978-1-61779-068-3_2; Sironi L, 2001, STROKE, V32, P753, DOI 10.1161/01.STR.32.3.753; Smith RL, 2011, AM J MED GENET B, V156B, P532, DOI 10.1002/ajmg.b.31191; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevanovic M, 2003, MOL BIOL REP, V30, P127, DOI 10.1023/A:1023961009869; Tewari S, 2018, HAEMATOLOGICA, V103, P1136, DOI 10.3324/haematol.2018.187815; Thorsell A, 2010, BRAIN RES, V1362, P13, DOI 10.1016/j.brainres.2010.09.073; Tizon B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009819; Tumblin A, 2010, HAEMATOL-HEMATOL J, V95, P1467, DOI 10.3324/haematol.2009.018044; Vendt BA, 2009, J DIGIT IMAGING, V22, P326, DOI 10.1007/s10278-008-9114-3; Voskaridou E, 2006, KIDNEY INT, V69, P2037, DOI 10.1038/sj.ki.5000248; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Ware RE, 2016, LANCET, V387, P661, DOI 10.1016/S0140-6736(15)01041-7; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; WASSIF WS, 1994, CLIN CHIM ACTA, V225, P57, DOI 10.1016/0009-8981(94)90027-2; WATSON JB, 1992, P NATL ACAD SCI USA, V89, P8581, DOI 10.1073/pnas.89.18.8581; Williams LM, 2010, PROTEOM CLIN APPL, V4, P926, DOI 10.1002/prca.201000054; Xiong ZG, 2007, FRONT BIOSCI-LANDMRK, V12, P1376, DOI 10.2741/2154; Yang J, 2015, CLIN BIOCHEM, V48, P843, DOI 10.1016/j.clinbiochem.2015.05.015; Yuditskaya S, 2010, EXPERT REV PROTEOMIC, V7, P833, DOI 10.1586/EPR.10.88; Yuditskaya S, 2009, BLOOD, V113, P1122, DOI 10.1182/blood-2008-03-142604; Zhang RL, 2003, GLIA, V42, P194, DOI 10.1002/glia.10222; Zupanc GKH, 2007, PROTEOM CLIN APPL, V1, P1362, DOI 10.1002/prca.200700420	81	1	1	1	2	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-8346	1862-8354		PROTEOM CLIN APPL	Proteom. Clin. Appl.	SEP	2021	15	5							e2100003	10.1002/prca.202100003		MAY 2021	14	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UQ7PZ	WOS:000653246700001	33915030	hybrid			2022-02-06	
J	Ben-Kraiem, A; Sauer, RS; Norwig, C; Popp, M; Bettenhausen, AL; Atalla, MS; Brack, A; Blum, R; Doppler, K; Rittner, HL				Ben-Kraiem, Adel; Sauer, Reine-Solange; Norwig, Carla; Popp, Maria; Bettenhausen, Anna-Lena; Atalla, Mariam Sobhy; Brack, Alexander; Blum, Robert; Doppler, Kathrin; Rittner, Heike Lydia			Selective blood-nerve barrier leakiness with claudin-1 and vessel-associated macrophage loss in diabetic polyneuropathy	JOURNAL OF MOLECULAR MEDICINE-JMM			English	Article						Neuropathy; Barrier; Pain; Macrophages	DORSAL-ROOT GANGLION; NEUROPATHIC PAIN; TIGHT JUNCTIONS; BRAIN-BARRIER; IMMUNE CELLS; PERMEABILITY; INFLAMMATION; PERINEURIUM; DYSFUNCTION; DISRUPTION	Diabetic polyneuropathy (DPN) is the most common complication in diabetes and can be painful in up to 26% of all diabetic patients. Peripheral nerves are shielded by the blood-nerve barrier (BNB) consisting of the perineurium and endoneurial vessels. So far, there are conflicting results regarding the role and function of the BNB in the pathophysiology of DPN. In this study, we analyzed the spatiotemporal tight junction protein profile, barrier permeability, and vessel-associated macrophages in Wistar rats with streptozotocin-induced DPN. In these rats, mechanical hypersensitivity developed after 2 weeks and loss of motor function after 8 weeks, while the BNB and the blood-DRG barrier were leakier for small, but not for large molecules after 8 weeks only. The blood-spinal cord barrier remained sealed throughout the observation period. No gross changes in tight junction protein or cytokine expression were observed in all barriers to blood. However, expression of Cldn1 mRNA in perineurium was specifically downregulated in conjunction with weaker vessel-associated macrophage shielding of the BNB. Our results underline the role of specific tight junction proteins and BNB breakdown in DPN maintenance and differentiate DPN from traumatic nerve injury. Targeting claudins and sealing the BNB could stabilize pain and prevent further nerve damage. Key messages In diabetic painful neuropathy in rats: Blood nerve barrier and blood DRG barrier are leaky for micromolecules. Perineurial Cldn1 sealing the blood nerve barrier is specifically downregulated. Endoneurial vessel-associated macrophages are also decreased. These changes occur after onset of hyperalgesia thereby maintaining rather than inducing pain.	[Ben-Kraiem, Adel; Sauer, Reine-Solange; Norwig, Carla; Popp, Maria; Bettenhausen, Anna-Lena; Atalla, Mariam Sobhy; Brack, Alexander; Rittner, Heike Lydia] Univ Hosp Wurzburg, Dept Anesthesiol, Ctr Interdisciplinary Pain Med, D-97080 Wurzburg, Germany; [Blum, Robert] Univ Hosp Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany; [Blum, Robert; Doppler, Kathrin] Univ Hosp Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany		Rittner, HL (corresponding author), Univ Hosp Wurzburg, Dept Anesthesiol, Ctr Interdisciplinary Pain Med, D-97080 Wurzburg, Germany.	rittner_h@ukw.de	Blum, Robert/E-8899-2013	Blum, Robert/0000-0002-5270-3854; Rittner, Heike/0000-0003-4867-0188	UniversityHospital of Wurzburg; Graduate School of Life Sciences; Interdisciplinary Center of Clinical Research Wurzburg [N-D-368]; Evangelisches Studienwerk Villigst; German Research FoundationGerman Research Foundation (DFG) [Ri 817/13-1]	This study was supported by funds from the UniversityHospital of Wurzburg, the Graduate School of Life Sciences (C.N. and M.P.), the Interdisciplinary Center of Clinical Research Wurzburg (R.B. and H.L.R.: N-D-368), and the Evangelisches Studienwerk Villigst (A.BK.). R.S. S. was supported by the German Research Foundation (H.L.R.: Ri 817/13-1).	BEAMISH NG, 1991, ACTA NEUROPATHOL, V81, P269, DOI 10.1007/BF00305868; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Calcutt NA, 2003, J CLIN INVEST, V111, P507, DOI 10.1172/JCI200315792; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; Chapouly C, 2016, CARDIOVASC RES, V109, P217, DOI 10.1093/cvr/cvv263; Chen J, 2019, J MOL ENDOCRINOL, V63, P227, DOI 10.1530/JME-19-0067; Conti G, 2002, J NEUROL SCI, V195, P35, DOI 10.1016/S0022-510X(01)00684-0; Deuis JR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00284; Doppler K, 2017, J PERIPHER NERV SYST, V22, P182, DOI 10.1111/jns.12224; Dull MM, 2019, PAIN, V160, P2497, DOI 10.1097/j.pain.0000000000001644; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Fox A, 1999, PAIN, V81, P307, DOI 10.1016/S0304-3959(99)00024-X; Geng JL, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00129; Goncalves NP, 2017, NAT REV NEUROL, V13, P135, DOI 10.1038/nrneurol.2016.201; Hackel D, 2012, ANN NY ACAD SCI, V1257, P199, DOI 10.1111/j.1749-6632.2012.06499.x; Hackel D, 2012, P NATL ACAD SCI USA, V109, pE2018, DOI 10.1073/pnas.1120800109; Hidmark AS, 2017, J NEUROIMMUNOL, V306, P76, DOI 10.1016/j.jneuroim.2017.03.008; Hill RE, 2004, J NEUROL SCI, V217, P157, DOI 10.1016/j.jns.2003.09.011; Karlsson P, 2021, PAIN, V162, P778, DOI 10.1097/j.pain.0000000000002054; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Koizumi T, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01291; Kusano KF, 2004, ARTERIOSCL THROM VAS, V24, P2102, DOI 10.1161/01.ATV.0000144813.44650.75; Lapenna A, 2018, NAT REV IMMUNOL, V18, P689, DOI 10.1038/s41577-018-0056-9; Lim TKY, 2014, PAIN, V155, P954, DOI 10.1016/j.pain.2014.01.026; Lux TJ, 2019, INT J MOL SCI, V21; MacAulay K, 2008, EXPERT OPIN THER TAR, V12, P1265, DOI 10.1517/14728222.12.10.1265 ; Malong L., 2020, MACROPHAGES ENFORCE; Mert T, 2009, N-S ARCH PHARMACOL, V379, P445, DOI 10.1007/s00210-008-0387-3; Mizisin Andrew P, 2014, Handb Clin Neurol, V126, P401, DOI 10.1016/B978-0-444-53480-4.00029-1; Montague-Cardoso K, 2020, BRAIN BEHAV IMMUN, V83, P248, DOI 10.1016/j.bbi.2019.10.018; Moreau N, 2016, PAIN, V157, P827, DOI 10.1097/j.pain.0000000000000444; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Pitre DA, 2001, NEUROSCI LETT, V303, P67, DOI 10.1016/S0304-3940(01)01696-2; PODUSLO JF, 1992, P NATL ACAD SCI USA, V89, P2218, DOI 10.1073/pnas.89.6.2218; Ramirez SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055972; Raputova J, 2017, PAIN, V158, P2340, DOI 10.1097/j.pain.0000000000001034; RECHTHAND E, 1987, J NEUROPATH EXP NEUR, V46, P302, DOI 10.1097/00005072-198705000-00006; Reinhold AK, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113244; Reinhold AK, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00936; Reinhold AK, 2019, BBA-MOL BASIS DIS, V1865, P1160, DOI 10.1016/j.bbadis.2019.01.008; Richner M, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01038; Rom S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64349-x; Sauer RS, 2017, ANN NY ACAD SCI, V1405, P71, DOI 10.1111/nyas.13436; Sauer RS, 2014, J CONTROL RELEASE, V185, P88, DOI 10.1016/j.jconrel.2014.04.029; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Schwarz D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64585-1; Seneviratne K N, 1972, J Neurol Neurosurg Psychiatry, V35, P156, DOI 10.1136/jnnp.35.2.156; Shimizu F, 2011, DIABETOLOGIA, V54, P1517, DOI 10.1007/s00125-011-2107-7; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; Wang DY, 2018, EUR RADIOL, V28, P1234, DOI 10.1007/s00330-017-5043-1; Wang DY, 2015, EUR RADIOL, V25, P463, DOI 10.1007/s00330-014-3423-3; Yang SB, 2016, BIOMATERIALS, V82, P20, DOI 10.1016/j.biomaterials.2015.11.053; Zuvic-Butorac M, 2001, BBA-MOL BASIS DIS, V1537, P110, DOI 10.1016/S0925-4439(01)00063-1; Zwanziger D, 2012, MOL PHARMACEUT, V9, P1785, DOI 10.1021/mp3000937	55	1	1	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0946-2716	1432-1440		J MOL MED	J. Mol. Med.	SEP	2021	99	9					1237	1250		10.1007/s00109-021-02091-1		MAY 2021	14	Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Research & Experimental Medicine	UC6JG	WOS:000652452600001	34018017	hybrid, Green Published			2022-02-06	
J	Buscemi, L; Blochet, C; Magistretti, PJ; Hirt, L				Buscemi, Lara; Blochet, Camille; Magistretti, Pierre J.; Hirt, Lorenz			Hydroxycarboxylic Acid Receptor 1 and Neuroprotection in a Mouse Model of Cerebral Ischemia-Reperfusion	FRONTIERS IN PHYSIOLOGY			English	Article						metabolism; middle cerebral artery occlusion; ischemia; neuroprotection; lactate; hydroxycarboxylic acid receptor 1	ALKYLRESORCINOL METABOLITES; NEUROCHEMICAL PROFILE; AEROBIC GLYCOLYSIS; HUMAN URINE; L-LACTATE; BRAIN; IDENTIFICATION; GPR81; ANESTHETICS; ASTROCYTES	Lactate is an intriguing molecule with emerging physiological roles in the brain. It has beneficial effects in animal models of acute brain injuries and traumatic brain injury or subarachnoid hemorrhage patients. However, the mechanism by which lactate provides protection is unclear. While there is evidence of a metabolic effect of lactate providing energy to deprived neurons, it can also activate the hydroxycarboxylic acid receptor 1 (HCAR1), a Gi-coupled protein receptor that modulates neuronal firing rates. After cerebral hypoxia-ischemia, endogenously produced brain lactate is largely increased, and the exogenous administration of more lactate can decrease lesion size and ameliorate the neurological outcome. To test whether HCAR1 plays a role in lactate-induced neuroprotection, we injected the agonists 3-chloro-5-hydroxybenzoic acid and 3,5-dihydroxybenzoic acid into mice subjected to 30-min middle cerebral artery occlusion. The in vivo administration of HCAR1 agonists at reperfusion did not appear to exert any relevant protective effect as seen with lactate administration. Our results suggest that the protective effects of lactate after hypoxia-ischemia come rather from the metabolic effects of lactate than its signaling through HCAR1.	[Buscemi, Lara; Blochet, Camille; Hirt, Lorenz] Univ Lausanne, Univ Lausanne Hosp, Dept Clin Neurosci, Neurol Serv, Lausanne, Switzerland; [Buscemi, Lara; Blochet, Camille; Hirt, Lorenz] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Magistretti, Pierre J.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia		Hirt, L (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Dept Clin Neurosci, Neurol Serv, Lausanne, Switzerland.; Hirt, L (corresponding author), Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland.	lorenz.hirt@chuv.ch	Hirt, Lorenz/G-3553-2010	Hirt, Lorenz/0000-0002-2921-5000; Magistretti, Pierre Julius/0000-0002-6678-320X	Biaggi Foundation; Juchum Foundation; Novartis Foundation for Medical Biological ResearchUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [18C170]; Swissheart Foundation [FF 19053]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31003A_163465/1]	The authors declare that this work was supported by funding from the Biaggi and Juchum Foundations, the Novartis Foundation for Medical Biological Research grant 18C170, the Swissheart Foundation FF 19053, and the Swiss National Science Foundation grant 31003A_163465/1. The authors further declare that the funders were not involved in the study design, collection, analysis and interpretation of data, or the writing of the article and the decision to submit it for publication.	Abrantes HD, 2019, J NEUROSCI, V39, P4422, DOI 10.1523/JNEUROSCI.2092-18.2019; Adeva-Andany M, 2014, MITOCHONDRION, V17, P76, DOI 10.1016/j.mito.2014.05.007; Ahmed K, 2009, TRENDS PHARMACOL SCI, V30, P557, DOI 10.1016/j.tips.2009.09.001; Alf MF, 2012, NMR BIOMED, V25, P247, DOI 10.1002/nbm.1740; Bergersen Linda H, 2012, Front Neuroenergetics, V4, P5, DOI 10.3389/fnene.2012.00005; Berthet C, 2012, CEREBROVASC DIS, V34, P329, DOI 10.1159/000343657; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; Blochet C, 2020, J CEREBR BLOOD F MET, V40, P163, DOI 10.1177/0271678X18806893; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bozzo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071721; BRABEC MJ, 1984, ANESTHESIOLOGY, V61, P43, DOI 10.1097/00000542-198461010-00008; Burchell SR, 2013, J INVEST MED, V61, P1078, DOI 10.2310/JIM.0b013e3182a07921; Buscemi L., 2020, CLIN TRANSL NEUROSCI, V4, p2514183X20904571, DOI [10.1177/2514183X20904571, DOI 10.1177/2514183X20904571]; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Carteron L, 2018, CRIT CARE MED, V46, P1649, DOI 10.1097/CCM.0000000000003274; Castillo X, 2015, J CEREBR BLOOD F MET, V35, P1561, DOI 10.1038/jcbfm.2015.115; D'Adamo P, 2021, METABOLISM, V116, DOI 10.1016/j.metabol.2020.154463; DiNuzzo M, 2012, NEUROCHEM RES, V37, P2432, DOI 10.1007/s11064-012-0802-5; Dvorak CA, 2012, ACS MED CHEM LETT, V3, P637, DOI 10.1021/ml3000676; Goncalves CA, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01035; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; HARADA M, 1992, ANESTHESIOLOGY, V77, P728, DOI 10.1097/00000542-199210000-00017; Herrera-Lopez G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242309; Herrera-Lopez G, 2018, HIPPOCAMPUS, V28, P557, DOI 10.1002/hipo.22958; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Hirt L, 2004, STROKE, V35, P1738, DOI 10.1161/01.STR.0000131480.03994.b1; Horn T, 2013, NEUROCHEM INT, V62, P251, DOI 10.1016/j.neuint.2012.12.017; Horn T, 2010, NEUROCHEM INT, V57, P940, DOI 10.1016/j.neuint.2010.09.014; Hyacinthe JN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62319-x; Jourdain P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31534-y; Jourdain P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21250; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; Lei HX, 2009, J CEREBR BLOOD F MET, V29, P811, DOI 10.1038/jcbfm.2009.8; Lev-Vachnish Y, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00403; Li G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093041; Liu CL, 2012, J PHARMACOL EXP THER, V341, P794, DOI 10.1124/jpet.112.192799; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Magistretti PJ, 2018, NAT REV NEUROSCI, V19, P235, DOI 10.1038/nrn.2018.19; Mosienko V, 2018, NEUROGLIA, V1, P365, DOI [10.3390/neuroglia1020025, DOI 10.3390/NEUROGLIA1020025]; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Rosafio K, 2016, NEUROSCIENCE, V317, P108, DOI 10.1016/j.neuroscience.2015.12.052; Ross AB, 2004, J CHROMATOGR B, V809, P125, DOI 10.1016/j.jchromb.2004.06.015; Roumes H, 2021, J CEREBR BLOOD F MET, V41, P342, DOI 10.1177/0271678X20908355; Scavuzzo CJ, 2020, NEUROBIOL LEARN MEM, V168, DOI 10.1016/j.nlm.2019.107151; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Schurr A, 1997, J NEUROCHEM, V69, P423; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Vardjan N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00148; Vohra R, 2019, INVEST OPHTH VIS SCI, V60, P999, DOI 10.1167/iovs.18-25458; Wallenius K, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92564; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111; Zhou J, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0113-2; Zhu YD, 2014, J NUTR, V144, P114, DOI 10.3945/jn.113.184663; Zuend M, 2020, NAT METAB, V2, P179, DOI 10.1038/s42255-020-0170-4	60	1	1	2	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	MAY 21	2021	12								689239	10.3389/fphys.2021.689239			12	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	SM5NQ	WOS:000657652400001	34093243	Green Published, gold			2022-02-06	
J	Wang, YS; Hung, TW; Bae, EK; Wu, KJ; Hsieh, W; Yu, SJ				Wang, Yu-Syuan; Hung, Tsai-Wei; Bae, Eun-Kyung; Wu, Kuo-Jen; Hsieh, Wei; Yu, Seong-Jin			Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						inflammation; mu opioid receptor; naltrexone; traumatic brain injury	CELL-LINE; INFLAMMATION; NEURODEGENERATION; NEUROTOXICITY; DISORDERS; CYTOKINES; PROTECTS; NALOXONE; STRESS; ALPHA	Aims Naltrexone is a mu opioid receptor (MOR) antagonist used to treat drug dependence in patients. Previous reports indicated that MOR antagonists reduced neurodegeneration and inflammation after brain injury. The purpose of this study was to evaluate the neuroprotective effect of naltrexone in cell culture and a mouse model of traumatic brain injury (TBI). Methods The neuroprotective effect of naltrexone was examined in primary cortical neurons co-cultured with BV2 microglia. Controlled cortical impact (CCI) was delivered to the left cerebral cortex of adult male MOR wild-type (WT) and knockout (KO) mice. Naltrexone was given daily for 4 days, starting from day 2 after lesioning. Locomotor activity was evaluated on day 5 after the CCI. Brain tissues were collected for immunostaining, Western, and qPCR analysis. Results Glutamate reduced MAP2 immunoreactivity (-ir), while increased IBA1-ir in neuron/BV2 co-culture; both responses were antagonized by naltrexone. TBI significantly reduced locomotor activity and increased the expression of IBA1, iNOS, and CD4 in the lesioned cortex. Naltrexone significantly and equally antagonized the motor deficits and expression of IBA1 and iNOS in WT and KO mice. TBI-mediated CD4 protein production was attenuated by naltrexone in WT mice, but not in KO mice. Conclusion Naltrexone reduced TBI-mediated neurodegeneration and inflammation in MOR WT and KO mice. The protective effect of naltrexone involves non-MOR and MOR mechanisms.	[Wang, Yu-Syuan; Hung, Tsai-Wei; Bae, Eun-Kyung; Wu, Kuo-Jen; Hsieh, Wei; Yu, Seong-Jin] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan		Yu, SJ (corresponding author), Natl Hlth Res Inst, Ctr Neuropsychiat Res, 35 Keyan Rd, Miaoli 35053, Taiwan.	b7508@nhri.org.tw			National Health Research Institutes, TaiwanNational Health Research Institutes - Taiwan [NP-106-PP-02, NP-107-PP-02]; Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 108-2320-B-400 -023]	This research was supported in part by (i) National Health Research Institutes, Taiwan (NP-106-PP-02, NP-107-PP-02), and (ii) the Ministry of Science and Technology, Taiwan (MOST 108-2320-B-400 -023). The authors thank Dr. Yun Wang for his critical comments.	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Anttila JE, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0395-17.2018; Arvidsson A, 2001, NEUROSCIENCE, V106, P27, DOI 10.1016/S0306-4522(01)00268-8; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Borlongan CV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-31; Calvanio R, 2000, BRAIN INJURY, V14, P933; Chen HC, 2000, MOL BRAIN RES, V76, P170, DOI 10.1016/S0169-328X(99)00346-0; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; Gessi S, 2016, FEBS LETT, V590, P2813, DOI 10.1002/1873-3468.12313; Glushakov AO, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103151; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Harvey BK, 2007, CELL TRANSPLANT, V16, P483, DOI 10.3727/000000007783464984; Hsu YY, 2014, NEUROTOX RES, V25, P262, DOI 10.1007/s12640-013-9414-3; Huang ZJ, 2020, CNS NEUROSCI THER, V26, P698, DOI 10.1111/cns.13298; KWILASZ A, 2020, ANTIOXIDANTS-BASEL, V396; Liu B, 2000, NEUROSCIENCE, V97, P749, DOI 10.1016/S0306-4522(00)00057-9; Loh HH, 1998, MOL BRAIN RES, V54, P321, DOI 10.1016/S0169-328X(97)00353-7; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Pateliya BB, 2008, BIOL PHARM BULL, V31, P1755, DOI 10.1248/bpb.31.1755; Philippe D, 2003, J CLIN INVEST, V111, P1329, DOI 10.1172/JCI200316750; San-Emeterio EP, 2006, NEUROSCI LETT, V403, P276, DOI 10.1016/j.neulet.2006.04.053; Sarabi A, 2000, EXP NEUROL, V170, P283, DOI 10.1006/exnr.2001.7714; Sinha SP, 2017, BRAIN BEHAV IMMUN, V61, P353, DOI 10.1016/j.bbi.2017.01.006; Suzuki S, 2000, BIOCHEM BIOPH RES CO, V279, P621, DOI 10.1006/bbrc.2000.4006; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tomaiuolo F, 2021, J NEUROTRAUM, V38, P283, DOI 10.1089/neu.2020.7203; van Dijck JTJM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216743; Wang Y, 1997, J NEUROSCI, V17, P4341; Wang Z, 2018, TRANSL STROKE RES, V9, P74, DOI 10.1007/s12975-017-0559-x; Wu KJ, 2015, CELL TRANSPLANT, V24, P459, DOI 10.3727/096368915X686922; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Yang L, 2015, BRAIN RES, V1609, P1, DOI 10.1016/j.brainres.2015.03.022; Yang YX, 2019, NEUROIMMUNOMODULAT, V26, P43, DOI 10.1159/000495465; Yu SJ, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100866; Zhang HZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113093	43	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUL	2021	27	7					831	841		10.1111/cns.13655		MAY 2021	11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	SP9OX	WOS:000652480100001	34018697	gold, Green Published			2022-02-06	
J	Wen, JQ; Deng, XM; Huang, CQ; An, ZT; Liu, ML				Wen, Jianqiang; Deng, Xiaomeng; Huang, Chongquan; An, Zitong; Liu, Meili			Low-Intensity Pulsed Ultrasound Enhanced Neurite Guidance Growth through Netrin-1/DCC Signal Pathway in Primary Cultured Cortical Neurons of Rats	ACS CHEMICAL NEUROSCIENCE			English	Article						Low-intensity pulsed ultrasound; nerve injury; axonal growth guidance; netrin-1; DCC; nerve regeneration	TRAUMATIC BRAIN-INJURY; CELLS; NANOPARTICLES; EPIDEMIOLOGY; CAVITATION; OUTGROWTH; DISEASE; BARRIER; IMPACT	Low-intensity pulsed ultrasound is found to be effective in axonal regeneration, while the role of ultrasound in axonal growth guidance is still unclear. This study was performed to explore the neuroprotective role of low-intensity pulsed ultrasound (US) both in vitro and in vivo. Primary cultured rat cortical neurons were subjected to 1.0 MHz ultrasound for 5 min every day at intensity of 0, 0.008, 0.12, and 0.21 W/cm(2). Our results demonstrated that low-intensity pulsed ultrasound significantly increased neuronal cell viability and inhibited neuronal apoptosis in vitro as determined by fluorescein diacetate assay (FDA) and a TdT-mediated biotin-dUTP nicked-end labeling (TUNEL) assay. Moreover, low-intensity pulsed ultrasound at 0.12 W/cm(2) significantly enhanced the axonal growth guidance by activation of netrin-1 and DCC (deleted in colorectal carcinoma) expression as determined by Western blots assay. More interestingly, we further found that low-intensity pulsed ultrasound treatment at 0.21 W/cm(2) promoted the functional restoration of rat injured nerves in vivo, decreased hemorrhage, and reversed the injury process by activating positive netrin-1 expression as seen in the immunohistochemistry (IHC) assay. Thus, our study strongly demonstrated that low-intensity pulsed ultrasound activated netrin-1/DCC signaling and further mediated neurite outgrowth. It would be a new approach to nerve regeneration in the future.	[Deng, Xiaomeng; Huang, Chongquan; An, Zitong; Liu, Meili] Beihang Univ, Minist Educ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Beijing 100083, Peoples R China; [Liu, Meili] Beihang Univ, Beijing Adv Innovat Ctr Biomed Engn, Beijing 102402, Peoples R China; [Wen, Jianqiang] Chinese Acad Sci, Beijing Engn Technol Res Ctr Ocean Acoust Equipme, Inst Acoust, Underwater Acoust Transducer & Testing Lab, Beijing 100190, Peoples R China		Liu, ML (corresponding author), Beihang Univ, Minist Educ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Beijing 100083, Peoples R China.; Liu, ML (corresponding author), Beihang Univ, Beijing Adv Innovat Ctr Biomed Engn, Beijing 102402, Peoples R China.; Wen, JQ (corresponding author), Chinese Acad Sci, Beijing Engn Technol Res Ctr Ocean Acoust Equipme, Inst Acoust, Underwater Acoust Transducer & Testing Lab, Beijing 100190, Peoples R China.	wjq@mail.ioa.ac.cn; liuml@buaa.edu.cn			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [31971238, 61871014, 11827803, 52072015]; National key research and development program [2016YFC1100704, 2016YFC1102203]; 111 ProjectMinistry of Education, China - 111 Project [B13003]	This study was supported by funds from the National Natural Science Foundation of China (NSFC) Research Grant (31971238, 61871014, 11827803, 52072015) and National key research and development program (2016YFC1100704, 2016YFC1102203) and also supported by 111 Project (B13003).	Ahmadi F, 2012, PROG BIOPHYS MOL BIO, V108, P119, DOI 10.1016/j.pbiomolbio.2012.01.004; Aznar-Cervantes S, 2017, MAT SCI ENG C-MATER, V79, P315, DOI 10.1016/j.msec.2017.05.055; Ba MW, 2017, ONCOTARGET, V8, P50921, DOI 10.18632/oncotarget.17285; Batty NJ, 2017, NEUROSCI LETT, V652, P56, DOI 10.1016/j.neulet.2016.12.033; Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004; Coluccial D, 2014, J THER ULTRASOUND, V2, DOI [10.1186/2050-5736-217, 10.1186/2050-5736-2-17]; Deffieux T, 2013, CURR BIOL, V23, P2430, DOI 10.1016/j.cub.2013.10.029; Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731; di Biase L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00549; Dun XP, 2020, NEURAL REGEN RES, V15, P6, DOI 10.4103/1673-5374.264441; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Gosselet F, 2011, M S-MED SCI, V27, P987, DOI 10.1051/medsci/20112711015; Hu YX, 2013, ULTRASOUND MED BIOL, V39, P915, DOI 10.1016/j.ultrasmedbio.2012.12.003; Jack AS, 2018, J NEUROSCI RES, V96, P852, DOI 10.1002/jnr.24209; Kang DS, 2018, EMBO REP, V19, DOI 10.15252/embr.201846250; Kim J, 2020, GLIA, V68, P2070, DOI 10.1002/glia.23827; Kozminski BU, 2020, J ORTHOP, V19, P184, DOI 10.1016/j.jor.2019.11.042; LaLumiere RT, 2011, BRAIN STIMUL, V4, P1, DOI 10.1016/j.brs.2010.09.009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee IC, 2019, ACS CHEM NEUROSCI, V10, P1452, DOI 10.1021/acschemneuro.8b00483; Lee IC, 2014, ULTRASOUND MED BIOL, V40, P2195, DOI 10.1016/j.ultrasmedbio.2014.05.001; Legon W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28320-1; Leinenga G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2512; Liu ML, 2008, NEUROSCI LETT, V444, P236, DOI 10.1016/j.neulet.2008.08.029; Liu ML, 2018, J TISSUE ENG REGEN M, V12, P70, DOI 10.1002/term.2364; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063473; Liu X, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00132; Loverde J. R., 2011, J VISUALIZED EXP, V54; Lyons MK, 2011, MAYO CLIN PROC, V86, P662, DOI 10.4065/mcp.2011.0045; Meneghetti N, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/abae8b; Min BK, 2011, INT J IMAG SYST TECH, V21, P232, DOI 10.1002/ima.20284; Oh SJ, 2019, CURR BIOL, V29, P3386, DOI 10.1016/j.cub.2019.08.021; Pfister BJ, 2006, FEBS LETT, V580, P3525, DOI 10.1016/j.febslet.2006.05.030; Ren C, 2010, BIOMED ENVIRON SCI, V23, P244, DOI 10.1016/S0895-3988(10)60059-1; Shevtsov M, 2016, CURR DRUG METAB, V17, P737, DOI 10.2174/1389200217666160607232540; Sviridov A, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00393; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Varadarajan SG, 2017, DEV BIOL, V430, P177, DOI 10.1016/j.ydbio.2017.08.001; Wang MH, 2018, BIOSENS BIOELECTRON, V99, P99, DOI 10.1016/j.bios.2017.07.030; Woolf CJ, 2004, LIFE SCI, V74, P2605, DOI 10.1016/j.lfs.2004.01.003; Xu T, 2020, ULTRASON SONOCHEM, V63, DOI 10.1016/j.ultsonch.2019.104955; Zhao L, 2016, ULTRASOUND MED BIOL, V42, P2914, DOI 10.1016/j.ultrasmedbio.2016.07.017; Zhao L, 2015, ULTRASOUND MED BIOL, V41, P2755, DOI 10.1016/j.ultrasmedbio.2015.05.021	43	1	1	6	9	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JUN 2	2021	12	11					1931	1939		10.1021/acschemneuro.1c00020		MAY 2021	9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	SP1HC	WOS:000659421400010	34018719				2022-02-06	
J	Fedinec, AL; Liu, JX; Zhang, R; Harsono, M; Pourcyrous, M; Parfenova, H				Fedinec, Alex L.; Liu, Jianxiong; Zhang, Rong; Harsono, Mimily; Pourcyrous, Massroor; Parfenova, Helena			The cold receptor TRPM8 activation leads to attenuation of endothelium-dependent cerebral vascular functions during head cooling	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cerebral circulation; cranial window; hypothermia; icilin; newborn pigs	TRAUMATIC BRAIN-INJURY; CARBON-MONOXIDE; BLOOD-FLOW; CHANNELS; HYPOTHERMIA; NEWBORN; PHARMACOLOGY; INVOLVEMENT; GLUTAMATE	Using the cranial window technique, we investigated acute effects of head cooling on cerebral vascular functions in newborn pigs. Head cooling lowered the rectal and extradural brain temperatures to 34.3 +/- 0.6 degrees C and 26.1 +/- 0.6 degrees C, respectively. During the 3-h hypothermia period, responses of pial arterioles to endothelium-dependent dilators bradykinin and glutamate were reduced, whereas the responses to hypercapnia and an endothelium-independent dilator sodium nitroprusside (SNP) remained intact. All vasodilator responses were restored after rewarming, suggesting that head cooling did not produce endothelial injury. We tested the hypothesis that the cold-sensitive TRPM8 channel is involved in attenuation of cerebrovascular functions. TRPM8 is immunodetected in cerebral vessels and in the brain parenchyma. During normothermia, the TRPM8 agonist icilin produced constriction of pial arterioles that was antagonized by the channel blocker AMTB. Icilin reduced dilation of pial arterioles to bradykinin and glutamate but not to hypercapnia and SNP, thus mimicking the effects of head cooling on vascular functions. AMTB counteracted the impairment of endothelium-dependent vasodilation caused by hypothermia or icilin. Overall, mild hypothermia produced by head cooling leads to acute reversible reduction of selected endothelium-dependent cerebral vasodilator functions via TRPM8 activation, whereas cerebral arteriolar smooth muscle functions are largely preserved.	[Fedinec, Alex L.; Liu, Jianxiong; Zhang, Rong; Harsono, Mimily; Pourcyrous, Massroor; Parfenova, Helena] Univ Tennessee, Hlth Sci Ctr, Dept Physiol & Pediat Neonatol, Memphis, TN USA		Parfenova, H (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 956 Court Ave,Suite E332, Memphis, TN 38163 USA.	hparfeno@uthsc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS101717, NS105655]	The author(s) disclose receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institutes of Health Grants NS101717 and NS105655 (to H. Parfenova). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; BUSIJA DW, 1987, AM J PHYSIOL, V253, pH869, DOI 10.1152/ajpheart.1987.253.4.H869; Cladis, 2016, SMITHS ANESTHESIA IN, P633; DeFalco J, 2011, CURR TOP MED CHEM, V11, P2237, DOI 10.2174/156802611796904933; Diver MM, 2019, SCIENCE, V365, P1434, DOI 10.1126/science.aax6672; du Sert NP, 2020, BRIT J PHARMACOL, V177, P3617, DOI [10.1111/bph.15193, 10.1177/0271678X20943823]; Earley S, 2010, MICROCIRCULATION, V17, P237, DOI 10.1111/j.1549-8719.2010.00026.x; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Fiumana E, 2003, AM J PHYSIOL-HEART C, V284, pH1073, DOI 10.1152/ajpheart.00881.2002; Gonzalez-Muniz R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112618; Gunn A J, 2006, NeuroRx, V3, P154, DOI 10.1016/j.nurx.2006.01.007; Harris B, 2012, BRAIN INJURY, V26, P372, DOI 10.3310/hta16450; Harsono M, 2016, AM J PHYSIOL-HEART C, V311, pH1202, DOI 10.1152/ajpheart.00227.2016; Hoiland RL, 2019, COMPR PHYSIOL, V9, P1101, DOI 10.1002/cphy.c180021; Hooper WC, 2007, VASC PHARMACOL, V46, P315, DOI 10.1016/j.vph.2006.10.014; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; Leffler CW, 2006, J APPL PHYSIOL, V100, P1065, DOI 10.1152/japplphysiol.00793.2005; Liu YQ, 2020, EUR J PHARMACOL, V882, DOI 10.1016/j.ejphar.2020.173312; Malkia A, 2011, CURR PHARM BIOTECHNO, V12, P54, DOI 10.2174/138920111793937916; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Melanaphy D, 2016, AM J PHYSIOL-HEART C, V311, pH1416, DOI 10.1152/ajpheart.00222.2015; Mu YP, 2018, J PHARMACOL EXP THER, V365, P544, DOI 10.1124/jpet.117.247320; Olah E, 2018, J NEUROTRAUM, V35, P2407, DOI 10.1089/neu.2018.5649; Ordas P, 2021, J COMP NEUROL, V529, P234, DOI 10.1002/cne.24694; Parfenova H, 2006, AM J PHYSIOL-CELL PH, V290, pC1399, DOI 10.1152/ajpcell.00386.2005; Parfenova H, 1997, AM J PHYSIOL-CELL PH, V273, pC277, DOI 10.1152/ajpcell.1997.273.1.C277; Parfenova H, 2012, AM J PHYSIOL-HEART C, V302, pH2257, DOI 10.1152/ajpheart.01011.2011; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Peterson EC, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/823525; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Sun J, 2014, HYPERTENSION, V63, P1354, DOI 10.1161/HYPERTENSIONAHA.113.02573; Tang XN, 2009, J NEUROTRAUM, V26, P325, DOI 10.1089/neu.2008.0594; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; Tooley JR, 2005, ARCH DIS CHILD-FETAL, V90, P262, DOI 10.1136/adc.2003.044305; Wang H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00307; Willis AP, 2001, AM J PHYSIOL-HEART C, V281, pH2366, DOI 10.1152/ajpheart.2001.281.6.H2366; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Zholos A, 2011, ADV EXP MED BIOL, V704, P707, DOI 10.1007/978-94-007-0265-3_37; Zholos A, 2010, BRIT J PHARMACOL, V159, P1559, DOI 10.1111/j.1476-5381.2010.00649.x; Zimmermann A, 2007, AM J PHYSIOL-HEART C, V293, pH2501, DOI 10.1152/ajpheart.00354.2007	42	1	1	4	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2021	41	11					2897	2906	0271678X211018035	10.1177/0271678X211018035		MAY 2021	10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	WL1LL	WOS:000680601400001	34013806				2022-02-06	
J	Miller, ST; Cooper, CF; Elsbernd, P; Kerwin, J; Mejia-Alvarez, R; Willis, AM				Miller, Scott T.; Cooper, Candice F.; Elsbernd, Paul; Kerwin, Joseph; Mejia-Alvarez, Ricardo; Willis, Adam M.			Localizing Clinical Patterns of Blast Traumatic Brain Injury Through Computational Modeling and Simulation	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; blast; cavitation; simulation; computation; interfacial injury	POSSIBLE DAMAGE MECHANISM; CAVITATION; EXPOSURE; IMPACT; CONCUSSION; INDUCTION; DEATH; WAVES; RAT	Blast traumatic brain injury is ubiquitous in modern military conflict with significant morbidity and mortality. Yet the mechanism by which blast overpressure waves cause specific intracranial injury in humans remains unclear. Reviewing of both the clinical experience of neurointensivists and neurosurgeons who treated service members exposed to blast have revealed a pattern of injury to cerebral blood vessels, manifested as subarachnoid hemorrhage, pseudoaneurysm, and early diffuse cerebral edema. Additionally, a seminal neuropathologic case series of victims of blast traumatic brain injury (TBI) showed unique astroglial scarring patterns at the following tissue interfaces: subpial glial plate, perivascular, periventricular, and cerebral gray-white interface. The uniting feature of both the clinical and neuropathologic findings in blast TBI is the co-location of injury to material interfaces, be it solid-fluid or solid-solid interface. This motivates the hypothesis that blast TBI is an injury at the intracranial mechanical interfaces. In order to investigate the intracranial interface dynamics, we performed a novel set of computational simulations using a model human head simplified but containing models of gyri, sulci, cerebrospinal fluid (CSF), ventricles, and vasculature with high spatial resolution of the mechanical interfaces. Simulations were performed within a hybrid Eulerian-Lagrangian simulation suite (CTH coupled via Zapotec to Sierra Mechanics). Because of the large computational meshes, simulations required high performance computing resources. Twenty simulations were performed across multiple exposure scenarios-overpressures of 150, 250, and 500 kPa with 1 ms overpressure durations-for multiple blast exposures (front blast, side blast, and wall blast) across large variations in material model parameters (brain shear properties, skull elastic moduli). All simulations predict fluid cavitation within CSF (where intracerebral vasculature reside) with cavitation occurring deep and diffusely into cerebral sulci. These cavitation events are adjacent to high interface strain rates at the subpial glial plate. Larger overpressure simulations (250 and 500kPa) demonstrated intraventricular cavitation-also associated with adjacent high periventricular strain rates. Additionally, models of embedded intraparenchymal vascular structures-with diameters as small as 0.6 mm-predicted intravascular cavitation with adjacent high perivascular strain rates. The co-location of local maxima of strain rates near several of the regions that appear to be preferentially damaged in blast TBI (vascular structures, subpial glial plate, perivascular regions, and periventricular regions) suggest that intracranial interface dynamics may be important in understanding how blast overpressures leads to intracranial injury.	[Miller, Scott T.] Sandia Natl Labs, Computat Solid Mech & Struct Dynam, POB 5800, Albuquerque, NM 87185 USA; [Cooper, Candice F.] Sandia Natl Labs, Terminal Ballist Technol, POB 5800, Albuquerque, NM 87185 USA; [Elsbernd, Paul; Willis, Adam M.] Brooke Army Med Ctr, Dept Neurol, Ft Sam Houston, TX 78234 USA; [Kerwin, Joseph; Mejia-Alvarez, Ricardo; Willis, Adam M.] Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA		Willis, AM (corresponding author), Brooke Army Med Ctr, Dept Neurol, Ft Sam Houston, TX 78234 USA.; Willis, AM (corresponding author), Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA.	adam.m.willis.mil@mail.mil			59 Medical Wing -Office of the Chief Scientist	Funding provided by 59 Medical Wing -Office of the Chief Scientist.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; Bessette G., 2003, WIT T BUILT ENV, V71, DOI [10.2495/FSI030261, DOI 10.2495/FSI030261]; Bjarnason GA, 2009, INT J RADIAT ONCOL, V73, P166, DOI 10.1016/j.ijrobp.2008.07.009; Blacker TD., 1994, USERS MANUAL, V1; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; COOPER GJ, 1991, J BIOMECH, V24, P273, DOI 10.1016/0021-9290(91)90346-O; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elkhodary, 2013, NONLINEAR FINITE ELE; Falland-Cheung L, 2017, J MECH BEHAV BIOMED, V68, P303, DOI 10.1016/j.jmbbm.2017.02.023; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; Haslach HW, 2017, J MECH BEHAV BIOMED, V68, P88, DOI 10.1016/j.jmbbm.2017.01.036; Hertel E. S., 1993, P 19 INT S SHOCK WAV, P377, DOI DOI 10.1007/978-3-642-78829-1_61; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Kang W, 2018, ACTA BIOMATER, V67, P295, DOI 10.1016/j.actbio.2017.11.030; Klug C., EXPT SPHERE SPHERE T; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Piehler T, 2018, MIL MED, V183, P269, DOI 10.1093/milmed/usx158; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor P., 2014, PERS ARM SYST S 2014; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tunthanathip T, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS18311; Veilleux M., 2019, SIERRA SOLID MECH 4; Wardlaw A, 2010, IFMBE PROC, V32, P34, DOI 10.1007/978-3-642-14998-6_9; Wermer A, 2020, MIL MED, V185, P205, DOI 10.1093/milmed/usz228; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Zander NE, 2015, J NEUROSCI RES, V93, P1353, DOI 10.1002/jnr.23594	54	1	1	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 20	2021	12								547655	10.3389/fneur.2021.547655			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SM0LQ	WOS:000657304800001	34093380	gold, Green Published			2022-02-06	
J	Cecchi, NJ; Monroe, DC; Fote, GM; Small, SL; Hicks, JW				Cecchi, Nicholas J.; Monroe, Derek C.; Fote, Gianna M.; Small, Steven L.; Hicks, James W.			Head impact exposure and concussion in women's collegiate club lacrosse	RESEARCH IN SPORTS MEDICINE			English	Article; Early Access						Concussion; head impact sensor; female athletes; head injury; head acceleration		This study sought to describe head impact exposure in women's collegiate club lacrosse. Eleven women's collegiate club lacrosse players wore head impact sensors during eight intercollegiate competitions. Video recordings of competitions were used to verify impact data. Athletes completed questionnaires detailing their concussion history and perceived head impact exposure. During the monitored games, no diagnosed concussions were sustained. Three athletes reported sustaining head impacts (median = 0; range: 0-3 impacts per game). Six impacts registered by the sensors were verified on video across a total of 81 athlete-game exposures. Verified impacts had a median peak linear acceleration of 21.0 g (range: 18.3 g - 48.3 g) and peak rotational acceleration of 1.1 krad/s(2) (range: 0.7 krad/s(2) - 5.7 krad/s(2)). Women competing in collegiate club lacrosse are at a low risk of sustaining head impacts, comparable to previous reports of the high school and collegiate varsity levels of play.	[Cecchi, Nicholas J.; Hicks, James W.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Monroe, Derek C.] Univ N Carolina, Dept Kinesiol, Greensboro, NC USA; [Monroe, Derek C.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Fote, Gianna M.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Small, Steven L.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA		Hicks, JW (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	jhicks@uci.edu	Cecchi, Nicholas J/AAC-6547-2021	Cecchi, Nicholas J/0000-0001-9319-4163	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [5T32AR047752-15]	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) under [5T32AR047752-15].	Caswell SV, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120969685; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Cecchi NJ, 2020, J SCI MED SPORT, V23, P927, DOI 10.1016/j.jsams.2020.03.008; Cecchi NJ, 2020, P I MECH ENG P-J SPO, V234, P162, DOI 10.1177/1754337120901974; Cecchi NJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216369; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Foss KDB, 2018, CLIN J SPORT MED, V28, P406, DOI 10.1097/JSM.0000000000000458; Huber CM, 2021, ORTHOP J SPORTS MED, V9, DOI 10.1177/2325967120984423; Huber CM, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4048574; Kieffer EE, 2020, ANN BIOMED ENG, V48, P2613, DOI 10.1007/s10439-020-02647-1; Le RK, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118807678; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Patton DA, 2020, ANN BIOMED ENG, V48, P2497, DOI 10.1007/s10439-020-02642-6; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Sayre H. D., 2019, ATHLETIC TRAINING SP, V11, P143; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256	16	1	1	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.												10.1080/15438627.2021.1929226		MAY 2021	6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	SD3HZ	WOS:000651267000001	33998942				2022-02-06	
J	Gan, SQ; Shi, W; Wang, S; Sun, YX; Yin, B; Bai, GH; Jia, XY; Sun, CZ; Niu, X; Wang, ZN; Jiang, XF; Liu, J; Zhang, M; Bai, LJ				Gan, Shuoqiu; Shi, Wen; Wang, Shan; Sun, Yingxiang; Yin, Bo; Bai, Guanghui; Jia, Xiaoyan; Sun, Chuanzhu; Niu, Xuan; Wang, Zhuonan; Jiang, Xiaofan; Liu, Jun; Zhang, Ming; Bai, Lijun			Accelerated Brain Aging in Mild Traumatic Brain Injury: Longitudinal Pattern Recognition with White Matter Integrity	JOURNAL OF NEUROTRAUMA			English	Article						accelerated brain aging; mild traumatic brain injury; predicted age difference; relevance vector regression; white matter integrity	DIFFUSE AXONAL INJURY; COLLABORATING-CENTER; TASK-FORCE; AGE; SCHIZOPHRENIA; CONNECTIVITY; RELIABILITY; DEPOSITION; PROGNOSIS; DEMENTIA	Mild traumatic brain injury (mTBI) initiating long-term effects on white matter integrity resembles brain-aging changes, implying an aging process accelerated by mTBI. This longitudinal study aims to investigate the mTBI-induced acceleration of the brain-aging process by developing a neuroimaging model to predict brain age. The brain-age prediction model was defined using relevance vector regression based on fractional anisotropy from diffusion tensor imaging of 523 healthy individuals. The model was used to estimate the brain-predicted age difference (brain-PAD) between the chronological and estimated brain age in 116 acute mTBI patients and 63 healthy controls. Fifty patients were followed for 6 similar to 12 months to evaluate the longitudinal changes in brain-PAD. We investigated whether brain-PAD was greater in patients of older age, post-concussion complaints, and apolipoprotein E (APOE) e4 genotype, and whether it had the potential to predict neuropsychological outcomes. The brain-age prediction model predicted brain age accurately (r = 0.96). The brains of mTBI patients in the acute phase were estimated to be "older," with greater brain-PAD (2.59 +/- 5.97 years) than the healthy controls (0.12 +/- 3.19 years) (p < 0.05), and remained stable 6-12 month post-injury (2.50 +/- 4.54 years). Patients who were older or who had post-concussion complaints, rather than APOE e4 genotype, had greater brain-PADs (p < 0.001, p = 0.024). Additionally, brain-PAD in the acute phase predicted information processing speed at the 6 similar to 12 month follow-up (r = -0.36, p = 0.01). In conclusion, mTBI accelerates the brain-aging process, and brain-PAD may be capable of evaluating aging-associated issues post-injury, such as increased risks of neurodegeneration.	[Gan, Shuoqiu; Wang, Shan; Jia, Xiaoyan; Sun, Chuanzhu; Bai, Lijun] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Dept Biomed Engn, Minist Educ,Sch Life Sci & Technol, 28 Xianning West Rd, Xian 710049, Shaanxi, Peoples R China; [Gan, Shuoqiu; Sun, Yingxiang; Niu, Xuan; Wang, Zhuonan; Zhang, Ming] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Shi, Wen] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China; [Shi, Wen] Zhejiang Univ, Key Lab Biomed Engn, Dept Biomed Engn, Minist Educ,Coll Biomed Engn & Instrument Sci, Hangzhou, Peoples R China; [Yin, Bo] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Wenzhou, Peoples R China; [Bai, Guanghui] Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Wenzhou, Peoples R China; Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Jiang, Xiaofan] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian, Peoples R China; [Liu, Jun] Cent South Univ, Xiangya Hosp 2, Dept Radiol, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China		Bai, LJ (corresponding author), Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Dept Biomed Engn, Minist Educ,Sch Life Sci & Technol, 28 Xianning West Rd, Xian 710049, Shaanxi, Peoples R China.; Zhang, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.; Liu, J (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Radiol, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China.	junliu123@csu.edu.cn; zhangming01@mail.xjtu.edu.cn; bailijun@xjtu.edu.cn	Niu, Xuan/AAD-7351-2022; Shi, Wen/AAS-9141-2021	Shi, Wen/0000-0002-5312-4889	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82071993, 81771914, 81871331, 61971451, 81671671]; Key projects in Hunan Province [2020SK4001, 2019SK2131]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY19H180003]; Wenzhou Science and Technology Bureau in China [Y20180112]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [Xjj2018229, xzy022019045]	This study was funded by the National Natural Science Foundation of China (Grant Nos. 82071993, 81771914, 81871331, 61971451, 81671671), Key projects in Hunan Province (Grant Nos. 2020SK4001, 2019SK2131), Natural Science Foundation of Zhejiang Province (Nos. LY19H180003), Wenzhou Science and Technology Bureau in China (No. Y20180112), Fundamental Research Funds for the Central Universities (Grant Nos. Xjj2018229, xzy022019045).	Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Bright MG, 2013, NEUROIMAGE, V83, P559, DOI 10.1016/j.neuroimage.2013.07.007; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cole JH, 2017, TRENDS NEUROSCI, V40, P681, DOI 10.1016/j.tins.2017.10.001; Cole JH, 2017, NEUROBIOL AGING, V56, P41, DOI 10.1016/j.neurobiolaging.2017.04.006; Cole JH, 2017, NEUROLOGY, V88, P1349, DOI [10.1212/WNL.0000000000003790, 10.1212/wnl.0000000000003790]; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Cox SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13629; de Groot M, 2016, RADIOLOGY, V279, P532, DOI 10.1148/radiol.2015150103; DESPOSITO M, 1995, NEUROLOGY, V45, P1546, DOI 10.1212/WNL.45.8.1546; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gaser C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067346; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Jacquemont T, 2017, NEUROBIOL AGING, V55, P177, DOI 10.1016/j.neurobiolaging.2017.03.023; Jagust W, 2013, NEURON, V77, P219, DOI 10.1016/j.neuron.2013.01.002; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Koutsouleris N, 2014, SCHIZOPHRENIA BULL, V40, P1140, DOI 10.1093/schbul/sbt142; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liang HL, 2019, HUM BRAIN MAPP, V40, P3143, DOI 10.1002/hbm.24588; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mac Donald CL, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz031; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Merisaari H, 2019, NEUROIMAGE, V197, P598, DOI 10.1016/j.neuroimage.2019.04.067; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Savjani RR, 2017, J NEUROTRAUM, V34, P3107, DOI 10.1089/neu.2017.5022; Schnack HG, 2016, AM J PSYCHIAT, V173, P607, DOI 10.1176/appi.ajp.2015.15070922; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Wang J, 2019, P NATL ACAD SCI USA, V116, P21213, DOI 10.1073/pnas.1902376116; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; World Health Organization, 1992, ICD10 WHO, V67, P227	43	1	1	5	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2021	38	18					2549	2559		10.1089/neu.2020.7551		MAY 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	US2IV	WOS:000653097400001	33863259	Green Submitted			2022-02-06	
J	Liao, JF; Zhang, YS; Chen, XC; Zhang, J				Liao, Jiangfeng; Zhang, Yusi; Chen, Xiaochun; Zhang, Jing			The Roles of Peroxiredoxin 6 in Brain Diseases	MOLECULAR NEUROBIOLOGY			English	Article; Early Access						Peroxiredoxin 6; Neuropsychiatric disorders; Knockdown; Overexpression	PHOSPHOLIPASE A(2) ACTIVITY; LENS EPITHELIAL-CELLS; CEREBRAL ISCHEMIC-INJURY; PROTEOMIC ANALYSIS; ANTIOXIDANT ENZYME; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; UP-REGULATION; MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION	Peroxiredoxin 6 (PRDX6), the only mammalian 1-Cys member of the peroxiredoxins (PRDXs) family, has multiple functions of glutathione peroxidase (Gpx) activity, acidic calcium-independent phospholipase (aiPLA2) activity, and lysophosphatidylcholine acyl transferase (LPCAT) activity. It has been documented to be involved in redox homeostasis, phospholipid turnover, glycolipid metabolism, and cellular signaling. Here, we reviewed the characteristics of the available Prdx6 genetic mouse models and the research progresses made with regard to PRDX6 in neuropsychiatric disorders, including neurodegenerative diseases, brain aging, stroke, neurotrauma, gliomas, major depressive disorder, drug addiction, post-traumatic stress disorder, and schizophrenia. The present review highlights the important roles of PRDX6 in neuropsychiatric disorders and may provide novel insights for the development of effective pharmacological treatments and genetic therapies.	[Liao, Jiangfeng; Zhang, Yusi; Chen, Xiaochun; Zhang, Jing] Fujian Med Univ Union Hosp, Fujian Inst Geriatr, Dept Neurol, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China; [Liao, Jiangfeng; Zhang, Yusi; Chen, Xiaochun; Zhang, Jing] Fujian Med Univ, Inst Neurosci, Fujian Key Lab Mol Neurol, 88 Jiaotong Rd, Fuzhou 350005, Fujian, Peoples R China		Chen, XC; Zhang, J (corresponding author), Fujian Med Univ Union Hosp, Fujian Inst Geriatr, Dept Neurol, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China.; Chen, XC; Zhang, J (corresponding author), Fujian Med Univ, Inst Neurosci, Fujian Key Lab Mol Neurol, 88 Jiaotong Rd, Fuzhou 350005, Fujian, Peoples R China.	chen8c998@fjmu.edu.cn; drzj@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871068, 81671352, 91232709]; Joint Fund for Science and Technology Innovation of Fujian [2018Y9057]; Startup Fund for Scientific Research of Fujian Medical University [2019QH2014]	This work was supported by the National Natural Science Foundation of China to Prof. Xiaochun Chen (No. 81871068, No. 81671352, No. 91232709), Joint Fund for Science and Technology Innovation of Fujian to Prof. Jing Zhang (No. 2018Y9057), and Startup Fund for Scientific Research of Fujian Medical University (No. 2019QH2014) to Dr. Jiangfeng Liao.	Arevalo JA, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7120172; Arriga R, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9685607; Asuni AA, 2015, NEUROCHEM INT, V90, P152, DOI 10.1016/j.neuint.2015.08.006; Bettinger J, 2020, PRION, V14, P193, DOI 10.1080/19336896.2020.1796898; Bisgaard CF, 2012, J PSYCHOPHARMACOL, V26, P1569, DOI 10.1177/0269881112460110; Buonora JE, 2015, J NEUROTRAUM, V32, P1805, DOI 10.1089/neu.2014.3736; Buonora JE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00068; Chen WT, 2020, CELL, V182, P976, DOI 10.1016/j.cell.2020.06.038; Choi TM, 2016, J KOREAN NEUROSURG S, V59, P544, DOI 10.3340/jkns.2016.59.6.544; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; Correani V, 2015, MOL BIOSYST, V11, P1584, DOI 10.1039/c4mb00703d; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; Di Battista AP, 2018, J NEUROIMMUNOL, V319, P1, DOI 10.1016/j.jneuroim.2018.03.002; Di Battista AP, 2018, BRAIN INJURY, V32, P575, DOI 10.1080/02699052.2018.1432892; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Drummond E, 2017, ACTA NEUROPATHOL, V133, P933, DOI 10.1007/s00401-017-1691-0; Eismann T, 2009, AM J PHYSIOL-GASTR L, V296, pG266, DOI 10.1152/ajpgi.90583.2008; Elkharaz J, 2013, BBA-MOL BASIS DIS, V1832, P1930, DOI 10.1016/j.bbadis.2013.07.002; Farooqui AA, 1997, J NEUROCHEM, V69, P889; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Fatma N, 2005, CELL DEATH DIFFER, V12, P734, DOI 10.1038/sj.cdd.4401597; Fatma N, 2011, AM J PHYSIOL-CELL PH, V301, pC954, DOI 10.1152/ajpcell.00061.2011; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Fisher AB, 2018, J LIPID RES, V59, P1132, DOI 10.1194/jlr.R082578; Fisher AB, 2016, J LIPID RES, V57, P587, DOI 10.1194/jlr.M064758; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Flatscher-Bader T, 2008, ALCOHOL CLIN EXP RES, V32, P1849, DOI 10.1111/j.1530-0277.2008.00754.x; Gao L, 2005, J BIOL CHEM, V280, P39268, DOI 10.1074/jbc.M506116200; Goemaere J, 2012, J COMP NEUROL, V520, P258, DOI 10.1002/cne.22689; Gramage E, 2013, BEHAV BRAIN RES, V253, P223, DOI 10.1016/j.bbr.2013.07.026; Grassi S, 2020, J LIPID RES, V61, P636, DOI 10.1194/jlr.TR119000427; Gratuze M, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0298-9; Guadagno NA, 2017, NEUROBIOL DIS, V103, P32, DOI 10.1016/j.nbd.2017.03.010; Hofer T, 2018, NEUROTOX RES, V33, P824, DOI 10.1007/s12640-017-9833-7; Hwu HG, 2003, MOL PSYCHIATR, V8, P445, DOI 10.1038/sj.mp.4001235; Jia GW, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6597401; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Jo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091508; Kekesi KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050532; Kim IK, 2013, FREE RADICAL RES, V47, P836, DOI 10.3109/10715762.2013.833330; Kopacek J, 2000, J VIROL, V74, P411, DOI 10.1128/JVI.74.1.411-417.2000; Kovacs GG, 2018, HAND CLINIC, V145, P355, DOI 10.1016/B978-0-12-802395-2.00025-0; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; Krapfenbauer K, 2002, ELECTROPHORESIS, V23, P2541, DOI 10.1002/1522-2683(200208)23:15<2541::AID-ELPS2541>3.0.CO;2-1; Kuang X, 2014, FREE RADICAL BIO MED, V71, P165, DOI 10.1016/j.freeradbiomed.2014.03.028; Kubo E, 2010, AM J PHYSIOL-CELL PH, V298, pC342, DOI 10.1152/ajpcell.00336.2009; Kumin A, 2007, J CELL BIOL, V179, P747, DOI 10.1083/jcb.200706090; Kumin A, 2006, AM J PATHOL, V169, P1194, DOI 10.2353/ajpath.2006.060119; Lamoureux L, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700296; Li H, 2015, FREE RADICAL BIO MED, V87, P356, DOI 10.1016/j.freeradbiomed.2015.06.009; Li W, 2018, BIOCHEM BIOPH RES CO, V505, P898, DOI 10.1016/j.bbrc.2018.10.017; Li YC, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5408452; Liao JF, 2021, PHYSIOL BEHAV, V228, DOI 10.1016/j.physbeh.2020.113197; Liu DS, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0002-2; Lopez J, 2015, J NEUROSCI, V35, P2465, DOI 10.1523/JNEUROSCI.0735-14.2015; Lubec J, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00198; Ma SP, 2016, ANTIOXID REDOX SIGN, V24, P486, DOI 10.1089/ars.2015.6336; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Manevich Y, 2014, FREE RADICAL BIO MED, V72, P210, DOI 10.1016/j.freeradbiomed.2014.04.002; Maniatis S, 2019, SCIENCE, V364, P89, DOI 10.1126/science.aav9776; Martins-De-Souza D, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-17; McCann Heather, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS62, DOI 10.1016/S1353-8020(13)70017-8; McHugh PC, 2010, J PSYCHOPHARMACOL, V24, P1243, DOI 10.1177/0269881109102786; Melhem H, 2017, J CROHNS COLITIS, V11, P871, DOI 10.1093/ecco-jcc/jjx016; Mo YQ, 2003, FEBS LETT, V555, P192, DOI 10.1016/S0014-5793(03)01199-2; Moawad AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13411-2; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Odreman F, 2005, J PROTEOME RES, V4, P698, DOI 10.1021/pr0498180; Ozkosem B, 2015, REDOX BIOL, V5, P15, DOI 10.1016/j.redox.2015.02.004; Pacifici F, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040329; Pacifici F, 2019, ANTIOXID REDOX SIGN, V30, P399, DOI 10.1089/ars.2017.7427; Pacifici F, 2014, DIABETES, V63, P3210, DOI 10.2337/db14-0144; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Pan J, 2014, CURR MOL MED, V14, P1186, DOI 10.2174/1566524014666141021143333; Pankiewicz JE, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00401-8; Park CK, 2008, J CANCER RES CLIN, V134, P255, DOI 10.1007/s00432-007-0282-1; Park MH, 2017, THERANOSTICS, V7, P3624, DOI 10.7150/thno.21408; Patel P, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8030063; Phasuk S, 2021, MOL BRAIN, V14, DOI 10.1186/s13041-021-00754-1; Phelan SA, 2003, FREE RADICAL BIO MED, V35, P1110, DOI 10.1016/S0891-5849(03)00462-3; Power JHT, 2002, AM J PATHOL, V161, P885, DOI 10.1016/S0002-9440(10)64249-6; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Regier DA, 2013, WORLD PSYCHIATRY, V12, P92, DOI 10.1002/wps.20050; Rolfs F, 2013, CANCER RES, V73, P3460, DOI 10.1158/0008-5472.CAN-12-4369; Sanchez I, 2016, HUM MOL GENET, V25, P4021, DOI 10.1093/hmg/ddw242; Schattauer SS, 2019, J BIOL CHEM, V294, P16884, DOI 10.1074/jbc.RA119.009592; Schattauer SS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00791-2; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schmitt A, 2015, BIOCHEM J, V471, P267, DOI 10.1042/BJ20141204; Scialo C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030261; Seripa D, 2004, NEUROLOGY, V62, P1631, DOI 10.1212/01.WNL.0000125693.59817.31; Shanshan Y, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00099; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Shim SY, 2012, FREE RADICAL RES, V46, P231, DOI 10.3109/10715762.2011.649749; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sidyakin AA, 2018, J MOL NEUROSCI, V65, P28, DOI 10.1007/s12031-018-1064-8; Singh SP, 2016, AM J PHYSIOL-CELL PH, V310, pC1, DOI 10.1152/ajpcell.00229.2015; Sizova D, 2007, NEUROBIOL AGING, V28, P357, DOI 10.1016/j.neurobiolaging.2006.01.011; Slouzkey I, 2016, LEARN MEMORY, V23, P723, DOI 10.1101/lm.041806.116; Sorrell SL, 2016, KIDNEY INT, V89, P105, DOI 10.1038/ki.2015.277; Strey CW, 2004, AM J PATHOL, V165, P1701, DOI 10.1016/S0002-9440(10)63426-8; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Sundar IK, 2010, EXP LUNG RES, V36, P451, DOI 10.3109/01902141003754128; Sung JH, 2009, J PINEAL RES, V46, P300, DOI 10.1111/j.1600-079X.2008.00661.x; Tariq M, 2001, BRAIN RES BULL, V54, P77, DOI 10.1016/S0361-9230(00)00427-5; Tsai SY, 2012, SYNAPSE, V66, P42, DOI 10.1002/syn.20984; Vazquez-Medina JP, 2019, AM J PHYSIOL-LUNG C, V316, pL656, DOI 10.1152/ajplung.00344.2018; Vazquez-Medina JP, 2016, FASEB J, V30, P2885, DOI 10.1096/fj.201500146R; Vicente-Rodriguez M, 2015, CHEM RES TOXICOL, V28, P1443, DOI 10.1021/acs.chemrestox.5b00130; Vicente-Rodriguez M, 2013, TOXICOLOGY, V314, P166, DOI 10.1016/j.tox.2013.09.014; Wagner W, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-38; Wang XC, 2019, INT IMMUNOPHARMACOL, V68, P252, DOI 10.1016/j.intimp.2018.12.053; Wang XS, 2004, ATHEROSCLEROSIS, V177, P61, DOI 10.1016/j.atherosclerosis.2004.06.007; Wang XS, 2003, J BIOL CHEM, V278, P25179, DOI 10.1074/jbc.M302706200; Wang Y, 2006, ANTIOXID REDOX SIGN, V8, P229, DOI 10.1089/ars.2006.8.229; Wang Y, 2006, AM J RESP CELL MOL, V34, P481, DOI 10.1165/rcmb.2005-0333OC; Wang Y, 2008, J CELL BIOCHEM, V104, P1274, DOI 10.1002/jcb.21703; Yang D, 2011, CRIT CARE MED, V39, P756, DOI 10.1097/CCM.0b013e318206befd; Yata K, 2011, BRAIN RES, V1410, P12, DOI 10.1016/j.brainres.2011.06.064; Yeo IJ, 2019, MOL NEUROBIOL, V56, P3132, DOI 10.1007/s12035-018-1287-2; Yu SS, 2013, NEUROCHEM RES, V38, P1501, DOI 10.1007/s11064-013-1052-x; Yun HM, 2016, MOL NEUROBIOL, V53, P2409, DOI 10.1007/s12035-015-9208-0; Yun HM, 2015, MOL NEUROBIOL, V52, P422, DOI 10.1007/s12035-014-8885-4; Yun HM, 2013, MOL NEUROBIOL, V48, P941, DOI 10.1007/s12035-013-8479-6; Zhang J, 2019, FASEB J, V33, P7748, DOI 10.1096/fj.201802718R; Zhang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep08486; Zhang XX, 2020, AGING-US, V12, P11139, DOI 10.18632/aging.103328; Zhang X, 2013, NEUROBIOL LEARN MEM, V101, P46, DOI 10.1016/j.nlm.2013.01.002; Zhou Jinqiao, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P1255; Zhu DH, 2006, J NEUROSCI, V26, P11111, DOI 10.1523/JNEUROSCI.3505-06.2006	131	1	1	5	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.												10.1007/s12035-021-02427-5		MAY 2021	17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SE6FK	WOS:000652165900002	34013449				2022-02-06	
J	Bradshaw, DV; Knutsen, AK; Korotcov, A; Sullivan, GM; Radomski, KL; Dardzinski, BJ; Zi, XM; McDaniel, DP; Armstrong, RC				Bradshaw, Donald V.; Knutsen, Andrew K.; Korotcov, Alexandru; Sullivan, Genevieve M.; Radomski, Kryslaine L.; Dardzinski, Bernard J.; Zi, Xiaomei; McDaniel, Dennis P.; Armstrong, Regina C.			Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Chronic traumatic brain injury; SARM1; Sterile alpha and Toll; interleukin-1 receptor containing motif 1; White matter; Corpus callosum atrophy; Magnetic resonance imaging	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; WHITE-MATTER DEGENERATION; CORPUS-CALLOSUM; WALLERIAN DEGENERATION; MILD; DEMYELINATION; DAMAGE; NEURODEGENERATION; INFLAMMATION; ACTIVATION	Traumatic brain injury (TBI) causes chronic symptoms and increased risk of neurodegeneration. Axons in white matter tracts, such as the corpus callosum (CC), are critical components of neural circuits and particularly vulnerable to TBI. Treatments are needed to protect axons from traumatic injury and mitigate post-traumatic neurodegeneration. SARM1 protein is a central driver of axon degeneration through a conserved molecular pathway. Sarm1-/- mice with knockout (KO) of the Sarm1 gene enable genetic proof-of-concept testing of the SARM1 pathway as a therapeutic target. We evaluated Sarm1 deletion effects after TBI using a concussive model that causes traumatic axonal injury and progresses to CC atrophy at 10 weeks, indicating post-traumatic neurodegeneration. Sarm1 wild-type (WT) mice developed significant CC atrophy that was reduced in Sarm1 KO mice. Ultrastructural classification of pathology of individual axons, using electron microscopy, demonstrated that Sarm1 KO preserved more intact axons and reduced damaged or demyelinated axons. Longitudinal MRI studies in live mice identified significantly reduced CC volume after TBI in Sarm1 WT mice that was attenuated in Sarm1 KO mice. MR diffusion tensor imaging detected reduced fractional anisotropy in both genotypes while axial diffusivity remained higher in Sarm1 KO mice. Immunohistochemistry revealed significant attenuation of CC atrophy, myelin loss, and neuroinflammation in Sarm1 KO mice after TBI. Functionally, Sarm1 KO mice exhibited beneficial effects in motor learning and sleep behavior. Based on these findings, Sarm1 inactivation can protect axons and white matter tracts to improve translational outcomes associated with CC atrophy and post-traumatic neurodegeneration.	[Bradshaw, Donald V.; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Grad Program Neurosci, Bethesda, MD 20814 USA; [Bradshaw, Donald V.; Sullivan, Genevieve M.; Radomski, Kryslaine L.; Zi, Xiaomei; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Knutsen, Andrew K.; Korotcov, Alexandru; Dardzinski, Bernard J.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Radiol & Radiol Sci, Bethesda, MD 20814 USA; [Knutsen, Andrew K.; Korotcov, Alexandru; Radomski, Kryslaine L.; Dardzinski, Bernard J.; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [McDaniel, Dennis P.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Biomed Instrumentat Ctr, Bethesda, MD 20814 USA; [Dardzinski, Bernard J.] NIH, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA		Armstrong, RC (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	regina.armstrong@usuhs.edu		Armstrong, Regina/0000-0001-7296-6750	U.S. Department of DefenseUnited States Department of Defense; Uniformed Services University through the UCSF-USUHS Partnership: Brain Injury and Disease Prevention, Treatment, and Research; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense	These studies were funded by the U.S. Department of Defense and the Uniformed Services University through the UCSF-USUHS Partnership: Brain Injury and Disease Prevention, Treatment, and Research and the Center for Neuroscience and Regenerative Medicine.	Alawieh A, 2021, J NEUROSCI, V41, P1830, DOI 10.1523/JNEUROSCI.1734-20.2020; Altendahl M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235395; Anderson RJ, 2019, NEUROINFORMATICS, V17, P451, DOI 10.1007/s12021-018-9410-0; Andravizou A, 2019, AUTOIMMUN HIGHLIGHTS, V10, DOI 10.1186/s13317-019-0117-5; Armstrong RC, 2006, J NEUROPATH EXP NEUR, V65, P245, DOI 10.1097/01.jnen.0000205142.08716.7e; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Badea A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216596; Benjamini D, 2021, BRAIN, V144, P800, DOI 10.1093/brain/awaa447; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bratkowski M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107999; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chen YH, 2021, EXP NEUROL, V339, DOI 10.1016/j.expneurol.2021.113636; Cole JH, 2018, CLIN INFECT DIS, V66, P1899, DOI 10.1093/cid/cix1124; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Ferrazzano P, 2021, J NEUROTRAUM, V38, P1799, DOI 10.1089/neu.2019.6918; Figley MD, 2021, NEURON, V109, DOI 10.1016/j.neuron.2021.02.009; Figley MD, 2020, CURR OPIN NEUROBIOL, V63, P59, DOI 10.1016/j.conb.2020.02.012; Geisler S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129920; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gilley J, 2015, CELL REP, V10, P1974, DOI 10.1016/j.celrep.2015.02.060; Graham NSN, 2020, BRAIN, V143, P3685, DOI 10.1093/brain/awaa316; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Gu YZ, 2017, J CELL BIOL, V216, P2179, DOI 10.1083/jcb.201606065; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hibbits N, 2009, ASN NEURO, V1, DOI 10.1042/AN20090032; Hughes RO, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108588; Jang SH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017467; Jiang YF, 2020, NATURE, V588, P658, DOI 10.1038/s41586-020-2862-z; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Juengst SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01210; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Ko KW, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201912047; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kwiecien JM, 2021, CURR NEUROPHARMACOL, V19, P1191, DOI 10.2174/1570159X19666210125153308; Leconte C, 2020, J NEUROTRAUM, V37, P1342, DOI 10.1089/neu.2019.6679; Loreto A, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104678; Loring HS, 2020, CELL CHEM BIOL, V27, P1, DOI 10.1016/j.chembiol.2019.11.002; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mang GM, 2014, SLEEP, V37, P1383, DOI 10.5665/sleep.3936; Marion CM, 2019, EXP NEUROL, V321, DOI 10.1016/j.expneurol.2019.113040; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Martini DN, 2021, J NEUROTRAUM, V38, P218, DOI 10.1089/neu.2020.6986; Maxwell WL, 2015, J NEUROTRAUM, V32, P780, DOI 10.1089/neu.2014.3369; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Maynard ME, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113207; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mierzwa AJ, 2013, NEUROSCI LETT, V548, P280, DOI 10.1016/j.neulet.2013.05.010; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Mustafa Okan Irfanoglu AN, 2018, ISMRM 25 ANN M CIT; Nedergaard M, 2020, SCIENCE, V370, P50, DOI 10.1126/science.abb8739; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Nolan AL, 2021, J NEUROTRAUM, V38, P1620, DOI 10.1089/neu.2020.7373; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Pierpaoli CWL, 2010, ISMRM 18 ANN M CIT; Rabinowitz AR, 2019, J INT NEUROPSYCH SOC, V25, P998, DOI 10.1017/S1355617718000346; Roseborough A, 2020, JAMA NEUROL, V77, P793, DOI 10.1001/jamaneurol.2020.0814; Roy S, 2017, NEUROIMAGE, V146, P132, DOI 10.1016/j.neuroimage.2016.11.017; Saksvik SB, 2020, J NEUROTRAUM, V37, P2528, DOI 10.1089/neu.2019.6898; Shen C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023151118; Simon DJ, 2018, CURR OPIN NEUROL, V31, P693, DOI 10.1097/WCO.0000000000000621; Smith DH, 2020, NAT REV NEUROL, V16, P457, DOI 10.1038/s41582-020-0382-y; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sporny M, 2020, ELIFE, V9, DOI 10.7554/eLife.62021; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Sullivan GM, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00960-3; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Summers DW, 2016, P NATL ACAD SCI USA, V113, pE6271, DOI 10.1073/pnas.1601506113; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Tian WL, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0776-9; Tobin JE, 2011, J NEUROPATH EXP NEUR, V70, P157, DOI 10.1097/NEN.0b013e31820937e4; Uccellini MB, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.062; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; VIAL JD, 1958, J BIOPHYS BIOCHEM CY, V4, P551, DOI 10.1083/jcb.4.5.551; Wang XJ, 2014, NMR BIOMED, V27, P843, DOI 10.1002/nbm.3129; Williams PR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6683; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Yaghouby F, 2016, J NEUROSCI METH, V259, P90, DOI 10.1016/j.jneumeth.2015.11.004; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	96	1	1	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	MAY 17	2021	9	1							89	10.1186/s40478-021-01193-8			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SM6WQ	WOS:000657743500002	34001261	Green Submitted, Green Published, gold			2022-02-06	
J	Shi, J; Teng, J; Du, XP; Li, N				Shi, Jian; Teng, Jing; Du, Xianping; Li, Na			Multi-Modal Analysis of Resting-State fMRI Data in mTBI Patients and Association With Neuropsychological Outcomes	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; rs-fMRI; neurological disorders; regional homogeneity; clinical and imaging assessment; multi-modal analysis	TRAUMATIC BRAIN-INJURY; NETWORK; CONNECTIVITY; DISEASE	Various cognitive disorders have been reported for mild traumatic brain injury (mTBI) patients during the acute stage. This acute stage provides an opportunity for clinicians to optimize treatment protocols, which are based on the evaluation of brain structural connectivity. So far, most brain functional magnetic resonance imaging studies are focused on moderate to severe traumatic brain injuries (TBIs). In this study, we prospectively collected resting state data on 50 mTBI within 3 days of injury and 50 healthy volunteers and analyzed them using Amplitude of low-frequency fluctuation (ALFF), Regional Homogeneity (ReHo), graph theory methods and behavior measure, to explore the dysfunctional brain regions in acute mTBI. In our study, a total of 50 patients suffering <3 days mTBI and 50 healthy subjects were tested in rs-fMRI, as well as under neuropsychological examinations including the Wechsler Intelligence Scale and Stroop Color and Word Test. The correlation analysis was conducted between graph theoretic parameters and neuropsychological results. For the mTBI group, the ReHo of the inferior temporal gyrus and the cerebellum superior are significantly lower than in the control group, and the ALFF of the left insula, the cerebellum inferior, and the middle occipital gyrus were significantly higher than in the control group, which implies the dysfunctionality usually observed in Parkinson's disease. Executive function disorder was significantly correlated with the global efficiencies of the dorsolateral superior frontal gyrus and the anterior cingulate cortex, which is consistent with the literature: the acute mTBI patients demonstrate abnormality in terms of motor speed, association, information processing speed, attention, and short-term memory function. Correlation analysis between the neuropsychological outcomes and the network efficiency for the mTBI group indicates that executive dysfunction might be caused by local brain changes. Our data support the idea that the cerebral internal network has compensatory reactions in response to sudden pathological and neurophysiological changes. In the future, multimode rs-fMRI analysis could be a valuable tool for evaluating dysfunctional brain regions after mTBI.	[Shi, Jian] Cent South Univ, Xiangya Hosp 3, Dept Spine Surgury, Changsha, Peoples R China; [Teng, Jing] North China Elect Power Univ, Sch Control & Comp Engn, Beijing, Peoples R China; [Du, Xianping] Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ USA; [Li, Na] Cent South Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Peoples R China		Li, N (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Peoples R China.	lina2864@csu.edu.cn	TENG, Jing/AAX-3835-2020	TENG, Jing/0000-0001-9438-9683	National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61871181]; Excellent Postdoctoral Program for Innovative Talent of Hunan [2020RC2015]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2020TQ0364]; Natural Science Foundation of HunanNatural Science Foundation of Hunan Province [2020JJ5865]	This research was funded by the National Nature Science Foundation of China (Grant No. 61871181), the Excellent Postdoctoral Program for Innovative Talent of Hunan (2020RC2015), the China Postdoctoral Science Foundation (2020TQ0364), and the Natural Science Foundation of Hunan (2020JJ5865).	Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Cao J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082477; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; de Reus MA, 2013, NEUROIMAGE, V70, P402, DOI 10.1016/j.neuroimage.2012.12.066; Doose A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040900; Guise BJ, 2014, J NEUROPSYCHOL, V8, P20, DOI 10.1111/jnp.12002; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Langer N, 2012, HUM BRAIN MAPP, V33, P1393, DOI 10.1002/hbm.21297; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Misic B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111007; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Raizman R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65948-4; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wechsler D., 2014, WECHSLER ADULT INTEL, Vfourth; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Yi H., 2014, THESIS CENTRAL S U C; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	32	1	1	5	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 17	2021	12								639760	10.3389/fneur.2021.639760			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SK3QC	WOS:000656132400001	34079510	Green Published, gold			2022-02-06	
J	Khatib, A; Post, A; Hoshizaki, T; Gilchrist, MD				Khatib, Ali; Post, Andrew; Hoshizaki, Thomas; Gilchrist, Michael D.			Brain trauma characteristics for lightweight and heavyweight fighters in professional mixed martial arts	SPORTS BIOMECHANICS			English	Article; Early Access						Chronic traumatic brain injury; concussion; video analysis	DIFFUSE AXONAL INJURY; HEAD TRAUMA; WHITE-MATTER; CONCUSSION; ENCEPHALOPATHY; BIOMECHANICS; SPEED; PREDICTORS; FOOTBALL; SEGMENTS	Mixed martial arts (MMA) is a sport where the fighters are at high risk of brain trauma, with characteristics, such as the frequency, magnitude, and interval of head impacts influencing the risk of developing short- and long-term negative brain health outcomes. These characteristics may be influenced by weight class as they may have unique fighting styles. The purpose of this research was to compare frequency, magnitude, and interval of head impacts between lightweight and heavyweight fighters in professional MMA. Frequency, interval, event type, velocity, and location of head impacts were documented for 60 fighters from 15 Lightweight and 15 Heavyweight professional MMA fights. Head impact reconstructions of these events were performed using physical and finite element modelling methods to determine the strain in the brain tissues. The results found that LW and HW fighters sustained similar head impact frequencies and intervals. The LW fighters sustained a significantly higher frequency of very low and high magnitude impacts to the head from punches; HW a larger frequency of high category strains from elbow strikes. These brain trauma profiles reflect different fight strategies and may inform methods to manage and mitigate the long-term effects of repetitive impacts to the head.	[Khatib, Ali; Post, Andrew] Univ Ottawa, Dept Human Kinet, Ottawa, ON, Canada; [Hoshizaki, Thomas] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Ottawa, Dept Human Kinet, Ottawa, ON, Canada.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552			Adanty K, 2020, INT J CRASHWORTHINES, V25, P648, DOI 10.1080/13588265.2019.1628479; ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Chen W, 2020, STRUCT CONCRETE, DOI 10.1002/suco.201900389; Chinnasee C., 2006, J PHYS C SERIES, V1020, P1, DOI [10.1088/1742-6596/1020/1/012006/pdf, DOI 10.1088/1742-6596/1020/1/012006/PDF]; Cournoyer J, 2019, HEAD IMPACT SEVERITY; Cournoyer J, 2019, CLIN BIOMECH, V67, P96, DOI 10.1016/j.clinbiomech.2019.05.003; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Fogarty AE, 2019, AM J PHYS MED REHAB, V98, P859, DOI 10.1097/PHM.0000000000001205; Follmer B, 2020, PHYSICIAN SPORTSMED, V48, P417, DOI 10.1080/00913847.2020.1729668; Follmer B, 2019, SPORTS HEALTH, V11, P280, DOI 10.1177/1941738119827966; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Gavagan CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182645; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gennarelli T.A, 2015, CENTRIPETAL THEORY C; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gilchrist, 2016, TRAUM BRAIN INJ CLIN; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Ignacy T., 2017, BIOMECHANICS INJURY; Jordan Barry D, 2014, Continuum (Minneap Minn), V20, P1588, DOI 10.1212/01.CON.0000458972.94013.e1; Karton C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54874-9; Karton C, 2018, HAND CLINIC, V158, P39, DOI 10.1016/B978-0-444-63954-7.00005-7; Kendall M., 2016, COMP CHARACTERIZATIO; Khatib A., 2019, COMP BRAIN TRAUMA CH; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kotrlik J.W., 2011, J AGR ED, V52, P132, DOI [10.5032/jae.2011.01132, DOI 10.5032/JAE.2011.01132]; Lockwood J, 2018, TRAUMA, V20, P245, DOI 10.1177/1460408617740902; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lystad RP, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518492; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McGill SM, 2010, J STRENGTH COND RES, V24, P348, DOI 10.1519/JSC.0b013e3181cc23d5; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Miarka B, 2017, HUM MOVEMENT SCI, V55, P73, DOI 10.1016/j.humov.2017.07.009; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Nakano G, 2014, J SPORT SCI, V32, P517, DOI 10.1080/02640414.2013.843014; Neto OP, 2007, J APPL BIOMECH, V23, P139, DOI 10.1123/jab.23.2.139; Ngai KM, 2008, BRIT J SPORT MED, V42, P686, DOI 10.1136/bjsm.2007.044891; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Post A., 2019, 42 CAN MED BIOL ENG; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; SAE, 2014, INSTRUMENTATION IMPA, V211; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Sidthilaw, 1996, KINETIC KINEMATIC AN; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Smith P.K, 1986, INT S BIOM SPORTS; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stojsih S., 2010, BIOMECHANICS AMATEUR; Toninato J, 2018, CONT CLIN TRIAL COMM, V11, P102, DOI 10.1016/j.conctc.2018.06.007; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Weber K.M., 2020, CONCUSSION MANAGEMEN, P145; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Zanetti K., 2013, IDENTIFYING RISK PRO; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	70	1	1	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.												10.1080/14763141.2021.1922740		MAY 2021	23	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	SE5YM	WOS:000652147700001	34011240				2022-02-06	
J	Mansour, G; Barsky, D; Abuhasira, S; Ben-David, E; Cohen, J; Margalit, N; Hazon, D; Rajz, G				Mansour, Ghassan; Barsky, Daniel; Abuhasira, Shlomi; Ben-David, Eliel; Cohen, Jose; Margalit, Nevo; Hazon, David; Rajz, Gustavo			Traumatic cerebral dural sinus vein thrombosis/stenosis in pediatric patients-is anticoagulation necessary?	CHILDS NERVOUS SYSTEM			English	Article						Cerebral dural vein thrombosis; stenosis (CDVT; S); Traumatic brain injury; Anticoagulation	SKULL FRACTURES; HEAD-INJURY; COMPRESSION	Introduction Cerebral dural vein thrombosis/stenosis (CDVT/S) is a condition that affects the venous drainage of the brain. Risk factors and causes associated with CDVT/S include systemic risk factors that cause hypercoagulability, or local factors such as head trauma. While consensus is that non-traumatic sinus vein thrombosis should be treated with anticoagulation therapy, treatment of patients with TBI-induced CDVT is not yet established. Methods Retrospective review of clinical data of pediatric patients presented to our medical center from July 2017 to August 2020. Inclusion criteria were age, birth to 18 years, admission due to head trauma, head CT scan with positive traumatic findings, and follow-up in our clinic. Exclusion criteria were a normal head CT on admission and failure to follow-up. Data regarding demographics, clinical presentation, imaging findings, treatment, and status on follow-up were recorded. Study protocol was approved by our institutional ethics committee. Results One hundred sixty-two patients were enrolled. Falling accident occurred in 90.1%, a minority suffered from direct head trauma or gunshot wound. Of the patients, 95.1% suffered from mild TBI. Forty-two percent suffered from an associated intracranial injury. Fourteen cases with CDVT were included in the cohort. Linear fractures were significantly correlated with CDVT. Additionally, occipital/suboccipital fractures, associated intracranial injury, and proximity of injury to the sinus were correlated with CDVT. From this group, 12 were treated conservatively; one patient was treated surgically due to EDH. All patients with CDVT were neurologically intact at discharge. Only one patient was treated with therapeutic dose of LMWH. A total of 86.7% of patients with CDVT who were treated conservatively had full recanalization on follow-up imaging. Four patients had CDVS; all were neurologically intact at admission and discharge, and all were treated conservatively and had full recanalization on follow-up. Discussion Treatment with ACT is established in pediatric CDVT but not in the sub-group of TBI. While ACT prevents progression of thrombosis, it might cause worsening of extra-axial hemorrhage. In our study, no clinical deterioration was noted with expectant management; thus, we present an algorithm for diagnosis and treatment of trauma-induced CDVT/S in children with frequent clinical and radiologic imaging while avoiding anticoagulation. Conclusion In most cases, anticoagulation therapy is not necessary in traumatic CDVT/S. Initial expectant management in children is safe. However, each case should be evaluated individually and further studies should be performed.	[Mansour, Ghassan; Barsky, Daniel; Abuhasira, Shlomi; Ben-David, Eliel; Cohen, Jose; Margalit, Nevo; Rajz, Gustavo] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel; [Mansour, Ghassan; Barsky, Daniel; Margalit, Nevo; Rajz, Gustavo] Shaare Zedek Med Ctr, Dept Neurosurg, Jerusalem, Israel; [Ben-David, Eliel] Shaare Zedek Med Ctr, Dept Radiol, Jerusalem, Israel; [Cohen, Jose] Hadassah Med Ctr, Dept Neurosurg, Jerusalem, Israel; [Hazon, David] Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada		Rajz, G (corresponding author), Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel.; Rajz, G (corresponding author), Shaare Zedek Med Ctr, Dept Neurosurg, Jerusalem, Israel.	rajzgustavo@hotmail.com	Ben-David, Eliel/H-2296-2015	Ben-David, Eliel/0000-0001-7548-5725			Bokhari R, 2020, WORLD NEUROSURG, V142, P495, DOI 10.1016/j.wneu.2020.06.117; Capecchi M, 2018, J THROMB HAEMOST, V16, P1918, DOI 10.1111/jth.14210; Cohen JE, 2009, ISR MED ASSOC J, V11, P685; Coutinho JM, 2015, J THROMB HAEMOST, V13, pS238, DOI 10.1111/jth.12945; de Freitas Gabriel R, 2008, Front Neurol Neurosci, V23, P23; Giladi O, 2016, THROMB RES, V137, P26, DOI 10.1016/j.thromres.2015.11.035; Hejrati N, 2020, CHILD NERV SYST, V36, P251, DOI 10.1007/s00381-019-04482-9; Hersh DS, 2018, J NEUROSURG-PEDIATR, V21, P258, DOI 10.3171/2017.9.PEDS17311; Javed I, 2018, JCPSP-J COLL PHYSICI, V28, P390, DOI 10.29271/jcpsp.2018.05.390; Klingebiel R, 2007, EUR J NEUROL, V14, P139, DOI 10.1111/j.1468-1331.2006.01574.x; Leach JL, 2006, RADIOGRAPHICS, V26, pS19, DOI 10.1148/rg.26si055174; Martinelli I, 2012, INTERN EMERG MED, V7, pS221, DOI 10.1007/s11739-012-0806-9; Pikis S, 2013, J CLIN NEUROSCI, V20, P481, DOI 10.1016/j.jocn.2012.09.009; Singh S, 2016, PEDIATR RADIOL, V46, P67, DOI 10.1007/s00247-015-3458-x; Xavier F, 2014, PEDIATR BLOOD CANCER, V61, P2037, DOI 10.1002/pbc.25168; Zhao X, 2008, J NEUROTRAUM, V25, P104, DOI 10.1089/neu.2007.0351; Zuurbier SM, 2017, ADV EXP MED BIOL, V906, P183, DOI 10.1007/5584_2016_115	17	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	SEP	2021	37	9					2847	2855		10.1007/s00381-021-05204-w		MAY 2021	9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	UM8VT	WOS:000650554600002	33990877				2022-02-06	
J	Rogatzki, MJ; Morgan, JE; Baker, JS; Knox, A; Serrador, JM				Rogatzki, Matthew J.; Morgan, Jessica E.; Baker, Julien S.; Knox, Allan; Serrador, Jorge M.			Protein S100B and Brain Lipid-Binding Protein Concentrations in the Serum of Recently Concussed Rugby Players	JOURNAL OF NEUROTRAUMA			English	Article						brain-lipid binding protein; protein S100B; sports-related concussion	NEURON-SPECIFIC ENOLASE; BLOOD BIOMARKERS; ICE HOCKEY; BIOCHEMICAL MARKERS; NEUROFILAMENT LIGHT; ELITE PLAYERS; DAMAGE S-100B; INJURY; INCREASES; HEAD	The purpose of this study was to test the ability of serum protein S100B (S100B) and brain lipid-binding protein (BLBP) to identify athletes who sustained a sports-related concussion (SRC). Subjects included a non-athlete group, whereas the rugby players were separated into two match-control and two SRC groups. The match-control <1-h group included players undergoing venipuncture within 60-min post-match, and the match-control >1-h/<8-h group included players undergoing venipuncture between 1 and 8 h post-match; the SRC <1-h group included players undergoing venipuncture within 60-min post-SRC, and the SRC >1-h/<8-h group included players undergoing venipuncture between 1 and 8 h post-SRC. Serum S100B concentrations were not significantly different (p = 0.112) among protocols. Serum BLBP was greater in the match-control <1-h group (p < 0.001) and the SRC >1-h/<8-h group (p = 0.003) compared to the non-athlete group. The ability of serum BLBP to distinguish between SRC groups and the non-athlete group was shown to be good to excellent (AUROC, >0.8; p < 0.05), and between match-control groups and the non-athlete group were shown to be excellent (AUROC, >0.9; p < 0.05). Our results show that serum S100B is not useful in distinguishing concussed or post-match athletes from non-athletes. However, serum BLBP was shown to distinguish non-athletes from post-match or concussed athletes. Serum BLBP could not distinguish between athletes experiencing an SRC within 1 h of blood draw and those participating in a contact sport.	[Rogatzki, Matthew J.; Morgan, Jessica E.] Appalachian State Univ, Dept Hlth & Exercise Sci, Boone, NC 28608 USA; [Baker, Julien S.] Hong Kong Baptist Univ, Ctr Hlth & Exercise Sci Res, Kowloon Tong, Hong Kong, Peoples R China; [Knox, Allan] Calif Lutheran Univ, Exercise Sci Dept, Thousand Oaks, CA USA; [Serrador, Jorge M.] War Related Illness & Injury Study Ctr, Dept Veteran Affairs, E Orange, NJ USA; [Serrador, Jorge M.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA		Rogatzki, MJ (corresponding author), Leon Levine Hall Hlth Sci, Dept Hlth & Exercise Sci, 435,1179 State Farm Rd, Boone, NC 28608 USA.	rogatzkimj@appstate.edu			Beaver College of Health Sciences Summer Scholarly Support Program, Appalachian State University (Boone, NC)	The Beaver College of Health Sciences Summer Scholarly Support Program, Appalachian State University (Boone, NC).	Stocchero CMA, 2014, APPL PHYSIOL NUTR ME, V39, P340, DOI 10.1139/apnm-2013-0308; Asken BM, 2018, NEUROLOGY, V91, pE2133, DOI 10.1212/WNL.0000000000006617; Bouvier D, 2017, SPORTS MED, V47, P781, DOI 10.1007/s40279-016-0579-9; Di Battista AP, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01367; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; Graham MR, 2015, INT J IMMUNOPATH PH, V28, P539, DOI 10.1177/0394632015577045; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Meier TB, 2020, ANN NEUROL, V87, P907, DOI 10.1002/ana.25725; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; O'Connell B, 2018, BRAIN INJURY, V32, P1811, DOI 10.1080/02699052.2018.1532112; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Rogatzki MJ, 2018, SCAND J MED SCI SPOR, V28, P2505, DOI 10.1111/sms.13297; Rogatzki MJ, 2016, INT J IMMUNOPATH PH, V29, P450, DOI 10.1177/0394632016657091; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2015, BRAIN INJURY, V29, P872, DOI 10.3109/02699052.2015.1018324; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Straume-Naesheim TM, 2008, NEUROSURGERY, V62, P1297, DOI 10.1227/01.neu.0000333301.34189.3d; Zonner SW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00327	32	1	1	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2021	38	16					2247	2254		10.1089/neu.2021.0004		MAY 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TY0QY	WOS:000650331500001	33779297				2022-02-06	
J	Sarmiento, K; Haileyesus, T; Waltzman, D; Daugherty, J				Sarmiento, Kelly; Haileyesus, Tadesse; Waltzman, Dana; Daugherty, Jill			Emergency Department Visits for Bicycle-Related Traumatic Brain Injuries Among Children and Adults - United States, 2009-2018	MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT			English	Article									[Sarmiento, Kelly; Haileyesus, Tadesse; Waltzman, Dana; Daugherty, Jill] CDC, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA		Sarmiento, K (corresponding author), CDC, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	KSarmiento@cdc.gov					Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; CDC, 2018, C MAN TRAUIM BRAIN I; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Hoye A, 2018, ACCIDENT ANAL PREV, V120, P239, DOI 10.1016/j.aap.2018.08.001; Huybers S, 2017, J COMMUN HEALTH, V42, P83, DOI 10.1007/s10900-016-0233-3; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; National Highway Traffic Safety Administration, 2018, TRAFF SAF FACTS; Schneider RJ, 2017, ACCIDENT ANAL PREV, V106, P82, DOI 10.1016/j.aap.2017.04.018; Smith J, 2018, INJURY PREV, V24, pI52, DOI 10.1136/injuryprev-2017-042651; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972	10	1	1	0	0	CENTERS  DISEASE CONTROL & PREVENTION	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	0149-2195	1545-861X		MMWR-MORBID MORTAL W	MMWR-Morb. Mortal. Wkly. Rep.	MAY 14	2021	70	19					693	697		10.15585/mmwr.mm7019a1			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	SM0NX	WOS:000657310800001	33988186	Green Published, gold			2022-02-06	
